data_1e09_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1e09 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 74.9 t -104.02 135.91 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 110.241 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.637 ' CE1' ' CD1' ' A' ' 128' ' ' ILE . 12.6 m-85 -93.62 150.5 20.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 109.989 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.425 HG21 ' CE1' ' A' ' 119' ' ' HIS . 8.4 m -129.08 113.11 14.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.562 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 67.6 m-85 -127.44 136.73 52.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.87 . . . . 0.0 109.76 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 16.3 pt-20 -138.31 153.78 49.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 0.0 110.707 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.2 m -132.81 144.48 50.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.408 -0.808 . . . . 0.0 109.645 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -130.35 127.3 39.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.059 -1.026 . . . . 0.0 110.627 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.631 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.3 p90 -155.07 -171.52 3.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.815 . . . . 0.0 109.974 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.472 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 6.7 p -142.84 174.01 11.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.338 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.466 ' OG ' ' OE2' ' A' ' 148' ' ' GLU . 79.7 p -151.57 148.28 27.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.244 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -74.13 -6.12 45.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.132 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 2.7 mp -95.9 150.15 36.94 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.029 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 42.2 Cg_endo -67.41 143.88 65.31 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.107 1.583 . . . . 0.0 110.89 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.647 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.1 Cg_endo -71.31 -31.49 14.13 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 124.115 1.587 . . . . 0.0 112.698 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 39.5 Cg_endo -67.4 -21.05 47.62 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 N-CA-C 110.098 -0.77 . . . . 0.0 110.098 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.524 ' NE ' ' HA ' ' A' ' 159' ' ' ASN . 9.1 mmp_? -85.17 -46.18 11.33 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.507 ' HG ' ' CG2' ' A' ' 147' ' ' ILE . 1.2 tt -69.03 -28.18 66.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.622 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 68.9 t80 -69.27 -53.53 19.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.707 . . . . 0.0 109.818 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.487 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 45.8 mttp -57.28 -29.87 64.23 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.993 0.901 . . . . 0.0 108.899 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.684 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -77.7 -63.63 1.34 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.681 0.753 . . . . 0.0 111.269 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -56.28 -39.63 72.97 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.689 -0.632 . . . . 0.0 111.947 -178.151 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.585 ' CG1' ' CD1' ' A' ' 74' ' ' ILE . 15.7 t -102.13 -65.86 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.791 -1.193 . . . . 0.0 111.631 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 7.0 mp -64.9 -6.08 7.55 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.227 -0.921 . . . . 0.0 111.25 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.497 ' OD2' ' CD1' ' A' ' 158' ' ' TYR . 1.1 m-20 -146.47 24.41 1.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.862 -1.149 . . . . 0.0 110.49 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -57.46 -38.36 74.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.041 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.408 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 86.0 m-20 -67.66 -12.86 61.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 110.191 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.525 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 83.9 m-20 -125.18 -3.79 7.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.457 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.532 HD13 ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -85.98 -52.31 5.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.023 . . . . 0.0 110.394 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 14.7 t -63.3 -41.02 65.61 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.791 . . . . 0.0 111.193 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.7 Cg_endo -77.23 7.37 3.75 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.333 1.175 . . . . 0.0 111.021 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 69.9 mmtt -122.35 -23.64 5.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.095 -1.003 . . . . 0.0 109.724 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.57 HG12 ' CD1' ' A' ' 150' ' ' TYR . 8.0 mt -80.01 -56.27 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.495 -0.753 . . . . 0.0 109.773 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.52 106.27 2.56 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.46 -0.775 . . . . 0.0 110.02 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.03 0.53 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.069 1.563 . . . . 0.0 110.726 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -83.77 -11.81 56.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.149 -0.97 . . . . 0.0 109.708 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.67 -51.43 3.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.382 -0.824 . . . . 0.0 110.278 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.58 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 1.3 mt -122.24 147.64 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 110.25 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.513 ' N ' HG21 ' A' ' 38' ' ' ILE . 20.3 ttmm -80.13 -43.9 20.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.192 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.544 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -177.42 161.38 1.75 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.148 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.408 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 27.2 m -119.41 128.73 54.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 53.9 tt0 -133.48 111.53 10.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 43.0 mt -62.98 132.92 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 110.195 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.69 -43.14 7.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.877 . . . . 0.0 110.339 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 52' ' ' THR . 6.9 mt-10 -130.76 150.08 52.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.369 -0.832 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 76.92 -164.04 52.77 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 60.6 t0 -138.52 19.82 2.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -1.183 . . . . 0.0 110.312 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.23 -5.68 15.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -92.26 -165.93 39.1 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HA ' HG21 ' A' ' 71' ' ' ILE . 43.2 Cg_endo -69.77 134.1 27.14 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.046 1.551 . . . . 0.0 110.486 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.32 -6.89 68.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 30.4 m -79.95 136.16 36.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -1.145 . . . . 0.0 110.158 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.518 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 23.7 mm -107.18 113.25 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 110.267 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 77.7 mttt -98.28 148.2 23.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.4 -0.813 . . . . 0.0 110.36 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -118.1 92.37 3.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.535 ' CG2' HG12 ' A' ' 38' ' ' ILE . 78.4 mt -79.99 139.6 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 38' ' ' ILE . 4.4 p -111.3 159.56 17.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.595 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 26.2 m-85 -119.61 139.65 51.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.254 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.926 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.189 0.519 . . . . 0.0 110.046 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -124.31 135.64 9.71 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 10.9 p90 -178.91 159.36 1.02 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -1.104 . . . . 0.0 109.931 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.509 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.9 m -143.57 171.52 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.725 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.509 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 68.4 mttt -121.25 127.35 51.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.602 -0.686 . . . . 0.0 109.587 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.511 ' NE2' HD11 ' A' ' 85' ' ' LEU . 14.2 m170 -115.31 124.66 51.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.146 -0.971 . . . . 0.0 110.864 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.518 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 80.0 tttt -100.92 109.68 21.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.479 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.534 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.1 mm -48.32 139.59 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.005 . . . . 0.0 110.132 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.491 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 15.7 t0 -113.0 -40.05 4.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.854 . . . . 0.0 109.518 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 2.8 p 170.39 157.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 110.267 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.585 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 3.2 tt -146.22 163.83 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.796 . . . . 0.0 110.032 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -125.23 78.78 1.74 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.288 -0.883 . . . . 0.0 109.811 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.622 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 99.4 mttt -53.69 -16.54 1.69 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.448 -0.782 . . . . 0.0 110.794 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -91.96 -29.8 16.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.284 -0.885 . . . . 0.0 109.755 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -111.18 -0.18 16.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.563 -0.711 . . . . 0.0 109.651 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 87.9 m-85 63.26 50.05 3.1 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.377 0.608 . . . . 0.0 110.667 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.54 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -118.55 148.67 42.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.207 179.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.585 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 84.7 t80 -144.85 139.14 27.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.065 -1.022 . . . . 0.0 110.433 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 m -148.07 133.4 18.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 110.116 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.585 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 5.7 p90 -135.17 178.36 7.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.6 m -125.07 125.23 43.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.746 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.532 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 2.8 tp -94.11 136.94 33.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.997 . . . . 0.0 110.085 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 pt -124.1 -4.54 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 0.0 110.539 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 6.6 tt0 -137.87 156.49 47.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.004 . . . . 0.0 110.28 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.509 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 150.89 122.66 1.07 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.36 -17.35 4.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -1.171 . . . . 0.0 110.324 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -76.98 -29.22 55.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.524 HD23 ' CG1' ' A' ' 98' ' ' ILE . 17.2 mt -69.1 -27.63 65.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.06 -169.22 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.25 2.99 29.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -1.182 . . . . 0.0 110.175 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.513 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 30.5 p -85.74 -26.4 25.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.59 ' CD2' ' CG1' ' A' ' 128' ' ' ILE . 39.7 mt -122.25 156.59 33.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.868 . . . . 0.0 110.071 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 123' ' ' LYS . 65.5 mm-40 -132.71 -79.81 0.49 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.247 -0.908 . . . . 0.0 110.129 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 22.1 mttp -80.11 129.57 34.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.605 -0.685 . . . . 0.0 110.763 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.619 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 6.2 mm -118.62 141.68 37.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.815 -1.178 . . . . 0.0 109.543 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.2 m -120.45 126.08 49.53 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.381 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.619 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 11.9 m-85 -122.12 133.38 54.76 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.434 -0.791 . . . . 0.0 110.244 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -133.22 148.75 52.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.392 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 81' ' ' TYR . 38.9 m -148.21 140.8 24.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.396 -0.815 . . . . 0.0 110.01 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.468 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 7.8 tttt -132.87 148.97 52.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -0.953 . . . . 0.0 110.124 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 6.4 mt -126.39 148.39 49.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.149 -0.969 . . . . 0.0 110.346 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.5 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -152.31 -169.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.329 -0.857 . . . . 0.0 109.968 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -125.06 156.72 37.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 110.11 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 21.3 p -114.57 164.78 15.48 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.32 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.1 Cg_endo -72.6 -1.77 10.81 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.057 1.557 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.5 p -101.36 0.25 36.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.282 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.56 -38.05 3.39 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.16 -172.79 2.05 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.511 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 59.2 p -129.67 139.9 51.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -1.185 . . . . 0.0 110.251 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.472 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 20.9 mt -89.02 149.5 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 110.199 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.631 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 14.9 mt -133.28 110.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.259 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -102.56 126.0 49.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.004 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 5.0 t -119.56 162.18 19.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.49 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 92.9 m -159.82 144.07 14.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.154 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 92.2 p -143.7 160.8 40.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.505 ' C ' ' CD1' ' A' ' 120' ' ' TYR . 75.7 m-70 -143.41 166.88 23.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.214 -0.929 . . . . 0.0 110.37 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 10.1 m-85 -129.46 145.81 51.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 110.61 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.2 m-70 -124.44 87.21 2.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.352 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 2.2 p -65.39 157.82 28.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.411 -0.806 . . . . 0.0 110.644 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.464 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 74.6 tttt -137.84 126.08 23.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.462 -0.774 . . . . 0.0 110.124 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 99.71 23.27 11.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 8.6 t30 66.32 63.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -1.134 . . . . 0.0 110.189 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.528 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 30.2 m -137.03 166.03 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.129 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HA ' HG23 ' A' ' 122' ' ' THR . 92.2 mt-10 -135.79 166.8 22.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 110.303 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.637 ' CD1' ' CE1' ' A' ' 3' ' ' PHE . 4.8 mp -90.75 172.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 132' ' ' HIS . 54.1 mttt -112.22 131.22 55.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 109.829 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 99.5 mt-10 -43.27 -44.47 5.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 110.05 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -54.81 -26.33 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 9.6 t-160 -83.29 -60.57 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 110.102 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.58 HG22 ' CD2' ' A' ' 5' ' ' TYR . 7.5 p -63.41 -39.79 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.967 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 81.8 tttt -60.99 -37.74 83.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.89 . . . . 0.0 109.907 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.9 78.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.927 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.91 -33.47 85.77 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.04 -41.06 97.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -1.125 . . . . 0.0 109.906 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -75.03 -33.95 61.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.83 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -72.78 -37.29 67.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 109.781 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.49 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -72.23 -33.32 67.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.827 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.9 m -69.07 -44.32 72.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 109.944 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -63.54 -38.56 91.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.878 . . . . 0.0 109.9 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 147' ' ' ILE . 61.2 mt -64.77 -35.94 82.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.857 . . . . 0.0 109.989 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.622 ' CD2' ' CZ ' ' A' ' 9' ' ' PHE . 7.9 m-85 -63.55 -38.82 92.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.926 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -77.03 -14.5 59.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.873 . . . . 0.0 109.993 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.439 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 15.4 mt -84.02 -34.81 24.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.228 -0.92 . . . . 0.0 108.973 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.644 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 17.2 mt -71.56 -44.81 69.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.566 -0.709 . . . . 0.0 109.109 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' HG12 ' A' ' 13' ' ' ILE . 10.9 mm-40 -66.73 -38.75 87.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 0.0 109.651 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.7 m -69.99 -37.47 75.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -0.984 . . . . 0.0 109.669 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.596 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 77.7 t80 -56.4 -57.23 13.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.424 -0.797 . . . . 0.0 110.015 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.637 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 55.5 mt -68.58 -29.07 67.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.28 -0.887 . . . . 0.0 110.16 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.528 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 80.4 tttt -68.42 -33.59 74.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.66 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -100.8 -27.38 7.51 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.526 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.0 m-70 -107.45 89.19 4.7 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.303 -1.116 . . . . 0.0 110.045 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.2 Cg_endo -73.36 2.94 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.003 1.528 . . . . 0.0 110.833 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -106.9 -11.63 15.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 0.0 109.712 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.572 ' HB2' ' CE2' ' A' ' 150' ' ' TYR . . . -69.78 100.57 1.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.472 -0.768 . . . . 0.0 110.001 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.684 ' CE2' ' CB ' ' A' ' 21' ' ' ALA . 0.7 OUTLIER 34.34 33.11 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.751 -0.593 . . . . 0.0 110.483 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.524 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.831 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.563 HG12 ' CE1' ' A' ' 121' ' ' HIS . 76.1 t -109.52 109.74 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -1.143 . . . . 0.0 110.243 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.541 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 54.7 m-85 -74.58 155.95 37.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.231 -0.918 . . . . 0.0 110.414 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.4 m -140.89 89.08 2.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.078 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CG ' ' CG2' ' A' ' 133' ' ' VAL . 80.1 m-85 -109.73 127.58 54.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.809 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.2 pt-20 -128.35 152.36 48.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.204 -0.935 . . . . 0.0 110.527 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 p -128.35 142.27 51.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -0.823 . . . . 0.0 109.794 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -121.39 138.51 54.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.979 . . . . 0.0 110.647 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.3 p90 -157.21 -173.03 4.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.586 -0.696 . . . . 0.0 109.753 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.463 HG21 ' HA ' ' A' ' 113' ' ' ILE . 18.0 p -140.15 -177.1 4.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 110.647 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.512 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 2.9 t -159.59 160.0 33.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.436 -0.79 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -88.11 5.15 42.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 110.224 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.551 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 9.7 mm -108.46 149.65 39.62 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.006 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.9 Cg_endo -64.44 144.54 85.68 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.886 1.466 . . . . 0.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.626 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 Cg_endo -72.63 -31.24 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.015 1.534 . . . . 0.0 112.918 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.3 Cg_endo -69.39 -23.4 32.53 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 110.19 -0.735 . . . . 0.0 110.19 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.519 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 5.2 mmp_? -83.93 -44.15 14.53 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.524 HD22 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -69.78 -31.88 70.05 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.62 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 77.0 t80 -63.83 -56.91 11.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.496 -0.753 . . . . 0.0 109.426 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 51.4 mttt -52.63 -33.86 48.64 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.904 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.635 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -72.96 -60.91 2.01 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.637 0.732 . . . . 0.0 110.718 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.592 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.5 OUTLIER -51.96 -51.67 55.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.723 -0.611 . . . . 0.0 111.799 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.592 HG12 ' CD1' ' A' ' 81' ' ' TYR . 12.0 t -96.85 -61.71 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.012 -1.055 . . . . 0.0 112.334 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.9 mp -67.97 -1.09 5.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.057 -1.027 . . . . 0.0 111.872 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.516 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -147.69 15.22 1.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.664 -1.273 . . . . 0.0 110.845 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -54.05 -48.69 70.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 109.956 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 41' ' ' SER . 49.2 t0 -53.67 -20.34 5.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.955 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.425 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 69.5 m-80 -124.45 11.83 8.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.518 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -97.4 -46.02 6.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.0 110.26 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.668 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 6.0 p -75.59 -27.67 0.7 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.902 . . . . 0.0 112.032 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 50.7 Cg_endo -79.84 6.88 4.92 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 122.696 0.84 . . . . 0.0 110.297 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -130.94 -30.27 1.81 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.209 -0.932 . . . . 0.0 110.244 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.58 HG12 ' CD1' ' A' ' 150' ' ' TYR . 16.1 mt -74.67 -39.86 46.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.38 -0.825 . . . . 0.0 109.849 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -173.11 102.65 0.32 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.387 -0.821 . . . . 0.0 110.362 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.42 2.49 6.24 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.968 1.509 . . . . 0.0 110.56 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -85.03 -19.74 31.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.11 -0.994 . . . . 0.0 109.769 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.87 -44.94 8.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.416 -0.802 . . . . 0.0 110.048 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.523 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.2 mp -125.66 143.63 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 0.0 109.977 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 33.3 ttmt -79.63 -39.18 32.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.274 -0.891 . . . . 0.0 110.383 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.546 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER 178.73 139.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.917 . . . . 0.0 110.527 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 29.5 m -97.81 135.27 39.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 0.0 109.893 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.546 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 50.1 tt0 -143.77 110.26 5.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 110.397 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.9 mt -61.43 132.8 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.066 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.5 mt -92.88 -43.92 8.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.332 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.529 ' O ' ' CG2' ' A' ' 52' ' ' THR . 6.0 mm-40 -135.44 131.6 36.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 110.145 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.08 -172.0 37.85 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -116.83 -3.6 11.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -1.162 . . . . 0.0 110.23 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.82 -4.71 4.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 71' ' ' ILE . . . -79.73 -167.23 34.43 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.4 Cg_endo -70.06 131.83 21.61 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.047 1.551 . . . . 0.0 110.603 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.46 -8.85 66.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 21.9 m -79.94 145.04 32.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -1.13 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 27.6 mm -111.71 117.16 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 44.9 mtmt -101.3 144.99 29.45 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.318 -0.864 . . . . 0.0 110.397 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -117.39 101.56 8.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.177 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.523 ' CG2' HG12 ' A' ' 38' ' ' ILE . 80.6 mt -91.32 138.23 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.123 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.514 ' CG2' ' OH ' ' A' ' 64' ' ' TYR . 1.3 p -112.09 151.64 29.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.468 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' GLY . 32.9 m-85 -111.04 136.23 50.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.873 . . . . 0.0 110.241 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.514 ' OH ' ' CG2' ' A' ' 57' ' ' THR . 3.3 t80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -122.51 96.19 0.56 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 26.5 p90 -133.05 166.75 21.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -1.232 . . . . 0.0 110.103 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.529 HG13 ' CA ' ' A' ' 88' ' ' GLY . 9.7 m -141.06 170.79 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.675 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' NZ ' ' OE1' ' A' ' 87' ' ' GLU . 98.4 mttt -123.17 121.13 35.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.607 -0.683 . . . . 0.0 109.585 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.518 ' NE2' HD11 ' A' ' 85' ' ' LEU . 15.7 m170 -111.57 125.9 54.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 110.981 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 80.0 tttt -99.68 116.97 33.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 109.279 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 39.8 mm -51.96 137.62 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.391 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.512 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 30.5 t0 -109.06 -49.15 3.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 109.85 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 3.1 m -176.72 159.47 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.522 -0.736 . . . . 0.0 110.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.56 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 6.3 tt -151.16 168.37 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.154 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -138.03 84.48 2.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 110.232 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.62 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 94.3 mttt -58.04 -12.17 3.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.429 -0.794 . . . . 0.0 111.008 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -89.81 -31.39 17.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.112 -0.993 . . . . 0.0 109.571 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -114.21 -2.16 13.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 109.667 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 6.6 m-85 67.97 47.59 1.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.754 -0.591 . . . . 0.0 110.573 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.544 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -111.18 158.1 19.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 108.805 178.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.592 ' CD1' HG12 ' A' ' 23' ' ' VAL . 83.4 t80 -159.78 150.86 19.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.956 -1.09 . . . . 0.0 110.669 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.445 ' HB2' ' HA ' ' A' ' 101' ' ' GLU . 12.3 t -159.65 152.43 21.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 7.4 p90 -150.14 176.83 10.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.476 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 91.4 m -124.1 126.08 45.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.797 . . . . 0.0 109.683 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.534 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 2.9 tp -93.52 134.48 35.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.945 . . . . 0.0 110.029 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.08 -10.57 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 110.465 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.451 ' OE1' ' NZ ' ' A' ' 68' ' ' LYS . 23.2 tt0 -140.74 149.09 41.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.424 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.529 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 162.47 149.9 5.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -65.1 -35.07 79.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -1.157 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.61 -21.11 65.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.254 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.526 ' CD1' HD22 ' A' ' 85' ' ' LEU . 41.0 mt -71.3 -32.06 68.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.47 -171.2 0.02 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -84.11 5.1 27.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -1.15 . . . . 0.0 110.006 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.467 ' O ' ' OG1' ' A' ' 122' ' ' THR . 69.6 p -92.34 -43.24 9.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 110.242 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.528 ' CD2' HD13 ' A' ' 128' ' ' ILE . 78.1 mt -94.58 164.51 12.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 110.073 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 36.3 tp10 -144.84 -80.71 0.17 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.243 -0.911 . . . . 0.0 110.21 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 58.8 mttt -80.31 128.88 34.06 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.633 -0.667 . . . . 0.0 110.486 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.619 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 7.5 mm -122.51 143.55 34.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.944 -1.097 . . . . 0.0 110.072 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.91 131.26 53.93 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.453 -0.779 . . . . 0.0 109.044 178.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.619 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 10.9 m-85 -127.08 133.37 50.46 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 110.47 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 75.3 tt0 -131.59 154.26 49.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.885 . . . . 0.0 110.213 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 81' ' ' TYR . 81.6 m -155.0 123.56 6.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.988 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.419 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 12.4 tttt -119.38 150.33 40.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 110.311 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 114' ' ' ILE . 13.0 mt -124.82 150.35 46.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 110.651 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.492 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.37 -169.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.397 -0.815 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -120.64 167.85 12.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.868 . . . . 0.0 110.238 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.416 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 60.2 p -126.42 162.52 46.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.117 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.5 Cg_endo -71.98 -2.48 11.59 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.971 1.511 . . . . 0.0 110.486 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -101.6 -2.61 30.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.264 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.84 -35.95 4.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.12 -172.56 2.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.525 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 15.6 p -128.71 136.21 50.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -1.213 . . . . 0.0 110.435 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.463 ' HA ' HG21 ' A' ' 10' ' ' THR . 62.4 mt -84.93 149.32 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.599 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 9.8 mt -134.33 121.11 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.318 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -110.84 134.61 52.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.91 . . . . 0.0 110.093 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.5 t -125.26 158.4 34.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.89 . . . . 0.0 110.319 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 84.8 m -159.92 126.59 4.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.88 . . . . 0.0 110.322 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.573 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 18.8 t -126.5 155.84 41.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.288 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.529 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 80.6 m-70 -130.73 164.5 24.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.306 -0.871 . . . . 0.0 109.965 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 119' ' ' HIS . 18.6 m-85 -133.67 134.49 43.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 111.037 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.563 ' CE1' HG12 ' A' ' 2' ' ' VAL . 85.4 m-70 -121.07 90.2 3.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 108.848 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.525 ' OG1' ' CG2' ' A' ' 126' ' ' VAL . 2.2 t -91.59 -179.46 5.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 111.748 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -133.97 171.89 13.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.902 -0.498 . . . . 0.0 109.703 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 76.45 2.48 74.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 16.6 t30 68.68 60.41 0.37 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.268 -1.137 . . . . 0.0 110.728 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.525 ' CG2' ' OG1' ' A' ' 122' ' ' THR . 6.6 m -126.01 162.08 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.668 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -118.64 145.91 45.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.02 . . . . 0.0 110.725 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.528 HD13 ' CD2' ' A' ' 95' ' ' LEU . 24.1 mm -55.77 173.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.388 -0.82 . . . . 0.0 110.083 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 132' ' ' HIS . 29.5 mtpt -110.15 131.69 54.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.042 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 60.6 mt-10 -43.26 -42.37 4.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 110.103 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.45 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 48.8 tt0 -60.83 -26.33 67.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 109.923 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.0 t-160 -85.97 -53.05 5.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 110.081 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.606 ' CG2' ' CG ' ' A' ' 5' ' ' TYR . 3.9 p -69.07 -30.78 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 110.126 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 64.6 tttp -79.3 -53.94 6.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 109.801 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.52 -25.74 67.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.95 -36.52 81.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.471 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 96.5 mttt -65.57 -33.96 77.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -1.119 . . . . 0.0 109.866 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -81.53 -32.1 32.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.0 109.88 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -67.77 -44.67 76.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.374 -0.829 . . . . 0.0 109.873 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -71.2 -38.4 72.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 110.004 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.1 m -62.81 -49.35 75.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.395 -0.816 . . . . 0.0 109.993 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -56.29 -43.13 78.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.982 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 147' ' ' ILE . 23.4 mt -60.74 -40.69 93.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.91 . . . . 0.0 109.944 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 19.1 m-85 -60.61 -39.88 89.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.439 -0.788 . . . . 0.0 109.86 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -67.91 -17.94 64.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 110.037 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.0 mt -84.14 -34.9 23.96 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.19 -0.944 . . . . 0.0 108.965 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.592 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 55.2 mt -71.75 -41.64 70.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.548 -0.72 . . . . 0.0 109.06 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.512 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 14.9 mm-40 -59.97 -39.68 86.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.289 -0.882 . . . . 0.0 109.205 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.466 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 97.7 m -67.09 -35.99 81.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 109.185 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.585 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 72.3 t80 -53.15 -53.46 50.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.48 -0.763 . . . . 0.0 109.625 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.65 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 98.3 mt -76.08 -27.03 57.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.296 -0.877 . . . . 0.0 109.984 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.526 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 29.8 ttpt -75.88 -19.67 58.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.451 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -113.45 -30.73 2.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.475 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 15.3 m-70 -106.89 93.28 8.67 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.199 -1.177 . . . . 0.0 110.224 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.5 Cg_endo -74.22 4.77 4.05 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.086 1.572 . . . . 0.0 110.876 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -108.15 3.68 24.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 109.827 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.566 ' HB2' ' CE2' ' A' ' 150' ' ' TYR . . . -86.87 103.34 15.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.381 -0.824 . . . . 0.0 110.196 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.65 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.65 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.686 -0.634 . . . . 0.0 110.511 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.519 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.714 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 54.8 t -106.59 128.63 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -1.14 . . . . 0.0 110.306 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.64 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 9.0 m-85 -90.86 143.5 26.66 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.267 -0.896 . . . . 0.0 109.654 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.403 HG21 ' CE1' ' A' ' 119' ' ' HIS . 4.8 m -126.23 116.82 21.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.984 -1.073 . . . . 0.0 110.403 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 57.5 m-85 -131.76 137.25 48.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 109.915 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -136.08 149.75 48.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 110.565 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.4 p -139.69 149.98 44.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.78 . . . . 0.0 109.451 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.45 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 2.8 tt0 -133.79 138.33 45.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.968 -1.083 . . . . 0.0 110.854 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.608 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 3.6 p90 -154.34 -174.7 5.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.429 -0.794 . . . . 0.0 109.597 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 14.0 p -136.88 178.35 7.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 110.687 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.448 ' OG ' HD13 ' A' ' 114' ' ' ILE . 83.0 p -157.36 153.1 26.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 110.24 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -79.34 -15.45 57.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.912 . . . . 0.0 110.267 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 152' ' ' LYS . 1.9 mp -87.57 151.25 50.23 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 109.937 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.8 143.47 73.82 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.057 1.556 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.617 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.88 -31.14 10.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 124.065 1.561 . . . . 0.0 112.972 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.6 Cg_endo -70.52 -21.79 29.48 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 N-CA-C 110.103 -0.768 . . . . 0.0 110.103 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 159' ' ' ASN . 9.1 mmp_? -83.44 -47.12 11.72 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -66.51 -27.87 68.11 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.613 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 81.6 t80 -65.65 -60.36 2.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.715 -0.616 . . . . 0.0 109.604 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 52.3 mttt -52.03 -32.97 36.56 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.4 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -74.13 -56.02 5.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.399 -0.813 . . . . 0.0 110.661 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.637 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.4 OUTLIER -58.62 -49.15 78.55 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.542 -0.724 . . . . 0.0 111.384 -178.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.6 ' CG1' ' CD1' ' A' ' 74' ' ' ILE . 16.8 t -93.49 -65.25 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.973 -1.079 . . . . 0.0 111.717 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 6.9 mp -67.55 -1.07 4.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.287 -0.883 . . . . 0.0 111.819 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.525 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -149.04 25.24 0.92 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.795 -1.19 . . . . 0.0 110.729 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -63.79 -38.12 89.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.119 -0.988 . . . . 0.0 109.989 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' OD2' HD12 ' A' ' 43' ' ' ILE . 54.7 m-20 -65.02 -14.92 61.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 110.253 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -125.15 7.72 7.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 110.058 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -95.43 -57.03 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 110.103 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.598 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 96.1 t -62.69 -40.51 64.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.765 . . . . 0.0 111.153 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -77.4 7.09 3.94 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.371 1.195 . . . . 0.0 110.85 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -127.48 -29.8 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.902 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.529 HD12 ' CD1' ' A' ' 29' ' ' LEU . 32.3 mt -80.07 -44.37 22.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.51 -0.744 . . . . 0.0 110.044 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.02 102.14 2.11 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 110.348 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.21 3.63 5.55 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.049 1.552 . . . . 0.0 110.717 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -90.74 -13.84 33.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.141 -0.975 . . . . 0.0 110.208 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.83 -29.05 12.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.198 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.584 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 0.9 OUTLIER -142.07 150.26 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -88.69 -44.79 10.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.326 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.575 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -172.93 156.76 3.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.377 -0.827 . . . . 0.0 110.173 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -119.81 121.99 40.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 109.95 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 84.6 tt0 -124.31 114.49 19.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.491 HD11 HG22 ' A' ' 43' ' ' ILE . 23.4 mt -61.55 132.21 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.944 . . . . 0.0 110.088 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.464 HD13 ' HB2' ' A' ' 55' ' ' LYS . 53.4 mt -92.89 -25.54 18.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 52' ' ' THR . 41.8 tt0 -156.46 171.31 20.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 58.07 -165.92 6.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -131.55 29.42 4.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -1.112 . . . . 0.0 110.291 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.36 2.25 47.57 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.469 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -92.53 -167.33 39.42 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.458 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.4 132.86 23.15 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.058 1.557 . . . . 0.0 110.522 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.17 -6.62 68.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 19.4 m -80.06 147.91 31.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -1.174 . . . . 0.0 110.129 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.504 ' N ' HG21 ' A' ' 52' ' ' THR . 21.6 mm -116.53 114.96 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.071 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 35.7 mtmt -99.76 147.47 25.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.464 ' HB2' HD13 ' A' ' 44' ' ' LEU . 83.6 tttt -116.78 98.62 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.898 . . . . 0.0 110.09 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.522 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.7 mt -88.22 146.42 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.5 p -120.16 155.62 32.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.38 -0.825 . . . . 0.0 110.574 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 23.1 m-85 -116.58 145.36 43.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.449 -0.782 . . . . 0.0 110.145 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.401 ' CD1' ' HD2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.233 0.539 . . . . 0.0 110.186 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -118.86 94.98 0.6 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 20.8 p90 -134.8 167.97 19.9 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.049 -1.265 . . . . 0.0 110.478 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.535 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.8 m -139.69 172.89 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 110.447 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.512 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 30.3 mtpt -123.9 129.37 50.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.528 -0.732 . . . . 0.0 109.518 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.565 ' CD2' HD13 ' A' ' 85' ' ' LEU . 8.3 m170 -117.19 125.94 51.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.99 -1.069 . . . . 0.0 110.931 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HA ' HD12 ' A' ' 53' ' ' ILE . 64.6 tttp -104.94 110.49 22.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 109.3 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 29.2 mm -48.19 140.65 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.187 -0.945 . . . . 0.0 110.406 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.529 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 16.0 t0 -112.25 -40.32 4.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.393 -0.817 . . . . 0.0 109.629 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 0.6 OUTLIER 172.19 161.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.0 110.391 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.6 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 3.6 tt -152.03 165.33 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -131.34 80.73 1.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.613 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.6 mttt -55.78 -14.14 2.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.87 . . . . 0.0 110.827 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -90.18 -29.75 18.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.227 -0.92 . . . . 0.0 109.645 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -114.45 -1.68 13.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.486 -0.758 . . . . 0.0 109.965 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.575 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 8.3 m-85 67.48 48.04 1.17 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.639 -0.663 . . . . 0.0 110.646 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.539 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -115.06 154.2 29.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.208 -0.932 . . . . 0.0 109.095 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.57 ' CD1' HG12 ' A' ' 23' ' ' VAL . 84.7 t80 -154.98 148.32 25.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.9 -1.125 . . . . 0.0 110.523 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.479 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 17.9 m -156.22 147.16 22.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.366 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 4.9 p90 -144.21 178.3 7.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.409 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 71.0 m -124.83 125.19 43.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.535 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.565 HD13 ' CD2' ' A' ' 69' ' ' HIS . 5.3 tp -90.86 136.11 33.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.178 -0.951 . . . . 0.0 110.401 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 86' ' ' ILE . 23.2 pt -123.58 -6.14 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.551 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.512 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 11.2 tt0 -141.37 160.44 40.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 110.429 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.535 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 145.77 123.69 1.58 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.34 -15.41 6.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -1.16 . . . . 0.0 110.402 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -77.1 -29.37 54.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.524 ' CD2' HG13 ' A' ' 98' ' ' ILE . 28.6 mt -67.46 -39.33 85.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.366 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 178.05 44.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -74.46 -0.01 16.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -1.148 . . . . 0.0 110.162 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.523 ' CG2' HG12 ' A' ' 126' ' ' VAL . 15.4 p -95.2 -40.41 9.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.165 -0.959 . . . . 0.0 110.305 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.615 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 1.8 mm? -79.84 136.98 36.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.165 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 5.7 tp10 -124.98 -83.44 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.318 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 26.7 mttt -80.16 126.87 31.65 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 110.695 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.567 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.3 mm -121.14 141.04 43.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 120.614 -1.304 . . . . 0.0 109.235 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.72 134.23 55.05 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.879 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 8.2 m-85 -130.3 132.7 46.0 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.422 -0.799 . . . . 0.0 110.169 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 5.9 mt-10 -129.71 167.01 18.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.223 -0.923 . . . . 0.0 110.619 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 81' ' ' TYR . 45.6 m -162.9 137.69 6.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.381 -0.824 . . . . 0.0 109.909 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.4 mttt -135.58 137.88 42.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.391 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.513 ' CD2' HG12 ' A' ' 114' ' ' ILE . 9.8 mt -117.12 149.92 39.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.319 -0.863 . . . . 0.0 110.127 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.488 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -150.79 -169.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -0.936 . . . . 0.0 110.153 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -120.64 166.85 13.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.268 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 24.8 p -125.02 165.69 24.42 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -73.17 -0.65 9.42 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.995 1.524 . . . . 0.0 110.488 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.6 p -110.42 7.66 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.263 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.38 -38.66 3.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.03 -172.72 0.14 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.532 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 16.8 p -133.63 135.26 44.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.171 -1.194 . . . . 0.0 110.385 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 41.8 mt -86.44 152.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.056 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.608 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 5.3 mt -136.42 115.17 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.933 . . . . 0.0 110.614 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 44.4 tttp -101.06 127.28 47.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -0.842 . . . . 0.0 109.745 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.05 157.91 25.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.748 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.7 m -160.08 144.33 14.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.394 -0.816 . . . . 0.0 110.067 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.493 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -146.65 168.64 20.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.161 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.493 ' CG ' ' C ' ' A' ' 118' ' ' SER . 48.4 m-70 -148.87 174.56 12.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.166 -0.959 . . . . 0.0 110.552 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.573 ' CD2' HG12 ' A' ' 128' ' ' ILE . 87.9 m-85 -138.09 156.91 47.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.217 -0.927 . . . . 0.0 110.958 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 76.4 m-70 -140.84 81.49 1.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.406 -0.809 . . . . 0.0 109.251 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.444 ' HB ' ' HB ' ' A' ' 126' ' ' VAL . 0.1 OUTLIER -63.08 142.36 58.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.334 -0.854 . . . . 0.0 110.648 -179.352 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -69.19 110.4 4.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.896 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.63 -116.36 5.45 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 2.6 p-10 -137.13 49.3 2.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -1.172 . . . . 0.0 110.244 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.523 HG12 ' CG2' ' A' ' 94' ' ' THR . 66.7 t -96.42 174.96 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.416 -0.803 . . . . 0.0 109.952 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.411 ' N ' ' CG1' ' A' ' 126' ' ' VAL . 96.0 mt-10 -126.22 161.2 28.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.64 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 4.5 mp -88.38 172.94 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.867 . . . . 0.0 110.095 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.478 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 67.0 mmtt -90.83 151.96 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.332 -0.855 . . . . 0.0 109.958 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.471 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 61.7 mm-40 -58.16 -22.0 49.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.136 -0.978 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 98.2 mt-10 -68.03 -39.57 83.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.91 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 5.3 m170 -66.04 -47.55 74.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.162 -0.961 . . . . 0.0 110.02 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.577 HG22 ' CE1' ' A' ' 5' ' ' TYR . 2.5 p -76.47 -25.87 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.449 -0.782 . . . . 0.0 110.093 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 73.6 tttt -104.31 -65.37 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.958 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -56.68 -24.21 47.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.868 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.51 -28.58 67.33 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.11 -33.1 56.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -1.127 . . . . 0.0 110.017 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -81.39 -31.26 33.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.85 . . . . 0.0 109.813 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -73.42 -36.72 66.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 109.828 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.23 -35.94 61.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.852 . . . . 0.0 109.89 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.1 m -64.04 -45.46 88.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -0.821 . . . . 0.0 109.973 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -56.41 -50.67 70.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.993 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.412 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.9 mm? -60.51 -33.98 73.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.949 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -65.16 -37.49 87.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.414 -0.803 . . . . 0.0 109.833 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 29.3 ttmt -79.63 -15.45 57.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.441 -0.787 . . . . 0.0 110.042 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.501 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 13.8 mt -83.23 -37.02 24.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.081 -1.012 . . . . 0.0 108.933 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.637 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 86.6 mt -70.72 -44.36 76.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.466 ' O ' HD12 ' A' ' 13' ' ' ILE . 62.6 mt-10 -55.88 -40.01 72.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.327 -0.858 . . . . 0.0 109.202 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.6 m -71.25 -31.63 67.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.556 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.586 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 79.0 t80 -56.08 -49.94 72.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.474 -0.766 . . . . 0.0 109.775 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.637 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 59.3 mt -77.72 -29.02 51.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.997 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 52.4 tptt -66.98 -26.78 66.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.464 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.458 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -107.28 -28.41 4.92 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.556 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.7 m-70 -106.9 91.18 6.0 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.219 -1.165 . . . . 0.0 110.05 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.7 Cg_endo -73.29 4.58 3.74 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.062 1.559 . . . . 0.0 111.104 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -111.14 -7.72 14.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.019 -1.051 . . . . 0.0 109.97 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.556 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -70.49 101.33 1.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 110.109 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.638 ' CE2' ' CB ' ' A' ' 21' ' ' ALA . 0.8 OUTLIER 34.79 31.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.712 -0.618 . . . . 0.0 110.635 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.715 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 93.9 t -136.07 134.11 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -1.166 . . . . 0.0 110.363 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 128' ' ' ILE . 11.2 m-85 -101.18 131.9 46.94 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.66 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.408 ' HA ' ' HD1' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -100.78 126.41 47.34 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.858 -1.151 . . . . 0.0 110.687 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.582 ' CZ ' HG23 ' A' ' 133' ' ' VAL . 50.4 m-85 -133.58 125.59 29.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.806 . . . . 0.0 109.907 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.534 ' HG2' ' CG2' ' A' ' 117' ' ' THR . 3.8 mt-10 -136.49 145.61 45.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.398 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 m -132.03 158.82 40.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.805 . . . . 0.0 110.015 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.432 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 98.9 mt-10 -143.72 123.67 13.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.443 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 p90 -147.47 -173.64 4.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 12.5 p -138.34 -179.4 5.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.578 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.4 ' OG ' HD13 ' A' ' 114' ' ' ILE . 89.3 p -157.1 164.15 38.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.41 -0.806 . . . . 0.0 110.206 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -86.1 -21.74 27.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.53 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 8.2 mm -84.91 150.26 55.27 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.146 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 42.2 Cg_endo -66.1 150.4 85.21 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.158 1.61 . . . . 0.0 110.14 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.649 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.5 Cg_endo -70.15 -32.93 16.05 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.912 1.48 . . . . 0.0 113.304 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.5 Cg_endo -66.92 -23.23 47.49 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 122.381 0.674 . . . . 0.0 110.408 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.522 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 10.7 mmp_? -84.5 -45.66 12.41 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.519 HD23 ' CD2' ' A' ' 104' ' ' LEU . 1.1 tt -72.28 -25.4 61.58 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.564 -0.71 . . . . 0.0 109.241 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.589 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 85.2 t80 -70.74 -57.98 4.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.402 -0.811 . . . . 0.0 109.059 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.51 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 67.5 mttt -51.23 -35.99 39.62 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.33 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.575 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -74.48 -53.81 8.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 111.021 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.622 ' CD1' ' CD1' ' A' ' 147' ' ' ILE . 0.5 OUTLIER -59.54 -46.23 89.47 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 111.706 -178.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.558 HG11 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -98.18 -61.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.947 -1.096 . . . . 0.0 111.57 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 7.5 mp -70.18 0.31 6.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.149 -0.969 . . . . 0.0 111.55 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.492 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -154.55 46.92 0.57 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.79 -1.194 . . . . 0.0 110.856 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -84.64 -25.22 28.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -0.999 . . . . 0.0 110.062 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 60.6 t0 -73.76 -11.66 60.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 109.907 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.411 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 71.6 m-20 -128.6 10.46 6.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.37 -0.831 . . . . 0.0 109.652 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.533 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -97.9 -57.75 2.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.445 -0.784 . . . . 0.0 110.45 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.67 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.9 m -74.86 -29.1 0.87 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 112.101 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 51.0 Cg_endo -80.5 -1.51 11.35 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 O-C-N 122.878 0.936 . . . . 0.0 110.374 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -126.43 -32.09 2.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 109.756 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.58 HG12 ' CD1' ' A' ' 150' ' ' TYR . 11.9 mt -80.06 -34.17 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.489 -0.757 . . . . 0.0 109.393 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.38 99.06 1.4 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.586 -0.696 . . . . 0.0 109.896 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.33 -4.33 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.984 1.518 . . . . 0.0 110.427 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -87.17 1.88 51.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.865 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.494 ' C ' ' CD1' ' A' ' 38' ' ' ILE . . . -107.04 -47.6 3.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 109.997 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.507 ' HB ' ' CG2' ' A' ' 30' ' ' VAL . 1.9 mp -133.88 142.06 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 0.0 110.071 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -82.94 -36.57 25.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.553 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -175.42 132.69 0.29 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.375 -0.828 . . . . 0.0 109.946 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 2.3 m -100.26 131.24 46.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.553 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 77.5 tt0 -138.69 110.83 7.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 110.293 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 14.7 mt -64.11 134.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 110.203 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.498 HD12 ' CB ' ' A' ' 55' ' ' LYS . 9.7 mp -97.89 -44.46 6.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 52' ' ' THR . 3.5 mt-10 -128.77 145.37 51.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.237 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.24 -162.46 53.57 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -139.52 23.02 2.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -1.123 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.15 -11.67 11.55 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -80.83 -168.0 38.48 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.53 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.89 139.68 36.85 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.09 1.574 . . . . 0.0 110.377 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.05 -3.34 85.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 31.9 m -80.09 139.0 37.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -1.198 . . . . 0.0 110.05 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.535 HG22 ' CE ' ' A' ' 68' ' ' LYS . 25.7 mm -109.87 109.59 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 110.295 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 88.1 mttt -99.04 138.4 36.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.323 -0.861 . . . . 0.0 110.217 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' CB ' HD12 ' A' ' 44' ' ' LEU . 83.2 tttt -109.41 97.28 6.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.202 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.44 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 91.1 mt -84.15 141.88 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 0.0 110.177 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.3 p -116.08 155.22 28.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.147 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 23.5 m-85 -111.8 166.63 11.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.863 . . . . 0.0 110.358 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.157 0.503 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.14 88.29 0.28 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.5 p90 -126.84 164.36 21.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -1.168 . . . . 0.0 110.147 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.514 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.6 m -139.31 173.82 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 110.575 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.535 ' CE ' HG22 ' A' ' 53' ' ' ILE . 48.9 tttt -123.0 128.24 49.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.589 -0.694 . . . . 0.0 109.591 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.525 ' NE2' HD11 ' A' ' 85' ' ' LEU . 9.2 m170 -119.7 119.31 33.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 0.0 110.851 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 85.4 tttt -100.64 110.87 23.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.577 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.53 ' CG2' ' HA ' ' A' ' 50' ' ' PRO . 33.2 mm -46.33 142.79 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.475 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.532 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 12.9 t0 -114.64 -41.29 3.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.471 -0.768 . . . . 0.0 109.552 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 67.5 p -174.48 157.91 2.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.82 . . . . 0.0 109.457 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.99 151.02 23.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.084 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 6.5 m-20 -127.75 75.99 1.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.388 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 99.5 mttt -62.55 -12.85 25.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.101 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -97.98 -30.37 12.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 109.205 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -105.29 -3.08 23.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.653 -0.654 . . . . 0.0 109.715 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.596 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 83.1 m-85 61.26 53.35 3.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.49 -0.756 . . . . 0.0 110.083 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.523 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -125.82 152.67 45.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.568 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.558 ' CE1' HG11 ' A' ' 23' ' ' VAL . 25.8 t80 -138.78 134.5 33.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 110.391 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.457 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -141.54 123.13 15.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 110.555 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.602 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 8.8 p90 -135.0 175.89 9.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 110.134 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.6 m -124.41 127.82 48.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.533 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 3.3 tp -97.49 135.81 38.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 0.0 109.906 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.498 HG23 HD11 ' A' ' 86' ' ' ILE . 6.7 pt -128.53 -5.42 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 110.409 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.416 ' HB3' ' N ' ' A' ' 68' ' ' LYS . 23.0 tt0 -137.05 139.04 41.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.393 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.514 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 166.49 122.47 0.61 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -51.06 -21.31 1.78 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -1.105 . . . . 0.0 110.23 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.567 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -72.79 -27.09 61.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.069 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 92' ' ' GLY . 64.7 mt -66.28 -27.84 68.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.177 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.03 -169.67 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -84.62 4.6 31.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -1.147 . . . . 0.0 110.11 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.498 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 46.8 p -90.41 -30.06 17.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.063 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.593 ' CD2' ' CG1' ' A' ' 128' ' ' ILE . 44.8 mt -116.99 166.27 12.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.392 -0.818 . . . . 0.0 110.008 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 49.0 tt0 -143.23 -79.57 0.21 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.306 -0.871 . . . . 0.0 110.018 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 51.9 mttt -80.16 139.74 36.67 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.57 -0.706 . . . . 0.0 110.531 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.621 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 7.3 mm -128.24 140.91 47.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 120.861 -1.149 . . . . 0.0 109.722 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.6 m -118.35 125.88 50.94 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.462 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.621 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 11.3 m-85 -122.77 135.89 54.7 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 37.2 tt0 -141.86 138.45 32.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.844 . . . . 0.0 110.149 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 81' ' ' TYR . 88.8 m -135.76 157.65 46.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 110.059 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -149.31 144.16 26.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.266 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 114' ' ' ILE . 5.7 mt -121.33 149.19 43.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 110.776 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.492 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.82 -169.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 109.711 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -118.68 165.43 13.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.408 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 96.3 p -123.95 162.51 40.79 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.248 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.8 Cg_endo -72.03 -2.93 12.31 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.019 1.536 . . . . 0.0 110.422 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.7 p -102.12 -0.36 33.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.3 -35.42 5.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.59 -173.04 3.23 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 73.3 p -128.35 133.71 48.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -1.161 . . . . 0.0 110.337 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 71.9 mt -81.66 149.64 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 110.183 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.575 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 8.7 mt -132.98 107.56 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.268 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.2 tttt -95.32 132.63 40.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.882 . . . . 0.0 110.069 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.3 OUTLIER -126.2 151.62 47.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 110.259 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.534 ' CG2' ' HG2' ' A' ' 6' ' ' GLU . 99.2 m -150.06 137.2 19.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 5.4 p -142.8 146.08 33.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 109.938 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.511 ' CE1' ' CG2' ' A' ' 117' ' ' THR . 41.6 m-70 -131.33 163.44 27.83 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 110.62 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 9.3 m-85 -122.91 150.29 43.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.579 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.502 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 93.8 m-70 -128.98 93.72 3.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 109.472 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 94' ' ' THR . 1.7 p -71.3 157.63 37.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 110.693 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.472 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 47.6 tptt -140.45 106.1 5.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.311 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 118.81 29.27 1.88 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.83 65.76 0.99 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -1.145 . . . . 0.0 110.214 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 94' ' ' THR . 26.9 m -141.67 162.15 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.176 -0.953 . . . . 0.0 110.099 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -130.6 168.51 16.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.27 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.64 ' CD1' ' CE1' ' A' ' 3' ' ' PHE . 4.7 mp -94.92 173.07 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.25 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.453 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 34.5 mttt -110.38 129.92 55.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.387 -0.821 . . . . 0.0 109.658 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 57.3 mm-40 -42.51 -39.32 2.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 110.267 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -60.95 -28.08 68.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.948 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 15.8 t-160 -78.01 -54.83 5.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 110.057 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.582 HG23 ' CZ ' ' A' ' 5' ' ' TYR . 99.4 t -61.13 -38.32 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.847 . . . . 0.0 110.015 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.44 -39.46 88.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.062 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.35 83.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.991 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.79 -30.47 68.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 97.2 mttt -69.88 -31.41 69.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -1.123 . . . . 0.0 110.112 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.509 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 97.8 mt-10 -75.75 -39.33 57.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 110.05 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -62.45 -43.31 99.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -73.24 -34.52 65.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.018 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.0 m -71.51 -54.32 10.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.402 -0.811 . . . . 0.0 109.913 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 73.1 m-20 -51.53 -46.23 63.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.903 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 21.8 tp -57.74 -46.05 85.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 0.0 109.815 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 6.9 m-85 -53.89 -36.88 63.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.729 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 76.7 tttt -79.98 -13.14 59.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.461 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 20.9 mt -87.47 -36.57 17.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.211 -0.931 . . . . 0.0 108.927 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.622 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 45.3 mt -73.2 -41.67 58.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 13' ' ' ILE . 19.9 pt-20 -58.55 -31.98 68.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.344 -0.847 . . . . 0.0 109.243 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.446 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 31.8 m -80.0 -34.59 38.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.36 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.58 ' CD1' HG12 ' A' ' 33' ' ' ILE . 87.1 t80 -58.51 -53.88 53.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.501 -0.75 . . . . 0.0 109.883 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.629 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 76.5 mt -70.58 -31.35 68.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.268 -0.895 . . . . 0.0 110.047 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.492 ' HA ' HD13 ' A' ' 13' ' ' ILE . 45.4 tptt -70.08 -18.92 63.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.492 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -110.79 -31.65 2.88 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.592 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.0 m-70 -108.16 93.89 12.04 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.345 -1.091 . . . . 0.0 109.904 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.478 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.6 Cg_endo -74.01 5.81 3.3 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.077 1.567 . . . . 0.0 111.06 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -111.58 -9.07 14.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.056 -1.028 . . . . 0.0 109.683 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 150' ' ' TYR . . . -64.81 102.33 0.58 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 110.03 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.629 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.8 OUTLIER 34.68 33.55 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.716 -0.615 . . . . 0.0 110.351 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.522 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.85 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 74.4 t -122.53 142.37 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -1.159 . . . . 0.0 110.29 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.643 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 9.7 m-85 -91.72 152.36 20.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.891 . . . . 0.0 110.124 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 m -132.48 106.87 8.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 0.0 110.364 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.631 ' CD2' ' CG2' ' A' ' 133' ' ' VAL . 71.3 m-85 -121.54 143.04 49.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.867 . . . . 0.0 109.98 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 13.1 pt-20 -142.65 152.17 42.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.099 -1.001 . . . . 0.0 110.381 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.8 t -132.38 162.54 30.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 110.048 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -145.31 117.32 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.41 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.4 p90 -144.78 -171.48 3.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.879 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 19.2 p -138.6 -179.61 5.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 0.0 110.621 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.416 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 3.0 t -154.19 168.99 24.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.805 . . . . 0.0 110.22 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -92.58 -28.06 16.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 12.3 mm -82.96 148.02 55.88 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.057 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.554 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 40.4 Cg_endo -64.71 152.47 81.84 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.016 1.535 . . . . 0.0 110.821 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.649 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.4 Cg_endo -63.18 -36.25 58.91 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.917 1.483 . . . . 0.0 112.928 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -63.81 -20.29 68.29 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 N-CA-C 109.862 -0.861 . . . . 0.0 109.862 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.521 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 9.8 mmp_? -81.1 -46.03 15.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.602 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 4.1 mm? -74.03 -37.08 64.45 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.545 -0.862 . . . . 0.0 108.751 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.602 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 37.8 t80 -57.87 -56.69 18.65 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.158 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 89.0 mttt -58.2 -36.45 73.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.708 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.613 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . . . -80.09 -63.64 1.37 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.435 -0.791 . . . . 0.0 110.738 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.6 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.4 OUTLIER -51.95 -34.36 41.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.516 -0.74 . . . . 0.0 111.622 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.579 HG11 ' CE1' ' A' ' 81' ' ' TYR . 4.5 t -108.68 -65.03 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.974 -1.079 . . . . 0.0 111.637 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.1 mp -69.68 -1.6 9.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.22 -0.925 . . . . 0.0 111.303 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.53 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -148.47 23.09 1.03 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.879 -1.138 . . . . 0.0 110.476 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -62.49 -44.92 95.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.887 . . . . 0.0 110.201 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.484 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 63.8 m-20 -58.22 -15.39 9.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 110.207 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.458 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 74.0 m-20 -124.91 4.86 8.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.017 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.521 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -93.2 -49.09 6.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.425 -0.797 . . . . 0.0 109.946 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.5 t -71.17 -42.0 11.33 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.83 . . . . 0.0 110.895 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.7 Cg_endo -77.2 6.61 4.2 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.422 1.222 . . . . 0.0 110.722 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 63.3 mttt -124.63 -33.97 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.264 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.576 HG12 ' CD1' ' A' ' 150' ' ' TYR . 35.3 mt -80.1 -34.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.597 -0.69 . . . . 0.0 109.606 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.46 98.52 1.4 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.512 -0.742 . . . . 0.0 110.109 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.28 2.15 6.53 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.027 1.54 . . . . 0.0 110.726 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -90.54 -3.64 57.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.141 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.5 -33.48 6.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 110.165 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.541 HD12 ' CG2' ' A' ' 56' ' ' ILE . 6.7 mt -135.97 134.44 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.892 . . . . 0.0 110.284 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.55 ' CG ' ' CA ' ' A' ' 59' ' ' GLY . 9.1 mtmt -73.34 -39.14 65.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.373 -0.829 . . . . 0.0 110.302 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 177.01 164.16 0.49 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 110.211 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.484 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 69.5 m -124.73 120.07 30.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.921 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.514 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 51.0 tp10 -122.7 102.44 8.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.302 -0.874 . . . . 0.0 110.183 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 43' ' ' ILE . 28.2 mt -50.32 130.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 110.164 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.483 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 46.6 mt -88.61 -26.45 21.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 110.091 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.516 ' O ' ' CG2' ' A' ' 52' ' ' THR . 50.0 tt0 -157.08 173.88 16.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 110.23 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 58.98 -159.98 16.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -143.87 31.2 1.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -1.153 . . . . 0.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.42 3.0 41.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -97.49 -167.18 32.45 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.52 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 44.2 Cg_endo -70.32 137.09 33.07 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.065 1.56 . . . . 0.0 110.506 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.17 -6.72 83.31 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 46.4 m -80.05 138.17 36.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -1.14 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.585 ' CG2' ' CG ' ' A' ' 68' ' ' LYS . 36.7 mm -105.61 121.27 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 110.037 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.513 ' NZ ' ' OH ' ' A' ' 81' ' ' TYR . 52.3 mtmt -106.29 120.11 41.0 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 110.293 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.483 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 80.1 tttt -91.94 101.11 13.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 0.0 110.2 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.541 ' CG2' HD12 ' A' ' 38' ' ' ILE . 90.6 mt -91.51 147.13 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 110.111 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 3.3 p -119.84 153.09 36.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.952 . . . . 0.0 110.652 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 12.9 m-85 -116.22 125.49 52.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 110.152 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.55 ' CA ' ' CG ' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.206 0.527 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -136.19 80.62 0.3 Allowed Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 19.7 p90 -125.81 179.31 5.24 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.319 -1.106 . . . . 0.0 110.23 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.573 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 4.1 m -152.39 177.7 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.398 -0.813 . . . . 0.0 110.694 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.586 ' CE ' ' CD1' ' A' ' 86' ' ' ILE . 28.0 ttpt -134.93 107.64 7.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.49 -0.756 . . . . 0.0 109.689 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.504 ' CD2' HD11 ' A' ' 85' ' ' LEU . 13.5 m170 -96.66 130.67 43.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 111.247 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 56.8 tttt -102.75 109.04 20.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.366 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.1 mm -43.62 138.76 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 110.267 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.541 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 15.0 t0 -108.95 -40.47 5.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.654 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 11.0 p 178.39 158.57 0.5 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.427 -0.796 . . . . 0.0 109.782 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.417 HG13 ' HD1' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -140.24 156.54 24.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.104 -0.998 . . . . 0.0 110.909 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -139.4 80.96 1.81 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.689 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.602 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 35.1 ttpt -64.11 -12.33 38.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 110.093 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -87.36 -29.6 21.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 108.987 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -111.46 -3.23 15.27 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.409 0.623 . . . . 0.0 109.385 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.536 ' CB ' ' HB2' ' A' ' 104' ' ' LEU . 67.5 m-85 62.5 53.12 2.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.599 -0.688 . . . . 0.0 110.108 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.88 155.72 39.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.539 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.682 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 73.5 t80 -143.26 147.47 34.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 110.108 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 72' ' ' ASP . 68.8 m -153.6 135.01 14.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 110.97 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.682 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.4 p90 -144.8 173.08 12.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.37 -0.831 . . . . 0.0 110.118 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.458 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 87.4 m -126.67 124.8 40.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.818 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 68' ' ' LYS . 9.2 tp -92.6 133.0 36.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.0 110.205 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.586 ' CD1' ' CE ' ' A' ' 68' ' ' LYS . 13.3 pt -123.64 -25.64 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 110.59 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB3' ' CB ' ' A' ' 68' ' ' LYS . 42.6 tt0 -112.05 133.21 54.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.183 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.455 ' N ' HD13 ' A' ' 91' ' ' LEU . . . 168.23 140.74 3.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -69.87 -19.09 63.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -1.155 . . . . 0.0 110.279 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.95 -25.04 61.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.291 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 38.7 mt -62.37 -33.09 74.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 110.114 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.25 -179.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -76.79 1.27 17.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -1.156 . . . . 0.0 109.923 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.521 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 70.0 p -92.39 -33.57 14.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.528 ' CD2' HG13 ' A' ' 128' ' ' ILE . 34.8 mt -114.71 163.76 15.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 110.081 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.438 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 39.6 mt-10 -143.56 -79.78 0.2 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.249 -0.907 . . . . 0.0 110.006 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 53.8 mttt -80.12 141.6 35.61 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 110.668 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.621 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.2 mm -129.36 143.24 41.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.366 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.1 m -123.27 126.8 47.59 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.621 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 13.0 m-85 -121.63 135.27 54.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 110.221 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 117' ' ' THR . 74.6 tt0 -136.24 140.12 43.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.242 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 92.5 m -137.95 146.76 43.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 110.228 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 115' ' ' LYS . 19.3 mttt -138.09 145.72 42.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.536 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 2.8 mt -123.21 152.96 40.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 110.461 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.499 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.36 -169.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -127.35 125.55 40.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.26 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.428 ' HB3' HG13 ' A' ' 113' ' ' ILE . 95.4 p -82.21 160.57 62.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 110.187 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.36 -1.31 10.0 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.031 1.543 . . . . 0.0 110.553 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.1 t -98.73 -4.03 34.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.47 -41.61 2.19 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.92 -179.17 5.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 4.6 m -121.15 135.66 55.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.399 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 74.9 mt -84.85 149.96 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.361 -0.837 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.57 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 4.7 mt -134.98 113.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 110.398 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 103' ' ' LYS . 22.4 ttmt -100.45 122.34 43.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.91 . . . . 0.0 109.831 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.0 t -114.7 158.12 22.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 0.0 110.619 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 93.4 m -156.32 133.64 10.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.38 -0.825 . . . . 0.0 110.043 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.6 p -133.02 157.78 44.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.153 -0.967 . . . . 0.0 110.334 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 120' ' ' TYR . 74.7 m-70 -141.25 167.06 23.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.131 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 9.2 m-85 -131.33 150.03 52.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.43 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.9 m-70 -126.3 90.09 3.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 109.561 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.522 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 3.0 p -71.27 166.45 21.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.395 -0.815 . . . . 0.0 110.67 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.438 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 21.4 tttp -119.75 121.1 38.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -0.834 . . . . 0.0 110.153 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.46 -108.24 3.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.517 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 51.5 t30 -139.63 94.35 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -1.166 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.522 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 16.7 m -157.65 159.68 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 0.0 110.098 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -133.84 154.26 51.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 110.282 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.643 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 3.3 mp -76.97 173.07 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.383 -0.823 . . . . 0.0 110.257 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 132' ' ' HIS . 60.5 mttt -101.85 128.88 48.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.106 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.464 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 53.4 mm-40 -44.53 -48.56 10.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 110.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 35.3 tt0 -54.67 -31.22 57.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 109.861 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 129' ' ' LYS . 17.4 t-160 -75.58 -55.67 5.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.631 ' CG2' ' CD2' ' A' ' 5' ' ' TYR . 11.6 p -67.0 -40.96 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 93.7 mttt -66.59 -46.25 76.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.07 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -60.39 -33.29 72.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 110.045 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.07 -26.06 71.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -75.09 -35.13 61.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 110.172 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.34 -35.84 61.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 109.976 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -68.65 -37.69 79.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 109.845 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.55 78.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.863 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.7 t -65.88 -48.45 71.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.379 -0.825 . . . . 0.0 109.953 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -53.82 -42.28 68.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.928 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.469 ' O ' HG13 ' A' ' 147' ' ' ILE . 2.6 mm? -58.7 -47.8 83.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 109.951 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.432 ' CE1' HG23 ' A' ' 114' ' ' ILE . 9.8 m-85 -56.31 -38.42 71.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 110.162 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 78.3 mttt -74.03 -21.98 59.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.107 -0.995 . . . . 0.0 109.93 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.521 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 15.0 mt -87.4 -35.29 18.4 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 108.701 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.6 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 67.9 mt -75.44 -37.36 37.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.575 -0.703 . . . . 0.0 109.129 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 19.8 pt-20 -62.83 -32.82 74.1 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.144 -0.972 . . . . 0.0 109.006 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.467 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 16.8 m -79.93 -26.76 39.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.19 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.582 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 80.9 t80 -60.94 -52.22 65.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.596 -0.69 . . . . 0.0 109.845 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.635 ' CD2' ' CE1' ' A' ' 158' ' ' TYR . 80.5 mt -76.41 -36.65 57.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.266 -0.896 . . . . 0.0 109.972 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.524 ' CA ' HD13 ' A' ' 13' ' ' ILE . 45.0 tptt -64.36 -21.69 66.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.57 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -109.31 -32.14 3.07 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.573 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.9 m-70 -108.37 93.49 11.62 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -1.096 . . . . 0.0 110.025 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.14 5.05 3.79 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.0 1.526 . . . . 0.0 110.954 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -108.74 -6.33 15.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 109.886 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.552 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -75.35 101.33 4.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.865 . . . . 0.0 110.005 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.635 ' CE1' ' CD2' ' A' ' 151' ' ' LEU . 1.5 p90 34.03 36.8 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.817 -0.552 . . . . 0.0 110.82 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.509 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.728 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 45.8 t -120.2 117.55 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.169 . . . . 0.0 110.224 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.572 ' CE1' HG12 ' A' ' 128' ' ' ILE . 76.7 m-85 -88.15 125.4 34.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.407 HG22 ' CE1' ' A' ' 119' ' ' HIS . 25.1 m -105.48 113.73 27.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 110.388 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.572 ' CE1' HG11 ' A' ' 133' ' ' VAL . 60.3 m-85 -117.26 125.76 51.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.079 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 116' ' ' SER . 20.9 pt-20 -133.74 154.89 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 110.302 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t -127.47 164.68 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.119 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -142.6 116.48 9.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.9 p90 -148.29 -170.12 3.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.308 -0.87 . . . . 0.0 110.204 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 10.4 p -141.15 174.84 10.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.393 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.418 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 1.4 t -154.65 157.31 37.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -87.8 -14.48 39.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 110.118 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.533 ' CD1' ' HB2' ' A' ' 152' ' ' LYS . 2.3 mp -81.42 149.95 66.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.525 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 39.9 Cg_endo -66.36 145.75 78.45 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.003 1.528 . . . . 0.0 110.438 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.642 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 Cg_endo -72.23 -31.68 11.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.91 1.479 . . . . 0.0 113.054 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.9 Cg_endo -69.74 -21.14 33.99 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 110.108 -0.766 . . . . 0.0 110.108 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.529 ' CD ' ' HB2' ' A' ' 159' ' ' ASN . 7.1 mmp_? -85.68 -43.35 13.49 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.516 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.3 tt -72.2 -29.92 64.43 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.602 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 73.8 t80 -67.21 -56.98 7.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.565 -0.709 . . . . 0.0 109.58 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 66.0 mttt -54.84 -34.12 62.49 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.293 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.621 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -74.42 -55.8 5.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.519 -0.738 . . . . 0.0 110.918 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.639 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -58.61 -46.14 87.65 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.559 -0.713 . . . . 0.0 111.494 -178.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.589 ' CG1' ' CD1' ' A' ' 74' ' ' ILE . 18.2 t -98.17 -65.39 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.075 -1.015 . . . . 0.0 111.897 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 4.1 mm? -65.41 -4.64 5.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 111.548 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.541 ' OD2' ' CD1' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -148.19 36.64 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.942 -1.099 . . . . 0.0 110.427 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -73.97 -36.51 64.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 68.5 m-20 -62.86 -13.58 35.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.128 -0.982 . . . . 0.0 110.355 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 78.2 m-20 -127.53 7.19 6.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.928 . . . . 0.0 110.2 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.532 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -95.38 -52.18 4.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.903 179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.5 t -71.35 -41.47 10.29 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.574 -0.704 . . . . 0.0 110.871 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.4 Cg_endo -77.88 9.69 2.9 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.484 1.255 . . . . 0.0 110.964 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 29.3 mttm -129.83 -33.39 1.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.056 -1.027 . . . . 0.0 109.753 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.576 HG12 ' CD1' ' A' ' 150' ' ' TYR . 50.1 mt -80.18 -41.46 20.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.495 -0.753 . . . . 0.0 109.464 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.28 99.42 3.91 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.515 -0.741 . . . . 0.0 110.034 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.35 -1.31 9.48 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.089 1.573 . . . . 0.0 110.659 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -84.82 -11.45 55.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.113 -0.992 . . . . 0.0 109.669 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.41 -57.64 2.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.396 -0.815 . . . . 0.0 110.177 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.571 ' CG1' ' CG2' ' A' ' 56' ' ' ILE . 2.1 mp -121.74 107.36 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.402 -0.811 . . . . 0.0 110.176 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -59.82 -25.28 64.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.601 ' CG ' ' N ' ' A' ' 41' ' ' SER . 0.2 OUTLIER -173.44 176.77 2.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.601 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 70.5 m -150.86 151.16 31.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 109.905 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.412 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 82.3 tt0 -157.52 105.81 2.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.256 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 34.5 mt -51.71 132.97 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.449 ' HB3' ' O ' ' A' ' 53' ' ' ILE . 33.5 tp -93.85 -47.36 6.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.9 . . . . 0.0 110.326 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' O ' ' CG2' ' A' ' 52' ' ' THR . 5.1 mm-40 -132.09 134.59 45.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.62 -164.46 37.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -129.68 11.17 5.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.104 . . . . 0.0 110.162 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.04 -9.18 7.97 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -75.91 -168.76 26.27 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.6 Cg_endo -70.58 133.41 24.02 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.169 1.615 . . . . 0.0 110.526 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.38 -4.53 73.64 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.516 HG21 ' N ' ' A' ' 53' ' ' ILE . 16.9 m -80.14 147.63 31.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -1.149 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.516 ' N ' HG21 ' A' ' 52' ' ' THR . 25.8 mm -116.33 108.42 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.092 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 69' ' ' HIS . 90.1 mttt -91.83 134.97 34.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 0.0 110.319 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -106.24 94.05 4.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 110.052 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.571 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 86.8 mt -80.53 144.07 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.191 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.477 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 1.1 p -112.33 156.74 21.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 110.246 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.563 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 23.1 m-85 -114.04 162.99 15.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.871 . . . . 0.0 110.326 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.975 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.638 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 7.8 t80 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.252 0.549 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -134.93 134.48 7.36 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.638 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 15.1 p90 -177.71 168.63 2.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -1.203 . . . . 0.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.563 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 5.2 m -142.19 173.5 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.35 -0.844 . . . . 0.0 110.422 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.492 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . 91.7 mttt -119.75 131.38 55.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.481 -0.762 . . . . 0.0 109.709 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.65 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 14.2 m170 -113.51 132.37 55.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.93 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HA ' HD12 ' A' ' 53' ' ' ILE . 76.2 tttt -111.33 107.53 16.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.837 . . . . 0.0 109.253 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.8 mm -48.57 135.47 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.983 . . . . 0.0 110.412 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 73' ' ' SER . 15.8 m-20 -105.26 -45.36 4.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 109.398 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 29.0 p 177.4 156.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.641 -0.662 . . . . 0.0 110.13 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.589 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 3.8 tt -147.55 165.31 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.035 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-20 -134.84 80.1 1.83 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.328 -0.857 . . . . 0.0 110.041 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.602 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 24.0 mttt -56.13 -15.11 3.23 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.179 -0.95 . . . . 0.0 110.607 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -93.37 -30.81 14.91 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.294 -0.879 . . . . 0.0 109.557 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.4 m-80 -106.87 -1.34 22.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.552 -0.718 . . . . 0.0 109.424 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.582 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 68.7 m-85 63.66 52.85 2.14 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.369 0.604 . . . . 0.0 110.82 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.531 ' HB3' ' CG ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -126.88 151.11 48.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.634 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.596 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 77.3 t80 -145.57 163.64 34.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.189 -0.944 . . . . 0.0 110.14 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 73' ' ' SER . 84.8 p -168.51 146.21 4.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.015 -1.053 . . . . 0.0 110.799 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 2.6 p90 -148.23 -179.12 6.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.328 -0.857 . . . . 0.0 110.401 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.466 ' OG1' ' OD1' ' A' ' 72' ' ' ASP . 24.7 m -136.41 128.19 29.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.438 -0.789 . . . . 0.0 109.992 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.65 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 7.0 tp -80.39 121.97 26.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.275 -0.89 . . . . 0.0 110.073 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.492 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 27.5 pt -101.77 -11.56 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.89 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.438 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 66.7 tt0 -154.17 151.85 29.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.178 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.475 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 168.36 157.18 10.97 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' ALA . 65.8 t0 -72.2 -54.14 10.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -1.141 . . . . 0.0 110.366 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' ASP . . . -42.4 -31.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.525 HD22 ' CD2' ' A' ' 95' ' ' LEU . 21.2 mt -52.42 -53.17 48.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 110.128 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.76 -171.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -72.49 -2.08 18.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.126 . . . . 0.0 110.189 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 122' ' ' THR . 34.9 p -89.64 -60.46 1.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 110.37 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.537 ' CD1' ' CD1' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -105.06 163.07 12.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.317 -0.865 . . . . 0.0 109.258 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.465 ' O ' HD12 ' A' ' 91' ' ' LEU . 76.4 mm-40 -142.64 -81.12 0.21 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 110.324 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 71.2 mttt -80.25 153.64 28.39 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.545 -0.722 . . . . 0.0 110.621 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.613 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 35.1 mm -140.66 159.95 24.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.727 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -135.35 126.41 27.88 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.366 -0.834 . . . . 0.0 108.903 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.613 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 22.4 m-85 -123.77 135.68 53.96 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.189 -0.944 . . . . 0.0 110.497 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 71.7 tt0 -139.18 124.95 19.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 0.0 110.238 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 89.0 m -118.63 145.42 45.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.088 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.531 ' CG ' ' HB3' ' A' ' 80' ' ' SER . 7.5 mttt -136.72 132.89 35.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.317 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 79' ' ' TYR . 4.4 mt -106.74 153.51 22.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.086 -1.009 . . . . 0.0 110.07 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 1.9 t -150.96 -168.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.173 -0.954 . . . . 0.0 109.964 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.462 ' O ' ' CD1' ' A' ' 113' ' ' ILE . . . -119.46 158.61 25.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.225 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 25.8 p -119.67 165.35 17.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 110.216 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.6 Cg_endo -72.5 -1.48 10.33 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.089 1.573 . . . . 0.0 110.506 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.4 m -104.94 -5.9 20.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.149 -0.97 . . . . 0.0 110.227 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.33 -32.52 6.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.83 -171.76 2.88 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.478 ' OG ' ' HD3' ' A' ' 15' ' ' PRO . 5.9 m -129.85 132.72 46.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -1.14 . . . . 0.0 110.257 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 105' ' ' VAL . 11.4 mt -82.84 152.58 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.61 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 5.9 mt -133.55 114.31 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 110.184 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -103.31 108.81 20.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.2 m -99.42 157.33 16.5 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.266 -0.896 . . . . 0.0 110.29 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.467 HG23 ' NE2' ' A' ' 119' ' ' HIS . 71.6 m -156.5 131.46 9.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.848 . . . . 0.0 109.916 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 5' ' ' TYR . 89.3 p -134.31 148.9 50.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.029 . . . . 0.0 110.696 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 39.7 m-70 -131.56 138.92 49.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.775 . . . . 0.0 110.015 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.488 ' CE2' ' CE2' ' A' ' 5' ' ' TYR . 12.1 m-30 -100.13 150.98 21.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 110.691 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 98.5 m-70 -128.08 90.7 3.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 0.0 109.488 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.508 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 2.8 p -79.52 161.3 26.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 110.539 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -120.34 115.53 23.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 110.061 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.16 -141.54 15.37 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.405 ' C ' HG12 ' A' ' 126' ' ' VAL . 53.1 t30 -113.23 96.22 5.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 110.223 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 21.8 m -151.45 168.62 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.297 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -138.9 160.19 40.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.572 HG12 ' CE1' ' A' ' 3' ' ' PHE . 35.5 mm -74.9 173.36 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 130' ' ' GLU . 40.6 mttt -110.9 133.75 53.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 0.0 110.228 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 129' ' ' LYS . 1.1 mt-10 -43.5 -49.21 7.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.148 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -58.53 -36.06 73.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 110.108 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -68.88 -44.2 73.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.195 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.572 HG11 ' CE1' ' A' ' 5' ' ' TYR . 60.6 t -61.64 -38.05 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.983 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -77.82 -42.49 33.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.57 -37.61 87.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.098 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.27 -29.97 74.93 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 84.9 mttt -79.26 -31.26 43.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -1.114 . . . . 0.0 110.111 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -78.03 -32.93 51.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.852 . . . . 0.0 110.092 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -73.81 -28.18 61.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.412 -0.805 . . . . 0.0 110.015 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -80.05 -36.72 35.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.925 . . . . 0.0 110.051 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.0 p -71.29 -46.76 60.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.409 -0.807 . . . . 0.0 110.025 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.422 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 98.4 m-20 -55.47 -49.3 72.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 110.01 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 147' ' ' ILE . 69.8 mt -57.48 -41.98 81.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.915 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 6.3 m-85 -59.74 -40.92 89.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.485 -0.76 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.425 ' HB3' ' HE3' ' A' ' 145' ' ' LYS . 18.3 mtpp -80.0 -16.79 54.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.115 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.471 ' HB3' HG23 ' A' ' 33' ' ' ILE . 27.9 mt -84.26 -36.37 22.72 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.151 -0.968 . . . . 0.0 108.833 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.639 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 97.3 mt -72.58 -45.16 59.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.463 ' O ' HD12 ' A' ' 13' ' ' ILE . 69.1 mt-10 -57.09 -40.58 77.23 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.3 m -68.53 -35.61 77.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.94 . . . . 0.0 109.459 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.588 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 86.5 t80 -54.27 -46.46 72.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.518 -0.739 . . . . 0.0 109.908 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.648 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 94.7 mt -79.87 -31.07 40.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.533 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 73.3 tttt -71.11 -25.51 62.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.573 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.33 -34.21 3.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.538 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.9 m-70 -106.91 92.67 7.84 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.259 -1.142 . . . . 0.0 110.179 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.514 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.5 Cg_endo -74.26 6.44 3.06 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.097 1.578 . . . . 0.0 111.072 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -107.43 -2.6 20.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.916 -1.115 . . . . 0.0 109.775 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.575 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . . . -78.67 104.35 9.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.501 -0.749 . . . . 0.0 110.123 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.648 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.66 33.19 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.348 0.594 . . . . 0.0 110.357 -179.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.529 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.862 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 68.5 t -132.1 118.28 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 110.207 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CE1' HG12 ' A' ' 128' ' ' ILE . 64.8 m-85 -93.47 125.92 38.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.34 -0.85 . . . . 0.0 110.06 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.41 HG22 ' CE1' ' A' ' 119' ' ' HIS . 28.9 m -107.88 111.04 22.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.853 . . . . 0.0 110.304 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 60.0 m-85 -116.65 138.17 51.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.836 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 116' ' ' SER . 18.8 pt-20 -141.21 167.37 22.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.149 -0.97 . . . . 0.0 110.654 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.1 t -143.63 157.75 44.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.43 -0.794 . . . . 0.0 109.806 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -141.93 117.51 10.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.008 . . . . 0.0 110.628 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 p90 -138.5 -175.09 4.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.84 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 23.2 p -136.57 178.92 6.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.524 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.516 ' CB ' ' OE2' ' A' ' 148' ' ' GLU . 59.1 p -160.04 163.73 33.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.464 -0.773 . . . . 0.0 110.458 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -89.21 -10.2 47.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.906 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 3.4 mp -92.32 149.87 39.17 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.828 . . . . 0.0 110.058 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.6 Cg_endo -66.02 145.31 79.09 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.997 1.525 . . . . 0.0 110.367 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.638 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.7 Cg_endo -71.11 -32.25 13.47 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.888 1.468 . . . . 0.0 112.796 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -68.38 -20.91 41.65 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.525 ' CZ ' ' CB ' ' A' ' 159' ' ' ASN . 53.4 mmm-85 -84.29 -46.3 11.95 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.513 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -71.99 -24.95 61.66 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.617 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 89.1 t80 -68.61 -59.82 2.86 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.519 0.676 . . . . 0.0 109.346 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 77.5 mttt -52.04 -38.15 55.99 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.237 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.67 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -70.06 -55.44 9.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 110.711 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.604 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.6 OUTLIER -57.12 -49.7 75.09 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 111.235 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.596 HG12 ' CD1' ' A' ' 81' ' ' TYR . 10.3 t -95.28 -65.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.971 -1.08 . . . . 0.0 111.722 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 8.3 mp -64.83 -4.37 4.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.177 -0.952 . . . . 0.0 111.805 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.526 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -148.28 33.19 0.81 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.715 -1.24 . . . . 0.0 110.548 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -71.99 -34.03 68.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 0.0 110.241 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 41' ' ' SER . 12.8 t70 -64.97 -13.85 58.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.91 . . . . 0.0 110.287 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.469 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 80.9 m-20 -126.78 3.34 6.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.112 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.516 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -90.15 -54.78 3.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 110.234 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.585 ' CG1' ' CD1' ' A' ' 38' ' ' ILE . 92.6 t -65.81 -41.26 45.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 111.109 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.4 Cg_endo -76.73 4.98 5.16 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.369 1.194 . . . . 0.0 110.608 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 47.1 mttm -125.87 -31.69 2.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.58 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.576 HG12 ' CD1' ' A' ' 150' ' ' TYR . 23.5 mt -80.06 -39.22 19.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.523 -0.735 . . . . 0.0 109.859 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -163.17 97.74 1.05 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 110.19 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.83 5.23 4.53 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.009 1.531 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -87.1 -15.75 37.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 110.025 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.44 -35.38 10.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.207 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.585 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 0.9 OUTLIER -129.98 145.56 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 109.906 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -83.86 -35.18 24.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 110.48 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 178.8 157.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 110.249 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 58.5 m -118.19 126.95 53.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.066 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 58.2 tt0 -134.66 105.95 6.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 19.0 mt -59.63 134.0 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.5 tp -95.03 -44.31 7.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.334 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 52' ' ' THR . 11.5 mt-10 -127.18 159.32 34.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 61.8 -161.16 28.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -134.43 10.67 3.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -1.152 . . . . 0.0 110.181 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.08 -6.69 6.82 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 71' ' ' ILE . . . -86.68 -163.19 38.25 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -70.72 131.83 20.64 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.013 1.533 . . . . 0.0 110.601 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.01 -6.54 69.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 20.4 m -79.98 135.68 36.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -1.164 . . . . 0.0 110.144 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 25.9 mm -105.22 113.79 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.208 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 95.1 mttt -99.15 138.78 35.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.376 -0.828 . . . . 0.0 110.298 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -110.97 92.76 4.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.164 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.517 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.8 mt -79.99 143.83 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 109.881 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.495 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 6.8 p -116.87 160.16 21.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.688 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.424 ' O ' ' C ' ' A' ' 59' ' ' GLY . 28.4 m-85 -120.08 163.14 18.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.534 -0.729 . . . . 0.0 110.059 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.648 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 t80 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.234 0.54 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -129.18 137.21 9.44 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.648 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 13.4 p90 -178.26 169.43 1.85 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -1.135 . . . . 0.0 110.081 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.528 HG13 ' CA ' ' A' ' 88' ' ' GLY . 5.5 m -142.42 172.21 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.895 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.442 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 43.7 mtpt -122.95 121.2 35.55 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.582 ' CD2' ' HG ' ' A' ' 85' ' ' LEU . 21.7 m170 -116.39 135.28 54.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.023 . . . . 0.0 111.31 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 82.9 tttt -111.15 121.74 46.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.415 -0.803 . . . . 0.0 109.12 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.542 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.1 mm -60.58 134.89 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 110.436 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 82' ' ' SER . 19.2 t0 -105.73 -47.92 3.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.482 -0.761 . . . . 0.0 109.864 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 1.9 m -179.99 159.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.543 -0.723 . . . . 0.0 110.205 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.539 ' CD1' HG12 ' A' ' 23' ' ' VAL . 3.4 tt -149.13 164.55 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.992 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -127.13 78.9 1.85 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.877 . . . . 0.0 110.042 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.617 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 63.4 mttp -54.34 -15.81 1.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.42 -0.8 . . . . 0.0 110.819 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -92.07 -30.47 16.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.93 . . . . 0.0 109.861 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -110.59 -1.37 16.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.537 -0.727 . . . . 0.0 109.691 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 75' ' ' ASP . 9.1 m-85 66.01 48.48 1.76 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.688 -0.632 . . . . 0.0 110.518 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -118.56 151.77 37.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.345 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.654 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 84.4 t80 -148.11 143.79 27.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.047 -1.033 . . . . 0.0 110.285 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.468 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 66.5 m -149.61 134.0 17.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.393 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.654 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 4.0 p90 -137.54 179.29 6.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 110.048 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 90.2 m -125.08 128.97 49.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.913 . . . . 0.0 110.17 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.582 ' HG ' ' CD2' ' A' ' 69' ' ' HIS . 1.5 tt -91.75 140.99 29.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.137 -0.977 . . . . 0.0 110.121 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.409 HG23 HD11 ' A' ' 86' ' ' ILE . 21.1 pt -127.64 -24.62 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.033 -1.042 . . . . 0.0 110.487 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.442 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 72.6 tt0 -138.12 115.69 11.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.102 -0.999 . . . . 0.0 110.613 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.528 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . -165.03 132.79 2.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 88' ' ' GLY . 60.2 t0 -42.85 -36.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -1.194 . . . . 0.0 110.402 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.76 -25.3 68.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.146 -0.971 . . . . 0.0 110.354 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.452 HD23 HG12 ' A' ' 98' ' ' ILE . 96.8 mt -68.04 -28.18 67.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.288 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.34 -168.54 0.31 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -90.04 12.72 16.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -1.158 . . . . 0.0 110.183 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 122' ' ' THR . 25.2 p -105.54 -52.11 2.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.145 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.526 HD22 ' CD1' ' A' ' 128' ' ' ILE . 48.7 mt -79.95 151.01 30.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.069 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.429 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 68.3 mt-10 -127.4 -80.91 0.6 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.34 -0.85 . . . . 0.0 110.269 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 85.5 mttt -80.26 147.15 31.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.593 -0.692 . . . . 0.0 110.292 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.659 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 10.5 mm -135.46 145.91 30.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.94 -1.1 . . . . 0.0 110.043 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -122.66 124.79 44.24 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.465 -0.772 . . . . 0.0 108.92 178.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.659 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 14.7 m-85 -121.62 132.64 54.78 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.384 -0.823 . . . . 0.0 110.359 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.468 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 26.6 tt0 -132.8 146.91 52.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -0.859 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 81' ' ' TYR . 57.2 m -145.68 135.99 23.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 110.066 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 115' ' ' LYS . 4.1 tttt -129.07 148.63 51.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.185 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.498 ' C ' ' CG2' ' A' ' 105' ' ' VAL . 10.5 mt -122.64 148.06 45.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 110.458 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.498 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.09 -168.34 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.355 -0.84 . . . . 0.0 109.616 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -130.69 137.64 49.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.505 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.649 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 5.4 p -80.04 -161.09 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.367 -0.833 . . . . 0.0 109.211 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.649 ' CD ' ' CB ' ' A' ' 107' ' ' SER . 43.9 Cg_endo -83.46 70.72 6.32 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.348 1.183 . . . . 0.0 109.499 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 2.3 m 58.23 30.16 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.528 -0.733 . . . . 0.0 109.594 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.42 34.21 3.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 11' ' ' SER . . . 107.75 -147.84 16.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 57.5 p -138.05 139.34 39.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.129 -1.218 . . . . 0.0 110.079 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 33.3 mt -88.79 147.49 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 110.243 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.619 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 6.0 mt -127.63 108.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 110.069 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 103' ' ' LYS . 34.8 mtpt -90.22 145.95 24.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 110.291 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.2 t -140.95 155.7 46.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.12 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 24.2 m -159.99 153.31 22.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.342 -0.849 . . . . 0.0 110.137 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 99' ' ' SER . 94.4 p -153.26 154.7 35.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.173 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 51.9 m-70 -136.92 136.56 38.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.233 -0.917 . . . . 0.0 110.072 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 7.1 m-30 -99.01 151.06 21.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.245 -0.909 . . . . 0.0 110.719 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 96.9 m-70 -130.14 78.13 1.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.523 HG22 ' CG2' ' A' ' 126' ' ' VAL . 0.2 OUTLIER -73.5 157.44 36.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.359 -0.838 . . . . 0.0 110.686 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.429 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 86.2 tttt -105.43 120.41 41.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 110.237 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.28 -161.77 21.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.503 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 58.0 t30 -102.31 111.13 23.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -1.167 . . . . 0.0 110.245 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' A' ' 122' ' ' THR . 24.5 m -156.47 170.86 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.254 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -128.66 136.17 50.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.573 HG12 ' CE1' ' A' ' 3' ' ' PHE . 48.6 mm -57.91 173.4 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 0.0 110.035 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.411 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 39.9 mtpt -102.82 130.4 49.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.938 . . . . 0.0 110.255 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -45.72 -51.06 13.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 110.157 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 35.9 tt0 -58.77 -34.86 71.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 110.074 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -67.52 -41.48 84.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 0.0 110.074 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.635 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 85.7 t -65.94 -45.83 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.434 -0.791 . . . . 0.0 110.059 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -74.87 -39.28 61.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.049 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -62.67 -39.63 94.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 110.015 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.58 -29.67 75.7 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -76.5 -31.38 57.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -1.127 . . . . 0.0 110.075 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -78.8 -32.41 46.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.63 -41.12 69.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.0 109.938 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.574 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.27 -33.46 63.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.8 m -68.4 -48.47 64.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.82 . . . . 0.0 109.936 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -55.91 -44.25 78.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.853 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.9 mt -62.29 -35.7 79.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.89 . . . . 0.0 109.945 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 8.3 m-85 -64.12 -36.1 82.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.085 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -78.87 -13.95 59.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 0.0 110.169 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.502 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 17.3 mt -85.19 -36.82 20.76 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 108.969 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.604 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 11.6 mt -69.74 -44.31 79.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.516 ' OE2' ' CB ' ' A' ' 11' ' ' SER . 12.3 mm-40 -59.31 -44.95 92.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 66.0 m -60.78 -35.98 77.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.977 . . . . 0.0 109.392 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.576 ' CD1' HG12 ' A' ' 33' ' ' ILE . 71.8 t80 -54.24 -55.63 26.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.525 -0.734 . . . . 0.0 109.693 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.588 HD22 ' CE1' ' A' ' 158' ' ' TYR . 26.7 mt -71.69 -29.46 64.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.403 -0.811 . . . . 0.0 110.25 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HB2' HD12 ' A' ' 13' ' ' ILE . 74.5 tttt -61.15 -18.35 57.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.108 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -122.53 -16.26 3.84 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 14.5 m-70 -107.01 90.1 5.07 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.191 -1.182 . . . . 0.0 110.219 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.9 Cg_endo -73.15 2.21 5.8 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.072 1.564 . . . . 0.0 110.859 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -122.6 -2.03 8.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.109 -0.994 . . . . 0.0 109.933 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -49.45 110.02 0.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.421 -0.799 . . . . 0.0 110.398 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.67 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.46 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.584 -0.698 . . . . 0.0 110.618 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.525 ' CB ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.744 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.458 ' O ' ' OG1' ' A' ' 122' ' ' THR . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.404 HG23 ' ND1' ' A' ' 121' ' ' HIS . 26.4 t -129.09 134.94 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -1.15 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.638 ' CG ' ' CD1' ' A' ' 128' ' ' ILE . 25.4 m-85 -100.6 158.09 16.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.317 -0.865 . . . . 0.0 109.809 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.0 m -131.72 113.56 13.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -0.996 . . . . 0.0 110.504 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.574 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 85.7 m-85 -118.12 125.41 50.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 110.02 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.57 ' CG ' ' CG2' ' A' ' 117' ' ' THR . 7.3 mt-10 -137.12 151.59 49.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 110.128 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -133.97 153.76 51.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.283 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.432 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 94.6 mt-10 -133.88 116.68 15.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 110.142 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -146.57 -176.17 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 110.055 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -136.15 176.89 8.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.9 p -154.13 150.0 27.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.796 . . . . 0.0 110.186 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -73.45 -6.16 44.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.533 ' CD1' ' HB2' ' A' ' 152' ' ' LYS . 3.2 mp -94.06 149.59 37.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.034 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 40.4 Cg_endo -66.92 147.08 79.83 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.095 1.576 . . . . 0.0 110.246 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.634 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 Cg_endo -72.01 -32.09 11.5 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.836 1.44 . . . . 0.0 112.957 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.4 Cg_endo -71.31 -21.12 27.03 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 N-CA-C 110.058 -0.786 . . . . 0.0 110.058 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.542 ' CD ' ' HB2' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -83.28 -46.29 12.81 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.515 HD13 ' CD2' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -70.8 -30.57 67.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.599 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 53.6 t80 -64.99 -56.72 11.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.355 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 55.0 mttt -50.92 -40.33 56.8 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.027 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.596 ' HB1' ' CE1' ' A' ' 158' ' ' TYR . . . -68.71 -60.47 2.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.551 -0.718 . . . . 0.0 110.813 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.576 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.4 OUTLIER -50.16 -57.02 8.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.653 -0.654 . . . . 0.0 112.046 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.584 HG12 ' CD1' ' A' ' 81' ' ' TYR . 6.6 t -94.7 -59.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.951 -1.093 . . . . 0.0 112.287 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.2 mp -68.92 -0.74 5.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.055 -1.028 . . . . 0.0 111.712 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.569 ' OD2' ' CD2' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -152.64 30.03 0.53 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.84 -1.162 . . . . 0.0 110.635 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -67.03 -41.79 86.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 110.093 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 16.4 m-20 -58.14 -15.54 10.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.159 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.452 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 67.2 m-80 -127.16 10.13 6.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.255 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.507 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -96.85 -50.57 4.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.308 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.667 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 6.9 p -73.83 -27.22 0.78 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 112.128 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.667 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 52.1 Cg_endo -82.71 11.13 3.33 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.636 0.808 . . . . 0.0 110.588 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -136.83 -28.11 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.13 -0.981 . . . . 0.0 110.793 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.569 HG12 ' CD1' ' A' ' 150' ' ' TYR . 29.4 mt -76.27 -42.01 36.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.167 -0.958 . . . . 0.0 109.857 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.84 101.38 1.3 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.37 -0.831 . . . . 0.0 110.406 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.3 -0.45 9.21 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.086 1.571 . . . . 0.0 110.44 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -89.1 -17.9 28.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 110.015 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.21 -39.64 9.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 110.083 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.537 ' CD1' ' CG2' ' A' ' 30' ' ' VAL . 1.1 mp -133.69 142.28 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 109.911 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.452 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 35.3 ttmt -76.66 -42.52 41.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.871 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.538 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.44 158.68 0.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.9 . . . . 0.0 110.176 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.4 m -115.27 126.39 54.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.224 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -133.8 103.45 5.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.239 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.485 HG22 HD11 ' A' ' 43' ' ' ILE . 23.8 mt -52.58 130.45 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.53 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 44.8 mt -89.7 -46.85 8.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.516 ' O ' ' CG2' ' A' ' 52' ' ' THR . 9.4 mm-40 -132.52 151.83 51.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.411 -0.806 . . . . 0.0 110.192 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.54 -158.29 48.7 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -143.53 14.21 1.78 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -1.172 . . . . 0.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.27 -2.03 11.47 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -90.94 -168.07 41.77 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HA ' HG23 ' A' ' 71' ' ' ILE . 42.3 Cg_endo -69.82 130.95 20.15 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.146 1.603 . . . . 0.0 110.549 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.71 -2.76 70.35 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 42.5 m -79.96 145.43 32.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -1.182 . . . . 0.0 109.966 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.519 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 33.6 mm -111.14 114.88 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 110.44 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 99.5 mttt -100.74 139.79 35.93 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.415 -0.803 . . . . 0.0 110.033 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 85.6 tttt -116.09 95.47 5.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.096 -1.002 . . . . 0.0 110.438 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.521 ' CG2' HG12 ' A' ' 38' ' ' ILE . 78.3 mt -85.71 144.71 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 39' ' ' LYS . 5.5 p -114.57 158.16 22.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 110.842 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 28.3 m-85 -116.03 140.59 49.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.51 -0.744 . . . . 0.0 110.244 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.594 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 10.3 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.277 0.56 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -123.81 137.27 10.75 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.594 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 13.5 p90 -178.74 166.04 1.67 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.253 -1.145 . . . . 0.0 110.03 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.535 ' CG1' ' HA3' ' A' ' 88' ' ' GLY . 5.1 m -141.57 172.68 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 110.779 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.498 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 93.1 mttt -125.95 125.19 42.33 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.584 ' CD2' HD21 ' A' ' 85' ' ' LEU . 11.3 m170 -115.67 118.81 34.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.964 -1.085 . . . . 0.0 111.429 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HG2' ' CD1' ' A' ' 53' ' ' ILE . 35.5 mttt -92.59 104.32 16.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.193 -0.942 . . . . 0.0 108.878 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.544 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 44.2 mm -47.43 135.62 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.407 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.521 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 14.9 m-20 -109.22 -44.18 3.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.457 -0.777 . . . . 0.0 109.697 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER 175.5 160.2 0.25 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.45 -0.781 . . . . 0.0 110.509 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.542 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 4.4 tt -147.4 168.17 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.647 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.5 m-20 -134.97 82.22 1.95 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.106 -0.996 . . . . 0.0 110.263 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.599 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 95.4 mttt -58.43 -14.29 7.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.214 -0.929 . . . . 0.0 110.607 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.419 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 13.5 mm-40 -95.34 -30.54 13.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.217 -0.927 . . . . 0.0 109.591 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.4 m-80 -106.07 -2.84 22.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.712 -0.618 . . . . 0.0 109.428 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 75' ' ' ASP . 96.3 m-85 62.56 54.19 2.48 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.463 0.649 . . . . 0.0 110.651 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -132.2 150.4 52.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.584 ' CD1' HG12 ' A' ' 23' ' ' VAL . 72.0 t80 -143.42 152.46 41.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 109.991 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.454 ' HB3' ' CG ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -158.7 149.95 20.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.022 -1.049 . . . . 0.0 110.697 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 38.1 p90 -158.6 173.3 16.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.411 -0.805 . . . . 0.0 110.367 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 70' ' ' LYS . 88.5 m -113.29 123.66 50.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.376 -0.828 . . . . 0.0 109.871 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.584 HD21 ' CD2' ' A' ' 69' ' ' HIS . 2.5 tm? -95.73 136.49 36.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.51 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 13.3 pt -122.0 -28.33 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 110.548 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.458 ' OE1' ' HD2' ' A' ' 68' ' ' LYS . 2.2 tt0 -116.07 141.08 48.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 110.226 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.535 ' HA3' ' CG1' ' A' ' 67' ' ' VAL . . . 167.08 123.81 0.68 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 67.7 t0 -45.01 -25.08 0.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.418 -1.048 . . . . 0.0 110.139 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.02 -25.86 63.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.913 . . . . 0.0 110.343 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' A' ' 86' ' ' ILE . 89.6 mt -61.44 -33.02 73.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.3 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.71 -167.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -90.54 11.5 21.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -1.16 . . . . 0.0 110.227 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.42 ' O ' HG21 ' A' ' 122' ' ' THR . 36.9 p -102.93 -37.43 7.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.19 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.528 ' CD2' HD13 ' A' ' 128' ' ' ILE . 15.7 mt -110.26 157.17 19.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.042 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -131.33 -78.79 0.52 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.294 -0.879 . . . . 0.0 110.345 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 37.8 mttp -80.18 148.11 31.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 0.0 110.384 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.644 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 6.7 mm -132.44 142.66 42.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.936 -1.103 . . . . 0.0 110.055 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.9 m -116.3 120.44 38.91 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.644 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 11.7 m-85 -115.41 137.66 51.81 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 110.882 -178.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 117' ' ' THR . 4.7 mt-10 -141.21 137.11 32.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.453 -0.779 . . . . 0.0 109.803 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.9 m -131.98 148.01 52.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -136.99 133.83 35.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.077 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.515 ' CD2' HD13 ' A' ' 18' ' ' LEU . 8.0 mt -119.35 145.97 45.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 110.504 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.486 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.0 -169.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.375 -0.828 . . . . 0.0 109.86 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.45 ' O ' HD13 ' A' ' 113' ' ' ILE . . . -120.53 139.94 52.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.257 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.424 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 84.7 p -95.3 162.87 23.22 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 110.219 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.8 Cg_endo -73.43 -1.09 10.16 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.02 1.537 . . . . 0.0 110.549 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.7 p -98.67 -11.04 22.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.58 -29.22 7.36 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.73 -162.55 7.99 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.521 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 11.8 p -132.33 134.57 45.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -1.087 . . . . 0.0 110.285 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 15.7 mt -83.69 142.55 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.887 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.571 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 9.0 mt -129.62 113.0 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.972 . . . . 0.0 110.501 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 87.1 tttt -102.06 111.54 23.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.895 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 9' ' ' PHE . 1.5 m -93.47 160.08 14.96 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.197 -0.939 . . . . 0.0 110.475 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.57 ' CG2' ' CG ' ' A' ' 6' ' ' GLU . 40.5 m -154.7 142.47 19.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.391 -0.818 . . . . 0.0 110.29 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.455 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 4.4 p -155.53 139.21 16.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 29.2 m-70 -130.5 130.62 44.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.215 -0.928 . . . . 0.0 109.802 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 6.1 m-30 -91.54 154.57 19.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.972 . . . . 0.0 110.795 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.5 m-70 -128.08 85.37 2.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.842 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.47 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 1.2 p -63.18 152.45 37.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 110.295 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 123' ' ' LYS . 50.5 tttt -117.96 97.65 5.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.49 -148.27 17.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.515 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 46.6 t30 -97.93 91.75 5.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -1.088 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 125' ' ' ASN . 30.4 m -156.82 159.7 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -145.04 146.06 31.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.181 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.638 ' CD1' ' CG ' ' A' ' 3' ' ' PHE . 2.7 mp -69.75 173.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 110.106 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.443 ' HB3' ' HG2' ' A' ' 131' ' ' GLU . 46.1 mttt -105.91 160.77 15.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.186 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -66.71 -30.4 70.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 110.033 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.443 ' HG2' ' HB3' ' A' ' 129' ' ' LYS . 17.8 pt-20 -70.11 -36.66 75.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.939 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -70.09 -40.87 74.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.998 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.574 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 42.9 t -62.77 -40.2 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 0.0 109.986 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -78.07 -41.86 34.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 110.001 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.98 98.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.942 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.88 -31.9 81.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.418 ' HE3' HG11 ' A' ' 133' ' ' VAL . 89.2 mttt -75.9 -33.24 59.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -1.095 . . . . 0.0 110.048 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -77.91 -33.05 52.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.907 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -72.49 -36.39 68.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 109.943 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.488 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -73.72 -34.77 64.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 109.937 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.0 m -66.4 -51.5 56.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 109.982 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -50.51 -46.59 57.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 0.0 109.957 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.72 -50.0 75.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 19.0 m-85 -54.94 -35.46 64.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.454 -0.779 . . . . 0.0 109.61 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -79.88 -16.81 54.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -0.831 . . . . 0.0 109.909 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 25.9 mt -84.05 -35.59 23.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.216 -0.928 . . . . 0.0 108.931 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.576 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 70.0 mt -70.61 -42.53 77.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.473 ' HB3' HD11 ' A' ' 13' ' ' ILE . 55.8 mt-10 -57.06 -42.04 79.83 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.328 -0.857 . . . . 0.0 109.32 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.5 m -66.29 -34.35 77.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.572 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.569 ' CD1' HG12 ' A' ' 33' ' ' ILE . 76.4 t80 -54.97 -51.9 64.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.881 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.614 ' CD2' ' CE1' ' A' ' 158' ' ' TYR . 76.8 mt -77.37 -33.77 55.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.32 -0.863 . . . . 0.0 110.183 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.533 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 52.3 tptt -64.6 -22.41 66.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.36 -30.56 3.31 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.547 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 8.6 m-70 -106.68 92.31 7.13 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.287 -1.125 . . . . 0.0 110.148 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.1 Cg_endo -73.89 4.12 4.43 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.052 1.553 . . . . 0.0 110.831 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -110.58 -9.07 14.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.073 -1.017 . . . . 0.0 109.961 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.559 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -63.83 104.63 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.854 . . . . 0.0 109.976 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.614 ' CE1' ' CD2' ' A' ' 151' ' ' LEU . 1.0 OUTLIER 34.52 33.41 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.724 -0.61 . . . . 0.0 110.373 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.542 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.793 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.53 HG23 ' CE1' ' A' ' 121' ' ' HIS . 85.0 t -97.44 134.07 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -1.16 . . . . 0.0 110.418 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.578 ' CG ' HD11 ' A' ' 128' ' ' ILE . 10.7 m-85 -93.91 149.55 21.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 110.024 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -127.25 112.01 14.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 110.293 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.638 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 65.0 m-85 -126.31 136.98 53.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.069 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 4.6 pm0 -139.91 162.03 36.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.893 . . . . 0.0 110.298 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -147.74 154.81 41.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.427 -0.795 . . . . 0.0 109.963 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -134.01 118.85 18.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.975 . . . . 0.0 110.473 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.8 p90 -142.4 -172.66 3.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 109.86 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.47 HG23 HG12 ' A' ' 113' ' ' ILE . 9.4 p -143.03 178.72 7.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 110.603 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.432 ' OG ' HD13 ' A' ' 114' ' ' ILE . 23.4 p -151.48 176.54 11.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.786 . . . . 0.0 109.966 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -92.72 -27.11 17.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.918 . . . . 0.0 110.076 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.542 HG12 ' CG ' ' A' ' 152' ' ' LYS . 24.7 mm -84.23 148.03 51.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.932 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.558 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 40.5 Cg_endo -65.32 155.66 67.42 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.98 1.516 . . . . 0.0 111.007 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.632 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.3 Cg_endo -63.73 -37.21 47.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.87 1.458 . . . . 0.0 113.112 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -64.01 -19.68 66.75 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 N-CA-C 109.667 -0.936 . . . . 0.0 109.667 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.52 ' CG ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.91 -43.45 19.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 6.8 mp -75.7 -39.03 58.1 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.0 t80 -59.32 -54.71 43.67 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.455 0.645 . . . . 0.0 109.982 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.8 mttt -60.44 -34.06 73.44 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 109.839 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.597 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . . . -80.0 -59.36 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 0.0 110.923 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.56 ' CE1' HD12 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -54.66 -39.53 68.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.626 -0.671 . . . . 0.0 111.856 -178.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.581 HG12 ' CD1' ' A' ' 81' ' ' TYR . 21.6 t -106.86 -65.3 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.817 -1.177 . . . . 0.0 112.084 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.0 mp -63.62 -4.72 3.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.183 -0.948 . . . . 0.0 112.164 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.52 ' OD2' ' CD2' ' A' ' 158' ' ' TYR . 1.1 m-20 -144.82 8.19 1.27 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.638 -1.289 . . . . 0.0 110.939 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -52.05 -26.8 11.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 110.961 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -68.41 -26.38 65.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.937 -1.102 . . . . 0.0 109.592 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 8.9 p30 -125.7 17.22 8.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.604 -0.685 . . . . 0.0 109.473 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.534 HD22 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -94.5 -45.56 7.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.465 -0.772 . . . . 0.0 110.083 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.661 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 4.6 p -79.18 -28.18 0.54 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 112.267 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 51.4 Cg_endo -78.29 4.42 6.27 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 122.69 0.837 . . . . 0.0 110.277 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 28' ' ' ASN . 94.2 mttt -123.41 -28.38 3.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.659 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.59 HG12 ' CD1' ' A' ' 150' ' ' TYR . 25.0 mt -78.48 -31.22 15.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 109.676 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.59 98.24 0.44 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.514 -0.741 . . . . 0.0 110.194 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.58 0.2 8.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.062 1.559 . . . . 0.0 110.543 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -89.96 -18.7 25.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 0.0 110.1 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.54 -49.07 6.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.195 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.536 HG12 ' CG2' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -120.15 137.2 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 109.973 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 9.4 mmtt -75.43 -42.71 52.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 110.017 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.534 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.02 156.54 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.448 -0.783 . . . . 0.0 110.128 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 m -114.88 125.97 54.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -128.02 110.69 12.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.316 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 17.2 mt -60.85 131.08 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 110.125 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.7 mt -93.3 -44.7 8.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.525 ' O ' ' CG2' ' A' ' 52' ' ' THR . 1.7 tt0 -130.61 139.47 50.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.42 -0.8 . . . . 0.0 110.142 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.43 -163.92 46.97 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -130.82 2.7 4.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -1.123 . . . . 0.0 110.266 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.69 -4.61 4.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -85.04 -166.77 42.28 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.462 ' HA ' HG23 ' A' ' 71' ' ' ILE . 42.7 Cg_endo -70.09 131.17 20.23 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.067 1.562 . . . . 0.0 110.475 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.58 -5.6 67.29 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 39.7 m -80.04 140.46 36.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -1.096 . . . . 0.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 26.4 mm -110.18 114.6 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 110.276 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 92.4 mttt -98.0 159.45 14.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.826 . . . . 0.0 110.343 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -133.06 100.55 4.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 110.108 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.544 HG23 ' CE1' ' A' ' 58' ' ' PHE . 88.8 mt -89.11 140.09 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.305 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.2 p -111.06 154.25 24.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 110.849 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 23.6 m-85 -124.4 122.6 38.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.445 -0.784 . . . . 0.0 110.279 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.468 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.494 2.515 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.264 0.554 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -113.1 96.84 0.83 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 9.7 p90 -133.41 153.21 51.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -1.173 . . . . 0.0 109.992 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.559 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 5.6 m -125.28 172.5 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.186 -0.946 . . . . 0.0 110.774 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.455 ' HD2' ' OE1' ' A' ' 87' ' ' GLU . 69.6 mttt -124.92 129.19 49.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.708 -0.62 . . . . 0.0 109.371 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.514 ' NE2' HD11 ' A' ' 85' ' ' LEU . 10.1 m170 -117.59 120.31 37.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.161 -0.962 . . . . 0.0 110.993 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 55.3 tttm -96.67 109.85 22.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.821 . . . . 0.0 109.407 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.1 mm -48.55 139.46 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.982 . . . . 0.0 110.175 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.506 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 17.9 t0 -111.65 -40.55 4.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.477 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 0.7 OUTLIER 172.78 160.84 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.581 -0.7 . . . . 0.0 110.339 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.567 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 12.5 tt -149.27 172.24 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.536 -0.728 . . . . 0.0 109.505 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.7 m-20 -139.71 83.56 1.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.104 -0.998 . . . . 0.0 110.412 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.607 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 35.7 mtmm -59.27 -14.05 9.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.897 . . . . 0.0 110.44 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -96.02 -30.12 13.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 109.562 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.3 m-80 -107.68 -0.75 21.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.601 -0.687 . . . . 0.0 109.357 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' A' ' 75' ' ' ASP . 74.3 m-85 60.4 53.72 4.15 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.356 0.598 . . . . 0.0 110.598 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -127.74 156.0 43.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 109.617 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.581 ' CD1' HG12 ' A' ' 23' ' ' VAL . 86.5 t80 -152.99 146.89 25.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.079 -1.013 . . . . 0.0 110.434 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 101' ' ' GLU . 1.8 m -156.34 145.64 20.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.385 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 5.6 p90 -143.86 177.78 8.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.518 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 80.4 m -124.02 124.69 43.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.429 -0.794 . . . . 0.0 109.626 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.528 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 1.7 tp -93.59 137.32 32.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.32 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.3 pt -124.24 -12.2 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 110.257 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.467 ' O ' HD13 ' A' ' 91' ' ' LEU . 4.6 tt0 -129.21 160.45 32.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 110.236 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.528 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 146.55 132.0 2.29 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -64.81 -12.01 43.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -1.097 . . . . 0.0 110.033 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.53 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -81.38 -29.18 34.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.347 -0.846 . . . . 0.0 110.064 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.516 ' CD2' HG13 ' A' ' 98' ' ' ILE . 24.1 mt -66.11 -27.55 68.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 110.122 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.62 -172.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -82.49 6.38 17.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -1.163 . . . . 0.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 122' ' ' THR . 14.0 p -93.24 -30.8 15.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.064 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.539 ' CD2' ' CG1' ' A' ' 128' ' ' ILE . 34.0 mt -113.35 153.02 29.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.344 -0.848 . . . . 0.0 109.947 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 41.1 tt0 -131.45 -79.78 0.52 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.229 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.5 mttt -80.16 133.61 36.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.58 -0.7 . . . . 0.0 110.541 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.587 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 7.1 mm -123.9 143.36 37.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.863 -1.148 . . . . 0.0 109.683 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.76 127.43 50.63 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.203 179.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.587 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 10.2 m-85 -123.51 133.04 54.06 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.4 -0.812 . . . . 0.0 110.425 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 73.7 tt0 -130.3 158.17 40.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 110.118 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' TYR . 66.7 m -155.8 138.77 15.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.954 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 115' ' ' LYS . 3.4 mttt -132.28 136.05 46.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 114' ' ' ILE . 2.9 mt -119.06 149.66 41.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 110.467 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.497 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.54 -169.23 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.409 -0.807 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -123.56 134.11 53.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.453 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 52.4 p -89.03 164.39 31.14 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.9 Cg_endo -73.22 -0.27 8.92 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.045 1.55 . . . . 0.0 110.598 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.1 p -104.38 5.19 34.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 110.247 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.04 -41.28 2.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.66 -172.11 0.55 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.527 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 82.4 p -130.13 138.24 50.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -1.135 . . . . 0.0 110.29 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.47 HG12 HG23 ' A' ' 10' ' ' THR . 14.0 mt -88.05 151.6 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.889 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.575 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 5.5 mt -136.41 110.08 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.339 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 103' ' ' LYS . 78.0 tttt -98.25 119.49 37.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.936 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -112.94 155.34 24.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 110.395 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 98.9 m -158.09 126.04 5.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.87 . . . . 0.0 109.999 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 p -127.87 165.3 20.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 110.366 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.54 ' C ' ' CD1' ' A' ' 120' ' ' TYR . 56.9 m-70 -142.46 168.45 19.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.325 -0.86 . . . . 0.0 110.055 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 9.1 m-85 -130.74 148.72 52.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.377 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.53 ' CE1' HG23 ' A' ' 2' ' ' VAL . 95.0 m-70 -131.67 86.46 2.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.182 -0.949 . . . . 0.0 109.701 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 126' ' ' VAL . 1.1 p -56.54 160.7 3.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 66.0 tttt -119.13 107.61 13.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.238 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.8 -111.6 4.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.514 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 35.2 t30 -134.21 85.85 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -1.129 . . . . 0.0 110.402 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.514 ' CG1' ' O ' ' A' ' 125' ' ' ASN . 16.6 m -157.93 173.09 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 110.1 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.439 ' HA ' HG22 ' A' ' 122' ' ' THR . 84.1 mt-10 -144.84 171.43 14.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.248 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.578 HD11 ' CG ' ' A' ' 3' ' ' PHE . 3.9 mp -91.42 172.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 110.02 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 132' ' ' HIS . 19.7 mttt -114.39 131.26 56.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.89 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.508 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 83.9 mt-10 -43.39 -47.59 6.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 110.107 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 26.4 tt0 -58.3 -27.28 63.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.63 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 12.3 t-160 -83.42 -55.6 4.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.956 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.638 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 8.3 p -65.13 -42.15 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 109.961 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 35.7 ttmt -63.31 -42.94 99.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.814 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -62.71 -32.65 73.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.87 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.5 -35.61 92.0 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 5' ' ' TYR . 69.5 mmtt -64.35 -32.44 74.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -1.114 . . . . 0.0 109.908 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -72.27 -38.55 68.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.442 -0.786 . . . . 0.0 109.937 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -62.81 -46.51 87.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.806 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.47 -40.2 95.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.8 t -72.46 -52.0 17.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.403 -0.81 . . . . 0.0 109.799 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -50.47 -48.76 56.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.593 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.1 mp -54.62 -49.76 69.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -54.18 -41.88 69.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.725 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -66.46 -28.29 68.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 109.872 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.5 mt -80.59 -35.37 34.3 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.56 HD12 ' CE1' ' A' ' 22' ' ' PHE . 96.8 mt -66.79 -41.25 87.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 49.5 mt-10 -54.84 -47.16 74.49 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.403 -0.811 . . . . 0.0 109.18 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.3 m -61.15 -31.53 71.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.445 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.59 ' CD1' HG12 ' A' ' 33' ' ' ILE . 59.7 t80 -64.01 -52.89 57.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.789 . . . . 0.0 109.655 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.574 ' CD2' ' CE1' ' A' ' 158' ' ' TYR . 56.8 mt -80.07 -33.68 38.74 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 110.408 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.542 ' CG ' HG12 ' A' ' 13' ' ' ILE . 49.5 mtpt -65.71 -14.04 60.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 0.0 109.426 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.453 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.77 -30.27 1.4 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.508 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.1 m-70 -106.43 93.49 8.39 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.189 -1.183 . . . . 0.0 110.253 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.512 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.3 Cg_endo -74.26 3.82 4.89 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.101 1.58 . . . . 0.0 110.644 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -106.99 -11.25 15.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.55 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -67.83 100.62 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.757 . . . . 0.0 109.919 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.597 ' CE1' ' CB ' ' A' ' 21' ' ' ALA . 1.1 p90 34.59 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.25 0.548 . . . . 0.0 110.604 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.771 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.488 HG12 ' CE1' ' A' ' 121' ' ' HIS . 78.5 t -110.1 132.86 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -1.191 . . . . 0.0 110.236 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 128' ' ' ILE . 12.3 m-85 -94.3 149.08 21.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.253 -0.904 . . . . 0.0 109.983 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.554 HG21 ' CE1' ' A' ' 119' ' ' HIS . 8.6 m -127.56 114.19 17.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 110.443 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 64.8 m-85 -128.45 139.52 52.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.822 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 13.6 pt-20 -140.17 152.7 46.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 110.735 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 116' ' ' SER . 0.2 OUTLIER -147.22 166.04 28.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.499 -0.75 . . . . 0.0 109.45 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -144.23 145.78 32.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.058 -1.026 . . . . 0.0 110.553 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 6.3 p90 -159.01 -172.45 3.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.715 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 6.4 p -137.33 172.57 12.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.101 -1.0 . . . . 0.0 110.708 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 112' ' ' SER . 92.9 p -151.01 149.1 29.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 0.0 110.503 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.29 -25.97 66.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 0.0 110.184 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.526 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 4.7 mp -84.46 146.05 46.44 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 110.116 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.573 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 43.2 Cg_endo -67.96 154.65 72.25 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.136 1.598 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.642 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.0 Cg_endo -62.73 -37.13 58.53 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.748 1.394 . . . . 0.0 113.106 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 37.9 Cg_endo -63.58 -20.2 68.96 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 N-CA-C 109.823 -0.876 . . . . 0.0 109.823 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.534 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 5.7 mmp_? -80.64 -45.47 17.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.606 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 9.0 mp -75.51 -36.04 60.63 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.802 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.598 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 55.3 t80 -58.29 -58.01 10.38 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.107 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 87.4 mttt -59.86 -35.92 75.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.392 -0.818 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.615 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . . . -79.33 -61.55 1.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.357 -0.84 . . . . 0.0 111.019 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.608 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.9 OUTLIER -53.84 -38.28 64.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.448 -0.783 . . . . 0.0 111.653 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.537 HG12 ' CD1' ' A' ' 81' ' ' TYR . 8.0 t -105.22 -66.29 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.892 -1.13 . . . . 0.0 111.661 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.0 mp -66.74 -4.24 8.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.174 -0.954 . . . . 0.0 111.445 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.511 ' OD2' ' CD2' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -147.96 31.26 0.86 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.807 -1.183 . . . . 0.0 110.544 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.452 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -70.57 -32.67 70.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.98 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.523 ' OD2' ' CG1' ' A' ' 43' ' ' ILE . 94.7 m-20 -65.49 -15.89 63.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.869 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 74.0 m-80 -126.59 10.5 7.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.523 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -96.68 -54.2 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.6 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.0 t -67.38 -42.02 35.85 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 0.0 110.79 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -78.52 8.64 3.54 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.513 1.27 . . . . 0.0 110.693 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 35.1 mttt -126.77 -32.23 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.093 -1.005 . . . . 0.0 109.661 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.588 HG12 ' CD1' ' A' ' 150' ' ' TYR . 45.8 mt -80.0 -34.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.78 99.35 1.5 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.485 -0.759 . . . . 0.0 110.026 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.02 -0.75 8.98 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.092 1.575 . . . . 0.0 110.561 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -86.74 -9.69 55.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.878 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.18 -47.05 4.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.392 -0.817 . . . . 0.0 110.099 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.514 ' CD1' HG13 ' A' ' 30' ' ' VAL . 1.8 mp -124.98 143.02 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.459 -0.776 . . . . 0.0 109.874 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 36.5 ttmt -80.39 -37.92 31.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 110.262 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.525 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 178.8 139.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.248 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.513 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 3.2 m -102.17 128.11 48.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 110.314 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.525 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 27.0 tp10 -132.81 115.17 14.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 110.14 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.523 ' CG1' ' OD2' ' A' ' 27' ' ' ASP . 10.7 mt -64.97 133.05 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.363 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.43 HD13 ' HB2' ' A' ' 55' ' ' LYS . 24.3 mt -94.36 -45.74 7.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 110.204 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.526 ' O ' ' CG2' ' A' ' 52' ' ' THR . 6.9 mt-10 -130.51 141.3 50.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 110.116 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.86 -169.87 54.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -130.79 16.35 5.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -1.141 . . . . 0.0 110.304 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.39 -8.41 8.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -82.02 -168.92 42.31 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.462 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.2 Cg_endo -69.82 134.26 27.43 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.166 1.614 . . . . 0.0 110.468 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.21 76.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 37.2 m -79.97 138.75 37.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -1.145 . . . . 0.0 110.069 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.536 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 27.9 mm -109.35 111.66 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 110.288 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 81.6 mttt -97.14 154.72 17.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 110.204 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HB2' HD13 ' A' ' 44' ' ' LEU . 84.1 tttt -127.52 104.55 7.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.422 ' CG2' HG12 ' A' ' 38' ' ' ILE . 85.4 mt -90.82 140.84 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.3 p -113.28 150.97 31.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 110.333 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 23.7 m-85 -116.25 137.35 52.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 110.335 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.898 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.691 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 3.9 t80 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.153 0.502 . . . . 0.0 109.969 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -115.74 97.4 0.79 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.691 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 25.3 p90 -134.6 168.27 19.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.167 -1.196 . . . . 0.0 110.171 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.522 HG13 ' CA ' ' A' ' 88' ' ' GLY . 7.2 m -137.45 171.84 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 110.486 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.477 ' O ' HD11 ' A' ' 85' ' ' LEU . 87.3 mttt -123.03 124.05 42.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.617 -0.677 . . . . 0.0 109.577 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.574 ' CD2' HD12 ' A' ' 85' ' ' LEU . 22.5 m170 -111.62 136.27 51.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -0.988 . . . . 0.0 110.906 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 79.1 tttt -114.83 108.87 17.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.462 -0.774 . . . . 0.0 109.507 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 37.0 mm -44.99 137.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 110.047 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.501 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 25.8 t0 -107.47 -47.63 3.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 9.4 m -171.94 156.88 4.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.578 -0.702 . . . . 0.0 109.688 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.7 mt -136.86 157.31 35.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 110.119 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 4.7 m-20 -135.28 79.26 1.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.344 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.598 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 81.3 mttt -63.77 -11.43 26.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 9.4 mm-40 -98.14 -30.14 12.83 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.739 0.78 . . . . 0.0 109.177 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -105.12 -2.69 23.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.67 -0.644 . . . . 0.0 109.432 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.507 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 76.6 m-85 59.75 55.18 4.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.677 -0.639 . . . . 0.0 110.408 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -130.64 162.17 29.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.8 . . . . 0.0 109.782 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.537 ' CD1' HG12 ' A' ' 23' ' ' VAL . 37.5 t80 -144.56 137.32 26.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 110.096 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 72' ' ' ASP . 35.3 m -139.79 126.9 21.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.98 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 9.2 p90 -141.83 179.4 6.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.751 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.419 HG21 ' N ' ' A' ' 85' ' ' LEU . 91.5 m -135.88 152.17 50.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.494 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.574 HD12 ' CD2' ' A' ' 69' ' ' HIS . 52.3 tp -106.68 125.45 51.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.414 -0.804 . . . . 0.0 109.941 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.7 pt -109.28 -8.81 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.428 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 68' ' ' LYS . 30.1 tt0 -150.48 159.25 44.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.326 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.522 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 160.43 139.95 2.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -71.26 -24.93 62.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -1.115 . . . . 0.0 110.075 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.26 -22.95 61.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 110.146 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 98' ' ' ILE . 74.7 mt -60.81 -22.48 64.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.002 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.31 -179.39 0.01 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -80.14 6.01 12.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -1.139 . . . . 0.0 110.014 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.8 p -98.33 -23.29 15.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.583 ' CD2' ' CG1' ' A' ' 128' ' ' ILE . 42.1 mt -123.68 162.54 22.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 110.271 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -140.94 -81.69 0.24 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.3 -0.875 . . . . 0.0 109.861 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 34.8 mttt -80.41 161.04 25.14 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.709 -0.619 . . . . 0.0 110.103 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.6 HG22 ' CE2' ' A' ' 100' ' ' TYR . 0.1 OUTLIER -156.17 140.13 8.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 178.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 3.7 m -116.63 121.69 42.42 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.6 ' CE2' HG22 ' A' ' 98' ' ' ILE . 11.5 m-85 -112.82 139.78 48.16 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.413 -0.805 . . . . 0.0 110.3 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 80.8 tt0 -135.22 144.24 46.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 109.894 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.0 m -146.77 125.92 12.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.184 -0.948 . . . . 0.0 110.352 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 1.1 ttmt -116.22 146.94 41.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 109.813 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.534 ' CD2' HG12 ' A' ' 114' ' ' ILE . 6.3 mt -120.58 147.7 44.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.998 . . . . 0.0 110.78 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.497 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.89 -168.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.0 109.567 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -129.9 157.29 42.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 110.52 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.531 ' CB ' ' HD2' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -110.44 179.68 0.78 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.795 . . . . 0.0 109.618 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 107' ' ' SER . 40.6 Cg_endo -66.64 73.93 0.41 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.817 1.43 . . . . 0.0 109.577 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 4.0 m 57.35 37.29 27.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.497 -0.752 . . . . 0.0 109.742 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.53 42.72 1.47 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.34 -127.61 8.87 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' SER . 92.2 p -151.62 143.28 23.63 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.341 -1.093 . . . . 0.0 109.616 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 34.4 mt -90.46 150.32 3.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.196 -0.94 . . . . 0.0 110.571 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.632 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 5.8 mt -138.16 108.92 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.198 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -81.67 143.8 31.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 109.931 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -128.01 140.64 51.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 110.5 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 53.4 m -152.3 131.86 13.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.346 -0.846 . . . . 0.0 109.847 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.441 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 52.6 p -137.97 165.09 27.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 110.578 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.554 ' CE1' HG21 ' A' ' 4' ' ' THR . 48.1 m-70 -145.48 161.28 40.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.33 -0.856 . . . . 0.0 110.041 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 10.3 m-85 -121.97 147.54 45.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 110.359 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.534 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 99.6 m-70 -130.94 85.6 2.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.272 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.519 ' OG1' ' CG2' ' A' ' 126' ' ' VAL . 1.4 t -72.89 176.58 5.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.313 -0.867 . . . . 0.0 110.948 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -132.9 131.28 40.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.622 -0.673 . . . . 0.0 110.186 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.06 -111.13 4.18 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.429 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 36.0 t30 -151.41 81.34 1.3 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -1.143 . . . . 0.0 110.136 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.519 ' CG2' ' OG1' ' A' ' 122' ' ' THR . 30.8 m -154.1 160.82 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -126.94 161.26 28.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.638 ' CD1' ' CE1' ' A' ' 3' ' ' PHE . 4.7 mp -79.91 172.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.954 . . . . 0.0 110.351 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 132' ' ' HIS . 47.4 mttt -106.83 128.29 54.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.324 -0.86 . . . . 0.0 109.86 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 92.7 mt-10 -43.62 -46.99 7.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.46 -24.59 63.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 109.88 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 129' ' ' LYS . 12.5 t-160 -84.92 -54.16 4.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -0.805 . . . . 0.0 110.14 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.639 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 9.3 p -66.84 -41.41 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.065 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.402 ' N ' ' CG1' ' A' ' 133' ' ' VAL . 81.5 tttt -64.95 -43.56 92.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.907 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -29.27 69.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.926 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.76 -32.19 73.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -70.1 -36.69 75.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.986 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -68.73 -33.79 74.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 109.778 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -66.99 -37.37 84.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.823 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.16 90.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.296 -0.877 . . . . 0.0 109.791 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.7 m -61.32 -48.46 81.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.371 -0.831 . . . . 0.0 109.742 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 145' ' ' LYS . 98.4 m-20 -51.25 -42.69 61.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 146' ' ' LEU . 25.8 tp -56.32 -54.58 43.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.737 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.56 ' CE1' HG23 ' A' ' 114' ' ' ILE . 17.3 m-85 -48.03 -37.66 15.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.551 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 142' ' ' ASN . 98.9 mttt -68.75 -24.27 64.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.626 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.486 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 30.1 mt -84.51 -34.86 23.24 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.225 -0.922 . . . . 0.0 108.92 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.608 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 52.5 mt -71.88 -33.99 49.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.578 -0.702 . . . . 0.0 109.336 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.525 ' CB ' HD11 ' A' ' 13' ' ' ILE . 78.4 mt-10 -64.37 -38.49 91.23 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.502 -0.749 . . . . 0.0 109.55 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 90.0 m -70.06 -38.02 75.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 109.478 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.588 ' CD1' HG12 ' A' ' 33' ' ' ILE . 68.1 t80 -55.73 -51.52 67.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.416 -0.803 . . . . 0.0 109.774 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.596 ' CD2' ' CE1' ' A' ' 158' ' ' TYR . 77.8 mt -80.03 -41.48 25.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 110.1 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 49.2 tttp -64.06 -19.92 65.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.361 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.71 -34.78 2.75 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 3.8 m-70 -110.6 94.88 20.69 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.324 -1.104 . . . . 0.0 110.101 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -74.14 5.48 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.093 1.575 . . . . 0.0 110.985 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -105.55 -7.92 18.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.994 -1.066 . . . . 0.0 109.865 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.579 ' HB2' ' CE2' ' A' ' 150' ' ' TYR . . . -71.57 102.08 2.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.427 -0.795 . . . . 0.0 110.121 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.615 ' CE1' ' CB ' ' A' ' 21' ' ' ALA . 1.1 p90 34.24 32.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.797 -0.564 . . . . 0.0 110.71 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.527 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.763 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 86.0 t -122.35 118.53 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.133 -1.216 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.556 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 58.5 m-85 -86.31 163.29 17.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.7 m -141.35 92.87 2.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.595 ' CD1' ' CG1' ' A' ' 133' ' ' VAL . 83.5 m-85 -109.01 126.03 52.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.977 . . . . 0.0 109.815 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 16.1 pt-20 -128.79 153.03 47.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 110.445 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.8 m -123.88 141.06 52.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.917 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.423 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 83.0 mt-10 -121.62 124.02 43.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 110.447 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.2 p90 -151.13 -172.86 4.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.938 . . . . 0.0 109.947 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.466 HG21 ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -138.84 -178.21 5.22 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 110.547 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 112' ' ' SER . 98.9 p -157.27 150.05 23.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.432 -0.792 . . . . 0.0 110.349 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -75.51 -8.39 56.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.124 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 9.0 mm -96.79 149.78 36.16 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.414 -0.804 . . . . 0.0 110.084 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.0 Cg_endo -64.96 148.01 89.47 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.975 1.513 . . . . 0.0 110.376 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.643 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -71.14 -32.21 13.45 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.877 1.462 . . . . 0.0 112.899 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.12 -20.62 37.61 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 N-CA-C 109.871 -0.857 . . . . 0.0 109.871 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.522 ' HG2' ' CD1' ' A' ' 151' ' ' LEU . 4.5 ttm180 -83.36 -46.72 12.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.521 HD23 ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -72.95 -28.87 62.68 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.086 178.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.593 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 87.0 t80 -65.86 -56.52 11.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.436 -0.79 . . . . 0.0 109.544 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 25' ' ' ASP . 90.8 mttt -54.36 -39.25 66.98 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.279 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.629 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -68.82 -53.28 22.45 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.501 0.667 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' CD1' HD12 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -63.86 -45.47 89.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 111.511 -178.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.445 HG11 ' CE1' ' A' ' 81' ' ' TYR . 5.1 t -99.05 -57.23 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.99 -1.069 . . . . 0.0 111.725 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.495 ' CD1' ' HG2' ' A' ' 20' ' ' LYS . 27.5 mt -76.42 1.72 15.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.136 -0.977 . . . . 0.0 111.678 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.524 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -154.68 38.8 0.43 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.733 -1.229 . . . . 0.0 110.898 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -76.3 -31.29 58.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.082 -1.011 . . . . 0.0 110.228 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 79.8 m-20 -65.41 -13.6 59.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.093 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 66.9 m-20 -128.81 8.23 5.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 110.073 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.55 ' CD1' ' CD1' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -94.93 -51.17 4.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.431 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.657 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 8.2 p -75.37 -27.14 0.67 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.925 . . . . 0.0 112.267 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 53.0 Cg_endo -81.37 8.61 4.29 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 122.743 0.865 . . . . 0.0 110.625 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -137.39 -30.29 0.85 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.056 -1.028 . . . . 0.0 110.609 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.573 HG12 ' CD1' ' A' ' 150' ' ' TYR . 67.2 mt -75.24 -41.29 43.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.274 -0.891 . . . . 0.0 109.692 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.57 90.76 2.84 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.422 -0.798 . . . . 0.0 110.374 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.78 1.68 7.34 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.112 1.585 . . . . 0.0 110.321 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -87.2 -23.2 24.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.161 -0.962 . . . . 0.0 109.892 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.48 -42.59 8.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.575 ' CD1' ' CG2' ' A' ' 30' ' ' VAL . 1.1 mp -121.94 146.97 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.788 . . . . 0.0 109.827 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 17.1 tppt? -86.87 -42.22 13.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.371 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.526 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER 179.08 139.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 110.403 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.2 m -94.25 137.32 33.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.526 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 20.7 tt0 -142.03 110.08 5.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 45.5 mt -60.46 132.16 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.143 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.9 tp -95.71 -39.04 10.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.38 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.522 ' O ' ' CG2' ' A' ' 52' ' ' THR . 2.5 mt-10 -136.43 137.63 40.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.133 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.412 ' O ' ' OD1' ' A' ' 47' ' ' ASP . . . 81.08 -162.41 44.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 89.0 m-20 -137.65 20.99 2.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -1.167 . . . . 0.0 110.213 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.88 -12.14 11.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -75.01 -169.93 25.52 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.1 Cg_endo -71.65 132.46 20.38 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.123 1.591 . . . . 0.0 110.382 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.78 67.26 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 32.1 m -79.84 143.19 34.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.186 . . . . 0.0 110.042 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' A' ' 70' ' ' LYS . 27.4 mm -111.49 104.27 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.953 . . . . 0.0 110.328 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 51.9 mtpt -89.5 137.22 32.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.383 -0.823 . . . . 0.0 110.245 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -113.79 103.08 10.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.842 . . . . 0.0 110.356 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.527 ' CG2' HG12 ' A' ' 38' ' ' ILE . 87.3 mt -89.15 140.65 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.177 -0.952 . . . . 0.0 109.976 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 40' ' ' HIS . 1.3 p -112.49 152.94 28.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.52 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.454 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 30.9 m-85 -113.26 160.25 18.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.883 . . . . 0.0 110.145 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.679 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 8.3 t80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.187 0.518 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -113.36 135.03 12.27 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.679 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 11.4 p90 -178.52 160.26 1.23 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 110.112 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.467 HG13 ' HA3' ' A' ' 88' ' ' GLY . 5.8 m -141.36 171.65 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.39 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' O ' HD13 ' A' ' 85' ' ' LEU . 23.8 ttmt -123.09 124.11 42.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.598 -0.689 . . . . 0.0 109.881 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.521 ' NE2' HD11 ' A' ' 85' ' ' LEU . 10.6 m170 -113.56 123.52 50.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 110.751 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.463 ' HA ' HD12 ' A' ' 53' ' ' ILE . 84.4 tttt -100.09 110.79 23.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 109.612 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.534 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 33.4 mm -50.97 133.85 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 110.439 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 83.2 m-20 -106.25 -37.15 6.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.316 -0.865 . . . . 0.0 109.87 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.441 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 11.8 p 178.16 157.72 0.44 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.747 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.42 HG13 ' HD1' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -138.66 153.62 25.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.051 -179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 79' ' ' TYR . 6.3 m-20 -131.02 77.49 1.79 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.529 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.593 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 85.1 mttt -63.04 -11.85 22.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.232 -0.918 . . . . 0.0 110.005 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -98.12 -31.82 11.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.746 . . . . 0.0 109.235 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -102.45 -3.26 27.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.634 -0.666 . . . . 0.0 109.342 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.552 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 74.8 m-85 60.87 54.76 3.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.524 0.678 . . . . 0.0 110.6 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -130.97 156.53 44.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.679 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.703 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 61.2 t80 -143.67 141.61 30.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.931 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 53.6 m -148.7 136.97 21.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.14 -0.975 . . . . 0.0 110.755 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.703 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.0 p90 -147.82 175.61 10.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.399 -0.813 . . . . 0.0 110.29 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.469 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 44.9 m -124.47 128.84 49.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.858 . . . . 0.0 109.851 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 4.5 tp -95.47 124.88 39.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -0.978 . . . . 0.0 110.167 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.43 HG12 ' HB3' ' A' ' 68' ' ' LYS . 16.9 pt -109.23 -5.83 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 110.229 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.465 ' O ' HD12 ' A' ' 85' ' ' LEU . 9.1 tt0 -136.56 162.35 33.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 110.327 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.467 ' HA3' HG13 ' A' ' 67' ' ' VAL . . . 149.14 125.08 1.38 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -57.89 -31.39 66.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -1.11 . . . . 0.0 110.187 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.18 -18.58 65.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.079 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.483 HD23 ' CG1' ' A' ' 98' ' ' ILE . 86.9 mt -70.72 -30.45 66.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.62 -174.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -80.89 4.51 19.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -1.146 . . . . 0.0 110.26 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.42 ' O ' HG21 ' A' ' 122' ' ' THR . 78.1 p -89.47 -41.47 12.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.92 . . . . 0.0 110.108 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.528 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 62.9 mt -102.47 152.33 21.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.854 . . . . 0.0 109.987 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.513 ' CG ' ' HD3' ' A' ' 123' ' ' LYS . 5.6 tp10 -131.54 -80.56 0.52 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.304 -0.873 . . . . 0.0 110.087 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 59.3 mttt -80.21 127.78 32.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.581 -0.7 . . . . 0.0 110.522 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.626 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -116.77 139.05 45.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.702 -1.249 . . . . 0.0 109.856 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.49 127.68 54.24 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.405 -0.81 . . . . 0.0 108.974 178.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.626 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 9.6 m-85 -122.56 133.98 54.55 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.331 -0.856 . . . . 0.0 110.509 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 117' ' ' THR . 3.2 mt-10 -132.56 141.18 48.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.1 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 81' ' ' TYR . 63.6 m -137.04 143.13 42.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -137.19 135.76 37.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 110.169 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.521 ' CD2' HD23 ' A' ' 18' ' ' LEU . 4.9 mt -120.07 148.21 43.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.836 . . . . 0.0 110.533 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.483 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.7 -169.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 0.0 109.799 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.35 167.16 11.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 110.214 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.499 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 57.6 p -126.42 175.42 3.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 109.948 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.8 Cg_endo -87.29 22.8 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.87 1.458 . . . . 0.0 110.498 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 t -126.67 -10.99 6.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 110.409 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.96 -26.68 10.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.9 -149.59 1.56 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.536 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 8.4 p -149.12 137.79 21.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -1.17 . . . . 0.0 110.152 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' HG21 ' A' ' 10' ' ' THR . 68.5 mt -86.86 148.91 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 110.122 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.627 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 9.7 mt -132.79 125.26 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.391 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.423 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 75.1 tttt -115.86 108.43 16.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.2 m -98.84 158.85 15.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 110.538 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 53.4 m -159.35 126.01 4.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.398 -0.814 . . . . 0.0 110.278 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.4 m -128.97 160.01 34.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 0.0 110.183 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 62.3 m-70 -136.73 162.11 34.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.246 -0.909 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.8 m-85 -126.58 136.24 52.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.912 . . . . 0.0 110.99 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 93.3 m-70 -119.0 81.49 1.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.915 . . . . 0.0 109.34 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.528 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -66.69 154.52 40.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 111.102 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.513 ' HD3' ' CG ' ' A' ' 96' ' ' GLU . 37.8 mtmt -103.8 116.86 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.521 -0.737 . . . . 0.0 109.829 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 106.74 9.72 30.05 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 5.8 t30 69.4 51.4 0.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -1.134 . . . . 0.0 110.451 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 122' ' ' THR . 85.4 t -92.63 175.15 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.331 -0.855 . . . . 0.0 109.549 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.428 ' N ' ' CG1' ' A' ' 126' ' ' VAL . 90.8 mt-10 -124.3 149.34 46.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.969 -1.082 . . . . 0.0 110.563 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.525 ' CD1' HD22 ' A' ' 95' ' ' LEU . 15.8 mm -75.42 172.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 110.202 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 132' ' ' HIS . 70.3 mmtt -111.29 129.88 55.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.288 -0.882 . . . . 0.0 109.842 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' LYS . 54.1 mt-10 -43.09 -43.5 4.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 110.184 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -62.45 -25.36 67.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 110.025 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.8 t-160 -78.11 -50.54 11.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 110.147 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.595 ' CG1' ' CD1' ' A' ' 5' ' ' TYR . 72.7 t -57.24 -32.85 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.0 109.746 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -80.17 -40.77 26.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.831 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.92 -36.82 84.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.335 -0.853 . . . . 0.0 109.906 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.56 -30.04 69.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.455 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 91.7 mttt -77.49 -32.1 54.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 0.0 109.985 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -76.13 -33.24 59.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.387 -0.821 . . . . 0.0 109.973 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.21 -33.46 65.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.919 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -79.07 -36.11 41.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.0 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.0 m -62.11 -47.36 84.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.958 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -53.93 -50.03 67.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.816 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.442 ' HA ' HD11 ' A' ' 146' ' ' LEU . 15.9 tp -57.18 -45.32 83.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.789 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 21.6 m-85 -56.83 -41.34 77.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.406 -0.809 . . . . 0.0 109.643 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -78.84 -14.92 58.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 109.828 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.492 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 19.7 mt -83.22 -36.69 24.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -0.901 . . . . 0.0 108.818 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.571 HD12 ' CD1' ' A' ' 22' ' ' PHE . 16.1 mt -69.42 -46.22 76.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.473 ' O ' HG13 ' A' ' 13' ' ' ILE . 64.1 mt-10 -56.78 -36.65 70.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.402 -0.811 . . . . 0.0 109.551 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.4 m -72.23 -39.43 68.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.778 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.582 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 77.0 t80 -53.59 -52.13 60.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -0.843 . . . . 0.0 110.089 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.646 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 74.6 mt -75.25 -33.98 61.36 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.213 -0.93 . . . . 0.0 110.27 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.521 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 37.6 ttpt -69.98 -20.62 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -109.06 -31.13 3.42 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.53 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 9.9 m-70 -109.53 93.3 13.61 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 109.942 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.16 5.27 3.68 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.07 1.563 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -109.83 2.24 19.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.003 -1.06 . . . . 0.0 109.856 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.567 ' HB2' ' CE2' ' A' ' 150' ' ' TYR . . . -83.59 103.22 12.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 109.995 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.646 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.99 31.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.722 -0.611 . . . . 0.0 110.472 -179.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.721 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 120' ' ' TYR . 70.6 t -120.89 118.67 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.214 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.583 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 90.8 m-85 -75.91 149.88 37.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.162 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.416 HG22 ' CE1' ' A' ' 119' ' ' HIS . 39.9 m -133.1 119.94 20.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 110.228 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 69.9 m-85 -131.07 152.41 50.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 110.247 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -144.81 149.77 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.131 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.8 t -142.86 156.52 44.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.833 . . . . 0.0 109.816 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.23 145.89 36.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.005 . . . . 0.0 110.756 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 5.7 p90 -159.45 -172.89 3.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.608 -0.683 . . . . 0.0 109.704 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.475 HG23 HG12 ' A' ' 113' ' ' ILE . 20.8 p -136.39 177.99 7.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.065 -1.022 . . . . 0.0 110.717 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 3.2 t -157.83 159.89 37.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.432 -0.793 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -87.45 -2.72 58.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 110.248 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 12.0 mm -98.06 148.3 34.29 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 110.215 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.59 144.84 80.22 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.099 1.579 . . . . 0.0 110.494 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.642 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.52 -31.12 11.45 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 124.018 1.536 . . . . 0.0 112.988 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.9 Cg_endo -69.04 -23.66 33.85 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 N-CA-C 110.121 -0.761 . . . . 0.0 110.121 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.519 ' CZ ' ' O ' ' A' ' 158' ' ' TYR . 3.7 mmp_? -84.44 -42.7 15.37 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.507 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.1 tt -69.91 -31.31 69.03 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.6 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 48.8 t80 -66.27 -53.35 37.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.487 -0.758 . . . . 0.0 109.588 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 80.8 mttt -53.43 -37.48 62.61 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.212 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -72.3 -53.45 12.38 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.582 0.706 . . . . 0.0 110.769 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.56 ' CE1' HD13 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -61.37 -40.89 95.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.511 -0.743 . . . . 0.0 111.556 -178.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.455 HG12 HG12 ' A' ' 74' ' ' ILE . 4.6 t -104.68 -65.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.925 -1.109 . . . . 0.0 111.798 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.6 mp -65.95 -9.49 30.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.232 -0.917 . . . . 0.0 111.516 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.4 m-20 -145.68 33.39 1.04 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.823 -1.173 . . . . 0.0 110.71 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -73.46 -20.4 60.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.391 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.408 ' OD1' ' HB2' ' A' ' 41' ' ' SER . 36.9 t0 -73.6 -20.56 60.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 109.73 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 6.9 p30 -123.88 15.34 9.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.429 -0.794 . . . . 0.0 109.684 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -97.41 -57.75 2.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 109.754 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.589 ' CG1' ' CD1' ' A' ' 38' ' ' ILE . 11.7 t -62.12 -41.46 75.67 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.48 -0.763 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.2 Cg_endo -78.27 7.75 3.92 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.348 1.183 . . . . 0.0 110.831 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 72.1 mmtt -126.43 -27.74 3.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.052 -1.03 . . . . 0.0 109.907 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.574 HG12 ' CD1' ' A' ' 150' ' ' TYR . 20.9 mt -77.34 -42.77 30.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.387 -0.82 . . . . 0.0 109.58 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.03 101.99 1.58 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.498 -0.751 . . . . 0.0 110.073 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.97 1.18 6.8 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.077 1.567 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -84.42 -19.99 32.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.065 -1.022 . . . . 0.0 109.572 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.8 -53.31 4.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.321 -0.862 . . . . 0.0 109.913 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.589 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 1.2 mp -121.84 148.71 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.44 -0.788 . . . . 0.0 109.791 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.521 ' N ' HG21 ' A' ' 38' ' ' ILE . 18.1 tppt? -84.0 -41.14 17.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.931 . . . . 0.0 110.549 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -172.59 170.64 4.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.204 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.408 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 68.3 m -126.93 136.5 52.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.14 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.542 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 76.2 tt0 -140.56 107.99 5.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 43' ' ' ILE . 43.3 mt -58.7 133.27 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 110.206 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 52.8 mt -87.69 -27.64 22.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.3 -0.875 . . . . 0.0 110.044 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.46 ' O ' HG22 ' A' ' 52' ' ' THR . 29.4 tp10 -160.47 165.95 30.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 110.218 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.8 -168.99 27.02 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -127.69 24.6 6.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -1.182 . . . . 0.0 110.334 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.3 8.59 35.45 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -93.73 -164.09 36.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.79 130.8 18.64 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.047 1.551 . . . . 0.0 110.621 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.89 -3.69 77.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.467 ' HB ' HG13 ' A' ' 71' ' ' ILE . 23.6 m -79.98 142.47 35.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -1.161 . . . . 0.0 109.982 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 70' ' ' LYS . 32.5 mm -112.12 111.67 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.098 -1.001 . . . . 0.0 110.233 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.2 mttt -94.67 139.53 31.1 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.342 -0.849 . . . . 0.0 110.148 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HB2' HD13 ' A' ' 44' ' ' LEU . 80.3 tttt -111.34 96.21 5.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.327 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.515 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.6 mt -84.94 147.29 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.514 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 7.8 p -116.68 163.07 16.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 0.0 110.638 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 24.6 m-85 -117.2 158.95 23.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.522 -0.736 . . . . 0.0 110.142 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.228 0.537 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -132.93 135.23 7.98 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 10.7 p90 -177.95 163.1 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -1.18 . . . . 0.0 110.145 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.485 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.8 m -143.22 172.24 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.614 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.507 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . 98.4 mttt -122.17 133.37 54.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.591 -0.693 . . . . 0.0 109.767 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.656 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 14.8 m170 -112.31 137.28 50.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.118 -0.989 . . . . 0.0 110.706 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HA ' HD12 ' A' ' 53' ' ' ILE . 85.8 tttt -111.45 109.84 19.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.892 . . . . 0.0 109.211 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.532 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 36.1 mm -52.77 127.52 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.171 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.468 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 95.1 m-20 -99.03 -38.71 8.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.489 -0.757 . . . . 0.0 109.878 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 2.2 m -178.81 161.28 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.455 HG12 HG12 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -144.74 152.8 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.986 -1.071 . . . . 0.0 111.261 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -140.54 80.89 1.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.682 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.6 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 84.2 tttt -65.61 -11.72 46.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.13 -0.981 . . . . 0.0 109.968 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -85.7 -30.73 22.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 108.68 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -110.5 -2.92 16.27 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.566 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 72.8 m-85 62.65 52.11 2.94 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.543 0.687 . . . . 0.0 110.444 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -123.31 153.02 40.82 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 109.352 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.684 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 59.0 t80 -142.38 148.98 38.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.14 -0.975 . . . . 0.0 110.255 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.435 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 60.3 m -152.13 137.04 17.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.791 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.684 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 4.1 p90 -149.32 179.31 8.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 110.009 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.468 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 65.2 m -137.46 134.54 35.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.895 . . . . 0.0 110.372 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.656 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 9.2 tp -80.34 121.01 25.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.223 -0.923 . . . . 0.0 109.94 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.507 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 27.4 pt -100.16 -11.18 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.654 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -154.82 147.98 24.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.0 110.238 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.485 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 172.61 152.46 8.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -78.91 -35.38 43.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -1.122 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.509 ' HB3' ' NE2' ' A' ' 132' ' ' HIS . . . -58.78 -21.25 55.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.158 -0.964 . . . . 0.0 110.265 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.543 HD22 ' CD2' ' A' ' 95' ' ' LEU . 19.8 mt -65.2 -42.86 93.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.309 -0.869 . . . . 0.0 109.694 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.67 -172.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -73.01 -3.73 27.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -1.106 . . . . 0.0 110.008 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.471 ' HA ' HG12 ' A' ' 126' ' ' VAL . 41.6 p -88.58 -45.49 9.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.12 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.543 ' CD2' HD22 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -118.89 159.46 23.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.383 -0.823 . . . . 0.0 109.067 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.486 ' O ' HD21 ' A' ' 91' ' ' LEU . 35.3 tt0 -140.31 -80.84 0.27 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 110.39 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 43.0 mtmt -80.26 148.42 30.78 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.619 -0.676 . . . . 0.0 110.681 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.629 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 17.8 mm -136.51 148.48 27.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.018 -1.051 . . . . 0.0 109.694 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -121.58 124.45 44.39 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.629 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 16.0 m-85 -117.31 135.67 53.67 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.306 -0.871 . . . . 0.0 110.741 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -135.88 134.73 39.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 109.923 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.485 HG22 ' CZ ' ' A' ' 144' ' ' PHE . 89.3 m -134.1 147.8 50.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -0.988 . . . . 0.0 110.259 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 9.8 tttt -139.49 148.67 43.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 5.5 mt -125.06 152.36 44.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.257 -0.902 . . . . 0.0 110.447 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.492 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.77 -169.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.28 -0.888 . . . . 0.0 109.787 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -122.42 160.99 24.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.943 . . . . 0.0 110.311 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.439 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 35.3 p -120.59 164.12 24.95 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 110.13 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.5 -1.94 11.02 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.059 1.557 . . . . 0.0 110.363 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.6 m -102.72 0.45 32.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 110.326 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.46 -39.76 2.66 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.87 -171.67 0.36 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 54.8 p -131.93 134.62 45.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -1.166 . . . . 0.0 110.37 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.475 HG12 HG23 ' A' ' 10' ' ' THR . 31.9 mt -81.71 150.11 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.889 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.627 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 14.4 mt -135.45 112.98 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.593 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -103.54 136.37 43.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 109.759 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.6 t -131.91 158.67 40.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.976 . . . . 0.0 110.575 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 88.5 m -155.98 142.26 18.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 110.097 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.572 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 21.1 t -140.12 155.26 47.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.364 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 64.4 m-70 -133.36 168.12 19.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.177 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.516 ' HB3' ' CD1' ' A' ' 128' ' ' ILE . 32.0 m-85 -127.06 146.06 50.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.326 -0.859 . . . . 0.0 110.639 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.4 m-70 -127.18 92.07 3.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.475 ' CG2' ' O ' ' A' ' 126' ' ' VAL . 1.8 p -63.01 161.15 13.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.36 -0.837 . . . . 0.0 110.612 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 34.8 tttm -126.27 124.65 40.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.417 -0.802 . . . . 0.0 110.044 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 125' ' ' ASN . . . 93.48 22.61 26.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 11.9 t30 64.61 50.48 2.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -1.083 . . . . 0.0 110.304 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 127' ' ' GLU . 72.3 t -119.51 174.64 4.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.414 -0.804 . . . . 0.0 109.818 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.48 ' N ' ' CG1' ' A' ' 126' ' ' VAL . 81.3 mt-10 -127.26 153.16 46.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.174 -0.954 . . . . 0.0 110.094 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.546 HD11 ' CD1' ' A' ' 3' ' ' PHE . 3.4 mp -82.05 173.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.837 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.478 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 88.4 mttt -96.42 133.86 40.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 110.189 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.503 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 93.1 mt-10 -51.7 -49.35 62.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.139 -0.976 . . . . 0.0 110.051 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.49 -34.09 64.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.896 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 90' ' ' ALA . 12.6 t-160 -71.81 -53.04 14.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.355 -0.84 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.637 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 6.0 p -60.89 -35.32 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 110.023 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.503 ' N ' HG11 ' A' ' 133' ' ' VAL . 81.4 tttt -70.99 -43.9 67.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.847 . . . . 0.0 109.884 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.92 91.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.936 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.81 -31.63 78.91 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 95.2 mttt -63.06 -32.76 74.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.341 -1.094 . . . . 0.0 109.945 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.471 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 79.8 mt-10 -70.78 -35.12 72.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.845 . . . . 0.0 109.84 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.37 -42.83 87.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.388 -0.82 . . . . 0.0 109.875 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -70.73 -41.23 72.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.926 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.5 m -67.86 -53.71 24.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.781 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.2 m-20 -54.2 -40.07 67.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -0.905 . . . . 0.0 109.742 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.465 ' HG ' HD13 ' A' ' 147' ' ' ILE . 16.1 tp -60.98 -47.26 87.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.778 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 18.0 m-85 -53.6 -38.16 63.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.393 -0.817 . . . . 0.0 109.555 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -79.59 -17.11 54.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.225 -0.922 . . . . 0.0 109.671 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.517 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 26.8 mt -83.38 -35.52 25.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.291 -0.881 . . . . 0.0 108.625 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.56 HD13 ' CE1' ' A' ' 22' ' ' PHE . 27.3 mt -70.88 -46.65 67.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.469 ' OE2' HD11 ' A' ' 114' ' ' ILE . 57.9 mt-10 -58.23 -38.77 77.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.664 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 99.8 m -70.32 -38.33 74.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.781 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.587 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 80.3 t80 -54.36 -48.21 71.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 110.014 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.64 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 92.0 mt -79.55 -30.15 41.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 47.4 tptt -73.9 -21.31 60.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.91 . . . . 0.0 109.463 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.47 -31.88 3.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.548 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.0 m-70 -110.73 93.45 16.9 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.355 -1.085 . . . . 0.0 110.059 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.415 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.4 Cg_endo -74.35 6.72 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.997 1.525 . . . . 0.0 111.035 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -108.72 1.42 21.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.053 -1.029 . . . . 0.0 109.764 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.582 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . . . -81.87 104.5 12.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.365 -0.834 . . . . 0.0 110.196 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.64 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.3 OUTLIER 34.9 32.17 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.691 -0.63 . . . . 0.0 110.528 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.735 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 77.7 t -122.26 120.15 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -1.171 . . . . 0.0 110.265 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.58 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 94.2 m-85 -77.41 144.85 37.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.137 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.483 HG22 ' CE1' ' A' ' 119' ' ' HIS . 41.3 m -127.82 125.1 39.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 110.155 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 68.5 m-85 -134.47 159.13 42.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.237 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.7 pt-20 -151.28 152.48 33.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.886 . . . . 0.0 110.19 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 116' ' ' SER . 55.4 p -134.99 145.99 48.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.031 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.467 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 86.6 mt-10 -130.32 119.46 22.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.34 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.5 p90 -145.42 -175.98 4.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.834 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 18.4 p -136.56 -179.56 5.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.134 -0.979 . . . . 0.0 110.57 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.515 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 14.8 t -156.79 168.27 27.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 110.358 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.52 -16.24 24.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.972 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 6.8 mm -89.67 151.36 45.65 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.98 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 39.2 Cg_endo -64.74 145.28 86.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.053 1.554 . . . . 0.0 110.453 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.63 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -72.29 -31.63 11.41 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.028 1.541 . . . . 0.0 112.954 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.5 Cg_endo -69.33 -19.83 37.64 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 N-CA-C 110.148 -0.751 . . . . 0.0 110.148 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.53 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 4.2 mmp_? -85.65 -47.77 9.5 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.501 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.4 tt -67.3 -25.61 66.12 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 82.6 t80 -68.57 -58.68 3.92 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.505 0.669 . . . . 0.0 109.463 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 47.9 mttt -52.18 -30.47 27.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.159 0.98 . . . . 0.0 108.399 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.677 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -74.8 -63.53 1.24 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.677 0.751 . . . . 0.0 110.96 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -57.83 -35.64 71.15 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 111.459 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.6 HG12 ' CD1' ' A' ' 81' ' ' TYR . 20.1 t -104.62 -67.85 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.118 . . . . 0.0 111.493 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.577 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 4.0 mm? -65.29 -6.13 9.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 111.19 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -144.15 19.85 1.76 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.901 -1.124 . . . . 0.0 110.585 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -54.97 -34.44 63.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 110.164 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.531 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 89.6 m-20 -69.47 -12.0 61.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 110.279 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.445 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.7 m-20 -126.72 -4.98 6.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 110.3 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.547 HD11 ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -85.86 -46.78 10.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.124 -0.985 . . . . 0.0 110.294 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.591 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.3 t -75.92 -42.01 3.51 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.885 . . . . 0.0 111.13 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.5 Cg_endo -77.86 9.71 2.89 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.402 1.212 . . . . 0.0 110.855 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HG2' ' OH ' ' A' ' 150' ' ' TYR . 37.3 tptt -123.16 -28.69 3.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.59 HG12 ' CD1' ' A' ' 150' ' ' TYR . 9.6 mt -80.08 -47.21 21.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.447 -0.783 . . . . 0.0 109.499 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.0 101.96 4.17 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.486 -0.759 . . . . 0.0 109.981 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.34 0.05 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.023 1.538 . . . . 0.0 110.715 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -83.53 -13.04 55.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 109.419 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.96 -62.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.994 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 57' ' ' THR . 1.8 mp -108.98 132.11 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.451 -0.781 . . . . 0.0 110.001 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 31.7 ttpt -83.33 -38.07 22.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.0 110.416 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.461 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -174.55 141.42 0.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.165 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.531 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 7.3 m -107.03 135.92 47.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.041 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 55.2 tt0 -136.31 109.15 7.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.3 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 9.1 mt -62.43 130.55 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.462 ' CD1' ' O ' ' A' ' 42' ' ' GLU . 10.6 mp -94.59 -41.99 9.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.38 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.526 ' O ' ' CG2' ' A' ' 52' ' ' THR . 5.3 mt-10 -132.91 142.79 49.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.134 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.99 -170.2 54.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -124.82 6.58 8.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 110.215 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.32 -4.82 5.95 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 71' ' ' ILE . . . -85.39 -164.68 39.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.6 Cg_endo -70.38 132.03 21.53 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.153 1.607 . . . . 0.0 110.418 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.69 69.99 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 29.6 m -80.06 136.47 36.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -1.155 . . . . 0.0 109.857 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.521 HG22 ' CE ' ' A' ' 68' ' ' LYS . 20.5 mm -107.15 117.97 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 110.17 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 87.2 mttt -105.2 145.9 29.99 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.3 -0.875 . . . . 0.0 110.496 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -118.88 101.43 8.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 110.058 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.74 141.99 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.883 . . . . 0.0 110.444 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.8 p -110.27 153.19 25.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 109.965 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CZ ' HG23 ' A' ' 67' ' ' VAL . 24.5 m-85 -111.75 123.95 51.32 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.0 111.001 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 2.6 t80 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.233 0.54 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -126.32 99.05 0.54 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.508 ' CD2' ' CD2' ' A' ' 64' ' ' TYR . 33.2 p90 -138.83 169.98 16.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.134 -1.216 . . . . 0.0 110.369 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.567 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 5.9 m -137.49 173.44 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 110.563 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.521 ' CE ' HG22 ' A' ' 53' ' ' ILE . 37.8 tttt -122.81 127.96 49.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.596 -0.69 . . . . 0.0 109.43 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.568 ' CD2' HD11 ' A' ' 85' ' ' LEU . 10.5 m170 -117.32 126.37 52.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.965 . . . . 0.0 111.035 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HG3' HD12 ' A' ' 53' ' ' ILE . 84.1 tttt -106.01 118.04 35.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.287 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.536 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.0 mm -57.34 135.03 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.93 . . . . 0.0 110.454 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' O ' ' OG ' ' A' ' 73' ' ' SER . 9.5 t0 -107.05 -39.47 5.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.794 . . . . 0.0 109.795 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 0.7 OUTLIER 171.95 161.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.537 -0.727 . . . . 0.0 109.957 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.581 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 3.1 tt -154.64 163.51 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.224 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -125.84 78.01 1.71 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.259 -0.9 . . . . 0.0 109.671 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.607 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 86.3 mttt -53.94 -15.26 1.29 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.331 -0.855 . . . . 0.0 110.863 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -91.76 -32.39 15.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 109.788 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.3 m-80 -107.83 -4.51 17.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.639 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.596 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 6.5 m-85 69.22 49.07 0.63 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.322 0.582 . . . . 0.0 110.543 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.536 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -118.43 147.18 43.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 109.107 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.681 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 79.7 t80 -141.49 142.89 33.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.02 . . . . 0.0 110.617 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.447 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 61.1 m -147.14 128.21 14.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 110.007 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.681 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 3.9 p90 -137.07 -176.71 4.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.062 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.4 m -135.41 140.07 44.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.296 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.568 HD11 ' CD2' ' A' ' 69' ' ' HIS . 49.0 tp -100.47 128.67 46.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.964 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.439 HG12 ' HB3' ' A' ' 68' ' ' LYS . 16.5 pt -118.73 -7.7 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.366 -0.834 . . . . 0.0 110.246 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 79.7 tt0 -146.05 135.27 22.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.527 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 174.35 159.9 21.54 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 46.1 p-10 -71.29 -7.73 48.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -1.159 . . . . 0.0 110.285 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.455 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -79.07 -46.14 18.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.536 ' CD2' ' HG ' ' A' ' 95' ' ' LEU . 19.6 mt -40.96 -46.42 2.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.595 -0.691 . . . . 0.0 110.224 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 41.31 -132.73 3.41 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -115.89 21.72 13.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -1.104 . . . . 0.0 110.062 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.413 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 72.5 p -122.4 -41.58 2.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -0.866 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.536 ' HG ' ' CD2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -114.41 163.35 15.44 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.341 -0.85 . . . . 0.0 109.141 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.514 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 28.1 tp10 -142.03 -79.54 0.24 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.135 -0.978 . . . . 0.0 110.282 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 21.2 mtpt -80.18 151.66 29.59 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.616 -0.677 . . . . 0.0 109.845 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.601 HG22 ' CE2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -146.62 135.37 16.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.063 -1.023 . . . . 0.0 109.819 179.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.1 m -114.99 118.41 33.34 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.43 -0.794 . . . . 0.0 109.597 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.601 ' CE2' HG22 ' A' ' 98' ' ' ILE . 9.7 m-85 -110.39 137.74 47.7 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.469 -0.769 . . . . 0.0 110.173 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.461 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 76.9 tt0 -132.85 143.18 49.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.203 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.6 m -139.39 135.67 33.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -128.31 138.89 52.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.531 ' CD2' HG12 ' A' ' 114' ' ' ILE . 6.5 mt -118.56 149.76 40.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.197 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.47 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -150.03 -169.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 109.961 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -123.2 125.7 45.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.972 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.472 ' HB3' ' CG1' ' A' ' 113' ' ' ILE . 3.2 p -80.15 170.36 16.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 110.219 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 50.7 Cg_endo -83.52 22.47 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.056 1.556 . . . . 0.0 110.966 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.5 p -127.89 4.03 5.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.938 -1.101 . . . . 0.0 110.412 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.16 -25.74 25.21 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.46 -174.33 43.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.534 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 19.9 p -124.35 131.32 53.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -1.201 . . . . 0.0 110.37 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 84.8 mt -82.82 149.68 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 110.195 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.597 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 7.6 mt -133.68 128.82 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 110.359 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.467 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 85.9 tttt -118.66 111.11 18.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.315 -0.865 . . . . 0.0 109.781 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.445 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 1.4 m -101.58 162.31 13.0 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.158 -0.964 . . . . 0.0 110.834 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 53.7 m -160.05 132.65 6.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.44 -0.787 . . . . 0.0 109.773 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.1 p -132.58 159.11 40.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.107 -0.995 . . . . 0.0 110.745 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.483 ' CE1' HG22 ' A' ' 4' ' ' THR . 60.7 m-70 -141.37 155.37 45.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.419 -0.8 . . . . 0.0 110.038 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 28.2 m-85 -119.03 138.07 53.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.39 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.539 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 95.4 m-70 -119.32 93.13 3.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 109.675 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.517 ' CG2' HD13 ' A' ' 128' ' ' ILE . 1.0 OUTLIER -62.86 159.22 17.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.156 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HD2' ' HG2' ' A' ' 96' ' ' GLU . 43.7 tttm -142.7 128.34 19.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 110.19 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 93.31 26.38 16.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 8.2 t30 64.91 65.96 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -1.189 . . . . 0.0 110.173 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.452 HG21 ' HB ' ' A' ' 122' ' ' THR . 7.0 m -144.37 171.21 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.428 ' HA ' HG22 ' A' ' 122' ' ' THR . 86.5 mt-10 -140.25 152.37 45.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.215 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.566 HD11 ' CD1' ' A' ' 3' ' ' PHE . 4.9 mp -81.89 173.53 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 109.964 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.441 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 57.0 mttt -104.85 132.15 51.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.229 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.465 ' O ' HG11 ' A' ' 133' ' ' VAL . 52.1 mt-10 -48.48 -39.79 24.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 110.101 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.01 -30.39 70.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.948 . . . . 0.0 109.882 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -75.34 -50.97 14.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 110.18 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.635 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 10.3 p -65.47 -41.81 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 110.038 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.459 ' N ' HG12 ' A' ' 133' ' ' VAL . 72.5 mmtt -63.04 -40.02 96.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.979 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.54 -34.69 72.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.831 . . . . 0.0 110.0 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 139' ' ' LYS . . . -73.08 -29.76 64.17 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 56.2 mtpt -73.71 -32.95 64.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -1.08 . . . . 0.0 110.076 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -70.28 -54.73 11.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 109.948 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 136' ' ' GLY . 20.7 ptmt -56.54 -28.49 60.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.795 . . . . 0.0 109.866 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.81 -45.88 70.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.051 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -61.96 -40.88 97.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.978 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -62.07 -41.42 98.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.464 ' O ' HG13 ' A' ' 147' ' ' ILE . 30.1 mt -61.1 -41.22 96.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.934 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -61.54 -33.21 73.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.416 -0.802 . . . . 0.0 109.951 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 47.4 tptt -80.02 -19.05 48.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 110.26 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.4 mt -79.95 -35.16 38.08 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.104 -0.997 . . . . 0.0 108.515 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.652 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 67.4 mt -70.67 -51.73 34.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.515 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 78.0 mt-10 -49.41 -34.67 16.98 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.288 -0.883 . . . . 0.0 109.016 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.4 m -79.99 -28.33 39.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -0.916 . . . . 0.0 109.296 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.59 ' CD1' HG12 ' A' ' 33' ' ' ILE . 86.7 t80 -61.36 -54.07 48.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.561 -0.712 . . . . 0.0 109.977 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.644 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 59.0 mt -69.56 -27.96 65.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 110.077 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.457 ' HA ' HD13 ' A' ' 13' ' ' ILE . 57.3 tptt -74.04 -29.39 61.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 109.727 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -101.33 -29.15 6.45 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.521 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.5 m-70 -107.15 90.98 6.05 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.447 -1.031 . . . . 0.0 109.7 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.5 Cg_endo -73.54 5.22 3.4 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.009 1.531 . . . . 0.0 111.025 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 44.3 p30 -109.82 -9.37 14.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.013 -1.054 . . . . 0.0 109.685 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.571 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . . . -69.36 99.62 1.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.477 -0.764 . . . . 0.0 110.091 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.677 ' CE2' ' CB ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER 34.9 31.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.727 -0.608 . . . . 0.0 110.554 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.53 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.799 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.583 HG22 ' CG ' ' A' ' 121' ' ' HIS . 2.5 p -79.86 145.64 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -1.206 . . . . 0.0 110.563 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 77.5 m-85 -93.18 167.7 11.59 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.332 -0.855 . . . . 0.0 110.242 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.9 m -131.39 110.84 11.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.944 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.582 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 24.3 m-85 -113.18 125.34 54.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 110.085 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.5 pt-20 -133.13 152.94 51.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 110.085 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.2 t -128.52 155.81 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.359 -0.838 . . . . 0.0 110.172 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.466 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 76.0 mt-10 -136.0 118.03 15.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.333 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.2 p90 -147.24 -170.98 3.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.939 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 18.2 p -140.64 -179.44 6.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 110.561 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 3.2 t -156.74 160.12 38.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.759 . . . . 0.0 110.165 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -84.7 -16.12 42.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.853 . . . . 0.0 110.251 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 7.4 mm -87.61 149.96 47.47 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 110.135 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -65.13 149.02 89.49 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.098 1.578 . . . . 0.0 110.412 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.651 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 Cg_endo -70.14 -32.72 16.46 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.899 1.473 . . . . 0.0 113.0 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.0 Cg_endo -68.0 -21.75 42.82 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 122.504 0.739 . . . . 0.0 110.207 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.521 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -83.65 -46.78 11.95 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.499 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.1 tt -69.07 -28.33 66.42 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 62.6 t80 -66.04 -59.34 3.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.468 -0.77 . . . . 0.0 109.514 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 51.2 mttp -51.6 -34.79 38.88 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.521 -0.737 . . . . 0.0 109.604 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . . . -75.29 -55.5 5.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.391 -0.818 . . . . 0.0 111.152 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.639 ' CD1' ' CD1' ' A' ' 147' ' ' ILE . 0.7 OUTLIER -59.77 -45.51 92.05 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.48 -0.762 . . . . 0.0 111.738 -178.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.37 -66.3 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.02 -1.05 . . . . 0.0 111.392 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.6 mm? -64.44 -5.97 6.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.262 -0.899 . . . . 0.0 111.444 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.524 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -143.79 25.88 1.6 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.862 -1.149 . . . . 0.0 110.849 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -66.37 -30.02 70.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 110.195 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.56 -12.77 61.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 72.5 m-20 -129.1 6.32 5.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 110.118 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -92.99 -53.35 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -0.832 . . . . 0.0 110.056 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 17.1 t -67.2 -41.42 33.97 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 111.176 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -76.91 6.03 4.5 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.334 1.176 . . . . 0.0 110.881 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 66.6 mttt -127.54 -31.84 2.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 109.787 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.575 HG12 ' CD1' ' A' ' 150' ' ' TYR . 16.0 mt -79.89 -43.17 22.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.462 -0.774 . . . . 0.0 109.775 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.7 91.8 3.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.0 110.188 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.26 3.51 5.69 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.114 1.586 . . . . 0.0 110.594 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -87.23 -19.9 27.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.134 -0.979 . . . . 0.0 110.061 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.38 -40.77 8.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 110.201 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.583 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 1.1 mt -125.72 145.99 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.447 -0.783 . . . . 0.0 110.047 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.458 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 28.2 ttpt -80.93 -46.36 15.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 110.32 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -176.93 158.88 1.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.88 . . . . 0.0 110.038 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -113.01 120.57 41.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.945 . . . . 0.0 110.162 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.543 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 32.0 tt0 -121.46 102.08 8.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.003 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 37.6 mt -50.7 129.32 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.307 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 19.9 tp -91.72 -40.07 11.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.468 -0.77 . . . . 0.0 110.354 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.525 ' O ' ' CG2' ' A' ' 52' ' ' THR . 2.9 mt-10 -138.32 138.02 37.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 110.172 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 47' ' ' ASP . . . 82.21 -159.53 39.32 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 87.1 m-20 -138.24 9.55 2.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -1.192 . . . . 0.0 110.348 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.29 -2.94 5.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.491 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -87.6 -168.49 44.62 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.486 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.5 Cg_endo -69.82 137.74 35.98 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.091 1.574 . . . . 0.0 110.507 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.93 -5.47 85.04 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 18.0 m -80.0 138.94 37.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -1.177 . . . . 0.0 109.998 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 32.2 mm -105.15 127.58 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.0 110.001 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 93.5 mttt -110.39 126.71 54.56 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 110.019 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' A' ' 44' ' ' LEU . 43.4 mtmt -99.15 98.12 9.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.139 -0.976 . . . . 0.0 110.589 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.527 ' CG2' HG12 ' A' ' 38' ' ' ILE . 96.4 mt -87.07 146.71 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.155 -0.966 . . . . 0.0 109.66 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.471 ' N ' HG21 ' A' ' 56' ' ' ILE . 5.4 p -118.76 153.16 34.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.124 -0.985 . . . . 0.0 111.116 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 25.5 m-85 -117.44 138.47 51.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.509 -0.745 . . . . 0.0 109.973 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.849 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.21 0.529 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -115.2 93.28 0.62 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.541 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.4 p90 -128.96 164.91 22.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -1.228 . . . . 0.0 110.234 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.527 HG13 ' CA ' ' A' ' 88' ' ' GLY . 5.9 m -134.63 175.28 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 0.0 110.486 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.536 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 59.5 mttt -133.15 106.46 7.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.46 -0.775 . . . . 0.0 109.701 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.563 ' CD2' HD11 ' A' ' 85' ' ' LEU . 13.0 m170 -98.16 128.44 44.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 111.023 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.528 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 54.6 tttm -101.88 109.56 21.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.329 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.507 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.0 mm -42.59 140.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.341 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.531 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 23.9 t0 -111.43 -48.87 3.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.527 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.485 ' N ' ' OG ' ' A' ' 82' ' ' SER . 8.7 m -165.88 156.16 12.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.527 -0.733 . . . . 0.0 109.746 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 mt -138.36 153.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.396 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.7 m-20 -141.7 80.74 1.74 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.517 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.585 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 34.4 tttt -65.65 -13.32 58.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.179 -0.951 . . . . 0.0 109.853 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -89.94 -30.87 17.54 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.803 0.811 . . . . 0.0 109.013 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m-80 -106.91 -2.98 20.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.584 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 73.8 m-85 60.94 54.35 3.47 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.652 0.739 . . . . 0.0 110.167 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -127.26 156.53 41.75 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.637 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.507 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 27.6 t80 -142.83 137.38 29.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.947 . . . . 0.0 110.003 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.485 ' OG ' ' N ' ' A' ' 73' ' ' SER . 13.9 p -143.87 124.18 13.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.112 -0.993 . . . . 0.0 111.263 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 13.7 p90 -137.73 172.53 12.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 110.23 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 97.1 m -129.39 134.52 47.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.332 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.563 HD11 ' CD2' ' A' ' 69' ' ' HIS . 11.7 tp -101.5 133.78 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.05 -1.031 . . . . 0.0 110.221 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.5 HG23 HD11 ' A' ' 86' ' ' ILE . 13.8 pt -113.11 -30.88 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.458 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.437 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 70.1 tt0 -119.41 157.35 28.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.258 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.527 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 159.05 140.69 2.96 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.6 -25.58 64.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -1.148 . . . . 0.0 110.139 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.08 -26.61 61.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.146 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 15.5 mt -63.22 -31.59 72.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 110.104 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.54 -174.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 52.8 t0 -77.1 -1.02 26.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.138 . . . . 0.0 110.057 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.459 ' HA ' HG12 ' A' ' 126' ' ' VAL . 43.2 p -87.82 -41.96 12.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 110.056 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.536 ' CD2' HD13 ' A' ' 128' ' ' ILE . 68.4 mt -98.25 153.55 18.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.815 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 35.4 tt0 -137.24 -83.33 0.34 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.301 -0.874 . . . . 0.0 109.629 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.49 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 96.0 mttt -80.35 125.02 29.38 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.75 -0.594 . . . . 0.0 110.447 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.616 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 3.3 mm -116.86 135.01 58.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.789 -1.195 . . . . 0.0 109.827 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -120.89 127.07 51.53 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.616 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 11.1 m-85 -119.61 134.43 55.23 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.326 -0.859 . . . . 0.0 110.573 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 117' ' ' THR . 26.5 tt0 -137.16 133.58 35.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.427 -0.796 . . . . 0.0 109.92 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 54.5 m -134.35 144.1 48.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 110.361 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.413 ' N ' HG21 ' A' ' 102' ' ' THR . 4.2 tttt -135.25 146.93 49.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.503 ' CD2' HG12 ' A' ' 114' ' ' ILE . 6.1 mt -119.22 153.73 34.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.339 -0.851 . . . . 0.0 110.433 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.484 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -150.94 -168.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.289 -0.882 . . . . 0.0 109.93 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -121.88 128.19 51.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 110.27 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.2 p -81.47 160.02 65.72 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.181 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -2.26 11.45 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.082 1.569 . . . . 0.0 110.547 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.4 p -103.07 4.82 37.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.351 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.62 -34.38 5.82 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.09 -174.18 6.51 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.471 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 23.6 p -123.66 135.82 54.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 23.4 mt -87.04 150.41 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.566 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 7.0 mt -132.85 117.67 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.178 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 80.8 tttt -110.05 109.69 20.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 110.079 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 8.6 m -97.6 164.21 12.52 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.173 -0.954 . . . . 0.0 110.474 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 101' ' ' GLU . 29.4 m -160.01 126.17 4.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.411 -0.805 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.0 m -128.37 156.95 42.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.163 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 90.9 m-70 -129.24 136.31 49.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -0.93 . . . . 0.0 110.255 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.0 m-30 -109.59 111.69 23.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.962 . . . . 0.0 111.169 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.583 ' CG ' HG22 ' A' ' 2' ' ' VAL . 90.3 m-70 -99.09 117.38 33.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.196 -0.94 . . . . 0.0 109.514 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 94' ' ' THR . 0.7 OUTLIER -87.27 138.76 31.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 110.569 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 74.1 tttt -72.3 123.1 22.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 110.223 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.48 -128.86 8.71 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -121.09 51.72 1.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -1.188 . . . . 0.0 110.12 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 127' ' ' GLU . 85.9 t -94.61 174.6 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.416 -0.802 . . . . 0.0 110.02 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.479 ' N ' HG13 ' A' ' 126' ' ' VAL . 45.8 mt-10 -143.16 125.73 15.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 110.408 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 1.8 mp -60.45 174.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.855 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.527 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 62.3 mttt -100.7 151.52 21.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.26 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -66.55 -34.29 77.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.199 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 132' ' ' HIS . 22.2 pt-20 -68.26 -36.96 80.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 110.198 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.445 ' N ' ' CG ' ' A' ' 131' ' ' GLU . 17.8 t-160 -67.79 -33.53 75.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.582 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 89.3 t -67.85 -43.77 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.22 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -73.83 -43.0 60.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.003 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.72 91.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.083 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.92 -26.3 73.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -75.99 -31.94 59.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -1.156 . . . . 0.0 110.144 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.456 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 78.3 tt0 -79.02 -28.55 43.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.125 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.99 -32.86 59.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.71 -33.29 46.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.5 t -64.58 -45.29 87.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.165 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 73.5 m-20 -52.81 -48.72 66.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.03 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.3 tp -55.89 -48.59 75.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.941 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.427 ' O ' ' CD ' ' A' ' 148' ' ' GLU . 25.8 m-85 -54.4 -39.77 67.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.807 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.444 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 42.7 tttm -79.81 -14.03 58.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.464 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 17.8 mt -83.97 -37.69 21.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.1 -1.0 . . . . 0.0 108.954 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.639 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 75.6 mt -71.21 -44.1 74.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.822 -0.751 . . . . 0.0 108.983 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 13' ' ' ILE . 65.0 mt-10 -56.62 -36.24 69.23 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.435 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.6 m -76.68 -30.57 56.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.926 . . . . 0.0 109.511 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.591 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 89.9 t80 -57.38 -48.19 79.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.54 -0.725 . . . . 0.0 110.045 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.593 ' CD2' ' CE1' ' A' ' 158' ' ' TYR . 72.1 mt -76.48 -38.53 55.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 110.065 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.481 ' HA ' HD13 ' A' ' 13' ' ' ILE . 83.8 tttt -61.23 -14.83 28.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.374 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -116.52 -28.13 2.63 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.574 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 8.5 m-70 -109.08 93.91 13.86 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.333 -1.098 . . . . 0.0 110.058 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.8 4.24 4.28 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.028 1.541 . . . . 0.0 110.961 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -113.77 -6.56 13.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.124 -0.985 . . . . 0.0 110.047 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.556 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . . . -67.03 102.67 1.03 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 21' ' ' ALA . 0.6 OUTLIER 34.65 32.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.741 -0.599 . . . . 0.0 110.604 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.521 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.756 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 77.1 t -114.13 109.33 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.195 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.583 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 82.6 m-85 -77.48 144.86 37.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 110.298 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.4 m -122.71 115.77 22.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 110.396 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.63 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 67.2 m-85 -124.08 154.54 39.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.897 . . . . 0.0 109.951 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 13.6 pt-20 -147.3 151.4 36.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 0.0 110.566 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 m -137.36 144.21 42.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.777 . . . . 0.0 109.456 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -132.82 143.46 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.114 -0.991 . . . . 0.0 110.928 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.605 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.3 p90 -158.79 -176.04 5.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.57 -0.706 . . . . 0.0 109.492 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 21.1 p -135.64 -179.46 5.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.041 -1.037 . . . . 0.0 110.764 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 10.0 t -159.96 167.16 28.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.529 -0.732 . . . . 0.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -98.38 9.81 42.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 109.972 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 2.7 mp -107.75 149.88 39.54 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.033 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.81 143.19 72.71 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.081 1.569 . . . . 0.0 110.554 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.647 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.9 Cg_endo -71.82 -31.67 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 124.027 1.541 . . . . 0.0 112.804 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.9 Cg_endo -67.94 -21.93 42.92 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 O-C-N 122.468 0.72 . . . . 0.0 110.322 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.508 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 8.7 mmp_? -83.91 -46.99 11.51 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.532 HD22 ' CG2' ' A' ' 147' ' ' ILE . 0.4 OUTLIER -68.25 -29.3 68.08 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.591 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.0 t80 -66.3 -56.16 12.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.863 . . . . 0.0 109.9 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.506 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 76.1 mttt -53.92 -32.1 52.37 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.691 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -73.18 -64.82 0.9 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.713 0.768 . . . . 0.0 111.11 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.596 ' CE1' HD11 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -56.97 -39.08 73.93 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.634 -0.666 . . . . 0.0 112.228 -178.128 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.467 ' CG1' HD12 ' A' ' 74' ' ' ILE . 5.5 t -101.77 -58.03 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.777 -1.202 . . . . 0.0 111.578 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.545 ' CD1' ' N ' ' A' ' 24' ' ' LEU . 7.4 mp -78.14 0.1 26.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.079 -1.013 . . . . 0.0 111.331 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.53 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -147.3 15.17 1.14 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.944 -1.098 . . . . 0.0 110.556 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -53.85 -39.88 66.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.95 . . . . 0.0 109.916 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 65.2 t0 -64.42 -14.19 55.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 109.907 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.46 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 81.2 m-20 -127.3 0.19 6.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.369 -0.832 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.533 ' CD2' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -88.09 -45.52 10.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.355 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.592 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 31.2 t -72.89 -40.36 6.1 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.263 -0.898 . . . . 0.0 111.482 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -77.44 10.11 2.61 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.329 1.173 . . . . 0.0 111.113 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 49.6 mttt -122.77 -25.77 4.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.054 -1.029 . . . . 0.0 109.628 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.582 HG12 ' CD1' ' A' ' 150' ' ' TYR . 28.7 mt -79.99 -49.86 18.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.475 -0.765 . . . . 0.0 109.926 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.37 104.02 2.21 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.383 -0.823 . . . . 0.0 110.128 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.17 1.01 6.46 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.02 1.537 . . . . 0.0 110.794 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -83.54 -14.41 52.28 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.36 -53.88 3.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 110.071 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.574 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 1.1 mp -117.65 149.02 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.453 -0.779 . . . . 0.0 110.017 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.506 ' N ' HG21 ' A' ' 38' ' ' ILE . 19.9 ttmm -85.35 -42.3 14.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.861 . . . . 0.0 110.41 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -178.77 141.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 110.369 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.454 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 38.6 m -97.84 134.3 41.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 110.093 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.512 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 30.8 tt0 -137.26 110.98 8.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.211 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.49 HD11 HG22 ' A' ' 43' ' ' ILE . 37.2 mt -60.71 131.7 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.277 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.527 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 81.2 mt -92.18 -26.45 18.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.148 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' O ' ' CG2' ' A' ' 52' ' ' THR . 38.8 tt0 -151.41 173.53 14.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.895 . . . . 0.0 110.085 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.01 -155.23 2.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -147.97 34.17 0.83 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 110.22 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.5 -9.29 35.3 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.47 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -81.41 -172.84 47.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.525 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.9 Cg_endo -71.1 137.97 32.64 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 124.173 1.617 . . . . 0.0 110.464 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.84 -4.8 83.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 27.3 m -79.98 146.38 32.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -1.193 . . . . 0.0 110.116 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 70' ' ' LYS . 32.3 mm -113.38 110.21 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 110.154 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 69' ' ' HIS . 46.2 mtpt -93.11 141.99 27.8 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 110.474 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 83.3 tttt -111.7 113.26 25.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.091 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 38' ' ' ILE . 62.6 mt -102.97 138.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 110.118 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.472 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 1.6 p -114.03 152.53 30.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 110.562 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 30.5 m-85 -112.88 137.6 50.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.333 -0.854 . . . . 0.0 110.079 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.926 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.266 0.555 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -131.92 90.8 0.28 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.53 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 17.5 p90 -138.73 168.15 20.42 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.201 -1.176 . . . . 0.0 110.402 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.517 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.4 m -137.49 172.72 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.449 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.56 ' CB ' ' CG1' ' A' ' 86' ' ' ILE . 91.7 mttt -123.95 131.44 53.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.593 -0.692 . . . . 0.0 109.719 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.648 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 13.6 m170 -111.43 138.42 47.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.132 -0.98 . . . . 0.0 110.532 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HA ' HD12 ' A' ' 53' ' ' ILE . 82.0 tttt -114.93 107.82 15.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.436 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 33.4 mm -53.2 122.43 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 110.489 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.8 m-20 -94.89 -40.71 9.57 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.534 -0.729 . . . . 0.0 109.543 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 3.2 m -176.63 158.76 1.77 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.514 -0.741 . . . . 0.0 109.558 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.467 HD12 ' CG1' ' A' ' 23' ' ' VAL . 2.4 mt -138.16 159.32 32.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.25 -0.907 . . . . 0.0 110.124 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.493 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -145.63 83.85 1.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.574 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.591 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 86.0 tttt -68.18 -13.42 62.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 110.168 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -85.47 -30.38 23.53 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -109.44 -3.68 16.86 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.201 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CB ' ' HB2' ' A' ' 104' ' ' LEU . 48.4 m-85 63.36 52.02 2.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.666 -0.646 . . . . 0.0 110.359 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 13.5 t -121.59 174.34 6.85 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.152 -0.968 . . . . 0.0 110.208 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.528 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 21.0 t80 -157.77 146.55 19.39 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.149 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 50.6 m -149.98 125.24 10.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.042 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 6.7 p90 -142.49 176.45 9.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.404 -0.81 . . . . 0.0 109.862 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 53.1 m -135.54 141.54 45.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.648 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 9.2 tp -87.66 120.27 28.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.233 -0.917 . . . . 0.0 110.247 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.56 ' CG1' ' CB ' ' A' ' 68' ' ' LYS . 24.3 pt -100.63 -12.04 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.425 -0.797 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 71.0 tt0 -153.46 145.54 23.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.479 -0.763 . . . . 0.0 110.203 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.517 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 174.77 165.93 31.89 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 29.7 p-10 -79.9 -44.79 19.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -1.173 . . . . 0.0 110.522 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.482 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -50.8 -40.69 56.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 110.155 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.515 HD22 ' CD2' ' A' ' 95' ' ' LEU . 38.0 mt -40.42 -50.45 2.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.575 -0.703 . . . . 0.0 110.339 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.41 -166.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -81.5 5.21 18.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -1.132 . . . . 0.0 110.139 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 55.3 p -97.69 -45.85 6.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.393 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.534 HD12 ' CD1' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -118.4 163.06 17.29 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.112 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.524 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 62.7 tt0 -140.79 -79.79 0.27 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.524 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 33.8 mttt -80.28 145.95 31.89 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 110.735 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.63 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 25.4 mm -134.49 150.98 31.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.123 -0.985 . . . . 0.0 109.57 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -123.89 124.39 42.52 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.7 178.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.63 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 19.7 m-85 -117.86 134.64 54.73 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.32 -0.863 . . . . 0.0 110.625 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 117' ' ' THR . 6.0 mt-10 -134.36 126.43 29.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.821 . . . . 0.0 109.99 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 86.8 m -119.88 147.87 44.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.972 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LYS . 23.7 mttt -140.33 133.81 30.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 110.51 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.518 ' CD2' HD13 ' A' ' 18' ' ' LEU . 5.8 mt -112.71 151.81 29.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 110.185 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -151.36 -169.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.0 109.97 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -127.41 131.0 50.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.187 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 54.7 p -87.31 162.27 43.5 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.6 Cg_endo -72.51 -1.41 10.21 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.058 1.557 . . . . 0.0 110.594 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.9 p -101.05 -0.93 35.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.279 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.68 -39.72 2.79 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.78 -175.08 2.56 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 4.0 m -126.63 137.74 53.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -1.18 . . . . 0.0 110.468 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.473 ' HB ' ' HB ' ' A' ' 105' ' ' VAL . 65.0 mt -87.89 151.5 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.394 -0.816 . . . . 0.0 110.105 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.605 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 9.8 mt -134.24 113.31 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.294 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 103' ' ' LYS . 79.4 tttt -102.11 131.34 48.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 109.974 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.74 154.74 33.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.488 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 101' ' ' GLU . 64.6 m -155.47 123.04 5.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.399 -0.813 . . . . 0.0 110.02 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.464 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 42.0 t -129.06 157.19 42.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 44.6 m-70 -134.51 173.22 11.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.217 -0.927 . . . . 0.0 110.44 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.467 ' HA ' HD12 ' A' ' 98' ' ' ILE . 21.2 m-85 -129.91 144.44 51.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.271 -0.893 . . . . 0.0 110.575 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 96.8 m-70 -125.51 95.95 4.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 109.495 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 127' ' ' GLU . 3.1 p -56.87 164.93 1.36 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 0.0 110.572 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 78.9 tttt -115.52 119.2 35.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.45 -107.78 2.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.518 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 43.4 t30 -130.51 86.8 2.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -1.145 . . . . 0.0 110.266 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 125' ' ' ASN . 35.5 m -156.39 173.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 110.208 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.444 ' HA ' HG22 ' A' ' 122' ' ' THR . 96.9 mt-10 -148.27 147.7 29.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.216 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.57 HD11 ' CD1' ' A' ' 3' ' ' PHE . 5.2 mp -78.68 173.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.064 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.433 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 36.2 mtpt -103.94 136.04 44.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -49.45 -29.18 6.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 110.234 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.07 -35.51 78.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.064 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.424 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 17.6 t-160 -66.81 -42.64 85.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.097 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.63 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 68.9 t -62.57 -39.82 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.998 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -72.82 -39.16 66.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 110.179 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.15 93.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.133 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.24 -22.63 76.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.528 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 82.6 mttt -75.98 -32.67 59.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 110.094 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.56 -32.07 60.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.038 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -75.83 -27.59 57.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -84.76 -35.72 22.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 110.115 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 80.4 p -64.21 -46.0 85.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.876 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.19 -50.29 74.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.976 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.469 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.6 mm? -58.49 -32.72 69.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.853 . . . . 0.0 109.993 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 4.9 m-85 -63.33 -38.43 91.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.051 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -78.54 -18.1 55.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.468 ' HB3' HG22 ' A' ' 33' ' ' ILE . 15.4 mt -81.09 -35.14 32.06 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.126 -0.984 . . . . 0.0 108.829 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.596 HD11 ' CE1' ' A' ' 22' ' ' PHE . 34.7 mt -69.62 -49.06 61.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.857 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.474 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 65.1 mm-40 -54.12 -41.7 68.65 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.394 -0.816 . . . . 0.0 109.362 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 45.1 m -71.38 -32.6 68.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.592 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.588 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 76.2 t80 -53.9 -58.75 6.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.934 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.612 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 62.8 mt -69.03 -29.73 67.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -0.962 . . . . 0.0 109.968 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.525 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 43.5 tptt -68.59 -35.64 77.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 109.775 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.451 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -98.44 -28.69 7.87 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.511 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.8 m-70 -107.2 89.1 4.36 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.359 -1.083 . . . . 0.0 109.897 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.0 Cg_endo -72.76 4.46 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.095 1.576 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 24.2 p30 -107.74 -12.64 15.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.007 -1.058 . . . . 0.0 109.728 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.569 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . . . -66.49 100.57 0.67 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.409 -0.807 . . . . 0.0 109.999 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.691 ' CE2' ' CB ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER 34.86 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.279 0.562 . . . . 0.0 110.584 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.378 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.783 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 73.8 t -135.65 125.33 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.162 . . . . 0.0 110.456 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.559 ' CE1' HG12 ' A' ' 128' ' ' ILE . 52.9 m-85 -96.91 173.51 7.25 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.254 -0.904 . . . . 0.0 110.094 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.489 HG21 ' CE1' ' A' ' 119' ' ' HIS . 54.4 m -148.11 98.38 2.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.575 ' CZ ' HG23 ' A' ' 133' ' ' VAL . 78.5 m-85 -114.89 132.03 56.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.023 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 116' ' ' SER . 18.9 pt-20 -130.84 159.6 36.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.569 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 p -132.0 143.91 50.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.424 -0.798 . . . . 0.0 109.895 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -124.81 125.71 44.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 0.0 110.387 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.624 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 3.8 p90 -152.84 -172.86 4.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 110.005 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.46 HG23 HG12 ' A' ' 113' ' ' ILE . 10.8 p -140.19 179.89 6.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.272 -0.893 . . . . 0.0 110.446 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 112' ' ' SER . 2.6 t -157.51 158.96 36.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.268 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.482 ' OE2' ' NZ ' ' A' ' 152' ' ' LYS . 17.1 pt-20 -85.76 -10.89 54.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.915 . . . . 0.0 110.044 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 2.0 mp -90.5 151.37 44.12 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.711 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.3 Cg_endo -66.86 143.04 65.18 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.975 1.513 . . . . 0.0 110.723 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.638 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 Cg_endo -71.63 -31.73 12.96 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.952 1.501 . . . . 0.0 112.584 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -69.53 -18.99 37.77 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.511 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -84.47 -48.57 9.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.512 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.1 tt -68.62 -24.55 64.58 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.621 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 82.8 t80 -69.83 -57.12 5.46 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.498 0.666 . . . . 0.0 109.789 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 81.6 mttt -54.88 -30.56 58.31 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.692 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -73.3 -64.62 0.94 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.771 0.796 . . . . 0.0 111.167 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.627 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -57.43 -40.37 78.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.66 -0.65 . . . . 0.0 111.955 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.596 HG12 ' CD1' ' A' ' 81' ' ' TYR . 11.5 t -99.6 -59.41 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.786 -1.196 . . . . 0.0 111.798 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 7.3 mp -77.1 -0.55 25.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.015 . . . . 0.0 111.71 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -145.35 7.01 1.13 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.756 -1.215 . . . . 0.0 111.193 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -46.02 -48.06 16.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.873 -1.142 . . . . 0.0 110.01 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.441 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 74.0 m-20 -58.91 -15.43 12.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.831 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 25' ' ' ASP . 80.0 m-20 -129.54 10.93 5.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.556 HD13 ' CB ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -95.25 -46.26 6.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.982 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.645 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 6.3 p -76.91 -27.63 0.62 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 112.419 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.7 Cg_endo -75.68 3.14 6.22 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 122.563 0.77 . . . . 0.0 110.611 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.528 ' CD ' ' OH ' ' A' ' 150' ' ' TYR . 95.0 mttt -119.15 -26.5 5.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -0.941 . . . . 0.0 109.127 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.586 HG12 ' CD1' ' A' ' 150' ' ' TYR . 49.4 mt -79.35 -41.02 22.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.553 -0.717 . . . . 0.0 109.533 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.75 103.79 0.46 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.49 -0.756 . . . . 0.0 109.829 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.56 -3.01 11.02 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.979 1.515 . . . . 0.0 110.688 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -83.16 -14.87 52.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.494 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 58' ' ' PHE . . . -92.06 -71.97 0.61 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 110.201 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.549 ' CD1' HG22 ' A' ' 30' ' ' VAL . 1.7 mp -94.06 125.79 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.868 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -74.19 -36.19 64.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.339 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.538 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -179.56 151.96 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.862 . . . . 0.0 109.974 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.441 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 39.3 p -112.01 133.59 54.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.07 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 71.9 tt0 -139.88 108.72 5.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.971 . . . . 0.0 110.29 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.8 mt -66.07 134.54 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 110.189 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.8 tp -90.31 -27.03 19.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.522 ' O ' ' CG2' ' A' ' 52' ' ' THR . 33.3 tp10 -158.84 169.32 24.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.228 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 64.75 -166.17 32.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 48.7 t0 -135.88 29.71 3.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -1.167 . . . . 0.0 110.287 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.36 4.85 43.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -96.45 -167.31 33.91 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.462 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.64 132.12 21.3 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.143 1.602 . . . . 0.0 110.514 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.25 -7.31 66.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 26.7 m -80.02 139.0 37.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -1.106 . . . . 0.0 110.161 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.517 HD12 ' CB ' ' A' ' 70' ' ' LYS . 18.7 mm -109.06 110.84 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 110.226 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.1 mttt -97.84 153.27 18.42 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.378 -0.827 . . . . 0.0 110.392 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -124.94 100.6 6.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.075 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.481 HD11 HG22 ' A' ' 56' ' ' ILE . 88.5 mt -88.27 138.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.35 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.9 p -111.58 157.59 20.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.184 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 28.6 m-85 -117.83 159.44 23.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.356 -0.84 . . . . 0.0 110.3 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.92 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.305 0.574 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -139.47 82.83 0.24 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 14.7 p90 -131.6 163.65 27.59 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.219 -1.165 . . . . 0.0 110.198 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.51 HG13 ' CA ' ' A' ' 88' ' ' GLY . 9.5 m -137.71 172.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 110.627 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.526 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . 70.7 mttt -123.78 130.65 52.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.667 -0.646 . . . . 0.0 109.503 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.646 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 9.6 m170 -118.44 130.7 56.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.004 . . . . 0.0 111.0 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.517 ' CB ' HD12 ' A' ' 53' ' ' ILE . 85.0 tttt -104.05 120.04 40.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.416 -0.802 . . . . 0.0 109.174 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.536 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 21.0 mm -62.4 129.58 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 110.693 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 73' ' ' SER . 72.3 m-20 -101.37 -49.6 4.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.359 -0.838 . . . . 0.0 109.308 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 79.6 p -179.68 157.36 0.74 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.529 -0.732 . . . . 0.0 110.286 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.584 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 3.2 tt -145.97 164.32 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -134.31 81.5 1.92 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 110.123 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.621 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 41.6 ttmt -55.9 -14.38 2.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.278 -0.889 . . . . 0.0 110.824 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -84.1 -29.91 26.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 0.0 109.006 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -116.63 -1.1 12.22 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.357 0.599 . . . . 0.0 109.532 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.553 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 7.6 m-85 65.5 49.82 1.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.684 -0.635 . . . . 0.0 110.108 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.518 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -116.41 142.14 47.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 109.285 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.646 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 72.9 t80 -137.24 155.1 49.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.267 -0.895 . . . . 0.0 110.284 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 73' ' ' SER . 77.9 p -158.51 140.86 14.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 110.474 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.646 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 5.9 p90 -148.59 177.69 9.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 110.161 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.467 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 90.0 m -128.5 131.6 48.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 110.004 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.646 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 15.5 tp -83.62 123.7 30.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.201 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.526 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 33.7 pt -104.93 -8.99 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 110.228 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -163.57 166.26 22.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.51 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 155.04 153.23 6.43 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -79.96 -22.18 42.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -1.214 . . . . 0.0 110.268 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.99 -20.23 63.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.307 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.558 ' CD2' ' CD1' ' A' ' 98' ' ' ILE . 71.1 mt -67.79 -18.75 64.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.27 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.87 -167.19 0.51 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.41 9.53 25.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -1.151 . . . . 0.0 110.128 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 122' ' ' THR . 40.8 p -110.55 -32.11 7.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 110.079 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.577 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 72.3 mt -109.42 154.74 22.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 110.169 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 68.8 tt0 -137.37 -80.83 0.37 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.159 -0.963 . . . . 0.0 110.004 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' A' ' 98' ' ' ILE . 32.1 mttm -80.22 156.15 27.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.495 -0.753 . . . . 0.0 110.513 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.635 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.2 mm -145.49 126.28 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.092 -1.005 . . . . 0.0 109.82 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -93.23 126.51 38.38 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.45 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 15.0 m-85 -121.05 144.56 48.47 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.317 -0.864 . . . . 0.0 110.961 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -149.89 128.02 11.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.481 -0.762 . . . . 0.0 109.938 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 85.6 m -127.69 134.62 49.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.989 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 115' ' ' LYS . 15.5 mttt -124.44 136.81 54.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.287 -0.883 . . . . 0.0 110.362 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.522 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 8.5 mt -117.19 150.33 38.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.359 -0.838 . . . . 0.0 110.063 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.482 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -151.57 -169.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.257 -0.902 . . . . 0.0 110.107 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -117.81 140.42 49.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.408 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 92.1 p -96.74 162.5 22.94 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -72.6 -1.73 10.75 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.469 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p -99.9 -8.86 23.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.3 -21.81 21.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 11' ' ' SER . . . -74.34 -146.05 1.08 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.519 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 27.3 p -149.36 131.67 15.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -1.158 . . . . 0.0 110.057 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.46 HG12 HG23 ' A' ' 10' ' ' THR . 37.0 mt -83.19 148.98 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 110.132 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.624 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 7.0 mt -133.41 115.55 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 110.463 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 103' ' ' LYS . 81.3 tttt -108.37 117.66 34.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.325 -0.859 . . . . 0.0 109.748 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 8.7 t -113.5 164.72 13.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.753 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.5 HG23 ' CE1' ' A' ' 119' ' ' HIS . 30.8 m -160.01 120.23 2.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.375 -0.828 . . . . 0.0 109.795 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.558 ' OG ' ' CD1' ' A' ' 100' ' ' TYR . 26.5 m -122.69 133.93 54.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.383 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.5 ' CE1' HG23 ' A' ' 117' ' ' THR . 35.8 m-70 -114.3 156.82 23.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 109.763 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.8 m-85 -114.37 149.28 36.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 110.595 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 90.1 m-70 -125.74 88.17 2.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.018 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.577 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -74.15 146.06 43.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.514 -0.741 . . . . 0.0 111.083 -178.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 63.7 pttt -105.41 130.89 53.41 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.543 -0.723 . . . . 0.0 110.137 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.24 -117.47 4.62 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.523 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 46.2 t30 -138.27 103.28 4.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.275 -1.132 . . . . 0.0 110.418 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 8.7 m -159.5 165.49 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.833 . . . . 0.0 109.896 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -134.7 158.46 44.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.142 -0.974 . . . . 0.0 110.32 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.559 HG12 ' CE1' ' A' ' 3' ' ' PHE . 22.7 mm -70.7 172.93 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 110.196 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 132' ' ' HIS . 13.9 mttm -116.61 131.45 56.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.972 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 69.5 mm-40 -43.66 -44.4 6.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.15 -0.969 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -63.29 -24.63 67.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.933 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 129' ' ' LYS . 15.1 t-160 -81.06 -49.25 11.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.118 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.575 HG23 ' CZ ' ' A' ' 5' ' ' TYR . 59.5 t -58.79 -37.66 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.758 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.03 -44.81 37.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.902 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -64.27 -32.69 74.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.349 -0.844 . . . . 0.0 110.057 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.06 -32.17 66.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -75.83 -34.08 60.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -1.1 . . . . 0.0 109.997 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.99 -37.73 58.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.916 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 94.3 mttt -69.5 -37.53 77.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 109.861 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.477 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -69.79 -34.98 74.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.797 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 64.9 m -72.64 -44.19 62.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.805 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -57.61 -43.94 85.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.877 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.6 -43.75 98.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.913 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.48 ' HA ' HD13 ' A' ' 147' ' ' ILE . 8.6 m-85 -59.89 -32.87 71.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.443 -0.786 . . . . 0.0 109.84 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -78.27 -20.21 52.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.457 ' HB3' HG23 ' A' ' 33' ' ' ILE . 17.5 mt -83.25 -36.29 24.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.174 -0.954 . . . . 0.0 108.826 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 8.9 mt -72.51 -43.75 62.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.475 ' O ' HG12 ' A' ' 13' ' ' ILE . 54.7 mt-10 -60.95 -41.11 95.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.435 -0.791 . . . . 0.0 109.372 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.8 m -72.9 -32.8 65.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.622 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.594 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 86.2 t80 -56.48 -54.68 42.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.495 -0.753 . . . . 0.0 109.886 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.649 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 69.4 mt -69.27 -31.22 69.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.307 -0.871 . . . . 0.0 110.288 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 43.1 tttt -68.55 -28.43 66.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.88 . . . . 0.0 109.782 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.81 -26.72 6.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.513 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 11.2 m-70 -107.27 90.41 5.67 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.951 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.8 Cg_endo -73.47 3.75 4.51 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.101 1.579 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -109.56 -9.69 14.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.76 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.583 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . . . -68.48 100.28 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.468 -0.77 . . . . 0.0 110.136 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.692 ' CE2' ' CB ' ' A' ' 21' ' ' ALA . 0.7 OUTLIER 34.4 32.72 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.253 0.549 . . . . 0.0 110.542 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.846 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 50.0 t -125.43 114.31 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.187 -1.184 . . . . 0.0 110.406 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.57 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 93.1 m-85 -74.83 152.83 38.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.954 . . . . 0.0 110.184 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.491 HG21 ' CE1' ' A' ' 119' ' ' HIS . 7.9 m -130.38 113.76 14.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.638 ' CD2' ' CG1' ' A' ' 133' ' ' VAL . 39.1 m-85 -126.61 125.84 42.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.089 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.576 ' CG ' ' N ' ' A' ' 7' ' ' SER . 16.3 tt0 -114.82 176.15 5.18 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.277 -0.889 . . . . 0.0 109.61 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.576 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 19.1 m -153.0 147.4 25.87 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.646 -0.659 . . . . 0.0 109.852 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 47.6 mt-10 -140.26 116.33 10.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.054 -1.028 . . . . 0.0 110.566 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.9 p90 -145.17 -172.08 3.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 109.887 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.47 HG21 ' HA ' ' A' ' 113' ' ' ILE . 5.6 p -140.59 172.63 12.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.458 ' OG ' ' OG ' ' A' ' 112' ' ' SER . 53.8 p -150.69 142.24 23.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.465 -0.772 . . . . 0.0 110.097 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.17 -25.93 68.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.278 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 5.1 mp -81.34 146.38 57.74 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.148 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.562 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 41.7 Cg_endo -66.76 152.94 79.58 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.116 1.587 . . . . 0.0 110.719 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.645 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.7 Cg_endo -64.5 -36.08 45.38 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.763 1.401 . . . . 0.0 113.204 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 39.5 Cg_endo -65.24 -20.17 62.43 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 N-CA-C 109.748 -0.905 . . . . 0.0 109.748 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.524 ' HG3' ' CD1' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.92 -43.4 19.85 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.595 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 8.0 mp -72.68 -38.08 67.69 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.587 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 47.9 t80 -56.84 -57.56 11.93 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.24 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 92.5 mttt -57.58 -37.47 73.22 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.529 -0.732 . . . . 0.0 110.134 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.628 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . . . -80.03 -58.74 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 111.1 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.618 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -53.73 -40.52 66.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 0.0 111.958 -178.606 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.589 ' CG1' ' CD1' ' A' ' 74' ' ' ILE . 21.1 t -106.27 -65.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.845 -1.159 . . . . 0.0 111.693 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.554 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 4.2 mm? -62.77 -8.58 7.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 111.216 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.533 ' OD2' ' CD2' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -144.76 28.52 1.27 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.876 -1.14 . . . . 0.0 110.63 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -67.57 -35.51 79.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -0.907 . . . . 0.0 110.112 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.449 ' OD1' ' CB ' ' A' ' 41' ' ' SER . 19.8 t70 -63.25 -16.05 59.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 81.8 m-20 -126.94 8.1 6.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.029 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -92.94 -53.64 4.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.178 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.588 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.5 t -72.02 -42.47 9.78 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.415 -0.803 . . . . 0.0 110.905 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.3 Cg_endo -77.74 9.48 2.94 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.541 1.285 . . . . 0.0 111.005 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 33.3 ttmt -127.21 -31.2 2.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.968 -1.083 . . . . 0.0 109.831 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.582 HG12 ' CD1' ' A' ' 150' ' ' TYR . 36.7 mt -80.01 -38.97 19.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.443 -0.785 . . . . 0.0 109.733 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.28 99.75 2.49 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.449 -0.782 . . . . 0.0 110.026 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.27 -2.0 10.51 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.066 1.561 . . . . 0.0 110.481 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -86.36 -12.6 48.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.751 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.03 -56.34 2.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.081 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.529 ' CD1' HG13 ' A' ' 30' ' ' VAL . 2.0 mp -115.12 132.28 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 110.08 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.587 ' CG ' ' CA ' ' A' ' 59' ' ' GLY . 0.5 OUTLIER -68.62 -37.28 79.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.891 . . . . 0.0 110.193 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.554 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 177.61 153.82 0.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 110.018 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.449 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 62.7 m -115.04 125.7 53.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.979 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.554 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 84.5 tt0 -130.18 106.93 8.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.293 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 43' ' ' ILE . 22.2 mt -61.08 131.68 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.176 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.4 HD13 HG23 ' A' ' 53' ' ' ILE . 49.7 mt -88.93 -26.09 21.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 110.044 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.454 ' O ' ' CG2' ' A' ' 52' ' ' THR . 55.7 tt0 -152.31 171.14 18.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.97 -169.03 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -130.37 28.14 4.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -1.121 . . . . 0.0 110.232 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.36 -5.49 24.96 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -79.97 -170.99 41.86 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.478 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -70.44 133.55 24.56 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.195 1.629 . . . . 0.0 110.574 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.27 -1.42 76.77 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.465 HG21 ' N ' ' A' ' 53' ' ' ILE . 32.4 m -80.16 145.42 32.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -1.193 . . . . 0.0 110.158 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.481 HD12 ' HA ' ' A' ' 70' ' ' LYS . 36.0 mm -111.92 112.02 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 110.184 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HE2' HD12 ' A' ' 71' ' ' ILE . 46.5 mtmt -99.12 150.57 21.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 110.374 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -123.14 98.84 6.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.877 . . . . 0.0 110.053 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.471 ' HB ' HG22 ' A' ' 67' ' ' VAL . 96.6 mt -88.97 140.12 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 110.193 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.9 p -115.0 152.77 31.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.56 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 26.7 m-85 -117.62 129.2 55.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.499 -0.75 . . . . 0.0 109.993 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.587 ' CA ' ' CG ' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.225 0.536 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -122.38 88.0 0.4 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.1 p90 -123.62 163.42 21.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -1.211 . . . . 0.0 110.124 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.521 HG13 ' CA ' ' A' ' 88' ' ' GLY . 8.6 m -141.32 172.03 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.938 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.445 ' HD2' ' OE1' ' A' ' 87' ' ' GLU . 86.4 mttt -127.4 125.85 41.4 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.512 ' CD2' HD13 ' A' ' 85' ' ' LEU . 10.1 m170 -116.92 121.02 40.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 111.161 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.517 ' HE2' ' CG2' ' A' ' 86' ' ' ILE . 23.5 mtmt -96.46 106.88 19.2 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.324 -0.86 . . . . 0.0 109.242 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.7 mm -48.34 136.68 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.872 . . . . 0.0 110.074 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 73' ' ' SER . 14.9 m-20 -107.34 -44.6 4.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.343 -0.848 . . . . 0.0 109.744 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 12.9 p 176.18 156.57 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.522 -0.736 . . . . 0.0 110.365 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.589 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 6.1 tt -144.96 169.86 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.504 -0.748 . . . . 0.0 109.597 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.4 m-20 -142.47 84.29 1.85 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.075 -1.016 . . . . 0.0 110.317 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.587 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 81.1 tttt -59.67 -13.9 11.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 110.221 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -92.79 -34.2 13.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.2 m-80 -102.21 -3.9 26.61 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.524 0.678 . . . . 0.0 109.229 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 75' ' ' ASP . 90.5 m-85 62.58 55.78 2.14 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.253 0.549 . . . . 0.0 110.919 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 2.7 m -132.14 162.38 31.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 0.0 109.658 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.61 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 80.2 t80 -158.08 146.71 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -0.974 . . . . 0.0 110.198 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 100' ' ' TYR . 3.8 t -153.56 147.63 25.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.692 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.61 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 9.2 p90 -149.76 175.58 11.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.429 -0.794 . . . . 0.0 110.015 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.44 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 97.6 m -125.61 128.82 48.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.52 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 2.7 tp -96.39 122.97 39.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.573 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.517 ' CG2' ' HE2' ' A' ' 70' ' ' LYS . 20.8 pt -112.63 -5.39 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 110.894 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 22.9 tt0 -147.29 120.86 9.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 110.672 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.521 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . -168.74 149.05 13.11 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.68 -8.04 24.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -1.123 . . . . 0.0 110.065 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.4 -53.54 6.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.471 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.547 ' CB ' ' HG ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -63.94 -30.7 71.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.269 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 39.08 -124.42 1.75 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -106.04 -6.46 18.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -1.125 . . . . 0.0 110.494 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.512 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 64.1 p -80.04 -50.63 10.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 109.703 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.547 ' HG ' ' CB ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -109.43 163.66 13.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.416 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 42.0 tt0 -133.18 -77.84 0.48 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 110.912 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.6 mtpt -80.08 128.96 34.11 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.615 -0.678 . . . . 0.0 111.125 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.617 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.2 mm -117.74 140.47 40.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 120.868 -1.145 . . . . 0.0 109.811 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -117.76 126.72 52.97 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.38 -0.825 . . . . 0.0 108.974 178.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.617 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 9.4 m-85 -121.8 136.07 54.93 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.915 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.46 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 48.3 tt0 -137.14 150.72 48.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.571 -0.706 . . . . 0.0 109.606 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' TYR . 36.7 m -149.21 150.4 32.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -0.997 . . . . 0.0 110.408 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.511 ' N ' HG21 ' A' ' 102' ' ' THR . 2.3 tttt -138.68 147.22 42.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.681 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 79' ' ' TYR . 2.7 mt -128.45 147.3 50.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.001 . . . . 0.0 110.688 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.495 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.72 -168.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.475 -0.765 . . . . 0.0 109.806 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -120.86 172.7 7.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.131 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 32.8 p -130.48 164.96 37.71 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -73.16 -1.3 10.35 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.995 1.524 . . . . 0.0 110.599 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.0 p -103.93 3.68 33.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.374 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.04 -36.76 3.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.97 -173.85 3.09 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.5 p -130.33 140.24 50.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -1.189 . . . . 0.0 110.357 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.47 ' HA ' HG21 ' A' ' 10' ' ' THR . 27.5 mt -89.8 149.5 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.854 . . . . 0.0 110.077 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.627 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 10.5 mt -135.95 110.61 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.313 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 37.1 ttmt -99.73 129.85 45.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.941 . . . . 0.0 110.135 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.6 t -121.03 157.18 30.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.958 . . . . 0.0 110.282 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 85.7 m -154.3 138.02 16.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 110.15 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.454 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 34.7 p -141.61 154.46 45.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 110.184 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.491 ' CE1' HG21 ' A' ' 4' ' ' THR . 82.2 m-70 -133.41 164.63 26.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 0.0 110.387 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.587 ' CD2' HG13 ' A' ' 128' ' ' ILE . 8.2 m-85 -124.06 141.92 51.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 110.435 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.2 m-70 -122.52 89.43 3.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.924 -1.11 . . . . 0.0 109.793 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.466 ' CG2' HG22 ' A' ' 126' ' ' VAL . 2.7 p -60.25 163.44 5.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 110.301 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 85.0 tttt -126.0 114.9 19.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.275 -0.891 . . . . 0.0 110.242 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.36 -105.37 2.99 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.522 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 24.7 t30 -135.6 93.43 2.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -1.169 . . . . 0.0 110.202 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 125' ' ' ASN . 15.9 m -157.76 165.55 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.305 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -145.21 149.5 35.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 110.316 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.587 HG13 ' CD2' ' A' ' 120' ' ' TYR . 37.8 mm -75.97 173.41 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 110.203 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.482 ' N ' HG23 ' A' ' 128' ' ' ILE . 31.5 mtpt -116.54 136.21 53.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.4 -0.813 . . . . 0.0 110.078 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -45.43 -43.26 11.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 37.1 tt0 -61.62 -31.28 71.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 110.142 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -74.02 -47.69 35.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 110.081 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.638 ' CG1' ' CD2' ' A' ' 5' ' ' TYR . 73.0 t -62.21 -40.96 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.381 -0.824 . . . . 0.0 110.008 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -69.37 -42.73 74.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.997 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -62.4 -38.66 90.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.026 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -30.23 68.16 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 52.7 mtpt -77.37 -31.85 54.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -1.147 . . . . 0.0 110.055 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -76.67 -30.49 56.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 109.927 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 46.1 mttp -68.37 -37.5 80.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.864 . . . . 0.0 110.051 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.42 -43.08 64.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.902 . . . . 0.0 110.007 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.1 p -63.42 -43.46 97.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.943 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -57.73 -41.68 82.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.863 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.464 ' O ' HG13 ' A' ' 147' ' ' ILE . 66.4 mt -58.61 -46.32 87.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 0.0 109.966 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.458 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 20.9 m-85 -54.42 -39.53 67.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.383 -0.823 . . . . 0.0 109.913 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.88 -28.19 68.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.88 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.515 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 16.9 mt -82.93 -34.5 26.53 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.222 -0.924 . . . . 0.0 108.791 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.618 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 81.8 mt -72.01 -34.79 51.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.606 -0.684 . . . . 0.0 109.329 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 152' ' ' LYS . 30.8 mt-10 -64.91 -39.43 93.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.403 -0.811 . . . . 0.0 109.428 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.7 m -69.6 -35.47 75.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.498 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.591 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 71.5 t80 -58.58 -51.84 68.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.819 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.587 ' CD2' ' CE1' ' A' ' 158' ' ' TYR . 78.0 mt -80.05 -39.15 30.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 110.27 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 82.6 tttt -64.2 -19.16 65.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.495 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.31 -34.72 2.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.613 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 3.6 m-70 -107.03 94.47 10.88 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.276 -1.132 . . . . 0.0 109.983 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.432 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.4 Cg_endo -74.04 5.38 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.089 1.573 . . . . 0.0 110.973 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -106.89 -9.66 16.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.046 -1.034 . . . . 0.0 109.856 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 150' ' ' TYR . . . -69.68 100.82 1.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.348 -0.845 . . . . 0.0 110.083 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.628 ' CE1' ' CB ' ' A' ' 21' ' ' ALA . 1.0 OUTLIER 34.09 33.6 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.342 0.591 . . . . 0.0 110.642 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.516 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 118.009 -0.995 . . . . 0.0 109.852 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.591 HG22 ' CD2' ' A' ' 121' ' ' HIS . 2.9 p -80.12 150.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -1.131 . . . . 0.0 110.35 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.567 ' CD1' HD13 ' A' ' 128' ' ' ILE . 26.1 m-85 -89.07 176.38 7.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 110.368 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.4 m -145.45 103.66 3.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.396 -0.815 . . . . 0.0 110.083 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.577 ' CE1' HG12 ' A' ' 133' ' ' VAL . 51.5 m-85 -116.23 129.34 56.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 110.098 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 25.5 pt-20 -131.52 157.94 42.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 110.505 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.4 m -133.95 139.42 46.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.895 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.452 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 99.9 mt-10 -121.24 127.32 51.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.385 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 3.8 p90 -154.3 -171.76 3.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.038 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 18.0 p -141.35 -176.46 4.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.57 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.489 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 3.7 t -159.6 160.9 34.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.776 . . . . 0.0 110.152 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -85.16 -19.11 32.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.978 . . . . 0.0 110.153 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 10.0 mm -85.47 149.8 52.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 110.095 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.55 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 40.9 Cg_endo -65.82 148.5 86.5 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.06 1.558 . . . . 0.0 110.57 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.649 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.3 Cg_endo -70.05 -32.57 17.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.885 1.466 . . . . 0.0 112.893 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.2 Cg_endo -67.58 -20.62 47.0 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 N-CA-C 110.149 -0.75 . . . . 0.0 110.149 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CD ' ' HB2' ' A' ' 159' ' ' ASN . 4.6 ttm180 -84.73 -49.16 8.72 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.52 HD23 ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -69.06 -26.73 65.1 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.205 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.604 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.9 t80 -71.29 -55.03 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 109.236 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 63.3 mttt -51.72 -32.98 32.49 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.403 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.619 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -79.83 -55.09 5.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 111.188 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 1.0 OUTLIER -57.29 -44.39 84.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.527 -0.733 . . . . 0.0 112.52 -177.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.454 HG12 HG12 ' A' ' 74' ' ' ILE . 3.5 t -106.8 -55.68 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.792 -1.192 . . . . 0.0 112.06 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.9 mm? -68.84 -10.64 58.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.01 -1.056 . . . . 0.0 111.174 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 1.2 m-20 -145.36 28.58 1.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.886 -1.134 . . . . 0.0 110.734 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -67.29 -20.04 65.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.152 -0.968 . . . . 0.0 110.436 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -72.61 -20.19 61.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.096 -1.003 . . . . 0.0 109.588 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.456 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 5.7 p30 -126.85 14.76 7.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 109.672 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.571 HD22 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -96.42 -50.16 4.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.224 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.664 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 9.7 p -73.26 -26.99 0.79 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.332 -0.855 . . . . 0.0 112.183 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 52.1 Cg_endo -82.91 10.38 3.66 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 122.621 0.8 . . . . 0.0 110.51 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -134.37 -27.04 1.4 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.13 -0.982 . . . . 0.0 110.603 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.57 HG12 ' CD1' ' A' ' 150' ' ' TYR . 34.3 mt -77.87 -36.29 21.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.225 -0.922 . . . . 0.0 109.899 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.95 100.13 0.82 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.342 -0.849 . . . . 0.0 110.338 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.85 -0.1 9.0 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.109 1.584 . . . . 0.0 110.346 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -88.29 -13.09 41.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 110.007 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.13 -47.1 4.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 110.315 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.55 ' CD1' ' CG2' ' A' ' 30' ' ' VAL . 1.1 mp -125.79 145.24 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -0.82 . . . . 0.0 110.103 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -83.18 -42.04 17.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.269 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.543 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -178.44 163.53 1.58 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 110.123 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.6 m -120.27 125.68 48.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.185 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.528 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 83.9 tt0 -130.04 107.57 9.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 110.151 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 23.4 mt -56.54 134.89 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 110.071 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' CD2' ' HE3' ' A' ' 55' ' ' LYS . 63.8 tp -88.76 -46.51 8.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -0.958 . . . . 0.0 109.911 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 46' ' ' GLY . 16.8 mm-40 -131.97 -169.81 2.28 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.442 -0.786 . . . . 0.0 110.179 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.435 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.08 -150.05 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 47' ' ' ASP . 23.4 t0 -160.03 41.48 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -1.133 . . . . 0.0 110.093 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.31 -11.71 54.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -82.13 -175.54 50.62 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.3 Cg_endo -72.23 132.82 20.06 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.144 1.602 . . . . 0.0 110.43 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.91 -3.78 62.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.473 HG21 ' N ' ' A' ' 53' ' ' ILE . 42.4 m -80.02 150.04 30.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -1.175 . . . . 0.0 109.986 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.473 ' N ' HG21 ' A' ' 52' ' ' THR . 20.9 mm -116.76 107.62 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.948 . . . . 0.0 110.324 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 73.0 mttt -90.32 144.88 25.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.398 -0.814 . . . . 0.0 110.097 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.522 ' HE3' ' CD2' ' A' ' 44' ' ' LEU . 31.7 mttt -117.95 95.4 4.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.267 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 38' ' ' ILE . 86.9 mt -83.44 145.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.904 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.47 ' O ' HG22 ' A' ' 38' ' ' ILE . 6.2 p -116.48 158.35 23.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 110.74 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 28.9 m-85 -116.42 145.87 42.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.226 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.992 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.495 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 7.1 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.154 0.502 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -116.8 135.86 12.31 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.541 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.9 p90 -179.08 166.57 1.57 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -1.153 . . . . 0.0 110.271 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.535 HG13 ' CA ' ' A' ' 88' ' ' GLY . 3.6 m -142.09 174.7 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 110.362 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.465 ' O ' HD11 ' A' ' 85' ' ' LEU . 96.6 mttt -126.15 124.75 41.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.481 -0.762 . . . . 0.0 109.705 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.617 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 10.1 m170 -113.73 130.3 56.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.135 -0.978 . . . . 0.0 110.814 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HA ' HD12 ' A' ' 53' ' ' ILE . 76.7 tttt -107.31 102.31 11.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.381 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 49' ' ' GLY . 34.6 mm -45.25 135.35 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.466 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 12.2 t0 -108.66 -38.69 5.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.446 -0.784 . . . . 0.0 109.617 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 6.4 p 179.07 156.58 0.5 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.505 -0.747 . . . . 0.0 110.019 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.454 HG12 HG12 ' A' ' 23' ' ' VAL . 1.9 mt -136.97 159.17 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.07 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-20 -144.67 83.97 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.62 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.604 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 57.4 tttp -66.65 -15.82 63.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.276 -0.89 . . . . 0.0 110.17 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -86.29 -31.04 21.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 0.0 108.809 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m-80 -106.1 -3.9 20.98 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 75' ' ' ASP . 98.9 m-85 61.11 53.73 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.36 0.6 . . . . 0.0 110.584 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 12.9 t -125.47 175.2 7.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.85 . . . . 0.0 110.103 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.687 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 39.1 t80 -159.59 134.23 7.84 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.713 -0.617 . . . . 0.0 109.8 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 20.2 m -140.77 123.34 16.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 111.037 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.687 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 16.8 p90 -139.16 171.86 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.812 . . . . 0.0 110.01 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 58.0 m -124.33 137.1 54.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.978 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.617 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 15.5 tp -99.74 124.85 45.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.391 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.419 HG23 HD11 ' A' ' 86' ' ' ILE . 23.3 pt -102.22 -10.67 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 110.292 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 85' ' ' LEU . 81.7 tt0 -151.51 155.71 39.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 110.232 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.535 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 157.61 143.47 3.67 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -61.54 -25.9 67.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -1.107 . . . . 0.0 110.184 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.553 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -60.21 -25.87 65.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 110.253 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' A' ' 92' ' ' GLY . 89.6 mt -62.52 -11.76 18.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.199 -0.938 . . . . 0.0 110.137 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 42.57 28.95 0.67 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 66.9 m-20 56.29 16.1 2.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -1.185 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 92' ' ' GLY . 19.6 p -111.93 -34.27 6.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.736 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.53 HD23 ' CD1' ' A' ' 128' ' ' ILE . 96.2 mt -94.76 163.85 13.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.826 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.489 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 68.1 tt0 -127.98 -81.61 0.59 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.783 0.802 . . . . 0.0 109.782 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 60.4 mttt -80.3 127.97 32.99 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.657 -0.652 . . . . 0.0 110.142 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.637 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 3.8 mm -117.05 139.91 41.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.628 -1.295 . . . . 0.0 109.721 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -120.59 125.18 47.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.637 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 12.4 m-85 -120.07 132.06 55.31 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.398 -0.814 . . . . 0.0 110.396 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 117' ' ' THR . 5.7 mt-10 -131.53 133.87 45.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.022 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 88.8 m -129.35 146.65 51.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.917 . . . . 0.0 110.1 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 115' ' ' LYS . 1.5 mttm -139.89 134.45 31.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 110.294 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.521 ' CD2' HG12 ' A' ' 114' ' ' ILE . 10.1 mt -113.93 148.24 37.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.145 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -150.89 -168.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 110.092 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -122.96 161.09 24.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 26.1 p -119.73 163.95 24.75 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.28 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.6 Cg_endo -72.27 -1.97 10.95 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.064 1.56 . . . . 0.0 110.477 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.2 p -103.78 -0.74 28.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.263 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.17 -35.72 4.85 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.25 -174.05 2.57 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.5 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 55.5 p -129.17 137.5 51.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -1.171 . . . . 0.0 110.327 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 59.2 mt -88.71 150.79 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 110.326 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.632 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 8.5 mt -132.86 111.35 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.1 tttt -101.11 123.39 45.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.108 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.5 t -117.17 156.53 27.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 101' ' ' GLU . 57.7 m -158.97 125.23 4.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 110.201 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.488 ' HB2' ' CD1' ' A' ' 100' ' ' TYR . 31.3 t -127.09 162.23 26.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 110.172 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 44.0 m-70 -140.75 128.83 22.1 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 9.7 m-30 -100.28 119.76 38.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.182 -0.949 . . . . 0.0 110.953 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.591 ' CD2' HG22 ' A' ' 2' ' ' VAL . 84.5 m-70 -93.59 101.27 13.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.379 -0.826 . . . . 0.0 109.373 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.47 ' CG2' HD22 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -81.06 154.12 27.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.042 -1.036 . . . . 0.0 110.525 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.406 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 33.4 tttp -127.64 117.36 21.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 116.26 -135.31 12.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 3.2 p-10 -125.84 53.53 1.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -1.15 . . . . 0.0 110.235 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.3 m -135.27 155.54 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 110.134 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.02 157.13 47.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.958 . . . . 0.0 110.371 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.567 HD13 ' CD1' ' A' ' 3' ' ' PHE . 2.2 mp -65.36 173.27 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.973 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.516 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 34.0 mttt -118.31 148.13 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 109.915 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.523 ' HG2' ' N ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -51.71 -22.88 3.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 110.395 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.523 ' N ' ' HG2' ' A' ' 130' ' ' GLU . 49.2 tt0 -77.8 -35.46 51.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.838 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 19.8 t-160 -73.58 -36.47 65.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.577 HG12 ' CE1' ' A' ' 5' ' ' TYR . 59.5 t -63.73 -43.62 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.864 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.48 -42.94 77.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.84 . . . . 0.0 109.955 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.93 89.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.513 ' HA3' ' CD ' ' A' ' 139' ' ' LYS . . . -65.61 -29.88 76.16 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 141' ' ' SER . 94.5 mttt -78.43 -30.73 47.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -1.128 . . . . 0.0 110.156 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.504 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 96.5 mt-10 -76.27 -39.77 53.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.086 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.513 ' CD ' ' HA3' ' A' ' 136' ' ' GLY . 18.8 ptpt -66.69 -33.18 75.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.837 . . . . 0.0 109.875 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 139' ' ' LYS . . . -88.82 -40.13 13.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.002 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 137' ' ' LYS . 61.6 m -65.27 -44.74 87.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.349 -0.845 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.3 m-20 -58.81 -41.33 86.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.367 -0.833 . . . . 0.0 110.035 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.0 mt -61.28 -40.6 94.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.889 . . . . 0.0 110.053 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -61.54 -34.75 76.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.019 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -76.9 -17.84 58.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.017 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.492 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 16.7 mt -83.45 -35.19 25.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.242 -0.912 . . . . 0.0 108.938 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 93.1 mt -71.22 -43.14 74.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.489 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 55.1 mt-10 -57.62 -37.72 73.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.362 -0.836 . . . . 0.0 109.283 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 65.7 m -73.65 -33.56 64.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.458 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.593 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 80.1 t80 -54.3 -48.51 71.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.458 -0.776 . . . . 0.0 109.898 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.631 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 72.4 mt -78.35 -30.55 48.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.178 -0.951 . . . . 0.0 110.164 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.469 ' HA ' HD13 ' A' ' 13' ' ' ILE . 30.5 ttpt -71.65 -22.11 61.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.307 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.14 -31.24 3.88 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.562 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.9 m-70 -109.78 92.88 13.23 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.452 -1.028 . . . . 0.0 109.968 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.17 5.82 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.034 1.544 . . . . 0.0 111.067 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -109.35 -1.03 18.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 109.991 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.557 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -81.54 102.89 10.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 110.073 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.631 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.85 32.79 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.366 0.603 . . . . 0.0 110.517 -179.484 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.535 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.818 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 85.2 t -120.15 123.61 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -1.158 . . . . 0.0 110.375 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.579 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 86.9 m-85 -75.03 148.01 40.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 110.087 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.429 HG22 ' CE1' ' A' ' 119' ' ' HIS . 52.0 m -131.74 121.64 24.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 74.7 m-85 -131.17 156.7 44.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.059 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -148.67 152.95 37.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 110.105 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' A' ' 116' ' ' SER . 54.5 p -136.18 148.71 48.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.424 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 95.4 mt-10 -136.88 117.82 14.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 110.28 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.614 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 p90 -144.88 -175.71 4.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.899 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.479 HG23 HG12 ' A' ' 113' ' ' ILE . 17.8 p -138.39 179.58 6.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.565 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.529 ' CB ' ' HG3' ' A' ' 148' ' ' GLU . 8.8 p -157.02 163.78 38.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.229 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.84 -13.62 47.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.239 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 3.1 mp -90.78 149.68 40.84 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 0.0 110.139 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 41.8 Cg_endo -66.98 148.55 82.07 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.995 1.524 . . . . 0.0 110.553 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.644 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -69.96 -32.95 16.77 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 O-C-N 123.947 1.498 . . . . 0.0 113.096 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.4 Cg_endo -67.12 -22.09 47.85 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 N-CA-C 109.934 -0.833 . . . . 0.0 109.934 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 0.1 OUTLIER -82.23 -49.36 10.18 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.528 HD23 ' CD2' ' A' ' 104' ' ' LEU . 1.3 tt -68.21 -29.72 68.62 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.589 ' CZ ' ' HA ' ' A' ' 76' ' ' LYS . 67.6 t80 -61.85 -57.28 12.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.127 178.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 92.2 mttt -50.09 -53.08 29.59 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.137 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.649 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -55.29 -68.15 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 110.554 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.62 ' CD1' ' CD1' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -43.21 -58.89 2.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.714 -0.616 . . . . 0.0 111.845 -178.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 74' ' ' ILE . 3.7 t -91.2 -61.14 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.066 -1.021 . . . . 0.0 112.246 -178.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.604 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.7 mm? -69.94 -2.07 11.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.037 -1.039 . . . . 0.0 112.168 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -151.11 25.97 0.71 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.586 -1.321 . . . . 0.0 111.281 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -63.37 -37.53 87.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.031 . . . . 0.0 109.761 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 55.1 m-20 -64.75 -12.03 42.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.765 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.462 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 64.1 m-80 -130.17 7.83 5.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.456 -0.778 . . . . 0.0 109.889 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.525 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -94.14 -49.57 5.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.323 -0.861 . . . . 0.0 110.263 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.669 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 7.1 p -77.67 -26.21 0.52 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.352 -0.843 . . . . 0.0 112.526 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 52.1 Cg_endo -79.39 6.58 5.01 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 O-C-N 122.501 0.737 . . . . 0.0 110.585 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -131.42 -29.07 1.81 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.108 -0.995 . . . . 0.0 110.217 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.558 HG12 ' CD1' ' A' ' 150' ' ' TYR . 67.2 mt -79.29 -37.6 19.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.296 -0.878 . . . . 0.0 109.755 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.61 91.25 2.31 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.391 -0.818 . . . . 0.0 110.251 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.34 0.01 8.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.01 1.531 . . . . 0.0 110.563 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -90.85 -24.48 20.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.121 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.36 -37.88 13.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.098 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.535 HD12 ' CG2' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -125.3 133.22 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.0 109.893 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.516 ' HG3' ' CA ' ' A' ' 59' ' ' GLY . 11.5 mttt -72.89 -41.94 64.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.901 . . . . 0.0 110.075 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.548 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -179.89 161.22 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 110.19 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 m -125.02 118.34 26.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 110.021 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -124.5 111.21 15.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.504 HD11 HG22 ' A' ' 43' ' ' ILE . 21.6 mt -57.86 127.25 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.523 HD12 ' CE ' ' A' ' 55' ' ' LYS . 12.3 tp -90.93 -40.04 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 0.0 110.087 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.52 ' O ' ' CG2' ' A' ' 52' ' ' THR . 0.6 OUTLIER -132.08 156.08 46.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.35 -162.86 18.41 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -141.25 25.51 2.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -1.13 . . . . 0.0 110.059 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.66 -10.32 10.49 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -80.76 -170.57 42.9 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.473 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.8 Cg_endo -71.21 132.86 21.78 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.022 1.538 . . . . 0.0 110.443 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.7 -1.55 71.82 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 22.7 m -80.04 140.35 36.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.17 . . . . 0.0 109.976 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 28.8 mm -110.4 117.87 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 110.382 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 89.5 mttt -104.53 119.33 38.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 0.0 110.159 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.523 ' CE ' HD12 ' A' ' 44' ' ' LEU . 46.9 mttm -88.6 97.69 11.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.388 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.47 HD11 HG22 ' A' ' 56' ' ' ILE . 93.8 mt -89.58 139.68 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.895 . . . . 0.0 110.018 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 6.6 p -115.51 157.34 24.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.937 . . . . 0.0 110.736 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 26.4 m-85 -117.86 125.28 50.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.423 -0.798 . . . . 0.0 110.15 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.516 ' CA ' ' HG3' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.245 0.545 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.584 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -137.51 92.17 0.21 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 15.9 p90 -132.73 169.44 16.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -1.158 . . . . 0.0 110.131 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.522 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.0 m -142.29 174.94 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.663 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 94.1 mttt -132.39 106.49 7.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.731 . . . . 0.0 109.522 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.463 ' CD2' HD11 ' A' ' 85' ' ' LEU . 12.8 m170 -96.28 124.78 40.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 111.419 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 67.6 tttt -98.96 101.65 13.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.448 -0.782 . . . . 0.0 109.02 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.473 HG23 ' HA ' ' A' ' 50' ' ' PRO . 22.7 mm -41.69 140.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.488 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 17.9 t0 -112.42 -45.58 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.986 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 16.8 m -169.88 157.21 6.62 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.431 -0.793 . . . . 0.0 110.146 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.434 HG12 HG12 ' A' ' 23' ' ' VAL . 1.7 mt -141.48 157.2 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.397 -0.814 . . . . 0.0 109.877 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.53 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 2.0 m-20 -144.53 83.64 1.72 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.821 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 82.3 tttt -66.24 -13.22 60.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.363 -0.836 . . . . 0.0 109.888 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -90.79 -30.72 16.84 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.805 0.812 . . . . 0.0 109.157 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m-80 -105.52 -4.49 21.19 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.521 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 90.0 m-85 63.57 53.69 2.03 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.297 0.57 . . . . 0.0 110.74 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 13.1 t -127.58 175.34 8.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.961 -1.087 . . . . 0.0 110.455 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.651 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 34.4 t80 -160.02 137.59 9.73 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.612 -0.68 . . . . 0.0 109.744 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 28.7 m -148.0 123.84 10.6 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.129 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.651 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 29.5 p90 -139.41 168.14 20.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.887 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 25.4 m -122.19 140.9 52.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 110.228 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.538 ' CD1' ' O ' ' A' ' 68' ' ' LYS . 10.7 tp -107.38 132.21 53.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 110.099 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 86' ' ' ILE . 11.5 pt -112.87 -31.67 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 110.353 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.431 ' OE1' ' HD2' ' A' ' 68' ' ' LYS . 7.2 tt0 -116.52 141.63 47.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.898 . . . . 0.0 110.276 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.522 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 167.88 168.08 29.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.71 -28.87 45.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.281 -1.129 . . . . 0.0 110.227 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.99 -32.53 72.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.337 -0.852 . . . . 0.0 110.174 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.539 ' CD2' ' O ' ' A' ' 96' ' ' GLU . 6.8 mt -64.64 -44.2 91.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 110.393 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 44.18 -142.53 2.72 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -106.34 27.57 8.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -1.131 . . . . 0.0 110.237 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 122' ' ' THR . 80.8 p -124.74 -45.18 1.92 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 110.126 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.535 HD12 ' CD1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -102.41 160.57 14.44 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.448 -0.783 . . . . 0.0 109.272 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.539 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 85.1 mt-10 -135.37 -78.63 0.44 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 110.823 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 57.4 mttt -80.22 134.93 36.16 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.452 -0.78 . . . . 0.0 110.973 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.57 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.5 mm -121.36 139.49 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.975 -1.078 . . . . 0.0 109.633 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.3 m -118.45 126.53 52.25 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.187 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 7.3 m-85 -118.84 136.74 53.86 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.529 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -137.17 145.89 44.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.022 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.521 HG21 ' N ' ' A' ' 103' ' ' LYS . 45.3 m -145.43 152.6 40.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 110.019 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.521 ' N ' HG21 ' A' ' 102' ' ' THR . 0.0 OUTLIER -141.67 140.83 33.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 110.372 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.528 ' CD2' HD23 ' A' ' 18' ' ' LEU . 8.8 mt -124.24 145.24 49.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.358 -0.839 . . . . 0.0 110.271 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.488 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.22 -169.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.227 -0.921 . . . . 0.0 109.941 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -118.72 170.33 9.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 110.012 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.2 p -127.54 161.78 52.83 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 110.021 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.58 -8.71 23.76 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.954 1.502 . . . . 0.0 110.387 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.9 p -93.77 -9.5 37.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 110.215 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.02 -36.25 4.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.87 -176.22 6.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.514 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 60.5 p -123.67 136.85 54.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -1.146 . . . . 0.0 110.351 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.479 HG12 HG23 ' A' ' 10' ' ' THR . 18.8 mt -86.49 150.03 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.838 . . . . 0.0 110.109 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.591 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 6.3 mt -135.42 115.36 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.364 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 103' ' ' LYS . 84.8 tttt -106.42 123.13 47.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 109.873 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 3.5 t -118.45 159.68 23.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -0.979 . . . . 0.0 110.598 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 42.5 m -159.56 144.38 15.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.426 -0.796 . . . . 0.0 110.17 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.9 t -141.04 163.46 32.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.15 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 82.0 m-70 -143.89 160.98 39.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.915 . . . . 0.0 110.484 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 9.6 m-85 -124.85 140.88 52.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.316 -0.865 . . . . 0.0 110.224 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.8 m-70 -120.92 90.54 3.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 109.762 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 94' ' ' THR . 1.1 p -82.59 150.18 27.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.871 . . . . 0.0 110.364 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.41 ' HB3' ' CD ' ' A' ' 96' ' ' GLU . 78.4 tttt -123.03 129.1 51.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 110.202 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 -162.87 25.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.49 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 0.9 OUTLIER -87.62 54.13 3.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -1.181 . . . . 0.0 110.109 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.471 ' O ' ' HB ' ' A' ' 122' ' ' THR . 17.6 m -135.99 133.39 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.222 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.456 ' HA ' HG22 ' A' ' 122' ' ' THR . 17.9 pt-20 -127.7 165.54 19.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 0.0 110.092 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.572 HD11 ' CD1' ' A' ' 3' ' ' PHE . 3.8 mp -82.8 173.0 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.889 . . . . 0.0 110.042 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 132' ' ' HIS . 75.0 mmtt -106.28 122.83 47.03 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.348 -0.845 . . . . 0.0 110.149 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 131' ' ' GLU . 24.1 pt-20 -43.45 -42.65 4.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 110.145 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.482 ' N ' ' CG ' ' A' ' 130' ' ' GLU . 16.5 pt-20 -58.16 -29.33 65.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.206 -0.934 . . . . 0.0 109.896 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 129' ' ' LYS . 11.7 t-80 -74.36 -55.5 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.635 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 7.6 p -61.62 -39.39 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.387 -0.821 . . . . 0.0 110.009 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.461 ' N ' HG12 ' A' ' 133' ' ' VAL . 84.0 tttt -65.52 -45.83 81.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.84 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.39 87.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.89 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.08 -30.82 74.14 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 137' ' ' LYS . 59.0 mmtt -65.91 -34.75 78.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -1.106 . . . . 0.0 109.872 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -69.91 -35.62 74.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.859 . . . . 0.0 109.839 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -71.68 -29.95 65.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.738 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.31 -40.87 42.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.99 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.2 p -59.44 -45.3 91.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.752 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -56.44 -43.85 79.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.841 . . . . 0.0 109.779 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 39.4 tp -57.68 -47.31 82.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.767 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.457 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 29.3 m-85 -53.68 -44.57 69.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.648 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -75.78 -14.58 60.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.32 -0.862 . . . . 0.0 109.925 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.427 ' HB3' HG23 ' A' ' 33' ' ' ILE . 20.1 mt -83.2 -36.67 24.47 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.209 -0.932 . . . . 0.0 108.692 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.62 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 96.0 mt -67.16 -47.4 81.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.529 ' HG3' ' CB ' ' A' ' 11' ' ' SER . 5.9 mm-40 -51.49 -47.09 63.33 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.388 -0.82 . . . . 0.0 109.218 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.6 m -63.15 -40.52 97.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.593 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.573 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 79.6 t80 -47.12 -51.84 16.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.97 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.609 ' CD2' ' CZ ' ' A' ' 158' ' ' TYR . 80.3 mt -76.27 -37.97 56.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.789 . . . . 0.0 110.366 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 19.4 tptt -59.31 -16.9 24.8 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.166 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -117.61 -27.02 2.69 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 10.7 m-70 -106.28 91.89 6.19 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.266 -1.137 . . . . 0.0 110.167 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.1 Cg_endo -73.13 3.3 4.69 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.986 1.519 . . . . 0.0 111.006 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -119.0 -2.26 10.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.022 -1.049 . . . . 0.0 110.299 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.644 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -67.22 99.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.23 -0.918 . . . . 0.0 110.397 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.649 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 11.5 p90 37.55 23.45 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.55 -0.719 . . . . 0.0 112.346 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 9.1 m-80 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 120.473 -1.392 . . . . 0.0 109.992 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.543 HG12 ' CE1' ' A' ' 121' ' ' HIS . 85.8 t -101.04 119.23 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -1.114 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.574 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 77.6 m-85 -83.68 161.57 21.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.23 -0.919 . . . . 0.0 110.139 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.448 HG21 ' CE1' ' A' ' 119' ' ' HIS . 55.4 m -143.61 99.92 3.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.584 ' CZ ' HG23 ' A' ' 133' ' ' VAL . 77.9 m-85 -116.37 126.5 53.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.179 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.596 ' CG ' ' N ' ' A' ' 7' ' ' SER . 3.6 tt0 -126.16 178.57 5.71 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.204 -0.935 . . . . 0.0 109.89 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.596 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -155.56 -179.08 7.76 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.76 -0.587 . . . . 0.0 109.751 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 7' ' ' SER . 73.1 mt-10 -156.09 117.02 3.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 110.378 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 2.5 p90 -137.58 -174.05 3.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.213 -0.93 . . . . 0.0 109.954 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.495 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 4.4 p -142.15 173.94 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.718 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.417 ' HB2' ' CD ' ' A' ' 148' ' ' GLU . 85.8 p -150.26 147.96 28.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.432 -0.793 . . . . 0.0 110.065 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -72.03 -24.81 61.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.917 . . . . 0.0 110.138 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 6.1 mm -79.18 151.17 75.32 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.828 . . . . 0.0 109.979 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.0 Cg_endo -65.03 147.46 88.94 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.102 1.58 . . . . 0.0 110.394 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.643 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.6 Cg_endo -69.86 -32.46 18.11 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.006 1.529 . . . . 0.0 113.043 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.4 Cg_endo -67.66 -23.29 42.71 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 122.472 0.722 . . . . 0.0 110.233 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.539 ' CZ ' ' HA ' ' A' ' 17' ' ' ARG . 6.0 mmp_? -82.26 -47.25 12.64 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.52 ' CD1' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -67.54 -29.62 69.06 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.429 -0.908 . . . . 0.0 108.905 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.9 t80 -63.44 -55.45 24.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.1 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.0 mttt -49.13 -50.76 35.85 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.984 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.623 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -56.77 -70.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.623 0.725 . . . . 0.0 111.089 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -43.68 -57.45 3.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.633 -0.667 . . . . 0.0 112.138 -178.626 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.477 HG11 ' CE1' ' A' ' 81' ' ' TYR . 7.1 t -90.27 -60.42 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.057 . . . . 0.0 112.386 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.7 mp -73.35 0.59 11.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.054 -1.029 . . . . 0.0 112.114 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.557 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -153.52 27.77 0.5 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.59 -1.319 . . . . 0.0 111.233 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -64.24 -40.35 95.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.047 -1.033 . . . . 0.0 109.721 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.513 ' OD2' ' CG1' ' A' ' 43' ' ' ILE . 83.0 m-20 -64.91 -11.03 33.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.478 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.423 ' ND2' ' C ' ' A' ' 27' ' ' ASP . 2.3 m120 -125.13 3.17 7.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.537 -0.727 . . . . 0.0 109.662 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.553 ' CD1' ' CD1' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -94.9 -47.12 6.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 -179.572 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.659 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 9.4 p -75.38 -26.9 0.65 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.91 . . . . 0.0 112.373 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 50.5 Cg_endo -79.18 7.27 4.49 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 122.435 0.703 . . . . 0.0 110.593 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -135.77 -30.9 0.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.225 -0.922 . . . . 0.0 110.381 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.586 HG12 ' CD1' ' A' ' 150' ' ' TYR . 64.5 mt -75.07 -39.74 44.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.331 -0.856 . . . . 0.0 109.56 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.64 87.58 2.55 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.396 -0.815 . . . . 0.0 110.171 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.57 -1.32 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.115 1.587 . . . . 0.0 110.516 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -90.22 -19.46 24.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.944 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.35 -36.08 10.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.848 . . . . 0.0 110.317 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.527 HD12 ' CG2' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -125.38 139.68 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 110.021 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.477 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 27.1 ttmt -78.09 -41.45 35.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.558 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 178.71 164.77 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 110.131 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.4 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 1.7 m -121.53 122.27 39.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 110.028 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.524 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 86.1 tt0 -126.54 107.18 10.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.188 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.513 ' CG1' ' OD2' ' A' ' 27' ' ' ASP . 14.6 mt -56.11 131.58 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 58.7 mt -89.1 -23.72 22.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.124 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.521 ' O ' ' CG2' ' A' ' 52' ' ' THR . 41.1 tt0 -157.64 175.05 14.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 110.303 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 53.44 -160.33 3.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -137.66 16.71 2.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -1.103 . . . . 0.0 110.264 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.72 7.57 10.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -98.89 -166.63 30.5 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.1 Cg_endo -70.78 132.08 21.01 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.081 1.569 . . . . 0.0 110.551 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.8 -7.48 70.53 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 42.1 m -80.01 143.41 34.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -1.133 . . . . 0.0 110.097 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 32.9 mm -112.4 124.27 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.216 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -107.58 147.58 30.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.332 -0.855 . . . . 0.0 110.087 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 75.0 tttt -120.85 90.21 3.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.463 ' CG2' HG12 ' A' ' 38' ' ' ILE . 94.5 mt -80.57 143.01 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.477 ' OG1' ' HB3' ' A' ' 39' ' ' LYS . 3.6 p -113.51 160.42 18.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.669 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.492 ' CE2' HG12 ' A' ' 67' ' ' VAL . 27.9 m-85 -118.78 137.93 53.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.466 -0.771 . . . . 0.0 110.202 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.206 0.527 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -136.05 137.12 8.88 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.5 p90 -179.32 164.05 1.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -1.082 . . . . 0.0 110.068 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.527 ' CG1' ' HA3' ' A' ' 88' ' ' GLY . 4.7 m -142.39 171.99 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.92 . . . . 0.0 110.663 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -125.43 123.86 40.2 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.594 ' CD2' ' HG ' ' A' ' 85' ' ' LEU . 13.3 m170 -116.52 138.26 51.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.023 -1.048 . . . . 0.0 111.327 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 78.1 tttt -115.9 112.28 21.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.481 -0.762 . . . . 0.0 109.105 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.53 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 32.7 mm -49.0 136.63 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.96 . . . . 0.0 110.459 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 82' ' ' SER . 4.4 t0 -107.61 -50.11 3.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.396 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.476 ' HB2' ' OG ' ' A' ' 82' ' ' SER . 17.6 m -168.79 157.07 8.04 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.483 -0.76 . . . . 0.0 109.423 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.3 mt -134.94 157.94 41.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.078 -1.014 . . . . 0.0 110.616 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.9 m-20 -130.9 76.85 1.75 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.597 -0.69 . . . . 0.0 110.24 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.575 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 66.9 mttt -61.78 -12.75 18.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 109.918 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -96.4 -30.53 13.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 109.516 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -107.97 -1.44 20.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.661 -0.649 . . . . 0.0 109.744 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.578 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 87.2 m-85 61.11 52.36 4.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.729 . . . . 0.0 109.89 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -123.49 156.65 35.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 109.575 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.53 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 20.1 t80 -141.87 133.92 27.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.913 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 70.4 p -139.1 119.49 13.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.852 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 3.2 p90 -130.89 179.12 6.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 21.9 m -130.85 136.94 49.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.967 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' A' ' 69' ' ' HIS . 0.3 OUTLIER -95.41 134.72 37.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.551 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.0 pt -114.83 -6.11 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.895 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -168.24 113.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.361 -0.837 . . . . 0.0 110.556 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.527 ' HA3' ' CG1' ' A' ' 67' ' ' VAL . . . -153.22 130.34 2.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -48.48 -26.7 2.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -1.162 . . . . 0.0 110.432 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.577 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -68.65 -17.32 64.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 110.456 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.528 HD23 ' CG1' ' A' ' 98' ' ' ILE . 60.3 mt -63.96 -13.0 42.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 110.245 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.62 26.76 72.09 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 50.64 21.05 0.82 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.229 -1.159 . . . . 0.0 110.2 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.5 p -122.56 -33.07 3.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.084 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.595 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 2.3 mm? -80.04 170.27 16.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 110.283 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.455 ' HG3' ' HD2' ' A' ' 123' ' ' LYS . 60.9 mm-40 -137.0 -79.4 0.39 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.48 -0.763 . . . . 0.0 109.611 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 58.6 mttt -80.32 127.46 32.4 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.204 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.612 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 18.4 mm -118.52 147.68 21.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.658 -1.276 . . . . 0.0 110.237 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -126.13 128.37 47.22 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.441 -0.787 . . . . 0.0 109.278 178.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.612 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 13.8 m-85 -126.7 131.9 51.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 110.017 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -135.96 136.23 40.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.925 . . . . 0.0 110.575 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.5 m -132.5 143.95 50.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.414 -0.804 . . . . 0.0 109.724 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 115' ' ' LYS . 5.0 mttt -136.18 143.77 44.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 0.0 110.482 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.521 ' CD2' HG12 ' A' ' 114' ' ' ILE . 5.5 mt -118.8 151.06 38.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.244 -0.91 . . . . 0.0 110.49 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.494 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.73 -168.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 109.814 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.442 ' O ' HD13 ' A' ' 113' ' ' ILE . . . -120.51 157.96 28.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 110.189 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 33.2 p -118.22 165.44 16.35 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.897 . . . . 0.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -72.88 -1.35 10.31 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.02 1.537 . . . . 0.0 110.495 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.0 m -105.56 -0.65 25.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.902 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.21 -36.11 4.59 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.93 -171.46 0.75 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.52 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 6.1 p -131.3 134.38 46.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -1.096 . . . . 0.0 110.228 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.495 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 12.2 mt -84.33 148.07 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.638 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 9.1 mt -130.71 113.71 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.295 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 7.0 ttmt -87.4 138.58 31.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.162 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 1.1 p -124.43 132.04 53.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 110.257 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 62.0 m -148.22 123.25 10.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 110.533 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.7 m -130.91 164.9 24.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 109.886 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.457 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 30.8 m-70 -142.12 170.62 15.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.115 -0.991 . . . . 0.0 110.096 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.523 ' HB3' ' CD1' ' A' ' 95' ' ' LEU . 26.2 m-85 -136.24 147.32 47.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.496 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.543 ' CE1' HG12 ' A' ' 2' ' ' VAL . 83.6 m-70 -128.35 88.75 2.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.399 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.522 ' CG2' HG22 ' A' ' 126' ' ' VAL . 4.2 p -68.9 161.26 29.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.849 . . . . 0.0 110.711 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.455 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 33.0 ttmt -152.48 94.72 1.94 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 110.314 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 133.5 35.94 0.27 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 3.3 t30 63.61 56.59 1.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.171 -1.193 . . . . 0.0 110.252 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.522 HG22 ' CG2' ' A' ' 122' ' ' THR . 8.4 m -142.86 145.82 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 110.005 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.75 179.04 5.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.358 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.477 HG13 ' CD2' ' A' ' 120' ' ' TYR . 16.2 mm -84.67 173.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.21 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.476 ' N ' HG23 ' A' ' 128' ' ' ILE . 18.8 mtpt -117.63 136.82 53.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.009 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -43.61 -41.09 4.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.166 -0.958 . . . . 0.0 110.245 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 51.4 tt0 -64.38 -26.13 68.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.091 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 13.8 t-160 -77.91 -48.46 16.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.584 HG23 ' CZ ' ' A' ' 5' ' ' TYR . 69.1 t -56.26 -32.08 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 109.867 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -90.8 -51.37 5.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -57.9 -32.76 68.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.84 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.08 -33.81 62.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -78.55 -32.89 48.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -1.122 . . . . 0.0 109.982 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -73.43 -34.97 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.887 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -70.7 -43.45 68.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.798 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -72.49 -31.12 65.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 109.947 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 22.7 t -64.76 -54.0 38.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.395 -0.815 . . . . 0.0 109.928 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -51.78 -49.78 62.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.705 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 24.0 mt -52.91 -41.66 64.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 110.059 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 16.7 m-85 -59.87 -50.88 72.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.689 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 75.7 tttt -63.44 -13.67 42.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.915 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.527 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 13.1 mt -85.2 -37.77 19.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.213 -0.93 . . . . 0.0 108.813 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.569 HD12 ' CE1' ' A' ' 22' ' ' PHE . 33.8 mt -69.56 -45.3 78.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.482 ' O ' HG13 ' A' ' 13' ' ' ILE . 67.8 mm-40 -51.56 -38.15 52.97 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.286 -0.884 . . . . 0.0 108.785 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 88.3 m -72.36 -38.1 68.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.303 -0.873 . . . . 0.0 109.01 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.586 ' CD1' HG12 ' A' ' 33' ' ' ILE . 66.2 t80 -44.19 -54.84 5.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.465 -0.772 . . . . 0.0 109.604 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.597 HD23 ' CE1' ' A' ' 158' ' ' TYR . 78.5 mt -75.41 -29.07 59.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.467 -0.771 . . . . 0.0 110.267 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.484 ' HA ' HD13 ' A' ' 13' ' ' ILE . 39.3 tttp -69.48 -13.27 62.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.715 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -123.63 -26.46 1.59 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.561 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.2 m-70 -110.77 89.64 9.58 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 0.0 110.378 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.31 0.33 8.13 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.037 1.546 . . . . 0.0 110.559 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -111.92 12.72 20.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.882 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.646 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -86.57 101.25 13.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.416 -0.802 . . . . 0.0 110.282 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.646 ' CD1' ' O ' ' A' ' 157' ' ' ALA . 8.9 p90 38.52 21.8 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.689 -0.632 . . . . 0.0 112.354 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 33.4 m-20 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 120.415 -1.428 . . . . 0.0 110.12 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 120' ' ' TYR . 86.3 t -108.77 139.82 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -1.172 . . . . 0.0 110.223 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.644 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 16.3 m-85 -103.01 129.8 49.89 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.238 -0.914 . . . . 0.0 109.826 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.45 HG22 ' CE1' ' A' ' 119' ' ' HIS . 19.3 m -104.68 107.83 18.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.859 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.57 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 33.9 m-85 -116.27 124.92 51.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.552 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 23.1 pt-20 -122.63 164.17 18.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.15 -0.969 . . . . 0.0 111.035 -179.083 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.512 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.2 p -125.32 167.63 14.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.568 -0.707 . . . . 0.0 110.272 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 7' ' ' SER . 18.2 mt-10 -160.19 120.15 2.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.553 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 76.5 m-85 -141.18 -166.01 2.08 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.789 -1.194 . . . . 0.0 111.552 -178.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 25.5 p -158.32 155.29 28.52 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.758 0.789 . . . . 0.0 110.368 178.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.527 ' O ' ' CA ' ' A' ' 111' ' ' GLY . 83.6 p -159.29 146.23 16.93 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.791 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -70.55 -32.93 70.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 110.046 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 8.0 mm -58.99 149.96 63.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.863 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 39.8 Cg_endo -65.47 144.27 78.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.0 1.526 . . . . 0.0 110.585 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.637 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 Cg_endo -72.05 -31.61 12.05 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 124.023 1.538 . . . . 0.0 112.802 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -70.19 -21.51 31.37 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 N-CA-C 110.042 -0.791 . . . . 0.0 110.042 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.525 ' HG2' ' CD1' ' A' ' 151' ' ' LEU . 10.3 ttm180 -83.2 -47.16 11.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.5 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -68.01 -27.62 66.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.933 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.0 t80 -68.24 -55.75 11.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.474 -0.766 . . . . 0.0 109.378 179.079 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 89.6 mttt -50.27 -37.83 37.95 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.244 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.595 ' HB1' ' CE2' ' A' ' 158' ' ' TYR . . . -70.89 -57.82 4.22 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.687 0.756 . . . . 0.0 110.943 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.578 ' CD1' HD12 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -54.46 -54.33 42.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.556 -0.715 . . . . 0.0 111.843 -178.669 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.507 HG11 ' CE1' ' A' ' 81' ' ' TYR . 4.0 t -92.82 -62.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.078 -1.014 . . . . 0.0 111.964 -178.425 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.7 mp -69.09 0.23 4.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.197 -0.939 . . . . 0.0 111.974 -178.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.571 ' OD2' ' CD1' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -150.18 24.33 0.82 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.736 -1.228 . . . . 0.0 111.014 -179.99 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.465 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -63.24 -37.98 89.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.011 -1.056 . . . . 0.0 110.135 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 33.9 m-20 -63.49 -13.96 46.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.109 -0.994 . . . . 0.0 110.099 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 84.2 m-20 -128.3 10.46 6.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.826 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.53 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -96.41 -53.73 3.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 110.51 -179.871 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.669 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.9 m -74.69 -29.31 0.91 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 111.97 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.5 Cg_endo -79.18 4.58 6.44 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 122.851 0.921 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -125.17 -35.29 2.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 109.109 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.579 HG12 ' CD1' ' A' ' 150' ' ' TYR . 40.5 mt -79.96 -24.32 11.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.549 0.69 . . . . 0.0 109.235 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.92 95.43 0.4 Allowed Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.618 -0.676 . . . . 0.0 109.78 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.68 0.22 7.94 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.041 1.548 . . . . 0.0 110.655 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -89.52 5.95 43.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.238 -0.914 . . . . 0.0 109.872 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.89 -55.35 2.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 110.013 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.522 ' CB ' HG22 ' A' ' 30' ' ' VAL . 1.9 mp -115.11 132.14 65.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 110.029 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -79.99 -35.07 37.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.286 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.525 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -177.26 151.98 0.83 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.0 109.96 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.8 m -115.53 130.83 57.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.24 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.502 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 85.6 tt0 -137.79 110.59 7.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 0.0 110.207 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 43' ' ' ILE . 41.1 mt -62.25 135.51 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.302 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.45 HD21 HG23 ' A' ' 53' ' ' ILE . 47.9 tp -87.9 -25.61 23.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.988 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' O ' ' CG2' ' A' ' 52' ' ' THR . 28.8 tp10 -161.45 170.28 20.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.472 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 59.32 -169.69 6.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.7 23.39 6.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -1.155 . . . . 0.0 110.252 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.07 1.45 28.38 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -86.0 -169.46 45.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.458 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.3 Cg_endo -70.96 131.85 20.3 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.015 1.534 . . . . 0.0 110.468 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.21 -6.59 68.88 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 14.8 m -80.04 142.3 35.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -1.104 . . . . 0.0 109.961 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.501 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 27.3 mm -110.68 122.11 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 110.155 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.458 ' HG2' HG12 ' A' ' 43' ' ' ILE . 84.7 mttt -105.88 144.63 32.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 110.23 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -117.86 87.61 2.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 110.218 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.43 ' HB ' HG21 ' A' ' 67' ' ' VAL . 90.6 mt -80.01 144.39 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 110.331 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.509 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.7 p -111.48 164.2 13.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.478 ' CZ ' HG12 ' A' ' 67' ' ' VAL . 25.9 m-85 -115.32 155.36 27.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 110.434 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.434 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 8.6 t80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.191 0.52 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -128.81 135.3 8.43 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.4 p90 -178.73 162.84 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -1.167 . . . . 0.0 110.211 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.54 ' CG1' ' HA3' ' A' ' 88' ' ' GLY . 4.5 m -141.9 172.79 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -0.819 . . . . 0.0 110.512 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 88.5 mttt -124.49 129.41 50.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.575 -0.703 . . . . 0.0 109.449 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.518 ' NE2' HD11 ' A' ' 85' ' ' LEU . 8.2 m170 -118.14 123.98 46.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.15 -0.969 . . . . 0.0 111.034 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.501 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 85.0 tttt -100.32 113.64 26.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 25.8 mm -54.52 135.36 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.901 . . . . 0.0 110.468 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.467 ' O ' ' OG ' ' A' ' 73' ' ' SER . 1.6 t70 -110.16 -42.99 4.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 109.601 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 25.5 m -169.75 157.49 6.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 109.896 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mt -141.59 156.15 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 110.456 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.0 m-20 -136.18 79.04 1.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.576 -0.702 . . . . 0.0 109.991 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.509 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 78.4 mttt -62.62 -16.89 58.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.385 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -93.05 -30.72 15.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 109.529 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -103.87 -6.12 21.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.545 -0.722 . . . . 0.0 109.694 179.8 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.516 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.2 m-85 65.36 52.13 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 109.988 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -124.91 154.97 40.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.839 . . . . 0.0 109.782 179.706 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.529 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 22.3 t80 -142.5 128.81 19.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.352 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 37.6 m -131.89 121.24 23.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.471 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 21.9 p90 -138.64 170.97 15.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.359 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 98.9 m -123.46 132.6 53.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 109.893 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 3.1 tp -98.87 136.45 38.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.081 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.0 pt -119.46 -16.99 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.503 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 23.9 tt0 -133.09 150.08 52.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.143 -0.973 . . . . 0.0 110.488 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.54 ' HA3' ' CG1' ' A' ' 67' ' ' VAL . . . 165.46 142.31 3.38 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -65.73 -35.35 80.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -1.156 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.441 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -65.13 -26.17 68.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 110.13 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.523 ' CD1' HD22 ' A' ' 85' ' ' LEU . 35.3 mt -65.48 -25.38 67.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.181 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.84 -167.63 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -87.28 8.04 25.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -1.184 . . . . 0.0 110.149 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.481 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 60.6 p -93.88 -40.33 10.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.151 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.57 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 22.5 mt -102.11 155.04 18.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.027 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -134.65 -78.84 0.45 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.219 -0.925 . . . . 0.0 110.284 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 50.8 mttt -80.13 132.93 36.02 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.407 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.634 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.5 mm -124.77 136.93 59.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.734 -1.228 . . . . 0.0 110.06 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -116.3 127.1 54.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.74 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.634 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 9.4 m-85 -122.65 135.59 54.64 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 111.148 -178.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.467 ' O ' ' OG ' ' A' ' 116' ' ' SER . 4.2 mt-10 -133.0 133.26 42.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.567 -0.708 . . . . 0.0 109.658 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 81' ' ' TYR . 36.1 m -132.07 134.09 45.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.0 -1.062 . . . . 0.0 110.124 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.5 tttt -133.93 147.68 51.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 110.252 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 79' ' ' TYR . 22.7 mt -117.89 142.22 47.57 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.399 -0.813 . . . . 0.0 110.148 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 113' ' ' ILE . 1.6 t -131.42 -172.64 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 0.0 110.371 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.468 ' O ' HD11 ' A' ' 113' ' ' ILE . . . -118.13 148.53 42.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 110.454 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.459 ' HA ' HD13 ' A' ' 113' ' ' ILE . 52.9 p -106.92 163.78 16.23 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 110.366 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 44.4 Cg_endo -72.26 -2.13 11.19 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.017 1.535 . . . . 0.0 110.403 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.1 m -103.59 -7.17 20.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.072 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.79 -16.03 31.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 11' ' ' SER . . . -79.08 -171.66 41.03 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' SER . 42.1 p -128.81 122.31 30.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 110.221 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 7.0 mt -79.98 139.64 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.464 -0.772 . . . . 0.0 110.79 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.553 ' CD1' ' HB2' ' A' ' 9' ' ' PHE . 3.7 mp -93.02 151.88 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.049 179.076 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 103' ' ' LYS . 16.9 tttt -149.87 99.71 2.87 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 109.365 178.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 20.9 t -116.13 174.8 5.85 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.357 -0.839 . . . . 0.0 111.257 -178.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.578 HG23 ' CE1' ' A' ' 119' ' ' HIS . 31.4 m -160.07 128.97 4.98 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 5' ' ' TYR . 38.9 t -122.9 156.68 34.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.042 -1.036 . . . . 0.0 110.421 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.578 ' CE1' HG23 ' A' ' 117' ' ' THR . 76.7 m-70 -140.48 123.65 16.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.35 -0.844 . . . . 0.0 110.371 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 8.8 m-30 -93.87 149.79 20.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -0.871 . . . . 0.0 110.416 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 91.9 m-70 -127.65 84.82 2.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 109.743 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.57 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -67.39 152.64 45.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.406 -0.809 . . . . 0.0 110.618 -179.545 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -115.31 113.58 24.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 110.132 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.0 -145.74 16.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 2.1 p-10 -104.53 54.67 0.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.208 -1.172 . . . . 0.0 110.237 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 94' ' ' THR . 10.8 m -116.88 156.33 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 9.8 pm0 -143.7 157.1 44.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.051 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.644 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 2.9 mp -78.27 173.29 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.126 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.432 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 23.0 mttt -110.88 151.34 27.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.951 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.44 -31.88 64.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -0.975 . . . . 0.0 110.205 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -65.33 -40.87 94.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 109.982 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.441 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 17.2 t-160 -66.81 -45.5 78.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 110.043 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.57 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 61.2 t -62.89 -41.11 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -76.42 -42.01 45.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.65 96.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.959 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.51 -30.1 76.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.457 ' HE3' HG11 ' A' ' 133' ' ' VAL . 88.5 mttt -75.31 -32.81 61.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -1.137 . . . . 0.0 110.042 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -76.3 -34.32 59.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -0.863 . . . . 0.0 109.903 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.97 -34.77 64.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.5 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.51 -30.55 61.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.928 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.4 p -68.72 -50.99 46.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.904 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.414 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 82.5 m-20 -51.36 -44.48 62.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 18.7 tp -57.15 -50.05 74.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.867 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 25.9 m-85 -53.84 -39.57 65.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.431 -0.793 . . . . 0.0 109.765 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.451 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 32.3 mttp -78.51 -13.61 59.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.933 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.521 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 16.2 mt -84.81 -36.66 21.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.23 -0.919 . . . . 0.0 108.889 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.578 HD12 ' CD1' ' A' ' 22' ' ' PHE . 36.7 mt -70.47 -43.93 77.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 13' ' ' ILE . 52.3 mt-10 -59.27 -37.68 78.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.426 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 98.7 m -77.2 -38.9 50.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 179.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.58 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 80.7 t80 -52.6 -49.15 65.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.903 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.65 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 82.3 mt -79.03 -33.45 44.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 109.99 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.533 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 38.9 tttt -70.61 -16.97 62.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.347 179.237 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.77 -32.59 2.23 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.544 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 8.2 m-70 -109.41 94.8 16.81 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.389 -1.066 . . . . 0.0 109.978 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.34 6.75 2.92 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.061 1.559 . . . . 0.0 111.048 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -110.48 2.78 19.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.062 -1.024 . . . . 0.0 109.86 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.568 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . . . -83.23 103.61 12.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.65 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.57 32.44 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.747 -0.596 . . . . 0.0 110.532 -179.667 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.517 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.709 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 120' ' ' TYR . 73.2 t -130.33 122.01 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -1.226 . . . . 0.0 110.212 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.588 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 89.5 m-85 -73.69 147.42 43.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 110.138 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.405 HG21 ' CE1' ' A' ' 119' ' ' HIS . 52.9 m -129.32 119.57 24.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.242 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.64 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 61.6 m-85 -130.97 151.76 51.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.121 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -145.18 150.45 36.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 110.282 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 116' ' ' SER . 78.0 p -132.37 148.51 52.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.838 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -136.67 117.17 13.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.102 -0.999 . . . . 0.0 110.625 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 p90 -141.18 -177.17 4.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.39 -0.819 . . . . 0.0 109.733 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 27.2 p -136.75 -179.25 5.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 110.838 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 148' ' ' GLU . 11.8 t -159.92 170.38 21.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 110.17 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -93.82 -21.76 19.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.537 ' CD1' ' O ' ' A' ' 148' ' ' GLU . 2.6 mp -80.98 150.4 68.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 39.1 Cg_endo -66.51 145.49 76.78 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.991 1.522 . . . . 0.0 110.783 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.629 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 Cg_endo -72.14 -31.5 11.96 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 124.126 1.593 . . . . 0.0 112.993 -179.184 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.7 Cg_endo -69.3 -20.65 36.74 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 N-CA-C 109.724 -0.914 . . . . 0.0 109.724 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.538 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 1.3 mmp_? -82.74 -47.81 11.55 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.509 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.2 tt -67.94 -25.32 65.4 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 70.9 t80 -66.84 -61.2 2.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.512 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 34.3 mttp -49.0 -37.9 21.74 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.679 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -62.4 -66.32 0.56 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.803 0.811 . . . . 0.0 110.897 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.649 ' CD1' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -54.59 -47.48 73.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.842 -0.537 . . . . 0.0 111.959 -178.199 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.601 ' CG1' ' CD1' ' A' ' 74' ' ' ILE . 3.0 t -96.14 -64.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.87 -1.144 . . . . 0.0 112.154 -178.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.9 mm? -68.69 -3.63 12.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.051 -1.031 . . . . 0.0 111.644 -178.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.533 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -139.62 4.0 2.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.772 -1.205 . . . . 0.0 111.019 -179.706 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -42.57 -26.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.138 -0.976 . . . . 0.0 110.183 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 56.4 m-20 -74.7 -40.78 61.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.931 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -106.48 24.24 12.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.891 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.554 HD13 ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -106.11 -62.16 1.42 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 -179.867 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 44.7 t -61.92 -40.88 72.94 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.493 -0.754 . . . . 0.0 111.203 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -78.37 9.28 3.2 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.353 1.186 . . . . 0.0 110.827 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.459 ' HD2' ' OH ' ' A' ' 150' ' ' TYR . 17.7 mttt -121.87 -28.31 4.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.997 -1.064 . . . . 0.0 109.457 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.588 HG12 ' CD1' ' A' ' 150' ' ' TYR . 29.0 mt -79.99 -56.86 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.516 -0.74 . . . . 0.0 109.767 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.62 106.14 2.9 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.476 -0.765 . . . . 0.0 110.085 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.21 1.22 6.91 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.661 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.54 -9.47 56.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.952 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.09 -36.27 9.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 110.187 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.591 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 1.1 mt -136.49 149.74 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.332 -0.855 . . . . 0.0 110.009 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.529 ' CG ' ' HA3' ' A' ' 59' ' ' GLY . 10.5 mttt -78.9 -50.26 11.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 110.003 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -173.01 160.11 4.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.452 -0.78 . . . . 0.0 109.977 179.711 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.7 m -119.02 126.63 52.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.143 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -135.64 103.09 5.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 110.379 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 18.9 mt -50.42 131.32 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.3 tp -91.31 -46.55 7.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.253 -0.904 . . . . 0.0 110.218 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 52' ' ' THR . 3.9 mm-40 -132.63 136.97 46.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.246 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.82 -168.41 34.33 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -131.29 12.58 5.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -1.16 . . . . 0.0 110.255 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.47 -6.22 9.92 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -84.15 -168.31 43.76 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.493 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.2 Cg_endo -70.71 135.91 29.27 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.024 1.539 . . . . 0.0 110.501 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.75 -5.49 79.6 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 42.8 m -80.1 143.18 34.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -1.115 . . . . 0.0 110.042 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.521 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 29.2 mm -110.08 125.46 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.278 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 40.2 mtmt -108.29 139.7 42.62 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.365 -0.835 . . . . 0.0 110.083 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -112.9 89.94 3.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 110.129 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.453 ' CG2' HG12 ' A' ' 38' ' ' ILE . 88.8 mt -83.18 139.04 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.215 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.451 ' O ' HG21 ' A' ' 38' ' ' ILE . 6.7 p -110.27 160.81 16.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.494 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.451 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 27.3 m-85 -120.64 124.37 45.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -0.812 . . . . 0.0 110.377 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.443 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 9.2 t80 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.291 0.567 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -127.82 136.7 9.36 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.9 p90 -179.66 161.19 0.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -1.088 . . . . 0.0 109.989 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 66' ' ' TYR . 5.6 m -143.27 172.38 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.633 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.519 ' CE ' HG22 ' A' ' 53' ' ' ILE . 75.4 tttt -123.65 118.23 26.8 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -110.54 133.58 53.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.989 -1.069 . . . . 0.0 111.379 -178.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 77.1 tttt -111.12 119.23 38.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.563 -0.711 . . . . 0.0 109.218 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.533 HG22 HD11 ' A' ' 71' ' ' ILE . 42.2 mm -53.15 143.83 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 110.51 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.3 m-20 -117.49 -31.83 5.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.375 -0.828 . . . . 0.0 109.703 179.52 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 2.2 p 168.28 157.43 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 110.15 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.601 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 4.1 tt -153.59 165.62 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.3 -0.875 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -140.64 83.97 1.92 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.251 -0.906 . . . . 0.0 109.977 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 85.6 tttt -58.62 -12.53 4.21 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.29 -0.881 . . . . 0.0 110.776 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.457 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 17.5 mm-40 -85.46 -34.41 21.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.191 -0.943 . . . . 0.0 108.918 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m-80 -109.4 -1.97 18.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.587 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 9.7 m-85 65.95 49.81 1.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.343 0.592 . . . . 0.0 110.449 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.544 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -115.32 157.89 23.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.108 -0.995 . . . . 0.0 109.129 179.19 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.593 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 80.8 t80 -160.02 150.18 18.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.016 -1.052 . . . . 0.0 110.116 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 100' ' ' TYR . 9.7 t -160.98 150.52 17.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.94 . . . . 0.0 110.585 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.593 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 5.9 p90 -151.69 -171.13 3.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.51 -0.744 . . . . 0.0 109.871 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 54.0 m -132.64 135.91 46.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.364 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.552 ' CB ' ' HB ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -94.18 116.09 28.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.231 -0.918 . . . . 0.0 110.096 179.765 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.435 HD12 ' HE2' ' A' ' 68' ' ' LYS . 16.7 pt -107.82 -10.54 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.199 -0.938 . . . . 0.0 110.112 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -138.81 126.52 22.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.84 . . . . 0.0 110.044 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.512 ' N ' HD13 ' A' ' 91' ' ' LEU . . . -179.86 145.36 6.44 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 44.3 p-10 -65.16 -9.86 26.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -1.143 . . . . 0.0 110.243 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.535 ' CB ' ' CE1' ' A' ' 132' ' ' HIS . . . -78.09 -36.15 48.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 110.19 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.535 ' HA ' ' CG ' ' A' ' 95' ' ' LEU . 4.1 mt -58.18 -40.66 82.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.396 -0.815 . . . . 0.0 110.337 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 43.44 -132.33 5.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -114.12 12.6 17.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -1.188 . . . . 0.0 110.235 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.46 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 40.1 p -109.82 -33.15 6.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.544 HD12 ' CD1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -116.53 159.98 21.3 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.27 -0.894 . . . . 0.0 109.222 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.534 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 42.0 tt0 -138.53 -78.2 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.979 . . . . 0.0 110.807 -179.307 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 10.8 mttm -80.13 132.76 35.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.476 -0.765 . . . . 0.0 110.7 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.604 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 15.8 mm -118.56 148.63 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.885 -1.134 . . . . 0.0 110.212 179.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -125.14 125.23 43.38 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.057 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.604 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 13.5 m-85 -121.45 134.91 55.09 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.348 -0.845 . . . . 0.0 110.476 -178.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.404 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 58.6 tt0 -133.3 160.66 36.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 81' ' ' TYR . 35.9 m -160.92 121.09 2.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 0.4 OUTLIER -120.01 146.98 45.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.333 -179.889 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.534 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 14.7 mt -125.31 151.23 46.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -0.848 . . . . 0.0 110.266 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.49 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.35 -169.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.203 -0.936 . . . . 0.0 110.005 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -127.02 135.48 50.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 110.16 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.433 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 49.5 p -90.72 163.22 31.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.301 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -73.06 -2.87 12.68 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.14 1.6 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.4 p -96.87 -5.02 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 110.3 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.42 -40.46 2.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.26 -172.48 2.02 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.494 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -127.99 138.8 52.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -1.174 . . . . 0.0 110.336 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 26.6 mt -89.88 147.36 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.585 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 7.0 mt -130.95 112.96 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 110.318 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -104.1 122.34 45.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.961 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.466 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 7.4 t -116.49 163.5 15.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.41 HG21 ' NE2' ' A' ' 119' ' ' HIS . 59.6 m -160.01 138.2 10.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 110.228 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.4 m -135.18 148.97 49.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.957 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.503 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 73.8 m-70 -132.59 168.57 18.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.177 -0.952 . . . . 0.0 110.751 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.473 ' O ' ' CG1' ' A' ' 2' ' ' VAL . 35.9 m-85 -131.69 145.6 51.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.508 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.4 m-70 -126.34 95.01 4.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.129 -0.982 . . . . 0.0 109.956 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.509 ' CG2' ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -58.5 154.81 13.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.207 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 57.9 tttt -118.23 111.19 18.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.293 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.62 -115.64 5.0 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -129.84 71.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 110.145 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 94' ' ' THR . 16.9 m -142.72 -179.46 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.509 ' HA ' ' CG2' ' A' ' 122' ' ' THR . 92.8 mt-10 -154.54 149.33 26.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.194 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.577 HD11 ' CD1' ' A' ' 3' ' ' PHE . 4.9 mp -77.91 173.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.943 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.442 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 33.1 mttt -107.03 129.05 54.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.878 . . . . 0.0 110.251 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.449 ' O ' HG11 ' A' ' 133' ' ' VAL . 97.9 mt-10 -45.69 -44.89 13.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -58.52 -30.98 67.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 109.842 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.535 ' CE1' ' CB ' ' A' ' 90' ' ' ALA . 13.4 t-160 -73.7 -53.17 11.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.926 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.64 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 8.6 p -64.52 -40.14 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.442 -0.787 . . . . 0.0 109.959 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.493 ' N ' HG12 ' A' ' 133' ' ' VAL . 42.7 mtmt -63.61 -43.94 95.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.849 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.02 74.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 109.876 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.43 -30.52 66.74 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.42 ' HD2' ' HB3' ' A' ' 5' ' ' TYR . 3.9 mtpt -74.06 -32.41 63.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -1.099 . . . . 0.0 109.893 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -72.24 -29.78 64.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.38 -0.825 . . . . 0.0 109.884 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.48 -35.86 73.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -0.834 . . . . 0.0 109.883 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.05 -41.18 71.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.968 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.9 t -59.43 -49.86 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.367 -0.833 . . . . 0.0 109.92 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -55.06 -42.94 73.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.954 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.468 ' O ' HG13 ' A' ' 147' ' ' ILE . 59.3 mt -60.04 -39.03 84.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 0.0 109.924 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -62.39 -36.11 81.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 110.165 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 89.1 mttt -79.15 -8.88 59.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 110.078 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.517 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 13.2 mt -89.49 -37.37 14.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.257 -0.902 . . . . 0.0 108.747 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.649 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 32.6 mt -70.68 -44.63 76.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.715 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.537 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 23.5 pt-20 -52.1 -39.73 60.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.809 178.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.52 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 19.8 m -76.25 -33.69 59.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 109.065 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 73.8 t80 -47.72 -57.93 4.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.585 -0.697 . . . . 0.0 109.901 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.602 HD22 ' CZ ' ' A' ' 158' ' ' TYR . 62.8 mt -67.56 -45.74 74.74 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.437 -0.79 . . . . 0.0 110.709 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.443 ' HB2' HD12 ' A' ' 13' ' ' ILE . 81.9 tttt -58.81 -16.1 15.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 109.602 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.403 ' C ' ' CD2' ' A' ' 154' ' ' HIS . . . -115.21 -24.28 4.23 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.593 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.7 m-70 -119.56 92.84 46.7 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.248 -1.148 . . . . 0.0 110.313 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.61 0.54 7.42 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.049 1.552 . . . . 0.0 110.764 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -115.19 15.25 17.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.147 -0.97 . . . . 0.0 110.045 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.657 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -88.38 103.51 15.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.408 -0.807 . . . . 0.0 110.4 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.679 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 6.4 p90 38.99 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.574 -0.704 . . . . 0.0 112.32 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 28.8 m-20 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 120.457 -1.402 . . . . 0.0 110.132 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 74.9 t -104.02 135.91 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 110.241 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.637 ' CE1' ' CD1' ' A' ' 128' ' ' ILE . 12.6 m-85 -93.62 150.5 20.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 109.989 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.425 HG21 ' CE1' ' A' ' 119' ' ' HIS . 8.4 m -129.08 113.11 14.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.562 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 67.6 m-85 -127.44 136.73 52.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.87 . . . . 0.0 109.76 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 16.3 pt-20 -138.31 153.78 49.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 0.0 110.707 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.2 m -132.81 144.48 50.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.408 -0.808 . . . . 0.0 109.645 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -130.35 127.3 39.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.059 -1.026 . . . . 0.0 110.627 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.631 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.3 p90 -155.07 -171.52 3.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.815 . . . . 0.0 109.974 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.472 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 6.7 p -142.84 174.01 11.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.338 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.466 ' OG ' ' OE2' ' A' ' 148' ' ' GLU . 79.7 p -151.57 148.28 27.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.244 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -74.13 -6.12 45.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.132 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 2.7 mp -95.9 150.15 36.94 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.029 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 42.2 Cg_endo -67.41 143.88 65.31 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.107 1.583 . . . . 0.0 110.89 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.647 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.1 Cg_endo -71.31 -31.49 14.13 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 124.115 1.587 . . . . 0.0 112.698 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 39.5 Cg_endo -67.4 -21.05 47.62 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 N-CA-C 110.098 -0.77 . . . . 0.0 110.098 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.524 ' NE ' ' HA ' ' A' ' 159' ' ' ASN . 9.1 mmp_? -85.17 -46.18 11.33 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.507 ' HG ' ' CG2' ' A' ' 147' ' ' ILE . 1.2 tt -69.03 -28.18 66.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.622 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 68.9 t80 -69.27 -53.53 19.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.707 . . . . 0.0 109.818 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.487 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 45.8 mttp -57.28 -29.87 64.23 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.993 0.901 . . . . 0.0 108.899 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.684 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -77.7 -63.63 1.34 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.681 0.753 . . . . 0.0 111.269 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -56.28 -39.63 72.97 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.689 -0.632 . . . . 0.0 111.947 -178.151 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.585 ' CG1' ' CD1' ' A' ' 74' ' ' ILE . 15.7 t -102.13 -65.86 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.791 -1.193 . . . . 0.0 111.631 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 7.0 mp -64.9 -6.08 7.55 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.227 -0.921 . . . . 0.0 111.25 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.497 ' OD2' ' CD1' ' A' ' 158' ' ' TYR . 1.1 m-20 -146.47 24.41 1.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.862 -1.149 . . . . 0.0 110.49 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -57.46 -38.36 74.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.041 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 86.0 m-20 -67.66 -12.86 61.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 110.191 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.525 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 83.9 m-20 -125.18 -3.79 7.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.457 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.532 HD13 ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -85.98 -52.31 5.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.023 . . . . 0.0 110.394 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 14.7 t -63.3 -41.02 65.61 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.791 . . . . 0.0 111.193 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.7 Cg_endo -77.23 7.37 3.75 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.333 1.175 . . . . 0.0 111.021 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 69.9 mmtt -122.35 -23.64 5.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.095 -1.003 . . . . 0.0 109.724 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.57 HG12 ' CD1' ' A' ' 150' ' ' TYR . 8.0 mt -80.01 -56.27 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.495 -0.753 . . . . 0.0 109.773 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.52 106.27 2.56 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.46 -0.775 . . . . 0.0 110.02 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.03 0.53 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.069 1.563 . . . . 0.0 110.726 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -83.77 -11.81 56.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.149 -0.97 . . . . 0.0 109.708 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.67 -51.43 3.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.382 -0.824 . . . . 0.0 110.278 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.58 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 1.3 mt -122.24 147.64 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 110.25 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.513 ' N ' HG21 ' A' ' 38' ' ' ILE . 20.3 ttmm -80.13 -43.9 20.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.192 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.544 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -177.42 161.38 1.75 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.148 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.408 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 27.2 m -119.41 128.73 54.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 53.9 tt0 -133.48 111.53 10.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 43.0 mt -62.98 132.92 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 110.195 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.69 -43.14 7.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.877 . . . . 0.0 110.339 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 52' ' ' THR . 6.9 mt-10 -130.76 150.08 52.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.369 -0.832 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 76.92 -164.04 52.77 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 60.6 t0 -138.52 19.82 2.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -1.183 . . . . 0.0 110.312 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.23 -5.68 15.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -92.26 -165.93 39.1 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HA ' HG21 ' A' ' 71' ' ' ILE . 43.2 Cg_endo -69.77 134.1 27.14 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.046 1.551 . . . . 0.0 110.486 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.32 -6.89 68.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 30.4 m -79.95 136.16 36.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -1.145 . . . . 0.0 110.158 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.518 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 23.7 mm -107.18 113.25 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 110.267 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 77.7 mttt -98.28 148.2 23.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.4 -0.813 . . . . 0.0 110.36 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -118.1 92.37 3.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.535 ' CG2' HG12 ' A' ' 38' ' ' ILE . 78.4 mt -79.99 139.6 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 38' ' ' ILE . 4.4 p -111.3 159.56 17.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.595 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 26.2 m-85 -119.61 139.65 51.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.254 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.56 9.63 57.31 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -110.98 138.02 47.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 110.238 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.19 132.52 6.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 t -56.17 -43.88 78.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -1.137 . . . . 0.0 110.267 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -77.8 153.7 32.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.242 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 t80 -53.88 139.53 33.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.923 . . . . 0.0 110.046 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -124.31 135.64 9.71 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 10.9 p90 -178.91 159.36 1.02 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -1.104 . . . . 0.0 109.931 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.509 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.9 m -143.57 171.52 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.725 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.509 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 68.4 mttt -121.25 127.35 51.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.602 -0.686 . . . . 0.0 109.587 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.511 ' NE2' HD11 ' A' ' 85' ' ' LEU . 14.2 m170 -115.31 124.66 51.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.146 -0.971 . . . . 0.0 110.864 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 80.0 tttt -100.92 109.68 21.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.479 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.534 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.1 mm -48.32 139.59 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.005 . . . . 0.0 110.132 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.491 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 15.7 t0 -113.0 -40.05 4.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.854 . . . . 0.0 109.518 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 2.8 p 170.39 157.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 110.267 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.585 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 3.2 tt -146.22 163.83 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.796 . . . . 0.0 110.032 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -125.23 78.78 1.74 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.288 -0.883 . . . . 0.0 109.811 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.622 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 99.4 mttt -53.69 -16.54 1.69 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.448 -0.782 . . . . 0.0 110.794 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -91.96 -29.8 16.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.284 -0.885 . . . . 0.0 109.755 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -111.18 -0.18 16.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.563 -0.711 . . . . 0.0 109.651 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 87.9 m-85 63.26 50.05 3.1 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.377 0.608 . . . . 0.0 110.667 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.54 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -118.55 148.67 42.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.207 179.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.585 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 84.7 t80 -144.85 139.14 27.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.065 -1.022 . . . . 0.0 110.433 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 m -148.07 133.4 18.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 110.116 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.585 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 5.7 p90 -135.17 178.36 7.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.6 m -125.07 125.23 43.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.746 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.532 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 2.8 tp -94.11 136.94 33.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.997 . . . . 0.0 110.085 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 pt -124.1 -4.54 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 0.0 110.539 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 6.6 tt0 -137.87 156.49 47.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.004 . . . . 0.0 110.28 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.509 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 150.89 122.66 1.07 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.36 -17.35 4.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -1.171 . . . . 0.0 110.324 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -76.98 -29.22 55.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.524 HD23 ' CG1' ' A' ' 98' ' ' ILE . 17.2 mt -69.1 -27.63 65.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.06 -169.22 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.25 2.99 29.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -1.182 . . . . 0.0 110.175 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.513 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 30.5 p -85.74 -26.4 25.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.59 ' CD2' ' CG1' ' A' ' 128' ' ' ILE . 39.7 mt -122.25 156.59 33.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.868 . . . . 0.0 110.071 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 123' ' ' LYS . 65.5 mm-40 -132.71 -79.81 0.49 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.247 -0.908 . . . . 0.0 110.129 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 22.1 mttp -80.11 129.57 34.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.605 -0.685 . . . . 0.0 110.763 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.619 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 6.2 mm -118.62 141.68 37.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.815 -1.178 . . . . 0.0 109.543 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.2 m -120.45 126.08 49.53 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.381 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.619 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 11.9 m-85 -122.12 133.38 54.76 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.434 -0.791 . . . . 0.0 110.244 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -133.22 148.75 52.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.392 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 81' ' ' TYR . 38.9 m -148.21 140.8 24.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.396 -0.815 . . . . 0.0 110.01 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.468 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 7.8 tttt -132.87 148.97 52.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -0.953 . . . . 0.0 110.124 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 6.4 mt -126.39 148.39 49.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.149 -0.969 . . . . 0.0 110.346 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.5 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -152.31 -169.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.329 -0.857 . . . . 0.0 109.968 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -125.06 156.72 37.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 110.11 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 21.3 p -114.57 164.78 15.48 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.32 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.1 Cg_endo -72.6 -1.77 10.81 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.057 1.557 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.5 p -101.36 0.25 36.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.282 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.56 -38.05 3.39 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.16 -172.79 2.05 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.511 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 59.2 p -129.67 139.9 51.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -1.185 . . . . 0.0 110.251 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.472 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 20.9 mt -89.02 149.5 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 110.199 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.631 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 14.9 mt -133.28 110.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.259 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -102.56 126.0 49.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.004 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 5.0 t -119.56 162.18 19.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.49 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 92.9 m -159.82 144.07 14.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.154 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 92.2 p -143.7 160.8 40.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.505 ' C ' ' CD1' ' A' ' 120' ' ' TYR . 75.7 m-70 -143.41 166.88 23.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.214 -0.929 . . . . 0.0 110.37 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 10.1 m-85 -129.46 145.81 51.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 110.61 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.2 m-70 -124.44 87.21 2.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.352 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 2.2 p -65.39 157.82 28.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.411 -0.806 . . . . 0.0 110.644 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.464 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 74.6 tttt -137.84 126.08 23.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.462 -0.774 . . . . 0.0 110.124 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 99.71 23.27 11.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 8.6 t30 66.32 63.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -1.134 . . . . 0.0 110.189 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.528 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 30.2 m -137.03 166.03 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.129 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HA ' HG23 ' A' ' 122' ' ' THR . 92.2 mt-10 -135.79 166.8 22.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 110.303 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.637 ' CD1' ' CE1' ' A' ' 3' ' ' PHE . 4.8 mp -90.75 172.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 132' ' ' HIS . 54.1 mttt -112.22 131.22 55.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 109.829 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 99.5 mt-10 -43.27 -44.47 5.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 110.05 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -54.81 -26.33 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 9.6 t-160 -83.29 -60.57 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 110.102 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.58 HG22 ' CD2' ' A' ' 5' ' ' TYR . 7.5 p -63.41 -39.79 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.967 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 81.8 tttt -60.99 -37.74 83.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.89 . . . . 0.0 109.907 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.9 78.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.927 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.91 -33.47 85.77 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.04 -41.06 97.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -1.125 . . . . 0.0 109.906 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -75.03 -33.95 61.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.83 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -72.78 -37.29 67.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 109.781 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.49 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -72.23 -33.32 67.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.827 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.9 m -69.07 -44.32 72.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 109.944 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -63.54 -38.56 91.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.878 . . . . 0.0 109.9 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 147' ' ' ILE . 61.2 mt -64.77 -35.94 82.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.857 . . . . 0.0 109.989 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.622 ' CD2' ' CZ ' ' A' ' 9' ' ' PHE . 7.9 m-85 -63.55 -38.82 92.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.926 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -77.03 -14.5 59.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.873 . . . . 0.0 109.993 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.439 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 15.4 mt -84.02 -34.81 24.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.228 -0.92 . . . . 0.0 108.973 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.644 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 17.2 mt -71.56 -44.81 69.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.566 -0.709 . . . . 0.0 109.109 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' HG12 ' A' ' 13' ' ' ILE . 10.9 mm-40 -66.73 -38.75 87.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 0.0 109.651 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.7 m -69.99 -37.47 75.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -0.984 . . . . 0.0 109.669 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.596 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 77.7 t80 -56.4 -57.23 13.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.424 -0.797 . . . . 0.0 110.015 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.637 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 55.5 mt -68.58 -29.07 67.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.28 -0.887 . . . . 0.0 110.16 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.528 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 80.4 tttt -68.42 -33.59 74.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.66 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -100.8 -27.38 7.51 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.526 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.0 m-70 -107.45 89.19 4.7 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.303 -1.116 . . . . 0.0 110.045 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.2 Cg_endo -73.36 2.94 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.003 1.528 . . . . 0.0 110.833 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -106.9 -11.63 15.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 0.0 109.712 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.572 ' HB2' ' CE2' ' A' ' 150' ' ' TYR . . . -69.78 100.57 1.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.472 -0.768 . . . . 0.0 110.001 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.684 ' CE2' ' CB ' ' A' ' 21' ' ' ALA . 0.7 OUTLIER 34.34 33.11 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.751 -0.593 . . . . 0.0 110.483 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.524 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.831 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.563 HG12 ' CE1' ' A' ' 121' ' ' HIS . 76.1 t -109.52 109.74 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -1.143 . . . . 0.0 110.243 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.541 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 54.7 m-85 -74.58 155.95 37.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.231 -0.918 . . . . 0.0 110.414 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.4 m -140.89 89.08 2.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.078 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CG ' ' CG2' ' A' ' 133' ' ' VAL . 80.1 m-85 -109.73 127.58 54.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.809 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.2 pt-20 -128.35 152.36 48.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.204 -0.935 . . . . 0.0 110.527 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 p -128.35 142.27 51.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -0.823 . . . . 0.0 109.794 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -121.39 138.51 54.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.979 . . . . 0.0 110.647 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.3 p90 -157.21 -173.03 4.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.586 -0.696 . . . . 0.0 109.753 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.463 HG21 ' HA ' ' A' ' 113' ' ' ILE . 18.0 p -140.15 -177.1 4.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 110.647 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.512 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 2.9 t -159.59 160.0 33.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.436 -0.79 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -88.11 5.15 42.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 110.224 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.551 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 9.7 mm -108.46 149.65 39.62 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.006 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 38.9 Cg_endo -64.44 144.54 85.68 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.886 1.466 . . . . 0.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.626 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 Cg_endo -72.63 -31.24 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.015 1.534 . . . . 0.0 112.918 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.3 Cg_endo -69.39 -23.4 32.53 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 110.19 -0.735 . . . . 0.0 110.19 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.519 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 5.2 mmp_? -83.93 -44.15 14.53 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.524 HD22 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -69.78 -31.88 70.05 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.62 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 77.0 t80 -63.83 -56.91 11.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.496 -0.753 . . . . 0.0 109.426 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 51.4 mttt -52.63 -33.86 48.64 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.904 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.635 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -72.96 -60.91 2.01 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.637 0.732 . . . . 0.0 110.718 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.592 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.5 OUTLIER -51.96 -51.67 55.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.723 -0.611 . . . . 0.0 111.799 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.592 HG12 ' CD1' ' A' ' 81' ' ' TYR . 12.0 t -96.85 -61.71 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.012 -1.055 . . . . 0.0 112.334 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.9 mp -67.97 -1.09 5.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.057 -1.027 . . . . 0.0 111.872 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -147.69 15.22 1.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.664 -1.273 . . . . 0.0 110.845 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -54.05 -48.69 70.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 109.956 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 41' ' ' SER . 49.2 t0 -53.67 -20.34 5.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.955 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.425 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 69.5 m-80 -124.45 11.83 8.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.518 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -97.4 -46.02 6.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.0 110.26 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.668 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 6.0 p -75.59 -27.67 0.7 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.902 . . . . 0.0 112.032 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 50.7 Cg_endo -79.84 6.88 4.92 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 122.696 0.84 . . . . 0.0 110.297 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -130.94 -30.27 1.81 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.209 -0.932 . . . . 0.0 110.244 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.58 HG12 ' CD1' ' A' ' 150' ' ' TYR . 16.1 mt -74.67 -39.86 46.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.38 -0.825 . . . . 0.0 109.849 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -173.11 102.65 0.32 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.387 -0.821 . . . . 0.0 110.362 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.42 2.49 6.24 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.968 1.509 . . . . 0.0 110.56 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -85.03 -19.74 31.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.11 -0.994 . . . . 0.0 109.769 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.87 -44.94 8.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.416 -0.802 . . . . 0.0 110.048 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.523 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.2 mp -125.66 143.63 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 0.0 109.977 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 33.3 ttmt -79.63 -39.18 32.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.274 -0.891 . . . . 0.0 110.383 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.546 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER 178.73 139.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.917 . . . . 0.0 110.527 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 29.5 m -97.81 135.27 39.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 0.0 109.893 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.546 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 50.1 tt0 -143.77 110.26 5.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 110.397 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.9 mt -61.43 132.8 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.066 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.5 mt -92.88 -43.92 8.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.332 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.529 ' O ' ' CG2' ' A' ' 52' ' ' THR . 6.0 mm-40 -135.44 131.6 36.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 110.145 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.08 -172.0 37.85 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -116.83 -3.6 11.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -1.162 . . . . 0.0 110.23 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.82 -4.71 4.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 71' ' ' ILE . . . -79.73 -167.23 34.43 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.4 Cg_endo -70.06 131.83 21.61 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.047 1.551 . . . . 0.0 110.603 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.46 -8.85 66.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 21.9 m -79.94 145.04 32.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -1.13 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 27.6 mm -111.71 117.16 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 44.9 mtmt -101.3 144.99 29.45 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.318 -0.864 . . . . 0.0 110.397 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -117.39 101.56 8.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.177 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.523 ' CG2' HG12 ' A' ' 38' ' ' ILE . 80.6 mt -91.32 138.23 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.123 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.514 ' CG2' ' OH ' ' A' ' 64' ' ' TYR . 1.3 p -112.09 151.64 29.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.468 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' GLY . 32.9 m-85 -111.04 136.23 50.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.873 . . . . 0.0 110.241 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.23 23.56 34.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -118.13 127.38 53.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -1.165 . . . . 0.0 110.15 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.25 143.17 9.63 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.3 t -65.71 -38.12 88.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -1.178 . . . . 0.0 110.252 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -82.09 163.01 22.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 110.206 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.514 ' OH ' ' CG2' ' A' ' 57' ' ' THR . 3.3 t80 -69.33 128.18 35.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.963 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -122.51 96.19 0.56 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 26.5 p90 -133.05 166.75 21.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -1.232 . . . . 0.0 110.103 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.529 HG13 ' CA ' ' A' ' 88' ' ' GLY . 9.7 m -141.06 170.79 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.675 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' NZ ' ' OE1' ' A' ' 87' ' ' GLU . 98.4 mttt -123.17 121.13 35.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.607 -0.683 . . . . 0.0 109.585 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.518 ' NE2' HD11 ' A' ' 85' ' ' LEU . 15.7 m170 -111.57 125.9 54.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 110.981 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 80.0 tttt -99.68 116.97 33.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 109.279 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 39.8 mm -51.96 137.62 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.391 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.512 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 30.5 t0 -109.06 -49.15 3.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 109.85 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 3.1 m -176.72 159.47 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.522 -0.736 . . . . 0.0 110.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.56 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 6.3 tt -151.16 168.37 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.154 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -138.03 84.48 2.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 110.232 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.62 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 94.3 mttt -58.04 -12.17 3.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.429 -0.794 . . . . 0.0 111.008 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -89.81 -31.39 17.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.112 -0.993 . . . . 0.0 109.571 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -114.21 -2.16 13.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 109.667 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 6.6 m-85 67.97 47.59 1.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.754 -0.591 . . . . 0.0 110.573 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.544 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -111.18 158.1 19.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 108.805 178.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.592 ' CD1' HG12 ' A' ' 23' ' ' VAL . 83.4 t80 -159.78 150.86 19.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.956 -1.09 . . . . 0.0 110.669 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.445 ' HB2' ' HA ' ' A' ' 101' ' ' GLU . 12.3 t -159.65 152.43 21.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 7.4 p90 -150.14 176.83 10.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.476 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 91.4 m -124.1 126.08 45.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.797 . . . . 0.0 109.683 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.534 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 2.9 tp -93.52 134.48 35.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.945 . . . . 0.0 110.029 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.08 -10.57 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 110.465 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.451 ' OE1' ' NZ ' ' A' ' 68' ' ' LYS . 23.2 tt0 -140.74 149.09 41.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.424 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.529 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 162.47 149.9 5.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -65.1 -35.07 79.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -1.157 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.61 -21.11 65.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.254 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.526 ' CD1' HD22 ' A' ' 85' ' ' LEU . 41.0 mt -71.3 -32.06 68.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.47 -171.2 0.02 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -84.11 5.1 27.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -1.15 . . . . 0.0 110.006 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.467 ' O ' ' OG1' ' A' ' 122' ' ' THR . 69.6 p -92.34 -43.24 9.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 110.242 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.528 ' CD2' HD13 ' A' ' 128' ' ' ILE . 78.1 mt -94.58 164.51 12.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 110.073 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 36.3 tp10 -144.84 -80.71 0.17 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.243 -0.911 . . . . 0.0 110.21 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 58.8 mttt -80.31 128.88 34.06 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.633 -0.667 . . . . 0.0 110.486 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.619 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 7.5 mm -122.51 143.55 34.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.944 -1.097 . . . . 0.0 110.072 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.91 131.26 53.93 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.453 -0.779 . . . . 0.0 109.044 178.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.619 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 10.9 m-85 -127.08 133.37 50.46 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 110.47 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 75.3 tt0 -131.59 154.26 49.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.885 . . . . 0.0 110.213 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 81' ' ' TYR . 81.6 m -155.0 123.56 6.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.988 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.419 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 12.4 tttt -119.38 150.33 40.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 110.311 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 114' ' ' ILE . 13.0 mt -124.82 150.35 46.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 110.651 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.492 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.37 -169.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.397 -0.815 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -120.64 167.85 12.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.868 . . . . 0.0 110.238 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.416 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 60.2 p -126.42 162.52 46.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.117 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.5 Cg_endo -71.98 -2.48 11.59 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.971 1.511 . . . . 0.0 110.486 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -101.6 -2.61 30.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.264 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.84 -35.95 4.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.12 -172.56 2.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.525 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 15.6 p -128.71 136.21 50.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -1.213 . . . . 0.0 110.435 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.463 ' HA ' HG21 ' A' ' 10' ' ' THR . 62.4 mt -84.93 149.32 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.599 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 9.8 mt -134.33 121.11 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.318 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -110.84 134.61 52.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.91 . . . . 0.0 110.093 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.5 t -125.26 158.4 34.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.89 . . . . 0.0 110.319 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 84.8 m -159.92 126.59 4.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.88 . . . . 0.0 110.322 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.573 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 18.8 t -126.5 155.84 41.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.288 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.529 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 80.6 m-70 -130.73 164.5 24.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.306 -0.871 . . . . 0.0 109.965 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 119' ' ' HIS . 18.6 m-85 -133.67 134.49 43.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 111.037 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.563 ' CE1' HG12 ' A' ' 2' ' ' VAL . 85.4 m-70 -121.07 90.2 3.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 108.848 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.525 ' OG1' ' CG2' ' A' ' 126' ' ' VAL . 2.2 t -91.59 -179.46 5.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 111.748 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -133.97 171.89 13.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.902 -0.498 . . . . 0.0 109.703 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 76.45 2.48 74.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 16.6 t30 68.68 60.41 0.37 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.268 -1.137 . . . . 0.0 110.728 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.525 ' CG2' ' OG1' ' A' ' 122' ' ' THR . 6.6 m -126.01 162.08 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.668 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -118.64 145.91 45.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.02 . . . . 0.0 110.725 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.528 HD13 ' CD2' ' A' ' 95' ' ' LEU . 24.1 mm -55.77 173.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.388 -0.82 . . . . 0.0 110.083 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 132' ' ' HIS . 29.5 mtpt -110.15 131.69 54.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.042 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 60.6 mt-10 -43.26 -42.37 4.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 110.103 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.45 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 48.8 tt0 -60.83 -26.33 67.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 109.923 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.0 t-160 -85.97 -53.05 5.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 110.081 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.606 ' CG2' ' CG ' ' A' ' 5' ' ' TYR . 3.9 p -69.07 -30.78 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 110.126 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 64.6 tttp -79.3 -53.94 6.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 109.801 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.52 -25.74 67.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.95 -36.52 81.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.471 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 96.5 mttt -65.57 -33.96 77.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -1.119 . . . . 0.0 109.866 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -81.53 -32.1 32.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.0 109.88 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -67.77 -44.67 76.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.374 -0.829 . . . . 0.0 109.873 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -71.2 -38.4 72.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 110.004 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.1 m -62.81 -49.35 75.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.395 -0.816 . . . . 0.0 109.993 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -56.29 -43.13 78.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.982 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 147' ' ' ILE . 23.4 mt -60.74 -40.69 93.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.91 . . . . 0.0 109.944 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 19.1 m-85 -60.61 -39.88 89.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.439 -0.788 . . . . 0.0 109.86 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -67.91 -17.94 64.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 110.037 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.0 mt -84.14 -34.9 23.96 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.19 -0.944 . . . . 0.0 108.965 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.592 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 55.2 mt -71.75 -41.64 70.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.548 -0.72 . . . . 0.0 109.06 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.512 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 14.9 mm-40 -59.97 -39.68 86.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.289 -0.882 . . . . 0.0 109.205 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.466 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 97.7 m -67.09 -35.99 81.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 109.185 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.585 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 72.3 t80 -53.15 -53.46 50.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.48 -0.763 . . . . 0.0 109.625 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.65 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 98.3 mt -76.08 -27.03 57.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.296 -0.877 . . . . 0.0 109.984 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.526 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 29.8 ttpt -75.88 -19.67 58.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.451 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -113.45 -30.73 2.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.475 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 15.3 m-70 -106.89 93.28 8.67 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.199 -1.177 . . . . 0.0 110.224 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.5 Cg_endo -74.22 4.77 4.05 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.086 1.572 . . . . 0.0 110.876 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -108.15 3.68 24.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 109.827 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.566 ' HB2' ' CE2' ' A' ' 150' ' ' TYR . . . -86.87 103.34 15.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.381 -0.824 . . . . 0.0 110.196 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.65 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.65 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.686 -0.634 . . . . 0.0 110.511 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.519 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.714 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 54.8 t -106.59 128.63 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -1.14 . . . . 0.0 110.306 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.64 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 9.0 m-85 -90.86 143.5 26.66 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.267 -0.896 . . . . 0.0 109.654 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.403 HG21 ' CE1' ' A' ' 119' ' ' HIS . 4.8 m -126.23 116.82 21.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.984 -1.073 . . . . 0.0 110.403 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 57.5 m-85 -131.76 137.25 48.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 109.915 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -136.08 149.75 48.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 110.565 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.4 p -139.69 149.98 44.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.78 . . . . 0.0 109.451 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.45 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 2.8 tt0 -133.79 138.33 45.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.968 -1.083 . . . . 0.0 110.854 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.608 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 3.6 p90 -154.34 -174.7 5.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.429 -0.794 . . . . 0.0 109.597 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 14.0 p -136.88 178.35 7.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 110.687 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.448 ' OG ' HD13 ' A' ' 114' ' ' ILE . 83.0 p -157.36 153.1 26.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 110.24 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -79.34 -15.45 57.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.912 . . . . 0.0 110.267 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 152' ' ' LYS . 1.9 mp -87.57 151.25 50.23 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 109.937 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.8 143.47 73.82 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.057 1.556 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.617 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.88 -31.14 10.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 124.065 1.561 . . . . 0.0 112.972 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.6 Cg_endo -70.52 -21.79 29.48 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 N-CA-C 110.103 -0.768 . . . . 0.0 110.103 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 159' ' ' ASN . 9.1 mmp_? -83.44 -47.12 11.72 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -66.51 -27.87 68.11 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.613 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 81.6 t80 -65.65 -60.36 2.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.715 -0.616 . . . . 0.0 109.604 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 52.3 mttt -52.03 -32.97 36.56 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.4 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -74.13 -56.02 5.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.399 -0.813 . . . . 0.0 110.661 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.637 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.4 OUTLIER -58.62 -49.15 78.55 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.542 -0.724 . . . . 0.0 111.384 -178.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.6 ' CG1' ' CD1' ' A' ' 74' ' ' ILE . 16.8 t -93.49 -65.25 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.973 -1.079 . . . . 0.0 111.717 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 6.9 mp -67.55 -1.07 4.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.287 -0.883 . . . . 0.0 111.819 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.525 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -149.04 25.24 0.92 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.795 -1.19 . . . . 0.0 110.729 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -63.79 -38.12 89.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.119 -0.988 . . . . 0.0 109.989 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' OD2' HD12 ' A' ' 43' ' ' ILE . 54.7 m-20 -65.02 -14.92 61.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 110.253 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -125.15 7.72 7.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 110.058 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -95.43 -57.03 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 110.103 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.598 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 96.1 t -62.69 -40.51 64.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.765 . . . . 0.0 111.153 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -77.4 7.09 3.94 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.371 1.195 . . . . 0.0 110.85 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -127.48 -29.8 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.902 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.529 HD12 ' CD1' ' A' ' 29' ' ' LEU . 32.3 mt -80.07 -44.37 22.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.51 -0.744 . . . . 0.0 110.044 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.02 102.14 2.11 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 110.348 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.21 3.63 5.55 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.049 1.552 . . . . 0.0 110.717 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -90.74 -13.84 33.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.141 -0.975 . . . . 0.0 110.208 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.83 -29.05 12.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.198 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.584 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 0.9 OUTLIER -142.07 150.26 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -88.69 -44.79 10.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.326 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.575 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -172.93 156.76 3.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.377 -0.827 . . . . 0.0 110.173 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -119.81 121.99 40.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 109.95 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 84.6 tt0 -124.31 114.49 19.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.491 HD11 HG22 ' A' ' 43' ' ' ILE . 23.4 mt -61.55 132.21 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.944 . . . . 0.0 110.088 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.464 HD13 ' HB2' ' A' ' 55' ' ' LYS . 53.4 mt -92.89 -25.54 18.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 52' ' ' THR . 41.8 tt0 -156.46 171.31 20.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 58.07 -165.92 6.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -131.55 29.42 4.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -1.112 . . . . 0.0 110.291 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.36 2.25 47.57 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.469 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -92.53 -167.33 39.42 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.458 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.4 132.86 23.15 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.058 1.557 . . . . 0.0 110.522 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.17 -6.62 68.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 19.4 m -80.06 147.91 31.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -1.174 . . . . 0.0 110.129 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.504 ' N ' HG21 ' A' ' 52' ' ' THR . 21.6 mm -116.53 114.96 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.071 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 35.7 mtmt -99.76 147.47 25.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.464 ' HB2' HD13 ' A' ' 44' ' ' LEU . 83.6 tttt -116.78 98.62 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.898 . . . . 0.0 110.09 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.522 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.7 mt -88.22 146.42 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.5 p -120.16 155.62 32.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.38 -0.825 . . . . 0.0 110.574 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 23.1 m-85 -116.58 145.36 43.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.449 -0.782 . . . . 0.0 110.145 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.99 -8.59 57.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -118.03 148.66 42.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -1.138 . . . . 0.0 110.146 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.57 -157.69 14.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.0 p -57.52 -173.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -1.136 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -51.74 -66.48 0.38 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.205 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.401 ' CD1' ' HD2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -108.37 112.67 25.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.186 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -118.86 94.98 0.6 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 20.8 p90 -134.8 167.97 19.9 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.049 -1.265 . . . . 0.0 110.478 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.535 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.8 m -139.69 172.89 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 110.447 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.512 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 30.3 mtpt -123.9 129.37 50.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.528 -0.732 . . . . 0.0 109.518 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.565 ' CD2' HD13 ' A' ' 85' ' ' LEU . 8.3 m170 -117.19 125.94 51.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.99 -1.069 . . . . 0.0 110.931 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HA ' HD12 ' A' ' 53' ' ' ILE . 64.6 tttp -104.94 110.49 22.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 109.3 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 29.2 mm -48.19 140.65 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.187 -0.945 . . . . 0.0 110.406 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.529 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 16.0 t0 -112.25 -40.32 4.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.393 -0.817 . . . . 0.0 109.629 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 0.6 OUTLIER 172.19 161.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.0 110.391 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.6 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 3.6 tt -152.03 165.33 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -131.34 80.73 1.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.613 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.6 mttt -55.78 -14.14 2.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.87 . . . . 0.0 110.827 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -90.18 -29.75 18.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.227 -0.92 . . . . 0.0 109.645 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -114.45 -1.68 13.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.486 -0.758 . . . . 0.0 109.965 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.575 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 8.3 m-85 67.48 48.04 1.17 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.639 -0.663 . . . . 0.0 110.646 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.539 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -115.06 154.2 29.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.208 -0.932 . . . . 0.0 109.095 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.57 ' CD1' HG12 ' A' ' 23' ' ' VAL . 84.7 t80 -154.98 148.32 25.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.9 -1.125 . . . . 0.0 110.523 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.479 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 17.9 m -156.22 147.16 22.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.366 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 4.9 p90 -144.21 178.3 7.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.409 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 71.0 m -124.83 125.19 43.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.535 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.565 HD13 ' CD2' ' A' ' 69' ' ' HIS . 5.3 tp -90.86 136.11 33.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.178 -0.951 . . . . 0.0 110.401 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 86' ' ' ILE . 23.2 pt -123.58 -6.14 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.551 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.512 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 11.2 tt0 -141.37 160.44 40.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 110.429 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.535 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 145.77 123.69 1.58 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.34 -15.41 6.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -1.16 . . . . 0.0 110.402 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -77.1 -29.37 54.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.524 ' CD2' HG13 ' A' ' 98' ' ' ILE . 28.6 mt -67.46 -39.33 85.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.366 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 178.05 44.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -74.46 -0.01 16.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -1.148 . . . . 0.0 110.162 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.523 ' CG2' HG12 ' A' ' 126' ' ' VAL . 15.4 p -95.2 -40.41 9.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.165 -0.959 . . . . 0.0 110.305 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.615 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 1.8 mm? -79.84 136.98 36.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.165 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 5.7 tp10 -124.98 -83.44 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.318 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 26.7 mttt -80.16 126.87 31.65 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 110.695 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.567 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.3 mm -121.14 141.04 43.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 120.614 -1.304 . . . . 0.0 109.235 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.72 134.23 55.05 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.879 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 8.2 m-85 -130.3 132.7 46.0 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.422 -0.799 . . . . 0.0 110.169 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 5.9 mt-10 -129.71 167.01 18.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.223 -0.923 . . . . 0.0 110.619 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 81' ' ' TYR . 45.6 m -162.9 137.69 6.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.381 -0.824 . . . . 0.0 109.909 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.4 mttt -135.58 137.88 42.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.391 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.513 ' CD2' HG12 ' A' ' 114' ' ' ILE . 9.8 mt -117.12 149.92 39.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.319 -0.863 . . . . 0.0 110.127 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.488 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -150.79 -169.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -0.936 . . . . 0.0 110.153 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -120.64 166.85 13.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.268 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 24.8 p -125.02 165.69 24.42 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -73.17 -0.65 9.42 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.995 1.524 . . . . 0.0 110.488 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.6 p -110.42 7.66 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.263 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.38 -38.66 3.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.03 -172.72 0.14 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.532 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 16.8 p -133.63 135.26 44.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.171 -1.194 . . . . 0.0 110.385 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 41.8 mt -86.44 152.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.056 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.608 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 5.3 mt -136.42 115.17 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.933 . . . . 0.0 110.614 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 44.4 tttp -101.06 127.28 47.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -0.842 . . . . 0.0 109.745 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.05 157.91 25.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.748 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.7 m -160.08 144.33 14.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.394 -0.816 . . . . 0.0 110.067 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.493 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -146.65 168.64 20.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.161 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.493 ' CG ' ' C ' ' A' ' 118' ' ' SER . 48.4 m-70 -148.87 174.56 12.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.166 -0.959 . . . . 0.0 110.552 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.573 ' CD2' HG12 ' A' ' 128' ' ' ILE . 87.9 m-85 -138.09 156.91 47.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.217 -0.927 . . . . 0.0 110.958 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 76.4 m-70 -140.84 81.49 1.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.406 -0.809 . . . . 0.0 109.251 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.444 ' HB ' ' HB ' ' A' ' 126' ' ' VAL . 0.1 OUTLIER -63.08 142.36 58.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.334 -0.854 . . . . 0.0 110.648 -179.352 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -69.19 110.4 4.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.896 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.63 -116.36 5.45 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 2.6 p-10 -137.13 49.3 2.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -1.172 . . . . 0.0 110.244 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.523 HG12 ' CG2' ' A' ' 94' ' ' THR . 66.7 t -96.42 174.96 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.416 -0.803 . . . . 0.0 109.952 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.411 ' N ' ' CG1' ' A' ' 126' ' ' VAL . 96.0 mt-10 -126.22 161.2 28.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.64 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 4.5 mp -88.38 172.94 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.867 . . . . 0.0 110.095 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.478 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 67.0 mmtt -90.83 151.96 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.332 -0.855 . . . . 0.0 109.958 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.471 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 61.7 mm-40 -58.16 -22.0 49.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.136 -0.978 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 98.2 mt-10 -68.03 -39.57 83.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.91 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 5.3 m170 -66.04 -47.55 74.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.162 -0.961 . . . . 0.0 110.02 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.577 HG22 ' CE1' ' A' ' 5' ' ' TYR . 2.5 p -76.47 -25.87 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.449 -0.782 . . . . 0.0 110.093 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 73.6 tttt -104.31 -65.37 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.958 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -56.68 -24.21 47.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.868 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.51 -28.58 67.33 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.11 -33.1 56.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -1.127 . . . . 0.0 110.017 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -81.39 -31.26 33.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.85 . . . . 0.0 109.813 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -73.42 -36.72 66.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 109.828 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.23 -35.94 61.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.852 . . . . 0.0 109.89 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.1 m -64.04 -45.46 88.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -0.821 . . . . 0.0 109.973 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -56.41 -50.67 70.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.993 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.412 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.9 mm? -60.51 -33.98 73.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.949 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -65.16 -37.49 87.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.414 -0.803 . . . . 0.0 109.833 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 29.3 ttmt -79.63 -15.45 57.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.441 -0.787 . . . . 0.0 110.042 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.501 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 13.8 mt -83.23 -37.02 24.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.081 -1.012 . . . . 0.0 108.933 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.637 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 86.6 mt -70.72 -44.36 76.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.466 ' O ' HD12 ' A' ' 13' ' ' ILE . 62.6 mt-10 -55.88 -40.01 72.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.327 -0.858 . . . . 0.0 109.202 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.6 m -71.25 -31.63 67.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.556 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.586 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 79.0 t80 -56.08 -49.94 72.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.474 -0.766 . . . . 0.0 109.775 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.637 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 59.3 mt -77.72 -29.02 51.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.997 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 52.4 tptt -66.98 -26.78 66.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.464 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.458 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -107.28 -28.41 4.92 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.556 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.7 m-70 -106.9 91.18 6.0 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.219 -1.165 . . . . 0.0 110.05 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.7 Cg_endo -73.29 4.58 3.74 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.062 1.559 . . . . 0.0 111.104 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -111.14 -7.72 14.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.019 -1.051 . . . . 0.0 109.97 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.556 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -70.49 101.33 1.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 110.109 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.638 ' CE2' ' CB ' ' A' ' 21' ' ' ALA . 0.8 OUTLIER 34.79 31.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.712 -0.618 . . . . 0.0 110.635 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.715 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 93.9 t -136.07 134.11 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -1.166 . . . . 0.0 110.363 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 128' ' ' ILE . 11.2 m-85 -101.18 131.9 46.94 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.66 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.408 ' HA ' ' HD1' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -100.78 126.41 47.34 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.858 -1.151 . . . . 0.0 110.687 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.582 ' CZ ' HG23 ' A' ' 133' ' ' VAL . 50.4 m-85 -133.58 125.59 29.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.806 . . . . 0.0 109.907 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.534 ' HG2' ' CG2' ' A' ' 117' ' ' THR . 3.8 mt-10 -136.49 145.61 45.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.398 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 m -132.03 158.82 40.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.805 . . . . 0.0 110.015 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.432 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 98.9 mt-10 -143.72 123.67 13.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.443 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 p90 -147.47 -173.64 4.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 12.5 p -138.34 -179.4 5.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.578 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.4 ' OG ' HD13 ' A' ' 114' ' ' ILE . 89.3 p -157.1 164.15 38.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.41 -0.806 . . . . 0.0 110.206 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -86.1 -21.74 27.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.53 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 8.2 mm -84.91 150.26 55.27 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.146 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 42.2 Cg_endo -66.1 150.4 85.21 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.158 1.61 . . . . 0.0 110.14 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.649 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.5 Cg_endo -70.15 -32.93 16.05 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.912 1.48 . . . . 0.0 113.304 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.5 Cg_endo -66.92 -23.23 47.49 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 122.381 0.674 . . . . 0.0 110.408 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.522 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 10.7 mmp_? -84.5 -45.66 12.41 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.519 HD23 ' CD2' ' A' ' 104' ' ' LEU . 1.1 tt -72.28 -25.4 61.58 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.564 -0.71 . . . . 0.0 109.241 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.589 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 85.2 t80 -70.74 -57.98 4.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.402 -0.811 . . . . 0.0 109.059 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.51 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 67.5 mttt -51.23 -35.99 39.62 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.33 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.575 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -74.48 -53.81 8.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 111.021 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.622 ' CD1' ' CD1' ' A' ' 147' ' ' ILE . 0.5 OUTLIER -59.54 -46.23 89.47 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 111.706 -178.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.558 HG11 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -98.18 -61.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.947 -1.096 . . . . 0.0 111.57 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 7.5 mp -70.18 0.31 6.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.149 -0.969 . . . . 0.0 111.55 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.492 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -154.55 46.92 0.57 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.79 -1.194 . . . . 0.0 110.856 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -84.64 -25.22 28.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -0.999 . . . . 0.0 110.062 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 60.6 t0 -73.76 -11.66 60.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 109.907 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.411 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 71.6 m-20 -128.6 10.46 6.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.37 -0.831 . . . . 0.0 109.652 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.533 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -97.9 -57.75 2.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.445 -0.784 . . . . 0.0 110.45 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.67 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.9 m -74.86 -29.1 0.87 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 112.101 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 51.0 Cg_endo -80.5 -1.51 11.35 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 O-C-N 122.878 0.936 . . . . 0.0 110.374 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -126.43 -32.09 2.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 109.756 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.58 HG12 ' CD1' ' A' ' 150' ' ' TYR . 11.9 mt -80.06 -34.17 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.489 -0.757 . . . . 0.0 109.393 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.38 99.06 1.4 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.586 -0.696 . . . . 0.0 109.896 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.33 -4.33 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.984 1.518 . . . . 0.0 110.427 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -87.17 1.88 51.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.865 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.494 ' C ' ' CD1' ' A' ' 38' ' ' ILE . . . -107.04 -47.6 3.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 109.997 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.507 ' HB ' ' CG2' ' A' ' 30' ' ' VAL . 1.9 mp -133.88 142.06 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 0.0 110.071 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -82.94 -36.57 25.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.553 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -175.42 132.69 0.29 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.375 -0.828 . . . . 0.0 109.946 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 2.3 m -100.26 131.24 46.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.553 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 77.5 tt0 -138.69 110.83 7.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 110.293 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 14.7 mt -64.11 134.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 110.203 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.498 HD12 ' CB ' ' A' ' 55' ' ' LYS . 9.7 mp -97.89 -44.46 6.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 52' ' ' THR . 3.5 mt-10 -128.77 145.37 51.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.237 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.24 -162.46 53.57 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -139.52 23.02 2.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -1.123 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.15 -11.67 11.55 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -80.83 -168.0 38.48 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.53 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.89 139.68 36.85 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.09 1.574 . . . . 0.0 110.377 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.05 -3.34 85.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 31.9 m -80.09 139.0 37.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -1.198 . . . . 0.0 110.05 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.535 HG22 ' CE ' ' A' ' 68' ' ' LYS . 25.7 mm -109.87 109.59 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 110.295 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 88.1 mttt -99.04 138.4 36.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.323 -0.861 . . . . 0.0 110.217 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.498 ' CB ' HD12 ' A' ' 44' ' ' LEU . 83.2 tttt -109.41 97.28 6.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.202 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.44 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 91.1 mt -84.15 141.88 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 0.0 110.177 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.3 p -116.08 155.22 28.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.147 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 23.5 m-85 -111.8 166.63 11.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.863 . . . . 0.0 110.358 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.08 155.6 0.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -78.39 175.94 9.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -1.16 . . . . 0.0 110.215 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.42 -159.26 32.37 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.43 ' C ' ' HG3' ' A' ' 63' ' ' GLN . 97.3 p -49.47 -35.74 20.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -1.168 . . . . 0.0 110.099 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.43 ' HG3' ' C ' ' A' ' 62' ' ' SER . 62.7 mt-30 -141.15 149.22 41.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.848 . . . . 0.0 110.116 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -60.17 148.23 36.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.23 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.14 88.29 0.28 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.5 p90 -126.84 164.36 21.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -1.168 . . . . 0.0 110.147 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.514 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.6 m -139.31 173.82 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 110.575 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.535 ' CE ' HG22 ' A' ' 53' ' ' ILE . 48.9 tttt -123.0 128.24 49.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.589 -0.694 . . . . 0.0 109.591 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.525 ' NE2' HD11 ' A' ' 85' ' ' LEU . 9.2 m170 -119.7 119.31 33.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 0.0 110.851 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 85.4 tttt -100.64 110.87 23.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.577 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.53 ' CG2' ' HA ' ' A' ' 50' ' ' PRO . 33.2 mm -46.33 142.79 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.475 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.532 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 12.9 t0 -114.64 -41.29 3.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.471 -0.768 . . . . 0.0 109.552 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 67.5 p -174.48 157.91 2.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.82 . . . . 0.0 109.457 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.99 151.02 23.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.084 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 6.5 m-20 -127.75 75.99 1.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.388 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 99.5 mttt -62.55 -12.85 25.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.101 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -97.98 -30.37 12.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 109.205 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -105.29 -3.08 23.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.653 -0.654 . . . . 0.0 109.715 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.596 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 83.1 m-85 61.26 53.35 3.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.49 -0.756 . . . . 0.0 110.083 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.523 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -125.82 152.67 45.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.568 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.558 ' CE1' HG11 ' A' ' 23' ' ' VAL . 25.8 t80 -138.78 134.5 33.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 110.391 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.457 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -141.54 123.13 15.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 110.555 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.602 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 8.8 p90 -135.0 175.89 9.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 110.134 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.6 m -124.41 127.82 48.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.533 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 3.3 tp -97.49 135.81 38.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 0.0 109.906 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.498 HG23 HD11 ' A' ' 86' ' ' ILE . 6.7 pt -128.53 -5.42 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 110.409 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.416 ' HB3' ' N ' ' A' ' 68' ' ' LYS . 23.0 tt0 -137.05 139.04 41.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.393 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.514 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 166.49 122.47 0.61 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -51.06 -21.31 1.78 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -1.105 . . . . 0.0 110.23 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.567 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -72.79 -27.09 61.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.069 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 92' ' ' GLY . 64.7 mt -66.28 -27.84 68.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.177 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.03 -169.67 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -84.62 4.6 31.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -1.147 . . . . 0.0 110.11 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.498 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 46.8 p -90.41 -30.06 17.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.063 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.593 ' CD2' ' CG1' ' A' ' 128' ' ' ILE . 44.8 mt -116.99 166.27 12.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.392 -0.818 . . . . 0.0 110.008 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 49.0 tt0 -143.23 -79.57 0.21 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.306 -0.871 . . . . 0.0 110.018 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 51.9 mttt -80.16 139.74 36.67 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.57 -0.706 . . . . 0.0 110.531 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.621 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 7.3 mm -128.24 140.91 47.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 120.861 -1.149 . . . . 0.0 109.722 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.6 m -118.35 125.88 50.94 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.462 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.621 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 11.3 m-85 -122.77 135.89 54.7 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 37.2 tt0 -141.86 138.45 32.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.844 . . . . 0.0 110.149 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 81' ' ' TYR . 88.8 m -135.76 157.65 46.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 110.059 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -149.31 144.16 26.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.266 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 114' ' ' ILE . 5.7 mt -121.33 149.19 43.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 110.776 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.492 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.82 -169.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 109.711 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -118.68 165.43 13.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.408 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 96.3 p -123.95 162.51 40.79 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.248 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.8 Cg_endo -72.03 -2.93 12.31 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.019 1.536 . . . . 0.0 110.422 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.7 p -102.12 -0.36 33.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.3 -35.42 5.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.59 -173.04 3.23 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 73.3 p -128.35 133.71 48.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -1.161 . . . . 0.0 110.337 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 71.9 mt -81.66 149.64 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 110.183 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.575 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 8.7 mt -132.98 107.56 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.268 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.2 tttt -95.32 132.63 40.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.882 . . . . 0.0 110.069 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.3 OUTLIER -126.2 151.62 47.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 110.259 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.534 ' CG2' ' HG2' ' A' ' 6' ' ' GLU . 99.2 m -150.06 137.2 19.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 5.4 p -142.8 146.08 33.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 109.938 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.511 ' CE1' ' CG2' ' A' ' 117' ' ' THR . 41.6 m-70 -131.33 163.44 27.83 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 110.62 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 9.3 m-85 -122.91 150.29 43.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.579 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.502 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 93.8 m-70 -128.98 93.72 3.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 109.472 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 94' ' ' THR . 1.7 p -71.3 157.63 37.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 110.693 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.472 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 47.6 tptt -140.45 106.1 5.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.311 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 118.81 29.27 1.88 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.83 65.76 0.99 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -1.145 . . . . 0.0 110.214 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 94' ' ' THR . 26.9 m -141.67 162.15 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.176 -0.953 . . . . 0.0 110.099 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -130.6 168.51 16.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.27 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.64 ' CD1' ' CE1' ' A' ' 3' ' ' PHE . 4.7 mp -94.92 173.07 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.25 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.453 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 34.5 mttt -110.38 129.92 55.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.387 -0.821 . . . . 0.0 109.658 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 57.3 mm-40 -42.51 -39.32 2.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 110.267 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -60.95 -28.08 68.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.948 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 15.8 t-160 -78.01 -54.83 5.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 110.057 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.582 HG23 ' CZ ' ' A' ' 5' ' ' TYR . 99.4 t -61.13 -38.32 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.847 . . . . 0.0 110.015 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.44 -39.46 88.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.062 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.35 83.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.991 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.79 -30.47 68.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 97.2 mttt -69.88 -31.41 69.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -1.123 . . . . 0.0 110.112 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.509 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 97.8 mt-10 -75.75 -39.33 57.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 110.05 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -62.45 -43.31 99.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -73.24 -34.52 65.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.018 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.0 m -71.51 -54.32 10.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.402 -0.811 . . . . 0.0 109.913 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 73.1 m-20 -51.53 -46.23 63.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.903 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 21.8 tp -57.74 -46.05 85.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 0.0 109.815 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 6.9 m-85 -53.89 -36.88 63.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.729 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 76.7 tttt -79.98 -13.14 59.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.461 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 20.9 mt -87.47 -36.57 17.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.211 -0.931 . . . . 0.0 108.927 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.622 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 45.3 mt -73.2 -41.67 58.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 13' ' ' ILE . 19.9 pt-20 -58.55 -31.98 68.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.344 -0.847 . . . . 0.0 109.243 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.446 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 31.8 m -80.0 -34.59 38.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.36 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.58 ' CD1' HG12 ' A' ' 33' ' ' ILE . 87.1 t80 -58.51 -53.88 53.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.501 -0.75 . . . . 0.0 109.883 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.629 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 76.5 mt -70.58 -31.35 68.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.268 -0.895 . . . . 0.0 110.047 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.492 ' HA ' HD13 ' A' ' 13' ' ' ILE . 45.4 tptt -70.08 -18.92 63.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.492 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -110.79 -31.65 2.88 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.592 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.0 m-70 -108.16 93.89 12.04 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.345 -1.091 . . . . 0.0 109.904 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.478 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.6 Cg_endo -74.01 5.81 3.3 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.077 1.567 . . . . 0.0 111.06 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -111.58 -9.07 14.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.056 -1.028 . . . . 0.0 109.683 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 150' ' ' TYR . . . -64.81 102.33 0.58 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 110.03 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.629 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.8 OUTLIER 34.68 33.55 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.716 -0.615 . . . . 0.0 110.351 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.522 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.85 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 74.4 t -122.53 142.37 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -1.159 . . . . 0.0 110.29 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.643 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 9.7 m-85 -91.72 152.36 20.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.891 . . . . 0.0 110.124 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 m -132.48 106.87 8.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 0.0 110.364 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.631 ' CD2' ' CG2' ' A' ' 133' ' ' VAL . 71.3 m-85 -121.54 143.04 49.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.867 . . . . 0.0 109.98 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 13.1 pt-20 -142.65 152.17 42.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.099 -1.001 . . . . 0.0 110.381 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.8 t -132.38 162.54 30.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 110.048 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -145.31 117.32 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.41 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.4 p90 -144.78 -171.48 3.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.879 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 19.2 p -138.6 -179.61 5.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 0.0 110.621 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.416 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 3.0 t -154.19 168.99 24.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.805 . . . . 0.0 110.22 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -92.58 -28.06 16.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 12.3 mm -82.96 148.02 55.88 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.057 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.554 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 40.4 Cg_endo -64.71 152.47 81.84 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.016 1.535 . . . . 0.0 110.821 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.649 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.4 Cg_endo -63.18 -36.25 58.91 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.917 1.483 . . . . 0.0 112.928 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -63.81 -20.29 68.29 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 N-CA-C 109.862 -0.861 . . . . 0.0 109.862 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.521 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 9.8 mmp_? -81.1 -46.03 15.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.602 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 4.1 mm? -74.03 -37.08 64.45 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.545 -0.862 . . . . 0.0 108.751 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.602 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 37.8 t80 -57.87 -56.69 18.65 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.158 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 89.0 mttt -58.2 -36.45 73.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.708 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.613 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . . . -80.09 -63.64 1.37 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.435 -0.791 . . . . 0.0 110.738 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.6 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.4 OUTLIER -51.95 -34.36 41.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.516 -0.74 . . . . 0.0 111.622 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.579 HG11 ' CE1' ' A' ' 81' ' ' TYR . 4.5 t -108.68 -65.03 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.974 -1.079 . . . . 0.0 111.637 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.1 mp -69.68 -1.6 9.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.22 -0.925 . . . . 0.0 111.303 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.53 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -148.47 23.09 1.03 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.879 -1.138 . . . . 0.0 110.476 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -62.49 -44.92 95.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.887 . . . . 0.0 110.201 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.484 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 63.8 m-20 -58.22 -15.39 9.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 110.207 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.458 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 74.0 m-20 -124.91 4.86 8.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.017 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.521 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -93.2 -49.09 6.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.425 -0.797 . . . . 0.0 109.946 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.5 t -71.17 -42.0 11.33 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.83 . . . . 0.0 110.895 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.7 Cg_endo -77.2 6.61 4.2 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.422 1.222 . . . . 0.0 110.722 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 63.3 mttt -124.63 -33.97 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.264 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.576 HG12 ' CD1' ' A' ' 150' ' ' TYR . 35.3 mt -80.1 -34.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.597 -0.69 . . . . 0.0 109.606 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.46 98.52 1.4 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.512 -0.742 . . . . 0.0 110.109 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.28 2.15 6.53 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.027 1.54 . . . . 0.0 110.726 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -90.54 -3.64 57.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.141 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.5 -33.48 6.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 110.165 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.541 HD12 ' CG2' ' A' ' 56' ' ' ILE . 6.7 mt -135.97 134.44 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.892 . . . . 0.0 110.284 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.55 ' CG ' ' CA ' ' A' ' 59' ' ' GLY . 9.1 mtmt -73.34 -39.14 65.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.373 -0.829 . . . . 0.0 110.302 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 177.01 164.16 0.49 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 110.211 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.484 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 69.5 m -124.73 120.07 30.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.921 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.514 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 51.0 tp10 -122.7 102.44 8.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.302 -0.874 . . . . 0.0 110.183 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 43' ' ' ILE . 28.2 mt -50.32 130.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 110.164 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.483 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 46.6 mt -88.61 -26.45 21.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 110.091 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.516 ' O ' ' CG2' ' A' ' 52' ' ' THR . 50.0 tt0 -157.08 173.88 16.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 110.23 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 58.98 -159.98 16.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -143.87 31.2 1.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -1.153 . . . . 0.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.42 3.0 41.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -97.49 -167.18 32.45 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.52 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 44.2 Cg_endo -70.32 137.09 33.07 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.065 1.56 . . . . 0.0 110.506 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.17 -6.72 83.31 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 46.4 m -80.05 138.17 36.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -1.14 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.585 ' CG2' ' CG ' ' A' ' 68' ' ' LYS . 36.7 mm -105.61 121.27 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 110.037 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.513 ' NZ ' ' OH ' ' A' ' 81' ' ' TYR . 52.3 mtmt -106.29 120.11 41.0 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 110.293 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.483 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 80.1 tttt -91.94 101.11 13.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 0.0 110.2 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.541 ' CG2' HD12 ' A' ' 38' ' ' ILE . 90.6 mt -91.51 147.13 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 110.111 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 3.3 p -119.84 153.09 36.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.952 . . . . 0.0 110.652 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 12.9 m-85 -116.22 125.49 52.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 110.152 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.55 ' CA ' ' CG ' ' A' ' 39' ' ' LYS . . . -92.28 10.85 73.48 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -119.0 128.66 54.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -1.137 . . . . 0.0 110.127 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.55 -140.67 16.51 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 98.1 p -62.08 -165.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -1.165 . . . . 0.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -83.35 -35.54 25.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.88 . . . . 0.0 110.268 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.27 103.79 10.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.33 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -136.19 80.62 0.3 Allowed Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 19.7 p90 -125.81 179.31 5.24 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.319 -1.106 . . . . 0.0 110.23 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.573 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 4.1 m -152.39 177.7 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.398 -0.813 . . . . 0.0 110.694 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.586 ' CE ' ' CD1' ' A' ' 86' ' ' ILE . 28.0 ttpt -134.93 107.64 7.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.49 -0.756 . . . . 0.0 109.689 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.504 ' CD2' HD11 ' A' ' 85' ' ' LEU . 13.5 m170 -96.66 130.67 43.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 111.247 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 56.8 tttt -102.75 109.04 20.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.366 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.1 mm -43.62 138.76 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 110.267 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.541 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 15.0 t0 -108.95 -40.47 5.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.654 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 11.0 p 178.39 158.57 0.5 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.427 -0.796 . . . . 0.0 109.782 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.417 HG13 ' HD1' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -140.24 156.54 24.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.104 -0.998 . . . . 0.0 110.909 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -139.4 80.96 1.81 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.689 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.602 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 35.1 ttpt -64.11 -12.33 38.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 110.093 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -87.36 -29.6 21.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 108.987 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -111.46 -3.23 15.27 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.409 0.623 . . . . 0.0 109.385 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.536 ' CB ' ' HB2' ' A' ' 104' ' ' LEU . 67.5 m-85 62.5 53.12 2.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.599 -0.688 . . . . 0.0 110.108 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.88 155.72 39.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.539 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.682 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 73.5 t80 -143.26 147.47 34.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 110.108 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 72' ' ' ASP . 68.8 m -153.6 135.01 14.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 110.97 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.682 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.4 p90 -144.8 173.08 12.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.37 -0.831 . . . . 0.0 110.118 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.458 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 87.4 m -126.67 124.8 40.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.818 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 68' ' ' LYS . 9.2 tp -92.6 133.0 36.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.0 110.205 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.586 ' CD1' ' CE ' ' A' ' 68' ' ' LYS . 13.3 pt -123.64 -25.64 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 110.59 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB3' ' CB ' ' A' ' 68' ' ' LYS . 42.6 tt0 -112.05 133.21 54.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.183 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.455 ' N ' HD13 ' A' ' 91' ' ' LEU . . . 168.23 140.74 3.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -69.87 -19.09 63.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -1.155 . . . . 0.0 110.279 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.95 -25.04 61.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.291 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 38.7 mt -62.37 -33.09 74.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 110.114 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.25 -179.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -76.79 1.27 17.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -1.156 . . . . 0.0 109.923 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.521 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 70.0 p -92.39 -33.57 14.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.528 ' CD2' HG13 ' A' ' 128' ' ' ILE . 34.8 mt -114.71 163.76 15.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 110.081 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.438 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 39.6 mt-10 -143.56 -79.78 0.2 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.249 -0.907 . . . . 0.0 110.006 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 53.8 mttt -80.12 141.6 35.61 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 110.668 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.621 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.2 mm -129.36 143.24 41.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.366 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.1 m -123.27 126.8 47.59 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.621 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 13.0 m-85 -121.63 135.27 54.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 110.221 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 117' ' ' THR . 74.6 tt0 -136.24 140.12 43.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.242 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 92.5 m -137.95 146.76 43.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 110.228 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 115' ' ' LYS . 19.3 mttt -138.09 145.72 42.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.536 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 2.8 mt -123.21 152.96 40.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 110.461 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.499 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.36 -169.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -127.35 125.55 40.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.26 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.428 ' HB3' HG13 ' A' ' 113' ' ' ILE . 95.4 p -82.21 160.57 62.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 110.187 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.36 -1.31 10.0 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.031 1.543 . . . . 0.0 110.553 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.1 t -98.73 -4.03 34.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.47 -41.61 2.19 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.92 -179.17 5.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 4.6 m -121.15 135.66 55.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.399 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 74.9 mt -84.85 149.96 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.361 -0.837 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.57 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 4.7 mt -134.98 113.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 110.398 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 103' ' ' LYS . 22.4 ttmt -100.45 122.34 43.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.91 . . . . 0.0 109.831 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.0 t -114.7 158.12 22.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 0.0 110.619 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 93.4 m -156.32 133.64 10.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.38 -0.825 . . . . 0.0 110.043 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.6 p -133.02 157.78 44.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.153 -0.967 . . . . 0.0 110.334 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 120' ' ' TYR . 74.7 m-70 -141.25 167.06 23.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.131 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 9.2 m-85 -131.33 150.03 52.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.43 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.9 m-70 -126.3 90.09 3.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 109.561 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.522 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 3.0 p -71.27 166.45 21.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.395 -0.815 . . . . 0.0 110.67 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.438 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 21.4 tttp -119.75 121.1 38.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -0.834 . . . . 0.0 110.153 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.46 -108.24 3.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.517 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 51.5 t30 -139.63 94.35 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -1.166 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.522 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 16.7 m -157.65 159.68 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 0.0 110.098 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -133.84 154.26 51.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 110.282 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.643 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 3.3 mp -76.97 173.07 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.383 -0.823 . . . . 0.0 110.257 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 132' ' ' HIS . 60.5 mttt -101.85 128.88 48.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.106 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.464 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 53.4 mm-40 -44.53 -48.56 10.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 110.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 35.3 tt0 -54.67 -31.22 57.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 109.861 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 129' ' ' LYS . 17.4 t-160 -75.58 -55.67 5.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.631 ' CG2' ' CD2' ' A' ' 5' ' ' TYR . 11.6 p -67.0 -40.96 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 93.7 mttt -66.59 -46.25 76.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.07 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -60.39 -33.29 72.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 110.045 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.07 -26.06 71.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -75.09 -35.13 61.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 110.172 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.34 -35.84 61.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 109.976 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -68.65 -37.69 79.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 109.845 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.55 78.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.863 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.7 t -65.88 -48.45 71.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.379 -0.825 . . . . 0.0 109.953 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -53.82 -42.28 68.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.928 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.469 ' O ' HG13 ' A' ' 147' ' ' ILE . 2.6 mm? -58.7 -47.8 83.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 109.951 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.432 ' CE1' HG23 ' A' ' 114' ' ' ILE . 9.8 m-85 -56.31 -38.42 71.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 110.162 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 78.3 mttt -74.03 -21.98 59.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.107 -0.995 . . . . 0.0 109.93 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.521 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 15.0 mt -87.4 -35.29 18.4 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 108.701 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.6 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 67.9 mt -75.44 -37.36 37.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.575 -0.703 . . . . 0.0 109.129 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 19.8 pt-20 -62.83 -32.82 74.1 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.144 -0.972 . . . . 0.0 109.006 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.467 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 16.8 m -79.93 -26.76 39.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.19 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.582 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 80.9 t80 -60.94 -52.22 65.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.596 -0.69 . . . . 0.0 109.845 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.635 ' CD2' ' CE1' ' A' ' 158' ' ' TYR . 80.5 mt -76.41 -36.65 57.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.266 -0.896 . . . . 0.0 109.972 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.524 ' CA ' HD13 ' A' ' 13' ' ' ILE . 45.0 tptt -64.36 -21.69 66.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.57 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -109.31 -32.14 3.07 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.573 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.9 m-70 -108.37 93.49 11.62 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -1.096 . . . . 0.0 110.025 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.14 5.05 3.79 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.0 1.526 . . . . 0.0 110.954 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -108.74 -6.33 15.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 109.886 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.552 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -75.35 101.33 4.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.865 . . . . 0.0 110.005 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.635 ' CE1' ' CD2' ' A' ' 151' ' ' LEU . 1.5 p90 34.03 36.8 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.817 -0.552 . . . . 0.0 110.82 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.509 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.728 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 45.8 t -120.2 117.55 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.169 . . . . 0.0 110.224 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.572 ' CE1' HG12 ' A' ' 128' ' ' ILE . 76.7 m-85 -88.15 125.4 34.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.407 HG22 ' CE1' ' A' ' 119' ' ' HIS . 25.1 m -105.48 113.73 27.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 110.388 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.572 ' CE1' HG11 ' A' ' 133' ' ' VAL . 60.3 m-85 -117.26 125.76 51.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.079 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 116' ' ' SER . 20.9 pt-20 -133.74 154.89 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 110.302 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t -127.47 164.68 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.119 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -142.6 116.48 9.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.9 p90 -148.29 -170.12 3.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.308 -0.87 . . . . 0.0 110.204 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 10.4 p -141.15 174.84 10.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.393 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.418 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 1.4 t -154.65 157.31 37.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -87.8 -14.48 39.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 110.118 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.533 ' CD1' ' HB2' ' A' ' 152' ' ' LYS . 2.3 mp -81.42 149.95 66.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.525 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 39.9 Cg_endo -66.36 145.75 78.45 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.003 1.528 . . . . 0.0 110.438 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.642 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 Cg_endo -72.23 -31.68 11.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.91 1.479 . . . . 0.0 113.054 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.9 Cg_endo -69.74 -21.14 33.99 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 110.108 -0.766 . . . . 0.0 110.108 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.529 ' CD ' ' HB2' ' A' ' 159' ' ' ASN . 7.1 mmp_? -85.68 -43.35 13.49 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.516 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.3 tt -72.2 -29.92 64.43 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.602 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 73.8 t80 -67.21 -56.98 7.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.565 -0.709 . . . . 0.0 109.58 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 66.0 mttt -54.84 -34.12 62.49 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.293 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.621 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -74.42 -55.8 5.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.519 -0.738 . . . . 0.0 110.918 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.639 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -58.61 -46.14 87.65 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.559 -0.713 . . . . 0.0 111.494 -178.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.589 ' CG1' ' CD1' ' A' ' 74' ' ' ILE . 18.2 t -98.17 -65.39 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.075 -1.015 . . . . 0.0 111.897 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 4.1 mm? -65.41 -4.64 5.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 111.548 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.541 ' OD2' ' CD1' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -148.19 36.64 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.942 -1.099 . . . . 0.0 110.427 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -73.97 -36.51 64.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 68.5 m-20 -62.86 -13.58 35.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.128 -0.982 . . . . 0.0 110.355 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 78.2 m-20 -127.53 7.19 6.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.928 . . . . 0.0 110.2 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.532 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -95.38 -52.18 4.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.903 179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.5 t -71.35 -41.47 10.29 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.574 -0.704 . . . . 0.0 110.871 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.4 Cg_endo -77.88 9.69 2.9 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.484 1.255 . . . . 0.0 110.964 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 29.3 mttm -129.83 -33.39 1.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.056 -1.027 . . . . 0.0 109.753 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.576 HG12 ' CD1' ' A' ' 150' ' ' TYR . 50.1 mt -80.18 -41.46 20.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.495 -0.753 . . . . 0.0 109.464 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.28 99.42 3.91 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.515 -0.741 . . . . 0.0 110.034 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.35 -1.31 9.48 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.089 1.573 . . . . 0.0 110.659 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -84.82 -11.45 55.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.113 -0.992 . . . . 0.0 109.669 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.41 -57.64 2.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.396 -0.815 . . . . 0.0 110.177 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.571 ' CG1' ' CG2' ' A' ' 56' ' ' ILE . 2.1 mp -121.74 107.36 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.402 -0.811 . . . . 0.0 110.176 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -59.82 -25.28 64.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.601 ' CG ' ' N ' ' A' ' 41' ' ' SER . 0.2 OUTLIER -173.44 176.77 2.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.601 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 70.5 m -150.86 151.16 31.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 109.905 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.412 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 82.3 tt0 -157.52 105.81 2.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.256 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 34.5 mt -51.71 132.97 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.449 ' HB3' ' O ' ' A' ' 53' ' ' ILE . 33.5 tp -93.85 -47.36 6.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.9 . . . . 0.0 110.326 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' O ' ' CG2' ' A' ' 52' ' ' THR . 5.1 mm-40 -132.09 134.59 45.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.62 -164.46 37.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -129.68 11.17 5.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.104 . . . . 0.0 110.162 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.04 -9.18 7.97 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -75.91 -168.76 26.27 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.6 Cg_endo -70.58 133.41 24.02 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.169 1.615 . . . . 0.0 110.526 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.38 -4.53 73.64 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.516 HG21 ' N ' ' A' ' 53' ' ' ILE . 16.9 m -80.14 147.63 31.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -1.149 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.516 ' N ' HG21 ' A' ' 52' ' ' THR . 25.8 mm -116.33 108.42 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.092 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 69' ' ' HIS . 90.1 mttt -91.83 134.97 34.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 0.0 110.319 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -106.24 94.05 4.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 110.052 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.571 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 86.8 mt -80.53 144.07 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.191 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.477 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 1.1 p -112.33 156.74 21.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 110.246 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.563 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 23.1 m-85 -114.04 162.99 15.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.871 . . . . 0.0 110.326 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.47 89.43 1.01 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' CD ' ' O ' ' A' ' 63' ' ' GLN . 46.9 tt0 -131.47 137.83 48.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 110.153 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 62' ' ' SER . . . -92.58 -48.29 3.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 61' ' ' GLY . 70.7 m -43.89 -52.75 6.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -1.149 . . . . 0.0 110.292 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' O ' ' CD ' ' A' ' 60' ' ' GLU . 50.1 tt0 -153.29 157.33 39.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.167 -0.958 . . . . 0.0 110.236 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.638 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 7.8 t80 -55.25 142.36 31.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.336 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -134.93 134.48 7.36 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.638 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 15.1 p90 -177.71 168.63 2.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -1.203 . . . . 0.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.563 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 5.2 m -142.19 173.5 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.35 -0.844 . . . . 0.0 110.422 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.492 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . 91.7 mttt -119.75 131.38 55.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.481 -0.762 . . . . 0.0 109.709 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.65 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 14.2 m170 -113.51 132.37 55.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.93 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HA ' HD12 ' A' ' 53' ' ' ILE . 76.2 tttt -111.33 107.53 16.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.837 . . . . 0.0 109.253 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.8 mm -48.57 135.47 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.983 . . . . 0.0 110.412 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 73' ' ' SER . 15.8 m-20 -105.26 -45.36 4.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 109.398 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 29.0 p 177.4 156.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.641 -0.662 . . . . 0.0 110.13 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.589 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 3.8 tt -147.55 165.31 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.035 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-20 -134.84 80.1 1.83 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.328 -0.857 . . . . 0.0 110.041 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.602 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 24.0 mttt -56.13 -15.11 3.23 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.179 -0.95 . . . . 0.0 110.607 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -93.37 -30.81 14.91 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.294 -0.879 . . . . 0.0 109.557 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.4 m-80 -106.87 -1.34 22.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.552 -0.718 . . . . 0.0 109.424 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 68.7 m-85 63.66 52.85 2.14 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.369 0.604 . . . . 0.0 110.82 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.531 ' HB3' ' CG ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -126.88 151.11 48.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.634 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.596 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 77.3 t80 -145.57 163.64 34.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.189 -0.944 . . . . 0.0 110.14 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 73' ' ' SER . 84.8 p -168.51 146.21 4.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.015 -1.053 . . . . 0.0 110.799 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 2.6 p90 -148.23 -179.12 6.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.328 -0.857 . . . . 0.0 110.401 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.466 ' OG1' ' OD1' ' A' ' 72' ' ' ASP . 24.7 m -136.41 128.19 29.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.438 -0.789 . . . . 0.0 109.992 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.65 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 7.0 tp -80.39 121.97 26.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.275 -0.89 . . . . 0.0 110.073 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.492 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 27.5 pt -101.77 -11.56 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.89 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 66.7 tt0 -154.17 151.85 29.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.178 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.475 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 168.36 157.18 10.97 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' ALA . 65.8 t0 -72.2 -54.14 10.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -1.141 . . . . 0.0 110.366 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' ASP . . . -42.4 -31.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.525 HD22 ' CD2' ' A' ' 95' ' ' LEU . 21.2 mt -52.42 -53.17 48.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 110.128 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.76 -171.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -72.49 -2.08 18.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.126 . . . . 0.0 110.189 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 122' ' ' THR . 34.9 p -89.64 -60.46 1.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 110.37 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.537 ' CD1' ' CD1' ' A' ' 98' ' ' ILE . 0.3 OUTLIER -105.06 163.07 12.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.317 -0.865 . . . . 0.0 109.258 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' O ' HD12 ' A' ' 91' ' ' LEU . 76.4 mm-40 -142.64 -81.12 0.21 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 110.324 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 71.2 mttt -80.25 153.64 28.39 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.545 -0.722 . . . . 0.0 110.621 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.613 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 35.1 mm -140.66 159.95 24.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.727 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -135.35 126.41 27.88 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.366 -0.834 . . . . 0.0 108.903 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.613 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 22.4 m-85 -123.77 135.68 53.96 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.189 -0.944 . . . . 0.0 110.497 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 71.7 tt0 -139.18 124.95 19.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 0.0 110.238 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 89.0 m -118.63 145.42 45.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.088 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.531 ' CG ' ' HB3' ' A' ' 80' ' ' SER . 7.5 mttt -136.72 132.89 35.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.317 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 79' ' ' TYR . 4.4 mt -106.74 153.51 22.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.086 -1.009 . . . . 0.0 110.07 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 1.9 t -150.96 -168.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.173 -0.954 . . . . 0.0 109.964 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.462 ' O ' ' CD1' ' A' ' 113' ' ' ILE . . . -119.46 158.61 25.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.225 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 25.8 p -119.67 165.35 17.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 110.216 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.6 Cg_endo -72.5 -1.48 10.33 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.089 1.573 . . . . 0.0 110.506 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.4 m -104.94 -5.9 20.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.149 -0.97 . . . . 0.0 110.227 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.33 -32.52 6.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.83 -171.76 2.88 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.478 ' OG ' ' HD3' ' A' ' 15' ' ' PRO . 5.9 m -129.85 132.72 46.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -1.14 . . . . 0.0 110.257 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 105' ' ' VAL . 11.4 mt -82.84 152.58 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.61 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 5.9 mt -133.55 114.31 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 110.184 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -103.31 108.81 20.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.2 m -99.42 157.33 16.5 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.266 -0.896 . . . . 0.0 110.29 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.467 HG23 ' NE2' ' A' ' 119' ' ' HIS . 71.6 m -156.5 131.46 9.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.848 . . . . 0.0 109.916 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 5' ' ' TYR . 89.3 p -134.31 148.9 50.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.029 . . . . 0.0 110.696 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 39.7 m-70 -131.56 138.92 49.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.775 . . . . 0.0 110.015 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.488 ' CE2' ' CE2' ' A' ' 5' ' ' TYR . 12.1 m-30 -100.13 150.98 21.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 110.691 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 98.5 m-70 -128.08 90.7 3.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 0.0 109.488 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.508 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 2.8 p -79.52 161.3 26.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 110.539 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -120.34 115.53 23.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 110.061 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.16 -141.54 15.37 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.405 ' C ' HG12 ' A' ' 126' ' ' VAL . 53.1 t30 -113.23 96.22 5.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 110.223 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 21.8 m -151.45 168.62 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.297 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -138.9 160.19 40.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.572 HG12 ' CE1' ' A' ' 3' ' ' PHE . 35.5 mm -74.9 173.36 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 130' ' ' GLU . 40.6 mttt -110.9 133.75 53.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 0.0 110.228 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 129' ' ' LYS . 1.1 mt-10 -43.5 -49.21 7.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.148 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -58.53 -36.06 73.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 110.108 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -68.88 -44.2 73.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.195 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.572 HG11 ' CE1' ' A' ' 5' ' ' TYR . 60.6 t -61.64 -38.05 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.983 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -77.82 -42.49 33.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.57 -37.61 87.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.098 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.27 -29.97 74.93 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 84.9 mttt -79.26 -31.26 43.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -1.114 . . . . 0.0 110.111 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -78.03 -32.93 51.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.852 . . . . 0.0 110.092 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -73.81 -28.18 61.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.412 -0.805 . . . . 0.0 110.015 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -80.05 -36.72 35.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.925 . . . . 0.0 110.051 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.0 p -71.29 -46.76 60.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.409 -0.807 . . . . 0.0 110.025 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.422 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 98.4 m-20 -55.47 -49.3 72.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 110.01 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 147' ' ' ILE . 69.8 mt -57.48 -41.98 81.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.915 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 6.3 m-85 -59.74 -40.92 89.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.485 -0.76 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.425 ' HB3' ' HE3' ' A' ' 145' ' ' LYS . 18.3 mtpp -80.0 -16.79 54.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.115 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.471 ' HB3' HG23 ' A' ' 33' ' ' ILE . 27.9 mt -84.26 -36.37 22.72 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.151 -0.968 . . . . 0.0 108.833 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.639 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 97.3 mt -72.58 -45.16 59.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.463 ' O ' HD12 ' A' ' 13' ' ' ILE . 69.1 mt-10 -57.09 -40.58 77.23 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.3 m -68.53 -35.61 77.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.94 . . . . 0.0 109.459 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.588 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 86.5 t80 -54.27 -46.46 72.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.518 -0.739 . . . . 0.0 109.908 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.648 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 94.7 mt -79.87 -31.07 40.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.533 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 73.3 tttt -71.11 -25.51 62.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.573 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.33 -34.21 3.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.538 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.9 m-70 -106.91 92.67 7.84 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.259 -1.142 . . . . 0.0 110.179 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.514 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.5 Cg_endo -74.26 6.44 3.06 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.097 1.578 . . . . 0.0 111.072 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -107.43 -2.6 20.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.916 -1.115 . . . . 0.0 109.775 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.575 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . . . -78.67 104.35 9.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.501 -0.749 . . . . 0.0 110.123 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.648 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.66 33.19 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.348 0.594 . . . . 0.0 110.357 -179.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.529 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.862 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 68.5 t -132.1 118.28 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 110.207 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CE1' HG12 ' A' ' 128' ' ' ILE . 64.8 m-85 -93.47 125.92 38.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.34 -0.85 . . . . 0.0 110.06 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.41 HG22 ' CE1' ' A' ' 119' ' ' HIS . 28.9 m -107.88 111.04 22.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.853 . . . . 0.0 110.304 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 60.0 m-85 -116.65 138.17 51.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.836 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 116' ' ' SER . 18.8 pt-20 -141.21 167.37 22.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.149 -0.97 . . . . 0.0 110.654 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.1 t -143.63 157.75 44.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.43 -0.794 . . . . 0.0 109.806 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -141.93 117.51 10.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.008 . . . . 0.0 110.628 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 p90 -138.5 -175.09 4.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.84 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 23.2 p -136.57 178.92 6.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.524 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.516 ' CB ' ' OE2' ' A' ' 148' ' ' GLU . 59.1 p -160.04 163.73 33.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.464 -0.773 . . . . 0.0 110.458 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -89.21 -10.2 47.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.906 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 3.4 mp -92.32 149.87 39.17 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.828 . . . . 0.0 110.058 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.6 Cg_endo -66.02 145.31 79.09 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.997 1.525 . . . . 0.0 110.367 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.638 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.7 Cg_endo -71.11 -32.25 13.47 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.888 1.468 . . . . 0.0 112.796 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -68.38 -20.91 41.65 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.525 ' CZ ' ' CB ' ' A' ' 159' ' ' ASN . 53.4 mmm-85 -84.29 -46.3 11.95 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.513 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -71.99 -24.95 61.66 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.617 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 89.1 t80 -68.61 -59.82 2.86 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.519 0.676 . . . . 0.0 109.346 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 77.5 mttt -52.04 -38.15 55.99 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.237 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.67 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -70.06 -55.44 9.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 110.711 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.604 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.6 OUTLIER -57.12 -49.7 75.09 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 111.235 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.596 HG12 ' CD1' ' A' ' 81' ' ' TYR . 10.3 t -95.28 -65.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.971 -1.08 . . . . 0.0 111.722 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 8.3 mp -64.83 -4.37 4.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.177 -0.952 . . . . 0.0 111.805 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.526 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -148.28 33.19 0.81 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.715 -1.24 . . . . 0.0 110.548 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -71.99 -34.03 68.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 0.0 110.241 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 41' ' ' SER . 12.8 t70 -64.97 -13.85 58.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.91 . . . . 0.0 110.287 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.469 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 80.9 m-20 -126.78 3.34 6.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.112 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.516 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -90.15 -54.78 3.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 110.234 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.585 ' CG1' ' CD1' ' A' ' 38' ' ' ILE . 92.6 t -65.81 -41.26 45.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 111.109 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.4 Cg_endo -76.73 4.98 5.16 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.369 1.194 . . . . 0.0 110.608 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 47.1 mttm -125.87 -31.69 2.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.58 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.576 HG12 ' CD1' ' A' ' 150' ' ' TYR . 23.5 mt -80.06 -39.22 19.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.523 -0.735 . . . . 0.0 109.859 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -163.17 97.74 1.05 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 110.19 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.83 5.23 4.53 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.009 1.531 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -87.1 -15.75 37.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 110.025 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.44 -35.38 10.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.207 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.585 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 0.9 OUTLIER -129.98 145.56 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 109.906 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -83.86 -35.18 24.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 110.48 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 178.8 157.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 110.249 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 58.5 m -118.19 126.95 53.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.066 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 58.2 tt0 -134.66 105.95 6.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 19.0 mt -59.63 134.0 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.5 tp -95.03 -44.31 7.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.334 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 52' ' ' THR . 11.5 mt-10 -127.18 159.32 34.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 61.8 -161.16 28.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -134.43 10.67 3.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -1.152 . . . . 0.0 110.181 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.08 -6.69 6.82 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 71' ' ' ILE . . . -86.68 -163.19 38.25 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -70.72 131.83 20.64 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.013 1.533 . . . . 0.0 110.601 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.01 -6.54 69.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 20.4 m -79.98 135.68 36.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -1.164 . . . . 0.0 110.144 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 25.9 mm -105.22 113.79 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.208 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 95.1 mttt -99.15 138.78 35.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.376 -0.828 . . . . 0.0 110.298 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -110.97 92.76 4.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.164 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.517 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.8 mt -79.99 143.83 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 109.881 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.495 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 6.8 p -116.87 160.16 21.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.688 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.424 ' O ' ' C ' ' A' ' 59' ' ' GLY . 28.4 m-85 -120.08 163.14 18.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.534 -0.729 . . . . 0.0 110.059 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.69 144.35 1.73 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 63' ' ' GLN . 22.8 pt-20 -57.26 -39.19 75.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -1.194 . . . . 0.0 110.213 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 60' ' ' GLU . . . 43.52 -150.84 0.52 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.2 p -68.23 -34.43 76.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -1.162 . . . . 0.0 110.119 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 60' ' ' GLU . 72.2 mt-30 -136.58 161.03 37.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 110.117 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.648 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 t80 -60.71 136.63 58.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.264 -0.897 . . . . 0.0 110.159 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -129.18 137.21 9.44 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.648 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 13.4 p90 -178.26 169.43 1.85 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -1.135 . . . . 0.0 110.081 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.528 HG13 ' CA ' ' A' ' 88' ' ' GLY . 5.5 m -142.42 172.21 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.895 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.442 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 43.7 mtpt -122.95 121.2 35.55 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.582 ' CD2' ' HG ' ' A' ' 85' ' ' LEU . 21.7 m170 -116.39 135.28 54.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.023 . . . . 0.0 111.31 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 82.9 tttt -111.15 121.74 46.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.415 -0.803 . . . . 0.0 109.12 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.542 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.1 mm -60.58 134.89 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 110.436 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 82' ' ' SER . 19.2 t0 -105.73 -47.92 3.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.482 -0.761 . . . . 0.0 109.864 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 1.9 m -179.99 159.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.543 -0.723 . . . . 0.0 110.205 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.539 ' CD1' HG12 ' A' ' 23' ' ' VAL . 3.4 tt -149.13 164.55 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.992 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -127.13 78.9 1.85 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.877 . . . . 0.0 110.042 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.617 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 63.4 mttp -54.34 -15.81 1.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.42 -0.8 . . . . 0.0 110.819 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -92.07 -30.47 16.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.93 . . . . 0.0 109.861 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -110.59 -1.37 16.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.537 -0.727 . . . . 0.0 109.691 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 75' ' ' ASP . 9.1 m-85 66.01 48.48 1.76 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.688 -0.632 . . . . 0.0 110.518 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -118.56 151.77 37.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.345 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.654 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 84.4 t80 -148.11 143.79 27.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.047 -1.033 . . . . 0.0 110.285 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.468 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 66.5 m -149.61 134.0 17.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.393 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.654 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 4.0 p90 -137.54 179.29 6.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 110.048 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 90.2 m -125.08 128.97 49.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.913 . . . . 0.0 110.17 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.582 ' HG ' ' CD2' ' A' ' 69' ' ' HIS . 1.5 tt -91.75 140.99 29.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.137 -0.977 . . . . 0.0 110.121 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.409 HG23 HD11 ' A' ' 86' ' ' ILE . 21.1 pt -127.64 -24.62 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.033 -1.042 . . . . 0.0 110.487 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.442 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 72.6 tt0 -138.12 115.69 11.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.102 -0.999 . . . . 0.0 110.613 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.528 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . -165.03 132.79 2.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 88' ' ' GLY . 60.2 t0 -42.85 -36.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -1.194 . . . . 0.0 110.402 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.76 -25.3 68.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.146 -0.971 . . . . 0.0 110.354 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.452 HD23 HG12 ' A' ' 98' ' ' ILE . 96.8 mt -68.04 -28.18 67.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.288 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.34 -168.54 0.31 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -90.04 12.72 16.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -1.158 . . . . 0.0 110.183 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 122' ' ' THR . 25.2 p -105.54 -52.11 2.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.145 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.526 HD22 ' CD1' ' A' ' 128' ' ' ILE . 48.7 mt -79.95 151.01 30.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.069 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.429 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 68.3 mt-10 -127.4 -80.91 0.6 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.34 -0.85 . . . . 0.0 110.269 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 85.5 mttt -80.26 147.15 31.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.593 -0.692 . . . . 0.0 110.292 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.659 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 10.5 mm -135.46 145.91 30.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.94 -1.1 . . . . 0.0 110.043 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -122.66 124.79 44.24 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.465 -0.772 . . . . 0.0 108.92 178.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.659 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 14.7 m-85 -121.62 132.64 54.78 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.384 -0.823 . . . . 0.0 110.359 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.468 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 26.6 tt0 -132.8 146.91 52.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -0.859 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 81' ' ' TYR . 57.2 m -145.68 135.99 23.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 110.066 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 115' ' ' LYS . 4.1 tttt -129.07 148.63 51.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.185 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.498 ' C ' ' CG2' ' A' ' 105' ' ' VAL . 10.5 mt -122.64 148.06 45.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 110.458 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.498 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.09 -168.34 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.355 -0.84 . . . . 0.0 109.616 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -130.69 137.64 49.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.505 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.649 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 5.4 p -80.04 -161.09 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.367 -0.833 . . . . 0.0 109.211 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.649 ' CD ' ' CB ' ' A' ' 107' ' ' SER . 43.9 Cg_endo -83.46 70.72 6.32 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.348 1.183 . . . . 0.0 109.499 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 2.3 m 58.23 30.16 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.528 -0.733 . . . . 0.0 109.594 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.42 34.21 3.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 11' ' ' SER . . . 107.75 -147.84 16.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 57.5 p -138.05 139.34 39.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.129 -1.218 . . . . 0.0 110.079 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 33.3 mt -88.79 147.49 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 110.243 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.619 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 6.0 mt -127.63 108.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 110.069 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 103' ' ' LYS . 34.8 mtpt -90.22 145.95 24.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 110.291 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.2 t -140.95 155.7 46.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.12 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 24.2 m -159.99 153.31 22.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.342 -0.849 . . . . 0.0 110.137 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 99' ' ' SER . 94.4 p -153.26 154.7 35.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.173 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 51.9 m-70 -136.92 136.56 38.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.233 -0.917 . . . . 0.0 110.072 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 7.1 m-30 -99.01 151.06 21.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.245 -0.909 . . . . 0.0 110.719 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 96.9 m-70 -130.14 78.13 1.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.523 HG22 ' CG2' ' A' ' 126' ' ' VAL . 0.2 OUTLIER -73.5 157.44 36.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.359 -0.838 . . . . 0.0 110.686 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.429 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 86.2 tttt -105.43 120.41 41.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 110.237 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.28 -161.77 21.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.503 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 58.0 t30 -102.31 111.13 23.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -1.167 . . . . 0.0 110.245 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' A' ' 122' ' ' THR . 24.5 m -156.47 170.86 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.254 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -128.66 136.17 50.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.573 HG12 ' CE1' ' A' ' 3' ' ' PHE . 48.6 mm -57.91 173.4 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 0.0 110.035 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.411 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 39.9 mtpt -102.82 130.4 49.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.938 . . . . 0.0 110.255 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -45.72 -51.06 13.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 110.157 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 35.9 tt0 -58.77 -34.86 71.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 110.074 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -67.52 -41.48 84.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 0.0 110.074 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.635 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 85.7 t -65.94 -45.83 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.434 -0.791 . . . . 0.0 110.059 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -74.87 -39.28 61.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.049 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -62.67 -39.63 94.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 110.015 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.58 -29.67 75.7 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -76.5 -31.38 57.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -1.127 . . . . 0.0 110.075 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -78.8 -32.41 46.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.63 -41.12 69.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.0 109.938 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.574 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.27 -33.46 63.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.8 m -68.4 -48.47 64.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.82 . . . . 0.0 109.936 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -55.91 -44.25 78.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.853 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.9 mt -62.29 -35.7 79.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.89 . . . . 0.0 109.945 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 8.3 m-85 -64.12 -36.1 82.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.085 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -78.87 -13.95 59.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 0.0 110.169 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.502 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 17.3 mt -85.19 -36.82 20.76 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 108.969 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.604 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 11.6 mt -69.74 -44.31 79.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.516 ' OE2' ' CB ' ' A' ' 11' ' ' SER . 12.3 mm-40 -59.31 -44.95 92.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 66.0 m -60.78 -35.98 77.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.977 . . . . 0.0 109.392 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.576 ' CD1' HG12 ' A' ' 33' ' ' ILE . 71.8 t80 -54.24 -55.63 26.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.525 -0.734 . . . . 0.0 109.693 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.588 HD22 ' CE1' ' A' ' 158' ' ' TYR . 26.7 mt -71.69 -29.46 64.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.403 -0.811 . . . . 0.0 110.25 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HB2' HD12 ' A' ' 13' ' ' ILE . 74.5 tttt -61.15 -18.35 57.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.108 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -122.53 -16.26 3.84 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 14.5 m-70 -107.01 90.1 5.07 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.191 -1.182 . . . . 0.0 110.219 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.9 Cg_endo -73.15 2.21 5.8 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.072 1.564 . . . . 0.0 110.859 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -122.6 -2.03 8.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.109 -0.994 . . . . 0.0 109.933 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -49.45 110.02 0.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.421 -0.799 . . . . 0.0 110.398 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.67 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.46 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.584 -0.698 . . . . 0.0 110.618 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.525 ' CB ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.744 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.458 ' O ' ' OG1' ' A' ' 122' ' ' THR . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.404 HG23 ' ND1' ' A' ' 121' ' ' HIS . 26.4 t -129.09 134.94 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -1.15 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.638 ' CG ' ' CD1' ' A' ' 128' ' ' ILE . 25.4 m-85 -100.6 158.09 16.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.317 -0.865 . . . . 0.0 109.809 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.0 m -131.72 113.56 13.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -0.996 . . . . 0.0 110.504 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.574 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 85.7 m-85 -118.12 125.41 50.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 110.02 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.57 ' CG ' ' CG2' ' A' ' 117' ' ' THR . 7.3 mt-10 -137.12 151.59 49.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 110.128 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -133.97 153.76 51.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.283 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.432 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 94.6 mt-10 -133.88 116.68 15.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 110.142 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -146.57 -176.17 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 110.055 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -136.15 176.89 8.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.9 p -154.13 150.0 27.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.796 . . . . 0.0 110.186 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -73.45 -6.16 44.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.533 ' CD1' ' HB2' ' A' ' 152' ' ' LYS . 3.2 mp -94.06 149.59 37.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.034 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 40.4 Cg_endo -66.92 147.08 79.83 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.095 1.576 . . . . 0.0 110.246 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.634 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 Cg_endo -72.01 -32.09 11.5 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.836 1.44 . . . . 0.0 112.957 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.4 Cg_endo -71.31 -21.12 27.03 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 N-CA-C 110.058 -0.786 . . . . 0.0 110.058 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.542 ' CD ' ' HB2' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -83.28 -46.29 12.81 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.515 HD13 ' CD2' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -70.8 -30.57 67.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.599 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 53.6 t80 -64.99 -56.72 11.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.355 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 55.0 mttt -50.92 -40.33 56.8 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.027 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.596 ' HB1' ' CE1' ' A' ' 158' ' ' TYR . . . -68.71 -60.47 2.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.551 -0.718 . . . . 0.0 110.813 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.576 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.4 OUTLIER -50.16 -57.02 8.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.653 -0.654 . . . . 0.0 112.046 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.584 HG12 ' CD1' ' A' ' 81' ' ' TYR . 6.6 t -94.7 -59.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.951 -1.093 . . . . 0.0 112.287 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.2 mp -68.92 -0.74 5.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.055 -1.028 . . . . 0.0 111.712 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.569 ' OD2' ' CD2' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -152.64 30.03 0.53 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.84 -1.162 . . . . 0.0 110.635 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -67.03 -41.79 86.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 110.093 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 16.4 m-20 -58.14 -15.54 10.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.159 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.452 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 67.2 m-80 -127.16 10.13 6.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.255 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.507 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -96.85 -50.57 4.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.308 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.667 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 6.9 p -73.83 -27.22 0.78 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 112.128 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.667 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 52.1 Cg_endo -82.71 11.13 3.33 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.636 0.808 . . . . 0.0 110.588 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -136.83 -28.11 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.13 -0.981 . . . . 0.0 110.793 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.569 HG12 ' CD1' ' A' ' 150' ' ' TYR . 29.4 mt -76.27 -42.01 36.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.167 -0.958 . . . . 0.0 109.857 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.84 101.38 1.3 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.37 -0.831 . . . . 0.0 110.406 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.3 -0.45 9.21 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.086 1.571 . . . . 0.0 110.44 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -89.1 -17.9 28.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 110.015 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.21 -39.64 9.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 110.083 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.537 ' CD1' ' CG2' ' A' ' 30' ' ' VAL . 1.1 mp -133.69 142.28 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 109.911 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 35.3 ttmt -76.66 -42.52 41.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.871 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.538 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.44 158.68 0.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.9 . . . . 0.0 110.176 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.4 m -115.27 126.39 54.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.224 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -133.8 103.45 5.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.239 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.485 HG22 HD11 ' A' ' 43' ' ' ILE . 23.8 mt -52.58 130.45 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.53 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 44.8 mt -89.7 -46.85 8.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.516 ' O ' ' CG2' ' A' ' 52' ' ' THR . 9.4 mm-40 -132.52 151.83 51.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.411 -0.806 . . . . 0.0 110.192 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.54 -158.29 48.7 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -143.53 14.21 1.78 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -1.172 . . . . 0.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.27 -2.03 11.47 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -90.94 -168.07 41.77 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HA ' HG23 ' A' ' 71' ' ' ILE . 42.3 Cg_endo -69.82 130.95 20.15 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.146 1.603 . . . . 0.0 110.549 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.71 -2.76 70.35 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 42.5 m -79.96 145.43 32.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -1.182 . . . . 0.0 109.966 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.519 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 33.6 mm -111.14 114.88 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 110.44 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 99.5 mttt -100.74 139.79 35.93 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.415 -0.803 . . . . 0.0 110.033 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 85.6 tttt -116.09 95.47 5.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.096 -1.002 . . . . 0.0 110.438 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.521 ' CG2' HG12 ' A' ' 38' ' ' ILE . 78.3 mt -85.71 144.71 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 39' ' ' LYS . 5.5 p -114.57 158.16 22.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 110.842 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 28.3 m-85 -116.03 140.59 49.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.51 -0.744 . . . . 0.0 110.244 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.14 29.41 10.7 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -117.83 128.66 55.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -1.104 . . . . 0.0 110.271 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.6 142.21 12.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.6 t -60.41 -48.64 80.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.19 . . . . 0.0 110.229 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -57.97 156.9 8.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.877 . . . . 0.0 110.116 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.594 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 10.3 t80 -68.81 135.37 51.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -123.81 137.27 10.75 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.594 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 13.5 p90 -178.74 166.04 1.67 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.253 -1.145 . . . . 0.0 110.03 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.535 ' CG1' ' HA3' ' A' ' 88' ' ' GLY . 5.1 m -141.57 172.68 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 110.779 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.498 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 93.1 mttt -125.95 125.19 42.33 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.584 ' CD2' HD21 ' A' ' 85' ' ' LEU . 11.3 m170 -115.67 118.81 34.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.964 -1.085 . . . . 0.0 111.429 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HG2' ' CD1' ' A' ' 53' ' ' ILE . 35.5 mttt -92.59 104.32 16.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.193 -0.942 . . . . 0.0 108.878 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.544 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 44.2 mm -47.43 135.62 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.407 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.521 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 14.9 m-20 -109.22 -44.18 3.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.457 -0.777 . . . . 0.0 109.697 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER 175.5 160.2 0.25 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.45 -0.781 . . . . 0.0 110.509 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.542 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 4.4 tt -147.4 168.17 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.647 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.5 m-20 -134.97 82.22 1.95 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.106 -0.996 . . . . 0.0 110.263 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.599 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 95.4 mttt -58.43 -14.29 7.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.214 -0.929 . . . . 0.0 110.607 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.419 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 13.5 mm-40 -95.34 -30.54 13.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.217 -0.927 . . . . 0.0 109.591 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.4 m-80 -106.07 -2.84 22.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.712 -0.618 . . . . 0.0 109.428 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 75' ' ' ASP . 96.3 m-85 62.56 54.19 2.48 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.463 0.649 . . . . 0.0 110.651 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -132.2 150.4 52.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.584 ' CD1' HG12 ' A' ' 23' ' ' VAL . 72.0 t80 -143.42 152.46 41.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 109.991 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.454 ' HB3' ' CG ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -158.7 149.95 20.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.022 -1.049 . . . . 0.0 110.697 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 38.1 p90 -158.6 173.3 16.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.411 -0.805 . . . . 0.0 110.367 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 70' ' ' LYS . 88.5 m -113.29 123.66 50.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.376 -0.828 . . . . 0.0 109.871 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.584 HD21 ' CD2' ' A' ' 69' ' ' HIS . 2.5 tm? -95.73 136.49 36.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.51 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 13.3 pt -122.0 -28.33 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 110.548 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.458 ' OE1' ' HD2' ' A' ' 68' ' ' LYS . 2.2 tt0 -116.07 141.08 48.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 110.226 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.535 ' HA3' ' CG1' ' A' ' 67' ' ' VAL . . . 167.08 123.81 0.68 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 67.7 t0 -45.01 -25.08 0.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.418 -1.048 . . . . 0.0 110.139 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.02 -25.86 63.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.913 . . . . 0.0 110.343 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' A' ' 86' ' ' ILE . 89.6 mt -61.44 -33.02 73.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.3 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.71 -167.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -90.54 11.5 21.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -1.16 . . . . 0.0 110.227 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.42 ' O ' HG21 ' A' ' 122' ' ' THR . 36.9 p -102.93 -37.43 7.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.19 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.528 ' CD2' HD13 ' A' ' 128' ' ' ILE . 15.7 mt -110.26 157.17 19.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.042 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -131.33 -78.79 0.52 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.294 -0.879 . . . . 0.0 110.345 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 37.8 mttp -80.18 148.11 31.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 0.0 110.384 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.644 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 6.7 mm -132.44 142.66 42.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.936 -1.103 . . . . 0.0 110.055 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.9 m -116.3 120.44 38.91 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.644 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 11.7 m-85 -115.41 137.66 51.81 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 110.882 -178.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 117' ' ' THR . 4.7 mt-10 -141.21 137.11 32.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.453 -0.779 . . . . 0.0 109.803 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.9 m -131.98 148.01 52.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -136.99 133.83 35.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.077 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.515 ' CD2' HD13 ' A' ' 18' ' ' LEU . 8.0 mt -119.35 145.97 45.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 110.504 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.486 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.0 -169.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.375 -0.828 . . . . 0.0 109.86 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.45 ' O ' HD13 ' A' ' 113' ' ' ILE . . . -120.53 139.94 52.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.257 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.424 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 84.7 p -95.3 162.87 23.22 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 110.219 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.8 Cg_endo -73.43 -1.09 10.16 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.02 1.537 . . . . 0.0 110.549 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.7 p -98.67 -11.04 22.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.58 -29.22 7.36 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.73 -162.55 7.99 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.521 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 11.8 p -132.33 134.57 45.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -1.087 . . . . 0.0 110.285 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 15.7 mt -83.69 142.55 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.887 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.571 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 9.0 mt -129.62 113.0 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.972 . . . . 0.0 110.501 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 87.1 tttt -102.06 111.54 23.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.895 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 9' ' ' PHE . 1.5 m -93.47 160.08 14.96 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.197 -0.939 . . . . 0.0 110.475 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.57 ' CG2' ' CG ' ' A' ' 6' ' ' GLU . 40.5 m -154.7 142.47 19.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.391 -0.818 . . . . 0.0 110.29 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.455 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 4.4 p -155.53 139.21 16.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 29.2 m-70 -130.5 130.62 44.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.215 -0.928 . . . . 0.0 109.802 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 6.1 m-30 -91.54 154.57 19.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.972 . . . . 0.0 110.795 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.5 m-70 -128.08 85.37 2.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.842 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.47 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 1.2 p -63.18 152.45 37.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 110.295 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 123' ' ' LYS . 50.5 tttt -117.96 97.65 5.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.49 -148.27 17.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.515 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 46.6 t30 -97.93 91.75 5.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -1.088 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 125' ' ' ASN . 30.4 m -156.82 159.7 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -145.04 146.06 31.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.181 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.638 ' CD1' ' CG ' ' A' ' 3' ' ' PHE . 2.7 mp -69.75 173.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 110.106 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.443 ' HB3' ' HG2' ' A' ' 131' ' ' GLU . 46.1 mttt -105.91 160.77 15.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.186 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -66.71 -30.4 70.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 110.033 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.443 ' HG2' ' HB3' ' A' ' 129' ' ' LYS . 17.8 pt-20 -70.11 -36.66 75.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.939 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -70.09 -40.87 74.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.998 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.574 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 42.9 t -62.77 -40.2 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 0.0 109.986 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -78.07 -41.86 34.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 110.001 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.98 98.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.942 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.88 -31.9 81.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.418 ' HE3' HG11 ' A' ' 133' ' ' VAL . 89.2 mttt -75.9 -33.24 59.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -1.095 . . . . 0.0 110.048 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -77.91 -33.05 52.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.907 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -72.49 -36.39 68.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 109.943 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.488 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -73.72 -34.77 64.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 109.937 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.0 m -66.4 -51.5 56.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 109.982 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -50.51 -46.59 57.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 0.0 109.957 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.72 -50.0 75.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 19.0 m-85 -54.94 -35.46 64.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.454 -0.779 . . . . 0.0 109.61 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -79.88 -16.81 54.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -0.831 . . . . 0.0 109.909 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 25.9 mt -84.05 -35.59 23.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.216 -0.928 . . . . 0.0 108.931 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.576 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 70.0 mt -70.61 -42.53 77.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.473 ' HB3' HD11 ' A' ' 13' ' ' ILE . 55.8 mt-10 -57.06 -42.04 79.83 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.328 -0.857 . . . . 0.0 109.32 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.5 m -66.29 -34.35 77.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.572 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.569 ' CD1' HG12 ' A' ' 33' ' ' ILE . 76.4 t80 -54.97 -51.9 64.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.881 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.614 ' CD2' ' CE1' ' A' ' 158' ' ' TYR . 76.8 mt -77.37 -33.77 55.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.32 -0.863 . . . . 0.0 110.183 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.533 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 52.3 tptt -64.6 -22.41 66.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.36 -30.56 3.31 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.547 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 8.6 m-70 -106.68 92.31 7.13 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.287 -1.125 . . . . 0.0 110.148 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.1 Cg_endo -73.89 4.12 4.43 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.052 1.553 . . . . 0.0 110.831 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -110.58 -9.07 14.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.073 -1.017 . . . . 0.0 109.961 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.559 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -63.83 104.63 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.854 . . . . 0.0 109.976 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.614 ' CE1' ' CD2' ' A' ' 151' ' ' LEU . 1.0 OUTLIER 34.52 33.41 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.724 -0.61 . . . . 0.0 110.373 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.542 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.793 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.53 HG23 ' CE1' ' A' ' 121' ' ' HIS . 85.0 t -97.44 134.07 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -1.16 . . . . 0.0 110.418 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.578 ' CG ' HD11 ' A' ' 128' ' ' ILE . 10.7 m-85 -93.91 149.55 21.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 110.024 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -127.25 112.01 14.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 110.293 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.638 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 65.0 m-85 -126.31 136.98 53.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.069 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 4.6 pm0 -139.91 162.03 36.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.893 . . . . 0.0 110.298 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -147.74 154.81 41.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.427 -0.795 . . . . 0.0 109.963 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -134.01 118.85 18.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.975 . . . . 0.0 110.473 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.8 p90 -142.4 -172.66 3.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 109.86 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.47 HG23 HG12 ' A' ' 113' ' ' ILE . 9.4 p -143.03 178.72 7.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 110.603 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.432 ' OG ' HD13 ' A' ' 114' ' ' ILE . 23.4 p -151.48 176.54 11.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.786 . . . . 0.0 109.966 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -92.72 -27.11 17.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.918 . . . . 0.0 110.076 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.542 HG12 ' CG ' ' A' ' 152' ' ' LYS . 24.7 mm -84.23 148.03 51.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.932 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.558 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 40.5 Cg_endo -65.32 155.66 67.42 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.98 1.516 . . . . 0.0 111.007 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.632 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.3 Cg_endo -63.73 -37.21 47.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.87 1.458 . . . . 0.0 113.112 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -64.01 -19.68 66.75 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 N-CA-C 109.667 -0.936 . . . . 0.0 109.667 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.52 ' CG ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.91 -43.45 19.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 6.8 mp -75.7 -39.03 58.1 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.0 t80 -59.32 -54.71 43.67 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.455 0.645 . . . . 0.0 109.982 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.8 mttt -60.44 -34.06 73.44 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 109.839 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.597 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . . . -80.0 -59.36 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 0.0 110.923 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.56 ' CE1' HD12 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -54.66 -39.53 68.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.626 -0.671 . . . . 0.0 111.856 -178.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.581 HG12 ' CD1' ' A' ' 81' ' ' TYR . 21.6 t -106.86 -65.3 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.817 -1.177 . . . . 0.0 112.084 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.0 mp -63.62 -4.72 3.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.183 -0.948 . . . . 0.0 112.164 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' OD2' ' CD2' ' A' ' 158' ' ' TYR . 1.1 m-20 -144.82 8.19 1.27 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.638 -1.289 . . . . 0.0 110.939 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -52.05 -26.8 11.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 110.961 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -68.41 -26.38 65.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.937 -1.102 . . . . 0.0 109.592 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 8.9 p30 -125.7 17.22 8.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.604 -0.685 . . . . 0.0 109.473 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.534 HD22 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -94.5 -45.56 7.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.465 -0.772 . . . . 0.0 110.083 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.661 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 4.6 p -79.18 -28.18 0.54 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 112.267 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 51.4 Cg_endo -78.29 4.42 6.27 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 122.69 0.837 . . . . 0.0 110.277 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 28' ' ' ASN . 94.2 mttt -123.41 -28.38 3.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.659 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.59 HG12 ' CD1' ' A' ' 150' ' ' TYR . 25.0 mt -78.48 -31.22 15.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 109.676 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.59 98.24 0.44 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.514 -0.741 . . . . 0.0 110.194 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.58 0.2 8.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.062 1.559 . . . . 0.0 110.543 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -89.96 -18.7 25.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 0.0 110.1 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.54 -49.07 6.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.195 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.536 HG12 ' CG2' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -120.15 137.2 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 109.973 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 9.4 mmtt -75.43 -42.71 52.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 110.017 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.534 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.02 156.54 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.448 -0.783 . . . . 0.0 110.128 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 m -114.88 125.97 54.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -128.02 110.69 12.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.316 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 17.2 mt -60.85 131.08 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 110.125 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.7 mt -93.3 -44.7 8.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.525 ' O ' ' CG2' ' A' ' 52' ' ' THR . 1.7 tt0 -130.61 139.47 50.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.42 -0.8 . . . . 0.0 110.142 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.43 -163.92 46.97 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -130.82 2.7 4.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -1.123 . . . . 0.0 110.266 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.69 -4.61 4.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -85.04 -166.77 42.28 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.462 ' HA ' HG23 ' A' ' 71' ' ' ILE . 42.7 Cg_endo -70.09 131.17 20.23 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.067 1.562 . . . . 0.0 110.475 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.58 -5.6 67.29 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 39.7 m -80.04 140.46 36.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -1.096 . . . . 0.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 26.4 mm -110.18 114.6 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 110.276 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 92.4 mttt -98.0 159.45 14.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.826 . . . . 0.0 110.343 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -133.06 100.55 4.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 110.108 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.544 HG23 ' CE1' ' A' ' 58' ' ' PHE . 88.8 mt -89.11 140.09 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.305 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.2 p -111.06 154.25 24.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 110.849 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 23.6 m-85 -124.4 122.6 38.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.445 -0.784 . . . . 0.0 110.279 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.468 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . 40.6 -162.61 0.01 OUTLIER Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -166.32 139.69 4.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -1.125 . . . . 0.0 110.207 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 62' ' ' SER . . . 174.15 -154.26 18.85 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 61' ' ' GLY . 52.3 m -43.88 -52.16 7.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -1.138 . . . . 0.0 110.157 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -109.45 125.81 52.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.154 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -83.85 134.62 34.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.258 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -113.1 96.84 0.83 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 9.7 p90 -133.41 153.21 51.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -1.173 . . . . 0.0 109.992 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.559 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 5.6 m -125.28 172.5 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.186 -0.946 . . . . 0.0 110.774 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.455 ' HD2' ' OE1' ' A' ' 87' ' ' GLU . 69.6 mttt -124.92 129.19 49.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.708 -0.62 . . . . 0.0 109.371 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.514 ' NE2' HD11 ' A' ' 85' ' ' LEU . 10.1 m170 -117.59 120.31 37.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.161 -0.962 . . . . 0.0 110.993 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 55.3 tttm -96.67 109.85 22.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.821 . . . . 0.0 109.407 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.1 mm -48.55 139.46 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.982 . . . . 0.0 110.175 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.506 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 17.9 t0 -111.65 -40.55 4.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.477 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 0.7 OUTLIER 172.78 160.84 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.581 -0.7 . . . . 0.0 110.339 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.567 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 12.5 tt -149.27 172.24 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.536 -0.728 . . . . 0.0 109.505 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.7 m-20 -139.71 83.56 1.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.104 -0.998 . . . . 0.0 110.412 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.607 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 35.7 mtmm -59.27 -14.05 9.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.897 . . . . 0.0 110.44 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -96.02 -30.12 13.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 109.562 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.3 m-80 -107.68 -0.75 21.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.601 -0.687 . . . . 0.0 109.357 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' A' ' 75' ' ' ASP . 74.3 m-85 60.4 53.72 4.15 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.356 0.598 . . . . 0.0 110.598 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -127.74 156.0 43.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 109.617 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.581 ' CD1' HG12 ' A' ' 23' ' ' VAL . 86.5 t80 -152.99 146.89 25.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.079 -1.013 . . . . 0.0 110.434 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 101' ' ' GLU . 1.8 m -156.34 145.64 20.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.385 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 5.6 p90 -143.86 177.78 8.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.518 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 80.4 m -124.02 124.69 43.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.429 -0.794 . . . . 0.0 109.626 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.528 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 1.7 tp -93.59 137.32 32.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.32 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.3 pt -124.24 -12.2 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 110.257 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.467 ' O ' HD13 ' A' ' 91' ' ' LEU . 4.6 tt0 -129.21 160.45 32.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 110.236 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.528 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 146.55 132.0 2.29 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -64.81 -12.01 43.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -1.097 . . . . 0.0 110.033 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.53 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -81.38 -29.18 34.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.347 -0.846 . . . . 0.0 110.064 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.516 ' CD2' HG13 ' A' ' 98' ' ' ILE . 24.1 mt -66.11 -27.55 68.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 110.122 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.62 -172.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -82.49 6.38 17.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -1.163 . . . . 0.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 122' ' ' THR . 14.0 p -93.24 -30.8 15.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.064 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.539 ' CD2' ' CG1' ' A' ' 128' ' ' ILE . 34.0 mt -113.35 153.02 29.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.344 -0.848 . . . . 0.0 109.947 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 41.1 tt0 -131.45 -79.78 0.52 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.229 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.5 mttt -80.16 133.61 36.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.58 -0.7 . . . . 0.0 110.541 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.587 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 7.1 mm -123.9 143.36 37.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.863 -1.148 . . . . 0.0 109.683 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.76 127.43 50.63 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.203 179.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.587 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 10.2 m-85 -123.51 133.04 54.06 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.4 -0.812 . . . . 0.0 110.425 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 73.7 tt0 -130.3 158.17 40.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 110.118 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' TYR . 66.7 m -155.8 138.77 15.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.954 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 115' ' ' LYS . 3.4 mttt -132.28 136.05 46.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 114' ' ' ILE . 2.9 mt -119.06 149.66 41.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 110.467 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.497 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.54 -169.23 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.409 -0.807 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -123.56 134.11 53.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.453 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 52.4 p -89.03 164.39 31.14 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.9 Cg_endo -73.22 -0.27 8.92 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.045 1.55 . . . . 0.0 110.598 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.1 p -104.38 5.19 34.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 110.247 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.04 -41.28 2.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.66 -172.11 0.55 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.527 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 82.4 p -130.13 138.24 50.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -1.135 . . . . 0.0 110.29 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.47 HG12 HG23 ' A' ' 10' ' ' THR . 14.0 mt -88.05 151.6 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.889 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.575 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 5.5 mt -136.41 110.08 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.339 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 103' ' ' LYS . 78.0 tttt -98.25 119.49 37.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.936 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -112.94 155.34 24.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 110.395 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 98.9 m -158.09 126.04 5.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.87 . . . . 0.0 109.999 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 p -127.87 165.3 20.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 110.366 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.54 ' C ' ' CD1' ' A' ' 120' ' ' TYR . 56.9 m-70 -142.46 168.45 19.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.325 -0.86 . . . . 0.0 110.055 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 9.1 m-85 -130.74 148.72 52.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.377 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.53 ' CE1' HG23 ' A' ' 2' ' ' VAL . 95.0 m-70 -131.67 86.46 2.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.182 -0.949 . . . . 0.0 109.701 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 126' ' ' VAL . 1.1 p -56.54 160.7 3.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 66.0 tttt -119.13 107.61 13.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.238 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.8 -111.6 4.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.514 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 35.2 t30 -134.21 85.85 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -1.129 . . . . 0.0 110.402 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.514 ' CG1' ' O ' ' A' ' 125' ' ' ASN . 16.6 m -157.93 173.09 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 110.1 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.439 ' HA ' HG22 ' A' ' 122' ' ' THR . 84.1 mt-10 -144.84 171.43 14.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.248 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.578 HD11 ' CG ' ' A' ' 3' ' ' PHE . 3.9 mp -91.42 172.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 110.02 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 132' ' ' HIS . 19.7 mttt -114.39 131.26 56.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.89 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.508 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 83.9 mt-10 -43.39 -47.59 6.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 110.107 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 26.4 tt0 -58.3 -27.28 63.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.63 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 12.3 t-160 -83.42 -55.6 4.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.956 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.638 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 8.3 p -65.13 -42.15 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 109.961 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 35.7 ttmt -63.31 -42.94 99.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.814 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -62.71 -32.65 73.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.87 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.5 -35.61 92.0 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 5' ' ' TYR . 69.5 mmtt -64.35 -32.44 74.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -1.114 . . . . 0.0 109.908 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -72.27 -38.55 68.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.442 -0.786 . . . . 0.0 109.937 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -62.81 -46.51 87.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.806 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.47 -40.2 95.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.8 t -72.46 -52.0 17.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.403 -0.81 . . . . 0.0 109.799 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -50.47 -48.76 56.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.593 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.1 mp -54.62 -49.76 69.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -54.18 -41.88 69.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.725 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -66.46 -28.29 68.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 109.872 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.5 mt -80.59 -35.37 34.3 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.56 HD12 ' CE1' ' A' ' 22' ' ' PHE . 96.8 mt -66.79 -41.25 87.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 49.5 mt-10 -54.84 -47.16 74.49 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.403 -0.811 . . . . 0.0 109.18 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.3 m -61.15 -31.53 71.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.445 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.59 ' CD1' HG12 ' A' ' 33' ' ' ILE . 59.7 t80 -64.01 -52.89 57.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.789 . . . . 0.0 109.655 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.574 ' CD2' ' CE1' ' A' ' 158' ' ' TYR . 56.8 mt -80.07 -33.68 38.74 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 110.408 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.542 ' CG ' HG12 ' A' ' 13' ' ' ILE . 49.5 mtpt -65.71 -14.04 60.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 0.0 109.426 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.453 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.77 -30.27 1.4 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.508 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.1 m-70 -106.43 93.49 8.39 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.189 -1.183 . . . . 0.0 110.253 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.512 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.3 Cg_endo -74.26 3.82 4.89 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.101 1.58 . . . . 0.0 110.644 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -106.99 -11.25 15.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.55 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -67.83 100.62 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.757 . . . . 0.0 109.919 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.597 ' CE1' ' CB ' ' A' ' 21' ' ' ALA . 1.1 p90 34.59 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.25 0.548 . . . . 0.0 110.604 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.771 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.488 HG12 ' CE1' ' A' ' 121' ' ' HIS . 78.5 t -110.1 132.86 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -1.191 . . . . 0.0 110.236 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 128' ' ' ILE . 12.3 m-85 -94.3 149.08 21.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.253 -0.904 . . . . 0.0 109.983 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.554 HG21 ' CE1' ' A' ' 119' ' ' HIS . 8.6 m -127.56 114.19 17.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 110.443 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 64.8 m-85 -128.45 139.52 52.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.822 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 13.6 pt-20 -140.17 152.7 46.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 110.735 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 116' ' ' SER . 0.2 OUTLIER -147.22 166.04 28.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.499 -0.75 . . . . 0.0 109.45 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -144.23 145.78 32.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.058 -1.026 . . . . 0.0 110.553 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 6.3 p90 -159.01 -172.45 3.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.715 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 6.4 p -137.33 172.57 12.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.101 -1.0 . . . . 0.0 110.708 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 112' ' ' SER . 92.9 p -151.01 149.1 29.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 0.0 110.503 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.29 -25.97 66.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 0.0 110.184 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.526 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 4.7 mp -84.46 146.05 46.44 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 110.116 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.573 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 43.2 Cg_endo -67.96 154.65 72.25 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.136 1.598 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.642 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.0 Cg_endo -62.73 -37.13 58.53 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.748 1.394 . . . . 0.0 113.106 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 37.9 Cg_endo -63.58 -20.2 68.96 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 N-CA-C 109.823 -0.876 . . . . 0.0 109.823 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.534 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 5.7 mmp_? -80.64 -45.47 17.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.606 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 9.0 mp -75.51 -36.04 60.63 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.802 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.598 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 55.3 t80 -58.29 -58.01 10.38 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.107 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 87.4 mttt -59.86 -35.92 75.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.392 -0.818 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.615 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . . . -79.33 -61.55 1.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.357 -0.84 . . . . 0.0 111.019 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.608 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.9 OUTLIER -53.84 -38.28 64.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.448 -0.783 . . . . 0.0 111.653 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.537 HG12 ' CD1' ' A' ' 81' ' ' TYR . 8.0 t -105.22 -66.29 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.892 -1.13 . . . . 0.0 111.661 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.0 mp -66.74 -4.24 8.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.174 -0.954 . . . . 0.0 111.445 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.511 ' OD2' ' CD2' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -147.96 31.26 0.86 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.807 -1.183 . . . . 0.0 110.544 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.452 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -70.57 -32.67 70.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.98 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.523 ' OD2' ' CG1' ' A' ' 43' ' ' ILE . 94.7 m-20 -65.49 -15.89 63.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.869 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 74.0 m-80 -126.59 10.5 7.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.523 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -96.68 -54.2 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.6 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.0 t -67.38 -42.02 35.85 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 0.0 110.79 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -78.52 8.64 3.54 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.513 1.27 . . . . 0.0 110.693 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 35.1 mttt -126.77 -32.23 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.093 -1.005 . . . . 0.0 109.661 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.588 HG12 ' CD1' ' A' ' 150' ' ' TYR . 45.8 mt -80.0 -34.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.78 99.35 1.5 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.485 -0.759 . . . . 0.0 110.026 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.02 -0.75 8.98 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.092 1.575 . . . . 0.0 110.561 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -86.74 -9.69 55.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.878 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.18 -47.05 4.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.392 -0.817 . . . . 0.0 110.099 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.514 ' CD1' HG13 ' A' ' 30' ' ' VAL . 1.8 mp -124.98 143.02 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.459 -0.776 . . . . 0.0 109.874 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 36.5 ttmt -80.39 -37.92 31.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 110.262 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.525 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 178.8 139.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.248 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.513 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 3.2 m -102.17 128.11 48.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 110.314 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 27.0 tp10 -132.81 115.17 14.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 110.14 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.523 ' CG1' ' OD2' ' A' ' 27' ' ' ASP . 10.7 mt -64.97 133.05 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.363 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.43 HD13 ' HB2' ' A' ' 55' ' ' LYS . 24.3 mt -94.36 -45.74 7.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 110.204 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.526 ' O ' ' CG2' ' A' ' 52' ' ' THR . 6.9 mt-10 -130.51 141.3 50.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 110.116 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.86 -169.87 54.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -130.79 16.35 5.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -1.141 . . . . 0.0 110.304 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.39 -8.41 8.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -82.02 -168.92 42.31 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.462 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.2 Cg_endo -69.82 134.26 27.43 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.166 1.614 . . . . 0.0 110.468 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.21 76.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 37.2 m -79.97 138.75 37.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -1.145 . . . . 0.0 110.069 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.536 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 27.9 mm -109.35 111.66 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 110.288 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 81.6 mttt -97.14 154.72 17.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 110.204 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HB2' HD13 ' A' ' 44' ' ' LEU . 84.1 tttt -127.52 104.55 7.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.422 ' CG2' HG12 ' A' ' 38' ' ' ILE . 85.4 mt -90.82 140.84 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.3 p -113.28 150.97 31.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 110.333 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 23.7 m-85 -116.25 137.35 52.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 110.335 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -104.59 61.09 0.41 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -84.33 -23.7 30.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -1.117 . . . . 0.0 110.32 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.33 -160.7 27.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 t -61.32 -54.99 36.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.205 -1.174 . . . . 0.0 110.242 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -42.97 143.08 0.79 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.193 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.691 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 3.9 t80 -84.32 114.39 21.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.969 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -115.74 97.4 0.79 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.691 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 25.3 p90 -134.6 168.27 19.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.167 -1.196 . . . . 0.0 110.171 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.522 HG13 ' CA ' ' A' ' 88' ' ' GLY . 7.2 m -137.45 171.84 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 110.486 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.477 ' O ' HD11 ' A' ' 85' ' ' LEU . 87.3 mttt -123.03 124.05 42.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.617 -0.677 . . . . 0.0 109.577 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.574 ' CD2' HD12 ' A' ' 85' ' ' LEU . 22.5 m170 -111.62 136.27 51.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -0.988 . . . . 0.0 110.906 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 79.1 tttt -114.83 108.87 17.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.462 -0.774 . . . . 0.0 109.507 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 37.0 mm -44.99 137.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 110.047 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.501 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 25.8 t0 -107.47 -47.63 3.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 9.4 m -171.94 156.88 4.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.578 -0.702 . . . . 0.0 109.688 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.7 mt -136.86 157.31 35.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 110.119 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 4.7 m-20 -135.28 79.26 1.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.344 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.598 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 81.3 mttt -63.77 -11.43 26.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 9.4 mm-40 -98.14 -30.14 12.83 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.739 0.78 . . . . 0.0 109.177 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -105.12 -2.69 23.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.67 -0.644 . . . . 0.0 109.432 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.507 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 76.6 m-85 59.75 55.18 4.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.677 -0.639 . . . . 0.0 110.408 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -130.64 162.17 29.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.8 . . . . 0.0 109.782 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.537 ' CD1' HG12 ' A' ' 23' ' ' VAL . 37.5 t80 -144.56 137.32 26.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 110.096 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 72' ' ' ASP . 35.3 m -139.79 126.9 21.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.98 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 9.2 p90 -141.83 179.4 6.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.751 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.419 HG21 ' N ' ' A' ' 85' ' ' LEU . 91.5 m -135.88 152.17 50.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.494 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.574 HD12 ' CD2' ' A' ' 69' ' ' HIS . 52.3 tp -106.68 125.45 51.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.414 -0.804 . . . . 0.0 109.941 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.7 pt -109.28 -8.81 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.428 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 68' ' ' LYS . 30.1 tt0 -150.48 159.25 44.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.326 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.522 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 160.43 139.95 2.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -71.26 -24.93 62.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -1.115 . . . . 0.0 110.075 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.26 -22.95 61.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 110.146 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 98' ' ' ILE . 74.7 mt -60.81 -22.48 64.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.002 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.31 -179.39 0.01 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -80.14 6.01 12.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -1.139 . . . . 0.0 110.014 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.8 p -98.33 -23.29 15.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.583 ' CD2' ' CG1' ' A' ' 128' ' ' ILE . 42.1 mt -123.68 162.54 22.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 110.271 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -140.94 -81.69 0.24 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.3 -0.875 . . . . 0.0 109.861 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 34.8 mttt -80.41 161.04 25.14 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.709 -0.619 . . . . 0.0 110.103 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.6 HG22 ' CE2' ' A' ' 100' ' ' TYR . 0.1 OUTLIER -156.17 140.13 8.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 178.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 3.7 m -116.63 121.69 42.42 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.6 ' CE2' HG22 ' A' ' 98' ' ' ILE . 11.5 m-85 -112.82 139.78 48.16 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.413 -0.805 . . . . 0.0 110.3 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 80.8 tt0 -135.22 144.24 46.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 109.894 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.0 m -146.77 125.92 12.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.184 -0.948 . . . . 0.0 110.352 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 1.1 ttmt -116.22 146.94 41.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 109.813 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.534 ' CD2' HG12 ' A' ' 114' ' ' ILE . 6.3 mt -120.58 147.7 44.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.998 . . . . 0.0 110.78 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.497 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.89 -168.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.0 109.567 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -129.9 157.29 42.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 110.52 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.531 ' CB ' ' HD2' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -110.44 179.68 0.78 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.795 . . . . 0.0 109.618 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 107' ' ' SER . 40.6 Cg_endo -66.64 73.93 0.41 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.817 1.43 . . . . 0.0 109.577 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 4.0 m 57.35 37.29 27.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.497 -0.752 . . . . 0.0 109.742 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.53 42.72 1.47 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.34 -127.61 8.87 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' SER . 92.2 p -151.62 143.28 23.63 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.341 -1.093 . . . . 0.0 109.616 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 34.4 mt -90.46 150.32 3.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.196 -0.94 . . . . 0.0 110.571 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.632 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 5.8 mt -138.16 108.92 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.198 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -81.67 143.8 31.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 109.931 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -128.01 140.64 51.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 110.5 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 53.4 m -152.3 131.86 13.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.346 -0.846 . . . . 0.0 109.847 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.441 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 52.6 p -137.97 165.09 27.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 110.578 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.554 ' CE1' HG21 ' A' ' 4' ' ' THR . 48.1 m-70 -145.48 161.28 40.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.33 -0.856 . . . . 0.0 110.041 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 10.3 m-85 -121.97 147.54 45.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 110.359 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.534 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 99.6 m-70 -130.94 85.6 2.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.272 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.519 ' OG1' ' CG2' ' A' ' 126' ' ' VAL . 1.4 t -72.89 176.58 5.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.313 -0.867 . . . . 0.0 110.948 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -132.9 131.28 40.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.622 -0.673 . . . . 0.0 110.186 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.06 -111.13 4.18 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.429 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 36.0 t30 -151.41 81.34 1.3 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -1.143 . . . . 0.0 110.136 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.519 ' CG2' ' OG1' ' A' ' 122' ' ' THR . 30.8 m -154.1 160.82 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -126.94 161.26 28.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.638 ' CD1' ' CE1' ' A' ' 3' ' ' PHE . 4.7 mp -79.91 172.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.954 . . . . 0.0 110.351 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 132' ' ' HIS . 47.4 mttt -106.83 128.29 54.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.324 -0.86 . . . . 0.0 109.86 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 92.7 mt-10 -43.62 -46.99 7.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.46 -24.59 63.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 109.88 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 129' ' ' LYS . 12.5 t-160 -84.92 -54.16 4.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -0.805 . . . . 0.0 110.14 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.639 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 9.3 p -66.84 -41.41 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.065 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.402 ' N ' ' CG1' ' A' ' 133' ' ' VAL . 81.5 tttt -64.95 -43.56 92.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.907 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -29.27 69.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.926 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.76 -32.19 73.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -70.1 -36.69 75.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.986 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -68.73 -33.79 74.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 109.778 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -66.99 -37.37 84.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.823 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.16 90.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.296 -0.877 . . . . 0.0 109.791 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.7 m -61.32 -48.46 81.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.371 -0.831 . . . . 0.0 109.742 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 145' ' ' LYS . 98.4 m-20 -51.25 -42.69 61.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 146' ' ' LEU . 25.8 tp -56.32 -54.58 43.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.737 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.56 ' CE1' HG23 ' A' ' 114' ' ' ILE . 17.3 m-85 -48.03 -37.66 15.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.551 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 142' ' ' ASN . 98.9 mttt -68.75 -24.27 64.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.626 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.486 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 30.1 mt -84.51 -34.86 23.24 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.225 -0.922 . . . . 0.0 108.92 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.608 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 52.5 mt -71.88 -33.99 49.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.578 -0.702 . . . . 0.0 109.336 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.525 ' CB ' HD11 ' A' ' 13' ' ' ILE . 78.4 mt-10 -64.37 -38.49 91.23 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.502 -0.749 . . . . 0.0 109.55 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 90.0 m -70.06 -38.02 75.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 109.478 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.588 ' CD1' HG12 ' A' ' 33' ' ' ILE . 68.1 t80 -55.73 -51.52 67.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.416 -0.803 . . . . 0.0 109.774 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.596 ' CD2' ' CE1' ' A' ' 158' ' ' TYR . 77.8 mt -80.03 -41.48 25.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 110.1 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 49.2 tttp -64.06 -19.92 65.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.361 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.71 -34.78 2.75 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 3.8 m-70 -110.6 94.88 20.69 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.324 -1.104 . . . . 0.0 110.101 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -74.14 5.48 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.093 1.575 . . . . 0.0 110.985 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -105.55 -7.92 18.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.994 -1.066 . . . . 0.0 109.865 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.579 ' HB2' ' CE2' ' A' ' 150' ' ' TYR . . . -71.57 102.08 2.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.427 -0.795 . . . . 0.0 110.121 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.615 ' CE1' ' CB ' ' A' ' 21' ' ' ALA . 1.1 p90 34.24 32.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.797 -0.564 . . . . 0.0 110.71 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.527 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.763 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 86.0 t -122.35 118.53 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.133 -1.216 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.556 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 58.5 m-85 -86.31 163.29 17.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.7 m -141.35 92.87 2.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.595 ' CD1' ' CG1' ' A' ' 133' ' ' VAL . 83.5 m-85 -109.01 126.03 52.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.977 . . . . 0.0 109.815 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 16.1 pt-20 -128.79 153.03 47.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 110.445 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.8 m -123.88 141.06 52.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.917 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.423 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 83.0 mt-10 -121.62 124.02 43.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 110.447 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.2 p90 -151.13 -172.86 4.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.938 . . . . 0.0 109.947 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.466 HG21 ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -138.84 -178.21 5.22 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 110.547 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 112' ' ' SER . 98.9 p -157.27 150.05 23.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.432 -0.792 . . . . 0.0 110.349 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -75.51 -8.39 56.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.124 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 9.0 mm -96.79 149.78 36.16 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.414 -0.804 . . . . 0.0 110.084 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.0 Cg_endo -64.96 148.01 89.47 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.975 1.513 . . . . 0.0 110.376 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.643 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -71.14 -32.21 13.45 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.877 1.462 . . . . 0.0 112.899 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.12 -20.62 37.61 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 N-CA-C 109.871 -0.857 . . . . 0.0 109.871 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.522 ' HG2' ' CD1' ' A' ' 151' ' ' LEU . 4.5 ttm180 -83.36 -46.72 12.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.521 HD23 ' CD2' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -72.95 -28.87 62.68 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.086 178.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.593 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 87.0 t80 -65.86 -56.52 11.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.436 -0.79 . . . . 0.0 109.544 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 25' ' ' ASP . 90.8 mttt -54.36 -39.25 66.98 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.279 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.629 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -68.82 -53.28 22.45 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.501 0.667 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' CD1' HD12 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -63.86 -45.47 89.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 111.511 -178.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.445 HG11 ' CE1' ' A' ' 81' ' ' TYR . 5.1 t -99.05 -57.23 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.99 -1.069 . . . . 0.0 111.725 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.495 ' CD1' ' HG2' ' A' ' 20' ' ' LYS . 27.5 mt -76.42 1.72 15.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.136 -0.977 . . . . 0.0 111.678 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.524 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -154.68 38.8 0.43 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.733 -1.229 . . . . 0.0 110.898 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -76.3 -31.29 58.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.082 -1.011 . . . . 0.0 110.228 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 79.8 m-20 -65.41 -13.6 59.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.093 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 66.9 m-20 -128.81 8.23 5.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 110.073 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.55 ' CD1' ' CD1' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -94.93 -51.17 4.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.431 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.657 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 8.2 p -75.37 -27.14 0.67 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.925 . . . . 0.0 112.267 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 53.0 Cg_endo -81.37 8.61 4.29 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 122.743 0.865 . . . . 0.0 110.625 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -137.39 -30.29 0.85 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.056 -1.028 . . . . 0.0 110.609 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.573 HG12 ' CD1' ' A' ' 150' ' ' TYR . 67.2 mt -75.24 -41.29 43.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.274 -0.891 . . . . 0.0 109.692 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.57 90.76 2.84 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.422 -0.798 . . . . 0.0 110.374 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.78 1.68 7.34 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.112 1.585 . . . . 0.0 110.321 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -87.2 -23.2 24.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.161 -0.962 . . . . 0.0 109.892 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.48 -42.59 8.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.575 ' CD1' ' CG2' ' A' ' 30' ' ' VAL . 1.1 mp -121.94 146.97 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.788 . . . . 0.0 109.827 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 17.1 tppt? -86.87 -42.22 13.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.371 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.526 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER 179.08 139.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 110.403 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.2 m -94.25 137.32 33.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 20.7 tt0 -142.03 110.08 5.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 45.5 mt -60.46 132.16 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.143 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.9 tp -95.71 -39.04 10.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.38 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.522 ' O ' ' CG2' ' A' ' 52' ' ' THR . 2.5 mt-10 -136.43 137.63 40.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.133 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.412 ' O ' ' OD1' ' A' ' 47' ' ' ASP . . . 81.08 -162.41 44.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 89.0 m-20 -137.65 20.99 2.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -1.167 . . . . 0.0 110.213 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.88 -12.14 11.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -75.01 -169.93 25.52 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.1 Cg_endo -71.65 132.46 20.38 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.123 1.591 . . . . 0.0 110.382 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.78 67.26 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 32.1 m -79.84 143.19 34.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.186 . . . . 0.0 110.042 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' A' ' 70' ' ' LYS . 27.4 mm -111.49 104.27 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.953 . . . . 0.0 110.328 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 51.9 mtpt -89.5 137.22 32.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.383 -0.823 . . . . 0.0 110.245 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -113.79 103.08 10.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.842 . . . . 0.0 110.356 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.527 ' CG2' HG12 ' A' ' 38' ' ' ILE . 87.3 mt -89.15 140.65 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.177 -0.952 . . . . 0.0 109.976 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 40' ' ' HIS . 1.3 p -112.49 152.94 28.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.52 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.454 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 30.9 m-85 -113.26 160.25 18.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.883 . . . . 0.0 110.145 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.41 170.07 22.45 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 53.71 66.26 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -1.106 . . . . 0.0 110.193 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.24 -135.23 2.0 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.7 p -61.67 178.21 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -1.158 . . . . 0.0 110.087 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -54.2 -48.89 70.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.169 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.679 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 8.3 t80 -135.85 117.0 14.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -113.36 135.03 12.27 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.679 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 11.4 p90 -178.52 160.26 1.23 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 110.112 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.467 HG13 ' HA3' ' A' ' 88' ' ' GLY . 5.8 m -141.36 171.65 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.39 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' O ' HD13 ' A' ' 85' ' ' LEU . 23.8 ttmt -123.09 124.11 42.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.598 -0.689 . . . . 0.0 109.881 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.521 ' NE2' HD11 ' A' ' 85' ' ' LEU . 10.6 m170 -113.56 123.52 50.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 110.751 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.463 ' HA ' HD12 ' A' ' 53' ' ' ILE . 84.4 tttt -100.09 110.79 23.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 109.612 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.534 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 33.4 mm -50.97 133.85 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 110.439 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 83.2 m-20 -106.25 -37.15 6.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.316 -0.865 . . . . 0.0 109.87 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.441 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 11.8 p 178.16 157.72 0.44 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.747 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.42 HG13 ' HD1' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -138.66 153.62 25.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.051 -179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 79' ' ' TYR . 6.3 m-20 -131.02 77.49 1.79 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.529 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.593 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 85.1 mttt -63.04 -11.85 22.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.232 -0.918 . . . . 0.0 110.005 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -98.12 -31.82 11.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.746 . . . . 0.0 109.235 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -102.45 -3.26 27.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.634 -0.666 . . . . 0.0 109.342 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.552 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 74.8 m-85 60.87 54.76 3.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.524 0.678 . . . . 0.0 110.6 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -130.97 156.53 44.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.679 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.703 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 61.2 t80 -143.67 141.61 30.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.931 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 53.6 m -148.7 136.97 21.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.14 -0.975 . . . . 0.0 110.755 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.703 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.0 p90 -147.82 175.61 10.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.399 -0.813 . . . . 0.0 110.29 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.469 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 44.9 m -124.47 128.84 49.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.858 . . . . 0.0 109.851 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 4.5 tp -95.47 124.88 39.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -0.978 . . . . 0.0 110.167 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.43 HG12 ' HB3' ' A' ' 68' ' ' LYS . 16.9 pt -109.23 -5.83 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 110.229 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.465 ' O ' HD12 ' A' ' 85' ' ' LEU . 9.1 tt0 -136.56 162.35 33.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 110.327 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.467 ' HA3' HG13 ' A' ' 67' ' ' VAL . . . 149.14 125.08 1.38 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -57.89 -31.39 66.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -1.11 . . . . 0.0 110.187 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.18 -18.58 65.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.079 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.483 HD23 ' CG1' ' A' ' 98' ' ' ILE . 86.9 mt -70.72 -30.45 66.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.62 -174.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -80.89 4.51 19.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -1.146 . . . . 0.0 110.26 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.42 ' O ' HG21 ' A' ' 122' ' ' THR . 78.1 p -89.47 -41.47 12.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.92 . . . . 0.0 110.108 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.528 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 62.9 mt -102.47 152.33 21.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.854 . . . . 0.0 109.987 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.513 ' CG ' ' HD3' ' A' ' 123' ' ' LYS . 5.6 tp10 -131.54 -80.56 0.52 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.304 -0.873 . . . . 0.0 110.087 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 59.3 mttt -80.21 127.78 32.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.581 -0.7 . . . . 0.0 110.522 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.626 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -116.77 139.05 45.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.702 -1.249 . . . . 0.0 109.856 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.49 127.68 54.24 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.405 -0.81 . . . . 0.0 108.974 178.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.626 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 9.6 m-85 -122.56 133.98 54.55 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.331 -0.856 . . . . 0.0 110.509 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 117' ' ' THR . 3.2 mt-10 -132.56 141.18 48.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.1 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 81' ' ' TYR . 63.6 m -137.04 143.13 42.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -137.19 135.76 37.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 110.169 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.521 ' CD2' HD23 ' A' ' 18' ' ' LEU . 4.9 mt -120.07 148.21 43.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.836 . . . . 0.0 110.533 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.483 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.7 -169.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 0.0 109.799 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.35 167.16 11.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 110.214 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.499 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 57.6 p -126.42 175.42 3.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 109.948 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.8 Cg_endo -87.29 22.8 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.87 1.458 . . . . 0.0 110.498 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 t -126.67 -10.99 6.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 110.409 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.96 -26.68 10.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.9 -149.59 1.56 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.536 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 8.4 p -149.12 137.79 21.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -1.17 . . . . 0.0 110.152 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' HG21 ' A' ' 10' ' ' THR . 68.5 mt -86.86 148.91 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 110.122 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.627 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 9.7 mt -132.79 125.26 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.391 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.423 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 75.1 tttt -115.86 108.43 16.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.2 m -98.84 158.85 15.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 110.538 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 53.4 m -159.35 126.01 4.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.398 -0.814 . . . . 0.0 110.278 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.4 m -128.97 160.01 34.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 0.0 110.183 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 62.3 m-70 -136.73 162.11 34.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.246 -0.909 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.8 m-85 -126.58 136.24 52.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.912 . . . . 0.0 110.99 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 93.3 m-70 -119.0 81.49 1.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.915 . . . . 0.0 109.34 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.528 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -66.69 154.52 40.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 111.102 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.513 ' HD3' ' CG ' ' A' ' 96' ' ' GLU . 37.8 mtmt -103.8 116.86 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.521 -0.737 . . . . 0.0 109.829 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 106.74 9.72 30.05 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 5.8 t30 69.4 51.4 0.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -1.134 . . . . 0.0 110.451 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 122' ' ' THR . 85.4 t -92.63 175.15 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.331 -0.855 . . . . 0.0 109.549 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.428 ' N ' ' CG1' ' A' ' 126' ' ' VAL . 90.8 mt-10 -124.3 149.34 46.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.969 -1.082 . . . . 0.0 110.563 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.525 ' CD1' HD22 ' A' ' 95' ' ' LEU . 15.8 mm -75.42 172.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 110.202 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 132' ' ' HIS . 70.3 mmtt -111.29 129.88 55.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.288 -0.882 . . . . 0.0 109.842 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' LYS . 54.1 mt-10 -43.09 -43.5 4.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 110.184 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -62.45 -25.36 67.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 110.025 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.8 t-160 -78.11 -50.54 11.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 110.147 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.595 ' CG1' ' CD1' ' A' ' 5' ' ' TYR . 72.7 t -57.24 -32.85 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.0 109.746 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -80.17 -40.77 26.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.831 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.92 -36.82 84.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.335 -0.853 . . . . 0.0 109.906 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.56 -30.04 69.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.455 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 91.7 mttt -77.49 -32.1 54.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 0.0 109.985 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -76.13 -33.24 59.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.387 -0.821 . . . . 0.0 109.973 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.21 -33.46 65.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.919 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -79.07 -36.11 41.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.0 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.0 m -62.11 -47.36 84.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.958 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -53.93 -50.03 67.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.816 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.442 ' HA ' HD11 ' A' ' 146' ' ' LEU . 15.9 tp -57.18 -45.32 83.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.789 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 21.6 m-85 -56.83 -41.34 77.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.406 -0.809 . . . . 0.0 109.643 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -78.84 -14.92 58.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 109.828 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.492 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 19.7 mt -83.22 -36.69 24.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -0.901 . . . . 0.0 108.818 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.571 HD12 ' CD1' ' A' ' 22' ' ' PHE . 16.1 mt -69.42 -46.22 76.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.473 ' O ' HG13 ' A' ' 13' ' ' ILE . 64.1 mt-10 -56.78 -36.65 70.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.402 -0.811 . . . . 0.0 109.551 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.4 m -72.23 -39.43 68.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.778 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.582 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 77.0 t80 -53.59 -52.13 60.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -0.843 . . . . 0.0 110.089 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.646 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 74.6 mt -75.25 -33.98 61.36 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.213 -0.93 . . . . 0.0 110.27 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.521 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 37.6 ttpt -69.98 -20.62 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -109.06 -31.13 3.42 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.53 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 9.9 m-70 -109.53 93.3 13.61 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 109.942 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.16 5.27 3.68 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.07 1.563 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -109.83 2.24 19.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.003 -1.06 . . . . 0.0 109.856 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.567 ' HB2' ' CE2' ' A' ' 150' ' ' TYR . . . -83.59 103.22 12.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 109.995 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.646 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.99 31.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.722 -0.611 . . . . 0.0 110.472 -179.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.721 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 120' ' ' TYR . 70.6 t -120.89 118.67 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.214 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.583 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 90.8 m-85 -75.91 149.88 37.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.162 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.416 HG22 ' CE1' ' A' ' 119' ' ' HIS . 39.9 m -133.1 119.94 20.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 110.228 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 69.9 m-85 -131.07 152.41 50.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 110.247 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -144.81 149.77 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.131 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.8 t -142.86 156.52 44.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.833 . . . . 0.0 109.816 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.23 145.89 36.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.005 . . . . 0.0 110.756 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 5.7 p90 -159.45 -172.89 3.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.608 -0.683 . . . . 0.0 109.704 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.475 HG23 HG12 ' A' ' 113' ' ' ILE . 20.8 p -136.39 177.99 7.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.065 -1.022 . . . . 0.0 110.717 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 3.2 t -157.83 159.89 37.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.432 -0.793 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -87.45 -2.72 58.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 110.248 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 12.0 mm -98.06 148.3 34.29 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 110.215 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.59 144.84 80.22 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.099 1.579 . . . . 0.0 110.494 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.642 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.52 -31.12 11.45 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 124.018 1.536 . . . . 0.0 112.988 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.9 Cg_endo -69.04 -23.66 33.85 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 N-CA-C 110.121 -0.761 . . . . 0.0 110.121 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.519 ' CZ ' ' O ' ' A' ' 158' ' ' TYR . 3.7 mmp_? -84.44 -42.7 15.37 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.507 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.1 tt -69.91 -31.31 69.03 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.6 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 48.8 t80 -66.27 -53.35 37.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.487 -0.758 . . . . 0.0 109.588 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 80.8 mttt -53.43 -37.48 62.61 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.212 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -72.3 -53.45 12.38 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.582 0.706 . . . . 0.0 110.769 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.56 ' CE1' HD13 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -61.37 -40.89 95.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.511 -0.743 . . . . 0.0 111.556 -178.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.455 HG12 HG12 ' A' ' 74' ' ' ILE . 4.6 t -104.68 -65.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.925 -1.109 . . . . 0.0 111.798 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.6 mp -65.95 -9.49 30.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.232 -0.917 . . . . 0.0 111.516 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.4 m-20 -145.68 33.39 1.04 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.823 -1.173 . . . . 0.0 110.71 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -73.46 -20.4 60.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.391 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' OD1' ' HB2' ' A' ' 41' ' ' SER . 36.9 t0 -73.6 -20.56 60.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 109.73 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 6.9 p30 -123.88 15.34 9.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.429 -0.794 . . . . 0.0 109.684 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -97.41 -57.75 2.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 109.754 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.589 ' CG1' ' CD1' ' A' ' 38' ' ' ILE . 11.7 t -62.12 -41.46 75.67 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.48 -0.763 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.2 Cg_endo -78.27 7.75 3.92 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.348 1.183 . . . . 0.0 110.831 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 72.1 mmtt -126.43 -27.74 3.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.052 -1.03 . . . . 0.0 109.907 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.574 HG12 ' CD1' ' A' ' 150' ' ' TYR . 20.9 mt -77.34 -42.77 30.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.387 -0.82 . . . . 0.0 109.58 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.03 101.99 1.58 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.498 -0.751 . . . . 0.0 110.073 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.97 1.18 6.8 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.077 1.567 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -84.42 -19.99 32.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.065 -1.022 . . . . 0.0 109.572 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.8 -53.31 4.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.321 -0.862 . . . . 0.0 109.913 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.589 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 1.2 mp -121.84 148.71 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.44 -0.788 . . . . 0.0 109.791 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.521 ' N ' HG21 ' A' ' 38' ' ' ILE . 18.1 tppt? -84.0 -41.14 17.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.931 . . . . 0.0 110.549 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -172.59 170.64 4.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.204 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.408 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 68.3 m -126.93 136.5 52.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.14 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.542 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 76.2 tt0 -140.56 107.99 5.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 43' ' ' ILE . 43.3 mt -58.7 133.27 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 110.206 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 52.8 mt -87.69 -27.64 22.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.3 -0.875 . . . . 0.0 110.044 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.46 ' O ' HG22 ' A' ' 52' ' ' THR . 29.4 tp10 -160.47 165.95 30.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 110.218 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.8 -168.99 27.02 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -127.69 24.6 6.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -1.182 . . . . 0.0 110.334 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.3 8.59 35.45 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -93.73 -164.09 36.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.79 130.8 18.64 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.047 1.551 . . . . 0.0 110.621 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.89 -3.69 77.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.467 ' HB ' HG13 ' A' ' 71' ' ' ILE . 23.6 m -79.98 142.47 35.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -1.161 . . . . 0.0 109.982 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 70' ' ' LYS . 32.5 mm -112.12 111.67 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.098 -1.001 . . . . 0.0 110.233 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.2 mttt -94.67 139.53 31.1 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.342 -0.849 . . . . 0.0 110.148 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HB2' HD13 ' A' ' 44' ' ' LEU . 80.3 tttt -111.34 96.21 5.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.327 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.515 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.6 mt -84.94 147.29 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.514 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 7.8 p -116.68 163.07 16.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 0.0 110.638 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 24.6 m-85 -117.2 158.95 23.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.522 -0.736 . . . . 0.0 110.142 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -42.04 144.95 0.83 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -68.0 172.24 5.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -1.171 . . . . 0.0 110.243 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.02 -164.26 37.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.0 t -48.61 -45.43 38.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 110.092 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 64' ' ' TYR . 95.5 mt-30 -125.53 123.77 39.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.119 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' GLN . 5.0 t80 -44.62 150.5 0.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.977 . . . . 0.0 110.124 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -132.93 135.23 7.98 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 10.7 p90 -177.95 163.1 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -1.18 . . . . 0.0 110.145 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.485 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.8 m -143.22 172.24 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.614 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.507 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . 98.4 mttt -122.17 133.37 54.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.591 -0.693 . . . . 0.0 109.767 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.656 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 14.8 m170 -112.31 137.28 50.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.118 -0.989 . . . . 0.0 110.706 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HA ' HD12 ' A' ' 53' ' ' ILE . 85.8 tttt -111.45 109.84 19.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.892 . . . . 0.0 109.211 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.532 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 36.1 mm -52.77 127.52 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.171 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.468 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 95.1 m-20 -99.03 -38.71 8.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.489 -0.757 . . . . 0.0 109.878 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 2.2 m -178.81 161.28 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.455 HG12 HG12 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -144.74 152.8 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.986 -1.071 . . . . 0.0 111.261 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -140.54 80.89 1.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.682 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.6 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 84.2 tttt -65.61 -11.72 46.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.13 -0.981 . . . . 0.0 109.968 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -85.7 -30.73 22.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 108.68 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -110.5 -2.92 16.27 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.566 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 72.8 m-85 62.65 52.11 2.94 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.543 0.687 . . . . 0.0 110.444 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -123.31 153.02 40.82 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 109.352 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.684 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 59.0 t80 -142.38 148.98 38.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.14 -0.975 . . . . 0.0 110.255 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.435 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 60.3 m -152.13 137.04 17.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.791 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.684 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 4.1 p90 -149.32 179.31 8.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 110.009 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.468 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 65.2 m -137.46 134.54 35.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.895 . . . . 0.0 110.372 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.656 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 9.2 tp -80.34 121.01 25.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.223 -0.923 . . . . 0.0 109.94 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.507 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 27.4 pt -100.16 -11.18 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.654 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -154.82 147.98 24.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.0 110.238 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.485 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 172.61 152.46 8.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -78.91 -35.38 43.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -1.122 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.509 ' HB3' ' NE2' ' A' ' 132' ' ' HIS . . . -58.78 -21.25 55.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.158 -0.964 . . . . 0.0 110.265 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.543 HD22 ' CD2' ' A' ' 95' ' ' LEU . 19.8 mt -65.2 -42.86 93.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.309 -0.869 . . . . 0.0 109.694 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.67 -172.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -73.01 -3.73 27.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -1.106 . . . . 0.0 110.008 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.471 ' HA ' HG12 ' A' ' 126' ' ' VAL . 41.6 p -88.58 -45.49 9.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.12 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.543 ' CD2' HD22 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -118.89 159.46 23.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.383 -0.823 . . . . 0.0 109.067 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' O ' HD21 ' A' ' 91' ' ' LEU . 35.3 tt0 -140.31 -80.84 0.27 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 110.39 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 43.0 mtmt -80.26 148.42 30.78 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.619 -0.676 . . . . 0.0 110.681 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.629 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 17.8 mm -136.51 148.48 27.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.018 -1.051 . . . . 0.0 109.694 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -121.58 124.45 44.39 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.629 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 16.0 m-85 -117.31 135.67 53.67 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.306 -0.871 . . . . 0.0 110.741 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -135.88 134.73 39.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 109.923 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.485 HG22 ' CZ ' ' A' ' 144' ' ' PHE . 89.3 m -134.1 147.8 50.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -0.988 . . . . 0.0 110.259 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 9.8 tttt -139.49 148.67 43.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 5.5 mt -125.06 152.36 44.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.257 -0.902 . . . . 0.0 110.447 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.492 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.77 -169.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.28 -0.888 . . . . 0.0 109.787 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -122.42 160.99 24.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.943 . . . . 0.0 110.311 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.439 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 35.3 p -120.59 164.12 24.95 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 110.13 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.5 -1.94 11.02 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.059 1.557 . . . . 0.0 110.363 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.6 m -102.72 0.45 32.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 110.326 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.46 -39.76 2.66 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.87 -171.67 0.36 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 54.8 p -131.93 134.62 45.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -1.166 . . . . 0.0 110.37 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.475 HG12 HG23 ' A' ' 10' ' ' THR . 31.9 mt -81.71 150.11 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.889 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.627 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 14.4 mt -135.45 112.98 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.593 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -103.54 136.37 43.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 109.759 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.6 t -131.91 158.67 40.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.976 . . . . 0.0 110.575 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 88.5 m -155.98 142.26 18.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 110.097 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.572 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 21.1 t -140.12 155.26 47.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.364 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 64.4 m-70 -133.36 168.12 19.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.177 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.516 ' HB3' ' CD1' ' A' ' 128' ' ' ILE . 32.0 m-85 -127.06 146.06 50.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.326 -0.859 . . . . 0.0 110.639 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.4 m-70 -127.18 92.07 3.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.475 ' CG2' ' O ' ' A' ' 126' ' ' VAL . 1.8 p -63.01 161.15 13.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.36 -0.837 . . . . 0.0 110.612 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 34.8 tttm -126.27 124.65 40.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.417 -0.802 . . . . 0.0 110.044 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 125' ' ' ASN . . . 93.48 22.61 26.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 11.9 t30 64.61 50.48 2.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -1.083 . . . . 0.0 110.304 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 127' ' ' GLU . 72.3 t -119.51 174.64 4.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.414 -0.804 . . . . 0.0 109.818 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.48 ' N ' ' CG1' ' A' ' 126' ' ' VAL . 81.3 mt-10 -127.26 153.16 46.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.174 -0.954 . . . . 0.0 110.094 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.546 HD11 ' CD1' ' A' ' 3' ' ' PHE . 3.4 mp -82.05 173.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.837 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.478 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 88.4 mttt -96.42 133.86 40.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 110.189 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.503 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 93.1 mt-10 -51.7 -49.35 62.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.139 -0.976 . . . . 0.0 110.051 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.49 -34.09 64.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.896 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 90' ' ' ALA . 12.6 t-160 -71.81 -53.04 14.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.355 -0.84 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.637 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 6.0 p -60.89 -35.32 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 110.023 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.503 ' N ' HG11 ' A' ' 133' ' ' VAL . 81.4 tttt -70.99 -43.9 67.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.847 . . . . 0.0 109.884 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.92 91.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.936 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.81 -31.63 78.91 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 95.2 mttt -63.06 -32.76 74.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.341 -1.094 . . . . 0.0 109.945 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.471 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 79.8 mt-10 -70.78 -35.12 72.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.845 . . . . 0.0 109.84 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.37 -42.83 87.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.388 -0.82 . . . . 0.0 109.875 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -70.73 -41.23 72.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.926 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.5 m -67.86 -53.71 24.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.781 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.2 m-20 -54.2 -40.07 67.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -0.905 . . . . 0.0 109.742 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.465 ' HG ' HD13 ' A' ' 147' ' ' ILE . 16.1 tp -60.98 -47.26 87.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.778 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 18.0 m-85 -53.6 -38.16 63.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.393 -0.817 . . . . 0.0 109.555 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -79.59 -17.11 54.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.225 -0.922 . . . . 0.0 109.671 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.517 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 26.8 mt -83.38 -35.52 25.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.291 -0.881 . . . . 0.0 108.625 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.56 HD13 ' CE1' ' A' ' 22' ' ' PHE . 27.3 mt -70.88 -46.65 67.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.469 ' OE2' HD11 ' A' ' 114' ' ' ILE . 57.9 mt-10 -58.23 -38.77 77.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.664 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 99.8 m -70.32 -38.33 74.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.781 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.587 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 80.3 t80 -54.36 -48.21 71.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 110.014 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.64 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 92.0 mt -79.55 -30.15 41.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 47.4 tptt -73.9 -21.31 60.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.91 . . . . 0.0 109.463 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.47 -31.88 3.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.548 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.0 m-70 -110.73 93.45 16.9 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.355 -1.085 . . . . 0.0 110.059 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.415 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.4 Cg_endo -74.35 6.72 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.997 1.525 . . . . 0.0 111.035 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -108.72 1.42 21.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.053 -1.029 . . . . 0.0 109.764 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.582 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . . . -81.87 104.5 12.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.365 -0.834 . . . . 0.0 110.196 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.64 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.3 OUTLIER 34.9 32.17 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.691 -0.63 . . . . 0.0 110.528 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.735 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 77.7 t -122.26 120.15 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -1.171 . . . . 0.0 110.265 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.58 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 94.2 m-85 -77.41 144.85 37.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.137 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.483 HG22 ' CE1' ' A' ' 119' ' ' HIS . 41.3 m -127.82 125.1 39.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 110.155 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 68.5 m-85 -134.47 159.13 42.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.237 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.7 pt-20 -151.28 152.48 33.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.886 . . . . 0.0 110.19 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 116' ' ' SER . 55.4 p -134.99 145.99 48.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.031 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.467 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 86.6 mt-10 -130.32 119.46 22.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.34 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.5 p90 -145.42 -175.98 4.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.834 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 18.4 p -136.56 -179.56 5.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.134 -0.979 . . . . 0.0 110.57 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.515 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 14.8 t -156.79 168.27 27.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 110.358 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.52 -16.24 24.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.972 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 6.8 mm -89.67 151.36 45.65 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.98 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 39.2 Cg_endo -64.74 145.28 86.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.053 1.554 . . . . 0.0 110.453 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.63 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -72.29 -31.63 11.41 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.028 1.541 . . . . 0.0 112.954 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.5 Cg_endo -69.33 -19.83 37.64 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 N-CA-C 110.148 -0.751 . . . . 0.0 110.148 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.53 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 4.2 mmp_? -85.65 -47.77 9.5 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.501 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.4 tt -67.3 -25.61 66.12 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 82.6 t80 -68.57 -58.68 3.92 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.505 0.669 . . . . 0.0 109.463 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 47.9 mttt -52.18 -30.47 27.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.159 0.98 . . . . 0.0 108.399 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.677 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -74.8 -63.53 1.24 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.677 0.751 . . . . 0.0 110.96 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -57.83 -35.64 71.15 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 111.459 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.6 HG12 ' CD1' ' A' ' 81' ' ' TYR . 20.1 t -104.62 -67.85 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.118 . . . . 0.0 111.493 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.577 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 4.0 mm? -65.29 -6.13 9.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 111.19 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -144.15 19.85 1.76 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.901 -1.124 . . . . 0.0 110.585 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -54.97 -34.44 63.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 110.164 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.531 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 89.6 m-20 -69.47 -12.0 61.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 110.279 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.445 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.7 m-20 -126.72 -4.98 6.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 110.3 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.547 HD11 ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -85.86 -46.78 10.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.124 -0.985 . . . . 0.0 110.294 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.591 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.3 t -75.92 -42.01 3.51 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.885 . . . . 0.0 111.13 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.5 Cg_endo -77.86 9.71 2.89 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.402 1.212 . . . . 0.0 110.855 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HG2' ' OH ' ' A' ' 150' ' ' TYR . 37.3 tptt -123.16 -28.69 3.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.59 HG12 ' CD1' ' A' ' 150' ' ' TYR . 9.6 mt -80.08 -47.21 21.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.447 -0.783 . . . . 0.0 109.499 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.0 101.96 4.17 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.486 -0.759 . . . . 0.0 109.981 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.34 0.05 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.023 1.538 . . . . 0.0 110.715 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -83.53 -13.04 55.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 109.419 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.96 -62.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.994 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 57' ' ' THR . 1.8 mp -108.98 132.11 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.451 -0.781 . . . . 0.0 110.001 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 31.7 ttpt -83.33 -38.07 22.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.0 110.416 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.461 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -174.55 141.42 0.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.165 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.531 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 7.3 m -107.03 135.92 47.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.041 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 55.2 tt0 -136.31 109.15 7.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.3 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 9.1 mt -62.43 130.55 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.462 ' CD1' ' O ' ' A' ' 42' ' ' GLU . 10.6 mp -94.59 -41.99 9.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.38 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.526 ' O ' ' CG2' ' A' ' 52' ' ' THR . 5.3 mt-10 -132.91 142.79 49.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.134 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.99 -170.2 54.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -124.82 6.58 8.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 110.215 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.32 -4.82 5.95 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 71' ' ' ILE . . . -85.39 -164.68 39.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.6 Cg_endo -70.38 132.03 21.53 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.153 1.607 . . . . 0.0 110.418 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.69 69.99 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 29.6 m -80.06 136.47 36.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -1.155 . . . . 0.0 109.857 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.521 HG22 ' CE ' ' A' ' 68' ' ' LYS . 20.5 mm -107.15 117.97 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 110.17 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 87.2 mttt -105.2 145.9 29.99 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.3 -0.875 . . . . 0.0 110.496 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -118.88 101.43 8.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 110.058 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.74 141.99 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.883 . . . . 0.0 110.444 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.8 p -110.27 153.19 25.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 109.965 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CZ ' HG23 ' A' ' 67' ' ' VAL . 24.5 m-85 -111.75 123.95 51.32 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.0 111.001 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 58' ' ' PHE . . . 39.84 -162.78 0.01 OUTLIER Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.449 ' HB2' ' HD3' ' A' ' 39' ' ' LYS . 76.1 tt0 -146.92 131.12 17.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.459 -1.024 . . . . 0.0 110.011 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -176.21 -176.58 44.53 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.0 m -55.26 -33.94 63.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.355 -1.085 . . . . 0.0 110.334 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.14 112.86 24.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.345 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 2.6 t80 -72.34 126.53 30.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.253 -0.904 . . . . 0.0 110.033 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -126.32 99.05 0.54 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.508 ' CD2' ' CD2' ' A' ' 64' ' ' TYR . 33.2 p90 -138.83 169.98 16.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.134 -1.216 . . . . 0.0 110.369 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.567 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 5.9 m -137.49 173.44 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 110.563 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.521 ' CE ' HG22 ' A' ' 53' ' ' ILE . 37.8 tttt -122.81 127.96 49.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.596 -0.69 . . . . 0.0 109.43 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.568 ' CD2' HD11 ' A' ' 85' ' ' LEU . 10.5 m170 -117.32 126.37 52.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.965 . . . . 0.0 111.035 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HG3' HD12 ' A' ' 53' ' ' ILE . 84.1 tttt -106.01 118.04 35.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.287 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.536 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.0 mm -57.34 135.03 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.93 . . . . 0.0 110.454 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' O ' ' OG ' ' A' ' 73' ' ' SER . 9.5 t0 -107.05 -39.47 5.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.794 . . . . 0.0 109.795 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 0.7 OUTLIER 171.95 161.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.537 -0.727 . . . . 0.0 109.957 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.581 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 3.1 tt -154.64 163.51 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.224 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -125.84 78.01 1.71 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.259 -0.9 . . . . 0.0 109.671 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.607 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 86.3 mttt -53.94 -15.26 1.29 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.331 -0.855 . . . . 0.0 110.863 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -91.76 -32.39 15.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 109.788 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.3 m-80 -107.83 -4.51 17.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.639 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.596 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 6.5 m-85 69.22 49.07 0.63 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.322 0.582 . . . . 0.0 110.543 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.536 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -118.43 147.18 43.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 109.107 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.681 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 79.7 t80 -141.49 142.89 33.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.02 . . . . 0.0 110.617 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.447 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 61.1 m -147.14 128.21 14.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 110.007 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.681 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 3.9 p90 -137.07 -176.71 4.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.062 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.4 m -135.41 140.07 44.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.296 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.568 HD11 ' CD2' ' A' ' 69' ' ' HIS . 49.0 tp -100.47 128.67 46.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.964 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.439 HG12 ' HB3' ' A' ' 68' ' ' LYS . 16.5 pt -118.73 -7.7 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.366 -0.834 . . . . 0.0 110.246 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 79.7 tt0 -146.05 135.27 22.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.527 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 174.35 159.9 21.54 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 46.1 p-10 -71.29 -7.73 48.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -1.159 . . . . 0.0 110.285 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.455 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -79.07 -46.14 18.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.536 ' CD2' ' HG ' ' A' ' 95' ' ' LEU . 19.6 mt -40.96 -46.42 2.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.595 -0.691 . . . . 0.0 110.224 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 41.31 -132.73 3.41 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -115.89 21.72 13.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -1.104 . . . . 0.0 110.062 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.413 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 72.5 p -122.4 -41.58 2.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -0.866 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.536 ' HG ' ' CD2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -114.41 163.35 15.44 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.341 -0.85 . . . . 0.0 109.141 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.514 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 28.1 tp10 -142.03 -79.54 0.24 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.135 -0.978 . . . . 0.0 110.282 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 21.2 mtpt -80.18 151.66 29.59 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.616 -0.677 . . . . 0.0 109.845 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.601 HG22 ' CE2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -146.62 135.37 16.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.063 -1.023 . . . . 0.0 109.819 179.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.1 m -114.99 118.41 33.34 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.43 -0.794 . . . . 0.0 109.597 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.601 ' CE2' HG22 ' A' ' 98' ' ' ILE . 9.7 m-85 -110.39 137.74 47.7 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.469 -0.769 . . . . 0.0 110.173 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.461 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 76.9 tt0 -132.85 143.18 49.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.203 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.6 m -139.39 135.67 33.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -128.31 138.89 52.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.531 ' CD2' HG12 ' A' ' 114' ' ' ILE . 6.5 mt -118.56 149.76 40.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.197 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.47 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -150.03 -169.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 109.961 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -123.2 125.7 45.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.972 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.472 ' HB3' ' CG1' ' A' ' 113' ' ' ILE . 3.2 p -80.15 170.36 16.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 110.219 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 50.7 Cg_endo -83.52 22.47 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.056 1.556 . . . . 0.0 110.966 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.5 p -127.89 4.03 5.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.938 -1.101 . . . . 0.0 110.412 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.16 -25.74 25.21 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.46 -174.33 43.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.534 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 19.9 p -124.35 131.32 53.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -1.201 . . . . 0.0 110.37 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 84.8 mt -82.82 149.68 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 110.195 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.597 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 7.6 mt -133.68 128.82 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 110.359 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.467 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 85.9 tttt -118.66 111.11 18.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.315 -0.865 . . . . 0.0 109.781 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.445 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 1.4 m -101.58 162.31 13.0 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.158 -0.964 . . . . 0.0 110.834 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 53.7 m -160.05 132.65 6.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.44 -0.787 . . . . 0.0 109.773 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.1 p -132.58 159.11 40.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.107 -0.995 . . . . 0.0 110.745 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.483 ' CE1' HG22 ' A' ' 4' ' ' THR . 60.7 m-70 -141.37 155.37 45.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.419 -0.8 . . . . 0.0 110.038 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 28.2 m-85 -119.03 138.07 53.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.39 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.539 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 95.4 m-70 -119.32 93.13 3.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 109.675 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.517 ' CG2' HD13 ' A' ' 128' ' ' ILE . 1.0 OUTLIER -62.86 159.22 17.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.156 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HD2' ' HG2' ' A' ' 96' ' ' GLU . 43.7 tttm -142.7 128.34 19.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 110.19 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 93.31 26.38 16.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 8.2 t30 64.91 65.96 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -1.189 . . . . 0.0 110.173 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.452 HG21 ' HB ' ' A' ' 122' ' ' THR . 7.0 m -144.37 171.21 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.428 ' HA ' HG22 ' A' ' 122' ' ' THR . 86.5 mt-10 -140.25 152.37 45.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.215 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.566 HD11 ' CD1' ' A' ' 3' ' ' PHE . 4.9 mp -81.89 173.53 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 109.964 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.441 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 57.0 mttt -104.85 132.15 51.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.229 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.465 ' O ' HG11 ' A' ' 133' ' ' VAL . 52.1 mt-10 -48.48 -39.79 24.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 110.101 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.01 -30.39 70.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.948 . . . . 0.0 109.882 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -75.34 -50.97 14.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 110.18 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.635 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 10.3 p -65.47 -41.81 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 110.038 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.459 ' N ' HG12 ' A' ' 133' ' ' VAL . 72.5 mmtt -63.04 -40.02 96.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.979 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.54 -34.69 72.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.831 . . . . 0.0 110.0 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 139' ' ' LYS . . . -73.08 -29.76 64.17 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 56.2 mtpt -73.71 -32.95 64.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -1.08 . . . . 0.0 110.076 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -70.28 -54.73 11.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 109.948 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 136' ' ' GLY . 20.7 ptmt -56.54 -28.49 60.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.795 . . . . 0.0 109.866 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.81 -45.88 70.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.051 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -61.96 -40.88 97.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.978 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -62.07 -41.42 98.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.464 ' O ' HG13 ' A' ' 147' ' ' ILE . 30.1 mt -61.1 -41.22 96.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.934 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -61.54 -33.21 73.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.416 -0.802 . . . . 0.0 109.951 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 47.4 tptt -80.02 -19.05 48.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 110.26 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.4 mt -79.95 -35.16 38.08 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.104 -0.997 . . . . 0.0 108.515 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.652 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 67.4 mt -70.67 -51.73 34.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.515 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 78.0 mt-10 -49.41 -34.67 16.98 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.288 -0.883 . . . . 0.0 109.016 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.4 m -79.99 -28.33 39.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -0.916 . . . . 0.0 109.296 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.59 ' CD1' HG12 ' A' ' 33' ' ' ILE . 86.7 t80 -61.36 -54.07 48.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.561 -0.712 . . . . 0.0 109.977 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.644 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 59.0 mt -69.56 -27.96 65.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 110.077 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.457 ' HA ' HD13 ' A' ' 13' ' ' ILE . 57.3 tptt -74.04 -29.39 61.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 109.727 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -101.33 -29.15 6.45 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.521 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.5 m-70 -107.15 90.98 6.05 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.447 -1.031 . . . . 0.0 109.7 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.5 Cg_endo -73.54 5.22 3.4 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.009 1.531 . . . . 0.0 111.025 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 44.3 p30 -109.82 -9.37 14.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.013 -1.054 . . . . 0.0 109.685 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.571 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . . . -69.36 99.62 1.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.477 -0.764 . . . . 0.0 110.091 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.677 ' CE2' ' CB ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER 34.9 31.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.727 -0.608 . . . . 0.0 110.554 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.53 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.799 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.583 HG22 ' CG ' ' A' ' 121' ' ' HIS . 2.5 p -79.86 145.64 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -1.206 . . . . 0.0 110.563 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 77.5 m-85 -93.18 167.7 11.59 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.332 -0.855 . . . . 0.0 110.242 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.9 m -131.39 110.84 11.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.944 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.582 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 24.3 m-85 -113.18 125.34 54.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 110.085 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.5 pt-20 -133.13 152.94 51.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 110.085 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.2 t -128.52 155.81 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.359 -0.838 . . . . 0.0 110.172 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.466 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 76.0 mt-10 -136.0 118.03 15.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.333 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.2 p90 -147.24 -170.98 3.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.939 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 18.2 p -140.64 -179.44 6.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 110.561 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 3.2 t -156.74 160.12 38.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.759 . . . . 0.0 110.165 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -84.7 -16.12 42.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.853 . . . . 0.0 110.251 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 7.4 mm -87.61 149.96 47.47 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 110.135 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -65.13 149.02 89.49 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.098 1.578 . . . . 0.0 110.412 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.651 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 Cg_endo -70.14 -32.72 16.46 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.899 1.473 . . . . 0.0 113.0 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.0 Cg_endo -68.0 -21.75 42.82 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 122.504 0.739 . . . . 0.0 110.207 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.521 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -83.65 -46.78 11.95 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.499 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.1 tt -69.07 -28.33 66.42 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 62.6 t80 -66.04 -59.34 3.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.468 -0.77 . . . . 0.0 109.514 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 51.2 mttp -51.6 -34.79 38.88 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.521 -0.737 . . . . 0.0 109.604 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . . . -75.29 -55.5 5.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.391 -0.818 . . . . 0.0 111.152 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.639 ' CD1' ' CD1' ' A' ' 147' ' ' ILE . 0.7 OUTLIER -59.77 -45.51 92.05 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.48 -0.762 . . . . 0.0 111.738 -178.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.37 -66.3 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.02 -1.05 . . . . 0.0 111.392 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.6 mm? -64.44 -5.97 6.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.262 -0.899 . . . . 0.0 111.444 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.524 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -143.79 25.88 1.6 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.862 -1.149 . . . . 0.0 110.849 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -66.37 -30.02 70.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 110.195 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.56 -12.77 61.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 72.5 m-20 -129.1 6.32 5.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 110.118 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -92.99 -53.35 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -0.832 . . . . 0.0 110.056 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 17.1 t -67.2 -41.42 33.97 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 111.176 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -76.91 6.03 4.5 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.334 1.176 . . . . 0.0 110.881 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 66.6 mttt -127.54 -31.84 2.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 109.787 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.575 HG12 ' CD1' ' A' ' 150' ' ' TYR . 16.0 mt -79.89 -43.17 22.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.462 -0.774 . . . . 0.0 109.775 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.7 91.8 3.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.0 110.188 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.26 3.51 5.69 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.114 1.586 . . . . 0.0 110.594 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -87.23 -19.9 27.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.134 -0.979 . . . . 0.0 110.061 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.38 -40.77 8.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 110.201 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.583 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 1.1 mt -125.72 145.99 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.447 -0.783 . . . . 0.0 110.047 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.458 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 28.2 ttpt -80.93 -46.36 15.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 110.32 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -176.93 158.88 1.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.88 . . . . 0.0 110.038 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -113.01 120.57 41.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.945 . . . . 0.0 110.162 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.543 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 32.0 tt0 -121.46 102.08 8.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.003 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 37.6 mt -50.7 129.32 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.307 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 19.9 tp -91.72 -40.07 11.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.468 -0.77 . . . . 0.0 110.354 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.525 ' O ' ' CG2' ' A' ' 52' ' ' THR . 2.9 mt-10 -138.32 138.02 37.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 110.172 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 47' ' ' ASP . . . 82.21 -159.53 39.32 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 87.1 m-20 -138.24 9.55 2.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -1.192 . . . . 0.0 110.348 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.29 -2.94 5.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.491 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -87.6 -168.49 44.62 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.486 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.5 Cg_endo -69.82 137.74 35.98 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.091 1.574 . . . . 0.0 110.507 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.93 -5.47 85.04 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 18.0 m -80.0 138.94 37.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -1.177 . . . . 0.0 109.998 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 32.2 mm -105.15 127.58 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.0 110.001 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 93.5 mttt -110.39 126.71 54.56 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 110.019 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' A' ' 44' ' ' LEU . 43.4 mtmt -99.15 98.12 9.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.139 -0.976 . . . . 0.0 110.589 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.527 ' CG2' HG12 ' A' ' 38' ' ' ILE . 96.4 mt -87.07 146.71 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.155 -0.966 . . . . 0.0 109.66 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.471 ' N ' HG21 ' A' ' 56' ' ' ILE . 5.4 p -118.76 153.16 34.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.124 -0.985 . . . . 0.0 111.116 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 25.5 m-85 -117.44 138.47 51.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.509 -0.745 . . . . 0.0 109.973 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.12 41.86 2.06 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -60.8 -39.99 90.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -1.083 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.69 -153.01 7.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 63' ' ' GLN . 33.7 m -66.62 -55.89 13.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -1.138 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 62' ' ' SER . 94.9 mt-30 -41.93 138.88 1.41 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.879 . . . . 0.0 110.216 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.34 115.02 17.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.247 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -115.2 93.28 0.62 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.541 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.4 p90 -128.96 164.91 22.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -1.228 . . . . 0.0 110.234 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.527 HG13 ' CA ' ' A' ' 88' ' ' GLY . 5.9 m -134.63 175.28 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 0.0 110.486 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.536 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 59.5 mttt -133.15 106.46 7.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.46 -0.775 . . . . 0.0 109.701 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.563 ' CD2' HD11 ' A' ' 85' ' ' LEU . 13.0 m170 -98.16 128.44 44.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 111.023 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.528 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 54.6 tttm -101.88 109.56 21.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.329 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.507 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.0 mm -42.59 140.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.341 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.531 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 23.9 t0 -111.43 -48.87 3.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.527 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.485 ' N ' ' OG ' ' A' ' 82' ' ' SER . 8.7 m -165.88 156.16 12.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.527 -0.733 . . . . 0.0 109.746 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 mt -138.36 153.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.396 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.7 m-20 -141.7 80.74 1.74 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.517 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.585 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 34.4 tttt -65.65 -13.32 58.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.179 -0.951 . . . . 0.0 109.853 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -89.94 -30.87 17.54 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.803 0.811 . . . . 0.0 109.013 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m-80 -106.91 -2.98 20.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.584 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 73.8 m-85 60.94 54.35 3.47 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.652 0.739 . . . . 0.0 110.167 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -127.26 156.53 41.75 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.637 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.507 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 27.6 t80 -142.83 137.38 29.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.947 . . . . 0.0 110.003 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.485 ' OG ' ' N ' ' A' ' 73' ' ' SER . 13.9 p -143.87 124.18 13.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.112 -0.993 . . . . 0.0 111.263 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 13.7 p90 -137.73 172.53 12.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 110.23 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 97.1 m -129.39 134.52 47.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.332 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.563 HD11 ' CD2' ' A' ' 69' ' ' HIS . 11.7 tp -101.5 133.78 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.05 -1.031 . . . . 0.0 110.221 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.5 HG23 HD11 ' A' ' 86' ' ' ILE . 13.8 pt -113.11 -30.88 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.458 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.437 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 70.1 tt0 -119.41 157.35 28.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.258 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.527 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 159.05 140.69 2.96 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.6 -25.58 64.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -1.148 . . . . 0.0 110.139 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.08 -26.61 61.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.146 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 15.5 mt -63.22 -31.59 72.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 110.104 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.54 -174.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 52.8 t0 -77.1 -1.02 26.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.138 . . . . 0.0 110.057 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.459 ' HA ' HG12 ' A' ' 126' ' ' VAL . 43.2 p -87.82 -41.96 12.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 110.056 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.536 ' CD2' HD13 ' A' ' 128' ' ' ILE . 68.4 mt -98.25 153.55 18.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.815 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 35.4 tt0 -137.24 -83.33 0.34 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.301 -0.874 . . . . 0.0 109.629 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.49 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 96.0 mttt -80.35 125.02 29.38 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.75 -0.594 . . . . 0.0 110.447 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.616 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 3.3 mm -116.86 135.01 58.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.789 -1.195 . . . . 0.0 109.827 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -120.89 127.07 51.53 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.616 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 11.1 m-85 -119.61 134.43 55.23 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.326 -0.859 . . . . 0.0 110.573 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 117' ' ' THR . 26.5 tt0 -137.16 133.58 35.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.427 -0.796 . . . . 0.0 109.92 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 54.5 m -134.35 144.1 48.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 110.361 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.413 ' N ' HG21 ' A' ' 102' ' ' THR . 4.2 tttt -135.25 146.93 49.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.503 ' CD2' HG12 ' A' ' 114' ' ' ILE . 6.1 mt -119.22 153.73 34.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.339 -0.851 . . . . 0.0 110.433 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.484 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -150.94 -168.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.289 -0.882 . . . . 0.0 109.93 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -121.88 128.19 51.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 110.27 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.2 p -81.47 160.02 65.72 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.181 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -2.26 11.45 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.082 1.569 . . . . 0.0 110.547 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.4 p -103.07 4.82 37.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.351 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.62 -34.38 5.82 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.09 -174.18 6.51 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.471 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 23.6 p -123.66 135.82 54.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 23.4 mt -87.04 150.41 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.566 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 7.0 mt -132.85 117.67 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.178 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 80.8 tttt -110.05 109.69 20.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 110.079 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 8.6 m -97.6 164.21 12.52 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.173 -0.954 . . . . 0.0 110.474 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 101' ' ' GLU . 29.4 m -160.01 126.17 4.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.411 -0.805 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.0 m -128.37 156.95 42.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.163 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 90.9 m-70 -129.24 136.31 49.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -0.93 . . . . 0.0 110.255 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.0 m-30 -109.59 111.69 23.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.962 . . . . 0.0 111.169 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.583 ' CG ' HG22 ' A' ' 2' ' ' VAL . 90.3 m-70 -99.09 117.38 33.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.196 -0.94 . . . . 0.0 109.514 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 94' ' ' THR . 0.7 OUTLIER -87.27 138.76 31.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 110.569 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 74.1 tttt -72.3 123.1 22.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 110.223 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.48 -128.86 8.71 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -121.09 51.72 1.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -1.188 . . . . 0.0 110.12 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 127' ' ' GLU . 85.9 t -94.61 174.6 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.416 -0.802 . . . . 0.0 110.02 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.479 ' N ' HG13 ' A' ' 126' ' ' VAL . 45.8 mt-10 -143.16 125.73 15.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 110.408 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 1.8 mp -60.45 174.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.855 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.527 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 62.3 mttt -100.7 151.52 21.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.26 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -66.55 -34.29 77.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.199 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 132' ' ' HIS . 22.2 pt-20 -68.26 -36.96 80.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 110.198 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.445 ' N ' ' CG ' ' A' ' 131' ' ' GLU . 17.8 t-160 -67.79 -33.53 75.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.582 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 89.3 t -67.85 -43.77 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.22 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -73.83 -43.0 60.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.003 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.72 91.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.083 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.92 -26.3 73.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -75.99 -31.94 59.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -1.156 . . . . 0.0 110.144 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.456 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 78.3 tt0 -79.02 -28.55 43.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.125 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.99 -32.86 59.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.71 -33.29 46.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.5 t -64.58 -45.29 87.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.165 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 73.5 m-20 -52.81 -48.72 66.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.03 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.3 tp -55.89 -48.59 75.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.941 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.427 ' O ' ' CD ' ' A' ' 148' ' ' GLU . 25.8 m-85 -54.4 -39.77 67.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.807 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.444 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 42.7 tttm -79.81 -14.03 58.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.464 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 17.8 mt -83.97 -37.69 21.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.1 -1.0 . . . . 0.0 108.954 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.639 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 75.6 mt -71.21 -44.1 74.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.822 -0.751 . . . . 0.0 108.983 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 13' ' ' ILE . 65.0 mt-10 -56.62 -36.24 69.23 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.435 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.6 m -76.68 -30.57 56.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.926 . . . . 0.0 109.511 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.591 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 89.9 t80 -57.38 -48.19 79.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.54 -0.725 . . . . 0.0 110.045 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.593 ' CD2' ' CE1' ' A' ' 158' ' ' TYR . 72.1 mt -76.48 -38.53 55.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 110.065 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.481 ' HA ' HD13 ' A' ' 13' ' ' ILE . 83.8 tttt -61.23 -14.83 28.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.374 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -116.52 -28.13 2.63 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.574 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 8.5 m-70 -109.08 93.91 13.86 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.333 -1.098 . . . . 0.0 110.058 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.8 4.24 4.28 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.028 1.541 . . . . 0.0 110.961 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -113.77 -6.56 13.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.124 -0.985 . . . . 0.0 110.047 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.556 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . . . -67.03 102.67 1.03 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 21' ' ' ALA . 0.6 OUTLIER 34.65 32.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.741 -0.599 . . . . 0.0 110.604 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.521 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.756 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 77.1 t -114.13 109.33 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.195 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.583 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 82.6 m-85 -77.48 144.86 37.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 110.298 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.4 m -122.71 115.77 22.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 110.396 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.63 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 67.2 m-85 -124.08 154.54 39.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.897 . . . . 0.0 109.951 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 13.6 pt-20 -147.3 151.4 36.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 0.0 110.566 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 m -137.36 144.21 42.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.777 . . . . 0.0 109.456 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -132.82 143.46 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.114 -0.991 . . . . 0.0 110.928 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.605 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.3 p90 -158.79 -176.04 5.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.57 -0.706 . . . . 0.0 109.492 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 21.1 p -135.64 -179.46 5.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.041 -1.037 . . . . 0.0 110.764 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 10.0 t -159.96 167.16 28.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.529 -0.732 . . . . 0.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -98.38 9.81 42.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 109.972 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 2.7 mp -107.75 149.88 39.54 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.033 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.81 143.19 72.71 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.081 1.569 . . . . 0.0 110.554 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.647 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.9 Cg_endo -71.82 -31.67 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 124.027 1.541 . . . . 0.0 112.804 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.9 Cg_endo -67.94 -21.93 42.92 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 O-C-N 122.468 0.72 . . . . 0.0 110.322 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.508 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 8.7 mmp_? -83.91 -46.99 11.51 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.532 HD22 ' CG2' ' A' ' 147' ' ' ILE . 0.4 OUTLIER -68.25 -29.3 68.08 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.591 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.0 t80 -66.3 -56.16 12.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.863 . . . . 0.0 109.9 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.506 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 76.1 mttt -53.92 -32.1 52.37 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.691 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -73.18 -64.82 0.9 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.713 0.768 . . . . 0.0 111.11 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.596 ' CE1' HD11 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -56.97 -39.08 73.93 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.634 -0.666 . . . . 0.0 112.228 -178.128 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.467 ' CG1' HD12 ' A' ' 74' ' ' ILE . 5.5 t -101.77 -58.03 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.777 -1.202 . . . . 0.0 111.578 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.545 ' CD1' ' N ' ' A' ' 24' ' ' LEU . 7.4 mp -78.14 0.1 26.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.079 -1.013 . . . . 0.0 111.331 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.53 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -147.3 15.17 1.14 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.944 -1.098 . . . . 0.0 110.556 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -53.85 -39.88 66.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.95 . . . . 0.0 109.916 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 65.2 t0 -64.42 -14.19 55.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 109.907 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.46 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 81.2 m-20 -127.3 0.19 6.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.369 -0.832 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.533 ' CD2' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -88.09 -45.52 10.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.355 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.592 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 31.2 t -72.89 -40.36 6.1 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.263 -0.898 . . . . 0.0 111.482 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -77.44 10.11 2.61 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.329 1.173 . . . . 0.0 111.113 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 49.6 mttt -122.77 -25.77 4.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.054 -1.029 . . . . 0.0 109.628 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.582 HG12 ' CD1' ' A' ' 150' ' ' TYR . 28.7 mt -79.99 -49.86 18.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.475 -0.765 . . . . 0.0 109.926 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.37 104.02 2.21 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.383 -0.823 . . . . 0.0 110.128 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.17 1.01 6.46 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.02 1.537 . . . . 0.0 110.794 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -83.54 -14.41 52.28 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.36 -53.88 3.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 110.071 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.574 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 1.1 mp -117.65 149.02 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.453 -0.779 . . . . 0.0 110.017 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.506 ' N ' HG21 ' A' ' 38' ' ' ILE . 19.9 ttmm -85.35 -42.3 14.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.861 . . . . 0.0 110.41 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -178.77 141.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 110.369 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.454 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 38.6 m -97.84 134.3 41.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 110.093 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.512 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 30.8 tt0 -137.26 110.98 8.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.211 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.49 HD11 HG22 ' A' ' 43' ' ' ILE . 37.2 mt -60.71 131.7 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.277 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.527 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 81.2 mt -92.18 -26.45 18.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.148 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' O ' ' CG2' ' A' ' 52' ' ' THR . 38.8 tt0 -151.41 173.53 14.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.895 . . . . 0.0 110.085 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.01 -155.23 2.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -147.97 34.17 0.83 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 110.22 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.5 -9.29 35.3 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.47 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -81.41 -172.84 47.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.525 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.9 Cg_endo -71.1 137.97 32.64 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 124.173 1.617 . . . . 0.0 110.464 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.84 -4.8 83.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 27.3 m -79.98 146.38 32.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -1.193 . . . . 0.0 110.116 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 70' ' ' LYS . 32.3 mm -113.38 110.21 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 110.154 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 69' ' ' HIS . 46.2 mtpt -93.11 141.99 27.8 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 110.474 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 83.3 tttt -111.7 113.26 25.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.091 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 38' ' ' ILE . 62.6 mt -102.97 138.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 110.118 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.472 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 1.6 p -114.03 152.53 30.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 110.562 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 30.5 m-85 -112.88 137.6 50.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.333 -0.854 . . . . 0.0 110.079 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.91 -27.78 30.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -91.13 158.01 16.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.296 -1.12 . . . . 0.0 110.154 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.13 -156.16 20.81 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.6 m -62.18 179.31 0.31 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -1.11 . . . . 0.0 110.27 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -67.78 -27.38 66.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.351 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.24 95.85 4.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.189 -0.944 . . . . 0.0 110.35 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -131.92 90.8 0.28 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.53 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 17.5 p90 -138.73 168.15 20.42 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.201 -1.176 . . . . 0.0 110.402 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.517 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.4 m -137.49 172.72 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.449 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.56 ' CB ' ' CG1' ' A' ' 86' ' ' ILE . 91.7 mttt -123.95 131.44 53.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.593 -0.692 . . . . 0.0 109.719 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.648 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 13.6 m170 -111.43 138.42 47.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.132 -0.98 . . . . 0.0 110.532 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HA ' HD12 ' A' ' 53' ' ' ILE . 82.0 tttt -114.93 107.82 15.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.436 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 33.4 mm -53.2 122.43 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 110.489 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.8 m-20 -94.89 -40.71 9.57 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.534 -0.729 . . . . 0.0 109.543 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 3.2 m -176.63 158.76 1.77 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.514 -0.741 . . . . 0.0 109.558 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.467 HD12 ' CG1' ' A' ' 23' ' ' VAL . 2.4 mt -138.16 159.32 32.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.25 -0.907 . . . . 0.0 110.124 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.493 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -145.63 83.85 1.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.574 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.591 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 86.0 tttt -68.18 -13.42 62.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 110.168 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -85.47 -30.38 23.53 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -109.44 -3.68 16.86 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.201 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CB ' ' HB2' ' A' ' 104' ' ' LEU . 48.4 m-85 63.36 52.02 2.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.666 -0.646 . . . . 0.0 110.359 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 13.5 t -121.59 174.34 6.85 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.152 -0.968 . . . . 0.0 110.208 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.528 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 21.0 t80 -157.77 146.55 19.39 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.149 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 50.6 m -149.98 125.24 10.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.042 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 6.7 p90 -142.49 176.45 9.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.404 -0.81 . . . . 0.0 109.862 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 53.1 m -135.54 141.54 45.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.648 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 9.2 tp -87.66 120.27 28.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.233 -0.917 . . . . 0.0 110.247 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.56 ' CG1' ' CB ' ' A' ' 68' ' ' LYS . 24.3 pt -100.63 -12.04 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.425 -0.797 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 71.0 tt0 -153.46 145.54 23.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.479 -0.763 . . . . 0.0 110.203 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.517 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 174.77 165.93 31.89 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 29.7 p-10 -79.9 -44.79 19.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -1.173 . . . . 0.0 110.522 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.482 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -50.8 -40.69 56.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 110.155 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.515 HD22 ' CD2' ' A' ' 95' ' ' LEU . 38.0 mt -40.42 -50.45 2.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.575 -0.703 . . . . 0.0 110.339 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.41 -166.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -81.5 5.21 18.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -1.132 . . . . 0.0 110.139 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 55.3 p -97.69 -45.85 6.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.393 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.534 HD12 ' CD1' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -118.4 163.06 17.29 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.112 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.524 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 62.7 tt0 -140.79 -79.79 0.27 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.524 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 33.8 mttt -80.28 145.95 31.89 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 110.735 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.63 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 25.4 mm -134.49 150.98 31.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.123 -0.985 . . . . 0.0 109.57 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -123.89 124.39 42.52 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.7 178.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.63 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 19.7 m-85 -117.86 134.64 54.73 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.32 -0.863 . . . . 0.0 110.625 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 117' ' ' THR . 6.0 mt-10 -134.36 126.43 29.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.821 . . . . 0.0 109.99 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 86.8 m -119.88 147.87 44.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.972 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LYS . 23.7 mttt -140.33 133.81 30.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 110.51 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.518 ' CD2' HD13 ' A' ' 18' ' ' LEU . 5.8 mt -112.71 151.81 29.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 110.185 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -151.36 -169.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.0 109.97 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -127.41 131.0 50.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.187 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 54.7 p -87.31 162.27 43.5 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.6 Cg_endo -72.51 -1.41 10.21 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.058 1.557 . . . . 0.0 110.594 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.9 p -101.05 -0.93 35.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.279 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.68 -39.72 2.79 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.78 -175.08 2.56 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 4.0 m -126.63 137.74 53.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -1.18 . . . . 0.0 110.468 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.473 ' HB ' ' HB ' ' A' ' 105' ' ' VAL . 65.0 mt -87.89 151.5 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.394 -0.816 . . . . 0.0 110.105 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.605 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 9.8 mt -134.24 113.31 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.294 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 103' ' ' LYS . 79.4 tttt -102.11 131.34 48.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 109.974 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.74 154.74 33.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.488 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 101' ' ' GLU . 64.6 m -155.47 123.04 5.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.399 -0.813 . . . . 0.0 110.02 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.464 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 42.0 t -129.06 157.19 42.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 44.6 m-70 -134.51 173.22 11.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.217 -0.927 . . . . 0.0 110.44 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.467 ' HA ' HD12 ' A' ' 98' ' ' ILE . 21.2 m-85 -129.91 144.44 51.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.271 -0.893 . . . . 0.0 110.575 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 96.8 m-70 -125.51 95.95 4.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 109.495 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 127' ' ' GLU . 3.1 p -56.87 164.93 1.36 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 0.0 110.572 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 78.9 tttt -115.52 119.2 35.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.45 -107.78 2.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.518 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 43.4 t30 -130.51 86.8 2.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -1.145 . . . . 0.0 110.266 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 125' ' ' ASN . 35.5 m -156.39 173.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 110.208 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.444 ' HA ' HG22 ' A' ' 122' ' ' THR . 96.9 mt-10 -148.27 147.7 29.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.216 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.57 HD11 ' CD1' ' A' ' 3' ' ' PHE . 5.2 mp -78.68 173.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.064 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.433 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 36.2 mtpt -103.94 136.04 44.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -49.45 -29.18 6.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 110.234 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.07 -35.51 78.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.064 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.424 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 17.6 t-160 -66.81 -42.64 85.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.097 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.63 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 68.9 t -62.57 -39.82 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.998 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -72.82 -39.16 66.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 110.179 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.15 93.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.133 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.24 -22.63 76.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.528 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 82.6 mttt -75.98 -32.67 59.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 110.094 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.56 -32.07 60.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.038 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -75.83 -27.59 57.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -84.76 -35.72 22.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 110.115 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 80.4 p -64.21 -46.0 85.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.876 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.19 -50.29 74.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.976 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.469 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.6 mm? -58.49 -32.72 69.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.853 . . . . 0.0 109.993 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 4.9 m-85 -63.33 -38.43 91.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.051 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -78.54 -18.1 55.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.468 ' HB3' HG22 ' A' ' 33' ' ' ILE . 15.4 mt -81.09 -35.14 32.06 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.126 -0.984 . . . . 0.0 108.829 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.596 HD11 ' CE1' ' A' ' 22' ' ' PHE . 34.7 mt -69.62 -49.06 61.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.857 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.474 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 65.1 mm-40 -54.12 -41.7 68.65 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.394 -0.816 . . . . 0.0 109.362 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 45.1 m -71.38 -32.6 68.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.592 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.588 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 76.2 t80 -53.9 -58.75 6.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.934 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.612 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 62.8 mt -69.03 -29.73 67.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -0.962 . . . . 0.0 109.968 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.525 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 43.5 tptt -68.59 -35.64 77.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 109.775 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.451 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -98.44 -28.69 7.87 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.511 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.8 m-70 -107.2 89.1 4.36 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.359 -1.083 . . . . 0.0 109.897 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.0 Cg_endo -72.76 4.46 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.095 1.576 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 24.2 p30 -107.74 -12.64 15.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.007 -1.058 . . . . 0.0 109.728 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.569 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . . . -66.49 100.57 0.67 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.409 -0.807 . . . . 0.0 109.999 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.691 ' CE2' ' CB ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER 34.86 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.279 0.562 . . . . 0.0 110.584 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.378 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.783 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 73.8 t -135.65 125.33 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.162 . . . . 0.0 110.456 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.559 ' CE1' HG12 ' A' ' 128' ' ' ILE . 52.9 m-85 -96.91 173.51 7.25 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.254 -0.904 . . . . 0.0 110.094 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.489 HG21 ' CE1' ' A' ' 119' ' ' HIS . 54.4 m -148.11 98.38 2.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.575 ' CZ ' HG23 ' A' ' 133' ' ' VAL . 78.5 m-85 -114.89 132.03 56.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.023 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 116' ' ' SER . 18.9 pt-20 -130.84 159.6 36.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.569 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 p -132.0 143.91 50.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.424 -0.798 . . . . 0.0 109.895 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -124.81 125.71 44.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 0.0 110.387 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.624 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 3.8 p90 -152.84 -172.86 4.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 110.005 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.46 HG23 HG12 ' A' ' 113' ' ' ILE . 10.8 p -140.19 179.89 6.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.272 -0.893 . . . . 0.0 110.446 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 112' ' ' SER . 2.6 t -157.51 158.96 36.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.268 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.482 ' OE2' ' NZ ' ' A' ' 152' ' ' LYS . 17.1 pt-20 -85.76 -10.89 54.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.915 . . . . 0.0 110.044 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 2.0 mp -90.5 151.37 44.12 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.711 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.3 Cg_endo -66.86 143.04 65.18 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.975 1.513 . . . . 0.0 110.723 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.638 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 Cg_endo -71.63 -31.73 12.96 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.952 1.501 . . . . 0.0 112.584 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -69.53 -18.99 37.77 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.511 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -84.47 -48.57 9.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.512 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.1 tt -68.62 -24.55 64.58 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.621 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 82.8 t80 -69.83 -57.12 5.46 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.498 0.666 . . . . 0.0 109.789 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 81.6 mttt -54.88 -30.56 58.31 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.692 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -73.3 -64.62 0.94 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.771 0.796 . . . . 0.0 111.167 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.627 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -57.43 -40.37 78.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.66 -0.65 . . . . 0.0 111.955 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.596 HG12 ' CD1' ' A' ' 81' ' ' TYR . 11.5 t -99.6 -59.41 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.786 -1.196 . . . . 0.0 111.798 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 7.3 mp -77.1 -0.55 25.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.015 . . . . 0.0 111.71 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -145.35 7.01 1.13 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.756 -1.215 . . . . 0.0 111.193 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -46.02 -48.06 16.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.873 -1.142 . . . . 0.0 110.01 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.441 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 74.0 m-20 -58.91 -15.43 12.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.831 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 25' ' ' ASP . 80.0 m-20 -129.54 10.93 5.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.556 HD13 ' CB ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -95.25 -46.26 6.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.982 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.645 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 6.3 p -76.91 -27.63 0.62 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 112.419 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.7 Cg_endo -75.68 3.14 6.22 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 122.563 0.77 . . . . 0.0 110.611 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' CD ' ' OH ' ' A' ' 150' ' ' TYR . 95.0 mttt -119.15 -26.5 5.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -0.941 . . . . 0.0 109.127 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.586 HG12 ' CD1' ' A' ' 150' ' ' TYR . 49.4 mt -79.35 -41.02 22.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.553 -0.717 . . . . 0.0 109.533 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.75 103.79 0.46 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.49 -0.756 . . . . 0.0 109.829 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.56 -3.01 11.02 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.979 1.515 . . . . 0.0 110.688 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -83.16 -14.87 52.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.494 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 58' ' ' PHE . . . -92.06 -71.97 0.61 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 110.201 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.549 ' CD1' HG22 ' A' ' 30' ' ' VAL . 1.7 mp -94.06 125.79 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.868 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -74.19 -36.19 64.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.339 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.538 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -179.56 151.96 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.862 . . . . 0.0 109.974 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.441 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 39.3 p -112.01 133.59 54.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.07 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 71.9 tt0 -139.88 108.72 5.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.971 . . . . 0.0 110.29 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.8 mt -66.07 134.54 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 110.189 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.8 tp -90.31 -27.03 19.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.522 ' O ' ' CG2' ' A' ' 52' ' ' THR . 33.3 tp10 -158.84 169.32 24.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.228 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 64.75 -166.17 32.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 48.7 t0 -135.88 29.71 3.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -1.167 . . . . 0.0 110.287 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.36 4.85 43.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -96.45 -167.31 33.91 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.462 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.64 132.12 21.3 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.143 1.602 . . . . 0.0 110.514 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.25 -7.31 66.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 26.7 m -80.02 139.0 37.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -1.106 . . . . 0.0 110.161 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.517 HD12 ' CB ' ' A' ' 70' ' ' LYS . 18.7 mm -109.06 110.84 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 110.226 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.1 mttt -97.84 153.27 18.42 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.378 -0.827 . . . . 0.0 110.392 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -124.94 100.6 6.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.075 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.481 HD11 HG22 ' A' ' 56' ' ' ILE . 88.5 mt -88.27 138.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.35 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.9 p -111.58 157.59 20.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.184 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 28.6 m-85 -117.83 159.44 23.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.356 -0.84 . . . . 0.0 110.3 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -134.43 20.59 3.92 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -48.78 -24.99 1.61 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -1.158 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.18 -37.31 1.16 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.1 m -50.32 158.45 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -1.124 . . . . 0.0 110.158 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.56 -45.28 69.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.243 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.01 110.11 9.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.249 -0.907 . . . . 0.0 110.31 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -139.47 82.83 0.24 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 14.7 p90 -131.6 163.65 27.59 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.219 -1.165 . . . . 0.0 110.198 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.51 HG13 ' CA ' ' A' ' 88' ' ' GLY . 9.5 m -137.71 172.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 110.627 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.526 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . 70.7 mttt -123.78 130.65 52.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.667 -0.646 . . . . 0.0 109.503 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.646 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 9.6 m170 -118.44 130.7 56.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.004 . . . . 0.0 111.0 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.517 ' CB ' HD12 ' A' ' 53' ' ' ILE . 85.0 tttt -104.05 120.04 40.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.416 -0.802 . . . . 0.0 109.174 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.536 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 21.0 mm -62.4 129.58 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 110.693 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 73' ' ' SER . 72.3 m-20 -101.37 -49.6 4.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.359 -0.838 . . . . 0.0 109.308 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 79.6 p -179.68 157.36 0.74 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.529 -0.732 . . . . 0.0 110.286 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.584 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 3.2 tt -145.97 164.32 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -134.31 81.5 1.92 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 110.123 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.621 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 41.6 ttmt -55.9 -14.38 2.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.278 -0.889 . . . . 0.0 110.824 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -84.1 -29.91 26.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 0.0 109.006 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -116.63 -1.1 12.22 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.357 0.599 . . . . 0.0 109.532 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.553 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 7.6 m-85 65.5 49.82 1.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.684 -0.635 . . . . 0.0 110.108 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.518 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -116.41 142.14 47.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 109.285 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.646 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 72.9 t80 -137.24 155.1 49.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.267 -0.895 . . . . 0.0 110.284 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 73' ' ' SER . 77.9 p -158.51 140.86 14.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 110.474 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.646 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 5.9 p90 -148.59 177.69 9.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 110.161 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.467 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 90.0 m -128.5 131.6 48.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 110.004 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.646 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 15.5 tp -83.62 123.7 30.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.201 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.526 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 33.7 pt -104.93 -8.99 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 110.228 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -163.57 166.26 22.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.51 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 155.04 153.23 6.43 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -79.96 -22.18 42.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -1.214 . . . . 0.0 110.268 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.99 -20.23 63.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.307 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.558 ' CD2' ' CD1' ' A' ' 98' ' ' ILE . 71.1 mt -67.79 -18.75 64.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.27 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.87 -167.19 0.51 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.41 9.53 25.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -1.151 . . . . 0.0 110.128 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 122' ' ' THR . 40.8 p -110.55 -32.11 7.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 110.079 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.577 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 72.3 mt -109.42 154.74 22.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 110.169 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 68.8 tt0 -137.37 -80.83 0.37 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.159 -0.963 . . . . 0.0 110.004 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' A' ' 98' ' ' ILE . 32.1 mttm -80.22 156.15 27.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.495 -0.753 . . . . 0.0 110.513 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.635 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.2 mm -145.49 126.28 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.092 -1.005 . . . . 0.0 109.82 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -93.23 126.51 38.38 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.45 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 15.0 m-85 -121.05 144.56 48.47 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.317 -0.864 . . . . 0.0 110.961 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -149.89 128.02 11.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.481 -0.762 . . . . 0.0 109.938 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 85.6 m -127.69 134.62 49.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.989 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 115' ' ' LYS . 15.5 mttt -124.44 136.81 54.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.287 -0.883 . . . . 0.0 110.362 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.522 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 8.5 mt -117.19 150.33 38.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.359 -0.838 . . . . 0.0 110.063 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.482 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -151.57 -169.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.257 -0.902 . . . . 0.0 110.107 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -117.81 140.42 49.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.408 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 92.1 p -96.74 162.5 22.94 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -72.6 -1.73 10.75 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.469 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p -99.9 -8.86 23.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.3 -21.81 21.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 11' ' ' SER . . . -74.34 -146.05 1.08 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.519 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 27.3 p -149.36 131.67 15.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -1.158 . . . . 0.0 110.057 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.46 HG12 HG23 ' A' ' 10' ' ' THR . 37.0 mt -83.19 148.98 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 110.132 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.624 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 7.0 mt -133.41 115.55 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 110.463 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 103' ' ' LYS . 81.3 tttt -108.37 117.66 34.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.325 -0.859 . . . . 0.0 109.748 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 8.7 t -113.5 164.72 13.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.753 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.5 HG23 ' CE1' ' A' ' 119' ' ' HIS . 30.8 m -160.01 120.23 2.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.375 -0.828 . . . . 0.0 109.795 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.558 ' OG ' ' CD1' ' A' ' 100' ' ' TYR . 26.5 m -122.69 133.93 54.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.383 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.5 ' CE1' HG23 ' A' ' 117' ' ' THR . 35.8 m-70 -114.3 156.82 23.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 109.763 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.8 m-85 -114.37 149.28 36.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 110.595 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 90.1 m-70 -125.74 88.17 2.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.018 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.577 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -74.15 146.06 43.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.514 -0.741 . . . . 0.0 111.083 -178.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 63.7 pttt -105.41 130.89 53.41 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.543 -0.723 . . . . 0.0 110.137 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.24 -117.47 4.62 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.523 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 46.2 t30 -138.27 103.28 4.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.275 -1.132 . . . . 0.0 110.418 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 8.7 m -159.5 165.49 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.833 . . . . 0.0 109.896 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -134.7 158.46 44.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.142 -0.974 . . . . 0.0 110.32 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.559 HG12 ' CE1' ' A' ' 3' ' ' PHE . 22.7 mm -70.7 172.93 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 110.196 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 132' ' ' HIS . 13.9 mttm -116.61 131.45 56.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.972 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 69.5 mm-40 -43.66 -44.4 6.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.15 -0.969 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -63.29 -24.63 67.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.933 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 129' ' ' LYS . 15.1 t-160 -81.06 -49.25 11.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.118 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.575 HG23 ' CZ ' ' A' ' 5' ' ' TYR . 59.5 t -58.79 -37.66 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.758 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.03 -44.81 37.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.902 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -64.27 -32.69 74.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.349 -0.844 . . . . 0.0 110.057 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.06 -32.17 66.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -75.83 -34.08 60.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -1.1 . . . . 0.0 109.997 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.99 -37.73 58.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.916 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 94.3 mttt -69.5 -37.53 77.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 109.861 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.477 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -69.79 -34.98 74.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.797 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 64.9 m -72.64 -44.19 62.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.805 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -57.61 -43.94 85.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.877 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.6 -43.75 98.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.913 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.48 ' HA ' HD13 ' A' ' 147' ' ' ILE . 8.6 m-85 -59.89 -32.87 71.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.443 -0.786 . . . . 0.0 109.84 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -78.27 -20.21 52.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.457 ' HB3' HG23 ' A' ' 33' ' ' ILE . 17.5 mt -83.25 -36.29 24.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.174 -0.954 . . . . 0.0 108.826 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 8.9 mt -72.51 -43.75 62.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.475 ' O ' HG12 ' A' ' 13' ' ' ILE . 54.7 mt-10 -60.95 -41.11 95.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.435 -0.791 . . . . 0.0 109.372 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.8 m -72.9 -32.8 65.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.622 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.594 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 86.2 t80 -56.48 -54.68 42.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.495 -0.753 . . . . 0.0 109.886 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.649 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 69.4 mt -69.27 -31.22 69.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.307 -0.871 . . . . 0.0 110.288 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 43.1 tttt -68.55 -28.43 66.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.88 . . . . 0.0 109.782 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.81 -26.72 6.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.513 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 11.2 m-70 -107.27 90.41 5.67 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.951 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.8 Cg_endo -73.47 3.75 4.51 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.101 1.579 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -109.56 -9.69 14.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.76 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.583 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . . . -68.48 100.28 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.468 -0.77 . . . . 0.0 110.136 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.692 ' CE2' ' CB ' ' A' ' 21' ' ' ALA . 0.7 OUTLIER 34.4 32.72 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.253 0.549 . . . . 0.0 110.542 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.846 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 50.0 t -125.43 114.31 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.187 -1.184 . . . . 0.0 110.406 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.57 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 93.1 m-85 -74.83 152.83 38.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.954 . . . . 0.0 110.184 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.491 HG21 ' CE1' ' A' ' 119' ' ' HIS . 7.9 m -130.38 113.76 14.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.638 ' CD2' ' CG1' ' A' ' 133' ' ' VAL . 39.1 m-85 -126.61 125.84 42.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.089 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.576 ' CG ' ' N ' ' A' ' 7' ' ' SER . 16.3 tt0 -114.82 176.15 5.18 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.277 -0.889 . . . . 0.0 109.61 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.576 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 19.1 m -153.0 147.4 25.87 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.646 -0.659 . . . . 0.0 109.852 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 47.6 mt-10 -140.26 116.33 10.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.054 -1.028 . . . . 0.0 110.566 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.9 p90 -145.17 -172.08 3.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 109.887 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.47 HG21 ' HA ' ' A' ' 113' ' ' ILE . 5.6 p -140.59 172.63 12.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.458 ' OG ' ' OG ' ' A' ' 112' ' ' SER . 53.8 p -150.69 142.24 23.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.465 -0.772 . . . . 0.0 110.097 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.17 -25.93 68.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.278 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 5.1 mp -81.34 146.38 57.74 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.148 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.562 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 41.7 Cg_endo -66.76 152.94 79.58 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.116 1.587 . . . . 0.0 110.719 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.645 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.7 Cg_endo -64.5 -36.08 45.38 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.763 1.401 . . . . 0.0 113.204 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 39.5 Cg_endo -65.24 -20.17 62.43 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 N-CA-C 109.748 -0.905 . . . . 0.0 109.748 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.524 ' HG3' ' CD1' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.92 -43.4 19.85 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.595 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 8.0 mp -72.68 -38.08 67.69 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.587 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 47.9 t80 -56.84 -57.56 11.93 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.24 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 92.5 mttt -57.58 -37.47 73.22 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.529 -0.732 . . . . 0.0 110.134 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.628 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . . . -80.03 -58.74 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 111.1 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.618 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -53.73 -40.52 66.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 0.0 111.958 -178.606 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.589 ' CG1' ' CD1' ' A' ' 74' ' ' ILE . 21.1 t -106.27 -65.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.845 -1.159 . . . . 0.0 111.693 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.554 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 4.2 mm? -62.77 -8.58 7.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 111.216 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.533 ' OD2' ' CD2' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -144.76 28.52 1.27 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.876 -1.14 . . . . 0.0 110.63 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -67.57 -35.51 79.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -0.907 . . . . 0.0 110.112 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.449 ' OD1' ' CB ' ' A' ' 41' ' ' SER . 19.8 t70 -63.25 -16.05 59.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 81.8 m-20 -126.94 8.1 6.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.029 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -92.94 -53.64 4.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.178 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.588 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.5 t -72.02 -42.47 9.78 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.415 -0.803 . . . . 0.0 110.905 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.3 Cg_endo -77.74 9.48 2.94 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.541 1.285 . . . . 0.0 111.005 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 33.3 ttmt -127.21 -31.2 2.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.968 -1.083 . . . . 0.0 109.831 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.582 HG12 ' CD1' ' A' ' 150' ' ' TYR . 36.7 mt -80.01 -38.97 19.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.443 -0.785 . . . . 0.0 109.733 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.28 99.75 2.49 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.449 -0.782 . . . . 0.0 110.026 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.27 -2.0 10.51 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.066 1.561 . . . . 0.0 110.481 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -86.36 -12.6 48.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.751 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.03 -56.34 2.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.081 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.529 ' CD1' HG13 ' A' ' 30' ' ' VAL . 2.0 mp -115.12 132.28 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 110.08 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.587 ' CG ' ' CA ' ' A' ' 59' ' ' GLY . 0.5 OUTLIER -68.62 -37.28 79.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.891 . . . . 0.0 110.193 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.554 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 177.61 153.82 0.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 110.018 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.449 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 62.7 m -115.04 125.7 53.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.979 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.554 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 84.5 tt0 -130.18 106.93 8.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.293 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 43' ' ' ILE . 22.2 mt -61.08 131.68 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.176 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.4 HD13 HG23 ' A' ' 53' ' ' ILE . 49.7 mt -88.93 -26.09 21.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 110.044 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.454 ' O ' ' CG2' ' A' ' 52' ' ' THR . 55.7 tt0 -152.31 171.14 18.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.97 -169.03 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -130.37 28.14 4.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -1.121 . . . . 0.0 110.232 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.36 -5.49 24.96 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -79.97 -170.99 41.86 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.478 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -70.44 133.55 24.56 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.195 1.629 . . . . 0.0 110.574 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.27 -1.42 76.77 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.465 HG21 ' N ' ' A' ' 53' ' ' ILE . 32.4 m -80.16 145.42 32.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -1.193 . . . . 0.0 110.158 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.481 HD12 ' HA ' ' A' ' 70' ' ' LYS . 36.0 mm -111.92 112.02 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 110.184 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HE2' HD12 ' A' ' 71' ' ' ILE . 46.5 mtmt -99.12 150.57 21.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 110.374 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -123.14 98.84 6.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.877 . . . . 0.0 110.053 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.471 ' HB ' HG22 ' A' ' 67' ' ' VAL . 96.6 mt -88.97 140.12 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 110.193 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.9 p -115.0 152.77 31.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.56 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 26.7 m-85 -117.62 129.2 55.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.499 -0.75 . . . . 0.0 109.993 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.587 ' CA ' ' CG ' ' A' ' 39' ' ' LYS . . . -93.38 36.22 3.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -129.05 131.24 47.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -1.126 . . . . 0.0 110.269 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.67 138.54 9.83 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 65.2 p -55.63 -49.16 73.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -1.111 . . . . 0.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -73.65 153.0 40.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 110.076 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -62.31 136.23 57.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.2 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -122.38 88.0 0.4 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.1 p90 -123.62 163.42 21.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -1.211 . . . . 0.0 110.124 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.521 HG13 ' CA ' ' A' ' 88' ' ' GLY . 8.6 m -141.32 172.03 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.938 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.445 ' HD2' ' OE1' ' A' ' 87' ' ' GLU . 86.4 mttt -127.4 125.85 41.4 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.512 ' CD2' HD13 ' A' ' 85' ' ' LEU . 10.1 m170 -116.92 121.02 40.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 111.161 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.517 ' HE2' ' CG2' ' A' ' 86' ' ' ILE . 23.5 mtmt -96.46 106.88 19.2 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.324 -0.86 . . . . 0.0 109.242 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.7 mm -48.34 136.68 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.872 . . . . 0.0 110.074 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 73' ' ' SER . 14.9 m-20 -107.34 -44.6 4.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.343 -0.848 . . . . 0.0 109.744 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 12.9 p 176.18 156.57 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.522 -0.736 . . . . 0.0 110.365 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.589 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 6.1 tt -144.96 169.86 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.504 -0.748 . . . . 0.0 109.597 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.4 m-20 -142.47 84.29 1.85 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.075 -1.016 . . . . 0.0 110.317 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.587 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 81.1 tttt -59.67 -13.9 11.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 110.221 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -92.79 -34.2 13.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.2 m-80 -102.21 -3.9 26.61 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.524 0.678 . . . . 0.0 109.229 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 75' ' ' ASP . 90.5 m-85 62.58 55.78 2.14 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.253 0.549 . . . . 0.0 110.919 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 2.7 m -132.14 162.38 31.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 0.0 109.658 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.61 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 80.2 t80 -158.08 146.71 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -0.974 . . . . 0.0 110.198 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 100' ' ' TYR . 3.8 t -153.56 147.63 25.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.692 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.61 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 9.2 p90 -149.76 175.58 11.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.429 -0.794 . . . . 0.0 110.015 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.44 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 97.6 m -125.61 128.82 48.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.52 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 2.7 tp -96.39 122.97 39.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.573 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.517 ' CG2' ' HE2' ' A' ' 70' ' ' LYS . 20.8 pt -112.63 -5.39 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 110.894 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 22.9 tt0 -147.29 120.86 9.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 110.672 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.521 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . -168.74 149.05 13.11 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.68 -8.04 24.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -1.123 . . . . 0.0 110.065 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.4 -53.54 6.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.471 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.547 ' CB ' ' HG ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -63.94 -30.7 71.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.269 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 39.08 -124.42 1.75 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -106.04 -6.46 18.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -1.125 . . . . 0.0 110.494 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.512 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 64.1 p -80.04 -50.63 10.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 109.703 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.547 ' HG ' ' CB ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -109.43 163.66 13.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 42.0 tt0 -133.18 -77.84 0.48 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 110.912 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.6 mtpt -80.08 128.96 34.11 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.615 -0.678 . . . . 0.0 111.125 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.617 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.2 mm -117.74 140.47 40.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 120.868 -1.145 . . . . 0.0 109.811 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -117.76 126.72 52.97 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.38 -0.825 . . . . 0.0 108.974 178.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.617 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 9.4 m-85 -121.8 136.07 54.93 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.915 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.46 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 48.3 tt0 -137.14 150.72 48.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.571 -0.706 . . . . 0.0 109.606 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' TYR . 36.7 m -149.21 150.4 32.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -0.997 . . . . 0.0 110.408 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.511 ' N ' HG21 ' A' ' 102' ' ' THR . 2.3 tttt -138.68 147.22 42.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.681 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 79' ' ' TYR . 2.7 mt -128.45 147.3 50.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.001 . . . . 0.0 110.688 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.495 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.72 -168.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.475 -0.765 . . . . 0.0 109.806 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -120.86 172.7 7.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.131 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 32.8 p -130.48 164.96 37.71 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -73.16 -1.3 10.35 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.995 1.524 . . . . 0.0 110.599 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.0 p -103.93 3.68 33.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.374 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.04 -36.76 3.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.97 -173.85 3.09 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.5 p -130.33 140.24 50.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -1.189 . . . . 0.0 110.357 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.47 ' HA ' HG21 ' A' ' 10' ' ' THR . 27.5 mt -89.8 149.5 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.854 . . . . 0.0 110.077 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.627 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 10.5 mt -135.95 110.61 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.313 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 37.1 ttmt -99.73 129.85 45.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.941 . . . . 0.0 110.135 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.6 t -121.03 157.18 30.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.958 . . . . 0.0 110.282 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 85.7 m -154.3 138.02 16.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 110.15 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.454 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 34.7 p -141.61 154.46 45.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 110.184 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.491 ' CE1' HG21 ' A' ' 4' ' ' THR . 82.2 m-70 -133.41 164.63 26.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 0.0 110.387 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.587 ' CD2' HG13 ' A' ' 128' ' ' ILE . 8.2 m-85 -124.06 141.92 51.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 110.435 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.2 m-70 -122.52 89.43 3.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.924 -1.11 . . . . 0.0 109.793 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.466 ' CG2' HG22 ' A' ' 126' ' ' VAL . 2.7 p -60.25 163.44 5.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 110.301 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 85.0 tttt -126.0 114.9 19.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.275 -0.891 . . . . 0.0 110.242 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.36 -105.37 2.99 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.522 ' O ' ' CG1' ' A' ' 126' ' ' VAL . 24.7 t30 -135.6 93.43 2.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -1.169 . . . . 0.0 110.202 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 125' ' ' ASN . 15.9 m -157.76 165.55 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.305 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -145.21 149.5 35.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 110.316 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.587 HG13 ' CD2' ' A' ' 120' ' ' TYR . 37.8 mm -75.97 173.41 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 110.203 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.482 ' N ' HG23 ' A' ' 128' ' ' ILE . 31.5 mtpt -116.54 136.21 53.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.4 -0.813 . . . . 0.0 110.078 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -45.43 -43.26 11.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 37.1 tt0 -61.62 -31.28 71.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 110.142 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -74.02 -47.69 35.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 110.081 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.638 ' CG1' ' CD2' ' A' ' 5' ' ' TYR . 73.0 t -62.21 -40.96 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.381 -0.824 . . . . 0.0 110.008 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -69.37 -42.73 74.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.997 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -62.4 -38.66 90.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.026 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -30.23 68.16 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 52.7 mtpt -77.37 -31.85 54.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -1.147 . . . . 0.0 110.055 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -76.67 -30.49 56.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 109.927 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 46.1 mttp -68.37 -37.5 80.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.864 . . . . 0.0 110.051 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.42 -43.08 64.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.902 . . . . 0.0 110.007 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.1 p -63.42 -43.46 97.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.943 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -57.73 -41.68 82.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.863 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.464 ' O ' HG13 ' A' ' 147' ' ' ILE . 66.4 mt -58.61 -46.32 87.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 0.0 109.966 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.458 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 20.9 m-85 -54.42 -39.53 67.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.383 -0.823 . . . . 0.0 109.913 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.88 -28.19 68.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.88 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.515 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 16.9 mt -82.93 -34.5 26.53 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.222 -0.924 . . . . 0.0 108.791 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.618 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 81.8 mt -72.01 -34.79 51.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.606 -0.684 . . . . 0.0 109.329 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 152' ' ' LYS . 30.8 mt-10 -64.91 -39.43 93.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.403 -0.811 . . . . 0.0 109.428 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.7 m -69.6 -35.47 75.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.498 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.591 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 71.5 t80 -58.58 -51.84 68.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.819 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.587 ' CD2' ' CE1' ' A' ' 158' ' ' TYR . 78.0 mt -80.05 -39.15 30.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 110.27 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 82.6 tttt -64.2 -19.16 65.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.495 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.31 -34.72 2.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.613 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 3.6 m-70 -107.03 94.47 10.88 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.276 -1.132 . . . . 0.0 109.983 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.432 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.4 Cg_endo -74.04 5.38 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.089 1.573 . . . . 0.0 110.973 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -106.89 -9.66 16.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.046 -1.034 . . . . 0.0 109.856 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 150' ' ' TYR . . . -69.68 100.82 1.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.348 -0.845 . . . . 0.0 110.083 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.628 ' CE1' ' CB ' ' A' ' 21' ' ' ALA . 1.0 OUTLIER 34.09 33.6 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.342 0.591 . . . . 0.0 110.642 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.516 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 118.009 -0.995 . . . . 0.0 109.852 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.591 HG22 ' CD2' ' A' ' 121' ' ' HIS . 2.9 p -80.12 150.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -1.131 . . . . 0.0 110.35 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.567 ' CD1' HD13 ' A' ' 128' ' ' ILE . 26.1 m-85 -89.07 176.38 7.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 110.368 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.4 m -145.45 103.66 3.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.396 -0.815 . . . . 0.0 110.083 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.577 ' CE1' HG12 ' A' ' 133' ' ' VAL . 51.5 m-85 -116.23 129.34 56.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 110.098 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 25.5 pt-20 -131.52 157.94 42.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 110.505 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.4 m -133.95 139.42 46.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.895 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.452 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 99.9 mt-10 -121.24 127.32 51.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.385 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 3.8 p90 -154.3 -171.76 3.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.038 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 18.0 p -141.35 -176.46 4.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.57 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.489 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 3.7 t -159.6 160.9 34.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.776 . . . . 0.0 110.152 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -85.16 -19.11 32.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.978 . . . . 0.0 110.153 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 10.0 mm -85.47 149.8 52.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 110.095 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.55 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 40.9 Cg_endo -65.82 148.5 86.5 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.06 1.558 . . . . 0.0 110.57 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.649 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.3 Cg_endo -70.05 -32.57 17.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.885 1.466 . . . . 0.0 112.893 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.2 Cg_endo -67.58 -20.62 47.0 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 N-CA-C 110.149 -0.75 . . . . 0.0 110.149 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CD ' ' HB2' ' A' ' 159' ' ' ASN . 4.6 ttm180 -84.73 -49.16 8.72 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.52 HD23 ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -69.06 -26.73 65.1 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.205 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.604 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.9 t80 -71.29 -55.03 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 109.236 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 63.3 mttt -51.72 -32.98 32.49 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.403 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.619 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -79.83 -55.09 5.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 111.188 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 1.0 OUTLIER -57.29 -44.39 84.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.527 -0.733 . . . . 0.0 112.52 -177.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.454 HG12 HG12 ' A' ' 74' ' ' ILE . 3.5 t -106.8 -55.68 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.792 -1.192 . . . . 0.0 112.06 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.9 mm? -68.84 -10.64 58.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.01 -1.056 . . . . 0.0 111.174 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 1.2 m-20 -145.36 28.58 1.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.886 -1.134 . . . . 0.0 110.734 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -67.29 -20.04 65.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.152 -0.968 . . . . 0.0 110.436 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -72.61 -20.19 61.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.096 -1.003 . . . . 0.0 109.588 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.456 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 5.7 p30 -126.85 14.76 7.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 109.672 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.571 HD22 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -96.42 -50.16 4.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.224 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.664 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 9.7 p -73.26 -26.99 0.79 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.332 -0.855 . . . . 0.0 112.183 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 52.1 Cg_endo -82.91 10.38 3.66 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 122.621 0.8 . . . . 0.0 110.51 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -134.37 -27.04 1.4 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.13 -0.982 . . . . 0.0 110.603 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.57 HG12 ' CD1' ' A' ' 150' ' ' TYR . 34.3 mt -77.87 -36.29 21.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.225 -0.922 . . . . 0.0 109.899 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.95 100.13 0.82 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.342 -0.849 . . . . 0.0 110.338 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.85 -0.1 9.0 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.109 1.584 . . . . 0.0 110.346 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -88.29 -13.09 41.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 110.007 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.13 -47.1 4.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 110.315 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.55 ' CD1' ' CG2' ' A' ' 30' ' ' VAL . 1.1 mp -125.79 145.24 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -0.82 . . . . 0.0 110.103 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -83.18 -42.04 17.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.269 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.543 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -178.44 163.53 1.58 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 110.123 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.6 m -120.27 125.68 48.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.185 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.528 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 83.9 tt0 -130.04 107.57 9.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 110.151 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 23.4 mt -56.54 134.89 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 110.071 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' CD2' ' HE3' ' A' ' 55' ' ' LYS . 63.8 tp -88.76 -46.51 8.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -0.958 . . . . 0.0 109.911 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 46' ' ' GLY . 16.8 mm-40 -131.97 -169.81 2.28 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.442 -0.786 . . . . 0.0 110.179 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.435 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.08 -150.05 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 47' ' ' ASP . 23.4 t0 -160.03 41.48 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -1.133 . . . . 0.0 110.093 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.31 -11.71 54.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -82.13 -175.54 50.62 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.3 Cg_endo -72.23 132.82 20.06 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.144 1.602 . . . . 0.0 110.43 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.91 -3.78 62.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.473 HG21 ' N ' ' A' ' 53' ' ' ILE . 42.4 m -80.02 150.04 30.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -1.175 . . . . 0.0 109.986 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.473 ' N ' HG21 ' A' ' 52' ' ' THR . 20.9 mm -116.76 107.62 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.948 . . . . 0.0 110.324 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 73.0 mttt -90.32 144.88 25.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.398 -0.814 . . . . 0.0 110.097 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.522 ' HE3' ' CD2' ' A' ' 44' ' ' LEU . 31.7 mttt -117.95 95.4 4.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.267 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 38' ' ' ILE . 86.9 mt -83.44 145.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.904 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.47 ' O ' HG22 ' A' ' 38' ' ' ILE . 6.2 p -116.48 158.35 23.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 110.74 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 28.9 m-85 -116.42 145.87 42.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.226 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.91 4.93 53.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.65 151.54 51.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.167 -1.196 . . . . 0.0 110.285 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.51 -143.6 16.97 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.8 p -61.49 173.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -1.16 . . . . 0.0 110.208 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.447 ' HA ' ' OE1' ' A' ' 63' ' ' GLN . 10.8 tp60 -47.03 -58.43 4.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.085 -1.009 . . . . 0.0 110.112 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.495 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 7.1 t80 -108.51 116.67 32.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.26 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -116.8 135.86 12.31 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.541 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.9 p90 -179.08 166.57 1.57 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -1.153 . . . . 0.0 110.271 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.535 HG13 ' CA ' ' A' ' 88' ' ' GLY . 3.6 m -142.09 174.7 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 110.362 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.465 ' O ' HD11 ' A' ' 85' ' ' LEU . 96.6 mttt -126.15 124.75 41.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.481 -0.762 . . . . 0.0 109.705 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.617 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 10.1 m170 -113.73 130.3 56.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.135 -0.978 . . . . 0.0 110.814 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HA ' HD12 ' A' ' 53' ' ' ILE . 76.7 tttt -107.31 102.31 11.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.381 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 49' ' ' GLY . 34.6 mm -45.25 135.35 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.466 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 12.2 t0 -108.66 -38.69 5.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.446 -0.784 . . . . 0.0 109.617 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 6.4 p 179.07 156.58 0.5 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.505 -0.747 . . . . 0.0 110.019 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.454 HG12 HG12 ' A' ' 23' ' ' VAL . 1.9 mt -136.97 159.17 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.07 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-20 -144.67 83.97 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.62 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.604 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 57.4 tttp -66.65 -15.82 63.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.276 -0.89 . . . . 0.0 110.17 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -86.29 -31.04 21.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 0.0 108.809 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m-80 -106.1 -3.9 20.98 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 75' ' ' ASP . 98.9 m-85 61.11 53.73 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.36 0.6 . . . . 0.0 110.584 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 12.9 t -125.47 175.2 7.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.85 . . . . 0.0 110.103 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.687 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 39.1 t80 -159.59 134.23 7.84 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.713 -0.617 . . . . 0.0 109.8 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 20.2 m -140.77 123.34 16.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 111.037 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.687 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 16.8 p90 -139.16 171.86 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.812 . . . . 0.0 110.01 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 58.0 m -124.33 137.1 54.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.978 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.617 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 15.5 tp -99.74 124.85 45.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.391 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.419 HG23 HD11 ' A' ' 86' ' ' ILE . 23.3 pt -102.22 -10.67 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 110.292 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 85' ' ' LEU . 81.7 tt0 -151.51 155.71 39.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 110.232 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.535 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 157.61 143.47 3.67 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -61.54 -25.9 67.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -1.107 . . . . 0.0 110.184 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.553 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -60.21 -25.87 65.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 110.253 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' A' ' 92' ' ' GLY . 89.6 mt -62.52 -11.76 18.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.199 -0.938 . . . . 0.0 110.137 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 42.57 28.95 0.67 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 66.9 m-20 56.29 16.1 2.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -1.185 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 92' ' ' GLY . 19.6 p -111.93 -34.27 6.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.736 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.53 HD23 ' CD1' ' A' ' 128' ' ' ILE . 96.2 mt -94.76 163.85 13.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.826 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 68.1 tt0 -127.98 -81.61 0.59 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.783 0.802 . . . . 0.0 109.782 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 60.4 mttt -80.3 127.97 32.99 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.657 -0.652 . . . . 0.0 110.142 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.637 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 3.8 mm -117.05 139.91 41.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.628 -1.295 . . . . 0.0 109.721 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -120.59 125.18 47.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.637 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 12.4 m-85 -120.07 132.06 55.31 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.398 -0.814 . . . . 0.0 110.396 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 117' ' ' THR . 5.7 mt-10 -131.53 133.87 45.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.022 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 88.8 m -129.35 146.65 51.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.917 . . . . 0.0 110.1 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 115' ' ' LYS . 1.5 mttm -139.89 134.45 31.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 110.294 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.521 ' CD2' HG12 ' A' ' 114' ' ' ILE . 10.1 mt -113.93 148.24 37.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.145 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -150.89 -168.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 110.092 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -122.96 161.09 24.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 26.1 p -119.73 163.95 24.75 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.28 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.6 Cg_endo -72.27 -1.97 10.95 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.064 1.56 . . . . 0.0 110.477 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.2 p -103.78 -0.74 28.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.263 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.17 -35.72 4.85 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.25 -174.05 2.57 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.5 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 55.5 p -129.17 137.5 51.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -1.171 . . . . 0.0 110.327 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 59.2 mt -88.71 150.79 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 110.326 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.632 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 8.5 mt -132.86 111.35 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.1 tttt -101.11 123.39 45.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.108 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.5 t -117.17 156.53 27.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 101' ' ' GLU . 57.7 m -158.97 125.23 4.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 110.201 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.488 ' HB2' ' CD1' ' A' ' 100' ' ' TYR . 31.3 t -127.09 162.23 26.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 110.172 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 44.0 m-70 -140.75 128.83 22.1 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 9.7 m-30 -100.28 119.76 38.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.182 -0.949 . . . . 0.0 110.953 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.591 ' CD2' HG22 ' A' ' 2' ' ' VAL . 84.5 m-70 -93.59 101.27 13.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.379 -0.826 . . . . 0.0 109.373 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.47 ' CG2' HD22 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -81.06 154.12 27.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.042 -1.036 . . . . 0.0 110.525 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.406 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 33.4 tttp -127.64 117.36 21.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 116.26 -135.31 12.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 3.2 p-10 -125.84 53.53 1.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -1.15 . . . . 0.0 110.235 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.3 m -135.27 155.54 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 110.134 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.02 157.13 47.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.958 . . . . 0.0 110.371 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.567 HD13 ' CD1' ' A' ' 3' ' ' PHE . 2.2 mp -65.36 173.27 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.973 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.516 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 34.0 mttt -118.31 148.13 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 109.915 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.523 ' HG2' ' N ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -51.71 -22.88 3.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 110.395 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.523 ' N ' ' HG2' ' A' ' 130' ' ' GLU . 49.2 tt0 -77.8 -35.46 51.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.838 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 19.8 t-160 -73.58 -36.47 65.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.577 HG12 ' CE1' ' A' ' 5' ' ' TYR . 59.5 t -63.73 -43.62 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.864 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.48 -42.94 77.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.84 . . . . 0.0 109.955 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.93 89.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.513 ' HA3' ' CD ' ' A' ' 139' ' ' LYS . . . -65.61 -29.88 76.16 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 141' ' ' SER . 94.5 mttt -78.43 -30.73 47.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -1.128 . . . . 0.0 110.156 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.504 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 96.5 mt-10 -76.27 -39.77 53.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.086 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.513 ' CD ' ' HA3' ' A' ' 136' ' ' GLY . 18.8 ptpt -66.69 -33.18 75.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.837 . . . . 0.0 109.875 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 139' ' ' LYS . . . -88.82 -40.13 13.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.002 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 137' ' ' LYS . 61.6 m -65.27 -44.74 87.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.349 -0.845 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.3 m-20 -58.81 -41.33 86.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.367 -0.833 . . . . 0.0 110.035 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.0 mt -61.28 -40.6 94.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.889 . . . . 0.0 110.053 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -61.54 -34.75 76.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.019 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -76.9 -17.84 58.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.017 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.492 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 16.7 mt -83.45 -35.19 25.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.242 -0.912 . . . . 0.0 108.938 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 93.1 mt -71.22 -43.14 74.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.489 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 55.1 mt-10 -57.62 -37.72 73.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.362 -0.836 . . . . 0.0 109.283 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 65.7 m -73.65 -33.56 64.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.458 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.593 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 80.1 t80 -54.3 -48.51 71.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.458 -0.776 . . . . 0.0 109.898 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.631 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 72.4 mt -78.35 -30.55 48.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.178 -0.951 . . . . 0.0 110.164 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.469 ' HA ' HD13 ' A' ' 13' ' ' ILE . 30.5 ttpt -71.65 -22.11 61.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.307 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.14 -31.24 3.88 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.562 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.9 m-70 -109.78 92.88 13.23 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.452 -1.028 . . . . 0.0 109.968 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.17 5.82 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.034 1.544 . . . . 0.0 111.067 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -109.35 -1.03 18.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 109.991 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.557 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -81.54 102.89 10.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 110.073 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.631 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.85 32.79 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.366 0.603 . . . . 0.0 110.517 -179.484 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.535 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.818 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 85.2 t -120.15 123.61 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -1.158 . . . . 0.0 110.375 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.579 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 86.9 m-85 -75.03 148.01 40.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 110.087 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.429 HG22 ' CE1' ' A' ' 119' ' ' HIS . 52.0 m -131.74 121.64 24.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 74.7 m-85 -131.17 156.7 44.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.059 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -148.67 152.95 37.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 110.105 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' A' ' 116' ' ' SER . 54.5 p -136.18 148.71 48.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.424 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 95.4 mt-10 -136.88 117.82 14.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 110.28 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.614 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 p90 -144.88 -175.71 4.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.899 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.479 HG23 HG12 ' A' ' 113' ' ' ILE . 17.8 p -138.39 179.58 6.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.565 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.529 ' CB ' ' HG3' ' A' ' 148' ' ' GLU . 8.8 p -157.02 163.78 38.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.229 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.84 -13.62 47.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.239 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 3.1 mp -90.78 149.68 40.84 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 0.0 110.139 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 41.8 Cg_endo -66.98 148.55 82.07 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.995 1.524 . . . . 0.0 110.553 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.644 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -69.96 -32.95 16.77 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 O-C-N 123.947 1.498 . . . . 0.0 113.096 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.4 Cg_endo -67.12 -22.09 47.85 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 N-CA-C 109.934 -0.833 . . . . 0.0 109.934 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 0.1 OUTLIER -82.23 -49.36 10.18 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.528 HD23 ' CD2' ' A' ' 104' ' ' LEU . 1.3 tt -68.21 -29.72 68.62 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.589 ' CZ ' ' HA ' ' A' ' 76' ' ' LYS . 67.6 t80 -61.85 -57.28 12.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.127 178.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 92.2 mttt -50.09 -53.08 29.59 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.137 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.649 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -55.29 -68.15 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 110.554 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.62 ' CD1' ' CD1' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -43.21 -58.89 2.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.714 -0.616 . . . . 0.0 111.845 -178.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 74' ' ' ILE . 3.7 t -91.2 -61.14 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.066 -1.021 . . . . 0.0 112.246 -178.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.604 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.7 mm? -69.94 -2.07 11.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.037 -1.039 . . . . 0.0 112.168 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -151.11 25.97 0.71 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.586 -1.321 . . . . 0.0 111.281 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -63.37 -37.53 87.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.031 . . . . 0.0 109.761 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 55.1 m-20 -64.75 -12.03 42.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.765 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.462 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 64.1 m-80 -130.17 7.83 5.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.456 -0.778 . . . . 0.0 109.889 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.525 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -94.14 -49.57 5.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.323 -0.861 . . . . 0.0 110.263 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.669 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 7.1 p -77.67 -26.21 0.52 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.352 -0.843 . . . . 0.0 112.526 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 52.1 Cg_endo -79.39 6.58 5.01 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 O-C-N 122.501 0.737 . . . . 0.0 110.585 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -131.42 -29.07 1.81 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.108 -0.995 . . . . 0.0 110.217 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.558 HG12 ' CD1' ' A' ' 150' ' ' TYR . 67.2 mt -79.29 -37.6 19.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.296 -0.878 . . . . 0.0 109.755 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.61 91.25 2.31 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.391 -0.818 . . . . 0.0 110.251 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.34 0.01 8.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.01 1.531 . . . . 0.0 110.563 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -90.85 -24.48 20.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.121 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.36 -37.88 13.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.098 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.535 HD12 ' CG2' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -125.3 133.22 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.0 109.893 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.516 ' HG3' ' CA ' ' A' ' 59' ' ' GLY . 11.5 mttt -72.89 -41.94 64.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.901 . . . . 0.0 110.075 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.548 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -179.89 161.22 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 110.19 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 m -125.02 118.34 26.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 110.021 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -124.5 111.21 15.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.504 HD11 HG22 ' A' ' 43' ' ' ILE . 21.6 mt -57.86 127.25 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.523 HD12 ' CE ' ' A' ' 55' ' ' LYS . 12.3 tp -90.93 -40.04 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 0.0 110.087 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.52 ' O ' ' CG2' ' A' ' 52' ' ' THR . 0.6 OUTLIER -132.08 156.08 46.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.35 -162.86 18.41 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -141.25 25.51 2.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -1.13 . . . . 0.0 110.059 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.66 -10.32 10.49 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -80.76 -170.57 42.9 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.473 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.8 Cg_endo -71.21 132.86 21.78 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.022 1.538 . . . . 0.0 110.443 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.7 -1.55 71.82 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 22.7 m -80.04 140.35 36.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.17 . . . . 0.0 109.976 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 28.8 mm -110.4 117.87 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 110.382 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 89.5 mttt -104.53 119.33 38.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 0.0 110.159 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.523 ' CE ' HD12 ' A' ' 44' ' ' LEU . 46.9 mttm -88.6 97.69 11.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.388 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.47 HD11 HG22 ' A' ' 56' ' ' ILE . 93.8 mt -89.58 139.68 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.895 . . . . 0.0 110.018 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 6.6 p -115.51 157.34 24.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.937 . . . . 0.0 110.736 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 26.4 m-85 -117.86 125.28 50.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.423 -0.798 . . . . 0.0 110.15 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.516 ' CA ' ' HG3' ' A' ' 39' ' ' LYS . . . -106.91 11.29 41.23 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.64 -21.41 17.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -1.143 . . . . 0.0 110.211 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.27 166.72 26.68 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.9 p -71.02 -27.1 63.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -1.145 . . . . 0.0 110.238 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -63.26 161.73 13.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 110.161 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.44 120.06 23.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.584 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -137.51 92.17 0.21 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 15.9 p90 -132.73 169.44 16.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -1.158 . . . . 0.0 110.131 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.522 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.0 m -142.29 174.94 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.663 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 94.1 mttt -132.39 106.49 7.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.731 . . . . 0.0 109.522 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.463 ' CD2' HD11 ' A' ' 85' ' ' LEU . 12.8 m170 -96.28 124.78 40.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 111.419 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 67.6 tttt -98.96 101.65 13.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.448 -0.782 . . . . 0.0 109.02 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.473 HG23 ' HA ' ' A' ' 50' ' ' PRO . 22.7 mm -41.69 140.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.488 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 17.9 t0 -112.42 -45.58 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.986 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 16.8 m -169.88 157.21 6.62 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.431 -0.793 . . . . 0.0 110.146 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.434 HG12 HG12 ' A' ' 23' ' ' VAL . 1.7 mt -141.48 157.2 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.397 -0.814 . . . . 0.0 109.877 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.53 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 2.0 m-20 -144.53 83.64 1.72 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.821 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 82.3 tttt -66.24 -13.22 60.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.363 -0.836 . . . . 0.0 109.888 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -90.79 -30.72 16.84 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.805 0.812 . . . . 0.0 109.157 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m-80 -105.52 -4.49 21.19 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.521 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 90.0 m-85 63.57 53.69 2.03 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.297 0.57 . . . . 0.0 110.74 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 13.1 t -127.58 175.34 8.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.961 -1.087 . . . . 0.0 110.455 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.651 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 34.4 t80 -160.02 137.59 9.73 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.612 -0.68 . . . . 0.0 109.744 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 28.7 m -148.0 123.84 10.6 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.129 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.651 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 29.5 p90 -139.41 168.14 20.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.887 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 25.4 m -122.19 140.9 52.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 110.228 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.538 ' CD1' ' O ' ' A' ' 68' ' ' LYS . 10.7 tp -107.38 132.21 53.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 110.099 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 86' ' ' ILE . 11.5 pt -112.87 -31.67 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 110.353 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.431 ' OE1' ' HD2' ' A' ' 68' ' ' LYS . 7.2 tt0 -116.52 141.63 47.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.898 . . . . 0.0 110.276 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.522 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 167.88 168.08 29.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.71 -28.87 45.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.281 -1.129 . . . . 0.0 110.227 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.99 -32.53 72.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.337 -0.852 . . . . 0.0 110.174 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.539 ' CD2' ' O ' ' A' ' 96' ' ' GLU . 6.8 mt -64.64 -44.2 91.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 110.393 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 44.18 -142.53 2.72 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -106.34 27.57 8.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -1.131 . . . . 0.0 110.237 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 122' ' ' THR . 80.8 p -124.74 -45.18 1.92 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 110.126 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.535 HD12 ' CD1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -102.41 160.57 14.44 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.448 -0.783 . . . . 0.0 109.272 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.539 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 85.1 mt-10 -135.37 -78.63 0.44 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 110.823 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 57.4 mttt -80.22 134.93 36.16 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.452 -0.78 . . . . 0.0 110.973 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.57 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.5 mm -121.36 139.49 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.975 -1.078 . . . . 0.0 109.633 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.3 m -118.45 126.53 52.25 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.187 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 7.3 m-85 -118.84 136.74 53.86 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.529 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -137.17 145.89 44.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.022 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.521 HG21 ' N ' ' A' ' 103' ' ' LYS . 45.3 m -145.43 152.6 40.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 110.019 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.521 ' N ' HG21 ' A' ' 102' ' ' THR . 0.0 OUTLIER -141.67 140.83 33.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 110.372 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.528 ' CD2' HD23 ' A' ' 18' ' ' LEU . 8.8 mt -124.24 145.24 49.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.358 -0.839 . . . . 0.0 110.271 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.488 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.22 -169.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.227 -0.921 . . . . 0.0 109.941 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -118.72 170.33 9.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 110.012 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.2 p -127.54 161.78 52.83 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 110.021 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.58 -8.71 23.76 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.954 1.502 . . . . 0.0 110.387 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.9 p -93.77 -9.5 37.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 110.215 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.02 -36.25 4.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.87 -176.22 6.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.514 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 60.5 p -123.67 136.85 54.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -1.146 . . . . 0.0 110.351 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.479 HG12 HG23 ' A' ' 10' ' ' THR . 18.8 mt -86.49 150.03 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.838 . . . . 0.0 110.109 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.591 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 6.3 mt -135.42 115.36 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.364 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 103' ' ' LYS . 84.8 tttt -106.42 123.13 47.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 109.873 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 3.5 t -118.45 159.68 23.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -0.979 . . . . 0.0 110.598 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 42.5 m -159.56 144.38 15.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.426 -0.796 . . . . 0.0 110.17 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.9 t -141.04 163.46 32.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.15 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 82.0 m-70 -143.89 160.98 39.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.915 . . . . 0.0 110.484 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 9.6 m-85 -124.85 140.88 52.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.316 -0.865 . . . . 0.0 110.224 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.8 m-70 -120.92 90.54 3.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 109.762 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 94' ' ' THR . 1.1 p -82.59 150.18 27.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.871 . . . . 0.0 110.364 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.41 ' HB3' ' CD ' ' A' ' 96' ' ' GLU . 78.4 tttt -123.03 129.1 51.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 110.202 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 -162.87 25.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.49 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 0.9 OUTLIER -87.62 54.13 3.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -1.181 . . . . 0.0 110.109 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.471 ' O ' ' HB ' ' A' ' 122' ' ' THR . 17.6 m -135.99 133.39 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.222 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.456 ' HA ' HG22 ' A' ' 122' ' ' THR . 17.9 pt-20 -127.7 165.54 19.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 0.0 110.092 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.572 HD11 ' CD1' ' A' ' 3' ' ' PHE . 3.8 mp -82.8 173.0 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.889 . . . . 0.0 110.042 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 132' ' ' HIS . 75.0 mmtt -106.28 122.83 47.03 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.348 -0.845 . . . . 0.0 110.149 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 131' ' ' GLU . 24.1 pt-20 -43.45 -42.65 4.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 110.145 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.482 ' N ' ' CG ' ' A' ' 130' ' ' GLU . 16.5 pt-20 -58.16 -29.33 65.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.206 -0.934 . . . . 0.0 109.896 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 129' ' ' LYS . 11.7 t-80 -74.36 -55.5 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.635 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 7.6 p -61.62 -39.39 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.387 -0.821 . . . . 0.0 110.009 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.461 ' N ' HG12 ' A' ' 133' ' ' VAL . 84.0 tttt -65.52 -45.83 81.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.84 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.39 87.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.89 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.08 -30.82 74.14 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 137' ' ' LYS . 59.0 mmtt -65.91 -34.75 78.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -1.106 . . . . 0.0 109.872 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -69.91 -35.62 74.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.859 . . . . 0.0 109.839 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -71.68 -29.95 65.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.738 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.31 -40.87 42.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.99 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.2 p -59.44 -45.3 91.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.752 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -56.44 -43.85 79.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.841 . . . . 0.0 109.779 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 39.4 tp -57.68 -47.31 82.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.767 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.457 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 29.3 m-85 -53.68 -44.57 69.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.648 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -75.78 -14.58 60.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.32 -0.862 . . . . 0.0 109.925 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.427 ' HB3' HG23 ' A' ' 33' ' ' ILE . 20.1 mt -83.2 -36.67 24.47 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.209 -0.932 . . . . 0.0 108.692 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.62 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 96.0 mt -67.16 -47.4 81.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.529 ' HG3' ' CB ' ' A' ' 11' ' ' SER . 5.9 mm-40 -51.49 -47.09 63.33 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.388 -0.82 . . . . 0.0 109.218 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.6 m -63.15 -40.52 97.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.593 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.573 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 79.6 t80 -47.12 -51.84 16.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.97 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.609 ' CD2' ' CZ ' ' A' ' 158' ' ' TYR . 80.3 mt -76.27 -37.97 56.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.789 . . . . 0.0 110.366 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 19.4 tptt -59.31 -16.9 24.8 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.166 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -117.61 -27.02 2.69 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 10.7 m-70 -106.28 91.89 6.19 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.266 -1.137 . . . . 0.0 110.167 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.1 Cg_endo -73.13 3.3 4.69 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.986 1.519 . . . . 0.0 111.006 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -119.0 -2.26 10.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.022 -1.049 . . . . 0.0 110.299 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.644 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -67.22 99.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.23 -0.918 . . . . 0.0 110.397 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.649 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 11.5 p90 37.55 23.45 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.55 -0.719 . . . . 0.0 112.346 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 9.1 m-80 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 120.473 -1.392 . . . . 0.0 109.992 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.543 HG12 ' CE1' ' A' ' 121' ' ' HIS . 85.8 t -101.04 119.23 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -1.114 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.574 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 77.6 m-85 -83.68 161.57 21.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.23 -0.919 . . . . 0.0 110.139 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.448 HG21 ' CE1' ' A' ' 119' ' ' HIS . 55.4 m -143.61 99.92 3.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.584 ' CZ ' HG23 ' A' ' 133' ' ' VAL . 77.9 m-85 -116.37 126.5 53.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.179 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.596 ' CG ' ' N ' ' A' ' 7' ' ' SER . 3.6 tt0 -126.16 178.57 5.71 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.204 -0.935 . . . . 0.0 109.89 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.596 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -155.56 -179.08 7.76 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.76 -0.587 . . . . 0.0 109.751 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 7' ' ' SER . 73.1 mt-10 -156.09 117.02 3.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 110.378 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 2.5 p90 -137.58 -174.05 3.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.213 -0.93 . . . . 0.0 109.954 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.495 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 4.4 p -142.15 173.94 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.718 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.417 ' HB2' ' CD ' ' A' ' 148' ' ' GLU . 85.8 p -150.26 147.96 28.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.432 -0.793 . . . . 0.0 110.065 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -72.03 -24.81 61.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.917 . . . . 0.0 110.138 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 6.1 mm -79.18 151.17 75.32 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.828 . . . . 0.0 109.979 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.0 Cg_endo -65.03 147.46 88.94 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.102 1.58 . . . . 0.0 110.394 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.643 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.6 Cg_endo -69.86 -32.46 18.11 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.006 1.529 . . . . 0.0 113.043 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.4 Cg_endo -67.66 -23.29 42.71 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 122.472 0.722 . . . . 0.0 110.233 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.539 ' CZ ' ' HA ' ' A' ' 17' ' ' ARG . 6.0 mmp_? -82.26 -47.25 12.64 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.52 ' CD1' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -67.54 -29.62 69.06 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.429 -0.908 . . . . 0.0 108.905 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.9 t80 -63.44 -55.45 24.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.1 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.0 mttt -49.13 -50.76 35.85 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.984 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.623 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -56.77 -70.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.623 0.725 . . . . 0.0 111.089 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -43.68 -57.45 3.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.633 -0.667 . . . . 0.0 112.138 -178.626 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.477 HG11 ' CE1' ' A' ' 81' ' ' TYR . 7.1 t -90.27 -60.42 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.057 . . . . 0.0 112.386 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.7 mp -73.35 0.59 11.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.054 -1.029 . . . . 0.0 112.114 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.557 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -153.52 27.77 0.5 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.59 -1.319 . . . . 0.0 111.233 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -64.24 -40.35 95.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.047 -1.033 . . . . 0.0 109.721 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.513 ' OD2' ' CG1' ' A' ' 43' ' ' ILE . 83.0 m-20 -64.91 -11.03 33.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.478 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.423 ' ND2' ' C ' ' A' ' 27' ' ' ASP . 2.3 m120 -125.13 3.17 7.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.537 -0.727 . . . . 0.0 109.662 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.553 ' CD1' ' CD1' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -94.9 -47.12 6.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 -179.572 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.659 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 9.4 p -75.38 -26.9 0.65 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.91 . . . . 0.0 112.373 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 50.5 Cg_endo -79.18 7.27 4.49 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 122.435 0.703 . . . . 0.0 110.593 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -135.77 -30.9 0.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.225 -0.922 . . . . 0.0 110.381 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.586 HG12 ' CD1' ' A' ' 150' ' ' TYR . 64.5 mt -75.07 -39.74 44.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.331 -0.856 . . . . 0.0 109.56 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.64 87.58 2.55 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.396 -0.815 . . . . 0.0 110.171 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.57 -1.32 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.115 1.587 . . . . 0.0 110.516 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -90.22 -19.46 24.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.944 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.35 -36.08 10.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.848 . . . . 0.0 110.317 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.527 HD12 ' CG2' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -125.38 139.68 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 110.021 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.477 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 27.1 ttmt -78.09 -41.45 35.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.558 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 178.71 164.77 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 110.131 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.4 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 1.7 m -121.53 122.27 39.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 110.028 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.524 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 86.1 tt0 -126.54 107.18 10.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.188 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.513 ' CG1' ' OD2' ' A' ' 27' ' ' ASP . 14.6 mt -56.11 131.58 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 58.7 mt -89.1 -23.72 22.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.124 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.521 ' O ' ' CG2' ' A' ' 52' ' ' THR . 41.1 tt0 -157.64 175.05 14.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 110.303 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 53.44 -160.33 3.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -137.66 16.71 2.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -1.103 . . . . 0.0 110.264 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.72 7.57 10.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -98.89 -166.63 30.5 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.1 Cg_endo -70.78 132.08 21.01 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.081 1.569 . . . . 0.0 110.551 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.8 -7.48 70.53 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 42.1 m -80.01 143.41 34.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -1.133 . . . . 0.0 110.097 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 32.9 mm -112.4 124.27 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.216 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -107.58 147.58 30.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.332 -0.855 . . . . 0.0 110.087 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 75.0 tttt -120.85 90.21 3.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.463 ' CG2' HG12 ' A' ' 38' ' ' ILE . 94.5 mt -80.57 143.01 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.477 ' OG1' ' HB3' ' A' ' 39' ' ' LYS . 3.6 p -113.51 160.42 18.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.669 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.492 ' CE2' HG12 ' A' ' 67' ' ' VAL . 27.9 m-85 -118.78 137.93 53.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.466 -0.771 . . . . 0.0 110.202 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.37 96.59 0.82 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -126.71 169.47 13.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -1.188 . . . . 0.0 110.225 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.56 -65.56 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.429 ' C ' ' HG3' ' A' ' 63' ' ' GLN . 77.5 p -48.92 -49.63 39.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -1.148 . . . . 0.0 110.31 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.429 ' HG3' ' C ' ' A' ' 62' ' ' SER . 44.4 mt-30 -136.85 139.33 41.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.295 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -55.78 153.44 8.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.856 . . . . 0.0 110.247 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -136.05 137.12 8.88 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.5 p90 -179.32 164.05 1.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -1.082 . . . . 0.0 110.068 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.527 ' CG1' ' HA3' ' A' ' 88' ' ' GLY . 4.7 m -142.39 171.99 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.92 . . . . 0.0 110.663 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -125.43 123.86 40.2 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.594 ' CD2' ' HG ' ' A' ' 85' ' ' LEU . 13.3 m170 -116.52 138.26 51.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.023 -1.048 . . . . 0.0 111.327 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 78.1 tttt -115.9 112.28 21.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.481 -0.762 . . . . 0.0 109.105 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.53 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 32.7 mm -49.0 136.63 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.96 . . . . 0.0 110.459 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 82' ' ' SER . 4.4 t0 -107.61 -50.11 3.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.396 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.476 ' HB2' ' OG ' ' A' ' 82' ' ' SER . 17.6 m -168.79 157.07 8.04 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.483 -0.76 . . . . 0.0 109.423 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.3 mt -134.94 157.94 41.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.078 -1.014 . . . . 0.0 110.616 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.9 m-20 -130.9 76.85 1.75 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.597 -0.69 . . . . 0.0 110.24 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.575 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 66.9 mttt -61.78 -12.75 18.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 109.918 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -96.4 -30.53 13.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 109.516 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -107.97 -1.44 20.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.661 -0.649 . . . . 0.0 109.744 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.578 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 87.2 m-85 61.11 52.36 4.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.729 . . . . 0.0 109.89 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -123.49 156.65 35.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 109.575 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.53 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 20.1 t80 -141.87 133.92 27.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.913 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 70.4 p -139.1 119.49 13.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.852 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 3.2 p90 -130.89 179.12 6.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 21.9 m -130.85 136.94 49.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.967 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' A' ' 69' ' ' HIS . 0.3 OUTLIER -95.41 134.72 37.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.551 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.0 pt -114.83 -6.11 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.895 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -168.24 113.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.361 -0.837 . . . . 0.0 110.556 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.527 ' HA3' ' CG1' ' A' ' 67' ' ' VAL . . . -153.22 130.34 2.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -48.48 -26.7 2.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -1.162 . . . . 0.0 110.432 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.577 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -68.65 -17.32 64.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 110.456 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.528 HD23 ' CG1' ' A' ' 98' ' ' ILE . 60.3 mt -63.96 -13.0 42.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 110.245 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.62 26.76 72.09 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 50.64 21.05 0.82 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.229 -1.159 . . . . 0.0 110.2 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.5 p -122.56 -33.07 3.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.084 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.595 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 2.3 mm? -80.04 170.27 16.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 110.283 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.455 ' HG3' ' HD2' ' A' ' 123' ' ' LYS . 60.9 mm-40 -137.0 -79.4 0.39 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.48 -0.763 . . . . 0.0 109.611 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 58.6 mttt -80.32 127.46 32.4 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.204 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.612 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 18.4 mm -118.52 147.68 21.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.658 -1.276 . . . . 0.0 110.237 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -126.13 128.37 47.22 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.441 -0.787 . . . . 0.0 109.278 178.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.612 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 13.8 m-85 -126.7 131.9 51.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 110.017 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -135.96 136.23 40.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.925 . . . . 0.0 110.575 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.5 m -132.5 143.95 50.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.414 -0.804 . . . . 0.0 109.724 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 115' ' ' LYS . 5.0 mttt -136.18 143.77 44.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 0.0 110.482 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.521 ' CD2' HG12 ' A' ' 114' ' ' ILE . 5.5 mt -118.8 151.06 38.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.244 -0.91 . . . . 0.0 110.49 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.494 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.73 -168.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 109.814 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.442 ' O ' HD13 ' A' ' 113' ' ' ILE . . . -120.51 157.96 28.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 110.189 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 33.2 p -118.22 165.44 16.35 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.897 . . . . 0.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -72.88 -1.35 10.31 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.02 1.537 . . . . 0.0 110.495 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.0 m -105.56 -0.65 25.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.902 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.21 -36.11 4.59 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.93 -171.46 0.75 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.52 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 6.1 p -131.3 134.38 46.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -1.096 . . . . 0.0 110.228 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.495 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 12.2 mt -84.33 148.07 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.638 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 9.1 mt -130.71 113.71 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.295 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 7.0 ttmt -87.4 138.58 31.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.162 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 1.1 p -124.43 132.04 53.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 110.257 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 62.0 m -148.22 123.25 10.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 110.533 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.7 m -130.91 164.9 24.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 109.886 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.457 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 30.8 m-70 -142.12 170.62 15.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.115 -0.991 . . . . 0.0 110.096 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.523 ' HB3' ' CD1' ' A' ' 95' ' ' LEU . 26.2 m-85 -136.24 147.32 47.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.496 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.543 ' CE1' HG12 ' A' ' 2' ' ' VAL . 83.6 m-70 -128.35 88.75 2.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.399 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.522 ' CG2' HG22 ' A' ' 126' ' ' VAL . 4.2 p -68.9 161.26 29.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.849 . . . . 0.0 110.711 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.455 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 33.0 ttmt -152.48 94.72 1.94 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 110.314 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 133.5 35.94 0.27 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 3.3 t30 63.61 56.59 1.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.171 -1.193 . . . . 0.0 110.252 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.522 HG22 ' CG2' ' A' ' 122' ' ' THR . 8.4 m -142.86 145.82 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 110.005 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.75 179.04 5.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.358 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.477 HG13 ' CD2' ' A' ' 120' ' ' TYR . 16.2 mm -84.67 173.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.21 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.476 ' N ' HG23 ' A' ' 128' ' ' ILE . 18.8 mtpt -117.63 136.82 53.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.009 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -43.61 -41.09 4.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.166 -0.958 . . . . 0.0 110.245 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 51.4 tt0 -64.38 -26.13 68.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.091 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 13.8 t-160 -77.91 -48.46 16.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.584 HG23 ' CZ ' ' A' ' 5' ' ' TYR . 69.1 t -56.26 -32.08 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 109.867 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -90.8 -51.37 5.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -57.9 -32.76 68.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.84 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.08 -33.81 62.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -78.55 -32.89 48.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -1.122 . . . . 0.0 109.982 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -73.43 -34.97 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.887 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -70.7 -43.45 68.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.798 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -72.49 -31.12 65.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 109.947 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 22.7 t -64.76 -54.0 38.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.395 -0.815 . . . . 0.0 109.928 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -51.78 -49.78 62.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.705 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 24.0 mt -52.91 -41.66 64.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 110.059 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 16.7 m-85 -59.87 -50.88 72.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.689 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 75.7 tttt -63.44 -13.67 42.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.915 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.527 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 13.1 mt -85.2 -37.77 19.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.213 -0.93 . . . . 0.0 108.813 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.569 HD12 ' CE1' ' A' ' 22' ' ' PHE . 33.8 mt -69.56 -45.3 78.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.482 ' O ' HG13 ' A' ' 13' ' ' ILE . 67.8 mm-40 -51.56 -38.15 52.97 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.286 -0.884 . . . . 0.0 108.785 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 88.3 m -72.36 -38.1 68.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.303 -0.873 . . . . 0.0 109.01 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.586 ' CD1' HG12 ' A' ' 33' ' ' ILE . 66.2 t80 -44.19 -54.84 5.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.465 -0.772 . . . . 0.0 109.604 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.597 HD23 ' CE1' ' A' ' 158' ' ' TYR . 78.5 mt -75.41 -29.07 59.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.467 -0.771 . . . . 0.0 110.267 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.484 ' HA ' HD13 ' A' ' 13' ' ' ILE . 39.3 tttp -69.48 -13.27 62.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.715 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -123.63 -26.46 1.59 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.561 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.2 m-70 -110.77 89.64 9.58 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 0.0 110.378 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.31 0.33 8.13 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.037 1.546 . . . . 0.0 110.559 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -111.92 12.72 20.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.882 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.646 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -86.57 101.25 13.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.416 -0.802 . . . . 0.0 110.282 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.646 ' CD1' ' O ' ' A' ' 157' ' ' ALA . 8.9 p90 38.52 21.8 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.689 -0.632 . . . . 0.0 112.354 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 33.4 m-20 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 120.415 -1.428 . . . . 0.0 110.12 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 120' ' ' TYR . 86.3 t -108.77 139.82 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -1.172 . . . . 0.0 110.223 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.644 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 16.3 m-85 -103.01 129.8 49.89 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.238 -0.914 . . . . 0.0 109.826 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.45 HG22 ' CE1' ' A' ' 119' ' ' HIS . 19.3 m -104.68 107.83 18.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.859 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.57 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 33.9 m-85 -116.27 124.92 51.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.552 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 23.1 pt-20 -122.63 164.17 18.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.15 -0.969 . . . . 0.0 111.035 -179.083 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.512 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.2 p -125.32 167.63 14.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.568 -0.707 . . . . 0.0 110.272 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 7' ' ' SER . 18.2 mt-10 -160.19 120.15 2.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.553 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 76.5 m-85 -141.18 -166.01 2.08 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.789 -1.194 . . . . 0.0 111.552 -178.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 25.5 p -158.32 155.29 28.52 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.758 0.789 . . . . 0.0 110.368 178.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.527 ' O ' ' CA ' ' A' ' 111' ' ' GLY . 83.6 p -159.29 146.23 16.93 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.791 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -70.55 -32.93 70.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 110.046 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 8.0 mm -58.99 149.96 63.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.863 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 39.8 Cg_endo -65.47 144.27 78.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.0 1.526 . . . . 0.0 110.585 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.637 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 Cg_endo -72.05 -31.61 12.05 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 124.023 1.538 . . . . 0.0 112.802 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -70.19 -21.51 31.37 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 N-CA-C 110.042 -0.791 . . . . 0.0 110.042 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.525 ' HG2' ' CD1' ' A' ' 151' ' ' LEU . 10.3 ttm180 -83.2 -47.16 11.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.5 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -68.01 -27.62 66.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.933 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.0 t80 -68.24 -55.75 11.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.474 -0.766 . . . . 0.0 109.378 179.079 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 89.6 mttt -50.27 -37.83 37.95 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.244 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.595 ' HB1' ' CE2' ' A' ' 158' ' ' TYR . . . -70.89 -57.82 4.22 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.687 0.756 . . . . 0.0 110.943 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.578 ' CD1' HD12 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -54.46 -54.33 42.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.556 -0.715 . . . . 0.0 111.843 -178.669 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.507 HG11 ' CE1' ' A' ' 81' ' ' TYR . 4.0 t -92.82 -62.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.078 -1.014 . . . . 0.0 111.964 -178.425 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.7 mp -69.09 0.23 4.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.197 -0.939 . . . . 0.0 111.974 -178.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.571 ' OD2' ' CD1' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -150.18 24.33 0.82 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.736 -1.228 . . . . 0.0 111.014 -179.99 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.465 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -63.24 -37.98 89.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.011 -1.056 . . . . 0.0 110.135 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 33.9 m-20 -63.49 -13.96 46.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.109 -0.994 . . . . 0.0 110.099 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 84.2 m-20 -128.3 10.46 6.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.826 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.53 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -96.41 -53.73 3.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 110.51 -179.871 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.669 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.9 m -74.69 -29.31 0.91 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 111.97 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.5 Cg_endo -79.18 4.58 6.44 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 122.851 0.921 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -125.17 -35.29 2.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 109.109 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.579 HG12 ' CD1' ' A' ' 150' ' ' TYR . 40.5 mt -79.96 -24.32 11.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.549 0.69 . . . . 0.0 109.235 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.92 95.43 0.4 Allowed Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.618 -0.676 . . . . 0.0 109.78 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.68 0.22 7.94 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.041 1.548 . . . . 0.0 110.655 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -89.52 5.95 43.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.238 -0.914 . . . . 0.0 109.872 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.89 -55.35 2.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 110.013 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.522 ' CB ' HG22 ' A' ' 30' ' ' VAL . 1.9 mp -115.11 132.14 65.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 110.029 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.409 ' HE2' ' HG3' ' A' ' 60' ' ' GLU . 35.8 ttmt -79.99 -35.07 37.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.286 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.525 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -177.26 151.98 0.83 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.0 109.96 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.8 m -115.53 130.83 57.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.24 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.502 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 85.6 tt0 -137.79 110.59 7.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 0.0 110.207 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 43' ' ' ILE . 41.1 mt -62.25 135.51 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.302 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.45 HD21 HG23 ' A' ' 53' ' ' ILE . 47.9 tp -87.9 -25.61 23.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.988 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' O ' ' CG2' ' A' ' 52' ' ' THR . 28.8 tp10 -161.45 170.28 20.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.472 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 59.32 -169.69 6.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.7 23.39 6.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -1.155 . . . . 0.0 110.252 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.07 1.45 28.38 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -86.0 -169.46 45.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.458 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.3 Cg_endo -70.96 131.85 20.3 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.015 1.534 . . . . 0.0 110.468 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.21 -6.59 68.88 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 14.8 m -80.04 142.3 35.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -1.104 . . . . 0.0 109.961 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.501 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 27.3 mm -110.68 122.11 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 110.155 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.458 ' HG2' HG12 ' A' ' 43' ' ' ILE . 84.7 mttt -105.88 144.63 32.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 110.23 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -117.86 87.61 2.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 110.218 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.43 ' HB ' HG21 ' A' ' 67' ' ' VAL . 90.6 mt -80.01 144.39 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 110.331 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.509 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.7 p -111.48 164.2 13.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.478 ' CZ ' HG12 ' A' ' 67' ' ' VAL . 25.9 m-85 -115.32 155.36 27.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 110.434 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' PHE . . . -43.49 165.17 0.03 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HG3' ' HE2' ' A' ' 39' ' ' LYS . 60.7 mt-10 -70.53 164.1 25.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -1.108 . . . . 0.0 110.195 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.2 -157.44 18.94 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.418 ' C ' ' HG3' ' A' ' 63' ' ' GLN . 89.5 p -57.41 -32.88 67.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -1.124 . . . . 0.0 110.29 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HG3' ' C ' ' A' ' 62' ' ' SER . 44.2 mt-30 -145.58 147.65 32.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.923 . . . . 0.0 110.283 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.434 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 8.6 t80 -42.93 143.21 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.232 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -128.81 135.3 8.43 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.4 p90 -178.73 162.84 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -1.167 . . . . 0.0 110.211 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.54 ' CG1' ' HA3' ' A' ' 88' ' ' GLY . 4.5 m -141.9 172.79 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -0.819 . . . . 0.0 110.512 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 88.5 mttt -124.49 129.41 50.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.575 -0.703 . . . . 0.0 109.449 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.518 ' NE2' HD11 ' A' ' 85' ' ' LEU . 8.2 m170 -118.14 123.98 46.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.15 -0.969 . . . . 0.0 111.034 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.501 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 85.0 tttt -100.32 113.64 26.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 25.8 mm -54.52 135.36 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.901 . . . . 0.0 110.468 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.467 ' O ' ' OG ' ' A' ' 73' ' ' SER . 1.6 t70 -110.16 -42.99 4.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 109.601 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 25.5 m -169.75 157.49 6.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 109.896 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mt -141.59 156.15 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 110.456 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.0 m-20 -136.18 79.04 1.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.576 -0.702 . . . . 0.0 109.991 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.509 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 78.4 mttt -62.62 -16.89 58.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.385 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -93.05 -30.72 15.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 109.529 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -103.87 -6.12 21.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.545 -0.722 . . . . 0.0 109.694 179.8 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.516 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.2 m-85 65.36 52.13 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 109.988 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -124.91 154.97 40.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.839 . . . . 0.0 109.782 179.706 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.529 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 22.3 t80 -142.5 128.81 19.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.352 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 37.6 m -131.89 121.24 23.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.471 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 21.9 p90 -138.64 170.97 15.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.359 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 98.9 m -123.46 132.6 53.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 109.893 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 3.1 tp -98.87 136.45 38.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.081 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.0 pt -119.46 -16.99 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.503 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 23.9 tt0 -133.09 150.08 52.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.143 -0.973 . . . . 0.0 110.488 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.54 ' HA3' ' CG1' ' A' ' 67' ' ' VAL . . . 165.46 142.31 3.38 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -65.73 -35.35 80.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -1.156 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.441 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -65.13 -26.17 68.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 110.13 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.523 ' CD1' HD22 ' A' ' 85' ' ' LEU . 35.3 mt -65.48 -25.38 67.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.181 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.84 -167.63 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -87.28 8.04 25.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -1.184 . . . . 0.0 110.149 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.481 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 60.6 p -93.88 -40.33 10.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.151 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.57 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 22.5 mt -102.11 155.04 18.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.027 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -134.65 -78.84 0.45 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.219 -0.925 . . . . 0.0 110.284 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 50.8 mttt -80.13 132.93 36.02 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.407 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.634 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.5 mm -124.77 136.93 59.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.734 -1.228 . . . . 0.0 110.06 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -116.3 127.1 54.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.74 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.634 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 9.4 m-85 -122.65 135.59 54.64 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 111.148 -178.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.467 ' O ' ' OG ' ' A' ' 116' ' ' SER . 4.2 mt-10 -133.0 133.26 42.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.567 -0.708 . . . . 0.0 109.658 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 81' ' ' TYR . 36.1 m -132.07 134.09 45.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.0 -1.062 . . . . 0.0 110.124 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.5 tttt -133.93 147.68 51.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 110.252 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 79' ' ' TYR . 22.7 mt -117.89 142.22 47.57 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.399 -0.813 . . . . 0.0 110.148 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 113' ' ' ILE . 1.6 t -131.42 -172.64 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 0.0 110.371 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.468 ' O ' HD11 ' A' ' 113' ' ' ILE . . . -118.13 148.53 42.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 110.454 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.459 ' HA ' HD13 ' A' ' 113' ' ' ILE . 52.9 p -106.92 163.78 16.23 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 110.366 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 44.4 Cg_endo -72.26 -2.13 11.19 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.017 1.535 . . . . 0.0 110.403 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.1 m -103.59 -7.17 20.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.072 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.79 -16.03 31.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 11' ' ' SER . . . -79.08 -171.66 41.03 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' SER . 42.1 p -128.81 122.31 30.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 110.221 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 7.0 mt -79.98 139.64 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.464 -0.772 . . . . 0.0 110.79 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.553 ' CD1' ' HB2' ' A' ' 9' ' ' PHE . 3.7 mp -93.02 151.88 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.049 179.076 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 103' ' ' LYS . 16.9 tttt -149.87 99.71 2.87 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 109.365 178.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 20.9 t -116.13 174.8 5.85 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.357 -0.839 . . . . 0.0 111.257 -178.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.578 HG23 ' CE1' ' A' ' 119' ' ' HIS . 31.4 m -160.07 128.97 4.98 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 5' ' ' TYR . 38.9 t -122.9 156.68 34.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.042 -1.036 . . . . 0.0 110.421 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.578 ' CE1' HG23 ' A' ' 117' ' ' THR . 76.7 m-70 -140.48 123.65 16.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.35 -0.844 . . . . 0.0 110.371 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 8.8 m-30 -93.87 149.79 20.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -0.871 . . . . 0.0 110.416 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 91.9 m-70 -127.65 84.82 2.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 109.743 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.57 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -67.39 152.64 45.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.406 -0.809 . . . . 0.0 110.618 -179.545 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -115.31 113.58 24.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 110.132 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.0 -145.74 16.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 2.1 p-10 -104.53 54.67 0.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.208 -1.172 . . . . 0.0 110.237 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 94' ' ' THR . 10.8 m -116.88 156.33 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 9.8 pm0 -143.7 157.1 44.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.051 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.644 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 2.9 mp -78.27 173.29 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.126 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.432 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 23.0 mttt -110.88 151.34 27.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.951 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.44 -31.88 64.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -0.975 . . . . 0.0 110.205 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -65.33 -40.87 94.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 109.982 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.441 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 17.2 t-160 -66.81 -45.5 78.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 110.043 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.57 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 61.2 t -62.89 -41.11 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -76.42 -42.01 45.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.65 96.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.959 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.51 -30.1 76.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.457 ' HE3' HG11 ' A' ' 133' ' ' VAL . 88.5 mttt -75.31 -32.81 61.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -1.137 . . . . 0.0 110.042 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -76.3 -34.32 59.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -0.863 . . . . 0.0 109.903 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.97 -34.77 64.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.5 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.51 -30.55 61.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.928 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.4 p -68.72 -50.99 46.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.904 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.414 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 82.5 m-20 -51.36 -44.48 62.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 18.7 tp -57.15 -50.05 74.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.867 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 25.9 m-85 -53.84 -39.57 65.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.431 -0.793 . . . . 0.0 109.765 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.451 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 32.3 mttp -78.51 -13.61 59.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.933 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.521 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 16.2 mt -84.81 -36.66 21.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.23 -0.919 . . . . 0.0 108.889 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.578 HD12 ' CD1' ' A' ' 22' ' ' PHE . 36.7 mt -70.47 -43.93 77.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 13' ' ' ILE . 52.3 mt-10 -59.27 -37.68 78.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.426 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 98.7 m -77.2 -38.9 50.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 179.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.58 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 80.7 t80 -52.6 -49.15 65.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.903 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.65 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 82.3 mt -79.03 -33.45 44.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 109.99 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.533 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 38.9 tttt -70.61 -16.97 62.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.347 179.237 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.77 -32.59 2.23 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.544 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 8.2 m-70 -109.41 94.8 16.81 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.389 -1.066 . . . . 0.0 109.978 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.34 6.75 2.92 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.061 1.559 . . . . 0.0 111.048 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -110.48 2.78 19.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.062 -1.024 . . . . 0.0 109.86 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.568 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . . . -83.23 103.61 12.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.65 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.57 32.44 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.747 -0.596 . . . . 0.0 110.532 -179.667 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.517 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.709 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 120' ' ' TYR . 73.2 t -130.33 122.01 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -1.226 . . . . 0.0 110.212 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.588 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 89.5 m-85 -73.69 147.42 43.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 110.138 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.405 HG21 ' CE1' ' A' ' 119' ' ' HIS . 52.9 m -129.32 119.57 24.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.242 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.64 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 61.6 m-85 -130.97 151.76 51.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.121 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -145.18 150.45 36.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 110.282 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 116' ' ' SER . 78.0 p -132.37 148.51 52.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.838 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -136.67 117.17 13.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.102 -0.999 . . . . 0.0 110.625 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 p90 -141.18 -177.17 4.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.39 -0.819 . . . . 0.0 109.733 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 27.2 p -136.75 -179.25 5.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 110.838 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 148' ' ' GLU . 11.8 t -159.92 170.38 21.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 110.17 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -93.82 -21.76 19.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.537 ' CD1' ' O ' ' A' ' 148' ' ' GLU . 2.6 mp -80.98 150.4 68.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 39.1 Cg_endo -66.51 145.49 76.78 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.991 1.522 . . . . 0.0 110.783 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.629 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 Cg_endo -72.14 -31.5 11.96 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 124.126 1.593 . . . . 0.0 112.993 -179.184 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.7 Cg_endo -69.3 -20.65 36.74 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 N-CA-C 109.724 -0.914 . . . . 0.0 109.724 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.538 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 1.3 mmp_? -82.74 -47.81 11.55 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.509 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.2 tt -67.94 -25.32 65.4 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.597 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 70.9 t80 -66.84 -61.2 2.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.512 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 34.3 mttp -49.0 -37.9 21.74 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.679 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -62.4 -66.32 0.56 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.803 0.811 . . . . 0.0 110.897 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.649 ' CD1' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -54.59 -47.48 73.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.842 -0.537 . . . . 0.0 111.959 -178.199 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.601 ' CG1' ' CD1' ' A' ' 74' ' ' ILE . 3.0 t -96.14 -64.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.87 -1.144 . . . . 0.0 112.154 -178.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.9 mm? -68.69 -3.63 12.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.051 -1.031 . . . . 0.0 111.644 -178.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.533 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -139.62 4.0 2.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.772 -1.205 . . . . 0.0 111.019 -179.706 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -42.57 -26.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.138 -0.976 . . . . 0.0 110.183 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 56.4 m-20 -74.7 -40.78 61.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.931 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -106.48 24.24 12.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.891 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.554 HD13 ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -106.11 -62.16 1.42 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 -179.867 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 44.7 t -61.92 -40.88 72.94 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.493 -0.754 . . . . 0.0 111.203 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -78.37 9.28 3.2 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.353 1.186 . . . . 0.0 110.827 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.459 ' HD2' ' OH ' ' A' ' 150' ' ' TYR . 17.7 mttt -121.87 -28.31 4.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.997 -1.064 . . . . 0.0 109.457 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.588 HG12 ' CD1' ' A' ' 150' ' ' TYR . 29.0 mt -79.99 -56.86 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.516 -0.74 . . . . 0.0 109.767 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.62 106.14 2.9 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.476 -0.765 . . . . 0.0 110.085 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.21 1.22 6.91 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.661 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.54 -9.47 56.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.952 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.09 -36.27 9.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 110.187 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.591 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 1.1 mt -136.49 149.74 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.332 -0.855 . . . . 0.0 110.009 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.529 ' CG ' ' HA3' ' A' ' 59' ' ' GLY . 10.5 mttt -78.9 -50.26 11.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 110.003 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -173.01 160.11 4.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.452 -0.78 . . . . 0.0 109.977 179.711 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.7 m -119.02 126.63 52.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.143 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -135.64 103.09 5.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 110.379 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 18.9 mt -50.42 131.32 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.3 tp -91.31 -46.55 7.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.253 -0.904 . . . . 0.0 110.218 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 52' ' ' THR . 3.9 mm-40 -132.63 136.97 46.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.246 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.82 -168.41 34.33 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -131.29 12.58 5.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -1.16 . . . . 0.0 110.255 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.47 -6.22 9.92 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -84.15 -168.31 43.76 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.493 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.2 Cg_endo -70.71 135.91 29.27 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.024 1.539 . . . . 0.0 110.501 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.75 -5.49 79.6 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 42.8 m -80.1 143.18 34.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -1.115 . . . . 0.0 110.042 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.521 ' CD1' ' HB2' ' A' ' 70' ' ' LYS . 29.2 mm -110.08 125.46 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.278 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 40.2 mtmt -108.29 139.7 42.62 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.365 -0.835 . . . . 0.0 110.083 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -112.9 89.94 3.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 110.129 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.453 ' CG2' HG12 ' A' ' 38' ' ' ILE . 88.8 mt -83.18 139.04 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.215 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.451 ' O ' HG21 ' A' ' 38' ' ' ILE . 6.7 p -110.27 160.81 16.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.494 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.451 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 27.3 m-85 -120.64 124.37 45.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -0.812 . . . . 0.0 110.377 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 39' ' ' LYS . . . -66.6 -24.91 72.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -120.85 146.06 46.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -1.154 . . . . 0.0 110.177 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.35 92.13 0.48 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.3 t 48.7 -162.4 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -1.095 . . . . 0.0 110.245 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -53.97 -52.36 60.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.857 . . . . 0.0 110.289 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.443 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 9.2 t80 -135.46 141.83 45.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 110.28 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -127.82 136.7 9.36 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.9 p90 -179.66 161.19 0.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -1.088 . . . . 0.0 109.989 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 66' ' ' TYR . 5.6 m -143.27 172.38 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.633 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.519 ' CE ' HG22 ' A' ' 53' ' ' ILE . 75.4 tttt -123.65 118.23 26.8 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -110.54 133.58 53.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.989 -1.069 . . . . 0.0 111.379 -178.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HB2' ' CD1' ' A' ' 53' ' ' ILE . 77.1 tttt -111.12 119.23 38.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.563 -0.711 . . . . 0.0 109.218 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.533 HG22 HD11 ' A' ' 71' ' ' ILE . 42.2 mm -53.15 143.83 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 110.51 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.3 m-20 -117.49 -31.83 5.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.375 -0.828 . . . . 0.0 109.703 179.52 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 2.2 p 168.28 157.43 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 110.15 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.601 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 4.1 tt -153.59 165.62 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.3 -0.875 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -140.64 83.97 1.92 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.251 -0.906 . . . . 0.0 109.977 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 85.6 tttt -58.62 -12.53 4.21 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.29 -0.881 . . . . 0.0 110.776 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.457 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 17.5 mm-40 -85.46 -34.41 21.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.191 -0.943 . . . . 0.0 108.918 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m-80 -109.4 -1.97 18.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.587 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 9.7 m-85 65.95 49.81 1.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.343 0.592 . . . . 0.0 110.449 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.544 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -115.32 157.89 23.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.108 -0.995 . . . . 0.0 109.129 179.19 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.593 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 80.8 t80 -160.02 150.18 18.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.016 -1.052 . . . . 0.0 110.116 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 100' ' ' TYR . 9.7 t -160.98 150.52 17.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.94 . . . . 0.0 110.585 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.593 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 5.9 p90 -151.69 -171.13 3.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.51 -0.744 . . . . 0.0 109.871 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 54.0 m -132.64 135.91 46.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.364 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.552 ' CB ' ' HB ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -94.18 116.09 28.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.231 -0.918 . . . . 0.0 110.096 179.765 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.435 HD12 ' HE2' ' A' ' 68' ' ' LYS . 16.7 pt -107.82 -10.54 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.199 -0.938 . . . . 0.0 110.112 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -138.81 126.52 22.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.84 . . . . 0.0 110.044 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.512 ' N ' HD13 ' A' ' 91' ' ' LEU . . . -179.86 145.36 6.44 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 44.3 p-10 -65.16 -9.86 26.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -1.143 . . . . 0.0 110.243 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.535 ' CB ' ' CE1' ' A' ' 132' ' ' HIS . . . -78.09 -36.15 48.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 110.19 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.535 ' HA ' ' CG ' ' A' ' 95' ' ' LEU . 4.1 mt -58.18 -40.66 82.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.396 -0.815 . . . . 0.0 110.337 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 43.44 -132.33 5.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -114.12 12.6 17.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -1.188 . . . . 0.0 110.235 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.46 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 40.1 p -109.82 -33.15 6.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.544 HD12 ' CD1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -116.53 159.98 21.3 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.27 -0.894 . . . . 0.0 109.222 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.534 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 42.0 tt0 -138.53 -78.2 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.979 . . . . 0.0 110.807 -179.307 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 10.8 mttm -80.13 132.76 35.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.476 -0.765 . . . . 0.0 110.7 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.604 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 15.8 mm -118.56 148.63 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.885 -1.134 . . . . 0.0 110.212 179.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -125.14 125.23 43.38 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.057 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.604 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 13.5 m-85 -121.45 134.91 55.09 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.348 -0.845 . . . . 0.0 110.476 -178.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.404 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 58.6 tt0 -133.3 160.66 36.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 81' ' ' TYR . 35.9 m -160.92 121.09 2.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 0.4 OUTLIER -120.01 146.98 45.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.333 -179.889 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.534 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 14.7 mt -125.31 151.23 46.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -0.848 . . . . 0.0 110.266 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.49 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.35 -169.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.203 -0.936 . . . . 0.0 110.005 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -127.02 135.48 50.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 110.16 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.433 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 49.5 p -90.72 163.22 31.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.301 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -73.06 -2.87 12.68 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.14 1.6 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.4 p -96.87 -5.02 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 110.3 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.42 -40.46 2.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.26 -172.48 2.02 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.494 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -127.99 138.8 52.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -1.174 . . . . 0.0 110.336 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 26.6 mt -89.88 147.36 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.585 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 7.0 mt -130.95 112.96 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 110.318 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -104.1 122.34 45.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.961 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.466 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 7.4 t -116.49 163.5 15.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.41 HG21 ' NE2' ' A' ' 119' ' ' HIS . 59.6 m -160.01 138.2 10.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 110.228 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.4 m -135.18 148.97 49.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.957 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.503 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 73.8 m-70 -132.59 168.57 18.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.177 -0.952 . . . . 0.0 110.751 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.473 ' O ' ' CG1' ' A' ' 2' ' ' VAL . 35.9 m-85 -131.69 145.6 51.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.508 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.4 m-70 -126.34 95.01 4.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.129 -0.982 . . . . 0.0 109.956 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.509 ' CG2' ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -58.5 154.81 13.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.207 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 57.9 tttt -118.23 111.19 18.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.293 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.62 -115.64 5.0 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -129.84 71.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 110.145 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 94' ' ' THR . 16.9 m -142.72 -179.46 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.509 ' HA ' ' CG2' ' A' ' 122' ' ' THR . 92.8 mt-10 -154.54 149.33 26.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.194 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.577 HD11 ' CD1' ' A' ' 3' ' ' PHE . 4.9 mp -77.91 173.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.943 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.442 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 33.1 mttt -107.03 129.05 54.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.878 . . . . 0.0 110.251 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.449 ' O ' HG11 ' A' ' 133' ' ' VAL . 97.9 mt-10 -45.69 -44.89 13.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -58.52 -30.98 67.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 109.842 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.535 ' CE1' ' CB ' ' A' ' 90' ' ' ALA . 13.4 t-160 -73.7 -53.17 11.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.926 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.64 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 8.6 p -64.52 -40.14 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.442 -0.787 . . . . 0.0 109.959 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.493 ' N ' HG12 ' A' ' 133' ' ' VAL . 42.7 mtmt -63.61 -43.94 95.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.849 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.02 74.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 109.876 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.43 -30.52 66.74 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.42 ' HD2' ' HB3' ' A' ' 5' ' ' TYR . 3.9 mtpt -74.06 -32.41 63.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -1.099 . . . . 0.0 109.893 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -72.24 -29.78 64.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.38 -0.825 . . . . 0.0 109.884 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.48 -35.86 73.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -0.834 . . . . 0.0 109.883 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.05 -41.18 71.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.968 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.9 t -59.43 -49.86 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.367 -0.833 . . . . 0.0 109.92 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -55.06 -42.94 73.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.954 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.468 ' O ' HG13 ' A' ' 147' ' ' ILE . 59.3 mt -60.04 -39.03 84.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 0.0 109.924 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -62.39 -36.11 81.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 110.165 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 89.1 mttt -79.15 -8.88 59.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 110.078 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.517 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 13.2 mt -89.49 -37.37 14.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.257 -0.902 . . . . 0.0 108.747 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.649 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 32.6 mt -70.68 -44.63 76.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.715 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.537 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 23.5 pt-20 -52.1 -39.73 60.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.809 178.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.52 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 19.8 m -76.25 -33.69 59.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 109.065 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 73.8 t80 -47.72 -57.93 4.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.585 -0.697 . . . . 0.0 109.901 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.602 HD22 ' CZ ' ' A' ' 158' ' ' TYR . 62.8 mt -67.56 -45.74 74.74 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.437 -0.79 . . . . 0.0 110.709 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.443 ' HB2' HD12 ' A' ' 13' ' ' ILE . 81.9 tttt -58.81 -16.1 15.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 109.602 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.403 ' C ' ' CD2' ' A' ' 154' ' ' HIS . . . -115.21 -24.28 4.23 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.593 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.7 m-70 -119.56 92.84 46.7 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.248 -1.148 . . . . 0.0 110.313 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.61 0.54 7.42 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.049 1.552 . . . . 0.0 110.764 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -115.19 15.25 17.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.147 -0.97 . . . . 0.0 110.045 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.657 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -88.38 103.51 15.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.408 -0.807 . . . . 0.0 110.4 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.679 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 6.4 p90 38.99 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.574 -0.704 . . . . 0.0 112.32 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 28.8 m-20 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 120.457 -1.402 . . . . 0.0 110.132 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 74.9 t -104.02 135.91 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 110.241 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.662 ' CE1' HD12 ' A' ' 128' ' ' ILE . 12.6 m-85 -93.62 150.5 20.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 109.989 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.787 HG23 ' CE1' ' A' ' 119' ' ' HIS . 8.4 m -129.08 113.11 14.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.562 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.981 ' CE2' HG21 ' A' ' 133' ' ' VAL . 67.6 m-85 -127.44 136.73 52.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.87 . . . . 0.0 109.76 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 16.3 pt-20 -138.31 153.78 49.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 0.0 110.707 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.2 m -132.81 144.48 50.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.408 -0.808 . . . . 0.0 109.645 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.421 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 98.9 mt-10 -130.35 127.3 39.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.059 -1.026 . . . . 0.0 110.627 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.631 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.3 p90 -155.07 -171.52 3.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.815 . . . . 0.0 109.974 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.824 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.7 p -142.84 174.01 11.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.338 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.466 ' OG ' ' OE2' ' A' ' 148' ' ' GLU . 79.7 p -151.57 148.28 27.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.244 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -74.13 -6.12 45.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.132 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.829 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.7 mp -95.9 150.15 36.94 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.029 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.829 ' HD2' HG23 ' A' ' 13' ' ' ILE . 42.2 Cg_endo -67.41 143.88 65.31 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.107 1.583 . . . . 0.0 110.89 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.677 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.1 Cg_endo -71.31 -31.49 14.13 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 124.115 1.587 . . . . 0.0 112.698 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 39.5 Cg_endo -67.4 -21.05 47.62 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 N-CA-C 110.098 -0.77 . . . . 0.0 110.098 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 9.1 mmp_? -85.17 -46.18 11.33 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.763 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.2 tt -69.03 -28.18 66.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.617 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 68.9 t80 -69.27 -53.53 19.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.707 . . . . 0.0 109.818 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 45.8 mttp -57.28 -29.87 64.23 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.993 0.901 . . . . 0.0 108.899 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.961 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -77.7 -63.63 1.34 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.681 0.753 . . . . 0.0 111.269 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.008 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -56.28 -39.63 72.97 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.689 -0.632 . . . . 0.0 111.947 -178.151 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.136 HG11 ' CD1' ' A' ' 74' ' ' ILE . 15.7 t -102.13 -65.86 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.791 -1.193 . . . . 0.0 111.631 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.575 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.0 mp -64.9 -6.08 7.55 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.227 -0.921 . . . . 0.0 111.25 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.558 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 1.1 m-20 -146.47 24.41 1.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.862 -1.149 . . . . 0.0 110.49 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.008 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -57.46 -38.36 74.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.041 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 41' ' ' SER . 86.0 m-20 -67.66 -12.86 61.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 110.191 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.54 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 83.9 m-20 -125.18 -3.79 7.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.457 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.764 HD11 HG23 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -85.98 -52.31 5.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.023 . . . . 0.0 110.394 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.04 HG11 HD13 ' A' ' 38' ' ' ILE . 14.7 t -63.3 -41.02 65.61 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.791 . . . . 0.0 111.193 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.7 Cg_endo -77.23 7.37 3.75 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.333 1.175 . . . . 0.0 111.021 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 69.9 mmtt -122.35 -23.64 5.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.095 -1.003 . . . . 0.0 109.724 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.768 HG21 ' HB3' ' A' ' 146' ' ' LEU . 8.0 mt -80.01 -56.27 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.495 -0.753 . . . . 0.0 109.773 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.52 106.27 2.56 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.46 -0.775 . . . . 0.0 110.02 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.03 0.53 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.069 1.563 . . . . 0.0 110.726 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -83.77 -11.81 56.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.149 -0.97 . . . . 0.0 109.708 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.67 -51.43 3.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.382 -0.824 . . . . 0.0 110.278 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.04 HD13 HG11 ' A' ' 30' ' ' VAL . 1.3 mt -122.24 147.64 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 110.25 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -80.13 -43.9 20.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.192 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.439 ' N ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -177.42 161.38 1.75 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.148 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.449 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 27.2 m -119.41 128.73 54.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -133.48 111.53 10.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 43.0 mt -62.98 132.92 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 110.195 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 44' ' ' LEU . 55.0 tp -96.69 -43.14 7.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.877 . . . . 0.0 110.339 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.908 ' O ' HG23 ' A' ' 52' ' ' THR . 6.9 mt-10 -130.76 150.08 52.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.369 -0.832 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 76.92 -164.04 52.77 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 60.6 t0 -138.52 19.82 2.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -1.183 . . . . 0.0 110.312 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.438 ' H ' HG21 ' A' ' 52' ' ' THR . . . 118.23 -5.68 15.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -92.26 -165.93 39.1 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.2 Cg_endo -69.77 134.1 27.14 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.046 1.551 . . . . 0.0 110.486 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.32 -6.89 68.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 45' ' ' GLU . 30.4 m -79.95 136.16 36.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -1.145 . . . . 0.0 110.158 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.696 HD13 ' HA ' ' A' ' 70' ' ' LYS . 23.7 mm -107.18 113.25 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 110.267 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 77.7 mttt -98.28 148.2 23.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.4 -0.813 . . . . 0.0 110.36 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -118.1 92.37 3.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.545 ' CG2' HG12 ' A' ' 38' ' ' ILE . 78.4 mt -79.99 139.6 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 38' ' ' ILE . 4.4 p -111.3 159.56 17.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.595 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.652 ' HE2' HG13 ' A' ' 67' ' ' VAL . 26.2 m-85 -119.61 139.65 51.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.254 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.926 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.189 0.519 . . . . 0.0 110.046 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -124.31 135.64 9.71 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 10.9 p90 -178.91 159.36 1.02 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -1.104 . . . . 0.0 109.931 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.721 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.9 m -143.57 171.52 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.725 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.509 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 68.4 mttt -121.25 127.35 51.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.602 -0.686 . . . . 0.0 109.587 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.595 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -115.31 124.66 51.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.146 -0.971 . . . . 0.0 110.864 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HA ' HD13 ' A' ' 53' ' ' ILE . 80.0 tttt -100.92 109.68 21.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.479 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.534 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.1 mm -48.32 139.59 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.005 . . . . 0.0 110.132 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.549 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 15.7 t0 -113.0 -40.05 4.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.854 . . . . 0.0 109.518 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 2.8 p 170.39 157.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 110.267 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.136 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.2 tt -146.22 163.83 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.796 . . . . 0.0 110.032 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.552 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -125.23 78.78 1.74 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.288 -0.883 . . . . 0.0 109.811 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.617 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 99.4 mttt -53.69 -16.54 1.69 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.448 -0.782 . . . . 0.0 110.794 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -91.96 -29.8 16.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.284 -0.885 . . . . 0.0 109.755 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 m120 -111.18 -0.18 16.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.563 -0.711 . . . . 0.0 109.651 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.69 ' O ' HD12 ' A' ' 104' ' ' LEU . 87.9 m-85 63.26 50.05 3.1 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.377 0.608 . . . . 0.0 110.667 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.552 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -118.55 148.67 42.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.207 179.172 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.585 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 84.7 t80 -144.85 139.14 27.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.065 -1.022 . . . . 0.0 110.433 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 m -148.07 133.4 18.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 110.116 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.7 p90 -135.17 178.36 7.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 98' ' ' ILE . 62.6 m -125.07 125.23 43.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.746 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.732 HD21 HD11 ' A' ' 91' ' ' LEU . 2.8 tp -94.11 136.94 33.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.997 . . . . 0.0 110.085 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 pt -124.1 -4.54 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 0.0 110.539 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 6.6 tt0 -137.87 156.49 47.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.004 . . . . 0.0 110.28 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.721 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 150.89 122.66 1.07 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.36 -17.35 4.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -1.171 . . . . 0.0 110.324 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.765 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -76.98 -29.22 55.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.732 HD11 HD21 ' A' ' 85' ' ' LEU . 17.2 mt -69.1 -27.63 65.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.06 -169.22 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.25 2.99 29.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -1.182 . . . . 0.0 110.175 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.513 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 30.5 p -85.74 -26.4 25.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.04 HD21 ' CG1' ' A' ' 128' ' ' ILE . 39.7 mt -122.25 156.59 33.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.868 . . . . 0.0 110.071 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.508 ' HG3' ' HB3' ' A' ' 123' ' ' LYS . 65.5 mm-40 -132.71 -79.81 0.49 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.247 -0.908 . . . . 0.0 110.129 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 22.1 mttp -80.11 129.57 34.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.605 -0.685 . . . . 0.0 110.763 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.732 HG21 ' CE2' ' A' ' 100' ' ' TYR . 6.2 mm -118.62 141.68 37.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.815 -1.178 . . . . 0.0 109.543 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.2 m -120.45 126.08 49.53 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.381 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.732 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.9 m-85 -122.12 133.38 54.76 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.434 -0.791 . . . . 0.0 110.244 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -133.22 148.75 52.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.392 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 81' ' ' TYR . 38.9 m -148.21 140.8 24.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.396 -0.815 . . . . 0.0 110.01 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 7.8 tttt -132.87 148.97 52.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -0.953 . . . . 0.0 110.124 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 79' ' ' TYR . 6.4 mt -126.39 148.39 49.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.149 -0.969 . . . . 0.0 110.346 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -152.31 -169.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.329 -0.857 . . . . 0.0 109.968 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.695 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -125.06 156.72 37.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 110.11 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 21.3 p -114.57 164.78 15.48 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.32 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.1 Cg_endo -72.6 -1.77 10.81 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.057 1.557 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.5 p -101.36 0.25 36.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.282 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.56 -38.05 3.39 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.16 -172.79 2.05 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 59.2 p -129.67 139.9 51.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -1.185 . . . . 0.0 110.251 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.824 ' HA ' HG22 ' A' ' 10' ' ' THR . 20.9 mt -89.02 149.5 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 110.199 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.631 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 14.9 mt -133.28 110.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.259 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.421 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 74.9 tttt -102.56 126.0 49.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.004 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 5.0 t -119.56 162.18 19.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.49 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.462 HG22 ' NE2' ' A' ' 119' ' ' HIS . 92.9 m -159.82 144.07 14.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.154 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 92.2 p -143.7 160.8 40.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.787 ' CE1' HG23 ' A' ' 4' ' ' THR . 75.7 m-70 -143.41 166.88 23.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.214 -0.929 . . . . 0.0 110.37 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 10.1 m-85 -129.46 145.81 51.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 110.61 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.2 m-70 -124.44 87.21 2.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.352 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.536 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 2.2 p -65.39 157.82 28.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.411 -0.806 . . . . 0.0 110.644 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.508 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 74.6 tttt -137.84 126.08 23.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.462 -0.774 . . . . 0.0 110.124 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 99.71 23.27 11.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 8.6 t30 66.32 63.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -1.134 . . . . 0.0 110.189 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 30.2 m -137.03 166.03 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.129 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.488 ' HA ' HG21 ' A' ' 122' ' ' THR . 92.2 mt-10 -135.79 166.8 22.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 110.303 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.04 ' CG1' HD21 ' A' ' 95' ' ' LEU . 4.8 mp -90.75 172.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.575 ' N ' HG22 ' A' ' 128' ' ' ILE . 54.1 mttt -112.22 131.22 55.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 109.829 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 99.5 mt-10 -43.27 -44.47 5.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 110.05 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -54.81 -26.33 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.765 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 9.6 t-160 -83.29 -60.57 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 110.102 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.981 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.5 p -63.41 -39.79 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.967 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.523 ' N ' HG13 ' A' ' 133' ' ' VAL . 81.8 tttt -60.99 -37.74 83.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.89 . . . . 0.0 109.907 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.9 78.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.927 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.91 -33.47 85.77 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.04 -41.06 97.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -1.125 . . . . 0.0 109.906 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -75.03 -33.95 61.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.83 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -72.78 -37.29 67.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 109.781 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.49 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -72.23 -33.32 67.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.827 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.9 m -69.07 -44.32 72.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 109.944 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -63.54 -38.56 91.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.878 . . . . 0.0 109.9 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 146' ' ' LEU . 61.2 mt -64.77 -35.94 82.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.857 . . . . 0.0 109.989 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.622 ' CD2' ' CZ ' ' A' ' 9' ' ' PHE . 7.9 m-85 -63.55 -38.82 92.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.926 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -77.03 -14.5 59.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.873 . . . . 0.0 109.993 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.768 ' HB3' HG21 ' A' ' 33' ' ' ILE . 15.4 mt -84.02 -34.81 24.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.228 -0.92 . . . . 0.0 108.973 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.764 HG23 HD11 ' A' ' 29' ' ' LEU . 17.2 mt -71.56 -44.81 69.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.566 -0.709 . . . . 0.0 109.109 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.716 ' HB3' HD13 ' A' ' 13' ' ' ILE . 10.9 mm-40 -66.73 -38.75 87.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 0.0 109.651 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.7 m -69.99 -37.47 75.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -0.984 . . . . 0.0 109.669 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.651 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 77.7 t80 -56.4 -57.23 13.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.424 -0.797 . . . . 0.0 110.015 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.183 HD21 ' CE2' ' A' ' 158' ' ' TYR . 55.5 mt -68.58 -29.07 67.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.28 -0.887 . . . . 0.0 110.16 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.738 ' HD2' HD11 ' A' ' 13' ' ' ILE . 80.4 tttt -68.42 -33.59 74.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.66 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.494 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -100.8 -27.38 7.51 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 150' ' ' TYR . 7.6 m80 -107.45 89.19 4.7 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.303 -1.116 . . . . 0.0 110.045 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.2 Cg_endo -73.36 2.94 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.003 1.528 . . . . 0.0 110.833 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -106.9 -11.63 15.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 0.0 109.712 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.651 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -69.78 100.57 1.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.472 -0.768 . . . . 0.0 110.001 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.183 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.7 OUTLIER 34.34 33.11 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.751 -0.593 . . . . 0.0 110.483 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.831 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.707 HG22 ' ND1' ' A' ' 121' ' ' HIS . 76.1 t -109.52 109.74 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -1.143 . . . . 0.0 110.243 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.55 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 54.7 m-85 -74.58 155.95 37.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.231 -0.918 . . . . 0.0 110.414 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.889 HG23 ' CE1' ' A' ' 119' ' ' HIS . 89.4 m -140.89 89.08 2.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.078 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CG ' ' CG2' ' A' ' 133' ' ' VAL . 80.1 m-85 -109.73 127.58 54.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.809 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.2 pt-20 -128.35 152.36 48.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.204 -0.935 . . . . 0.0 110.527 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 p -128.35 142.27 51.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -0.823 . . . . 0.0 109.794 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -121.39 138.51 54.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.979 . . . . 0.0 110.647 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.663 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 4.3 p90 -157.21 -173.03 4.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.586 -0.696 . . . . 0.0 109.753 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 113' ' ' ILE . 18.0 p -140.15 -177.1 4.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 110.647 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.512 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 2.9 t -159.59 160.0 33.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.436 -0.79 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -88.11 5.15 42.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 110.224 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.785 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.7 mm -108.46 149.65 39.62 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.006 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.785 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.9 Cg_endo -64.44 144.54 85.68 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.886 1.466 . . . . 0.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.655 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 Cg_endo -72.63 -31.24 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.015 1.534 . . . . 0.0 112.918 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.3 Cg_endo -69.39 -23.4 32.53 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 110.19 -0.735 . . . . 0.0 110.19 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.535 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 5.2 mmp_? -83.93 -44.15 14.53 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.92 HD22 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -69.78 -31.88 70.05 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 77.0 t80 -63.83 -56.91 11.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.496 -0.753 . . . . 0.0 109.426 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 51.4 mttt -52.63 -33.86 48.64 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.904 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.065 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -72.96 -60.91 2.01 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.637 0.732 . . . . 0.0 110.718 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.038 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -51.96 -51.67 55.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.723 -0.611 . . . . 0.0 111.799 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.089 HG11 ' CD1' ' A' ' 74' ' ' ILE . 12.0 t -96.85 -61.71 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.012 -1.055 . . . . 0.0 112.334 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.617 HD12 ' N ' ' A' ' 24' ' ' LEU . 6.9 mp -67.97 -1.09 5.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.057 -1.027 . . . . 0.0 111.872 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.98 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -147.69 15.22 1.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.664 -1.273 . . . . 0.0 110.845 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.038 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -54.05 -48.69 70.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 109.956 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 41' ' ' SER . 49.2 t0 -53.67 -20.34 5.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.955 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 69.5 m-80 -124.45 11.83 8.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.98 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -97.4 -46.02 6.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.0 110.26 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.989 HG21 HD13 ' A' ' 38' ' ' ILE . 6.0 p -75.59 -27.67 0.7 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.902 . . . . 0.0 112.032 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.82 ' HD3' HG12 ' A' ' 30' ' ' VAL . 50.7 Cg_endo -79.84 6.88 4.92 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 122.696 0.84 . . . . 0.0 110.297 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -130.94 -30.27 1.81 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.209 -0.932 . . . . 0.0 110.244 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.619 HD11 ' CD1' ' A' ' 29' ' ' LEU . 16.1 mt -74.67 -39.86 46.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.38 -0.825 . . . . 0.0 109.849 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -173.11 102.65 0.32 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.387 -0.821 . . . . 0.0 110.362 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.42 2.49 6.24 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.968 1.509 . . . . 0.0 110.56 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -85.03 -19.74 31.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.11 -0.994 . . . . 0.0 109.769 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.87 -44.94 8.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.416 -0.802 . . . . 0.0 110.048 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.989 HD13 HG21 ' A' ' 30' ' ' VAL . 1.2 mp -125.66 143.63 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 0.0 109.977 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 33.3 ttmt -79.63 -39.18 32.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.274 -0.891 . . . . 0.0 110.383 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.466 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER 178.73 139.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.917 . . . . 0.0 110.527 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 29.5 m -97.81 135.27 39.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 0.0 109.893 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -143.77 110.26 5.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 110.397 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.9 mt -61.43 132.8 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.066 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 44' ' ' LEU . 19.5 mt -92.88 -43.92 8.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.332 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 52' ' ' THR . 6.0 mm-40 -135.44 131.6 36.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 110.145 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.08 -172.0 37.85 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -116.83 -3.6 11.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -1.162 . . . . 0.0 110.23 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.471 ' N ' HG21 ' A' ' 52' ' ' THR . . . 134.82 -4.71 4.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.531 ' C ' HG21 ' A' ' 71' ' ' ILE . . . -79.73 -167.23 34.43 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.06 131.83 21.61 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.047 1.551 . . . . 0.0 110.603 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.46 -8.85 66.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.91 HG23 ' O ' ' A' ' 45' ' ' GLU . 21.9 m -79.94 145.04 32.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -1.13 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.625 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.6 mm -111.71 117.16 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.64 ' HE2' HD11 ' A' ' 71' ' ' ILE . 44.9 mtmt -101.3 144.99 29.45 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.318 -0.864 . . . . 0.0 110.397 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -117.39 101.56 8.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.177 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.54 ' CG2' HG12 ' A' ' 38' ' ' ILE . 80.6 mt -91.32 138.23 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.123 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 38' ' ' ILE . 1.3 p -112.09 151.64 29.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.468 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' GLY . 32.9 m-85 -111.04 136.23 50.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.873 . . . . 0.0 110.241 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.523 ' OH ' HG21 ' A' ' 57' ' ' THR . 3.3 t80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -122.51 96.19 0.56 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 26.5 p90 -133.05 166.75 21.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -1.232 . . . . 0.0 110.103 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.841 HG12 ' HA2' ' A' ' 88' ' ' GLY . 9.7 m -141.06 170.79 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.675 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' NZ ' ' OE1' ' A' ' 87' ' ' GLU . 98.4 mttt -123.17 121.13 35.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.607 -0.683 . . . . 0.0 109.585 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.671 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -111.57 125.9 54.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 110.981 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.625 ' HA ' HD13 ' A' ' 53' ' ' ILE . 80.0 tttt -99.68 116.97 33.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 109.279 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.64 HD11 ' HE2' ' A' ' 54' ' ' LYS . 39.8 mm -51.96 137.62 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.391 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.537 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 30.5 t0 -109.06 -49.15 3.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 109.85 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 3.1 m -176.72 159.47 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.522 -0.736 . . . . 0.0 110.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.089 ' CD1' HG11 ' A' ' 23' ' ' VAL . 6.3 tt -151.16 168.37 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.154 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -138.03 84.48 2.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 110.232 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.607 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 94.3 mttt -58.04 -12.17 3.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.429 -0.794 . . . . 0.0 111.008 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -89.81 -31.39 17.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.112 -0.993 . . . . 0.0 109.571 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.7 m120 -114.21 -2.16 13.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 109.667 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.823 ' O ' HD12 ' A' ' 104' ' ' LEU . 6.6 m-85 67.97 47.59 1.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.754 -0.591 . . . . 0.0 110.573 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.544 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -111.18 158.1 19.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 108.805 178.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.528 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 83.4 t80 -159.78 150.86 19.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.956 -1.09 . . . . 0.0 110.669 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.425 ' HB2' ' HA ' ' A' ' 101' ' ' GLU . 12.3 t -159.65 152.43 21.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 7.4 p90 -150.14 176.83 10.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.476 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 98' ' ' ILE . 91.4 m -124.1 126.08 45.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.797 . . . . 0.0 109.683 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.671 HD13 ' CE1' ' A' ' 69' ' ' HIS . 2.9 tp -93.52 134.48 35.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.945 . . . . 0.0 110.029 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.08 -10.57 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 110.465 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.578 ' C ' HD12 ' A' ' 91' ' ' LEU . 23.2 tt0 -140.74 149.09 41.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.424 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.841 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 162.47 149.9 5.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -65.1 -35.07 79.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -1.157 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.408 ' HB1' ' HE2' ' A' ' 132' ' ' HIS . . . -67.61 -21.11 65.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.254 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.81 HD21 ' CG1' ' A' ' 98' ' ' ILE . 41.0 mt -71.3 -32.06 68.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.47 -171.2 0.02 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -84.11 5.1 27.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -1.15 . . . . 0.0 110.006 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.6 p -92.34 -43.24 9.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.097 HD21 HD11 ' A' ' 128' ' ' ILE . 78.1 mt -94.58 164.51 12.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 110.073 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 36.3 tp10 -144.84 -80.71 0.17 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.243 -0.911 . . . . 0.0 110.21 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 58.8 mttt -80.31 128.88 34.06 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.633 -0.667 . . . . 0.0 110.486 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.81 ' CG1' HD21 ' A' ' 91' ' ' LEU . 7.5 mm -122.51 143.55 34.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.944 -1.097 . . . . 0.0 110.072 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.91 131.26 53.93 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.453 -0.779 . . . . 0.0 109.044 178.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.724 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.9 m-85 -127.08 133.37 50.46 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 110.47 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.425 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 75.3 tt0 -131.59 154.26 49.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.885 . . . . 0.0 110.213 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 81' ' ' TYR . 81.6 m -155.0 123.56 6.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.988 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 12.4 tttt -119.38 150.33 40.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 110.311 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 79' ' ' TYR . 13.0 mt -124.82 150.35 46.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 110.651 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.37 -169.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.397 -0.815 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.64 167.85 12.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.868 . . . . 0.0 110.238 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 60.2 p -126.42 162.52 46.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.117 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.5 Cg_endo -71.98 -2.48 11.59 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.971 1.511 . . . . 0.0 110.486 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -101.6 -2.61 30.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.264 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.84 -35.95 4.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.12 -172.56 2.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 15.6 p -128.71 136.21 50.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -1.213 . . . . 0.0 110.435 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.59 ' HA ' HG22 ' A' ' 10' ' ' THR . 62.4 mt -84.93 149.32 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.663 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 9.8 mt -134.33 121.11 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.318 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -110.84 134.61 52.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.91 . . . . 0.0 110.093 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.5 t -125.26 158.4 34.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.89 . . . . 0.0 110.319 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 84.8 m -159.92 126.59 4.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.88 . . . . 0.0 110.322 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.457 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 18.8 t -126.5 155.84 41.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.288 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.889 ' CE1' HG23 ' A' ' 4' ' ' THR . 80.6 m-70 -130.73 164.5 24.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.306 -0.871 . . . . 0.0 109.965 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.612 ' HD1' HD12 ' A' ' 98' ' ' ILE . 18.6 m-85 -133.67 134.49 43.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 111.037 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.707 ' ND1' HG22 ' A' ' 2' ' ' VAL . 85.4 m-70 -121.07 90.2 3.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 108.848 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.877 ' HB ' HD23 ' A' ' 95' ' ' LEU . 2.2 t -91.59 -179.46 5.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 111.748 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -133.97 171.89 13.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.902 -0.498 . . . . 0.0 109.703 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 125' ' ' ASN . . . 76.45 2.48 74.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 16.6 t30 68.68 60.41 0.37 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.268 -1.137 . . . . 0.0 110.728 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.532 HG22 ' OG1' ' A' ' 122' ' ' THR . 6.6 m -126.01 162.08 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.668 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -118.64 145.91 45.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.02 . . . . 0.0 110.725 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.097 HD11 HD21 ' A' ' 95' ' ' LEU . 24.1 mm -55.77 173.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.388 -0.82 . . . . 0.0 110.083 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 128' ' ' ILE . 29.5 mtpt -110.15 131.69 54.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.042 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.53 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 60.6 mt-10 -43.26 -42.37 4.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 110.103 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 48.8 tt0 -60.83 -26.33 67.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 109.923 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.0 t-160 -85.97 -53.05 5.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 110.081 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.606 ' CG2' ' CG ' ' A' ' 5' ' ' TYR . 3.9 p -69.07 -30.78 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 110.126 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 64.6 tttp -79.3 -53.94 6.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 109.801 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -61.52 -25.74 67.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.95 -36.52 81.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.477 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 96.5 mttt -65.57 -33.96 77.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -1.119 . . . . 0.0 109.866 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.415 ' HG2' ' ND2' ' A' ' 142' ' ' ASN . 79.8 tt0 -81.53 -32.1 32.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.0 109.88 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -67.77 -44.67 76.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.374 -0.829 . . . . 0.0 109.873 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -71.2 -38.4 72.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 110.004 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.1 m -62.81 -49.35 75.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.395 -0.816 . . . . 0.0 109.993 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.415 ' ND2' ' HG2' ' A' ' 138' ' ' GLU . 80.3 m-20 -56.29 -43.13 78.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.982 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.47 ' O ' HG13 ' A' ' 147' ' ' ILE . 23.4 mt -60.74 -40.69 93.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.91 . . . . 0.0 109.944 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 19.1 m-85 -60.61 -39.88 89.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.439 -0.788 . . . . 0.0 109.86 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -67.91 -17.94 64.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 110.037 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 146' ' ' LEU . 16.0 mt -84.14 -34.9 23.96 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.19 -0.944 . . . . 0.0 108.965 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.714 HG22 HD23 ' A' ' 18' ' ' LEU . 55.2 mt -71.75 -41.64 70.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.548 -0.72 . . . . 0.0 109.06 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.663 ' OE2' HD11 ' A' ' 114' ' ' ILE . 14.9 mm-40 -59.97 -39.68 86.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.289 -0.882 . . . . 0.0 109.205 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 97.7 m -67.09 -35.99 81.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 109.185 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.648 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 72.3 t80 -53.15 -53.46 50.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.48 -0.763 . . . . 0.0 109.625 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.188 HD21 ' CE2' ' A' ' 158' ' ' TYR . 98.3 mt -76.08 -27.03 57.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.296 -0.877 . . . . 0.0 109.984 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.525 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 29.8 ttpt -75.88 -19.67 58.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -113.45 -30.73 2.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 15.3 m80 -106.89 93.28 8.67 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.199 -1.177 . . . . 0.0 110.224 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.5 Cg_endo -74.22 4.77 4.05 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.086 1.572 . . . . 0.0 110.876 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -108.15 3.68 24.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 109.827 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.648 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -86.87 103.34 15.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.381 -0.824 . . . . 0.0 110.196 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.188 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.65 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.686 -0.634 . . . . 0.0 110.511 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.714 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.734 HG22 ' CD2' ' A' ' 121' ' ' HIS . 54.8 t -106.59 128.63 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -1.14 . . . . 0.0 110.306 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.717 ' CG ' HD13 ' A' ' 128' ' ' ILE . 9.0 m-85 -90.86 143.5 26.66 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.267 -0.896 . . . . 0.0 109.654 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.711 HG23 ' CE1' ' A' ' 119' ' ' HIS . 4.8 m -126.23 116.82 21.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.984 -1.073 . . . . 0.0 110.403 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 57.5 m-85 -131.76 137.25 48.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 109.915 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -136.08 149.75 48.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 110.565 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.4 p -139.69 149.98 44.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.78 . . . . 0.0 109.451 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.45 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 2.8 tt0 -133.79 138.33 45.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.968 -1.083 . . . . 0.0 110.854 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.608 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 3.6 p90 -154.34 -174.7 5.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.429 -0.794 . . . . 0.0 109.597 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 113' ' ' ILE . 14.0 p -136.88 178.35 7.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 110.687 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.412 ' OG ' HD11 ' A' ' 114' ' ' ILE . 83.0 p -157.36 153.1 26.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 110.24 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -79.34 -15.45 57.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.912 . . . . 0.0 110.267 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.843 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.9 mp -87.57 151.25 50.23 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 109.937 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.843 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.8 143.47 73.82 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.057 1.556 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.642 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.88 -31.14 10.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 124.065 1.561 . . . . 0.0 112.972 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.6 Cg_endo -70.52 -21.79 29.48 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 N-CA-C 110.103 -0.768 . . . . 0.0 110.103 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.495 ' NE ' ' HA ' ' A' ' 159' ' ' ASN . 9.1 mmp_? -83.44 -47.12 11.72 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.75 ' C ' HD23 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -66.51 -27.87 68.11 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 81.6 t80 -65.65 -60.36 2.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.715 -0.616 . . . . 0.0 109.604 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 52.3 mttt -52.03 -32.97 36.56 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.4 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.023 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.13 -56.02 5.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.399 -0.813 . . . . 0.0 110.661 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.048 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -58.62 -49.15 78.55 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.542 -0.724 . . . . 0.0 111.384 -178.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.13 HG11 ' CD1' ' A' ' 74' ' ' ILE . 16.8 t -93.49 -65.25 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.973 -1.079 . . . . 0.0 111.717 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 24' ' ' LEU . 6.9 mp -67.55 -1.07 4.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.287 -0.883 . . . . 0.0 111.819 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.792 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -149.04 25.24 0.92 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.795 -1.19 . . . . 0.0 110.729 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.048 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -63.79 -38.12 89.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.119 -0.988 . . . . 0.0 109.989 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.498 ' OD2' HD11 ' A' ' 43' ' ' ILE . 54.7 m-20 -65.02 -14.92 61.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 110.253 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 72.8 m-80 -125.15 7.72 7.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 110.058 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.829 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -95.43 -57.03 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 110.103 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.975 HG11 HD13 ' A' ' 38' ' ' ILE . 96.1 t -62.69 -40.51 64.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.765 . . . . 0.0 111.153 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -77.4 7.09 3.94 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.371 1.195 . . . . 0.0 110.85 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -127.48 -29.8 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.902 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.692 HD11 ' CD1' ' A' ' 29' ' ' LEU . 32.3 mt -80.07 -44.37 22.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.51 -0.744 . . . . 0.0 110.044 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.02 102.14 2.11 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 110.348 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.21 3.63 5.55 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.049 1.552 . . . . 0.0 110.717 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -90.74 -13.84 33.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.141 -0.975 . . . . 0.0 110.208 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.83 -29.05 12.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.198 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.975 HD13 HG11 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -142.07 150.26 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -88.69 -44.79 10.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.326 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -172.93 156.76 3.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.377 -0.827 . . . . 0.0 110.173 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -119.81 121.99 40.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 109.95 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 84.6 tt0 -124.31 114.49 19.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.498 HD11 ' OD2' ' A' ' 27' ' ' ASP . 23.4 mt -61.55 132.21 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.944 . . . . 0.0 110.088 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 55' ' ' LYS . 53.4 mt -92.89 -25.54 18.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 1.073 ' O ' HG23 ' A' ' 52' ' ' THR . 41.8 tt0 -156.46 171.31 20.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 58.07 -165.92 6.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -131.55 29.42 4.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -1.112 . . . . 0.0 110.291 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.51 ' H ' HG21 ' A' ' 52' ' ' THR . . . 103.36 2.25 47.57 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.485 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -92.53 -167.33 39.42 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.4 132.86 23.15 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.058 1.557 . . . . 0.0 110.522 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.17 -6.62 68.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 1.073 HG23 ' O ' ' A' ' 45' ' ' GLU . 19.4 m -80.06 147.91 31.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -1.174 . . . . 0.0 110.129 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.606 HD13 ' HA ' ' A' ' 70' ' ' LYS . 21.6 mm -116.53 114.96 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.071 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 35.7 mtmt -99.76 147.47 25.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HB2' HD11 ' A' ' 44' ' ' LEU . 83.6 tttt -116.78 98.62 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.898 . . . . 0.0 110.09 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.531 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.7 mt -88.22 146.42 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.5 p -120.16 155.62 32.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.38 -0.825 . . . . 0.0 110.574 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.692 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.1 m-85 -116.58 145.36 43.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.449 -0.782 . . . . 0.0 110.145 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.401 ' CD1' ' HD2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.233 0.539 . . . . 0.0 110.186 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -118.86 94.98 0.6 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 20.8 p90 -134.8 167.97 19.9 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.049 -1.265 . . . . 0.0 110.478 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.821 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.8 m -139.69 172.89 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 110.447 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.512 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 30.3 mtpt -123.9 129.37 50.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.528 -0.732 . . . . 0.0 109.518 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.579 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -117.19 125.94 51.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.99 -1.069 . . . . 0.0 110.931 -179.336 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.606 ' HA ' HD13 ' A' ' 53' ' ' ILE . 64.6 tttp -104.94 110.49 22.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 109.3 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 29.2 mm -48.19 140.65 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.187 -0.945 . . . . 0.0 110.406 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 16.0 t0 -112.25 -40.32 4.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.393 -0.817 . . . . 0.0 109.629 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 0.6 OUTLIER 172.19 161.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.0 110.391 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.13 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.6 tt -152.03 165.33 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -131.34 80.73 1.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.601 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.6 mttt -55.78 -14.14 2.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.87 . . . . 0.0 110.827 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -90.18 -29.75 18.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.227 -0.92 . . . . 0.0 109.645 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.7 m120 -114.45 -1.68 13.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.486 -0.758 . . . . 0.0 109.965 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.766 ' O ' HD12 ' A' ' 104' ' ' LEU . 8.3 m-85 67.48 48.04 1.17 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.639 -0.663 . . . . 0.0 110.646 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -115.06 154.2 29.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.208 -0.932 . . . . 0.0 109.095 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.528 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 84.7 t80 -154.98 148.32 25.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.9 -1.125 . . . . 0.0 110.523 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.5 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 17.9 m -156.22 147.16 22.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.366 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 4.9 p90 -144.21 178.3 7.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.409 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 98' ' ' ILE . 71.0 m -124.83 125.19 43.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.535 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.68 HD21 HD11 ' A' ' 91' ' ' LEU . 5.3 tp -90.86 136.11 33.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.178 -0.951 . . . . 0.0 110.401 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.2 pt -123.58 -6.14 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.551 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.512 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 11.2 tt0 -141.37 160.44 40.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 110.429 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.821 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 145.77 123.69 1.58 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.34 -15.41 6.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -1.16 . . . . 0.0 110.402 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -77.1 -29.37 54.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.68 HD11 HD21 ' A' ' 85' ' ' LEU . 28.6 mt -67.46 -39.33 85.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.366 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 178.05 44.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -74.46 -0.01 16.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -1.148 . . . . 0.0 110.162 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.583 ' HB ' HG11 ' A' ' 126' ' ' VAL . 15.4 p -95.2 -40.41 9.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.165 -0.959 . . . . 0.0 110.305 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.891 HD11 HG13 ' A' ' 128' ' ' ILE . 1.8 mm? -79.84 136.98 36.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.165 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 5.7 tp10 -124.98 -83.44 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.318 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 26.7 mttt -80.16 126.87 31.65 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 110.695 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.69 HG21 ' HE2' ' A' ' 100' ' ' TYR . 5.3 mm -121.14 141.04 43.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 120.614 -1.304 . . . . 0.0 109.235 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.72 134.23 55.05 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.879 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.69 ' HE2' HG21 ' A' ' 98' ' ' ILE . 8.2 m-85 -130.3 132.7 46.0 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.422 -0.799 . . . . 0.0 110.169 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.5 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 5.9 mt-10 -129.71 167.01 18.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.223 -0.923 . . . . 0.0 110.619 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 81' ' ' TYR . 45.6 m -162.9 137.69 6.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.381 -0.824 . . . . 0.0 109.909 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.4 mttt -135.58 137.88 42.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.391 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.768 HD23 HG12 ' A' ' 114' ' ' ILE . 9.8 mt -117.12 149.92 39.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.319 -0.863 . . . . 0.0 110.127 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.79 -169.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -0.936 . . . . 0.0 110.153 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.64 166.85 13.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.268 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 24.8 p -125.02 165.69 24.42 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -73.17 -0.65 9.42 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.995 1.524 . . . . 0.0 110.488 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.6 p -110.42 7.66 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.263 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.38 -38.66 3.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.03 -172.72 0.14 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 16.8 p -133.63 135.26 44.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.171 -1.194 . . . . 0.0 110.385 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.623 ' HA ' HG22 ' A' ' 10' ' ' THR . 41.8 mt -86.44 152.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.056 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.768 HG12 HD23 ' A' ' 104' ' ' LEU . 5.3 mt -136.42 115.17 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.933 . . . . 0.0 110.614 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 44.4 tttp -101.06 127.28 47.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -0.842 . . . . 0.0 109.745 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.05 157.91 25.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.748 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.444 HG22 ' NE2' ' A' ' 119' ' ' HIS . 98.7 m -160.08 144.33 14.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.394 -0.816 . . . . 0.0 110.067 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.493 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -146.65 168.64 20.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.161 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.711 ' CE1' HG23 ' A' ' 4' ' ' THR . 48.4 m-70 -148.87 174.56 12.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.166 -0.959 . . . . 0.0 110.552 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.583 ' CD2' HG12 ' A' ' 128' ' ' ILE . 87.9 m-85 -138.09 156.91 47.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.217 -0.927 . . . . 0.0 110.958 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.734 ' CD2' HG22 ' A' ' 2' ' ' VAL . 74.7 m80 -140.84 81.49 1.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.406 -0.809 . . . . 0.0 109.251 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.458 ' HB ' ' HB ' ' A' ' 126' ' ' VAL . 0.1 OUTLIER -63.08 142.36 58.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.334 -0.854 . . . . 0.0 110.648 -179.352 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -69.19 110.4 4.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.896 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.63 -116.36 5.45 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 2.6 p-10 -137.13 49.3 2.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -1.172 . . . . 0.0 110.244 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 127' ' ' GLU . 66.7 t -96.42 174.96 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.416 -0.803 . . . . 0.0 109.952 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.597 ' N ' HG12 ' A' ' 126' ' ' VAL . 96.0 mt-10 -126.22 161.2 28.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.891 HG13 HD11 ' A' ' 95' ' ' LEU . 4.5 mp -88.38 172.94 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.867 . . . . 0.0 110.095 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.615 ' N ' HG22 ' A' ' 128' ' ' ILE . 67.0 mmtt -90.83 151.96 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.332 -0.855 . . . . 0.0 109.958 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 61.7 mm-40 -58.16 -22.0 49.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.136 -0.978 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.836 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 98.2 mt-10 -68.03 -39.57 83.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.91 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 5.3 m170 -66.04 -47.55 74.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.162 -0.961 . . . . 0.0 110.02 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.589 HG23 ' CD1' ' A' ' 5' ' ' TYR . 2.5 p -76.47 -25.87 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.449 -0.782 . . . . 0.0 110.093 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 73.6 tttt -104.31 -65.37 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.958 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.836 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.68 -24.21 47.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.868 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.51 -28.58 67.33 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.11 -33.1 56.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -1.127 . . . . 0.0 110.017 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -81.39 -31.26 33.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.85 . . . . 0.0 109.813 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.617 ' HE3' ' HB1' ' A' ' 135' ' ' ALA . 85.8 mttt -73.42 -36.72 66.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 109.828 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.23 -35.94 61.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.852 . . . . 0.0 109.89 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.1 m -64.04 -45.46 88.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -0.821 . . . . 0.0 109.973 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -56.41 -50.67 70.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.993 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.403 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.9 mm? -60.51 -33.98 73.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.949 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -65.16 -37.49 87.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.414 -0.803 . . . . 0.0 109.833 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 29.3 ttmt -79.63 -15.45 57.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.441 -0.787 . . . . 0.0 110.042 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.512 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 13.8 mt -83.23 -37.02 24.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.081 -1.012 . . . . 0.0 108.933 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.708 HD13 ' CD1' ' A' ' 22' ' ' PHE . 86.6 mt -70.72 -44.36 76.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.726 ' HB3' HD13 ' A' ' 13' ' ' ILE . 62.6 mt-10 -55.88 -40.01 72.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.327 -0.858 . . . . 0.0 109.202 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.436 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 18.6 m -71.25 -31.63 67.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.556 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.607 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 79.0 t80 -56.08 -49.94 72.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.474 -0.766 . . . . 0.0 109.775 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.171 HD21 ' CE2' ' A' ' 158' ' ' TYR . 59.3 mt -77.72 -29.02 51.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.997 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.679 ' HB2' HD11 ' A' ' 13' ' ' ILE . 52.4 tptt -66.98 -26.78 66.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.464 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -107.28 -28.41 4.92 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 4.9 m80 -106.9 91.18 6.0 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.219 -1.165 . . . . 0.0 110.05 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.7 Cg_endo -73.29 4.58 3.74 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.062 1.559 . . . . 0.0 111.104 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -111.14 -7.72 14.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.019 -1.051 . . . . 0.0 109.97 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.646 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -70.49 101.33 1.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 110.109 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.171 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.8 OUTLIER 34.79 31.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.712 -0.618 . . . . 0.0 110.635 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.715 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 93.9 t -136.07 134.11 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -1.166 . . . . 0.0 110.363 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 128' ' ' ILE . 11.2 m-85 -101.18 131.9 46.94 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.66 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.78 126.41 47.34 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.858 -1.151 . . . . 0.0 110.687 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.824 ' CE1' HG11 ' A' ' 133' ' ' VAL . 50.4 m-85 -133.58 125.59 29.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.806 . . . . 0.0 109.907 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.791 ' CG ' HG23 ' A' ' 117' ' ' THR . 3.8 mt-10 -136.49 145.61 45.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.398 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 m -132.03 158.82 40.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.805 . . . . 0.0 110.015 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.456 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 98.9 mt-10 -143.72 123.67 13.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.443 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 p90 -147.47 -173.64 4.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.616 HG22 HG12 ' A' ' 113' ' ' ILE . 12.5 p -138.34 -179.4 5.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.578 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.3 p -157.1 164.15 38.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.41 -0.806 . . . . 0.0 110.206 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -86.1 -21.74 27.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.2 mm -84.91 150.26 55.27 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.146 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 42.2 Cg_endo -66.1 150.4 85.21 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.158 1.61 . . . . 0.0 110.14 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.674 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.5 Cg_endo -70.15 -32.93 16.05 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.912 1.48 . . . . 0.0 113.304 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.5 Cg_endo -66.92 -23.23 47.49 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 122.381 0.674 . . . . 0.0 110.408 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.528 ' HG3' ' HG2' ' A' ' 14' ' ' PRO . 10.7 mmp_? -84.5 -45.66 12.41 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.765 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -72.28 -25.4 61.58 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.564 -0.71 . . . . 0.0 109.241 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.619 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 85.2 t80 -70.74 -57.98 4.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.402 -0.811 . . . . 0.0 109.059 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 67.5 mttt -51.23 -35.99 39.62 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.33 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.045 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.48 -53.81 8.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 111.021 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.738 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -59.54 -46.23 89.47 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 111.706 -178.69 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.771 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -98.18 -61.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.947 -1.096 . . . . 0.0 111.57 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.5 mp -70.18 0.31 6.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.149 -0.969 . . . . 0.0 111.55 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.683 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -154.55 46.92 0.57 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.79 -1.194 . . . . 0.0 110.856 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -84.64 -25.22 28.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -0.999 . . . . 0.0 110.062 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 60.6 t0 -73.76 -11.66 60.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 109.907 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 71.6 m-20 -128.6 10.46 6.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.37 -0.831 . . . . 0.0 109.652 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.794 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -97.9 -57.75 2.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.445 -0.784 . . . . 0.0 110.45 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.876 HG22 ' HD3' ' A' ' 31' ' ' PRO . 1.9 m -74.86 -29.1 0.87 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 112.101 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.876 ' HD3' HG22 ' A' ' 30' ' ' VAL . 51.0 Cg_endo -80.5 -1.51 11.35 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 O-C-N 122.878 0.936 . . . . 0.0 110.374 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -126.43 -32.09 2.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 109.756 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.634 ' CD1' HD13 ' A' ' 29' ' ' LEU . 11.9 mt -80.06 -34.17 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.489 -0.757 . . . . 0.0 109.393 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -160.38 99.06 1.4 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.586 -0.696 . . . . 0.0 109.896 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 43.2 Cg_endo -69.33 -4.33 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.984 1.518 . . . . 0.0 110.427 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -87.17 1.88 51.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.865 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.997 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -107.04 -47.6 3.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 109.997 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.997 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.9 mp -133.88 142.06 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 0.0 110.071 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -82.94 -36.57 25.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.468 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -175.42 132.69 0.29 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.375 -0.828 . . . . 0.0 109.946 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.491 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 2.3 m -100.26 131.24 46.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.45 ' O ' HD12 ' A' ' 44' ' ' LEU . 77.5 tt0 -138.69 110.83 7.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 110.293 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 14.7 mt -64.11 134.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 110.203 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 55' ' ' LYS . 9.7 mp -97.89 -44.46 6.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.944 ' O ' HG23 ' A' ' 52' ' ' THR . 3.5 mt-10 -128.77 145.37 51.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.237 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.24 -162.46 53.57 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -139.52 23.02 2.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -1.123 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.541 ' H ' HG21 ' A' ' 52' ' ' THR . . . 119.15 -11.67 11.55 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -80.83 -168.0 38.48 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.89 139.68 36.85 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.09 1.574 . . . . 0.0 110.377 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.05 -3.34 85.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.944 HG23 ' O ' ' A' ' 45' ' ' GLU . 31.9 m -80.09 139.0 37.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -1.198 . . . . 0.0 110.05 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.622 HD13 ' HA ' ' A' ' 70' ' ' LYS . 25.7 mm -109.87 109.59 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 110.295 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 88.1 mttt -99.04 138.4 36.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.323 -0.861 . . . . 0.0 110.217 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.496 ' HB2' HD13 ' A' ' 44' ' ' LEU . 83.2 tttt -109.41 97.28 6.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.202 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.44 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 91.1 mt -84.15 141.88 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 0.0 110.177 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.3 p -116.08 155.22 28.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.147 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 23.5 m-85 -111.8 166.63 11.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.863 . . . . 0.0 110.358 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.4 ' HE1' HG22 ' A' ' 57' ' ' THR . 1.8 t80 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.157 0.503 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.14 88.29 0.28 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.5 p90 -126.84 164.36 21.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -1.168 . . . . 0.0 110.147 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.852 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.6 m -139.31 173.82 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 110.575 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.504 ' HE3' HG21 ' A' ' 53' ' ' ILE . 48.9 tttt -123.0 128.24 49.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.589 -0.694 . . . . 0.0 109.591 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.67 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -119.7 119.31 33.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 0.0 110.851 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.622 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.4 tttt -100.64 110.87 23.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.577 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.53 HG23 HD11 ' A' ' 74' ' ' ILE . 33.2 mm -46.33 142.79 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.475 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 12.9 t0 -114.64 -41.29 3.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.471 -0.768 . . . . 0.0 109.552 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.578 ' C ' HD12 ' A' ' 74' ' ' ILE . 67.5 p -174.48 157.91 2.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.82 . . . . 0.0 109.457 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.578 HD12 ' C ' ' A' ' 73' ' ' SER . 1.0 OUTLIER -138.99 151.02 23.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.084 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 6.5 m-20 -127.75 75.99 1.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.388 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 99.5 mttt -62.55 -12.85 25.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.101 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -97.98 -30.37 12.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 109.205 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.3 m120 -105.29 -3.08 23.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.653 -0.654 . . . . 0.0 109.715 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.619 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 83.1 m-85 61.26 53.35 3.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.49 -0.756 . . . . 0.0 110.083 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.541 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -125.82 152.67 45.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.568 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.771 ' CE1' HG13 ' A' ' 23' ' ' VAL . 25.8 t80 -138.78 134.5 33.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 110.391 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.457 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -141.54 123.13 15.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 110.555 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 8.8 p90 -135.0 175.89 9.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 110.134 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.6 m -124.41 127.82 48.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.779 HD23 HG13 ' A' ' 98' ' ' ILE . 3.3 tp -97.49 135.81 38.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 0.0 109.906 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.499 HG12 ' HB3' ' A' ' 68' ' ' LYS . 6.7 pt -128.53 -5.42 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 110.409 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' O ' HD11 ' A' ' 85' ' ' LEU . 23.0 tt0 -137.05 139.04 41.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.393 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.852 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 166.49 122.47 0.61 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -51.06 -21.31 1.78 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -1.105 . . . . 0.0 110.23 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -72.79 -27.09 61.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.069 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.667 HD21 HG13 ' A' ' 98' ' ' ILE . 64.7 mt -66.28 -27.84 68.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.177 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.03 -169.67 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -84.62 4.6 31.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -1.147 . . . . 0.0 110.11 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.516 ' O ' HG21 ' A' ' 126' ' ' VAL . 46.8 p -90.41 -30.06 17.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.063 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.052 HD21 ' CG1' ' A' ' 128' ' ' ILE . 44.8 mt -116.99 166.27 12.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.392 -0.818 . . . . 0.0 110.008 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 49.0 tt0 -143.23 -79.57 0.21 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.306 -0.871 . . . . 0.0 110.018 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 51.9 mttt -80.16 139.74 36.67 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.57 -0.706 . . . . 0.0 110.531 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.779 HG13 HD23 ' A' ' 85' ' ' LEU . 7.3 mm -128.24 140.91 47.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 120.861 -1.149 . . . . 0.0 109.722 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.6 m -118.35 125.88 50.94 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.462 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.754 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.3 m-85 -122.77 135.89 54.7 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 37.2 tt0 -141.86 138.45 32.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.844 . . . . 0.0 110.149 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 81' ' ' TYR . 88.8 m -135.76 157.65 46.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 110.059 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 0.3 OUTLIER -149.31 144.16 26.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.266 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.665 HD23 HG12 ' A' ' 114' ' ' ILE . 5.7 mt -121.33 149.19 43.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 110.776 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.82 -169.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 109.711 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -118.68 165.43 13.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 96.3 p -123.95 162.51 40.79 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.248 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.8 Cg_endo -72.03 -2.93 12.31 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.019 1.536 . . . . 0.0 110.422 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.7 p -102.12 -0.36 33.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.3 -35.42 5.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.59 -173.04 3.23 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 73.3 p -128.35 133.71 48.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -1.161 . . . . 0.0 110.337 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 10' ' ' THR . 71.9 mt -81.66 149.64 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 110.183 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.665 HG12 HD23 ' A' ' 104' ' ' LEU . 8.7 mt -132.98 107.56 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.268 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.2 tttt -95.32 132.63 40.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.882 . . . . 0.0 110.069 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.3 OUTLIER -126.2 151.62 47.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 110.259 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.791 HG23 ' CG ' ' A' ' 6' ' ' GLU . 99.2 m -150.06 137.2 19.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.486 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 5.4 p -142.8 146.08 33.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 109.938 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.558 ' CE1' HG22 ' A' ' 117' ' ' THR . 41.6 m-70 -131.33 163.44 27.83 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 110.62 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 9.3 m-85 -122.91 150.29 43.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.579 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 93.8 m-70 -128.98 93.72 3.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 109.472 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.538 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.7 p -71.3 157.63 37.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 110.693 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.485 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 47.6 tptt -140.45 106.1 5.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.311 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 118.81 29.27 1.88 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.83 65.76 0.99 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -1.145 . . . . 0.0 110.214 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 94' ' ' THR . 26.9 m -141.67 162.15 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.176 -0.953 . . . . 0.0 110.099 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -130.6 168.51 16.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.27 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.052 ' CG1' HD21 ' A' ' 95' ' ' LEU . 4.7 mp -94.92 173.07 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.25 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.615 ' N ' HG22 ' A' ' 128' ' ' ILE . 34.5 mttt -110.38 129.92 55.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.387 -0.821 . . . . 0.0 109.658 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.42 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 57.3 mm-40 -42.51 -39.32 2.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 110.267 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -60.95 -28.08 68.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.948 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.7 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 15.8 t-160 -78.01 -54.83 5.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 110.057 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.824 HG11 ' CE1' ' A' ' 5' ' ' TYR . 99.4 t -61.13 -38.32 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.847 . . . . 0.0 110.015 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.44 -39.46 88.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.062 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.35 83.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.991 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.79 -30.47 68.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.494 ' HE3' HG12 ' A' ' 133' ' ' VAL . 97.2 mttt -69.88 -31.41 69.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -1.123 . . . . 0.0 110.112 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.509 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 97.8 mt-10 -75.75 -39.33 57.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 110.05 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -62.45 -43.31 99.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -73.24 -34.52 65.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.018 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.0 m -71.51 -54.32 10.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.402 -0.811 . . . . 0.0 109.913 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 73.1 m-20 -51.53 -46.23 63.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.903 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 21.8 tp -57.74 -46.05 85.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 0.0 109.815 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 6.9 m-85 -53.89 -36.88 63.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.729 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 76.7 tttt -79.98 -13.14 59.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.47 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 20.9 mt -87.47 -36.57 17.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.211 -0.931 . . . . 0.0 108.927 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.704 HD13 ' CD1' ' A' ' 22' ' ' PHE . 45.3 mt -73.2 -41.67 58.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.518 ' O ' HG13 ' A' ' 13' ' ' ILE . 19.9 pt-20 -58.55 -31.98 68.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.344 -0.847 . . . . 0.0 109.243 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.463 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 31.8 m -80.0 -34.59 38.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.36 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.674 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 87.1 t80 -58.51 -53.88 53.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.501 -0.75 . . . . 0.0 109.883 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.167 HD21 ' CE2' ' A' ' 158' ' ' TYR . 76.5 mt -70.58 -31.35 68.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.268 -0.895 . . . . 0.0 110.047 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.4 tptt -70.08 -18.92 63.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.492 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.417 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.79 -31.65 2.88 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 150' ' ' TYR . 2.1 m80 -108.16 93.89 12.04 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.345 -1.091 . . . . 0.0 109.904 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.478 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.6 Cg_endo -74.01 5.81 3.3 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.077 1.567 . . . . 0.0 111.06 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -111.58 -9.07 14.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.056 -1.028 . . . . 0.0 109.683 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.69 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -64.81 102.33 0.58 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 110.03 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.167 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.8 OUTLIER 34.68 33.55 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.716 -0.615 . . . . 0.0 110.351 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.85 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 120' ' ' TYR . 74.4 t -122.53 142.37 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -1.159 . . . . 0.0 110.29 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.768 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.7 m-85 -91.72 152.36 20.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.891 . . . . 0.0 110.124 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.81 HG23 ' CE1' ' A' ' 119' ' ' HIS . 17.6 m -132.48 106.87 8.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 0.0 110.364 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.971 ' CE2' HG21 ' A' ' 133' ' ' VAL . 71.3 m-85 -121.54 143.04 49.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.867 . . . . 0.0 109.98 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.65 152.17 42.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.099 -1.001 . . . . 0.0 110.381 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.8 t -132.38 162.54 30.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 110.048 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -145.31 117.32 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.41 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.4 p90 -144.78 -171.48 3.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.879 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.666 HG22 HG12 ' A' ' 113' ' ' ILE . 19.2 p -138.6 -179.61 5.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 0.0 110.621 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 3.0 t -154.19 168.99 24.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.805 . . . . 0.0 110.22 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -92.58 -28.06 16.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.765 HG23 ' HD2' ' A' ' 14' ' ' PRO . 12.3 mm -82.96 148.02 55.88 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.057 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.765 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.4 Cg_endo -64.71 152.47 81.84 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.016 1.535 . . . . 0.0 110.821 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.674 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.4 Cg_endo -63.18 -36.25 58.91 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.917 1.483 . . . . 0.0 112.928 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -63.81 -20.29 68.29 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 N-CA-C 109.862 -0.861 . . . . 0.0 109.862 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.925 ' HB3' HD13 ' A' ' 151' ' ' LEU . 9.8 mmp_? -81.1 -46.03 15.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.763 ' CD1' HG22 ' A' ' 147' ' ' ILE . 4.1 mm? -74.03 -37.08 64.45 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.545 -0.862 . . . . 0.0 108.751 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 37.8 t80 -57.87 -56.69 18.65 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.158 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 89.0 mttt -58.2 -36.45 73.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.708 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.08 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.09 -63.64 1.37 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.435 -0.791 . . . . 0.0 110.738 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.923 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -51.95 -34.36 41.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.516 -0.74 . . . . 0.0 111.622 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.777 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.5 t -108.68 -65.03 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.974 -1.079 . . . . 0.0 111.637 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.1 mp -69.68 -1.6 9.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.22 -0.925 . . . . 0.0 111.303 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.752 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -148.47 23.09 1.03 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.879 -1.138 . . . . 0.0 110.476 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.923 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -62.49 -44.92 95.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.887 . . . . 0.0 110.201 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.503 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 63.8 m-20 -58.22 -15.39 9.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 110.207 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 74.0 m-20 -124.91 4.86 8.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.017 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.83 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -93.2 -49.09 6.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.425 -0.797 . . . . 0.0 109.946 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.035 HG11 HD12 ' A' ' 38' ' ' ILE . 3.5 t -71.17 -42.0 11.33 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.83 . . . . 0.0 110.895 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.7 Cg_endo -77.2 6.61 4.2 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.422 1.222 . . . . 0.0 110.722 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 63.3 mttt -124.63 -33.97 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.264 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.598 HD11 ' CD1' ' A' ' 29' ' ' LEU . 35.3 mt -80.1 -34.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.597 -0.69 . . . . 0.0 109.606 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.46 98.52 1.4 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.512 -0.742 . . . . 0.0 110.109 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.28 2.15 6.53 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.027 1.54 . . . . 0.0 110.726 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -90.54 -3.64 57.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.141 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.5 -33.48 6.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 110.165 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.035 HD12 HG11 ' A' ' 30' ' ' VAL . 6.7 mt -135.97 134.44 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.892 . . . . 0.0 110.284 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.55 ' CG ' ' CA ' ' A' ' 59' ' ' GLY . 9.1 mtmt -73.34 -39.14 65.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.373 -0.829 . . . . 0.0 110.302 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 177.01 164.16 0.49 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 110.211 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 69.5 m -124.73 120.07 30.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.921 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -122.7 102.44 8.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.302 -0.874 . . . . 0.0 110.183 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 28.2 mt -50.32 130.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 110.164 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 55' ' ' LYS . 46.6 mt -88.61 -26.45 21.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 110.091 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 1.062 ' O ' HG23 ' A' ' 52' ' ' THR . 50.0 tt0 -157.08 173.88 16.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 110.23 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 58.98 -159.98 16.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -143.87 31.2 1.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -1.153 . . . . 0.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.783 ' H ' HG21 ' A' ' 52' ' ' THR . . . 105.42 3.0 41.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -97.49 -167.18 32.45 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.5 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 44.2 Cg_endo -70.32 137.09 33.07 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.065 1.56 . . . . 0.0 110.506 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.17 -6.72 83.31 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 1.062 HG23 ' O ' ' A' ' 45' ' ' GLU . 46.4 m -80.05 138.17 36.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -1.14 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' A' ' 70' ' ' LYS . 36.7 mm -105.61 121.27 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 110.037 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 52.3 mtmt -106.29 120.11 41.0 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 110.293 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HB2' HD11 ' A' ' 44' ' ' LEU . 80.1 tttt -91.94 101.11 13.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 0.0 110.2 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.555 ' CG2' HD13 ' A' ' 38' ' ' ILE . 90.6 mt -91.51 147.13 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 110.111 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.49 HG22 ' HB3' ' A' ' 66' ' ' TYR . 3.3 p -119.84 153.09 36.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.952 . . . . 0.0 110.652 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 12.9 m-85 -116.22 125.49 52.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 110.152 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.55 ' CA ' ' CG ' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.206 0.527 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -136.19 80.62 0.3 Allowed Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 19.7 p90 -125.81 179.31 5.24 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.319 -1.106 . . . . 0.0 110.23 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 66' ' ' TYR . 4.1 m -152.39 177.7 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.398 -0.813 . . . . 0.0 110.694 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 1.077 ' CE ' HD11 ' A' ' 86' ' ' ILE . 28.0 ttpt -134.93 107.64 7.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.49 -0.756 . . . . 0.0 109.689 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.902 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.5 m170 -96.66 130.67 43.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 111.247 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.709 ' HA ' HD13 ' A' ' 53' ' ' ILE . 56.8 tttt -102.75 109.04 20.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.366 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.1 mm -43.62 138.76 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 110.267 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.546 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 15.0 t0 -108.95 -40.47 5.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.654 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.475 ' C ' HD12 ' A' ' 74' ' ' ILE . 11.0 p 178.39 158.57 0.5 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.427 -0.796 . . . . 0.0 109.782 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.475 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -140.24 156.54 24.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.104 -0.998 . . . . 0.0 110.909 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -139.4 80.96 1.81 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.689 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.57 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 35.1 ttpt -64.11 -12.33 38.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 110.093 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -87.36 -29.6 21.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 108.987 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m120 -111.46 -3.23 15.27 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.409 0.623 . . . . 0.0 109.385 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.848 ' O ' HD12 ' A' ' 104' ' ' LEU . 67.5 m-85 62.5 53.12 2.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.599 -0.688 . . . . 0.0 110.108 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.88 155.72 39.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.539 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.777 ' CE1' HG13 ' A' ' 23' ' ' VAL . 73.5 t80 -143.26 147.47 34.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 110.108 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.4 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 68.8 m -153.6 135.01 14.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 110.97 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.682 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.4 p90 -144.8 173.08 12.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.37 -0.831 . . . . 0.0 110.118 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 98' ' ' ILE . 87.4 m -126.67 124.8 40.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.818 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.902 HD13 ' CD2' ' A' ' 69' ' ' HIS . 9.2 tp -92.6 133.0 36.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.0 110.205 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 1.077 HD11 ' CE ' ' A' ' 68' ' ' LYS . 13.3 pt -123.64 -25.64 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 110.59 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HB3' ' CB ' ' A' ' 68' ' ' LYS . 42.6 tt0 -112.05 133.21 54.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.183 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.44 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . 168.23 140.74 3.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -69.87 -19.09 63.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -1.155 . . . . 0.0 110.279 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.719 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -71.95 -25.04 61.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 92' ' ' GLY . 38.7 mt -62.37 -33.09 74.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 110.114 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.25 -179.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -76.79 1.27 17.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -1.156 . . . . 0.0 109.923 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.679 ' O ' HG21 ' A' ' 126' ' ' VAL . 70.0 p -92.39 -33.57 14.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.823 HD21 HG13 ' A' ' 128' ' ' ILE . 34.8 mt -114.71 163.76 15.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 110.081 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.445 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 39.6 mt-10 -143.56 -79.78 0.2 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.249 -0.907 . . . . 0.0 110.006 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 53.8 mttt -80.12 141.6 35.61 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 110.668 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 84' ' ' THR . 5.2 mm -129.36 143.24 41.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.366 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.1 m -123.27 126.8 47.59 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.731 ' HE2' HG21 ' A' ' 98' ' ' ILE . 13.0 m-85 -121.63 135.27 54.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 110.221 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 74.6 tt0 -136.24 140.12 43.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.242 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 92.5 m -137.95 146.76 43.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 110.228 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 115' ' ' LYS . 19.3 mttt -138.09 145.72 42.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.866 HD23 HG12 ' A' ' 114' ' ' ILE . 2.8 mt -123.21 152.96 40.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 110.461 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.36 -169.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -127.35 125.55 40.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.26 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.447 ' HB3' HG13 ' A' ' 113' ' ' ILE . 95.4 p -82.21 160.57 62.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 110.187 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.36 -1.31 10.0 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.031 1.543 . . . . 0.0 110.553 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.1 t -98.73 -4.03 34.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.47 -41.61 2.19 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.92 -179.17 5.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 4.6 m -121.15 135.66 55.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.399 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.666 HG12 HG22 ' A' ' 10' ' ' THR . 74.9 mt -84.85 149.96 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.361 -0.837 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.866 HG12 HD23 ' A' ' 104' ' ' LEU . 4.7 mt -134.98 113.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 110.398 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 103' ' ' LYS . 22.4 ttmt -100.45 122.34 43.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.91 . . . . 0.0 109.831 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.0 t -114.7 158.12 22.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 0.0 110.619 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.616 HG22 ' NE2' ' A' ' 119' ' ' HIS . 93.4 m -156.32 133.64 10.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.38 -0.825 . . . . 0.0 110.043 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.6 p -133.02 157.78 44.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.153 -0.967 . . . . 0.0 110.334 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.81 ' CE1' HG23 ' A' ' 4' ' ' THR . 74.7 m-70 -141.25 167.06 23.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.131 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.803 ' O ' HG13 ' A' ' 2' ' ' VAL . 9.2 m-85 -131.33 150.03 52.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.43 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 92.9 m-70 -126.3 90.09 3.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 109.561 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.619 ' HB ' HG23 ' A' ' 126' ' ' VAL . 3.0 p -71.27 166.45 21.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.395 -0.815 . . . . 0.0 110.67 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 21.4 tttp -119.75 121.1 38.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -0.834 . . . . 0.0 110.153 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.46 -108.24 3.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.615 ' O ' HG13 ' A' ' 126' ' ' VAL . 51.5 t30 -139.63 94.35 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -1.166 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.679 HG21 ' O ' ' A' ' 94' ' ' THR . 16.7 m -157.65 159.68 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 0.0 110.098 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -133.84 154.26 51.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 110.282 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.823 HG13 HD21 ' A' ' 95' ' ' LEU . 3.3 mp -76.97 173.07 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.383 -0.823 . . . . 0.0 110.257 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.599 ' N ' HG22 ' A' ' 128' ' ' ILE . 60.5 mttt -101.85 128.88 48.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.106 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.47 ' HA ' HG12 ' A' ' 133' ' ' VAL . 53.4 mm-40 -44.53 -48.56 10.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 110.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 35.3 tt0 -54.67 -31.22 57.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 109.861 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.719 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 17.4 t-160 -75.58 -55.67 5.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.971 HG21 ' CE2' ' A' ' 5' ' ' TYR . 11.6 p -67.0 -40.96 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.553 ' N ' HG13 ' A' ' 133' ' ' VAL . 93.7 mttt -66.59 -46.25 76.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.07 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -60.39 -33.29 72.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 110.045 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.07 -26.06 71.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -75.09 -35.13 61.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 110.172 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.34 -35.84 61.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 109.976 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.422 ' O ' HD23 ' A' ' 143' ' ' LEU . 48.2 mtmt -68.65 -37.69 79.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 109.845 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.55 78.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.863 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.7 t -65.88 -48.45 71.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.379 -0.825 . . . . 0.0 109.953 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -53.82 -42.28 68.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.928 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 147' ' ' ILE . 2.6 mm? -58.7 -47.8 83.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 109.951 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.458 ' CE1' HG21 ' A' ' 114' ' ' ILE . 9.8 m-85 -56.31 -38.42 71.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 110.162 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 78.3 mttt -74.03 -21.98 59.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.107 -0.995 . . . . 0.0 109.93 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 15.0 mt -87.4 -35.29 18.4 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 108.701 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.763 HG22 ' CD1' ' A' ' 18' ' ' LEU . 67.9 mt -75.44 -37.36 37.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.575 -0.703 . . . . 0.0 109.129 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 19.8 pt-20 -62.83 -32.82 74.1 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.144 -0.972 . . . . 0.0 109.006 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.482 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 16.8 m -79.93 -26.76 39.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.19 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.688 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.9 t80 -60.94 -52.22 65.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.596 -0.69 . . . . 0.0 109.845 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.18 HD21 ' CE1' ' A' ' 158' ' ' TYR . 80.5 mt -76.41 -36.65 57.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.266 -0.896 . . . . 0.0 109.972 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.745 ' HB2' HD11 ' A' ' 13' ' ' ILE . 45.0 tptt -64.36 -21.69 66.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.57 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -109.31 -32.14 3.07 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 4.3 m80 -108.37 93.49 11.62 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -1.096 . . . . 0.0 110.025 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.9 Cg_endo -74.14 5.05 3.79 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.0 1.526 . . . . 0.0 110.954 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -108.74 -6.33 15.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 109.886 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.688 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -75.35 101.33 4.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.865 . . . . 0.0 110.005 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.18 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.5 p90 34.03 36.8 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.817 -0.552 . . . . 0.0 110.82 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.526 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.728 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 120' ' ' TYR . 45.8 t -120.2 117.55 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.169 . . . . 0.0 110.224 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.595 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 76.7 m-85 -88.15 125.4 34.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.818 HG23 ' CE1' ' A' ' 119' ' ' HIS . 25.1 m -105.48 113.73 27.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 110.388 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.694 ' CE1' HG13 ' A' ' 133' ' ' VAL . 60.3 m-85 -117.26 125.76 51.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.079 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 116' ' ' SER . 20.9 pt-20 -133.74 154.89 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 110.302 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t -127.47 164.68 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.119 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -142.6 116.48 9.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.9 p90 -148.29 -170.12 3.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.308 -0.87 . . . . 0.0 110.204 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 113' ' ' ILE . 10.4 p -141.15 174.84 10.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.393 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.418 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 1.4 t -154.65 157.31 37.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -87.8 -14.48 39.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 110.118 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.812 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.3 mp -81.42 149.95 66.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.812 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.9 Cg_endo -66.36 145.75 78.45 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.003 1.528 . . . . 0.0 110.438 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.671 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 Cg_endo -72.23 -31.68 11.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.91 1.479 . . . . 0.0 113.054 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.9 Cg_endo -69.74 -21.14 33.99 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 110.108 -0.766 . . . . 0.0 110.108 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.63 ' HB3' HD13 ' A' ' 151' ' ' LEU . 7.1 mmp_? -85.68 -43.35 13.49 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.791 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.3 tt -72.2 -29.92 64.43 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 73.8 t80 -67.21 -56.98 7.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.565 -0.709 . . . . 0.0 109.58 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 66.0 mttt -54.84 -34.12 62.49 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.293 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.069 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.42 -55.8 5.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.519 -0.738 . . . . 0.0 110.918 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.929 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -58.61 -46.14 87.65 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.559 -0.713 . . . . 0.0 111.494 -178.729 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.129 HG11 ' CD1' ' A' ' 74' ' ' ILE . 18.2 t -98.17 -65.39 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.075 -1.015 . . . . 0.0 111.897 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.628 ' N ' HD22 ' A' ' 24' ' ' LEU . 4.1 mm? -65.41 -4.64 5.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 111.548 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.655 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -148.19 36.64 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.942 -1.099 . . . . 0.0 110.427 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.929 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -73.97 -36.51 64.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.419 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 68.5 m-20 -62.86 -13.58 35.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.128 -0.982 . . . . 0.0 110.355 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 78.2 m-20 -127.53 7.19 6.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.928 . . . . 0.0 110.2 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.684 HD13 HD11 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -95.38 -52.18 4.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.903 179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.927 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.5 t -71.35 -41.47 10.29 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.574 -0.704 . . . . 0.0 110.871 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.4 Cg_endo -77.88 9.69 2.9 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.484 1.255 . . . . 0.0 110.964 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 29.3 mttm -129.83 -33.39 1.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.056 -1.027 . . . . 0.0 109.753 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.684 HD11 HD13 ' A' ' 29' ' ' LEU . 50.1 mt -80.18 -41.46 20.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.495 -0.753 . . . . 0.0 109.464 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -147.28 99.42 3.91 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.515 -0.741 . . . . 0.0 110.034 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 45.7 Cg_endo -71.35 -1.31 9.48 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.089 1.573 . . . . 0.0 110.659 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -84.82 -11.45 55.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.113 -0.992 . . . . 0.0 109.669 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.861 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -102.41 -57.64 2.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.396 -0.815 . . . . 0.0 110.177 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.927 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.1 mp -121.74 107.36 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.402 -0.811 . . . . 0.0 110.176 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 16.8 tppt? -59.82 -25.28 64.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.601 ' CG ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -173.44 176.77 2.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.601 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 70.5 m -150.86 151.16 31.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 109.905 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -157.52 105.81 2.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.256 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 34.5 mt -51.71 132.97 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.461 ' HB3' ' O ' ' A' ' 53' ' ' ILE . 33.5 tp -93.85 -47.36 6.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.9 . . . . 0.0 110.326 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.873 ' O ' HG23 ' A' ' 52' ' ' THR . 5.1 mm-40 -132.09 134.59 45.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.62 -164.46 37.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -129.68 11.17 5.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.104 . . . . 0.0 110.162 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.455 ' N ' HG21 ' A' ' 52' ' ' THR . . . 125.04 -9.18 7.97 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -75.91 -168.76 26.27 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.413 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.6 Cg_endo -70.58 133.41 24.02 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.169 1.615 . . . . 0.0 110.526 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.38 -4.53 73.64 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.873 HG23 ' O ' ' A' ' 45' ' ' GLU . 16.9 m -80.14 147.63 31.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -1.149 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 70' ' ' LYS . 25.8 mm -116.33 108.42 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.092 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.645 ' HE3' HD11 ' A' ' 71' ' ' ILE . 90.1 mttt -91.83 134.97 34.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 0.0 110.319 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -106.24 94.05 4.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 110.052 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.661 HD12 ' CE1' ' A' ' 69' ' ' HIS . 86.8 mt -80.53 144.07 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.191 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.575 HG22 ' OH ' ' A' ' 64' ' ' TYR . 1.1 p -112.33 156.74 21.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 110.246 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.775 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.1 m-85 -114.04 162.99 15.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.871 . . . . 0.0 110.326 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.402 ' HA3' ' HE2' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.638 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 7.8 t80 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.252 0.549 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -134.93 134.48 7.36 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.638 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 15.1 p90 -177.71 168.63 2.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -1.203 . . . . 0.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.2 m -142.19 173.5 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.35 -0.844 . . . . 0.0 110.422 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.518 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . 91.7 mttt -119.75 131.38 55.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.481 -0.762 . . . . 0.0 109.709 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.661 ' CE1' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -113.51 132.37 55.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.93 -179.387 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.64 ' HA ' HD13 ' A' ' 53' ' ' ILE . 76.2 tttt -111.33 107.53 16.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.837 . . . . 0.0 109.253 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.645 HD11 ' HE3' ' A' ' 54' ' ' LYS . 27.8 mm -48.57 135.47 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.983 . . . . 0.0 110.412 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.466 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 15.8 m-20 -105.26 -45.36 4.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 109.398 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 29.0 p 177.4 156.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.641 -0.662 . . . . 0.0 110.13 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.129 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.8 tt -147.55 165.31 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.035 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-20 -134.84 80.1 1.83 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.328 -0.857 . . . . 0.0 110.041 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.566 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 24.0 mttt -56.13 -15.11 3.23 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.179 -0.95 . . . . 0.0 110.607 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -93.37 -30.81 14.91 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.294 -0.879 . . . . 0.0 109.557 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.7 m120 -106.87 -1.34 22.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.552 -0.718 . . . . 0.0 109.424 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.639 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 68.7 m-85 63.66 52.85 2.14 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.369 0.604 . . . . 0.0 110.82 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.54 ' HB3' ' CG ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -126.88 151.11 48.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.634 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.596 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 77.3 t80 -145.57 163.64 34.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.189 -0.944 . . . . 0.0 110.14 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.496 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 84.8 p -168.51 146.21 4.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.015 -1.053 . . . . 0.0 110.799 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 2.6 p90 -148.23 -179.12 6.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.328 -0.857 . . . . 0.0 110.401 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 98' ' ' ILE . 24.7 m -136.41 128.19 29.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.438 -0.789 . . . . 0.0 109.992 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.605 ' CB ' ' HB ' ' A' ' 98' ' ' ILE . 7.0 tp -80.39 121.97 26.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.275 -0.89 . . . . 0.0 110.073 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.518 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 27.5 pt -101.77 -11.56 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.89 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.438 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 66.7 tt0 -154.17 151.85 29.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.178 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.848 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 168.36 157.18 10.97 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' ALA . 65.8 t0 -72.2 -54.14 10.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -1.141 . . . . 0.0 110.366 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' ASP . . . -42.4 -31.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.543 HD23 ' CD2' ' A' ' 95' ' ' LEU . 21.2 mt -52.42 -53.17 48.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 110.128 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.76 -171.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -72.49 -2.08 18.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.126 . . . . 0.0 110.189 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.713 ' O ' HG21 ' A' ' 126' ' ' VAL . 34.9 p -89.64 -60.46 1.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 110.37 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.956 HD11 HD11 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -105.06 163.07 12.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.317 -0.865 . . . . 0.0 109.258 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.77 ' H ' HD12 ' A' ' 95' ' ' LEU . 76.4 mm-40 -142.64 -81.12 0.21 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 110.324 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.489 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 71.2 mttt -80.25 153.64 28.39 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.545 -0.722 . . . . 0.0 110.621 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.956 HD11 HD11 ' A' ' 95' ' ' LEU . 35.1 mm -140.66 159.95 24.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.727 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -135.35 126.41 27.88 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.366 -0.834 . . . . 0.0 108.903 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.809 ' CE2' HG21 ' A' ' 98' ' ' ILE . 22.4 m-85 -123.77 135.68 53.96 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.189 -0.944 . . . . 0.0 110.497 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 71.7 tt0 -139.18 124.95 19.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 0.0 110.238 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 89.0 m -118.63 145.42 45.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.088 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.54 ' CG ' ' HB3' ' A' ' 80' ' ' SER . 7.5 mttt -136.72 132.89 35.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.317 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.871 HD23 HG12 ' A' ' 114' ' ' ILE . 4.4 mt -106.74 153.51 22.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.086 -1.009 . . . . 0.0 110.07 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.96 -168.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.173 -0.954 . . . . 0.0 109.964 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.692 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -119.46 158.61 25.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.225 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 25.8 p -119.67 165.35 17.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 110.216 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.6 Cg_endo -72.5 -1.48 10.33 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.089 1.573 . . . . 0.0 110.506 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.4 m -104.94 -5.9 20.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.149 -0.97 . . . . 0.0 110.227 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.33 -32.52 6.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.83 -171.76 2.88 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 5.9 m -129.85 132.72 46.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -1.14 . . . . 0.0 110.257 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.563 ' HA ' HG22 ' A' ' 10' ' ' THR . 11.4 mt -82.84 152.58 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.871 HG12 HD23 ' A' ' 104' ' ' LEU . 5.9 mt -133.55 114.31 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 110.184 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 103' ' ' LYS . 69.5 tttt -103.31 108.81 20.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.2 m -99.42 157.33 16.5 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.266 -0.896 . . . . 0.0 110.29 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 71.6 m -156.5 131.46 9.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.848 . . . . 0.0 109.916 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 99' ' ' SER . 89.3 p -134.31 148.9 50.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.029 . . . . 0.0 110.696 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.818 ' CE1' HG23 ' A' ' 4' ' ' THR . 39.7 m-70 -131.56 138.92 49.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.775 . . . . 0.0 110.015 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.631 ' HA ' HD13 ' A' ' 98' ' ' ILE . 12.1 m-30 -100.13 150.98 21.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 110.691 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.489 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 98.5 m-70 -128.08 90.7 3.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 0.0 109.488 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 95' ' ' LEU . 2.8 p -79.52 161.3 26.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 110.539 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -120.34 115.53 23.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 110.061 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.16 -141.54 15.37 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.468 ' C ' HG13 ' A' ' 126' ' ' VAL . 53.1 t30 -113.23 96.22 5.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 110.223 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 94' ' ' THR . 21.8 m -151.45 168.62 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.297 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -138.9 160.19 40.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.591 HG12 ' CE1' ' A' ' 3' ' ' PHE . 35.5 mm -74.9 173.36 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.589 ' N ' HG22 ' A' ' 128' ' ' ILE . 40.6 mttt -110.9 133.75 53.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 0.0 110.228 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 129' ' ' LYS . 1.1 mt-10 -43.5 -49.21 7.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.148 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -58.53 -36.06 73.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 110.108 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -68.88 -44.2 73.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.195 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.694 HG13 ' CE1' ' A' ' 5' ' ' TYR . 60.6 t -61.64 -38.05 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.983 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -77.82 -42.49 33.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.57 -37.61 87.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.098 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.27 -29.97 74.93 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 84.9 mttt -79.26 -31.26 43.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -1.114 . . . . 0.0 110.111 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -78.03 -32.93 51.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.852 . . . . 0.0 110.092 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -73.81 -28.18 61.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.412 -0.805 . . . . 0.0 110.015 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -80.05 -36.72 35.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.925 . . . . 0.0 110.051 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.0 p -71.29 -46.76 60.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.409 -0.807 . . . . 0.0 110.025 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.429 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 98.4 m-20 -55.47 -49.3 72.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 110.01 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 147' ' ' ILE . 69.8 mt -57.48 -41.98 81.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.915 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 6.3 m-85 -59.74 -40.92 89.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.485 -0.76 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.43 ' HB3' ' HE3' ' A' ' 145' ' ' LYS . 18.3 mtpp -80.0 -16.79 54.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.115 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 142' ' ' ASN . 27.9 mt -84.26 -36.37 22.72 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.151 -0.968 . . . . 0.0 108.833 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.74 HD13 ' CD1' ' A' ' 22' ' ' PHE . 97.3 mt -72.58 -45.16 59.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.799 ' HB3' HD13 ' A' ' 13' ' ' ILE . 69.1 mt-10 -57.09 -40.58 77.23 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.3 m -68.53 -35.61 77.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.94 . . . . 0.0 109.459 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.653 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.5 t80 -54.27 -46.46 72.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.518 -0.739 . . . . 0.0 109.908 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.181 HD21 ' CE2' ' A' ' 158' ' ' TYR . 94.7 mt -79.87 -31.07 40.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.716 ' HB2' HD11 ' A' ' 13' ' ' ILE . 73.3 tttt -71.11 -25.51 62.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.573 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.33 -34.21 3.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 5.3 m80 -106.91 92.67 7.84 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.259 -1.142 . . . . 0.0 110.179 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.514 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.5 Cg_endo -74.26 6.44 3.06 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.097 1.578 . . . . 0.0 111.072 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -107.43 -2.6 20.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.916 -1.115 . . . . 0.0 109.775 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.653 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -78.67 104.35 9.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.501 -0.749 . . . . 0.0 110.123 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.181 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.66 33.19 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.348 0.594 . . . . 0.0 110.357 -179.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.54 ' HA ' ' NH1' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.862 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 68.5 t -132.1 118.28 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 110.207 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.589 ' CE1' HG12 ' A' ' 128' ' ' ILE . 64.8 m-85 -93.47 125.92 38.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.34 -0.85 . . . . 0.0 110.06 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.854 HG23 ' CE1' ' A' ' 119' ' ' HIS . 28.9 m -107.88 111.04 22.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.853 . . . . 0.0 110.304 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.646 ' CE1' HG13 ' A' ' 133' ' ' VAL . 60.0 m-85 -116.65 138.17 51.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.836 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.576 ' HB3' HG23 ' A' ' 117' ' ' THR . 18.8 pt-20 -141.21 167.37 22.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.149 -0.97 . . . . 0.0 110.654 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.404 ' C ' ' HG3' ' A' ' 8' ' ' GLU . 32.1 t -143.63 157.75 44.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.43 -0.794 . . . . 0.0 109.806 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 7' ' ' SER . 97.1 mt-10 -141.93 117.51 10.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.008 . . . . 0.0 110.628 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 p90 -138.5 -175.09 4.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.84 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.563 HG22 HG12 ' A' ' 113' ' ' ILE . 23.2 p -136.57 178.92 6.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.524 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.516 ' CB ' ' OE2' ' A' ' 148' ' ' GLU . 59.1 p -160.04 163.73 33.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.464 -0.773 . . . . 0.0 110.458 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -89.21 -10.2 47.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.906 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.78 HG23 ' HD2' ' A' ' 14' ' ' PRO . 3.4 mp -92.32 149.87 39.17 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.828 . . . . 0.0 110.058 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.78 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.6 Cg_endo -66.02 145.31 79.09 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.997 1.525 . . . . 0.0 110.367 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.67 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.7 Cg_endo -71.11 -32.25 13.47 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.888 1.468 . . . . 0.0 112.796 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -68.38 -20.91 41.65 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.545 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 53.4 mmm-85 -84.29 -46.3 11.95 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.766 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -71.99 -24.95 61.66 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.609 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 89.1 t80 -68.61 -59.82 2.86 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.519 0.676 . . . . 0.0 109.346 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 77.5 mttt -52.04 -38.15 55.99 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.237 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.018 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -70.06 -55.44 9.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 110.711 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.044 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -57.12 -49.7 75.09 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 111.235 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.979 HG11 ' CD1' ' A' ' 74' ' ' ILE . 10.3 t -95.28 -65.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.971 -1.08 . . . . 0.0 111.722 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 24' ' ' LEU . 8.3 mp -64.83 -4.37 4.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.177 -0.952 . . . . 0.0 111.805 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.634 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -148.28 33.19 0.81 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.715 -1.24 . . . . 0.0 110.548 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.044 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -71.99 -34.03 68.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 0.0 110.241 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 41' ' ' SER . 12.8 t70 -64.97 -13.85 58.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.91 . . . . 0.0 110.287 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.524 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 80.9 m-20 -126.78 3.34 6.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.112 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.702 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -90.15 -54.78 3.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 110.234 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.049 HG11 HD13 ' A' ' 38' ' ' ILE . 92.6 t -65.81 -41.26 45.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 111.109 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 48.4 Cg_endo -76.73 4.98 5.16 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.369 1.194 . . . . 0.0 110.608 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 47.1 mttm -125.87 -31.69 2.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.58 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.702 HD11 ' CD1' ' A' ' 29' ' ' LEU . 23.5 mt -80.06 -39.22 19.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.523 -0.735 . . . . 0.0 109.859 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -163.17 97.74 1.05 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 110.19 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.83 5.23 4.53 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.009 1.531 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -87.1 -15.75 37.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 110.025 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.44 -35.38 10.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.207 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.049 HD13 HG11 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -129.98 145.56 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 109.906 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -83.86 -35.18 24.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 110.48 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.449 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER 178.8 157.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 110.249 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 58.5 m -118.19 126.95 53.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.066 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -134.66 105.95 6.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 19.0 mt -59.63 134.0 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.5 tp -95.03 -44.31 7.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.334 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 1.02 ' O ' HG23 ' A' ' 52' ' ' THR . 11.5 mt-10 -127.18 159.32 34.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 61.8 -161.16 28.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -134.43 10.67 3.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -1.152 . . . . 0.0 110.181 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.526 ' N ' HG21 ' A' ' 52' ' ' THR . . . 128.08 -6.69 6.82 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.555 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -86.68 -163.19 38.25 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.72 131.83 20.64 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.013 1.533 . . . . 0.0 110.601 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.01 -6.54 69.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 1.02 HG23 ' O ' ' A' ' 45' ' ' GLU . 20.4 m -79.98 135.68 36.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -1.164 . . . . 0.0 110.144 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.55 HD13 ' HA ' ' A' ' 70' ' ' LYS . 25.9 mm -105.22 113.79 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.208 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.616 ' HE3' HD11 ' A' ' 71' ' ' ILE . 95.1 mttt -99.15 138.78 35.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.376 -0.828 . . . . 0.0 110.298 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -110.97 92.76 4.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.164 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.8 mt -79.99 143.83 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 109.881 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.489 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 6.8 p -116.87 160.16 21.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.688 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.768 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.4 m-85 -120.08 163.14 18.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.534 -0.729 . . . . 0.0 110.059 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.648 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 t80 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.234 0.54 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -129.18 137.21 9.44 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.648 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 13.4 p90 -178.26 169.43 1.85 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -1.135 . . . . 0.0 110.081 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.992 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.5 m -142.42 172.21 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.895 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.442 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 43.7 mtpt -122.95 121.2 35.55 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.539 ' CE1' ' HG ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -116.39 135.28 54.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.023 . . . . 0.0 111.31 -178.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HA ' HD13 ' A' ' 53' ' ' ILE . 82.9 tttt -111.15 121.74 46.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.415 -0.803 . . . . 0.0 109.12 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.616 HD11 ' HE3' ' A' ' 54' ' ' LYS . 30.1 mm -60.58 134.89 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 110.436 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 19.2 t0 -105.73 -47.92 3.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.482 -0.761 . . . . 0.0 109.864 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -179.99 159.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.543 -0.723 . . . . 0.0 110.205 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.979 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.4 tt -149.13 164.55 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.992 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -127.13 78.9 1.85 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.877 . . . . 0.0 110.042 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.609 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 63.4 mttp -54.34 -15.81 1.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.42 -0.8 . . . . 0.0 110.819 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -92.07 -30.47 16.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.93 . . . . 0.0 109.861 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 m120 -110.59 -1.37 16.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.537 -0.727 . . . . 0.0 109.691 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.742 ' O ' HD12 ' A' ' 104' ' ' LEU . 9.1 m-85 66.01 48.48 1.76 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.688 -0.632 . . . . 0.0 110.518 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -118.56 151.77 37.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.345 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.654 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 84.4 t80 -148.11 143.79 27.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.047 -1.033 . . . . 0.0 110.285 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.487 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 66.5 m -149.61 134.0 17.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.393 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.654 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 4.0 p90 -137.54 179.29 6.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 110.048 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.86 HG23 ' O ' ' A' ' 98' ' ' ILE . 90.2 m -125.08 128.97 49.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.913 . . . . 0.0 110.17 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.762 HD22 HD11 ' A' ' 91' ' ' LEU . 1.5 tt -91.75 140.99 29.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.137 -0.977 . . . . 0.0 110.121 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.672 ' N ' HD23 ' A' ' 85' ' ' LEU . 21.1 pt -127.64 -24.62 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.033 -1.042 . . . . 0.0 110.487 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.442 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 72.6 tt0 -138.12 115.69 11.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.102 -0.999 . . . . 0.0 110.613 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.992 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -165.03 132.79 2.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 88' ' ' GLY . 60.2 t0 -42.85 -36.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -1.194 . . . . 0.0 110.402 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.855 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -62.76 -25.3 68.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.146 -0.971 . . . . 0.0 110.354 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.907 HD21 HG13 ' A' ' 98' ' ' ILE . 96.8 mt -68.04 -28.18 67.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.288 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.34 -168.54 0.31 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -90.04 12.72 16.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -1.158 . . . . 0.0 110.183 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 122' ' ' THR . 25.2 p -105.54 -52.11 2.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.145 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.919 HD21 ' CD1' ' A' ' 128' ' ' ILE . 48.7 mt -79.95 151.01 30.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.069 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.45 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 68.3 mt-10 -127.4 -80.91 0.6 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.34 -0.85 . . . . 0.0 110.269 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 85.5 mttt -80.26 147.15 31.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.593 -0.692 . . . . 0.0 110.292 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.907 HG13 HD21 ' A' ' 91' ' ' LEU . 10.5 mm -135.46 145.91 30.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.94 -1.1 . . . . 0.0 110.043 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -122.66 124.79 44.24 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.465 -0.772 . . . . 0.0 108.92 178.462 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.853 ' CE2' HG21 ' A' ' 98' ' ' ILE . 14.7 m-85 -121.62 132.64 54.78 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.384 -0.823 . . . . 0.0 110.359 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.487 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 26.6 tt0 -132.8 146.91 52.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -0.859 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 81' ' ' TYR . 57.2 m -145.68 135.99 23.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 110.066 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 115' ' ' LYS . 4.1 tttt -129.07 148.63 51.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.185 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 79' ' ' TYR . 10.5 mt -122.64 148.06 45.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 110.458 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.712 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.09 -168.34 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.355 -0.84 . . . . 0.0 109.616 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.712 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -130.69 137.64 49.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.505 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.649 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 5.4 p -80.04 -161.09 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.367 -0.833 . . . . 0.0 109.211 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.649 ' CD ' ' CB ' ' A' ' 107' ' ' SER . 43.9 Cg_endo -83.46 70.72 6.32 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.348 1.183 . . . . 0.0 109.499 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 2.3 m 58.23 30.16 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.528 -0.733 . . . . 0.0 109.594 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.42 34.21 3.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . 107.75 -147.84 16.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 57.5 p -138.05 139.34 39.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.129 -1.218 . . . . 0.0 110.079 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.563 HG12 HG22 ' A' ' 10' ' ' THR . 33.3 mt -88.79 147.49 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 110.243 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.731 HD11 ' OE2' ' A' ' 148' ' ' GLU . 6.0 mt -127.63 108.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 110.069 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 103' ' ' LYS . 34.8 mtpt -90.22 145.95 24.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 110.291 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.2 t -140.95 155.7 46.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.12 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.576 HG23 ' HB3' ' A' ' 6' ' ' GLU . 24.2 m -159.99 153.31 22.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.342 -0.849 . . . . 0.0 110.137 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 99' ' ' SER . 94.4 p -153.26 154.7 35.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.173 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.854 ' CE1' HG23 ' A' ' 4' ' ' THR . 51.9 m-70 -136.92 136.56 38.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.233 -0.917 . . . . 0.0 110.072 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 7.1 m-30 -99.01 151.06 21.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.245 -0.909 . . . . 0.0 110.719 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 96.9 m-70 -130.14 78.13 1.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.729 HG23 HD23 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -73.5 157.44 36.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.359 -0.838 . . . . 0.0 110.686 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 86.2 tttt -105.43 120.41 41.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 110.237 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.28 -161.77 21.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.558 ' C ' HG13 ' A' ' 126' ' ' VAL . 58.0 t30 -102.31 111.13 23.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -1.167 . . . . 0.0 110.245 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.558 HG13 ' C ' ' A' ' 125' ' ' ASN . 24.5 m -156.47 170.86 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.254 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -128.66 136.17 50.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.919 ' CD1' HD21 ' A' ' 95' ' ' LEU . 48.6 mm -57.91 173.4 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 0.0 110.035 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.587 ' N ' HG22 ' A' ' 128' ' ' ILE . 39.9 mtpt -102.82 130.4 49.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.938 . . . . 0.0 110.255 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -45.72 -51.06 13.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 110.157 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 35.9 tt0 -58.77 -34.86 71.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 110.074 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.855 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 18.3 t-160 -67.52 -41.48 84.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 0.0 110.074 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.646 HG13 ' CE1' ' A' ' 5' ' ' TYR . 85.7 t -65.94 -45.83 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.434 -0.791 . . . . 0.0 110.059 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -74.87 -39.28 61.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.049 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -62.67 -39.63 94.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 110.015 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.58 -29.67 75.7 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -76.5 -31.38 57.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -1.127 . . . . 0.0 110.075 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -78.8 -32.41 46.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.63 -41.12 69.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.0 109.938 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.574 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.27 -33.46 63.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.8 m -68.4 -48.47 64.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.82 . . . . 0.0 109.936 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -55.91 -44.25 78.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.853 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 143' ' ' LEU . 24.9 mt -62.29 -35.7 79.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.89 . . . . 0.0 109.945 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 8.3 m-85 -64.12 -36.1 82.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.085 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -78.87 -13.95 59.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 0.0 110.169 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.515 ' HB3' HG21 ' A' ' 33' ' ' ILE . 17.3 mt -85.19 -36.82 20.76 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 108.969 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.675 HD11 ' CE1' ' A' ' 22' ' ' PHE . 11.6 mt -69.74 -44.31 79.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.731 ' OE2' HD11 ' A' ' 114' ' ' ILE . 12.3 mm-40 -59.31 -44.95 92.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 66.0 m -60.78 -35.98 77.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.977 . . . . 0.0 109.392 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.595 ' CD1' HG12 ' A' ' 33' ' ' ILE . 71.8 t80 -54.24 -55.63 26.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.525 -0.734 . . . . 0.0 109.693 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.968 HD21 ' CE1' ' A' ' 158' ' ' TYR . 26.7 mt -71.69 -29.46 64.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.403 -0.811 . . . . 0.0 110.25 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.758 ' HB2' HD11 ' A' ' 13' ' ' ILE . 74.5 tttt -61.15 -18.35 57.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.108 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.495 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -122.53 -16.26 3.84 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -107.01 90.1 5.07 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.191 -1.182 . . . . 0.0 110.219 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.9 Cg_endo -73.15 2.21 5.8 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.072 1.564 . . . . 0.0 110.859 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -122.6 -2.03 8.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.109 -0.994 . . . . 0.0 109.933 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.675 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -49.45 110.02 0.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.421 -0.799 . . . . 0.0 110.398 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.018 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.46 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.584 -0.698 . . . . 0.0 110.618 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.536 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.744 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.453 ' O ' ' OG1' ' A' ' 122' ' ' THR . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 120' ' ' TYR . 26.4 t -129.09 134.94 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -1.15 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.638 ' CG ' ' CD1' ' A' ' 128' ' ' ILE . 25.4 m-85 -100.6 158.09 16.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.317 -0.865 . . . . 0.0 109.809 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.708 HG23 ' ND1' ' A' ' 119' ' ' HIS . 96.0 m -131.72 113.56 13.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -0.996 . . . . 0.0 110.504 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.814 ' CE1' HG22 ' A' ' 133' ' ' VAL . 85.7 m-85 -118.12 125.41 50.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 110.02 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.003 ' CG ' HG23 ' A' ' 117' ' ' THR . 7.3 mt-10 -137.12 151.59 49.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 110.128 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -133.97 153.76 51.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.283 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 94.6 mt-10 -133.88 116.68 15.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 110.142 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -146.57 -176.17 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 110.055 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -136.15 176.89 8.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 112' ' ' SER . 90.9 p -154.13 150.0 27.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.796 . . . . 0.0 110.186 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -73.45 -6.16 44.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.895 HD13 ' HB3' ' A' ' 148' ' ' GLU . 3.2 mp -94.06 149.59 37.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.034 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.812 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.4 Cg_endo -66.92 147.08 79.83 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.095 1.576 . . . . 0.0 110.246 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 Cg_endo -72.01 -32.09 11.5 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.836 1.44 . . . . 0.0 112.957 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.4 Cg_endo -71.31 -21.12 27.03 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 N-CA-C 110.058 -0.786 . . . . 0.0 110.058 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.95 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -83.28 -46.29 12.81 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.927 HD22 ' O ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -70.8 -30.57 67.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.102 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 53.6 t80 -64.99 -56.72 11.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.355 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 55.0 mttt -50.92 -40.33 56.8 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.027 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.016 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -68.71 -60.47 2.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.551 -0.718 . . . . 0.0 110.813 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.024 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -50.16 -57.02 8.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.653 -0.654 . . . . 0.0 112.046 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.039 HG11 ' CD1' ' A' ' 74' ' ' ILE . 6.6 t -94.7 -59.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.951 -1.093 . . . . 0.0 112.287 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.2 mp -68.92 -0.74 5.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.055 -1.028 . . . . 0.0 111.712 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.732 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -152.64 30.03 0.53 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.84 -1.162 . . . . 0.0 110.635 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.024 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.03 -41.79 86.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 110.093 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 16.4 m-20 -58.14 -15.54 10.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.159 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.532 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 67.2 m-80 -127.16 10.13 6.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.255 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.732 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -96.85 -50.57 4.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.308 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.004 HG21 HD13 ' A' ' 38' ' ' ILE . 6.9 p -73.83 -27.22 0.78 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 112.128 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.804 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -82.71 11.13 3.33 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.636 0.808 . . . . 0.0 110.588 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 28' ' ' ASN . 52.6 mtpt -136.83 -28.11 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.13 -0.981 . . . . 0.0 110.793 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.63 HD11 ' CD1' ' A' ' 29' ' ' LEU . 29.4 mt -76.27 -42.01 36.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.167 -0.958 . . . . 0.0 109.857 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.84 101.38 1.3 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.37 -0.831 . . . . 0.0 110.406 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.3 -0.45 9.21 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.086 1.571 . . . . 0.0 110.44 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -89.1 -17.9 28.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 110.015 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.21 -39.64 9.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 110.083 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.004 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -133.69 142.28 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 109.911 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 57' ' ' THR . 35.3 ttmt -76.66 -42.52 41.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.871 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.451 ' N ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER 179.44 158.68 0.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.9 . . . . 0.0 110.176 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 24.4 m -115.27 126.39 54.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.224 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -133.8 103.45 5.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.239 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 23.8 mt -52.58 130.45 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.541 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 44.8 mt -89.7 -46.85 8.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.931 ' O ' HG23 ' A' ' 52' ' ' THR . 9.4 mm-40 -132.52 151.83 51.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.411 -0.806 . . . . 0.0 110.192 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.54 -158.29 48.7 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -143.53 14.21 1.78 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -1.172 . . . . 0.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.588 ' H ' HG21 ' A' ' 52' ' ' THR . . . 121.27 -2.03 11.47 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.61 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -90.94 -168.07 41.77 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.82 130.95 20.15 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.146 1.603 . . . . 0.0 110.549 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.71 -2.76 70.35 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.931 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.5 m -79.96 145.43 32.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -1.182 . . . . 0.0 109.966 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.506 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 33.6 mm -111.14 114.88 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 110.44 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.717 ' CE ' HD11 ' A' ' 71' ' ' ILE . 99.5 mttt -100.74 139.79 35.93 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.415 -0.803 . . . . 0.0 110.033 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 85.6 tttt -116.09 95.47 5.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.096 -1.002 . . . . 0.0 110.438 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.535 ' CG2' HG12 ' A' ' 38' ' ' ILE . 78.3 mt -85.71 144.71 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 38' ' ' ILE . 5.5 p -114.57 158.16 22.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 110.842 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.808 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.3 m-85 -116.03 140.59 49.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.51 -0.744 . . . . 0.0 110.244 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.594 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 10.3 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.277 0.56 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -123.81 137.27 10.75 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.594 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 13.5 p90 -178.74 166.04 1.67 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.253 -1.145 . . . . 0.0 110.03 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.922 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.1 m -141.57 172.68 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 110.779 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.614 ' O ' HD22 ' A' ' 85' ' ' LEU . 93.1 mttt -125.95 125.19 42.33 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.771 ' ND1' HD23 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -115.67 118.81 34.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.964 -1.085 . . . . 0.0 111.429 -178.802 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 1.085 ' HE3' HD13 ' A' ' 86' ' ' ILE . 35.5 mttt -92.59 104.32 16.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.193 -0.942 . . . . 0.0 108.878 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.717 HD11 ' CE ' ' A' ' 54' ' ' LYS . 44.2 mm -47.43 135.62 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.407 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.518 ' CB ' ' HA ' ' A' ' 83' ' ' TYR . 14.9 m-20 -109.22 -44.18 3.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.457 -0.777 . . . . 0.0 109.697 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER 175.5 160.2 0.25 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.45 -0.781 . . . . 0.0 110.509 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.039 ' CD1' HG11 ' A' ' 23' ' ' VAL . 4.4 tt -147.4 168.17 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.647 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.5 m-20 -134.97 82.22 1.95 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.106 -0.996 . . . . 0.0 110.263 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.583 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 95.4 mttt -58.43 -14.29 7.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.214 -0.929 . . . . 0.0 110.607 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -95.34 -30.54 13.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.217 -0.927 . . . . 0.0 109.591 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.7 m120 -106.07 -2.84 22.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.712 -0.618 . . . . 0.0 109.428 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.514 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 96.3 m-85 62.56 54.19 2.48 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.463 0.649 . . . . 0.0 110.651 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -132.2 150.4 52.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.544 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 72.0 t80 -143.42 152.46 41.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 109.991 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.473 ' HB3' ' CG ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -158.7 149.95 20.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.022 -1.049 . . . . 0.0 110.697 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 38.1 p90 -158.6 173.3 16.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.411 -0.805 . . . . 0.0 110.367 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.496 ' HB ' ' HB2' ' A' ' 70' ' ' LYS . 88.5 m -113.29 123.66 50.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.376 -0.828 . . . . 0.0 109.871 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.8 ' C ' HD13 ' A' ' 85' ' ' LEU . 2.5 tm? -95.73 136.49 36.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 1.085 HD13 ' HE3' ' A' ' 70' ' ' LYS . 13.3 pt -122.0 -28.33 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 110.548 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.585 ' O ' HD21 ' A' ' 85' ' ' LEU . 2.2 tt0 -116.07 141.08 48.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 110.226 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.922 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 167.08 123.81 0.68 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 67.7 t0 -45.01 -25.08 0.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.418 -1.048 . . . . 0.0 110.139 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.403 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -70.02 -25.86 63.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.913 . . . . 0.0 110.343 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.538 HD21 ' CG1' ' A' ' 98' ' ' ILE . 89.6 mt -61.44 -33.02 73.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.3 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.71 -167.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -90.54 11.5 21.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -1.16 . . . . 0.0 110.227 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 122' ' ' THR . 36.9 p -102.93 -37.43 7.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.19 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.917 HD23 HG23 ' A' ' 122' ' ' THR . 15.7 mt -110.26 157.17 19.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.042 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -131.33 -78.79 0.52 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.294 -0.879 . . . . 0.0 110.345 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 37.8 mttp -80.18 148.11 31.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 0.0 110.384 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.909 HG21 ' CE2' ' A' ' 100' ' ' TYR . 6.7 mm -132.44 142.66 42.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.936 -1.103 . . . . 0.0 110.055 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.9 m -116.3 120.44 38.91 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.909 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.7 m-85 -115.41 137.66 51.81 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 110.882 -178.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.473 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 4.7 mt-10 -141.21 137.11 32.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.453 -0.779 . . . . 0.0 109.803 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.9 m -131.98 148.01 52.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -136.99 133.83 35.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.077 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.69 HD22 HD12 ' A' ' 18' ' ' LEU . 8.0 mt -119.35 145.97 45.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 110.504 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.0 -169.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.375 -0.828 . . . . 0.0 109.86 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.7 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.53 139.94 52.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.257 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.425 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 84.7 p -95.3 162.87 23.22 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 110.219 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.8 Cg_endo -73.43 -1.09 10.16 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.02 1.537 . . . . 0.0 110.549 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.7 p -98.67 -11.04 22.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.58 -29.22 7.36 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.73 -162.55 7.99 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.504 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 11.8 p -132.33 134.57 45.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -1.087 . . . . 0.0 110.285 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' HG22 ' A' ' 10' ' ' THR . 15.7 mt -83.69 142.55 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.887 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.659 HG12 HD23 ' A' ' 104' ' ' LEU . 9.0 mt -129.62 113.0 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.972 . . . . 0.0 110.501 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 87.1 tttt -102.06 111.54 23.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.895 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 9' ' ' PHE . 1.5 m -93.47 160.08 14.96 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.197 -0.939 . . . . 0.0 110.475 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.003 HG23 ' CG ' ' A' ' 6' ' ' GLU . 40.5 m -154.7 142.47 19.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.391 -0.818 . . . . 0.0 110.29 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 99' ' ' SER . 4.4 p -155.53 139.21 16.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.708 ' ND1' HG23 ' A' ' 4' ' ' THR . 29.2 m-70 -130.5 130.62 44.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.215 -0.928 . . . . 0.0 109.802 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.721 ' HB3' HD22 ' A' ' 95' ' ' LEU . 6.1 m-30 -91.54 154.57 19.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.972 . . . . 0.0 110.795 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.5 m-70 -128.08 85.37 2.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.842 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.917 HG23 HD23 ' A' ' 95' ' ' LEU . 1.2 p -63.18 152.45 37.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 110.295 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 123' ' ' LYS . 50.5 tttt -117.96 97.65 5.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.49 -148.27 17.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.568 ' C ' HG13 ' A' ' 126' ' ' VAL . 46.6 t30 -97.93 91.75 5.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -1.088 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.568 HG13 ' C ' ' A' ' 125' ' ' ASN . 30.4 m -156.82 159.7 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HG3' ' C ' ' A' ' 126' ' ' VAL . 91.4 mt-10 -145.04 146.06 31.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.181 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.774 ' CG1' HD21 ' A' ' 95' ' ' LEU . 2.7 mp -69.75 173.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 110.106 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.596 ' N ' HG22 ' A' ' 128' ' ' ILE . 46.1 mttt -105.91 160.77 15.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.186 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -66.71 -30.4 70.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 110.033 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.48 ' HG2' ' HB3' ' A' ' 129' ' ' LYS . 17.8 pt-20 -70.11 -36.66 75.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.939 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.493 ' HD1' HG23 ' A' ' 128' ' ' ILE . 20.2 t-160 -70.09 -40.87 74.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.998 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.814 HG22 ' CE1' ' A' ' 5' ' ' TYR . 42.9 t -62.77 -40.2 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 0.0 109.986 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -78.07 -41.86 34.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 110.001 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.98 98.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.942 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.88 -31.9 81.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -75.9 -33.24 59.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -1.095 . . . . 0.0 110.048 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -77.91 -33.05 52.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.907 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -72.49 -36.39 68.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 109.943 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.488 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -73.72 -34.77 64.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 109.937 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.0 m -66.4 -51.5 56.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 109.982 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -50.51 -46.59 57.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 0.0 109.957 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.72 -50.0 75.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 19.0 m-85 -54.94 -35.46 64.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.454 -0.779 . . . . 0.0 109.61 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -79.88 -16.81 54.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -0.831 . . . . 0.0 109.909 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 25.9 mt -84.05 -35.59 23.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.216 -0.928 . . . . 0.0 108.931 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.803 ' CG2' HD23 ' A' ' 18' ' ' LEU . 70.0 mt -70.61 -42.53 77.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.895 ' HB3' HD13 ' A' ' 13' ' ' ILE . 55.8 mt-10 -57.06 -42.04 79.83 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.328 -0.857 . . . . 0.0 109.32 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.445 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 86.5 m -66.29 -34.35 77.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.572 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.638 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 76.4 t80 -54.97 -51.9 64.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.881 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.111 HD21 ' CE1' ' A' ' 158' ' ' TYR . 76.8 mt -77.37 -33.77 55.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.32 -0.863 . . . . 0.0 110.183 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.785 ' HB2' HD11 ' A' ' 13' ' ' ILE . 52.3 tptt -64.6 -22.41 66.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.36 -30.56 3.31 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 5.5 m80 -106.68 92.31 7.13 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.287 -1.125 . . . . 0.0 110.148 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.1 Cg_endo -73.89 4.12 4.43 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.052 1.553 . . . . 0.0 110.831 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -110.58 -9.07 14.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.073 -1.017 . . . . 0.0 109.961 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.649 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -63.83 104.63 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.854 . . . . 0.0 109.976 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.111 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.0 OUTLIER 34.52 33.41 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.724 -0.61 . . . . 0.0 110.373 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.547 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.793 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.582 HG22 ' ND1' ' A' ' 121' ' ' HIS . 85.0 t -97.44 134.07 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -1.16 . . . . 0.0 110.418 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.595 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 10.7 m-85 -93.91 149.55 21.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 110.024 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.746 HG23 ' CE1' ' A' ' 119' ' ' HIS . 6.5 m -127.25 112.01 14.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 110.293 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.087 ' CE2' HG21 ' A' ' 133' ' ' VAL . 65.0 m-85 -126.31 136.98 53.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.069 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 4.6 pm0 -139.91 162.03 36.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.893 . . . . 0.0 110.298 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -147.74 154.81 41.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.427 -0.795 . . . . 0.0 109.963 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -134.01 118.85 18.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.975 . . . . 0.0 110.473 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.65 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 3.8 p90 -142.4 -172.66 3.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 109.86 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.7 HG22 ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -143.03 178.72 7.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 110.603 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.406 ' OG ' ' OG ' ' A' ' 112' ' ' SER . 23.4 p -151.48 176.54 11.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.786 . . . . 0.0 109.966 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -92.72 -27.11 17.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.918 . . . . 0.0 110.076 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.78 HG23 ' HD2' ' A' ' 14' ' ' PRO . 24.7 mm -84.23 148.03 51.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.932 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.78 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.32 155.66 67.42 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.98 1.516 . . . . 0.0 111.007 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.655 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.3 Cg_endo -63.73 -37.21 47.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.87 1.458 . . . . 0.0 113.112 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -64.01 -19.68 66.75 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 N-CA-C 109.667 -0.936 . . . . 0.0 109.667 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.75 ' HG2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.91 -43.45 19.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 6.8 mp -75.7 -39.03 58.1 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.588 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.0 t80 -59.32 -54.71 43.67 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.455 0.645 . . . . 0.0 109.982 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.8 mttt -60.44 -34.06 73.44 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 109.839 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.047 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.0 -59.36 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 0.0 110.923 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.065 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -54.66 -39.53 68.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.626 -0.671 . . . . 0.0 111.856 -178.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.101 HG11 ' CD1' ' A' ' 74' ' ' ILE . 21.6 t -106.86 -65.3 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.817 -1.177 . . . . 0.0 112.084 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.0 mp -63.62 -4.72 3.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.183 -0.948 . . . . 0.0 112.164 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.95 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.1 m-20 -144.82 8.19 1.27 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.638 -1.289 . . . . 0.0 110.939 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.065 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -52.05 -26.8 11.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 110.961 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -68.41 -26.38 65.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.937 -1.102 . . . . 0.0 109.592 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 8.9 p30 -125.7 17.22 8.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.604 -0.685 . . . . 0.0 109.473 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.002 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -94.5 -45.56 7.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.465 -0.772 . . . . 0.0 110.083 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.035 HG21 HD13 ' A' ' 38' ' ' ILE . 4.6 p -79.18 -28.18 0.54 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 112.267 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.867 ' HD3' HG12 ' A' ' 30' ' ' VAL . 51.4 Cg_endo -78.29 4.42 6.27 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 122.69 0.837 . . . . 0.0 110.277 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 28' ' ' ASN . 94.2 mttt -123.41 -28.38 3.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.659 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.616 HG12 ' CD1' ' A' ' 150' ' ' TYR . 25.0 mt -78.48 -31.22 15.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 109.676 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.59 98.24 0.44 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.514 -0.741 . . . . 0.0 110.194 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.58 0.2 8.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.062 1.559 . . . . 0.0 110.543 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -89.96 -18.7 25.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 0.0 110.1 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.54 -49.07 6.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.195 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.035 HD13 HG21 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -120.15 137.2 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 109.973 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 9.4 mmtt -75.43 -42.71 52.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 110.017 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.448 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 179.02 156.54 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.448 -0.783 . . . . 0.0 110.128 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 m -114.88 125.97 54.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -128.02 110.69 12.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.316 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 17.2 mt -60.85 131.08 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 110.125 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.508 HD11 ' HD2' ' A' ' 55' ' ' LYS . 47.7 mt -93.3 -44.7 8.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 52' ' ' THR . 1.7 tt0 -130.61 139.47 50.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.42 -0.8 . . . . 0.0 110.142 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.43 -163.92 46.97 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -130.82 2.7 4.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -1.123 . . . . 0.0 110.266 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.561 ' N ' HG21 ' A' ' 52' ' ' THR . . . 133.69 -4.61 4.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.527 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -85.04 -166.77 42.28 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.09 131.17 20.23 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.067 1.562 . . . . 0.0 110.475 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.58 -5.6 67.29 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 45' ' ' GLU . 39.7 m -80.04 140.46 36.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -1.096 . . . . 0.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.694 HD13 ' HA ' ' A' ' 70' ' ' LYS . 26.4 mm -110.18 114.6 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 110.276 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.55 ' HE3' HD11 ' A' ' 71' ' ' ILE . 92.4 mttt -98.0 159.45 14.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.826 . . . . 0.0 110.343 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HD2' HD11 ' A' ' 44' ' ' LEU . 88.3 tttt -133.06 100.55 4.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 110.108 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.557 ' CG2' HG12 ' A' ' 38' ' ' ILE . 88.8 mt -89.11 140.09 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.305 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.2 p -111.06 154.25 24.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 110.849 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.6 m-85 -124.4 122.6 38.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.445 -0.784 . . . . 0.0 110.279 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.494 2.515 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.264 0.554 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -113.1 96.84 0.83 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 9.7 p90 -133.41 153.21 51.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -1.173 . . . . 0.0 109.992 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.858 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.6 m -125.28 172.5 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.186 -0.946 . . . . 0.0 110.774 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HD2' ' OE1' ' A' ' 87' ' ' GLU . 69.6 mttt -124.92 129.19 49.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.708 -0.62 . . . . 0.0 109.371 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.593 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -117.59 120.31 37.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.161 -0.962 . . . . 0.0 110.993 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.694 ' HA ' HD13 ' A' ' 53' ' ' ILE . 55.3 tttm -96.67 109.85 22.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.821 . . . . 0.0 109.407 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.55 HD11 ' HE3' ' A' ' 54' ' ' LYS . 26.1 mm -48.55 139.46 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.982 . . . . 0.0 110.175 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.541 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 17.9 t0 -111.65 -40.55 4.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.477 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 0.7 OUTLIER 172.78 160.84 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.581 -0.7 . . . . 0.0 110.339 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.101 ' CD1' HG11 ' A' ' 23' ' ' VAL . 12.5 tt -149.27 172.24 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.536 -0.728 . . . . 0.0 109.505 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.7 m-20 -139.71 83.56 1.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.104 -0.998 . . . . 0.0 110.412 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.588 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 35.7 mtmm -59.27 -14.05 9.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.897 . . . . 0.0 110.44 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -96.02 -30.12 13.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 109.562 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.5 m120 -107.68 -0.75 21.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.601 -0.687 . . . . 0.0 109.357 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.552 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 74.3 m-85 60.4 53.72 4.15 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.356 0.598 . . . . 0.0 110.598 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -127.74 156.0 43.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 109.617 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.531 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 86.5 t80 -152.99 146.89 25.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.079 -1.013 . . . . 0.0 110.434 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.435 ' CB ' ' HA ' ' A' ' 101' ' ' GLU . 1.8 m -156.34 145.64 20.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.385 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.6 p90 -143.86 177.78 8.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.518 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 98' ' ' ILE . 80.4 m -124.02 124.69 43.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.429 -0.794 . . . . 0.0 109.626 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.631 HD21 HD11 ' A' ' 91' ' ' LEU . 1.7 tp -93.59 137.32 32.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.32 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.3 pt -124.24 -12.2 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 110.257 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.465 ' O ' HD11 ' A' ' 85' ' ' LEU . 4.6 tt0 -129.21 160.45 32.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 110.236 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.858 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 146.55 132.0 2.29 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -64.81 -12.01 43.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -1.097 . . . . 0.0 110.033 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.585 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -81.38 -29.18 34.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.347 -0.846 . . . . 0.0 110.064 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.745 HD21 HG13 ' A' ' 98' ' ' ILE . 24.1 mt -66.11 -27.55 68.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 110.122 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.62 -172.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -82.49 6.38 17.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -1.163 . . . . 0.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 122' ' ' THR . 14.0 p -93.24 -30.8 15.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.064 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.022 HD21 ' CG1' ' A' ' 128' ' ' ILE . 34.0 mt -113.35 153.02 29.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.344 -0.848 . . . . 0.0 109.947 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 41.1 tt0 -131.45 -79.78 0.52 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.229 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.5 mttt -80.16 133.61 36.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.58 -0.7 . . . . 0.0 110.541 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.745 HG13 HD21 ' A' ' 91' ' ' LEU . 7.1 mm -123.9 143.36 37.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.863 -1.148 . . . . 0.0 109.683 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.76 127.43 50.63 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.203 179.102 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.693 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.2 m-85 -123.51 133.04 54.06 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.4 -0.812 . . . . 0.0 110.425 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.435 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 73.7 tt0 -130.3 158.17 40.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 110.118 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' TYR . 66.7 m -155.8 138.77 15.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.954 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 115' ' ' LYS . 3.4 mttt -132.28 136.05 46.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.818 HD23 HG12 ' A' ' 114' ' ' ILE . 2.9 mt -119.06 149.66 41.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 110.467 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.54 -169.23 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.409 -0.807 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.698 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.56 134.11 53.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 52.4 p -89.03 164.39 31.14 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.9 Cg_endo -73.22 -0.27 8.92 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.045 1.55 . . . . 0.0 110.598 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.1 p -104.38 5.19 34.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 110.247 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.04 -41.28 2.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.66 -172.11 0.55 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 82.4 p -130.13 138.24 50.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -1.135 . . . . 0.0 110.29 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.7 ' HA ' HG22 ' A' ' 10' ' ' THR . 14.0 mt -88.05 151.6 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.889 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.818 HG12 HD23 ' A' ' 104' ' ' LEU . 5.5 mt -136.41 110.08 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.339 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 103' ' ' LYS . 78.0 tttt -98.25 119.49 37.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.936 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -112.94 155.34 24.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 110.395 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.458 HG22 ' NE2' ' A' ' 119' ' ' HIS . 98.9 m -158.09 126.04 5.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.87 . . . . 0.0 109.999 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 p -127.87 165.3 20.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 110.366 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.746 ' CE1' HG23 ' A' ' 4' ' ' THR . 56.9 m-70 -142.46 168.45 19.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.325 -0.86 . . . . 0.0 110.055 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 9.1 m-85 -130.74 148.72 52.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.377 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.582 ' ND1' HG22 ' A' ' 2' ' ' VAL . 95.0 m-70 -131.67 86.46 2.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.182 -0.949 . . . . 0.0 109.701 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.527 HG21 ' O ' ' A' ' 126' ' ' VAL . 1.1 p -56.54 160.7 3.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 66.0 tttt -119.13 107.61 13.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.238 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.8 -111.6 4.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.611 ' O ' HG13 ' A' ' 126' ' ' VAL . 35.2 t30 -134.21 85.85 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -1.129 . . . . 0.0 110.402 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 125' ' ' ASN . 16.6 m -157.93 173.09 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 110.1 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HA ' HG21 ' A' ' 122' ' ' THR . 84.1 mt-10 -144.84 171.43 14.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.248 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.022 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.9 mp -91.42 172.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 110.02 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.607 ' N ' HG22 ' A' ' 128' ' ' ILE . 19.7 mttt -114.39 131.26 56.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.89 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.543 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 83.9 mt-10 -43.39 -47.59 6.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 110.107 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -58.3 -27.28 63.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.63 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.585 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 12.3 t-160 -83.42 -55.6 4.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.956 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.087 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.3 p -65.13 -42.15 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 109.961 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.56 ' N ' HG13 ' A' ' 133' ' ' VAL . 35.7 ttmt -63.31 -42.94 99.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.814 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.65 73.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.87 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.5 -35.61 92.0 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 5' ' ' TYR . 69.5 mmtt -64.35 -32.44 74.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -1.114 . . . . 0.0 109.908 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -72.27 -38.55 68.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.442 -0.786 . . . . 0.0 109.937 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -62.81 -46.51 87.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.806 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.47 -40.2 95.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.8 t -72.46 -52.0 17.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.403 -0.81 . . . . 0.0 109.799 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -50.47 -48.76 56.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.593 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.1 mp -54.62 -49.76 69.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.481 ' HA ' HD12 ' A' ' 147' ' ' ILE . 4.1 m-85 -54.18 -41.88 69.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.725 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -66.46 -28.29 68.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 109.872 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.513 ' HA ' HD23 ' A' ' 146' ' ' LEU . 14.5 mt -80.59 -35.37 34.3 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.542 ' HA ' HD13 ' A' ' 33' ' ' ILE . 96.8 mt -66.79 -41.25 87.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 49.5 mt-10 -54.84 -47.16 74.49 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.403 -0.811 . . . . 0.0 109.18 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.3 m -61.15 -31.53 71.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.445 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.616 ' CD1' HG12 ' A' ' 33' ' ' ILE . 59.7 t80 -64.01 -52.89 57.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.789 . . . . 0.0 109.655 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.061 HD21 ' CE1' ' A' ' 158' ' ' TYR . 56.8 mt -80.07 -33.68 38.74 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 110.408 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.568 ' CG ' HG12 ' A' ' 13' ' ' ILE . 49.5 mtpt -65.71 -14.04 60.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 0.0 109.426 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.481 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.77 -30.27 1.4 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 8.0 m80 -106.43 93.49 8.39 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.189 -1.183 . . . . 0.0 110.253 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.512 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.3 Cg_endo -74.26 3.82 4.89 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.101 1.58 . . . . 0.0 110.644 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -106.99 -11.25 15.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -67.83 100.62 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.757 . . . . 0.0 109.919 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.061 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.1 p90 34.59 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.25 0.548 . . . . 0.0 110.604 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.771 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 78.5 t -110.1 132.86 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -1.191 . . . . 0.0 110.236 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.681 ' CE1' HD12 ' A' ' 128' ' ' ILE . 12.3 m-85 -94.3 149.08 21.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.253 -0.904 . . . . 0.0 109.983 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.627 HG23 ' CE1' ' A' ' 119' ' ' HIS . 8.6 m -127.56 114.19 17.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 110.443 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.155 ' CE2' HG21 ' A' ' 133' ' ' VAL . 64.8 m-85 -128.45 139.52 52.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.822 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 13.6 pt-20 -140.17 152.7 46.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 110.735 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.529 ' C ' ' HG ' ' A' ' 116' ' ' SER . 0.2 OUTLIER -147.22 166.04 28.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.499 -0.75 . . . . 0.0 109.45 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -144.23 145.78 32.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.058 -1.026 . . . . 0.0 110.553 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.642 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 6.3 p90 -159.01 -172.45 3.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.715 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.4 p -137.33 172.57 12.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.101 -1.0 . . . . 0.0 110.708 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 112' ' ' SER . 92.9 p -151.01 149.1 29.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 0.0 110.503 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.29 -25.97 66.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 0.0 110.184 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.721 HD13 ' CB ' ' A' ' 148' ' ' GLU . 4.7 mp -84.46 146.05 46.44 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 110.116 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.679 ' HD2' HG23 ' A' ' 13' ' ' ILE . 43.2 Cg_endo -67.96 154.65 72.25 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.136 1.598 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.667 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.0 Cg_endo -62.73 -37.13 58.53 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.748 1.394 . . . . 0.0 113.106 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 37.9 Cg_endo -63.58 -20.2 68.96 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 N-CA-C 109.823 -0.876 . . . . 0.0 109.823 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.855 ' HB3' HD13 ' A' ' 151' ' ' LEU . 5.7 mmp_? -80.64 -45.47 17.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.714 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.0 mp -75.51 -36.04 60.63 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.802 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 55.3 t80 -58.29 -58.01 10.38 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.107 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 87.4 mttt -59.86 -35.92 75.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.392 -0.818 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.083 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -79.33 -61.55 1.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.357 -0.84 . . . . 0.0 111.019 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.958 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -53.84 -38.28 64.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.448 -0.783 . . . . 0.0 111.653 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.827 HG13 ' CE1' ' A' ' 81' ' ' TYR . 8.0 t -105.22 -66.29 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.892 -1.13 . . . . 0.0 111.661 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.0 mp -66.74 -4.24 8.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.174 -0.954 . . . . 0.0 111.445 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.685 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -147.96 31.26 0.86 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.807 -1.183 . . . . 0.0 110.544 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.958 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -70.57 -32.67 70.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.98 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.57 ' OD2' HD11 ' A' ' 43' ' ' ILE . 94.7 m-20 -65.49 -15.89 63.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.869 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 74.0 m-80 -126.59 10.5 7.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.736 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -96.68 -54.2 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.926 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.0 t -67.38 -42.02 35.85 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 0.0 110.79 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -78.52 8.64 3.54 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.513 1.27 . . . . 0.0 110.693 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 35.1 mttt -126.77 -32.23 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.093 -1.005 . . . . 0.0 109.661 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.741 HD13 ' HA ' ' A' ' 147' ' ' ILE . 45.8 mt -80.0 -34.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.78 99.35 1.5 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.485 -0.759 . . . . 0.0 110.026 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.02 -0.75 8.98 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.092 1.575 . . . . 0.0 110.561 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -86.74 -9.69 55.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.878 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.714 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -101.18 -47.05 4.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.392 -0.817 . . . . 0.0 110.099 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.926 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.8 mp -124.98 143.02 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.459 -0.776 . . . . 0.0 109.874 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' THR . 36.5 ttmt -80.39 -37.92 31.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 110.262 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.442 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.2 OUTLIER 178.8 139.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.248 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 3.2 m -102.17 128.11 48.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 110.314 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -132.81 115.17 14.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 110.14 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.57 HD11 ' OD2' ' A' ' 27' ' ' ASP . 10.7 mt -64.97 133.05 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.363 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 44' ' ' LEU . 24.3 mt -94.36 -45.74 7.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 110.204 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.894 ' O ' HG23 ' A' ' 52' ' ' THR . 6.9 mt-10 -130.51 141.3 50.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 110.116 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.86 -169.87 54.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -130.79 16.35 5.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -1.141 . . . . 0.0 110.304 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.495 ' N ' HG21 ' A' ' 52' ' ' THR . . . 124.39 -8.41 8.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -82.02 -168.92 42.31 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.2 Cg_endo -69.82 134.26 27.43 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.166 1.614 . . . . 0.0 110.468 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.21 76.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.894 HG23 ' O ' ' A' ' 45' ' ' GLU . 37.2 m -79.97 138.75 37.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -1.145 . . . . 0.0 110.069 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.635 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.9 mm -109.35 111.66 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 110.288 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 81.6 mttt -97.14 154.72 17.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 110.204 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -127.52 104.55 7.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.446 ' CG2' HG12 ' A' ' 38' ' ' ILE . 85.4 mt -90.82 140.84 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.3 p -113.28 150.97 31.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 110.333 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.7 m-85 -116.25 137.35 52.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 110.335 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.898 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.691 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 3.9 t80 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.153 0.502 . . . . 0.0 109.969 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -115.74 97.4 0.79 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.691 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 25.3 p90 -134.6 168.27 19.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.167 -1.196 . . . . 0.0 110.171 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.887 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.2 m -137.45 171.84 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 110.486 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' O ' HD12 ' A' ' 85' ' ' LEU . 87.3 mttt -123.03 124.05 42.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.617 -0.677 . . . . 0.0 109.577 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.715 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -111.62 136.27 51.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -0.988 . . . . 0.0 110.906 -179.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.635 ' HA ' HD13 ' A' ' 53' ' ' ILE . 79.1 tttt -114.83 108.87 17.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.462 -0.774 . . . . 0.0 109.507 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 37.0 mm -44.99 137.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 110.047 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.522 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 25.8 t0 -107.47 -47.63 3.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 9.4 m -171.94 156.88 4.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.578 -0.702 . . . . 0.0 109.688 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.7 mt -136.86 157.31 35.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 110.119 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 4.7 m-20 -135.28 79.26 1.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.344 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.582 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 81.3 mttt -63.77 -11.43 26.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -98.14 -30.14 12.83 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.739 0.78 . . . . 0.0 109.177 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m120 -105.12 -2.69 23.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.67 -0.644 . . . . 0.0 109.432 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.545 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 76.6 m-85 59.75 55.18 4.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.677 -0.639 . . . . 0.0 110.408 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -130.64 162.17 29.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.8 . . . . 0.0 109.782 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.827 ' CE1' HG13 ' A' ' 23' ' ' VAL . 37.5 t80 -144.56 137.32 26.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 110.096 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 35.3 m -139.79 126.9 21.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.98 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 9.2 p90 -141.83 179.4 6.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.751 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 98' ' ' ILE . 91.5 m -135.88 152.17 50.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.494 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.715 HD13 ' CE1' ' A' ' 69' ' ' HIS . 52.3 tp -106.68 125.45 51.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.414 -0.804 . . . . 0.0 109.941 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.7 pt -109.28 -8.81 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.428 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.427 ' OE1' ' HD2' ' A' ' 68' ' ' LYS . 30.1 tt0 -150.48 159.25 44.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.326 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.887 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 160.43 139.95 2.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -71.26 -24.93 62.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -1.115 . . . . 0.0 110.075 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.26 -22.95 61.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 110.146 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.658 HD22 HD12 ' A' ' 98' ' ' ILE . 74.7 mt -60.81 -22.48 64.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.002 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.31 -179.39 0.01 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -80.14 6.01 12.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -1.139 . . . . 0.0 110.014 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.472 ' HA ' HG21 ' A' ' 126' ' ' VAL . 30.8 p -98.33 -23.29 15.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.038 HD21 ' CG1' ' A' ' 128' ' ' ILE . 42.1 mt -123.68 162.54 22.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 110.271 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -140.94 -81.69 0.24 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.3 -0.875 . . . . 0.0 109.861 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.556 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 34.8 mttt -80.41 161.04 25.14 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.709 -0.619 . . . . 0.0 110.103 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.658 HD12 HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -156.17 140.13 8.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 178.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 3.7 m -116.63 121.69 42.42 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 11.5 m-85 -112.82 139.78 48.16 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.413 -0.805 . . . . 0.0 110.3 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 80.8 tt0 -135.22 144.24 46.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 109.894 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.0 m -146.77 125.92 12.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.184 -0.948 . . . . 0.0 110.352 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 1.1 ttmt -116.22 146.94 41.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 109.813 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.787 HD23 HG12 ' A' ' 114' ' ' ILE . 6.3 mt -120.58 147.7 44.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.998 . . . . 0.0 110.78 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.89 -168.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.0 109.567 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.713 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -129.9 157.29 42.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 110.52 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -110.44 179.68 0.78 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.795 . . . . 0.0 109.618 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 107' ' ' SER . 40.6 Cg_endo -66.64 73.93 0.41 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.817 1.43 . . . . 0.0 109.577 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 4.0 m 57.35 37.29 27.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.497 -0.752 . . . . 0.0 109.742 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.53 42.72 1.47 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.34 -127.61 8.87 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 92.2 p -151.62 143.28 23.63 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.341 -1.093 . . . . 0.0 109.616 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.579 ' HA ' HG22 ' A' ' 10' ' ' THR . 34.4 mt -90.46 150.32 3.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.196 -0.94 . . . . 0.0 110.571 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.787 HG12 HD23 ' A' ' 104' ' ' LEU . 5.8 mt -138.16 108.92 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.198 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -81.67 143.8 31.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 109.931 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.529 ' HG ' ' C ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -128.01 140.64 51.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 110.5 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 53.4 m -152.3 131.86 13.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.346 -0.846 . . . . 0.0 109.847 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.441 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 52.6 p -137.97 165.09 27.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 110.578 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.627 ' CE1' HG23 ' A' ' 4' ' ' THR . 48.1 m-70 -145.48 161.28 40.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.33 -0.856 . . . . 0.0 110.041 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 10.3 m-85 -121.97 147.54 45.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 110.359 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.556 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 99.6 m-70 -130.94 85.6 2.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.272 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.535 ' OG1' HG23 ' A' ' 126' ' ' VAL . 1.4 t -72.89 176.58 5.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.313 -0.867 . . . . 0.0 110.948 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -132.9 131.28 40.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.622 -0.673 . . . . 0.0 110.186 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.06 -111.13 4.18 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.533 ' C ' HG13 ' A' ' 126' ' ' VAL . 36.0 t30 -151.41 81.34 1.3 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -1.143 . . . . 0.0 110.136 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.535 HG23 ' OG1' ' A' ' 122' ' ' THR . 30.8 m -154.1 160.82 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -126.94 161.26 28.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.038 ' CG1' HD21 ' A' ' 95' ' ' LEU . 4.7 mp -79.91 172.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.954 . . . . 0.0 110.351 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.587 ' N ' HG22 ' A' ' 128' ' ' ILE . 47.4 mttt -106.83 128.29 54.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.324 -0.86 . . . . 0.0 109.86 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.459 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 92.7 mt-10 -43.62 -46.99 7.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.46 -24.59 63.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 109.88 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 129' ' ' LYS . 12.5 t-160 -84.92 -54.16 4.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -0.805 . . . . 0.0 110.14 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.155 HG21 ' CE2' ' A' ' 5' ' ' TYR . 9.3 p -66.84 -41.41 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.065 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.551 ' N ' HG13 ' A' ' 133' ' ' VAL . 81.5 tttt -64.95 -43.56 92.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.907 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -29.27 69.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.926 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.76 -32.19 73.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -70.1 -36.69 75.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.986 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -68.73 -33.79 74.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 109.778 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -66.99 -37.37 84.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.823 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.16 90.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.296 -0.877 . . . . 0.0 109.791 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.7 m -61.32 -48.46 81.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.371 -0.831 . . . . 0.0 109.742 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 145' ' ' LYS . 98.4 m-20 -51.25 -42.69 61.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 146' ' ' LEU . 25.8 tp -56.32 -54.58 43.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.737 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.585 ' CE1' HG21 ' A' ' 114' ' ' ILE . 17.3 m-85 -48.03 -37.66 15.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.551 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 142' ' ' ASN . 98.9 mttt -68.75 -24.27 64.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.626 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.493 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 30.1 mt -84.51 -34.86 23.24 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.225 -0.922 . . . . 0.0 108.92 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.741 ' HA ' HD13 ' A' ' 33' ' ' ILE . 52.5 mt -71.88 -33.99 49.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.578 -0.702 . . . . 0.0 109.336 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.721 ' CB ' HD13 ' A' ' 13' ' ' ILE . 78.4 mt-10 -64.37 -38.49 91.23 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.502 -0.749 . . . . 0.0 109.55 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 90.0 m -70.06 -38.02 75.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 109.478 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.612 ' CD1' HG12 ' A' ' 33' ' ' ILE . 68.1 t80 -55.73 -51.52 67.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.416 -0.803 . . . . 0.0 109.774 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.09 HD21 ' CE1' ' A' ' 158' ' ' TYR . 77.8 mt -80.03 -41.48 25.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 110.1 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.635 ' HB2' HD11 ' A' ' 13' ' ' ILE . 49.2 tttp -64.06 -19.92 65.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.361 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.71 -34.78 2.75 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 2.1 m80 -110.6 94.88 20.69 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.324 -1.104 . . . . 0.0 110.101 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -74.14 5.48 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.093 1.575 . . . . 0.0 110.985 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -105.55 -7.92 18.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.994 -1.066 . . . . 0.0 109.865 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -71.57 102.08 2.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.427 -0.795 . . . . 0.0 110.121 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.09 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.1 p90 34.24 32.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.797 -0.564 . . . . 0.0 110.71 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.763 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 86.0 t -122.35 118.53 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.133 -1.216 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.572 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 58.5 m-85 -86.31 163.29 17.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.867 HG23 ' CE1' ' A' ' 119' ' ' HIS . 75.7 m -141.35 92.87 2.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.686 ' CE1' HG11 ' A' ' 133' ' ' VAL . 83.5 m-85 -109.01 126.03 52.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.977 . . . . 0.0 109.815 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 116' ' ' SER . 16.1 pt-20 -128.79 153.03 47.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 110.445 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.8 m -123.88 141.06 52.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.917 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.443 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 83.0 mt-10 -121.62 124.02 43.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 110.447 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.2 p90 -151.13 -172.86 4.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.938 . . . . 0.0 109.947 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.568 HG22 HG12 ' A' ' 113' ' ' ILE . 17.3 p -138.84 -178.21 5.22 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 110.547 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 112' ' ' SER . 98.9 p -157.27 150.05 23.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.432 -0.792 . . . . 0.0 110.349 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -75.51 -8.39 56.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.124 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.0 mm -96.79 149.78 36.16 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.414 -0.804 . . . . 0.0 110.084 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -64.96 148.01 89.47 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.975 1.513 . . . . 0.0 110.376 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.668 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -71.14 -32.21 13.45 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.877 1.462 . . . . 0.0 112.899 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.12 -20.62 37.61 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 N-CA-C 109.871 -0.857 . . . . 0.0 109.871 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.866 ' HG2' HD13 ' A' ' 151' ' ' LEU . 4.5 ttm180 -83.36 -46.72 12.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.756 ' C ' HD23 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -72.95 -28.87 62.68 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.086 178.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 87.0 t80 -65.86 -56.52 11.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.436 -0.79 . . . . 0.0 109.544 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.779 ' HA ' HD12 ' A' ' 24' ' ' LEU . 90.8 mttt -54.36 -39.25 66.98 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.279 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.061 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -68.82 -53.28 22.45 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.501 0.667 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.806 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -63.86 -45.47 89.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 111.511 -178.677 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.657 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.1 t -99.05 -57.23 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.99 -1.069 . . . . 0.0 111.725 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 20' ' ' LYS . 27.5 mt -76.42 1.72 15.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.136 -0.977 . . . . 0.0 111.678 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.707 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -154.68 38.8 0.43 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.733 -1.229 . . . . 0.0 110.898 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -76.3 -31.29 58.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.082 -1.011 . . . . 0.0 110.228 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 79.8 m-20 -65.41 -13.6 59.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.093 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.547 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 66.9 m-20 -128.81 8.23 5.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 110.073 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.9 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -94.93 -51.17 4.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.431 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.095 HG21 HD13 ' A' ' 38' ' ' ILE . 8.2 p -75.37 -27.14 0.67 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.925 . . . . 0.0 112.267 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.814 ' HD3' HG12 ' A' ' 30' ' ' VAL . 53.0 Cg_endo -81.37 8.61 4.29 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 122.743 0.865 . . . . 0.0 110.625 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -137.39 -30.29 0.85 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.056 -1.028 . . . . 0.0 110.609 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.9 HD11 ' CD1' ' A' ' 29' ' ' LEU . 67.2 mt -75.24 -41.29 43.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.274 -0.891 . . . . 0.0 109.692 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.57 90.76 2.84 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.422 -0.798 . . . . 0.0 110.374 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.78 1.68 7.34 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.112 1.585 . . . . 0.0 110.321 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -87.2 -23.2 24.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.161 -0.962 . . . . 0.0 109.892 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.48 -42.59 8.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.095 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -121.94 146.97 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.788 . . . . 0.0 109.827 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 17.1 tppt? -86.87 -42.22 13.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.371 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.466 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.6 OUTLIER 179.08 139.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 110.403 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 4.2 m -94.25 137.32 33.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -142.03 110.08 5.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 45.5 mt -60.46 132.16 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.143 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.9 tp -95.71 -39.04 10.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.38 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 52' ' ' THR . 2.5 mt-10 -136.43 137.63 40.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.133 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.412 ' O ' ' OD1' ' A' ' 47' ' ' ASP . . . 81.08 -162.41 44.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 89.0 m-20 -137.65 20.99 2.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -1.167 . . . . 0.0 110.213 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.537 ' H ' HG21 ' A' ' 52' ' ' THR . . . 118.88 -12.14 11.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.536 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -75.01 -169.93 25.52 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.65 132.46 20.38 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.123 1.591 . . . . 0.0 110.382 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.78 67.26 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 45' ' ' GLU . 32.1 m -79.84 143.19 34.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.186 . . . . 0.0 110.042 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.4 mm -111.49 104.27 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.953 . . . . 0.0 110.328 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 51.9 mtpt -89.5 137.22 32.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.383 -0.823 . . . . 0.0 110.245 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -113.79 103.08 10.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.842 . . . . 0.0 110.356 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.541 ' CG2' HG12 ' A' ' 38' ' ' ILE . 87.3 mt -89.15 140.65 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.177 -0.952 . . . . 0.0 109.976 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 40' ' ' HIS . 1.3 p -112.49 152.94 28.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.52 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.711 ' HE2' HG13 ' A' ' 67' ' ' VAL . 30.9 m-85 -113.26 160.25 18.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.883 . . . . 0.0 110.145 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.679 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 8.3 t80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.187 0.518 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -113.36 135.03 12.27 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.679 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 11.4 p90 -178.52 160.26 1.23 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 110.112 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.833 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.8 m -141.36 171.65 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.39 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.802 ' CD ' HD11 ' A' ' 86' ' ' ILE . 23.8 ttmt -123.09 124.11 42.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.598 -0.689 . . . . 0.0 109.881 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.668 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -113.56 123.52 50.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 110.751 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.562 ' HA ' HD13 ' A' ' 53' ' ' ILE . 84.4 tttt -100.09 110.79 23.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 109.612 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 49' ' ' GLY . 33.4 mm -50.97 133.85 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 110.439 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB2' ' C ' ' A' ' 82' ' ' SER . 83.2 m-20 -106.25 -37.15 6.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.316 -0.865 . . . . 0.0 109.87 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 11.8 p 178.16 157.72 0.44 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.747 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.466 HG13 ' HD1' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -138.66 153.62 25.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.051 -179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 79' ' ' TYR . 6.3 m-20 -131.02 77.49 1.79 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.529 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 85.1 mttt -63.04 -11.85 22.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.232 -0.918 . . . . 0.0 110.005 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -98.12 -31.82 11.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.746 . . . . 0.0 109.235 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m120 -102.45 -3.26 27.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.634 -0.666 . . . . 0.0 109.342 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.552 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 74.8 m-85 60.87 54.76 3.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.524 0.678 . . . . 0.0 110.6 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -130.97 156.53 44.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.679 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.703 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 61.2 t80 -143.67 141.61 30.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.931 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.47 ' OG ' ' HG2' ' A' ' 101' ' ' GLU . 53.6 m -148.7 136.97 21.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.14 -0.975 . . . . 0.0 110.755 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.703 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.0 p90 -147.82 175.61 10.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.399 -0.813 . . . . 0.0 110.29 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 98' ' ' ILE . 44.9 m -124.47 128.84 49.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.858 . . . . 0.0 109.851 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.668 HD13 ' CE1' ' A' ' 69' ' ' HIS . 4.5 tp -95.47 124.88 39.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -0.978 . . . . 0.0 110.167 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.802 HD11 ' CD ' ' A' ' 68' ' ' LYS . 16.9 pt -109.23 -5.83 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 110.229 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.552 ' O ' HD11 ' A' ' 85' ' ' LEU . 9.1 tt0 -136.56 162.35 33.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 110.327 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.833 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 149.14 125.08 1.38 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -57.89 -31.39 66.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -1.11 . . . . 0.0 110.187 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.18 -18.58 65.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.079 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.599 HD21 HG13 ' A' ' 98' ' ' ILE . 86.9 mt -70.72 -30.45 66.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.62 -174.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -80.89 4.51 19.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -1.146 . . . . 0.0 110.26 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.634 ' O ' HG22 ' A' ' 122' ' ' THR . 78.1 p -89.47 -41.47 12.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.92 . . . . 0.0 110.108 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.011 HD23 HG23 ' A' ' 122' ' ' THR . 62.9 mt -102.47 152.33 21.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.854 . . . . 0.0 109.987 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.51 ' CG ' ' HD3' ' A' ' 123' ' ' LYS . 5.6 tp10 -131.54 -80.56 0.52 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.304 -0.873 . . . . 0.0 110.087 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 59.3 mttt -80.21 127.78 32.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.581 -0.7 . . . . 0.0 110.522 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.746 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -116.77 139.05 45.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.702 -1.249 . . . . 0.0 109.856 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.49 127.68 54.24 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.405 -0.81 . . . . 0.0 108.974 178.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.746 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.6 m-85 -122.56 133.98 54.55 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.331 -0.856 . . . . 0.0 110.509 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.47 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 3.2 mt-10 -132.56 141.18 48.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.1 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 81' ' ' TYR . 63.6 m -137.04 143.13 42.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -137.19 135.76 37.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 110.169 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.752 HD23 HG12 ' A' ' 114' ' ' ILE . 4.9 mt -120.07 148.21 43.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.836 . . . . 0.0 110.533 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.7 -169.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 0.0 109.799 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.698 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -115.35 167.16 11.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 110.214 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.532 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 57.6 p -126.42 175.42 3.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 109.948 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.8 Cg_endo -87.29 22.8 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.87 1.458 . . . . 0.0 110.498 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 t -126.67 -10.99 6.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 110.409 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.96 -26.68 10.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.9 -149.59 1.56 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 8.4 p -149.12 137.79 21.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -1.17 . . . . 0.0 110.152 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.568 HG12 HG22 ' A' ' 10' ' ' THR . 68.5 mt -86.86 148.91 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 110.122 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.752 HG12 HD23 ' A' ' 104' ' ' LEU . 9.7 mt -132.79 125.26 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.391 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 75.1 tttt -115.86 108.43 16.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.2 m -98.84 158.85 15.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 110.538 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 101' ' ' GLU . 53.4 m -159.35 126.01 4.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.398 -0.814 . . . . 0.0 110.278 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.4 m -128.97 160.01 34.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 0.0 110.183 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.867 ' CE1' HG23 ' A' ' 4' ' ' THR . 62.3 m-70 -136.73 162.11 34.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.246 -0.909 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.8 m-85 -126.58 136.24 52.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.912 . . . . 0.0 110.99 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 93.3 m-70 -119.0 81.49 1.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.915 . . . . 0.0 109.34 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 1.011 HG23 HD23 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -66.69 154.52 40.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 111.102 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HD3' ' CG ' ' A' ' 96' ' ' GLU . 37.8 mtmt -103.8 116.86 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.521 -0.737 . . . . 0.0 109.829 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 106.74 9.72 30.05 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 5.8 t30 69.4 51.4 0.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -1.134 . . . . 0.0 110.451 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 127' ' ' GLU . 85.4 t -92.63 175.15 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.331 -0.855 . . . . 0.0 109.549 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.601 ' N ' HG12 ' A' ' 126' ' ' VAL . 90.8 mt-10 -124.3 149.34 46.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.969 -1.082 . . . . 0.0 110.563 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.881 ' CD1' HD21 ' A' ' 95' ' ' LEU . 15.8 mm -75.42 172.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 110.202 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.594 ' N ' HG22 ' A' ' 128' ' ' ILE . 70.3 mmtt -111.29 129.88 55.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.288 -0.882 . . . . 0.0 109.842 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' LYS . 54.1 mt-10 -43.09 -43.5 4.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 110.184 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -62.45 -25.36 67.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 110.025 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.8 t-160 -78.11 -50.54 11.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 110.147 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.686 HG11 ' CE1' ' A' ' 5' ' ' TYR . 72.7 t -57.24 -32.85 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.0 109.746 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -80.17 -40.77 26.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.831 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.92 -36.82 84.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.335 -0.853 . . . . 0.0 109.906 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.56 -30.04 69.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.461 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 91.7 mttt -77.49 -32.1 54.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 0.0 109.985 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -76.13 -33.24 59.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.387 -0.821 . . . . 0.0 109.973 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.21 -33.46 65.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.919 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -79.07 -36.11 41.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.0 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.0 m -62.11 -47.36 84.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.958 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -53.93 -50.03 67.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.816 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.48 ' HA ' HD12 ' A' ' 143' ' ' LEU . 15.9 tp -57.18 -45.32 83.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.789 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 21.6 m-85 -56.83 -41.34 77.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.406 -0.809 . . . . 0.0 109.643 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.417 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 45.9 mtmt -78.84 -14.92 58.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 109.828 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.498 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 19.7 mt -83.22 -36.69 24.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -0.901 . . . . 0.0 108.818 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.747 HD11 ' CE1' ' A' ' 22' ' ' PHE . 16.1 mt -69.42 -46.22 76.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.495 ' O ' HG13 ' A' ' 13' ' ' ILE . 64.1 mt-10 -56.78 -36.65 70.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.402 -0.811 . . . . 0.0 109.551 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.4 m -72.23 -39.43 68.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.778 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.651 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 77.0 t80 -53.59 -52.13 60.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -0.843 . . . . 0.0 110.089 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.194 HD21 ' CE2' ' A' ' 158' ' ' TYR . 74.6 mt -75.25 -33.98 61.36 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.213 -0.93 . . . . 0.0 110.27 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 37.6 ttpt -69.98 -20.62 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -109.06 -31.13 3.42 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 8.4 m80 -109.53 93.3 13.61 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 109.942 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.16 5.27 3.68 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.07 1.563 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -109.83 2.24 19.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.003 -1.06 . . . . 0.0 109.856 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.651 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -83.59 103.22 12.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 109.995 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.194 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.99 31.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.722 -0.611 . . . . 0.0 110.472 -179.548 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.721 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.876 HG13 ' O ' ' A' ' 120' ' ' TYR . 70.6 t -120.89 118.67 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.214 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.603 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 90.8 m-85 -75.91 149.88 37.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.162 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.725 HG23 ' CE1' ' A' ' 119' ' ' HIS . 39.9 m -133.1 119.94 20.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 110.228 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.015 ' CE2' HG21 ' A' ' 133' ' ' VAL . 69.9 m-85 -131.07 152.41 50.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 110.247 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -144.81 149.77 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.131 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.8 t -142.86 156.52 44.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.833 . . . . 0.0 109.816 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.23 145.89 36.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.005 . . . . 0.0 110.756 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.689 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 5.7 p90 -159.45 -172.89 3.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.608 -0.683 . . . . 0.0 109.704 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 113' ' ' ILE . 20.8 p -136.39 177.99 7.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.065 -1.022 . . . . 0.0 110.717 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 3.2 t -157.83 159.89 37.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.432 -0.793 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -87.45 -2.72 58.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 110.248 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.752 HG23 ' HD2' ' A' ' 14' ' ' PRO . 12.0 mm -98.06 148.3 34.29 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 110.215 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.752 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.59 144.84 80.22 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.099 1.579 . . . . 0.0 110.494 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.67 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.52 -31.12 11.45 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 124.018 1.536 . . . . 0.0 112.988 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.9 Cg_endo -69.04 -23.66 33.85 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 N-CA-C 110.121 -0.761 . . . . 0.0 110.121 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.541 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 3.7 mmp_? -84.44 -42.7 15.37 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.778 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -69.91 -31.31 69.03 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.565 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 48.8 t80 -66.27 -53.35 37.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.487 -0.758 . . . . 0.0 109.588 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 80.8 mttt -53.43 -37.48 62.61 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.212 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.06 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -72.3 -53.45 12.38 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.582 0.706 . . . . 0.0 110.769 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.055 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -61.37 -40.89 95.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.511 -0.743 . . . . 0.0 111.556 -178.645 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.532 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.6 t -104.68 -65.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.925 -1.109 . . . . 0.0 111.798 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.6 mp -65.95 -9.49 30.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.232 -0.917 . . . . 0.0 111.516 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 1.4 m-20 -145.68 33.39 1.04 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.823 -1.173 . . . . 0.0 110.71 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.055 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -73.46 -20.4 60.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.391 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 41' ' ' SER . 36.9 t0 -73.6 -20.56 60.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 109.73 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 6.9 p30 -123.88 15.34 9.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.429 -0.794 . . . . 0.0 109.684 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.866 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER -97.41 -57.75 2.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 109.754 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.018 ' CG1' HD13 ' A' ' 38' ' ' ILE . 11.7 t -62.12 -41.46 75.67 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.48 -0.763 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.2 Cg_endo -78.27 7.75 3.92 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.348 1.183 . . . . 0.0 110.831 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 72.1 mmtt -126.43 -27.74 3.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.052 -1.03 . . . . 0.0 109.907 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 146' ' ' LEU . 20.9 mt -77.34 -42.77 30.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.387 -0.82 . . . . 0.0 109.58 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.03 101.99 1.58 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.498 -0.751 . . . . 0.0 110.073 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.97 1.18 6.8 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.077 1.567 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -84.42 -19.99 32.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.065 -1.022 . . . . 0.0 109.572 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.8 -53.31 4.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.321 -0.862 . . . . 0.0 109.913 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.018 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.2 mp -121.84 148.71 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.44 -0.788 . . . . 0.0 109.791 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -84.0 -41.14 17.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.931 . . . . 0.0 110.549 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.579 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -172.59 170.64 4.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.204 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.428 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 68.3 m -126.93 136.5 52.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.14 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 76.2 tt0 -140.56 107.99 5.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 43.3 mt -58.7 133.27 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 110.206 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.556 HD12 HG22 ' A' ' 53' ' ' ILE . 52.8 mt -87.69 -27.64 22.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.3 -0.875 . . . . 0.0 110.044 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.985 ' O ' HG23 ' A' ' 52' ' ' THR . 29.4 tp10 -160.47 165.95 30.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 110.218 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.8 -168.99 27.02 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -127.69 24.6 6.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -1.182 . . . . 0.0 110.334 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.637 ' H ' HG21 ' A' ' 52' ' ' THR . . . 105.3 8.59 35.45 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.587 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -93.73 -164.09 36.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.79 130.8 18.64 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.047 1.551 . . . . 0.0 110.621 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.89 -3.69 77.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.985 HG23 ' O ' ' A' ' 45' ' ' GLU . 23.6 m -79.98 142.47 35.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -1.161 . . . . 0.0 109.982 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.556 HG22 HD12 ' A' ' 44' ' ' LEU . 32.5 mm -112.12 111.67 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.098 -1.001 . . . . 0.0 110.233 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.2 mttt -94.67 139.53 31.1 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.342 -0.849 . . . . 0.0 110.148 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HB2' ' HG ' ' A' ' 44' ' ' LEU . 80.3 tttt -111.34 96.21 5.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.327 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.686 HD12 ' CE1' ' A' ' 69' ' ' HIS . 63.6 mt -84.94 147.29 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.819 ' O ' HG23 ' A' ' 38' ' ' ILE . 7.8 p -116.68 163.07 16.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 0.0 110.638 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.655 ' HE2' HG13 ' A' ' 67' ' ' VAL . 24.6 m-85 -117.2 158.95 23.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.522 -0.736 . . . . 0.0 110.142 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.228 0.537 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -132.93 135.23 7.98 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 10.7 p90 -177.95 163.1 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -1.18 . . . . 0.0 110.145 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.772 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.8 m -143.22 172.24 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.614 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.6 ' O ' HD12 ' A' ' 85' ' ' LEU . 98.4 mttt -122.17 133.37 54.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.591 -0.693 . . . . 0.0 109.767 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.686 ' CE1' HD12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -112.31 137.28 50.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.118 -0.989 . . . . 0.0 110.706 -179.49 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.8 tttt -111.45 109.84 19.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.892 . . . . 0.0 109.211 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.668 HG23 HD11 ' A' ' 74' ' ' ILE . 36.1 mm -52.77 127.52 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.171 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.45 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 95.1 m-20 -99.03 -38.71 8.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.489 -0.757 . . . . 0.0 109.878 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.633 ' C ' HD12 ' A' ' 74' ' ' ILE . 2.2 m -178.81 161.28 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.668 HD11 HG23 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -144.74 152.8 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.986 -1.071 . . . . 0.0 111.261 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -140.54 80.89 1.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.682 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.565 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 84.2 tttt -65.61 -11.72 46.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.13 -0.981 . . . . 0.0 109.968 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -85.7 -30.73 22.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 108.68 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m120 -110.5 -2.92 16.27 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.612 ' O ' HD12 ' A' ' 104' ' ' LEU . 72.8 m-85 62.65 52.11 2.94 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.543 0.687 . . . . 0.0 110.444 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -123.31 153.02 40.82 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 109.352 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.684 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 59.0 t80 -142.38 148.98 38.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.14 -0.975 . . . . 0.0 110.255 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.436 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 60.3 m -152.13 137.04 17.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.791 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.684 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 4.1 p90 -149.32 179.31 8.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 110.009 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' ILE . 65.2 m -137.46 134.54 35.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.895 . . . . 0.0 110.372 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.608 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 9.2 tp -80.34 121.01 25.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.223 -0.923 . . . . 0.0 109.94 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.532 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 27.4 pt -100.16 -11.18 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.654 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -154.82 147.98 24.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.0 110.238 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.772 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 172.61 152.46 8.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -78.91 -35.38 43.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -1.122 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.869 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -58.78 -21.25 55.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.158 -0.964 . . . . 0.0 110.265 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.825 HD22 ' O ' ' A' ' 96' ' ' GLU . 19.8 mt -65.2 -42.86 93.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.309 -0.869 . . . . 0.0 109.694 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.67 -172.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -73.01 -3.73 27.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -1.106 . . . . 0.0 110.008 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.682 ' HA ' HG11 ' A' ' 126' ' ' VAL . 41.6 p -88.58 -45.49 9.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.12 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.801 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -118.89 159.46 23.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.383 -0.823 . . . . 0.0 109.067 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.825 ' O ' HD22 ' A' ' 91' ' ' LEU . 35.3 tt0 -140.31 -80.84 0.27 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 110.39 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 43.0 mtmt -80.26 148.42 30.78 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.619 -0.676 . . . . 0.0 110.681 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.858 HG21 ' CE2' ' A' ' 100' ' ' TYR . 17.8 mm -136.51 148.48 27.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.018 -1.051 . . . . 0.0 109.694 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -121.58 124.45 44.39 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.37 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.858 ' CE2' HG21 ' A' ' 98' ' ' ILE . 16.0 m-85 -117.31 135.67 53.67 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.306 -0.871 . . . . 0.0 110.741 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -135.88 134.73 39.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 109.923 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 89.3 m -134.1 147.8 50.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -0.988 . . . . 0.0 110.259 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 9.8 tttt -139.49 148.67 43.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.83 HD23 HG12 ' A' ' 114' ' ' ILE . 5.5 mt -125.06 152.36 44.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.257 -0.902 . . . . 0.0 110.447 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.77 -169.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.28 -0.888 . . . . 0.0 109.787 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.702 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.42 160.99 24.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.943 . . . . 0.0 110.311 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.441 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 35.3 p -120.59 164.12 24.95 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 110.13 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.5 -1.94 11.02 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.059 1.557 . . . . 0.0 110.363 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.6 m -102.72 0.45 32.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 110.326 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.46 -39.76 2.66 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.87 -171.67 0.36 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 54.8 p -131.93 134.62 45.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -1.166 . . . . 0.0 110.37 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.519 ' HA ' HG22 ' A' ' 10' ' ' THR . 31.9 mt -81.71 150.11 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.889 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.83 HG12 HD23 ' A' ' 104' ' ' LEU . 14.4 mt -135.45 112.98 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.593 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -103.54 136.37 43.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 109.759 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.6 t -131.91 158.67 40.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.976 . . . . 0.0 110.575 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 88.5 m -155.98 142.26 18.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 110.097 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.1 t -140.12 155.26 47.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.364 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.725 ' CE1' HG23 ' A' ' 4' ' ' THR . 64.4 m-70 -133.36 168.12 19.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.177 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.876 ' O ' HG13 ' A' ' 2' ' ' VAL . 32.0 m-85 -127.06 146.06 50.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.326 -0.859 . . . . 0.0 110.639 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 97.4 m-70 -127.18 92.07 3.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.702 HG21 ' O ' ' A' ' 126' ' ' VAL . 1.8 p -63.01 161.15 13.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.36 -0.837 . . . . 0.0 110.612 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 34.8 tttm -126.27 124.65 40.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.417 -0.802 . . . . 0.0 110.044 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 125' ' ' ASN . . . 93.48 22.61 26.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 11.9 t30 64.61 50.48 2.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -1.083 . . . . 0.0 110.304 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.702 ' O ' HG21 ' A' ' 122' ' ' THR . 72.3 t -119.51 174.64 4.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.414 -0.804 . . . . 0.0 109.818 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.668 ' HA ' HG21 ' A' ' 122' ' ' THR . 81.3 mt-10 -127.26 153.16 46.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.174 -0.954 . . . . 0.0 110.094 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.599 HG22 ' N ' ' A' ' 129' ' ' LYS . 3.4 mp -82.05 173.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.837 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.599 ' N ' HG22 ' A' ' 128' ' ' ILE . 88.4 mttt -96.42 133.86 40.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 110.189 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.558 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 93.1 mt-10 -51.7 -49.35 62.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.139 -0.976 . . . . 0.0 110.051 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.49 -34.09 64.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.896 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.869 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 12.6 t-160 -71.81 -53.04 14.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.355 -0.84 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.015 HG21 ' CE2' ' A' ' 5' ' ' TYR . 6.0 p -60.89 -35.32 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 110.023 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 81.4 tttt -70.99 -43.9 67.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.847 . . . . 0.0 109.884 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.92 91.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.936 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.81 -31.63 78.91 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.499 ' HE3' HG22 ' A' ' 133' ' ' VAL . 95.2 mttt -63.06 -32.76 74.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.341 -1.094 . . . . 0.0 109.945 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.471 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 79.8 mt-10 -70.78 -35.12 72.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.845 . . . . 0.0 109.84 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.37 -42.83 87.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.388 -0.82 . . . . 0.0 109.875 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -70.73 -41.23 72.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.926 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.5 m -67.86 -53.71 24.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.781 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.2 m-20 -54.2 -40.07 67.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -0.905 . . . . 0.0 109.742 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.468 ' HG ' HD11 ' A' ' 147' ' ' ILE . 16.1 tp -60.98 -47.26 87.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.778 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 18.0 m-85 -53.6 -38.16 63.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.393 -0.817 . . . . 0.0 109.555 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -79.59 -17.11 54.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.225 -0.922 . . . . 0.0 109.671 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.67 ' HB3' HG21 ' A' ' 33' ' ' ILE . 26.8 mt -83.38 -35.52 25.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.291 -0.881 . . . . 0.0 108.625 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.574 HD11 ' CE1' ' A' ' 22' ' ' PHE . 27.3 mt -70.88 -46.65 67.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 13' ' ' ILE . 57.9 mt-10 -58.23 -38.77 77.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.664 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.404 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 99.8 m -70.32 -38.33 74.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.781 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.634 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.3 t80 -54.36 -48.21 71.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 110.014 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.176 HD21 ' CE2' ' A' ' 158' ' ' TYR . 92.0 mt -79.55 -30.15 41.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.545 ' CD ' HD11 ' A' ' 13' ' ' ILE . 47.4 tptt -73.9 -21.31 60.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.91 . . . . 0.0 109.463 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.47 -31.88 3.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 5.2 m80 -110.73 93.45 16.9 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.355 -1.085 . . . . 0.0 110.059 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.415 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.4 Cg_endo -74.35 6.72 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.997 1.525 . . . . 0.0 111.035 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -108.72 1.42 21.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.053 -1.029 . . . . 0.0 109.764 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.634 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -81.87 104.5 12.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.365 -0.834 . . . . 0.0 110.196 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.176 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 34.9 32.17 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.691 -0.63 . . . . 0.0 110.528 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.735 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 120' ' ' TYR . 77.7 t -122.26 120.15 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -1.171 . . . . 0.0 110.265 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.6 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 94.2 m-85 -77.41 144.85 37.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.137 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.607 HG23 ' CE1' ' A' ' 119' ' ' HIS . 41.3 m -127.82 125.1 39.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 110.155 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.122 ' CE2' HG21 ' A' ' 133' ' ' VAL . 68.5 m-85 -134.47 159.13 42.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.237 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.7 pt-20 -151.28 152.48 33.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.886 . . . . 0.0 110.19 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 116' ' ' SER . 55.4 p -134.99 145.99 48.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.031 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 86.6 mt-10 -130.32 119.46 22.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.34 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.5 p90 -145.42 -175.98 4.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.834 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.678 HG22 HG12 ' A' ' 113' ' ' ILE . 18.4 p -136.56 -179.56 5.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.134 -0.979 . . . . 0.0 110.57 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.515 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 14.8 t -156.79 168.27 27.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 110.358 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.52 -16.24 24.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.972 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.837 HG23 ' HD2' ' A' ' 14' ' ' PRO . 6.8 mm -89.67 151.36 45.65 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.98 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.837 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.2 Cg_endo -64.74 145.28 86.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.053 1.554 . . . . 0.0 110.453 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -72.29 -31.63 11.41 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.028 1.541 . . . . 0.0 112.954 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.5 Cg_endo -69.33 -19.83 37.64 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 N-CA-C 110.148 -0.751 . . . . 0.0 110.148 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 4.2 mmp_? -85.65 -47.77 9.5 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.773 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.4 tt -67.3 -25.61 66.12 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 74' ' ' ILE . 82.6 t80 -68.57 -58.68 3.92 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.505 0.669 . . . . 0.0 109.463 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 47.9 mttt -52.18 -30.47 27.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.159 0.98 . . . . 0.0 108.399 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.974 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.8 -63.53 1.24 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.677 0.751 . . . . 0.0 110.96 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.026 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -57.83 -35.64 71.15 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 111.459 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.125 HG11 ' CD1' ' A' ' 74' ' ' ILE . 20.1 t -104.62 -67.85 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.118 . . . . 0.0 111.493 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.626 ' N ' HD22 ' A' ' 24' ' ' LEU . 4.0 mm? -65.29 -6.13 9.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 111.19 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -144.15 19.85 1.76 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.901 -1.124 . . . . 0.0 110.585 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.026 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -54.97 -34.44 63.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 110.164 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.54 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 89.6 m-20 -69.47 -12.0 61.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 110.279 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.507 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.7 m-20 -126.72 -4.98 6.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 110.3 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -85.86 -46.78 10.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.124 -0.985 . . . . 0.0 110.294 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.813 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.3 t -75.92 -42.01 3.51 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.885 . . . . 0.0 111.13 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.5 Cg_endo -77.86 9.71 2.89 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.402 1.212 . . . . 0.0 110.855 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HG2' ' OH ' ' A' ' 150' ' ' TYR . 37.3 tptt -123.16 -28.69 3.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.614 HG12 ' CD1' ' A' ' 150' ' ' TYR . 9.6 mt -80.08 -47.21 21.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.447 -0.783 . . . . 0.0 109.499 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.0 101.96 4.17 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.486 -0.759 . . . . 0.0 109.981 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.34 0.05 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.023 1.538 . . . . 0.0 110.715 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -83.53 -13.04 55.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 109.419 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.456 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -101.96 -62.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.994 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.813 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.8 mp -108.98 132.11 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.451 -0.781 . . . . 0.0 110.001 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HE2' ' HB ' ' A' ' 57' ' ' THR . 31.7 ttpt -83.33 -38.07 22.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.0 110.416 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.443 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -174.55 141.42 0.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.165 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.54 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 7.3 m -107.03 135.92 47.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.041 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 55.2 tt0 -136.31 109.15 7.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.3 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 9.1 mt -62.43 130.55 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.462 ' CD1' ' O ' ' A' ' 42' ' ' GLU . 10.6 mp -94.59 -41.99 9.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.38 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.898 ' O ' HG23 ' A' ' 52' ' ' THR . 5.3 mt-10 -132.91 142.79 49.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.134 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.4 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 77.99 -170.2 54.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -124.82 6.58 8.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 110.215 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.556 ' N ' HG21 ' A' ' 52' ' ' THR . . . 130.32 -4.82 5.95 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.528 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -85.39 -164.68 39.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.38 132.03 21.53 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.153 1.607 . . . . 0.0 110.418 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.69 69.99 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.898 HG23 ' O ' ' A' ' 45' ' ' GLU . 29.6 m -80.06 136.47 36.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -1.155 . . . . 0.0 109.857 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.708 HG21 ' HE3' ' A' ' 68' ' ' LYS . 20.5 mm -107.15 117.97 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 110.17 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 87.2 mttt -105.2 145.9 29.99 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.3 -0.875 . . . . 0.0 110.496 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -118.88 101.43 8.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 110.058 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.74 141.99 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.883 . . . . 0.0 110.444 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.8 p -110.27 153.19 25.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 109.965 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.769 ' HE2' HG13 ' A' ' 67' ' ' VAL . 24.5 m-85 -111.75 123.95 51.32 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.0 111.001 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 2.6 t80 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.233 0.54 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -126.32 99.05 0.54 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.508 ' CD2' ' CD2' ' A' ' 64' ' ' TYR . 33.2 p90 -138.83 169.98 16.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.134 -1.216 . . . . 0.0 110.369 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.921 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.9 m -137.49 173.44 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 110.563 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.708 ' HE3' HG21 ' A' ' 53' ' ' ILE . 37.8 tttt -122.81 127.96 49.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.596 -0.69 . . . . 0.0 109.43 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.83 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -117.32 126.37 52.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.965 . . . . 0.0 111.035 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HA ' HD13 ' A' ' 53' ' ' ILE . 84.1 tttt -106.01 118.04 35.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.287 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.536 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.0 mm -57.34 135.03 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.93 . . . . 0.0 110.454 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.51 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 9.5 t0 -107.05 -39.47 5.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.794 . . . . 0.0 109.795 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 0.7 OUTLIER 171.95 161.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.537 -0.727 . . . . 0.0 109.957 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.125 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.1 tt -154.64 163.51 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.224 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -125.84 78.01 1.71 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.259 -0.9 . . . . 0.0 109.671 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.592 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 86.3 mttt -53.94 -15.26 1.29 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.331 -0.855 . . . . 0.0 110.863 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -91.76 -32.39 15.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 109.788 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.4 m120 -107.83 -4.51 17.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.639 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.636 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 6.5 m-85 69.22 49.07 0.63 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.322 0.582 . . . . 0.0 110.543 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.547 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -118.43 147.18 43.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 109.107 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.681 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 79.7 t80 -141.49 142.89 33.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.02 . . . . 0.0 110.617 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.447 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 61.1 m -147.14 128.21 14.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 110.007 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.681 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 3.9 p90 -137.07 -176.71 4.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.062 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.4 m -135.41 140.07 44.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.296 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.83 HD13 ' CE1' ' A' ' 69' ' ' HIS . 49.0 tp -100.47 128.67 46.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.964 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.537 HD11 ' HE2' ' A' ' 68' ' ' LYS . 16.5 pt -118.73 -7.7 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.366 -0.834 . . . . 0.0 110.246 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 79.7 tt0 -146.05 135.27 22.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.921 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 174.35 159.9 21.54 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 46.1 p-10 -71.29 -7.73 48.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -1.159 . . . . 0.0 110.285 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.455 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -79.07 -46.14 18.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.612 HD22 ' O ' ' A' ' 96' ' ' GLU . 19.6 mt -40.96 -46.42 2.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.595 -0.691 . . . . 0.0 110.224 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 41.31 -132.73 3.41 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.746 ' OD1' HG23 ' A' ' 94' ' ' THR . 57.5 p-10 -115.89 21.72 13.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -1.104 . . . . 0.0 110.062 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.746 HG23 ' OD1' ' A' ' 93' ' ' ASP . 72.5 p -122.4 -41.58 2.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -0.866 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.056 HD21 HD11 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -114.41 163.35 15.44 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.341 -0.85 . . . . 0.0 109.141 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.805 ' H ' HD12 ' A' ' 95' ' ' LEU . 28.1 tp10 -142.03 -79.54 0.24 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.135 -0.978 . . . . 0.0 110.282 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.559 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 21.2 mtpt -80.18 151.66 29.59 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.616 -0.677 . . . . 0.0 109.845 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.056 HD11 HD21 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -146.62 135.37 16.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.063 -1.023 . . . . 0.0 109.819 179.527 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 5.1 m -114.99 118.41 33.34 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.43 -0.794 . . . . 0.0 109.597 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.621 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.7 m-85 -110.39 137.74 47.7 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.469 -0.769 . . . . 0.0 110.173 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 76.9 tt0 -132.85 143.18 49.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.203 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.6 m -139.39 135.67 33.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -128.31 138.89 52.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.823 HD23 HG12 ' A' ' 114' ' ' ILE . 6.5 mt -118.56 149.76 40.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.197 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.03 -169.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 109.961 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.2 125.7 45.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.972 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.47 ' HB3' ' CG1' ' A' ' 113' ' ' ILE . 3.2 p -80.15 170.36 16.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 110.219 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 50.7 Cg_endo -83.52 22.47 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.056 1.556 . . . . 0.0 110.966 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.5 p -127.89 4.03 5.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.938 -1.101 . . . . 0.0 110.412 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.16 -25.74 25.21 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.46 -174.33 43.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.52 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 19.9 p -124.35 131.32 53.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -1.201 . . . . 0.0 110.37 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.678 HG12 HG22 ' A' ' 10' ' ' THR . 84.8 mt -82.82 149.68 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 110.195 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.823 HG12 HD23 ' A' ' 104' ' ' LEU . 7.6 mt -133.68 128.82 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 110.359 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 85.9 tttt -118.66 111.11 18.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.315 -0.865 . . . . 0.0 109.781 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.44 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 1.4 m -101.58 162.31 13.0 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.158 -0.964 . . . . 0.0 110.834 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 53.7 m -160.05 132.65 6.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.44 -0.787 . . . . 0.0 109.773 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.1 p -132.58 159.11 40.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.107 -0.995 . . . . 0.0 110.745 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.607 ' CE1' HG23 ' A' ' 4' ' ' THR . 60.7 m-70 -141.37 155.37 45.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.419 -0.8 . . . . 0.0 110.038 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.653 ' O ' HG13 ' A' ' 2' ' ' VAL . 28.2 m-85 -119.03 138.07 53.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.39 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.559 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 95.4 m-70 -119.32 93.13 3.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 109.675 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.864 HG21 ' HA ' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -62.86 159.22 17.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.156 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 43.7 tttm -142.7 128.34 19.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 110.19 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 93.31 26.38 16.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 8.2 t30 64.91 65.96 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -1.189 . . . . 0.0 110.173 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.615 ' O ' HG21 ' A' ' 122' ' ' THR . 7.0 m -144.37 171.21 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.864 ' HA ' HG21 ' A' ' 122' ' ' THR . 86.5 mt-10 -140.25 152.37 45.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.215 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 129' ' ' LYS . 4.9 mp -81.89 173.53 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 109.964 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.591 ' N ' HG22 ' A' ' 128' ' ' ILE . 57.0 mttt -104.85 132.15 51.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.229 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.449 ' HA ' HG12 ' A' ' 133' ' ' VAL . 52.1 mt-10 -48.48 -39.79 24.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 110.101 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.01 -30.39 70.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.948 . . . . 0.0 109.882 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -75.34 -50.97 14.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 110.18 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.122 HG21 ' CE2' ' A' ' 5' ' ' TYR . 10.3 p -65.47 -41.81 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 110.038 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.551 ' N ' HG13 ' A' ' 133' ' ' VAL . 72.5 mmtt -63.04 -40.02 96.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.979 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.54 -34.69 72.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.831 . . . . 0.0 110.0 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 139' ' ' LYS . . . -73.08 -29.76 64.17 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -73.71 -32.95 64.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -1.08 . . . . 0.0 110.076 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -70.28 -54.73 11.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 109.948 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 136' ' ' GLY . 20.7 ptmt -56.54 -28.49 60.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.795 . . . . 0.0 109.866 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.81 -45.88 70.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.051 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -61.96 -40.88 97.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.978 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -62.07 -41.42 98.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 147' ' ' ILE . 30.1 mt -61.1 -41.22 96.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.934 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -61.54 -33.21 73.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.416 -0.802 . . . . 0.0 109.951 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 47.4 tptt -80.02 -19.05 48.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 110.26 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 146' ' ' LEU . 13.4 mt -79.95 -35.16 38.08 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.104 -0.997 . . . . 0.0 108.515 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.652 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 67.4 mt -70.67 -51.73 34.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 13' ' ' ILE . 78.0 mt-10 -49.41 -34.67 16.98 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.288 -0.883 . . . . 0.0 109.016 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.4 m -79.99 -28.33 39.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -0.916 . . . . 0.0 109.296 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.634 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.7 t80 -61.36 -54.07 48.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.561 -0.712 . . . . 0.0 109.977 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.192 HD21 ' CE2' ' A' ' 158' ' ' TYR . 59.0 mt -69.56 -27.96 65.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 110.077 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.454 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 57.3 tptt -74.04 -29.39 61.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 109.727 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -101.33 -29.15 6.45 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 9.1 m80 -107.15 90.98 6.05 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.447 -1.031 . . . . 0.0 109.7 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.5 Cg_endo -73.54 5.22 3.4 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.009 1.531 . . . . 0.0 111.025 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 44.3 p30 -109.82 -9.37 14.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.013 -1.054 . . . . 0.0 109.685 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.634 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -69.36 99.62 1.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.477 -0.764 . . . . 0.0 110.091 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.192 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.9 31.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.727 -0.608 . . . . 0.0 110.554 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.799 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.039 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.5 p -79.86 145.64 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -1.206 . . . . 0.0 110.563 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 77.5 m-85 -93.18 167.7 11.59 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.332 -0.855 . . . . 0.0 110.242 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.731 HG23 ' CD2' ' A' ' 119' ' ' HIS . 91.9 m -131.39 110.84 11.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.944 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CZ ' HG22 ' A' ' 133' ' ' VAL . 24.3 m-85 -113.18 125.34 54.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 110.085 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.5 pt-20 -133.13 152.94 51.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 110.085 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.2 t -128.52 155.81 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.359 -0.838 . . . . 0.0 110.172 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 76.0 mt-10 -136.0 118.03 15.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.333 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.2 p90 -147.24 -170.98 3.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.939 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 113' ' ' ILE . 18.2 p -140.64 -179.44 6.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 110.561 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 3.2 t -156.74 160.12 38.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.759 . . . . 0.0 110.165 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -84.7 -16.12 42.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.853 . . . . 0.0 110.251 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.789 HG23 ' HD2' ' A' ' 14' ' ' PRO . 7.4 mm -87.61 149.96 47.47 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 110.135 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.789 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.13 149.02 89.49 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.098 1.578 . . . . 0.0 110.412 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.677 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 Cg_endo -70.14 -32.72 16.46 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.899 1.473 . . . . 0.0 113.0 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.0 Cg_endo -68.0 -21.75 42.82 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 122.504 0.739 . . . . 0.0 110.207 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.676 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -83.65 -46.78 11.95 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.132 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.757 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -69.07 -28.33 66.42 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.635 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 62.6 t80 -66.04 -59.34 3.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.468 -0.77 . . . . 0.0 109.514 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 51.2 mttp -51.6 -34.79 38.88 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.521 -0.737 . . . . 0.0 109.604 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.04 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -75.29 -55.5 5.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.391 -0.818 . . . . 0.0 111.152 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.039 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -59.77 -45.51 92.05 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.48 -0.762 . . . . 0.0 111.738 -178.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.713 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.7 t -97.37 -66.3 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.02 -1.05 . . . . 0.0 111.392 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.6 mm? -64.44 -5.97 6.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.262 -0.899 . . . . 0.0 111.444 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.687 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -143.79 25.88 1.6 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.862 -1.149 . . . . 0.0 110.849 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.039 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -66.37 -30.02 70.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 110.195 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.56 -12.77 61.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.501 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 72.5 m-20 -129.1 6.32 5.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 110.118 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -92.99 -53.35 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -0.832 . . . . 0.0 110.056 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.01 HG11 HD13 ' A' ' 38' ' ' ILE . 17.1 t -67.2 -41.42 33.97 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 111.176 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -76.91 6.03 4.5 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.334 1.176 . . . . 0.0 110.881 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 66.6 mttt -127.54 -31.84 2.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 109.787 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.621 HD11 ' CD1' ' A' ' 29' ' ' LEU . 16.0 mt -79.89 -43.17 22.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.462 -0.774 . . . . 0.0 109.775 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.7 91.8 3.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.0 110.188 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.26 3.51 5.69 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.114 1.586 . . . . 0.0 110.594 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -87.23 -19.9 27.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.134 -0.979 . . . . 0.0 110.061 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.38 -40.77 8.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 110.201 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.01 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mt -125.72 145.99 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.447 -0.783 . . . . 0.0 110.047 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.461 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 28.2 ttpt -80.93 -46.36 15.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 110.32 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -176.93 158.88 1.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.88 . . . . 0.0 110.038 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -113.01 120.57 41.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.945 . . . . 0.0 110.162 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.479 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 32.0 tt0 -121.46 102.08 8.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.003 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 37.6 mt -50.7 129.32 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.307 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.662 HD23 HG21 ' A' ' 53' ' ' ILE . 19.9 tp -91.72 -40.07 11.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.468 -0.77 . . . . 0.0 110.354 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.879 ' O ' HG23 ' A' ' 52' ' ' THR . 2.9 mt-10 -138.32 138.02 37.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 110.172 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 47' ' ' ASP . . . 82.21 -159.53 39.32 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 87.1 m-20 -138.24 9.55 2.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -1.192 . . . . 0.0 110.348 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.621 ' N ' HG21 ' A' ' 52' ' ' THR . . . 130.29 -2.94 5.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -87.6 -168.49 44.62 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -69.82 137.74 35.98 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.091 1.574 . . . . 0.0 110.507 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.93 -5.47 85.04 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.879 HG23 ' O ' ' A' ' 45' ' ' GLU . 18.0 m -80.0 138.94 37.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -1.177 . . . . 0.0 109.998 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.662 HG21 HD23 ' A' ' 44' ' ' LEU . 32.2 mm -105.15 127.58 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.0 110.001 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 93.5 mttt -110.39 126.71 54.56 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 110.019 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.638 ' HD3' HD13 ' A' ' 44' ' ' LEU . 43.4 mtmt -99.15 98.12 9.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.139 -0.976 . . . . 0.0 110.589 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.535 ' CG2' HG12 ' A' ' 38' ' ' ILE . 96.4 mt -87.07 146.71 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.155 -0.966 . . . . 0.0 109.66 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 38' ' ' ILE . 5.4 p -118.76 153.16 34.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.124 -0.985 . . . . 0.0 111.116 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.626 ' HE2' HG13 ' A' ' 67' ' ' VAL . 25.5 m-85 -117.44 138.47 51.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.509 -0.745 . . . . 0.0 109.973 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.849 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.21 0.529 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -115.2 93.28 0.62 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.541 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.4 p90 -128.96 164.91 22.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -1.228 . . . . 0.0 110.234 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.734 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.9 m -134.63 175.28 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 0.0 110.486 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.664 ' O ' HD12 ' A' ' 85' ' ' LEU . 59.5 mttt -133.15 106.46 7.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.46 -0.775 . . . . 0.0 109.701 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.989 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.0 m170 -98.16 128.44 44.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 111.023 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.625 ' HA ' HD13 ' A' ' 53' ' ' ILE . 54.6 tttm -101.88 109.56 21.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.329 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.507 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.0 mm -42.59 140.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.341 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.521 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 23.9 t0 -111.43 -48.87 3.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.527 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.485 ' N ' ' OG ' ' A' ' 82' ' ' SER . 8.7 m -165.88 156.16 12.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.527 -0.733 . . . . 0.0 109.746 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 mt -138.36 153.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.396 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.7 m-20 -141.7 80.74 1.74 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.517 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 34.4 tttt -65.65 -13.32 58.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.179 -0.951 . . . . 0.0 109.853 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -89.94 -30.87 17.54 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.803 0.811 . . . . 0.0 109.013 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.0 m120 -106.91 -2.98 20.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.757 ' O ' HD12 ' A' ' 104' ' ' LEU . 73.8 m-85 60.94 54.35 3.47 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.652 0.739 . . . . 0.0 110.167 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -127.26 156.53 41.75 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.637 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.713 ' CE1' HG13 ' A' ' 23' ' ' VAL . 27.6 t80 -142.83 137.38 29.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.947 . . . . 0.0 110.003 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.485 ' OG ' ' N ' ' A' ' 73' ' ' SER . 13.9 p -143.87 124.18 13.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.112 -0.993 . . . . 0.0 111.263 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 13.7 p90 -137.73 172.53 12.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 110.23 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 98' ' ' ILE . 97.1 m -129.39 134.52 47.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.332 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.989 HD13 ' CD2' ' A' ' 69' ' ' HIS . 11.7 tp -101.5 133.78 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.05 -1.031 . . . . 0.0 110.221 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 85' ' ' LEU . 13.8 pt -113.11 -30.88 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.458 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.644 ' O ' HD11 ' A' ' 85' ' ' LEU . 70.1 tt0 -119.41 157.35 28.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.258 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.734 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 159.05 140.69 2.96 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.415 ' OD2' ' HA2' ' A' ' 65' ' ' GLY . 98.3 m-20 -69.6 -25.58 64.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -1.148 . . . . 0.0 110.139 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.08 -26.61 61.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.146 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 88' ' ' GLY . 15.5 mt -63.22 -31.59 72.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 110.104 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.54 -174.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 52.8 t0 -77.1 -1.02 26.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.138 . . . . 0.0 110.057 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 122' ' ' THR . 43.2 p -87.82 -41.96 12.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 110.056 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.062 HD21 ' CG1' ' A' ' 128' ' ' ILE . 68.4 mt -98.25 153.55 18.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.815 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 35.4 tt0 -137.24 -83.33 0.34 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.301 -0.874 . . . . 0.0 109.629 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.485 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 96.0 mttt -80.35 125.02 29.38 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.75 -0.594 . . . . 0.0 110.447 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.843 ' O ' HG23 ' A' ' 84' ' ' THR . 3.3 mm -116.86 135.01 58.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.789 -1.195 . . . . 0.0 109.827 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -120.89 127.07 51.53 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.644 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.1 m-85 -119.61 134.43 55.23 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.326 -0.859 . . . . 0.0 110.573 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.491 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 26.5 tt0 -137.16 133.58 35.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.427 -0.796 . . . . 0.0 109.92 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 54.5 m -134.35 144.1 48.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 110.361 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -135.25 146.93 49.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 110.256 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.769 HD23 HG12 ' A' ' 114' ' ' ILE . 6.1 mt -119.22 153.73 34.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.339 -0.851 . . . . 0.0 110.433 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.717 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.94 -168.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.289 -0.882 . . . . 0.0 109.93 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.717 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.88 128.19 51.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 110.27 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.567 ' HA ' HD11 ' A' ' 113' ' ' ILE . 87.2 p -81.47 160.02 65.72 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.181 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -2.26 11.45 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.082 1.569 . . . . 0.0 110.547 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.4 p -103.07 4.82 37.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.351 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.62 -34.38 5.82 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.09 -174.18 6.51 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 23.6 p -123.66 135.82 54.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 107' ' ' SER . 23.4 mt -87.04 150.41 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.769 HG12 HD23 ' A' ' 104' ' ' LEU . 7.0 mt -132.85 117.67 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.178 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.487 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 80.8 tttt -110.05 109.69 20.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 110.079 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 8.6 m -97.6 164.21 12.52 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.173 -0.954 . . . . 0.0 110.474 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 29.4 m -160.01 126.17 4.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.411 -0.805 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.0 m -128.37 156.95 42.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.163 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.731 ' CD2' HG23 ' A' ' 4' ' ' THR . 37.2 m80 -129.24 136.31 49.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -0.93 . . . . 0.0 110.255 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 1.039 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.0 m-30 -109.59 111.69 23.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.962 . . . . 0.0 111.169 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.673 ' CE1' HG21 ' A' ' 2' ' ' VAL . 90.3 m-70 -99.09 117.38 33.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.196 -0.94 . . . . 0.0 109.514 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 94' ' ' THR . 0.7 OUTLIER -87.27 138.76 31.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 110.569 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 74.1 tttt -72.3 123.1 22.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 110.223 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.48 -128.86 8.71 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -121.09 51.72 1.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -1.188 . . . . 0.0 110.12 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 127' ' ' GLU . 85.9 t -94.61 174.6 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.416 -0.802 . . . . 0.0 110.02 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.605 ' N ' HG12 ' A' ' 126' ' ' VAL . 45.8 mt-10 -143.16 125.73 15.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 110.408 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.062 ' CG1' HD21 ' A' ' 95' ' ' LEU . 1.8 mp -60.45 174.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.855 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.608 ' N ' HG22 ' A' ' 128' ' ' ILE . 62.3 mttt -100.7 151.52 21.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.26 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -66.55 -34.29 77.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.199 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 132' ' ' HIS . 22.2 pt-20 -68.26 -36.96 80.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 110.198 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.445 ' N ' ' CG ' ' A' ' 131' ' ' GLU . 17.8 t-160 -67.79 -33.53 75.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.648 HG22 ' CZ ' ' A' ' 5' ' ' TYR . 89.3 t -67.85 -43.77 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.22 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -73.83 -43.0 60.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.003 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.72 91.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.083 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.92 -26.3 73.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -75.99 -31.94 59.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -1.156 . . . . 0.0 110.144 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -79.02 -28.55 43.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.125 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.99 -32.86 59.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.71 -33.29 46.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.5 t -64.58 -45.29 87.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.165 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -52.81 -48.72 66.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.03 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 143' ' ' LEU . 19.3 tp -55.89 -48.59 75.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.941 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.427 ' O ' ' CD ' ' A' ' 148' ' ' GLU . 25.8 m-85 -54.4 -39.77 67.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.807 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.439 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 42.7 tttm -79.81 -14.03 58.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.473 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 17.8 mt -83.97 -37.69 21.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.1 -1.0 . . . . 0.0 108.954 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.765 HD13 ' CD1' ' A' ' 22' ' ' PHE . 75.6 mt -71.21 -44.1 74.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.822 -0.751 . . . . 0.0 108.983 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' HG13 ' A' ' 13' ' ' ILE . 65.0 mt-10 -56.62 -36.24 69.23 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.435 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.6 m -76.68 -30.57 56.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.926 . . . . 0.0 109.511 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.648 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 89.9 t80 -57.38 -48.19 79.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.54 -0.725 . . . . 0.0 110.045 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.128 HD21 ' CE1' ' A' ' 158' ' ' TYR . 72.1 mt -76.48 -38.53 55.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 110.065 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.42 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 83.8 tttt -61.23 -14.83 28.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.374 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -116.52 -28.13 2.63 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -109.08 93.91 13.86 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.333 -1.098 . . . . 0.0 110.058 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.8 4.24 4.28 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.028 1.541 . . . . 0.0 110.961 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -113.77 -6.56 13.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.124 -0.985 . . . . 0.0 110.047 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.685 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -67.03 102.67 1.03 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.128 ' CE1' HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.65 32.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.741 -0.599 . . . . 0.0 110.604 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.511 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.756 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 77.1 t -114.13 109.33 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.195 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.61 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 82.6 m-85 -77.48 144.86 37.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 110.298 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.76 HG23 ' CE1' ' A' ' 119' ' ' HIS . 95.4 m -122.71 115.77 22.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 110.396 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.778 ' CE2' HG21 ' A' ' 133' ' ' VAL . 67.2 m-85 -124.08 154.54 39.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.897 . . . . 0.0 109.951 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 13.6 pt-20 -147.3 151.4 36.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 0.0 110.566 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 m -137.36 144.21 42.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.777 . . . . 0.0 109.456 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -132.82 143.46 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.114 -0.991 . . . . 0.0 110.928 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.605 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.3 p90 -158.79 -176.04 5.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.57 -0.706 . . . . 0.0 109.492 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.6 HG22 HG12 ' A' ' 113' ' ' ILE . 21.1 p -135.64 -179.46 5.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.041 -1.037 . . . . 0.0 110.764 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 10.0 t -159.96 167.16 28.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.529 -0.732 . . . . 0.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -98.38 9.81 42.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 109.972 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.816 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.7 mp -107.75 149.88 39.54 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.033 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.816 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.81 143.19 72.71 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.081 1.569 . . . . 0.0 110.554 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.676 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.9 Cg_endo -71.82 -31.67 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 124.027 1.541 . . . . 0.0 112.804 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.9 Cg_endo -67.94 -21.93 42.92 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 O-C-N 122.468 0.72 . . . . 0.0 110.322 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.529 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 8.7 mmp_? -83.91 -46.99 11.51 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.845 HD22 ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -68.25 -29.3 68.08 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.551 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.0 t80 -66.3 -56.16 12.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.863 . . . . 0.0 109.9 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.529 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 76.1 mttt -53.92 -32.1 52.37 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.947 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -73.18 -64.82 0.9 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.713 0.768 . . . . 0.0 111.11 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.072 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -56.97 -39.08 73.93 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.634 -0.666 . . . . 0.0 112.228 -178.128 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.542 ' HB ' HD12 ' A' ' 24' ' ' LEU . 5.5 t -101.77 -58.03 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.777 -1.202 . . . . 0.0 111.578 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.751 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.4 mp -78.14 0.1 26.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.079 -1.013 . . . . 0.0 111.331 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.596 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -147.3 15.17 1.14 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.944 -1.098 . . . . 0.0 110.556 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.072 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -53.85 -39.88 66.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.95 . . . . 0.0 109.916 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 65.2 t0 -64.42 -14.19 55.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 109.907 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.526 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.2 m-20 -127.3 0.19 6.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.369 -0.832 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -88.09 -45.52 10.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.355 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.054 ' CG1' HD13 ' A' ' 38' ' ' ILE . 31.2 t -72.89 -40.36 6.1 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.263 -0.898 . . . . 0.0 111.482 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -77.44 10.11 2.61 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.329 1.173 . . . . 0.0 111.113 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 49.6 mttt -122.77 -25.77 4.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.054 -1.029 . . . . 0.0 109.628 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.605 HG12 ' CD1' ' A' ' 150' ' ' TYR . 28.7 mt -79.99 -49.86 18.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.475 -0.765 . . . . 0.0 109.926 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.37 104.02 2.21 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.383 -0.823 . . . . 0.0 110.128 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.17 1.01 6.46 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.02 1.537 . . . . 0.0 110.794 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -83.54 -14.41 52.28 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.36 -53.88 3.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 110.071 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.054 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.1 mp -117.65 149.02 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.453 -0.779 . . . . 0.0 110.017 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -85.35 -42.3 14.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.861 . . . . 0.0 110.41 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.461 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.4 OUTLIER -178.77 141.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 110.369 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.477 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 38.6 m -97.84 134.3 41.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 110.093 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -137.26 110.98 8.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.211 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 37.2 mt -60.71 131.7 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.277 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 81.2 mt -92.18 -26.45 18.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.148 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 1.064 ' O ' HG23 ' A' ' 52' ' ' THR . 38.8 tt0 -151.41 173.53 14.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.895 . . . . 0.0 110.085 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.01 -155.23 2.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -147.97 34.17 0.83 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 110.22 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.709 ' H ' HG21 ' A' ' 52' ' ' THR . . . 108.5 -9.29 35.3 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.429 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -81.41 -172.84 47.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.9 Cg_endo -71.1 137.97 32.64 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 124.173 1.617 . . . . 0.0 110.464 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.84 -4.8 83.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 1.064 HG23 ' O ' ' A' ' 45' ' ' GLU . 27.3 m -79.98 146.38 32.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -1.193 . . . . 0.0 110.116 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 70' ' ' LYS . 32.3 mm -113.38 110.21 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 110.154 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.756 ' NZ ' ' HB3' ' A' ' 26' ' ' ALA . 46.2 mtpt -93.11 141.99 27.8 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 110.474 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 83.3 tttt -111.7 113.26 25.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.091 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.555 ' CG2' HG12 ' A' ' 38' ' ' ILE . 62.6 mt -102.97 138.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 110.118 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 38' ' ' ILE . 1.6 p -114.03 152.53 30.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 110.562 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 30.5 m-85 -112.88 137.6 50.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.333 -0.854 . . . . 0.0 110.079 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.926 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.266 0.555 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -131.92 90.8 0.28 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.53 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 17.5 p90 -138.73 168.15 20.42 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.201 -1.176 . . . . 0.0 110.402 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.903 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.4 m -137.49 172.72 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.449 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.56 ' CB ' ' CG1' ' A' ' 86' ' ' ILE . 91.7 mttt -123.95 131.44 53.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.593 -0.692 . . . . 0.0 109.719 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.494 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -111.43 138.42 47.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.132 -0.98 . . . . 0.0 110.532 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.546 ' HA ' HD13 ' A' ' 53' ' ' ILE . 82.0 tttt -114.93 107.82 15.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.436 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 50' ' ' PRO . 33.4 mm -53.2 122.43 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 110.489 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.8 m-20 -94.89 -40.71 9.57 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.534 -0.729 . . . . 0.0 109.543 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 m -176.63 158.76 1.77 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.514 -0.741 . . . . 0.0 109.558 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.402 HG12 ' HD1' ' A' ' 81' ' ' TYR . 2.4 mt -138.16 159.32 32.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.25 -0.907 . . . . 0.0 110.124 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -145.63 83.85 1.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.574 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.551 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 86.0 tttt -68.18 -13.42 62.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 110.168 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -85.47 -30.38 23.53 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m120 -109.44 -3.68 16.86 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.541 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 48.4 m-85 63.36 52.02 2.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.666 -0.646 . . . . 0.0 110.359 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 13.5 t -121.59 174.34 6.85 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.152 -0.968 . . . . 0.0 110.208 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.528 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 21.0 t80 -157.77 146.55 19.39 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.149 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 50.6 m -149.98 125.24 10.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.042 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 6.7 p90 -142.49 176.45 9.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.404 -0.81 . . . . 0.0 109.862 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.93 HG23 ' O ' ' A' ' 98' ' ' ILE . 53.1 m -135.54 141.54 45.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.591 ' CB ' ' HB ' ' A' ' 98' ' ' ILE . 9.2 tp -87.66 120.27 28.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.233 -0.917 . . . . 0.0 110.247 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.56 ' CG1' ' CB ' ' A' ' 68' ' ' LYS . 24.3 pt -100.63 -12.04 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.425 -0.797 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 71.0 tt0 -153.46 145.54 23.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.479 -0.763 . . . . 0.0 110.203 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.903 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 174.77 165.93 31.89 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 29.7 p-10 -79.9 -44.79 19.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -1.173 . . . . 0.0 110.522 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.825 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -50.8 -40.69 56.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 110.155 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.564 HD22 ' O ' ' A' ' 96' ' ' GLU . 38.0 mt -40.42 -50.45 2.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.575 -0.703 . . . . 0.0 110.339 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.41 -166.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -81.5 5.21 18.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -1.132 . . . . 0.0 110.139 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 55.3 p -97.69 -45.85 6.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.393 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.784 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -118.4 163.06 17.29 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.112 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.784 ' H ' HD12 ' A' ' 95' ' ' LEU . 62.7 tt0 -140.79 -79.79 0.27 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.527 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 33.8 mttt -80.28 145.95 31.89 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 110.735 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.93 ' O ' HG23 ' A' ' 84' ' ' THR . 25.4 mm -134.49 150.98 31.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.123 -0.985 . . . . 0.0 109.57 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -123.89 124.39 42.52 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.7 178.377 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.853 ' CE2' HG21 ' A' ' 98' ' ' ILE . 19.7 m-85 -117.86 134.64 54.73 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.32 -0.863 . . . . 0.0 110.625 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 117' ' ' THR . 6.0 mt-10 -134.36 126.43 29.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.821 . . . . 0.0 109.99 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 86.8 m -119.88 147.87 44.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.972 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LYS . 23.7 mttt -140.33 133.81 30.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 110.51 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.792 HD23 HG12 ' A' ' 114' ' ' ILE . 5.8 mt -112.71 151.81 29.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 110.185 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.36 -169.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.0 109.97 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.71 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -127.41 131.0 50.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.187 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.406 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 54.7 p -87.31 162.27 43.5 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.6 Cg_endo -72.51 -1.41 10.21 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.058 1.557 . . . . 0.0 110.594 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.9 p -101.05 -0.93 35.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.279 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.68 -39.72 2.79 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.78 -175.08 2.56 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 4.0 m -126.63 137.74 53.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -1.18 . . . . 0.0 110.468 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.6 HG12 HG22 ' A' ' 10' ' ' THR . 65.0 mt -87.89 151.5 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.394 -0.816 . . . . 0.0 110.105 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.792 HG12 HD23 ' A' ' 104' ' ' LEU . 9.8 mt -134.24 113.31 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.294 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 103' ' ' LYS . 79.4 tttt -102.11 131.34 48.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 109.974 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.74 154.74 33.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.488 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 101' ' ' GLU . 64.6 m -155.47 123.04 5.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.399 -0.813 . . . . 0.0 110.02 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 99' ' ' SER . 42.0 t -129.06 157.19 42.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.76 ' CE1' HG23 ' A' ' 4' ' ' THR . 44.6 m-70 -134.51 173.22 11.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.217 -0.927 . . . . 0.0 110.44 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.701 ' HA ' HD13 ' A' ' 98' ' ' ILE . 21.2 m-85 -129.91 144.44 51.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.271 -0.893 . . . . 0.0 110.575 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 96.8 m-70 -125.51 95.95 4.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 109.495 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.647 HG21 ' O ' ' A' ' 126' ' ' VAL . 3.1 p -56.87 164.93 1.36 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 0.0 110.572 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 78.9 tttt -115.52 119.2 35.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.45 -107.78 2.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.593 ' C ' HG13 ' A' ' 126' ' ' VAL . 43.4 t30 -130.51 86.8 2.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -1.145 . . . . 0.0 110.266 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.647 ' O ' HG21 ' A' ' 122' ' ' THR . 35.5 m -156.39 173.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 110.208 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.58 ' HA ' HG21 ' A' ' 122' ' ' THR . 96.9 mt-10 -148.27 147.7 29.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.216 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 128' ' ' ILE . 5.2 mp -78.68 173.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.064 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.601 ' N ' HG22 ' A' ' 128' ' ' ILE . 36.2 mtpt -103.94 136.04 44.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -49.45 -29.18 6.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 110.234 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.07 -35.51 78.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.064 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.825 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 17.6 t-160 -66.81 -42.64 85.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.097 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.778 HG21 ' CE2' ' A' ' 5' ' ' TYR . 68.9 t -62.57 -39.82 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.998 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -72.82 -39.16 66.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 110.179 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.15 93.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.133 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.24 -22.63 76.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.543 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 82.6 mttt -75.98 -32.67 59.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 110.094 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.56 -32.07 60.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.038 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -75.83 -27.59 57.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -84.76 -35.72 22.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 110.115 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 80.4 p -64.21 -46.0 85.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.876 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.19 -50.29 74.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.976 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.6 mm? -58.49 -32.72 69.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.853 . . . . 0.0 109.993 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 4.9 m-85 -63.33 -38.43 91.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.051 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -78.54 -18.1 55.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.497 ' HA ' HD23 ' A' ' 146' ' ' LEU . 15.4 mt -81.09 -35.14 32.06 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.126 -0.984 . . . . 0.0 108.829 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.705 HG22 HD23 ' A' ' 18' ' ' LEU . 34.7 mt -69.62 -49.06 61.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.857 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.576 ' HB3' HD13 ' A' ' 13' ' ' ILE . 65.1 mm-40 -54.12 -41.7 68.65 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.394 -0.816 . . . . 0.0 109.362 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.436 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 45.1 m -71.38 -32.6 68.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.592 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.658 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 76.2 t80 -53.9 -58.75 6.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.934 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.162 HD21 ' CE2' ' A' ' 158' ' ' TYR . 62.8 mt -69.03 -29.73 67.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -0.962 . . . . 0.0 109.968 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.585 ' HB2' HD11 ' A' ' 13' ' ' ILE . 43.5 tptt -68.59 -35.64 77.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 109.775 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -98.44 -28.69 7.87 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 150' ' ' TYR . 9.5 m80 -107.2 89.1 4.36 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.359 -1.083 . . . . 0.0 109.897 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.0 Cg_endo -72.76 4.46 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.095 1.576 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 24.2 p30 -107.74 -12.64 15.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.007 -1.058 . . . . 0.0 109.728 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.658 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -66.49 100.57 0.67 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.409 -0.807 . . . . 0.0 109.999 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.162 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.86 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.279 0.562 . . . . 0.0 110.584 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.378 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.783 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 73.8 t -135.65 125.33 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.162 . . . . 0.0 110.456 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.572 ' CE1' HG12 ' A' ' 128' ' ' ILE . 52.9 m-85 -96.91 173.51 7.25 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.254 -0.904 . . . . 0.0 110.094 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.748 HG23 ' CE1' ' A' ' 119' ' ' HIS . 54.4 m -148.11 98.38 2.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CE1' HG11 ' A' ' 133' ' ' VAL . 78.5 m-85 -114.89 132.03 56.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.023 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.503 ' HB3' HG23 ' A' ' 117' ' ' THR . 18.9 pt-20 -130.84 159.6 36.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.569 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 p -132.0 143.91 50.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.424 -0.798 . . . . 0.0 109.895 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -124.81 125.71 44.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 0.0 110.387 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.624 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 3.8 p90 -152.84 -172.86 4.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 110.005 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 113' ' ' ILE . 10.8 p -140.19 179.89 6.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.272 -0.893 . . . . 0.0 110.446 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 112' ' ' SER . 2.6 t -157.51 158.96 36.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.268 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.603 ' CG ' HD12 ' A' ' 13' ' ' ILE . 17.1 pt-20 -85.76 -10.89 54.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.915 . . . . 0.0 110.044 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.845 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.0 mp -90.5 151.37 44.12 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.711 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.845 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.3 Cg_endo -66.86 143.04 65.18 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.975 1.513 . . . . 0.0 110.723 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.666 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 Cg_endo -71.63 -31.73 12.96 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.952 1.501 . . . . 0.0 112.584 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -69.53 -18.99 37.77 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.511 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -84.47 -48.57 9.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.776 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -68.62 -24.55 64.58 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.593 ' CZ ' HD11 ' A' ' 74' ' ' ILE . 82.8 t80 -69.83 -57.12 5.46 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.498 0.666 . . . . 0.0 109.789 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 81.6 mttt -54.88 -30.56 58.31 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.892 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -73.3 -64.62 0.94 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.771 0.796 . . . . 0.0 111.167 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.046 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -57.43 -40.37 78.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.66 -0.65 . . . . 0.0 111.955 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.118 HG11 ' CD1' ' A' ' 74' ' ' ILE . 11.5 t -99.6 -59.41 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.786 -1.196 . . . . 0.0 111.798 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.3 mp -77.1 -0.55 25.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.015 . . . . 0.0 111.71 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.567 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -145.35 7.01 1.13 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.756 -1.215 . . . . 0.0 111.193 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.046 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -46.02 -48.06 16.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.873 -1.142 . . . . 0.0 110.01 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 74.0 m-20 -58.91 -15.43 12.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.831 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HA ' ' CG ' ' A' ' 31' ' ' PRO . 80.0 m-20 -129.54 10.93 5.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.796 HD12 ' C ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -95.25 -46.26 6.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.982 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.998 HG21 HD13 ' A' ' 38' ' ' ILE . 6.3 p -76.91 -27.63 0.62 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 112.419 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.821 ' HD3' HG12 ' A' ' 30' ' ' VAL . 47.7 Cg_endo -75.68 3.14 6.22 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 122.563 0.77 . . . . 0.0 110.611 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.528 ' CD ' ' OH ' ' A' ' 150' ' ' TYR . 95.0 mttt -119.15 -26.5 5.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -0.941 . . . . 0.0 109.127 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.612 HG12 ' CD1' ' A' ' 150' ' ' TYR . 49.4 mt -79.35 -41.02 22.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.553 -0.717 . . . . 0.0 109.533 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -169.75 103.79 0.46 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.49 -0.756 . . . . 0.0 109.829 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 43.3 Cg_endo -69.56 -3.01 11.02 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.979 1.515 . . . . 0.0 110.688 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -83.16 -14.87 52.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.494 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.452 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -92.06 -71.97 0.61 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 110.201 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.998 HD13 HG21 ' A' ' 30' ' ' VAL . 1.7 mp -94.06 125.79 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.868 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 57' ' ' THR . 13.0 tppt? -74.19 -36.19 64.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.339 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.424 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -179.56 151.96 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.862 . . . . 0.0 109.974 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.443 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 39.3 p -112.01 133.59 54.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.07 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 71.9 tt0 -139.88 108.72 5.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.971 . . . . 0.0 110.29 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.8 mt -66.07 134.54 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 110.189 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.8 tp -90.31 -27.03 19.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 1.073 ' O ' HG23 ' A' ' 52' ' ' THR . 33.3 tp10 -158.84 169.32 24.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.228 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 64.75 -166.17 32.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 48.7 t0 -135.88 29.71 3.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -1.167 . . . . 0.0 110.287 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.516 ' H ' HG21 ' A' ' 52' ' ' THR . . . 104.36 4.85 43.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.513 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -96.45 -167.31 33.91 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.64 132.12 21.3 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.143 1.602 . . . . 0.0 110.514 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.25 -7.31 66.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 1.073 HG23 ' O ' ' A' ' 45' ' ' GLU . 26.7 m -80.02 139.0 37.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -1.106 . . . . 0.0 110.161 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 70' ' ' LYS . 18.7 mm -109.06 110.84 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 110.226 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.1 mttt -97.84 153.27 18.42 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.378 -0.827 . . . . 0.0 110.392 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 78.2 tttt -124.94 100.6 6.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.075 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.5 mt -88.27 138.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.35 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.9 p -111.58 157.59 20.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.184 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 28.6 m-85 -117.83 159.44 23.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.356 -0.84 . . . . 0.0 110.3 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.92 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.305 0.574 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -139.47 82.83 0.24 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 14.7 p90 -131.6 163.65 27.59 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.219 -1.165 . . . . 0.0 110.198 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.83 HG12 ' HA2' ' A' ' 88' ' ' GLY . 9.5 m -137.71 172.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 110.627 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . 70.7 mttt -123.78 130.65 52.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.667 -0.646 . . . . 0.0 109.503 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.586 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -118.44 130.7 56.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.004 . . . . 0.0 111.0 -179.298 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.59 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.0 tttt -104.05 120.04 40.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.416 -0.802 . . . . 0.0 109.174 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.536 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 21.0 mm -62.4 129.58 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 110.693 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.467 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 72.3 m-20 -101.37 -49.6 4.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.359 -0.838 . . . . 0.0 109.308 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 79.6 p -179.68 157.36 0.74 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.529 -0.732 . . . . 0.0 110.286 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.118 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.2 tt -145.97 164.32 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -134.31 81.5 1.92 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 110.123 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 41.6 ttmt -55.9 -14.38 2.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.278 -0.889 . . . . 0.0 110.824 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -84.1 -29.91 26.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 0.0 109.006 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m120 -116.63 -1.1 12.22 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.357 0.599 . . . . 0.0 109.532 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.592 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 7.6 m-85 65.5 49.82 1.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.684 -0.635 . . . . 0.0 110.108 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.518 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -116.41 142.14 47.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 109.285 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.646 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 72.9 t80 -137.24 155.1 49.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.267 -0.895 . . . . 0.0 110.284 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.451 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 77.9 p -158.51 140.86 14.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 110.474 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.646 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 5.9 p90 -148.59 177.69 9.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 110.161 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 90.0 m -128.5 131.6 48.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 110.004 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.896 HD23 HG13 ' A' ' 98' ' ' ILE . 15.5 tp -83.62 123.7 30.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.201 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.55 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 33.7 pt -104.93 -8.99 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 110.228 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -163.57 166.26 22.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.83 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 155.04 153.23 6.43 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -79.96 -22.18 42.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -1.214 . . . . 0.0 110.268 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.99 -20.23 63.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.307 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.91 ' CD2' HD11 ' A' ' 98' ' ' ILE . 71.1 mt -67.79 -18.75 64.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.27 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.87 -167.19 0.51 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.41 9.53 25.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -1.151 . . . . 0.0 110.128 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 122' ' ' THR . 40.8 p -110.55 -32.11 7.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 110.079 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.9 HD23 HG23 ' A' ' 122' ' ' THR . 72.3 mt -109.42 154.74 22.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 110.169 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.529 ' O ' HD13 ' A' ' 91' ' ' LEU . 68.8 tt0 -137.37 -80.83 0.37 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.159 -0.963 . . . . 0.0 110.004 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.916 ' O ' HD13 ' A' ' 98' ' ' ILE . 32.1 mttm -80.22 156.15 27.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.495 -0.753 . . . . 0.0 110.513 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 97' ' ' LYS . 4.2 mm -145.49 126.28 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.092 -1.005 . . . . 0.0 109.82 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -93.23 126.51 38.38 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.45 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 15.0 m-85 -121.05 144.56 48.47 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.317 -0.864 . . . . 0.0 110.961 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -149.89 128.02 11.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.481 -0.762 . . . . 0.0 109.938 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 85.6 m -127.69 134.62 49.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.989 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 115' ' ' LYS . 15.5 mttt -124.44 136.81 54.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.287 -0.883 . . . . 0.0 110.362 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.787 HD23 HG12 ' A' ' 114' ' ' ILE . 8.5 mt -117.19 150.33 38.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.359 -0.838 . . . . 0.0 110.063 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.57 -169.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.257 -0.902 . . . . 0.0 110.107 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -117.81 140.42 49.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.411 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 92.1 p -96.74 162.5 22.94 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -72.6 -1.73 10.75 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.469 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p -99.9 -8.86 23.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.3 -21.81 21.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . -74.34 -146.05 1.08 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 27.3 p -149.36 131.67 15.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -1.158 . . . . 0.0 110.057 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.609 ' HA ' HG22 ' A' ' 10' ' ' THR . 37.0 mt -83.19 148.98 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 110.132 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.787 HG12 HD23 ' A' ' 104' ' ' LEU . 7.0 mt -133.41 115.55 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 110.463 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 103' ' ' LYS . 81.3 tttt -108.37 117.66 34.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.325 -0.859 . . . . 0.0 109.748 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 8.7 t -113.5 164.72 13.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.753 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.533 HG22 ' CE1' ' A' ' 119' ' ' HIS . 30.8 m -160.01 120.23 2.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.375 -0.828 . . . . 0.0 109.795 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.492 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 26.5 m -122.69 133.93 54.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.383 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.748 ' CE1' HG23 ' A' ' 4' ' ' THR . 35.8 m-70 -114.3 156.82 23.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 109.763 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.8 m-85 -114.37 149.28 36.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 110.595 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 90.1 m-70 -125.74 88.17 2.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.018 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.9 HG23 HD23 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -74.15 146.06 43.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.514 -0.741 . . . . 0.0 111.083 -178.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 63.7 pttt -105.41 130.89 53.41 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.543 -0.723 . . . . 0.0 110.137 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.24 -117.47 4.62 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.678 ' O ' HG13 ' A' ' 126' ' ' VAL . 46.2 t30 -138.27 103.28 4.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.275 -1.132 . . . . 0.0 110.418 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 125' ' ' ASN . 8.7 m -159.5 165.49 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.833 . . . . 0.0 109.896 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -134.7 158.46 44.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.142 -0.974 . . . . 0.0 110.32 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.862 ' CD1' HD21 ' A' ' 95' ' ' LEU . 22.7 mm -70.7 172.93 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 110.196 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.582 ' N ' HG22 ' A' ' 128' ' ' ILE . 13.9 mttm -116.61 131.45 56.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.972 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 69.5 mm-40 -43.66 -44.4 6.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.15 -0.969 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -63.29 -24.63 67.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.933 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 129' ' ' LYS . 15.1 t-160 -81.06 -49.25 11.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.118 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.591 HG11 ' CE1' ' A' ' 5' ' ' TYR . 59.5 t -58.79 -37.66 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.758 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.03 -44.81 37.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.902 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -64.27 -32.69 74.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.349 -0.844 . . . . 0.0 110.057 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.06 -32.17 66.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -75.83 -34.08 60.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -1.1 . . . . 0.0 109.997 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.99 -37.73 58.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.916 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 94.3 mttt -69.5 -37.53 77.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 109.861 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.477 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -69.79 -34.98 74.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.797 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 64.9 m -72.64 -44.19 62.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.805 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -57.61 -43.94 85.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.877 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.6 -43.75 98.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.913 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.511 ' HA ' HD12 ' A' ' 147' ' ' ILE . 8.6 m-85 -59.89 -32.87 71.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.443 -0.786 . . . . 0.0 109.84 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -78.27 -20.21 52.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.483 ' HB3' HG21 ' A' ' 33' ' ' ILE . 17.5 mt -83.25 -36.29 24.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.174 -0.954 . . . . 0.0 108.826 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.648 HG23 HD11 ' A' ' 29' ' ' LEU . 8.9 mt -72.51 -43.75 62.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.557 ' HB3' HD13 ' A' ' 13' ' ' ILE . 54.7 mt-10 -60.95 -41.11 95.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.435 -0.791 . . . . 0.0 109.372 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.8 m -72.9 -32.8 65.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.622 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.656 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.2 t80 -56.48 -54.68 42.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.495 -0.753 . . . . 0.0 109.886 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.197 HD21 ' CE2' ' A' ' 158' ' ' TYR . 69.4 mt -69.27 -31.22 69.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.307 -0.871 . . . . 0.0 110.288 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.554 ' HB2' HD11 ' A' ' 13' ' ' ILE . 43.1 tttt -68.55 -28.43 66.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.88 . . . . 0.0 109.782 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.81 -26.72 6.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 150' ' ' TYR . 8.8 m80 -107.27 90.41 5.67 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.951 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.8 Cg_endo -73.47 3.75 4.51 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.101 1.579 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -109.56 -9.69 14.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.76 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.656 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -68.48 100.28 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.468 -0.77 . . . . 0.0 110.136 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.197 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.7 OUTLIER 34.4 32.72 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.253 0.549 . . . . 0.0 110.542 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.846 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 50.0 t -125.43 114.31 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.187 -1.184 . . . . 0.0 110.406 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.594 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 93.1 m-85 -74.83 152.83 38.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.954 . . . . 0.0 110.184 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.657 HG23 ' CE1' ' A' ' 119' ' ' HIS . 7.9 m -130.38 113.76 14.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.756 ' CD2' HG13 ' A' ' 133' ' ' VAL . 39.1 m-85 -126.61 125.84 42.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.089 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.576 ' CG ' ' N ' ' A' ' 7' ' ' SER . 16.3 tt0 -114.82 176.15 5.18 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.277 -0.889 . . . . 0.0 109.61 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.576 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 19.1 m -153.0 147.4 25.87 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.646 -0.659 . . . . 0.0 109.852 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.429 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 47.6 mt-10 -140.26 116.33 10.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.054 -1.028 . . . . 0.0 110.566 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.715 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 3.9 p90 -145.17 -172.08 3.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 109.887 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.78 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.6 p -140.59 172.63 12.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.465 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 53.8 p -150.69 142.24 23.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.465 -0.772 . . . . 0.0 110.097 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.17 -25.93 68.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.278 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.744 HD11 ' HB2' ' A' ' 152' ' ' LYS . 5.1 mp -81.34 146.38 57.74 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.148 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.677 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.7 Cg_endo -66.76 152.94 79.58 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.116 1.587 . . . . 0.0 110.719 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.7 Cg_endo -64.5 -36.08 45.38 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.763 1.401 . . . . 0.0 113.204 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 39.5 Cg_endo -65.24 -20.17 62.43 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 N-CA-C 109.748 -0.905 . . . . 0.0 109.748 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.974 ' HG3' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.92 -43.4 19.85 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 18' ' ' LEU . 8.0 mp -72.68 -38.08 67.69 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 47.9 t80 -56.84 -57.56 11.93 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.24 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 92.5 mttt -57.58 -37.47 73.22 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.529 -0.732 . . . . 0.0 110.134 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.073 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.03 -58.74 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 111.1 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.007 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -53.73 -40.52 66.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 0.0 111.958 -178.606 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.119 HG11 ' CD1' ' A' ' 74' ' ' ILE . 21.1 t -106.27 -65.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.845 -1.159 . . . . 0.0 111.693 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.637 ' N ' HD22 ' A' ' 24' ' ' LEU . 4.2 mm? -62.77 -8.58 7.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 111.216 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.734 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -144.76 28.52 1.27 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.876 -1.14 . . . . 0.0 110.63 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.007 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.57 -35.51 79.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -0.907 . . . . 0.0 110.112 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.449 ' OD1' ' CB ' ' A' ' 41' ' ' SER . 19.8 t70 -63.25 -16.05 59.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 81.8 m-20 -126.94 8.1 6.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.029 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.752 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -92.94 -53.64 4.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.178 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.911 ' CG1' HD13 ' A' ' 38' ' ' ILE . 2.5 t -72.02 -42.47 9.78 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.415 -0.803 . . . . 0.0 110.905 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.3 Cg_endo -77.74 9.48 2.94 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.541 1.285 . . . . 0.0 111.005 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 28' ' ' ASN . 33.3 ttmt -127.21 -31.2 2.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.968 -1.083 . . . . 0.0 109.831 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.605 HG12 ' CD1' ' A' ' 150' ' ' TYR . 36.7 mt -80.01 -38.97 19.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.443 -0.785 . . . . 0.0 109.733 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -154.28 99.75 2.49 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.449 -0.782 . . . . 0.0 110.026 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 43.7 Cg_endo -71.27 -2.0 10.51 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.066 1.561 . . . . 0.0 110.481 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -86.36 -12.6 48.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.751 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.659 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -96.03 -56.34 2.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.081 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.911 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.0 mp -115.12 132.28 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 110.08 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.587 ' CG ' ' CA ' ' A' ' 59' ' ' GLY . 0.5 OUTLIER -68.62 -37.28 79.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.891 . . . . 0.0 110.193 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.443 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER 177.61 153.82 0.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 110.018 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.449 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 62.7 m -115.04 125.7 53.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.979 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 84.5 tt0 -130.18 106.93 8.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.293 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 22.2 mt -61.08 131.68 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.176 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 44' ' ' LEU . 49.7 mt -88.93 -26.09 21.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 110.044 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 1.013 ' O ' HG23 ' A' ' 52' ' ' THR . 55.7 tt0 -152.31 171.14 18.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.97 -169.03 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -130.37 28.14 4.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -1.121 . . . . 0.0 110.232 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.604 ' H ' HG21 ' A' ' 52' ' ' THR . . . 113.36 -5.49 24.96 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.516 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -79.97 -170.99 41.86 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -70.44 133.55 24.56 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.195 1.629 . . . . 0.0 110.574 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.27 -1.42 76.77 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 1.013 HG23 ' O ' ' A' ' 45' ' ' GLU . 32.4 m -80.16 145.42 32.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -1.193 . . . . 0.0 110.158 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 70' ' ' LYS . 36.0 mm -111.92 112.02 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 110.184 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 46.5 mtmt -99.12 150.57 21.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 110.374 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -123.14 98.84 6.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.877 . . . . 0.0 110.053 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.498 ' HB ' HG23 ' A' ' 67' ' ' VAL . 96.6 mt -88.97 140.12 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 110.193 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.9 p -115.0 152.77 31.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.56 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 26.7 m-85 -117.62 129.2 55.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.499 -0.75 . . . . 0.0 109.993 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.587 ' CA ' ' CG ' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.225 0.536 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -122.38 88.0 0.4 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.1 p90 -123.62 163.42 21.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -1.211 . . . . 0.0 110.124 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.787 HG12 ' HA2' ' A' ' 88' ' ' GLY . 8.6 m -141.32 172.03 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.938 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.433 ' HD2' ' OE1' ' A' ' 87' ' ' GLU . 86.4 mttt -127.4 125.85 41.4 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.702 ' CE1' HD13 ' A' ' 85' ' ' LEU . 1.2 m80 -116.92 121.02 40.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 111.161 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.616 ' HD3' HD13 ' A' ' 86' ' ' ILE . 23.5 mtmt -96.46 106.88 19.2 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.324 -0.86 . . . . 0.0 109.242 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.7 mm -48.34 136.68 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.872 . . . . 0.0 110.074 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 73' ' ' SER . 14.9 m-20 -107.34 -44.6 4.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.343 -0.848 . . . . 0.0 109.744 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 12.9 p 176.18 156.57 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.522 -0.736 . . . . 0.0 110.365 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.119 ' CD1' HG11 ' A' ' 23' ' ' VAL . 6.1 tt -144.96 169.86 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.504 -0.748 . . . . 0.0 109.597 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.4 m-20 -142.47 84.29 1.85 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.075 -1.016 . . . . 0.0 110.317 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.544 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 81.1 tttt -59.67 -13.9 11.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 110.221 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -92.79 -34.2 13.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 3.7 m120 -102.21 -3.9 26.61 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.524 0.678 . . . . 0.0 109.229 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.571 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 90.5 m-85 62.58 55.78 2.14 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.253 0.549 . . . . 0.0 110.919 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 2.7 m -132.14 162.38 31.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 0.0 109.658 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.61 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 80.2 t80 -158.08 146.71 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -0.974 . . . . 0.0 110.198 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.425 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 3.8 t -153.56 147.63 25.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.692 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 9.2 p90 -149.76 175.58 11.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.429 -0.794 . . . . 0.0 110.015 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 98' ' ' ILE . 97.6 m -125.61 128.82 48.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.702 HD13 ' CE1' ' A' ' 69' ' ' HIS . 2.7 tp -96.39 122.97 39.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.573 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.616 HD13 ' HD3' ' A' ' 70' ' ' LYS . 20.8 pt -112.63 -5.39 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 110.894 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 22.9 tt0 -147.29 120.86 9.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 110.672 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.787 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -168.74 149.05 13.11 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.68 -8.04 24.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -1.123 . . . . 0.0 110.065 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.768 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -80.4 -53.54 6.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.471 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.721 HD21 ' N ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -63.94 -30.7 71.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.269 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 39.08 -124.42 1.75 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -106.04 -6.46 18.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -1.125 . . . . 0.0 110.494 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.771 ' O ' HG21 ' A' ' 126' ' ' VAL . 64.1 p -80.04 -50.63 10.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 109.703 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.779 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -109.43 163.66 13.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.779 ' H ' HD12 ' A' ' 95' ' ' LEU . 42.0 tt0 -133.18 -77.84 0.48 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 110.912 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.6 mtpt -80.08 128.96 34.11 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.615 -0.678 . . . . 0.0 111.125 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.763 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.2 mm -117.74 140.47 40.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 120.868 -1.145 . . . . 0.0 109.811 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -117.76 126.72 52.97 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.38 -0.825 . . . . 0.0 108.974 178.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.763 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.4 m-85 -121.8 136.07 54.93 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.915 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 48.3 tt0 -137.14 150.72 48.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.571 -0.706 . . . . 0.0 109.606 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' TYR . 36.7 m -149.21 150.4 32.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -0.997 . . . . 0.0 110.408 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 2.3 tttt -138.68 147.22 42.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.681 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.803 HD23 HG12 ' A' ' 114' ' ' ILE . 2.7 mt -128.45 147.3 50.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.001 . . . . 0.0 110.688 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.72 -168.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.475 -0.765 . . . . 0.0 109.806 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.86 172.7 7.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.131 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.459 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 32.8 p -130.48 164.96 37.71 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -73.16 -1.3 10.35 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.995 1.524 . . . . 0.0 110.599 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.0 p -103.93 3.68 33.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.374 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.04 -36.76 3.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.97 -173.85 3.09 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.5 p -130.33 140.24 50.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -1.189 . . . . 0.0 110.357 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.78 ' HA ' HG22 ' A' ' 10' ' ' THR . 27.5 mt -89.8 149.5 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.854 . . . . 0.0 110.077 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.803 HG12 HD23 ' A' ' 104' ' ' LEU . 10.5 mt -135.95 110.61 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.313 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 37.1 ttmt -99.73 129.85 45.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.941 . . . . 0.0 110.135 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.6 t -121.03 157.18 30.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.958 . . . . 0.0 110.282 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 85.7 m -154.3 138.02 16.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 110.15 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.477 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 34.7 p -141.61 154.46 45.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 110.184 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.657 ' CE1' HG23 ' A' ' 4' ' ' THR . 82.2 m-70 -133.41 164.63 26.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 0.0 110.387 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.587 ' CD2' HG13 ' A' ' 128' ' ' ILE . 8.2 m-85 -124.06 141.92 51.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 110.435 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 72.5 m80 -122.52 89.43 3.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.924 -1.11 . . . . 0.0 109.793 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.624 ' HB ' HG23 ' A' ' 126' ' ' VAL . 2.7 p -60.25 163.44 5.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 110.301 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 85.0 tttt -126.0 114.9 19.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.275 -0.891 . . . . 0.0 110.242 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.36 -105.37 2.99 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.628 ' O ' HG13 ' A' ' 126' ' ' VAL . 24.7 t30 -135.6 93.43 2.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -1.169 . . . . 0.0 110.202 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.771 HG21 ' O ' ' A' ' 94' ' ' THR . 15.9 m -157.76 165.55 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.305 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -145.21 149.5 35.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 110.316 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.762 HD11 ' HB2' ' A' ' 95' ' ' LEU . 37.8 mm -75.97 173.41 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 110.203 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.61 ' N ' HG22 ' A' ' 128' ' ' ILE . 31.5 mtpt -116.54 136.21 53.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.4 -0.813 . . . . 0.0 110.078 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -45.43 -43.26 11.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.62 -31.28 71.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 110.142 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.768 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 16.0 t-160 -74.02 -47.69 35.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 110.081 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.756 HG13 ' CD2' ' A' ' 5' ' ' TYR . 73.0 t -62.21 -40.96 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.381 -0.824 . . . . 0.0 110.008 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -69.37 -42.73 74.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.997 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.502 ' HB1' ' NZ ' ' A' ' 139' ' ' LYS . . . -62.4 -38.66 90.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.026 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -30.23 68.16 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 52.7 mtpt -77.37 -31.85 54.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -1.147 . . . . 0.0 110.055 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -76.67 -30.49 56.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 109.927 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.502 ' NZ ' ' HB1' ' A' ' 135' ' ' ALA . 46.1 mttp -68.37 -37.5 80.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.864 . . . . 0.0 110.051 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.42 -43.08 64.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.902 . . . . 0.0 110.007 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.1 p -63.42 -43.46 97.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.943 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -57.73 -41.68 82.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.863 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 147' ' ' ILE . 66.4 mt -58.61 -46.32 87.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 0.0 109.966 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.441 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 20.9 m-85 -54.42 -39.53 67.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.383 -0.823 . . . . 0.0 109.913 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.88 -28.19 68.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.88 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.562 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.9 mt -82.93 -34.5 26.53 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.222 -0.924 . . . . 0.0 108.791 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.636 HD13 ' CD1' ' A' ' 22' ' ' PHE . 81.8 mt -72.01 -34.79 51.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.606 -0.684 . . . . 0.0 109.329 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.597 ' CB ' HD13 ' A' ' 13' ' ' ILE . 30.8 mt-10 -64.91 -39.43 93.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.403 -0.811 . . . . 0.0 109.428 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.7 m -69.6 -35.47 75.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.498 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.609 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 71.5 t80 -58.58 -51.84 68.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.819 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.069 HD21 ' CE1' ' A' ' 158' ' ' TYR . 78.0 mt -80.05 -39.15 30.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 110.27 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.744 ' HB2' HD11 ' A' ' 13' ' ' ILE . 82.6 tttt -64.2 -19.16 65.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.495 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.31 -34.72 2.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 1.6 m80 -107.03 94.47 10.88 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.276 -1.132 . . . . 0.0 109.983 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.4 Cg_endo -74.04 5.38 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.089 1.573 . . . . 0.0 110.973 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -106.89 -9.66 16.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.046 -1.034 . . . . 0.0 109.856 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.633 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -69.68 100.82 1.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.348 -0.845 . . . . 0.0 110.083 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.073 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 1.0 OUTLIER 34.09 33.6 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.342 0.591 . . . . 0.0 110.642 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.508 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 118.009 -0.995 . . . . 0.0 109.852 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.031 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.9 p -80.12 150.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -1.131 . . . . 0.0 110.35 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.612 ' CD1' HD12 ' A' ' 128' ' ' ILE . 26.1 m-85 -89.07 176.38 7.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 110.368 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.84 HG23 ' CE1' ' A' ' 119' ' ' HIS . 97.4 m -145.45 103.66 3.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.396 -0.815 . . . . 0.0 110.083 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.687 ' CD1' HG13 ' A' ' 133' ' ' VAL . 51.5 m-85 -116.23 129.34 56.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 110.098 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 116' ' ' SER . 25.5 pt-20 -131.52 157.94 42.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 110.505 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.4 m -133.95 139.42 46.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.895 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.481 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 99.9 mt-10 -121.24 127.32 51.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.385 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 3.8 p90 -154.3 -171.76 3.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.038 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.568 HG22 HG12 ' A' ' 113' ' ' ILE . 18.0 p -141.35 -176.46 4.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.57 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.489 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 3.7 t -159.6 160.9 34.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.776 . . . . 0.0 110.152 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -85.16 -19.11 32.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.978 . . . . 0.0 110.153 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 10.0 mm -85.47 149.8 52.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 110.095 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.9 Cg_endo -65.82 148.5 86.5 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.06 1.558 . . . . 0.0 110.57 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.682 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.3 Cg_endo -70.05 -32.57 17.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.885 1.466 . . . . 0.0 112.893 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.682 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.2 Cg_endo -67.58 -20.62 47.0 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 N-CA-C 110.149 -0.75 . . . . 0.0 110.149 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.883 ' HG2' HD13 ' A' ' 151' ' ' LEU . 4.6 ttm180 -84.73 -49.16 8.72 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.752 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -69.06 -26.73 65.1 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.205 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.9 t80 -71.29 -55.03 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 109.236 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 63.3 mttt -51.72 -32.98 32.49 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.403 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.079 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -79.83 -55.09 5.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 111.188 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.056 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -57.29 -44.39 84.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.527 -0.733 . . . . 0.0 112.52 -177.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.554 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -106.8 -55.68 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.792 -1.192 . . . . 0.0 112.06 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.661 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.9 mm? -68.84 -10.64 58.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.01 -1.056 . . . . 0.0 111.174 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.584 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.2 m-20 -145.36 28.58 1.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.886 -1.134 . . . . 0.0 110.734 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.056 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.29 -20.04 65.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.152 -0.968 . . . . 0.0 110.436 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -72.61 -20.19 61.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.096 -1.003 . . . . 0.0 109.588 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.5 p-10 -126.85 14.76 7.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 109.672 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.913 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -96.42 -50.16 4.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.224 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.079 HG21 HD13 ' A' ' 38' ' ' ILE . 9.7 p -73.26 -26.99 0.79 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.332 -0.855 . . . . 0.0 112.183 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.802 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -82.91 10.38 3.66 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 122.621 0.8 . . . . 0.0 110.51 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -134.37 -27.04 1.4 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.13 -0.982 . . . . 0.0 110.603 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.687 HD11 ' CD1' ' A' ' 29' ' ' LEU . 34.3 mt -77.87 -36.29 21.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.225 -0.922 . . . . 0.0 109.899 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.95 100.13 0.82 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.342 -0.849 . . . . 0.0 110.338 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.85 -0.1 9.0 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.109 1.584 . . . . 0.0 110.346 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -88.29 -13.09 41.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 110.007 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.13 -47.1 4.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 110.315 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.079 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -125.79 145.24 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -0.82 . . . . 0.0 110.103 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -83.18 -42.04 17.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.269 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.44 163.53 1.58 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 110.123 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.6 m -120.27 125.68 48.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.185 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -130.04 107.57 9.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 110.151 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 23.4 mt -56.54 134.89 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 110.071 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.83 HD22 ' CE ' ' A' ' 55' ' ' LYS . 63.8 tp -88.76 -46.51 8.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -0.958 . . . . 0.0 109.911 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.83 ' O ' HG23 ' A' ' 52' ' ' THR . 16.8 mm-40 -131.97 -169.81 2.28 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.442 -0.786 . . . . 0.0 110.179 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.44 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.08 -150.05 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 47' ' ' ASP . 23.4 t0 -160.03 41.48 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -1.133 . . . . 0.0 110.093 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.655 ' H ' HG21 ' A' ' 52' ' ' THR . . . 103.31 -11.71 54.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -82.13 -175.54 50.62 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.3 Cg_endo -72.23 132.82 20.06 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.144 1.602 . . . . 0.0 110.43 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.91 -3.78 62.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.4 m -80.02 150.04 30.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -1.175 . . . . 0.0 109.986 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.718 HD13 ' HA ' ' A' ' 70' ' ' LYS . 20.9 mm -116.76 107.62 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.948 . . . . 0.0 110.324 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 73.0 mttt -90.32 144.88 25.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.398 -0.814 . . . . 0.0 110.097 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.83 ' CE ' HD22 ' A' ' 44' ' ' LEU . 31.7 mttt -117.95 95.4 4.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.267 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CG2' HG12 ' A' ' 38' ' ' ILE . 86.9 mt -83.44 145.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.904 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 38' ' ' ILE . 6.2 p -116.48 158.35 23.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 110.74 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.812 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.9 m-85 -116.42 145.87 42.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.226 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.992 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.495 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 7.1 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.154 0.502 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -116.8 135.86 12.31 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.541 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.9 p90 -179.08 166.57 1.57 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -1.153 . . . . 0.0 110.271 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.96 HG12 ' HA2' ' A' ' 88' ' ' GLY . 3.6 m -142.09 174.7 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 110.362 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.65 ' O ' HD12 ' A' ' 85' ' ' LEU . 96.6 mttt -126.15 124.75 41.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.481 -0.762 . . . . 0.0 109.705 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.765 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -113.73 130.3 56.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.135 -0.978 . . . . 0.0 110.814 -179.527 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.718 ' HA ' HD13 ' A' ' 53' ' ' ILE . 76.7 tttt -107.31 102.31 11.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.381 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.503 HG22 ' HA ' ' A' ' 50' ' ' PRO . 34.6 mm -45.25 135.35 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.466 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.485 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 12.2 t0 -108.66 -38.69 5.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.446 -0.784 . . . . 0.0 109.617 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.488 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 6.4 p 179.07 156.58 0.5 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.505 -0.747 . . . . 0.0 110.019 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.447 HG12 HG11 ' A' ' 23' ' ' VAL . 1.9 mt -136.97 159.17 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.07 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 1.1 m-20 -144.67 83.97 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.62 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.578 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 57.4 tttp -66.65 -15.82 63.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.276 -0.89 . . . . 0.0 110.17 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -86.29 -31.04 21.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 0.0 108.809 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.2 m120 -106.1 -3.9 20.98 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.559 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 98.9 m-85 61.11 53.73 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.36 0.6 . . . . 0.0 110.584 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 12.9 t -125.47 175.2 7.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.85 . . . . 0.0 110.103 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.687 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 39.1 t80 -159.59 134.23 7.84 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.713 -0.617 . . . . 0.0 109.8 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.488 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 20.2 m -140.77 123.34 16.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 111.037 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.687 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 16.8 p90 -139.16 171.86 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.812 . . . . 0.0 110.01 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 98' ' ' ILE . 58.0 m -124.33 137.1 54.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.978 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.765 HD13 ' CE1' ' A' ' 69' ' ' HIS . 15.5 tp -99.74 124.85 45.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.391 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.3 pt -102.22 -10.67 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 110.292 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.4 ' OE1' ' HE3' ' A' ' 68' ' ' LYS . 81.7 tt0 -151.51 155.71 39.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 110.232 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.96 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 157.61 143.47 3.67 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -61.54 -25.9 67.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -1.107 . . . . 0.0 110.184 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.553 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -60.21 -25.87 65.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 110.253 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.459 HD21 ' CG1' ' A' ' 98' ' ' ILE . 89.6 mt -62.52 -11.76 18.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.199 -0.938 . . . . 0.0 110.137 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.923 ' O ' HG23 ' A' ' 94' ' ' THR . . . 42.57 28.95 0.67 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 66.9 m-20 56.29 16.1 2.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -1.185 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.923 HG23 ' O ' ' A' ' 92' ' ' GLY . 19.6 p -111.93 -34.27 6.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.736 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.818 HD23 HG23 ' A' ' 122' ' ' THR . 96.2 mt -94.76 163.85 13.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.826 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.482 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 68.1 tt0 -127.98 -81.61 0.59 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.783 0.802 . . . . 0.0 109.782 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 60.4 mttt -80.3 127.97 32.99 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.657 -0.652 . . . . 0.0 110.142 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.81 ' O ' HG23 ' A' ' 84' ' ' THR . 3.8 mm -117.05 139.91 41.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.628 -1.295 . . . . 0.0 109.721 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -120.59 125.18 47.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.772 ' CE2' HG21 ' A' ' 98' ' ' ILE . 12.4 m-85 -120.07 132.06 55.31 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.398 -0.814 . . . . 0.0 110.396 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 117' ' ' THR . 5.7 mt-10 -131.53 133.87 45.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.022 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 88.8 m -129.35 146.65 51.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.917 . . . . 0.0 110.1 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 115' ' ' LYS . 1.5 mttm -139.89 134.45 31.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 110.294 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.708 HD23 HG12 ' A' ' 114' ' ' ILE . 10.1 mt -113.93 148.24 37.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.145 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.89 -168.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 110.092 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.697 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.96 161.09 24.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 26.1 p -119.73 163.95 24.75 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.28 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.6 Cg_endo -72.27 -1.97 10.95 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.064 1.56 . . . . 0.0 110.477 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.2 p -103.78 -0.74 28.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.263 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.17 -35.72 4.85 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.25 -174.05 2.57 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 55.5 p -129.17 137.5 51.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -1.171 . . . . 0.0 110.327 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.568 HG12 HG22 ' A' ' 10' ' ' THR . 59.2 mt -88.71 150.79 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 110.326 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.708 HG12 HD23 ' A' ' 104' ' ' LEU . 8.5 mt -132.86 111.35 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.1 tttt -101.11 123.39 45.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.108 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.5 t -117.17 156.53 27.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.49 HG22 ' CE1' ' A' ' 119' ' ' HIS . 57.7 m -158.97 125.23 4.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 110.201 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.482 ' HB2' ' CD1' ' A' ' 100' ' ' TYR . 31.3 t -127.09 162.23 26.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 110.172 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.84 ' CE1' HG23 ' A' ' 4' ' ' THR . 44.0 m-70 -140.75 128.83 22.1 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 1.031 ' C ' HG23 ' A' ' 2' ' ' VAL . 9.7 m-30 -100.28 119.76 38.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.182 -0.949 . . . . 0.0 110.953 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.581 ' N ' HG23 ' A' ' 2' ' ' VAL . 84.5 m-70 -93.59 101.27 13.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.379 -0.826 . . . . 0.0 109.373 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.818 HG23 HD23 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -81.06 154.12 27.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.042 -1.036 . . . . 0.0 110.525 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.423 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 33.4 tttp -127.64 117.36 21.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 116.26 -135.31 12.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 3.2 p-10 -125.84 53.53 1.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -1.15 . . . . 0.0 110.235 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 122' ' ' THR . 28.3 m -135.27 155.54 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 110.134 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.02 157.13 47.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.958 . . . . 0.0 110.371 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 129' ' ' LYS . 2.2 mp -65.36 173.27 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.973 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.623 ' N ' HG22 ' A' ' 128' ' ' ILE . 34.0 mttt -118.31 148.13 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 109.915 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.525 ' HG2' ' N ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -51.71 -22.88 3.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 110.395 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' HG2' ' A' ' 130' ' ' GLU . 49.2 tt0 -77.8 -35.46 51.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.838 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 19.8 t-160 -73.58 -36.47 65.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.687 HG13 ' CD1' ' A' ' 5' ' ' TYR . 59.5 t -63.73 -43.62 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.864 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.48 -42.94 77.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.84 . . . . 0.0 109.955 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.93 89.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.523 ' HA2' ' CD ' ' A' ' 139' ' ' LYS . . . -65.61 -29.88 76.16 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 141' ' ' SER . 94.5 mttt -78.43 -30.73 47.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -1.128 . . . . 0.0 110.156 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.504 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 96.5 mt-10 -76.27 -39.77 53.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.086 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.523 ' CD ' ' HA2' ' A' ' 136' ' ' GLY . 18.8 ptpt -66.69 -33.18 75.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.837 . . . . 0.0 109.875 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.506 ' N ' ' HG3' ' A' ' 139' ' ' LYS . . . -88.82 -40.13 13.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.002 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 137' ' ' LYS . 61.6 m -65.27 -44.74 87.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.349 -0.845 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.3 m-20 -58.81 -41.33 86.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.367 -0.833 . . . . 0.0 110.035 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.0 mt -61.28 -40.6 94.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.889 . . . . 0.0 110.053 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -61.54 -34.75 76.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.019 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -76.9 -17.84 58.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.017 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.503 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 16.7 mt -83.45 -35.19 25.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.242 -0.912 . . . . 0.0 108.938 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.759 HD13 ' CD1' ' A' ' 22' ' ' PHE . 93.1 mt -71.22 -43.14 74.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.508 ' HG3' HD12 ' A' ' 18' ' ' LEU . 55.1 mt-10 -57.62 -37.72 73.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.362 -0.836 . . . . 0.0 109.283 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 65.7 m -73.65 -33.56 64.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.458 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.621 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.1 t80 -54.3 -48.51 71.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.458 -0.776 . . . . 0.0 109.898 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.178 HD21 ' CE2' ' A' ' 158' ' ' TYR . 72.4 mt -78.35 -30.55 48.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.178 -0.951 . . . . 0.0 110.164 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.454 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 30.5 ttpt -71.65 -22.11 61.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.307 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.14 -31.24 3.88 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 4.8 m80 -109.78 92.88 13.23 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.452 -1.028 . . . . 0.0 109.968 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.17 5.82 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.034 1.544 . . . . 0.0 111.067 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -109.35 -1.03 18.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 109.991 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.621 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -81.54 102.89 10.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 110.073 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.178 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.85 32.79 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.366 0.603 . . . . 0.0 110.517 -179.484 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.535 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.818 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' ' 120' ' ' TYR . 85.2 t -120.15 123.61 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -1.158 . . . . 0.0 110.375 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.6 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 86.9 m-85 -75.03 148.01 40.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 110.087 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.835 HG23 ' CE1' ' A' ' 119' ' ' HIS . 52.0 m -131.74 121.64 24.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.189 ' CE2' HG21 ' A' ' 133' ' ' VAL . 74.7 m-85 -131.17 156.7 44.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.059 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -148.67 152.95 37.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 110.105 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 116' ' ' SER . 54.5 p -136.18 148.71 48.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.442 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 95.4 mt-10 -136.88 117.82 14.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 110.28 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 2.9 p90 -144.88 -175.71 4.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.899 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.8 p -138.39 179.58 6.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.565 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.542 ' OG ' HD11 ' A' ' 114' ' ' ILE . 8.8 p -157.02 163.78 38.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.229 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.84 -13.62 47.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.239 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.877 HD11 ' HB2' ' A' ' 152' ' ' LYS . 3.1 mp -90.78 149.68 40.84 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 0.0 110.139 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.807 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.8 Cg_endo -66.98 148.55 82.07 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.995 1.524 . . . . 0.0 110.553 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.671 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -69.96 -32.95 16.77 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 O-C-N 123.947 1.498 . . . . 0.0 113.096 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.4 Cg_endo -67.12 -22.09 47.85 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 N-CA-C 109.934 -0.833 . . . . 0.0 109.934 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.995 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -82.23 -49.36 10.18 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.897 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.777 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.3 tt -68.21 -29.72 68.62 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 76' ' ' LYS . 67.6 t80 -61.85 -57.28 12.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.127 178.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 92.2 mttt -50.09 -53.08 29.59 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.137 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.18 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -55.29 -68.15 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 110.554 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.055 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -43.21 -58.89 2.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.714 -0.616 . . . . 0.0 111.845 -178.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG11 HG12 ' A' ' 74' ' ' ILE . 3.7 t -91.2 -61.14 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.066 -1.021 . . . . 0.0 112.246 -178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.604 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.7 mm? -69.94 -2.07 11.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.037 -1.039 . . . . 0.0 112.168 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.878 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.11 25.97 0.71 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.586 -1.321 . . . . 0.0 111.281 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.055 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -63.37 -37.53 87.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.031 . . . . 0.0 109.761 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' OD2' HD11 ' A' ' 43' ' ' ILE . 55.1 m-20 -64.75 -12.03 42.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.765 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.528 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 64.1 m-80 -130.17 7.83 5.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.456 -0.778 . . . . 0.0 109.889 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.878 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -94.14 -49.57 5.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.323 -0.861 . . . . 0.0 110.263 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.041 HG21 HD13 ' A' ' 38' ' ' ILE . 7.1 p -77.67 -26.21 0.52 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.352 -0.843 . . . . 0.0 112.526 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.738 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -79.39 6.58 5.01 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 O-C-N 122.501 0.737 . . . . 0.0 110.585 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -131.42 -29.07 1.81 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.108 -0.995 . . . . 0.0 110.217 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.613 HD11 HD13 ' A' ' 29' ' ' LEU . 67.2 mt -79.29 -37.6 19.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.296 -0.878 . . . . 0.0 109.755 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.61 91.25 2.31 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.391 -0.818 . . . . 0.0 110.251 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.34 0.01 8.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.01 1.531 . . . . 0.0 110.563 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -90.85 -24.48 20.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.121 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.36 -37.88 13.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.098 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.041 HD13 HG21 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -125.3 133.22 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.0 109.893 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.54 ' HG3' ' CA ' ' A' ' 59' ' ' GLY . 11.5 mttt -72.89 -41.94 64.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.901 . . . . 0.0 110.075 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -179.89 161.22 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 110.19 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 m -125.02 118.34 26.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 110.021 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -124.5 111.21 15.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.533 HD11 ' OD2' ' A' ' 27' ' ' ASP . 21.6 mt -57.86 127.25 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.756 HD13 ' CE ' ' A' ' 55' ' ' LYS . 12.3 tp -90.93 -40.04 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 0.0 110.087 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 1.003 ' O ' HG23 ' A' ' 52' ' ' THR . 0.6 OUTLIER -132.08 156.08 46.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.35 -162.86 18.41 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -141.25 25.51 2.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -1.13 . . . . 0.0 110.059 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.624 ' H ' HG21 ' A' ' 52' ' ' THR . . . 120.66 -10.32 10.49 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.535 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -80.76 -170.57 42.9 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.8 Cg_endo -71.21 132.86 21.78 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.022 1.538 . . . . 0.0 110.443 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.7 -1.55 71.82 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 1.003 HG23 ' O ' ' A' ' 45' ' ' GLU . 22.7 m -80.04 140.35 36.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.17 . . . . 0.0 109.976 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.877 HD13 ' HA ' ' A' ' 70' ' ' LYS . 28.8 mm -110.4 117.87 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 110.382 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 89.5 mttt -104.53 119.33 38.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 0.0 110.159 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.756 ' CE ' HD13 ' A' ' 44' ' ' LEU . 46.9 mttm -88.6 97.69 11.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.388 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' HB ' HG23 ' A' ' 67' ' ' VAL . 93.8 mt -89.58 139.68 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.895 . . . . 0.0 110.018 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 6.6 p -115.51 157.34 24.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.937 . . . . 0.0 110.736 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 26.4 m-85 -117.86 125.28 50.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.423 -0.798 . . . . 0.0 110.15 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.54 ' CA ' ' HG3' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.245 0.545 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.584 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -137.51 92.17 0.21 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 15.9 p90 -132.73 169.44 16.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -1.158 . . . . 0.0 110.131 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.7 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.0 m -142.29 174.94 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.663 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.657 ' O ' HD12 ' A' ' 85' ' ' LEU . 94.1 mttt -132.39 106.49 7.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.731 . . . . 0.0 109.522 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.876 ' CD2' HD13 ' A' ' 85' ' ' LEU . 12.8 m170 -96.28 124.78 40.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 111.419 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.877 ' HA ' HD13 ' A' ' 53' ' ' ILE . 67.6 tttt -98.96 101.65 13.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.448 -0.782 . . . . 0.0 109.02 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.535 HG21 ' O ' ' A' ' 49' ' ' GLY . 22.7 mm -41.69 140.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 17.9 t0 -112.42 -45.58 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.986 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 16.8 m -169.88 157.21 6.62 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.431 -0.793 . . . . 0.0 110.146 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.411 HG12 HG11 ' A' ' 23' ' ' VAL . 1.7 mt -141.48 157.2 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.397 -0.814 . . . . 0.0 109.877 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 2.0 m-20 -144.53 83.64 1.72 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.821 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 82.3 tttt -66.24 -13.22 60.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.363 -0.836 . . . . 0.0 109.888 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -90.79 -30.72 16.84 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.805 0.812 . . . . 0.0 109.157 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.7 m120 -105.52 -4.49 21.19 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.516 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 90.0 m-85 63.57 53.69 2.03 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.297 0.57 . . . . 0.0 110.74 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 13.1 t -127.58 175.34 8.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.961 -1.087 . . . . 0.0 110.455 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.651 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 34.4 t80 -160.02 137.59 9.73 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.612 -0.68 . . . . 0.0 109.744 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 28.7 m -148.0 123.84 10.6 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.129 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.651 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 29.5 p90 -139.41 168.14 20.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.887 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 98' ' ' ILE . 25.4 m -122.19 140.9 52.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 110.228 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.876 HD13 ' CD2' ' A' ' 69' ' ' HIS . 10.7 tp -107.38 132.21 53.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 110.099 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 85' ' ' LEU . 11.5 pt -112.87 -31.67 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 110.353 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.668 ' O ' HD11 ' A' ' 85' ' ' LEU . 7.2 tt0 -116.52 141.63 47.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.898 . . . . 0.0 110.276 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.7 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 167.88 168.08 29.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.71 -28.87 45.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.281 -1.129 . . . . 0.0 110.227 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.73 ' HB1' ' HE1' ' A' ' 132' ' ' HIS . . . -60.99 -32.53 72.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.337 -0.852 . . . . 0.0 110.174 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.965 HD23 ' HG ' ' A' ' 95' ' ' LEU . 6.8 mt -64.64 -44.2 91.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 110.393 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 44.18 -142.53 2.72 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -106.34 27.57 8.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -1.131 . . . . 0.0 110.237 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 122' ' ' THR . 80.8 p -124.74 -45.18 1.92 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 110.126 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.965 ' HG ' HD23 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -102.41 160.57 14.44 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.448 -0.783 . . . . 0.0 109.272 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.863 ' H ' HD12 ' A' ' 95' ' ' LEU . 85.1 mt-10 -135.37 -78.63 0.44 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 110.823 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 57.4 mttt -80.22 134.93 36.16 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.452 -0.78 . . . . 0.0 110.973 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.733 ' O ' HG23 ' A' ' 84' ' ' THR . 4.5 mm -121.36 139.49 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.975 -1.078 . . . . 0.0 109.633 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.3 m -118.45 126.53 52.25 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.187 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.679 ' HE2' HG21 ' A' ' 98' ' ' ILE . 7.3 m-85 -118.84 136.74 53.86 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.529 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -137.17 145.89 44.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.022 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 45.3 m -145.43 152.6 40.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 110.019 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -141.67 140.83 33.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 110.372 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.653 HD23 HG12 ' A' ' 114' ' ' ILE . 8.8 mt -124.24 145.24 49.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.358 -0.839 . . . . 0.0 110.271 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.703 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.22 -169.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.227 -0.921 . . . . 0.0 109.941 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.703 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -118.72 170.33 9.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 110.012 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.2 p -127.54 161.78 52.83 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 110.021 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.58 -8.71 23.76 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.954 1.502 . . . . 0.0 110.387 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.9 p -93.77 -9.5 37.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 110.215 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.02 -36.25 4.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.87 -176.22 6.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 60.5 p -123.67 136.85 54.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -1.146 . . . . 0.0 110.351 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.599 HD12 ' O ' ' A' ' 106' ' ' ALA . 18.8 mt -86.49 150.03 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.838 . . . . 0.0 110.109 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.653 HG12 HD23 ' A' ' 104' ' ' LEU . 6.3 mt -135.42 115.36 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.364 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 103' ' ' LYS . 84.8 tttt -106.42 123.13 47.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 109.873 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 3.5 t -118.45 159.68 23.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -0.979 . . . . 0.0 110.598 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 5' ' ' TYR . 42.5 m -159.56 144.38 15.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.426 -0.796 . . . . 0.0 110.17 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.9 t -141.04 163.46 32.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.15 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.835 ' CE1' HG23 ' A' ' 4' ' ' THR . 82.0 m-70 -143.89 160.98 39.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.915 . . . . 0.0 110.484 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.804 ' O ' HG13 ' A' ' 2' ' ' VAL . 9.6 m-85 -124.85 140.88 52.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.316 -0.865 . . . . 0.0 110.224 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.504 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.8 m-70 -120.92 90.54 3.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 109.762 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.676 HG23 HD11 ' A' ' 128' ' ' ILE . 1.1 p -82.59 150.18 27.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.871 . . . . 0.0 110.364 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.432 ' HB3' ' CD ' ' A' ' 96' ' ' GLU . 78.4 tttt -123.03 129.1 51.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 110.202 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 -162.87 25.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.49 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 0.9 OUTLIER -87.62 54.13 3.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -1.181 . . . . 0.0 110.109 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.48 ' O ' ' HB ' ' A' ' 122' ' ' THR . 17.6 m -135.99 133.39 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.222 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.524 ' HA ' HG21 ' A' ' 122' ' ' THR . 17.9 pt-20 -127.7 165.54 19.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 0.0 110.092 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.676 HD11 HG23 ' A' ' 122' ' ' THR . 3.8 mp -82.8 173.0 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.889 . . . . 0.0 110.042 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.598 ' N ' HG22 ' A' ' 128' ' ' ILE . 75.0 mmtt -106.28 122.83 47.03 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.348 -0.845 . . . . 0.0 110.149 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 131' ' ' GLU . 24.1 pt-20 -43.45 -42.65 4.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 110.145 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.482 ' N ' ' CG ' ' A' ' 130' ' ' GLU . 16.5 pt-20 -58.16 -29.33 65.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.206 -0.934 . . . . 0.0 109.896 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.73 ' HE1' ' HB1' ' A' ' 90' ' ' ALA . 11.7 t-80 -74.36 -55.5 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.189 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.6 p -61.62 -39.39 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.387 -0.821 . . . . 0.0 110.009 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.515 ' N ' HG13 ' A' ' 133' ' ' VAL . 84.0 tttt -65.52 -45.83 81.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.84 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.39 87.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.89 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.08 -30.82 74.14 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 137' ' ' LYS . 59.0 mmtt -65.91 -34.75 78.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -1.106 . . . . 0.0 109.872 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -69.91 -35.62 74.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.859 . . . . 0.0 109.839 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -71.68 -29.95 65.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.738 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.31 -40.87 42.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.99 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.2 p -59.44 -45.3 91.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.752 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -56.44 -43.85 79.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.841 . . . . 0.0 109.779 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 39.4 tp -57.68 -47.31 82.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.767 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.474 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 29.3 m-85 -53.68 -44.57 69.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.648 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -75.78 -14.58 60.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.32 -0.862 . . . . 0.0 109.925 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.446 ' HB3' HG21 ' A' ' 33' ' ' ILE . 20.1 mt -83.2 -36.67 24.47 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.209 -0.932 . . . . 0.0 108.692 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.62 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 96.0 mt -67.16 -47.4 81.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.789 ' HB3' HD13 ' A' ' 13' ' ' ILE . 5.9 mm-40 -51.49 -47.09 63.33 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.388 -0.82 . . . . 0.0 109.218 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.6 m -63.15 -40.52 97.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.593 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.728 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 79.6 t80 -47.12 -51.84 16.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.97 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.14 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 80.3 mt -76.27 -37.97 56.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.789 . . . . 0.0 110.366 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.877 ' HB2' HD11 ' A' ' 13' ' ' ILE . 19.4 tptt -59.31 -16.9 24.8 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.166 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.493 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -117.61 -27.02 2.69 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 5.2 m80 -106.28 91.89 6.19 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.266 -1.137 . . . . 0.0 110.167 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.1 Cg_endo -73.13 3.3 4.69 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.986 1.519 . . . . 0.0 111.006 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -119.0 -2.26 10.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.022 -1.049 . . . . 0.0 110.299 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.728 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -67.22 99.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.23 -0.918 . . . . 0.0 110.397 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.18 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 11.5 p90 37.55 23.45 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.55 -0.719 . . . . 0.0 112.346 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.727 ' OD1' HD22 ' A' ' 151' ' ' LEU . 9.1 m-80 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 120.473 -1.392 . . . . 0.0 109.992 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 85.8 t -101.04 119.23 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -1.114 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.597 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 77.6 m-85 -83.68 161.57 21.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.23 -0.919 . . . . 0.0 110.139 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.823 HG23 ' CE1' ' A' ' 119' ' ' HIS . 55.4 m -143.61 99.92 3.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CE2' HG22 ' A' ' 133' ' ' VAL . 77.9 m-85 -116.37 126.5 53.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.179 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.596 ' CG ' ' N ' ' A' ' 7' ' ' SER . 3.6 tt0 -126.16 178.57 5.71 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.204 -0.935 . . . . 0.0 109.89 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.596 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -155.56 -179.08 7.76 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.76 -0.587 . . . . 0.0 109.751 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 7' ' ' SER . 73.1 mt-10 -156.09 117.02 3.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 110.378 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 2.5 p90 -137.58 -174.05 3.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.213 -0.93 . . . . 0.0 109.954 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.817 HG22 ' HA ' ' A' ' 113' ' ' ILE . 4.4 p -142.15 173.94 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.718 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.432 ' HB2' ' CD ' ' A' ' 148' ' ' GLU . 85.8 p -150.26 147.96 28.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.432 -0.793 . . . . 0.0 110.065 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -72.03 -24.81 61.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.917 . . . . 0.0 110.138 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.8 HG23 ' HD2' ' A' ' 14' ' ' PRO . 6.1 mm -79.18 151.17 75.32 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.828 . . . . 0.0 109.979 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.8 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -65.03 147.46 88.94 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.102 1.58 . . . . 0.0 110.394 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.673 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.6 Cg_endo -69.86 -32.46 18.11 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.006 1.529 . . . . 0.0 113.043 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.4 Cg_endo -67.66 -23.29 42.71 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 122.472 0.722 . . . . 0.0 110.233 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.875 ' HB3' HD13 ' A' ' 151' ' ' LEU . 6.0 mmp_? -82.26 -47.25 12.64 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.98 HD22 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.54 -29.62 69.06 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.429 -0.908 . . . . 0.0 108.905 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.9 t80 -63.44 -55.45 24.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.1 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.0 mttt -49.13 -50.76 35.85 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.984 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.156 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -56.77 -70.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.623 0.725 . . . . 0.0 111.089 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.067 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -43.68 -57.45 3.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.633 -0.667 . . . . 0.0 112.138 -178.626 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.625 ' HB ' HD12 ' A' ' 24' ' ' LEU . 7.1 t -90.27 -60.42 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.057 . . . . 0.0 112.386 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 24' ' ' LEU . 6.7 mp -73.35 0.59 11.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.054 -1.029 . . . . 0.0 112.114 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.892 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -153.52 27.77 0.5 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.59 -1.319 . . . . 0.0 111.233 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.067 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -64.24 -40.35 95.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.047 -1.033 . . . . 0.0 109.721 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.513 ' OD2' ' CG1' ' A' ' 43' ' ' ILE . 83.0 m-20 -64.91 -11.03 33.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.478 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.433 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 5.5 m-20 -125.13 3.17 7.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.537 -0.727 . . . . 0.0 109.662 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.909 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -94.9 -47.12 6.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 -179.572 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.954 ' CG2' HD13 ' A' ' 38' ' ' ILE . 9.4 p -75.38 -26.9 0.65 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.91 . . . . 0.0 112.373 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.779 ' HD3' HG12 ' A' ' 30' ' ' VAL . 50.5 Cg_endo -79.18 7.27 4.49 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 122.435 0.703 . . . . 0.0 110.593 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -135.77 -30.9 0.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.225 -0.922 . . . . 0.0 110.381 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.909 HD11 ' CD1' ' A' ' 29' ' ' LEU . 64.5 mt -75.07 -39.74 44.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.331 -0.856 . . . . 0.0 109.56 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.64 87.58 2.55 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.396 -0.815 . . . . 0.0 110.171 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.57 -1.32 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.115 1.587 . . . . 0.0 110.516 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -90.22 -19.46 24.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.944 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.35 -36.08 10.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.848 . . . . 0.0 110.317 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.954 HD13 ' CG2' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -125.38 139.68 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 110.021 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 27.1 ttmt -78.09 -41.45 35.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.456 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 178.71 164.77 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 110.131 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.411 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 1.7 m -121.53 122.27 39.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 110.028 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -126.54 107.18 10.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.188 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.513 ' CG1' ' OD2' ' A' ' 27' ' ' ASP . 14.6 mt -56.11 131.58 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 55' ' ' LYS . 58.7 mt -89.1 -23.72 22.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.124 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 1.06 ' O ' HG23 ' A' ' 52' ' ' THR . 41.1 tt0 -157.64 175.05 14.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 110.303 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 53.44 -160.33 3.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -137.66 16.71 2.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -1.103 . . . . 0.0 110.264 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.464 ' H ' HG21 ' A' ' 52' ' ' THR . . . 118.72 7.57 10.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -98.89 -166.63 30.5 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.1 Cg_endo -70.78 132.08 21.01 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.081 1.569 . . . . 0.0 110.551 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.8 -7.48 70.53 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 1.06 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.1 m -80.01 143.41 34.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -1.133 . . . . 0.0 110.097 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.619 HD13 ' HA ' ' A' ' 70' ' ' LYS . 32.9 mm -112.4 124.27 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.216 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.448 ' NZ ' HD11 ' A' ' 71' ' ' ILE . 66.9 mttt -107.58 147.58 30.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.332 -0.855 . . . . 0.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB2' HD11 ' A' ' 44' ' ' LEU . 75.0 tttt -120.85 90.21 3.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.482 ' CG2' HG12 ' A' ' 38' ' ' ILE . 94.5 mt -80.57 143.01 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.6 p -113.51 160.42 18.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.669 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.831 ' HE2' HG13 ' A' ' 67' ' ' VAL . 27.9 m-85 -118.78 137.93 53.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.466 -0.771 . . . . 0.0 110.202 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.206 0.527 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -136.05 137.12 8.88 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.5 p90 -179.32 164.05 1.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -1.082 . . . . 0.0 110.068 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.066 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.7 m -142.39 171.99 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.92 . . . . 0.0 110.663 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -125.43 123.86 40.2 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.601 ' CD2' ' HG ' ' A' ' 85' ' ' LEU . 13.3 m170 -116.52 138.26 51.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.023 -1.048 . . . . 0.0 111.327 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HA ' HD13 ' A' ' 53' ' ' ILE . 78.1 tttt -115.9 112.28 21.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.481 -0.762 . . . . 0.0 109.105 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.53 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 32.7 mm -49.0 136.63 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.96 . . . . 0.0 110.459 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 4.4 t0 -107.61 -50.11 3.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.396 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.482 ' HB2' ' OG ' ' A' ' 82' ' ' SER . 17.6 m -168.79 157.07 8.04 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.483 -0.76 . . . . 0.0 109.423 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.3 mt -134.94 157.94 41.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.078 -1.014 . . . . 0.0 110.616 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.563 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.9 m-20 -130.9 76.85 1.75 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.597 -0.69 . . . . 0.0 110.24 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.566 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 66.9 mttt -61.78 -12.75 18.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 109.918 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -96.4 -30.53 13.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 109.516 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.3 m120 -107.97 -1.44 20.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.661 -0.649 . . . . 0.0 109.744 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.837 ' O ' HD12 ' A' ' 104' ' ' LEU . 87.2 m-85 61.11 52.36 4.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.729 . . . . 0.0 109.89 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.563 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -123.49 156.65 35.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 109.575 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.53 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 20.1 t80 -141.87 133.92 27.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.913 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 73' ' ' SER . 70.4 p -139.1 119.49 13.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.852 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 3.2 p90 -130.89 179.12 6.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.986 HG23 ' O ' ' A' ' 98' ' ' ILE . 21.9 m -130.85 136.94 49.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.967 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.657 HD23 ' H ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -95.41 134.72 37.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.551 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.0 pt -114.83 -6.11 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.895 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.657 ' H ' HD23 ' A' ' 85' ' ' LEU . 87.3 tt0 -168.24 113.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.361 -0.837 . . . . 0.0 110.556 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 1.066 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -153.22 130.34 2.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -48.48 -26.7 2.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -1.162 . . . . 0.0 110.432 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.577 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -68.65 -17.32 64.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 110.456 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.802 HD21 HG13 ' A' ' 98' ' ' ILE . 60.3 mt -63.96 -13.0 42.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 110.245 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 94' ' ' THR . . . 65.62 26.76 72.09 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 50.64 21.05 0.82 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.229 -1.159 . . . . 0.0 110.2 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 92' ' ' GLY . 18.5 p -122.56 -33.07 3.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.084 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.792 HD11 HD11 ' A' ' 128' ' ' ILE . 2.3 mm? -80.04 170.27 16.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 110.283 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HG3' ' HB3' ' A' ' 123' ' ' LYS . 60.9 mm-40 -137.0 -79.4 0.39 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.48 -0.763 . . . . 0.0 109.611 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 58.6 mttt -80.32 127.46 32.4 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.204 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.986 ' O ' HG23 ' A' ' 84' ' ' THR . 18.4 mm -118.52 147.68 21.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.658 -1.276 . . . . 0.0 110.237 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -126.13 128.37 47.22 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.441 -0.787 . . . . 0.0 109.278 178.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.741 ' CE2' HG21 ' A' ' 98' ' ' ILE . 13.8 m-85 -126.7 131.9 51.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 110.017 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -135.96 136.23 40.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.925 . . . . 0.0 110.575 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.5 m -132.5 143.95 50.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.414 -0.804 . . . . 0.0 109.724 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 115' ' ' LYS . 5.0 mttt -136.18 143.77 44.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 0.0 110.482 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 79' ' ' TYR . 5.5 mt -118.8 151.06 38.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.244 -0.91 . . . . 0.0 110.49 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.73 -168.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 109.814 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.716 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.51 157.96 28.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 110.189 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 33.2 p -118.22 165.44 16.35 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.897 . . . . 0.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -72.88 -1.35 10.31 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.02 1.537 . . . . 0.0 110.495 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.0 m -105.56 -0.65 25.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.902 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.21 -36.11 4.59 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.93 -171.46 0.75 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.504 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 6.1 p -131.3 134.38 46.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -1.096 . . . . 0.0 110.228 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.817 ' HA ' HG22 ' A' ' 10' ' ' THR . 12.2 mt -84.33 148.07 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.81 HG12 HD23 ' A' ' 104' ' ' LEU . 9.1 mt -130.71 113.71 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.295 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 7.0 ttmt -87.4 138.58 31.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.162 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 1.1 p -124.43 132.04 53.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 110.257 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.507 HG23 ' HB2' ' A' ' 6' ' ' GLU . 62.0 m -148.22 123.25 10.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 110.533 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.7 m -130.91 164.9 24.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 109.886 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.823 ' CE1' HG23 ' A' ' 4' ' ' THR . 30.8 m-70 -142.12 170.62 15.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.115 -0.991 . . . . 0.0 110.096 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.536 ' HB3' ' CD1' ' A' ' 95' ' ' LEU . 26.2 m-85 -136.24 147.32 47.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.496 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 83.6 m-70 -128.35 88.75 2.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.399 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.586 HG22 HD22 ' A' ' 95' ' ' LEU . 4.2 p -68.9 161.26 29.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.849 . . . . 0.0 110.711 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.475 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 33.0 ttmt -152.48 94.72 1.94 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 110.314 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 133.5 35.94 0.27 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 3.3 t30 63.61 56.59 1.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.171 -1.193 . . . . 0.0 110.252 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.541 HG23 ' CG2' ' A' ' 122' ' ' THR . 8.4 m -142.86 145.82 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 110.005 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.75 179.04 5.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.358 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.792 HD11 HD11 ' A' ' 95' ' ' LEU . 16.2 mm -84.67 173.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.21 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.593 ' N ' HG22 ' A' ' 128' ' ' ILE . 18.8 mtpt -117.63 136.82 53.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.009 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -43.61 -41.09 4.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.166 -0.958 . . . . 0.0 110.245 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 51.4 tt0 -64.38 -26.13 68.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.091 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 13.8 t-160 -77.91 -48.46 16.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.649 HG22 ' CE2' ' A' ' 5' ' ' TYR . 69.1 t -56.26 -32.08 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 109.867 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -90.8 -51.37 5.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -57.9 -32.76 68.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.84 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.08 -33.81 62.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 141' ' ' SER . 52.5 mmtt -78.55 -32.89 48.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -1.122 . . . . 0.0 109.982 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -73.43 -34.97 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.887 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -70.7 -43.45 68.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.798 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -72.49 -31.12 65.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 109.947 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 22.7 t -64.76 -54.0 38.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.395 -0.815 . . . . 0.0 109.928 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -51.78 -49.78 62.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.705 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 24.0 mt -52.91 -41.66 64.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 110.059 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 16.7 m-85 -59.87 -50.88 72.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.689 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 75.7 tttt -63.44 -13.67 42.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.915 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.541 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 13.1 mt -85.2 -37.77 19.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.213 -0.93 . . . . 0.0 108.813 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.749 ' CG2' HD23 ' A' ' 18' ' ' LEU . 33.8 mt -69.56 -45.3 78.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 13' ' ' ILE . 67.8 mm-40 -51.56 -38.15 52.97 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.286 -0.884 . . . . 0.0 108.785 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 88.3 m -72.36 -38.1 68.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.303 -0.873 . . . . 0.0 109.01 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.818 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 66.2 t80 -44.19 -54.84 5.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.465 -0.772 . . . . 0.0 109.604 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.121 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 78.5 mt -75.41 -29.07 59.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.467 -0.771 . . . . 0.0 110.267 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 149' ' ' THR . 39.3 tttp -69.48 -13.27 62.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.715 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -123.63 -26.46 1.59 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -110.77 89.64 9.58 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 0.0 110.378 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.31 0.33 8.13 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.037 1.546 . . . . 0.0 110.559 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -111.92 12.72 20.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.882 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.818 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -86.57 101.25 13.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.416 -0.802 . . . . 0.0 110.282 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.156 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 8.9 p90 38.52 21.8 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.689 -0.632 . . . . 0.0 112.354 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.551 ' OD1' HD22 ' A' ' 151' ' ' LEU . 33.4 m-20 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 120.415 -1.428 . . . . 0.0 110.12 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.956 HG13 ' O ' ' A' ' 120' ' ' TYR . 86.3 t -108.77 139.82 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -1.172 . . . . 0.0 110.223 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.644 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 16.3 m-85 -103.01 129.8 49.89 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.238 -0.914 . . . . 0.0 109.826 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.823 HG23 ' CE1' ' A' ' 119' ' ' HIS . 19.3 m -104.68 107.83 18.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.859 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.57 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 33.9 m-85 -116.27 124.92 51.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.552 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 116' ' ' SER . 23.1 pt-20 -122.63 164.17 18.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.15 -0.969 . . . . 0.0 111.035 -179.083 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.512 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.2 p -125.32 167.63 14.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.568 -0.707 . . . . 0.0 110.272 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 7' ' ' SER . 18.2 mt-10 -160.19 120.15 2.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.924 ' HB2' HD13 ' A' ' 114' ' ' ILE . 76.5 m-85 -141.18 -166.01 2.08 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.789 -1.194 . . . . 0.0 111.552 -178.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 9' ' ' PHE . 25.5 p -158.32 155.29 28.52 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.758 0.789 . . . . 0.0 110.368 178.31 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.527 ' O ' ' CA ' ' A' ' 111' ' ' GLY . 83.6 p -159.29 146.23 16.93 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.791 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -70.55 -32.93 70.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 110.046 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.777 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.0 mm -58.99 149.96 63.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.863 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.777 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.8 Cg_endo -65.47 144.27 78.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.0 1.526 . . . . 0.0 110.585 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.661 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 Cg_endo -72.05 -31.61 12.05 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 124.023 1.538 . . . . 0.0 112.802 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -70.19 -21.51 31.37 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 N-CA-C 110.042 -0.791 . . . . 0.0 110.042 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.964 ' HG2' HD13 ' A' ' 151' ' ' LEU . 10.3 ttm180 -83.2 -47.16 11.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.759 ' C ' HD23 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -68.01 -27.62 66.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.933 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.51 ' N ' HD23 ' A' ' 18' ' ' LEU . 52.0 t80 -68.24 -55.75 11.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.474 -0.766 . . . . 0.0 109.378 179.079 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 89.6 mttt -50.27 -37.83 37.95 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.244 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.029 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -70.89 -57.82 4.22 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.687 0.756 . . . . 0.0 110.943 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.961 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -54.46 -54.33 42.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.556 -0.715 . . . . 0.0 111.843 -178.669 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.704 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.0 t -92.82 -62.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.078 -1.014 . . . . 0.0 111.964 -178.425 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 24' ' ' LEU . 6.7 mp -69.09 0.23 4.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.197 -0.939 . . . . 0.0 111.974 -178.291 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.819 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -150.18 24.33 0.82 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.736 -1.228 . . . . 0.0 111.014 -179.99 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.961 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -63.24 -37.98 89.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.011 -1.056 . . . . 0.0 110.135 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 33.9 m-20 -63.49 -13.96 46.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.109 -0.994 . . . . 0.0 110.099 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.512 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 84.2 m-20 -128.3 10.46 6.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.826 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.819 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -96.41 -53.73 3.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 110.51 -179.871 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.86 HG22 ' HD3' ' A' ' 31' ' ' PRO . 1.9 m -74.69 -29.31 0.91 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 111.97 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.86 ' HD3' HG22 ' A' ' 30' ' ' VAL . 49.5 Cg_endo -79.18 4.58 6.44 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 122.851 0.921 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -125.17 -35.29 2.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 109.109 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.773 HG21 ' HB3' ' A' ' 146' ' ' LEU . 40.5 mt -79.96 -24.32 11.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.549 0.69 . . . . 0.0 109.235 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.92 95.43 0.4 Allowed Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.618 -0.676 . . . . 0.0 109.78 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.68 0.22 7.94 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.041 1.548 . . . . 0.0 110.655 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -89.52 5.95 43.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.238 -0.914 . . . . 0.0 109.872 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.667 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -113.89 -55.35 2.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 110.013 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.667 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.9 mp -115.11 132.14 65.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 110.029 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -79.99 -35.07 37.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.286 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.455 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -177.26 151.98 0.83 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.0 109.96 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.8 m -115.53 130.83 57.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.24 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 85.6 tt0 -137.79 110.59 7.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 0.0 110.207 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.1 mt -62.25 135.51 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.302 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 tp -87.9 -25.61 23.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.988 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 1.029 ' O ' HG23 ' A' ' 52' ' ' THR . 28.8 tp10 -161.45 170.28 20.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 59.32 -169.69 6.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.7 23.39 6.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -1.155 . . . . 0.0 110.252 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.493 ' H ' HG21 ' A' ' 52' ' ' THR . . . 111.07 1.45 28.38 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.496 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -86.0 -169.46 45.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.3 Cg_endo -70.96 131.85 20.3 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.015 1.534 . . . . 0.0 110.468 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.21 -6.59 68.88 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' THR . . . . . 1.029 HG23 ' O ' ' A' ' 45' ' ' GLU . 14.8 m -80.04 142.3 35.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -1.104 . . . . 0.0 109.961 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.607 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.3 mm -110.68 122.11 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 110.155 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 84.7 mttt -105.88 144.63 32.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 110.23 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -117.86 87.61 2.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 110.218 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.409 ' HB ' HG23 ' A' ' 67' ' ' VAL . 90.6 mt -80.01 144.39 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 110.331 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.509 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.7 p -111.48 164.2 13.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.766 ' HE2' HG13 ' A' ' 67' ' ' VAL . 25.9 m-85 -115.32 155.36 27.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 110.434 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.434 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 8.6 t80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.191 0.52 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -128.81 135.3 8.43 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.4 p90 -178.73 162.84 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -1.167 . . . . 0.0 110.211 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.937 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.5 m -141.9 172.79 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -0.819 . . . . 0.0 110.512 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 88.5 mttt -124.49 129.41 50.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.575 -0.703 . . . . 0.0 109.449 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.642 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -118.14 123.98 46.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.15 -0.969 . . . . 0.0 111.034 -179.151 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.607 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.0 tttt -100.32 113.64 26.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 25.8 mm -54.52 135.36 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.901 . . . . 0.0 110.468 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 1.6 t70 -110.16 -42.99 4.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 109.601 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 82' ' ' SER . 25.5 m -169.75 157.49 6.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 109.896 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mt -141.59 156.15 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 110.456 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.0 m-20 -136.18 79.04 1.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.576 -0.702 . . . . 0.0 109.991 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 78.4 mttt -62.62 -16.89 58.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.385 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -93.05 -30.72 15.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 109.529 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -103.87 -6.12 21.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.545 -0.722 . . . . 0.0 109.694 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.582 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.2 m-85 65.36 52.13 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 109.988 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.536 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -124.91 154.97 40.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.839 . . . . 0.0 109.782 179.706 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.704 ' CE1' HG13 ' A' ' 23' ' ' VAL . 22.3 t80 -142.5 128.81 19.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.352 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 37.6 m -131.89 121.24 23.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.471 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 21.9 p90 -138.64 170.97 15.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.359 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 98' ' ' ILE . 98.9 m -123.46 132.6 53.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 109.893 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.747 HD21 HD11 ' A' ' 91' ' ' LEU . 3.1 tp -98.87 136.45 38.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.081 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.0 pt -119.46 -16.99 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.532 ' O ' HD11 ' A' ' 85' ' ' LEU . 23.9 tt0 -133.09 150.08 52.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.143 -0.973 . . . . 0.0 110.488 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.937 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 165.46 142.31 3.38 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -65.73 -35.35 80.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -1.156 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.735 ' HB1' ' HE2' ' A' ' 132' ' ' HIS . . . -65.13 -26.17 68.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 110.13 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.786 HD12 ' N ' ' A' ' 88' ' ' GLY . 35.3 mt -65.48 -25.38 67.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.181 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.84 -167.63 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -87.28 8.04 25.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -1.184 . . . . 0.0 110.149 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.695 ' O ' HG21 ' A' ' 126' ' ' VAL . 60.6 p -93.88 -40.33 10.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.151 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.001 HD23 HG23 ' A' ' 122' ' ' THR . 22.5 mt -102.11 155.04 18.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.027 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -134.65 -78.84 0.45 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.219 -0.925 . . . . 0.0 110.284 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 50.8 mttt -80.13 132.93 36.02 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.407 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.765 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.5 mm -124.77 136.93 59.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.734 -1.228 . . . . 0.0 110.06 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -116.3 127.1 54.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.74 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.765 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.4 m-85 -122.65 135.59 54.64 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 111.148 -178.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 117' ' ' THR . 4.2 mt-10 -133.0 133.26 42.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.567 -0.708 . . . . 0.0 109.658 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 81' ' ' TYR . 36.1 m -132.07 134.09 45.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.0 -1.062 . . . . 0.0 110.124 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.5 tttt -133.93 147.68 51.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 110.252 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 79' ' ' TYR . 22.7 mt -117.89 142.22 47.57 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.399 -0.813 . . . . 0.0 110.148 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.6 t -131.42 -172.64 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 0.0 110.371 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.637 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -118.13 148.53 42.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 110.454 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.438 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 52.9 p -106.92 163.78 16.23 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 110.366 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 44.4 Cg_endo -72.26 -2.13 11.19 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.017 1.535 . . . . 0.0 110.403 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.1 m -103.59 -7.17 20.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.072 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.79 -16.03 31.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 11' ' ' SER . . . -79.08 -171.66 41.03 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' SER . 42.1 p -128.81 122.31 30.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 110.221 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 10' ' ' THR . 7.0 mt -79.98 139.64 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.464 -0.772 . . . . 0.0 110.79 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.924 HD13 ' HB2' ' A' ' 9' ' ' PHE . 3.7 mp -93.02 151.88 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.049 179.076 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 103' ' ' LYS . 16.9 tttt -149.87 99.71 2.87 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 109.365 178.436 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 20.9 t -116.13 174.8 5.85 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.357 -0.839 . . . . 0.0 111.257 -178.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.572 HG22 ' CE1' ' A' ' 119' ' ' HIS . 31.4 m -160.07 128.97 4.98 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 5' ' ' TYR . 38.9 t -122.9 156.68 34.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.042 -1.036 . . . . 0.0 110.421 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.823 ' CE1' HG23 ' A' ' 4' ' ' THR . 76.7 m-70 -140.48 123.65 16.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.35 -0.844 . . . . 0.0 110.371 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.956 ' O ' HG13 ' A' ' 2' ' ' VAL . 8.8 m-30 -93.87 149.79 20.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -0.871 . . . . 0.0 110.416 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 91.9 m-70 -127.65 84.82 2.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 109.743 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' THR . . . . . 1.001 HG23 HD23 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -67.39 152.64 45.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.406 -0.809 . . . . 0.0 110.618 -179.545 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -115.31 113.58 24.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 110.132 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.0 -145.74 16.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 2.1 p-10 -104.53 54.67 0.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.208 -1.172 . . . . 0.0 110.237 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.695 HG21 ' O ' ' A' ' 94' ' ' THR . 10.8 m -116.88 156.33 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 9.8 pm0 -143.7 157.1 44.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.051 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.688 ' CG1' HD21 ' A' ' 95' ' ' LEU . 2.9 mp -78.27 173.29 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.126 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.602 ' N ' HG22 ' A' ' 128' ' ' ILE . 23.0 mttt -110.88 151.34 27.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.951 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.44 -31.88 64.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -0.975 . . . . 0.0 110.205 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -65.33 -40.87 94.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 109.982 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.735 ' HE2' ' HB1' ' A' ' 90' ' ' ALA . 17.2 t-160 -66.81 -45.5 78.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 110.043 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.57 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 61.2 t -62.89 -41.11 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -76.42 -42.01 45.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.65 96.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.959 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.51 -30.1 76.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.433 ' HE3' HG12 ' A' ' 133' ' ' VAL . 88.5 mttt -75.31 -32.81 61.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -1.137 . . . . 0.0 110.042 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -76.3 -34.32 59.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -0.863 . . . . 0.0 109.903 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.97 -34.77 64.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 179.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.5 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.51 -30.55 61.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.928 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.4 p -68.72 -50.99 46.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.904 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.421 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 82.5 m-20 -51.36 -44.48 62.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 18.7 tp -57.15 -50.05 74.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.867 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 25.9 m-85 -53.84 -39.57 65.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.431 -0.793 . . . . 0.0 109.765 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.447 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 32.3 mttp -78.51 -13.61 59.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.933 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.773 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.2 mt -84.81 -36.66 21.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.23 -0.919 . . . . 0.0 108.889 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.648 HD11 ' CE1' ' A' ' 22' ' ' PHE . 36.7 mt -70.47 -43.93 77.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 13' ' ' ILE . 52.3 mt-10 -59.27 -37.68 78.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.426 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 98.7 m -77.2 -38.9 50.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 179.471 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.656 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.7 t80 -52.6 -49.15 65.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.903 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.181 HD21 ' CE2' ' A' ' 158' ' ' TYR . 82.3 mt -79.03 -33.45 44.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 109.99 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.538 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 38.9 tttt -70.61 -16.97 62.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.347 179.237 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.77 -32.59 2.23 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 6.2 m80 -109.41 94.8 16.81 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.389 -1.066 . . . . 0.0 109.978 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.34 6.75 2.92 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.061 1.559 . . . . 0.0 111.048 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -110.48 2.78 19.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.062 -1.024 . . . . 0.0 109.86 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.656 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -83.23 103.61 12.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.181 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.57 32.44 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.747 -0.596 . . . . 0.0 110.532 -179.667 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.709 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.903 HG13 ' O ' ' A' ' 120' ' ' TYR . 73.2 t -130.33 122.01 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -1.226 . . . . 0.0 110.212 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.609 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 89.5 m-85 -73.69 147.42 43.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 110.138 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.834 HG23 ' CE1' ' A' ' 119' ' ' HIS . 52.9 m -129.32 119.57 24.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.242 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.171 ' CE2' HG21 ' A' ' 133' ' ' VAL . 61.6 m-85 -130.97 151.76 51.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.121 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -145.18 150.45 36.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 110.282 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.48 ' OG ' ' HB3' ' A' ' 116' ' ' SER . 78.0 p -132.37 148.51 52.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.838 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -136.67 117.17 13.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.102 -0.999 . . . . 0.0 110.625 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 p90 -141.18 -177.17 4.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.39 -0.819 . . . . 0.0 109.733 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.5 HG22 HG12 ' A' ' 113' ' ' ILE . 27.2 p -136.75 -179.25 5.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 110.838 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 148' ' ' GLU . 11.8 t -159.92 170.38 21.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 110.17 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -93.82 -21.76 19.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.819 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.6 mp -80.98 150.4 68.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.819 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.1 Cg_endo -66.51 145.49 76.78 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.991 1.522 . . . . 0.0 110.783 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.66 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 Cg_endo -72.14 -31.5 11.96 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 124.126 1.593 . . . . 0.0 112.993 -179.184 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.7 Cg_endo -69.3 -20.65 36.74 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 N-CA-C 109.724 -0.914 . . . . 0.0 109.724 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 1.033 ' HB3' HD13 ' A' ' 151' ' ' LEU . 1.3 mmp_? -82.74 -47.81 11.55 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.803 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.766 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.2 tt -67.94 -25.32 65.4 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.684 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.63 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 70.9 t80 -66.84 -61.2 2.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.512 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.616 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 34.3 mttp -49.0 -37.9 21.74 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.129 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -62.4 -66.32 0.56 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.803 0.811 . . . . 0.0 110.897 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.041 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -54.59 -47.48 73.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.842 -0.537 . . . . 0.0 111.959 -178.199 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.102 HG11 ' CD1' ' A' ' 74' ' ' ILE . 3.0 t -96.14 -64.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.87 -1.144 . . . . 0.0 112.154 -178.466 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.668 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.9 mm? -68.69 -3.63 12.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.051 -1.031 . . . . 0.0 111.644 -178.285 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.598 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -139.62 4.0 2.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.772 -1.205 . . . . 0.0 111.019 -179.706 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.041 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -42.57 -26.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.138 -0.976 . . . . 0.0 110.183 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 56.4 m-20 -74.7 -40.78 61.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.931 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -106.48 24.24 12.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.891 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.887 HD12 ' C ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -106.11 -62.16 1.42 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 -179.867 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.027 HG11 HD13 ' A' ' 38' ' ' ILE . 44.7 t -61.92 -40.88 72.94 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.493 -0.754 . . . . 0.0 111.203 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -78.37 9.28 3.2 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.353 1.186 . . . . 0.0 110.827 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HD2' ' OH ' ' A' ' 150' ' ' TYR . 17.7 mttt -121.87 -28.31 4.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.997 -1.064 . . . . 0.0 109.457 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.783 HG21 ' HB3' ' A' ' 146' ' ' LEU . 29.0 mt -79.99 -56.86 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.516 -0.74 . . . . 0.0 109.767 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.62 106.14 2.9 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.476 -0.765 . . . . 0.0 110.085 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.21 1.22 6.91 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.661 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -86.54 -9.47 56.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.952 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.09 -36.27 9.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 110.187 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.027 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mt -136.49 149.74 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.332 -0.855 . . . . 0.0 110.009 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.542 ' CG ' ' HA2' ' A' ' 59' ' ' GLY . 10.5 mttt -78.9 -50.26 11.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 110.003 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -173.01 160.11 4.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.452 -0.78 . . . . 0.0 109.977 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.7 m -119.02 126.63 52.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.143 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -135.64 103.09 5.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 110.379 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 18.9 mt -50.42 131.32 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.3 tp -91.31 -46.55 7.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.253 -0.904 . . . . 0.0 110.218 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.855 ' O ' HG23 ' A' ' 52' ' ' THR . 3.9 mm-40 -132.63 136.97 46.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.246 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.82 -168.41 34.33 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -131.29 12.58 5.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -1.16 . . . . 0.0 110.255 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.507 ' H ' HG21 ' A' ' 52' ' ' THR . . . 122.47 -6.22 9.92 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -84.15 -168.31 43.76 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.2 Cg_endo -70.71 135.91 29.27 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.024 1.539 . . . . 0.0 110.501 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.75 -5.49 79.6 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.8 m -80.1 143.18 34.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -1.115 . . . . 0.0 110.042 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.777 HG21 ' HE3' ' A' ' 68' ' ' LYS . 29.2 mm -110.08 125.46 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.278 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 40.2 mtmt -108.29 139.7 42.62 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.365 -0.835 . . . . 0.0 110.083 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -112.9 89.94 3.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 110.129 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.46 ' CG2' HG12 ' A' ' 38' ' ' ILE . 88.8 mt -83.18 139.04 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.215 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 38' ' ' ILE . 6.7 p -110.27 160.81 16.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.494 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.751 ' HE2' HG13 ' A' ' 67' ' ' VAL . 27.3 m-85 -120.64 124.37 45.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -0.812 . . . . 0.0 110.377 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' HA2' ' CG ' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.443 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 9.2 t80 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.291 0.567 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -127.82 136.7 9.36 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.9 p90 -179.66 161.19 0.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -1.088 . . . . 0.0 109.989 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.768 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.6 m -143.27 172.38 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.633 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.777 ' HE3' HG21 ' A' ' 53' ' ' ILE . 75.4 tttt -123.65 118.23 26.8 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -110.54 133.58 53.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.989 -1.069 . . . . 0.0 111.379 -178.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.542 ' HA ' HD13 ' A' ' 53' ' ' ILE . 77.1 tttt -111.12 119.23 38.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.563 -0.711 . . . . 0.0 109.218 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.531 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 42.2 mm -53.15 143.83 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 110.51 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.3 m-20 -117.49 -31.83 5.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.375 -0.828 . . . . 0.0 109.703 179.52 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 2.2 p 168.28 157.43 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 110.15 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.102 ' CD1' HG11 ' A' ' 23' ' ' VAL . 4.1 tt -153.59 165.62 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.3 -0.875 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -140.64 83.97 1.92 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.251 -0.906 . . . . 0.0 109.977 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.563 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 85.6 tttt -58.62 -12.53 4.21 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.29 -0.881 . . . . 0.0 110.776 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 17.5 mm-40 -85.46 -34.41 21.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.191 -0.943 . . . . 0.0 108.918 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.3 m120 -109.4 -1.97 18.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.63 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 9.7 m-85 65.95 49.81 1.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.343 0.592 . . . . 0.0 110.449 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.544 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -115.32 157.89 23.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.108 -0.995 . . . . 0.0 109.129 179.19 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.593 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 80.8 t80 -160.02 150.18 18.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.016 -1.052 . . . . 0.0 110.116 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.418 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 9.7 t -160.98 150.52 17.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.94 . . . . 0.0 110.585 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.9 p90 -151.69 -171.13 3.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.51 -0.744 . . . . 0.0 109.871 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.921 HG23 ' O ' ' A' ' 98' ' ' ILE . 54.0 m -132.64 135.91 46.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.364 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.697 HD12 ' HE2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -94.18 116.09 28.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.231 -0.918 . . . . 0.0 110.096 179.765 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.731 HD11 ' HD3' ' A' ' 68' ' ' LYS . 16.7 pt -107.82 -10.54 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.199 -0.938 . . . . 0.0 110.112 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -138.81 126.52 22.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.84 . . . . 0.0 110.044 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.768 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -179.86 145.36 6.44 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 44.3 p-10 -65.16 -9.86 26.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -1.143 . . . . 0.0 110.243 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.869 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -78.09 -36.15 48.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 110.19 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.967 HD23 ' HG ' ' A' ' 95' ' ' LEU . 4.1 mt -58.18 -40.66 82.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.396 -0.815 . . . . 0.0 110.337 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 43.44 -132.33 5.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.664 ' OD1' HG23 ' A' ' 94' ' ' THR . 59.1 p30 -114.12 12.6 17.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -1.188 . . . . 0.0 110.235 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.664 HG23 ' OD1' ' A' ' 93' ' ' ASP . 40.1 p -109.82 -33.15 6.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.967 ' HG ' HD23 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -116.53 159.98 21.3 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.27 -0.894 . . . . 0.0 109.222 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.797 ' O ' HD22 ' A' ' 91' ' ' LEU . 42.0 tt0 -138.53 -78.2 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.979 . . . . 0.0 110.807 -179.307 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 10.8 mttm -80.13 132.76 35.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.476 -0.765 . . . . 0.0 110.7 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.921 ' O ' HG23 ' A' ' 84' ' ' THR . 15.8 mm -118.56 148.63 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.885 -1.134 . . . . 0.0 110.212 179.272 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.538 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -125.14 125.23 43.38 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.057 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.828 ' CE2' HG21 ' A' ' 98' ' ' ILE . 13.5 m-85 -121.45 134.91 55.09 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.348 -0.845 . . . . 0.0 110.476 -178.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 58.6 tt0 -133.3 160.66 36.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 81' ' ' TYR . 35.9 m -160.92 121.09 2.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 0.4 OUTLIER -120.01 146.98 45.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.333 -179.889 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.555 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 14.7 mt -125.31 151.23 46.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -0.848 . . . . 0.0 110.266 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.708 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.35 -169.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.203 -0.936 . . . . 0.0 110.005 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.708 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -127.02 135.48 50.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 110.16 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.431 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 49.5 p -90.72 163.22 31.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.301 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -73.06 -2.87 12.68 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.14 1.6 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.4 p -96.87 -5.02 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 110.3 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.42 -40.46 2.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.26 -172.48 2.02 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -127.99 138.8 52.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -1.174 . . . . 0.0 110.336 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.5 HG12 HG22 ' A' ' 10' ' ' THR . 26.6 mt -89.88 147.36 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.589 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 7.0 mt -130.95 112.96 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 110.318 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -104.1 122.34 45.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.961 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.48 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 7.4 t -116.49 163.5 15.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.536 HG22 ' NE2' ' A' ' 119' ' ' HIS . 59.6 m -160.01 138.2 10.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 110.228 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.4 m -135.18 148.97 49.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.957 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.834 ' CE1' HG23 ' A' ' 4' ' ' THR . 73.8 m-70 -132.59 168.57 18.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.177 -0.952 . . . . 0.0 110.751 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.903 ' O ' HG13 ' A' ' 2' ' ' VAL . 35.9 m-85 -131.69 145.6 51.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.508 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.496 ' HA ' HG22 ' A' ' 2' ' ' VAL . 92.4 m-70 -126.34 95.01 4.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.129 -0.982 . . . . 0.0 109.956 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.719 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -58.5 154.81 13.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.207 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.526 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 57.9 tttt -118.23 111.19 18.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.293 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.62 -115.64 5.0 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -129.84 71.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 110.145 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.573 ' O ' HG21 ' A' ' 122' ' ' THR . 16.9 m -142.72 -179.46 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.719 ' HA ' HG21 ' A' ' 122' ' ' THR . 92.8 mt-10 -154.54 149.33 26.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.194 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.633 HD12 ' H ' ' A' ' 128' ' ' ILE . 4.9 mp -77.91 173.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.943 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.595 ' N ' HG22 ' A' ' 128' ' ' ILE . 33.1 mttt -107.03 129.05 54.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.878 . . . . 0.0 110.251 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.473 ' HB3' ' HE2' ' A' ' 134' ' ' LYS . 97.9 mt-10 -45.69 -44.89 13.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -58.52 -30.98 67.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 109.842 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.869 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 13.4 t-160 -73.7 -53.17 11.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.926 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.171 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.6 p -64.52 -40.14 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.442 -0.787 . . . . 0.0 109.959 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.524 ' N ' HG13 ' A' ' 133' ' ' VAL . 42.7 mtmt -63.61 -43.94 95.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.849 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.02 74.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 109.876 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.43 -30.52 66.74 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.465 ' HD2' ' HB3' ' A' ' 5' ' ' TYR . 3.9 mtpt -74.06 -32.41 63.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -1.099 . . . . 0.0 109.893 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -72.24 -29.78 64.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.38 -0.825 . . . . 0.0 109.884 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.48 -35.86 73.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -0.834 . . . . 0.0 109.883 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.05 -41.18 71.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.968 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.9 t -59.43 -49.86 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.367 -0.833 . . . . 0.0 109.92 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -55.06 -42.94 73.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.954 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.472 ' O ' HG13 ' A' ' 147' ' ' ILE . 59.3 mt -60.04 -39.03 84.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 0.0 109.924 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -62.39 -36.11 81.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 110.165 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 89.1 mttt -79.15 -8.88 59.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 110.078 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.783 ' HB3' HG21 ' A' ' 33' ' ' ILE . 13.2 mt -89.49 -37.37 14.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.257 -0.902 . . . . 0.0 108.747 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.746 HD11 ' CE1' ' A' ' 22' ' ' PHE . 32.6 mt -70.68 -44.63 76.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.715 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.537 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 23.5 pt-20 -52.1 -39.73 60.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.809 178.793 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.535 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 19.8 m -76.25 -33.69 59.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 109.065 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.85 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 73.8 t80 -47.72 -57.93 4.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.585 -0.697 . . . . 0.0 109.901 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.057 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 62.8 mt -67.56 -45.74 74.74 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.437 -0.79 . . . . 0.0 110.709 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.619 ' HB2' HD11 ' A' ' 13' ' ' ILE . 81.9 tttt -58.81 -16.1 15.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 109.602 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -115.21 -24.28 4.23 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 150' ' ' TYR . 2.6 m80 -119.56 92.84 46.7 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.248 -1.148 . . . . 0.0 110.313 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.61 0.54 7.42 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.049 1.552 . . . . 0.0 110.764 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -115.19 15.25 17.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.147 -0.97 . . . . 0.0 110.045 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.85 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -88.38 103.51 15.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.408 -0.807 . . . . 0.0 110.4 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.129 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 6.4 p90 38.99 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.574 -0.704 . . . . 0.0 112.32 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 28.8 m-20 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 120.457 -1.402 . . . . 0.0 110.132 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 74.9 t -104.02 135.91 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 110.241 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.662 ' CE1' HD12 ' A' ' 128' ' ' ILE . 12.6 m-85 -93.62 150.5 20.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 109.989 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.787 HG23 ' CE1' ' A' ' 119' ' ' HIS . 8.4 m -129.08 113.11 14.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.562 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.981 ' CE2' HG21 ' A' ' 133' ' ' VAL . 67.6 m-85 -127.44 136.73 52.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.87 . . . . 0.0 109.76 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 16.3 pt-20 -138.31 153.78 49.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 0.0 110.707 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.2 m -132.81 144.48 50.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.408 -0.808 . . . . 0.0 109.645 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.421 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 98.9 mt-10 -130.35 127.3 39.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.059 -1.026 . . . . 0.0 110.627 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.631 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.3 p90 -155.07 -171.52 3.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.815 . . . . 0.0 109.974 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.824 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.7 p -142.84 174.01 11.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.338 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.466 ' OG ' ' OE2' ' A' ' 148' ' ' GLU . 79.7 p -151.57 148.28 27.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.244 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -74.13 -6.12 45.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.132 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.829 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.7 mp -95.9 150.15 36.94 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.029 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.829 ' HD2' HG23 ' A' ' 13' ' ' ILE . 42.2 Cg_endo -67.41 143.88 65.31 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.107 1.583 . . . . 0.0 110.89 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.677 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.1 Cg_endo -71.31 -31.49 14.13 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 124.115 1.587 . . . . 0.0 112.698 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 39.5 Cg_endo -67.4 -21.05 47.62 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 N-CA-C 110.098 -0.77 . . . . 0.0 110.098 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 9.1 mmp_? -85.17 -46.18 11.33 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.763 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.2 tt -69.03 -28.18 66.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.617 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 68.9 t80 -69.27 -53.53 19.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.707 . . . . 0.0 109.818 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 45.8 mttp -57.28 -29.87 64.23 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.993 0.901 . . . . 0.0 108.899 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.961 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -77.7 -63.63 1.34 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.681 0.753 . . . . 0.0 111.269 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.008 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -56.28 -39.63 72.97 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.689 -0.632 . . . . 0.0 111.947 -178.151 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.136 HG11 ' CD1' ' A' ' 74' ' ' ILE . 15.7 t -102.13 -65.86 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.791 -1.193 . . . . 0.0 111.631 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.575 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.0 mp -64.9 -6.08 7.55 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.227 -0.921 . . . . 0.0 111.25 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.558 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 1.1 m-20 -146.47 24.41 1.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.862 -1.149 . . . . 0.0 110.49 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.008 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -57.46 -38.36 74.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.041 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 41' ' ' SER . 86.0 m-20 -67.66 -12.86 61.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 110.191 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.54 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 83.9 m-20 -125.18 -3.79 7.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.457 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.764 HD11 HG23 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -85.98 -52.31 5.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.023 . . . . 0.0 110.394 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.04 HG11 HD13 ' A' ' 38' ' ' ILE . 14.7 t -63.3 -41.02 65.61 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.791 . . . . 0.0 111.193 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.7 Cg_endo -77.23 7.37 3.75 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.333 1.175 . . . . 0.0 111.021 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 69.9 mmtt -122.35 -23.64 5.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.095 -1.003 . . . . 0.0 109.724 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.768 HG21 ' HB3' ' A' ' 146' ' ' LEU . 8.0 mt -80.01 -56.27 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.495 -0.753 . . . . 0.0 109.773 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.52 106.27 2.56 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.46 -0.775 . . . . 0.0 110.02 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.03 0.53 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.069 1.563 . . . . 0.0 110.726 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -83.77 -11.81 56.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.149 -0.97 . . . . 0.0 109.708 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.67 -51.43 3.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.382 -0.824 . . . . 0.0 110.278 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.04 HD13 HG11 ' A' ' 30' ' ' VAL . 1.3 mt -122.24 147.64 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 110.25 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -80.13 -43.9 20.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.192 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.439 ' N ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -177.42 161.38 1.75 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.148 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.449 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 27.2 m -119.41 128.73 54.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -133.48 111.53 10.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 43.0 mt -62.98 132.92 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 110.195 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 44' ' ' LEU . 55.0 tp -96.69 -43.14 7.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.877 . . . . 0.0 110.339 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.908 ' O ' HG23 ' A' ' 52' ' ' THR . 6.9 mt-10 -130.76 150.08 52.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.369 -0.832 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 76.92 -164.04 52.77 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 60.6 t0 -138.52 19.82 2.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -1.183 . . . . 0.0 110.312 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.438 ' H ' HG21 ' A' ' 52' ' ' THR . . . 118.23 -5.68 15.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -92.26 -165.93 39.1 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.2 Cg_endo -69.77 134.1 27.14 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.046 1.551 . . . . 0.0 110.486 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.32 -6.89 68.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 45' ' ' GLU . 30.4 m -79.95 136.16 36.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -1.145 . . . . 0.0 110.158 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.696 HD13 ' HA ' ' A' ' 70' ' ' LYS . 23.7 mm -107.18 113.25 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 110.267 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 77.7 mttt -98.28 148.2 23.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.4 -0.813 . . . . 0.0 110.36 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -118.1 92.37 3.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.545 ' CG2' HG12 ' A' ' 38' ' ' ILE . 78.4 mt -79.99 139.6 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 38' ' ' ILE . 4.4 p -111.3 159.56 17.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.595 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.652 ' HE2' HG13 ' A' ' 67' ' ' VAL . 26.2 m-85 -119.61 139.65 51.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.254 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.56 9.63 57.31 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -110.98 138.02 47.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 110.238 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.19 132.52 6.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 t -56.17 -43.88 78.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -1.137 . . . . 0.0 110.267 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -77.8 153.7 32.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.242 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 t80 -53.88 139.53 33.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.923 . . . . 0.0 110.046 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -124.31 135.64 9.71 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 10.9 p90 -178.91 159.36 1.02 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -1.104 . . . . 0.0 109.931 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.721 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.9 m -143.57 171.52 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.725 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.509 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 68.4 mttt -121.25 127.35 51.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.602 -0.686 . . . . 0.0 109.587 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.595 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -115.31 124.66 51.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.146 -0.971 . . . . 0.0 110.864 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HA ' HD13 ' A' ' 53' ' ' ILE . 80.0 tttt -100.92 109.68 21.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.479 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.534 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.1 mm -48.32 139.59 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.005 . . . . 0.0 110.132 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.549 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 15.7 t0 -113.0 -40.05 4.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.854 . . . . 0.0 109.518 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 2.8 p 170.39 157.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 110.267 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.136 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.2 tt -146.22 163.83 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.796 . . . . 0.0 110.032 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.552 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -125.23 78.78 1.74 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.288 -0.883 . . . . 0.0 109.811 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.617 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 99.4 mttt -53.69 -16.54 1.69 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.448 -0.782 . . . . 0.0 110.794 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -91.96 -29.8 16.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.284 -0.885 . . . . 0.0 109.755 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 m120 -111.18 -0.18 16.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.563 -0.711 . . . . 0.0 109.651 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.69 ' O ' HD12 ' A' ' 104' ' ' LEU . 87.9 m-85 63.26 50.05 3.1 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.377 0.608 . . . . 0.0 110.667 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.552 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -118.55 148.67 42.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.207 179.172 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.585 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 84.7 t80 -144.85 139.14 27.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.065 -1.022 . . . . 0.0 110.433 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 m -148.07 133.4 18.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 110.116 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.7 p90 -135.17 178.36 7.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 98' ' ' ILE . 62.6 m -125.07 125.23 43.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.746 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.732 HD21 HD11 ' A' ' 91' ' ' LEU . 2.8 tp -94.11 136.94 33.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.997 . . . . 0.0 110.085 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 pt -124.1 -4.54 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 0.0 110.539 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 6.6 tt0 -137.87 156.49 47.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.004 . . . . 0.0 110.28 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.721 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 150.89 122.66 1.07 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.36 -17.35 4.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -1.171 . . . . 0.0 110.324 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.765 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -76.98 -29.22 55.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.732 HD11 HD21 ' A' ' 85' ' ' LEU . 17.2 mt -69.1 -27.63 65.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.06 -169.22 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.25 2.99 29.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -1.182 . . . . 0.0 110.175 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.513 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 30.5 p -85.74 -26.4 25.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.04 HD21 ' CG1' ' A' ' 128' ' ' ILE . 39.7 mt -122.25 156.59 33.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.868 . . . . 0.0 110.071 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.508 ' HG3' ' HB3' ' A' ' 123' ' ' LYS . 65.5 mm-40 -132.71 -79.81 0.49 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.247 -0.908 . . . . 0.0 110.129 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 22.1 mttp -80.11 129.57 34.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.605 -0.685 . . . . 0.0 110.763 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.732 HG21 ' CE2' ' A' ' 100' ' ' TYR . 6.2 mm -118.62 141.68 37.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.815 -1.178 . . . . 0.0 109.543 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.2 m -120.45 126.08 49.53 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.381 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.732 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.9 m-85 -122.12 133.38 54.76 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.434 -0.791 . . . . 0.0 110.244 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -133.22 148.75 52.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.392 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 81' ' ' TYR . 38.9 m -148.21 140.8 24.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.396 -0.815 . . . . 0.0 110.01 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 7.8 tttt -132.87 148.97 52.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -0.953 . . . . 0.0 110.124 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 79' ' ' TYR . 6.4 mt -126.39 148.39 49.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.149 -0.969 . . . . 0.0 110.346 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -152.31 -169.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.329 -0.857 . . . . 0.0 109.968 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.695 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -125.06 156.72 37.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 110.11 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 21.3 p -114.57 164.78 15.48 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.32 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.1 Cg_endo -72.6 -1.77 10.81 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.057 1.557 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.5 p -101.36 0.25 36.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.282 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.56 -38.05 3.39 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.16 -172.79 2.05 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 59.2 p -129.67 139.9 51.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -1.185 . . . . 0.0 110.251 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.824 ' HA ' HG22 ' A' ' 10' ' ' THR . 20.9 mt -89.02 149.5 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 110.199 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.631 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 14.9 mt -133.28 110.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.259 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.421 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 74.9 tttt -102.56 126.0 49.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.004 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 5.0 t -119.56 162.18 19.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.49 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.462 HG22 ' NE2' ' A' ' 119' ' ' HIS . 92.9 m -159.82 144.07 14.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.154 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 92.2 p -143.7 160.8 40.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.787 ' CE1' HG23 ' A' ' 4' ' ' THR . 75.7 m-70 -143.41 166.88 23.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.214 -0.929 . . . . 0.0 110.37 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 10.1 m-85 -129.46 145.81 51.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 110.61 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.2 m-70 -124.44 87.21 2.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.352 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.536 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 2.2 p -65.39 157.82 28.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.411 -0.806 . . . . 0.0 110.644 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.508 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 74.6 tttt -137.84 126.08 23.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.462 -0.774 . . . . 0.0 110.124 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 99.71 23.27 11.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 8.6 t30 66.32 63.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -1.134 . . . . 0.0 110.189 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 30.2 m -137.03 166.03 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.129 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.488 ' HA ' HG21 ' A' ' 122' ' ' THR . 92.2 mt-10 -135.79 166.8 22.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 110.303 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.04 ' CG1' HD21 ' A' ' 95' ' ' LEU . 4.8 mp -90.75 172.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.575 ' N ' HG22 ' A' ' 128' ' ' ILE . 54.1 mttt -112.22 131.22 55.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 109.829 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 99.5 mt-10 -43.27 -44.47 5.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 110.05 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -54.81 -26.33 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.765 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 9.6 t-160 -83.29 -60.57 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 110.102 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.981 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.5 p -63.41 -39.79 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.967 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.523 ' N ' HG13 ' A' ' 133' ' ' VAL . 81.8 tttt -60.99 -37.74 83.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.89 . . . . 0.0 109.907 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.9 78.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.927 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.91 -33.47 85.77 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.04 -41.06 97.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -1.125 . . . . 0.0 109.906 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -75.03 -33.95 61.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.83 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -72.78 -37.29 67.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 109.781 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.49 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -72.23 -33.32 67.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.827 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.9 m -69.07 -44.32 72.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 109.944 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -63.54 -38.56 91.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.878 . . . . 0.0 109.9 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 146' ' ' LEU . 61.2 mt -64.77 -35.94 82.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.857 . . . . 0.0 109.989 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.622 ' CD2' ' CZ ' ' A' ' 9' ' ' PHE . 7.9 m-85 -63.55 -38.82 92.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.926 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -77.03 -14.5 59.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.873 . . . . 0.0 109.993 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.768 ' HB3' HG21 ' A' ' 33' ' ' ILE . 15.4 mt -84.02 -34.81 24.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.228 -0.92 . . . . 0.0 108.973 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.764 HG23 HD11 ' A' ' 29' ' ' LEU . 17.2 mt -71.56 -44.81 69.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.566 -0.709 . . . . 0.0 109.109 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.716 ' HB3' HD13 ' A' ' 13' ' ' ILE . 10.9 mm-40 -66.73 -38.75 87.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 0.0 109.651 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.7 m -69.99 -37.47 75.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -0.984 . . . . 0.0 109.669 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.651 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 77.7 t80 -56.4 -57.23 13.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.424 -0.797 . . . . 0.0 110.015 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.183 HD21 ' CE2' ' A' ' 158' ' ' TYR . 55.5 mt -68.58 -29.07 67.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.28 -0.887 . . . . 0.0 110.16 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.738 ' HD2' HD11 ' A' ' 13' ' ' ILE . 80.4 tttt -68.42 -33.59 74.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.66 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.494 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -100.8 -27.38 7.51 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 150' ' ' TYR . 7.6 m80 -107.45 89.19 4.7 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.303 -1.116 . . . . 0.0 110.045 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.2 Cg_endo -73.36 2.94 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.003 1.528 . . . . 0.0 110.833 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -106.9 -11.63 15.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 0.0 109.712 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.651 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -69.78 100.57 1.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.472 -0.768 . . . . 0.0 110.001 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.183 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.7 OUTLIER 34.34 33.11 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.751 -0.593 . . . . 0.0 110.483 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.831 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.707 HG22 ' ND1' ' A' ' 121' ' ' HIS . 76.1 t -109.52 109.74 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -1.143 . . . . 0.0 110.243 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.55 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 54.7 m-85 -74.58 155.95 37.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.231 -0.918 . . . . 0.0 110.414 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.889 HG23 ' CE1' ' A' ' 119' ' ' HIS . 89.4 m -140.89 89.08 2.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.078 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CG ' ' CG2' ' A' ' 133' ' ' VAL . 80.1 m-85 -109.73 127.58 54.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.809 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.2 pt-20 -128.35 152.36 48.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.204 -0.935 . . . . 0.0 110.527 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 p -128.35 142.27 51.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -0.823 . . . . 0.0 109.794 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -121.39 138.51 54.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.979 . . . . 0.0 110.647 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.663 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 4.3 p90 -157.21 -173.03 4.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.586 -0.696 . . . . 0.0 109.753 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 113' ' ' ILE . 18.0 p -140.15 -177.1 4.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 110.647 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.512 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 2.9 t -159.59 160.0 33.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.436 -0.79 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -88.11 5.15 42.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 110.224 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.785 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.7 mm -108.46 149.65 39.62 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.006 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.785 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.9 Cg_endo -64.44 144.54 85.68 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.886 1.466 . . . . 0.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.655 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 Cg_endo -72.63 -31.24 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.015 1.534 . . . . 0.0 112.918 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.3 Cg_endo -69.39 -23.4 32.53 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 110.19 -0.735 . . . . 0.0 110.19 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.535 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 5.2 mmp_? -83.93 -44.15 14.53 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.92 HD22 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -69.78 -31.88 70.05 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 77.0 t80 -63.83 -56.91 11.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.496 -0.753 . . . . 0.0 109.426 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 51.4 mttt -52.63 -33.86 48.64 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.904 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.065 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -72.96 -60.91 2.01 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.637 0.732 . . . . 0.0 110.718 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.038 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -51.96 -51.67 55.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.723 -0.611 . . . . 0.0 111.799 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.089 HG11 ' CD1' ' A' ' 74' ' ' ILE . 12.0 t -96.85 -61.71 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.012 -1.055 . . . . 0.0 112.334 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.617 HD12 ' N ' ' A' ' 24' ' ' LEU . 6.9 mp -67.97 -1.09 5.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.057 -1.027 . . . . 0.0 111.872 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.98 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -147.69 15.22 1.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.664 -1.273 . . . . 0.0 110.845 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.038 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -54.05 -48.69 70.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 109.956 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 41' ' ' SER . 49.2 t0 -53.67 -20.34 5.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.955 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 69.5 m-80 -124.45 11.83 8.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.98 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -97.4 -46.02 6.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.0 110.26 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.989 HG21 HD13 ' A' ' 38' ' ' ILE . 6.0 p -75.59 -27.67 0.7 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.902 . . . . 0.0 112.032 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.82 ' HD3' HG12 ' A' ' 30' ' ' VAL . 50.7 Cg_endo -79.84 6.88 4.92 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 122.696 0.84 . . . . 0.0 110.297 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -130.94 -30.27 1.81 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.209 -0.932 . . . . 0.0 110.244 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.619 HD11 ' CD1' ' A' ' 29' ' ' LEU . 16.1 mt -74.67 -39.86 46.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.38 -0.825 . . . . 0.0 109.849 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -173.11 102.65 0.32 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.387 -0.821 . . . . 0.0 110.362 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.42 2.49 6.24 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.968 1.509 . . . . 0.0 110.56 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -85.03 -19.74 31.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.11 -0.994 . . . . 0.0 109.769 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.87 -44.94 8.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.416 -0.802 . . . . 0.0 110.048 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.989 HD13 HG21 ' A' ' 30' ' ' VAL . 1.2 mp -125.66 143.63 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 0.0 109.977 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 33.3 ttmt -79.63 -39.18 32.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.274 -0.891 . . . . 0.0 110.383 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.466 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER 178.73 139.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.917 . . . . 0.0 110.527 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 29.5 m -97.81 135.27 39.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 0.0 109.893 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -143.77 110.26 5.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 110.397 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.9 mt -61.43 132.8 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.066 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 44' ' ' LEU . 19.5 mt -92.88 -43.92 8.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.332 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 52' ' ' THR . 6.0 mm-40 -135.44 131.6 36.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 110.145 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.08 -172.0 37.85 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -116.83 -3.6 11.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -1.162 . . . . 0.0 110.23 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.471 ' N ' HG21 ' A' ' 52' ' ' THR . . . 134.82 -4.71 4.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.531 ' C ' HG21 ' A' ' 71' ' ' ILE . . . -79.73 -167.23 34.43 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.06 131.83 21.61 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.047 1.551 . . . . 0.0 110.603 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.46 -8.85 66.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.91 HG23 ' O ' ' A' ' 45' ' ' GLU . 21.9 m -79.94 145.04 32.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -1.13 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.625 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.6 mm -111.71 117.16 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.64 ' HE2' HD11 ' A' ' 71' ' ' ILE . 44.9 mtmt -101.3 144.99 29.45 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.318 -0.864 . . . . 0.0 110.397 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -117.39 101.56 8.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.177 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.54 ' CG2' HG12 ' A' ' 38' ' ' ILE . 80.6 mt -91.32 138.23 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.123 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 38' ' ' ILE . 1.3 p -112.09 151.64 29.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.468 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' GLY . 32.9 m-85 -111.04 136.23 50.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.873 . . . . 0.0 110.241 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.23 23.56 34.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -118.13 127.38 53.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -1.165 . . . . 0.0 110.15 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.25 143.17 9.63 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.3 t -65.71 -38.12 88.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -1.178 . . . . 0.0 110.252 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -82.09 163.01 22.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 110.206 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.523 ' OH ' HG21 ' A' ' 57' ' ' THR . 3.3 t80 -69.33 128.18 35.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.963 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -122.51 96.19 0.56 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 26.5 p90 -133.05 166.75 21.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -1.232 . . . . 0.0 110.103 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.841 HG12 ' HA2' ' A' ' 88' ' ' GLY . 9.7 m -141.06 170.79 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.675 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' NZ ' ' OE1' ' A' ' 87' ' ' GLU . 98.4 mttt -123.17 121.13 35.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.607 -0.683 . . . . 0.0 109.585 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.671 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -111.57 125.9 54.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 110.981 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.625 ' HA ' HD13 ' A' ' 53' ' ' ILE . 80.0 tttt -99.68 116.97 33.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 109.279 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.64 HD11 ' HE2' ' A' ' 54' ' ' LYS . 39.8 mm -51.96 137.62 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.391 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.537 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 30.5 t0 -109.06 -49.15 3.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 109.85 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 3.1 m -176.72 159.47 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.522 -0.736 . . . . 0.0 110.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.089 ' CD1' HG11 ' A' ' 23' ' ' VAL . 6.3 tt -151.16 168.37 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.154 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -138.03 84.48 2.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 110.232 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.607 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 94.3 mttt -58.04 -12.17 3.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.429 -0.794 . . . . 0.0 111.008 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -89.81 -31.39 17.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.112 -0.993 . . . . 0.0 109.571 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.7 m120 -114.21 -2.16 13.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 109.667 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.823 ' O ' HD12 ' A' ' 104' ' ' LEU . 6.6 m-85 67.97 47.59 1.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.754 -0.591 . . . . 0.0 110.573 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.544 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -111.18 158.1 19.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 108.805 178.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.528 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 83.4 t80 -159.78 150.86 19.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.956 -1.09 . . . . 0.0 110.669 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.425 ' HB2' ' HA ' ' A' ' 101' ' ' GLU . 12.3 t -159.65 152.43 21.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 7.4 p90 -150.14 176.83 10.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.476 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 98' ' ' ILE . 91.4 m -124.1 126.08 45.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.797 . . . . 0.0 109.683 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.671 HD13 ' CE1' ' A' ' 69' ' ' HIS . 2.9 tp -93.52 134.48 35.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.945 . . . . 0.0 110.029 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.08 -10.57 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 110.465 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.578 ' C ' HD12 ' A' ' 91' ' ' LEU . 23.2 tt0 -140.74 149.09 41.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.424 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.841 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 162.47 149.9 5.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -65.1 -35.07 79.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -1.157 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.408 ' HB1' ' HE2' ' A' ' 132' ' ' HIS . . . -67.61 -21.11 65.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.254 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.81 HD21 ' CG1' ' A' ' 98' ' ' ILE . 41.0 mt -71.3 -32.06 68.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.47 -171.2 0.02 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -84.11 5.1 27.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -1.15 . . . . 0.0 110.006 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.6 p -92.34 -43.24 9.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.097 HD21 HD11 ' A' ' 128' ' ' ILE . 78.1 mt -94.58 164.51 12.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 110.073 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 36.3 tp10 -144.84 -80.71 0.17 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.243 -0.911 . . . . 0.0 110.21 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 58.8 mttt -80.31 128.88 34.06 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.633 -0.667 . . . . 0.0 110.486 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.81 ' CG1' HD21 ' A' ' 91' ' ' LEU . 7.5 mm -122.51 143.55 34.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.944 -1.097 . . . . 0.0 110.072 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.91 131.26 53.93 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.453 -0.779 . . . . 0.0 109.044 178.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.724 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.9 m-85 -127.08 133.37 50.46 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 110.47 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.425 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 75.3 tt0 -131.59 154.26 49.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.885 . . . . 0.0 110.213 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 81' ' ' TYR . 81.6 m -155.0 123.56 6.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.988 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 12.4 tttt -119.38 150.33 40.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 110.311 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 79' ' ' TYR . 13.0 mt -124.82 150.35 46.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 110.651 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.37 -169.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.397 -0.815 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.64 167.85 12.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.868 . . . . 0.0 110.238 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 60.2 p -126.42 162.52 46.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.117 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.5 Cg_endo -71.98 -2.48 11.59 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.971 1.511 . . . . 0.0 110.486 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -101.6 -2.61 30.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.264 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.84 -35.95 4.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.12 -172.56 2.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 15.6 p -128.71 136.21 50.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -1.213 . . . . 0.0 110.435 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.59 ' HA ' HG22 ' A' ' 10' ' ' THR . 62.4 mt -84.93 149.32 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.663 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 9.8 mt -134.33 121.11 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.318 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -110.84 134.61 52.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.91 . . . . 0.0 110.093 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.5 t -125.26 158.4 34.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.89 . . . . 0.0 110.319 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 84.8 m -159.92 126.59 4.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.88 . . . . 0.0 110.322 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.457 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 18.8 t -126.5 155.84 41.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.288 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.889 ' CE1' HG23 ' A' ' 4' ' ' THR . 80.6 m-70 -130.73 164.5 24.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.306 -0.871 . . . . 0.0 109.965 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.612 ' HD1' HD12 ' A' ' 98' ' ' ILE . 18.6 m-85 -133.67 134.49 43.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 111.037 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.707 ' ND1' HG22 ' A' ' 2' ' ' VAL . 85.4 m-70 -121.07 90.2 3.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 108.848 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.877 ' HB ' HD23 ' A' ' 95' ' ' LEU . 2.2 t -91.59 -179.46 5.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 111.748 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -133.97 171.89 13.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.902 -0.498 . . . . 0.0 109.703 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 125' ' ' ASN . . . 76.45 2.48 74.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 16.6 t30 68.68 60.41 0.37 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.268 -1.137 . . . . 0.0 110.728 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.532 HG22 ' OG1' ' A' ' 122' ' ' THR . 6.6 m -126.01 162.08 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.668 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -118.64 145.91 45.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.02 . . . . 0.0 110.725 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.097 HD11 HD21 ' A' ' 95' ' ' LEU . 24.1 mm -55.77 173.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.388 -0.82 . . . . 0.0 110.083 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 128' ' ' ILE . 29.5 mtpt -110.15 131.69 54.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.042 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.53 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 60.6 mt-10 -43.26 -42.37 4.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 110.103 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 48.8 tt0 -60.83 -26.33 67.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 109.923 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.0 t-160 -85.97 -53.05 5.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 110.081 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.606 ' CG2' ' CG ' ' A' ' 5' ' ' TYR . 3.9 p -69.07 -30.78 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 110.126 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 64.6 tttp -79.3 -53.94 6.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 109.801 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -61.52 -25.74 67.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.95 -36.52 81.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.477 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 96.5 mttt -65.57 -33.96 77.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -1.119 . . . . 0.0 109.866 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.415 ' HG2' ' ND2' ' A' ' 142' ' ' ASN . 79.8 tt0 -81.53 -32.1 32.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.0 109.88 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -67.77 -44.67 76.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.374 -0.829 . . . . 0.0 109.873 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -71.2 -38.4 72.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 110.004 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.1 m -62.81 -49.35 75.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.395 -0.816 . . . . 0.0 109.993 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.415 ' ND2' ' HG2' ' A' ' 138' ' ' GLU . 80.3 m-20 -56.29 -43.13 78.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.982 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.47 ' O ' HG13 ' A' ' 147' ' ' ILE . 23.4 mt -60.74 -40.69 93.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.91 . . . . 0.0 109.944 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 19.1 m-85 -60.61 -39.88 89.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.439 -0.788 . . . . 0.0 109.86 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -67.91 -17.94 64.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 110.037 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 146' ' ' LEU . 16.0 mt -84.14 -34.9 23.96 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.19 -0.944 . . . . 0.0 108.965 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.714 HG22 HD23 ' A' ' 18' ' ' LEU . 55.2 mt -71.75 -41.64 70.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.548 -0.72 . . . . 0.0 109.06 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.663 ' OE2' HD11 ' A' ' 114' ' ' ILE . 14.9 mm-40 -59.97 -39.68 86.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.289 -0.882 . . . . 0.0 109.205 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 97.7 m -67.09 -35.99 81.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 109.185 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.648 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 72.3 t80 -53.15 -53.46 50.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.48 -0.763 . . . . 0.0 109.625 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.188 HD21 ' CE2' ' A' ' 158' ' ' TYR . 98.3 mt -76.08 -27.03 57.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.296 -0.877 . . . . 0.0 109.984 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.525 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 29.8 ttpt -75.88 -19.67 58.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -113.45 -30.73 2.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 15.3 m80 -106.89 93.28 8.67 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.199 -1.177 . . . . 0.0 110.224 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.5 Cg_endo -74.22 4.77 4.05 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.086 1.572 . . . . 0.0 110.876 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -108.15 3.68 24.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 109.827 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.648 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -86.87 103.34 15.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.381 -0.824 . . . . 0.0 110.196 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.188 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.65 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.686 -0.634 . . . . 0.0 110.511 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.714 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.734 HG22 ' CD2' ' A' ' 121' ' ' HIS . 54.8 t -106.59 128.63 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -1.14 . . . . 0.0 110.306 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.717 ' CG ' HD13 ' A' ' 128' ' ' ILE . 9.0 m-85 -90.86 143.5 26.66 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.267 -0.896 . . . . 0.0 109.654 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.711 HG23 ' CE1' ' A' ' 119' ' ' HIS . 4.8 m -126.23 116.82 21.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.984 -1.073 . . . . 0.0 110.403 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 57.5 m-85 -131.76 137.25 48.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 109.915 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -136.08 149.75 48.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 110.565 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.4 p -139.69 149.98 44.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.78 . . . . 0.0 109.451 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.45 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 2.8 tt0 -133.79 138.33 45.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.968 -1.083 . . . . 0.0 110.854 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.608 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 3.6 p90 -154.34 -174.7 5.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.429 -0.794 . . . . 0.0 109.597 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 113' ' ' ILE . 14.0 p -136.88 178.35 7.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 110.687 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.412 ' OG ' HD11 ' A' ' 114' ' ' ILE . 83.0 p -157.36 153.1 26.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 110.24 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -79.34 -15.45 57.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.912 . . . . 0.0 110.267 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.843 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.9 mp -87.57 151.25 50.23 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 109.937 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.843 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.8 143.47 73.82 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.057 1.556 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.642 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.88 -31.14 10.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 124.065 1.561 . . . . 0.0 112.972 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.6 Cg_endo -70.52 -21.79 29.48 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 N-CA-C 110.103 -0.768 . . . . 0.0 110.103 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.495 ' NE ' ' HA ' ' A' ' 159' ' ' ASN . 9.1 mmp_? -83.44 -47.12 11.72 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.75 ' C ' HD23 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -66.51 -27.87 68.11 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 81.6 t80 -65.65 -60.36 2.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.715 -0.616 . . . . 0.0 109.604 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 52.3 mttt -52.03 -32.97 36.56 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.4 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.023 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.13 -56.02 5.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.399 -0.813 . . . . 0.0 110.661 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.048 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -58.62 -49.15 78.55 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.542 -0.724 . . . . 0.0 111.384 -178.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.13 HG11 ' CD1' ' A' ' 74' ' ' ILE . 16.8 t -93.49 -65.25 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.973 -1.079 . . . . 0.0 111.717 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 24' ' ' LEU . 6.9 mp -67.55 -1.07 4.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.287 -0.883 . . . . 0.0 111.819 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.792 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -149.04 25.24 0.92 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.795 -1.19 . . . . 0.0 110.729 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.048 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -63.79 -38.12 89.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.119 -0.988 . . . . 0.0 109.989 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.498 ' OD2' HD11 ' A' ' 43' ' ' ILE . 54.7 m-20 -65.02 -14.92 61.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 110.253 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 72.8 m-80 -125.15 7.72 7.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 110.058 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.829 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -95.43 -57.03 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 110.103 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.975 HG11 HD13 ' A' ' 38' ' ' ILE . 96.1 t -62.69 -40.51 64.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.765 . . . . 0.0 111.153 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -77.4 7.09 3.94 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.371 1.195 . . . . 0.0 110.85 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -127.48 -29.8 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.902 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.692 HD11 ' CD1' ' A' ' 29' ' ' LEU . 32.3 mt -80.07 -44.37 22.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.51 -0.744 . . . . 0.0 110.044 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.02 102.14 2.11 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 110.348 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.21 3.63 5.55 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.049 1.552 . . . . 0.0 110.717 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -90.74 -13.84 33.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.141 -0.975 . . . . 0.0 110.208 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.83 -29.05 12.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.198 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.975 HD13 HG11 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -142.07 150.26 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -88.69 -44.79 10.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.326 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -172.93 156.76 3.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.377 -0.827 . . . . 0.0 110.173 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -119.81 121.99 40.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 109.95 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 84.6 tt0 -124.31 114.49 19.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.498 HD11 ' OD2' ' A' ' 27' ' ' ASP . 23.4 mt -61.55 132.21 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.944 . . . . 0.0 110.088 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 55' ' ' LYS . 53.4 mt -92.89 -25.54 18.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 1.073 ' O ' HG23 ' A' ' 52' ' ' THR . 41.8 tt0 -156.46 171.31 20.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 58.07 -165.92 6.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -131.55 29.42 4.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -1.112 . . . . 0.0 110.291 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.51 ' H ' HG21 ' A' ' 52' ' ' THR . . . 103.36 2.25 47.57 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.485 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -92.53 -167.33 39.42 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.4 132.86 23.15 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.058 1.557 . . . . 0.0 110.522 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.17 -6.62 68.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 1.073 HG23 ' O ' ' A' ' 45' ' ' GLU . 19.4 m -80.06 147.91 31.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -1.174 . . . . 0.0 110.129 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.606 HD13 ' HA ' ' A' ' 70' ' ' LYS . 21.6 mm -116.53 114.96 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.071 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 35.7 mtmt -99.76 147.47 25.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HB2' HD11 ' A' ' 44' ' ' LEU . 83.6 tttt -116.78 98.62 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.898 . . . . 0.0 110.09 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.531 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.7 mt -88.22 146.42 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.5 p -120.16 155.62 32.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.38 -0.825 . . . . 0.0 110.574 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.692 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.1 m-85 -116.58 145.36 43.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.449 -0.782 . . . . 0.0 110.145 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.99 -8.59 57.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -118.03 148.66 42.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -1.138 . . . . 0.0 110.146 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.57 -157.69 14.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.0 p -57.52 -173.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -1.136 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -51.74 -66.48 0.38 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.205 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.401 ' CD1' ' HD2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -108.37 112.67 25.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.186 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -118.86 94.98 0.6 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 20.8 p90 -134.8 167.97 19.9 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.049 -1.265 . . . . 0.0 110.478 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.821 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.8 m -139.69 172.89 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 110.447 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.512 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 30.3 mtpt -123.9 129.37 50.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.528 -0.732 . . . . 0.0 109.518 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.579 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -117.19 125.94 51.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.99 -1.069 . . . . 0.0 110.931 -179.336 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.606 ' HA ' HD13 ' A' ' 53' ' ' ILE . 64.6 tttp -104.94 110.49 22.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 109.3 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 29.2 mm -48.19 140.65 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.187 -0.945 . . . . 0.0 110.406 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 16.0 t0 -112.25 -40.32 4.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.393 -0.817 . . . . 0.0 109.629 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 0.6 OUTLIER 172.19 161.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.0 110.391 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.13 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.6 tt -152.03 165.33 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -131.34 80.73 1.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.601 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.6 mttt -55.78 -14.14 2.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.87 . . . . 0.0 110.827 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -90.18 -29.75 18.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.227 -0.92 . . . . 0.0 109.645 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.7 m120 -114.45 -1.68 13.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.486 -0.758 . . . . 0.0 109.965 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.766 ' O ' HD12 ' A' ' 104' ' ' LEU . 8.3 m-85 67.48 48.04 1.17 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.639 -0.663 . . . . 0.0 110.646 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -115.06 154.2 29.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.208 -0.932 . . . . 0.0 109.095 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.528 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 84.7 t80 -154.98 148.32 25.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.9 -1.125 . . . . 0.0 110.523 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.5 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 17.9 m -156.22 147.16 22.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.366 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 4.9 p90 -144.21 178.3 7.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.409 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 98' ' ' ILE . 71.0 m -124.83 125.19 43.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.535 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.68 HD21 HD11 ' A' ' 91' ' ' LEU . 5.3 tp -90.86 136.11 33.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.178 -0.951 . . . . 0.0 110.401 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.2 pt -123.58 -6.14 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.551 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.512 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 11.2 tt0 -141.37 160.44 40.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 110.429 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.821 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 145.77 123.69 1.58 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.34 -15.41 6.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -1.16 . . . . 0.0 110.402 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -77.1 -29.37 54.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.68 HD11 HD21 ' A' ' 85' ' ' LEU . 28.6 mt -67.46 -39.33 85.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.366 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 178.05 44.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -74.46 -0.01 16.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -1.148 . . . . 0.0 110.162 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.583 ' HB ' HG11 ' A' ' 126' ' ' VAL . 15.4 p -95.2 -40.41 9.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.165 -0.959 . . . . 0.0 110.305 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.891 HD11 HG13 ' A' ' 128' ' ' ILE . 1.8 mm? -79.84 136.98 36.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.165 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 5.7 tp10 -124.98 -83.44 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.318 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 26.7 mttt -80.16 126.87 31.65 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 110.695 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.69 HG21 ' HE2' ' A' ' 100' ' ' TYR . 5.3 mm -121.14 141.04 43.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 120.614 -1.304 . . . . 0.0 109.235 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.72 134.23 55.05 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.879 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.69 ' HE2' HG21 ' A' ' 98' ' ' ILE . 8.2 m-85 -130.3 132.7 46.0 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.422 -0.799 . . . . 0.0 110.169 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.5 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 5.9 mt-10 -129.71 167.01 18.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.223 -0.923 . . . . 0.0 110.619 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 81' ' ' TYR . 45.6 m -162.9 137.69 6.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.381 -0.824 . . . . 0.0 109.909 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.4 mttt -135.58 137.88 42.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.391 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.768 HD23 HG12 ' A' ' 114' ' ' ILE . 9.8 mt -117.12 149.92 39.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.319 -0.863 . . . . 0.0 110.127 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.79 -169.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -0.936 . . . . 0.0 110.153 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.64 166.85 13.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.268 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 24.8 p -125.02 165.69 24.42 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -73.17 -0.65 9.42 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.995 1.524 . . . . 0.0 110.488 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.6 p -110.42 7.66 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.263 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.38 -38.66 3.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.03 -172.72 0.14 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 16.8 p -133.63 135.26 44.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.171 -1.194 . . . . 0.0 110.385 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.623 ' HA ' HG22 ' A' ' 10' ' ' THR . 41.8 mt -86.44 152.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.056 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.768 HG12 HD23 ' A' ' 104' ' ' LEU . 5.3 mt -136.42 115.17 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.933 . . . . 0.0 110.614 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 44.4 tttp -101.06 127.28 47.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -0.842 . . . . 0.0 109.745 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.05 157.91 25.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.748 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.444 HG22 ' NE2' ' A' ' 119' ' ' HIS . 98.7 m -160.08 144.33 14.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.394 -0.816 . . . . 0.0 110.067 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.493 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -146.65 168.64 20.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.161 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.711 ' CE1' HG23 ' A' ' 4' ' ' THR . 48.4 m-70 -148.87 174.56 12.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.166 -0.959 . . . . 0.0 110.552 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.583 ' CD2' HG12 ' A' ' 128' ' ' ILE . 87.9 m-85 -138.09 156.91 47.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.217 -0.927 . . . . 0.0 110.958 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.734 ' CD2' HG22 ' A' ' 2' ' ' VAL . 74.7 m80 -140.84 81.49 1.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.406 -0.809 . . . . 0.0 109.251 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.458 ' HB ' ' HB ' ' A' ' 126' ' ' VAL . 0.1 OUTLIER -63.08 142.36 58.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.334 -0.854 . . . . 0.0 110.648 -179.352 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -69.19 110.4 4.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.896 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.63 -116.36 5.45 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 2.6 p-10 -137.13 49.3 2.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -1.172 . . . . 0.0 110.244 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 127' ' ' GLU . 66.7 t -96.42 174.96 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.416 -0.803 . . . . 0.0 109.952 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.597 ' N ' HG12 ' A' ' 126' ' ' VAL . 96.0 mt-10 -126.22 161.2 28.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.891 HG13 HD11 ' A' ' 95' ' ' LEU . 4.5 mp -88.38 172.94 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.867 . . . . 0.0 110.095 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.615 ' N ' HG22 ' A' ' 128' ' ' ILE . 67.0 mmtt -90.83 151.96 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.332 -0.855 . . . . 0.0 109.958 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 61.7 mm-40 -58.16 -22.0 49.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.136 -0.978 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.836 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 98.2 mt-10 -68.03 -39.57 83.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.91 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 5.3 m170 -66.04 -47.55 74.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.162 -0.961 . . . . 0.0 110.02 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.589 HG23 ' CD1' ' A' ' 5' ' ' TYR . 2.5 p -76.47 -25.87 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.449 -0.782 . . . . 0.0 110.093 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 73.6 tttt -104.31 -65.37 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.958 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.836 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.68 -24.21 47.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.868 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.51 -28.58 67.33 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.11 -33.1 56.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -1.127 . . . . 0.0 110.017 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -81.39 -31.26 33.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.85 . . . . 0.0 109.813 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.617 ' HE3' ' HB1' ' A' ' 135' ' ' ALA . 85.8 mttt -73.42 -36.72 66.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 109.828 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.23 -35.94 61.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.852 . . . . 0.0 109.89 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.1 m -64.04 -45.46 88.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -0.821 . . . . 0.0 109.973 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -56.41 -50.67 70.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.993 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.403 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.9 mm? -60.51 -33.98 73.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.949 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -65.16 -37.49 87.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.414 -0.803 . . . . 0.0 109.833 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 29.3 ttmt -79.63 -15.45 57.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.441 -0.787 . . . . 0.0 110.042 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.512 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 13.8 mt -83.23 -37.02 24.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.081 -1.012 . . . . 0.0 108.933 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.708 HD13 ' CD1' ' A' ' 22' ' ' PHE . 86.6 mt -70.72 -44.36 76.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.726 ' HB3' HD13 ' A' ' 13' ' ' ILE . 62.6 mt-10 -55.88 -40.01 72.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.327 -0.858 . . . . 0.0 109.202 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.436 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 18.6 m -71.25 -31.63 67.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.556 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.607 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 79.0 t80 -56.08 -49.94 72.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.474 -0.766 . . . . 0.0 109.775 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.171 HD21 ' CE2' ' A' ' 158' ' ' TYR . 59.3 mt -77.72 -29.02 51.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.997 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.679 ' HB2' HD11 ' A' ' 13' ' ' ILE . 52.4 tptt -66.98 -26.78 66.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.464 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -107.28 -28.41 4.92 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 4.9 m80 -106.9 91.18 6.0 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.219 -1.165 . . . . 0.0 110.05 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.7 Cg_endo -73.29 4.58 3.74 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.062 1.559 . . . . 0.0 111.104 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -111.14 -7.72 14.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.019 -1.051 . . . . 0.0 109.97 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.646 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -70.49 101.33 1.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 110.109 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.171 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.8 OUTLIER 34.79 31.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.712 -0.618 . . . . 0.0 110.635 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.715 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 93.9 t -136.07 134.11 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -1.166 . . . . 0.0 110.363 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 128' ' ' ILE . 11.2 m-85 -101.18 131.9 46.94 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.66 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.78 126.41 47.34 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.858 -1.151 . . . . 0.0 110.687 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.824 ' CE1' HG11 ' A' ' 133' ' ' VAL . 50.4 m-85 -133.58 125.59 29.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.806 . . . . 0.0 109.907 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.791 ' CG ' HG23 ' A' ' 117' ' ' THR . 3.8 mt-10 -136.49 145.61 45.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.398 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 m -132.03 158.82 40.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.805 . . . . 0.0 110.015 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.456 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 98.9 mt-10 -143.72 123.67 13.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.443 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 p90 -147.47 -173.64 4.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.616 HG22 HG12 ' A' ' 113' ' ' ILE . 12.5 p -138.34 -179.4 5.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.578 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.3 p -157.1 164.15 38.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.41 -0.806 . . . . 0.0 110.206 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -86.1 -21.74 27.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.2 mm -84.91 150.26 55.27 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.146 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 42.2 Cg_endo -66.1 150.4 85.21 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.158 1.61 . . . . 0.0 110.14 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.674 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.5 Cg_endo -70.15 -32.93 16.05 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.912 1.48 . . . . 0.0 113.304 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.5 Cg_endo -66.92 -23.23 47.49 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 122.381 0.674 . . . . 0.0 110.408 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.528 ' HG3' ' HG2' ' A' ' 14' ' ' PRO . 10.7 mmp_? -84.5 -45.66 12.41 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.765 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -72.28 -25.4 61.58 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.564 -0.71 . . . . 0.0 109.241 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.619 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 85.2 t80 -70.74 -57.98 4.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.402 -0.811 . . . . 0.0 109.059 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 67.5 mttt -51.23 -35.99 39.62 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.33 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.045 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.48 -53.81 8.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 111.021 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.738 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -59.54 -46.23 89.47 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 111.706 -178.69 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.771 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -98.18 -61.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.947 -1.096 . . . . 0.0 111.57 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.5 mp -70.18 0.31 6.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.149 -0.969 . . . . 0.0 111.55 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.683 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -154.55 46.92 0.57 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.79 -1.194 . . . . 0.0 110.856 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -84.64 -25.22 28.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -0.999 . . . . 0.0 110.062 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 60.6 t0 -73.76 -11.66 60.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 109.907 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 71.6 m-20 -128.6 10.46 6.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.37 -0.831 . . . . 0.0 109.652 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.794 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -97.9 -57.75 2.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.445 -0.784 . . . . 0.0 110.45 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.876 HG22 ' HD3' ' A' ' 31' ' ' PRO . 1.9 m -74.86 -29.1 0.87 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 112.101 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.876 ' HD3' HG22 ' A' ' 30' ' ' VAL . 51.0 Cg_endo -80.5 -1.51 11.35 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 O-C-N 122.878 0.936 . . . . 0.0 110.374 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -126.43 -32.09 2.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 109.756 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.634 ' CD1' HD13 ' A' ' 29' ' ' LEU . 11.9 mt -80.06 -34.17 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.489 -0.757 . . . . 0.0 109.393 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -160.38 99.06 1.4 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.586 -0.696 . . . . 0.0 109.896 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 43.2 Cg_endo -69.33 -4.33 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.984 1.518 . . . . 0.0 110.427 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -87.17 1.88 51.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.865 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.997 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -107.04 -47.6 3.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 109.997 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.997 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.9 mp -133.88 142.06 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 0.0 110.071 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -82.94 -36.57 25.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.468 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -175.42 132.69 0.29 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.375 -0.828 . . . . 0.0 109.946 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.491 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 2.3 m -100.26 131.24 46.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.45 ' O ' HD12 ' A' ' 44' ' ' LEU . 77.5 tt0 -138.69 110.83 7.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 110.293 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 14.7 mt -64.11 134.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 110.203 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 55' ' ' LYS . 9.7 mp -97.89 -44.46 6.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.944 ' O ' HG23 ' A' ' 52' ' ' THR . 3.5 mt-10 -128.77 145.37 51.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.237 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.24 -162.46 53.57 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -139.52 23.02 2.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -1.123 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.541 ' H ' HG21 ' A' ' 52' ' ' THR . . . 119.15 -11.67 11.55 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -80.83 -168.0 38.48 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.89 139.68 36.85 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.09 1.574 . . . . 0.0 110.377 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.05 -3.34 85.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.944 HG23 ' O ' ' A' ' 45' ' ' GLU . 31.9 m -80.09 139.0 37.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -1.198 . . . . 0.0 110.05 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.622 HD13 ' HA ' ' A' ' 70' ' ' LYS . 25.7 mm -109.87 109.59 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 110.295 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 88.1 mttt -99.04 138.4 36.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.323 -0.861 . . . . 0.0 110.217 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.496 ' HB2' HD13 ' A' ' 44' ' ' LEU . 83.2 tttt -109.41 97.28 6.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.202 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.44 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 91.1 mt -84.15 141.88 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 0.0 110.177 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.3 p -116.08 155.22 28.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.147 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 23.5 m-85 -111.8 166.63 11.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.863 . . . . 0.0 110.358 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.08 155.6 0.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -78.39 175.94 9.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -1.16 . . . . 0.0 110.215 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.42 -159.26 32.37 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.445 ' C ' ' HG3' ' A' ' 63' ' ' GLN . 97.3 p -49.47 -35.74 20.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -1.168 . . . . 0.0 110.099 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.445 ' HG3' ' C ' ' A' ' 62' ' ' SER . 62.7 mt-30 -141.15 149.22 41.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.848 . . . . 0.0 110.116 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.4 ' HE1' HG22 ' A' ' 57' ' ' THR . 1.8 t80 -60.17 148.23 36.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.23 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.14 88.29 0.28 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.5 p90 -126.84 164.36 21.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -1.168 . . . . 0.0 110.147 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.852 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.6 m -139.31 173.82 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 110.575 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.504 ' HE3' HG21 ' A' ' 53' ' ' ILE . 48.9 tttt -123.0 128.24 49.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.589 -0.694 . . . . 0.0 109.591 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.67 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -119.7 119.31 33.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 0.0 110.851 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.622 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.4 tttt -100.64 110.87 23.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.577 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.53 HG23 HD11 ' A' ' 74' ' ' ILE . 33.2 mm -46.33 142.79 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.475 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 12.9 t0 -114.64 -41.29 3.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.471 -0.768 . . . . 0.0 109.552 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.578 ' C ' HD12 ' A' ' 74' ' ' ILE . 67.5 p -174.48 157.91 2.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.82 . . . . 0.0 109.457 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.578 HD12 ' C ' ' A' ' 73' ' ' SER . 1.0 OUTLIER -138.99 151.02 23.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.084 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 6.5 m-20 -127.75 75.99 1.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.388 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 99.5 mttt -62.55 -12.85 25.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.101 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -97.98 -30.37 12.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 109.205 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.3 m120 -105.29 -3.08 23.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.653 -0.654 . . . . 0.0 109.715 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.619 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 83.1 m-85 61.26 53.35 3.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.49 -0.756 . . . . 0.0 110.083 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.541 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -125.82 152.67 45.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.568 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.771 ' CE1' HG13 ' A' ' 23' ' ' VAL . 25.8 t80 -138.78 134.5 33.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 110.391 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.457 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -141.54 123.13 15.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 110.555 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 8.8 p90 -135.0 175.89 9.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 110.134 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.6 m -124.41 127.82 48.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.779 HD23 HG13 ' A' ' 98' ' ' ILE . 3.3 tp -97.49 135.81 38.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 0.0 109.906 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.499 HG12 ' HB3' ' A' ' 68' ' ' LYS . 6.7 pt -128.53 -5.42 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 110.409 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' O ' HD11 ' A' ' 85' ' ' LEU . 23.0 tt0 -137.05 139.04 41.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.393 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.852 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 166.49 122.47 0.61 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -51.06 -21.31 1.78 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -1.105 . . . . 0.0 110.23 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -72.79 -27.09 61.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.069 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.667 HD21 HG13 ' A' ' 98' ' ' ILE . 64.7 mt -66.28 -27.84 68.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.177 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.03 -169.67 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -84.62 4.6 31.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -1.147 . . . . 0.0 110.11 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.516 ' O ' HG21 ' A' ' 126' ' ' VAL . 46.8 p -90.41 -30.06 17.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.063 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.052 HD21 ' CG1' ' A' ' 128' ' ' ILE . 44.8 mt -116.99 166.27 12.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.392 -0.818 . . . . 0.0 110.008 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 49.0 tt0 -143.23 -79.57 0.21 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.306 -0.871 . . . . 0.0 110.018 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 51.9 mttt -80.16 139.74 36.67 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.57 -0.706 . . . . 0.0 110.531 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.779 HG13 HD23 ' A' ' 85' ' ' LEU . 7.3 mm -128.24 140.91 47.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 120.861 -1.149 . . . . 0.0 109.722 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.6 m -118.35 125.88 50.94 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.462 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.754 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.3 m-85 -122.77 135.89 54.7 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 37.2 tt0 -141.86 138.45 32.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.844 . . . . 0.0 110.149 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 81' ' ' TYR . 88.8 m -135.76 157.65 46.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 110.059 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 0.3 OUTLIER -149.31 144.16 26.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.266 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.665 HD23 HG12 ' A' ' 114' ' ' ILE . 5.7 mt -121.33 149.19 43.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 110.776 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.82 -169.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 109.711 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -118.68 165.43 13.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 96.3 p -123.95 162.51 40.79 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.248 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.8 Cg_endo -72.03 -2.93 12.31 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.019 1.536 . . . . 0.0 110.422 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.7 p -102.12 -0.36 33.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.3 -35.42 5.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.59 -173.04 3.23 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 73.3 p -128.35 133.71 48.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -1.161 . . . . 0.0 110.337 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 10' ' ' THR . 71.9 mt -81.66 149.64 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 110.183 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.665 HG12 HD23 ' A' ' 104' ' ' LEU . 8.7 mt -132.98 107.56 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.268 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.2 tttt -95.32 132.63 40.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.882 . . . . 0.0 110.069 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.3 OUTLIER -126.2 151.62 47.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 110.259 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.791 HG23 ' CG ' ' A' ' 6' ' ' GLU . 99.2 m -150.06 137.2 19.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.486 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 5.4 p -142.8 146.08 33.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 109.938 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.558 ' CE1' HG22 ' A' ' 117' ' ' THR . 41.6 m-70 -131.33 163.44 27.83 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 110.62 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 9.3 m-85 -122.91 150.29 43.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.579 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 93.8 m-70 -128.98 93.72 3.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 109.472 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.538 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.7 p -71.3 157.63 37.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 110.693 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.485 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 47.6 tptt -140.45 106.1 5.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.311 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 118.81 29.27 1.88 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.83 65.76 0.99 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -1.145 . . . . 0.0 110.214 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 94' ' ' THR . 26.9 m -141.67 162.15 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.176 -0.953 . . . . 0.0 110.099 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -130.6 168.51 16.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.27 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.052 ' CG1' HD21 ' A' ' 95' ' ' LEU . 4.7 mp -94.92 173.07 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.25 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.615 ' N ' HG22 ' A' ' 128' ' ' ILE . 34.5 mttt -110.38 129.92 55.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.387 -0.821 . . . . 0.0 109.658 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 57.3 mm-40 -42.51 -39.32 2.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 110.267 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -60.95 -28.08 68.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.948 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.7 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 15.8 t-160 -78.01 -54.83 5.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 110.057 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.824 HG11 ' CE1' ' A' ' 5' ' ' TYR . 99.4 t -61.13 -38.32 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.847 . . . . 0.0 110.015 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.44 -39.46 88.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.062 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.35 83.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.991 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.79 -30.47 68.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.494 ' HE3' HG12 ' A' ' 133' ' ' VAL . 97.2 mttt -69.88 -31.41 69.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -1.123 . . . . 0.0 110.112 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.509 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 97.8 mt-10 -75.75 -39.33 57.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 110.05 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -62.45 -43.31 99.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -73.24 -34.52 65.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.018 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.0 m -71.51 -54.32 10.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.402 -0.811 . . . . 0.0 109.913 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 73.1 m-20 -51.53 -46.23 63.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.903 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 21.8 tp -57.74 -46.05 85.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 0.0 109.815 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 6.9 m-85 -53.89 -36.88 63.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.729 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 76.7 tttt -79.98 -13.14 59.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.47 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 20.9 mt -87.47 -36.57 17.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.211 -0.931 . . . . 0.0 108.927 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.704 HD13 ' CD1' ' A' ' 22' ' ' PHE . 45.3 mt -73.2 -41.67 58.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.518 ' O ' HG13 ' A' ' 13' ' ' ILE . 19.9 pt-20 -58.55 -31.98 68.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.344 -0.847 . . . . 0.0 109.243 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.463 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 31.8 m -80.0 -34.59 38.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.36 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.674 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 87.1 t80 -58.51 -53.88 53.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.501 -0.75 . . . . 0.0 109.883 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.167 HD21 ' CE2' ' A' ' 158' ' ' TYR . 76.5 mt -70.58 -31.35 68.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.268 -0.895 . . . . 0.0 110.047 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.4 tptt -70.08 -18.92 63.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.492 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.417 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.79 -31.65 2.88 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 150' ' ' TYR . 2.1 m80 -108.16 93.89 12.04 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.345 -1.091 . . . . 0.0 109.904 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.478 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.6 Cg_endo -74.01 5.81 3.3 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.077 1.567 . . . . 0.0 111.06 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -111.58 -9.07 14.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.056 -1.028 . . . . 0.0 109.683 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.69 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -64.81 102.33 0.58 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 110.03 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.167 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.8 OUTLIER 34.68 33.55 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.716 -0.615 . . . . 0.0 110.351 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.85 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 120' ' ' TYR . 74.4 t -122.53 142.37 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -1.159 . . . . 0.0 110.29 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.768 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.7 m-85 -91.72 152.36 20.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.891 . . . . 0.0 110.124 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.81 HG23 ' CE1' ' A' ' 119' ' ' HIS . 17.6 m -132.48 106.87 8.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 0.0 110.364 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.971 ' CE2' HG21 ' A' ' 133' ' ' VAL . 71.3 m-85 -121.54 143.04 49.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.867 . . . . 0.0 109.98 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.65 152.17 42.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.099 -1.001 . . . . 0.0 110.381 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.8 t -132.38 162.54 30.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 110.048 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -145.31 117.32 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.41 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.4 p90 -144.78 -171.48 3.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.879 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.666 HG22 HG12 ' A' ' 113' ' ' ILE . 19.2 p -138.6 -179.61 5.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 0.0 110.621 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 3.0 t -154.19 168.99 24.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.805 . . . . 0.0 110.22 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -92.58 -28.06 16.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.765 HG23 ' HD2' ' A' ' 14' ' ' PRO . 12.3 mm -82.96 148.02 55.88 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.057 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.765 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.4 Cg_endo -64.71 152.47 81.84 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.016 1.535 . . . . 0.0 110.821 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.674 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.4 Cg_endo -63.18 -36.25 58.91 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.917 1.483 . . . . 0.0 112.928 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -63.81 -20.29 68.29 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 N-CA-C 109.862 -0.861 . . . . 0.0 109.862 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.925 ' HB3' HD13 ' A' ' 151' ' ' LEU . 9.8 mmp_? -81.1 -46.03 15.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.763 ' CD1' HG22 ' A' ' 147' ' ' ILE . 4.1 mm? -74.03 -37.08 64.45 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.545 -0.862 . . . . 0.0 108.751 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 37.8 t80 -57.87 -56.69 18.65 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.158 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 89.0 mttt -58.2 -36.45 73.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.708 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.08 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.09 -63.64 1.37 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.435 -0.791 . . . . 0.0 110.738 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.923 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -51.95 -34.36 41.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.516 -0.74 . . . . 0.0 111.622 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.777 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.5 t -108.68 -65.03 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.974 -1.079 . . . . 0.0 111.637 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.1 mp -69.68 -1.6 9.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.22 -0.925 . . . . 0.0 111.303 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.752 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -148.47 23.09 1.03 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.879 -1.138 . . . . 0.0 110.476 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.923 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -62.49 -44.92 95.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.887 . . . . 0.0 110.201 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.503 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 63.8 m-20 -58.22 -15.39 9.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 110.207 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 74.0 m-20 -124.91 4.86 8.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.017 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.83 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -93.2 -49.09 6.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.425 -0.797 . . . . 0.0 109.946 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.035 HG11 HD12 ' A' ' 38' ' ' ILE . 3.5 t -71.17 -42.0 11.33 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.83 . . . . 0.0 110.895 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.7 Cg_endo -77.2 6.61 4.2 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.422 1.222 . . . . 0.0 110.722 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 63.3 mttt -124.63 -33.97 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.264 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.598 HD11 ' CD1' ' A' ' 29' ' ' LEU . 35.3 mt -80.1 -34.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.597 -0.69 . . . . 0.0 109.606 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.46 98.52 1.4 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.512 -0.742 . . . . 0.0 110.109 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.28 2.15 6.53 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.027 1.54 . . . . 0.0 110.726 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -90.54 -3.64 57.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.141 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.5 -33.48 6.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 110.165 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.035 HD12 HG11 ' A' ' 30' ' ' VAL . 6.7 mt -135.97 134.44 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.892 . . . . 0.0 110.284 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.55 ' CG ' ' CA ' ' A' ' 59' ' ' GLY . 9.1 mtmt -73.34 -39.14 65.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.373 -0.829 . . . . 0.0 110.302 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 177.01 164.16 0.49 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 110.211 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 69.5 m -124.73 120.07 30.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.921 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -122.7 102.44 8.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.302 -0.874 . . . . 0.0 110.183 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 28.2 mt -50.32 130.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 110.164 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 55' ' ' LYS . 46.6 mt -88.61 -26.45 21.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 110.091 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 1.062 ' O ' HG23 ' A' ' 52' ' ' THR . 50.0 tt0 -157.08 173.88 16.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 110.23 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 58.98 -159.98 16.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -143.87 31.2 1.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -1.153 . . . . 0.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.783 ' H ' HG21 ' A' ' 52' ' ' THR . . . 105.42 3.0 41.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -97.49 -167.18 32.45 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.5 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 44.2 Cg_endo -70.32 137.09 33.07 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.065 1.56 . . . . 0.0 110.506 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.17 -6.72 83.31 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 1.062 HG23 ' O ' ' A' ' 45' ' ' GLU . 46.4 m -80.05 138.17 36.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -1.14 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' A' ' 70' ' ' LYS . 36.7 mm -105.61 121.27 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 110.037 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 52.3 mtmt -106.29 120.11 41.0 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 110.293 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HB2' HD11 ' A' ' 44' ' ' LEU . 80.1 tttt -91.94 101.11 13.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 0.0 110.2 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.555 ' CG2' HD13 ' A' ' 38' ' ' ILE . 90.6 mt -91.51 147.13 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 110.111 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.49 HG22 ' HB3' ' A' ' 66' ' ' TYR . 3.3 p -119.84 153.09 36.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.952 . . . . 0.0 110.652 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 12.9 m-85 -116.22 125.49 52.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 110.152 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.55 ' CA ' ' CG ' ' A' ' 39' ' ' LYS . . . -92.28 10.85 73.48 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -119.0 128.66 54.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -1.137 . . . . 0.0 110.127 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.55 -140.67 16.51 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 98.1 p -62.08 -165.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -1.165 . . . . 0.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -83.35 -35.54 25.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.88 . . . . 0.0 110.268 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.27 103.79 10.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.33 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -136.19 80.62 0.3 Allowed Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 19.7 p90 -125.81 179.31 5.24 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.319 -1.106 . . . . 0.0 110.23 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 66' ' ' TYR . 4.1 m -152.39 177.7 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.398 -0.813 . . . . 0.0 110.694 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 1.077 ' CE ' HD11 ' A' ' 86' ' ' ILE . 28.0 ttpt -134.93 107.64 7.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.49 -0.756 . . . . 0.0 109.689 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.902 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.5 m170 -96.66 130.67 43.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 111.247 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.709 ' HA ' HD13 ' A' ' 53' ' ' ILE . 56.8 tttt -102.75 109.04 20.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.366 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.1 mm -43.62 138.76 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 110.267 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.546 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 15.0 t0 -108.95 -40.47 5.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.654 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.475 ' C ' HD12 ' A' ' 74' ' ' ILE . 11.0 p 178.39 158.57 0.5 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.427 -0.796 . . . . 0.0 109.782 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.475 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -140.24 156.54 24.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.104 -0.998 . . . . 0.0 110.909 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -139.4 80.96 1.81 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.689 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.57 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 35.1 ttpt -64.11 -12.33 38.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 110.093 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -87.36 -29.6 21.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 108.987 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m120 -111.46 -3.23 15.27 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.409 0.623 . . . . 0.0 109.385 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.848 ' O ' HD12 ' A' ' 104' ' ' LEU . 67.5 m-85 62.5 53.12 2.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.599 -0.688 . . . . 0.0 110.108 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.88 155.72 39.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.539 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.777 ' CE1' HG13 ' A' ' 23' ' ' VAL . 73.5 t80 -143.26 147.47 34.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 110.108 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.4 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 68.8 m -153.6 135.01 14.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 110.97 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.682 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.4 p90 -144.8 173.08 12.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.37 -0.831 . . . . 0.0 110.118 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 98' ' ' ILE . 87.4 m -126.67 124.8 40.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.818 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.902 HD13 ' CD2' ' A' ' 69' ' ' HIS . 9.2 tp -92.6 133.0 36.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.0 110.205 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 1.077 HD11 ' CE ' ' A' ' 68' ' ' LYS . 13.3 pt -123.64 -25.64 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 110.59 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HB3' ' CB ' ' A' ' 68' ' ' LYS . 42.6 tt0 -112.05 133.21 54.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.183 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.44 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . 168.23 140.74 3.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -69.87 -19.09 63.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -1.155 . . . . 0.0 110.279 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.719 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -71.95 -25.04 61.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 92' ' ' GLY . 38.7 mt -62.37 -33.09 74.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 110.114 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.25 -179.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -76.79 1.27 17.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -1.156 . . . . 0.0 109.923 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.679 ' O ' HG21 ' A' ' 126' ' ' VAL . 70.0 p -92.39 -33.57 14.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.823 HD21 HG13 ' A' ' 128' ' ' ILE . 34.8 mt -114.71 163.76 15.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 110.081 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.445 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 39.6 mt-10 -143.56 -79.78 0.2 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.249 -0.907 . . . . 0.0 110.006 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 53.8 mttt -80.12 141.6 35.61 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 110.668 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 84' ' ' THR . 5.2 mm -129.36 143.24 41.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.366 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.1 m -123.27 126.8 47.59 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.731 ' HE2' HG21 ' A' ' 98' ' ' ILE . 13.0 m-85 -121.63 135.27 54.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 110.221 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 74.6 tt0 -136.24 140.12 43.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.242 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 92.5 m -137.95 146.76 43.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 110.228 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 115' ' ' LYS . 19.3 mttt -138.09 145.72 42.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.866 HD23 HG12 ' A' ' 114' ' ' ILE . 2.8 mt -123.21 152.96 40.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 110.461 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.36 -169.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -127.35 125.55 40.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.26 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.447 ' HB3' HG13 ' A' ' 113' ' ' ILE . 95.4 p -82.21 160.57 62.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 110.187 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.36 -1.31 10.0 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.031 1.543 . . . . 0.0 110.553 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.1 t -98.73 -4.03 34.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.47 -41.61 2.19 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.92 -179.17 5.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 4.6 m -121.15 135.66 55.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.399 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.666 HG12 HG22 ' A' ' 10' ' ' THR . 74.9 mt -84.85 149.96 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.361 -0.837 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.866 HG12 HD23 ' A' ' 104' ' ' LEU . 4.7 mt -134.98 113.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 110.398 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 103' ' ' LYS . 22.4 ttmt -100.45 122.34 43.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.91 . . . . 0.0 109.831 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.0 t -114.7 158.12 22.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 0.0 110.619 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.616 HG22 ' NE2' ' A' ' 119' ' ' HIS . 93.4 m -156.32 133.64 10.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.38 -0.825 . . . . 0.0 110.043 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.6 p -133.02 157.78 44.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.153 -0.967 . . . . 0.0 110.334 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.81 ' CE1' HG23 ' A' ' 4' ' ' THR . 74.7 m-70 -141.25 167.06 23.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.131 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.803 ' O ' HG13 ' A' ' 2' ' ' VAL . 9.2 m-85 -131.33 150.03 52.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.43 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 92.9 m-70 -126.3 90.09 3.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 109.561 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.619 ' HB ' HG23 ' A' ' 126' ' ' VAL . 3.0 p -71.27 166.45 21.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.395 -0.815 . . . . 0.0 110.67 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 21.4 tttp -119.75 121.1 38.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -0.834 . . . . 0.0 110.153 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.46 -108.24 3.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.615 ' O ' HG13 ' A' ' 126' ' ' VAL . 51.5 t30 -139.63 94.35 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -1.166 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.679 HG21 ' O ' ' A' ' 94' ' ' THR . 16.7 m -157.65 159.68 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 0.0 110.098 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -133.84 154.26 51.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 110.282 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.823 HG13 HD21 ' A' ' 95' ' ' LEU . 3.3 mp -76.97 173.07 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.383 -0.823 . . . . 0.0 110.257 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.599 ' N ' HG22 ' A' ' 128' ' ' ILE . 60.5 mttt -101.85 128.88 48.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.106 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.47 ' HA ' HG12 ' A' ' 133' ' ' VAL . 53.4 mm-40 -44.53 -48.56 10.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 110.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 35.3 tt0 -54.67 -31.22 57.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 109.861 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.719 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 17.4 t-160 -75.58 -55.67 5.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.971 HG21 ' CE2' ' A' ' 5' ' ' TYR . 11.6 p -67.0 -40.96 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.553 ' N ' HG13 ' A' ' 133' ' ' VAL . 93.7 mttt -66.59 -46.25 76.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.07 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -60.39 -33.29 72.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 110.045 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.07 -26.06 71.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -75.09 -35.13 61.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 110.172 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.34 -35.84 61.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 109.976 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.422 ' O ' HD23 ' A' ' 143' ' ' LEU . 48.2 mtmt -68.65 -37.69 79.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 109.845 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.55 78.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.863 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.7 t -65.88 -48.45 71.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.379 -0.825 . . . . 0.0 109.953 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -53.82 -42.28 68.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.928 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 147' ' ' ILE . 2.6 mm? -58.7 -47.8 83.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 109.951 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.458 ' CE1' HG21 ' A' ' 114' ' ' ILE . 9.8 m-85 -56.31 -38.42 71.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 110.162 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 78.3 mttt -74.03 -21.98 59.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.107 -0.995 . . . . 0.0 109.93 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 15.0 mt -87.4 -35.29 18.4 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 108.701 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.763 HG22 ' CD1' ' A' ' 18' ' ' LEU . 67.9 mt -75.44 -37.36 37.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.575 -0.703 . . . . 0.0 109.129 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 19.8 pt-20 -62.83 -32.82 74.1 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.144 -0.972 . . . . 0.0 109.006 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.482 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 16.8 m -79.93 -26.76 39.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.19 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.688 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.9 t80 -60.94 -52.22 65.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.596 -0.69 . . . . 0.0 109.845 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.18 HD21 ' CE1' ' A' ' 158' ' ' TYR . 80.5 mt -76.41 -36.65 57.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.266 -0.896 . . . . 0.0 109.972 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.745 ' HB2' HD11 ' A' ' 13' ' ' ILE . 45.0 tptt -64.36 -21.69 66.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.57 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -109.31 -32.14 3.07 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 4.3 m80 -108.37 93.49 11.62 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -1.096 . . . . 0.0 110.025 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.9 Cg_endo -74.14 5.05 3.79 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.0 1.526 . . . . 0.0 110.954 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -108.74 -6.33 15.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 109.886 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.688 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -75.35 101.33 4.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.865 . . . . 0.0 110.005 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.18 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.5 p90 34.03 36.8 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.817 -0.552 . . . . 0.0 110.82 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.526 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.728 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 120' ' ' TYR . 45.8 t -120.2 117.55 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.169 . . . . 0.0 110.224 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.595 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 76.7 m-85 -88.15 125.4 34.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.818 HG23 ' CE1' ' A' ' 119' ' ' HIS . 25.1 m -105.48 113.73 27.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 110.388 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.694 ' CE1' HG13 ' A' ' 133' ' ' VAL . 60.3 m-85 -117.26 125.76 51.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.079 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 116' ' ' SER . 20.9 pt-20 -133.74 154.89 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 110.302 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t -127.47 164.68 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.119 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -142.6 116.48 9.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.9 p90 -148.29 -170.12 3.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.308 -0.87 . . . . 0.0 110.204 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 113' ' ' ILE . 10.4 p -141.15 174.84 10.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.393 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.418 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 1.4 t -154.65 157.31 37.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -87.8 -14.48 39.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 110.118 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.812 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.3 mp -81.42 149.95 66.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.812 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.9 Cg_endo -66.36 145.75 78.45 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.003 1.528 . . . . 0.0 110.438 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.671 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 Cg_endo -72.23 -31.68 11.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.91 1.479 . . . . 0.0 113.054 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.9 Cg_endo -69.74 -21.14 33.99 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 110.108 -0.766 . . . . 0.0 110.108 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.63 ' HB3' HD13 ' A' ' 151' ' ' LEU . 7.1 mmp_? -85.68 -43.35 13.49 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.791 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.3 tt -72.2 -29.92 64.43 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 73.8 t80 -67.21 -56.98 7.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.565 -0.709 . . . . 0.0 109.58 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 66.0 mttt -54.84 -34.12 62.49 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.293 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.069 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.42 -55.8 5.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.519 -0.738 . . . . 0.0 110.918 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.929 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -58.61 -46.14 87.65 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.559 -0.713 . . . . 0.0 111.494 -178.729 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.129 HG11 ' CD1' ' A' ' 74' ' ' ILE . 18.2 t -98.17 -65.39 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.075 -1.015 . . . . 0.0 111.897 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.628 ' N ' HD22 ' A' ' 24' ' ' LEU . 4.1 mm? -65.41 -4.64 5.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 111.548 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.655 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -148.19 36.64 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.942 -1.099 . . . . 0.0 110.427 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.929 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -73.97 -36.51 64.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.419 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 68.5 m-20 -62.86 -13.58 35.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.128 -0.982 . . . . 0.0 110.355 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 78.2 m-20 -127.53 7.19 6.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.928 . . . . 0.0 110.2 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.684 HD13 HD11 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -95.38 -52.18 4.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.903 179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.927 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.5 t -71.35 -41.47 10.29 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.574 -0.704 . . . . 0.0 110.871 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.4 Cg_endo -77.88 9.69 2.9 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.484 1.255 . . . . 0.0 110.964 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 29.3 mttm -129.83 -33.39 1.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.056 -1.027 . . . . 0.0 109.753 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.684 HD11 HD13 ' A' ' 29' ' ' LEU . 50.1 mt -80.18 -41.46 20.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.495 -0.753 . . . . 0.0 109.464 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -147.28 99.42 3.91 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.515 -0.741 . . . . 0.0 110.034 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 45.7 Cg_endo -71.35 -1.31 9.48 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.089 1.573 . . . . 0.0 110.659 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -84.82 -11.45 55.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.113 -0.992 . . . . 0.0 109.669 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.861 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -102.41 -57.64 2.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.396 -0.815 . . . . 0.0 110.177 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.927 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.1 mp -121.74 107.36 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.402 -0.811 . . . . 0.0 110.176 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 16.8 tppt? -59.82 -25.28 64.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.601 ' CG ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -173.44 176.77 2.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.601 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 70.5 m -150.86 151.16 31.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 109.905 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -157.52 105.81 2.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.256 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 34.5 mt -51.71 132.97 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.461 ' HB3' ' O ' ' A' ' 53' ' ' ILE . 33.5 tp -93.85 -47.36 6.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.9 . . . . 0.0 110.326 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.873 ' O ' HG23 ' A' ' 52' ' ' THR . 5.1 mm-40 -132.09 134.59 45.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.62 -164.46 37.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -129.68 11.17 5.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.104 . . . . 0.0 110.162 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.455 ' N ' HG21 ' A' ' 52' ' ' THR . . . 125.04 -9.18 7.97 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -75.91 -168.76 26.27 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.413 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.6 Cg_endo -70.58 133.41 24.02 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.169 1.615 . . . . 0.0 110.526 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.38 -4.53 73.64 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.873 HG23 ' O ' ' A' ' 45' ' ' GLU . 16.9 m -80.14 147.63 31.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -1.149 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 70' ' ' LYS . 25.8 mm -116.33 108.42 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.092 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.645 ' HE3' HD11 ' A' ' 71' ' ' ILE . 90.1 mttt -91.83 134.97 34.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 0.0 110.319 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -106.24 94.05 4.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 110.052 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.661 HD12 ' CE1' ' A' ' 69' ' ' HIS . 86.8 mt -80.53 144.07 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.191 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.575 HG22 ' OH ' ' A' ' 64' ' ' TYR . 1.1 p -112.33 156.74 21.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 110.246 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.775 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.1 m-85 -114.04 162.99 15.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.871 . . . . 0.0 110.326 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.402 ' HA3' ' HE2' ' A' ' 39' ' ' LYS . . . -97.47 89.43 1.01 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' CD ' ' O ' ' A' ' 63' ' ' GLN . 46.9 tt0 -131.47 137.83 48.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 110.153 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 62' ' ' SER . . . -92.58 -48.29 3.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 61' ' ' GLY . 70.7 m -43.89 -52.75 6.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -1.149 . . . . 0.0 110.292 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' O ' ' CD ' ' A' ' 60' ' ' GLU . 50.1 tt0 -153.29 157.33 39.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.167 -0.958 . . . . 0.0 110.236 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.638 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 7.8 t80 -55.25 142.36 31.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.336 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -134.93 134.48 7.36 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.638 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 15.1 p90 -177.71 168.63 2.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -1.203 . . . . 0.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.2 m -142.19 173.5 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.35 -0.844 . . . . 0.0 110.422 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.518 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . 91.7 mttt -119.75 131.38 55.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.481 -0.762 . . . . 0.0 109.709 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.661 ' CE1' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -113.51 132.37 55.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.93 -179.387 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.64 ' HA ' HD13 ' A' ' 53' ' ' ILE . 76.2 tttt -111.33 107.53 16.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.837 . . . . 0.0 109.253 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.645 HD11 ' HE3' ' A' ' 54' ' ' LYS . 27.8 mm -48.57 135.47 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.983 . . . . 0.0 110.412 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.466 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 15.8 m-20 -105.26 -45.36 4.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 109.398 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 29.0 p 177.4 156.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.641 -0.662 . . . . 0.0 110.13 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.129 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.8 tt -147.55 165.31 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.035 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-20 -134.84 80.1 1.83 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.328 -0.857 . . . . 0.0 110.041 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.566 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 24.0 mttt -56.13 -15.11 3.23 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.179 -0.95 . . . . 0.0 110.607 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -93.37 -30.81 14.91 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.294 -0.879 . . . . 0.0 109.557 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.7 m120 -106.87 -1.34 22.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.552 -0.718 . . . . 0.0 109.424 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.639 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 68.7 m-85 63.66 52.85 2.14 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.369 0.604 . . . . 0.0 110.82 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.54 ' HB3' ' CG ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -126.88 151.11 48.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.634 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.596 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 77.3 t80 -145.57 163.64 34.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.189 -0.944 . . . . 0.0 110.14 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.496 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 84.8 p -168.51 146.21 4.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.015 -1.053 . . . . 0.0 110.799 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 2.6 p90 -148.23 -179.12 6.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.328 -0.857 . . . . 0.0 110.401 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 98' ' ' ILE . 24.7 m -136.41 128.19 29.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.438 -0.789 . . . . 0.0 109.992 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.605 ' CB ' ' HB ' ' A' ' 98' ' ' ILE . 7.0 tp -80.39 121.97 26.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.275 -0.89 . . . . 0.0 110.073 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.518 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 27.5 pt -101.77 -11.56 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.89 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 66.7 tt0 -154.17 151.85 29.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.178 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.848 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 168.36 157.18 10.97 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' ALA . 65.8 t0 -72.2 -54.14 10.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -1.141 . . . . 0.0 110.366 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' ASP . . . -42.4 -31.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.543 HD23 ' CD2' ' A' ' 95' ' ' LEU . 21.2 mt -52.42 -53.17 48.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 110.128 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.76 -171.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -72.49 -2.08 18.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.126 . . . . 0.0 110.189 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.713 ' O ' HG21 ' A' ' 126' ' ' VAL . 34.9 p -89.64 -60.46 1.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 110.37 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.956 HD11 HD11 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -105.06 163.07 12.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.317 -0.865 . . . . 0.0 109.258 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.77 ' H ' HD12 ' A' ' 95' ' ' LEU . 76.4 mm-40 -142.64 -81.12 0.21 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 110.324 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.489 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 71.2 mttt -80.25 153.64 28.39 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.545 -0.722 . . . . 0.0 110.621 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.956 HD11 HD11 ' A' ' 95' ' ' LEU . 35.1 mm -140.66 159.95 24.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.727 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -135.35 126.41 27.88 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.366 -0.834 . . . . 0.0 108.903 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.809 ' CE2' HG21 ' A' ' 98' ' ' ILE . 22.4 m-85 -123.77 135.68 53.96 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.189 -0.944 . . . . 0.0 110.497 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 71.7 tt0 -139.18 124.95 19.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 0.0 110.238 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 89.0 m -118.63 145.42 45.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.088 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.54 ' CG ' ' HB3' ' A' ' 80' ' ' SER . 7.5 mttt -136.72 132.89 35.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.317 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.871 HD23 HG12 ' A' ' 114' ' ' ILE . 4.4 mt -106.74 153.51 22.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.086 -1.009 . . . . 0.0 110.07 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.96 -168.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.173 -0.954 . . . . 0.0 109.964 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.692 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -119.46 158.61 25.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.225 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 25.8 p -119.67 165.35 17.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 110.216 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.6 Cg_endo -72.5 -1.48 10.33 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.089 1.573 . . . . 0.0 110.506 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.4 m -104.94 -5.9 20.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.149 -0.97 . . . . 0.0 110.227 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.33 -32.52 6.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.83 -171.76 2.88 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 5.9 m -129.85 132.72 46.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -1.14 . . . . 0.0 110.257 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.563 ' HA ' HG22 ' A' ' 10' ' ' THR . 11.4 mt -82.84 152.58 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.871 HG12 HD23 ' A' ' 104' ' ' LEU . 5.9 mt -133.55 114.31 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 110.184 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 103' ' ' LYS . 69.5 tttt -103.31 108.81 20.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.2 m -99.42 157.33 16.5 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.266 -0.896 . . . . 0.0 110.29 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 71.6 m -156.5 131.46 9.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.848 . . . . 0.0 109.916 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 99' ' ' SER . 89.3 p -134.31 148.9 50.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.029 . . . . 0.0 110.696 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.818 ' CE1' HG23 ' A' ' 4' ' ' THR . 39.7 m-70 -131.56 138.92 49.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.775 . . . . 0.0 110.015 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.631 ' HA ' HD13 ' A' ' 98' ' ' ILE . 12.1 m-30 -100.13 150.98 21.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 110.691 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.489 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 98.5 m-70 -128.08 90.7 3.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 0.0 109.488 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 95' ' ' LEU . 2.8 p -79.52 161.3 26.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 110.539 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -120.34 115.53 23.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 110.061 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.16 -141.54 15.37 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.468 ' C ' HG13 ' A' ' 126' ' ' VAL . 53.1 t30 -113.23 96.22 5.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 110.223 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 94' ' ' THR . 21.8 m -151.45 168.62 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.297 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -138.9 160.19 40.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.591 HG12 ' CE1' ' A' ' 3' ' ' PHE . 35.5 mm -74.9 173.36 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.589 ' N ' HG22 ' A' ' 128' ' ' ILE . 40.6 mttt -110.9 133.75 53.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 0.0 110.228 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 129' ' ' LYS . 1.1 mt-10 -43.5 -49.21 7.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.148 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -58.53 -36.06 73.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 110.108 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -68.88 -44.2 73.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.195 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.694 HG13 ' CE1' ' A' ' 5' ' ' TYR . 60.6 t -61.64 -38.05 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.983 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -77.82 -42.49 33.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.57 -37.61 87.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.098 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.27 -29.97 74.93 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 84.9 mttt -79.26 -31.26 43.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -1.114 . . . . 0.0 110.111 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -78.03 -32.93 51.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.852 . . . . 0.0 110.092 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -73.81 -28.18 61.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.412 -0.805 . . . . 0.0 110.015 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -80.05 -36.72 35.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.925 . . . . 0.0 110.051 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.0 p -71.29 -46.76 60.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.409 -0.807 . . . . 0.0 110.025 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.429 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 98.4 m-20 -55.47 -49.3 72.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 110.01 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 147' ' ' ILE . 69.8 mt -57.48 -41.98 81.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.915 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 6.3 m-85 -59.74 -40.92 89.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.485 -0.76 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.43 ' HB3' ' HE3' ' A' ' 145' ' ' LYS . 18.3 mtpp -80.0 -16.79 54.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.115 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 142' ' ' ASN . 27.9 mt -84.26 -36.37 22.72 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.151 -0.968 . . . . 0.0 108.833 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.74 HD13 ' CD1' ' A' ' 22' ' ' PHE . 97.3 mt -72.58 -45.16 59.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.799 ' HB3' HD13 ' A' ' 13' ' ' ILE . 69.1 mt-10 -57.09 -40.58 77.23 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.3 m -68.53 -35.61 77.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.94 . . . . 0.0 109.459 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.653 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.5 t80 -54.27 -46.46 72.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.518 -0.739 . . . . 0.0 109.908 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.181 HD21 ' CE2' ' A' ' 158' ' ' TYR . 94.7 mt -79.87 -31.07 40.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.716 ' HB2' HD11 ' A' ' 13' ' ' ILE . 73.3 tttt -71.11 -25.51 62.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.573 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.33 -34.21 3.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 5.3 m80 -106.91 92.67 7.84 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.259 -1.142 . . . . 0.0 110.179 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.514 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.5 Cg_endo -74.26 6.44 3.06 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.097 1.578 . . . . 0.0 111.072 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -107.43 -2.6 20.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.916 -1.115 . . . . 0.0 109.775 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.653 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -78.67 104.35 9.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.501 -0.749 . . . . 0.0 110.123 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.181 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.66 33.19 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.348 0.594 . . . . 0.0 110.357 -179.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.54 ' HA ' ' NH1' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.862 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 68.5 t -132.1 118.28 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 110.207 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.589 ' CE1' HG12 ' A' ' 128' ' ' ILE . 64.8 m-85 -93.47 125.92 38.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.34 -0.85 . . . . 0.0 110.06 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.854 HG23 ' CE1' ' A' ' 119' ' ' HIS . 28.9 m -107.88 111.04 22.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.853 . . . . 0.0 110.304 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.646 ' CE1' HG13 ' A' ' 133' ' ' VAL . 60.0 m-85 -116.65 138.17 51.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.836 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.576 ' HB3' HG23 ' A' ' 117' ' ' THR . 18.8 pt-20 -141.21 167.37 22.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.149 -0.97 . . . . 0.0 110.654 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.404 ' C ' ' HG3' ' A' ' 8' ' ' GLU . 32.1 t -143.63 157.75 44.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.43 -0.794 . . . . 0.0 109.806 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 7' ' ' SER . 97.1 mt-10 -141.93 117.51 10.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.008 . . . . 0.0 110.628 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 p90 -138.5 -175.09 4.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.84 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.563 HG22 HG12 ' A' ' 113' ' ' ILE . 23.2 p -136.57 178.92 6.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.524 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.516 ' CB ' ' OE2' ' A' ' 148' ' ' GLU . 59.1 p -160.04 163.73 33.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.464 -0.773 . . . . 0.0 110.458 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -89.21 -10.2 47.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.906 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.78 HG23 ' HD2' ' A' ' 14' ' ' PRO . 3.4 mp -92.32 149.87 39.17 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.828 . . . . 0.0 110.058 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.78 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.6 Cg_endo -66.02 145.31 79.09 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.997 1.525 . . . . 0.0 110.367 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.67 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.7 Cg_endo -71.11 -32.25 13.47 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.888 1.468 . . . . 0.0 112.796 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -68.38 -20.91 41.65 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.545 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 53.4 mmm-85 -84.29 -46.3 11.95 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.766 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -71.99 -24.95 61.66 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.609 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 89.1 t80 -68.61 -59.82 2.86 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.519 0.676 . . . . 0.0 109.346 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 77.5 mttt -52.04 -38.15 55.99 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.237 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.018 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -70.06 -55.44 9.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 110.711 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.044 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -57.12 -49.7 75.09 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 111.235 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.979 HG11 ' CD1' ' A' ' 74' ' ' ILE . 10.3 t -95.28 -65.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.971 -1.08 . . . . 0.0 111.722 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 24' ' ' LEU . 8.3 mp -64.83 -4.37 4.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.177 -0.952 . . . . 0.0 111.805 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.634 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -148.28 33.19 0.81 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.715 -1.24 . . . . 0.0 110.548 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.044 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -71.99 -34.03 68.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 0.0 110.241 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 41' ' ' SER . 12.8 t70 -64.97 -13.85 58.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.91 . . . . 0.0 110.287 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 80.9 m-20 -126.78 3.34 6.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.112 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.702 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -90.15 -54.78 3.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 110.234 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.049 HG11 HD13 ' A' ' 38' ' ' ILE . 92.6 t -65.81 -41.26 45.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 111.109 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 48.4 Cg_endo -76.73 4.98 5.16 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.369 1.194 . . . . 0.0 110.608 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 47.1 mttm -125.87 -31.69 2.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.58 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.702 HD11 ' CD1' ' A' ' 29' ' ' LEU . 23.5 mt -80.06 -39.22 19.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.523 -0.735 . . . . 0.0 109.859 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -163.17 97.74 1.05 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 110.19 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.83 5.23 4.53 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.009 1.531 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -87.1 -15.75 37.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 110.025 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.44 -35.38 10.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.207 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.049 HD13 HG11 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -129.98 145.56 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 109.906 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -83.86 -35.18 24.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 110.48 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.449 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER 178.8 157.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 110.249 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 58.5 m -118.19 126.95 53.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.066 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -134.66 105.95 6.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 19.0 mt -59.63 134.0 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.5 tp -95.03 -44.31 7.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.334 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 1.02 ' O ' HG23 ' A' ' 52' ' ' THR . 11.5 mt-10 -127.18 159.32 34.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 61.8 -161.16 28.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -134.43 10.67 3.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -1.152 . . . . 0.0 110.181 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.526 ' N ' HG21 ' A' ' 52' ' ' THR . . . 128.08 -6.69 6.82 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.555 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -86.68 -163.19 38.25 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.72 131.83 20.64 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.013 1.533 . . . . 0.0 110.601 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.01 -6.54 69.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 1.02 HG23 ' O ' ' A' ' 45' ' ' GLU . 20.4 m -79.98 135.68 36.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -1.164 . . . . 0.0 110.144 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.55 HD13 ' HA ' ' A' ' 70' ' ' LYS . 25.9 mm -105.22 113.79 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.208 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.616 ' HE3' HD11 ' A' ' 71' ' ' ILE . 95.1 mttt -99.15 138.78 35.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.376 -0.828 . . . . 0.0 110.298 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -110.97 92.76 4.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.164 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.8 mt -79.99 143.83 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 109.881 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.489 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 6.8 p -116.87 160.16 21.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.688 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.768 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.4 m-85 -120.08 163.14 18.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.534 -0.729 . . . . 0.0 110.059 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.69 144.35 1.73 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 63' ' ' GLN . 22.8 pt-20 -57.26 -39.19 75.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -1.194 . . . . 0.0 110.213 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 60' ' ' GLU . . . 43.52 -150.84 0.52 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.2 p -68.23 -34.43 76.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -1.162 . . . . 0.0 110.119 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 60' ' ' GLU . 72.2 mt-30 -136.58 161.03 37.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 110.117 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.648 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 t80 -60.71 136.63 58.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.264 -0.897 . . . . 0.0 110.159 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -129.18 137.21 9.44 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.648 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 13.4 p90 -178.26 169.43 1.85 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -1.135 . . . . 0.0 110.081 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.992 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.5 m -142.42 172.21 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.895 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.442 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 43.7 mtpt -122.95 121.2 35.55 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.539 ' CE1' ' HG ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -116.39 135.28 54.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.023 . . . . 0.0 111.31 -178.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HA ' HD13 ' A' ' 53' ' ' ILE . 82.9 tttt -111.15 121.74 46.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.415 -0.803 . . . . 0.0 109.12 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.616 HD11 ' HE3' ' A' ' 54' ' ' LYS . 30.1 mm -60.58 134.89 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 110.436 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 19.2 t0 -105.73 -47.92 3.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.482 -0.761 . . . . 0.0 109.864 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -179.99 159.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.543 -0.723 . . . . 0.0 110.205 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.979 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.4 tt -149.13 164.55 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.992 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -127.13 78.9 1.85 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.877 . . . . 0.0 110.042 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.609 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 63.4 mttp -54.34 -15.81 1.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.42 -0.8 . . . . 0.0 110.819 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -92.07 -30.47 16.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.93 . . . . 0.0 109.861 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 m120 -110.59 -1.37 16.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.537 -0.727 . . . . 0.0 109.691 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.742 ' O ' HD12 ' A' ' 104' ' ' LEU . 9.1 m-85 66.01 48.48 1.76 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.688 -0.632 . . . . 0.0 110.518 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -118.56 151.77 37.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.345 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.654 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 84.4 t80 -148.11 143.79 27.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.047 -1.033 . . . . 0.0 110.285 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.487 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 66.5 m -149.61 134.0 17.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.393 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.654 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 4.0 p90 -137.54 179.29 6.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 110.048 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.86 HG23 ' O ' ' A' ' 98' ' ' ILE . 90.2 m -125.08 128.97 49.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.913 . . . . 0.0 110.17 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.762 HD22 HD11 ' A' ' 91' ' ' LEU . 1.5 tt -91.75 140.99 29.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.137 -0.977 . . . . 0.0 110.121 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.672 ' N ' HD23 ' A' ' 85' ' ' LEU . 21.1 pt -127.64 -24.62 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.033 -1.042 . . . . 0.0 110.487 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.442 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 72.6 tt0 -138.12 115.69 11.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.102 -0.999 . . . . 0.0 110.613 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.992 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -165.03 132.79 2.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 88' ' ' GLY . 60.2 t0 -42.85 -36.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -1.194 . . . . 0.0 110.402 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.855 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -62.76 -25.3 68.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.146 -0.971 . . . . 0.0 110.354 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.907 HD21 HG13 ' A' ' 98' ' ' ILE . 96.8 mt -68.04 -28.18 67.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.288 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.34 -168.54 0.31 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -90.04 12.72 16.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -1.158 . . . . 0.0 110.183 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 122' ' ' THR . 25.2 p -105.54 -52.11 2.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.145 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.919 HD21 ' CD1' ' A' ' 128' ' ' ILE . 48.7 mt -79.95 151.01 30.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.069 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.45 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 68.3 mt-10 -127.4 -80.91 0.6 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.34 -0.85 . . . . 0.0 110.269 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 85.5 mttt -80.26 147.15 31.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.593 -0.692 . . . . 0.0 110.292 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.907 HG13 HD21 ' A' ' 91' ' ' LEU . 10.5 mm -135.46 145.91 30.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.94 -1.1 . . . . 0.0 110.043 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -122.66 124.79 44.24 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.465 -0.772 . . . . 0.0 108.92 178.462 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.853 ' CE2' HG21 ' A' ' 98' ' ' ILE . 14.7 m-85 -121.62 132.64 54.78 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.384 -0.823 . . . . 0.0 110.359 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.487 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 26.6 tt0 -132.8 146.91 52.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -0.859 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 81' ' ' TYR . 57.2 m -145.68 135.99 23.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 110.066 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 115' ' ' LYS . 4.1 tttt -129.07 148.63 51.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.185 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 79' ' ' TYR . 10.5 mt -122.64 148.06 45.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 110.458 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.712 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.09 -168.34 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.355 -0.84 . . . . 0.0 109.616 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.712 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -130.69 137.64 49.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.505 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.649 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 5.4 p -80.04 -161.09 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.367 -0.833 . . . . 0.0 109.211 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.649 ' CD ' ' CB ' ' A' ' 107' ' ' SER . 43.9 Cg_endo -83.46 70.72 6.32 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.348 1.183 . . . . 0.0 109.499 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 2.3 m 58.23 30.16 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.528 -0.733 . . . . 0.0 109.594 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.42 34.21 3.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . 107.75 -147.84 16.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 57.5 p -138.05 139.34 39.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.129 -1.218 . . . . 0.0 110.079 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.563 HG12 HG22 ' A' ' 10' ' ' THR . 33.3 mt -88.79 147.49 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 110.243 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.731 HD11 ' OE2' ' A' ' 148' ' ' GLU . 6.0 mt -127.63 108.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 110.069 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 103' ' ' LYS . 34.8 mtpt -90.22 145.95 24.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 110.291 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.2 t -140.95 155.7 46.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.12 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.576 HG23 ' HB3' ' A' ' 6' ' ' GLU . 24.2 m -159.99 153.31 22.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.342 -0.849 . . . . 0.0 110.137 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 99' ' ' SER . 94.4 p -153.26 154.7 35.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.173 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.854 ' CE1' HG23 ' A' ' 4' ' ' THR . 51.9 m-70 -136.92 136.56 38.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.233 -0.917 . . . . 0.0 110.072 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 7.1 m-30 -99.01 151.06 21.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.245 -0.909 . . . . 0.0 110.719 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 96.9 m-70 -130.14 78.13 1.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.729 HG23 HD23 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -73.5 157.44 36.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.359 -0.838 . . . . 0.0 110.686 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 86.2 tttt -105.43 120.41 41.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 110.237 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.28 -161.77 21.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.558 ' C ' HG13 ' A' ' 126' ' ' VAL . 58.0 t30 -102.31 111.13 23.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -1.167 . . . . 0.0 110.245 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.558 HG13 ' C ' ' A' ' 125' ' ' ASN . 24.5 m -156.47 170.86 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.254 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -128.66 136.17 50.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.919 ' CD1' HD21 ' A' ' 95' ' ' LEU . 48.6 mm -57.91 173.4 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 0.0 110.035 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.587 ' N ' HG22 ' A' ' 128' ' ' ILE . 39.9 mtpt -102.82 130.4 49.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.938 . . . . 0.0 110.255 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -45.72 -51.06 13.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 110.157 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 35.9 tt0 -58.77 -34.86 71.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 110.074 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.855 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 18.3 t-160 -67.52 -41.48 84.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 0.0 110.074 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.646 HG13 ' CE1' ' A' ' 5' ' ' TYR . 85.7 t -65.94 -45.83 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.434 -0.791 . . . . 0.0 110.059 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -74.87 -39.28 61.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.049 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -62.67 -39.63 94.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 110.015 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.58 -29.67 75.7 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -76.5 -31.38 57.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -1.127 . . . . 0.0 110.075 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -78.8 -32.41 46.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.63 -41.12 69.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.0 109.938 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.574 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.27 -33.46 63.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.8 m -68.4 -48.47 64.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.82 . . . . 0.0 109.936 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -55.91 -44.25 78.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.853 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 143' ' ' LEU . 24.9 mt -62.29 -35.7 79.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.89 . . . . 0.0 109.945 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 8.3 m-85 -64.12 -36.1 82.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.085 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -78.87 -13.95 59.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 0.0 110.169 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.515 ' HB3' HG21 ' A' ' 33' ' ' ILE . 17.3 mt -85.19 -36.82 20.76 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 108.969 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.675 HD11 ' CE1' ' A' ' 22' ' ' PHE . 11.6 mt -69.74 -44.31 79.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.731 ' OE2' HD11 ' A' ' 114' ' ' ILE . 12.3 mm-40 -59.31 -44.95 92.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 66.0 m -60.78 -35.98 77.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.977 . . . . 0.0 109.392 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.595 ' CD1' HG12 ' A' ' 33' ' ' ILE . 71.8 t80 -54.24 -55.63 26.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.525 -0.734 . . . . 0.0 109.693 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.968 HD21 ' CE1' ' A' ' 158' ' ' TYR . 26.7 mt -71.69 -29.46 64.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.403 -0.811 . . . . 0.0 110.25 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.758 ' HB2' HD11 ' A' ' 13' ' ' ILE . 74.5 tttt -61.15 -18.35 57.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.108 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.495 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -122.53 -16.26 3.84 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -107.01 90.1 5.07 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.191 -1.182 . . . . 0.0 110.219 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.9 Cg_endo -73.15 2.21 5.8 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.072 1.564 . . . . 0.0 110.859 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -122.6 -2.03 8.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.109 -0.994 . . . . 0.0 109.933 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.675 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -49.45 110.02 0.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.421 -0.799 . . . . 0.0 110.398 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.018 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.46 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.584 -0.698 . . . . 0.0 110.618 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.536 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.744 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.453 ' O ' ' OG1' ' A' ' 122' ' ' THR . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 120' ' ' TYR . 26.4 t -129.09 134.94 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -1.15 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.638 ' CG ' ' CD1' ' A' ' 128' ' ' ILE . 25.4 m-85 -100.6 158.09 16.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.317 -0.865 . . . . 0.0 109.809 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.708 HG23 ' ND1' ' A' ' 119' ' ' HIS . 96.0 m -131.72 113.56 13.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -0.996 . . . . 0.0 110.504 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.814 ' CE1' HG22 ' A' ' 133' ' ' VAL . 85.7 m-85 -118.12 125.41 50.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 110.02 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.003 ' CG ' HG23 ' A' ' 117' ' ' THR . 7.3 mt-10 -137.12 151.59 49.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 110.128 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -133.97 153.76 51.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.283 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 94.6 mt-10 -133.88 116.68 15.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 110.142 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -146.57 -176.17 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 110.055 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -136.15 176.89 8.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 112' ' ' SER . 90.9 p -154.13 150.0 27.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.796 . . . . 0.0 110.186 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -73.45 -6.16 44.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.895 HD13 ' HB3' ' A' ' 148' ' ' GLU . 3.2 mp -94.06 149.59 37.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.034 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.812 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.4 Cg_endo -66.92 147.08 79.83 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.095 1.576 . . . . 0.0 110.246 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 Cg_endo -72.01 -32.09 11.5 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.836 1.44 . . . . 0.0 112.957 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.4 Cg_endo -71.31 -21.12 27.03 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 N-CA-C 110.058 -0.786 . . . . 0.0 110.058 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.95 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -83.28 -46.29 12.81 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.927 HD22 ' O ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -70.8 -30.57 67.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.102 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 53.6 t80 -64.99 -56.72 11.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.355 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 55.0 mttt -50.92 -40.33 56.8 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.027 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.016 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -68.71 -60.47 2.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.551 -0.718 . . . . 0.0 110.813 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.024 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -50.16 -57.02 8.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.653 -0.654 . . . . 0.0 112.046 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.039 HG11 ' CD1' ' A' ' 74' ' ' ILE . 6.6 t -94.7 -59.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.951 -1.093 . . . . 0.0 112.287 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.2 mp -68.92 -0.74 5.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.055 -1.028 . . . . 0.0 111.712 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.732 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -152.64 30.03 0.53 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.84 -1.162 . . . . 0.0 110.635 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.024 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.03 -41.79 86.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 110.093 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 16.4 m-20 -58.14 -15.54 10.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.159 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.532 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 67.2 m-80 -127.16 10.13 6.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.255 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.732 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -96.85 -50.57 4.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.308 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.004 HG21 HD13 ' A' ' 38' ' ' ILE . 6.9 p -73.83 -27.22 0.78 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 112.128 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.804 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -82.71 11.13 3.33 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.636 0.808 . . . . 0.0 110.588 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 28' ' ' ASN . 52.6 mtpt -136.83 -28.11 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.13 -0.981 . . . . 0.0 110.793 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.63 HD11 ' CD1' ' A' ' 29' ' ' LEU . 29.4 mt -76.27 -42.01 36.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.167 -0.958 . . . . 0.0 109.857 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.84 101.38 1.3 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.37 -0.831 . . . . 0.0 110.406 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.3 -0.45 9.21 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.086 1.571 . . . . 0.0 110.44 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -89.1 -17.9 28.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 110.015 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.21 -39.64 9.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 110.083 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.004 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -133.69 142.28 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 109.911 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 57' ' ' THR . 35.3 ttmt -76.66 -42.52 41.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.871 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.451 ' N ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER 179.44 158.68 0.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.9 . . . . 0.0 110.176 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 24.4 m -115.27 126.39 54.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.224 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -133.8 103.45 5.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.239 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 23.8 mt -52.58 130.45 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.541 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 44.8 mt -89.7 -46.85 8.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.931 ' O ' HG23 ' A' ' 52' ' ' THR . 9.4 mm-40 -132.52 151.83 51.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.411 -0.806 . . . . 0.0 110.192 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.54 -158.29 48.7 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -143.53 14.21 1.78 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -1.172 . . . . 0.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.588 ' H ' HG21 ' A' ' 52' ' ' THR . . . 121.27 -2.03 11.47 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.61 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -90.94 -168.07 41.77 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.82 130.95 20.15 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.146 1.603 . . . . 0.0 110.549 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.71 -2.76 70.35 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.931 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.5 m -79.96 145.43 32.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -1.182 . . . . 0.0 109.966 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.506 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 33.6 mm -111.14 114.88 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 110.44 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.717 ' CE ' HD11 ' A' ' 71' ' ' ILE . 99.5 mttt -100.74 139.79 35.93 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.415 -0.803 . . . . 0.0 110.033 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 85.6 tttt -116.09 95.47 5.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.096 -1.002 . . . . 0.0 110.438 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.535 ' CG2' HG12 ' A' ' 38' ' ' ILE . 78.3 mt -85.71 144.71 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 38' ' ' ILE . 5.5 p -114.57 158.16 22.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 110.842 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.808 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.3 m-85 -116.03 140.59 49.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.51 -0.744 . . . . 0.0 110.244 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.14 29.41 10.7 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -117.83 128.66 55.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -1.104 . . . . 0.0 110.271 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.6 142.21 12.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.6 t -60.41 -48.64 80.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.19 . . . . 0.0 110.229 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -57.97 156.9 8.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.877 . . . . 0.0 110.116 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.594 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 10.3 t80 -68.81 135.37 51.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -123.81 137.27 10.75 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.594 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 13.5 p90 -178.74 166.04 1.67 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.253 -1.145 . . . . 0.0 110.03 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.922 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.1 m -141.57 172.68 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 110.779 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.614 ' O ' HD22 ' A' ' 85' ' ' LEU . 93.1 mttt -125.95 125.19 42.33 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.771 ' ND1' HD23 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -115.67 118.81 34.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.964 -1.085 . . . . 0.0 111.429 -178.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 1.085 ' HE3' HD13 ' A' ' 86' ' ' ILE . 35.5 mttt -92.59 104.32 16.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.193 -0.942 . . . . 0.0 108.878 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.717 HD11 ' CE ' ' A' ' 54' ' ' LYS . 44.2 mm -47.43 135.62 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.407 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.518 ' CB ' ' HA ' ' A' ' 83' ' ' TYR . 14.9 m-20 -109.22 -44.18 3.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.457 -0.777 . . . . 0.0 109.697 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER 175.5 160.2 0.25 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.45 -0.781 . . . . 0.0 110.509 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.039 ' CD1' HG11 ' A' ' 23' ' ' VAL . 4.4 tt -147.4 168.17 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.647 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.5 m-20 -134.97 82.22 1.95 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.106 -0.996 . . . . 0.0 110.263 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.583 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 95.4 mttt -58.43 -14.29 7.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.214 -0.929 . . . . 0.0 110.607 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -95.34 -30.54 13.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.217 -0.927 . . . . 0.0 109.591 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.7 m120 -106.07 -2.84 22.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.712 -0.618 . . . . 0.0 109.428 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.514 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 96.3 m-85 62.56 54.19 2.48 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.463 0.649 . . . . 0.0 110.651 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -132.2 150.4 52.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.544 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 72.0 t80 -143.42 152.46 41.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 109.991 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.473 ' HB3' ' CG ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -158.7 149.95 20.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.022 -1.049 . . . . 0.0 110.697 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 38.1 p90 -158.6 173.3 16.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.411 -0.805 . . . . 0.0 110.367 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.496 ' HB ' ' HB2' ' A' ' 70' ' ' LYS . 88.5 m -113.29 123.66 50.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.376 -0.828 . . . . 0.0 109.871 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.8 ' C ' HD13 ' A' ' 85' ' ' LEU . 2.5 tm? -95.73 136.49 36.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 1.085 HD13 ' HE3' ' A' ' 70' ' ' LYS . 13.3 pt -122.0 -28.33 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 110.548 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.585 ' O ' HD21 ' A' ' 85' ' ' LEU . 2.2 tt0 -116.07 141.08 48.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 110.226 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.922 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 167.08 123.81 0.68 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 67.7 t0 -45.01 -25.08 0.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.418 -1.048 . . . . 0.0 110.139 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.403 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -70.02 -25.86 63.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.913 . . . . 0.0 110.343 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.538 HD21 ' CG1' ' A' ' 98' ' ' ILE . 89.6 mt -61.44 -33.02 73.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.3 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.71 -167.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -90.54 11.5 21.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -1.16 . . . . 0.0 110.227 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 122' ' ' THR . 36.9 p -102.93 -37.43 7.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.19 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.917 HD23 HG23 ' A' ' 122' ' ' THR . 15.7 mt -110.26 157.17 19.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.042 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -131.33 -78.79 0.52 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.294 -0.879 . . . . 0.0 110.345 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 37.8 mttp -80.18 148.11 31.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 0.0 110.384 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.909 HG21 ' CE2' ' A' ' 100' ' ' TYR . 6.7 mm -132.44 142.66 42.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.936 -1.103 . . . . 0.0 110.055 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.9 m -116.3 120.44 38.91 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.909 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.7 m-85 -115.41 137.66 51.81 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 110.882 -178.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.473 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 4.7 mt-10 -141.21 137.11 32.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.453 -0.779 . . . . 0.0 109.803 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.9 m -131.98 148.01 52.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -136.99 133.83 35.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.077 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.69 HD22 HD12 ' A' ' 18' ' ' LEU . 8.0 mt -119.35 145.97 45.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 110.504 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.0 -169.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.375 -0.828 . . . . 0.0 109.86 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.7 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.53 139.94 52.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.257 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.425 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 84.7 p -95.3 162.87 23.22 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 110.219 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.8 Cg_endo -73.43 -1.09 10.16 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.02 1.537 . . . . 0.0 110.549 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.7 p -98.67 -11.04 22.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.58 -29.22 7.36 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.73 -162.55 7.99 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.504 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 11.8 p -132.33 134.57 45.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -1.087 . . . . 0.0 110.285 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' HG22 ' A' ' 10' ' ' THR . 15.7 mt -83.69 142.55 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.887 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.659 HG12 HD23 ' A' ' 104' ' ' LEU . 9.0 mt -129.62 113.0 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.972 . . . . 0.0 110.501 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 87.1 tttt -102.06 111.54 23.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.895 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 9' ' ' PHE . 1.5 m -93.47 160.08 14.96 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.197 -0.939 . . . . 0.0 110.475 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.003 HG23 ' CG ' ' A' ' 6' ' ' GLU . 40.5 m -154.7 142.47 19.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.391 -0.818 . . . . 0.0 110.29 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 99' ' ' SER . 4.4 p -155.53 139.21 16.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.708 ' ND1' HG23 ' A' ' 4' ' ' THR . 29.2 m-70 -130.5 130.62 44.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.215 -0.928 . . . . 0.0 109.802 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.721 ' HB3' HD22 ' A' ' 95' ' ' LEU . 6.1 m-30 -91.54 154.57 19.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.972 . . . . 0.0 110.795 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.5 m-70 -128.08 85.37 2.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.842 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.917 HG23 HD23 ' A' ' 95' ' ' LEU . 1.2 p -63.18 152.45 37.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 110.295 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 123' ' ' LYS . 50.5 tttt -117.96 97.65 5.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.49 -148.27 17.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.568 ' C ' HG13 ' A' ' 126' ' ' VAL . 46.6 t30 -97.93 91.75 5.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -1.088 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.568 HG13 ' C ' ' A' ' 125' ' ' ASN . 30.4 m -156.82 159.7 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HG3' ' C ' ' A' ' 126' ' ' VAL . 91.4 mt-10 -145.04 146.06 31.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.181 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.774 ' CG1' HD21 ' A' ' 95' ' ' LEU . 2.7 mp -69.75 173.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 110.106 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.596 ' N ' HG22 ' A' ' 128' ' ' ILE . 46.1 mttt -105.91 160.77 15.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.186 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -66.71 -30.4 70.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 110.033 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.48 ' HG2' ' HB3' ' A' ' 129' ' ' LYS . 17.8 pt-20 -70.11 -36.66 75.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.939 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.493 ' HD1' HG23 ' A' ' 128' ' ' ILE . 20.2 t-160 -70.09 -40.87 74.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.998 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.814 HG22 ' CE1' ' A' ' 5' ' ' TYR . 42.9 t -62.77 -40.2 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 0.0 109.986 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -78.07 -41.86 34.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 110.001 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.98 98.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.942 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.88 -31.9 81.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -75.9 -33.24 59.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -1.095 . . . . 0.0 110.048 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -77.91 -33.05 52.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.907 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -72.49 -36.39 68.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 109.943 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.488 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -73.72 -34.77 64.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 109.937 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.0 m -66.4 -51.5 56.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 109.982 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -50.51 -46.59 57.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 0.0 109.957 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.72 -50.0 75.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 19.0 m-85 -54.94 -35.46 64.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.454 -0.779 . . . . 0.0 109.61 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -79.88 -16.81 54.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -0.831 . . . . 0.0 109.909 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 25.9 mt -84.05 -35.59 23.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.216 -0.928 . . . . 0.0 108.931 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.803 ' CG2' HD23 ' A' ' 18' ' ' LEU . 70.0 mt -70.61 -42.53 77.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.895 ' HB3' HD13 ' A' ' 13' ' ' ILE . 55.8 mt-10 -57.06 -42.04 79.83 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.328 -0.857 . . . . 0.0 109.32 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.445 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 86.5 m -66.29 -34.35 77.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.572 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.638 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 76.4 t80 -54.97 -51.9 64.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.881 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.111 HD21 ' CE1' ' A' ' 158' ' ' TYR . 76.8 mt -77.37 -33.77 55.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.32 -0.863 . . . . 0.0 110.183 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.785 ' HB2' HD11 ' A' ' 13' ' ' ILE . 52.3 tptt -64.6 -22.41 66.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.36 -30.56 3.31 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 5.5 m80 -106.68 92.31 7.13 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.287 -1.125 . . . . 0.0 110.148 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.1 Cg_endo -73.89 4.12 4.43 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.052 1.553 . . . . 0.0 110.831 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -110.58 -9.07 14.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.073 -1.017 . . . . 0.0 109.961 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.649 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -63.83 104.63 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.854 . . . . 0.0 109.976 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.111 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.0 OUTLIER 34.52 33.41 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.724 -0.61 . . . . 0.0 110.373 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.547 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.793 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.582 HG22 ' ND1' ' A' ' 121' ' ' HIS . 85.0 t -97.44 134.07 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -1.16 . . . . 0.0 110.418 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.595 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 10.7 m-85 -93.91 149.55 21.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 110.024 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.746 HG23 ' CE1' ' A' ' 119' ' ' HIS . 6.5 m -127.25 112.01 14.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 110.293 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.087 ' CE2' HG21 ' A' ' 133' ' ' VAL . 65.0 m-85 -126.31 136.98 53.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.069 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 4.6 pm0 -139.91 162.03 36.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.893 . . . . 0.0 110.298 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -147.74 154.81 41.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.427 -0.795 . . . . 0.0 109.963 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -134.01 118.85 18.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.975 . . . . 0.0 110.473 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.65 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 3.8 p90 -142.4 -172.66 3.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 109.86 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.7 HG22 ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -143.03 178.72 7.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 110.603 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.406 ' OG ' ' OG ' ' A' ' 112' ' ' SER . 23.4 p -151.48 176.54 11.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.786 . . . . 0.0 109.966 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -92.72 -27.11 17.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.918 . . . . 0.0 110.076 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.78 HG23 ' HD2' ' A' ' 14' ' ' PRO . 24.7 mm -84.23 148.03 51.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.932 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.78 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.32 155.66 67.42 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.98 1.516 . . . . 0.0 111.007 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.655 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.3 Cg_endo -63.73 -37.21 47.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.87 1.458 . . . . 0.0 113.112 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -64.01 -19.68 66.75 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 N-CA-C 109.667 -0.936 . . . . 0.0 109.667 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.75 ' HG2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.91 -43.45 19.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 6.8 mp -75.7 -39.03 58.1 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.588 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.0 t80 -59.32 -54.71 43.67 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.455 0.645 . . . . 0.0 109.982 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.8 mttt -60.44 -34.06 73.44 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 109.839 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.047 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.0 -59.36 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 0.0 110.923 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.065 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -54.66 -39.53 68.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.626 -0.671 . . . . 0.0 111.856 -178.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.101 HG11 ' CD1' ' A' ' 74' ' ' ILE . 21.6 t -106.86 -65.3 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.817 -1.177 . . . . 0.0 112.084 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.0 mp -63.62 -4.72 3.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.183 -0.948 . . . . 0.0 112.164 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.95 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.1 m-20 -144.82 8.19 1.27 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.638 -1.289 . . . . 0.0 110.939 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.065 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -52.05 -26.8 11.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 110.961 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -68.41 -26.38 65.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.937 -1.102 . . . . 0.0 109.592 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 8.9 p30 -125.7 17.22 8.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.604 -0.685 . . . . 0.0 109.473 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.002 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -94.5 -45.56 7.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.465 -0.772 . . . . 0.0 110.083 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.035 HG21 HD13 ' A' ' 38' ' ' ILE . 4.6 p -79.18 -28.18 0.54 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 112.267 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.867 ' HD3' HG12 ' A' ' 30' ' ' VAL . 51.4 Cg_endo -78.29 4.42 6.27 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 122.69 0.837 . . . . 0.0 110.277 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 28' ' ' ASN . 94.2 mttt -123.41 -28.38 3.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.659 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.616 HG12 ' CD1' ' A' ' 150' ' ' TYR . 25.0 mt -78.48 -31.22 15.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 109.676 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.59 98.24 0.44 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.514 -0.741 . . . . 0.0 110.194 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.58 0.2 8.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.062 1.559 . . . . 0.0 110.543 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -89.96 -18.7 25.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 0.0 110.1 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.54 -49.07 6.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.195 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.035 HD13 HG21 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -120.15 137.2 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 109.973 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 9.4 mmtt -75.43 -42.71 52.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 110.017 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.448 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 179.02 156.54 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.448 -0.783 . . . . 0.0 110.128 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 m -114.88 125.97 54.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -128.02 110.69 12.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.316 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 17.2 mt -60.85 131.08 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 110.125 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.508 HD11 ' HD2' ' A' ' 55' ' ' LYS . 47.7 mt -93.3 -44.7 8.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 52' ' ' THR . 1.7 tt0 -130.61 139.47 50.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.42 -0.8 . . . . 0.0 110.142 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.43 -163.92 46.97 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -130.82 2.7 4.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -1.123 . . . . 0.0 110.266 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.561 ' N ' HG21 ' A' ' 52' ' ' THR . . . 133.69 -4.61 4.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.527 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -85.04 -166.77 42.28 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.09 131.17 20.23 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.067 1.562 . . . . 0.0 110.475 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.58 -5.6 67.29 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 45' ' ' GLU . 39.7 m -80.04 140.46 36.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -1.096 . . . . 0.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.694 HD13 ' HA ' ' A' ' 70' ' ' LYS . 26.4 mm -110.18 114.6 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 110.276 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.55 ' HE3' HD11 ' A' ' 71' ' ' ILE . 92.4 mttt -98.0 159.45 14.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.826 . . . . 0.0 110.343 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HD2' HD11 ' A' ' 44' ' ' LEU . 88.3 tttt -133.06 100.55 4.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 110.108 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.557 ' CG2' HG12 ' A' ' 38' ' ' ILE . 88.8 mt -89.11 140.09 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.305 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.2 p -111.06 154.25 24.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 110.849 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.6 m-85 -124.4 122.6 38.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.445 -0.784 . . . . 0.0 110.279 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . 40.6 -162.61 0.01 OUTLIER Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -166.32 139.69 4.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -1.125 . . . . 0.0 110.207 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 62' ' ' SER . . . 174.15 -154.26 18.85 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 61' ' ' GLY . 52.3 m -43.88 -52.16 7.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -1.138 . . . . 0.0 110.157 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -109.45 125.81 52.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.154 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -83.85 134.62 34.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.258 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -113.1 96.84 0.83 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 9.7 p90 -133.41 153.21 51.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -1.173 . . . . 0.0 109.992 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.858 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.6 m -125.28 172.5 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.186 -0.946 . . . . 0.0 110.774 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HD2' ' OE1' ' A' ' 87' ' ' GLU . 69.6 mttt -124.92 129.19 49.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.708 -0.62 . . . . 0.0 109.371 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.593 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -117.59 120.31 37.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.161 -0.962 . . . . 0.0 110.993 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.694 ' HA ' HD13 ' A' ' 53' ' ' ILE . 55.3 tttm -96.67 109.85 22.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.821 . . . . 0.0 109.407 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.55 HD11 ' HE3' ' A' ' 54' ' ' LYS . 26.1 mm -48.55 139.46 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.982 . . . . 0.0 110.175 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.541 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 17.9 t0 -111.65 -40.55 4.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.477 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 0.7 OUTLIER 172.78 160.84 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.581 -0.7 . . . . 0.0 110.339 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.101 ' CD1' HG11 ' A' ' 23' ' ' VAL . 12.5 tt -149.27 172.24 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.536 -0.728 . . . . 0.0 109.505 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.7 m-20 -139.71 83.56 1.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.104 -0.998 . . . . 0.0 110.412 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.588 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 35.7 mtmm -59.27 -14.05 9.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.897 . . . . 0.0 110.44 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -96.02 -30.12 13.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 109.562 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.5 m120 -107.68 -0.75 21.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.601 -0.687 . . . . 0.0 109.357 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.552 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 74.3 m-85 60.4 53.72 4.15 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.356 0.598 . . . . 0.0 110.598 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -127.74 156.0 43.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 109.617 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 86.5 t80 -152.99 146.89 25.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.079 -1.013 . . . . 0.0 110.434 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.435 ' CB ' ' HA ' ' A' ' 101' ' ' GLU . 1.8 m -156.34 145.64 20.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.385 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.6 p90 -143.86 177.78 8.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.518 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 98' ' ' ILE . 80.4 m -124.02 124.69 43.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.429 -0.794 . . . . 0.0 109.626 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.631 HD21 HD11 ' A' ' 91' ' ' LEU . 1.7 tp -93.59 137.32 32.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.32 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.3 pt -124.24 -12.2 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 110.257 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.465 ' O ' HD11 ' A' ' 85' ' ' LEU . 4.6 tt0 -129.21 160.45 32.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 110.236 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.858 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 146.55 132.0 2.29 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -64.81 -12.01 43.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -1.097 . . . . 0.0 110.033 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.585 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -81.38 -29.18 34.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.347 -0.846 . . . . 0.0 110.064 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.745 HD21 HG13 ' A' ' 98' ' ' ILE . 24.1 mt -66.11 -27.55 68.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 110.122 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.62 -172.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -82.49 6.38 17.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -1.163 . . . . 0.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 122' ' ' THR . 14.0 p -93.24 -30.8 15.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.064 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.022 HD21 ' CG1' ' A' ' 128' ' ' ILE . 34.0 mt -113.35 153.02 29.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.344 -0.848 . . . . 0.0 109.947 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 41.1 tt0 -131.45 -79.78 0.52 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.229 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.5 mttt -80.16 133.61 36.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.58 -0.7 . . . . 0.0 110.541 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.745 HG13 HD21 ' A' ' 91' ' ' LEU . 7.1 mm -123.9 143.36 37.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.863 -1.148 . . . . 0.0 109.683 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.76 127.43 50.63 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.203 179.102 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.693 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.2 m-85 -123.51 133.04 54.06 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.4 -0.812 . . . . 0.0 110.425 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.435 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 73.7 tt0 -130.3 158.17 40.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 110.118 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' TYR . 66.7 m -155.8 138.77 15.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.954 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 115' ' ' LYS . 3.4 mttt -132.28 136.05 46.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.818 HD23 HG12 ' A' ' 114' ' ' ILE . 2.9 mt -119.06 149.66 41.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 110.467 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.54 -169.23 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.409 -0.807 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.698 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.56 134.11 53.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 52.4 p -89.03 164.39 31.14 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.9 Cg_endo -73.22 -0.27 8.92 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.045 1.55 . . . . 0.0 110.598 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.1 p -104.38 5.19 34.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 110.247 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.04 -41.28 2.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.66 -172.11 0.55 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 82.4 p -130.13 138.24 50.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -1.135 . . . . 0.0 110.29 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.7 ' HA ' HG22 ' A' ' 10' ' ' THR . 14.0 mt -88.05 151.6 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.889 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.818 HG12 HD23 ' A' ' 104' ' ' LEU . 5.5 mt -136.41 110.08 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.339 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 103' ' ' LYS . 78.0 tttt -98.25 119.49 37.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.936 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -112.94 155.34 24.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 110.395 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.458 HG22 ' NE2' ' A' ' 119' ' ' HIS . 98.9 m -158.09 126.04 5.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.87 . . . . 0.0 109.999 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 p -127.87 165.3 20.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 110.366 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.746 ' CE1' HG23 ' A' ' 4' ' ' THR . 56.9 m-70 -142.46 168.45 19.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.325 -0.86 . . . . 0.0 110.055 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 9.1 m-85 -130.74 148.72 52.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.377 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.582 ' ND1' HG22 ' A' ' 2' ' ' VAL . 95.0 m-70 -131.67 86.46 2.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.182 -0.949 . . . . 0.0 109.701 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.527 HG21 ' O ' ' A' ' 126' ' ' VAL . 1.1 p -56.54 160.7 3.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 66.0 tttt -119.13 107.61 13.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.238 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.8 -111.6 4.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.611 ' O ' HG13 ' A' ' 126' ' ' VAL . 35.2 t30 -134.21 85.85 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -1.129 . . . . 0.0 110.402 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 125' ' ' ASN . 16.6 m -157.93 173.09 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 110.1 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HA ' HG21 ' A' ' 122' ' ' THR . 84.1 mt-10 -144.84 171.43 14.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.248 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.022 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.9 mp -91.42 172.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 110.02 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.607 ' N ' HG22 ' A' ' 128' ' ' ILE . 19.7 mttt -114.39 131.26 56.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.89 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.543 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 83.9 mt-10 -43.39 -47.59 6.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 110.107 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -58.3 -27.28 63.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.63 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.585 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 12.3 t-160 -83.42 -55.6 4.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.956 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.087 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.3 p -65.13 -42.15 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 109.961 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.56 ' N ' HG13 ' A' ' 133' ' ' VAL . 35.7 ttmt -63.31 -42.94 99.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.814 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.65 73.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.87 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.5 -35.61 92.0 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 5' ' ' TYR . 69.5 mmtt -64.35 -32.44 74.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -1.114 . . . . 0.0 109.908 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -72.27 -38.55 68.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.442 -0.786 . . . . 0.0 109.937 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -62.81 -46.51 87.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.806 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.47 -40.2 95.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.8 t -72.46 -52.0 17.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.403 -0.81 . . . . 0.0 109.799 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -50.47 -48.76 56.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.593 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.1 mp -54.62 -49.76 69.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.481 ' HA ' HD12 ' A' ' 147' ' ' ILE . 4.1 m-85 -54.18 -41.88 69.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.725 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -66.46 -28.29 68.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 109.872 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.513 ' HA ' HD23 ' A' ' 146' ' ' LEU . 14.5 mt -80.59 -35.37 34.3 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.542 ' HA ' HD13 ' A' ' 33' ' ' ILE . 96.8 mt -66.79 -41.25 87.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 49.5 mt-10 -54.84 -47.16 74.49 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.403 -0.811 . . . . 0.0 109.18 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.3 m -61.15 -31.53 71.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.445 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.616 ' CD1' HG12 ' A' ' 33' ' ' ILE . 59.7 t80 -64.01 -52.89 57.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.789 . . . . 0.0 109.655 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.061 HD21 ' CE1' ' A' ' 158' ' ' TYR . 56.8 mt -80.07 -33.68 38.74 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 110.408 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.568 ' CG ' HG12 ' A' ' 13' ' ' ILE . 49.5 mtpt -65.71 -14.04 60.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 0.0 109.426 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.481 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.77 -30.27 1.4 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 8.0 m80 -106.43 93.49 8.39 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.189 -1.183 . . . . 0.0 110.253 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.512 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.3 Cg_endo -74.26 3.82 4.89 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.101 1.58 . . . . 0.0 110.644 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -106.99 -11.25 15.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -67.83 100.62 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.757 . . . . 0.0 109.919 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.061 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.1 p90 34.59 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.25 0.548 . . . . 0.0 110.604 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.771 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 78.5 t -110.1 132.86 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -1.191 . . . . 0.0 110.236 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.681 ' CE1' HD12 ' A' ' 128' ' ' ILE . 12.3 m-85 -94.3 149.08 21.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.253 -0.904 . . . . 0.0 109.983 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.627 HG23 ' CE1' ' A' ' 119' ' ' HIS . 8.6 m -127.56 114.19 17.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 110.443 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.155 ' CE2' HG21 ' A' ' 133' ' ' VAL . 64.8 m-85 -128.45 139.52 52.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.822 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 13.6 pt-20 -140.17 152.7 46.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 110.735 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.529 ' C ' ' HG ' ' A' ' 116' ' ' SER . 0.2 OUTLIER -147.22 166.04 28.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.499 -0.75 . . . . 0.0 109.45 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -144.23 145.78 32.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.058 -1.026 . . . . 0.0 110.553 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.642 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 6.3 p90 -159.01 -172.45 3.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.715 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.4 p -137.33 172.57 12.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.101 -1.0 . . . . 0.0 110.708 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 112' ' ' SER . 92.9 p -151.01 149.1 29.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 0.0 110.503 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.29 -25.97 66.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 0.0 110.184 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.721 HD13 ' CB ' ' A' ' 148' ' ' GLU . 4.7 mp -84.46 146.05 46.44 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 110.116 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.679 ' HD2' HG23 ' A' ' 13' ' ' ILE . 43.2 Cg_endo -67.96 154.65 72.25 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.136 1.598 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.667 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.0 Cg_endo -62.73 -37.13 58.53 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.748 1.394 . . . . 0.0 113.106 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 37.9 Cg_endo -63.58 -20.2 68.96 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 N-CA-C 109.823 -0.876 . . . . 0.0 109.823 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.855 ' HB3' HD13 ' A' ' 151' ' ' LEU . 5.7 mmp_? -80.64 -45.47 17.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.714 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.0 mp -75.51 -36.04 60.63 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.802 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 55.3 t80 -58.29 -58.01 10.38 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.107 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 87.4 mttt -59.86 -35.92 75.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.392 -0.818 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.083 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -79.33 -61.55 1.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.357 -0.84 . . . . 0.0 111.019 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.958 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -53.84 -38.28 64.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.448 -0.783 . . . . 0.0 111.653 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.827 HG13 ' CE1' ' A' ' 81' ' ' TYR . 8.0 t -105.22 -66.29 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.892 -1.13 . . . . 0.0 111.661 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.0 mp -66.74 -4.24 8.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.174 -0.954 . . . . 0.0 111.445 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.685 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -147.96 31.26 0.86 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.807 -1.183 . . . . 0.0 110.544 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.958 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -70.57 -32.67 70.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.98 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.57 ' OD2' HD11 ' A' ' 43' ' ' ILE . 94.7 m-20 -65.49 -15.89 63.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.869 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 74.0 m-80 -126.59 10.5 7.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.736 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -96.68 -54.2 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.926 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.0 t -67.38 -42.02 35.85 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 0.0 110.79 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -78.52 8.64 3.54 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.513 1.27 . . . . 0.0 110.693 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 35.1 mttt -126.77 -32.23 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.093 -1.005 . . . . 0.0 109.661 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.741 HD13 ' HA ' ' A' ' 147' ' ' ILE . 45.8 mt -80.0 -34.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.78 99.35 1.5 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.485 -0.759 . . . . 0.0 110.026 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.02 -0.75 8.98 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.092 1.575 . . . . 0.0 110.561 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -86.74 -9.69 55.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.878 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.714 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -101.18 -47.05 4.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.392 -0.817 . . . . 0.0 110.099 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.926 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.8 mp -124.98 143.02 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.459 -0.776 . . . . 0.0 109.874 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' THR . 36.5 ttmt -80.39 -37.92 31.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 110.262 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.442 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.2 OUTLIER 178.8 139.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.248 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 3.2 m -102.17 128.11 48.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 110.314 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -132.81 115.17 14.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 110.14 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.57 HD11 ' OD2' ' A' ' 27' ' ' ASP . 10.7 mt -64.97 133.05 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.363 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 44' ' ' LEU . 24.3 mt -94.36 -45.74 7.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 110.204 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.894 ' O ' HG23 ' A' ' 52' ' ' THR . 6.9 mt-10 -130.51 141.3 50.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 110.116 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.86 -169.87 54.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -130.79 16.35 5.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -1.141 . . . . 0.0 110.304 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.495 ' N ' HG21 ' A' ' 52' ' ' THR . . . 124.39 -8.41 8.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -82.02 -168.92 42.31 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.2 Cg_endo -69.82 134.26 27.43 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.166 1.614 . . . . 0.0 110.468 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.21 76.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.894 HG23 ' O ' ' A' ' 45' ' ' GLU . 37.2 m -79.97 138.75 37.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -1.145 . . . . 0.0 110.069 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.635 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.9 mm -109.35 111.66 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 110.288 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 81.6 mttt -97.14 154.72 17.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 110.204 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -127.52 104.55 7.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.446 ' CG2' HG12 ' A' ' 38' ' ' ILE . 85.4 mt -90.82 140.84 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.3 p -113.28 150.97 31.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 110.333 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.7 m-85 -116.25 137.35 52.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 110.335 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -104.59 61.09 0.41 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -84.33 -23.7 30.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -1.117 . . . . 0.0 110.32 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.33 -160.7 27.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 t -61.32 -54.99 36.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.205 -1.174 . . . . 0.0 110.242 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -42.97 143.08 0.79 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.193 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.691 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 3.9 t80 -84.32 114.39 21.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.969 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -115.74 97.4 0.79 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.691 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 25.3 p90 -134.6 168.27 19.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.167 -1.196 . . . . 0.0 110.171 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.887 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.2 m -137.45 171.84 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 110.486 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' O ' HD12 ' A' ' 85' ' ' LEU . 87.3 mttt -123.03 124.05 42.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.617 -0.677 . . . . 0.0 109.577 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.715 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -111.62 136.27 51.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -0.988 . . . . 0.0 110.906 -179.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.635 ' HA ' HD13 ' A' ' 53' ' ' ILE . 79.1 tttt -114.83 108.87 17.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.462 -0.774 . . . . 0.0 109.507 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 37.0 mm -44.99 137.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 110.047 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.522 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 25.8 t0 -107.47 -47.63 3.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 9.4 m -171.94 156.88 4.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.578 -0.702 . . . . 0.0 109.688 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.7 mt -136.86 157.31 35.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 110.119 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 4.7 m-20 -135.28 79.26 1.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.344 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.582 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 81.3 mttt -63.77 -11.43 26.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -98.14 -30.14 12.83 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.739 0.78 . . . . 0.0 109.177 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m120 -105.12 -2.69 23.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.67 -0.644 . . . . 0.0 109.432 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.545 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 76.6 m-85 59.75 55.18 4.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.677 -0.639 . . . . 0.0 110.408 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -130.64 162.17 29.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.8 . . . . 0.0 109.782 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.827 ' CE1' HG13 ' A' ' 23' ' ' VAL . 37.5 t80 -144.56 137.32 26.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 110.096 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 35.3 m -139.79 126.9 21.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.98 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 9.2 p90 -141.83 179.4 6.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.751 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 98' ' ' ILE . 91.5 m -135.88 152.17 50.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.494 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.715 HD13 ' CE1' ' A' ' 69' ' ' HIS . 52.3 tp -106.68 125.45 51.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.414 -0.804 . . . . 0.0 109.941 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.7 pt -109.28 -8.81 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.428 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.427 ' OE1' ' HD2' ' A' ' 68' ' ' LYS . 30.1 tt0 -150.48 159.25 44.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.326 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.887 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 160.43 139.95 2.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -71.26 -24.93 62.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -1.115 . . . . 0.0 110.075 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.26 -22.95 61.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 110.146 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.658 HD22 HD12 ' A' ' 98' ' ' ILE . 74.7 mt -60.81 -22.48 64.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.002 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.31 -179.39 0.01 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -80.14 6.01 12.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -1.139 . . . . 0.0 110.014 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.472 ' HA ' HG21 ' A' ' 126' ' ' VAL . 30.8 p -98.33 -23.29 15.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.038 HD21 ' CG1' ' A' ' 128' ' ' ILE . 42.1 mt -123.68 162.54 22.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 110.271 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -140.94 -81.69 0.24 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.3 -0.875 . . . . 0.0 109.861 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.556 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 34.8 mttt -80.41 161.04 25.14 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.709 -0.619 . . . . 0.0 110.103 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.658 HD12 HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -156.17 140.13 8.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 178.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 3.7 m -116.63 121.69 42.42 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 11.5 m-85 -112.82 139.78 48.16 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.413 -0.805 . . . . 0.0 110.3 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 80.8 tt0 -135.22 144.24 46.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 109.894 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.0 m -146.77 125.92 12.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.184 -0.948 . . . . 0.0 110.352 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 1.1 ttmt -116.22 146.94 41.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 109.813 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.787 HD23 HG12 ' A' ' 114' ' ' ILE . 6.3 mt -120.58 147.7 44.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.998 . . . . 0.0 110.78 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.89 -168.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.0 109.567 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.713 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -129.9 157.29 42.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 110.52 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -110.44 179.68 0.78 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.795 . . . . 0.0 109.618 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 107' ' ' SER . 40.6 Cg_endo -66.64 73.93 0.41 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.817 1.43 . . . . 0.0 109.577 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 4.0 m 57.35 37.29 27.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.497 -0.752 . . . . 0.0 109.742 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.53 42.72 1.47 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.34 -127.61 8.87 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 92.2 p -151.62 143.28 23.63 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.341 -1.093 . . . . 0.0 109.616 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.579 ' HA ' HG22 ' A' ' 10' ' ' THR . 34.4 mt -90.46 150.32 3.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.196 -0.94 . . . . 0.0 110.571 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.787 HG12 HD23 ' A' ' 104' ' ' LEU . 5.8 mt -138.16 108.92 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.198 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -81.67 143.8 31.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 109.931 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.529 ' HG ' ' C ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -128.01 140.64 51.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 110.5 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 53.4 m -152.3 131.86 13.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.346 -0.846 . . . . 0.0 109.847 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.441 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 52.6 p -137.97 165.09 27.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 110.578 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.627 ' CE1' HG23 ' A' ' 4' ' ' THR . 48.1 m-70 -145.48 161.28 40.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.33 -0.856 . . . . 0.0 110.041 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 10.3 m-85 -121.97 147.54 45.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 110.359 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.556 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 99.6 m-70 -130.94 85.6 2.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.272 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.535 ' OG1' HG23 ' A' ' 126' ' ' VAL . 1.4 t -72.89 176.58 5.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.313 -0.867 . . . . 0.0 110.948 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -132.9 131.28 40.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.622 -0.673 . . . . 0.0 110.186 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.06 -111.13 4.18 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.533 ' C ' HG13 ' A' ' 126' ' ' VAL . 36.0 t30 -151.41 81.34 1.3 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -1.143 . . . . 0.0 110.136 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.535 HG23 ' OG1' ' A' ' 122' ' ' THR . 30.8 m -154.1 160.82 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -126.94 161.26 28.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.038 ' CG1' HD21 ' A' ' 95' ' ' LEU . 4.7 mp -79.91 172.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.954 . . . . 0.0 110.351 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.587 ' N ' HG22 ' A' ' 128' ' ' ILE . 47.4 mttt -106.83 128.29 54.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.324 -0.86 . . . . 0.0 109.86 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.459 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 92.7 mt-10 -43.62 -46.99 7.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.46 -24.59 63.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 109.88 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 129' ' ' LYS . 12.5 t-160 -84.92 -54.16 4.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -0.805 . . . . 0.0 110.14 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.155 HG21 ' CE2' ' A' ' 5' ' ' TYR . 9.3 p -66.84 -41.41 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.065 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.551 ' N ' HG13 ' A' ' 133' ' ' VAL . 81.5 tttt -64.95 -43.56 92.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.907 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -29.27 69.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.926 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.76 -32.19 73.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -70.1 -36.69 75.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.986 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -68.73 -33.79 74.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 109.778 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -66.99 -37.37 84.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.823 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.16 90.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.296 -0.877 . . . . 0.0 109.791 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.7 m -61.32 -48.46 81.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.371 -0.831 . . . . 0.0 109.742 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 145' ' ' LYS . 98.4 m-20 -51.25 -42.69 61.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 146' ' ' LEU . 25.8 tp -56.32 -54.58 43.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.737 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.585 ' CE1' HG21 ' A' ' 114' ' ' ILE . 17.3 m-85 -48.03 -37.66 15.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.551 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 142' ' ' ASN . 98.9 mttt -68.75 -24.27 64.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.626 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.493 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 30.1 mt -84.51 -34.86 23.24 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.225 -0.922 . . . . 0.0 108.92 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.741 ' HA ' HD13 ' A' ' 33' ' ' ILE . 52.5 mt -71.88 -33.99 49.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.578 -0.702 . . . . 0.0 109.336 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.721 ' CB ' HD13 ' A' ' 13' ' ' ILE . 78.4 mt-10 -64.37 -38.49 91.23 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.502 -0.749 . . . . 0.0 109.55 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 90.0 m -70.06 -38.02 75.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 109.478 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.612 ' CD1' HG12 ' A' ' 33' ' ' ILE . 68.1 t80 -55.73 -51.52 67.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.416 -0.803 . . . . 0.0 109.774 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.09 HD21 ' CE1' ' A' ' 158' ' ' TYR . 77.8 mt -80.03 -41.48 25.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 110.1 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.635 ' HB2' HD11 ' A' ' 13' ' ' ILE . 49.2 tttp -64.06 -19.92 65.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.361 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.71 -34.78 2.75 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 2.1 m80 -110.6 94.88 20.69 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.324 -1.104 . . . . 0.0 110.101 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -74.14 5.48 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.093 1.575 . . . . 0.0 110.985 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -105.55 -7.92 18.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.994 -1.066 . . . . 0.0 109.865 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -71.57 102.08 2.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.427 -0.795 . . . . 0.0 110.121 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.09 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.1 p90 34.24 32.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.797 -0.564 . . . . 0.0 110.71 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.763 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 86.0 t -122.35 118.53 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.133 -1.216 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.572 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 58.5 m-85 -86.31 163.29 17.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.867 HG23 ' CE1' ' A' ' 119' ' ' HIS . 75.7 m -141.35 92.87 2.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.686 ' CE1' HG11 ' A' ' 133' ' ' VAL . 83.5 m-85 -109.01 126.03 52.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.977 . . . . 0.0 109.815 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 116' ' ' SER . 16.1 pt-20 -128.79 153.03 47.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 110.445 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.8 m -123.88 141.06 52.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.917 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.443 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 83.0 mt-10 -121.62 124.02 43.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 110.447 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.2 p90 -151.13 -172.86 4.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.938 . . . . 0.0 109.947 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.568 HG22 HG12 ' A' ' 113' ' ' ILE . 17.3 p -138.84 -178.21 5.22 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 110.547 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 112' ' ' SER . 98.9 p -157.27 150.05 23.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.432 -0.792 . . . . 0.0 110.349 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -75.51 -8.39 56.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.124 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.0 mm -96.79 149.78 36.16 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.414 -0.804 . . . . 0.0 110.084 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -64.96 148.01 89.47 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.975 1.513 . . . . 0.0 110.376 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.668 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -71.14 -32.21 13.45 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.877 1.462 . . . . 0.0 112.899 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.12 -20.62 37.61 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 N-CA-C 109.871 -0.857 . . . . 0.0 109.871 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.866 ' HG2' HD13 ' A' ' 151' ' ' LEU . 4.5 ttm180 -83.36 -46.72 12.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.756 ' C ' HD23 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -72.95 -28.87 62.68 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.086 178.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 87.0 t80 -65.86 -56.52 11.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.436 -0.79 . . . . 0.0 109.544 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.779 ' HA ' HD12 ' A' ' 24' ' ' LEU . 90.8 mttt -54.36 -39.25 66.98 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.279 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.061 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -68.82 -53.28 22.45 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.501 0.667 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.806 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -63.86 -45.47 89.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 111.511 -178.677 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.657 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.1 t -99.05 -57.23 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.99 -1.069 . . . . 0.0 111.725 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 20' ' ' LYS . 27.5 mt -76.42 1.72 15.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.136 -0.977 . . . . 0.0 111.678 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.707 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -154.68 38.8 0.43 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.733 -1.229 . . . . 0.0 110.898 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -76.3 -31.29 58.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.082 -1.011 . . . . 0.0 110.228 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 79.8 m-20 -65.41 -13.6 59.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.093 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.547 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 66.9 m-20 -128.81 8.23 5.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 110.073 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.9 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -94.93 -51.17 4.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.431 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.095 HG21 HD13 ' A' ' 38' ' ' ILE . 8.2 p -75.37 -27.14 0.67 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.925 . . . . 0.0 112.267 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.814 ' HD3' HG12 ' A' ' 30' ' ' VAL . 53.0 Cg_endo -81.37 8.61 4.29 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 122.743 0.865 . . . . 0.0 110.625 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -137.39 -30.29 0.85 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.056 -1.028 . . . . 0.0 110.609 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.9 HD11 ' CD1' ' A' ' 29' ' ' LEU . 67.2 mt -75.24 -41.29 43.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.274 -0.891 . . . . 0.0 109.692 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.57 90.76 2.84 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.422 -0.798 . . . . 0.0 110.374 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.78 1.68 7.34 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.112 1.585 . . . . 0.0 110.321 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -87.2 -23.2 24.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.161 -0.962 . . . . 0.0 109.892 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.48 -42.59 8.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.095 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -121.94 146.97 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.788 . . . . 0.0 109.827 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 17.1 tppt? -86.87 -42.22 13.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.371 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.466 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.6 OUTLIER 179.08 139.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 110.403 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 4.2 m -94.25 137.32 33.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -142.03 110.08 5.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 45.5 mt -60.46 132.16 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.143 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.9 tp -95.71 -39.04 10.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.38 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 52' ' ' THR . 2.5 mt-10 -136.43 137.63 40.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.133 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.412 ' O ' ' OD1' ' A' ' 47' ' ' ASP . . . 81.08 -162.41 44.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 89.0 m-20 -137.65 20.99 2.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -1.167 . . . . 0.0 110.213 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.537 ' H ' HG21 ' A' ' 52' ' ' THR . . . 118.88 -12.14 11.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.536 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -75.01 -169.93 25.52 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.65 132.46 20.38 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.123 1.591 . . . . 0.0 110.382 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.78 67.26 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 45' ' ' GLU . 32.1 m -79.84 143.19 34.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.186 . . . . 0.0 110.042 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.4 mm -111.49 104.27 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.953 . . . . 0.0 110.328 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 51.9 mtpt -89.5 137.22 32.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.383 -0.823 . . . . 0.0 110.245 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -113.79 103.08 10.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.842 . . . . 0.0 110.356 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.541 ' CG2' HG12 ' A' ' 38' ' ' ILE . 87.3 mt -89.15 140.65 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.177 -0.952 . . . . 0.0 109.976 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 40' ' ' HIS . 1.3 p -112.49 152.94 28.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.52 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.711 ' HE2' HG13 ' A' ' 67' ' ' VAL . 30.9 m-85 -113.26 160.25 18.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.883 . . . . 0.0 110.145 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.41 170.07 22.45 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 53.71 66.26 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -1.106 . . . . 0.0 110.193 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.24 -135.23 2.0 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.7 p -61.67 178.21 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -1.158 . . . . 0.0 110.087 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -54.2 -48.89 70.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.169 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.679 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 8.3 t80 -135.85 117.0 14.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -113.36 135.03 12.27 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.679 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 11.4 p90 -178.52 160.26 1.23 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 110.112 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.833 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.8 m -141.36 171.65 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.39 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.802 ' CD ' HD11 ' A' ' 86' ' ' ILE . 23.8 ttmt -123.09 124.11 42.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.598 -0.689 . . . . 0.0 109.881 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.668 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -113.56 123.52 50.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 110.751 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.562 ' HA ' HD13 ' A' ' 53' ' ' ILE . 84.4 tttt -100.09 110.79 23.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 109.612 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 49' ' ' GLY . 33.4 mm -50.97 133.85 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 110.439 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB2' ' C ' ' A' ' 82' ' ' SER . 83.2 m-20 -106.25 -37.15 6.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.316 -0.865 . . . . 0.0 109.87 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 11.8 p 178.16 157.72 0.44 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.747 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.466 HG13 ' HD1' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -138.66 153.62 25.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.051 -179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 79' ' ' TYR . 6.3 m-20 -131.02 77.49 1.79 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.529 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 85.1 mttt -63.04 -11.85 22.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.232 -0.918 . . . . 0.0 110.005 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -98.12 -31.82 11.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.746 . . . . 0.0 109.235 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m120 -102.45 -3.26 27.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.634 -0.666 . . . . 0.0 109.342 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.552 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 74.8 m-85 60.87 54.76 3.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.524 0.678 . . . . 0.0 110.6 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -130.97 156.53 44.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.679 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.703 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 61.2 t80 -143.67 141.61 30.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.931 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.47 ' OG ' ' HG2' ' A' ' 101' ' ' GLU . 53.6 m -148.7 136.97 21.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.14 -0.975 . . . . 0.0 110.755 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.703 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.0 p90 -147.82 175.61 10.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.399 -0.813 . . . . 0.0 110.29 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 98' ' ' ILE . 44.9 m -124.47 128.84 49.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.858 . . . . 0.0 109.851 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.668 HD13 ' CE1' ' A' ' 69' ' ' HIS . 4.5 tp -95.47 124.88 39.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -0.978 . . . . 0.0 110.167 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.802 HD11 ' CD ' ' A' ' 68' ' ' LYS . 16.9 pt -109.23 -5.83 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 110.229 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.552 ' O ' HD11 ' A' ' 85' ' ' LEU . 9.1 tt0 -136.56 162.35 33.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 110.327 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.833 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 149.14 125.08 1.38 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -57.89 -31.39 66.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -1.11 . . . . 0.0 110.187 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.18 -18.58 65.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.079 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.599 HD21 HG13 ' A' ' 98' ' ' ILE . 86.9 mt -70.72 -30.45 66.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.62 -174.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -80.89 4.51 19.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -1.146 . . . . 0.0 110.26 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.634 ' O ' HG22 ' A' ' 122' ' ' THR . 78.1 p -89.47 -41.47 12.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.92 . . . . 0.0 110.108 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.011 HD23 HG23 ' A' ' 122' ' ' THR . 62.9 mt -102.47 152.33 21.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.854 . . . . 0.0 109.987 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.51 ' CG ' ' HD3' ' A' ' 123' ' ' LYS . 5.6 tp10 -131.54 -80.56 0.52 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.304 -0.873 . . . . 0.0 110.087 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 59.3 mttt -80.21 127.78 32.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.581 -0.7 . . . . 0.0 110.522 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.746 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -116.77 139.05 45.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.702 -1.249 . . . . 0.0 109.856 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.49 127.68 54.24 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.405 -0.81 . . . . 0.0 108.974 178.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.746 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.6 m-85 -122.56 133.98 54.55 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.331 -0.856 . . . . 0.0 110.509 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.47 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 3.2 mt-10 -132.56 141.18 48.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.1 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 81' ' ' TYR . 63.6 m -137.04 143.13 42.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -137.19 135.76 37.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 110.169 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.752 HD23 HG12 ' A' ' 114' ' ' ILE . 4.9 mt -120.07 148.21 43.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.836 . . . . 0.0 110.533 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.7 -169.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 0.0 109.799 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.698 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -115.35 167.16 11.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 110.214 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.532 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 57.6 p -126.42 175.42 3.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 109.948 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.8 Cg_endo -87.29 22.8 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.87 1.458 . . . . 0.0 110.498 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 t -126.67 -10.99 6.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 110.409 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.96 -26.68 10.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.9 -149.59 1.56 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 8.4 p -149.12 137.79 21.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -1.17 . . . . 0.0 110.152 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.568 HG12 HG22 ' A' ' 10' ' ' THR . 68.5 mt -86.86 148.91 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 110.122 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.752 HG12 HD23 ' A' ' 104' ' ' LEU . 9.7 mt -132.79 125.26 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.391 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 75.1 tttt -115.86 108.43 16.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.2 m -98.84 158.85 15.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 110.538 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 101' ' ' GLU . 53.4 m -159.35 126.01 4.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.398 -0.814 . . . . 0.0 110.278 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.4 m -128.97 160.01 34.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 0.0 110.183 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.867 ' CE1' HG23 ' A' ' 4' ' ' THR . 62.3 m-70 -136.73 162.11 34.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.246 -0.909 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.8 m-85 -126.58 136.24 52.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.912 . . . . 0.0 110.99 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 93.3 m-70 -119.0 81.49 1.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.915 . . . . 0.0 109.34 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 1.011 HG23 HD23 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -66.69 154.52 40.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 111.102 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HD3' ' CG ' ' A' ' 96' ' ' GLU . 37.8 mtmt -103.8 116.86 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.521 -0.737 . . . . 0.0 109.829 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 106.74 9.72 30.05 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 5.8 t30 69.4 51.4 0.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -1.134 . . . . 0.0 110.451 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 127' ' ' GLU . 85.4 t -92.63 175.15 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.331 -0.855 . . . . 0.0 109.549 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.601 ' N ' HG12 ' A' ' 126' ' ' VAL . 90.8 mt-10 -124.3 149.34 46.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.969 -1.082 . . . . 0.0 110.563 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.881 ' CD1' HD21 ' A' ' 95' ' ' LEU . 15.8 mm -75.42 172.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 110.202 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.594 ' N ' HG22 ' A' ' 128' ' ' ILE . 70.3 mmtt -111.29 129.88 55.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.288 -0.882 . . . . 0.0 109.842 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' LYS . 54.1 mt-10 -43.09 -43.5 4.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 110.184 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -62.45 -25.36 67.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 110.025 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.8 t-160 -78.11 -50.54 11.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 110.147 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.686 HG11 ' CE1' ' A' ' 5' ' ' TYR . 72.7 t -57.24 -32.85 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.0 109.746 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -80.17 -40.77 26.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.831 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.92 -36.82 84.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.335 -0.853 . . . . 0.0 109.906 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.56 -30.04 69.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.461 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 91.7 mttt -77.49 -32.1 54.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 0.0 109.985 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -76.13 -33.24 59.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.387 -0.821 . . . . 0.0 109.973 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.21 -33.46 65.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.919 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -79.07 -36.11 41.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.0 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.0 m -62.11 -47.36 84.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.958 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -53.93 -50.03 67.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.816 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.48 ' HA ' HD12 ' A' ' 143' ' ' LEU . 15.9 tp -57.18 -45.32 83.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.789 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 21.6 m-85 -56.83 -41.34 77.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.406 -0.809 . . . . 0.0 109.643 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.417 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 45.9 mtmt -78.84 -14.92 58.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 109.828 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.498 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 19.7 mt -83.22 -36.69 24.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -0.901 . . . . 0.0 108.818 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.747 HD11 ' CE1' ' A' ' 22' ' ' PHE . 16.1 mt -69.42 -46.22 76.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.495 ' O ' HG13 ' A' ' 13' ' ' ILE . 64.1 mt-10 -56.78 -36.65 70.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.402 -0.811 . . . . 0.0 109.551 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.4 m -72.23 -39.43 68.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.778 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.651 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 77.0 t80 -53.59 -52.13 60.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -0.843 . . . . 0.0 110.089 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.194 HD21 ' CE2' ' A' ' 158' ' ' TYR . 74.6 mt -75.25 -33.98 61.36 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.213 -0.93 . . . . 0.0 110.27 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 37.6 ttpt -69.98 -20.62 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -109.06 -31.13 3.42 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 8.4 m80 -109.53 93.3 13.61 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 109.942 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.16 5.27 3.68 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.07 1.563 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -109.83 2.24 19.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.003 -1.06 . . . . 0.0 109.856 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.651 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -83.59 103.22 12.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 109.995 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.194 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.99 31.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.722 -0.611 . . . . 0.0 110.472 -179.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.721 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.876 HG13 ' O ' ' A' ' 120' ' ' TYR . 70.6 t -120.89 118.67 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.214 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.603 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 90.8 m-85 -75.91 149.88 37.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.162 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.725 HG23 ' CE1' ' A' ' 119' ' ' HIS . 39.9 m -133.1 119.94 20.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 110.228 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.015 ' CE2' HG21 ' A' ' 133' ' ' VAL . 69.9 m-85 -131.07 152.41 50.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 110.247 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -144.81 149.77 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.131 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.8 t -142.86 156.52 44.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.833 . . . . 0.0 109.816 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.23 145.89 36.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.005 . . . . 0.0 110.756 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.689 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 5.7 p90 -159.45 -172.89 3.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.608 -0.683 . . . . 0.0 109.704 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 113' ' ' ILE . 20.8 p -136.39 177.99 7.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.065 -1.022 . . . . 0.0 110.717 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 3.2 t -157.83 159.89 37.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.432 -0.793 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -87.45 -2.72 58.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 110.248 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.752 HG23 ' HD2' ' A' ' 14' ' ' PRO . 12.0 mm -98.06 148.3 34.29 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 110.215 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.752 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.59 144.84 80.22 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.099 1.579 . . . . 0.0 110.494 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.67 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.52 -31.12 11.45 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 124.018 1.536 . . . . 0.0 112.988 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.9 Cg_endo -69.04 -23.66 33.85 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 N-CA-C 110.121 -0.761 . . . . 0.0 110.121 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.541 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 3.7 mmp_? -84.44 -42.7 15.37 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.778 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -69.91 -31.31 69.03 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.565 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 48.8 t80 -66.27 -53.35 37.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.487 -0.758 . . . . 0.0 109.588 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 80.8 mttt -53.43 -37.48 62.61 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.212 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.06 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -72.3 -53.45 12.38 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.582 0.706 . . . . 0.0 110.769 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.055 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -61.37 -40.89 95.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.511 -0.743 . . . . 0.0 111.556 -178.645 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.532 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.6 t -104.68 -65.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.925 -1.109 . . . . 0.0 111.798 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.6 mp -65.95 -9.49 30.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.232 -0.917 . . . . 0.0 111.516 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 1.4 m-20 -145.68 33.39 1.04 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.823 -1.173 . . . . 0.0 110.71 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.055 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -73.46 -20.4 60.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.391 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 41' ' ' SER . 36.9 t0 -73.6 -20.56 60.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 109.73 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 6.9 p30 -123.88 15.34 9.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.429 -0.794 . . . . 0.0 109.684 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.866 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER -97.41 -57.75 2.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 109.754 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.018 ' CG1' HD13 ' A' ' 38' ' ' ILE . 11.7 t -62.12 -41.46 75.67 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.48 -0.763 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.2 Cg_endo -78.27 7.75 3.92 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.348 1.183 . . . . 0.0 110.831 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 72.1 mmtt -126.43 -27.74 3.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.052 -1.03 . . . . 0.0 109.907 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 146' ' ' LEU . 20.9 mt -77.34 -42.77 30.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.387 -0.82 . . . . 0.0 109.58 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.03 101.99 1.58 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.498 -0.751 . . . . 0.0 110.073 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.97 1.18 6.8 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.077 1.567 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -84.42 -19.99 32.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.065 -1.022 . . . . 0.0 109.572 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.8 -53.31 4.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.321 -0.862 . . . . 0.0 109.913 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.018 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.2 mp -121.84 148.71 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.44 -0.788 . . . . 0.0 109.791 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -84.0 -41.14 17.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.931 . . . . 0.0 110.549 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.579 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -172.59 170.64 4.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.204 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.428 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 68.3 m -126.93 136.5 52.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.14 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 76.2 tt0 -140.56 107.99 5.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 43.3 mt -58.7 133.27 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 110.206 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.556 HD12 HG22 ' A' ' 53' ' ' ILE . 52.8 mt -87.69 -27.64 22.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.3 -0.875 . . . . 0.0 110.044 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.985 ' O ' HG23 ' A' ' 52' ' ' THR . 29.4 tp10 -160.47 165.95 30.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 110.218 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.8 -168.99 27.02 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -127.69 24.6 6.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -1.182 . . . . 0.0 110.334 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.637 ' H ' HG21 ' A' ' 52' ' ' THR . . . 105.3 8.59 35.45 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.587 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -93.73 -164.09 36.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.79 130.8 18.64 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.047 1.551 . . . . 0.0 110.621 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.89 -3.69 77.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.985 HG23 ' O ' ' A' ' 45' ' ' GLU . 23.6 m -79.98 142.47 35.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -1.161 . . . . 0.0 109.982 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.556 HG22 HD12 ' A' ' 44' ' ' LEU . 32.5 mm -112.12 111.67 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.098 -1.001 . . . . 0.0 110.233 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.2 mttt -94.67 139.53 31.1 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.342 -0.849 . . . . 0.0 110.148 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HB2' ' HG ' ' A' ' 44' ' ' LEU . 80.3 tttt -111.34 96.21 5.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.327 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.686 HD12 ' CE1' ' A' ' 69' ' ' HIS . 63.6 mt -84.94 147.29 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.819 ' O ' HG23 ' A' ' 38' ' ' ILE . 7.8 p -116.68 163.07 16.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 0.0 110.638 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.655 ' HE2' HG13 ' A' ' 67' ' ' VAL . 24.6 m-85 -117.2 158.95 23.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.522 -0.736 . . . . 0.0 110.142 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -42.04 144.95 0.83 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -68.0 172.24 5.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -1.171 . . . . 0.0 110.243 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.02 -164.26 37.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.0 t -48.61 -45.43 38.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 110.092 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 64' ' ' TYR . 95.5 mt-30 -125.53 123.77 39.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.119 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' GLN . 5.0 t80 -44.62 150.5 0.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.977 . . . . 0.0 110.124 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -132.93 135.23 7.98 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 10.7 p90 -177.95 163.1 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -1.18 . . . . 0.0 110.145 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.772 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.8 m -143.22 172.24 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.614 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.6 ' O ' HD12 ' A' ' 85' ' ' LEU . 98.4 mttt -122.17 133.37 54.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.591 -0.693 . . . . 0.0 109.767 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.686 ' CE1' HD12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -112.31 137.28 50.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.118 -0.989 . . . . 0.0 110.706 -179.49 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.8 tttt -111.45 109.84 19.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.892 . . . . 0.0 109.211 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.668 HG23 HD11 ' A' ' 74' ' ' ILE . 36.1 mm -52.77 127.52 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.171 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.45 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 95.1 m-20 -99.03 -38.71 8.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.489 -0.757 . . . . 0.0 109.878 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.633 ' C ' HD12 ' A' ' 74' ' ' ILE . 2.2 m -178.81 161.28 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.668 HD11 HG23 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -144.74 152.8 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.986 -1.071 . . . . 0.0 111.261 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -140.54 80.89 1.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.682 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.565 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 84.2 tttt -65.61 -11.72 46.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.13 -0.981 . . . . 0.0 109.968 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -85.7 -30.73 22.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 108.68 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m120 -110.5 -2.92 16.27 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.612 ' O ' HD12 ' A' ' 104' ' ' LEU . 72.8 m-85 62.65 52.11 2.94 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.543 0.687 . . . . 0.0 110.444 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -123.31 153.02 40.82 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 109.352 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.684 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 59.0 t80 -142.38 148.98 38.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.14 -0.975 . . . . 0.0 110.255 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.436 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 60.3 m -152.13 137.04 17.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.791 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.684 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 4.1 p90 -149.32 179.31 8.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 110.009 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' ILE . 65.2 m -137.46 134.54 35.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.895 . . . . 0.0 110.372 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.608 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 9.2 tp -80.34 121.01 25.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.223 -0.923 . . . . 0.0 109.94 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.532 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 27.4 pt -100.16 -11.18 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.654 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -154.82 147.98 24.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.0 110.238 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.772 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 172.61 152.46 8.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -78.91 -35.38 43.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -1.122 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.869 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -58.78 -21.25 55.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.158 -0.964 . . . . 0.0 110.265 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.825 HD22 ' O ' ' A' ' 96' ' ' GLU . 19.8 mt -65.2 -42.86 93.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.309 -0.869 . . . . 0.0 109.694 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.67 -172.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -73.01 -3.73 27.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -1.106 . . . . 0.0 110.008 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.682 ' HA ' HG11 ' A' ' 126' ' ' VAL . 41.6 p -88.58 -45.49 9.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.12 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.801 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -118.89 159.46 23.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.383 -0.823 . . . . 0.0 109.067 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.825 ' O ' HD22 ' A' ' 91' ' ' LEU . 35.3 tt0 -140.31 -80.84 0.27 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 110.39 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 43.0 mtmt -80.26 148.42 30.78 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.619 -0.676 . . . . 0.0 110.681 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.858 HG21 ' CE2' ' A' ' 100' ' ' TYR . 17.8 mm -136.51 148.48 27.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.018 -1.051 . . . . 0.0 109.694 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -121.58 124.45 44.39 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.37 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.858 ' CE2' HG21 ' A' ' 98' ' ' ILE . 16.0 m-85 -117.31 135.67 53.67 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.306 -0.871 . . . . 0.0 110.741 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -135.88 134.73 39.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 109.923 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 89.3 m -134.1 147.8 50.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -0.988 . . . . 0.0 110.259 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 9.8 tttt -139.49 148.67 43.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.83 HD23 HG12 ' A' ' 114' ' ' ILE . 5.5 mt -125.06 152.36 44.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.257 -0.902 . . . . 0.0 110.447 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.77 -169.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.28 -0.888 . . . . 0.0 109.787 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.702 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.42 160.99 24.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.943 . . . . 0.0 110.311 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.441 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 35.3 p -120.59 164.12 24.95 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 110.13 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.5 -1.94 11.02 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.059 1.557 . . . . 0.0 110.363 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.6 m -102.72 0.45 32.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 110.326 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.46 -39.76 2.66 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.87 -171.67 0.36 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 54.8 p -131.93 134.62 45.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -1.166 . . . . 0.0 110.37 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.519 ' HA ' HG22 ' A' ' 10' ' ' THR . 31.9 mt -81.71 150.11 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.889 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.83 HG12 HD23 ' A' ' 104' ' ' LEU . 14.4 mt -135.45 112.98 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.593 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -103.54 136.37 43.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 109.759 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.6 t -131.91 158.67 40.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.976 . . . . 0.0 110.575 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 88.5 m -155.98 142.26 18.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 110.097 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.1 t -140.12 155.26 47.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.364 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.725 ' CE1' HG23 ' A' ' 4' ' ' THR . 64.4 m-70 -133.36 168.12 19.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.177 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.876 ' O ' HG13 ' A' ' 2' ' ' VAL . 32.0 m-85 -127.06 146.06 50.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.326 -0.859 . . . . 0.0 110.639 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 97.4 m-70 -127.18 92.07 3.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.702 HG21 ' O ' ' A' ' 126' ' ' VAL . 1.8 p -63.01 161.15 13.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.36 -0.837 . . . . 0.0 110.612 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 34.8 tttm -126.27 124.65 40.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.417 -0.802 . . . . 0.0 110.044 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 125' ' ' ASN . . . 93.48 22.61 26.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 11.9 t30 64.61 50.48 2.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -1.083 . . . . 0.0 110.304 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.702 ' O ' HG21 ' A' ' 122' ' ' THR . 72.3 t -119.51 174.64 4.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.414 -0.804 . . . . 0.0 109.818 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.668 ' HA ' HG21 ' A' ' 122' ' ' THR . 81.3 mt-10 -127.26 153.16 46.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.174 -0.954 . . . . 0.0 110.094 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.599 HG22 ' N ' ' A' ' 129' ' ' LYS . 3.4 mp -82.05 173.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.837 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.599 ' N ' HG22 ' A' ' 128' ' ' ILE . 88.4 mttt -96.42 133.86 40.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 110.189 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.558 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 93.1 mt-10 -51.7 -49.35 62.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.139 -0.976 . . . . 0.0 110.051 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.49 -34.09 64.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.896 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.869 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 12.6 t-160 -71.81 -53.04 14.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.355 -0.84 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.015 HG21 ' CE2' ' A' ' 5' ' ' TYR . 6.0 p -60.89 -35.32 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 110.023 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 81.4 tttt -70.99 -43.9 67.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.847 . . . . 0.0 109.884 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.92 91.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.936 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.81 -31.63 78.91 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.499 ' HE3' HG22 ' A' ' 133' ' ' VAL . 95.2 mttt -63.06 -32.76 74.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.341 -1.094 . . . . 0.0 109.945 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.471 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 79.8 mt-10 -70.78 -35.12 72.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.845 . . . . 0.0 109.84 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.37 -42.83 87.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.388 -0.82 . . . . 0.0 109.875 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -70.73 -41.23 72.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.926 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.5 m -67.86 -53.71 24.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.781 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.2 m-20 -54.2 -40.07 67.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -0.905 . . . . 0.0 109.742 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.468 ' HG ' HD11 ' A' ' 147' ' ' ILE . 16.1 tp -60.98 -47.26 87.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.778 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 18.0 m-85 -53.6 -38.16 63.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.393 -0.817 . . . . 0.0 109.555 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -79.59 -17.11 54.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.225 -0.922 . . . . 0.0 109.671 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.67 ' HB3' HG21 ' A' ' 33' ' ' ILE . 26.8 mt -83.38 -35.52 25.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.291 -0.881 . . . . 0.0 108.625 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.574 HD11 ' CE1' ' A' ' 22' ' ' PHE . 27.3 mt -70.88 -46.65 67.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 13' ' ' ILE . 57.9 mt-10 -58.23 -38.77 77.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.664 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.404 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 99.8 m -70.32 -38.33 74.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.781 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.634 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.3 t80 -54.36 -48.21 71.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 110.014 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.176 HD21 ' CE2' ' A' ' 158' ' ' TYR . 92.0 mt -79.55 -30.15 41.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.545 ' CD ' HD11 ' A' ' 13' ' ' ILE . 47.4 tptt -73.9 -21.31 60.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.91 . . . . 0.0 109.463 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.47 -31.88 3.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 5.2 m80 -110.73 93.45 16.9 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.355 -1.085 . . . . 0.0 110.059 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.415 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.4 Cg_endo -74.35 6.72 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.997 1.525 . . . . 0.0 111.035 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -108.72 1.42 21.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.053 -1.029 . . . . 0.0 109.764 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.634 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -81.87 104.5 12.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.365 -0.834 . . . . 0.0 110.196 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.176 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 34.9 32.17 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.691 -0.63 . . . . 0.0 110.528 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.735 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 120' ' ' TYR . 77.7 t -122.26 120.15 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -1.171 . . . . 0.0 110.265 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.6 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 94.2 m-85 -77.41 144.85 37.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.137 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.607 HG23 ' CE1' ' A' ' 119' ' ' HIS . 41.3 m -127.82 125.1 39.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 110.155 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.122 ' CE2' HG21 ' A' ' 133' ' ' VAL . 68.5 m-85 -134.47 159.13 42.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.237 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.7 pt-20 -151.28 152.48 33.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.886 . . . . 0.0 110.19 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 116' ' ' SER . 55.4 p -134.99 145.99 48.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.031 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 86.6 mt-10 -130.32 119.46 22.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.34 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.5 p90 -145.42 -175.98 4.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.834 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.678 HG22 HG12 ' A' ' 113' ' ' ILE . 18.4 p -136.56 -179.56 5.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.134 -0.979 . . . . 0.0 110.57 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.515 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 14.8 t -156.79 168.27 27.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 110.358 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.52 -16.24 24.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.972 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.837 HG23 ' HD2' ' A' ' 14' ' ' PRO . 6.8 mm -89.67 151.36 45.65 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.98 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.837 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.2 Cg_endo -64.74 145.28 86.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.053 1.554 . . . . 0.0 110.453 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -72.29 -31.63 11.41 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.028 1.541 . . . . 0.0 112.954 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.5 Cg_endo -69.33 -19.83 37.64 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 N-CA-C 110.148 -0.751 . . . . 0.0 110.148 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 4.2 mmp_? -85.65 -47.77 9.5 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.773 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.4 tt -67.3 -25.61 66.12 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 74' ' ' ILE . 82.6 t80 -68.57 -58.68 3.92 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.505 0.669 . . . . 0.0 109.463 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 47.9 mttt -52.18 -30.47 27.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.159 0.98 . . . . 0.0 108.399 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.974 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.8 -63.53 1.24 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.677 0.751 . . . . 0.0 110.96 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.026 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -57.83 -35.64 71.15 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 111.459 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.125 HG11 ' CD1' ' A' ' 74' ' ' ILE . 20.1 t -104.62 -67.85 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.118 . . . . 0.0 111.493 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.626 ' N ' HD22 ' A' ' 24' ' ' LEU . 4.0 mm? -65.29 -6.13 9.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 111.19 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -144.15 19.85 1.76 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.901 -1.124 . . . . 0.0 110.585 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.026 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -54.97 -34.44 63.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 110.164 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.54 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 89.6 m-20 -69.47 -12.0 61.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 110.279 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.507 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.7 m-20 -126.72 -4.98 6.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 110.3 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -85.86 -46.78 10.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.124 -0.985 . . . . 0.0 110.294 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.813 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.3 t -75.92 -42.01 3.51 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.885 . . . . 0.0 111.13 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.5 Cg_endo -77.86 9.71 2.89 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.402 1.212 . . . . 0.0 110.855 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HG2' ' OH ' ' A' ' 150' ' ' TYR . 37.3 tptt -123.16 -28.69 3.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.614 HG12 ' CD1' ' A' ' 150' ' ' TYR . 9.6 mt -80.08 -47.21 21.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.447 -0.783 . . . . 0.0 109.499 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.0 101.96 4.17 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.486 -0.759 . . . . 0.0 109.981 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.34 0.05 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.023 1.538 . . . . 0.0 110.715 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -83.53 -13.04 55.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 109.419 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.456 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -101.96 -62.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.994 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.813 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.8 mp -108.98 132.11 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.451 -0.781 . . . . 0.0 110.001 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HE2' ' HB ' ' A' ' 57' ' ' THR . 31.7 ttpt -83.33 -38.07 22.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.0 110.416 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.443 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -174.55 141.42 0.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.165 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.54 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 7.3 m -107.03 135.92 47.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.041 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 55.2 tt0 -136.31 109.15 7.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.3 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 9.1 mt -62.43 130.55 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.462 ' CD1' ' O ' ' A' ' 42' ' ' GLU . 10.6 mp -94.59 -41.99 9.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.38 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.898 ' O ' HG23 ' A' ' 52' ' ' THR . 5.3 mt-10 -132.91 142.79 49.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.134 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.4 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 77.99 -170.2 54.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -124.82 6.58 8.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 110.215 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.556 ' N ' HG21 ' A' ' 52' ' ' THR . . . 130.32 -4.82 5.95 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.528 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -85.39 -164.68 39.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.38 132.03 21.53 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.153 1.607 . . . . 0.0 110.418 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.69 69.99 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.898 HG23 ' O ' ' A' ' 45' ' ' GLU . 29.6 m -80.06 136.47 36.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -1.155 . . . . 0.0 109.857 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.708 HG21 ' HE3' ' A' ' 68' ' ' LYS . 20.5 mm -107.15 117.97 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 110.17 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 87.2 mttt -105.2 145.9 29.99 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.3 -0.875 . . . . 0.0 110.496 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -118.88 101.43 8.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 110.058 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.74 141.99 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.883 . . . . 0.0 110.444 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.8 p -110.27 153.19 25.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 109.965 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.769 ' HE2' HG13 ' A' ' 67' ' ' VAL . 24.5 m-85 -111.75 123.95 51.32 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.0 111.001 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 58' ' ' PHE . . . 39.84 -162.78 0.01 OUTLIER Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.464 ' HB2' ' HD3' ' A' ' 39' ' ' LYS . 76.1 tt0 -146.92 131.12 17.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.459 -1.024 . . . . 0.0 110.011 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -176.21 -176.58 44.53 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.0 m -55.26 -33.94 63.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.355 -1.085 . . . . 0.0 110.334 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.14 112.86 24.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.345 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 2.6 t80 -72.34 126.53 30.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.253 -0.904 . . . . 0.0 110.033 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -126.32 99.05 0.54 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.508 ' CD2' ' CD2' ' A' ' 64' ' ' TYR . 33.2 p90 -138.83 169.98 16.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.134 -1.216 . . . . 0.0 110.369 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.921 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.9 m -137.49 173.44 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 110.563 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.708 ' HE3' HG21 ' A' ' 53' ' ' ILE . 37.8 tttt -122.81 127.96 49.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.596 -0.69 . . . . 0.0 109.43 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.83 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -117.32 126.37 52.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.965 . . . . 0.0 111.035 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HA ' HD13 ' A' ' 53' ' ' ILE . 84.1 tttt -106.01 118.04 35.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.287 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.536 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.0 mm -57.34 135.03 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.93 . . . . 0.0 110.454 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.51 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 9.5 t0 -107.05 -39.47 5.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.794 . . . . 0.0 109.795 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 0.7 OUTLIER 171.95 161.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.537 -0.727 . . . . 0.0 109.957 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.125 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.1 tt -154.64 163.51 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.224 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -125.84 78.01 1.71 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.259 -0.9 . . . . 0.0 109.671 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.592 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 86.3 mttt -53.94 -15.26 1.29 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.331 -0.855 . . . . 0.0 110.863 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -91.76 -32.39 15.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 109.788 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.4 m120 -107.83 -4.51 17.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.639 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.636 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 6.5 m-85 69.22 49.07 0.63 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.322 0.582 . . . . 0.0 110.543 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.547 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -118.43 147.18 43.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 109.107 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.681 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 79.7 t80 -141.49 142.89 33.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.02 . . . . 0.0 110.617 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.447 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 61.1 m -147.14 128.21 14.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 110.007 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.681 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 3.9 p90 -137.07 -176.71 4.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.062 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.4 m -135.41 140.07 44.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.296 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.83 HD13 ' CE1' ' A' ' 69' ' ' HIS . 49.0 tp -100.47 128.67 46.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.964 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.537 HD11 ' HE2' ' A' ' 68' ' ' LYS . 16.5 pt -118.73 -7.7 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.366 -0.834 . . . . 0.0 110.246 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 79.7 tt0 -146.05 135.27 22.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.921 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 174.35 159.9 21.54 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 46.1 p-10 -71.29 -7.73 48.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -1.159 . . . . 0.0 110.285 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.455 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -79.07 -46.14 18.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.612 HD22 ' O ' ' A' ' 96' ' ' GLU . 19.6 mt -40.96 -46.42 2.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.595 -0.691 . . . . 0.0 110.224 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 41.31 -132.73 3.41 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.746 ' OD1' HG23 ' A' ' 94' ' ' THR . 57.5 p-10 -115.89 21.72 13.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -1.104 . . . . 0.0 110.062 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.746 HG23 ' OD1' ' A' ' 93' ' ' ASP . 72.5 p -122.4 -41.58 2.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -0.866 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.056 HD21 HD11 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -114.41 163.35 15.44 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.341 -0.85 . . . . 0.0 109.141 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.805 ' H ' HD12 ' A' ' 95' ' ' LEU . 28.1 tp10 -142.03 -79.54 0.24 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.135 -0.978 . . . . 0.0 110.282 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.559 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 21.2 mtpt -80.18 151.66 29.59 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.616 -0.677 . . . . 0.0 109.845 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.056 HD11 HD21 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -146.62 135.37 16.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.063 -1.023 . . . . 0.0 109.819 179.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 5.1 m -114.99 118.41 33.34 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.43 -0.794 . . . . 0.0 109.597 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.621 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.7 m-85 -110.39 137.74 47.7 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.469 -0.769 . . . . 0.0 110.173 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 76.9 tt0 -132.85 143.18 49.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.203 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.6 m -139.39 135.67 33.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -128.31 138.89 52.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.823 HD23 HG12 ' A' ' 114' ' ' ILE . 6.5 mt -118.56 149.76 40.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.197 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.03 -169.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 109.961 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.2 125.7 45.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.972 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.47 ' HB3' ' CG1' ' A' ' 113' ' ' ILE . 3.2 p -80.15 170.36 16.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 110.219 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 50.7 Cg_endo -83.52 22.47 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.056 1.556 . . . . 0.0 110.966 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.5 p -127.89 4.03 5.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.938 -1.101 . . . . 0.0 110.412 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.16 -25.74 25.21 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.46 -174.33 43.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.52 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 19.9 p -124.35 131.32 53.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -1.201 . . . . 0.0 110.37 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.678 HG12 HG22 ' A' ' 10' ' ' THR . 84.8 mt -82.82 149.68 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 110.195 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.823 HG12 HD23 ' A' ' 104' ' ' LEU . 7.6 mt -133.68 128.82 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 110.359 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 85.9 tttt -118.66 111.11 18.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.315 -0.865 . . . . 0.0 109.781 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.44 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 1.4 m -101.58 162.31 13.0 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.158 -0.964 . . . . 0.0 110.834 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 53.7 m -160.05 132.65 6.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.44 -0.787 . . . . 0.0 109.773 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.1 p -132.58 159.11 40.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.107 -0.995 . . . . 0.0 110.745 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.607 ' CE1' HG23 ' A' ' 4' ' ' THR . 60.7 m-70 -141.37 155.37 45.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.419 -0.8 . . . . 0.0 110.038 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.653 ' O ' HG13 ' A' ' 2' ' ' VAL . 28.2 m-85 -119.03 138.07 53.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.39 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.559 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 95.4 m-70 -119.32 93.13 3.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 109.675 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.864 HG21 ' HA ' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -62.86 159.22 17.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.156 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 43.7 tttm -142.7 128.34 19.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 110.19 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 93.31 26.38 16.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 8.2 t30 64.91 65.96 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -1.189 . . . . 0.0 110.173 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.615 ' O ' HG21 ' A' ' 122' ' ' THR . 7.0 m -144.37 171.21 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.864 ' HA ' HG21 ' A' ' 122' ' ' THR . 86.5 mt-10 -140.25 152.37 45.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.215 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 129' ' ' LYS . 4.9 mp -81.89 173.53 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 109.964 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.591 ' N ' HG22 ' A' ' 128' ' ' ILE . 57.0 mttt -104.85 132.15 51.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.229 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.449 ' HA ' HG12 ' A' ' 133' ' ' VAL . 52.1 mt-10 -48.48 -39.79 24.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 110.101 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.01 -30.39 70.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.948 . . . . 0.0 109.882 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -75.34 -50.97 14.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 110.18 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.122 HG21 ' CE2' ' A' ' 5' ' ' TYR . 10.3 p -65.47 -41.81 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 110.038 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.551 ' N ' HG13 ' A' ' 133' ' ' VAL . 72.5 mmtt -63.04 -40.02 96.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.979 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.54 -34.69 72.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.831 . . . . 0.0 110.0 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 139' ' ' LYS . . . -73.08 -29.76 64.17 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -73.71 -32.95 64.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -1.08 . . . . 0.0 110.076 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -70.28 -54.73 11.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 109.948 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 136' ' ' GLY . 20.7 ptmt -56.54 -28.49 60.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.795 . . . . 0.0 109.866 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.81 -45.88 70.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.051 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -61.96 -40.88 97.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.978 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -62.07 -41.42 98.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 147' ' ' ILE . 30.1 mt -61.1 -41.22 96.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.934 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -61.54 -33.21 73.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.416 -0.802 . . . . 0.0 109.951 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 47.4 tptt -80.02 -19.05 48.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 110.26 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 146' ' ' LEU . 13.4 mt -79.95 -35.16 38.08 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.104 -0.997 . . . . 0.0 108.515 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.652 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 67.4 mt -70.67 -51.73 34.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 13' ' ' ILE . 78.0 mt-10 -49.41 -34.67 16.98 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.288 -0.883 . . . . 0.0 109.016 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.4 m -79.99 -28.33 39.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -0.916 . . . . 0.0 109.296 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.634 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.7 t80 -61.36 -54.07 48.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.561 -0.712 . . . . 0.0 109.977 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.192 HD21 ' CE2' ' A' ' 158' ' ' TYR . 59.0 mt -69.56 -27.96 65.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 110.077 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.454 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 57.3 tptt -74.04 -29.39 61.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 109.727 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -101.33 -29.15 6.45 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 9.1 m80 -107.15 90.98 6.05 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.447 -1.031 . . . . 0.0 109.7 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.5 Cg_endo -73.54 5.22 3.4 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.009 1.531 . . . . 0.0 111.025 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 44.3 p30 -109.82 -9.37 14.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.013 -1.054 . . . . 0.0 109.685 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.634 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -69.36 99.62 1.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.477 -0.764 . . . . 0.0 110.091 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.192 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.9 31.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.727 -0.608 . . . . 0.0 110.554 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.799 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.039 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.5 p -79.86 145.64 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -1.206 . . . . 0.0 110.563 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 77.5 m-85 -93.18 167.7 11.59 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.332 -0.855 . . . . 0.0 110.242 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.731 HG23 ' CD2' ' A' ' 119' ' ' HIS . 91.9 m -131.39 110.84 11.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.944 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CZ ' HG22 ' A' ' 133' ' ' VAL . 24.3 m-85 -113.18 125.34 54.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 110.085 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.5 pt-20 -133.13 152.94 51.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 110.085 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.2 t -128.52 155.81 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.359 -0.838 . . . . 0.0 110.172 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 76.0 mt-10 -136.0 118.03 15.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.333 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.2 p90 -147.24 -170.98 3.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.939 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 113' ' ' ILE . 18.2 p -140.64 -179.44 6.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 110.561 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 3.2 t -156.74 160.12 38.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.759 . . . . 0.0 110.165 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -84.7 -16.12 42.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.853 . . . . 0.0 110.251 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.789 HG23 ' HD2' ' A' ' 14' ' ' PRO . 7.4 mm -87.61 149.96 47.47 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 110.135 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.789 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.13 149.02 89.49 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.098 1.578 . . . . 0.0 110.412 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.677 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 Cg_endo -70.14 -32.72 16.46 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.899 1.473 . . . . 0.0 113.0 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.0 Cg_endo -68.0 -21.75 42.82 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 122.504 0.739 . . . . 0.0 110.207 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.676 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -83.65 -46.78 11.95 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.132 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.757 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -69.07 -28.33 66.42 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.635 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 62.6 t80 -66.04 -59.34 3.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.468 -0.77 . . . . 0.0 109.514 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 51.2 mttp -51.6 -34.79 38.88 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.521 -0.737 . . . . 0.0 109.604 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.04 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -75.29 -55.5 5.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.391 -0.818 . . . . 0.0 111.152 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.039 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -59.77 -45.51 92.05 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.48 -0.762 . . . . 0.0 111.738 -178.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.713 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.7 t -97.37 -66.3 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.02 -1.05 . . . . 0.0 111.392 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.6 mm? -64.44 -5.97 6.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.262 -0.899 . . . . 0.0 111.444 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.687 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -143.79 25.88 1.6 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.862 -1.149 . . . . 0.0 110.849 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.039 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -66.37 -30.02 70.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 110.195 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.56 -12.77 61.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.501 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 72.5 m-20 -129.1 6.32 5.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 110.118 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -92.99 -53.35 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -0.832 . . . . 0.0 110.056 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.01 HG11 HD13 ' A' ' 38' ' ' ILE . 17.1 t -67.2 -41.42 33.97 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 111.176 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -76.91 6.03 4.5 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.334 1.176 . . . . 0.0 110.881 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 66.6 mttt -127.54 -31.84 2.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 109.787 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.621 HD11 ' CD1' ' A' ' 29' ' ' LEU . 16.0 mt -79.89 -43.17 22.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.462 -0.774 . . . . 0.0 109.775 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.7 91.8 3.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.0 110.188 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.26 3.51 5.69 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.114 1.586 . . . . 0.0 110.594 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -87.23 -19.9 27.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.134 -0.979 . . . . 0.0 110.061 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.38 -40.77 8.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 110.201 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.01 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mt -125.72 145.99 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.447 -0.783 . . . . 0.0 110.047 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.461 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 28.2 ttpt -80.93 -46.36 15.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 110.32 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -176.93 158.88 1.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.88 . . . . 0.0 110.038 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -113.01 120.57 41.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.945 . . . . 0.0 110.162 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.479 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 32.0 tt0 -121.46 102.08 8.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.003 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 37.6 mt -50.7 129.32 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.307 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.662 HD23 HG21 ' A' ' 53' ' ' ILE . 19.9 tp -91.72 -40.07 11.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.468 -0.77 . . . . 0.0 110.354 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.879 ' O ' HG23 ' A' ' 52' ' ' THR . 2.9 mt-10 -138.32 138.02 37.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 110.172 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 47' ' ' ASP . . . 82.21 -159.53 39.32 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 87.1 m-20 -138.24 9.55 2.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -1.192 . . . . 0.0 110.348 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.621 ' N ' HG21 ' A' ' 52' ' ' THR . . . 130.29 -2.94 5.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -87.6 -168.49 44.62 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -69.82 137.74 35.98 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.091 1.574 . . . . 0.0 110.507 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.93 -5.47 85.04 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.879 HG23 ' O ' ' A' ' 45' ' ' GLU . 18.0 m -80.0 138.94 37.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -1.177 . . . . 0.0 109.998 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.662 HG21 HD23 ' A' ' 44' ' ' LEU . 32.2 mm -105.15 127.58 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.0 110.001 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 93.5 mttt -110.39 126.71 54.56 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 110.019 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.638 ' HD3' HD13 ' A' ' 44' ' ' LEU . 43.4 mtmt -99.15 98.12 9.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.139 -0.976 . . . . 0.0 110.589 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.535 ' CG2' HG12 ' A' ' 38' ' ' ILE . 96.4 mt -87.07 146.71 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.155 -0.966 . . . . 0.0 109.66 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 38' ' ' ILE . 5.4 p -118.76 153.16 34.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.124 -0.985 . . . . 0.0 111.116 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.626 ' HE2' HG13 ' A' ' 67' ' ' VAL . 25.5 m-85 -117.44 138.47 51.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.509 -0.745 . . . . 0.0 109.973 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.12 41.86 2.06 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -60.8 -39.99 90.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -1.083 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.69 -153.01 7.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 63' ' ' GLN . 33.7 m -66.62 -55.89 13.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -1.138 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 62' ' ' SER . 94.9 mt-30 -41.93 138.88 1.41 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.879 . . . . 0.0 110.216 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.34 115.02 17.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.247 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -115.2 93.28 0.62 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.541 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.4 p90 -128.96 164.91 22.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -1.228 . . . . 0.0 110.234 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.734 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.9 m -134.63 175.28 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 0.0 110.486 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.664 ' O ' HD12 ' A' ' 85' ' ' LEU . 59.5 mttt -133.15 106.46 7.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.46 -0.775 . . . . 0.0 109.701 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.989 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.0 m170 -98.16 128.44 44.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 111.023 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.625 ' HA ' HD13 ' A' ' 53' ' ' ILE . 54.6 tttm -101.88 109.56 21.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.329 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.507 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.0 mm -42.59 140.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.341 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.521 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 23.9 t0 -111.43 -48.87 3.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.527 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.485 ' N ' ' OG ' ' A' ' 82' ' ' SER . 8.7 m -165.88 156.16 12.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.527 -0.733 . . . . 0.0 109.746 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 mt -138.36 153.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.396 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.7 m-20 -141.7 80.74 1.74 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.517 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 34.4 tttt -65.65 -13.32 58.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.179 -0.951 . . . . 0.0 109.853 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -89.94 -30.87 17.54 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.803 0.811 . . . . 0.0 109.013 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.0 m120 -106.91 -2.98 20.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.757 ' O ' HD12 ' A' ' 104' ' ' LEU . 73.8 m-85 60.94 54.35 3.47 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.652 0.739 . . . . 0.0 110.167 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -127.26 156.53 41.75 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.637 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.713 ' CE1' HG13 ' A' ' 23' ' ' VAL . 27.6 t80 -142.83 137.38 29.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.947 . . . . 0.0 110.003 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.485 ' OG ' ' N ' ' A' ' 73' ' ' SER . 13.9 p -143.87 124.18 13.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.112 -0.993 . . . . 0.0 111.263 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 13.7 p90 -137.73 172.53 12.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 110.23 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 98' ' ' ILE . 97.1 m -129.39 134.52 47.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.332 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.989 HD13 ' CD2' ' A' ' 69' ' ' HIS . 11.7 tp -101.5 133.78 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.05 -1.031 . . . . 0.0 110.221 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 85' ' ' LEU . 13.8 pt -113.11 -30.88 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.458 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.644 ' O ' HD11 ' A' ' 85' ' ' LEU . 70.1 tt0 -119.41 157.35 28.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.258 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.734 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 159.05 140.69 2.96 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.415 ' OD2' ' HA2' ' A' ' 65' ' ' GLY . 98.3 m-20 -69.6 -25.58 64.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -1.148 . . . . 0.0 110.139 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.08 -26.61 61.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.146 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 88' ' ' GLY . 15.5 mt -63.22 -31.59 72.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 110.104 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.54 -174.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 52.8 t0 -77.1 -1.02 26.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.138 . . . . 0.0 110.057 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 122' ' ' THR . 43.2 p -87.82 -41.96 12.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 110.056 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.062 HD21 ' CG1' ' A' ' 128' ' ' ILE . 68.4 mt -98.25 153.55 18.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.815 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 35.4 tt0 -137.24 -83.33 0.34 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.301 -0.874 . . . . 0.0 109.629 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.485 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 96.0 mttt -80.35 125.02 29.38 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.75 -0.594 . . . . 0.0 110.447 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.843 ' O ' HG23 ' A' ' 84' ' ' THR . 3.3 mm -116.86 135.01 58.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.789 -1.195 . . . . 0.0 109.827 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -120.89 127.07 51.53 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.644 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.1 m-85 -119.61 134.43 55.23 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.326 -0.859 . . . . 0.0 110.573 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.491 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 26.5 tt0 -137.16 133.58 35.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.427 -0.796 . . . . 0.0 109.92 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 54.5 m -134.35 144.1 48.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 110.361 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -135.25 146.93 49.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 110.256 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.769 HD23 HG12 ' A' ' 114' ' ' ILE . 6.1 mt -119.22 153.73 34.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.339 -0.851 . . . . 0.0 110.433 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.717 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.94 -168.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.289 -0.882 . . . . 0.0 109.93 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.717 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.88 128.19 51.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 110.27 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.567 ' HA ' HD11 ' A' ' 113' ' ' ILE . 87.2 p -81.47 160.02 65.72 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.181 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -2.26 11.45 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.082 1.569 . . . . 0.0 110.547 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.4 p -103.07 4.82 37.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.351 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.62 -34.38 5.82 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.09 -174.18 6.51 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 23.6 p -123.66 135.82 54.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 107' ' ' SER . 23.4 mt -87.04 150.41 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.769 HG12 HD23 ' A' ' 104' ' ' LEU . 7.0 mt -132.85 117.67 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.178 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.487 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 80.8 tttt -110.05 109.69 20.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 110.079 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 8.6 m -97.6 164.21 12.52 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.173 -0.954 . . . . 0.0 110.474 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 29.4 m -160.01 126.17 4.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.411 -0.805 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.0 m -128.37 156.95 42.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.163 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.731 ' CD2' HG23 ' A' ' 4' ' ' THR . 37.2 m80 -129.24 136.31 49.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -0.93 . . . . 0.0 110.255 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 1.039 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.0 m-30 -109.59 111.69 23.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.962 . . . . 0.0 111.169 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.673 ' CE1' HG21 ' A' ' 2' ' ' VAL . 90.3 m-70 -99.09 117.38 33.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.196 -0.94 . . . . 0.0 109.514 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 94' ' ' THR . 0.7 OUTLIER -87.27 138.76 31.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 110.569 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 74.1 tttt -72.3 123.1 22.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 110.223 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.48 -128.86 8.71 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -121.09 51.72 1.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -1.188 . . . . 0.0 110.12 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 127' ' ' GLU . 85.9 t -94.61 174.6 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.416 -0.802 . . . . 0.0 110.02 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.605 ' N ' HG12 ' A' ' 126' ' ' VAL . 45.8 mt-10 -143.16 125.73 15.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 110.408 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.062 ' CG1' HD21 ' A' ' 95' ' ' LEU . 1.8 mp -60.45 174.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.855 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.608 ' N ' HG22 ' A' ' 128' ' ' ILE . 62.3 mttt -100.7 151.52 21.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.26 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -66.55 -34.29 77.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.199 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 132' ' ' HIS . 22.2 pt-20 -68.26 -36.96 80.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 110.198 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.445 ' N ' ' CG ' ' A' ' 131' ' ' GLU . 17.8 t-160 -67.79 -33.53 75.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.648 HG22 ' CZ ' ' A' ' 5' ' ' TYR . 89.3 t -67.85 -43.77 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.22 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -73.83 -43.0 60.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.003 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.72 91.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.083 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.92 -26.3 73.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -75.99 -31.94 59.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -1.156 . . . . 0.0 110.144 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -79.02 -28.55 43.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.125 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.99 -32.86 59.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.71 -33.29 46.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.5 t -64.58 -45.29 87.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.165 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -52.81 -48.72 66.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.03 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 143' ' ' LEU . 19.3 tp -55.89 -48.59 75.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.941 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.427 ' O ' ' CD ' ' A' ' 148' ' ' GLU . 25.8 m-85 -54.4 -39.77 67.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.807 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.439 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 42.7 tttm -79.81 -14.03 58.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.473 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 17.8 mt -83.97 -37.69 21.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.1 -1.0 . . . . 0.0 108.954 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.765 HD13 ' CD1' ' A' ' 22' ' ' PHE . 75.6 mt -71.21 -44.1 74.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.822 -0.751 . . . . 0.0 108.983 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' HG13 ' A' ' 13' ' ' ILE . 65.0 mt-10 -56.62 -36.24 69.23 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.435 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.6 m -76.68 -30.57 56.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.926 . . . . 0.0 109.511 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.648 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 89.9 t80 -57.38 -48.19 79.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.54 -0.725 . . . . 0.0 110.045 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.128 HD21 ' CE1' ' A' ' 158' ' ' TYR . 72.1 mt -76.48 -38.53 55.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 110.065 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.42 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 83.8 tttt -61.23 -14.83 28.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.374 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -116.52 -28.13 2.63 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -109.08 93.91 13.86 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.333 -1.098 . . . . 0.0 110.058 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.8 4.24 4.28 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.028 1.541 . . . . 0.0 110.961 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -113.77 -6.56 13.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.124 -0.985 . . . . 0.0 110.047 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.685 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -67.03 102.67 1.03 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.128 ' CE1' HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.65 32.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.741 -0.599 . . . . 0.0 110.604 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.511 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.756 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 77.1 t -114.13 109.33 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.195 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.61 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 82.6 m-85 -77.48 144.86 37.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 110.298 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.76 HG23 ' CE1' ' A' ' 119' ' ' HIS . 95.4 m -122.71 115.77 22.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 110.396 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.778 ' CE2' HG21 ' A' ' 133' ' ' VAL . 67.2 m-85 -124.08 154.54 39.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.897 . . . . 0.0 109.951 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 13.6 pt-20 -147.3 151.4 36.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 0.0 110.566 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 m -137.36 144.21 42.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.777 . . . . 0.0 109.456 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -132.82 143.46 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.114 -0.991 . . . . 0.0 110.928 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.605 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.3 p90 -158.79 -176.04 5.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.57 -0.706 . . . . 0.0 109.492 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.6 HG22 HG12 ' A' ' 113' ' ' ILE . 21.1 p -135.64 -179.46 5.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.041 -1.037 . . . . 0.0 110.764 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 10.0 t -159.96 167.16 28.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.529 -0.732 . . . . 0.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -98.38 9.81 42.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 109.972 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.816 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.7 mp -107.75 149.88 39.54 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.033 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.816 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.81 143.19 72.71 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.081 1.569 . . . . 0.0 110.554 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.676 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.9 Cg_endo -71.82 -31.67 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 124.027 1.541 . . . . 0.0 112.804 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.9 Cg_endo -67.94 -21.93 42.92 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 O-C-N 122.468 0.72 . . . . 0.0 110.322 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.529 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 8.7 mmp_? -83.91 -46.99 11.51 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.845 HD22 ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -68.25 -29.3 68.08 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.551 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.0 t80 -66.3 -56.16 12.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.863 . . . . 0.0 109.9 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.529 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 76.1 mttt -53.92 -32.1 52.37 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.947 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -73.18 -64.82 0.9 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.713 0.768 . . . . 0.0 111.11 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.072 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -56.97 -39.08 73.93 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.634 -0.666 . . . . 0.0 112.228 -178.128 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.542 ' HB ' HD12 ' A' ' 24' ' ' LEU . 5.5 t -101.77 -58.03 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.777 -1.202 . . . . 0.0 111.578 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.751 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.4 mp -78.14 0.1 26.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.079 -1.013 . . . . 0.0 111.331 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.596 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -147.3 15.17 1.14 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.944 -1.098 . . . . 0.0 110.556 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.072 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -53.85 -39.88 66.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.95 . . . . 0.0 109.916 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 65.2 t0 -64.42 -14.19 55.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 109.907 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.526 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.2 m-20 -127.3 0.19 6.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.369 -0.832 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -88.09 -45.52 10.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.355 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.054 ' CG1' HD13 ' A' ' 38' ' ' ILE . 31.2 t -72.89 -40.36 6.1 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.263 -0.898 . . . . 0.0 111.482 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -77.44 10.11 2.61 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.329 1.173 . . . . 0.0 111.113 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 49.6 mttt -122.77 -25.77 4.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.054 -1.029 . . . . 0.0 109.628 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.605 HG12 ' CD1' ' A' ' 150' ' ' TYR . 28.7 mt -79.99 -49.86 18.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.475 -0.765 . . . . 0.0 109.926 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.37 104.02 2.21 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.383 -0.823 . . . . 0.0 110.128 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.17 1.01 6.46 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.02 1.537 . . . . 0.0 110.794 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -83.54 -14.41 52.28 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.36 -53.88 3.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 110.071 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.054 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.1 mp -117.65 149.02 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.453 -0.779 . . . . 0.0 110.017 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -85.35 -42.3 14.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.861 . . . . 0.0 110.41 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.461 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.4 OUTLIER -178.77 141.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 110.369 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.477 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 38.6 m -97.84 134.3 41.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 110.093 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -137.26 110.98 8.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.211 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 37.2 mt -60.71 131.7 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.277 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 81.2 mt -92.18 -26.45 18.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.148 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 1.064 ' O ' HG23 ' A' ' 52' ' ' THR . 38.8 tt0 -151.41 173.53 14.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.895 . . . . 0.0 110.085 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.01 -155.23 2.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -147.97 34.17 0.83 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 110.22 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.709 ' H ' HG21 ' A' ' 52' ' ' THR . . . 108.5 -9.29 35.3 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.429 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -81.41 -172.84 47.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.9 Cg_endo -71.1 137.97 32.64 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 124.173 1.617 . . . . 0.0 110.464 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.84 -4.8 83.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 1.064 HG23 ' O ' ' A' ' 45' ' ' GLU . 27.3 m -79.98 146.38 32.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -1.193 . . . . 0.0 110.116 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 70' ' ' LYS . 32.3 mm -113.38 110.21 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 110.154 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.756 ' NZ ' ' HB3' ' A' ' 26' ' ' ALA . 46.2 mtpt -93.11 141.99 27.8 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 110.474 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 83.3 tttt -111.7 113.26 25.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.091 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.555 ' CG2' HG12 ' A' ' 38' ' ' ILE . 62.6 mt -102.97 138.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 110.118 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 38' ' ' ILE . 1.6 p -114.03 152.53 30.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 110.562 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 30.5 m-85 -112.88 137.6 50.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.333 -0.854 . . . . 0.0 110.079 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.91 -27.78 30.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -91.13 158.01 16.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.296 -1.12 . . . . 0.0 110.154 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.13 -156.16 20.81 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.6 m -62.18 179.31 0.31 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -1.11 . . . . 0.0 110.27 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -67.78 -27.38 66.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.351 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.24 95.85 4.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.189 -0.944 . . . . 0.0 110.35 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -131.92 90.8 0.28 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.53 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 17.5 p90 -138.73 168.15 20.42 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.201 -1.176 . . . . 0.0 110.402 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.903 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.4 m -137.49 172.72 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.449 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.56 ' CB ' ' CG1' ' A' ' 86' ' ' ILE . 91.7 mttt -123.95 131.44 53.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.593 -0.692 . . . . 0.0 109.719 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.494 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -111.43 138.42 47.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.132 -0.98 . . . . 0.0 110.532 -179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.546 ' HA ' HD13 ' A' ' 53' ' ' ILE . 82.0 tttt -114.93 107.82 15.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.436 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 50' ' ' PRO . 33.4 mm -53.2 122.43 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 110.489 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.8 m-20 -94.89 -40.71 9.57 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.534 -0.729 . . . . 0.0 109.543 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 m -176.63 158.76 1.77 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.514 -0.741 . . . . 0.0 109.558 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.402 HG12 ' HD1' ' A' ' 81' ' ' TYR . 2.4 mt -138.16 159.32 32.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.25 -0.907 . . . . 0.0 110.124 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -145.63 83.85 1.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.574 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.551 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 86.0 tttt -68.18 -13.42 62.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 110.168 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -85.47 -30.38 23.53 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m120 -109.44 -3.68 16.86 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.541 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 48.4 m-85 63.36 52.02 2.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.666 -0.646 . . . . 0.0 110.359 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 13.5 t -121.59 174.34 6.85 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.152 -0.968 . . . . 0.0 110.208 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.528 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 21.0 t80 -157.77 146.55 19.39 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.149 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 50.6 m -149.98 125.24 10.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.042 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 6.7 p90 -142.49 176.45 9.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.404 -0.81 . . . . 0.0 109.862 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.93 HG23 ' O ' ' A' ' 98' ' ' ILE . 53.1 m -135.54 141.54 45.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.591 ' CB ' ' HB ' ' A' ' 98' ' ' ILE . 9.2 tp -87.66 120.27 28.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.233 -0.917 . . . . 0.0 110.247 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.56 ' CG1' ' CB ' ' A' ' 68' ' ' LYS . 24.3 pt -100.63 -12.04 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.425 -0.797 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 71.0 tt0 -153.46 145.54 23.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.479 -0.763 . . . . 0.0 110.203 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.903 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 174.77 165.93 31.89 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 29.7 p-10 -79.9 -44.79 19.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -1.173 . . . . 0.0 110.522 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.825 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -50.8 -40.69 56.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 110.155 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.564 HD22 ' O ' ' A' ' 96' ' ' GLU . 38.0 mt -40.42 -50.45 2.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.575 -0.703 . . . . 0.0 110.339 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.41 -166.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -81.5 5.21 18.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -1.132 . . . . 0.0 110.139 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 55.3 p -97.69 -45.85 6.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.393 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.784 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -118.4 163.06 17.29 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.112 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.784 ' H ' HD12 ' A' ' 95' ' ' LEU . 62.7 tt0 -140.79 -79.79 0.27 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.527 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 33.8 mttt -80.28 145.95 31.89 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 110.735 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.93 ' O ' HG23 ' A' ' 84' ' ' THR . 25.4 mm -134.49 150.98 31.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.123 -0.985 . . . . 0.0 109.57 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -123.89 124.39 42.52 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.7 178.377 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.853 ' CE2' HG21 ' A' ' 98' ' ' ILE . 19.7 m-85 -117.86 134.64 54.73 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.32 -0.863 . . . . 0.0 110.625 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 117' ' ' THR . 6.0 mt-10 -134.36 126.43 29.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.821 . . . . 0.0 109.99 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 86.8 m -119.88 147.87 44.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.972 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LYS . 23.7 mttt -140.33 133.81 30.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 110.51 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.792 HD23 HG12 ' A' ' 114' ' ' ILE . 5.8 mt -112.71 151.81 29.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 110.185 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.36 -169.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.0 109.97 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.71 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -127.41 131.0 50.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.187 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.406 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 54.7 p -87.31 162.27 43.5 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.6 Cg_endo -72.51 -1.41 10.21 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.058 1.557 . . . . 0.0 110.594 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.9 p -101.05 -0.93 35.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.279 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.68 -39.72 2.79 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.78 -175.08 2.56 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 4.0 m -126.63 137.74 53.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -1.18 . . . . 0.0 110.468 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.6 HG12 HG22 ' A' ' 10' ' ' THR . 65.0 mt -87.89 151.5 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.394 -0.816 . . . . 0.0 110.105 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.792 HG12 HD23 ' A' ' 104' ' ' LEU . 9.8 mt -134.24 113.31 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.294 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 103' ' ' LYS . 79.4 tttt -102.11 131.34 48.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 109.974 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.74 154.74 33.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.488 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 101' ' ' GLU . 64.6 m -155.47 123.04 5.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.399 -0.813 . . . . 0.0 110.02 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 99' ' ' SER . 42.0 t -129.06 157.19 42.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.76 ' CE1' HG23 ' A' ' 4' ' ' THR . 44.6 m-70 -134.51 173.22 11.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.217 -0.927 . . . . 0.0 110.44 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.701 ' HA ' HD13 ' A' ' 98' ' ' ILE . 21.2 m-85 -129.91 144.44 51.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.271 -0.893 . . . . 0.0 110.575 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 96.8 m-70 -125.51 95.95 4.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 109.495 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.647 HG21 ' O ' ' A' ' 126' ' ' VAL . 3.1 p -56.87 164.93 1.36 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 0.0 110.572 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 78.9 tttt -115.52 119.2 35.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.45 -107.78 2.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.593 ' C ' HG13 ' A' ' 126' ' ' VAL . 43.4 t30 -130.51 86.8 2.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -1.145 . . . . 0.0 110.266 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.647 ' O ' HG21 ' A' ' 122' ' ' THR . 35.5 m -156.39 173.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 110.208 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.58 ' HA ' HG21 ' A' ' 122' ' ' THR . 96.9 mt-10 -148.27 147.7 29.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.216 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 128' ' ' ILE . 5.2 mp -78.68 173.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.064 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.601 ' N ' HG22 ' A' ' 128' ' ' ILE . 36.2 mtpt -103.94 136.04 44.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -49.45 -29.18 6.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 110.234 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.07 -35.51 78.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.064 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.825 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 17.6 t-160 -66.81 -42.64 85.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.097 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.778 HG21 ' CE2' ' A' ' 5' ' ' TYR . 68.9 t -62.57 -39.82 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.998 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -72.82 -39.16 66.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 110.179 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.15 93.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.133 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.24 -22.63 76.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.543 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 82.6 mttt -75.98 -32.67 59.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 110.094 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.56 -32.07 60.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.038 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -75.83 -27.59 57.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -84.76 -35.72 22.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 110.115 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 80.4 p -64.21 -46.0 85.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.876 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.19 -50.29 74.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.976 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.6 mm? -58.49 -32.72 69.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.853 . . . . 0.0 109.993 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 4.9 m-85 -63.33 -38.43 91.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.051 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -78.54 -18.1 55.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.497 ' HA ' HD23 ' A' ' 146' ' ' LEU . 15.4 mt -81.09 -35.14 32.06 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.126 -0.984 . . . . 0.0 108.829 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.705 HG22 HD23 ' A' ' 18' ' ' LEU . 34.7 mt -69.62 -49.06 61.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.857 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.576 ' HB3' HD13 ' A' ' 13' ' ' ILE . 65.1 mm-40 -54.12 -41.7 68.65 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.394 -0.816 . . . . 0.0 109.362 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.436 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 45.1 m -71.38 -32.6 68.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.592 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.658 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 76.2 t80 -53.9 -58.75 6.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.934 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.162 HD21 ' CE2' ' A' ' 158' ' ' TYR . 62.8 mt -69.03 -29.73 67.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -0.962 . . . . 0.0 109.968 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.585 ' HB2' HD11 ' A' ' 13' ' ' ILE . 43.5 tptt -68.59 -35.64 77.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 109.775 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -98.44 -28.69 7.87 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 150' ' ' TYR . 9.5 m80 -107.2 89.1 4.36 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.359 -1.083 . . . . 0.0 109.897 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.0 Cg_endo -72.76 4.46 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.095 1.576 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 24.2 p30 -107.74 -12.64 15.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.007 -1.058 . . . . 0.0 109.728 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.658 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -66.49 100.57 0.67 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.409 -0.807 . . . . 0.0 109.999 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.162 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.86 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.279 0.562 . . . . 0.0 110.584 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.378 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.783 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 73.8 t -135.65 125.33 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.162 . . . . 0.0 110.456 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.572 ' CE1' HG12 ' A' ' 128' ' ' ILE . 52.9 m-85 -96.91 173.51 7.25 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.254 -0.904 . . . . 0.0 110.094 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.748 HG23 ' CE1' ' A' ' 119' ' ' HIS . 54.4 m -148.11 98.38 2.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CE1' HG11 ' A' ' 133' ' ' VAL . 78.5 m-85 -114.89 132.03 56.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.023 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.503 ' HB3' HG23 ' A' ' 117' ' ' THR . 18.9 pt-20 -130.84 159.6 36.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.569 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 p -132.0 143.91 50.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.424 -0.798 . . . . 0.0 109.895 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -124.81 125.71 44.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 0.0 110.387 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.624 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 3.8 p90 -152.84 -172.86 4.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 110.005 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 113' ' ' ILE . 10.8 p -140.19 179.89 6.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.272 -0.893 . . . . 0.0 110.446 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 112' ' ' SER . 2.6 t -157.51 158.96 36.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.268 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.603 ' CG ' HD12 ' A' ' 13' ' ' ILE . 17.1 pt-20 -85.76 -10.89 54.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.915 . . . . 0.0 110.044 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.845 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.0 mp -90.5 151.37 44.12 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.711 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.845 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.3 Cg_endo -66.86 143.04 65.18 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.975 1.513 . . . . 0.0 110.723 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.666 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 Cg_endo -71.63 -31.73 12.96 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.952 1.501 . . . . 0.0 112.584 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -69.53 -18.99 37.77 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.511 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -84.47 -48.57 9.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.776 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -68.62 -24.55 64.58 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.593 ' CZ ' HD11 ' A' ' 74' ' ' ILE . 82.8 t80 -69.83 -57.12 5.46 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.498 0.666 . . . . 0.0 109.789 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 81.6 mttt -54.88 -30.56 58.31 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.892 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -73.3 -64.62 0.94 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.771 0.796 . . . . 0.0 111.167 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.046 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -57.43 -40.37 78.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.66 -0.65 . . . . 0.0 111.955 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.118 HG11 ' CD1' ' A' ' 74' ' ' ILE . 11.5 t -99.6 -59.41 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.786 -1.196 . . . . 0.0 111.798 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.3 mp -77.1 -0.55 25.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.015 . . . . 0.0 111.71 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.567 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -145.35 7.01 1.13 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.756 -1.215 . . . . 0.0 111.193 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.046 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -46.02 -48.06 16.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.873 -1.142 . . . . 0.0 110.01 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 74.0 m-20 -58.91 -15.43 12.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.831 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HA ' ' CG ' ' A' ' 31' ' ' PRO . 80.0 m-20 -129.54 10.93 5.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.796 HD12 ' C ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -95.25 -46.26 6.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.982 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.998 HG21 HD13 ' A' ' 38' ' ' ILE . 6.3 p -76.91 -27.63 0.62 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 112.419 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.821 ' HD3' HG12 ' A' ' 30' ' ' VAL . 47.7 Cg_endo -75.68 3.14 6.22 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 122.563 0.77 . . . . 0.0 110.611 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' CD ' ' OH ' ' A' ' 150' ' ' TYR . 95.0 mttt -119.15 -26.5 5.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -0.941 . . . . 0.0 109.127 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.612 HG12 ' CD1' ' A' ' 150' ' ' TYR . 49.4 mt -79.35 -41.02 22.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.553 -0.717 . . . . 0.0 109.533 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -169.75 103.79 0.46 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.49 -0.756 . . . . 0.0 109.829 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 43.3 Cg_endo -69.56 -3.01 11.02 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.979 1.515 . . . . 0.0 110.688 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -83.16 -14.87 52.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.494 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -92.06 -71.97 0.61 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 110.201 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.998 HD13 HG21 ' A' ' 30' ' ' VAL . 1.7 mp -94.06 125.79 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.868 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 57' ' ' THR . 13.0 tppt? -74.19 -36.19 64.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.339 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.424 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -179.56 151.96 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.862 . . . . 0.0 109.974 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.443 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 39.3 p -112.01 133.59 54.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.07 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 71.9 tt0 -139.88 108.72 5.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.971 . . . . 0.0 110.29 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.8 mt -66.07 134.54 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 110.189 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.8 tp -90.31 -27.03 19.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 1.073 ' O ' HG23 ' A' ' 52' ' ' THR . 33.3 tp10 -158.84 169.32 24.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.228 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 64.75 -166.17 32.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 48.7 t0 -135.88 29.71 3.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -1.167 . . . . 0.0 110.287 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.516 ' H ' HG21 ' A' ' 52' ' ' THR . . . 104.36 4.85 43.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.513 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -96.45 -167.31 33.91 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.64 132.12 21.3 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.143 1.602 . . . . 0.0 110.514 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.25 -7.31 66.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 1.073 HG23 ' O ' ' A' ' 45' ' ' GLU . 26.7 m -80.02 139.0 37.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -1.106 . . . . 0.0 110.161 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 70' ' ' LYS . 18.7 mm -109.06 110.84 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 110.226 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.1 mttt -97.84 153.27 18.42 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.378 -0.827 . . . . 0.0 110.392 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 78.2 tttt -124.94 100.6 6.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.075 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.5 mt -88.27 138.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.35 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.9 p -111.58 157.59 20.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.184 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 28.6 m-85 -117.83 159.44 23.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.356 -0.84 . . . . 0.0 110.3 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -134.43 20.59 3.92 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -48.78 -24.99 1.61 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -1.158 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.18 -37.31 1.16 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.1 m -50.32 158.45 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -1.124 . . . . 0.0 110.158 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.56 -45.28 69.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.243 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.01 110.11 9.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.249 -0.907 . . . . 0.0 110.31 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -139.47 82.83 0.24 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 14.7 p90 -131.6 163.65 27.59 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.219 -1.165 . . . . 0.0 110.198 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.83 HG12 ' HA2' ' A' ' 88' ' ' GLY . 9.5 m -137.71 172.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 110.627 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . 70.7 mttt -123.78 130.65 52.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.667 -0.646 . . . . 0.0 109.503 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.586 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -118.44 130.7 56.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.004 . . . . 0.0 111.0 -179.298 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.59 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.0 tttt -104.05 120.04 40.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.416 -0.802 . . . . 0.0 109.174 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.536 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 21.0 mm -62.4 129.58 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 110.693 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.467 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 72.3 m-20 -101.37 -49.6 4.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.359 -0.838 . . . . 0.0 109.308 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 79.6 p -179.68 157.36 0.74 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.529 -0.732 . . . . 0.0 110.286 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.118 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.2 tt -145.97 164.32 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -134.31 81.5 1.92 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 110.123 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 41.6 ttmt -55.9 -14.38 2.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.278 -0.889 . . . . 0.0 110.824 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -84.1 -29.91 26.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 0.0 109.006 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m120 -116.63 -1.1 12.22 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.357 0.599 . . . . 0.0 109.532 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.592 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 7.6 m-85 65.5 49.82 1.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.684 -0.635 . . . . 0.0 110.108 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.518 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -116.41 142.14 47.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 109.285 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.646 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 72.9 t80 -137.24 155.1 49.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.267 -0.895 . . . . 0.0 110.284 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.451 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 77.9 p -158.51 140.86 14.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 110.474 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.646 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 5.9 p90 -148.59 177.69 9.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 110.161 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 90.0 m -128.5 131.6 48.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 110.004 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.896 HD23 HG13 ' A' ' 98' ' ' ILE . 15.5 tp -83.62 123.7 30.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.201 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.55 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 33.7 pt -104.93 -8.99 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 110.228 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -163.57 166.26 22.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.83 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 155.04 153.23 6.43 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -79.96 -22.18 42.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -1.214 . . . . 0.0 110.268 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.99 -20.23 63.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.307 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.91 ' CD2' HD11 ' A' ' 98' ' ' ILE . 71.1 mt -67.79 -18.75 64.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.27 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.87 -167.19 0.51 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.41 9.53 25.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -1.151 . . . . 0.0 110.128 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 122' ' ' THR . 40.8 p -110.55 -32.11 7.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 110.079 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.9 HD23 HG23 ' A' ' 122' ' ' THR . 72.3 mt -109.42 154.74 22.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 110.169 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.529 ' O ' HD13 ' A' ' 91' ' ' LEU . 68.8 tt0 -137.37 -80.83 0.37 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.159 -0.963 . . . . 0.0 110.004 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.916 ' O ' HD13 ' A' ' 98' ' ' ILE . 32.1 mttm -80.22 156.15 27.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.495 -0.753 . . . . 0.0 110.513 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 97' ' ' LYS . 4.2 mm -145.49 126.28 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.092 -1.005 . . . . 0.0 109.82 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -93.23 126.51 38.38 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.45 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 15.0 m-85 -121.05 144.56 48.47 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.317 -0.864 . . . . 0.0 110.961 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -149.89 128.02 11.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.481 -0.762 . . . . 0.0 109.938 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 85.6 m -127.69 134.62 49.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.989 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 115' ' ' LYS . 15.5 mttt -124.44 136.81 54.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.287 -0.883 . . . . 0.0 110.362 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.787 HD23 HG12 ' A' ' 114' ' ' ILE . 8.5 mt -117.19 150.33 38.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.359 -0.838 . . . . 0.0 110.063 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.57 -169.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.257 -0.902 . . . . 0.0 110.107 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -117.81 140.42 49.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.411 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 92.1 p -96.74 162.5 22.94 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -72.6 -1.73 10.75 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.469 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p -99.9 -8.86 23.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.3 -21.81 21.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . -74.34 -146.05 1.08 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 27.3 p -149.36 131.67 15.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -1.158 . . . . 0.0 110.057 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.609 ' HA ' HG22 ' A' ' 10' ' ' THR . 37.0 mt -83.19 148.98 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 110.132 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.787 HG12 HD23 ' A' ' 104' ' ' LEU . 7.0 mt -133.41 115.55 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 110.463 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 103' ' ' LYS . 81.3 tttt -108.37 117.66 34.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.325 -0.859 . . . . 0.0 109.748 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 8.7 t -113.5 164.72 13.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.753 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.533 HG22 ' CE1' ' A' ' 119' ' ' HIS . 30.8 m -160.01 120.23 2.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.375 -0.828 . . . . 0.0 109.795 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.492 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 26.5 m -122.69 133.93 54.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.383 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.748 ' CE1' HG23 ' A' ' 4' ' ' THR . 35.8 m-70 -114.3 156.82 23.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 109.763 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.8 m-85 -114.37 149.28 36.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 110.595 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 90.1 m-70 -125.74 88.17 2.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.018 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.9 HG23 HD23 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -74.15 146.06 43.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.514 -0.741 . . . . 0.0 111.083 -178.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 63.7 pttt -105.41 130.89 53.41 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.543 -0.723 . . . . 0.0 110.137 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.24 -117.47 4.62 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.678 ' O ' HG13 ' A' ' 126' ' ' VAL . 46.2 t30 -138.27 103.28 4.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.275 -1.132 . . . . 0.0 110.418 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 125' ' ' ASN . 8.7 m -159.5 165.49 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.833 . . . . 0.0 109.896 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -134.7 158.46 44.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.142 -0.974 . . . . 0.0 110.32 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.862 ' CD1' HD21 ' A' ' 95' ' ' LEU . 22.7 mm -70.7 172.93 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 110.196 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.582 ' N ' HG22 ' A' ' 128' ' ' ILE . 13.9 mttm -116.61 131.45 56.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.972 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 69.5 mm-40 -43.66 -44.4 6.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.15 -0.969 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -63.29 -24.63 67.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.933 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 129' ' ' LYS . 15.1 t-160 -81.06 -49.25 11.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.118 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.591 HG11 ' CE1' ' A' ' 5' ' ' TYR . 59.5 t -58.79 -37.66 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.758 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.03 -44.81 37.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.902 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -64.27 -32.69 74.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.349 -0.844 . . . . 0.0 110.057 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.06 -32.17 66.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -75.83 -34.08 60.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -1.1 . . . . 0.0 109.997 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.99 -37.73 58.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.916 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 94.3 mttt -69.5 -37.53 77.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 109.861 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.477 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -69.79 -34.98 74.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.797 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 64.9 m -72.64 -44.19 62.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.805 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -57.61 -43.94 85.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.877 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.6 -43.75 98.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.913 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.511 ' HA ' HD12 ' A' ' 147' ' ' ILE . 8.6 m-85 -59.89 -32.87 71.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.443 -0.786 . . . . 0.0 109.84 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -78.27 -20.21 52.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.483 ' HB3' HG21 ' A' ' 33' ' ' ILE . 17.5 mt -83.25 -36.29 24.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.174 -0.954 . . . . 0.0 108.826 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.648 HG23 HD11 ' A' ' 29' ' ' LEU . 8.9 mt -72.51 -43.75 62.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.557 ' HB3' HD13 ' A' ' 13' ' ' ILE . 54.7 mt-10 -60.95 -41.11 95.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.435 -0.791 . . . . 0.0 109.372 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.8 m -72.9 -32.8 65.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.622 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.656 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.2 t80 -56.48 -54.68 42.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.495 -0.753 . . . . 0.0 109.886 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.197 HD21 ' CE2' ' A' ' 158' ' ' TYR . 69.4 mt -69.27 -31.22 69.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.307 -0.871 . . . . 0.0 110.288 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.554 ' HB2' HD11 ' A' ' 13' ' ' ILE . 43.1 tttt -68.55 -28.43 66.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.88 . . . . 0.0 109.782 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.81 -26.72 6.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 150' ' ' TYR . 8.8 m80 -107.27 90.41 5.67 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.951 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.8 Cg_endo -73.47 3.75 4.51 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.101 1.579 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -109.56 -9.69 14.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.76 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.656 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -68.48 100.28 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.468 -0.77 . . . . 0.0 110.136 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.197 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.7 OUTLIER 34.4 32.72 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.253 0.549 . . . . 0.0 110.542 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.846 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 50.0 t -125.43 114.31 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.187 -1.184 . . . . 0.0 110.406 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.594 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 93.1 m-85 -74.83 152.83 38.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.954 . . . . 0.0 110.184 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.657 HG23 ' CE1' ' A' ' 119' ' ' HIS . 7.9 m -130.38 113.76 14.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.756 ' CD2' HG13 ' A' ' 133' ' ' VAL . 39.1 m-85 -126.61 125.84 42.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.089 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.576 ' CG ' ' N ' ' A' ' 7' ' ' SER . 16.3 tt0 -114.82 176.15 5.18 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.277 -0.889 . . . . 0.0 109.61 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.576 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 19.1 m -153.0 147.4 25.87 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.646 -0.659 . . . . 0.0 109.852 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.429 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 47.6 mt-10 -140.26 116.33 10.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.054 -1.028 . . . . 0.0 110.566 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.715 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 3.9 p90 -145.17 -172.08 3.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 109.887 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.78 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.6 p -140.59 172.63 12.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.465 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 53.8 p -150.69 142.24 23.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.465 -0.772 . . . . 0.0 110.097 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.17 -25.93 68.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.278 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.744 HD11 ' HB2' ' A' ' 152' ' ' LYS . 5.1 mp -81.34 146.38 57.74 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.148 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.677 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.7 Cg_endo -66.76 152.94 79.58 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.116 1.587 . . . . 0.0 110.719 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.7 Cg_endo -64.5 -36.08 45.38 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.763 1.401 . . . . 0.0 113.204 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 39.5 Cg_endo -65.24 -20.17 62.43 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 N-CA-C 109.748 -0.905 . . . . 0.0 109.748 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.974 ' HG3' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.92 -43.4 19.85 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 18' ' ' LEU . 8.0 mp -72.68 -38.08 67.69 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 47.9 t80 -56.84 -57.56 11.93 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.24 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 92.5 mttt -57.58 -37.47 73.22 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.529 -0.732 . . . . 0.0 110.134 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.073 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.03 -58.74 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 111.1 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.007 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -53.73 -40.52 66.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 0.0 111.958 -178.606 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.119 HG11 ' CD1' ' A' ' 74' ' ' ILE . 21.1 t -106.27 -65.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.845 -1.159 . . . . 0.0 111.693 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.637 ' N ' HD22 ' A' ' 24' ' ' LEU . 4.2 mm? -62.77 -8.58 7.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 111.216 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.734 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -144.76 28.52 1.27 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.876 -1.14 . . . . 0.0 110.63 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.007 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.57 -35.51 79.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -0.907 . . . . 0.0 110.112 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.449 ' OD1' ' CB ' ' A' ' 41' ' ' SER . 19.8 t70 -63.25 -16.05 59.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 81.8 m-20 -126.94 8.1 6.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.029 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.752 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -92.94 -53.64 4.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.178 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.911 ' CG1' HD13 ' A' ' 38' ' ' ILE . 2.5 t -72.02 -42.47 9.78 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.415 -0.803 . . . . 0.0 110.905 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.3 Cg_endo -77.74 9.48 2.94 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.541 1.285 . . . . 0.0 111.005 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 28' ' ' ASN . 33.3 ttmt -127.21 -31.2 2.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.968 -1.083 . . . . 0.0 109.831 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.605 HG12 ' CD1' ' A' ' 150' ' ' TYR . 36.7 mt -80.01 -38.97 19.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.443 -0.785 . . . . 0.0 109.733 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -154.28 99.75 2.49 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.449 -0.782 . . . . 0.0 110.026 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 43.7 Cg_endo -71.27 -2.0 10.51 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.066 1.561 . . . . 0.0 110.481 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -86.36 -12.6 48.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.751 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.659 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -96.03 -56.34 2.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.081 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.911 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.0 mp -115.12 132.28 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 110.08 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.587 ' CG ' ' CA ' ' A' ' 59' ' ' GLY . 0.5 OUTLIER -68.62 -37.28 79.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.891 . . . . 0.0 110.193 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.443 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER 177.61 153.82 0.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 110.018 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.449 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 62.7 m -115.04 125.7 53.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.979 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 84.5 tt0 -130.18 106.93 8.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.293 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 22.2 mt -61.08 131.68 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.176 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 44' ' ' LEU . 49.7 mt -88.93 -26.09 21.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 110.044 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 1.013 ' O ' HG23 ' A' ' 52' ' ' THR . 55.7 tt0 -152.31 171.14 18.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.97 -169.03 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -130.37 28.14 4.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -1.121 . . . . 0.0 110.232 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.604 ' H ' HG21 ' A' ' 52' ' ' THR . . . 113.36 -5.49 24.96 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.516 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -79.97 -170.99 41.86 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -70.44 133.55 24.56 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.195 1.629 . . . . 0.0 110.574 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.27 -1.42 76.77 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 1.013 HG23 ' O ' ' A' ' 45' ' ' GLU . 32.4 m -80.16 145.42 32.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -1.193 . . . . 0.0 110.158 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 70' ' ' LYS . 36.0 mm -111.92 112.02 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 110.184 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 46.5 mtmt -99.12 150.57 21.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 110.374 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -123.14 98.84 6.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.877 . . . . 0.0 110.053 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.498 ' HB ' HG23 ' A' ' 67' ' ' VAL . 96.6 mt -88.97 140.12 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 110.193 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.9 p -115.0 152.77 31.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.56 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 26.7 m-85 -117.62 129.2 55.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.499 -0.75 . . . . 0.0 109.993 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.587 ' CA ' ' CG ' ' A' ' 39' ' ' LYS . . . -93.38 36.22 3.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -129.05 131.24 47.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -1.126 . . . . 0.0 110.269 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.67 138.54 9.83 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 65.2 p -55.63 -49.16 73.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -1.111 . . . . 0.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -73.65 153.0 40.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 110.076 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -62.31 136.23 57.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.2 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -122.38 88.0 0.4 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.1 p90 -123.62 163.42 21.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -1.211 . . . . 0.0 110.124 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.787 HG12 ' HA2' ' A' ' 88' ' ' GLY . 8.6 m -141.32 172.03 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.938 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.433 ' HD2' ' OE1' ' A' ' 87' ' ' GLU . 86.4 mttt -127.4 125.85 41.4 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.702 ' CE1' HD13 ' A' ' 85' ' ' LEU . 1.2 m80 -116.92 121.02 40.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 111.161 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.616 ' HD3' HD13 ' A' ' 86' ' ' ILE . 23.5 mtmt -96.46 106.88 19.2 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.324 -0.86 . . . . 0.0 109.242 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.7 mm -48.34 136.68 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.872 . . . . 0.0 110.074 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 73' ' ' SER . 14.9 m-20 -107.34 -44.6 4.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.343 -0.848 . . . . 0.0 109.744 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 12.9 p 176.18 156.57 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.522 -0.736 . . . . 0.0 110.365 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.119 ' CD1' HG11 ' A' ' 23' ' ' VAL . 6.1 tt -144.96 169.86 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.504 -0.748 . . . . 0.0 109.597 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.4 m-20 -142.47 84.29 1.85 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.075 -1.016 . . . . 0.0 110.317 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.544 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 81.1 tttt -59.67 -13.9 11.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 110.221 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -92.79 -34.2 13.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 3.7 m120 -102.21 -3.9 26.61 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.524 0.678 . . . . 0.0 109.229 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.571 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 90.5 m-85 62.58 55.78 2.14 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.253 0.549 . . . . 0.0 110.919 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 2.7 m -132.14 162.38 31.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 0.0 109.658 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.61 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 80.2 t80 -158.08 146.71 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -0.974 . . . . 0.0 110.198 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.425 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 3.8 t -153.56 147.63 25.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.692 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 9.2 p90 -149.76 175.58 11.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.429 -0.794 . . . . 0.0 110.015 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 98' ' ' ILE . 97.6 m -125.61 128.82 48.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.702 HD13 ' CE1' ' A' ' 69' ' ' HIS . 2.7 tp -96.39 122.97 39.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.573 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.616 HD13 ' HD3' ' A' ' 70' ' ' LYS . 20.8 pt -112.63 -5.39 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 110.894 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 22.9 tt0 -147.29 120.86 9.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 110.672 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.787 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -168.74 149.05 13.11 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.68 -8.04 24.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -1.123 . . . . 0.0 110.065 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.768 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -80.4 -53.54 6.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.471 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.721 HD21 ' N ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -63.94 -30.7 71.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.269 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 39.08 -124.42 1.75 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -106.04 -6.46 18.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -1.125 . . . . 0.0 110.494 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.771 ' O ' HG21 ' A' ' 126' ' ' VAL . 64.1 p -80.04 -50.63 10.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 109.703 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.779 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -109.43 163.66 13.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.779 ' H ' HD12 ' A' ' 95' ' ' LEU . 42.0 tt0 -133.18 -77.84 0.48 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 110.912 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.6 mtpt -80.08 128.96 34.11 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.615 -0.678 . . . . 0.0 111.125 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.763 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.2 mm -117.74 140.47 40.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 120.868 -1.145 . . . . 0.0 109.811 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -117.76 126.72 52.97 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.38 -0.825 . . . . 0.0 108.974 178.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.763 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.4 m-85 -121.8 136.07 54.93 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.915 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 48.3 tt0 -137.14 150.72 48.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.571 -0.706 . . . . 0.0 109.606 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' TYR . 36.7 m -149.21 150.4 32.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -0.997 . . . . 0.0 110.408 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 2.3 tttt -138.68 147.22 42.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.681 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.803 HD23 HG12 ' A' ' 114' ' ' ILE . 2.7 mt -128.45 147.3 50.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.001 . . . . 0.0 110.688 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.72 -168.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.475 -0.765 . . . . 0.0 109.806 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.86 172.7 7.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.131 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.459 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 32.8 p -130.48 164.96 37.71 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -73.16 -1.3 10.35 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.995 1.524 . . . . 0.0 110.599 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.0 p -103.93 3.68 33.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.374 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.04 -36.76 3.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.97 -173.85 3.09 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.5 p -130.33 140.24 50.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -1.189 . . . . 0.0 110.357 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.78 ' HA ' HG22 ' A' ' 10' ' ' THR . 27.5 mt -89.8 149.5 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.854 . . . . 0.0 110.077 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.803 HG12 HD23 ' A' ' 104' ' ' LEU . 10.5 mt -135.95 110.61 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.313 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 37.1 ttmt -99.73 129.85 45.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.941 . . . . 0.0 110.135 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.6 t -121.03 157.18 30.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.958 . . . . 0.0 110.282 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 85.7 m -154.3 138.02 16.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 110.15 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.477 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 34.7 p -141.61 154.46 45.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 110.184 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.657 ' CE1' HG23 ' A' ' 4' ' ' THR . 82.2 m-70 -133.41 164.63 26.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 0.0 110.387 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.587 ' CD2' HG13 ' A' ' 128' ' ' ILE . 8.2 m-85 -124.06 141.92 51.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 110.435 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 72.5 m80 -122.52 89.43 3.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.924 -1.11 . . . . 0.0 109.793 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.624 ' HB ' HG23 ' A' ' 126' ' ' VAL . 2.7 p -60.25 163.44 5.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 110.301 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 85.0 tttt -126.0 114.9 19.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.275 -0.891 . . . . 0.0 110.242 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.36 -105.37 2.99 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.628 ' O ' HG13 ' A' ' 126' ' ' VAL . 24.7 t30 -135.6 93.43 2.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -1.169 . . . . 0.0 110.202 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.771 HG21 ' O ' ' A' ' 94' ' ' THR . 15.9 m -157.76 165.55 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.305 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -145.21 149.5 35.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 110.316 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.762 HD11 ' HB2' ' A' ' 95' ' ' LEU . 37.8 mm -75.97 173.41 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 110.203 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.61 ' N ' HG22 ' A' ' 128' ' ' ILE . 31.5 mtpt -116.54 136.21 53.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.4 -0.813 . . . . 0.0 110.078 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -45.43 -43.26 11.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.62 -31.28 71.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 110.142 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.768 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 16.0 t-160 -74.02 -47.69 35.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 110.081 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.756 HG13 ' CD2' ' A' ' 5' ' ' TYR . 73.0 t -62.21 -40.96 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.381 -0.824 . . . . 0.0 110.008 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -69.37 -42.73 74.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.997 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.502 ' HB1' ' NZ ' ' A' ' 139' ' ' LYS . . . -62.4 -38.66 90.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.026 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -30.23 68.16 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 52.7 mtpt -77.37 -31.85 54.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -1.147 . . . . 0.0 110.055 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -76.67 -30.49 56.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 109.927 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.502 ' NZ ' ' HB1' ' A' ' 135' ' ' ALA . 46.1 mttp -68.37 -37.5 80.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.864 . . . . 0.0 110.051 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.42 -43.08 64.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.902 . . . . 0.0 110.007 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.1 p -63.42 -43.46 97.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.943 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -57.73 -41.68 82.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.863 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 147' ' ' ILE . 66.4 mt -58.61 -46.32 87.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 0.0 109.966 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.441 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 20.9 m-85 -54.42 -39.53 67.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.383 -0.823 . . . . 0.0 109.913 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.88 -28.19 68.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.88 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.562 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.9 mt -82.93 -34.5 26.53 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.222 -0.924 . . . . 0.0 108.791 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.636 HD13 ' CD1' ' A' ' 22' ' ' PHE . 81.8 mt -72.01 -34.79 51.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.606 -0.684 . . . . 0.0 109.329 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.597 ' CB ' HD13 ' A' ' 13' ' ' ILE . 30.8 mt-10 -64.91 -39.43 93.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.403 -0.811 . . . . 0.0 109.428 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.7 m -69.6 -35.47 75.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.498 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.609 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 71.5 t80 -58.58 -51.84 68.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.819 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.069 HD21 ' CE1' ' A' ' 158' ' ' TYR . 78.0 mt -80.05 -39.15 30.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 110.27 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.744 ' HB2' HD11 ' A' ' 13' ' ' ILE . 82.6 tttt -64.2 -19.16 65.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.495 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.31 -34.72 2.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 1.6 m80 -107.03 94.47 10.88 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.276 -1.132 . . . . 0.0 109.983 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.4 Cg_endo -74.04 5.38 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.089 1.573 . . . . 0.0 110.973 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -106.89 -9.66 16.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.046 -1.034 . . . . 0.0 109.856 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.633 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -69.68 100.82 1.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.348 -0.845 . . . . 0.0 110.083 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.073 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 1.0 OUTLIER 34.09 33.6 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.342 0.591 . . . . 0.0 110.642 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.508 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 118.009 -0.995 . . . . 0.0 109.852 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.031 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.9 p -80.12 150.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -1.131 . . . . 0.0 110.35 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.612 ' CD1' HD12 ' A' ' 128' ' ' ILE . 26.1 m-85 -89.07 176.38 7.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 110.368 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.84 HG23 ' CE1' ' A' ' 119' ' ' HIS . 97.4 m -145.45 103.66 3.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.396 -0.815 . . . . 0.0 110.083 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.687 ' CD1' HG13 ' A' ' 133' ' ' VAL . 51.5 m-85 -116.23 129.34 56.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 110.098 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 116' ' ' SER . 25.5 pt-20 -131.52 157.94 42.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 110.505 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.4 m -133.95 139.42 46.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.895 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.481 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 99.9 mt-10 -121.24 127.32 51.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.385 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 3.8 p90 -154.3 -171.76 3.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.038 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.568 HG22 HG12 ' A' ' 113' ' ' ILE . 18.0 p -141.35 -176.46 4.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.57 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.489 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 3.7 t -159.6 160.9 34.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.776 . . . . 0.0 110.152 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -85.16 -19.11 32.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.978 . . . . 0.0 110.153 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 10.0 mm -85.47 149.8 52.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 110.095 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.9 Cg_endo -65.82 148.5 86.5 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.06 1.558 . . . . 0.0 110.57 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.682 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.3 Cg_endo -70.05 -32.57 17.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.885 1.466 . . . . 0.0 112.893 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.682 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.2 Cg_endo -67.58 -20.62 47.0 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 N-CA-C 110.149 -0.75 . . . . 0.0 110.149 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.883 ' HG2' HD13 ' A' ' 151' ' ' LEU . 4.6 ttm180 -84.73 -49.16 8.72 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.752 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -69.06 -26.73 65.1 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.205 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.9 t80 -71.29 -55.03 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 109.236 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 63.3 mttt -51.72 -32.98 32.49 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.403 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.079 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -79.83 -55.09 5.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 111.188 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.056 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -57.29 -44.39 84.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.527 -0.733 . . . . 0.0 112.52 -177.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.554 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -106.8 -55.68 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.792 -1.192 . . . . 0.0 112.06 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.661 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.9 mm? -68.84 -10.64 58.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.01 -1.056 . . . . 0.0 111.174 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.584 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.2 m-20 -145.36 28.58 1.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.886 -1.134 . . . . 0.0 110.734 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.056 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.29 -20.04 65.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.152 -0.968 . . . . 0.0 110.436 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -72.61 -20.19 61.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.096 -1.003 . . . . 0.0 109.588 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.5 p-10 -126.85 14.76 7.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 109.672 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.913 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -96.42 -50.16 4.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.224 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.079 HG21 HD13 ' A' ' 38' ' ' ILE . 9.7 p -73.26 -26.99 0.79 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.332 -0.855 . . . . 0.0 112.183 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.802 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -82.91 10.38 3.66 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 122.621 0.8 . . . . 0.0 110.51 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -134.37 -27.04 1.4 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.13 -0.982 . . . . 0.0 110.603 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.687 HD11 ' CD1' ' A' ' 29' ' ' LEU . 34.3 mt -77.87 -36.29 21.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.225 -0.922 . . . . 0.0 109.899 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.95 100.13 0.82 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.342 -0.849 . . . . 0.0 110.338 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.85 -0.1 9.0 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.109 1.584 . . . . 0.0 110.346 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -88.29 -13.09 41.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 110.007 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.13 -47.1 4.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 110.315 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.079 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -125.79 145.24 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -0.82 . . . . 0.0 110.103 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -83.18 -42.04 17.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.269 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.44 163.53 1.58 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 110.123 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.6 m -120.27 125.68 48.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.185 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -130.04 107.57 9.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 110.151 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 23.4 mt -56.54 134.89 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 110.071 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.83 HD22 ' CE ' ' A' ' 55' ' ' LYS . 63.8 tp -88.76 -46.51 8.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -0.958 . . . . 0.0 109.911 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.83 ' O ' HG23 ' A' ' 52' ' ' THR . 16.8 mm-40 -131.97 -169.81 2.28 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.442 -0.786 . . . . 0.0 110.179 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.44 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.08 -150.05 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 47' ' ' ASP . 23.4 t0 -160.03 41.48 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -1.133 . . . . 0.0 110.093 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.655 ' H ' HG21 ' A' ' 52' ' ' THR . . . 103.31 -11.71 54.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -82.13 -175.54 50.62 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.3 Cg_endo -72.23 132.82 20.06 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.144 1.602 . . . . 0.0 110.43 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.91 -3.78 62.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.4 m -80.02 150.04 30.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -1.175 . . . . 0.0 109.986 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.718 HD13 ' HA ' ' A' ' 70' ' ' LYS . 20.9 mm -116.76 107.62 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.948 . . . . 0.0 110.324 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 73.0 mttt -90.32 144.88 25.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.398 -0.814 . . . . 0.0 110.097 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.83 ' CE ' HD22 ' A' ' 44' ' ' LEU . 31.7 mttt -117.95 95.4 4.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.267 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CG2' HG12 ' A' ' 38' ' ' ILE . 86.9 mt -83.44 145.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.904 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 38' ' ' ILE . 6.2 p -116.48 158.35 23.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 110.74 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.812 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.9 m-85 -116.42 145.87 42.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.226 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.91 4.93 53.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.65 151.54 51.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.167 -1.196 . . . . 0.0 110.285 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.51 -143.6 16.97 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.8 p -61.49 173.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -1.16 . . . . 0.0 110.208 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 63' ' ' GLN . 10.8 tp60 -47.03 -58.43 4.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.085 -1.009 . . . . 0.0 110.112 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.495 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 7.1 t80 -108.51 116.67 32.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.26 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -116.8 135.86 12.31 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.541 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.9 p90 -179.08 166.57 1.57 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -1.153 . . . . 0.0 110.271 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.96 HG12 ' HA2' ' A' ' 88' ' ' GLY . 3.6 m -142.09 174.7 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 110.362 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.65 ' O ' HD12 ' A' ' 85' ' ' LEU . 96.6 mttt -126.15 124.75 41.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.481 -0.762 . . . . 0.0 109.705 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.765 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -113.73 130.3 56.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.135 -0.978 . . . . 0.0 110.814 -179.527 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.718 ' HA ' HD13 ' A' ' 53' ' ' ILE . 76.7 tttt -107.31 102.31 11.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.381 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.503 HG22 ' HA ' ' A' ' 50' ' ' PRO . 34.6 mm -45.25 135.35 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.466 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.485 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 12.2 t0 -108.66 -38.69 5.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.446 -0.784 . . . . 0.0 109.617 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.488 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 6.4 p 179.07 156.58 0.5 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.505 -0.747 . . . . 0.0 110.019 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.447 HG12 HG11 ' A' ' 23' ' ' VAL . 1.9 mt -136.97 159.17 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.07 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 1.1 m-20 -144.67 83.97 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.62 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.578 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 57.4 tttp -66.65 -15.82 63.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.276 -0.89 . . . . 0.0 110.17 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -86.29 -31.04 21.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 0.0 108.809 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.2 m120 -106.1 -3.9 20.98 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.559 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 98.9 m-85 61.11 53.73 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.36 0.6 . . . . 0.0 110.584 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 12.9 t -125.47 175.2 7.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.85 . . . . 0.0 110.103 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.687 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 39.1 t80 -159.59 134.23 7.84 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.713 -0.617 . . . . 0.0 109.8 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.488 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 20.2 m -140.77 123.34 16.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 111.037 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.687 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 16.8 p90 -139.16 171.86 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.812 . . . . 0.0 110.01 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 98' ' ' ILE . 58.0 m -124.33 137.1 54.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.978 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.765 HD13 ' CE1' ' A' ' 69' ' ' HIS . 15.5 tp -99.74 124.85 45.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.391 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.3 pt -102.22 -10.67 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 110.292 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.4 ' OE1' ' HE3' ' A' ' 68' ' ' LYS . 81.7 tt0 -151.51 155.71 39.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 110.232 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.96 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 157.61 143.47 3.67 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -61.54 -25.9 67.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -1.107 . . . . 0.0 110.184 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.553 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -60.21 -25.87 65.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 110.253 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.459 HD21 ' CG1' ' A' ' 98' ' ' ILE . 89.6 mt -62.52 -11.76 18.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.199 -0.938 . . . . 0.0 110.137 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.923 ' O ' HG23 ' A' ' 94' ' ' THR . . . 42.57 28.95 0.67 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 66.9 m-20 56.29 16.1 2.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -1.185 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.923 HG23 ' O ' ' A' ' 92' ' ' GLY . 19.6 p -111.93 -34.27 6.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.736 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.818 HD23 HG23 ' A' ' 122' ' ' THR . 96.2 mt -94.76 163.85 13.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.826 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.482 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 68.1 tt0 -127.98 -81.61 0.59 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.783 0.802 . . . . 0.0 109.782 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 60.4 mttt -80.3 127.97 32.99 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.657 -0.652 . . . . 0.0 110.142 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.81 ' O ' HG23 ' A' ' 84' ' ' THR . 3.8 mm -117.05 139.91 41.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.628 -1.295 . . . . 0.0 109.721 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -120.59 125.18 47.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.772 ' CE2' HG21 ' A' ' 98' ' ' ILE . 12.4 m-85 -120.07 132.06 55.31 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.398 -0.814 . . . . 0.0 110.396 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 117' ' ' THR . 5.7 mt-10 -131.53 133.87 45.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.022 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 88.8 m -129.35 146.65 51.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.917 . . . . 0.0 110.1 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 115' ' ' LYS . 1.5 mttm -139.89 134.45 31.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 110.294 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.708 HD23 HG12 ' A' ' 114' ' ' ILE . 10.1 mt -113.93 148.24 37.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.145 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.89 -168.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 110.092 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.697 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.96 161.09 24.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 26.1 p -119.73 163.95 24.75 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.28 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.6 Cg_endo -72.27 -1.97 10.95 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.064 1.56 . . . . 0.0 110.477 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.2 p -103.78 -0.74 28.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.263 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.17 -35.72 4.85 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.25 -174.05 2.57 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 55.5 p -129.17 137.5 51.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -1.171 . . . . 0.0 110.327 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.568 HG12 HG22 ' A' ' 10' ' ' THR . 59.2 mt -88.71 150.79 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 110.326 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.708 HG12 HD23 ' A' ' 104' ' ' LEU . 8.5 mt -132.86 111.35 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.1 tttt -101.11 123.39 45.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.108 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.5 t -117.17 156.53 27.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.49 HG22 ' CE1' ' A' ' 119' ' ' HIS . 57.7 m -158.97 125.23 4.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 110.201 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.482 ' HB2' ' CD1' ' A' ' 100' ' ' TYR . 31.3 t -127.09 162.23 26.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 110.172 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.84 ' CE1' HG23 ' A' ' 4' ' ' THR . 44.0 m-70 -140.75 128.83 22.1 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 1.031 ' C ' HG23 ' A' ' 2' ' ' VAL . 9.7 m-30 -100.28 119.76 38.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.182 -0.949 . . . . 0.0 110.953 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.581 ' N ' HG23 ' A' ' 2' ' ' VAL . 84.5 m-70 -93.59 101.27 13.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.379 -0.826 . . . . 0.0 109.373 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.818 HG23 HD23 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -81.06 154.12 27.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.042 -1.036 . . . . 0.0 110.525 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.423 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 33.4 tttp -127.64 117.36 21.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 116.26 -135.31 12.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 3.2 p-10 -125.84 53.53 1.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -1.15 . . . . 0.0 110.235 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 122' ' ' THR . 28.3 m -135.27 155.54 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 110.134 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.02 157.13 47.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.958 . . . . 0.0 110.371 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 129' ' ' LYS . 2.2 mp -65.36 173.27 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.973 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.623 ' N ' HG22 ' A' ' 128' ' ' ILE . 34.0 mttt -118.31 148.13 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 109.915 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.525 ' HG2' ' N ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -51.71 -22.88 3.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 110.395 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' HG2' ' A' ' 130' ' ' GLU . 49.2 tt0 -77.8 -35.46 51.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.838 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 19.8 t-160 -73.58 -36.47 65.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.687 HG13 ' CD1' ' A' ' 5' ' ' TYR . 59.5 t -63.73 -43.62 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.864 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.48 -42.94 77.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.84 . . . . 0.0 109.955 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.93 89.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.523 ' HA2' ' CD ' ' A' ' 139' ' ' LYS . . . -65.61 -29.88 76.16 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 141' ' ' SER . 94.5 mttt -78.43 -30.73 47.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -1.128 . . . . 0.0 110.156 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.504 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 96.5 mt-10 -76.27 -39.77 53.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.086 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.523 ' CD ' ' HA2' ' A' ' 136' ' ' GLY . 18.8 ptpt -66.69 -33.18 75.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.837 . . . . 0.0 109.875 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.506 ' N ' ' HG3' ' A' ' 139' ' ' LYS . . . -88.82 -40.13 13.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.002 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 137' ' ' LYS . 61.6 m -65.27 -44.74 87.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.349 -0.845 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.3 m-20 -58.81 -41.33 86.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.367 -0.833 . . . . 0.0 110.035 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.0 mt -61.28 -40.6 94.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.889 . . . . 0.0 110.053 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -61.54 -34.75 76.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.019 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -76.9 -17.84 58.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.017 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.503 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 16.7 mt -83.45 -35.19 25.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.242 -0.912 . . . . 0.0 108.938 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.759 HD13 ' CD1' ' A' ' 22' ' ' PHE . 93.1 mt -71.22 -43.14 74.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.508 ' HG3' HD12 ' A' ' 18' ' ' LEU . 55.1 mt-10 -57.62 -37.72 73.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.362 -0.836 . . . . 0.0 109.283 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 65.7 m -73.65 -33.56 64.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.458 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.621 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.1 t80 -54.3 -48.51 71.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.458 -0.776 . . . . 0.0 109.898 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.178 HD21 ' CE2' ' A' ' 158' ' ' TYR . 72.4 mt -78.35 -30.55 48.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.178 -0.951 . . . . 0.0 110.164 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.454 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 30.5 ttpt -71.65 -22.11 61.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.307 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.14 -31.24 3.88 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 4.8 m80 -109.78 92.88 13.23 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.452 -1.028 . . . . 0.0 109.968 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.17 5.82 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.034 1.544 . . . . 0.0 111.067 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -109.35 -1.03 18.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 109.991 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.621 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -81.54 102.89 10.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 110.073 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.178 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.85 32.79 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.366 0.603 . . . . 0.0 110.517 -179.484 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.535 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.818 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' ' 120' ' ' TYR . 85.2 t -120.15 123.61 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -1.158 . . . . 0.0 110.375 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.6 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 86.9 m-85 -75.03 148.01 40.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 110.087 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.835 HG23 ' CE1' ' A' ' 119' ' ' HIS . 52.0 m -131.74 121.64 24.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.189 ' CE2' HG21 ' A' ' 133' ' ' VAL . 74.7 m-85 -131.17 156.7 44.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.059 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -148.67 152.95 37.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 110.105 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 116' ' ' SER . 54.5 p -136.18 148.71 48.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.442 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 95.4 mt-10 -136.88 117.82 14.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 110.28 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 2.9 p90 -144.88 -175.71 4.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.899 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.8 p -138.39 179.58 6.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.565 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.542 ' OG ' HD11 ' A' ' 114' ' ' ILE . 8.8 p -157.02 163.78 38.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.229 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.84 -13.62 47.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.239 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.877 HD11 ' HB2' ' A' ' 152' ' ' LYS . 3.1 mp -90.78 149.68 40.84 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 0.0 110.139 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.807 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.8 Cg_endo -66.98 148.55 82.07 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.995 1.524 . . . . 0.0 110.553 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.671 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -69.96 -32.95 16.77 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 O-C-N 123.947 1.498 . . . . 0.0 113.096 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.4 Cg_endo -67.12 -22.09 47.85 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 N-CA-C 109.934 -0.833 . . . . 0.0 109.934 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.995 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -82.23 -49.36 10.18 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.897 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.777 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.3 tt -68.21 -29.72 68.62 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 76' ' ' LYS . 67.6 t80 -61.85 -57.28 12.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.127 178.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 92.2 mttt -50.09 -53.08 29.59 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.137 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.18 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -55.29 -68.15 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 110.554 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.055 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -43.21 -58.89 2.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.714 -0.616 . . . . 0.0 111.845 -178.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG11 HG12 ' A' ' 74' ' ' ILE . 3.7 t -91.2 -61.14 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.066 -1.021 . . . . 0.0 112.246 -178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.604 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.7 mm? -69.94 -2.07 11.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.037 -1.039 . . . . 0.0 112.168 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.878 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.11 25.97 0.71 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.586 -1.321 . . . . 0.0 111.281 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.055 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -63.37 -37.53 87.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.031 . . . . 0.0 109.761 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' OD2' HD11 ' A' ' 43' ' ' ILE . 55.1 m-20 -64.75 -12.03 42.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.765 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.528 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 64.1 m-80 -130.17 7.83 5.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.456 -0.778 . . . . 0.0 109.889 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.878 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -94.14 -49.57 5.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.323 -0.861 . . . . 0.0 110.263 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.041 HG21 HD13 ' A' ' 38' ' ' ILE . 7.1 p -77.67 -26.21 0.52 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.352 -0.843 . . . . 0.0 112.526 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.738 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -79.39 6.58 5.01 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 O-C-N 122.501 0.737 . . . . 0.0 110.585 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -131.42 -29.07 1.81 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.108 -0.995 . . . . 0.0 110.217 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.613 HD11 HD13 ' A' ' 29' ' ' LEU . 67.2 mt -79.29 -37.6 19.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.296 -0.878 . . . . 0.0 109.755 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.61 91.25 2.31 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.391 -0.818 . . . . 0.0 110.251 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.34 0.01 8.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.01 1.531 . . . . 0.0 110.563 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -90.85 -24.48 20.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.121 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.36 -37.88 13.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.098 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.041 HD13 HG21 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -125.3 133.22 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.0 109.893 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.54 ' HG3' ' CA ' ' A' ' 59' ' ' GLY . 11.5 mttt -72.89 -41.94 64.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.901 . . . . 0.0 110.075 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -179.89 161.22 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 110.19 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 m -125.02 118.34 26.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 110.021 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -124.5 111.21 15.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.533 HD11 ' OD2' ' A' ' 27' ' ' ASP . 21.6 mt -57.86 127.25 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.756 HD13 ' CE ' ' A' ' 55' ' ' LYS . 12.3 tp -90.93 -40.04 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 0.0 110.087 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 1.003 ' O ' HG23 ' A' ' 52' ' ' THR . 0.6 OUTLIER -132.08 156.08 46.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.35 -162.86 18.41 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -141.25 25.51 2.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -1.13 . . . . 0.0 110.059 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.624 ' H ' HG21 ' A' ' 52' ' ' THR . . . 120.66 -10.32 10.49 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.535 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -80.76 -170.57 42.9 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.8 Cg_endo -71.21 132.86 21.78 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.022 1.538 . . . . 0.0 110.443 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.7 -1.55 71.82 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 1.003 HG23 ' O ' ' A' ' 45' ' ' GLU . 22.7 m -80.04 140.35 36.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.17 . . . . 0.0 109.976 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.877 HD13 ' HA ' ' A' ' 70' ' ' LYS . 28.8 mm -110.4 117.87 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 110.382 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 89.5 mttt -104.53 119.33 38.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 0.0 110.159 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.756 ' CE ' HD13 ' A' ' 44' ' ' LEU . 46.9 mttm -88.6 97.69 11.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.388 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' HB ' HG23 ' A' ' 67' ' ' VAL . 93.8 mt -89.58 139.68 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.895 . . . . 0.0 110.018 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 6.6 p -115.51 157.34 24.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.937 . . . . 0.0 110.736 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 26.4 m-85 -117.86 125.28 50.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.423 -0.798 . . . . 0.0 110.15 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.54 ' CA ' ' HG3' ' A' ' 39' ' ' LYS . . . -106.91 11.29 41.23 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.64 -21.41 17.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -1.143 . . . . 0.0 110.211 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.27 166.72 26.68 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.9 p -71.02 -27.1 63.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -1.145 . . . . 0.0 110.238 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -63.26 161.73 13.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 110.161 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.44 120.06 23.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.584 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -137.51 92.17 0.21 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 15.9 p90 -132.73 169.44 16.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -1.158 . . . . 0.0 110.131 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.7 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.0 m -142.29 174.94 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.663 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.657 ' O ' HD12 ' A' ' 85' ' ' LEU . 94.1 mttt -132.39 106.49 7.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.731 . . . . 0.0 109.522 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.876 ' CD2' HD13 ' A' ' 85' ' ' LEU . 12.8 m170 -96.28 124.78 40.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 111.419 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.877 ' HA ' HD13 ' A' ' 53' ' ' ILE . 67.6 tttt -98.96 101.65 13.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.448 -0.782 . . . . 0.0 109.02 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.535 HG21 ' O ' ' A' ' 49' ' ' GLY . 22.7 mm -41.69 140.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 17.9 t0 -112.42 -45.58 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.986 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 16.8 m -169.88 157.21 6.62 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.431 -0.793 . . . . 0.0 110.146 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.411 HG12 HG11 ' A' ' 23' ' ' VAL . 1.7 mt -141.48 157.2 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.397 -0.814 . . . . 0.0 109.877 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 2.0 m-20 -144.53 83.64 1.72 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.821 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 82.3 tttt -66.24 -13.22 60.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.363 -0.836 . . . . 0.0 109.888 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -90.79 -30.72 16.84 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.805 0.812 . . . . 0.0 109.157 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.7 m120 -105.52 -4.49 21.19 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.516 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 90.0 m-85 63.57 53.69 2.03 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.297 0.57 . . . . 0.0 110.74 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 13.1 t -127.58 175.34 8.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.961 -1.087 . . . . 0.0 110.455 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.651 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 34.4 t80 -160.02 137.59 9.73 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.612 -0.68 . . . . 0.0 109.744 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 28.7 m -148.0 123.84 10.6 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.129 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.651 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 29.5 p90 -139.41 168.14 20.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.887 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 98' ' ' ILE . 25.4 m -122.19 140.9 52.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 110.228 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.876 HD13 ' CD2' ' A' ' 69' ' ' HIS . 10.7 tp -107.38 132.21 53.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 110.099 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 85' ' ' LEU . 11.5 pt -112.87 -31.67 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 110.353 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.668 ' O ' HD11 ' A' ' 85' ' ' LEU . 7.2 tt0 -116.52 141.63 47.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.898 . . . . 0.0 110.276 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.7 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 167.88 168.08 29.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.71 -28.87 45.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.281 -1.129 . . . . 0.0 110.227 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.73 ' HB1' ' HE1' ' A' ' 132' ' ' HIS . . . -60.99 -32.53 72.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.337 -0.852 . . . . 0.0 110.174 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.965 HD23 ' HG ' ' A' ' 95' ' ' LEU . 6.8 mt -64.64 -44.2 91.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 110.393 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 44.18 -142.53 2.72 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -106.34 27.57 8.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -1.131 . . . . 0.0 110.237 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 122' ' ' THR . 80.8 p -124.74 -45.18 1.92 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 110.126 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.965 ' HG ' HD23 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -102.41 160.57 14.44 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.448 -0.783 . . . . 0.0 109.272 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.863 ' H ' HD12 ' A' ' 95' ' ' LEU . 85.1 mt-10 -135.37 -78.63 0.44 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 110.823 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 57.4 mttt -80.22 134.93 36.16 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.452 -0.78 . . . . 0.0 110.973 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.733 ' O ' HG23 ' A' ' 84' ' ' THR . 4.5 mm -121.36 139.49 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.975 -1.078 . . . . 0.0 109.633 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.3 m -118.45 126.53 52.25 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.187 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.679 ' HE2' HG21 ' A' ' 98' ' ' ILE . 7.3 m-85 -118.84 136.74 53.86 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.529 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -137.17 145.89 44.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.022 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 45.3 m -145.43 152.6 40.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 110.019 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -141.67 140.83 33.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 110.372 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.653 HD23 HG12 ' A' ' 114' ' ' ILE . 8.8 mt -124.24 145.24 49.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.358 -0.839 . . . . 0.0 110.271 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.703 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.22 -169.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.227 -0.921 . . . . 0.0 109.941 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.703 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -118.72 170.33 9.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 110.012 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.2 p -127.54 161.78 52.83 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 110.021 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.58 -8.71 23.76 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.954 1.502 . . . . 0.0 110.387 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.9 p -93.77 -9.5 37.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 110.215 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.02 -36.25 4.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.87 -176.22 6.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 60.5 p -123.67 136.85 54.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -1.146 . . . . 0.0 110.351 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.599 HD12 ' O ' ' A' ' 106' ' ' ALA . 18.8 mt -86.49 150.03 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.838 . . . . 0.0 110.109 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.653 HG12 HD23 ' A' ' 104' ' ' LEU . 6.3 mt -135.42 115.36 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.364 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 103' ' ' LYS . 84.8 tttt -106.42 123.13 47.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 109.873 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 3.5 t -118.45 159.68 23.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -0.979 . . . . 0.0 110.598 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 5' ' ' TYR . 42.5 m -159.56 144.38 15.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.426 -0.796 . . . . 0.0 110.17 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.9 t -141.04 163.46 32.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.15 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.835 ' CE1' HG23 ' A' ' 4' ' ' THR . 82.0 m-70 -143.89 160.98 39.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.915 . . . . 0.0 110.484 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.804 ' O ' HG13 ' A' ' 2' ' ' VAL . 9.6 m-85 -124.85 140.88 52.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.316 -0.865 . . . . 0.0 110.224 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.504 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.8 m-70 -120.92 90.54 3.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 109.762 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.676 HG23 HD11 ' A' ' 128' ' ' ILE . 1.1 p -82.59 150.18 27.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.871 . . . . 0.0 110.364 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.432 ' HB3' ' CD ' ' A' ' 96' ' ' GLU . 78.4 tttt -123.03 129.1 51.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 110.202 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 -162.87 25.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.49 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 0.9 OUTLIER -87.62 54.13 3.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -1.181 . . . . 0.0 110.109 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.48 ' O ' ' HB ' ' A' ' 122' ' ' THR . 17.6 m -135.99 133.39 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.222 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.524 ' HA ' HG21 ' A' ' 122' ' ' THR . 17.9 pt-20 -127.7 165.54 19.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 0.0 110.092 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.676 HD11 HG23 ' A' ' 122' ' ' THR . 3.8 mp -82.8 173.0 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.889 . . . . 0.0 110.042 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.598 ' N ' HG22 ' A' ' 128' ' ' ILE . 75.0 mmtt -106.28 122.83 47.03 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.348 -0.845 . . . . 0.0 110.149 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 131' ' ' GLU . 24.1 pt-20 -43.45 -42.65 4.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 110.145 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.482 ' N ' ' CG ' ' A' ' 130' ' ' GLU . 16.5 pt-20 -58.16 -29.33 65.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.206 -0.934 . . . . 0.0 109.896 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.73 ' HE1' ' HB1' ' A' ' 90' ' ' ALA . 11.7 t-80 -74.36 -55.5 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.189 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.6 p -61.62 -39.39 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.387 -0.821 . . . . 0.0 110.009 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.515 ' N ' HG13 ' A' ' 133' ' ' VAL . 84.0 tttt -65.52 -45.83 81.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.84 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.39 87.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.89 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.08 -30.82 74.14 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 137' ' ' LYS . 59.0 mmtt -65.91 -34.75 78.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -1.106 . . . . 0.0 109.872 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -69.91 -35.62 74.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.859 . . . . 0.0 109.839 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -71.68 -29.95 65.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.738 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.31 -40.87 42.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.99 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.2 p -59.44 -45.3 91.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.752 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -56.44 -43.85 79.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.841 . . . . 0.0 109.779 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 39.4 tp -57.68 -47.31 82.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.767 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.474 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 29.3 m-85 -53.68 -44.57 69.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.648 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -75.78 -14.58 60.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.32 -0.862 . . . . 0.0 109.925 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.446 ' HB3' HG21 ' A' ' 33' ' ' ILE . 20.1 mt -83.2 -36.67 24.47 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.209 -0.932 . . . . 0.0 108.692 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.62 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 96.0 mt -67.16 -47.4 81.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.789 ' HB3' HD13 ' A' ' 13' ' ' ILE . 5.9 mm-40 -51.49 -47.09 63.33 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.388 -0.82 . . . . 0.0 109.218 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.6 m -63.15 -40.52 97.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.593 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.728 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 79.6 t80 -47.12 -51.84 16.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.97 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.14 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 80.3 mt -76.27 -37.97 56.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.789 . . . . 0.0 110.366 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.877 ' HB2' HD11 ' A' ' 13' ' ' ILE . 19.4 tptt -59.31 -16.9 24.8 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.166 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.493 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -117.61 -27.02 2.69 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 5.2 m80 -106.28 91.89 6.19 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.266 -1.137 . . . . 0.0 110.167 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.1 Cg_endo -73.13 3.3 4.69 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.986 1.519 . . . . 0.0 111.006 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -119.0 -2.26 10.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.022 -1.049 . . . . 0.0 110.299 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.728 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -67.22 99.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.23 -0.918 . . . . 0.0 110.397 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.18 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 11.5 p90 37.55 23.45 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.55 -0.719 . . . . 0.0 112.346 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.727 ' OD1' HD22 ' A' ' 151' ' ' LEU . 9.1 m-80 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 120.473 -1.392 . . . . 0.0 109.992 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 85.8 t -101.04 119.23 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -1.114 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.597 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 77.6 m-85 -83.68 161.57 21.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.23 -0.919 . . . . 0.0 110.139 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.823 HG23 ' CE1' ' A' ' 119' ' ' HIS . 55.4 m -143.61 99.92 3.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CE2' HG22 ' A' ' 133' ' ' VAL . 77.9 m-85 -116.37 126.5 53.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.179 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.596 ' CG ' ' N ' ' A' ' 7' ' ' SER . 3.6 tt0 -126.16 178.57 5.71 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.204 -0.935 . . . . 0.0 109.89 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.596 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -155.56 -179.08 7.76 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.76 -0.587 . . . . 0.0 109.751 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 7' ' ' SER . 73.1 mt-10 -156.09 117.02 3.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 110.378 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 2.5 p90 -137.58 -174.05 3.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.213 -0.93 . . . . 0.0 109.954 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.817 HG22 ' HA ' ' A' ' 113' ' ' ILE . 4.4 p -142.15 173.94 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.718 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.432 ' HB2' ' CD ' ' A' ' 148' ' ' GLU . 85.8 p -150.26 147.96 28.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.432 -0.793 . . . . 0.0 110.065 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -72.03 -24.81 61.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.917 . . . . 0.0 110.138 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.8 HG23 ' HD2' ' A' ' 14' ' ' PRO . 6.1 mm -79.18 151.17 75.32 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.828 . . . . 0.0 109.979 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.8 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -65.03 147.46 88.94 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.102 1.58 . . . . 0.0 110.394 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.673 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.6 Cg_endo -69.86 -32.46 18.11 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.006 1.529 . . . . 0.0 113.043 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.4 Cg_endo -67.66 -23.29 42.71 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 122.472 0.722 . . . . 0.0 110.233 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.875 ' HB3' HD13 ' A' ' 151' ' ' LEU . 6.0 mmp_? -82.26 -47.25 12.64 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.98 HD22 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.54 -29.62 69.06 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.429 -0.908 . . . . 0.0 108.905 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.9 t80 -63.44 -55.45 24.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.1 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.0 mttt -49.13 -50.76 35.85 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.984 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.156 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -56.77 -70.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.623 0.725 . . . . 0.0 111.089 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.067 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -43.68 -57.45 3.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.633 -0.667 . . . . 0.0 112.138 -178.626 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.625 ' HB ' HD12 ' A' ' 24' ' ' LEU . 7.1 t -90.27 -60.42 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.057 . . . . 0.0 112.386 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 24' ' ' LEU . 6.7 mp -73.35 0.59 11.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.054 -1.029 . . . . 0.0 112.114 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.892 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -153.52 27.77 0.5 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.59 -1.319 . . . . 0.0 111.233 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.067 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -64.24 -40.35 95.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.047 -1.033 . . . . 0.0 109.721 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.513 ' OD2' ' CG1' ' A' ' 43' ' ' ILE . 83.0 m-20 -64.91 -11.03 33.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.478 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.433 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 5.5 m-20 -125.13 3.17 7.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.537 -0.727 . . . . 0.0 109.662 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.909 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -94.9 -47.12 6.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 -179.572 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.954 ' CG2' HD13 ' A' ' 38' ' ' ILE . 9.4 p -75.38 -26.9 0.65 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.91 . . . . 0.0 112.373 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.779 ' HD3' HG12 ' A' ' 30' ' ' VAL . 50.5 Cg_endo -79.18 7.27 4.49 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 122.435 0.703 . . . . 0.0 110.593 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -135.77 -30.9 0.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.225 -0.922 . . . . 0.0 110.381 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.909 HD11 ' CD1' ' A' ' 29' ' ' LEU . 64.5 mt -75.07 -39.74 44.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.331 -0.856 . . . . 0.0 109.56 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.64 87.58 2.55 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.396 -0.815 . . . . 0.0 110.171 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.57 -1.32 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.115 1.587 . . . . 0.0 110.516 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -90.22 -19.46 24.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.944 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.35 -36.08 10.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.848 . . . . 0.0 110.317 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.954 HD13 ' CG2' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -125.38 139.68 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 110.021 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 27.1 ttmt -78.09 -41.45 35.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.456 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 178.71 164.77 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 110.131 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.411 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 1.7 m -121.53 122.27 39.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 110.028 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -126.54 107.18 10.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.188 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.513 ' CG1' ' OD2' ' A' ' 27' ' ' ASP . 14.6 mt -56.11 131.58 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 55' ' ' LYS . 58.7 mt -89.1 -23.72 22.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.124 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 1.06 ' O ' HG23 ' A' ' 52' ' ' THR . 41.1 tt0 -157.64 175.05 14.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 110.303 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 53.44 -160.33 3.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -137.66 16.71 2.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -1.103 . . . . 0.0 110.264 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.464 ' H ' HG21 ' A' ' 52' ' ' THR . . . 118.72 7.57 10.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -98.89 -166.63 30.5 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.1 Cg_endo -70.78 132.08 21.01 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.081 1.569 . . . . 0.0 110.551 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.8 -7.48 70.53 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 1.06 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.1 m -80.01 143.41 34.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -1.133 . . . . 0.0 110.097 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.619 HD13 ' HA ' ' A' ' 70' ' ' LYS . 32.9 mm -112.4 124.27 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.216 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.448 ' NZ ' HD11 ' A' ' 71' ' ' ILE . 66.9 mttt -107.58 147.58 30.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.332 -0.855 . . . . 0.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB2' HD11 ' A' ' 44' ' ' LEU . 75.0 tttt -120.85 90.21 3.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.482 ' CG2' HG12 ' A' ' 38' ' ' ILE . 94.5 mt -80.57 143.01 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.6 p -113.51 160.42 18.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.669 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.831 ' HE2' HG13 ' A' ' 67' ' ' VAL . 27.9 m-85 -118.78 137.93 53.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.466 -0.771 . . . . 0.0 110.202 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.37 96.59 0.82 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -126.71 169.47 13.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -1.188 . . . . 0.0 110.225 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.56 -65.56 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.438 ' C ' ' HG3' ' A' ' 63' ' ' GLN . 77.5 p -48.92 -49.63 39.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -1.148 . . . . 0.0 110.31 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.438 ' HG3' ' C ' ' A' ' 62' ' ' SER . 44.4 mt-30 -136.85 139.33 41.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.295 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -55.78 153.44 8.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.856 . . . . 0.0 110.247 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -136.05 137.12 8.88 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.5 p90 -179.32 164.05 1.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -1.082 . . . . 0.0 110.068 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.066 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.7 m -142.39 171.99 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.92 . . . . 0.0 110.663 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -125.43 123.86 40.2 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.601 ' CD2' ' HG ' ' A' ' 85' ' ' LEU . 13.3 m170 -116.52 138.26 51.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.023 -1.048 . . . . 0.0 111.327 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HA ' HD13 ' A' ' 53' ' ' ILE . 78.1 tttt -115.9 112.28 21.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.481 -0.762 . . . . 0.0 109.105 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.53 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 32.7 mm -49.0 136.63 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.96 . . . . 0.0 110.459 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 4.4 t0 -107.61 -50.11 3.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.396 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.482 ' HB2' ' OG ' ' A' ' 82' ' ' SER . 17.6 m -168.79 157.07 8.04 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.483 -0.76 . . . . 0.0 109.423 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.3 mt -134.94 157.94 41.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.078 -1.014 . . . . 0.0 110.616 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.563 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.9 m-20 -130.9 76.85 1.75 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.597 -0.69 . . . . 0.0 110.24 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.566 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 66.9 mttt -61.78 -12.75 18.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 109.918 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -96.4 -30.53 13.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 109.516 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.3 m120 -107.97 -1.44 20.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.661 -0.649 . . . . 0.0 109.744 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.837 ' O ' HD12 ' A' ' 104' ' ' LEU . 87.2 m-85 61.11 52.36 4.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.729 . . . . 0.0 109.89 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.563 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -123.49 156.65 35.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 109.575 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.53 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 20.1 t80 -141.87 133.92 27.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.913 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 73' ' ' SER . 70.4 p -139.1 119.49 13.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.852 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 3.2 p90 -130.89 179.12 6.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.986 HG23 ' O ' ' A' ' 98' ' ' ILE . 21.9 m -130.85 136.94 49.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.967 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.657 HD23 ' H ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -95.41 134.72 37.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.551 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.0 pt -114.83 -6.11 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.895 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.657 ' H ' HD23 ' A' ' 85' ' ' LEU . 87.3 tt0 -168.24 113.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.361 -0.837 . . . . 0.0 110.556 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 1.066 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -153.22 130.34 2.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -48.48 -26.7 2.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -1.162 . . . . 0.0 110.432 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.577 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -68.65 -17.32 64.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 110.456 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.802 HD21 HG13 ' A' ' 98' ' ' ILE . 60.3 mt -63.96 -13.0 42.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 110.245 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 94' ' ' THR . . . 65.62 26.76 72.09 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 50.64 21.05 0.82 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.229 -1.159 . . . . 0.0 110.2 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 92' ' ' GLY . 18.5 p -122.56 -33.07 3.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.084 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.792 HD11 HD11 ' A' ' 128' ' ' ILE . 2.3 mm? -80.04 170.27 16.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 110.283 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HG3' ' HB3' ' A' ' 123' ' ' LYS . 60.9 mm-40 -137.0 -79.4 0.39 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.48 -0.763 . . . . 0.0 109.611 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 58.6 mttt -80.32 127.46 32.4 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.204 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.986 ' O ' HG23 ' A' ' 84' ' ' THR . 18.4 mm -118.52 147.68 21.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.658 -1.276 . . . . 0.0 110.237 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -126.13 128.37 47.22 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.441 -0.787 . . . . 0.0 109.278 178.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.741 ' CE2' HG21 ' A' ' 98' ' ' ILE . 13.8 m-85 -126.7 131.9 51.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 110.017 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -135.96 136.23 40.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.925 . . . . 0.0 110.575 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.5 m -132.5 143.95 50.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.414 -0.804 . . . . 0.0 109.724 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 115' ' ' LYS . 5.0 mttt -136.18 143.77 44.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 0.0 110.482 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 79' ' ' TYR . 5.5 mt -118.8 151.06 38.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.244 -0.91 . . . . 0.0 110.49 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.73 -168.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 109.814 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.716 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.51 157.96 28.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 110.189 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 33.2 p -118.22 165.44 16.35 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.897 . . . . 0.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -72.88 -1.35 10.31 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.02 1.537 . . . . 0.0 110.495 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.0 m -105.56 -0.65 25.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.902 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.21 -36.11 4.59 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.93 -171.46 0.75 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.504 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 6.1 p -131.3 134.38 46.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -1.096 . . . . 0.0 110.228 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.817 ' HA ' HG22 ' A' ' 10' ' ' THR . 12.2 mt -84.33 148.07 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.81 HG12 HD23 ' A' ' 104' ' ' LEU . 9.1 mt -130.71 113.71 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.295 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 7.0 ttmt -87.4 138.58 31.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.162 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 1.1 p -124.43 132.04 53.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 110.257 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.507 HG23 ' HB2' ' A' ' 6' ' ' GLU . 62.0 m -148.22 123.25 10.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 110.533 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.7 m -130.91 164.9 24.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 109.886 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.823 ' CE1' HG23 ' A' ' 4' ' ' THR . 30.8 m-70 -142.12 170.62 15.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.115 -0.991 . . . . 0.0 110.096 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.536 ' HB3' ' CD1' ' A' ' 95' ' ' LEU . 26.2 m-85 -136.24 147.32 47.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.496 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 83.6 m-70 -128.35 88.75 2.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.399 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.586 HG22 HD22 ' A' ' 95' ' ' LEU . 4.2 p -68.9 161.26 29.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.849 . . . . 0.0 110.711 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.475 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 33.0 ttmt -152.48 94.72 1.94 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 110.314 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 133.5 35.94 0.27 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 3.3 t30 63.61 56.59 1.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.171 -1.193 . . . . 0.0 110.252 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.541 HG23 ' CG2' ' A' ' 122' ' ' THR . 8.4 m -142.86 145.82 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 110.005 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.75 179.04 5.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.358 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.792 HD11 HD11 ' A' ' 95' ' ' LEU . 16.2 mm -84.67 173.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.21 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.593 ' N ' HG22 ' A' ' 128' ' ' ILE . 18.8 mtpt -117.63 136.82 53.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.009 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -43.61 -41.09 4.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.166 -0.958 . . . . 0.0 110.245 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 51.4 tt0 -64.38 -26.13 68.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.091 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 13.8 t-160 -77.91 -48.46 16.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.649 HG22 ' CE2' ' A' ' 5' ' ' TYR . 69.1 t -56.26 -32.08 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 109.867 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -90.8 -51.37 5.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -57.9 -32.76 68.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.84 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.08 -33.81 62.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 141' ' ' SER . 52.5 mmtt -78.55 -32.89 48.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -1.122 . . . . 0.0 109.982 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -73.43 -34.97 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.887 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -70.7 -43.45 68.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.798 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -72.49 -31.12 65.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 109.947 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 22.7 t -64.76 -54.0 38.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.395 -0.815 . . . . 0.0 109.928 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -51.78 -49.78 62.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.705 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 24.0 mt -52.91 -41.66 64.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 110.059 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 16.7 m-85 -59.87 -50.88 72.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.689 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 75.7 tttt -63.44 -13.67 42.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.915 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.541 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 13.1 mt -85.2 -37.77 19.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.213 -0.93 . . . . 0.0 108.813 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.749 ' CG2' HD23 ' A' ' 18' ' ' LEU . 33.8 mt -69.56 -45.3 78.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 13' ' ' ILE . 67.8 mm-40 -51.56 -38.15 52.97 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.286 -0.884 . . . . 0.0 108.785 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 88.3 m -72.36 -38.1 68.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.303 -0.873 . . . . 0.0 109.01 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.818 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 66.2 t80 -44.19 -54.84 5.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.465 -0.772 . . . . 0.0 109.604 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.121 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 78.5 mt -75.41 -29.07 59.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.467 -0.771 . . . . 0.0 110.267 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 149' ' ' THR . 39.3 tttp -69.48 -13.27 62.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.715 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -123.63 -26.46 1.59 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -110.77 89.64 9.58 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 0.0 110.378 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.31 0.33 8.13 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.037 1.546 . . . . 0.0 110.559 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -111.92 12.72 20.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.882 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.818 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -86.57 101.25 13.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.416 -0.802 . . . . 0.0 110.282 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.156 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 8.9 p90 38.52 21.8 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.689 -0.632 . . . . 0.0 112.354 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.551 ' OD1' HD22 ' A' ' 151' ' ' LEU . 33.4 m-20 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 120.415 -1.428 . . . . 0.0 110.12 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.956 HG13 ' O ' ' A' ' 120' ' ' TYR . 86.3 t -108.77 139.82 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -1.172 . . . . 0.0 110.223 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.644 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 16.3 m-85 -103.01 129.8 49.89 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.238 -0.914 . . . . 0.0 109.826 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.823 HG23 ' CE1' ' A' ' 119' ' ' HIS . 19.3 m -104.68 107.83 18.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.859 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.57 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 33.9 m-85 -116.27 124.92 51.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.552 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 116' ' ' SER . 23.1 pt-20 -122.63 164.17 18.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.15 -0.969 . . . . 0.0 111.035 -179.083 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.512 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.2 p -125.32 167.63 14.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.568 -0.707 . . . . 0.0 110.272 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 7' ' ' SER . 18.2 mt-10 -160.19 120.15 2.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.924 ' HB2' HD13 ' A' ' 114' ' ' ILE . 76.5 m-85 -141.18 -166.01 2.08 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.789 -1.194 . . . . 0.0 111.552 -178.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 9' ' ' PHE . 25.5 p -158.32 155.29 28.52 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.758 0.789 . . . . 0.0 110.368 178.31 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.527 ' O ' ' CA ' ' A' ' 111' ' ' GLY . 83.6 p -159.29 146.23 16.93 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.791 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -70.55 -32.93 70.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 110.046 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.777 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.0 mm -58.99 149.96 63.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.863 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.777 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.8 Cg_endo -65.47 144.27 78.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.0 1.526 . . . . 0.0 110.585 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.661 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 Cg_endo -72.05 -31.61 12.05 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 124.023 1.538 . . . . 0.0 112.802 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -70.19 -21.51 31.37 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 N-CA-C 110.042 -0.791 . . . . 0.0 110.042 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.964 ' HG2' HD13 ' A' ' 151' ' ' LEU . 10.3 ttm180 -83.2 -47.16 11.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.759 ' C ' HD23 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -68.01 -27.62 66.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.933 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.51 ' N ' HD23 ' A' ' 18' ' ' LEU . 52.0 t80 -68.24 -55.75 11.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.474 -0.766 . . . . 0.0 109.378 179.079 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 89.6 mttt -50.27 -37.83 37.95 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.244 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.029 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -70.89 -57.82 4.22 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.687 0.756 . . . . 0.0 110.943 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.961 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -54.46 -54.33 42.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.556 -0.715 . . . . 0.0 111.843 -178.669 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.704 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.0 t -92.82 -62.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.078 -1.014 . . . . 0.0 111.964 -178.425 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 24' ' ' LEU . 6.7 mp -69.09 0.23 4.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.197 -0.939 . . . . 0.0 111.974 -178.291 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.819 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -150.18 24.33 0.82 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.736 -1.228 . . . . 0.0 111.014 -179.99 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.961 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -63.24 -37.98 89.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.011 -1.056 . . . . 0.0 110.135 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 33.9 m-20 -63.49 -13.96 46.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.109 -0.994 . . . . 0.0 110.099 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.512 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 84.2 m-20 -128.3 10.46 6.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.826 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.819 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -96.41 -53.73 3.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 110.51 -179.871 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.86 HG22 ' HD3' ' A' ' 31' ' ' PRO . 1.9 m -74.69 -29.31 0.91 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 111.97 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.86 ' HD3' HG22 ' A' ' 30' ' ' VAL . 49.5 Cg_endo -79.18 4.58 6.44 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 122.851 0.921 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -125.17 -35.29 2.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 109.109 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.773 HG21 ' HB3' ' A' ' 146' ' ' LEU . 40.5 mt -79.96 -24.32 11.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.549 0.69 . . . . 0.0 109.235 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.92 95.43 0.4 Allowed Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.618 -0.676 . . . . 0.0 109.78 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.68 0.22 7.94 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.041 1.548 . . . . 0.0 110.655 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -89.52 5.95 43.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.238 -0.914 . . . . 0.0 109.872 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.667 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -113.89 -55.35 2.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 110.013 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.667 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.9 mp -115.11 132.14 65.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 110.029 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.448 ' HE2' ' HG3' ' A' ' 60' ' ' GLU . 35.8 ttmt -79.99 -35.07 37.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.286 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.455 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -177.26 151.98 0.83 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.0 109.96 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.8 m -115.53 130.83 57.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.24 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 85.6 tt0 -137.79 110.59 7.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 0.0 110.207 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.1 mt -62.25 135.51 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.302 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 tp -87.9 -25.61 23.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.988 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 1.029 ' O ' HG23 ' A' ' 52' ' ' THR . 28.8 tp10 -161.45 170.28 20.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 59.32 -169.69 6.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.7 23.39 6.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -1.155 . . . . 0.0 110.252 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.493 ' H ' HG21 ' A' ' 52' ' ' THR . . . 111.07 1.45 28.38 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.496 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -86.0 -169.46 45.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.3 Cg_endo -70.96 131.85 20.3 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.015 1.534 . . . . 0.0 110.468 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.21 -6.59 68.88 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' THR . . . . . 1.029 HG23 ' O ' ' A' ' 45' ' ' GLU . 14.8 m -80.04 142.3 35.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -1.104 . . . . 0.0 109.961 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.607 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.3 mm -110.68 122.11 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 110.155 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 84.7 mttt -105.88 144.63 32.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 110.23 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -117.86 87.61 2.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 110.218 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.409 ' HB ' HG23 ' A' ' 67' ' ' VAL . 90.6 mt -80.01 144.39 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 110.331 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.509 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.7 p -111.48 164.2 13.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.766 ' HE2' HG13 ' A' ' 67' ' ' VAL . 25.9 m-85 -115.32 155.36 27.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 110.434 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' PHE . . . -43.49 165.17 0.03 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' HG3' ' HE2' ' A' ' 39' ' ' LYS . 60.7 mt-10 -70.53 164.1 25.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -1.108 . . . . 0.0 110.195 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.2 -157.44 18.94 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.43 ' C ' ' HG3' ' A' ' 63' ' ' GLN . 89.5 p -57.41 -32.88 67.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -1.124 . . . . 0.0 110.29 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.43 ' HG3' ' C ' ' A' ' 62' ' ' SER . 44.2 mt-30 -145.58 147.65 32.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.923 . . . . 0.0 110.283 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.434 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 8.6 t80 -42.93 143.21 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.232 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -128.81 135.3 8.43 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.4 p90 -178.73 162.84 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -1.167 . . . . 0.0 110.211 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.937 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.5 m -141.9 172.79 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -0.819 . . . . 0.0 110.512 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 88.5 mttt -124.49 129.41 50.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.575 -0.703 . . . . 0.0 109.449 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.642 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -118.14 123.98 46.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.15 -0.969 . . . . 0.0 111.034 -179.151 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.607 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.0 tttt -100.32 113.64 26.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 25.8 mm -54.52 135.36 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.901 . . . . 0.0 110.468 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 1.6 t70 -110.16 -42.99 4.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 109.601 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 82' ' ' SER . 25.5 m -169.75 157.49 6.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 109.896 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mt -141.59 156.15 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 110.456 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.0 m-20 -136.18 79.04 1.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.576 -0.702 . . . . 0.0 109.991 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 78.4 mttt -62.62 -16.89 58.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.385 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -93.05 -30.72 15.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 109.529 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -103.87 -6.12 21.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.545 -0.722 . . . . 0.0 109.694 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.2 m-85 65.36 52.13 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 109.988 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.536 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -124.91 154.97 40.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.839 . . . . 0.0 109.782 179.706 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.704 ' CE1' HG13 ' A' ' 23' ' ' VAL . 22.3 t80 -142.5 128.81 19.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.352 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 37.6 m -131.89 121.24 23.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.471 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 21.9 p90 -138.64 170.97 15.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.359 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 98' ' ' ILE . 98.9 m -123.46 132.6 53.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 109.893 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.747 HD21 HD11 ' A' ' 91' ' ' LEU . 3.1 tp -98.87 136.45 38.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.081 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.0 pt -119.46 -16.99 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.532 ' O ' HD11 ' A' ' 85' ' ' LEU . 23.9 tt0 -133.09 150.08 52.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.143 -0.973 . . . . 0.0 110.488 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.937 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 165.46 142.31 3.38 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -65.73 -35.35 80.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -1.156 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.735 ' HB1' ' HE2' ' A' ' 132' ' ' HIS . . . -65.13 -26.17 68.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 110.13 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.786 HD12 ' N ' ' A' ' 88' ' ' GLY . 35.3 mt -65.48 -25.38 67.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.181 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.84 -167.63 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -87.28 8.04 25.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -1.184 . . . . 0.0 110.149 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.695 ' O ' HG21 ' A' ' 126' ' ' VAL . 60.6 p -93.88 -40.33 10.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.151 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.001 HD23 HG23 ' A' ' 122' ' ' THR . 22.5 mt -102.11 155.04 18.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.027 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -134.65 -78.84 0.45 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.219 -0.925 . . . . 0.0 110.284 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 50.8 mttt -80.13 132.93 36.02 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.407 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.765 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.5 mm -124.77 136.93 59.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.734 -1.228 . . . . 0.0 110.06 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -116.3 127.1 54.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.74 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.765 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.4 m-85 -122.65 135.59 54.64 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 111.148 -178.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 117' ' ' THR . 4.2 mt-10 -133.0 133.26 42.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.567 -0.708 . . . . 0.0 109.658 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 81' ' ' TYR . 36.1 m -132.07 134.09 45.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.0 -1.062 . . . . 0.0 110.124 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.5 tttt -133.93 147.68 51.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 110.252 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 79' ' ' TYR . 22.7 mt -117.89 142.22 47.57 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.399 -0.813 . . . . 0.0 110.148 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.6 t -131.42 -172.64 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 0.0 110.371 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.637 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -118.13 148.53 42.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 110.454 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.438 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 52.9 p -106.92 163.78 16.23 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 110.366 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 44.4 Cg_endo -72.26 -2.13 11.19 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.017 1.535 . . . . 0.0 110.403 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.1 m -103.59 -7.17 20.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.072 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.79 -16.03 31.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 11' ' ' SER . . . -79.08 -171.66 41.03 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' SER . 42.1 p -128.81 122.31 30.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 110.221 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 10' ' ' THR . 7.0 mt -79.98 139.64 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.464 -0.772 . . . . 0.0 110.79 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.924 HD13 ' HB2' ' A' ' 9' ' ' PHE . 3.7 mp -93.02 151.88 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.049 179.076 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 103' ' ' LYS . 16.9 tttt -149.87 99.71 2.87 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 109.365 178.436 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 20.9 t -116.13 174.8 5.85 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.357 -0.839 . . . . 0.0 111.257 -178.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.572 HG22 ' CE1' ' A' ' 119' ' ' HIS . 31.4 m -160.07 128.97 4.98 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 5' ' ' TYR . 38.9 t -122.9 156.68 34.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.042 -1.036 . . . . 0.0 110.421 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.823 ' CE1' HG23 ' A' ' 4' ' ' THR . 76.7 m-70 -140.48 123.65 16.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.35 -0.844 . . . . 0.0 110.371 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.956 ' O ' HG13 ' A' ' 2' ' ' VAL . 8.8 m-30 -93.87 149.79 20.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -0.871 . . . . 0.0 110.416 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 91.9 m-70 -127.65 84.82 2.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 109.743 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' THR . . . . . 1.001 HG23 HD23 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -67.39 152.64 45.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.406 -0.809 . . . . 0.0 110.618 -179.545 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -115.31 113.58 24.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 110.132 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.0 -145.74 16.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 2.1 p-10 -104.53 54.67 0.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.208 -1.172 . . . . 0.0 110.237 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.695 HG21 ' O ' ' A' ' 94' ' ' THR . 10.8 m -116.88 156.33 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 9.8 pm0 -143.7 157.1 44.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.051 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.688 ' CG1' HD21 ' A' ' 95' ' ' LEU . 2.9 mp -78.27 173.29 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.126 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.602 ' N ' HG22 ' A' ' 128' ' ' ILE . 23.0 mttt -110.88 151.34 27.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.951 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.44 -31.88 64.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -0.975 . . . . 0.0 110.205 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -65.33 -40.87 94.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 109.982 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.735 ' HE2' ' HB1' ' A' ' 90' ' ' ALA . 17.2 t-160 -66.81 -45.5 78.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 110.043 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.57 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 61.2 t -62.89 -41.11 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -76.42 -42.01 45.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.65 96.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.959 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.51 -30.1 76.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.433 ' HE3' HG12 ' A' ' 133' ' ' VAL . 88.5 mttt -75.31 -32.81 61.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -1.137 . . . . 0.0 110.042 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -76.3 -34.32 59.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -0.863 . . . . 0.0 109.903 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.97 -34.77 64.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 179.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.5 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.51 -30.55 61.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.928 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.4 p -68.72 -50.99 46.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.904 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.421 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 82.5 m-20 -51.36 -44.48 62.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 18.7 tp -57.15 -50.05 74.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.867 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 25.9 m-85 -53.84 -39.57 65.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.431 -0.793 . . . . 0.0 109.765 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.447 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 32.3 mttp -78.51 -13.61 59.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.933 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.773 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.2 mt -84.81 -36.66 21.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.23 -0.919 . . . . 0.0 108.889 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.648 HD11 ' CE1' ' A' ' 22' ' ' PHE . 36.7 mt -70.47 -43.93 77.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 13' ' ' ILE . 52.3 mt-10 -59.27 -37.68 78.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.426 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 98.7 m -77.2 -38.9 50.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 179.471 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.656 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.7 t80 -52.6 -49.15 65.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.903 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.181 HD21 ' CE2' ' A' ' 158' ' ' TYR . 82.3 mt -79.03 -33.45 44.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 109.99 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.538 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 38.9 tttt -70.61 -16.97 62.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.347 179.237 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.77 -32.59 2.23 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 6.2 m80 -109.41 94.8 16.81 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.389 -1.066 . . . . 0.0 109.978 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.34 6.75 2.92 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.061 1.559 . . . . 0.0 111.048 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -110.48 2.78 19.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.062 -1.024 . . . . 0.0 109.86 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.656 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -83.23 103.61 12.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.181 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.57 32.44 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.747 -0.596 . . . . 0.0 110.532 -179.667 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.709 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.903 HG13 ' O ' ' A' ' 120' ' ' TYR . 73.2 t -130.33 122.01 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -1.226 . . . . 0.0 110.212 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.609 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 89.5 m-85 -73.69 147.42 43.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 110.138 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.834 HG23 ' CE1' ' A' ' 119' ' ' HIS . 52.9 m -129.32 119.57 24.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.242 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.171 ' CE2' HG21 ' A' ' 133' ' ' VAL . 61.6 m-85 -130.97 151.76 51.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.121 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -145.18 150.45 36.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 110.282 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.48 ' OG ' ' HB3' ' A' ' 116' ' ' SER . 78.0 p -132.37 148.51 52.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.838 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -136.67 117.17 13.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.102 -0.999 . . . . 0.0 110.625 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 p90 -141.18 -177.17 4.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.39 -0.819 . . . . 0.0 109.733 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.5 HG22 HG12 ' A' ' 113' ' ' ILE . 27.2 p -136.75 -179.25 5.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 110.838 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 148' ' ' GLU . 11.8 t -159.92 170.38 21.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 110.17 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -93.82 -21.76 19.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.819 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.6 mp -80.98 150.4 68.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.819 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.1 Cg_endo -66.51 145.49 76.78 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.991 1.522 . . . . 0.0 110.783 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.66 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 Cg_endo -72.14 -31.5 11.96 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 124.126 1.593 . . . . 0.0 112.993 -179.184 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.7 Cg_endo -69.3 -20.65 36.74 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 N-CA-C 109.724 -0.914 . . . . 0.0 109.724 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 1.033 ' HB3' HD13 ' A' ' 151' ' ' LEU . 1.3 mmp_? -82.74 -47.81 11.55 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.766 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.2 tt -67.94 -25.32 65.4 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.63 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 70.9 t80 -66.84 -61.2 2.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.512 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.616 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 34.3 mttp -49.0 -37.9 21.74 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.129 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -62.4 -66.32 0.56 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.803 0.811 . . . . 0.0 110.897 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.041 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -54.59 -47.48 73.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.842 -0.537 . . . . 0.0 111.959 -178.199 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.102 HG11 ' CD1' ' A' ' 74' ' ' ILE . 3.0 t -96.14 -64.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.87 -1.144 . . . . 0.0 112.154 -178.466 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.668 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.9 mm? -68.69 -3.63 12.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.051 -1.031 . . . . 0.0 111.644 -178.285 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.598 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -139.62 4.0 2.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.772 -1.205 . . . . 0.0 111.019 -179.706 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.041 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -42.57 -26.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.138 -0.976 . . . . 0.0 110.183 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 56.4 m-20 -74.7 -40.78 61.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.931 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -106.48 24.24 12.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.891 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.887 HD12 ' C ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -106.11 -62.16 1.42 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 -179.867 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.027 HG11 HD13 ' A' ' 38' ' ' ILE . 44.7 t -61.92 -40.88 72.94 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.493 -0.754 . . . . 0.0 111.203 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -78.37 9.28 3.2 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.353 1.186 . . . . 0.0 110.827 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HD2' ' OH ' ' A' ' 150' ' ' TYR . 17.7 mttt -121.87 -28.31 4.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.997 -1.064 . . . . 0.0 109.457 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.783 HG21 ' HB3' ' A' ' 146' ' ' LEU . 29.0 mt -79.99 -56.86 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.516 -0.74 . . . . 0.0 109.767 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.62 106.14 2.9 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.476 -0.765 . . . . 0.0 110.085 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.21 1.22 6.91 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.661 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -86.54 -9.47 56.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.952 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.09 -36.27 9.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 110.187 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.027 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mt -136.49 149.74 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.332 -0.855 . . . . 0.0 110.009 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.542 ' CG ' ' HA2' ' A' ' 59' ' ' GLY . 10.5 mttt -78.9 -50.26 11.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 110.003 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -173.01 160.11 4.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.452 -0.78 . . . . 0.0 109.977 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.7 m -119.02 126.63 52.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.143 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -135.64 103.09 5.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 110.379 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 18.9 mt -50.42 131.32 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.3 tp -91.31 -46.55 7.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.253 -0.904 . . . . 0.0 110.218 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.855 ' O ' HG23 ' A' ' 52' ' ' THR . 3.9 mm-40 -132.63 136.97 46.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.246 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.82 -168.41 34.33 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -131.29 12.58 5.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -1.16 . . . . 0.0 110.255 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.507 ' H ' HG21 ' A' ' 52' ' ' THR . . . 122.47 -6.22 9.92 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -84.15 -168.31 43.76 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.2 Cg_endo -70.71 135.91 29.27 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.024 1.539 . . . . 0.0 110.501 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.75 -5.49 79.6 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.8 m -80.1 143.18 34.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -1.115 . . . . 0.0 110.042 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.777 HG21 ' HE3' ' A' ' 68' ' ' LYS . 29.2 mm -110.08 125.46 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.278 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 40.2 mtmt -108.29 139.7 42.62 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.365 -0.835 . . . . 0.0 110.083 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -112.9 89.94 3.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 110.129 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.46 ' CG2' HG12 ' A' ' 38' ' ' ILE . 88.8 mt -83.18 139.04 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.215 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 38' ' ' ILE . 6.7 p -110.27 160.81 16.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.494 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.751 ' HE2' HG13 ' A' ' 67' ' ' VAL . 27.3 m-85 -120.64 124.37 45.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -0.812 . . . . 0.0 110.377 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' HA2' ' CG ' ' A' ' 39' ' ' LYS . . . -66.6 -24.91 72.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -120.85 146.06 46.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -1.154 . . . . 0.0 110.177 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.35 92.13 0.48 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.3 t 48.7 -162.4 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -1.095 . . . . 0.0 110.245 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -53.97 -52.36 60.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.857 . . . . 0.0 110.289 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.443 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 9.2 t80 -135.46 141.83 45.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 110.28 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -127.82 136.7 9.36 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.9 p90 -179.66 161.19 0.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -1.088 . . . . 0.0 109.989 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.768 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.6 m -143.27 172.38 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.633 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.777 ' HE3' HG21 ' A' ' 53' ' ' ILE . 75.4 tttt -123.65 118.23 26.8 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -110.54 133.58 53.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.989 -1.069 . . . . 0.0 111.379 -178.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.542 ' HA ' HD13 ' A' ' 53' ' ' ILE . 77.1 tttt -111.12 119.23 38.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.563 -0.711 . . . . 0.0 109.218 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.531 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 42.2 mm -53.15 143.83 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 110.51 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.3 m-20 -117.49 -31.83 5.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.375 -0.828 . . . . 0.0 109.703 179.52 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 2.2 p 168.28 157.43 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 110.15 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.102 ' CD1' HG11 ' A' ' 23' ' ' VAL . 4.1 tt -153.59 165.62 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.3 -0.875 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -140.64 83.97 1.92 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.251 -0.906 . . . . 0.0 109.977 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.563 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 85.6 tttt -58.62 -12.53 4.21 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.29 -0.881 . . . . 0.0 110.776 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 17.5 mm-40 -85.46 -34.41 21.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.191 -0.943 . . . . 0.0 108.918 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.3 m120 -109.4 -1.97 18.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.63 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 9.7 m-85 65.95 49.81 1.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.343 0.592 . . . . 0.0 110.449 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.544 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -115.32 157.89 23.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.108 -0.995 . . . . 0.0 109.129 179.19 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.593 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 80.8 t80 -160.02 150.18 18.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.016 -1.052 . . . . 0.0 110.116 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.418 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 9.7 t -160.98 150.52 17.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.94 . . . . 0.0 110.585 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.9 p90 -151.69 -171.13 3.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.51 -0.744 . . . . 0.0 109.871 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.921 HG23 ' O ' ' A' ' 98' ' ' ILE . 54.0 m -132.64 135.91 46.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.364 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.697 HD12 ' HE2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -94.18 116.09 28.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.231 -0.918 . . . . 0.0 110.096 179.765 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.731 HD11 ' HD3' ' A' ' 68' ' ' LYS . 16.7 pt -107.82 -10.54 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.199 -0.938 . . . . 0.0 110.112 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -138.81 126.52 22.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.84 . . . . 0.0 110.044 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.768 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -179.86 145.36 6.44 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 44.3 p-10 -65.16 -9.86 26.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -1.143 . . . . 0.0 110.243 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.869 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -78.09 -36.15 48.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 110.19 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.967 HD23 ' HG ' ' A' ' 95' ' ' LEU . 4.1 mt -58.18 -40.66 82.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.396 -0.815 . . . . 0.0 110.337 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 43.44 -132.33 5.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.664 ' OD1' HG23 ' A' ' 94' ' ' THR . 59.1 p30 -114.12 12.6 17.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -1.188 . . . . 0.0 110.235 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.664 HG23 ' OD1' ' A' ' 93' ' ' ASP . 40.1 p -109.82 -33.15 6.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.967 ' HG ' HD23 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -116.53 159.98 21.3 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.27 -0.894 . . . . 0.0 109.222 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.797 ' O ' HD22 ' A' ' 91' ' ' LEU . 42.0 tt0 -138.53 -78.2 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.979 . . . . 0.0 110.807 -179.307 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 10.8 mttm -80.13 132.76 35.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.476 -0.765 . . . . 0.0 110.7 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.921 ' O ' HG23 ' A' ' 84' ' ' THR . 15.8 mm -118.56 148.63 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.885 -1.134 . . . . 0.0 110.212 179.272 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.538 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -125.14 125.23 43.38 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.057 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.828 ' CE2' HG21 ' A' ' 98' ' ' ILE . 13.5 m-85 -121.45 134.91 55.09 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.348 -0.845 . . . . 0.0 110.476 -178.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 58.6 tt0 -133.3 160.66 36.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 81' ' ' TYR . 35.9 m -160.92 121.09 2.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 0.4 OUTLIER -120.01 146.98 45.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.333 -179.889 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.555 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 14.7 mt -125.31 151.23 46.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -0.848 . . . . 0.0 110.266 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.708 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.35 -169.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.203 -0.936 . . . . 0.0 110.005 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.708 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -127.02 135.48 50.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 110.16 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.431 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 49.5 p -90.72 163.22 31.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.301 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -73.06 -2.87 12.68 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.14 1.6 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.4 p -96.87 -5.02 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 110.3 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.42 -40.46 2.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.26 -172.48 2.02 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -127.99 138.8 52.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -1.174 . . . . 0.0 110.336 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.5 HG12 HG22 ' A' ' 10' ' ' THR . 26.6 mt -89.88 147.36 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.589 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 7.0 mt -130.95 112.96 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 110.318 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -104.1 122.34 45.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.961 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.48 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 7.4 t -116.49 163.5 15.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.536 HG22 ' NE2' ' A' ' 119' ' ' HIS . 59.6 m -160.01 138.2 10.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 110.228 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.4 m -135.18 148.97 49.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.957 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.834 ' CE1' HG23 ' A' ' 4' ' ' THR . 73.8 m-70 -132.59 168.57 18.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.177 -0.952 . . . . 0.0 110.751 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.903 ' O ' HG13 ' A' ' 2' ' ' VAL . 35.9 m-85 -131.69 145.6 51.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.508 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.496 ' HA ' HG22 ' A' ' 2' ' ' VAL . 92.4 m-70 -126.34 95.01 4.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.129 -0.982 . . . . 0.0 109.956 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.719 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -58.5 154.81 13.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.207 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.526 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 57.9 tttt -118.23 111.19 18.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.293 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.62 -115.64 5.0 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -129.84 71.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 110.145 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.573 ' O ' HG21 ' A' ' 122' ' ' THR . 16.9 m -142.72 -179.46 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.719 ' HA ' HG21 ' A' ' 122' ' ' THR . 92.8 mt-10 -154.54 149.33 26.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.194 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.633 HD12 ' H ' ' A' ' 128' ' ' ILE . 4.9 mp -77.91 173.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.943 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.595 ' N ' HG22 ' A' ' 128' ' ' ILE . 33.1 mttt -107.03 129.05 54.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.878 . . . . 0.0 110.251 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.473 ' HB3' ' HE2' ' A' ' 134' ' ' LYS . 97.9 mt-10 -45.69 -44.89 13.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -58.52 -30.98 67.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 109.842 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.869 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 13.4 t-160 -73.7 -53.17 11.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.926 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.171 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.6 p -64.52 -40.14 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.442 -0.787 . . . . 0.0 109.959 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.524 ' N ' HG13 ' A' ' 133' ' ' VAL . 42.7 mtmt -63.61 -43.94 95.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.849 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.02 74.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 109.876 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.43 -30.52 66.74 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.465 ' HD2' ' HB3' ' A' ' 5' ' ' TYR . 3.9 mtpt -74.06 -32.41 63.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -1.099 . . . . 0.0 109.893 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -72.24 -29.78 64.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.38 -0.825 . . . . 0.0 109.884 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.48 -35.86 73.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -0.834 . . . . 0.0 109.883 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.05 -41.18 71.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.968 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.9 t -59.43 -49.86 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.367 -0.833 . . . . 0.0 109.92 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -55.06 -42.94 73.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.954 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.472 ' O ' HG13 ' A' ' 147' ' ' ILE . 59.3 mt -60.04 -39.03 84.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 0.0 109.924 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -62.39 -36.11 81.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 110.165 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 89.1 mttt -79.15 -8.88 59.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 110.078 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.783 ' HB3' HG21 ' A' ' 33' ' ' ILE . 13.2 mt -89.49 -37.37 14.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.257 -0.902 . . . . 0.0 108.747 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.746 HD11 ' CE1' ' A' ' 22' ' ' PHE . 32.6 mt -70.68 -44.63 76.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.715 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.537 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 23.5 pt-20 -52.1 -39.73 60.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.809 178.793 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.535 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 19.8 m -76.25 -33.69 59.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 109.065 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.85 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 73.8 t80 -47.72 -57.93 4.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.585 -0.697 . . . . 0.0 109.901 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.057 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 62.8 mt -67.56 -45.74 74.74 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.437 -0.79 . . . . 0.0 110.709 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.619 ' HB2' HD11 ' A' ' 13' ' ' ILE . 81.9 tttt -58.81 -16.1 15.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 109.602 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -115.21 -24.28 4.23 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 150' ' ' TYR . 2.6 m80 -119.56 92.84 46.7 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.248 -1.148 . . . . 0.0 110.313 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.61 0.54 7.42 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.049 1.552 . . . . 0.0 110.764 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -115.19 15.25 17.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.147 -0.97 . . . . 0.0 110.045 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.85 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -88.38 103.51 15.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.408 -0.807 . . . . 0.0 110.4 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.129 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 6.4 p90 38.99 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.574 -0.704 . . . . 0.0 112.32 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 28.8 m-20 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 120.457 -1.402 . . . . 0.0 110.132 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 74.9 t -104.02 135.91 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 110.241 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.662 ' CE1' HD12 ' A' ' 128' ' ' ILE . 12.6 m-85 -93.62 150.5 20.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 109.989 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.787 HG23 ' CE1' ' A' ' 119' ' ' HIS . 8.4 m -129.08 113.11 14.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.562 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.981 ' CE2' HG21 ' A' ' 133' ' ' VAL . 67.6 m-85 -127.44 136.73 52.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.87 . . . . 0.0 109.76 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 16.3 pt-20 -138.31 153.78 49.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 0.0 110.707 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.2 m -132.81 144.48 50.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.408 -0.808 . . . . 0.0 109.645 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.421 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 98.9 mt-10 -130.35 127.3 39.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.059 -1.026 . . . . 0.0 110.627 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.631 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.3 p90 -155.07 -171.52 3.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.815 . . . . 0.0 109.974 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.824 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.7 p -142.84 174.01 11.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.338 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.466 ' OG ' ' OE2' ' A' ' 148' ' ' GLU . 79.7 p -151.57 148.28 27.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.244 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -74.13 -6.12 45.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.132 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.829 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.7 mp -95.9 150.15 36.94 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.029 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.829 ' HD2' HG23 ' A' ' 13' ' ' ILE . 42.2 Cg_endo -67.41 143.88 65.31 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.107 1.583 . . . . 0.0 110.89 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.677 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.1 Cg_endo -71.31 -31.49 14.13 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 124.115 1.587 . . . . 0.0 112.698 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 39.5 Cg_endo -67.4 -21.05 47.62 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 N-CA-C 110.098 -0.77 . . . . 0.0 110.098 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 9.1 mmp_? -85.17 -46.18 11.33 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.763 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.2 tt -69.03 -28.18 66.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.617 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 68.9 t80 -69.27 -53.53 19.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.707 . . . . 0.0 109.818 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 45.8 mttp -57.28 -29.87 64.23 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.993 0.901 . . . . 0.0 108.899 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.961 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -77.7 -63.63 1.34 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.681 0.753 . . . . 0.0 111.269 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.008 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -56.28 -39.63 72.97 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.689 -0.632 . . . . 0.0 111.947 -178.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.136 HG11 ' CD1' ' A' ' 74' ' ' ILE . 15.7 t -102.13 -65.86 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.791 -1.193 . . . . 0.0 111.631 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.0 mp -64.9 -6.08 7.55 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.227 -0.921 . . . . 0.0 111.25 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.558 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 1.1 m-20 -146.47 24.41 1.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.862 -1.149 . . . . 0.0 110.49 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.008 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -57.46 -38.36 74.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.041 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 41' ' ' SER . 86.0 m-20 -67.66 -12.86 61.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 110.191 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.54 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 83.9 m-20 -125.18 -3.79 7.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.457 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.764 HD11 HG23 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -85.98 -52.31 5.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.023 . . . . 0.0 110.394 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.04 HG11 HD13 ' A' ' 38' ' ' ILE . 14.7 t -63.3 -41.02 65.61 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.791 . . . . 0.0 111.193 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.7 Cg_endo -77.23 7.37 3.75 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.333 1.175 . . . . 0.0 111.021 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 69.9 mmtt -122.35 -23.64 5.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.095 -1.003 . . . . 0.0 109.724 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.768 HG21 ' HB3' ' A' ' 146' ' ' LEU . 8.0 mt -80.01 -56.27 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.495 -0.753 . . . . 0.0 109.773 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.52 106.27 2.56 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.46 -0.775 . . . . 0.0 110.02 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.03 0.53 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.069 1.563 . . . . 0.0 110.726 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -83.77 -11.81 56.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.149 -0.97 . . . . 0.0 109.708 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.67 -51.43 3.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.382 -0.824 . . . . 0.0 110.278 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.04 HD13 HG11 ' A' ' 30' ' ' VAL . 1.3 mt -122.24 147.64 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 110.25 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -80.13 -43.9 20.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.192 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.544 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -177.42 161.38 1.75 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.148 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.449 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 27.2 m -119.41 128.73 54.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 53.9 tt0 -133.48 111.53 10.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 43.0 mt -62.98 132.92 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 110.195 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.409 ' HA ' HD12 ' A' ' 44' ' ' LEU . 55.0 tp -96.69 -43.14 7.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.877 . . . . 0.0 110.339 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.908 ' O ' HG23 ' A' ' 52' ' ' THR . 6.9 mt-10 -130.76 150.08 52.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.369 -0.832 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 76.92 -164.04 52.77 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 60.6 t0 -138.52 19.82 2.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -1.183 . . . . 0.0 110.312 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.438 ' H ' HG21 ' A' ' 52' ' ' THR . . . 118.23 -5.68 15.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -92.26 -165.93 39.1 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.2 Cg_endo -69.77 134.1 27.14 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.046 1.551 . . . . 0.0 110.486 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.32 -6.89 68.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 45' ' ' GLU . 30.4 m -79.95 136.16 36.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -1.145 . . . . 0.0 110.158 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.696 HD13 ' HA ' ' A' ' 70' ' ' LYS . 23.7 mm -107.18 113.25 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 110.267 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 77.7 mttt -98.28 148.2 23.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.4 -0.813 . . . . 0.0 110.36 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -118.1 92.37 3.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.545 ' CG2' HG12 ' A' ' 38' ' ' ILE . 78.4 mt -79.99 139.6 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 38' ' ' ILE . 4.4 p -111.3 159.56 17.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.595 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.652 ' HE2' HG13 ' A' ' 67' ' ' VAL . 26.2 m-85 -119.61 139.65 51.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.254 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.926 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.189 0.519 . . . . 0.0 110.046 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -124.31 135.64 9.71 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 10.9 p90 -178.91 159.36 1.02 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -1.104 . . . . 0.0 109.931 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.721 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.9 m -143.57 171.52 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.725 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.509 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 68.4 mttt -121.25 127.35 51.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.602 -0.686 . . . . 0.0 109.587 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.567 ' CD2' HD12 ' A' ' 85' ' ' LEU . 14.2 m170 -115.31 124.66 51.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.146 -0.971 . . . . 0.0 110.864 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HA ' HD13 ' A' ' 53' ' ' ILE . 80.0 tttt -100.92 109.68 21.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.479 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.534 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.1 mm -48.32 139.59 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.005 . . . . 0.0 110.132 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.549 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 15.7 t0 -113.0 -40.05 4.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.854 . . . . 0.0 109.518 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 2.8 p 170.39 157.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 110.267 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.136 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.2 tt -146.22 163.83 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.796 . . . . 0.0 110.032 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.552 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -125.23 78.78 1.74 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.288 -0.883 . . . . 0.0 109.811 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.617 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 99.4 mttt -53.69 -16.54 1.69 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.448 -0.782 . . . . 0.0 110.794 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -91.96 -29.8 16.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.284 -0.885 . . . . 0.0 109.755 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -111.18 -0.18 16.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.563 -0.711 . . . . 0.0 109.651 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.69 ' O ' HD12 ' A' ' 104' ' ' LEU . 87.9 m-85 63.26 50.05 3.1 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.377 0.608 . . . . 0.0 110.667 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.552 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -118.55 148.67 42.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.207 179.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.585 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 84.7 t80 -144.85 139.14 27.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.065 -1.022 . . . . 0.0 110.433 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 m -148.07 133.4 18.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 110.116 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.7 p90 -135.17 178.36 7.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 98' ' ' ILE . 62.6 m -125.07 125.23 43.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.746 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.732 HD21 HD11 ' A' ' 91' ' ' LEU . 2.8 tp -94.11 136.94 33.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.997 . . . . 0.0 110.085 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 pt -124.1 -4.54 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 0.0 110.539 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 6.6 tt0 -137.87 156.49 47.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.004 . . . . 0.0 110.28 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.721 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 150.89 122.66 1.07 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.36 -17.35 4.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -1.171 . . . . 0.0 110.324 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.765 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -76.98 -29.22 55.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.732 HD11 HD21 ' A' ' 85' ' ' LEU . 17.2 mt -69.1 -27.63 65.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.06 -169.22 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.25 2.99 29.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -1.182 . . . . 0.0 110.175 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.513 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 30.5 p -85.74 -26.4 25.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.04 HD21 ' CG1' ' A' ' 128' ' ' ILE . 39.7 mt -122.25 156.59 33.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.868 . . . . 0.0 110.071 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.508 ' HG3' ' HB3' ' A' ' 123' ' ' LYS . 65.5 mm-40 -132.71 -79.81 0.49 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.247 -0.908 . . . . 0.0 110.129 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 22.1 mttp -80.11 129.57 34.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.605 -0.685 . . . . 0.0 110.763 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.732 HG21 ' CE2' ' A' ' 100' ' ' TYR . 6.2 mm -118.62 141.68 37.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.815 -1.178 . . . . 0.0 109.543 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.2 m -120.45 126.08 49.53 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.381 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.732 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.9 m-85 -122.12 133.38 54.76 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.434 -0.791 . . . . 0.0 110.244 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -133.22 148.75 52.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.392 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 81' ' ' TYR . 38.9 m -148.21 140.8 24.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.396 -0.815 . . . . 0.0 110.01 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 7.8 tttt -132.87 148.97 52.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -0.953 . . . . 0.0 110.124 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 79' ' ' TYR . 6.4 mt -126.39 148.39 49.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.149 -0.969 . . . . 0.0 110.346 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -152.31 -169.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.329 -0.857 . . . . 0.0 109.968 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.695 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -125.06 156.72 37.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 110.11 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 21.3 p -114.57 164.78 15.48 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.32 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.1 Cg_endo -72.6 -1.77 10.81 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.057 1.557 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.5 p -101.36 0.25 36.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.282 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.56 -38.05 3.39 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.16 -172.79 2.05 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 59.2 p -129.67 139.9 51.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -1.185 . . . . 0.0 110.251 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.824 ' HA ' HG22 ' A' ' 10' ' ' THR . 20.9 mt -89.02 149.5 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 110.199 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.631 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 14.9 mt -133.28 110.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.259 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.421 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 74.9 tttt -102.56 126.0 49.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.004 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 5.0 t -119.56 162.18 19.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.49 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.462 HG22 ' NE2' ' A' ' 119' ' ' HIS . 92.9 m -159.82 144.07 14.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.154 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 92.2 p -143.7 160.8 40.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.787 ' CE1' HG23 ' A' ' 4' ' ' THR . 75.7 m-70 -143.41 166.88 23.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.214 -0.929 . . . . 0.0 110.37 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 10.1 m-85 -129.46 145.81 51.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 110.61 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.2 m-70 -124.44 87.21 2.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.352 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.536 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 2.2 p -65.39 157.82 28.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.411 -0.806 . . . . 0.0 110.644 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.508 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 74.6 tttt -137.84 126.08 23.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.462 -0.774 . . . . 0.0 110.124 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 99.71 23.27 11.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 8.6 t30 66.32 63.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -1.134 . . . . 0.0 110.189 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 30.2 m -137.03 166.03 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.129 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.488 ' HA ' HG21 ' A' ' 122' ' ' THR . 92.2 mt-10 -135.79 166.8 22.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 110.303 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.04 ' CG1' HD21 ' A' ' 95' ' ' LEU . 4.8 mp -90.75 172.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.575 ' N ' HG22 ' A' ' 128' ' ' ILE . 54.1 mttt -112.22 131.22 55.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 109.829 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 99.5 mt-10 -43.27 -44.47 5.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 110.05 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -54.81 -26.33 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.765 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 9.6 t-160 -83.29 -60.57 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 110.102 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.981 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.5 p -63.41 -39.79 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.967 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.523 ' N ' HG13 ' A' ' 133' ' ' VAL . 81.8 tttt -60.99 -37.74 83.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.89 . . . . 0.0 109.907 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.9 78.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.927 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.91 -33.47 85.77 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.04 -41.06 97.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -1.125 . . . . 0.0 109.906 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -75.03 -33.95 61.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.83 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -72.78 -37.29 67.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 109.781 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.49 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -72.23 -33.32 67.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.827 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.9 m -69.07 -44.32 72.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 109.944 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -63.54 -38.56 91.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.878 . . . . 0.0 109.9 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 146' ' ' LEU . 61.2 mt -64.77 -35.94 82.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.857 . . . . 0.0 109.989 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.622 ' CD2' ' CZ ' ' A' ' 9' ' ' PHE . 7.9 m-85 -63.55 -38.82 92.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.926 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -77.03 -14.5 59.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.873 . . . . 0.0 109.993 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.768 ' HB3' HG21 ' A' ' 33' ' ' ILE . 15.4 mt -84.02 -34.81 24.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.228 -0.92 . . . . 0.0 108.973 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.764 HG23 HD11 ' A' ' 29' ' ' LEU . 17.2 mt -71.56 -44.81 69.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.566 -0.709 . . . . 0.0 109.109 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.716 ' HB3' HD13 ' A' ' 13' ' ' ILE . 10.9 mm-40 -66.73 -38.75 87.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 0.0 109.651 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.7 m -69.99 -37.47 75.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -0.984 . . . . 0.0 109.669 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.651 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 77.7 t80 -56.4 -57.23 13.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.424 -0.797 . . . . 0.0 110.015 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.183 HD21 ' CE2' ' A' ' 158' ' ' TYR . 55.5 mt -68.58 -29.07 67.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.28 -0.887 . . . . 0.0 110.16 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.738 ' HD2' HD11 ' A' ' 13' ' ' ILE . 80.4 tttt -68.42 -33.59 74.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.66 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.494 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -100.8 -27.38 7.51 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.526 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.0 m-70 -107.45 89.19 4.7 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.303 -1.116 . . . . 0.0 110.045 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.2 Cg_endo -73.36 2.94 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.003 1.528 . . . . 0.0 110.833 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -106.9 -11.63 15.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 0.0 109.712 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.651 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -69.78 100.57 1.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.472 -0.768 . . . . 0.0 110.001 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.183 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.7 OUTLIER 34.34 33.11 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.751 -0.593 . . . . 0.0 110.483 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.831 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.707 HG22 ' ND1' ' A' ' 121' ' ' HIS . 76.1 t -109.52 109.74 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -1.143 . . . . 0.0 110.243 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.55 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 54.7 m-85 -74.58 155.95 37.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.231 -0.918 . . . . 0.0 110.414 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.889 HG23 ' CE1' ' A' ' 119' ' ' HIS . 89.4 m -140.89 89.08 2.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.078 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CG ' ' CG2' ' A' ' 133' ' ' VAL . 80.1 m-85 -109.73 127.58 54.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.809 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.2 pt-20 -128.35 152.36 48.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.204 -0.935 . . . . 0.0 110.527 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 p -128.35 142.27 51.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -0.823 . . . . 0.0 109.794 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -121.39 138.51 54.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.979 . . . . 0.0 110.647 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.663 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 4.3 p90 -157.21 -173.03 4.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.586 -0.696 . . . . 0.0 109.753 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 113' ' ' ILE . 18.0 p -140.15 -177.1 4.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 110.647 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.512 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 2.9 t -159.59 160.0 33.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.436 -0.79 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -88.11 5.15 42.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 110.224 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.785 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.7 mm -108.46 149.65 39.62 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.006 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.785 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.9 Cg_endo -64.44 144.54 85.68 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.886 1.466 . . . . 0.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.655 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 Cg_endo -72.63 -31.24 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.015 1.534 . . . . 0.0 112.918 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.3 Cg_endo -69.39 -23.4 32.53 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 110.19 -0.735 . . . . 0.0 110.19 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.535 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 5.2 mmp_? -83.93 -44.15 14.53 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.92 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -69.78 -31.88 70.05 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 77.0 t80 -63.83 -56.91 11.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.496 -0.753 . . . . 0.0 109.426 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 51.4 mttt -52.63 -33.86 48.64 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.904 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.065 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -72.96 -60.91 2.01 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.637 0.732 . . . . 0.0 110.718 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.038 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -51.96 -51.67 55.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.723 -0.611 . . . . 0.0 111.799 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.089 HG11 ' CD1' ' A' ' 74' ' ' ILE . 12.0 t -96.85 -61.71 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.012 -1.055 . . . . 0.0 112.334 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.617 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.9 mp -67.97 -1.09 5.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.057 -1.027 . . . . 0.0 111.872 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.98 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -147.69 15.22 1.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.664 -1.273 . . . . 0.0 110.845 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.038 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -54.05 -48.69 70.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 109.956 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 41' ' ' SER . 49.2 t0 -53.67 -20.34 5.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.955 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 69.5 m-80 -124.45 11.83 8.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.98 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -97.4 -46.02 6.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.0 110.26 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.989 HG21 HD13 ' A' ' 38' ' ' ILE . 6.0 p -75.59 -27.67 0.7 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.902 . . . . 0.0 112.032 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.82 ' HD3' HG12 ' A' ' 30' ' ' VAL . 50.7 Cg_endo -79.84 6.88 4.92 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 122.696 0.84 . . . . 0.0 110.297 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -130.94 -30.27 1.81 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.209 -0.932 . . . . 0.0 110.244 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.619 HD11 ' CD1' ' A' ' 29' ' ' LEU . 16.1 mt -74.67 -39.86 46.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.38 -0.825 . . . . 0.0 109.849 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -173.11 102.65 0.32 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.387 -0.821 . . . . 0.0 110.362 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.42 2.49 6.24 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.968 1.509 . . . . 0.0 110.56 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -85.03 -19.74 31.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.11 -0.994 . . . . 0.0 109.769 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.87 -44.94 8.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.416 -0.802 . . . . 0.0 110.048 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.989 HD13 HG21 ' A' ' 30' ' ' VAL . 1.2 mp -125.66 143.63 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 0.0 109.977 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 33.3 ttmt -79.63 -39.18 32.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.274 -0.891 . . . . 0.0 110.383 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.568 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER 178.73 139.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.917 . . . . 0.0 110.527 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 29.5 m -97.81 135.27 39.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 0.0 109.893 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 50.1 tt0 -143.77 110.26 5.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 110.397 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.9 mt -61.43 132.8 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.066 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 44' ' ' LEU . 19.5 mt -92.88 -43.92 8.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.332 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 52' ' ' THR . 6.0 mm-40 -135.44 131.6 36.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 110.145 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.08 -172.0 37.85 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -116.83 -3.6 11.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -1.162 . . . . 0.0 110.23 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.471 ' N ' HG21 ' A' ' 52' ' ' THR . . . 134.82 -4.71 4.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.531 ' C ' HG21 ' A' ' 71' ' ' ILE . . . -79.73 -167.23 34.43 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.06 131.83 21.61 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.047 1.551 . . . . 0.0 110.603 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.46 -8.85 66.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.91 HG23 ' O ' ' A' ' 45' ' ' GLU . 21.9 m -79.94 145.04 32.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -1.13 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.625 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.6 mm -111.71 117.16 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.64 ' HE2' HD11 ' A' ' 71' ' ' ILE . 44.9 mtmt -101.3 144.99 29.45 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.318 -0.864 . . . . 0.0 110.397 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -117.39 101.56 8.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.177 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.54 ' CG2' HG12 ' A' ' 38' ' ' ILE . 80.6 mt -91.32 138.23 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.123 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 38' ' ' ILE . 1.3 p -112.09 151.64 29.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.468 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' GLY . 32.9 m-85 -111.04 136.23 50.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.873 . . . . 0.0 110.241 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.523 ' OH ' HG21 ' A' ' 57' ' ' THR . 3.3 t80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -122.51 96.19 0.56 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.486 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 26.5 p90 -133.05 166.75 21.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -1.232 . . . . 0.0 110.103 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.841 HG12 ' HA2' ' A' ' 88' ' ' GLY . 9.7 m -141.06 170.79 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.675 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' NZ ' ' OE1' ' A' ' 87' ' ' GLU . 98.4 mttt -123.17 121.13 35.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.607 -0.683 . . . . 0.0 109.585 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.504 ' CD2' HD12 ' A' ' 85' ' ' LEU . 15.7 m170 -111.57 125.9 54.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 110.981 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.625 ' HA ' HD13 ' A' ' 53' ' ' ILE . 80.0 tttt -99.68 116.97 33.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 109.279 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.64 HD11 ' HE2' ' A' ' 54' ' ' LYS . 39.8 mm -51.96 137.62 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.391 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.537 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 30.5 t0 -109.06 -49.15 3.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 109.85 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 3.1 m -176.72 159.47 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.522 -0.736 . . . . 0.0 110.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.089 ' CD1' HG11 ' A' ' 23' ' ' VAL . 6.3 tt -151.16 168.37 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.154 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -138.03 84.48 2.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 110.232 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.607 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 94.3 mttt -58.04 -12.17 3.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.429 -0.794 . . . . 0.0 111.008 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -89.81 -31.39 17.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.112 -0.993 . . . . 0.0 109.571 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -114.21 -2.16 13.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 109.667 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.823 ' O ' HD12 ' A' ' 104' ' ' LEU . 6.6 m-85 67.97 47.59 1.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.754 -0.591 . . . . 0.0 110.573 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.544 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -111.18 158.1 19.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 108.805 178.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.528 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 83.4 t80 -159.78 150.86 19.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.956 -1.09 . . . . 0.0 110.669 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.425 ' HB2' ' HA ' ' A' ' 101' ' ' GLU . 12.3 t -159.65 152.43 21.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 7.4 p90 -150.14 176.83 10.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.476 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 98' ' ' ILE . 91.4 m -124.1 126.08 45.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.797 . . . . 0.0 109.683 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.639 HD23 HG13 ' A' ' 98' ' ' ILE . 2.9 tp -93.52 134.48 35.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.945 . . . . 0.0 110.029 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.08 -10.57 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 110.465 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.578 ' C ' HD12 ' A' ' 91' ' ' LEU . 23.2 tt0 -140.74 149.09 41.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.424 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.841 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 162.47 149.9 5.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -65.1 -35.07 79.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -1.157 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.408 ' HB1' ' HE2' ' A' ' 132' ' ' HIS . . . -67.61 -21.11 65.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.254 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.81 HD21 ' CG1' ' A' ' 98' ' ' ILE . 41.0 mt -71.3 -32.06 68.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.47 -171.2 0.02 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -84.11 5.1 27.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -1.15 . . . . 0.0 110.006 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.6 p -92.34 -43.24 9.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.097 HD21 HD11 ' A' ' 128' ' ' ILE . 78.1 mt -94.58 164.51 12.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 110.073 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 36.3 tp10 -144.84 -80.71 0.17 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.243 -0.911 . . . . 0.0 110.21 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 58.8 mttt -80.31 128.88 34.06 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.633 -0.667 . . . . 0.0 110.486 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.81 ' CG1' HD21 ' A' ' 91' ' ' LEU . 7.5 mm -122.51 143.55 34.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.944 -1.097 . . . . 0.0 110.072 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.91 131.26 53.93 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.453 -0.779 . . . . 0.0 109.044 178.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.724 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.9 m-85 -127.08 133.37 50.46 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 110.47 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.425 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 75.3 tt0 -131.59 154.26 49.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.885 . . . . 0.0 110.213 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 81' ' ' TYR . 81.6 m -155.0 123.56 6.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.988 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 12.4 tttt -119.38 150.33 40.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 110.311 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 79' ' ' TYR . 13.0 mt -124.82 150.35 46.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 110.651 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.37 -169.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.397 -0.815 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.64 167.85 12.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.868 . . . . 0.0 110.238 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 60.2 p -126.42 162.52 46.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.117 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.5 Cg_endo -71.98 -2.48 11.59 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.971 1.511 . . . . 0.0 110.486 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -101.6 -2.61 30.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.264 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.84 -35.95 4.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.12 -172.56 2.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 15.6 p -128.71 136.21 50.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -1.213 . . . . 0.0 110.435 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.59 ' HA ' HG22 ' A' ' 10' ' ' THR . 62.4 mt -84.93 149.32 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.663 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 9.8 mt -134.33 121.11 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.318 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -110.84 134.61 52.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.91 . . . . 0.0 110.093 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.5 t -125.26 158.4 34.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.89 . . . . 0.0 110.319 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 84.8 m -159.92 126.59 4.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.88 . . . . 0.0 110.322 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.457 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 18.8 t -126.5 155.84 41.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.288 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.889 ' CE1' HG23 ' A' ' 4' ' ' THR . 80.6 m-70 -130.73 164.5 24.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.306 -0.871 . . . . 0.0 109.965 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.612 ' HD1' HD12 ' A' ' 98' ' ' ILE . 18.6 m-85 -133.67 134.49 43.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 111.037 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.707 ' ND1' HG22 ' A' ' 2' ' ' VAL . 85.4 m-70 -121.07 90.2 3.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 108.848 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.877 ' HB ' HD23 ' A' ' 95' ' ' LEU . 2.2 t -91.59 -179.46 5.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 111.748 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -133.97 171.89 13.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.902 -0.498 . . . . 0.0 109.703 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 125' ' ' ASN . . . 76.45 2.48 74.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 16.6 t30 68.68 60.41 0.37 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.268 -1.137 . . . . 0.0 110.728 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.532 HG22 ' OG1' ' A' ' 122' ' ' THR . 6.6 m -126.01 162.08 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.668 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -118.64 145.91 45.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.02 . . . . 0.0 110.725 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.097 HD11 HD21 ' A' ' 95' ' ' LEU . 24.1 mm -55.77 173.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.388 -0.82 . . . . 0.0 110.083 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 128' ' ' ILE . 29.5 mtpt -110.15 131.69 54.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.042 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.53 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 60.6 mt-10 -43.26 -42.37 4.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 110.103 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 48.8 tt0 -60.83 -26.33 67.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 109.923 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.0 t-160 -85.97 -53.05 5.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 110.081 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.606 ' CG2' ' CG ' ' A' ' 5' ' ' TYR . 3.9 p -69.07 -30.78 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 110.126 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 64.6 tttp -79.3 -53.94 6.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 109.801 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -61.52 -25.74 67.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.95 -36.52 81.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.477 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 96.5 mttt -65.57 -33.96 77.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -1.119 . . . . 0.0 109.866 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.415 ' HG2' ' ND2' ' A' ' 142' ' ' ASN . 79.8 tt0 -81.53 -32.1 32.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.0 109.88 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -67.77 -44.67 76.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.374 -0.829 . . . . 0.0 109.873 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -71.2 -38.4 72.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 110.004 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.1 m -62.81 -49.35 75.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.395 -0.816 . . . . 0.0 109.993 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.415 ' ND2' ' HG2' ' A' ' 138' ' ' GLU . 80.3 m-20 -56.29 -43.13 78.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.982 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.47 ' O ' HG13 ' A' ' 147' ' ' ILE . 23.4 mt -60.74 -40.69 93.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.91 . . . . 0.0 109.944 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 19.1 m-85 -60.61 -39.88 89.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.439 -0.788 . . . . 0.0 109.86 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -67.91 -17.94 64.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 110.037 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 146' ' ' LEU . 16.0 mt -84.14 -34.9 23.96 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.19 -0.944 . . . . 0.0 108.965 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.714 HG22 HD23 ' A' ' 18' ' ' LEU . 55.2 mt -71.75 -41.64 70.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.548 -0.72 . . . . 0.0 109.06 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.663 ' OE2' HD11 ' A' ' 114' ' ' ILE . 14.9 mm-40 -59.97 -39.68 86.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.289 -0.882 . . . . 0.0 109.205 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 97.7 m -67.09 -35.99 81.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 109.185 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.648 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 72.3 t80 -53.15 -53.46 50.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.48 -0.763 . . . . 0.0 109.625 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.188 HD21 ' CE2' ' A' ' 158' ' ' TYR . 98.3 mt -76.08 -27.03 57.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.296 -0.877 . . . . 0.0 109.984 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.525 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 29.8 ttpt -75.88 -19.67 58.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -113.45 -30.73 2.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.475 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 15.3 m-70 -106.89 93.28 8.67 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.199 -1.177 . . . . 0.0 110.224 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.5 Cg_endo -74.22 4.77 4.05 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.086 1.572 . . . . 0.0 110.876 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -108.15 3.68 24.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 109.827 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.648 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -86.87 103.34 15.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.381 -0.824 . . . . 0.0 110.196 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.188 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.65 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.686 -0.634 . . . . 0.0 110.511 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.714 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.534 HG22 ' ND1' ' A' ' 121' ' ' HIS . 54.8 t -106.59 128.63 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -1.14 . . . . 0.0 110.306 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.717 ' CG ' HD13 ' A' ' 128' ' ' ILE . 9.0 m-85 -90.86 143.5 26.66 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.267 -0.896 . . . . 0.0 109.654 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.711 HG23 ' CE1' ' A' ' 119' ' ' HIS . 4.8 m -126.23 116.82 21.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.984 -1.073 . . . . 0.0 110.403 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 57.5 m-85 -131.76 137.25 48.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 109.915 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -136.08 149.75 48.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 110.565 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.4 p -139.69 149.98 44.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.78 . . . . 0.0 109.451 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.45 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 2.8 tt0 -133.79 138.33 45.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.968 -1.083 . . . . 0.0 110.854 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.608 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 3.6 p90 -154.34 -174.7 5.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.429 -0.794 . . . . 0.0 109.597 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 113' ' ' ILE . 14.0 p -136.88 178.35 7.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 110.687 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.412 ' OG ' HD11 ' A' ' 114' ' ' ILE . 83.0 p -157.36 153.1 26.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 110.24 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -79.34 -15.45 57.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.912 . . . . 0.0 110.267 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.843 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.9 mp -87.57 151.25 50.23 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 109.937 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.843 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.8 143.47 73.82 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.057 1.556 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.642 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.88 -31.14 10.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 124.065 1.561 . . . . 0.0 112.972 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.6 Cg_endo -70.52 -21.79 29.48 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 N-CA-C 110.103 -0.768 . . . . 0.0 110.103 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.495 ' NE ' ' HA ' ' A' ' 159' ' ' ASN . 9.1 mmp_? -83.44 -47.12 11.72 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -66.51 -27.87 68.11 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 81.6 t80 -65.65 -60.36 2.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.715 -0.616 . . . . 0.0 109.604 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 52.3 mttt -52.03 -32.97 36.56 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.4 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.023 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.13 -56.02 5.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.399 -0.813 . . . . 0.0 110.661 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.048 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -58.62 -49.15 78.55 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.542 -0.724 . . . . 0.0 111.384 -178.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.13 HG11 ' CD1' ' A' ' 74' ' ' ILE . 16.8 t -93.49 -65.25 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.973 -1.079 . . . . 0.0 111.717 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.9 mp -67.55 -1.07 4.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.287 -0.883 . . . . 0.0 111.819 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.792 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -149.04 25.24 0.92 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.795 -1.19 . . . . 0.0 110.729 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.048 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -63.79 -38.12 89.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.119 -0.988 . . . . 0.0 109.989 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.498 ' OD2' HD11 ' A' ' 43' ' ' ILE . 54.7 m-20 -65.02 -14.92 61.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 110.253 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 72.8 m-80 -125.15 7.72 7.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 110.058 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.829 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -95.43 -57.03 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 110.103 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.975 HG11 HD13 ' A' ' 38' ' ' ILE . 96.1 t -62.69 -40.51 64.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.765 . . . . 0.0 111.153 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -77.4 7.09 3.94 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.371 1.195 . . . . 0.0 110.85 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -127.48 -29.8 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.902 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.692 HD11 ' CD1' ' A' ' 29' ' ' LEU . 32.3 mt -80.07 -44.37 22.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.51 -0.744 . . . . 0.0 110.044 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.02 102.14 2.11 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 110.348 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.21 3.63 5.55 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.049 1.552 . . . . 0.0 110.717 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -90.74 -13.84 33.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.141 -0.975 . . . . 0.0 110.208 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.83 -29.05 12.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.198 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.975 HD13 HG11 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -142.07 150.26 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -88.69 -44.79 10.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.326 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.59 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -172.93 156.76 3.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.377 -0.827 . . . . 0.0 110.173 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -119.81 121.99 40.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 109.95 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.59 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 84.6 tt0 -124.31 114.49 19.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.498 HD11 ' OD2' ' A' ' 27' ' ' ASP . 23.4 mt -61.55 132.21 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.944 . . . . 0.0 110.088 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 55' ' ' LYS . 53.4 mt -92.89 -25.54 18.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 1.073 ' O ' HG23 ' A' ' 52' ' ' THR . 41.8 tt0 -156.46 171.31 20.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 58.07 -165.92 6.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -131.55 29.42 4.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -1.112 . . . . 0.0 110.291 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.51 ' H ' HG21 ' A' ' 52' ' ' THR . . . 103.36 2.25 47.57 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.485 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -92.53 -167.33 39.42 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.4 132.86 23.15 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.058 1.557 . . . . 0.0 110.522 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.17 -6.62 68.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 1.073 HG23 ' O ' ' A' ' 45' ' ' GLU . 19.4 m -80.06 147.91 31.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -1.174 . . . . 0.0 110.129 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.606 HD13 ' HA ' ' A' ' 70' ' ' LYS . 21.6 mm -116.53 114.96 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.071 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 35.7 mtmt -99.76 147.47 25.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HB2' HD11 ' A' ' 44' ' ' LEU . 83.6 tttt -116.78 98.62 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.898 . . . . 0.0 110.09 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.531 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.7 mt -88.22 146.42 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.5 p -120.16 155.62 32.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.38 -0.825 . . . . 0.0 110.574 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.692 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.1 m-85 -116.58 145.36 43.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.449 -0.782 . . . . 0.0 110.145 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.401 ' CD1' ' HD2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.233 0.539 . . . . 0.0 110.186 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -118.86 94.98 0.6 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 20.8 p90 -134.8 167.97 19.9 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.049 -1.265 . . . . 0.0 110.478 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.821 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.8 m -139.69 172.89 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 110.447 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.512 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 30.3 mtpt -123.9 129.37 50.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.528 -0.732 . . . . 0.0 109.518 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.605 ' CD2' HD12 ' A' ' 85' ' ' LEU . 8.3 m170 -117.19 125.94 51.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.99 -1.069 . . . . 0.0 110.931 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.606 ' HA ' HD13 ' A' ' 53' ' ' ILE . 64.6 tttp -104.94 110.49 22.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 109.3 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 29.2 mm -48.19 140.65 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.187 -0.945 . . . . 0.0 110.406 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 16.0 t0 -112.25 -40.32 4.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.393 -0.817 . . . . 0.0 109.629 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 0.6 OUTLIER 172.19 161.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.0 110.391 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.13 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.6 tt -152.03 165.33 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -131.34 80.73 1.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.601 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.6 mttt -55.78 -14.14 2.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.87 . . . . 0.0 110.827 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -90.18 -29.75 18.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.227 -0.92 . . . . 0.0 109.645 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -114.45 -1.68 13.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.486 -0.758 . . . . 0.0 109.965 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.766 ' O ' HD12 ' A' ' 104' ' ' LEU . 8.3 m-85 67.48 48.04 1.17 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.639 -0.663 . . . . 0.0 110.646 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -115.06 154.2 29.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.208 -0.932 . . . . 0.0 109.095 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.528 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 84.7 t80 -154.98 148.32 25.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.9 -1.125 . . . . 0.0 110.523 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.5 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 17.9 m -156.22 147.16 22.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.366 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 4.9 p90 -144.21 178.3 7.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.409 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 98' ' ' ILE . 71.0 m -124.83 125.19 43.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.535 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.68 HD21 HD11 ' A' ' 91' ' ' LEU . 5.3 tp -90.86 136.11 33.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.178 -0.951 . . . . 0.0 110.401 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.2 pt -123.58 -6.14 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.551 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.512 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 11.2 tt0 -141.37 160.44 40.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 110.429 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.821 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 145.77 123.69 1.58 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.34 -15.41 6.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -1.16 . . . . 0.0 110.402 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -77.1 -29.37 54.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.68 HD11 HD21 ' A' ' 85' ' ' LEU . 28.6 mt -67.46 -39.33 85.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.366 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 178.05 44.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -74.46 -0.01 16.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -1.148 . . . . 0.0 110.162 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.583 ' HB ' HG11 ' A' ' 126' ' ' VAL . 15.4 p -95.2 -40.41 9.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.165 -0.959 . . . . 0.0 110.305 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.891 HD11 HG13 ' A' ' 128' ' ' ILE . 1.8 mm? -79.84 136.98 36.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.165 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 5.7 tp10 -124.98 -83.44 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.318 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 26.7 mttt -80.16 126.87 31.65 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 110.695 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.69 HG21 ' HE2' ' A' ' 100' ' ' TYR . 5.3 mm -121.14 141.04 43.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 120.614 -1.304 . . . . 0.0 109.235 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.72 134.23 55.05 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.879 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.69 ' HE2' HG21 ' A' ' 98' ' ' ILE . 8.2 m-85 -130.3 132.7 46.0 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.422 -0.799 . . . . 0.0 110.169 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.5 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 5.9 mt-10 -129.71 167.01 18.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.223 -0.923 . . . . 0.0 110.619 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 81' ' ' TYR . 45.6 m -162.9 137.69 6.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.381 -0.824 . . . . 0.0 109.909 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.4 mttt -135.58 137.88 42.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.391 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.768 HD23 HG12 ' A' ' 114' ' ' ILE . 9.8 mt -117.12 149.92 39.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.319 -0.863 . . . . 0.0 110.127 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.79 -169.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -0.936 . . . . 0.0 110.153 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.64 166.85 13.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.268 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 24.8 p -125.02 165.69 24.42 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -73.17 -0.65 9.42 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.995 1.524 . . . . 0.0 110.488 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.6 p -110.42 7.66 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.263 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.38 -38.66 3.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.03 -172.72 0.14 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 16.8 p -133.63 135.26 44.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.171 -1.194 . . . . 0.0 110.385 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.623 ' HA ' HG22 ' A' ' 10' ' ' THR . 41.8 mt -86.44 152.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.056 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.768 HG12 HD23 ' A' ' 104' ' ' LEU . 5.3 mt -136.42 115.17 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.933 . . . . 0.0 110.614 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 44.4 tttp -101.06 127.28 47.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -0.842 . . . . 0.0 109.745 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.05 157.91 25.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.748 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.444 HG22 ' NE2' ' A' ' 119' ' ' HIS . 98.7 m -160.08 144.33 14.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.394 -0.816 . . . . 0.0 110.067 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.493 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -146.65 168.64 20.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.161 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.711 ' CE1' HG23 ' A' ' 4' ' ' THR . 48.4 m-70 -148.87 174.56 12.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.166 -0.959 . . . . 0.0 110.552 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.583 ' CD2' HG12 ' A' ' 128' ' ' ILE . 87.9 m-85 -138.09 156.91 47.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.217 -0.927 . . . . 0.0 110.958 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.534 ' ND1' HG22 ' A' ' 2' ' ' VAL . 76.4 m-70 -140.84 81.49 1.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.406 -0.809 . . . . 0.0 109.251 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.458 ' HB ' ' HB ' ' A' ' 126' ' ' VAL . 0.1 OUTLIER -63.08 142.36 58.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.334 -0.854 . . . . 0.0 110.648 -179.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -69.19 110.4 4.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.896 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.63 -116.36 5.45 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.516 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 2.6 p-10 -137.13 49.3 2.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -1.172 . . . . 0.0 110.244 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 127' ' ' GLU . 66.7 t -96.42 174.96 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.416 -0.803 . . . . 0.0 109.952 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.597 ' N ' HG12 ' A' ' 126' ' ' VAL . 96.0 mt-10 -126.22 161.2 28.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.891 HG13 HD11 ' A' ' 95' ' ' LEU . 4.5 mp -88.38 172.94 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.867 . . . . 0.0 110.095 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.615 ' N ' HG22 ' A' ' 128' ' ' ILE . 67.0 mmtt -90.83 151.96 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.332 -0.855 . . . . 0.0 109.958 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 61.7 mm-40 -58.16 -22.0 49.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.136 -0.978 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.836 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 98.2 mt-10 -68.03 -39.57 83.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.91 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 5.3 m170 -66.04 -47.55 74.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.162 -0.961 . . . . 0.0 110.02 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.589 HG23 ' CD1' ' A' ' 5' ' ' TYR . 2.5 p -76.47 -25.87 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.449 -0.782 . . . . 0.0 110.093 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 73.6 tttt -104.31 -65.37 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.958 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.836 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.68 -24.21 47.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.868 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.51 -28.58 67.33 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.11 -33.1 56.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -1.127 . . . . 0.0 110.017 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -81.39 -31.26 33.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.85 . . . . 0.0 109.813 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.617 ' HE3' ' HB1' ' A' ' 135' ' ' ALA . 85.8 mttt -73.42 -36.72 66.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 109.828 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.23 -35.94 61.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.852 . . . . 0.0 109.89 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.1 m -64.04 -45.46 88.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -0.821 . . . . 0.0 109.973 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -56.41 -50.67 70.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.993 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.403 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.9 mm? -60.51 -33.98 73.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.949 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -65.16 -37.49 87.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.414 -0.803 . . . . 0.0 109.833 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 29.3 ttmt -79.63 -15.45 57.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.441 -0.787 . . . . 0.0 110.042 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.512 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 13.8 mt -83.23 -37.02 24.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.081 -1.012 . . . . 0.0 108.933 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.708 HD13 ' CD1' ' A' ' 22' ' ' PHE . 86.6 mt -70.72 -44.36 76.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.726 ' HB3' HD13 ' A' ' 13' ' ' ILE . 62.6 mt-10 -55.88 -40.01 72.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.327 -0.858 . . . . 0.0 109.202 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.436 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 18.6 m -71.25 -31.63 67.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.556 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.607 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 79.0 t80 -56.08 -49.94 72.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.474 -0.766 . . . . 0.0 109.775 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.171 HD21 ' CE2' ' A' ' 158' ' ' TYR . 59.3 mt -77.72 -29.02 51.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.997 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.679 ' HB2' HD11 ' A' ' 13' ' ' ILE . 52.4 tptt -66.98 -26.78 66.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.464 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -107.28 -28.41 4.92 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.556 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.7 m-70 -106.9 91.18 6.0 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.219 -1.165 . . . . 0.0 110.05 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.7 Cg_endo -73.29 4.58 3.74 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.062 1.559 . . . . 0.0 111.104 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -111.14 -7.72 14.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.019 -1.051 . . . . 0.0 109.97 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.646 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -70.49 101.33 1.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 110.109 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.171 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.8 OUTLIER 34.79 31.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.712 -0.618 . . . . 0.0 110.635 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.715 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 93.9 t -136.07 134.11 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -1.166 . . . . 0.0 110.363 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 128' ' ' ILE . 11.2 m-85 -101.18 131.9 46.94 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.66 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.78 126.41 47.34 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.858 -1.151 . . . . 0.0 110.687 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.824 ' CE1' HG11 ' A' ' 133' ' ' VAL . 50.4 m-85 -133.58 125.59 29.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.806 . . . . 0.0 109.907 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.791 ' CG ' HG23 ' A' ' 117' ' ' THR . 3.8 mt-10 -136.49 145.61 45.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.398 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 m -132.03 158.82 40.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.805 . . . . 0.0 110.015 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.456 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 98.9 mt-10 -143.72 123.67 13.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.443 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 p90 -147.47 -173.64 4.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.616 HG22 HG12 ' A' ' 113' ' ' ILE . 12.5 p -138.34 -179.4 5.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.578 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.3 p -157.1 164.15 38.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.41 -0.806 . . . . 0.0 110.206 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -86.1 -21.74 27.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.2 mm -84.91 150.26 55.27 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.146 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 42.2 Cg_endo -66.1 150.4 85.21 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.158 1.61 . . . . 0.0 110.14 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.674 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.5 Cg_endo -70.15 -32.93 16.05 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.912 1.48 . . . . 0.0 113.304 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.5 Cg_endo -66.92 -23.23 47.49 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 122.381 0.674 . . . . 0.0 110.408 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.528 ' HG3' ' HG2' ' A' ' 14' ' ' PRO . 10.7 mmp_? -84.5 -45.66 12.41 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.765 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -72.28 -25.4 61.58 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.564 -0.71 . . . . 0.0 109.241 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.619 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 85.2 t80 -70.74 -57.98 4.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.402 -0.811 . . . . 0.0 109.059 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 67.5 mttt -51.23 -35.99 39.62 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.33 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.045 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.48 -53.81 8.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 111.021 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.738 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -59.54 -46.23 89.47 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 111.706 -178.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.771 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -98.18 -61.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.947 -1.096 . . . . 0.0 111.57 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.5 mp -70.18 0.31 6.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.149 -0.969 . . . . 0.0 111.55 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.683 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -154.55 46.92 0.57 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.79 -1.194 . . . . 0.0 110.856 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -84.64 -25.22 28.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -0.999 . . . . 0.0 110.062 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 60.6 t0 -73.76 -11.66 60.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 109.907 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 71.6 m-20 -128.6 10.46 6.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.37 -0.831 . . . . 0.0 109.652 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.794 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -97.9 -57.75 2.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.445 -0.784 . . . . 0.0 110.45 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.876 HG22 ' HD3' ' A' ' 31' ' ' PRO . 1.9 m -74.86 -29.1 0.87 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 112.101 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.876 ' HD3' HG22 ' A' ' 30' ' ' VAL . 51.0 Cg_endo -80.5 -1.51 11.35 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 O-C-N 122.878 0.936 . . . . 0.0 110.374 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -126.43 -32.09 2.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 109.756 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.634 ' CD1' HD13 ' A' ' 29' ' ' LEU . 11.9 mt -80.06 -34.17 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.489 -0.757 . . . . 0.0 109.393 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -160.38 99.06 1.4 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.586 -0.696 . . . . 0.0 109.896 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 43.2 Cg_endo -69.33 -4.33 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.984 1.518 . . . . 0.0 110.427 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -87.17 1.88 51.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.865 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.997 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -107.04 -47.6 3.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 109.997 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.997 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.9 mp -133.88 142.06 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 0.0 110.071 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -82.94 -36.57 25.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.576 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -175.42 132.69 0.29 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.375 -0.828 . . . . 0.0 109.946 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.491 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 2.3 m -100.26 131.24 46.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 77.5 tt0 -138.69 110.83 7.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 110.293 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 14.7 mt -64.11 134.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 110.203 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 55' ' ' LYS . 9.7 mp -97.89 -44.46 6.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.944 ' O ' HG23 ' A' ' 52' ' ' THR . 3.5 mt-10 -128.77 145.37 51.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.237 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.24 -162.46 53.57 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -139.52 23.02 2.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -1.123 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.541 ' H ' HG21 ' A' ' 52' ' ' THR . . . 119.15 -11.67 11.55 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -80.83 -168.0 38.48 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.89 139.68 36.85 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.09 1.574 . . . . 0.0 110.377 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.05 -3.34 85.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.944 HG23 ' O ' ' A' ' 45' ' ' GLU . 31.9 m -80.09 139.0 37.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -1.198 . . . . 0.0 110.05 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.622 HD13 ' HA ' ' A' ' 70' ' ' LYS . 25.7 mm -109.87 109.59 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 110.295 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 88.1 mttt -99.04 138.4 36.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.323 -0.861 . . . . 0.0 110.217 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.496 ' HB2' HD13 ' A' ' 44' ' ' LEU . 83.2 tttt -109.41 97.28 6.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.202 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.44 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 91.1 mt -84.15 141.88 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 0.0 110.177 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.3 p -116.08 155.22 28.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.147 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 23.5 m-85 -111.8 166.63 11.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.863 . . . . 0.0 110.358 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.4 ' HE1' HG22 ' A' ' 57' ' ' THR . 1.8 t80 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.157 0.503 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.14 88.29 0.28 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.5 p90 -126.84 164.36 21.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -1.168 . . . . 0.0 110.147 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.852 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.6 m -139.31 173.82 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 110.575 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.504 ' HE3' HG21 ' A' ' 53' ' ' ILE . 48.9 tttt -123.0 128.24 49.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.589 -0.694 . . . . 0.0 109.591 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.47 ' NE2' HD13 ' A' ' 85' ' ' LEU . 9.2 m170 -119.7 119.31 33.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 0.0 110.851 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.622 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.4 tttt -100.64 110.87 23.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.577 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.53 HG23 HD11 ' A' ' 74' ' ' ILE . 33.2 mm -46.33 142.79 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.475 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 12.9 t0 -114.64 -41.29 3.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.471 -0.768 . . . . 0.0 109.552 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.578 ' C ' HD12 ' A' ' 74' ' ' ILE . 67.5 p -174.48 157.91 2.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.82 . . . . 0.0 109.457 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.578 HD12 ' C ' ' A' ' 73' ' ' SER . 1.0 OUTLIER -138.99 151.02 23.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.084 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 6.5 m-20 -127.75 75.99 1.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.388 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 99.5 mttt -62.55 -12.85 25.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.101 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -97.98 -30.37 12.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 109.205 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -105.29 -3.08 23.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.653 -0.654 . . . . 0.0 109.715 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.619 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 83.1 m-85 61.26 53.35 3.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.49 -0.756 . . . . 0.0 110.083 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.541 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -125.82 152.67 45.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.568 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.771 ' CE1' HG13 ' A' ' 23' ' ' VAL . 25.8 t80 -138.78 134.5 33.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 110.391 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.457 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -141.54 123.13 15.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 110.555 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 8.8 p90 -135.0 175.89 9.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 110.134 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.6 m -124.41 127.82 48.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.779 HD23 HG13 ' A' ' 98' ' ' ILE . 3.3 tp -97.49 135.81 38.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 0.0 109.906 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.499 HG12 ' HB3' ' A' ' 68' ' ' LYS . 6.7 pt -128.53 -5.42 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 110.409 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' O ' HD11 ' A' ' 85' ' ' LEU . 23.0 tt0 -137.05 139.04 41.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.393 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.852 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 166.49 122.47 0.61 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -51.06 -21.31 1.78 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -1.105 . . . . 0.0 110.23 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -72.79 -27.09 61.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.069 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.667 HD21 HG13 ' A' ' 98' ' ' ILE . 64.7 mt -66.28 -27.84 68.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.177 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.03 -169.67 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -84.62 4.6 31.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -1.147 . . . . 0.0 110.11 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.516 ' O ' HG21 ' A' ' 126' ' ' VAL . 46.8 p -90.41 -30.06 17.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.063 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.052 HD21 ' CG1' ' A' ' 128' ' ' ILE . 44.8 mt -116.99 166.27 12.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.392 -0.818 . . . . 0.0 110.008 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 49.0 tt0 -143.23 -79.57 0.21 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.306 -0.871 . . . . 0.0 110.018 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 51.9 mttt -80.16 139.74 36.67 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.57 -0.706 . . . . 0.0 110.531 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.779 HG13 HD23 ' A' ' 85' ' ' LEU . 7.3 mm -128.24 140.91 47.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 120.861 -1.149 . . . . 0.0 109.722 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.6 m -118.35 125.88 50.94 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.462 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.754 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.3 m-85 -122.77 135.89 54.7 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 37.2 tt0 -141.86 138.45 32.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.844 . . . . 0.0 110.149 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 81' ' ' TYR . 88.8 m -135.76 157.65 46.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 110.059 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 0.3 OUTLIER -149.31 144.16 26.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.266 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.665 HD23 HG12 ' A' ' 114' ' ' ILE . 5.7 mt -121.33 149.19 43.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 110.776 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.82 -169.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 109.711 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -118.68 165.43 13.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 96.3 p -123.95 162.51 40.79 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.248 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.8 Cg_endo -72.03 -2.93 12.31 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.019 1.536 . . . . 0.0 110.422 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.7 p -102.12 -0.36 33.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.3 -35.42 5.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.59 -173.04 3.23 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 73.3 p -128.35 133.71 48.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -1.161 . . . . 0.0 110.337 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 10' ' ' THR . 71.9 mt -81.66 149.64 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 110.183 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.665 HG12 HD23 ' A' ' 104' ' ' LEU . 8.7 mt -132.98 107.56 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.268 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.2 tttt -95.32 132.63 40.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.882 . . . . 0.0 110.069 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.3 OUTLIER -126.2 151.62 47.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 110.259 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.791 HG23 ' CG ' ' A' ' 6' ' ' GLU . 99.2 m -150.06 137.2 19.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.486 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 5.4 p -142.8 146.08 33.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 109.938 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.558 ' CE1' HG22 ' A' ' 117' ' ' THR . 41.6 m-70 -131.33 163.44 27.83 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 110.62 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 9.3 m-85 -122.91 150.29 43.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.579 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 93.8 m-70 -128.98 93.72 3.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 109.472 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.538 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.7 p -71.3 157.63 37.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 110.693 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.485 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 47.6 tptt -140.45 106.1 5.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.311 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 118.81 29.27 1.88 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.83 65.76 0.99 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -1.145 . . . . 0.0 110.214 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 94' ' ' THR . 26.9 m -141.67 162.15 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.176 -0.953 . . . . 0.0 110.099 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -130.6 168.51 16.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.27 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.052 ' CG1' HD21 ' A' ' 95' ' ' LEU . 4.7 mp -94.92 173.07 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.25 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.615 ' N ' HG22 ' A' ' 128' ' ' ILE . 34.5 mttt -110.38 129.92 55.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.387 -0.821 . . . . 0.0 109.658 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 130' ' ' GLU . 57.3 mm-40 -42.51 -39.32 2.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 110.267 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -60.95 -28.08 68.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.948 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.7 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 15.8 t-160 -78.01 -54.83 5.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 110.057 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.824 HG11 ' CE1' ' A' ' 5' ' ' TYR . 99.4 t -61.13 -38.32 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.847 . . . . 0.0 110.015 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.44 -39.46 88.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.062 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.35 83.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.991 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.79 -30.47 68.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.494 ' HE3' HG12 ' A' ' 133' ' ' VAL . 97.2 mttt -69.88 -31.41 69.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -1.123 . . . . 0.0 110.112 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.509 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 97.8 mt-10 -75.75 -39.33 57.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 110.05 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -62.45 -43.31 99.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -73.24 -34.52 65.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.018 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.0 m -71.51 -54.32 10.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.402 -0.811 . . . . 0.0 109.913 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 73.1 m-20 -51.53 -46.23 63.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.903 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 21.8 tp -57.74 -46.05 85.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 0.0 109.815 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 6.9 m-85 -53.89 -36.88 63.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.729 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 76.7 tttt -79.98 -13.14 59.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.47 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 20.9 mt -87.47 -36.57 17.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.211 -0.931 . . . . 0.0 108.927 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.704 HD13 ' CD1' ' A' ' 22' ' ' PHE . 45.3 mt -73.2 -41.67 58.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.518 ' O ' HG13 ' A' ' 13' ' ' ILE . 19.9 pt-20 -58.55 -31.98 68.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.344 -0.847 . . . . 0.0 109.243 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.463 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 31.8 m -80.0 -34.59 38.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.36 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.674 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 87.1 t80 -58.51 -53.88 53.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.501 -0.75 . . . . 0.0 109.883 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.167 HD21 ' CE2' ' A' ' 158' ' ' TYR . 76.5 mt -70.58 -31.35 68.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.268 -0.895 . . . . 0.0 110.047 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.4 tptt -70.08 -18.92 63.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.492 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.417 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.79 -31.65 2.88 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.592 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.0 m-70 -108.16 93.89 12.04 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.345 -1.091 . . . . 0.0 109.904 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.478 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.6 Cg_endo -74.01 5.81 3.3 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.077 1.567 . . . . 0.0 111.06 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -111.58 -9.07 14.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.056 -1.028 . . . . 0.0 109.683 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.69 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -64.81 102.33 0.58 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 110.03 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.167 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.8 OUTLIER 34.68 33.55 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.716 -0.615 . . . . 0.0 110.351 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.85 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 120' ' ' TYR . 74.4 t -122.53 142.37 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -1.159 . . . . 0.0 110.29 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.768 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.7 m-85 -91.72 152.36 20.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.891 . . . . 0.0 110.124 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.81 HG23 ' CE1' ' A' ' 119' ' ' HIS . 17.6 m -132.48 106.87 8.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 0.0 110.364 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.971 ' CE2' HG21 ' A' ' 133' ' ' VAL . 71.3 m-85 -121.54 143.04 49.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.867 . . . . 0.0 109.98 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.65 152.17 42.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.099 -1.001 . . . . 0.0 110.381 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.8 t -132.38 162.54 30.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 110.048 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -145.31 117.32 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.41 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.4 p90 -144.78 -171.48 3.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.879 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.666 HG22 HG12 ' A' ' 113' ' ' ILE . 19.2 p -138.6 -179.61 5.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 0.0 110.621 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 3.0 t -154.19 168.99 24.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.805 . . . . 0.0 110.22 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -92.58 -28.06 16.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.765 HG23 ' HD2' ' A' ' 14' ' ' PRO . 12.3 mm -82.96 148.02 55.88 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.057 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.765 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.4 Cg_endo -64.71 152.47 81.84 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.016 1.535 . . . . 0.0 110.821 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.674 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.4 Cg_endo -63.18 -36.25 58.91 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.917 1.483 . . . . 0.0 112.928 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -63.81 -20.29 68.29 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 N-CA-C 109.862 -0.861 . . . . 0.0 109.862 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.925 ' HB3' HD13 ' A' ' 151' ' ' LEU . 9.8 mmp_? -81.1 -46.03 15.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.763 ' CD1' HG22 ' A' ' 147' ' ' ILE . 4.1 mm? -74.03 -37.08 64.45 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.545 -0.862 . . . . 0.0 108.751 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 37.8 t80 -57.87 -56.69 18.65 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.158 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 89.0 mttt -58.2 -36.45 73.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.708 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.08 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.09 -63.64 1.37 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.435 -0.791 . . . . 0.0 110.738 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.923 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -51.95 -34.36 41.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.516 -0.74 . . . . 0.0 111.622 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.777 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.5 t -108.68 -65.03 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.974 -1.079 . . . . 0.0 111.637 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.1 mp -69.68 -1.6 9.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.22 -0.925 . . . . 0.0 111.303 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.752 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -148.47 23.09 1.03 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.879 -1.138 . . . . 0.0 110.476 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.923 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -62.49 -44.92 95.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.887 . . . . 0.0 110.201 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.503 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 63.8 m-20 -58.22 -15.39 9.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 110.207 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 74.0 m-20 -124.91 4.86 8.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.017 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.83 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -93.2 -49.09 6.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.425 -0.797 . . . . 0.0 109.946 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.035 HG11 HD12 ' A' ' 38' ' ' ILE . 3.5 t -71.17 -42.0 11.33 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.83 . . . . 0.0 110.895 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.7 Cg_endo -77.2 6.61 4.2 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.422 1.222 . . . . 0.0 110.722 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 63.3 mttt -124.63 -33.97 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.264 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.598 HD11 ' CD1' ' A' ' 29' ' ' LEU . 35.3 mt -80.1 -34.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.597 -0.69 . . . . 0.0 109.606 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.46 98.52 1.4 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.512 -0.742 . . . . 0.0 110.109 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.28 2.15 6.53 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.027 1.54 . . . . 0.0 110.726 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -90.54 -3.64 57.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.141 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.5 -33.48 6.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 110.165 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.035 HD12 HG11 ' A' ' 30' ' ' VAL . 6.7 mt -135.97 134.44 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.892 . . . . 0.0 110.284 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.55 ' CG ' ' CA ' ' A' ' 59' ' ' GLY . 9.1 mtmt -73.34 -39.14 65.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.373 -0.829 . . . . 0.0 110.302 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.568 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 177.01 164.16 0.49 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 110.211 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 69.5 m -124.73 120.07 30.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.921 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.529 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 51.0 tp10 -122.7 102.44 8.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.302 -0.874 . . . . 0.0 110.183 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 28.2 mt -50.32 130.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 110.164 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 55' ' ' LYS . 46.6 mt -88.61 -26.45 21.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 110.091 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 1.062 ' O ' HG23 ' A' ' 52' ' ' THR . 50.0 tt0 -157.08 173.88 16.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 110.23 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 58.98 -159.98 16.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -143.87 31.2 1.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -1.153 . . . . 0.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.783 ' H ' HG21 ' A' ' 52' ' ' THR . . . 105.42 3.0 41.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -97.49 -167.18 32.45 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.5 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 44.2 Cg_endo -70.32 137.09 33.07 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.065 1.56 . . . . 0.0 110.506 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.17 -6.72 83.31 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 1.062 HG23 ' O ' ' A' ' 45' ' ' GLU . 46.4 m -80.05 138.17 36.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -1.14 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' A' ' 70' ' ' LYS . 36.7 mm -105.61 121.27 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 110.037 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 52.3 mtmt -106.29 120.11 41.0 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 110.293 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HB2' HD11 ' A' ' 44' ' ' LEU . 80.1 tttt -91.94 101.11 13.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 0.0 110.2 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.555 ' CG2' HD13 ' A' ' 38' ' ' ILE . 90.6 mt -91.51 147.13 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 110.111 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.49 HG22 ' HB3' ' A' ' 66' ' ' TYR . 3.3 p -119.84 153.09 36.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.952 . . . . 0.0 110.652 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 12.9 m-85 -116.22 125.49 52.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 110.152 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.55 ' CA ' ' CG ' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.206 0.527 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -136.19 80.62 0.3 Allowed Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 19.7 p90 -125.81 179.31 5.24 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.319 -1.106 . . . . 0.0 110.23 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 66' ' ' TYR . 4.1 m -152.39 177.7 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.398 -0.813 . . . . 0.0 110.694 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 1.077 ' CE ' HD11 ' A' ' 86' ' ' ILE . 28.0 ttpt -134.93 107.64 7.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.49 -0.756 . . . . 0.0 109.689 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.902 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.5 m170 -96.66 130.67 43.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 111.247 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.709 ' HA ' HD13 ' A' ' 53' ' ' ILE . 56.8 tttt -102.75 109.04 20.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.366 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.1 mm -43.62 138.76 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 110.267 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.546 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 15.0 t0 -108.95 -40.47 5.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.654 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.475 ' C ' HD12 ' A' ' 74' ' ' ILE . 11.0 p 178.39 158.57 0.5 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.427 -0.796 . . . . 0.0 109.782 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.475 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -140.24 156.54 24.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.104 -0.998 . . . . 0.0 110.909 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -139.4 80.96 1.81 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.689 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.57 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 35.1 ttpt -64.11 -12.33 38.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 110.093 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -87.36 -29.6 21.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 108.987 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -111.46 -3.23 15.27 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.409 0.623 . . . . 0.0 109.385 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.848 ' O ' HD12 ' A' ' 104' ' ' LEU . 67.5 m-85 62.5 53.12 2.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.599 -0.688 . . . . 0.0 110.108 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.88 155.72 39.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.539 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.777 ' CE1' HG13 ' A' ' 23' ' ' VAL . 73.5 t80 -143.26 147.47 34.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 110.108 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.4 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 68.8 m -153.6 135.01 14.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 110.97 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.682 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.4 p90 -144.8 173.08 12.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.37 -0.831 . . . . 0.0 110.118 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 98' ' ' ILE . 87.4 m -126.67 124.8 40.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.818 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.902 HD13 ' CD2' ' A' ' 69' ' ' HIS . 9.2 tp -92.6 133.0 36.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.0 110.205 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 1.077 HD11 ' CE ' ' A' ' 68' ' ' LYS . 13.3 pt -123.64 -25.64 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 110.59 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HB3' ' CB ' ' A' ' 68' ' ' LYS . 42.6 tt0 -112.05 133.21 54.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.183 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.44 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . 168.23 140.74 3.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -69.87 -19.09 63.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -1.155 . . . . 0.0 110.279 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.719 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -71.95 -25.04 61.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 92' ' ' GLY . 38.7 mt -62.37 -33.09 74.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 110.114 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.25 -179.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -76.79 1.27 17.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -1.156 . . . . 0.0 109.923 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.679 ' O ' HG21 ' A' ' 126' ' ' VAL . 70.0 p -92.39 -33.57 14.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.823 HD21 HG13 ' A' ' 128' ' ' ILE . 34.8 mt -114.71 163.76 15.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 110.081 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.445 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 39.6 mt-10 -143.56 -79.78 0.2 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.249 -0.907 . . . . 0.0 110.006 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 53.8 mttt -80.12 141.6 35.61 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 110.668 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 84' ' ' THR . 5.2 mm -129.36 143.24 41.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.366 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.1 m -123.27 126.8 47.59 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.731 ' HE2' HG21 ' A' ' 98' ' ' ILE . 13.0 m-85 -121.63 135.27 54.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 110.221 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 74.6 tt0 -136.24 140.12 43.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.242 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 92.5 m -137.95 146.76 43.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 110.228 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 115' ' ' LYS . 19.3 mttt -138.09 145.72 42.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.866 HD23 HG12 ' A' ' 114' ' ' ILE . 2.8 mt -123.21 152.96 40.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 110.461 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.36 -169.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -127.35 125.55 40.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.26 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.447 ' HB3' HG13 ' A' ' 113' ' ' ILE . 95.4 p -82.21 160.57 62.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 110.187 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.36 -1.31 10.0 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.031 1.543 . . . . 0.0 110.553 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.1 t -98.73 -4.03 34.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.47 -41.61 2.19 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.92 -179.17 5.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 4.6 m -121.15 135.66 55.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.399 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.666 HG12 HG22 ' A' ' 10' ' ' THR . 74.9 mt -84.85 149.96 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.361 -0.837 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.866 HG12 HD23 ' A' ' 104' ' ' LEU . 4.7 mt -134.98 113.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 110.398 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 103' ' ' LYS . 22.4 ttmt -100.45 122.34 43.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.91 . . . . 0.0 109.831 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.0 t -114.7 158.12 22.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 0.0 110.619 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.616 HG22 ' NE2' ' A' ' 119' ' ' HIS . 93.4 m -156.32 133.64 10.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.38 -0.825 . . . . 0.0 110.043 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.6 p -133.02 157.78 44.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.153 -0.967 . . . . 0.0 110.334 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.81 ' CE1' HG23 ' A' ' 4' ' ' THR . 74.7 m-70 -141.25 167.06 23.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.131 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.803 ' O ' HG13 ' A' ' 2' ' ' VAL . 9.2 m-85 -131.33 150.03 52.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.43 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 92.9 m-70 -126.3 90.09 3.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 109.561 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.619 ' HB ' HG23 ' A' ' 126' ' ' VAL . 3.0 p -71.27 166.45 21.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.395 -0.815 . . . . 0.0 110.67 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 21.4 tttp -119.75 121.1 38.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -0.834 . . . . 0.0 110.153 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.46 -108.24 3.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.615 ' O ' HG13 ' A' ' 126' ' ' VAL . 51.5 t30 -139.63 94.35 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -1.166 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.679 HG21 ' O ' ' A' ' 94' ' ' THR . 16.7 m -157.65 159.68 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 0.0 110.098 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -133.84 154.26 51.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 110.282 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.823 HG13 HD21 ' A' ' 95' ' ' LEU . 3.3 mp -76.97 173.07 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.383 -0.823 . . . . 0.0 110.257 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.599 ' N ' HG22 ' A' ' 128' ' ' ILE . 60.5 mttt -101.85 128.88 48.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.106 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.47 ' HA ' HG12 ' A' ' 133' ' ' VAL . 53.4 mm-40 -44.53 -48.56 10.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 110.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 35.3 tt0 -54.67 -31.22 57.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 109.861 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.719 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 17.4 t-160 -75.58 -55.67 5.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.971 HG21 ' CE2' ' A' ' 5' ' ' TYR . 11.6 p -67.0 -40.96 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.553 ' N ' HG13 ' A' ' 133' ' ' VAL . 93.7 mttt -66.59 -46.25 76.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.07 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -60.39 -33.29 72.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 110.045 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.07 -26.06 71.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -75.09 -35.13 61.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 110.172 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.34 -35.84 61.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 109.976 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.422 ' O ' HD23 ' A' ' 143' ' ' LEU . 48.2 mtmt -68.65 -37.69 79.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 109.845 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.55 78.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.863 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.7 t -65.88 -48.45 71.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.379 -0.825 . . . . 0.0 109.953 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -53.82 -42.28 68.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.928 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 147' ' ' ILE . 2.6 mm? -58.7 -47.8 83.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 109.951 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.458 ' CE1' HG21 ' A' ' 114' ' ' ILE . 9.8 m-85 -56.31 -38.42 71.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 110.162 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 78.3 mttt -74.03 -21.98 59.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.107 -0.995 . . . . 0.0 109.93 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 15.0 mt -87.4 -35.29 18.4 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 108.701 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.763 HG22 ' CD1' ' A' ' 18' ' ' LEU . 67.9 mt -75.44 -37.36 37.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.575 -0.703 . . . . 0.0 109.129 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 19.8 pt-20 -62.83 -32.82 74.1 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.144 -0.972 . . . . 0.0 109.006 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.482 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 16.8 m -79.93 -26.76 39.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.19 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.688 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.9 t80 -60.94 -52.22 65.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.596 -0.69 . . . . 0.0 109.845 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.18 HD21 ' CE1' ' A' ' 158' ' ' TYR . 80.5 mt -76.41 -36.65 57.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.266 -0.896 . . . . 0.0 109.972 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.745 ' HB2' HD11 ' A' ' 13' ' ' ILE . 45.0 tptt -64.36 -21.69 66.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.57 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -109.31 -32.14 3.07 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.573 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.9 m-70 -108.37 93.49 11.62 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -1.096 . . . . 0.0 110.025 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.9 Cg_endo -74.14 5.05 3.79 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.0 1.526 . . . . 0.0 110.954 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -108.74 -6.33 15.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 109.886 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.688 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -75.35 101.33 4.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.865 . . . . 0.0 110.005 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.18 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.5 p90 34.03 36.8 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.817 -0.552 . . . . 0.0 110.82 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.526 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.728 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 120' ' ' TYR . 45.8 t -120.2 117.55 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.169 . . . . 0.0 110.224 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.595 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 76.7 m-85 -88.15 125.4 34.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.818 HG23 ' CE1' ' A' ' 119' ' ' HIS . 25.1 m -105.48 113.73 27.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 110.388 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.694 ' CE1' HG13 ' A' ' 133' ' ' VAL . 60.3 m-85 -117.26 125.76 51.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.079 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 116' ' ' SER . 20.9 pt-20 -133.74 154.89 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 110.302 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t -127.47 164.68 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.119 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -142.6 116.48 9.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.9 p90 -148.29 -170.12 3.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.308 -0.87 . . . . 0.0 110.204 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 113' ' ' ILE . 10.4 p -141.15 174.84 10.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.393 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.418 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 1.4 t -154.65 157.31 37.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -87.8 -14.48 39.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 110.118 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.812 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.3 mp -81.42 149.95 66.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.812 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.9 Cg_endo -66.36 145.75 78.45 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.003 1.528 . . . . 0.0 110.438 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.671 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 Cg_endo -72.23 -31.68 11.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.91 1.479 . . . . 0.0 113.054 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.9 Cg_endo -69.74 -21.14 33.99 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 110.108 -0.766 . . . . 0.0 110.108 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.63 ' HB3' HD13 ' A' ' 151' ' ' LEU . 7.1 mmp_? -85.68 -43.35 13.49 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.791 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.3 tt -72.2 -29.92 64.43 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 73.8 t80 -67.21 -56.98 7.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.565 -0.709 . . . . 0.0 109.58 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 66.0 mttt -54.84 -34.12 62.49 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.293 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.069 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.42 -55.8 5.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.519 -0.738 . . . . 0.0 110.918 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.929 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -58.61 -46.14 87.65 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.559 -0.713 . . . . 0.0 111.494 -178.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.129 HG11 ' CD1' ' A' ' 74' ' ' ILE . 18.2 t -98.17 -65.39 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.075 -1.015 . . . . 0.0 111.897 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.628 HD22 ' N ' ' A' ' 24' ' ' LEU . 4.1 mm? -65.41 -4.64 5.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 111.548 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.655 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -148.19 36.64 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.942 -1.099 . . . . 0.0 110.427 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.929 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -73.97 -36.51 64.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.419 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 68.5 m-20 -62.86 -13.58 35.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.128 -0.982 . . . . 0.0 110.355 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 78.2 m-20 -127.53 7.19 6.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.928 . . . . 0.0 110.2 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.684 HD13 HD11 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -95.38 -52.18 4.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.903 179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.927 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.5 t -71.35 -41.47 10.29 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.574 -0.704 . . . . 0.0 110.871 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.4 Cg_endo -77.88 9.69 2.9 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.484 1.255 . . . . 0.0 110.964 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 29.3 mttm -129.83 -33.39 1.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.056 -1.027 . . . . 0.0 109.753 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.684 HD11 HD13 ' A' ' 29' ' ' LEU . 50.1 mt -80.18 -41.46 20.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.495 -0.753 . . . . 0.0 109.464 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -147.28 99.42 3.91 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.515 -0.741 . . . . 0.0 110.034 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 45.7 Cg_endo -71.35 -1.31 9.48 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.089 1.573 . . . . 0.0 110.659 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -84.82 -11.45 55.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.113 -0.992 . . . . 0.0 109.669 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.861 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -102.41 -57.64 2.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.396 -0.815 . . . . 0.0 110.177 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.927 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.1 mp -121.74 107.36 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.402 -0.811 . . . . 0.0 110.176 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 16.8 tppt? -59.82 -25.28 64.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.601 ' CG ' ' N ' ' A' ' 41' ' ' SER . 0.2 OUTLIER -173.44 176.77 2.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.601 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 70.5 m -150.86 151.16 31.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 109.905 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 82.3 tt0 -157.52 105.81 2.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.256 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 34.5 mt -51.71 132.97 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.461 ' HB3' ' O ' ' A' ' 53' ' ' ILE . 33.5 tp -93.85 -47.36 6.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.9 . . . . 0.0 110.326 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.873 ' O ' HG23 ' A' ' 52' ' ' THR . 5.1 mm-40 -132.09 134.59 45.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.62 -164.46 37.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -129.68 11.17 5.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.104 . . . . 0.0 110.162 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.455 ' N ' HG21 ' A' ' 52' ' ' THR . . . 125.04 -9.18 7.97 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -75.91 -168.76 26.27 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.413 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.6 Cg_endo -70.58 133.41 24.02 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.169 1.615 . . . . 0.0 110.526 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.38 -4.53 73.64 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.873 HG23 ' O ' ' A' ' 45' ' ' GLU . 16.9 m -80.14 147.63 31.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -1.149 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 70' ' ' LYS . 25.8 mm -116.33 108.42 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.092 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.645 ' HE3' HD11 ' A' ' 71' ' ' ILE . 90.1 mttt -91.83 134.97 34.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 0.0 110.319 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -106.24 94.05 4.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 110.052 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.662 HD12 ' CE1' ' A' ' 69' ' ' HIS . 86.8 mt -80.53 144.07 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.191 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.575 HG22 ' OH ' ' A' ' 64' ' ' TYR . 1.1 p -112.33 156.74 21.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 110.246 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.775 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.1 m-85 -114.04 162.99 15.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.871 . . . . 0.0 110.326 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.402 ' HA3' ' HE2' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.638 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 7.8 t80 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.252 0.549 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -134.93 134.48 7.36 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.638 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 15.1 p90 -177.71 168.63 2.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -1.203 . . . . 0.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.2 m -142.19 173.5 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.35 -0.844 . . . . 0.0 110.422 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.518 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . 91.7 mttt -119.75 131.38 55.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.481 -0.762 . . . . 0.0 109.709 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.662 ' CE1' HD12 ' A' ' 56' ' ' ILE . 14.2 m170 -113.51 132.37 55.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.93 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.64 ' HA ' HD13 ' A' ' 53' ' ' ILE . 76.2 tttt -111.33 107.53 16.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.837 . . . . 0.0 109.253 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.645 HD11 ' HE3' ' A' ' 54' ' ' LYS . 27.8 mm -48.57 135.47 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.983 . . . . 0.0 110.412 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.466 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 15.8 m-20 -105.26 -45.36 4.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 109.398 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 29.0 p 177.4 156.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.641 -0.662 . . . . 0.0 110.13 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.129 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.8 tt -147.55 165.31 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.035 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-20 -134.84 80.1 1.83 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.328 -0.857 . . . . 0.0 110.041 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.566 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 24.0 mttt -56.13 -15.11 3.23 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.179 -0.95 . . . . 0.0 110.607 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -93.37 -30.81 14.91 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.294 -0.879 . . . . 0.0 109.557 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.4 m-80 -106.87 -1.34 22.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.552 -0.718 . . . . 0.0 109.424 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.639 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 68.7 m-85 63.66 52.85 2.14 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.369 0.604 . . . . 0.0 110.82 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.54 ' HB3' ' CG ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -126.88 151.11 48.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.634 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.596 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 77.3 t80 -145.57 163.64 34.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.189 -0.944 . . . . 0.0 110.14 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.496 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 84.8 p -168.51 146.21 4.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.015 -1.053 . . . . 0.0 110.799 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.622 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 2.6 p90 -148.23 -179.12 6.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.328 -0.857 . . . . 0.0 110.401 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 98' ' ' ILE . 24.7 m -136.41 128.19 29.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.438 -0.789 . . . . 0.0 109.992 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.65 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 7.0 tp -80.39 121.97 26.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.275 -0.89 . . . . 0.0 110.073 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.518 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 27.5 pt -101.77 -11.56 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.89 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.438 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 66.7 tt0 -154.17 151.85 29.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.178 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.848 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 168.36 157.18 10.97 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' ALA . 65.8 t0 -72.2 -54.14 10.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -1.141 . . . . 0.0 110.366 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' ASP . . . -42.4 -31.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.543 HD23 ' CD2' ' A' ' 95' ' ' LEU . 21.2 mt -52.42 -53.17 48.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 110.128 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.76 -171.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -72.49 -2.08 18.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.126 . . . . 0.0 110.189 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.713 ' O ' HG21 ' A' ' 126' ' ' VAL . 34.9 p -89.64 -60.46 1.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 110.37 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.956 HD11 HD11 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -105.06 163.07 12.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.317 -0.865 . . . . 0.0 109.258 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.77 ' H ' HD12 ' A' ' 95' ' ' LEU . 76.4 mm-40 -142.64 -81.12 0.21 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 110.324 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.489 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 71.2 mttt -80.25 153.64 28.39 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.545 -0.722 . . . . 0.0 110.621 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.956 HD11 HD11 ' A' ' 95' ' ' LEU . 35.1 mm -140.66 159.95 24.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.727 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -135.35 126.41 27.88 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.366 -0.834 . . . . 0.0 108.903 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.809 ' CE2' HG21 ' A' ' 98' ' ' ILE . 22.4 m-85 -123.77 135.68 53.96 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.189 -0.944 . . . . 0.0 110.497 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 71.7 tt0 -139.18 124.95 19.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 0.0 110.238 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 89.0 m -118.63 145.42 45.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.088 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.54 ' CG ' ' HB3' ' A' ' 80' ' ' SER . 7.5 mttt -136.72 132.89 35.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.317 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.871 HD23 HG12 ' A' ' 114' ' ' ILE . 4.4 mt -106.74 153.51 22.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.086 -1.009 . . . . 0.0 110.07 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.96 -168.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.173 -0.954 . . . . 0.0 109.964 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.692 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -119.46 158.61 25.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.225 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 25.8 p -119.67 165.35 17.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 110.216 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.6 Cg_endo -72.5 -1.48 10.33 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.089 1.573 . . . . 0.0 110.506 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.4 m -104.94 -5.9 20.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.149 -0.97 . . . . 0.0 110.227 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.33 -32.52 6.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.83 -171.76 2.88 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 5.9 m -129.85 132.72 46.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -1.14 . . . . 0.0 110.257 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.563 ' HA ' HG22 ' A' ' 10' ' ' THR . 11.4 mt -82.84 152.58 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.871 HG12 HD23 ' A' ' 104' ' ' LEU . 5.9 mt -133.55 114.31 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 110.184 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 103' ' ' LYS . 69.5 tttt -103.31 108.81 20.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.2 m -99.42 157.33 16.5 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.266 -0.896 . . . . 0.0 110.29 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 71.6 m -156.5 131.46 9.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.848 . . . . 0.0 109.916 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 99' ' ' SER . 89.3 p -134.31 148.9 50.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.029 . . . . 0.0 110.696 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.818 ' CE1' HG23 ' A' ' 4' ' ' THR . 39.7 m-70 -131.56 138.92 49.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.775 . . . . 0.0 110.015 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.631 ' HA ' HD13 ' A' ' 98' ' ' ILE . 12.1 m-30 -100.13 150.98 21.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 110.691 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.489 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 98.5 m-70 -128.08 90.7 3.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 0.0 109.488 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 95' ' ' LEU . 2.8 p -79.52 161.3 26.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 110.539 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -120.34 115.53 23.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 110.061 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.16 -141.54 15.37 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.468 ' C ' HG13 ' A' ' 126' ' ' VAL . 53.1 t30 -113.23 96.22 5.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 110.223 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 94' ' ' THR . 21.8 m -151.45 168.62 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.297 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -138.9 160.19 40.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.591 HG12 ' CE1' ' A' ' 3' ' ' PHE . 35.5 mm -74.9 173.36 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.589 ' N ' HG22 ' A' ' 128' ' ' ILE . 40.6 mttt -110.9 133.75 53.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 0.0 110.228 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 129' ' ' LYS . 1.1 mt-10 -43.5 -49.21 7.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.148 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -58.53 -36.06 73.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 110.108 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -68.88 -44.2 73.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.195 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.694 HG13 ' CE1' ' A' ' 5' ' ' TYR . 60.6 t -61.64 -38.05 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.983 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -77.82 -42.49 33.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.57 -37.61 87.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.098 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.27 -29.97 74.93 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 84.9 mttt -79.26 -31.26 43.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -1.114 . . . . 0.0 110.111 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -78.03 -32.93 51.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.852 . . . . 0.0 110.092 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -73.81 -28.18 61.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.412 -0.805 . . . . 0.0 110.015 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -80.05 -36.72 35.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.925 . . . . 0.0 110.051 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.0 p -71.29 -46.76 60.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.409 -0.807 . . . . 0.0 110.025 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.429 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 98.4 m-20 -55.47 -49.3 72.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 110.01 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 147' ' ' ILE . 69.8 mt -57.48 -41.98 81.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.915 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 6.3 m-85 -59.74 -40.92 89.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.485 -0.76 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.43 ' HB3' ' HE3' ' A' ' 145' ' ' LYS . 18.3 mtpp -80.0 -16.79 54.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.115 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 142' ' ' ASN . 27.9 mt -84.26 -36.37 22.72 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.151 -0.968 . . . . 0.0 108.833 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.74 HD13 ' CD1' ' A' ' 22' ' ' PHE . 97.3 mt -72.58 -45.16 59.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.799 ' HB3' HD13 ' A' ' 13' ' ' ILE . 69.1 mt-10 -57.09 -40.58 77.23 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.3 m -68.53 -35.61 77.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.94 . . . . 0.0 109.459 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.653 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.5 t80 -54.27 -46.46 72.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.518 -0.739 . . . . 0.0 109.908 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.181 HD21 ' CE2' ' A' ' 158' ' ' TYR . 94.7 mt -79.87 -31.07 40.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.716 ' HB2' HD11 ' A' ' 13' ' ' ILE . 73.3 tttt -71.11 -25.51 62.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.573 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.33 -34.21 3.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.538 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.9 m-70 -106.91 92.67 7.84 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.259 -1.142 . . . . 0.0 110.179 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.514 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.5 Cg_endo -74.26 6.44 3.06 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.097 1.578 . . . . 0.0 111.072 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -107.43 -2.6 20.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.916 -1.115 . . . . 0.0 109.775 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.653 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -78.67 104.35 9.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.501 -0.749 . . . . 0.0 110.123 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.181 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.66 33.19 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.348 0.594 . . . . 0.0 110.357 -179.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.54 ' HA ' ' NH1' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.862 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 68.5 t -132.1 118.28 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 110.207 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.589 ' CE1' HG12 ' A' ' 128' ' ' ILE . 64.8 m-85 -93.47 125.92 38.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.34 -0.85 . . . . 0.0 110.06 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.854 HG23 ' CE1' ' A' ' 119' ' ' HIS . 28.9 m -107.88 111.04 22.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.853 . . . . 0.0 110.304 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.646 ' CE1' HG13 ' A' ' 133' ' ' VAL . 60.0 m-85 -116.65 138.17 51.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.836 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.576 ' HB3' HG23 ' A' ' 117' ' ' THR . 18.8 pt-20 -141.21 167.37 22.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.149 -0.97 . . . . 0.0 110.654 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.404 ' C ' ' HG3' ' A' ' 8' ' ' GLU . 32.1 t -143.63 157.75 44.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.43 -0.794 . . . . 0.0 109.806 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 7' ' ' SER . 97.1 mt-10 -141.93 117.51 10.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.008 . . . . 0.0 110.628 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 p90 -138.5 -175.09 4.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.84 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.563 HG22 HG12 ' A' ' 113' ' ' ILE . 23.2 p -136.57 178.92 6.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.524 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.516 ' CB ' ' OE2' ' A' ' 148' ' ' GLU . 59.1 p -160.04 163.73 33.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.464 -0.773 . . . . 0.0 110.458 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -89.21 -10.2 47.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.906 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.78 HG23 ' HD2' ' A' ' 14' ' ' PRO . 3.4 mp -92.32 149.87 39.17 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.828 . . . . 0.0 110.058 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.78 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.6 Cg_endo -66.02 145.31 79.09 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.997 1.525 . . . . 0.0 110.367 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.67 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.7 Cg_endo -71.11 -32.25 13.47 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.888 1.468 . . . . 0.0 112.796 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -68.38 -20.91 41.65 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.545 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 53.4 mmm-85 -84.29 -46.3 11.95 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.766 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -71.99 -24.95 61.66 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.609 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 89.1 t80 -68.61 -59.82 2.86 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.519 0.676 . . . . 0.0 109.346 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 77.5 mttt -52.04 -38.15 55.99 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.237 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.018 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -70.06 -55.44 9.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 110.711 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.044 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -57.12 -49.7 75.09 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 111.235 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.979 HG11 ' CD1' ' A' ' 74' ' ' ILE . 10.3 t -95.28 -65.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.971 -1.08 . . . . 0.0 111.722 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.598 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.3 mp -64.83 -4.37 4.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.177 -0.952 . . . . 0.0 111.805 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.634 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -148.28 33.19 0.81 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.715 -1.24 . . . . 0.0 110.548 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.044 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -71.99 -34.03 68.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 0.0 110.241 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 41' ' ' SER . 12.8 t70 -64.97 -13.85 58.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.91 . . . . 0.0 110.287 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.524 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 80.9 m-20 -126.78 3.34 6.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.112 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.702 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -90.15 -54.78 3.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 110.234 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.049 HG11 HD13 ' A' ' 38' ' ' ILE . 92.6 t -65.81 -41.26 45.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 111.109 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 48.4 Cg_endo -76.73 4.98 5.16 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.369 1.194 . . . . 0.0 110.608 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 47.1 mttm -125.87 -31.69 2.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.58 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.702 HD11 ' CD1' ' A' ' 29' ' ' LEU . 23.5 mt -80.06 -39.22 19.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.523 -0.735 . . . . 0.0 109.859 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -163.17 97.74 1.05 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 110.19 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.83 5.23 4.53 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.009 1.531 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -87.1 -15.75 37.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 110.025 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.44 -35.38 10.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.207 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.049 HD13 HG11 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -129.98 145.56 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 109.906 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -83.86 -35.18 24.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 110.48 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.564 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 178.8 157.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 110.249 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 58.5 m -118.19 126.95 53.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.066 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 58.2 tt0 -134.66 105.95 6.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 19.0 mt -59.63 134.0 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.5 tp -95.03 -44.31 7.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.334 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 1.02 ' O ' HG23 ' A' ' 52' ' ' THR . 11.5 mt-10 -127.18 159.32 34.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 61.8 -161.16 28.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -134.43 10.67 3.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -1.152 . . . . 0.0 110.181 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.526 ' N ' HG21 ' A' ' 52' ' ' THR . . . 128.08 -6.69 6.82 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.555 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -86.68 -163.19 38.25 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.72 131.83 20.64 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.013 1.533 . . . . 0.0 110.601 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.01 -6.54 69.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 1.02 HG23 ' O ' ' A' ' 45' ' ' GLU . 20.4 m -79.98 135.68 36.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -1.164 . . . . 0.0 110.144 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.55 HD13 ' HA ' ' A' ' 70' ' ' LYS . 25.9 mm -105.22 113.79 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.208 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.616 ' HE3' HD11 ' A' ' 71' ' ' ILE . 95.1 mttt -99.15 138.78 35.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.376 -0.828 . . . . 0.0 110.298 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -110.97 92.76 4.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.164 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.8 mt -79.99 143.83 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 109.881 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.489 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 6.8 p -116.87 160.16 21.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.688 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.768 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.4 m-85 -120.08 163.14 18.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.534 -0.729 . . . . 0.0 110.059 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.648 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 t80 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.234 0.54 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -129.18 137.21 9.44 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.648 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 13.4 p90 -178.26 169.43 1.85 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -1.135 . . . . 0.0 110.081 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.992 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.5 m -142.42 172.21 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.895 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.442 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 43.7 mtpt -122.95 121.2 35.55 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.59 ' CD2' ' HG ' ' A' ' 85' ' ' LEU . 21.7 m170 -116.39 135.28 54.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.023 . . . . 0.0 111.31 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HA ' HD13 ' A' ' 53' ' ' ILE . 82.9 tttt -111.15 121.74 46.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.415 -0.803 . . . . 0.0 109.12 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.616 HD11 ' HE3' ' A' ' 54' ' ' LYS . 30.1 mm -60.58 134.89 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 110.436 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 19.2 t0 -105.73 -47.92 3.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.482 -0.761 . . . . 0.0 109.864 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -179.99 159.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.543 -0.723 . . . . 0.0 110.205 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.979 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.4 tt -149.13 164.55 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.992 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -127.13 78.9 1.85 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.877 . . . . 0.0 110.042 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.609 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 63.4 mttp -54.34 -15.81 1.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.42 -0.8 . . . . 0.0 110.819 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -92.07 -30.47 16.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.93 . . . . 0.0 109.861 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -110.59 -1.37 16.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.537 -0.727 . . . . 0.0 109.691 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.742 ' O ' HD12 ' A' ' 104' ' ' LEU . 9.1 m-85 66.01 48.48 1.76 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.688 -0.632 . . . . 0.0 110.518 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -118.56 151.77 37.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.345 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.654 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 84.4 t80 -148.11 143.79 27.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.047 -1.033 . . . . 0.0 110.285 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.487 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 66.5 m -149.61 134.0 17.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.393 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.654 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 4.0 p90 -137.54 179.29 6.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 110.048 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.86 HG23 ' O ' ' A' ' 98' ' ' ILE . 90.2 m -125.08 128.97 49.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.913 . . . . 0.0 110.17 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.762 HD22 HD11 ' A' ' 91' ' ' LEU . 1.5 tt -91.75 140.99 29.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.137 -0.977 . . . . 0.0 110.121 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.672 ' N ' HD23 ' A' ' 85' ' ' LEU . 21.1 pt -127.64 -24.62 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.033 -1.042 . . . . 0.0 110.487 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.442 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 72.6 tt0 -138.12 115.69 11.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.102 -0.999 . . . . 0.0 110.613 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.992 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -165.03 132.79 2.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 88' ' ' GLY . 60.2 t0 -42.85 -36.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -1.194 . . . . 0.0 110.402 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.855 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -62.76 -25.3 68.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.146 -0.971 . . . . 0.0 110.354 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.907 HD21 HG13 ' A' ' 98' ' ' ILE . 96.8 mt -68.04 -28.18 67.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.288 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.34 -168.54 0.31 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -90.04 12.72 16.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -1.158 . . . . 0.0 110.183 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 122' ' ' THR . 25.2 p -105.54 -52.11 2.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.145 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.919 HD21 ' CD1' ' A' ' 128' ' ' ILE . 48.7 mt -79.95 151.01 30.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.069 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.45 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 68.3 mt-10 -127.4 -80.91 0.6 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.34 -0.85 . . . . 0.0 110.269 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 85.5 mttt -80.26 147.15 31.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.593 -0.692 . . . . 0.0 110.292 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.907 HG13 HD21 ' A' ' 91' ' ' LEU . 10.5 mm -135.46 145.91 30.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.94 -1.1 . . . . 0.0 110.043 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -122.66 124.79 44.24 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.465 -0.772 . . . . 0.0 108.92 178.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.853 ' CE2' HG21 ' A' ' 98' ' ' ILE . 14.7 m-85 -121.62 132.64 54.78 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.384 -0.823 . . . . 0.0 110.359 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.487 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 26.6 tt0 -132.8 146.91 52.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -0.859 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 81' ' ' TYR . 57.2 m -145.68 135.99 23.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 110.066 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 115' ' ' LYS . 4.1 tttt -129.07 148.63 51.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.185 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 79' ' ' TYR . 10.5 mt -122.64 148.06 45.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 110.458 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.712 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.09 -168.34 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.355 -0.84 . . . . 0.0 109.616 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.712 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -130.69 137.64 49.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.505 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.649 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 5.4 p -80.04 -161.09 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.367 -0.833 . . . . 0.0 109.211 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.649 ' CD ' ' CB ' ' A' ' 107' ' ' SER . 43.9 Cg_endo -83.46 70.72 6.32 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.348 1.183 . . . . 0.0 109.499 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 2.3 m 58.23 30.16 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.528 -0.733 . . . . 0.0 109.594 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.42 34.21 3.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . 107.75 -147.84 16.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 57.5 p -138.05 139.34 39.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.129 -1.218 . . . . 0.0 110.079 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.563 HG12 HG22 ' A' ' 10' ' ' THR . 33.3 mt -88.79 147.49 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 110.243 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.731 HD11 ' OE2' ' A' ' 148' ' ' GLU . 6.0 mt -127.63 108.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 110.069 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 103' ' ' LYS . 34.8 mtpt -90.22 145.95 24.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 110.291 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.2 t -140.95 155.7 46.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.12 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.576 HG23 ' HB3' ' A' ' 6' ' ' GLU . 24.2 m -159.99 153.31 22.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.342 -0.849 . . . . 0.0 110.137 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 99' ' ' SER . 94.4 p -153.26 154.7 35.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.173 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.854 ' CE1' HG23 ' A' ' 4' ' ' THR . 51.9 m-70 -136.92 136.56 38.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.233 -0.917 . . . . 0.0 110.072 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 7.1 m-30 -99.01 151.06 21.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.245 -0.909 . . . . 0.0 110.719 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 96.9 m-70 -130.14 78.13 1.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.729 HG23 HD23 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -73.5 157.44 36.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.359 -0.838 . . . . 0.0 110.686 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 86.2 tttt -105.43 120.41 41.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 110.237 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.28 -161.77 21.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.558 ' C ' HG13 ' A' ' 126' ' ' VAL . 58.0 t30 -102.31 111.13 23.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -1.167 . . . . 0.0 110.245 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.558 HG13 ' C ' ' A' ' 125' ' ' ASN . 24.5 m -156.47 170.86 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.254 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -128.66 136.17 50.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.919 ' CD1' HD21 ' A' ' 95' ' ' LEU . 48.6 mm -57.91 173.4 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 0.0 110.035 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.587 ' N ' HG22 ' A' ' 128' ' ' ILE . 39.9 mtpt -102.82 130.4 49.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.938 . . . . 0.0 110.255 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -45.72 -51.06 13.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 110.157 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 35.9 tt0 -58.77 -34.86 71.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 110.074 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.855 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 18.3 t-160 -67.52 -41.48 84.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 0.0 110.074 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.646 HG13 ' CE1' ' A' ' 5' ' ' TYR . 85.7 t -65.94 -45.83 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.434 -0.791 . . . . 0.0 110.059 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -74.87 -39.28 61.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.049 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -62.67 -39.63 94.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 110.015 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.58 -29.67 75.7 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -76.5 -31.38 57.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -1.127 . . . . 0.0 110.075 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -78.8 -32.41 46.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.63 -41.12 69.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.0 109.938 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.574 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.27 -33.46 63.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.8 m -68.4 -48.47 64.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.82 . . . . 0.0 109.936 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -55.91 -44.25 78.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.853 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 143' ' ' LEU . 24.9 mt -62.29 -35.7 79.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.89 . . . . 0.0 109.945 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 8.3 m-85 -64.12 -36.1 82.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.085 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -78.87 -13.95 59.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 0.0 110.169 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.515 ' HB3' HG21 ' A' ' 33' ' ' ILE . 17.3 mt -85.19 -36.82 20.76 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 108.969 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.675 HD11 ' CE1' ' A' ' 22' ' ' PHE . 11.6 mt -69.74 -44.31 79.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.731 ' OE2' HD11 ' A' ' 114' ' ' ILE . 12.3 mm-40 -59.31 -44.95 92.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 66.0 m -60.78 -35.98 77.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.977 . . . . 0.0 109.392 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.595 ' CD1' HG12 ' A' ' 33' ' ' ILE . 71.8 t80 -54.24 -55.63 26.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.525 -0.734 . . . . 0.0 109.693 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.968 HD21 ' CE1' ' A' ' 158' ' ' TYR . 26.7 mt -71.69 -29.46 64.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.403 -0.811 . . . . 0.0 110.25 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.758 ' HB2' HD11 ' A' ' 13' ' ' ILE . 74.5 tttt -61.15 -18.35 57.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.108 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.495 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -122.53 -16.26 3.84 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 14.5 m-70 -107.01 90.1 5.07 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.191 -1.182 . . . . 0.0 110.219 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.9 Cg_endo -73.15 2.21 5.8 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.072 1.564 . . . . 0.0 110.859 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -122.6 -2.03 8.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.109 -0.994 . . . . 0.0 109.933 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.675 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -49.45 110.02 0.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.421 -0.799 . . . . 0.0 110.398 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.018 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.46 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.584 -0.698 . . . . 0.0 110.618 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.536 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.744 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.453 ' O ' ' OG1' ' A' ' 122' ' ' THR . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 120' ' ' TYR . 26.4 t -129.09 134.94 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -1.15 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.638 ' CG ' ' CD1' ' A' ' 128' ' ' ILE . 25.4 m-85 -100.6 158.09 16.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.317 -0.865 . . . . 0.0 109.809 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.708 HG23 ' ND1' ' A' ' 119' ' ' HIS . 96.0 m -131.72 113.56 13.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -0.996 . . . . 0.0 110.504 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.814 ' CE1' HG22 ' A' ' 133' ' ' VAL . 85.7 m-85 -118.12 125.41 50.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 110.02 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.003 ' CG ' HG23 ' A' ' 117' ' ' THR . 7.3 mt-10 -137.12 151.59 49.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 110.128 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -133.97 153.76 51.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.283 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 94.6 mt-10 -133.88 116.68 15.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 110.142 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -146.57 -176.17 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 110.055 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -136.15 176.89 8.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 112' ' ' SER . 90.9 p -154.13 150.0 27.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.796 . . . . 0.0 110.186 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -73.45 -6.16 44.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.895 HD13 ' HB3' ' A' ' 148' ' ' GLU . 3.2 mp -94.06 149.59 37.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.034 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.812 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.4 Cg_endo -66.92 147.08 79.83 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.095 1.576 . . . . 0.0 110.246 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 Cg_endo -72.01 -32.09 11.5 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.836 1.44 . . . . 0.0 112.957 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.4 Cg_endo -71.31 -21.12 27.03 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 N-CA-C 110.058 -0.786 . . . . 0.0 110.058 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.95 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -83.28 -46.29 12.81 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.927 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -70.8 -30.57 67.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 53.6 t80 -64.99 -56.72 11.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.355 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 55.0 mttt -50.92 -40.33 56.8 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.027 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.016 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -68.71 -60.47 2.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.551 -0.718 . . . . 0.0 110.813 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.024 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -50.16 -57.02 8.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.653 -0.654 . . . . 0.0 112.046 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.039 HG11 ' CD1' ' A' ' 74' ' ' ILE . 6.6 t -94.7 -59.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.951 -1.093 . . . . 0.0 112.287 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.2 mp -68.92 -0.74 5.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.055 -1.028 . . . . 0.0 111.712 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.732 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -152.64 30.03 0.53 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.84 -1.162 . . . . 0.0 110.635 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.024 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.03 -41.79 86.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 110.093 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 16.4 m-20 -58.14 -15.54 10.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.159 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.532 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 67.2 m-80 -127.16 10.13 6.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.255 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.732 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -96.85 -50.57 4.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.308 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.004 HG21 HD13 ' A' ' 38' ' ' ILE . 6.9 p -73.83 -27.22 0.78 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 112.128 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.804 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -82.71 11.13 3.33 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.636 0.808 . . . . 0.0 110.588 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 28' ' ' ASN . 52.6 mtpt -136.83 -28.11 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.13 -0.981 . . . . 0.0 110.793 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.63 HD11 ' CD1' ' A' ' 29' ' ' LEU . 29.4 mt -76.27 -42.01 36.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.167 -0.958 . . . . 0.0 109.857 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.84 101.38 1.3 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.37 -0.831 . . . . 0.0 110.406 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.3 -0.45 9.21 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.086 1.571 . . . . 0.0 110.44 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -89.1 -17.9 28.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 110.015 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.21 -39.64 9.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 110.083 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.004 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -133.69 142.28 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 109.911 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 57' ' ' THR . 35.3 ttmt -76.66 -42.52 41.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.871 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.538 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.44 158.68 0.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.9 . . . . 0.0 110.176 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 24.4 m -115.27 126.39 54.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.224 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.41 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 66.1 tt0 -133.8 103.45 5.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.239 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 23.8 mt -52.58 130.45 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.541 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 44.8 mt -89.7 -46.85 8.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.931 ' O ' HG23 ' A' ' 52' ' ' THR . 9.4 mm-40 -132.52 151.83 51.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.411 -0.806 . . . . 0.0 110.192 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.54 -158.29 48.7 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -143.53 14.21 1.78 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -1.172 . . . . 0.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.588 ' H ' HG21 ' A' ' 52' ' ' THR . . . 121.27 -2.03 11.47 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.61 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -90.94 -168.07 41.77 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.82 130.95 20.15 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.146 1.603 . . . . 0.0 110.549 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.71 -2.76 70.35 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.931 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.5 m -79.96 145.43 32.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -1.182 . . . . 0.0 109.966 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.506 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 33.6 mm -111.14 114.88 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 110.44 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.717 ' CE ' HD11 ' A' ' 71' ' ' ILE . 99.5 mttt -100.74 139.79 35.93 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.415 -0.803 . . . . 0.0 110.033 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 85.6 tttt -116.09 95.47 5.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.096 -1.002 . . . . 0.0 110.438 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.535 ' CG2' HG12 ' A' ' 38' ' ' ILE . 78.3 mt -85.71 144.71 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 38' ' ' ILE . 5.5 p -114.57 158.16 22.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 110.842 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.808 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.3 m-85 -116.03 140.59 49.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.51 -0.744 . . . . 0.0 110.244 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.594 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 10.3 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.277 0.56 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -123.81 137.27 10.75 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.594 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 13.5 p90 -178.74 166.04 1.67 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.253 -1.145 . . . . 0.0 110.03 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.922 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.1 m -141.57 172.68 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 110.779 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.614 ' O ' HD22 ' A' ' 85' ' ' LEU . 93.1 mttt -125.95 125.19 42.33 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.971 ' CD2' HD23 ' A' ' 85' ' ' LEU . 11.3 m170 -115.67 118.81 34.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.964 -1.085 . . . . 0.0 111.429 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 1.085 ' HE3' HD13 ' A' ' 86' ' ' ILE . 35.5 mttt -92.59 104.32 16.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.193 -0.942 . . . . 0.0 108.878 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.717 HD11 ' CE ' ' A' ' 54' ' ' LYS . 44.2 mm -47.43 135.62 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.407 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.518 ' CB ' ' HA ' ' A' ' 83' ' ' TYR . 14.9 m-20 -109.22 -44.18 3.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.457 -0.777 . . . . 0.0 109.697 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER 175.5 160.2 0.25 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.45 -0.781 . . . . 0.0 110.509 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.039 ' CD1' HG11 ' A' ' 23' ' ' VAL . 4.4 tt -147.4 168.17 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.647 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.5 m-20 -134.97 82.22 1.95 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.106 -0.996 . . . . 0.0 110.263 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.583 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 95.4 mttt -58.43 -14.29 7.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.214 -0.929 . . . . 0.0 110.607 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -95.34 -30.54 13.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.217 -0.927 . . . . 0.0 109.591 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.4 m-80 -106.07 -2.84 22.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.712 -0.618 . . . . 0.0 109.428 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.514 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 96.3 m-85 62.56 54.19 2.48 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.463 0.649 . . . . 0.0 110.651 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -132.2 150.4 52.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.544 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 72.0 t80 -143.42 152.46 41.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 109.991 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.473 ' HB3' ' CG ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -158.7 149.95 20.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.022 -1.049 . . . . 0.0 110.697 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 38.1 p90 -158.6 173.3 16.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.411 -0.805 . . . . 0.0 110.367 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.496 ' HB ' ' HB2' ' A' ' 70' ' ' LYS . 88.5 m -113.29 123.66 50.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.376 -0.828 . . . . 0.0 109.871 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.971 HD23 ' CD2' ' A' ' 69' ' ' HIS . 2.5 tm? -95.73 136.49 36.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 1.085 HD13 ' HE3' ' A' ' 70' ' ' LYS . 13.3 pt -122.0 -28.33 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 110.548 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.585 ' O ' HD21 ' A' ' 85' ' ' LEU . 2.2 tt0 -116.07 141.08 48.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 110.226 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.922 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 167.08 123.81 0.68 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 67.7 t0 -45.01 -25.08 0.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.418 -1.048 . . . . 0.0 110.139 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.403 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -70.02 -25.86 63.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.913 . . . . 0.0 110.343 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.538 HD21 ' CG1' ' A' ' 98' ' ' ILE . 89.6 mt -61.44 -33.02 73.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.3 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.71 -167.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -90.54 11.5 21.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -1.16 . . . . 0.0 110.227 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 122' ' ' THR . 36.9 p -102.93 -37.43 7.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.19 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.917 HD23 HG23 ' A' ' 122' ' ' THR . 15.7 mt -110.26 157.17 19.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.042 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -131.33 -78.79 0.52 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.294 -0.879 . . . . 0.0 110.345 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 37.8 mttp -80.18 148.11 31.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 0.0 110.384 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.909 HG21 ' CE2' ' A' ' 100' ' ' TYR . 6.7 mm -132.44 142.66 42.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.936 -1.103 . . . . 0.0 110.055 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.9 m -116.3 120.44 38.91 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.909 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.7 m-85 -115.41 137.66 51.81 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 110.882 -178.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.473 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 4.7 mt-10 -141.21 137.11 32.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.453 -0.779 . . . . 0.0 109.803 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.9 m -131.98 148.01 52.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -136.99 133.83 35.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.077 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.69 HD22 HD12 ' A' ' 18' ' ' LEU . 8.0 mt -119.35 145.97 45.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 110.504 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.0 -169.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.375 -0.828 . . . . 0.0 109.86 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.7 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.53 139.94 52.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.257 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.425 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 84.7 p -95.3 162.87 23.22 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 110.219 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.8 Cg_endo -73.43 -1.09 10.16 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.02 1.537 . . . . 0.0 110.549 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.7 p -98.67 -11.04 22.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.58 -29.22 7.36 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.73 -162.55 7.99 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.504 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 11.8 p -132.33 134.57 45.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -1.087 . . . . 0.0 110.285 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' HG22 ' A' ' 10' ' ' THR . 15.7 mt -83.69 142.55 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.887 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.659 HG12 HD23 ' A' ' 104' ' ' LEU . 9.0 mt -129.62 113.0 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.972 . . . . 0.0 110.501 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 87.1 tttt -102.06 111.54 23.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.895 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 9' ' ' PHE . 1.5 m -93.47 160.08 14.96 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.197 -0.939 . . . . 0.0 110.475 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.003 HG23 ' CG ' ' A' ' 6' ' ' GLU . 40.5 m -154.7 142.47 19.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.391 -0.818 . . . . 0.0 110.29 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 99' ' ' SER . 4.4 p -155.53 139.21 16.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.708 ' ND1' HG23 ' A' ' 4' ' ' THR . 29.2 m-70 -130.5 130.62 44.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.215 -0.928 . . . . 0.0 109.802 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.721 ' HB3' HD22 ' A' ' 95' ' ' LEU . 6.1 m-30 -91.54 154.57 19.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.972 . . . . 0.0 110.795 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.5 m-70 -128.08 85.37 2.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.842 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.917 HG23 HD23 ' A' ' 95' ' ' LEU . 1.2 p -63.18 152.45 37.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 110.295 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 123' ' ' LYS . 50.5 tttt -117.96 97.65 5.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.49 -148.27 17.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.568 ' C ' HG13 ' A' ' 126' ' ' VAL . 46.6 t30 -97.93 91.75 5.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -1.088 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.568 HG13 ' C ' ' A' ' 125' ' ' ASN . 30.4 m -156.82 159.7 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HG3' ' C ' ' A' ' 126' ' ' VAL . 91.4 mt-10 -145.04 146.06 31.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.181 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.774 ' CG1' HD21 ' A' ' 95' ' ' LEU . 2.7 mp -69.75 173.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 110.106 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.596 ' N ' HG22 ' A' ' 128' ' ' ILE . 46.1 mttt -105.91 160.77 15.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.186 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -66.71 -30.4 70.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 110.033 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.48 ' HG2' ' HB3' ' A' ' 129' ' ' LYS . 17.8 pt-20 -70.11 -36.66 75.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.939 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.493 ' HD1' HG23 ' A' ' 128' ' ' ILE . 20.2 t-160 -70.09 -40.87 74.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.998 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.814 HG22 ' CE1' ' A' ' 5' ' ' TYR . 42.9 t -62.77 -40.2 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 0.0 109.986 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -78.07 -41.86 34.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 110.001 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.98 98.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.942 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.88 -31.9 81.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -75.9 -33.24 59.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -1.095 . . . . 0.0 110.048 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -77.91 -33.05 52.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.907 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -72.49 -36.39 68.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 109.943 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.488 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -73.72 -34.77 64.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 109.937 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.0 m -66.4 -51.5 56.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 109.982 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -50.51 -46.59 57.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 0.0 109.957 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.72 -50.0 75.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 19.0 m-85 -54.94 -35.46 64.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.454 -0.779 . . . . 0.0 109.61 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -79.88 -16.81 54.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -0.831 . . . . 0.0 109.909 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 25.9 mt -84.05 -35.59 23.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.216 -0.928 . . . . 0.0 108.931 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.803 ' CG2' HD23 ' A' ' 18' ' ' LEU . 70.0 mt -70.61 -42.53 77.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.895 ' HB3' HD13 ' A' ' 13' ' ' ILE . 55.8 mt-10 -57.06 -42.04 79.83 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.328 -0.857 . . . . 0.0 109.32 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.445 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 86.5 m -66.29 -34.35 77.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.572 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.638 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 76.4 t80 -54.97 -51.9 64.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.881 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.111 HD21 ' CE1' ' A' ' 158' ' ' TYR . 76.8 mt -77.37 -33.77 55.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.32 -0.863 . . . . 0.0 110.183 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.785 ' HB2' HD11 ' A' ' 13' ' ' ILE . 52.3 tptt -64.6 -22.41 66.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.36 -30.56 3.31 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.547 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 8.6 m-70 -106.68 92.31 7.13 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.287 -1.125 . . . . 0.0 110.148 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.1 Cg_endo -73.89 4.12 4.43 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.052 1.553 . . . . 0.0 110.831 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -110.58 -9.07 14.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.073 -1.017 . . . . 0.0 109.961 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.649 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -63.83 104.63 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.854 . . . . 0.0 109.976 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.111 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.0 OUTLIER 34.52 33.41 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.724 -0.61 . . . . 0.0 110.373 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.547 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.793 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.582 HG22 ' ND1' ' A' ' 121' ' ' HIS . 85.0 t -97.44 134.07 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -1.16 . . . . 0.0 110.418 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.595 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 10.7 m-85 -93.91 149.55 21.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 110.024 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.746 HG23 ' CE1' ' A' ' 119' ' ' HIS . 6.5 m -127.25 112.01 14.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 110.293 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.087 ' CE2' HG21 ' A' ' 133' ' ' VAL . 65.0 m-85 -126.31 136.98 53.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.069 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 4.6 pm0 -139.91 162.03 36.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.893 . . . . 0.0 110.298 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -147.74 154.81 41.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.427 -0.795 . . . . 0.0 109.963 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -134.01 118.85 18.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.975 . . . . 0.0 110.473 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.65 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 3.8 p90 -142.4 -172.66 3.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 109.86 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.7 HG22 ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -143.03 178.72 7.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 110.603 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.406 ' OG ' ' OG ' ' A' ' 112' ' ' SER . 23.4 p -151.48 176.54 11.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.786 . . . . 0.0 109.966 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -92.72 -27.11 17.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.918 . . . . 0.0 110.076 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.78 HG23 ' HD2' ' A' ' 14' ' ' PRO . 24.7 mm -84.23 148.03 51.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.932 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.78 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.32 155.66 67.42 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.98 1.516 . . . . 0.0 111.007 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.655 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.3 Cg_endo -63.73 -37.21 47.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.87 1.458 . . . . 0.0 113.112 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -64.01 -19.68 66.75 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 N-CA-C 109.667 -0.936 . . . . 0.0 109.667 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.75 ' HG2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.91 -43.45 19.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 6.8 mp -75.7 -39.03 58.1 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.588 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.0 t80 -59.32 -54.71 43.67 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.455 0.645 . . . . 0.0 109.982 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.8 mttt -60.44 -34.06 73.44 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 109.839 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.047 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.0 -59.36 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 0.0 110.923 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.065 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -54.66 -39.53 68.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.626 -0.671 . . . . 0.0 111.856 -178.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.101 HG11 ' CD1' ' A' ' 74' ' ' ILE . 21.6 t -106.86 -65.3 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.817 -1.177 . . . . 0.0 112.084 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.0 mp -63.62 -4.72 3.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.183 -0.948 . . . . 0.0 112.164 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.95 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.1 m-20 -144.82 8.19 1.27 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.638 -1.289 . . . . 0.0 110.939 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.065 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -52.05 -26.8 11.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 110.961 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -68.41 -26.38 65.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.937 -1.102 . . . . 0.0 109.592 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 8.9 p30 -125.7 17.22 8.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.604 -0.685 . . . . 0.0 109.473 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.002 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -94.5 -45.56 7.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.465 -0.772 . . . . 0.0 110.083 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.035 HG21 HD13 ' A' ' 38' ' ' ILE . 4.6 p -79.18 -28.18 0.54 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 112.267 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.867 ' HD3' HG12 ' A' ' 30' ' ' VAL . 51.4 Cg_endo -78.29 4.42 6.27 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 122.69 0.837 . . . . 0.0 110.277 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 28' ' ' ASN . 94.2 mttt -123.41 -28.38 3.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.659 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.616 HG12 ' CD1' ' A' ' 150' ' ' TYR . 25.0 mt -78.48 -31.22 15.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 109.676 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.59 98.24 0.44 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.514 -0.741 . . . . 0.0 110.194 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.58 0.2 8.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.062 1.559 . . . . 0.0 110.543 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -89.96 -18.7 25.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 0.0 110.1 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.54 -49.07 6.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.195 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.035 HD13 HG21 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -120.15 137.2 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 109.973 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 9.4 mmtt -75.43 -42.71 52.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 110.017 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.534 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.02 156.54 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.448 -0.783 . . . . 0.0 110.128 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 m -114.88 125.97 54.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.41 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 55.1 tt0 -128.02 110.69 12.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.316 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 17.2 mt -60.85 131.08 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 110.125 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.508 HD11 ' HD2' ' A' ' 55' ' ' LYS . 47.7 mt -93.3 -44.7 8.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 52' ' ' THR . 1.7 tt0 -130.61 139.47 50.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.42 -0.8 . . . . 0.0 110.142 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.43 -163.92 46.97 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -130.82 2.7 4.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -1.123 . . . . 0.0 110.266 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.561 ' N ' HG21 ' A' ' 52' ' ' THR . . . 133.69 -4.61 4.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.527 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -85.04 -166.77 42.28 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.09 131.17 20.23 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.067 1.562 . . . . 0.0 110.475 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.58 -5.6 67.29 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 45' ' ' GLU . 39.7 m -80.04 140.46 36.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -1.096 . . . . 0.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.694 HD13 ' HA ' ' A' ' 70' ' ' LYS . 26.4 mm -110.18 114.6 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 110.276 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.55 ' HE3' HD11 ' A' ' 71' ' ' ILE . 92.4 mttt -98.0 159.45 14.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.826 . . . . 0.0 110.343 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HD2' HD11 ' A' ' 44' ' ' LEU . 88.3 tttt -133.06 100.55 4.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 110.108 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.557 ' CG2' HG12 ' A' ' 38' ' ' ILE . 88.8 mt -89.11 140.09 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.305 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.2 p -111.06 154.25 24.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 110.849 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.6 m-85 -124.4 122.6 38.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.445 -0.784 . . . . 0.0 110.279 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.494 2.515 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.264 0.554 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -113.1 96.84 0.83 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 9.7 p90 -133.41 153.21 51.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -1.173 . . . . 0.0 109.992 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.858 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.6 m -125.28 172.5 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.186 -0.946 . . . . 0.0 110.774 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HD2' ' OE1' ' A' ' 87' ' ' GLU . 69.6 mttt -124.92 129.19 49.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.708 -0.62 . . . . 0.0 109.371 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.582 ' CD2' HD12 ' A' ' 85' ' ' LEU . 10.1 m170 -117.59 120.31 37.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.161 -0.962 . . . . 0.0 110.993 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.694 ' HA ' HD13 ' A' ' 53' ' ' ILE . 55.3 tttm -96.67 109.85 22.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.821 . . . . 0.0 109.407 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.55 HD11 ' HE3' ' A' ' 54' ' ' LYS . 26.1 mm -48.55 139.46 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.982 . . . . 0.0 110.175 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.541 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 17.9 t0 -111.65 -40.55 4.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.477 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 0.7 OUTLIER 172.78 160.84 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.581 -0.7 . . . . 0.0 110.339 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.101 ' CD1' HG11 ' A' ' 23' ' ' VAL . 12.5 tt -149.27 172.24 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.536 -0.728 . . . . 0.0 109.505 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.7 m-20 -139.71 83.56 1.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.104 -0.998 . . . . 0.0 110.412 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.588 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 35.7 mtmm -59.27 -14.05 9.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.897 . . . . 0.0 110.44 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -96.02 -30.12 13.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 109.562 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.3 m-80 -107.68 -0.75 21.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.601 -0.687 . . . . 0.0 109.357 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.552 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 74.3 m-85 60.4 53.72 4.15 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.356 0.598 . . . . 0.0 110.598 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -127.74 156.0 43.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 109.617 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.531 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 86.5 t80 -152.99 146.89 25.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.079 -1.013 . . . . 0.0 110.434 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.435 ' CB ' ' HA ' ' A' ' 101' ' ' GLU . 1.8 m -156.34 145.64 20.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.385 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.6 p90 -143.86 177.78 8.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.518 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 98' ' ' ILE . 80.4 m -124.02 124.69 43.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.429 -0.794 . . . . 0.0 109.626 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.631 HD21 HD11 ' A' ' 91' ' ' LEU . 1.7 tp -93.59 137.32 32.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.32 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.3 pt -124.24 -12.2 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 110.257 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.465 ' O ' HD11 ' A' ' 85' ' ' LEU . 4.6 tt0 -129.21 160.45 32.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 110.236 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.858 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 146.55 132.0 2.29 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -64.81 -12.01 43.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -1.097 . . . . 0.0 110.033 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.585 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -81.38 -29.18 34.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.347 -0.846 . . . . 0.0 110.064 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.745 HD21 HG13 ' A' ' 98' ' ' ILE . 24.1 mt -66.11 -27.55 68.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 110.122 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.62 -172.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -82.49 6.38 17.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -1.163 . . . . 0.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 122' ' ' THR . 14.0 p -93.24 -30.8 15.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.064 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.022 HD21 ' CG1' ' A' ' 128' ' ' ILE . 34.0 mt -113.35 153.02 29.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.344 -0.848 . . . . 0.0 109.947 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 41.1 tt0 -131.45 -79.78 0.52 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.229 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.5 mttt -80.16 133.61 36.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.58 -0.7 . . . . 0.0 110.541 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.745 HG13 HD21 ' A' ' 91' ' ' LEU . 7.1 mm -123.9 143.36 37.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.863 -1.148 . . . . 0.0 109.683 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.76 127.43 50.63 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.203 179.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.693 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.2 m-85 -123.51 133.04 54.06 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.4 -0.812 . . . . 0.0 110.425 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.435 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 73.7 tt0 -130.3 158.17 40.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 110.118 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' TYR . 66.7 m -155.8 138.77 15.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.954 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 115' ' ' LYS . 3.4 mttt -132.28 136.05 46.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.818 HD23 HG12 ' A' ' 114' ' ' ILE . 2.9 mt -119.06 149.66 41.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 110.467 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.54 -169.23 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.409 -0.807 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.698 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.56 134.11 53.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 52.4 p -89.03 164.39 31.14 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.9 Cg_endo -73.22 -0.27 8.92 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.045 1.55 . . . . 0.0 110.598 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.1 p -104.38 5.19 34.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 110.247 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.04 -41.28 2.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.66 -172.11 0.55 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 82.4 p -130.13 138.24 50.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -1.135 . . . . 0.0 110.29 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.7 ' HA ' HG22 ' A' ' 10' ' ' THR . 14.0 mt -88.05 151.6 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.889 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.818 HG12 HD23 ' A' ' 104' ' ' LEU . 5.5 mt -136.41 110.08 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.339 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 103' ' ' LYS . 78.0 tttt -98.25 119.49 37.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.936 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -112.94 155.34 24.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 110.395 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.458 HG22 ' NE2' ' A' ' 119' ' ' HIS . 98.9 m -158.09 126.04 5.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.87 . . . . 0.0 109.999 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 p -127.87 165.3 20.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 110.366 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.746 ' CE1' HG23 ' A' ' 4' ' ' THR . 56.9 m-70 -142.46 168.45 19.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.325 -0.86 . . . . 0.0 110.055 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.542 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 9.1 m-85 -130.74 148.72 52.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.377 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.582 ' ND1' HG22 ' A' ' 2' ' ' VAL . 95.0 m-70 -131.67 86.46 2.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.182 -0.949 . . . . 0.0 109.701 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.527 HG21 ' O ' ' A' ' 126' ' ' VAL . 1.1 p -56.54 160.7 3.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 66.0 tttt -119.13 107.61 13.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.238 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.8 -111.6 4.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.611 ' O ' HG13 ' A' ' 126' ' ' VAL . 35.2 t30 -134.21 85.85 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -1.129 . . . . 0.0 110.402 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 125' ' ' ASN . 16.6 m -157.93 173.09 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 110.1 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HA ' HG21 ' A' ' 122' ' ' THR . 84.1 mt-10 -144.84 171.43 14.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.248 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.022 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.9 mp -91.42 172.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 110.02 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.607 ' N ' HG22 ' A' ' 128' ' ' ILE . 19.7 mttt -114.39 131.26 56.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.89 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.543 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 83.9 mt-10 -43.39 -47.59 6.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 110.107 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -58.3 -27.28 63.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.63 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.585 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 12.3 t-160 -83.42 -55.6 4.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.956 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.087 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.3 p -65.13 -42.15 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 109.961 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.56 ' N ' HG13 ' A' ' 133' ' ' VAL . 35.7 ttmt -63.31 -42.94 99.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.814 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.65 73.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.87 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.5 -35.61 92.0 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 5' ' ' TYR . 69.5 mmtt -64.35 -32.44 74.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -1.114 . . . . 0.0 109.908 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -72.27 -38.55 68.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.442 -0.786 . . . . 0.0 109.937 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -62.81 -46.51 87.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.806 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.47 -40.2 95.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.8 t -72.46 -52.0 17.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.403 -0.81 . . . . 0.0 109.799 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -50.47 -48.76 56.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.593 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.1 mp -54.62 -49.76 69.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.481 ' HA ' HD12 ' A' ' 147' ' ' ILE . 4.1 m-85 -54.18 -41.88 69.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.725 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -66.46 -28.29 68.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 109.872 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 146' ' ' LEU . 14.5 mt -80.59 -35.37 34.3 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.542 ' HA ' HD13 ' A' ' 33' ' ' ILE . 96.8 mt -66.79 -41.25 87.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 49.5 mt-10 -54.84 -47.16 74.49 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.403 -0.811 . . . . 0.0 109.18 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.3 m -61.15 -31.53 71.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.445 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.616 ' CD1' HG12 ' A' ' 33' ' ' ILE . 59.7 t80 -64.01 -52.89 57.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.789 . . . . 0.0 109.655 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.061 HD21 ' CE1' ' A' ' 158' ' ' TYR . 56.8 mt -80.07 -33.68 38.74 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 110.408 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.568 ' CG ' HG12 ' A' ' 13' ' ' ILE . 49.5 mtpt -65.71 -14.04 60.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 0.0 109.426 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.481 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.77 -30.27 1.4 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.508 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.1 m-70 -106.43 93.49 8.39 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.189 -1.183 . . . . 0.0 110.253 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.512 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.3 Cg_endo -74.26 3.82 4.89 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.101 1.58 . . . . 0.0 110.644 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -106.99 -11.25 15.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -67.83 100.62 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.757 . . . . 0.0 109.919 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.061 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.1 p90 34.59 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.25 0.548 . . . . 0.0 110.604 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.771 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 78.5 t -110.1 132.86 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -1.191 . . . . 0.0 110.236 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.681 ' CE1' HD12 ' A' ' 128' ' ' ILE . 12.3 m-85 -94.3 149.08 21.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.253 -0.904 . . . . 0.0 109.983 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.627 HG23 ' CE1' ' A' ' 119' ' ' HIS . 8.6 m -127.56 114.19 17.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 110.443 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.155 ' CE2' HG21 ' A' ' 133' ' ' VAL . 64.8 m-85 -128.45 139.52 52.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.822 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 13.6 pt-20 -140.17 152.7 46.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 110.735 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.529 ' C ' ' HG ' ' A' ' 116' ' ' SER . 0.2 OUTLIER -147.22 166.04 28.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.499 -0.75 . . . . 0.0 109.45 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -144.23 145.78 32.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.058 -1.026 . . . . 0.0 110.553 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.642 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 6.3 p90 -159.01 -172.45 3.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.715 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.4 p -137.33 172.57 12.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.101 -1.0 . . . . 0.0 110.708 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 112' ' ' SER . 92.9 p -151.01 149.1 29.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 0.0 110.503 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.29 -25.97 66.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 0.0 110.184 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.721 HD13 ' CB ' ' A' ' 148' ' ' GLU . 4.7 mp -84.46 146.05 46.44 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 110.116 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.679 ' HD2' HG23 ' A' ' 13' ' ' ILE . 43.2 Cg_endo -67.96 154.65 72.25 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.136 1.598 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.667 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.0 Cg_endo -62.73 -37.13 58.53 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.748 1.394 . . . . 0.0 113.106 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 37.9 Cg_endo -63.58 -20.2 68.96 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 N-CA-C 109.823 -0.876 . . . . 0.0 109.823 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.855 ' HB3' HD13 ' A' ' 151' ' ' LEU . 5.7 mmp_? -80.64 -45.47 17.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.714 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.0 mp -75.51 -36.04 60.63 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.802 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 55.3 t80 -58.29 -58.01 10.38 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.107 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 87.4 mttt -59.86 -35.92 75.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.392 -0.818 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.083 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -79.33 -61.55 1.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.357 -0.84 . . . . 0.0 111.019 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.958 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -53.84 -38.28 64.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.448 -0.783 . . . . 0.0 111.653 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.827 HG13 ' CE1' ' A' ' 81' ' ' TYR . 8.0 t -105.22 -66.29 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.892 -1.13 . . . . 0.0 111.661 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.0 mp -66.74 -4.24 8.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.174 -0.954 . . . . 0.0 111.445 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.685 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -147.96 31.26 0.86 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.807 -1.183 . . . . 0.0 110.544 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.958 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -70.57 -32.67 70.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.98 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.57 ' OD2' HD11 ' A' ' 43' ' ' ILE . 94.7 m-20 -65.49 -15.89 63.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.869 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 74.0 m-80 -126.59 10.5 7.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.736 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -96.68 -54.2 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.926 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.0 t -67.38 -42.02 35.85 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 0.0 110.79 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -78.52 8.64 3.54 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.513 1.27 . . . . 0.0 110.693 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 35.1 mttt -126.77 -32.23 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.093 -1.005 . . . . 0.0 109.661 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.741 HD13 ' HA ' ' A' ' 147' ' ' ILE . 45.8 mt -80.0 -34.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.78 99.35 1.5 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.485 -0.759 . . . . 0.0 110.026 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.02 -0.75 8.98 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.092 1.575 . . . . 0.0 110.561 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -86.74 -9.69 55.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.878 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.714 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -101.18 -47.05 4.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.392 -0.817 . . . . 0.0 110.099 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.926 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.8 mp -124.98 143.02 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.459 -0.776 . . . . 0.0 109.874 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' THR . 36.5 ttmt -80.39 -37.92 31.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 110.262 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.549 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 178.8 139.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.248 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 3.2 m -102.17 128.11 48.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 110.314 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.549 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 27.0 tp10 -132.81 115.17 14.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 110.14 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.57 HD11 ' OD2' ' A' ' 27' ' ' ASP . 10.7 mt -64.97 133.05 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.363 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 44' ' ' LEU . 24.3 mt -94.36 -45.74 7.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 110.204 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.894 ' O ' HG23 ' A' ' 52' ' ' THR . 6.9 mt-10 -130.51 141.3 50.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 110.116 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.86 -169.87 54.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -130.79 16.35 5.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -1.141 . . . . 0.0 110.304 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.495 ' N ' HG21 ' A' ' 52' ' ' THR . . . 124.39 -8.41 8.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -82.02 -168.92 42.31 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.2 Cg_endo -69.82 134.26 27.43 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.166 1.614 . . . . 0.0 110.468 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.21 76.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.894 HG23 ' O ' ' A' ' 45' ' ' GLU . 37.2 m -79.97 138.75 37.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -1.145 . . . . 0.0 110.069 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.635 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.9 mm -109.35 111.66 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 110.288 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 81.6 mttt -97.14 154.72 17.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 110.204 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -127.52 104.55 7.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.455 HD12 ' CE1' ' A' ' 69' ' ' HIS . 85.4 mt -90.82 140.84 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.3 p -113.28 150.97 31.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 110.333 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.7 m-85 -116.25 137.35 52.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 110.335 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.898 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.691 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 3.9 t80 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.153 0.502 . . . . 0.0 109.969 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -115.74 97.4 0.79 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.691 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 25.3 p90 -134.6 168.27 19.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.167 -1.196 . . . . 0.0 110.171 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.887 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.2 m -137.45 171.84 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 110.486 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' O ' HD12 ' A' ' 85' ' ' LEU . 87.3 mttt -123.03 124.05 42.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.617 -0.677 . . . . 0.0 109.577 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.599 ' CD2' HD13 ' A' ' 85' ' ' LEU . 22.5 m170 -111.62 136.27 51.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -0.988 . . . . 0.0 110.906 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.635 ' HA ' HD13 ' A' ' 53' ' ' ILE . 79.1 tttt -114.83 108.87 17.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.462 -0.774 . . . . 0.0 109.507 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 37.0 mm -44.99 137.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 110.047 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.522 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 25.8 t0 -107.47 -47.63 3.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 9.4 m -171.94 156.88 4.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.578 -0.702 . . . . 0.0 109.688 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.7 mt -136.86 157.31 35.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 110.119 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 4.7 m-20 -135.28 79.26 1.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.344 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.582 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 81.3 mttt -63.77 -11.43 26.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -98.14 -30.14 12.83 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.739 0.78 . . . . 0.0 109.177 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -105.12 -2.69 23.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.67 -0.644 . . . . 0.0 109.432 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.545 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 76.6 m-85 59.75 55.18 4.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.677 -0.639 . . . . 0.0 110.408 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -130.64 162.17 29.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.8 . . . . 0.0 109.782 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.827 ' CE1' HG13 ' A' ' 23' ' ' VAL . 37.5 t80 -144.56 137.32 26.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 110.096 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 35.3 m -139.79 126.9 21.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.98 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 9.2 p90 -141.83 179.4 6.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.751 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 98' ' ' ILE . 91.5 m -135.88 152.17 50.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.494 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.599 HD13 ' CD2' ' A' ' 69' ' ' HIS . 52.3 tp -106.68 125.45 51.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.414 -0.804 . . . . 0.0 109.941 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.7 pt -109.28 -8.81 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.428 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.427 ' OE1' ' HD2' ' A' ' 68' ' ' LYS . 30.1 tt0 -150.48 159.25 44.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.326 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.887 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 160.43 139.95 2.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -71.26 -24.93 62.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -1.115 . . . . 0.0 110.075 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.26 -22.95 61.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 110.146 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.658 HD22 HD12 ' A' ' 98' ' ' ILE . 74.7 mt -60.81 -22.48 64.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.002 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.31 -179.39 0.01 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -80.14 6.01 12.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -1.139 . . . . 0.0 110.014 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.472 ' HA ' HG21 ' A' ' 126' ' ' VAL . 30.8 p -98.33 -23.29 15.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.038 HD21 ' CG1' ' A' ' 128' ' ' ILE . 42.1 mt -123.68 162.54 22.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 110.271 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -140.94 -81.69 0.24 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.3 -0.875 . . . . 0.0 109.861 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.556 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 34.8 mttt -80.41 161.04 25.14 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.709 -0.619 . . . . 0.0 110.103 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.658 HD12 HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -156.17 140.13 8.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 178.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 3.7 m -116.63 121.69 42.42 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 11.5 m-85 -112.82 139.78 48.16 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.413 -0.805 . . . . 0.0 110.3 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 80.8 tt0 -135.22 144.24 46.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 109.894 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.0 m -146.77 125.92 12.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.184 -0.948 . . . . 0.0 110.352 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 1.1 ttmt -116.22 146.94 41.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 109.813 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.787 HD23 HG12 ' A' ' 114' ' ' ILE . 6.3 mt -120.58 147.7 44.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.998 . . . . 0.0 110.78 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.89 -168.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.0 109.567 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.713 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -129.9 157.29 42.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 110.52 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -110.44 179.68 0.78 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.795 . . . . 0.0 109.618 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 107' ' ' SER . 40.6 Cg_endo -66.64 73.93 0.41 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.817 1.43 . . . . 0.0 109.577 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 4.0 m 57.35 37.29 27.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.497 -0.752 . . . . 0.0 109.742 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.53 42.72 1.47 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.34 -127.61 8.87 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 92.2 p -151.62 143.28 23.63 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.341 -1.093 . . . . 0.0 109.616 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.579 ' HA ' HG22 ' A' ' 10' ' ' THR . 34.4 mt -90.46 150.32 3.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.196 -0.94 . . . . 0.0 110.571 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.787 HG12 HD23 ' A' ' 104' ' ' LEU . 5.8 mt -138.16 108.92 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.198 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -81.67 143.8 31.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 109.931 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.529 ' HG ' ' C ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -128.01 140.64 51.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 110.5 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 53.4 m -152.3 131.86 13.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.346 -0.846 . . . . 0.0 109.847 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.441 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 52.6 p -137.97 165.09 27.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 110.578 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.627 ' CE1' HG23 ' A' ' 4' ' ' THR . 48.1 m-70 -145.48 161.28 40.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.33 -0.856 . . . . 0.0 110.041 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 10.3 m-85 -121.97 147.54 45.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 110.359 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.556 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 99.6 m-70 -130.94 85.6 2.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.272 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.535 ' OG1' HG23 ' A' ' 126' ' ' VAL . 1.4 t -72.89 176.58 5.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.313 -0.867 . . . . 0.0 110.948 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -132.9 131.28 40.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.622 -0.673 . . . . 0.0 110.186 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.06 -111.13 4.18 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.533 ' C ' HG13 ' A' ' 126' ' ' VAL . 36.0 t30 -151.41 81.34 1.3 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -1.143 . . . . 0.0 110.136 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.535 HG23 ' OG1' ' A' ' 122' ' ' THR . 30.8 m -154.1 160.82 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -126.94 161.26 28.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.038 ' CG1' HD21 ' A' ' 95' ' ' LEU . 4.7 mp -79.91 172.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.954 . . . . 0.0 110.351 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.587 ' N ' HG22 ' A' ' 128' ' ' ILE . 47.4 mttt -106.83 128.29 54.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.324 -0.86 . . . . 0.0 109.86 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.459 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 92.7 mt-10 -43.62 -46.99 7.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.46 -24.59 63.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 109.88 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 129' ' ' LYS . 12.5 t-160 -84.92 -54.16 4.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -0.805 . . . . 0.0 110.14 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.155 HG21 ' CE2' ' A' ' 5' ' ' TYR . 9.3 p -66.84 -41.41 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.065 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.551 ' N ' HG13 ' A' ' 133' ' ' VAL . 81.5 tttt -64.95 -43.56 92.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.907 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -29.27 69.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.926 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.76 -32.19 73.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -70.1 -36.69 75.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.986 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -68.73 -33.79 74.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 109.778 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -66.99 -37.37 84.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.823 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.16 90.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.296 -0.877 . . . . 0.0 109.791 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.7 m -61.32 -48.46 81.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.371 -0.831 . . . . 0.0 109.742 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 145' ' ' LYS . 98.4 m-20 -51.25 -42.69 61.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 146' ' ' LEU . 25.8 tp -56.32 -54.58 43.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.737 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.585 ' CE1' HG21 ' A' ' 114' ' ' ILE . 17.3 m-85 -48.03 -37.66 15.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.551 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 142' ' ' ASN . 98.9 mttt -68.75 -24.27 64.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.626 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.493 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 30.1 mt -84.51 -34.86 23.24 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.225 -0.922 . . . . 0.0 108.92 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.741 ' HA ' HD13 ' A' ' 33' ' ' ILE . 52.5 mt -71.88 -33.99 49.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.578 -0.702 . . . . 0.0 109.336 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.721 ' CB ' HD13 ' A' ' 13' ' ' ILE . 78.4 mt-10 -64.37 -38.49 91.23 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.502 -0.749 . . . . 0.0 109.55 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 90.0 m -70.06 -38.02 75.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 109.478 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.612 ' CD1' HG12 ' A' ' 33' ' ' ILE . 68.1 t80 -55.73 -51.52 67.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.416 -0.803 . . . . 0.0 109.774 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.09 HD21 ' CE1' ' A' ' 158' ' ' TYR . 77.8 mt -80.03 -41.48 25.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 110.1 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.635 ' HB2' HD11 ' A' ' 13' ' ' ILE . 49.2 tttp -64.06 -19.92 65.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.361 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.71 -34.78 2.75 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 3.8 m-70 -110.6 94.88 20.69 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.324 -1.104 . . . . 0.0 110.101 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -74.14 5.48 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.093 1.575 . . . . 0.0 110.985 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -105.55 -7.92 18.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.994 -1.066 . . . . 0.0 109.865 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -71.57 102.08 2.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.427 -0.795 . . . . 0.0 110.121 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.09 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.1 p90 34.24 32.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.797 -0.564 . . . . 0.0 110.71 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.763 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 86.0 t -122.35 118.53 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.133 -1.216 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.572 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 58.5 m-85 -86.31 163.29 17.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.867 HG23 ' CE1' ' A' ' 119' ' ' HIS . 75.7 m -141.35 92.87 2.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.686 ' CE1' HG11 ' A' ' 133' ' ' VAL . 83.5 m-85 -109.01 126.03 52.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.977 . . . . 0.0 109.815 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 116' ' ' SER . 16.1 pt-20 -128.79 153.03 47.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 110.445 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.8 m -123.88 141.06 52.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.917 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.443 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 83.0 mt-10 -121.62 124.02 43.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 110.447 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.2 p90 -151.13 -172.86 4.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.938 . . . . 0.0 109.947 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.568 HG22 HG12 ' A' ' 113' ' ' ILE . 17.3 p -138.84 -178.21 5.22 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 110.547 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 112' ' ' SER . 98.9 p -157.27 150.05 23.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.432 -0.792 . . . . 0.0 110.349 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -75.51 -8.39 56.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.124 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.0 mm -96.79 149.78 36.16 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.414 -0.804 . . . . 0.0 110.084 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -64.96 148.01 89.47 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.975 1.513 . . . . 0.0 110.376 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.668 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -71.14 -32.21 13.45 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.877 1.462 . . . . 0.0 112.899 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.12 -20.62 37.61 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 N-CA-C 109.871 -0.857 . . . . 0.0 109.871 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.866 ' HG2' HD13 ' A' ' 151' ' ' LEU . 4.5 ttm180 -83.36 -46.72 12.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.756 HD23 ' C ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -72.95 -28.87 62.68 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.086 178.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 87.0 t80 -65.86 -56.52 11.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.436 -0.79 . . . . 0.0 109.544 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.779 ' HA ' HD12 ' A' ' 24' ' ' LEU . 90.8 mttt -54.36 -39.25 66.98 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.279 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.061 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -68.82 -53.28 22.45 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.501 0.667 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.806 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -63.86 -45.47 89.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 111.511 -178.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.657 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.1 t -99.05 -57.23 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.99 -1.069 . . . . 0.0 111.725 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 20' ' ' LYS . 27.5 mt -76.42 1.72 15.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.136 -0.977 . . . . 0.0 111.678 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.707 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -154.68 38.8 0.43 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.733 -1.229 . . . . 0.0 110.898 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -76.3 -31.29 58.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.082 -1.011 . . . . 0.0 110.228 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 79.8 m-20 -65.41 -13.6 59.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.093 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.547 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 66.9 m-20 -128.81 8.23 5.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 110.073 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.9 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -94.93 -51.17 4.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.431 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.095 HG21 HD13 ' A' ' 38' ' ' ILE . 8.2 p -75.37 -27.14 0.67 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.925 . . . . 0.0 112.267 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.814 ' HD3' HG12 ' A' ' 30' ' ' VAL . 53.0 Cg_endo -81.37 8.61 4.29 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 122.743 0.865 . . . . 0.0 110.625 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -137.39 -30.29 0.85 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.056 -1.028 . . . . 0.0 110.609 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.9 HD11 ' CD1' ' A' ' 29' ' ' LEU . 67.2 mt -75.24 -41.29 43.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.274 -0.891 . . . . 0.0 109.692 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.57 90.76 2.84 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.422 -0.798 . . . . 0.0 110.374 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.78 1.68 7.34 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.112 1.585 . . . . 0.0 110.321 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -87.2 -23.2 24.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.161 -0.962 . . . . 0.0 109.892 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.48 -42.59 8.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.095 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -121.94 146.97 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.788 . . . . 0.0 109.827 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 17.1 tppt? -86.87 -42.22 13.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.371 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.55 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER 179.08 139.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 110.403 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 4.2 m -94.25 137.32 33.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.55 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 20.7 tt0 -142.03 110.08 5.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 45.5 mt -60.46 132.16 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.143 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.9 tp -95.71 -39.04 10.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.38 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 52' ' ' THR . 2.5 mt-10 -136.43 137.63 40.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.133 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.412 ' O ' ' OD1' ' A' ' 47' ' ' ASP . . . 81.08 -162.41 44.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 89.0 m-20 -137.65 20.99 2.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -1.167 . . . . 0.0 110.213 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.537 ' H ' HG21 ' A' ' 52' ' ' THR . . . 118.88 -12.14 11.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.536 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -75.01 -169.93 25.52 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.65 132.46 20.38 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.123 1.591 . . . . 0.0 110.382 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.78 67.26 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 45' ' ' GLU . 32.1 m -79.84 143.19 34.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.186 . . . . 0.0 110.042 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.4 mm -111.49 104.27 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.953 . . . . 0.0 110.328 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 51.9 mtpt -89.5 137.22 32.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.383 -0.823 . . . . 0.0 110.245 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -113.79 103.08 10.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.842 . . . . 0.0 110.356 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.541 ' CG2' HG12 ' A' ' 38' ' ' ILE . 87.3 mt -89.15 140.65 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.177 -0.952 . . . . 0.0 109.976 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 40' ' ' HIS . 1.3 p -112.49 152.94 28.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.52 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.711 ' HE2' HG13 ' A' ' 67' ' ' VAL . 30.9 m-85 -113.26 160.25 18.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.883 . . . . 0.0 110.145 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.679 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 8.3 t80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.187 0.518 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -113.36 135.03 12.27 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.679 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 11.4 p90 -178.52 160.26 1.23 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 110.112 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.833 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.8 m -141.36 171.65 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.39 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.802 ' CD ' HD11 ' A' ' 86' ' ' ILE . 23.8 ttmt -123.09 124.11 42.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.598 -0.689 . . . . 0.0 109.881 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.468 ' NE2' HD13 ' A' ' 85' ' ' LEU . 10.6 m170 -113.56 123.52 50.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 110.751 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.562 ' HA ' HD13 ' A' ' 53' ' ' ILE . 84.4 tttt -100.09 110.79 23.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 109.612 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 49' ' ' GLY . 33.4 mm -50.97 133.85 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 110.439 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 83.2 m-20 -106.25 -37.15 6.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.316 -0.865 . . . . 0.0 109.87 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 11.8 p 178.16 157.72 0.44 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.747 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.466 HG13 ' HD1' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -138.66 153.62 25.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.051 -179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 79' ' ' TYR . 6.3 m-20 -131.02 77.49 1.79 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.529 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 85.1 mttt -63.04 -11.85 22.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.232 -0.918 . . . . 0.0 110.005 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -98.12 -31.82 11.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.746 . . . . 0.0 109.235 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -102.45 -3.26 27.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.634 -0.666 . . . . 0.0 109.342 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.552 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 74.8 m-85 60.87 54.76 3.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.524 0.678 . . . . 0.0 110.6 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -130.97 156.53 44.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.679 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.703 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 61.2 t80 -143.67 141.61 30.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.931 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.47 ' OG ' ' HG2' ' A' ' 101' ' ' GLU . 53.6 m -148.7 136.97 21.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.14 -0.975 . . . . 0.0 110.755 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.703 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.0 p90 -147.82 175.61 10.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.399 -0.813 . . . . 0.0 110.29 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 98' ' ' ILE . 44.9 m -124.47 128.84 49.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.858 . . . . 0.0 109.851 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.552 HD11 ' O ' ' A' ' 87' ' ' GLU . 4.5 tp -95.47 124.88 39.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -0.978 . . . . 0.0 110.167 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.802 HD11 ' CD ' ' A' ' 68' ' ' LYS . 16.9 pt -109.23 -5.83 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 110.229 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.552 ' O ' HD11 ' A' ' 85' ' ' LEU . 9.1 tt0 -136.56 162.35 33.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 110.327 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.833 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 149.14 125.08 1.38 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -57.89 -31.39 66.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -1.11 . . . . 0.0 110.187 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.18 -18.58 65.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.079 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.599 HD21 HG13 ' A' ' 98' ' ' ILE . 86.9 mt -70.72 -30.45 66.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.62 -174.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -80.89 4.51 19.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -1.146 . . . . 0.0 110.26 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.634 ' O ' HG22 ' A' ' 122' ' ' THR . 78.1 p -89.47 -41.47 12.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.92 . . . . 0.0 110.108 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.011 HD23 HG23 ' A' ' 122' ' ' THR . 62.9 mt -102.47 152.33 21.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.854 . . . . 0.0 109.987 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.51 ' CG ' ' HD3' ' A' ' 123' ' ' LYS . 5.6 tp10 -131.54 -80.56 0.52 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.304 -0.873 . . . . 0.0 110.087 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 59.3 mttt -80.21 127.78 32.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.581 -0.7 . . . . 0.0 110.522 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.746 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -116.77 139.05 45.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.702 -1.249 . . . . 0.0 109.856 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.49 127.68 54.24 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.405 -0.81 . . . . 0.0 108.974 178.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.746 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.6 m-85 -122.56 133.98 54.55 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.331 -0.856 . . . . 0.0 110.509 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.47 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 3.2 mt-10 -132.56 141.18 48.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.1 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 81' ' ' TYR . 63.6 m -137.04 143.13 42.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -137.19 135.76 37.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 110.169 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.752 HD23 HG12 ' A' ' 114' ' ' ILE . 4.9 mt -120.07 148.21 43.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.836 . . . . 0.0 110.533 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.7 -169.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 0.0 109.799 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.698 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -115.35 167.16 11.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 110.214 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.532 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 57.6 p -126.42 175.42 3.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 109.948 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.8 Cg_endo -87.29 22.8 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.87 1.458 . . . . 0.0 110.498 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 t -126.67 -10.99 6.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 110.409 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.96 -26.68 10.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.9 -149.59 1.56 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 8.4 p -149.12 137.79 21.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -1.17 . . . . 0.0 110.152 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.568 HG12 HG22 ' A' ' 10' ' ' THR . 68.5 mt -86.86 148.91 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 110.122 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.752 HG12 HD23 ' A' ' 104' ' ' LEU . 9.7 mt -132.79 125.26 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.391 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 75.1 tttt -115.86 108.43 16.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.2 m -98.84 158.85 15.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 110.538 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 101' ' ' GLU . 53.4 m -159.35 126.01 4.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.398 -0.814 . . . . 0.0 110.278 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.4 m -128.97 160.01 34.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 0.0 110.183 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.867 ' CE1' HG23 ' A' ' 4' ' ' THR . 62.3 m-70 -136.73 162.11 34.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.246 -0.909 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.8 m-85 -126.58 136.24 52.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.912 . . . . 0.0 110.99 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 93.3 m-70 -119.0 81.49 1.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.915 . . . . 0.0 109.34 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 1.011 HG23 HD23 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -66.69 154.52 40.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 111.102 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HD3' ' CG ' ' A' ' 96' ' ' GLU . 37.8 mtmt -103.8 116.86 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.521 -0.737 . . . . 0.0 109.829 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 106.74 9.72 30.05 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 5.8 t30 69.4 51.4 0.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -1.134 . . . . 0.0 110.451 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 127' ' ' GLU . 85.4 t -92.63 175.15 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.331 -0.855 . . . . 0.0 109.549 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.601 ' N ' HG12 ' A' ' 126' ' ' VAL . 90.8 mt-10 -124.3 149.34 46.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.969 -1.082 . . . . 0.0 110.563 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.881 ' CD1' HD21 ' A' ' 95' ' ' LEU . 15.8 mm -75.42 172.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 110.202 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.594 ' N ' HG22 ' A' ' 128' ' ' ILE . 70.3 mmtt -111.29 129.88 55.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.288 -0.882 . . . . 0.0 109.842 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' LYS . 54.1 mt-10 -43.09 -43.5 4.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 110.184 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -62.45 -25.36 67.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 110.025 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.8 t-160 -78.11 -50.54 11.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 110.147 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.686 HG11 ' CE1' ' A' ' 5' ' ' TYR . 72.7 t -57.24 -32.85 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.0 109.746 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -80.17 -40.77 26.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.831 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.92 -36.82 84.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.335 -0.853 . . . . 0.0 109.906 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.56 -30.04 69.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.461 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 91.7 mttt -77.49 -32.1 54.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 0.0 109.985 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -76.13 -33.24 59.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.387 -0.821 . . . . 0.0 109.973 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.21 -33.46 65.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.919 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -79.07 -36.11 41.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.0 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.0 m -62.11 -47.36 84.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.958 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -53.93 -50.03 67.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.816 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.48 ' HA ' HD12 ' A' ' 143' ' ' LEU . 15.9 tp -57.18 -45.32 83.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.789 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 21.6 m-85 -56.83 -41.34 77.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.406 -0.809 . . . . 0.0 109.643 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.417 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 45.9 mtmt -78.84 -14.92 58.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 109.828 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.498 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 19.7 mt -83.22 -36.69 24.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -0.901 . . . . 0.0 108.818 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.747 HD11 ' CE1' ' A' ' 22' ' ' PHE . 16.1 mt -69.42 -46.22 76.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.495 ' O ' HG13 ' A' ' 13' ' ' ILE . 64.1 mt-10 -56.78 -36.65 70.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.402 -0.811 . . . . 0.0 109.551 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.4 m -72.23 -39.43 68.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.778 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.651 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 77.0 t80 -53.59 -52.13 60.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -0.843 . . . . 0.0 110.089 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.194 HD21 ' CE2' ' A' ' 158' ' ' TYR . 74.6 mt -75.25 -33.98 61.36 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.213 -0.93 . . . . 0.0 110.27 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 37.6 ttpt -69.98 -20.62 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -109.06 -31.13 3.42 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.53 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 9.9 m-70 -109.53 93.3 13.61 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 109.942 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.16 5.27 3.68 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.07 1.563 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -109.83 2.24 19.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.003 -1.06 . . . . 0.0 109.856 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.651 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -83.59 103.22 12.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 109.995 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.194 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.99 31.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.722 -0.611 . . . . 0.0 110.472 -179.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.721 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.876 HG13 ' O ' ' A' ' 120' ' ' TYR . 70.6 t -120.89 118.67 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.214 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.603 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 90.8 m-85 -75.91 149.88 37.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.162 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.725 HG23 ' CE1' ' A' ' 119' ' ' HIS . 39.9 m -133.1 119.94 20.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 110.228 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.015 ' CE2' HG21 ' A' ' 133' ' ' VAL . 69.9 m-85 -131.07 152.41 50.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 110.247 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -144.81 149.77 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.131 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.8 t -142.86 156.52 44.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.833 . . . . 0.0 109.816 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.23 145.89 36.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.005 . . . . 0.0 110.756 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.689 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 5.7 p90 -159.45 -172.89 3.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.608 -0.683 . . . . 0.0 109.704 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 113' ' ' ILE . 20.8 p -136.39 177.99 7.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.065 -1.022 . . . . 0.0 110.717 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 3.2 t -157.83 159.89 37.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.432 -0.793 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -87.45 -2.72 58.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 110.248 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.752 HG23 ' HD2' ' A' ' 14' ' ' PRO . 12.0 mm -98.06 148.3 34.29 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 110.215 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.752 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.59 144.84 80.22 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.099 1.579 . . . . 0.0 110.494 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.67 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.52 -31.12 11.45 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 124.018 1.536 . . . . 0.0 112.988 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.9 Cg_endo -69.04 -23.66 33.85 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 N-CA-C 110.121 -0.761 . . . . 0.0 110.121 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.541 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 3.7 mmp_? -84.44 -42.7 15.37 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.778 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -69.91 -31.31 69.03 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.565 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 48.8 t80 -66.27 -53.35 37.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.487 -0.758 . . . . 0.0 109.588 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 80.8 mttt -53.43 -37.48 62.61 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.212 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.06 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -72.3 -53.45 12.38 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.582 0.706 . . . . 0.0 110.769 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.055 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -61.37 -40.89 95.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.511 -0.743 . . . . 0.0 111.556 -178.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.532 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.6 t -104.68 -65.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.925 -1.109 . . . . 0.0 111.798 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.63 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.6 mp -65.95 -9.49 30.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.232 -0.917 . . . . 0.0 111.516 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 1.4 m-20 -145.68 33.39 1.04 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.823 -1.173 . . . . 0.0 110.71 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.055 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -73.46 -20.4 60.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.391 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 41' ' ' SER . 36.9 t0 -73.6 -20.56 60.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 109.73 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 6.9 p30 -123.88 15.34 9.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.429 -0.794 . . . . 0.0 109.684 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.866 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER -97.41 -57.75 2.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 109.754 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.018 ' CG1' HD13 ' A' ' 38' ' ' ILE . 11.7 t -62.12 -41.46 75.67 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.48 -0.763 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.2 Cg_endo -78.27 7.75 3.92 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.348 1.183 . . . . 0.0 110.831 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 72.1 mmtt -126.43 -27.74 3.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.052 -1.03 . . . . 0.0 109.907 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 146' ' ' LEU . 20.9 mt -77.34 -42.77 30.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.387 -0.82 . . . . 0.0 109.58 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.03 101.99 1.58 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.498 -0.751 . . . . 0.0 110.073 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.97 1.18 6.8 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.077 1.567 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -84.42 -19.99 32.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.065 -1.022 . . . . 0.0 109.572 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.8 -53.31 4.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.321 -0.862 . . . . 0.0 109.913 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.018 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.2 mp -121.84 148.71 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.44 -0.788 . . . . 0.0 109.791 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -84.0 -41.14 17.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.931 . . . . 0.0 110.549 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.555 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -172.59 170.64 4.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.204 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.428 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 68.3 m -126.93 136.5 52.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.14 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.555 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 76.2 tt0 -140.56 107.99 5.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 43.3 mt -58.7 133.27 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 110.206 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.556 HD12 HG22 ' A' ' 53' ' ' ILE . 52.8 mt -87.69 -27.64 22.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.3 -0.875 . . . . 0.0 110.044 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.985 ' O ' HG23 ' A' ' 52' ' ' THR . 29.4 tp10 -160.47 165.95 30.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 110.218 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.8 -168.99 27.02 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -127.69 24.6 6.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -1.182 . . . . 0.0 110.334 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.637 ' H ' HG21 ' A' ' 52' ' ' THR . . . 105.3 8.59 35.45 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.587 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -93.73 -164.09 36.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.79 130.8 18.64 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.047 1.551 . . . . 0.0 110.621 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.89 -3.69 77.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.985 HG23 ' O ' ' A' ' 45' ' ' GLU . 23.6 m -79.98 142.47 35.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -1.161 . . . . 0.0 109.982 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.556 HG22 HD12 ' A' ' 44' ' ' LEU . 32.5 mm -112.12 111.67 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.098 -1.001 . . . . 0.0 110.233 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.2 mttt -94.67 139.53 31.1 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.342 -0.849 . . . . 0.0 110.148 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HB2' ' HG ' ' A' ' 44' ' ' LEU . 80.3 tttt -111.34 96.21 5.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.327 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.519 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.6 mt -84.94 147.29 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.819 ' O ' HG23 ' A' ' 38' ' ' ILE . 7.8 p -116.68 163.07 16.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 0.0 110.638 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.655 ' HE2' HG13 ' A' ' 67' ' ' VAL . 24.6 m-85 -117.2 158.95 23.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.522 -0.736 . . . . 0.0 110.142 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.228 0.537 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -132.93 135.23 7.98 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 10.7 p90 -177.95 163.1 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -1.18 . . . . 0.0 110.145 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.772 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.8 m -143.22 172.24 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.614 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.6 ' O ' HD12 ' A' ' 85' ' ' LEU . 98.4 mttt -122.17 133.37 54.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.591 -0.693 . . . . 0.0 109.767 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.656 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 14.8 m170 -112.31 137.28 50.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.118 -0.989 . . . . 0.0 110.706 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.8 tttt -111.45 109.84 19.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.892 . . . . 0.0 109.211 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.668 HG23 HD11 ' A' ' 74' ' ' ILE . 36.1 mm -52.77 127.52 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.171 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.45 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 95.1 m-20 -99.03 -38.71 8.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.489 -0.757 . . . . 0.0 109.878 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.633 ' C ' HD12 ' A' ' 74' ' ' ILE . 2.2 m -178.81 161.28 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.668 HD11 HG23 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -144.74 152.8 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.986 -1.071 . . . . 0.0 111.261 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -140.54 80.89 1.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.682 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.565 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 84.2 tttt -65.61 -11.72 46.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.13 -0.981 . . . . 0.0 109.968 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -85.7 -30.73 22.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 108.68 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -110.5 -2.92 16.27 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.612 ' O ' HD12 ' A' ' 104' ' ' LEU . 72.8 m-85 62.65 52.11 2.94 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.543 0.687 . . . . 0.0 110.444 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -123.31 153.02 40.82 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 109.352 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.684 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 59.0 t80 -142.38 148.98 38.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.14 -0.975 . . . . 0.0 110.255 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.436 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 60.3 m -152.13 137.04 17.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.791 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.684 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 4.1 p90 -149.32 179.31 8.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 110.009 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' ILE . 65.2 m -137.46 134.54 35.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.895 . . . . 0.0 110.372 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.656 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 9.2 tp -80.34 121.01 25.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.223 -0.923 . . . . 0.0 109.94 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.532 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 27.4 pt -100.16 -11.18 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.654 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -154.82 147.98 24.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.0 110.238 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.772 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 172.61 152.46 8.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -78.91 -35.38 43.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -1.122 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.869 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -58.78 -21.25 55.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.158 -0.964 . . . . 0.0 110.265 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.825 HD22 ' O ' ' A' ' 96' ' ' GLU . 19.8 mt -65.2 -42.86 93.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.309 -0.869 . . . . 0.0 109.694 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.67 -172.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -73.01 -3.73 27.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -1.106 . . . . 0.0 110.008 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.682 ' HA ' HG11 ' A' ' 126' ' ' VAL . 41.6 p -88.58 -45.49 9.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.12 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.801 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -118.89 159.46 23.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.383 -0.823 . . . . 0.0 109.067 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.825 ' O ' HD22 ' A' ' 91' ' ' LEU . 35.3 tt0 -140.31 -80.84 0.27 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 110.39 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 43.0 mtmt -80.26 148.42 30.78 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.619 -0.676 . . . . 0.0 110.681 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.858 HG21 ' CE2' ' A' ' 100' ' ' TYR . 17.8 mm -136.51 148.48 27.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.018 -1.051 . . . . 0.0 109.694 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -121.58 124.45 44.39 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.858 ' CE2' HG21 ' A' ' 98' ' ' ILE . 16.0 m-85 -117.31 135.67 53.67 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.306 -0.871 . . . . 0.0 110.741 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -135.88 134.73 39.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 109.923 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 89.3 m -134.1 147.8 50.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -0.988 . . . . 0.0 110.259 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 9.8 tttt -139.49 148.67 43.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.83 HD23 HG12 ' A' ' 114' ' ' ILE . 5.5 mt -125.06 152.36 44.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.257 -0.902 . . . . 0.0 110.447 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.77 -169.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.28 -0.888 . . . . 0.0 109.787 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.702 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.42 160.99 24.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.943 . . . . 0.0 110.311 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.441 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 35.3 p -120.59 164.12 24.95 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 110.13 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.5 -1.94 11.02 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.059 1.557 . . . . 0.0 110.363 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.6 m -102.72 0.45 32.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 110.326 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.46 -39.76 2.66 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.87 -171.67 0.36 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 54.8 p -131.93 134.62 45.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -1.166 . . . . 0.0 110.37 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.519 ' HA ' HG22 ' A' ' 10' ' ' THR . 31.9 mt -81.71 150.11 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.889 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.83 HG12 HD23 ' A' ' 104' ' ' LEU . 14.4 mt -135.45 112.98 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.593 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -103.54 136.37 43.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 109.759 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.6 t -131.91 158.67 40.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.976 . . . . 0.0 110.575 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 88.5 m -155.98 142.26 18.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 110.097 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.1 t -140.12 155.26 47.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.364 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.725 ' CE1' HG23 ' A' ' 4' ' ' THR . 64.4 m-70 -133.36 168.12 19.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.177 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.876 ' O ' HG13 ' A' ' 2' ' ' VAL . 32.0 m-85 -127.06 146.06 50.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.326 -0.859 . . . . 0.0 110.639 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 97.4 m-70 -127.18 92.07 3.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.702 HG21 ' O ' ' A' ' 126' ' ' VAL . 1.8 p -63.01 161.15 13.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.36 -0.837 . . . . 0.0 110.612 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 34.8 tttm -126.27 124.65 40.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.417 -0.802 . . . . 0.0 110.044 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 125' ' ' ASN . . . 93.48 22.61 26.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 11.9 t30 64.61 50.48 2.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -1.083 . . . . 0.0 110.304 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.702 ' O ' HG21 ' A' ' 122' ' ' THR . 72.3 t -119.51 174.64 4.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.414 -0.804 . . . . 0.0 109.818 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.668 ' HA ' HG21 ' A' ' 122' ' ' THR . 81.3 mt-10 -127.26 153.16 46.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.174 -0.954 . . . . 0.0 110.094 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.599 HG22 ' N ' ' A' ' 129' ' ' LYS . 3.4 mp -82.05 173.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.837 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.599 ' N ' HG22 ' A' ' 128' ' ' ILE . 88.4 mttt -96.42 133.86 40.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 110.189 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.558 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 93.1 mt-10 -51.7 -49.35 62.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.139 -0.976 . . . . 0.0 110.051 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.49 -34.09 64.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.896 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.869 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 12.6 t-160 -71.81 -53.04 14.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.355 -0.84 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.015 HG21 ' CE2' ' A' ' 5' ' ' TYR . 6.0 p -60.89 -35.32 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 110.023 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 81.4 tttt -70.99 -43.9 67.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.847 . . . . 0.0 109.884 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.92 91.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.936 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.81 -31.63 78.91 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.499 ' HE3' HG22 ' A' ' 133' ' ' VAL . 95.2 mttt -63.06 -32.76 74.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.341 -1.094 . . . . 0.0 109.945 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.471 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 79.8 mt-10 -70.78 -35.12 72.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.845 . . . . 0.0 109.84 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.37 -42.83 87.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.388 -0.82 . . . . 0.0 109.875 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -70.73 -41.23 72.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.926 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.5 m -67.86 -53.71 24.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.781 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.2 m-20 -54.2 -40.07 67.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -0.905 . . . . 0.0 109.742 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.468 ' HG ' HD11 ' A' ' 147' ' ' ILE . 16.1 tp -60.98 -47.26 87.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.778 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 18.0 m-85 -53.6 -38.16 63.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.393 -0.817 . . . . 0.0 109.555 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -79.59 -17.11 54.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.225 -0.922 . . . . 0.0 109.671 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.67 ' HB3' HG21 ' A' ' 33' ' ' ILE . 26.8 mt -83.38 -35.52 25.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.291 -0.881 . . . . 0.0 108.625 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.574 HD11 ' CE1' ' A' ' 22' ' ' PHE . 27.3 mt -70.88 -46.65 67.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 13' ' ' ILE . 57.9 mt-10 -58.23 -38.77 77.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.664 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.404 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 99.8 m -70.32 -38.33 74.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.781 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.634 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.3 t80 -54.36 -48.21 71.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 110.014 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.176 HD21 ' CE2' ' A' ' 158' ' ' TYR . 92.0 mt -79.55 -30.15 41.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.545 ' CD ' HD11 ' A' ' 13' ' ' ILE . 47.4 tptt -73.9 -21.31 60.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.91 . . . . 0.0 109.463 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.47 -31.88 3.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.548 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.0 m-70 -110.73 93.45 16.9 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.355 -1.085 . . . . 0.0 110.059 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.415 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.4 Cg_endo -74.35 6.72 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.997 1.525 . . . . 0.0 111.035 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -108.72 1.42 21.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.053 -1.029 . . . . 0.0 109.764 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.634 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -81.87 104.5 12.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.365 -0.834 . . . . 0.0 110.196 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.176 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 34.9 32.17 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.691 -0.63 . . . . 0.0 110.528 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.735 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 120' ' ' TYR . 77.7 t -122.26 120.15 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -1.171 . . . . 0.0 110.265 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.6 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 94.2 m-85 -77.41 144.85 37.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.137 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.607 HG23 ' CE1' ' A' ' 119' ' ' HIS . 41.3 m -127.82 125.1 39.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 110.155 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.122 ' CE2' HG21 ' A' ' 133' ' ' VAL . 68.5 m-85 -134.47 159.13 42.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.237 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.7 pt-20 -151.28 152.48 33.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.886 . . . . 0.0 110.19 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 116' ' ' SER . 55.4 p -134.99 145.99 48.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.031 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 86.6 mt-10 -130.32 119.46 22.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.34 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.5 p90 -145.42 -175.98 4.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.834 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.678 HG22 HG12 ' A' ' 113' ' ' ILE . 18.4 p -136.56 -179.56 5.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.134 -0.979 . . . . 0.0 110.57 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.515 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 14.8 t -156.79 168.27 27.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 110.358 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.52 -16.24 24.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.972 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.837 HG23 ' HD2' ' A' ' 14' ' ' PRO . 6.8 mm -89.67 151.36 45.65 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.98 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.837 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.2 Cg_endo -64.74 145.28 86.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.053 1.554 . . . . 0.0 110.453 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -72.29 -31.63 11.41 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.028 1.541 . . . . 0.0 112.954 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.5 Cg_endo -69.33 -19.83 37.64 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 N-CA-C 110.148 -0.751 . . . . 0.0 110.148 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 4.2 mmp_? -85.65 -47.77 9.5 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.773 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.4 tt -67.3 -25.61 66.12 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 74' ' ' ILE . 82.6 t80 -68.57 -58.68 3.92 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.505 0.669 . . . . 0.0 109.463 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 47.9 mttt -52.18 -30.47 27.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.159 0.98 . . . . 0.0 108.399 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.974 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.8 -63.53 1.24 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.677 0.751 . . . . 0.0 110.96 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.026 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -57.83 -35.64 71.15 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 111.459 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.125 HG11 ' CD1' ' A' ' 74' ' ' ILE . 20.1 t -104.62 -67.85 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.118 . . . . 0.0 111.493 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.626 HD22 ' N ' ' A' ' 24' ' ' LEU . 4.0 mm? -65.29 -6.13 9.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 111.19 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -144.15 19.85 1.76 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.901 -1.124 . . . . 0.0 110.585 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.026 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -54.97 -34.44 63.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 110.164 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.54 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 89.6 m-20 -69.47 -12.0 61.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 110.279 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.507 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.7 m-20 -126.72 -4.98 6.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 110.3 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -85.86 -46.78 10.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.124 -0.985 . . . . 0.0 110.294 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.813 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.3 t -75.92 -42.01 3.51 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.885 . . . . 0.0 111.13 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.5 Cg_endo -77.86 9.71 2.89 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.402 1.212 . . . . 0.0 110.855 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HG2' ' OH ' ' A' ' 150' ' ' TYR . 37.3 tptt -123.16 -28.69 3.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.614 HG12 ' CD1' ' A' ' 150' ' ' TYR . 9.6 mt -80.08 -47.21 21.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.447 -0.783 . . . . 0.0 109.499 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.0 101.96 4.17 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.486 -0.759 . . . . 0.0 109.981 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.34 0.05 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.023 1.538 . . . . 0.0 110.715 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -83.53 -13.04 55.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 109.419 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.456 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -101.96 -62.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.994 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.813 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.8 mp -108.98 132.11 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.451 -0.781 . . . . 0.0 110.001 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HE2' ' HB ' ' A' ' 57' ' ' THR . 31.7 ttpt -83.33 -38.07 22.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.0 110.416 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -174.55 141.42 0.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.165 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.54 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 7.3 m -107.03 135.92 47.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.041 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.479 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 55.2 tt0 -136.31 109.15 7.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.3 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 9.1 mt -62.43 130.55 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.462 ' CD1' ' O ' ' A' ' 42' ' ' GLU . 10.6 mp -94.59 -41.99 9.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.38 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.898 ' O ' HG23 ' A' ' 52' ' ' THR . 5.3 mt-10 -132.91 142.79 49.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.134 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.4 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 77.99 -170.2 54.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -124.82 6.58 8.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 110.215 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.556 ' N ' HG21 ' A' ' 52' ' ' THR . . . 130.32 -4.82 5.95 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.528 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -85.39 -164.68 39.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.38 132.03 21.53 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.153 1.607 . . . . 0.0 110.418 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.69 69.99 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.898 HG23 ' O ' ' A' ' 45' ' ' GLU . 29.6 m -80.06 136.47 36.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -1.155 . . . . 0.0 109.857 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.708 HG21 ' HE3' ' A' ' 68' ' ' LYS . 20.5 mm -107.15 117.97 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 110.17 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 87.2 mttt -105.2 145.9 29.99 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.3 -0.875 . . . . 0.0 110.496 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -118.88 101.43 8.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 110.058 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.74 141.99 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.883 . . . . 0.0 110.444 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.8 p -110.27 153.19 25.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 109.965 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.769 ' HE2' HG13 ' A' ' 67' ' ' VAL . 24.5 m-85 -111.75 123.95 51.32 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.0 111.001 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 2.6 t80 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.233 0.54 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -126.32 99.05 0.54 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.508 ' CD2' ' CD2' ' A' ' 64' ' ' TYR . 33.2 p90 -138.83 169.98 16.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.134 -1.216 . . . . 0.0 110.369 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.921 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.9 m -137.49 173.44 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 110.563 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.708 ' HE3' HG21 ' A' ' 53' ' ' ILE . 37.8 tttt -122.81 127.96 49.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.596 -0.69 . . . . 0.0 109.43 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.64 ' CD2' HD13 ' A' ' 85' ' ' LEU . 10.5 m170 -117.32 126.37 52.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.965 . . . . 0.0 111.035 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HA ' HD13 ' A' ' 53' ' ' ILE . 84.1 tttt -106.01 118.04 35.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.287 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.536 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.0 mm -57.34 135.03 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.93 . . . . 0.0 110.454 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.51 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 9.5 t0 -107.05 -39.47 5.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.794 . . . . 0.0 109.795 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 0.7 OUTLIER 171.95 161.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.537 -0.727 . . . . 0.0 109.957 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.125 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.1 tt -154.64 163.51 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.224 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -125.84 78.01 1.71 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.259 -0.9 . . . . 0.0 109.671 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.592 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 86.3 mttt -53.94 -15.26 1.29 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.331 -0.855 . . . . 0.0 110.863 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -91.76 -32.39 15.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 109.788 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.3 m-80 -107.83 -4.51 17.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.639 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.636 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 6.5 m-85 69.22 49.07 0.63 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.322 0.582 . . . . 0.0 110.543 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.547 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -118.43 147.18 43.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 109.107 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.681 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 79.7 t80 -141.49 142.89 33.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.02 . . . . 0.0 110.617 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.447 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 61.1 m -147.14 128.21 14.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 110.007 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.681 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 3.9 p90 -137.07 -176.71 4.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.062 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.4 m -135.41 140.07 44.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.296 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.667 HD12 ' O ' ' A' ' 68' ' ' LYS . 49.0 tp -100.47 128.67 46.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.964 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.537 HD11 ' HE2' ' A' ' 68' ' ' LYS . 16.5 pt -118.73 -7.7 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.366 -0.834 . . . . 0.0 110.246 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 79.7 tt0 -146.05 135.27 22.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.921 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 174.35 159.9 21.54 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 46.1 p-10 -71.29 -7.73 48.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -1.159 . . . . 0.0 110.285 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.455 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -79.07 -46.14 18.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.612 HD22 ' O ' ' A' ' 96' ' ' GLU . 19.6 mt -40.96 -46.42 2.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.595 -0.691 . . . . 0.0 110.224 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 41.31 -132.73 3.41 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.746 ' OD1' HG23 ' A' ' 94' ' ' THR . 57.5 p-10 -115.89 21.72 13.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -1.104 . . . . 0.0 110.062 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.746 HG23 ' OD1' ' A' ' 93' ' ' ASP . 72.5 p -122.4 -41.58 2.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -0.866 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.056 HD21 HD11 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -114.41 163.35 15.44 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.341 -0.85 . . . . 0.0 109.141 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.805 ' H ' HD12 ' A' ' 95' ' ' LEU . 28.1 tp10 -142.03 -79.54 0.24 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.135 -0.978 . . . . 0.0 110.282 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.559 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 21.2 mtpt -80.18 151.66 29.59 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.616 -0.677 . . . . 0.0 109.845 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.056 HD11 HD21 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -146.62 135.37 16.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.063 -1.023 . . . . 0.0 109.819 179.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 5.1 m -114.99 118.41 33.34 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.43 -0.794 . . . . 0.0 109.597 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.621 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.7 m-85 -110.39 137.74 47.7 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.469 -0.769 . . . . 0.0 110.173 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 76.9 tt0 -132.85 143.18 49.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.203 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.6 m -139.39 135.67 33.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -128.31 138.89 52.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.823 HD23 HG12 ' A' ' 114' ' ' ILE . 6.5 mt -118.56 149.76 40.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.197 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.03 -169.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 109.961 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.2 125.7 45.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.972 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.47 ' HB3' ' CG1' ' A' ' 113' ' ' ILE . 3.2 p -80.15 170.36 16.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 110.219 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 50.7 Cg_endo -83.52 22.47 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.056 1.556 . . . . 0.0 110.966 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.5 p -127.89 4.03 5.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.938 -1.101 . . . . 0.0 110.412 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.16 -25.74 25.21 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.46 -174.33 43.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.52 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 19.9 p -124.35 131.32 53.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -1.201 . . . . 0.0 110.37 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.678 HG12 HG22 ' A' ' 10' ' ' THR . 84.8 mt -82.82 149.68 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 110.195 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.823 HG12 HD23 ' A' ' 104' ' ' LEU . 7.6 mt -133.68 128.82 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 110.359 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 85.9 tttt -118.66 111.11 18.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.315 -0.865 . . . . 0.0 109.781 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.44 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 1.4 m -101.58 162.31 13.0 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.158 -0.964 . . . . 0.0 110.834 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 53.7 m -160.05 132.65 6.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.44 -0.787 . . . . 0.0 109.773 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.1 p -132.58 159.11 40.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.107 -0.995 . . . . 0.0 110.745 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.607 ' CE1' HG23 ' A' ' 4' ' ' THR . 60.7 m-70 -141.37 155.37 45.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.419 -0.8 . . . . 0.0 110.038 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.653 ' O ' HG13 ' A' ' 2' ' ' VAL . 28.2 m-85 -119.03 138.07 53.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.39 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.559 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 95.4 m-70 -119.32 93.13 3.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 109.675 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.864 HG21 ' HA ' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -62.86 159.22 17.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.156 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 43.7 tttm -142.7 128.34 19.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 110.19 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 93.31 26.38 16.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 8.2 t30 64.91 65.96 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -1.189 . . . . 0.0 110.173 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.615 ' O ' HG21 ' A' ' 122' ' ' THR . 7.0 m -144.37 171.21 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.864 ' HA ' HG21 ' A' ' 122' ' ' THR . 86.5 mt-10 -140.25 152.37 45.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.215 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 129' ' ' LYS . 4.9 mp -81.89 173.53 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 109.964 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.591 ' N ' HG22 ' A' ' 128' ' ' ILE . 57.0 mttt -104.85 132.15 51.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.229 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.449 ' HA ' HG12 ' A' ' 133' ' ' VAL . 52.1 mt-10 -48.48 -39.79 24.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 110.101 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.01 -30.39 70.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.948 . . . . 0.0 109.882 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -75.34 -50.97 14.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 110.18 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.122 HG21 ' CE2' ' A' ' 5' ' ' TYR . 10.3 p -65.47 -41.81 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 110.038 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.551 ' N ' HG13 ' A' ' 133' ' ' VAL . 72.5 mmtt -63.04 -40.02 96.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.979 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.54 -34.69 72.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.831 . . . . 0.0 110.0 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 139' ' ' LYS . . . -73.08 -29.76 64.17 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -73.71 -32.95 64.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -1.08 . . . . 0.0 110.076 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -70.28 -54.73 11.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 109.948 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 136' ' ' GLY . 20.7 ptmt -56.54 -28.49 60.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.795 . . . . 0.0 109.866 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.81 -45.88 70.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.051 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -61.96 -40.88 97.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.978 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -62.07 -41.42 98.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 147' ' ' ILE . 30.1 mt -61.1 -41.22 96.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.934 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -61.54 -33.21 73.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.416 -0.802 . . . . 0.0 109.951 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 47.4 tptt -80.02 -19.05 48.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 110.26 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 146' ' ' LEU . 13.4 mt -79.95 -35.16 38.08 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.104 -0.997 . . . . 0.0 108.515 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.652 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 67.4 mt -70.67 -51.73 34.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 13' ' ' ILE . 78.0 mt-10 -49.41 -34.67 16.98 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.288 -0.883 . . . . 0.0 109.016 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.4 m -79.99 -28.33 39.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -0.916 . . . . 0.0 109.296 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.634 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.7 t80 -61.36 -54.07 48.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.561 -0.712 . . . . 0.0 109.977 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.192 HD21 ' CE2' ' A' ' 158' ' ' TYR . 59.0 mt -69.56 -27.96 65.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 110.077 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.454 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 57.3 tptt -74.04 -29.39 61.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 109.727 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -101.33 -29.15 6.45 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.521 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.5 m-70 -107.15 90.98 6.05 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.447 -1.031 . . . . 0.0 109.7 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.5 Cg_endo -73.54 5.22 3.4 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.009 1.531 . . . . 0.0 111.025 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 44.3 p30 -109.82 -9.37 14.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.013 -1.054 . . . . 0.0 109.685 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.634 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -69.36 99.62 1.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.477 -0.764 . . . . 0.0 110.091 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.192 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.9 31.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.727 -0.608 . . . . 0.0 110.554 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.799 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.039 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.5 p -79.86 145.64 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -1.206 . . . . 0.0 110.563 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 77.5 m-85 -93.18 167.7 11.59 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.332 -0.855 . . . . 0.0 110.242 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.769 HG23 ' CE1' ' A' ' 119' ' ' HIS . 91.9 m -131.39 110.84 11.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.944 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CZ ' HG22 ' A' ' 133' ' ' VAL . 24.3 m-85 -113.18 125.34 54.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 110.085 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.5 pt-20 -133.13 152.94 51.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 110.085 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.2 t -128.52 155.81 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.359 -0.838 . . . . 0.0 110.172 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 76.0 mt-10 -136.0 118.03 15.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.333 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.2 p90 -147.24 -170.98 3.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.939 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 113' ' ' ILE . 18.2 p -140.64 -179.44 6.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 110.561 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 3.2 t -156.74 160.12 38.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.759 . . . . 0.0 110.165 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -84.7 -16.12 42.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.853 . . . . 0.0 110.251 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.789 HG23 ' HD2' ' A' ' 14' ' ' PRO . 7.4 mm -87.61 149.96 47.47 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 110.135 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.789 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.13 149.02 89.49 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.098 1.578 . . . . 0.0 110.412 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.677 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 Cg_endo -70.14 -32.72 16.46 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.899 1.473 . . . . 0.0 113.0 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.0 Cg_endo -68.0 -21.75 42.82 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 122.504 0.739 . . . . 0.0 110.207 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.676 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -83.65 -46.78 11.95 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.132 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.757 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -69.07 -28.33 66.42 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.635 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 62.6 t80 -66.04 -59.34 3.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.468 -0.77 . . . . 0.0 109.514 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 51.2 mttp -51.6 -34.79 38.88 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.521 -0.737 . . . . 0.0 109.604 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.04 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -75.29 -55.5 5.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.391 -0.818 . . . . 0.0 111.152 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.039 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -59.77 -45.51 92.05 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.48 -0.762 . . . . 0.0 111.738 -178.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.713 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.7 t -97.37 -66.3 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.02 -1.05 . . . . 0.0 111.392 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.6 mm? -64.44 -5.97 6.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.262 -0.899 . . . . 0.0 111.444 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.687 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -143.79 25.88 1.6 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.862 -1.149 . . . . 0.0 110.849 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.039 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -66.37 -30.02 70.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 110.195 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.56 -12.77 61.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.501 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 72.5 m-20 -129.1 6.32 5.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 110.118 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -92.99 -53.35 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -0.832 . . . . 0.0 110.056 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.01 HG11 HD13 ' A' ' 38' ' ' ILE . 17.1 t -67.2 -41.42 33.97 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 111.176 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -76.91 6.03 4.5 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.334 1.176 . . . . 0.0 110.881 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 66.6 mttt -127.54 -31.84 2.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 109.787 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.621 HD11 ' CD1' ' A' ' 29' ' ' LEU . 16.0 mt -79.89 -43.17 22.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.462 -0.774 . . . . 0.0 109.775 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.7 91.8 3.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.0 110.188 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.26 3.51 5.69 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.114 1.586 . . . . 0.0 110.594 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -87.23 -19.9 27.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.134 -0.979 . . . . 0.0 110.061 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.38 -40.77 8.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 110.201 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.01 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mt -125.72 145.99 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.447 -0.783 . . . . 0.0 110.047 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.461 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 28.2 ttpt -80.93 -46.36 15.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 110.32 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.557 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -176.93 158.88 1.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.88 . . . . 0.0 110.038 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -113.01 120.57 41.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.945 . . . . 0.0 110.162 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.557 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 32.0 tt0 -121.46 102.08 8.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.003 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 37.6 mt -50.7 129.32 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.307 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.662 HD23 HG21 ' A' ' 53' ' ' ILE . 19.9 tp -91.72 -40.07 11.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.468 -0.77 . . . . 0.0 110.354 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.879 ' O ' HG23 ' A' ' 52' ' ' THR . 2.9 mt-10 -138.32 138.02 37.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 110.172 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 47' ' ' ASP . . . 82.21 -159.53 39.32 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 87.1 m-20 -138.24 9.55 2.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -1.192 . . . . 0.0 110.348 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.621 ' N ' HG21 ' A' ' 52' ' ' THR . . . 130.29 -2.94 5.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -87.6 -168.49 44.62 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -69.82 137.74 35.98 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.091 1.574 . . . . 0.0 110.507 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.93 -5.47 85.04 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.879 HG23 ' O ' ' A' ' 45' ' ' GLU . 18.0 m -80.0 138.94 37.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -1.177 . . . . 0.0 109.998 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.662 HG21 HD23 ' A' ' 44' ' ' LEU . 32.2 mm -105.15 127.58 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.0 110.001 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 93.5 mttt -110.39 126.71 54.56 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 110.019 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.638 ' HD3' HD13 ' A' ' 44' ' ' LEU . 43.4 mtmt -99.15 98.12 9.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.139 -0.976 . . . . 0.0 110.589 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.535 ' CG2' HG12 ' A' ' 38' ' ' ILE . 96.4 mt -87.07 146.71 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.155 -0.966 . . . . 0.0 109.66 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 38' ' ' ILE . 5.4 p -118.76 153.16 34.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.124 -0.985 . . . . 0.0 111.116 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.626 ' HE2' HG13 ' A' ' 67' ' ' VAL . 25.5 m-85 -117.44 138.47 51.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.509 -0.745 . . . . 0.0 109.973 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.849 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.21 0.529 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -115.2 93.28 0.62 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.4 p90 -128.96 164.91 22.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -1.228 . . . . 0.0 110.234 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.734 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.9 m -134.63 175.28 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 0.0 110.486 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.664 ' O ' HD12 ' A' ' 85' ' ' LEU . 59.5 mttt -133.15 106.46 7.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.46 -0.775 . . . . 0.0 109.701 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.989 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.0 m170 -98.16 128.44 44.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 111.023 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.625 ' HA ' HD13 ' A' ' 53' ' ' ILE . 54.6 tttm -101.88 109.56 21.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.329 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.507 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.0 mm -42.59 140.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.341 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.521 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 23.9 t0 -111.43 -48.87 3.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.527 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.485 ' N ' ' OG ' ' A' ' 82' ' ' SER . 8.7 m -165.88 156.16 12.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.527 -0.733 . . . . 0.0 109.746 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 mt -138.36 153.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.396 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.7 m-20 -141.7 80.74 1.74 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.517 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 34.4 tttt -65.65 -13.32 58.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.179 -0.951 . . . . 0.0 109.853 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -89.94 -30.87 17.54 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.803 0.811 . . . . 0.0 109.013 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m-80 -106.91 -2.98 20.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.757 ' O ' HD12 ' A' ' 104' ' ' LEU . 73.8 m-85 60.94 54.35 3.47 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.652 0.739 . . . . 0.0 110.167 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -127.26 156.53 41.75 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.637 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.713 ' CE1' HG13 ' A' ' 23' ' ' VAL . 27.6 t80 -142.83 137.38 29.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.947 . . . . 0.0 110.003 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.485 ' OG ' ' N ' ' A' ' 73' ' ' SER . 13.9 p -143.87 124.18 13.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.112 -0.993 . . . . 0.0 111.263 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 13.7 p90 -137.73 172.53 12.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 110.23 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 98' ' ' ILE . 97.1 m -129.39 134.52 47.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.332 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.989 HD13 ' CD2' ' A' ' 69' ' ' HIS . 11.7 tp -101.5 133.78 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.05 -1.031 . . . . 0.0 110.221 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 85' ' ' LEU . 13.8 pt -113.11 -30.88 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.458 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.644 ' O ' HD11 ' A' ' 85' ' ' LEU . 70.1 tt0 -119.41 157.35 28.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.258 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.734 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 159.05 140.69 2.96 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.415 ' OD2' ' HA2' ' A' ' 65' ' ' GLY . 98.3 m-20 -69.6 -25.58 64.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -1.148 . . . . 0.0 110.139 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.08 -26.61 61.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.146 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 88' ' ' GLY . 15.5 mt -63.22 -31.59 72.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 110.104 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.54 -174.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 52.8 t0 -77.1 -1.02 26.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.138 . . . . 0.0 110.057 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 122' ' ' THR . 43.2 p -87.82 -41.96 12.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 110.056 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.062 HD21 ' CG1' ' A' ' 128' ' ' ILE . 68.4 mt -98.25 153.55 18.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.815 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 35.4 tt0 -137.24 -83.33 0.34 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.301 -0.874 . . . . 0.0 109.629 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.485 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 96.0 mttt -80.35 125.02 29.38 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.75 -0.594 . . . . 0.0 110.447 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.843 ' O ' HG23 ' A' ' 84' ' ' THR . 3.3 mm -116.86 135.01 58.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.789 -1.195 . . . . 0.0 109.827 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -120.89 127.07 51.53 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.644 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.1 m-85 -119.61 134.43 55.23 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.326 -0.859 . . . . 0.0 110.573 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.491 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 26.5 tt0 -137.16 133.58 35.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.427 -0.796 . . . . 0.0 109.92 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 54.5 m -134.35 144.1 48.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 110.361 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -135.25 146.93 49.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 110.256 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.769 HD23 HG12 ' A' ' 114' ' ' ILE . 6.1 mt -119.22 153.73 34.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.339 -0.851 . . . . 0.0 110.433 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.717 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.94 -168.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.289 -0.882 . . . . 0.0 109.93 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.717 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.88 128.19 51.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 110.27 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.567 ' HA ' HD11 ' A' ' 113' ' ' ILE . 87.2 p -81.47 160.02 65.72 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.181 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -2.26 11.45 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.082 1.569 . . . . 0.0 110.547 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.4 p -103.07 4.82 37.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.351 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.62 -34.38 5.82 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.09 -174.18 6.51 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 23.6 p -123.66 135.82 54.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 107' ' ' SER . 23.4 mt -87.04 150.41 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.769 HG12 HD23 ' A' ' 104' ' ' LEU . 7.0 mt -132.85 117.67 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.178 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.487 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 80.8 tttt -110.05 109.69 20.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 110.079 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 8.6 m -97.6 164.21 12.52 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.173 -0.954 . . . . 0.0 110.474 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 29.4 m -160.01 126.17 4.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.411 -0.805 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.0 m -128.37 156.95 42.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.163 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.769 ' CE1' HG23 ' A' ' 4' ' ' THR . 90.9 m-70 -129.24 136.31 49.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -0.93 . . . . 0.0 110.255 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 1.039 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.0 m-30 -109.59 111.69 23.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.962 . . . . 0.0 111.169 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.673 ' CE1' HG21 ' A' ' 2' ' ' VAL . 90.3 m-70 -99.09 117.38 33.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.196 -0.94 . . . . 0.0 109.514 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 94' ' ' THR . 0.7 OUTLIER -87.27 138.76 31.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 110.569 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 74.1 tttt -72.3 123.1 22.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 110.223 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.48 -128.86 8.71 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -121.09 51.72 1.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -1.188 . . . . 0.0 110.12 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 127' ' ' GLU . 85.9 t -94.61 174.6 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.416 -0.802 . . . . 0.0 110.02 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.605 ' N ' HG12 ' A' ' 126' ' ' VAL . 45.8 mt-10 -143.16 125.73 15.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 110.408 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.062 ' CG1' HD21 ' A' ' 95' ' ' LEU . 1.8 mp -60.45 174.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.855 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.608 ' N ' HG22 ' A' ' 128' ' ' ILE . 62.3 mttt -100.7 151.52 21.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.26 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -66.55 -34.29 77.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.199 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 132' ' ' HIS . 22.2 pt-20 -68.26 -36.96 80.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 110.198 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.445 ' N ' ' CG ' ' A' ' 131' ' ' GLU . 17.8 t-160 -67.79 -33.53 75.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.648 HG22 ' CZ ' ' A' ' 5' ' ' TYR . 89.3 t -67.85 -43.77 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.22 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -73.83 -43.0 60.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.003 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.72 91.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.083 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.92 -26.3 73.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -75.99 -31.94 59.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -1.156 . . . . 0.0 110.144 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.456 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 78.3 tt0 -79.02 -28.55 43.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.125 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.99 -32.86 59.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.71 -33.29 46.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.5 t -64.58 -45.29 87.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.165 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 73.5 m-20 -52.81 -48.72 66.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.03 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 143' ' ' LEU . 19.3 tp -55.89 -48.59 75.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.941 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.427 ' O ' ' CD ' ' A' ' 148' ' ' GLU . 25.8 m-85 -54.4 -39.77 67.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.807 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.439 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 42.7 tttm -79.81 -14.03 58.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.473 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 17.8 mt -83.97 -37.69 21.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.1 -1.0 . . . . 0.0 108.954 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.765 HD13 ' CD1' ' A' ' 22' ' ' PHE . 75.6 mt -71.21 -44.1 74.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.822 -0.751 . . . . 0.0 108.983 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' HG13 ' A' ' 13' ' ' ILE . 65.0 mt-10 -56.62 -36.24 69.23 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.435 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.6 m -76.68 -30.57 56.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.926 . . . . 0.0 109.511 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.648 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 89.9 t80 -57.38 -48.19 79.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.54 -0.725 . . . . 0.0 110.045 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.128 HD21 ' CE1' ' A' ' 158' ' ' TYR . 72.1 mt -76.48 -38.53 55.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 110.065 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.42 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 83.8 tttt -61.23 -14.83 28.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.374 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -116.52 -28.13 2.63 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.574 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 8.5 m-70 -109.08 93.91 13.86 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.333 -1.098 . . . . 0.0 110.058 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.8 4.24 4.28 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.028 1.541 . . . . 0.0 110.961 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -113.77 -6.56 13.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.124 -0.985 . . . . 0.0 110.047 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.685 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -67.03 102.67 1.03 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.128 ' CE1' HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.65 32.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.741 -0.599 . . . . 0.0 110.604 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.511 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.756 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 77.1 t -114.13 109.33 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.195 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.61 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 82.6 m-85 -77.48 144.86 37.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 110.298 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.76 HG23 ' CE1' ' A' ' 119' ' ' HIS . 95.4 m -122.71 115.77 22.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 110.396 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.778 ' CE2' HG21 ' A' ' 133' ' ' VAL . 67.2 m-85 -124.08 154.54 39.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.897 . . . . 0.0 109.951 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 13.6 pt-20 -147.3 151.4 36.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 0.0 110.566 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 m -137.36 144.21 42.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.777 . . . . 0.0 109.456 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -132.82 143.46 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.114 -0.991 . . . . 0.0 110.928 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.605 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.3 p90 -158.79 -176.04 5.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.57 -0.706 . . . . 0.0 109.492 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.6 HG22 HG12 ' A' ' 113' ' ' ILE . 21.1 p -135.64 -179.46 5.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.041 -1.037 . . . . 0.0 110.764 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 10.0 t -159.96 167.16 28.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.529 -0.732 . . . . 0.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -98.38 9.81 42.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 109.972 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.816 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.7 mp -107.75 149.88 39.54 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.033 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.816 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.81 143.19 72.71 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.081 1.569 . . . . 0.0 110.554 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.676 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.9 Cg_endo -71.82 -31.67 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 124.027 1.541 . . . . 0.0 112.804 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.9 Cg_endo -67.94 -21.93 42.92 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 O-C-N 122.468 0.72 . . . . 0.0 110.322 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.529 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 8.7 mmp_? -83.91 -46.99 11.51 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.845 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -68.25 -29.3 68.08 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.551 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.0 t80 -66.3 -56.16 12.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.863 . . . . 0.0 109.9 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.529 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 76.1 mttt -53.92 -32.1 52.37 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.947 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -73.18 -64.82 0.9 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.713 0.768 . . . . 0.0 111.11 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.072 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -56.97 -39.08 73.93 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.634 -0.666 . . . . 0.0 112.228 -178.128 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.542 ' HB ' HD12 ' A' ' 24' ' ' LEU . 5.5 t -101.77 -58.03 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.777 -1.202 . . . . 0.0 111.578 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.751 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.4 mp -78.14 0.1 26.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.079 -1.013 . . . . 0.0 111.331 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.596 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -147.3 15.17 1.14 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.944 -1.098 . . . . 0.0 110.556 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.072 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -53.85 -39.88 66.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.95 . . . . 0.0 109.916 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 65.2 t0 -64.42 -14.19 55.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 109.907 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.526 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.2 m-20 -127.3 0.19 6.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.369 -0.832 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -88.09 -45.52 10.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.355 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.054 ' CG1' HD13 ' A' ' 38' ' ' ILE . 31.2 t -72.89 -40.36 6.1 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.263 -0.898 . . . . 0.0 111.482 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -77.44 10.11 2.61 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.329 1.173 . . . . 0.0 111.113 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 49.6 mttt -122.77 -25.77 4.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.054 -1.029 . . . . 0.0 109.628 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.605 HG12 ' CD1' ' A' ' 150' ' ' TYR . 28.7 mt -79.99 -49.86 18.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.475 -0.765 . . . . 0.0 109.926 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.37 104.02 2.21 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.383 -0.823 . . . . 0.0 110.128 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.17 1.01 6.46 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.02 1.537 . . . . 0.0 110.794 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -83.54 -14.41 52.28 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.36 -53.88 3.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 110.071 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.054 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.1 mp -117.65 149.02 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.453 -0.779 . . . . 0.0 110.017 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -85.35 -42.3 14.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.861 . . . . 0.0 110.41 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.536 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -178.77 141.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 110.369 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.477 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 38.6 m -97.84 134.3 41.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 110.093 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.536 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 30.8 tt0 -137.26 110.98 8.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.211 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 37.2 mt -60.71 131.7 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.277 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 81.2 mt -92.18 -26.45 18.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.148 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 1.064 ' O ' HG23 ' A' ' 52' ' ' THR . 38.8 tt0 -151.41 173.53 14.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.895 . . . . 0.0 110.085 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.01 -155.23 2.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -147.97 34.17 0.83 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 110.22 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.709 ' H ' HG21 ' A' ' 52' ' ' THR . . . 108.5 -9.29 35.3 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.429 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -81.41 -172.84 47.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.9 Cg_endo -71.1 137.97 32.64 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 124.173 1.617 . . . . 0.0 110.464 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.84 -4.8 83.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 1.064 HG23 ' O ' ' A' ' 45' ' ' GLU . 27.3 m -79.98 146.38 32.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -1.193 . . . . 0.0 110.116 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 70' ' ' LYS . 32.3 mm -113.38 110.21 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 110.154 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.756 ' NZ ' ' HB3' ' A' ' 26' ' ' ALA . 46.2 mtpt -93.11 141.99 27.8 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 110.474 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 83.3 tttt -111.7 113.26 25.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.091 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.555 ' CG2' HG12 ' A' ' 38' ' ' ILE . 62.6 mt -102.97 138.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 110.118 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 38' ' ' ILE . 1.6 p -114.03 152.53 30.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 110.562 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 30.5 m-85 -112.88 137.6 50.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.333 -0.854 . . . . 0.0 110.079 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.926 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.266 0.555 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -131.92 90.8 0.28 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 17.5 p90 -138.73 168.15 20.42 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.201 -1.176 . . . . 0.0 110.402 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.903 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.4 m -137.49 172.72 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.449 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.56 ' CB ' ' CG1' ' A' ' 86' ' ' ILE . 91.7 mttt -123.95 131.44 53.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.593 -0.692 . . . . 0.0 109.719 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.648 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 13.6 m170 -111.43 138.42 47.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.132 -0.98 . . . . 0.0 110.532 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.546 ' HA ' HD13 ' A' ' 53' ' ' ILE . 82.0 tttt -114.93 107.82 15.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.436 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 50' ' ' PRO . 33.4 mm -53.2 122.43 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 110.489 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.8 m-20 -94.89 -40.71 9.57 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.534 -0.729 . . . . 0.0 109.543 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 m -176.63 158.76 1.77 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.514 -0.741 . . . . 0.0 109.558 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.402 HG12 ' HD1' ' A' ' 81' ' ' TYR . 2.4 mt -138.16 159.32 32.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.25 -0.907 . . . . 0.0 110.124 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -145.63 83.85 1.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.574 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.551 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 86.0 tttt -68.18 -13.42 62.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 110.168 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -85.47 -30.38 23.53 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -109.44 -3.68 16.86 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.201 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.541 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 48.4 m-85 63.36 52.02 2.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.666 -0.646 . . . . 0.0 110.359 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 13.5 t -121.59 174.34 6.85 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.152 -0.968 . . . . 0.0 110.208 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.528 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 21.0 t80 -157.77 146.55 19.39 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.149 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 50.6 m -149.98 125.24 10.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.042 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 6.7 p90 -142.49 176.45 9.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.404 -0.81 . . . . 0.0 109.862 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.93 HG23 ' O ' ' A' ' 98' ' ' ILE . 53.1 m -135.54 141.54 45.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.648 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 9.2 tp -87.66 120.27 28.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.233 -0.917 . . . . 0.0 110.247 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.56 ' CG1' ' CB ' ' A' ' 68' ' ' LYS . 24.3 pt -100.63 -12.04 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.425 -0.797 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 71.0 tt0 -153.46 145.54 23.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.479 -0.763 . . . . 0.0 110.203 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.903 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 174.77 165.93 31.89 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 29.7 p-10 -79.9 -44.79 19.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -1.173 . . . . 0.0 110.522 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.825 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -50.8 -40.69 56.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 110.155 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.564 HD22 ' O ' ' A' ' 96' ' ' GLU . 38.0 mt -40.42 -50.45 2.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.575 -0.703 . . . . 0.0 110.339 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.41 -166.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -81.5 5.21 18.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -1.132 . . . . 0.0 110.139 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 55.3 p -97.69 -45.85 6.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.393 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.784 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -118.4 163.06 17.29 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.112 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.784 ' H ' HD12 ' A' ' 95' ' ' LEU . 62.7 tt0 -140.79 -79.79 0.27 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.527 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 33.8 mttt -80.28 145.95 31.89 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 110.735 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.93 ' O ' HG23 ' A' ' 84' ' ' THR . 25.4 mm -134.49 150.98 31.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.123 -0.985 . . . . 0.0 109.57 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -123.89 124.39 42.52 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.7 178.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.853 ' CE2' HG21 ' A' ' 98' ' ' ILE . 19.7 m-85 -117.86 134.64 54.73 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.32 -0.863 . . . . 0.0 110.625 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 117' ' ' THR . 6.0 mt-10 -134.36 126.43 29.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.821 . . . . 0.0 109.99 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 86.8 m -119.88 147.87 44.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.972 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LYS . 23.7 mttt -140.33 133.81 30.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 110.51 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.792 HD23 HG12 ' A' ' 114' ' ' ILE . 5.8 mt -112.71 151.81 29.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 110.185 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.36 -169.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.0 109.97 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.71 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -127.41 131.0 50.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.187 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.406 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 54.7 p -87.31 162.27 43.5 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.6 Cg_endo -72.51 -1.41 10.21 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.058 1.557 . . . . 0.0 110.594 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.9 p -101.05 -0.93 35.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.279 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.68 -39.72 2.79 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.78 -175.08 2.56 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 4.0 m -126.63 137.74 53.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -1.18 . . . . 0.0 110.468 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.6 HG12 HG22 ' A' ' 10' ' ' THR . 65.0 mt -87.89 151.5 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.394 -0.816 . . . . 0.0 110.105 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.792 HG12 HD23 ' A' ' 104' ' ' LEU . 9.8 mt -134.24 113.31 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.294 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 103' ' ' LYS . 79.4 tttt -102.11 131.34 48.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 109.974 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.74 154.74 33.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.488 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 101' ' ' GLU . 64.6 m -155.47 123.04 5.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.399 -0.813 . . . . 0.0 110.02 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 99' ' ' SER . 42.0 t -129.06 157.19 42.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.76 ' CE1' HG23 ' A' ' 4' ' ' THR . 44.6 m-70 -134.51 173.22 11.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.217 -0.927 . . . . 0.0 110.44 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.701 ' HA ' HD13 ' A' ' 98' ' ' ILE . 21.2 m-85 -129.91 144.44 51.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.271 -0.893 . . . . 0.0 110.575 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 96.8 m-70 -125.51 95.95 4.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 109.495 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.647 HG21 ' O ' ' A' ' 126' ' ' VAL . 3.1 p -56.87 164.93 1.36 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 0.0 110.572 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 78.9 tttt -115.52 119.2 35.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.45 -107.78 2.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.593 ' C ' HG13 ' A' ' 126' ' ' VAL . 43.4 t30 -130.51 86.8 2.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -1.145 . . . . 0.0 110.266 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.647 ' O ' HG21 ' A' ' 122' ' ' THR . 35.5 m -156.39 173.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 110.208 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.58 ' HA ' HG21 ' A' ' 122' ' ' THR . 96.9 mt-10 -148.27 147.7 29.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.216 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 128' ' ' ILE . 5.2 mp -78.68 173.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.064 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.601 ' N ' HG22 ' A' ' 128' ' ' ILE . 36.2 mtpt -103.94 136.04 44.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -49.45 -29.18 6.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 110.234 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.07 -35.51 78.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.064 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.825 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 17.6 t-160 -66.81 -42.64 85.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.097 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.778 HG21 ' CE2' ' A' ' 5' ' ' TYR . 68.9 t -62.57 -39.82 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.998 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -72.82 -39.16 66.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 110.179 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.15 93.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.133 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.24 -22.63 76.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.543 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 82.6 mttt -75.98 -32.67 59.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 110.094 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.56 -32.07 60.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.038 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -75.83 -27.59 57.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -84.76 -35.72 22.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 110.115 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 80.4 p -64.21 -46.0 85.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.876 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.19 -50.29 74.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.976 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.6 mm? -58.49 -32.72 69.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.853 . . . . 0.0 109.993 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 4.9 m-85 -63.33 -38.43 91.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.051 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -78.54 -18.1 55.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.497 HD23 ' HA ' ' A' ' 146' ' ' LEU . 15.4 mt -81.09 -35.14 32.06 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.126 -0.984 . . . . 0.0 108.829 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.705 HG22 HD23 ' A' ' 18' ' ' LEU . 34.7 mt -69.62 -49.06 61.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.857 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.576 ' HB3' HD13 ' A' ' 13' ' ' ILE . 65.1 mm-40 -54.12 -41.7 68.65 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.394 -0.816 . . . . 0.0 109.362 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.436 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 45.1 m -71.38 -32.6 68.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.592 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.658 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 76.2 t80 -53.9 -58.75 6.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.934 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.162 HD21 ' CE2' ' A' ' 158' ' ' TYR . 62.8 mt -69.03 -29.73 67.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -0.962 . . . . 0.0 109.968 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.585 ' HB2' HD11 ' A' ' 13' ' ' ILE . 43.5 tptt -68.59 -35.64 77.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 109.775 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -98.44 -28.69 7.87 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.511 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.8 m-70 -107.2 89.1 4.36 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.359 -1.083 . . . . 0.0 109.897 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.0 Cg_endo -72.76 4.46 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.095 1.576 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 24.2 p30 -107.74 -12.64 15.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.007 -1.058 . . . . 0.0 109.728 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.658 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -66.49 100.57 0.67 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.409 -0.807 . . . . 0.0 109.999 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.162 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.86 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.279 0.562 . . . . 0.0 110.584 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.378 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.783 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 73.8 t -135.65 125.33 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.162 . . . . 0.0 110.456 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.572 ' CE1' HG12 ' A' ' 128' ' ' ILE . 52.9 m-85 -96.91 173.51 7.25 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.254 -0.904 . . . . 0.0 110.094 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.748 HG23 ' CE1' ' A' ' 119' ' ' HIS . 54.4 m -148.11 98.38 2.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CE1' HG11 ' A' ' 133' ' ' VAL . 78.5 m-85 -114.89 132.03 56.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.023 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.503 ' HB3' HG23 ' A' ' 117' ' ' THR . 18.9 pt-20 -130.84 159.6 36.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.569 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 p -132.0 143.91 50.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.424 -0.798 . . . . 0.0 109.895 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -124.81 125.71 44.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 0.0 110.387 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.624 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 3.8 p90 -152.84 -172.86 4.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 110.005 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 113' ' ' ILE . 10.8 p -140.19 179.89 6.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.272 -0.893 . . . . 0.0 110.446 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 112' ' ' SER . 2.6 t -157.51 158.96 36.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.268 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.603 ' CG ' HD12 ' A' ' 13' ' ' ILE . 17.1 pt-20 -85.76 -10.89 54.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.915 . . . . 0.0 110.044 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.845 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.0 mp -90.5 151.37 44.12 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.711 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.845 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.3 Cg_endo -66.86 143.04 65.18 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.975 1.513 . . . . 0.0 110.723 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.666 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 Cg_endo -71.63 -31.73 12.96 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.952 1.501 . . . . 0.0 112.584 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -69.53 -18.99 37.77 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.511 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -84.47 -48.57 9.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.776 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -68.62 -24.55 64.58 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.593 ' CZ ' HD11 ' A' ' 74' ' ' ILE . 82.8 t80 -69.83 -57.12 5.46 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.498 0.666 . . . . 0.0 109.789 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 81.6 mttt -54.88 -30.56 58.31 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.892 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -73.3 -64.62 0.94 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.771 0.796 . . . . 0.0 111.167 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.046 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -57.43 -40.37 78.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.66 -0.65 . . . . 0.0 111.955 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.118 HG11 ' CD1' ' A' ' 74' ' ' ILE . 11.5 t -99.6 -59.41 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.786 -1.196 . . . . 0.0 111.798 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.671 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.3 mp -77.1 -0.55 25.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.015 . . . . 0.0 111.71 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.567 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -145.35 7.01 1.13 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.756 -1.215 . . . . 0.0 111.193 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.046 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -46.02 -48.06 16.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.873 -1.142 . . . . 0.0 110.01 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 74.0 m-20 -58.91 -15.43 12.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.831 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HA ' ' CG ' ' A' ' 31' ' ' PRO . 80.0 m-20 -129.54 10.93 5.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.796 HD12 ' C ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -95.25 -46.26 6.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.982 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.998 HG21 HD13 ' A' ' 38' ' ' ILE . 6.3 p -76.91 -27.63 0.62 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 112.419 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.821 ' HD3' HG12 ' A' ' 30' ' ' VAL . 47.7 Cg_endo -75.68 3.14 6.22 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 122.563 0.77 . . . . 0.0 110.611 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.528 ' CD ' ' OH ' ' A' ' 150' ' ' TYR . 95.0 mttt -119.15 -26.5 5.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -0.941 . . . . 0.0 109.127 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.612 HG12 ' CD1' ' A' ' 150' ' ' TYR . 49.4 mt -79.35 -41.02 22.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.553 -0.717 . . . . 0.0 109.533 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -169.75 103.79 0.46 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.49 -0.756 . . . . 0.0 109.829 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 43.3 Cg_endo -69.56 -3.01 11.02 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.979 1.515 . . . . 0.0 110.688 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.421 HE21 ' HB1' ' A' ' 34' ' ' ALA . 13.2 pt20 -83.16 -14.87 52.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.494 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.452 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -92.06 -71.97 0.61 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 110.201 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.998 HD13 HG21 ' A' ' 30' ' ' VAL . 1.7 mp -94.06 125.79 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.868 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 57' ' ' THR . 13.0 tppt? -74.19 -36.19 64.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.339 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.538 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -179.56 151.96 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.862 . . . . 0.0 109.974 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.443 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 39.3 p -112.01 133.59 54.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.07 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.481 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 71.9 tt0 -139.88 108.72 5.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.971 . . . . 0.0 110.29 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.8 mt -66.07 134.54 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 110.189 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.8 tp -90.31 -27.03 19.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 1.073 ' O ' HG23 ' A' ' 52' ' ' THR . 33.3 tp10 -158.84 169.32 24.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.228 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 64.75 -166.17 32.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 48.7 t0 -135.88 29.71 3.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -1.167 . . . . 0.0 110.287 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.516 ' H ' HG21 ' A' ' 52' ' ' THR . . . 104.36 4.85 43.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.513 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -96.45 -167.31 33.91 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.64 132.12 21.3 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.143 1.602 . . . . 0.0 110.514 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.25 -7.31 66.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 1.073 HG23 ' O ' ' A' ' 45' ' ' GLU . 26.7 m -80.02 139.0 37.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -1.106 . . . . 0.0 110.161 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 70' ' ' LYS . 18.7 mm -109.06 110.84 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 110.226 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.1 mttt -97.84 153.27 18.42 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.378 -0.827 . . . . 0.0 110.392 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 78.2 tttt -124.94 100.6 6.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.075 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.5 mt -88.27 138.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.35 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.9 p -111.58 157.59 20.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.184 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 28.6 m-85 -117.83 159.44 23.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.356 -0.84 . . . . 0.0 110.3 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.92 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.305 0.574 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -139.47 82.83 0.24 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 14.7 p90 -131.6 163.65 27.59 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.219 -1.165 . . . . 0.0 110.198 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.83 HG12 ' HA2' ' A' ' 88' ' ' GLY . 9.5 m -137.71 172.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 110.627 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . 70.7 mttt -123.78 130.65 52.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.667 -0.646 . . . . 0.0 109.503 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.646 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 9.6 m170 -118.44 130.7 56.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.004 . . . . 0.0 111.0 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.59 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.0 tttt -104.05 120.04 40.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.416 -0.802 . . . . 0.0 109.174 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.536 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 21.0 mm -62.4 129.58 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 110.693 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 73' ' ' SER . 72.3 m-20 -101.37 -49.6 4.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.359 -0.838 . . . . 0.0 109.308 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 79.6 p -179.68 157.36 0.74 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.529 -0.732 . . . . 0.0 110.286 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.118 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.2 tt -145.97 164.32 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -134.31 81.5 1.92 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 110.123 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 41.6 ttmt -55.9 -14.38 2.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.278 -0.889 . . . . 0.0 110.824 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -84.1 -29.91 26.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 0.0 109.006 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -116.63 -1.1 12.22 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.357 0.599 . . . . 0.0 109.532 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.592 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 7.6 m-85 65.5 49.82 1.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.684 -0.635 . . . . 0.0 110.108 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.518 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -116.41 142.14 47.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 109.285 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.646 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 72.9 t80 -137.24 155.1 49.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.267 -0.895 . . . . 0.0 110.284 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.451 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 77.9 p -158.51 140.86 14.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 110.474 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.646 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 5.9 p90 -148.59 177.69 9.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 110.161 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 90.0 m -128.5 131.6 48.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 110.004 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.896 HD23 HG13 ' A' ' 98' ' ' ILE . 15.5 tp -83.62 123.7 30.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.201 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.55 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 33.7 pt -104.93 -8.99 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 110.228 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -163.57 166.26 22.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.83 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 155.04 153.23 6.43 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -79.96 -22.18 42.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -1.214 . . . . 0.0 110.268 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.99 -20.23 63.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.307 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.91 ' CD2' HD11 ' A' ' 98' ' ' ILE . 71.1 mt -67.79 -18.75 64.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.27 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.87 -167.19 0.51 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.41 9.53 25.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -1.151 . . . . 0.0 110.128 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 122' ' ' THR . 40.8 p -110.55 -32.11 7.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 110.079 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.9 HD23 HG23 ' A' ' 122' ' ' THR . 72.3 mt -109.42 154.74 22.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 110.169 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.529 ' O ' HD13 ' A' ' 91' ' ' LEU . 68.8 tt0 -137.37 -80.83 0.37 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.159 -0.963 . . . . 0.0 110.004 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.916 ' O ' HD13 ' A' ' 98' ' ' ILE . 32.1 mttm -80.22 156.15 27.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.495 -0.753 . . . . 0.0 110.513 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 97' ' ' LYS . 4.2 mm -145.49 126.28 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.092 -1.005 . . . . 0.0 109.82 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -93.23 126.51 38.38 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.45 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 15.0 m-85 -121.05 144.56 48.47 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.317 -0.864 . . . . 0.0 110.961 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -149.89 128.02 11.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.481 -0.762 . . . . 0.0 109.938 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 85.6 m -127.69 134.62 49.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.989 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 115' ' ' LYS . 15.5 mttt -124.44 136.81 54.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.287 -0.883 . . . . 0.0 110.362 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.787 HD23 HG12 ' A' ' 114' ' ' ILE . 8.5 mt -117.19 150.33 38.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.359 -0.838 . . . . 0.0 110.063 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.57 -169.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.257 -0.902 . . . . 0.0 110.107 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -117.81 140.42 49.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.411 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 92.1 p -96.74 162.5 22.94 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -72.6 -1.73 10.75 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.469 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p -99.9 -8.86 23.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.3 -21.81 21.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . -74.34 -146.05 1.08 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 27.3 p -149.36 131.67 15.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -1.158 . . . . 0.0 110.057 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.609 ' HA ' HG22 ' A' ' 10' ' ' THR . 37.0 mt -83.19 148.98 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 110.132 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.787 HG12 HD23 ' A' ' 104' ' ' LEU . 7.0 mt -133.41 115.55 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 110.463 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 103' ' ' LYS . 81.3 tttt -108.37 117.66 34.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.325 -0.859 . . . . 0.0 109.748 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 8.7 t -113.5 164.72 13.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.753 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.533 HG22 ' CE1' ' A' ' 119' ' ' HIS . 30.8 m -160.01 120.23 2.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.375 -0.828 . . . . 0.0 109.795 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.492 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 26.5 m -122.69 133.93 54.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.383 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.748 ' CE1' HG23 ' A' ' 4' ' ' THR . 35.8 m-70 -114.3 156.82 23.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 109.763 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.8 m-85 -114.37 149.28 36.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 110.595 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 90.1 m-70 -125.74 88.17 2.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.018 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.9 HG23 HD23 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -74.15 146.06 43.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.514 -0.741 . . . . 0.0 111.083 -178.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 63.7 pttt -105.41 130.89 53.41 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.543 -0.723 . . . . 0.0 110.137 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.24 -117.47 4.62 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.678 ' O ' HG13 ' A' ' 126' ' ' VAL . 46.2 t30 -138.27 103.28 4.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.275 -1.132 . . . . 0.0 110.418 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 125' ' ' ASN . 8.7 m -159.5 165.49 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.833 . . . . 0.0 109.896 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -134.7 158.46 44.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.142 -0.974 . . . . 0.0 110.32 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.862 ' CD1' HD21 ' A' ' 95' ' ' LEU . 22.7 mm -70.7 172.93 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 110.196 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.582 ' N ' HG22 ' A' ' 128' ' ' ILE . 13.9 mttm -116.61 131.45 56.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.972 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 69.5 mm-40 -43.66 -44.4 6.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.15 -0.969 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -63.29 -24.63 67.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.933 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 129' ' ' LYS . 15.1 t-160 -81.06 -49.25 11.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.118 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.591 HG11 ' CE1' ' A' ' 5' ' ' TYR . 59.5 t -58.79 -37.66 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.758 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.03 -44.81 37.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.902 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -64.27 -32.69 74.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.349 -0.844 . . . . 0.0 110.057 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.06 -32.17 66.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -75.83 -34.08 60.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -1.1 . . . . 0.0 109.997 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.99 -37.73 58.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.916 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 94.3 mttt -69.5 -37.53 77.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 109.861 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.477 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -69.79 -34.98 74.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.797 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 64.9 m -72.64 -44.19 62.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.805 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -57.61 -43.94 85.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.877 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.6 -43.75 98.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.913 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.511 ' HA ' HD12 ' A' ' 147' ' ' ILE . 8.6 m-85 -59.89 -32.87 71.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.443 -0.786 . . . . 0.0 109.84 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -78.27 -20.21 52.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.483 ' HB3' HG21 ' A' ' 33' ' ' ILE . 17.5 mt -83.25 -36.29 24.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.174 -0.954 . . . . 0.0 108.826 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.648 HG23 HD11 ' A' ' 29' ' ' LEU . 8.9 mt -72.51 -43.75 62.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.557 ' HB3' HD13 ' A' ' 13' ' ' ILE . 54.7 mt-10 -60.95 -41.11 95.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.435 -0.791 . . . . 0.0 109.372 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.8 m -72.9 -32.8 65.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.622 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.656 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.2 t80 -56.48 -54.68 42.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.495 -0.753 . . . . 0.0 109.886 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.197 HD21 ' CE2' ' A' ' 158' ' ' TYR . 69.4 mt -69.27 -31.22 69.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.307 -0.871 . . . . 0.0 110.288 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.554 ' HB2' HD11 ' A' ' 13' ' ' ILE . 43.1 tttt -68.55 -28.43 66.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.88 . . . . 0.0 109.782 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.81 -26.72 6.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.513 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 11.2 m-70 -107.27 90.41 5.67 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.951 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.8 Cg_endo -73.47 3.75 4.51 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.101 1.579 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -109.56 -9.69 14.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.76 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.656 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -68.48 100.28 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.468 -0.77 . . . . 0.0 110.136 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.197 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.7 OUTLIER 34.4 32.72 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.253 0.549 . . . . 0.0 110.542 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.846 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 50.0 t -125.43 114.31 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.187 -1.184 . . . . 0.0 110.406 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.594 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 93.1 m-85 -74.83 152.83 38.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.954 . . . . 0.0 110.184 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.657 HG23 ' CE1' ' A' ' 119' ' ' HIS . 7.9 m -130.38 113.76 14.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.756 ' CD2' HG13 ' A' ' 133' ' ' VAL . 39.1 m-85 -126.61 125.84 42.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.089 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.576 ' CG ' ' N ' ' A' ' 7' ' ' SER . 16.3 tt0 -114.82 176.15 5.18 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.277 -0.889 . . . . 0.0 109.61 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.576 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 19.1 m -153.0 147.4 25.87 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.646 -0.659 . . . . 0.0 109.852 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.429 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 47.6 mt-10 -140.26 116.33 10.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.054 -1.028 . . . . 0.0 110.566 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.715 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 3.9 p90 -145.17 -172.08 3.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 109.887 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.78 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.6 p -140.59 172.63 12.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.465 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 53.8 p -150.69 142.24 23.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.465 -0.772 . . . . 0.0 110.097 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.17 -25.93 68.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.278 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.744 HD11 ' HB2' ' A' ' 152' ' ' LYS . 5.1 mp -81.34 146.38 57.74 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.148 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.677 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.7 Cg_endo -66.76 152.94 79.58 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.116 1.587 . . . . 0.0 110.719 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.7 Cg_endo -64.5 -36.08 45.38 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.763 1.401 . . . . 0.0 113.204 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 39.5 Cg_endo -65.24 -20.17 62.43 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 N-CA-C 109.748 -0.905 . . . . 0.0 109.748 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.974 ' HG3' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.92 -43.4 19.85 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 18' ' ' LEU . 8.0 mp -72.68 -38.08 67.69 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 47.9 t80 -56.84 -57.56 11.93 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.24 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 92.5 mttt -57.58 -37.47 73.22 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.529 -0.732 . . . . 0.0 110.134 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.073 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.03 -58.74 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 111.1 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.007 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -53.73 -40.52 66.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 0.0 111.958 -178.606 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.119 HG11 ' CD1' ' A' ' 74' ' ' ILE . 21.1 t -106.27 -65.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.845 -1.159 . . . . 0.0 111.693 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 24' ' ' LEU . 4.2 mm? -62.77 -8.58 7.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 111.216 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.734 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -144.76 28.52 1.27 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.876 -1.14 . . . . 0.0 110.63 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.007 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.57 -35.51 79.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -0.907 . . . . 0.0 110.112 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.449 ' OD1' ' CB ' ' A' ' 41' ' ' SER . 19.8 t70 -63.25 -16.05 59.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 81.8 m-20 -126.94 8.1 6.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.029 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.752 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -92.94 -53.64 4.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.178 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.911 ' CG1' HD13 ' A' ' 38' ' ' ILE . 2.5 t -72.02 -42.47 9.78 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.415 -0.803 . . . . 0.0 110.905 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.3 Cg_endo -77.74 9.48 2.94 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.541 1.285 . . . . 0.0 111.005 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 28' ' ' ASN . 33.3 ttmt -127.21 -31.2 2.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.968 -1.083 . . . . 0.0 109.831 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.605 HG12 ' CD1' ' A' ' 150' ' ' TYR . 36.7 mt -80.01 -38.97 19.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.443 -0.785 . . . . 0.0 109.733 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -154.28 99.75 2.49 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.449 -0.782 . . . . 0.0 110.026 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 43.7 Cg_endo -71.27 -2.0 10.51 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.066 1.561 . . . . 0.0 110.481 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -86.36 -12.6 48.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.751 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.659 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -96.03 -56.34 2.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.081 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.911 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.0 mp -115.12 132.28 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 110.08 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.587 ' CG ' ' CA ' ' A' ' 59' ' ' GLY . 0.5 OUTLIER -68.62 -37.28 79.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.891 . . . . 0.0 110.193 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.574 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 177.61 153.82 0.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 110.018 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.449 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 62.7 m -115.04 125.7 53.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.979 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.574 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 84.5 tt0 -130.18 106.93 8.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.293 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 22.2 mt -61.08 131.68 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.176 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 44' ' ' LEU . 49.7 mt -88.93 -26.09 21.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 110.044 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 1.013 ' O ' HG23 ' A' ' 52' ' ' THR . 55.7 tt0 -152.31 171.14 18.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.97 -169.03 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -130.37 28.14 4.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -1.121 . . . . 0.0 110.232 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.604 ' H ' HG21 ' A' ' 52' ' ' THR . . . 113.36 -5.49 24.96 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.516 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -79.97 -170.99 41.86 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -70.44 133.55 24.56 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.195 1.629 . . . . 0.0 110.574 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.27 -1.42 76.77 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 1.013 HG23 ' O ' ' A' ' 45' ' ' GLU . 32.4 m -80.16 145.42 32.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -1.193 . . . . 0.0 110.158 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 70' ' ' LYS . 36.0 mm -111.92 112.02 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 110.184 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 46.5 mtmt -99.12 150.57 21.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 110.374 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -123.14 98.84 6.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.877 . . . . 0.0 110.053 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.498 ' HB ' HG23 ' A' ' 67' ' ' VAL . 96.6 mt -88.97 140.12 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 110.193 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.9 p -115.0 152.77 31.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.56 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 26.7 m-85 -117.62 129.2 55.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.499 -0.75 . . . . 0.0 109.993 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.587 ' CA ' ' CG ' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.225 0.536 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -122.38 88.0 0.4 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.1 p90 -123.62 163.42 21.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -1.211 . . . . 0.0 110.124 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.787 HG12 ' HA2' ' A' ' 88' ' ' GLY . 8.6 m -141.32 172.03 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.938 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.433 ' HD2' ' OE1' ' A' ' 87' ' ' GLU . 86.4 mttt -127.4 125.85 41.4 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.524 ' CD2' HD12 ' A' ' 85' ' ' LEU . 10.1 m170 -116.92 121.02 40.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 111.161 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.616 ' HD3' HD13 ' A' ' 86' ' ' ILE . 23.5 mtmt -96.46 106.88 19.2 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.324 -0.86 . . . . 0.0 109.242 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.7 mm -48.34 136.68 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.872 . . . . 0.0 110.074 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 73' ' ' SER . 14.9 m-20 -107.34 -44.6 4.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.343 -0.848 . . . . 0.0 109.744 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 12.9 p 176.18 156.57 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.522 -0.736 . . . . 0.0 110.365 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.119 ' CD1' HG11 ' A' ' 23' ' ' VAL . 6.1 tt -144.96 169.86 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.504 -0.748 . . . . 0.0 109.597 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.4 m-20 -142.47 84.29 1.85 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.075 -1.016 . . . . 0.0 110.317 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.544 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 81.1 tttt -59.67 -13.9 11.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 110.221 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -92.79 -34.2 13.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.2 m-80 -102.21 -3.9 26.61 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.524 0.678 . . . . 0.0 109.229 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.571 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 90.5 m-85 62.58 55.78 2.14 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.253 0.549 . . . . 0.0 110.919 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 2.7 m -132.14 162.38 31.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 0.0 109.658 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.61 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 80.2 t80 -158.08 146.71 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -0.974 . . . . 0.0 110.198 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.425 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 3.8 t -153.56 147.63 25.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.692 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 9.2 p90 -149.76 175.58 11.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.429 -0.794 . . . . 0.0 110.015 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 98' ' ' ILE . 97.6 m -125.61 128.82 48.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 2.7 tp -96.39 122.97 39.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.573 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.616 HD13 ' HD3' ' A' ' 70' ' ' LYS . 20.8 pt -112.63 -5.39 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 110.894 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 22.9 tt0 -147.29 120.86 9.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 110.672 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.787 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -168.74 149.05 13.11 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.68 -8.04 24.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -1.123 . . . . 0.0 110.065 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.768 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -80.4 -53.54 6.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.471 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.721 HD21 ' N ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -63.94 -30.7 71.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.269 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 39.08 -124.42 1.75 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -106.04 -6.46 18.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -1.125 . . . . 0.0 110.494 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.771 ' O ' HG21 ' A' ' 126' ' ' VAL . 64.1 p -80.04 -50.63 10.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 109.703 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.779 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -109.43 163.66 13.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.779 ' H ' HD12 ' A' ' 95' ' ' LEU . 42.0 tt0 -133.18 -77.84 0.48 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 110.912 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.6 mtpt -80.08 128.96 34.11 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.615 -0.678 . . . . 0.0 111.125 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.763 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.2 mm -117.74 140.47 40.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 120.868 -1.145 . . . . 0.0 109.811 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -117.76 126.72 52.97 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.38 -0.825 . . . . 0.0 108.974 178.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.763 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.4 m-85 -121.8 136.07 54.93 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.915 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 48.3 tt0 -137.14 150.72 48.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.571 -0.706 . . . . 0.0 109.606 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' TYR . 36.7 m -149.21 150.4 32.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -0.997 . . . . 0.0 110.408 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 2.3 tttt -138.68 147.22 42.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.681 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.803 HD23 HG12 ' A' ' 114' ' ' ILE . 2.7 mt -128.45 147.3 50.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.001 . . . . 0.0 110.688 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.72 -168.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.475 -0.765 . . . . 0.0 109.806 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.86 172.7 7.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.131 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.459 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 32.8 p -130.48 164.96 37.71 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -73.16 -1.3 10.35 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.995 1.524 . . . . 0.0 110.599 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.0 p -103.93 3.68 33.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.374 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.04 -36.76 3.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.97 -173.85 3.09 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.5 p -130.33 140.24 50.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -1.189 . . . . 0.0 110.357 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.78 ' HA ' HG22 ' A' ' 10' ' ' THR . 27.5 mt -89.8 149.5 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.854 . . . . 0.0 110.077 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.803 HG12 HD23 ' A' ' 104' ' ' LEU . 10.5 mt -135.95 110.61 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.313 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 37.1 ttmt -99.73 129.85 45.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.941 . . . . 0.0 110.135 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.6 t -121.03 157.18 30.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.958 . . . . 0.0 110.282 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 85.7 m -154.3 138.02 16.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 110.15 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.477 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 34.7 p -141.61 154.46 45.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 110.184 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.657 ' CE1' HG23 ' A' ' 4' ' ' THR . 82.2 m-70 -133.41 164.63 26.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 0.0 110.387 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.587 ' CD2' HG13 ' A' ' 128' ' ' ILE . 8.2 m-85 -124.06 141.92 51.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 110.435 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.2 m-70 -122.52 89.43 3.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.924 -1.11 . . . . 0.0 109.793 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.624 ' HB ' HG23 ' A' ' 126' ' ' VAL . 2.7 p -60.25 163.44 5.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 110.301 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 85.0 tttt -126.0 114.9 19.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.275 -0.891 . . . . 0.0 110.242 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.36 -105.37 2.99 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.628 ' O ' HG13 ' A' ' 126' ' ' VAL . 24.7 t30 -135.6 93.43 2.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -1.169 . . . . 0.0 110.202 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.771 HG21 ' O ' ' A' ' 94' ' ' THR . 15.9 m -157.76 165.55 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.305 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -145.21 149.5 35.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 110.316 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.762 HD11 ' HB2' ' A' ' 95' ' ' LEU . 37.8 mm -75.97 173.41 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 110.203 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.61 ' N ' HG22 ' A' ' 128' ' ' ILE . 31.5 mtpt -116.54 136.21 53.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.4 -0.813 . . . . 0.0 110.078 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -45.43 -43.26 11.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.62 -31.28 71.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 110.142 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.768 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 16.0 t-160 -74.02 -47.69 35.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 110.081 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.756 HG13 ' CD2' ' A' ' 5' ' ' TYR . 73.0 t -62.21 -40.96 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.381 -0.824 . . . . 0.0 110.008 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -69.37 -42.73 74.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.997 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.502 ' HB1' ' NZ ' ' A' ' 139' ' ' LYS . . . -62.4 -38.66 90.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.026 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -30.23 68.16 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 52.7 mtpt -77.37 -31.85 54.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -1.147 . . . . 0.0 110.055 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -76.67 -30.49 56.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 109.927 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.502 ' NZ ' ' HB1' ' A' ' 135' ' ' ALA . 46.1 mttp -68.37 -37.5 80.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.864 . . . . 0.0 110.051 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.42 -43.08 64.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.902 . . . . 0.0 110.007 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.1 p -63.42 -43.46 97.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.943 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -57.73 -41.68 82.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.863 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 147' ' ' ILE . 66.4 mt -58.61 -46.32 87.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 0.0 109.966 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.441 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 20.9 m-85 -54.42 -39.53 67.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.383 -0.823 . . . . 0.0 109.913 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.88 -28.19 68.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.88 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.562 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.9 mt -82.93 -34.5 26.53 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.222 -0.924 . . . . 0.0 108.791 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.636 HD13 ' CD1' ' A' ' 22' ' ' PHE . 81.8 mt -72.01 -34.79 51.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.606 -0.684 . . . . 0.0 109.329 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.597 ' CB ' HD13 ' A' ' 13' ' ' ILE . 30.8 mt-10 -64.91 -39.43 93.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.403 -0.811 . . . . 0.0 109.428 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.7 m -69.6 -35.47 75.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.498 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.609 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 71.5 t80 -58.58 -51.84 68.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.819 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.069 HD21 ' CE1' ' A' ' 158' ' ' TYR . 78.0 mt -80.05 -39.15 30.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 110.27 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.744 ' HB2' HD11 ' A' ' 13' ' ' ILE . 82.6 tttt -64.2 -19.16 65.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.495 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.31 -34.72 2.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.613 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 3.6 m-70 -107.03 94.47 10.88 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.276 -1.132 . . . . 0.0 109.983 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.4 Cg_endo -74.04 5.38 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.089 1.573 . . . . 0.0 110.973 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -106.89 -9.66 16.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.046 -1.034 . . . . 0.0 109.856 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.633 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -69.68 100.82 1.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.348 -0.845 . . . . 0.0 110.083 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.073 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 1.0 OUTLIER 34.09 33.6 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.342 0.591 . . . . 0.0 110.642 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.508 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 118.009 -0.995 . . . . 0.0 109.852 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.031 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.9 p -80.12 150.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -1.131 . . . . 0.0 110.35 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.612 ' CD1' HD12 ' A' ' 128' ' ' ILE . 26.1 m-85 -89.07 176.38 7.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 110.368 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.84 HG23 ' CE1' ' A' ' 119' ' ' HIS . 97.4 m -145.45 103.66 3.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.396 -0.815 . . . . 0.0 110.083 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.687 ' CD1' HG13 ' A' ' 133' ' ' VAL . 51.5 m-85 -116.23 129.34 56.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 110.098 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 116' ' ' SER . 25.5 pt-20 -131.52 157.94 42.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 110.505 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.4 m -133.95 139.42 46.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.895 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.481 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 99.9 mt-10 -121.24 127.32 51.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.385 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 3.8 p90 -154.3 -171.76 3.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.038 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.568 HG22 HG12 ' A' ' 113' ' ' ILE . 18.0 p -141.35 -176.46 4.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.57 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.489 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 3.7 t -159.6 160.9 34.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.776 . . . . 0.0 110.152 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -85.16 -19.11 32.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.978 . . . . 0.0 110.153 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 10.0 mm -85.47 149.8 52.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 110.095 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.9 Cg_endo -65.82 148.5 86.5 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.06 1.558 . . . . 0.0 110.57 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.682 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.3 Cg_endo -70.05 -32.57 17.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.885 1.466 . . . . 0.0 112.893 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.682 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.2 Cg_endo -67.58 -20.62 47.0 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 N-CA-C 110.149 -0.75 . . . . 0.0 110.149 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.883 ' HG2' HD13 ' A' ' 151' ' ' LEU . 4.6 ttm180 -84.73 -49.16 8.72 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.752 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -69.06 -26.73 65.1 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.205 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.9 t80 -71.29 -55.03 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 109.236 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 63.3 mttt -51.72 -32.98 32.49 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.403 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.079 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -79.83 -55.09 5.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 111.188 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.056 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -57.29 -44.39 84.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.527 -0.733 . . . . 0.0 112.52 -177.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.554 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -106.8 -55.68 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.792 -1.192 . . . . 0.0 112.06 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.661 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.9 mm? -68.84 -10.64 58.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.01 -1.056 . . . . 0.0 111.174 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.584 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.2 m-20 -145.36 28.58 1.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.886 -1.134 . . . . 0.0 110.734 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.056 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.29 -20.04 65.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.152 -0.968 . . . . 0.0 110.436 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -72.61 -20.19 61.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.096 -1.003 . . . . 0.0 109.588 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 5.7 p30 -126.85 14.76 7.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 109.672 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.913 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -96.42 -50.16 4.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.224 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.079 HG21 HD13 ' A' ' 38' ' ' ILE . 9.7 p -73.26 -26.99 0.79 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.332 -0.855 . . . . 0.0 112.183 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.802 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -82.91 10.38 3.66 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 122.621 0.8 . . . . 0.0 110.51 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -134.37 -27.04 1.4 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.13 -0.982 . . . . 0.0 110.603 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.687 HD11 ' CD1' ' A' ' 29' ' ' LEU . 34.3 mt -77.87 -36.29 21.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.225 -0.922 . . . . 0.0 109.899 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.95 100.13 0.82 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.342 -0.849 . . . . 0.0 110.338 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.85 -0.1 9.0 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.109 1.584 . . . . 0.0 110.346 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -88.29 -13.09 41.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 110.007 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.13 -47.1 4.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 110.315 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.079 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -125.79 145.24 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -0.82 . . . . 0.0 110.103 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -83.18 -42.04 17.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.269 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.546 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -178.44 163.53 1.58 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 110.123 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.6 m -120.27 125.68 48.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.185 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.546 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 83.9 tt0 -130.04 107.57 9.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 110.151 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 23.4 mt -56.54 134.89 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 110.071 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.83 HD22 ' CE ' ' A' ' 55' ' ' LYS . 63.8 tp -88.76 -46.51 8.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -0.958 . . . . 0.0 109.911 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.83 ' O ' HG23 ' A' ' 52' ' ' THR . 16.8 mm-40 -131.97 -169.81 2.28 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.442 -0.786 . . . . 0.0 110.179 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.44 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.08 -150.05 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 23.4 t0 -160.03 41.48 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -1.133 . . . . 0.0 110.093 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.655 ' H ' HG21 ' A' ' 52' ' ' THR . . . 103.31 -11.71 54.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -82.13 -175.54 50.62 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.3 Cg_endo -72.23 132.82 20.06 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.144 1.602 . . . . 0.0 110.43 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.91 -3.78 62.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.4 m -80.02 150.04 30.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -1.175 . . . . 0.0 109.986 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.718 HD13 ' HA ' ' A' ' 70' ' ' LYS . 20.9 mm -116.76 107.62 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.948 . . . . 0.0 110.324 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 73.0 mttt -90.32 144.88 25.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.398 -0.814 . . . . 0.0 110.097 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.83 ' CE ' HD22 ' A' ' 44' ' ' LEU . 31.7 mttt -117.95 95.4 4.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.267 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CG2' HG12 ' A' ' 38' ' ' ILE . 86.9 mt -83.44 145.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.904 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 38' ' ' ILE . 6.2 p -116.48 158.35 23.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 110.74 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.812 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.9 m-85 -116.42 145.87 42.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.226 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.992 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.495 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 7.1 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.154 0.502 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -116.8 135.86 12.31 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.9 p90 -179.08 166.57 1.57 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -1.153 . . . . 0.0 110.271 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.96 HG12 ' HA2' ' A' ' 88' ' ' GLY . 3.6 m -142.09 174.7 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 110.362 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.65 ' O ' HD12 ' A' ' 85' ' ' LEU . 96.6 mttt -126.15 124.75 41.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.481 -0.762 . . . . 0.0 109.705 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.617 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 10.1 m170 -113.73 130.3 56.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.135 -0.978 . . . . 0.0 110.814 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.718 ' HA ' HD13 ' A' ' 53' ' ' ILE . 76.7 tttt -107.31 102.31 11.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.381 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.503 HG22 ' HA ' ' A' ' 50' ' ' PRO . 34.6 mm -45.25 135.35 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.466 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.485 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 12.2 t0 -108.66 -38.69 5.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.446 -0.784 . . . . 0.0 109.617 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.488 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 6.4 p 179.07 156.58 0.5 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.505 -0.747 . . . . 0.0 110.019 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.447 HG12 HG11 ' A' ' 23' ' ' VAL . 1.9 mt -136.97 159.17 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.07 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 1.1 m-20 -144.67 83.97 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.62 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.578 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 57.4 tttp -66.65 -15.82 63.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.276 -0.89 . . . . 0.0 110.17 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -86.29 -31.04 21.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 0.0 108.809 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m-80 -106.1 -3.9 20.98 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.559 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 98.9 m-85 61.11 53.73 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.36 0.6 . . . . 0.0 110.584 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 12.9 t -125.47 175.2 7.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.85 . . . . 0.0 110.103 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.687 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 39.1 t80 -159.59 134.23 7.84 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.713 -0.617 . . . . 0.0 109.8 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.488 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 20.2 m -140.77 123.34 16.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 111.037 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.687 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 16.8 p90 -139.16 171.86 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.812 . . . . 0.0 110.01 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 98' ' ' ILE . 58.0 m -124.33 137.1 54.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.978 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 68' ' ' LYS . 15.5 tp -99.74 124.85 45.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.391 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.3 pt -102.22 -10.67 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 110.292 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.4 ' OE1' ' HE3' ' A' ' 68' ' ' LYS . 81.7 tt0 -151.51 155.71 39.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 110.232 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.96 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 157.61 143.47 3.67 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -61.54 -25.9 67.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -1.107 . . . . 0.0 110.184 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.553 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -60.21 -25.87 65.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 110.253 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.459 HD21 ' CG1' ' A' ' 98' ' ' ILE . 89.6 mt -62.52 -11.76 18.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.199 -0.938 . . . . 0.0 110.137 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.923 ' O ' HG23 ' A' ' 94' ' ' THR . . . 42.57 28.95 0.67 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 66.9 m-20 56.29 16.1 2.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -1.185 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.923 HG23 ' O ' ' A' ' 92' ' ' GLY . 19.6 p -111.93 -34.27 6.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.736 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.818 HD23 HG23 ' A' ' 122' ' ' THR . 96.2 mt -94.76 163.85 13.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.826 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.482 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 68.1 tt0 -127.98 -81.61 0.59 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.783 0.802 . . . . 0.0 109.782 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 60.4 mttt -80.3 127.97 32.99 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.657 -0.652 . . . . 0.0 110.142 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.81 ' O ' HG23 ' A' ' 84' ' ' THR . 3.8 mm -117.05 139.91 41.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.628 -1.295 . . . . 0.0 109.721 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -120.59 125.18 47.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.772 ' CE2' HG21 ' A' ' 98' ' ' ILE . 12.4 m-85 -120.07 132.06 55.31 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.398 -0.814 . . . . 0.0 110.396 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 117' ' ' THR . 5.7 mt-10 -131.53 133.87 45.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.022 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 88.8 m -129.35 146.65 51.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.917 . . . . 0.0 110.1 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 115' ' ' LYS . 1.5 mttm -139.89 134.45 31.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 110.294 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.708 HD23 HG12 ' A' ' 114' ' ' ILE . 10.1 mt -113.93 148.24 37.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.145 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.89 -168.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 110.092 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.697 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.96 161.09 24.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 26.1 p -119.73 163.95 24.75 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.28 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.6 Cg_endo -72.27 -1.97 10.95 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.064 1.56 . . . . 0.0 110.477 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.2 p -103.78 -0.74 28.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.263 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.17 -35.72 4.85 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.25 -174.05 2.57 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 55.5 p -129.17 137.5 51.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -1.171 . . . . 0.0 110.327 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.568 HG12 HG22 ' A' ' 10' ' ' THR . 59.2 mt -88.71 150.79 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 110.326 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.708 HG12 HD23 ' A' ' 104' ' ' LEU . 8.5 mt -132.86 111.35 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.1 tttt -101.11 123.39 45.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.108 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.5 t -117.17 156.53 27.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.49 HG22 ' CE1' ' A' ' 119' ' ' HIS . 57.7 m -158.97 125.23 4.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 110.201 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.482 ' HB2' ' CD1' ' A' ' 100' ' ' TYR . 31.3 t -127.09 162.23 26.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 110.172 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.84 ' CE1' HG23 ' A' ' 4' ' ' THR . 44.0 m-70 -140.75 128.83 22.1 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 1.031 ' C ' HG23 ' A' ' 2' ' ' VAL . 9.7 m-30 -100.28 119.76 38.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.182 -0.949 . . . . 0.0 110.953 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.581 ' N ' HG23 ' A' ' 2' ' ' VAL . 84.5 m-70 -93.59 101.27 13.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.379 -0.826 . . . . 0.0 109.373 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.818 HG23 HD23 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -81.06 154.12 27.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.042 -1.036 . . . . 0.0 110.525 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.423 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 33.4 tttp -127.64 117.36 21.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 116.26 -135.31 12.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.526 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 3.2 p-10 -125.84 53.53 1.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -1.15 . . . . 0.0 110.235 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 122' ' ' THR . 28.3 m -135.27 155.54 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 110.134 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.02 157.13 47.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.958 . . . . 0.0 110.371 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 129' ' ' LYS . 2.2 mp -65.36 173.27 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.973 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.623 ' N ' HG22 ' A' ' 128' ' ' ILE . 34.0 mttt -118.31 148.13 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 109.915 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.525 ' HG2' ' N ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -51.71 -22.88 3.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 110.395 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' HG2' ' A' ' 130' ' ' GLU . 49.2 tt0 -77.8 -35.46 51.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.838 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 19.8 t-160 -73.58 -36.47 65.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.687 HG13 ' CD1' ' A' ' 5' ' ' TYR . 59.5 t -63.73 -43.62 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.864 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.48 -42.94 77.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.84 . . . . 0.0 109.955 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.93 89.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.523 ' HA2' ' CD ' ' A' ' 139' ' ' LYS . . . -65.61 -29.88 76.16 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 141' ' ' SER . 94.5 mttt -78.43 -30.73 47.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -1.128 . . . . 0.0 110.156 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.504 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 96.5 mt-10 -76.27 -39.77 53.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.086 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.523 ' CD ' ' HA2' ' A' ' 136' ' ' GLY . 18.8 ptpt -66.69 -33.18 75.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.837 . . . . 0.0 109.875 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.506 ' N ' ' HG3' ' A' ' 139' ' ' LYS . . . -88.82 -40.13 13.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.002 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 137' ' ' LYS . 61.6 m -65.27 -44.74 87.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.349 -0.845 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.3 m-20 -58.81 -41.33 86.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.367 -0.833 . . . . 0.0 110.035 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.0 mt -61.28 -40.6 94.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.889 . . . . 0.0 110.053 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -61.54 -34.75 76.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.019 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -76.9 -17.84 58.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.017 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.503 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 16.7 mt -83.45 -35.19 25.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.242 -0.912 . . . . 0.0 108.938 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.759 HD13 ' CD1' ' A' ' 22' ' ' PHE . 93.1 mt -71.22 -43.14 74.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.508 ' HG3' HD12 ' A' ' 18' ' ' LEU . 55.1 mt-10 -57.62 -37.72 73.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.362 -0.836 . . . . 0.0 109.283 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 65.7 m -73.65 -33.56 64.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.458 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.621 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.1 t80 -54.3 -48.51 71.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.458 -0.776 . . . . 0.0 109.898 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.178 HD21 ' CE2' ' A' ' 158' ' ' TYR . 72.4 mt -78.35 -30.55 48.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.178 -0.951 . . . . 0.0 110.164 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.454 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 30.5 ttpt -71.65 -22.11 61.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.307 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.14 -31.24 3.88 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.562 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.9 m-70 -109.78 92.88 13.23 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.452 -1.028 . . . . 0.0 109.968 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.17 5.82 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.034 1.544 . . . . 0.0 111.067 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -109.35 -1.03 18.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 109.991 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.621 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -81.54 102.89 10.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 110.073 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.178 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.85 32.79 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.366 0.603 . . . . 0.0 110.517 -179.484 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.535 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.818 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' ' 120' ' ' TYR . 85.2 t -120.15 123.61 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -1.158 . . . . 0.0 110.375 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.6 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 86.9 m-85 -75.03 148.01 40.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 110.087 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.835 HG23 ' CE1' ' A' ' 119' ' ' HIS . 52.0 m -131.74 121.64 24.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.189 ' CE2' HG21 ' A' ' 133' ' ' VAL . 74.7 m-85 -131.17 156.7 44.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.059 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -148.67 152.95 37.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 110.105 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 116' ' ' SER . 54.5 p -136.18 148.71 48.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.442 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 95.4 mt-10 -136.88 117.82 14.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 110.28 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 2.9 p90 -144.88 -175.71 4.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.899 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.8 p -138.39 179.58 6.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.565 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.542 ' OG ' HD11 ' A' ' 114' ' ' ILE . 8.8 p -157.02 163.78 38.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.229 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.84 -13.62 47.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.239 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.877 HD11 ' HB2' ' A' ' 152' ' ' LYS . 3.1 mp -90.78 149.68 40.84 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 0.0 110.139 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.807 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.8 Cg_endo -66.98 148.55 82.07 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.995 1.524 . . . . 0.0 110.553 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.671 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -69.96 -32.95 16.77 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 O-C-N 123.947 1.498 . . . . 0.0 113.096 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.4 Cg_endo -67.12 -22.09 47.85 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 N-CA-C 109.934 -0.833 . . . . 0.0 109.934 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.995 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -82.23 -49.36 10.18 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.777 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.3 tt -68.21 -29.72 68.62 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 76' ' ' LYS . 67.6 t80 -61.85 -57.28 12.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.127 178.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 92.2 mttt -50.09 -53.08 29.59 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.137 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.18 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -55.29 -68.15 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 110.554 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.055 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -43.21 -58.89 2.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.714 -0.616 . . . . 0.0 111.845 -178.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG11 HG12 ' A' ' 74' ' ' ILE . 3.7 t -91.2 -61.14 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.066 -1.021 . . . . 0.0 112.246 -178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.604 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.7 mm? -69.94 -2.07 11.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.037 -1.039 . . . . 0.0 112.168 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.878 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.11 25.97 0.71 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.586 -1.321 . . . . 0.0 111.281 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.055 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -63.37 -37.53 87.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.031 . . . . 0.0 109.761 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' OD2' HD11 ' A' ' 43' ' ' ILE . 55.1 m-20 -64.75 -12.03 42.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.765 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.528 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 64.1 m-80 -130.17 7.83 5.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.456 -0.778 . . . . 0.0 109.889 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.878 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -94.14 -49.57 5.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.323 -0.861 . . . . 0.0 110.263 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.041 HG21 HD13 ' A' ' 38' ' ' ILE . 7.1 p -77.67 -26.21 0.52 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.352 -0.843 . . . . 0.0 112.526 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.738 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -79.39 6.58 5.01 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 O-C-N 122.501 0.737 . . . . 0.0 110.585 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -131.42 -29.07 1.81 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.108 -0.995 . . . . 0.0 110.217 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.613 HD11 HD13 ' A' ' 29' ' ' LEU . 67.2 mt -79.29 -37.6 19.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.296 -0.878 . . . . 0.0 109.755 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.61 91.25 2.31 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.391 -0.818 . . . . 0.0 110.251 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.34 0.01 8.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.01 1.531 . . . . 0.0 110.563 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -90.85 -24.48 20.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.121 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.36 -37.88 13.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.098 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.041 HD13 HG21 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -125.3 133.22 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.0 109.893 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.54 ' HG3' ' CA ' ' A' ' 59' ' ' GLY . 11.5 mttt -72.89 -41.94 64.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.901 . . . . 0.0 110.075 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.548 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -179.89 161.22 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 110.19 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 m -125.02 118.34 26.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 110.021 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -124.5 111.21 15.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.533 HD11 ' OD2' ' A' ' 27' ' ' ASP . 21.6 mt -57.86 127.25 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.756 HD13 ' CE ' ' A' ' 55' ' ' LYS . 12.3 tp -90.93 -40.04 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 0.0 110.087 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 1.003 ' O ' HG23 ' A' ' 52' ' ' THR . 0.6 OUTLIER -132.08 156.08 46.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.35 -162.86 18.41 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -141.25 25.51 2.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -1.13 . . . . 0.0 110.059 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.624 ' H ' HG21 ' A' ' 52' ' ' THR . . . 120.66 -10.32 10.49 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.535 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -80.76 -170.57 42.9 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.8 Cg_endo -71.21 132.86 21.78 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.022 1.538 . . . . 0.0 110.443 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.7 -1.55 71.82 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 1.003 HG23 ' O ' ' A' ' 45' ' ' GLU . 22.7 m -80.04 140.35 36.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.17 . . . . 0.0 109.976 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.877 HD13 ' HA ' ' A' ' 70' ' ' LYS . 28.8 mm -110.4 117.87 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 110.382 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 89.5 mttt -104.53 119.33 38.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 0.0 110.159 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.756 ' CE ' HD13 ' A' ' 44' ' ' LEU . 46.9 mttm -88.6 97.69 11.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.388 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' HB ' HG23 ' A' ' 67' ' ' VAL . 93.8 mt -89.58 139.68 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.895 . . . . 0.0 110.018 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 6.6 p -115.51 157.34 24.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.937 . . . . 0.0 110.736 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 26.4 m-85 -117.86 125.28 50.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.423 -0.798 . . . . 0.0 110.15 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.54 ' CA ' ' HG3' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.245 0.545 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.584 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -137.51 92.17 0.21 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 15.9 p90 -132.73 169.44 16.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -1.158 . . . . 0.0 110.131 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.7 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.0 m -142.29 174.94 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.663 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.657 ' O ' HD12 ' A' ' 85' ' ' LEU . 94.1 mttt -132.39 106.49 7.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.731 . . . . 0.0 109.522 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.876 ' CD2' HD13 ' A' ' 85' ' ' LEU . 12.8 m170 -96.28 124.78 40.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 111.419 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.877 ' HA ' HD13 ' A' ' 53' ' ' ILE . 67.6 tttt -98.96 101.65 13.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.448 -0.782 . . . . 0.0 109.02 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.535 HG21 ' O ' ' A' ' 49' ' ' GLY . 22.7 mm -41.69 140.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 17.9 t0 -112.42 -45.58 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.986 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 16.8 m -169.88 157.21 6.62 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.431 -0.793 . . . . 0.0 110.146 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.411 HG12 HG11 ' A' ' 23' ' ' VAL . 1.7 mt -141.48 157.2 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.397 -0.814 . . . . 0.0 109.877 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 2.0 m-20 -144.53 83.64 1.72 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.821 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 82.3 tttt -66.24 -13.22 60.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.363 -0.836 . . . . 0.0 109.888 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -90.79 -30.72 16.84 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.805 0.812 . . . . 0.0 109.157 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m-80 -105.52 -4.49 21.19 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.516 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 90.0 m-85 63.57 53.69 2.03 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.297 0.57 . . . . 0.0 110.74 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 13.1 t -127.58 175.34 8.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.961 -1.087 . . . . 0.0 110.455 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.651 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 34.4 t80 -160.02 137.59 9.73 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.612 -0.68 . . . . 0.0 109.744 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 28.7 m -148.0 123.84 10.6 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.129 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.651 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 29.5 p90 -139.41 168.14 20.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.887 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 98' ' ' ILE . 25.4 m -122.19 140.9 52.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 110.228 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.876 HD13 ' CD2' ' A' ' 69' ' ' HIS . 10.7 tp -107.38 132.21 53.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 110.099 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 85' ' ' LEU . 11.5 pt -112.87 -31.67 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 110.353 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.668 ' O ' HD11 ' A' ' 85' ' ' LEU . 7.2 tt0 -116.52 141.63 47.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.898 . . . . 0.0 110.276 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.7 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 167.88 168.08 29.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.71 -28.87 45.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.281 -1.129 . . . . 0.0 110.227 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.73 ' HB1' ' HE1' ' A' ' 132' ' ' HIS . . . -60.99 -32.53 72.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.337 -0.852 . . . . 0.0 110.174 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.965 HD23 ' HG ' ' A' ' 95' ' ' LEU . 6.8 mt -64.64 -44.2 91.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 110.393 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 44.18 -142.53 2.72 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -106.34 27.57 8.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -1.131 . . . . 0.0 110.237 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 122' ' ' THR . 80.8 p -124.74 -45.18 1.92 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 110.126 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.965 ' HG ' HD23 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -102.41 160.57 14.44 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.448 -0.783 . . . . 0.0 109.272 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.863 ' H ' HD12 ' A' ' 95' ' ' LEU . 85.1 mt-10 -135.37 -78.63 0.44 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 110.823 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 57.4 mttt -80.22 134.93 36.16 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.452 -0.78 . . . . 0.0 110.973 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.733 ' O ' HG23 ' A' ' 84' ' ' THR . 4.5 mm -121.36 139.49 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.975 -1.078 . . . . 0.0 109.633 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.3 m -118.45 126.53 52.25 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.187 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.679 ' HE2' HG21 ' A' ' 98' ' ' ILE . 7.3 m-85 -118.84 136.74 53.86 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.529 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -137.17 145.89 44.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.022 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 45.3 m -145.43 152.6 40.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 110.019 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -141.67 140.83 33.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 110.372 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.653 HD23 HG12 ' A' ' 114' ' ' ILE . 8.8 mt -124.24 145.24 49.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.358 -0.839 . . . . 0.0 110.271 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.703 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.22 -169.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.227 -0.921 . . . . 0.0 109.941 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.703 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -118.72 170.33 9.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 110.012 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.2 p -127.54 161.78 52.83 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 110.021 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.58 -8.71 23.76 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.954 1.502 . . . . 0.0 110.387 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.9 p -93.77 -9.5 37.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 110.215 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.02 -36.25 4.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.87 -176.22 6.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.504 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 60.5 p -123.67 136.85 54.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -1.146 . . . . 0.0 110.351 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.599 HD12 ' O ' ' A' ' 106' ' ' ALA . 18.8 mt -86.49 150.03 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.838 . . . . 0.0 110.109 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.653 HG12 HD23 ' A' ' 104' ' ' LEU . 6.3 mt -135.42 115.36 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.364 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 103' ' ' LYS . 84.8 tttt -106.42 123.13 47.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 109.873 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 3.5 t -118.45 159.68 23.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -0.979 . . . . 0.0 110.598 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 5' ' ' TYR . 42.5 m -159.56 144.38 15.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.426 -0.796 . . . . 0.0 110.17 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.9 t -141.04 163.46 32.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.15 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.835 ' CE1' HG23 ' A' ' 4' ' ' THR . 82.0 m-70 -143.89 160.98 39.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.915 . . . . 0.0 110.484 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.804 ' O ' HG13 ' A' ' 2' ' ' VAL . 9.6 m-85 -124.85 140.88 52.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.316 -0.865 . . . . 0.0 110.224 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.504 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.8 m-70 -120.92 90.54 3.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 109.762 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.676 HG23 HD11 ' A' ' 128' ' ' ILE . 1.1 p -82.59 150.18 27.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.871 . . . . 0.0 110.364 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.432 ' HB3' ' CD ' ' A' ' 96' ' ' GLU . 78.4 tttt -123.03 129.1 51.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 110.202 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 -162.87 25.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.49 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 0.9 OUTLIER -87.62 54.13 3.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -1.181 . . . . 0.0 110.109 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.48 ' O ' ' HB ' ' A' ' 122' ' ' THR . 17.6 m -135.99 133.39 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.222 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.524 ' HA ' HG21 ' A' ' 122' ' ' THR . 17.9 pt-20 -127.7 165.54 19.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 0.0 110.092 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.676 HD11 HG23 ' A' ' 122' ' ' THR . 3.8 mp -82.8 173.0 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.889 . . . . 0.0 110.042 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.598 ' N ' HG22 ' A' ' 128' ' ' ILE . 75.0 mmtt -106.28 122.83 47.03 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.348 -0.845 . . . . 0.0 110.149 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 131' ' ' GLU . 24.1 pt-20 -43.45 -42.65 4.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 110.145 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.482 ' N ' ' CG ' ' A' ' 130' ' ' GLU . 16.5 pt-20 -58.16 -29.33 65.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.206 -0.934 . . . . 0.0 109.896 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.73 ' HE1' ' HB1' ' A' ' 90' ' ' ALA . 11.7 t-80 -74.36 -55.5 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.189 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.6 p -61.62 -39.39 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.387 -0.821 . . . . 0.0 110.009 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.515 ' N ' HG13 ' A' ' 133' ' ' VAL . 84.0 tttt -65.52 -45.83 81.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.84 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.39 87.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.89 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.08 -30.82 74.14 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 137' ' ' LYS . 59.0 mmtt -65.91 -34.75 78.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -1.106 . . . . 0.0 109.872 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -69.91 -35.62 74.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.859 . . . . 0.0 109.839 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -71.68 -29.95 65.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.738 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.31 -40.87 42.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.99 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.2 p -59.44 -45.3 91.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.752 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -56.44 -43.85 79.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.841 . . . . 0.0 109.779 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 39.4 tp -57.68 -47.31 82.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.767 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.474 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 29.3 m-85 -53.68 -44.57 69.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.648 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -75.78 -14.58 60.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.32 -0.862 . . . . 0.0 109.925 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.446 ' HB3' HG21 ' A' ' 33' ' ' ILE . 20.1 mt -83.2 -36.67 24.47 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.209 -0.932 . . . . 0.0 108.692 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.62 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 96.0 mt -67.16 -47.4 81.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.789 ' HB3' HD13 ' A' ' 13' ' ' ILE . 5.9 mm-40 -51.49 -47.09 63.33 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.388 -0.82 . . . . 0.0 109.218 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.6 m -63.15 -40.52 97.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.593 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.728 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 79.6 t80 -47.12 -51.84 16.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.97 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.14 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 80.3 mt -76.27 -37.97 56.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.789 . . . . 0.0 110.366 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.877 ' HB2' HD11 ' A' ' 13' ' ' ILE . 19.4 tptt -59.31 -16.9 24.8 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.166 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.493 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -117.61 -27.02 2.69 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 10.7 m-70 -106.28 91.89 6.19 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.266 -1.137 . . . . 0.0 110.167 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.1 Cg_endo -73.13 3.3 4.69 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.986 1.519 . . . . 0.0 111.006 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -119.0 -2.26 10.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.022 -1.049 . . . . 0.0 110.299 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.728 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -67.22 99.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.23 -0.918 . . . . 0.0 110.397 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.18 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 11.5 p90 37.55 23.45 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.55 -0.719 . . . . 0.0 112.346 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.727 ' OD1' HD22 ' A' ' 151' ' ' LEU . 9.1 m-80 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 120.473 -1.392 . . . . 0.0 109.992 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 85.8 t -101.04 119.23 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -1.114 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.597 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 77.6 m-85 -83.68 161.57 21.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.23 -0.919 . . . . 0.0 110.139 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.823 HG23 ' CE1' ' A' ' 119' ' ' HIS . 55.4 m -143.61 99.92 3.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CE2' HG22 ' A' ' 133' ' ' VAL . 77.9 m-85 -116.37 126.5 53.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.179 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.596 ' CG ' ' N ' ' A' ' 7' ' ' SER . 3.6 tt0 -126.16 178.57 5.71 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.204 -0.935 . . . . 0.0 109.89 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.596 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -155.56 -179.08 7.76 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.76 -0.587 . . . . 0.0 109.751 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 7' ' ' SER . 73.1 mt-10 -156.09 117.02 3.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 110.378 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 2.5 p90 -137.58 -174.05 3.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.213 -0.93 . . . . 0.0 109.954 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.817 HG22 ' HA ' ' A' ' 113' ' ' ILE . 4.4 p -142.15 173.94 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.718 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.432 ' HB2' ' CD ' ' A' ' 148' ' ' GLU . 85.8 p -150.26 147.96 28.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.432 -0.793 . . . . 0.0 110.065 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -72.03 -24.81 61.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.917 . . . . 0.0 110.138 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.8 HG23 ' HD2' ' A' ' 14' ' ' PRO . 6.1 mm -79.18 151.17 75.32 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.828 . . . . 0.0 109.979 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.8 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -65.03 147.46 88.94 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.102 1.58 . . . . 0.0 110.394 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.673 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.6 Cg_endo -69.86 -32.46 18.11 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.006 1.529 . . . . 0.0 113.043 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.4 Cg_endo -67.66 -23.29 42.71 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 122.472 0.722 . . . . 0.0 110.233 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.875 ' HB3' HD13 ' A' ' 151' ' ' LEU . 6.0 mmp_? -82.26 -47.25 12.64 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.98 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.54 -29.62 69.06 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.429 -0.908 . . . . 0.0 108.905 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.9 t80 -63.44 -55.45 24.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.1 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.0 mttt -49.13 -50.76 35.85 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.984 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.156 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -56.77 -70.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.623 0.725 . . . . 0.0 111.089 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.067 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -43.68 -57.45 3.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.633 -0.667 . . . . 0.0 112.138 -178.626 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.625 ' HB ' HD12 ' A' ' 24' ' ' LEU . 7.1 t -90.27 -60.42 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.057 . . . . 0.0 112.386 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.7 mp -73.35 0.59 11.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.054 -1.029 . . . . 0.0 112.114 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.892 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -153.52 27.77 0.5 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.59 -1.319 . . . . 0.0 111.233 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.067 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -64.24 -40.35 95.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.047 -1.033 . . . . 0.0 109.721 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.513 ' OD2' ' CG1' ' A' ' 43' ' ' ILE . 83.0 m-20 -64.91 -11.03 33.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.478 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.433 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 2.3 m120 -125.13 3.17 7.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.537 -0.727 . . . . 0.0 109.662 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.909 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -94.9 -47.12 6.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 -179.572 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.954 ' CG2' HD13 ' A' ' 38' ' ' ILE . 9.4 p -75.38 -26.9 0.65 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.91 . . . . 0.0 112.373 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.779 ' HD3' HG12 ' A' ' 30' ' ' VAL . 50.5 Cg_endo -79.18 7.27 4.49 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 122.435 0.703 . . . . 0.0 110.593 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -135.77 -30.9 0.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.225 -0.922 . . . . 0.0 110.381 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.909 HD11 ' CD1' ' A' ' 29' ' ' LEU . 64.5 mt -75.07 -39.74 44.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.331 -0.856 . . . . 0.0 109.56 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.64 87.58 2.55 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.396 -0.815 . . . . 0.0 110.171 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.57 -1.32 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.115 1.587 . . . . 0.0 110.516 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -90.22 -19.46 24.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.944 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.35 -36.08 10.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.848 . . . . 0.0 110.317 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.954 HD13 ' CG2' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -125.38 139.68 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 110.021 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 27.1 ttmt -78.09 -41.45 35.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.558 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 178.71 164.77 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 110.131 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.411 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 1.7 m -121.53 122.27 39.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 110.028 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 86.1 tt0 -126.54 107.18 10.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.188 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.513 ' CG1' ' OD2' ' A' ' 27' ' ' ASP . 14.6 mt -56.11 131.58 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 55' ' ' LYS . 58.7 mt -89.1 -23.72 22.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.124 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 1.06 ' O ' HG23 ' A' ' 52' ' ' THR . 41.1 tt0 -157.64 175.05 14.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 110.303 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 53.44 -160.33 3.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -137.66 16.71 2.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -1.103 . . . . 0.0 110.264 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.464 ' H ' HG21 ' A' ' 52' ' ' THR . . . 118.72 7.57 10.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -98.89 -166.63 30.5 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.1 Cg_endo -70.78 132.08 21.01 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.081 1.569 . . . . 0.0 110.551 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.8 -7.48 70.53 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 1.06 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.1 m -80.01 143.41 34.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -1.133 . . . . 0.0 110.097 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.619 HD13 ' HA ' ' A' ' 70' ' ' LYS . 32.9 mm -112.4 124.27 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.216 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.448 ' NZ ' HD11 ' A' ' 71' ' ' ILE . 66.9 mttt -107.58 147.58 30.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.332 -0.855 . . . . 0.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB2' HD11 ' A' ' 44' ' ' LEU . 75.0 tttt -120.85 90.21 3.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.482 ' CG2' HG12 ' A' ' 38' ' ' ILE . 94.5 mt -80.57 143.01 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.6 p -113.51 160.42 18.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.669 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.831 ' HE2' HG13 ' A' ' 67' ' ' VAL . 27.9 m-85 -118.78 137.93 53.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.466 -0.771 . . . . 0.0 110.202 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.206 0.527 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -136.05 137.12 8.88 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.5 p90 -179.32 164.05 1.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -1.082 . . . . 0.0 110.068 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.066 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.7 m -142.39 171.99 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.92 . . . . 0.0 110.663 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -125.43 123.86 40.2 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.601 ' CD2' ' HG ' ' A' ' 85' ' ' LEU . 13.3 m170 -116.52 138.26 51.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.023 -1.048 . . . . 0.0 111.327 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HA ' HD13 ' A' ' 53' ' ' ILE . 78.1 tttt -115.9 112.28 21.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.481 -0.762 . . . . 0.0 109.105 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.53 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 32.7 mm -49.0 136.63 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.96 . . . . 0.0 110.459 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 4.4 t0 -107.61 -50.11 3.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.396 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.482 ' HB2' ' OG ' ' A' ' 82' ' ' SER . 17.6 m -168.79 157.07 8.04 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.483 -0.76 . . . . 0.0 109.423 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.3 mt -134.94 157.94 41.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.078 -1.014 . . . . 0.0 110.616 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.563 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.9 m-20 -130.9 76.85 1.75 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.597 -0.69 . . . . 0.0 110.24 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.566 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 66.9 mttt -61.78 -12.75 18.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 109.918 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -96.4 -30.53 13.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 109.516 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -107.97 -1.44 20.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.661 -0.649 . . . . 0.0 109.744 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.837 ' O ' HD12 ' A' ' 104' ' ' LEU . 87.2 m-85 61.11 52.36 4.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.729 . . . . 0.0 109.89 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.563 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -123.49 156.65 35.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 109.575 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.53 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 20.1 t80 -141.87 133.92 27.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.913 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 73' ' ' SER . 70.4 p -139.1 119.49 13.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.852 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 3.2 p90 -130.89 179.12 6.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.986 HG23 ' O ' ' A' ' 98' ' ' ILE . 21.9 m -130.85 136.94 49.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.967 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.657 HD23 ' H ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -95.41 134.72 37.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.551 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.0 pt -114.83 -6.11 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.895 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.657 ' H ' HD23 ' A' ' 85' ' ' LEU . 87.3 tt0 -168.24 113.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.361 -0.837 . . . . 0.0 110.556 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 1.066 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -153.22 130.34 2.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -48.48 -26.7 2.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -1.162 . . . . 0.0 110.432 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.577 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -68.65 -17.32 64.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 110.456 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.802 HD21 HG13 ' A' ' 98' ' ' ILE . 60.3 mt -63.96 -13.0 42.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 110.245 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 94' ' ' THR . . . 65.62 26.76 72.09 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 50.64 21.05 0.82 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.229 -1.159 . . . . 0.0 110.2 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 92' ' ' GLY . 18.5 p -122.56 -33.07 3.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.084 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.792 HD11 HD11 ' A' ' 128' ' ' ILE . 2.3 mm? -80.04 170.27 16.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 110.283 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HG3' ' HB3' ' A' ' 123' ' ' LYS . 60.9 mm-40 -137.0 -79.4 0.39 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.48 -0.763 . . . . 0.0 109.611 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 58.6 mttt -80.32 127.46 32.4 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.204 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.986 ' O ' HG23 ' A' ' 84' ' ' THR . 18.4 mm -118.52 147.68 21.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.658 -1.276 . . . . 0.0 110.237 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -126.13 128.37 47.22 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.441 -0.787 . . . . 0.0 109.278 178.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.741 ' CE2' HG21 ' A' ' 98' ' ' ILE . 13.8 m-85 -126.7 131.9 51.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 110.017 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -135.96 136.23 40.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.925 . . . . 0.0 110.575 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.5 m -132.5 143.95 50.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.414 -0.804 . . . . 0.0 109.724 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 115' ' ' LYS . 5.0 mttt -136.18 143.77 44.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 0.0 110.482 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 79' ' ' TYR . 5.5 mt -118.8 151.06 38.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.244 -0.91 . . . . 0.0 110.49 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.73 -168.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 109.814 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.716 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.51 157.96 28.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 110.189 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 33.2 p -118.22 165.44 16.35 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.897 . . . . 0.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -72.88 -1.35 10.31 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.02 1.537 . . . . 0.0 110.495 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.0 m -105.56 -0.65 25.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.902 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.21 -36.11 4.59 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.93 -171.46 0.75 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.504 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 6.1 p -131.3 134.38 46.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -1.096 . . . . 0.0 110.228 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.817 ' HA ' HG22 ' A' ' 10' ' ' THR . 12.2 mt -84.33 148.07 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.81 HG12 HD23 ' A' ' 104' ' ' LEU . 9.1 mt -130.71 113.71 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.295 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 7.0 ttmt -87.4 138.58 31.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.162 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 1.1 p -124.43 132.04 53.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 110.257 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.507 HG23 ' HB2' ' A' ' 6' ' ' GLU . 62.0 m -148.22 123.25 10.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 110.533 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.7 m -130.91 164.9 24.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 109.886 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.823 ' CE1' HG23 ' A' ' 4' ' ' THR . 30.8 m-70 -142.12 170.62 15.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.115 -0.991 . . . . 0.0 110.096 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.536 ' HB3' ' CD1' ' A' ' 95' ' ' LEU . 26.2 m-85 -136.24 147.32 47.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.496 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 83.6 m-70 -128.35 88.75 2.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.399 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.586 HG22 HD22 ' A' ' 95' ' ' LEU . 4.2 p -68.9 161.26 29.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.849 . . . . 0.0 110.711 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.475 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 33.0 ttmt -152.48 94.72 1.94 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 110.314 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 133.5 35.94 0.27 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 3.3 t30 63.61 56.59 1.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.171 -1.193 . . . . 0.0 110.252 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.541 HG23 ' CG2' ' A' ' 122' ' ' THR . 8.4 m -142.86 145.82 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 110.005 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.75 179.04 5.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.358 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.792 HD11 HD11 ' A' ' 95' ' ' LEU . 16.2 mm -84.67 173.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.21 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.593 ' N ' HG22 ' A' ' 128' ' ' ILE . 18.8 mtpt -117.63 136.82 53.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.009 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -43.61 -41.09 4.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.166 -0.958 . . . . 0.0 110.245 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 51.4 tt0 -64.38 -26.13 68.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.091 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 13.8 t-160 -77.91 -48.46 16.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.649 HG22 ' CE2' ' A' ' 5' ' ' TYR . 69.1 t -56.26 -32.08 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 109.867 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -90.8 -51.37 5.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -57.9 -32.76 68.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.84 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.08 -33.81 62.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 141' ' ' SER . 52.5 mmtt -78.55 -32.89 48.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -1.122 . . . . 0.0 109.982 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -73.43 -34.97 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.887 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -70.7 -43.45 68.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.798 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -72.49 -31.12 65.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 109.947 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 22.7 t -64.76 -54.0 38.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.395 -0.815 . . . . 0.0 109.928 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -51.78 -49.78 62.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.705 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 24.0 mt -52.91 -41.66 64.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 110.059 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 16.7 m-85 -59.87 -50.88 72.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.689 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 75.7 tttt -63.44 -13.67 42.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.915 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.541 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 13.1 mt -85.2 -37.77 19.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.213 -0.93 . . . . 0.0 108.813 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.749 ' CG2' HD23 ' A' ' 18' ' ' LEU . 33.8 mt -69.56 -45.3 78.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 13' ' ' ILE . 67.8 mm-40 -51.56 -38.15 52.97 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.286 -0.884 . . . . 0.0 108.785 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 88.3 m -72.36 -38.1 68.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.303 -0.873 . . . . 0.0 109.01 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.818 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 66.2 t80 -44.19 -54.84 5.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.465 -0.772 . . . . 0.0 109.604 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.121 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 78.5 mt -75.41 -29.07 59.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.467 -0.771 . . . . 0.0 110.267 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 149' ' ' THR . 39.3 tttp -69.48 -13.27 62.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.715 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -123.63 -26.46 1.59 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.561 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.2 m-70 -110.77 89.64 9.58 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 0.0 110.378 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.31 0.33 8.13 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.037 1.546 . . . . 0.0 110.559 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -111.92 12.72 20.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.882 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.818 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -86.57 101.25 13.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.416 -0.802 . . . . 0.0 110.282 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.156 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 8.9 p90 38.52 21.8 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.689 -0.632 . . . . 0.0 112.354 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.551 ' OD1' HD22 ' A' ' 151' ' ' LEU . 33.4 m-20 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 120.415 -1.428 . . . . 0.0 110.12 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.956 HG13 ' O ' ' A' ' 120' ' ' TYR . 86.3 t -108.77 139.82 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -1.172 . . . . 0.0 110.223 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.644 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 16.3 m-85 -103.01 129.8 49.89 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.238 -0.914 . . . . 0.0 109.826 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.823 HG23 ' CE1' ' A' ' 119' ' ' HIS . 19.3 m -104.68 107.83 18.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.859 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.57 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 33.9 m-85 -116.27 124.92 51.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.552 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 116' ' ' SER . 23.1 pt-20 -122.63 164.17 18.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.15 -0.969 . . . . 0.0 111.035 -179.083 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.512 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.2 p -125.32 167.63 14.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.568 -0.707 . . . . 0.0 110.272 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 7' ' ' SER . 18.2 mt-10 -160.19 120.15 2.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.924 ' HB2' HD13 ' A' ' 114' ' ' ILE . 76.5 m-85 -141.18 -166.01 2.08 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.789 -1.194 . . . . 0.0 111.552 -178.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 9' ' ' PHE . 25.5 p -158.32 155.29 28.52 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.758 0.789 . . . . 0.0 110.368 178.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.527 ' O ' ' CA ' ' A' ' 111' ' ' GLY . 83.6 p -159.29 146.23 16.93 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.791 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -70.55 -32.93 70.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 110.046 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.777 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.0 mm -58.99 149.96 63.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.863 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.777 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.8 Cg_endo -65.47 144.27 78.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.0 1.526 . . . . 0.0 110.585 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.661 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 Cg_endo -72.05 -31.61 12.05 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 124.023 1.538 . . . . 0.0 112.802 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -70.19 -21.51 31.37 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 N-CA-C 110.042 -0.791 . . . . 0.0 110.042 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.964 ' HG2' HD13 ' A' ' 151' ' ' LEU . 10.3 ttm180 -83.2 -47.16 11.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.759 HD23 ' C ' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -68.01 -27.62 66.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.933 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.51 ' N ' HD23 ' A' ' 18' ' ' LEU . 52.0 t80 -68.24 -55.75 11.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.474 -0.766 . . . . 0.0 109.378 179.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 89.6 mttt -50.27 -37.83 37.95 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.244 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.029 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -70.89 -57.82 4.22 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.687 0.756 . . . . 0.0 110.943 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.961 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -54.46 -54.33 42.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.556 -0.715 . . . . 0.0 111.843 -178.669 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.704 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.0 t -92.82 -62.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.078 -1.014 . . . . 0.0 111.964 -178.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.7 mp -69.09 0.23 4.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.197 -0.939 . . . . 0.0 111.974 -178.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.819 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -150.18 24.33 0.82 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.736 -1.228 . . . . 0.0 111.014 -179.99 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.961 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -63.24 -37.98 89.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.011 -1.056 . . . . 0.0 110.135 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 33.9 m-20 -63.49 -13.96 46.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.109 -0.994 . . . . 0.0 110.099 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.512 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 84.2 m-20 -128.3 10.46 6.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.826 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.819 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -96.41 -53.73 3.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 110.51 -179.871 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.86 HG22 ' HD3' ' A' ' 31' ' ' PRO . 1.9 m -74.69 -29.31 0.91 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 111.97 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.86 ' HD3' HG22 ' A' ' 30' ' ' VAL . 49.5 Cg_endo -79.18 4.58 6.44 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 122.851 0.921 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -125.17 -35.29 2.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 109.109 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.773 HG21 ' HB3' ' A' ' 146' ' ' LEU . 40.5 mt -79.96 -24.32 11.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.549 0.69 . . . . 0.0 109.235 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.92 95.43 0.4 Allowed Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.618 -0.676 . . . . 0.0 109.78 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.68 0.22 7.94 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.041 1.548 . . . . 0.0 110.655 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -89.52 5.95 43.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.238 -0.914 . . . . 0.0 109.872 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.667 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -113.89 -55.35 2.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 110.013 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.667 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.9 mp -115.11 132.14 65.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 110.029 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -79.99 -35.07 37.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.286 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.525 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -177.26 151.98 0.83 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.0 109.96 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.8 m -115.53 130.83 57.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.24 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 85.6 tt0 -137.79 110.59 7.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 0.0 110.207 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.1 mt -62.25 135.51 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.302 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 tp -87.9 -25.61 23.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.988 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 1.029 ' O ' HG23 ' A' ' 52' ' ' THR . 28.8 tp10 -161.45 170.28 20.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 59.32 -169.69 6.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.7 23.39 6.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -1.155 . . . . 0.0 110.252 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.493 ' H ' HG21 ' A' ' 52' ' ' THR . . . 111.07 1.45 28.38 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.496 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -86.0 -169.46 45.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.3 Cg_endo -70.96 131.85 20.3 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.015 1.534 . . . . 0.0 110.468 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.21 -6.59 68.88 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 1.029 HG23 ' O ' ' A' ' 45' ' ' GLU . 14.8 m -80.04 142.3 35.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -1.104 . . . . 0.0 109.961 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.607 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.3 mm -110.68 122.11 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 110.155 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 84.7 mttt -105.88 144.63 32.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 110.23 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -117.86 87.61 2.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 110.218 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.409 ' HB ' HG23 ' A' ' 67' ' ' VAL . 90.6 mt -80.01 144.39 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 110.331 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.509 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.7 p -111.48 164.2 13.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.766 ' HE2' HG13 ' A' ' 67' ' ' VAL . 25.9 m-85 -115.32 155.36 27.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 110.434 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.434 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 8.6 t80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.191 0.52 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -128.81 135.3 8.43 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.4 p90 -178.73 162.84 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -1.167 . . . . 0.0 110.211 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.937 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.5 m -141.9 172.79 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -0.819 . . . . 0.0 110.512 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 88.5 mttt -124.49 129.41 50.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.575 -0.703 . . . . 0.0 109.449 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.482 ' CD2' HD12 ' A' ' 85' ' ' LEU . 8.2 m170 -118.14 123.98 46.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.15 -0.969 . . . . 0.0 111.034 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.607 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.0 tttt -100.32 113.64 26.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 25.8 mm -54.52 135.36 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.901 . . . . 0.0 110.468 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 1.6 t70 -110.16 -42.99 4.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 109.601 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 82' ' ' SER . 25.5 m -169.75 157.49 6.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 109.896 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mt -141.59 156.15 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 110.456 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.0 m-20 -136.18 79.04 1.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.576 -0.702 . . . . 0.0 109.991 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 78.4 mttt -62.62 -16.89 58.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.385 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -93.05 -30.72 15.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 109.529 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -103.87 -6.12 21.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.545 -0.722 . . . . 0.0 109.694 179.8 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.582 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.2 m-85 65.36 52.13 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 109.988 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.536 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -124.91 154.97 40.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.839 . . . . 0.0 109.782 179.706 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.704 ' CE1' HG13 ' A' ' 23' ' ' VAL . 22.3 t80 -142.5 128.81 19.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.352 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 37.6 m -131.89 121.24 23.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.471 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 21.9 p90 -138.64 170.97 15.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.359 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 98' ' ' ILE . 98.9 m -123.46 132.6 53.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 109.893 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.747 HD21 HD11 ' A' ' 91' ' ' LEU . 3.1 tp -98.87 136.45 38.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.081 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.0 pt -119.46 -16.99 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.532 ' O ' HD11 ' A' ' 85' ' ' LEU . 23.9 tt0 -133.09 150.08 52.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.143 -0.973 . . . . 0.0 110.488 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.937 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 165.46 142.31 3.38 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -65.73 -35.35 80.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -1.156 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.735 ' HB1' ' HE2' ' A' ' 132' ' ' HIS . . . -65.13 -26.17 68.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 110.13 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.786 HD12 ' N ' ' A' ' 88' ' ' GLY . 35.3 mt -65.48 -25.38 67.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.181 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.84 -167.63 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -87.28 8.04 25.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -1.184 . . . . 0.0 110.149 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.695 ' O ' HG21 ' A' ' 126' ' ' VAL . 60.6 p -93.88 -40.33 10.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.151 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.001 HD23 HG23 ' A' ' 122' ' ' THR . 22.5 mt -102.11 155.04 18.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.027 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -134.65 -78.84 0.45 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.219 -0.925 . . . . 0.0 110.284 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 50.8 mttt -80.13 132.93 36.02 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.407 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.765 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.5 mm -124.77 136.93 59.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.734 -1.228 . . . . 0.0 110.06 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -116.3 127.1 54.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.74 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.765 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.4 m-85 -122.65 135.59 54.64 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 111.148 -178.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 117' ' ' THR . 4.2 mt-10 -133.0 133.26 42.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.567 -0.708 . . . . 0.0 109.658 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 81' ' ' TYR . 36.1 m -132.07 134.09 45.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.0 -1.062 . . . . 0.0 110.124 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.5 tttt -133.93 147.68 51.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 110.252 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 79' ' ' TYR . 22.7 mt -117.89 142.22 47.57 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.399 -0.813 . . . . 0.0 110.148 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.6 t -131.42 -172.64 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 0.0 110.371 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.637 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -118.13 148.53 42.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 110.454 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.438 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 52.9 p -106.92 163.78 16.23 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 110.366 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 44.4 Cg_endo -72.26 -2.13 11.19 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.017 1.535 . . . . 0.0 110.403 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.1 m -103.59 -7.17 20.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.072 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.79 -16.03 31.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 11' ' ' SER . . . -79.08 -171.66 41.03 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' SER . 42.1 p -128.81 122.31 30.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 110.221 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 10' ' ' THR . 7.0 mt -79.98 139.64 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.464 -0.772 . . . . 0.0 110.79 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.924 HD13 ' HB2' ' A' ' 9' ' ' PHE . 3.7 mp -93.02 151.88 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.049 179.076 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 103' ' ' LYS . 16.9 tttt -149.87 99.71 2.87 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 109.365 178.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 20.9 t -116.13 174.8 5.85 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.357 -0.839 . . . . 0.0 111.257 -178.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.572 HG22 ' CE1' ' A' ' 119' ' ' HIS . 31.4 m -160.07 128.97 4.98 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 5' ' ' TYR . 38.9 t -122.9 156.68 34.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.042 -1.036 . . . . 0.0 110.421 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.823 ' CE1' HG23 ' A' ' 4' ' ' THR . 76.7 m-70 -140.48 123.65 16.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.35 -0.844 . . . . 0.0 110.371 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.956 ' O ' HG13 ' A' ' 2' ' ' VAL . 8.8 m-30 -93.87 149.79 20.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -0.871 . . . . 0.0 110.416 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 91.9 m-70 -127.65 84.82 2.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 109.743 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 1.001 HG23 HD23 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -67.39 152.64 45.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.406 -0.809 . . . . 0.0 110.618 -179.545 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -115.31 113.58 24.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 110.132 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.0 -145.74 16.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.509 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 2.1 p-10 -104.53 54.67 0.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.208 -1.172 . . . . 0.0 110.237 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.695 HG21 ' O ' ' A' ' 94' ' ' THR . 10.8 m -116.88 156.33 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 9.8 pm0 -143.7 157.1 44.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.051 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.688 ' CG1' HD21 ' A' ' 95' ' ' LEU . 2.9 mp -78.27 173.29 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.126 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.602 ' N ' HG22 ' A' ' 128' ' ' ILE . 23.0 mttt -110.88 151.34 27.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.951 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.44 -31.88 64.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -0.975 . . . . 0.0 110.205 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -65.33 -40.87 94.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 109.982 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.735 ' HE2' ' HB1' ' A' ' 90' ' ' ALA . 17.2 t-160 -66.81 -45.5 78.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 110.043 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.57 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 61.2 t -62.89 -41.11 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -76.42 -42.01 45.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.65 96.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.959 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.51 -30.1 76.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.433 ' HE3' HG12 ' A' ' 133' ' ' VAL . 88.5 mttt -75.31 -32.81 61.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -1.137 . . . . 0.0 110.042 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -76.3 -34.32 59.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -0.863 . . . . 0.0 109.903 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.97 -34.77 64.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 179.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.5 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.51 -30.55 61.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.928 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.4 p -68.72 -50.99 46.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.904 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.421 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 82.5 m-20 -51.36 -44.48 62.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 18.7 tp -57.15 -50.05 74.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.867 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 25.9 m-85 -53.84 -39.57 65.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.431 -0.793 . . . . 0.0 109.765 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.447 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 32.3 mttp -78.51 -13.61 59.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.933 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.773 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.2 mt -84.81 -36.66 21.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.23 -0.919 . . . . 0.0 108.889 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.648 HD11 ' CE1' ' A' ' 22' ' ' PHE . 36.7 mt -70.47 -43.93 77.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 13' ' ' ILE . 52.3 mt-10 -59.27 -37.68 78.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.426 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 98.7 m -77.2 -38.9 50.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 179.471 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.656 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.7 t80 -52.6 -49.15 65.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.903 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.181 HD21 ' CE2' ' A' ' 158' ' ' TYR . 82.3 mt -79.03 -33.45 44.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 109.99 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.538 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 38.9 tttt -70.61 -16.97 62.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.347 179.237 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.77 -32.59 2.23 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.544 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 8.2 m-70 -109.41 94.8 16.81 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.389 -1.066 . . . . 0.0 109.978 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.34 6.75 2.92 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.061 1.559 . . . . 0.0 111.048 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -110.48 2.78 19.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.062 -1.024 . . . . 0.0 109.86 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.656 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -83.23 103.61 12.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.181 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.57 32.44 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.747 -0.596 . . . . 0.0 110.532 -179.667 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.709 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.903 HG13 ' O ' ' A' ' 120' ' ' TYR . 73.2 t -130.33 122.01 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -1.226 . . . . 0.0 110.212 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.609 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 89.5 m-85 -73.69 147.42 43.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 110.138 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.834 HG23 ' CE1' ' A' ' 119' ' ' HIS . 52.9 m -129.32 119.57 24.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.242 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.171 ' CE2' HG21 ' A' ' 133' ' ' VAL . 61.6 m-85 -130.97 151.76 51.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.121 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -145.18 150.45 36.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 110.282 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.48 ' OG ' ' HB3' ' A' ' 116' ' ' SER . 78.0 p -132.37 148.51 52.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.838 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -136.67 117.17 13.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.102 -0.999 . . . . 0.0 110.625 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 p90 -141.18 -177.17 4.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.39 -0.819 . . . . 0.0 109.733 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.5 HG22 HG12 ' A' ' 113' ' ' ILE . 27.2 p -136.75 -179.25 5.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 110.838 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 148' ' ' GLU . 11.8 t -159.92 170.38 21.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 110.17 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -93.82 -21.76 19.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.819 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.6 mp -80.98 150.4 68.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.819 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.1 Cg_endo -66.51 145.49 76.78 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.991 1.522 . . . . 0.0 110.783 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.66 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 Cg_endo -72.14 -31.5 11.96 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 124.126 1.593 . . . . 0.0 112.993 -179.184 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.7 Cg_endo -69.3 -20.65 36.74 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 N-CA-C 109.724 -0.914 . . . . 0.0 109.724 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 1.033 ' HB3' HD13 ' A' ' 151' ' ' LEU . 1.3 mmp_? -82.74 -47.81 11.55 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.766 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.2 tt -67.94 -25.32 65.4 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.63 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 70.9 t80 -66.84 -61.2 2.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.512 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.616 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 34.3 mttp -49.0 -37.9 21.74 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.129 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -62.4 -66.32 0.56 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.803 0.811 . . . . 0.0 110.897 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.041 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -54.59 -47.48 73.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.842 -0.537 . . . . 0.0 111.959 -178.199 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.102 HG11 ' CD1' ' A' ' 74' ' ' ILE . 3.0 t -96.14 -64.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.87 -1.144 . . . . 0.0 112.154 -178.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.9 mm? -68.69 -3.63 12.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.051 -1.031 . . . . 0.0 111.644 -178.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.598 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -139.62 4.0 2.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.772 -1.205 . . . . 0.0 111.019 -179.706 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.041 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -42.57 -26.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.138 -0.976 . . . . 0.0 110.183 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 56.4 m-20 -74.7 -40.78 61.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.931 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -106.48 24.24 12.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.891 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.887 HD12 ' C ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -106.11 -62.16 1.42 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 -179.867 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.027 HG11 HD13 ' A' ' 38' ' ' ILE . 44.7 t -61.92 -40.88 72.94 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.493 -0.754 . . . . 0.0 111.203 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -78.37 9.28 3.2 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.353 1.186 . . . . 0.0 110.827 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HD2' ' OH ' ' A' ' 150' ' ' TYR . 17.7 mttt -121.87 -28.31 4.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.997 -1.064 . . . . 0.0 109.457 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.783 HG21 ' HB3' ' A' ' 146' ' ' LEU . 29.0 mt -79.99 -56.86 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.516 -0.74 . . . . 0.0 109.767 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.439 ' HB1' HE21 ' A' ' 36' ' ' GLN . . . -151.62 106.14 2.9 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.476 -0.765 . . . . 0.0 110.085 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.21 1.22 6.91 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.661 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.439 HE21 ' HB1' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -86.54 -9.47 56.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.952 179.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.09 -36.27 9.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 110.187 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.027 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mt -136.49 149.74 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.332 -0.855 . . . . 0.0 110.009 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.542 ' CG ' ' HA2' ' A' ' 59' ' ' GLY . 10.5 mttt -78.9 -50.26 11.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 110.003 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -173.01 160.11 4.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.452 -0.78 . . . . 0.0 109.977 179.711 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.7 m -119.02 126.63 52.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.143 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -135.64 103.09 5.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 110.379 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 18.9 mt -50.42 131.32 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.3 tp -91.31 -46.55 7.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.253 -0.904 . . . . 0.0 110.218 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.855 ' O ' HG23 ' A' ' 52' ' ' THR . 3.9 mm-40 -132.63 136.97 46.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.246 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.82 -168.41 34.33 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -131.29 12.58 5.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -1.16 . . . . 0.0 110.255 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.507 ' H ' HG21 ' A' ' 52' ' ' THR . . . 122.47 -6.22 9.92 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -84.15 -168.31 43.76 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.2 Cg_endo -70.71 135.91 29.27 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.024 1.539 . . . . 0.0 110.501 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.75 -5.49 79.6 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.8 m -80.1 143.18 34.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -1.115 . . . . 0.0 110.042 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.777 HG21 ' HE3' ' A' ' 68' ' ' LYS . 29.2 mm -110.08 125.46 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.278 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 40.2 mtmt -108.29 139.7 42.62 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.365 -0.835 . . . . 0.0 110.083 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -112.9 89.94 3.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 110.129 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.46 ' CG2' HG12 ' A' ' 38' ' ' ILE . 88.8 mt -83.18 139.04 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.215 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 38' ' ' ILE . 6.7 p -110.27 160.81 16.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.494 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.751 ' HE2' HG13 ' A' ' 67' ' ' VAL . 27.3 m-85 -120.64 124.37 45.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -0.812 . . . . 0.0 110.377 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' HA2' ' CG ' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.443 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 9.2 t80 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.291 0.567 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -127.82 136.7 9.36 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.536 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.9 p90 -179.66 161.19 0.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -1.088 . . . . 0.0 109.989 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.768 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.6 m -143.27 172.38 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.633 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.777 ' HE3' HG21 ' A' ' 53' ' ' ILE . 75.4 tttt -123.65 118.23 26.8 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -110.54 133.58 53.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.989 -1.069 . . . . 0.0 111.379 -178.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.542 ' HA ' HD13 ' A' ' 53' ' ' ILE . 77.1 tttt -111.12 119.23 38.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.563 -0.711 . . . . 0.0 109.218 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.531 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 42.2 mm -53.15 143.83 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 110.51 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.3 m-20 -117.49 -31.83 5.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.375 -0.828 . . . . 0.0 109.703 179.52 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 2.2 p 168.28 157.43 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 110.15 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.102 ' CD1' HG11 ' A' ' 23' ' ' VAL . 4.1 tt -153.59 165.62 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.3 -0.875 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -140.64 83.97 1.92 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.251 -0.906 . . . . 0.0 109.977 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.563 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 85.6 tttt -58.62 -12.53 4.21 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.29 -0.881 . . . . 0.0 110.776 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.42 ' OE1' ' HA ' ' A' ' 77' ' ' GLU . 17.5 mm-40 -85.46 -34.41 21.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.191 -0.943 . . . . 0.0 108.918 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m-80 -109.4 -1.97 18.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.63 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 9.7 m-85 65.95 49.81 1.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.343 0.592 . . . . 0.0 110.449 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.544 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -115.32 157.89 23.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.108 -0.995 . . . . 0.0 109.129 179.19 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.593 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 80.8 t80 -160.02 150.18 18.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.016 -1.052 . . . . 0.0 110.116 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.418 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 9.7 t -160.98 150.52 17.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.94 . . . . 0.0 110.585 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.9 p90 -151.69 -171.13 3.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.51 -0.744 . . . . 0.0 109.871 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.921 HG23 ' O ' ' A' ' 98' ' ' ILE . 54.0 m -132.64 135.91 46.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.364 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.697 HD12 ' HE2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -94.18 116.09 28.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.231 -0.918 . . . . 0.0 110.096 179.765 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.731 HD11 ' HD3' ' A' ' 68' ' ' LYS . 16.7 pt -107.82 -10.54 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.199 -0.938 . . . . 0.0 110.112 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -138.81 126.52 22.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.84 . . . . 0.0 110.044 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.768 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -179.86 145.36 6.44 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 89' ' ' ASP . 44.3 p-10 -65.16 -9.86 26.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -1.143 . . . . 0.0 110.243 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.869 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -78.09 -36.15 48.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 110.19 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.967 HD23 ' HG ' ' A' ' 95' ' ' LEU . 4.1 mt -58.18 -40.66 82.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.396 -0.815 . . . . 0.0 110.337 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 43.44 -132.33 5.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.664 ' OD1' HG23 ' A' ' 94' ' ' THR . 59.1 p30 -114.12 12.6 17.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -1.188 . . . . 0.0 110.235 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.664 HG23 ' OD1' ' A' ' 93' ' ' ASP . 40.1 p -109.82 -33.15 6.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.967 ' HG ' HD23 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -116.53 159.98 21.3 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.27 -0.894 . . . . 0.0 109.222 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.797 ' O ' HD22 ' A' ' 91' ' ' LEU . 42.0 tt0 -138.53 -78.2 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.979 . . . . 0.0 110.807 -179.307 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 10.8 mttm -80.13 132.76 35.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.476 -0.765 . . . . 0.0 110.7 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.921 ' O ' HG23 ' A' ' 84' ' ' THR . 15.8 mm -118.56 148.63 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.885 -1.134 . . . . 0.0 110.212 179.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.538 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -125.14 125.23 43.38 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.057 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.828 ' CE2' HG21 ' A' ' 98' ' ' ILE . 13.5 m-85 -121.45 134.91 55.09 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.348 -0.845 . . . . 0.0 110.476 -178.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 58.6 tt0 -133.3 160.66 36.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 81' ' ' TYR . 35.9 m -160.92 121.09 2.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 0.4 OUTLIER -120.01 146.98 45.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.333 -179.889 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.555 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 14.7 mt -125.31 151.23 46.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -0.848 . . . . 0.0 110.266 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.708 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.35 -169.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.203 -0.936 . . . . 0.0 110.005 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.708 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -127.02 135.48 50.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 110.16 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.431 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 49.5 p -90.72 163.22 31.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.301 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -73.06 -2.87 12.68 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.14 1.6 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.4 p -96.87 -5.02 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 110.3 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.42 -40.46 2.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.26 -172.48 2.02 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -127.99 138.8 52.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -1.174 . . . . 0.0 110.336 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.5 HG12 HG22 ' A' ' 10' ' ' THR . 26.6 mt -89.88 147.36 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.589 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 7.0 mt -130.95 112.96 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 110.318 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -104.1 122.34 45.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.961 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.48 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 7.4 t -116.49 163.5 15.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.536 HG22 ' NE2' ' A' ' 119' ' ' HIS . 59.6 m -160.01 138.2 10.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 110.228 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.4 m -135.18 148.97 49.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.957 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.834 ' CE1' HG23 ' A' ' 4' ' ' THR . 73.8 m-70 -132.59 168.57 18.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.177 -0.952 . . . . 0.0 110.751 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.903 ' O ' HG13 ' A' ' 2' ' ' VAL . 35.9 m-85 -131.69 145.6 51.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.508 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.496 ' HA ' HG22 ' A' ' 2' ' ' VAL . 92.4 m-70 -126.34 95.01 4.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.129 -0.982 . . . . 0.0 109.956 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.719 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -58.5 154.81 13.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.207 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.526 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 57.9 tttt -118.23 111.19 18.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.293 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.62 -115.64 5.0 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -129.84 71.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 110.145 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.573 ' O ' HG21 ' A' ' 122' ' ' THR . 16.9 m -142.72 -179.46 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.719 ' HA ' HG21 ' A' ' 122' ' ' THR . 92.8 mt-10 -154.54 149.33 26.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.194 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.633 HD12 ' H ' ' A' ' 128' ' ' ILE . 4.9 mp -77.91 173.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.943 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.595 ' N ' HG22 ' A' ' 128' ' ' ILE . 33.1 mttt -107.03 129.05 54.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.878 . . . . 0.0 110.251 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.473 ' HB3' ' HE2' ' A' ' 134' ' ' LYS . 97.9 mt-10 -45.69 -44.89 13.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -58.52 -30.98 67.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 109.842 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.869 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 13.4 t-160 -73.7 -53.17 11.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.926 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.171 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.6 p -64.52 -40.14 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.442 -0.787 . . . . 0.0 109.959 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.524 ' N ' HG13 ' A' ' 133' ' ' VAL . 42.7 mtmt -63.61 -43.94 95.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.849 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.02 74.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 109.876 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.43 -30.52 66.74 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.465 ' HD2' ' HB3' ' A' ' 5' ' ' TYR . 3.9 mtpt -74.06 -32.41 63.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -1.099 . . . . 0.0 109.893 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -72.24 -29.78 64.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.38 -0.825 . . . . 0.0 109.884 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.48 -35.86 73.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -0.834 . . . . 0.0 109.883 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.05 -41.18 71.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.968 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.9 t -59.43 -49.86 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.367 -0.833 . . . . 0.0 109.92 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -55.06 -42.94 73.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.954 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.472 ' O ' HG13 ' A' ' 147' ' ' ILE . 59.3 mt -60.04 -39.03 84.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 0.0 109.924 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -62.39 -36.11 81.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 110.165 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 89.1 mttt -79.15 -8.88 59.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 110.078 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.783 ' HB3' HG21 ' A' ' 33' ' ' ILE . 13.2 mt -89.49 -37.37 14.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.257 -0.902 . . . . 0.0 108.747 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.746 HD11 ' CE1' ' A' ' 22' ' ' PHE . 32.6 mt -70.68 -44.63 76.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.715 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.537 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 23.5 pt-20 -52.1 -39.73 60.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.809 178.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.535 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 19.8 m -76.25 -33.69 59.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 109.065 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.85 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 73.8 t80 -47.72 -57.93 4.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.585 -0.697 . . . . 0.0 109.901 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.057 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 62.8 mt -67.56 -45.74 74.74 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.437 -0.79 . . . . 0.0 110.709 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.619 ' HB2' HD11 ' A' ' 13' ' ' ILE . 81.9 tttt -58.81 -16.1 15.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 109.602 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.403 ' C ' ' CD2' ' A' ' 154' ' ' HIS . . . -115.21 -24.28 4.23 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.593 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.7 m-70 -119.56 92.84 46.7 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.248 -1.148 . . . . 0.0 110.313 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.61 0.54 7.42 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.049 1.552 . . . . 0.0 110.764 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -115.19 15.25 17.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.147 -0.97 . . . . 0.0 110.045 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.85 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -88.38 103.51 15.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.408 -0.807 . . . . 0.0 110.4 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.129 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 6.4 p90 38.99 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.574 -0.704 . . . . 0.0 112.32 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 28.8 m-20 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 120.457 -1.402 . . . . 0.0 110.132 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 74.9 t -104.02 135.91 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 110.241 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.662 ' CE1' HD12 ' A' ' 128' ' ' ILE . 12.6 m-85 -93.62 150.5 20.37 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 109.989 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.787 HG23 ' CE1' ' A' ' 119' ' ' HIS . 8.4 m -129.08 113.11 14.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.562 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.981 ' CE2' HG21 ' A' ' 133' ' ' VAL . 67.6 m-85 -127.44 136.73 52.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.87 . . . . 0.0 109.76 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 16.3 pt-20 -138.31 153.78 49.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 0.0 110.707 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.2 m -132.81 144.48 50.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.408 -0.808 . . . . 0.0 109.645 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.421 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 98.9 mt-10 -130.35 127.3 39.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.059 -1.026 . . . . 0.0 110.627 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.631 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.3 p90 -155.07 -171.52 3.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.815 . . . . 0.0 109.974 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.824 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.7 p -142.84 174.01 11.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.338 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.466 ' OG ' ' OE2' ' A' ' 148' ' ' GLU . 79.7 p -151.57 148.28 27.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.244 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -74.13 -6.12 45.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.132 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.829 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.7 mp -95.9 150.15 36.94 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.029 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.829 ' HD2' HG23 ' A' ' 13' ' ' ILE . 42.2 Cg_endo -67.41 143.88 65.31 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.107 1.583 . . . . 0.0 110.89 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.677 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.1 Cg_endo -71.31 -31.49 14.13 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 124.115 1.587 . . . . 0.0 112.698 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 39.5 Cg_endo -67.4 -21.05 47.62 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 N-CA-C 110.098 -0.77 . . . . 0.0 110.098 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 9.1 mmp_? -85.17 -46.18 11.33 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.763 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.2 tt -69.03 -28.18 66.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.617 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 68.9 t80 -69.27 -53.53 19.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.707 . . . . 0.0 109.818 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 45.8 mttp -57.28 -29.87 64.23 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.993 0.901 . . . . 0.0 108.899 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.961 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -77.7 -63.63 1.34 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.681 0.753 . . . . 0.0 111.269 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.008 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -56.28 -39.63 72.97 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.689 -0.632 . . . . 0.0 111.947 -178.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.136 HG11 ' CD1' ' A' ' 74' ' ' ILE . 15.7 t -102.13 -65.86 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.791 -1.193 . . . . 0.0 111.631 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.0 mp -64.9 -6.08 7.55 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.227 -0.921 . . . . 0.0 111.25 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.558 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 1.1 m-20 -146.47 24.41 1.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.862 -1.149 . . . . 0.0 110.49 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.008 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -57.46 -38.36 74.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.041 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 41' ' ' SER . 86.0 m-20 -67.66 -12.86 61.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 110.191 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.54 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 83.9 m-20 -125.18 -3.79 7.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.457 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.764 HD11 HG23 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -85.98 -52.31 5.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.064 -1.023 . . . . 0.0 110.394 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.04 HG11 HD13 ' A' ' 38' ' ' ILE . 14.7 t -63.3 -41.02 65.61 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.791 . . . . 0.0 111.193 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.7 Cg_endo -77.23 7.37 3.75 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.333 1.175 . . . . 0.0 111.021 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 69.9 mmtt -122.35 -23.64 5.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.095 -1.003 . . . . 0.0 109.724 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.768 HG21 ' HB3' ' A' ' 146' ' ' LEU . 8.0 mt -80.01 -56.27 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.495 -0.753 . . . . 0.0 109.773 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.52 106.27 2.56 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.46 -0.775 . . . . 0.0 110.02 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.03 0.53 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.069 1.563 . . . . 0.0 110.726 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -83.77 -11.81 56.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.149 -0.97 . . . . 0.0 109.708 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.67 -51.43 3.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.382 -0.824 . . . . 0.0 110.278 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.04 HD13 HG11 ' A' ' 30' ' ' VAL . 1.3 mt -122.24 147.64 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 110.25 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -80.13 -43.9 20.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 110.192 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.544 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -177.42 161.38 1.75 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.148 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.449 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 27.2 m -119.41 128.73 54.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 53.9 tt0 -133.48 111.53 10.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.273 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 43.0 mt -62.98 132.92 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 110.195 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.409 ' HA ' HD12 ' A' ' 44' ' ' LEU . 55.0 tp -96.69 -43.14 7.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.877 . . . . 0.0 110.339 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.908 ' O ' HG23 ' A' ' 52' ' ' THR . 6.9 mt-10 -130.76 150.08 52.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.369 -0.832 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 76.92 -164.04 52.77 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 60.6 t0 -138.52 19.82 2.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -1.183 . . . . 0.0 110.312 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.438 ' H ' HG21 ' A' ' 52' ' ' THR . . . 118.23 -5.68 15.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -92.26 -165.93 39.1 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.2 Cg_endo -69.77 134.1 27.14 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.046 1.551 . . . . 0.0 110.486 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.32 -6.89 68.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 45' ' ' GLU . 30.4 m -79.95 136.16 36.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -1.145 . . . . 0.0 110.158 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.696 HD13 ' HA ' ' A' ' 70' ' ' LYS . 23.7 mm -107.18 113.25 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 110.267 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 77.7 mttt -98.28 148.2 23.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.4 -0.813 . . . . 0.0 110.36 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -118.1 92.37 3.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.545 ' CG2' HG12 ' A' ' 38' ' ' ILE . 78.4 mt -79.99 139.6 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 38' ' ' ILE . 4.4 p -111.3 159.56 17.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.595 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.652 ' HE2' HG13 ' A' ' 67' ' ' VAL . 26.2 m-85 -119.61 139.65 51.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.254 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.56 9.63 57.31 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -110.98 138.02 47.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 110.238 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.19 132.52 6.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 t -56.17 -43.88 78.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -1.137 . . . . 0.0 110.267 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -77.8 153.7 32.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 110.242 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 t80 -53.88 139.53 33.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.923 . . . . 0.0 110.046 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -124.31 135.64 9.71 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 10.9 p90 -178.91 159.36 1.02 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -1.104 . . . . 0.0 109.931 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.721 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.9 m -143.57 171.52 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.725 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.509 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 68.4 mttt -121.25 127.35 51.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.602 -0.686 . . . . 0.0 109.587 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.567 ' CD2' HD12 ' A' ' 85' ' ' LEU . 14.2 m170 -115.31 124.66 51.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.146 -0.971 . . . . 0.0 110.864 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HA ' HD13 ' A' ' 53' ' ' ILE . 80.0 tttt -100.92 109.68 21.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.479 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.534 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.1 mm -48.32 139.59 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.005 . . . . 0.0 110.132 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.549 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 15.7 t0 -113.0 -40.05 4.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.854 . . . . 0.0 109.518 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 2.8 p 170.39 157.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 110.267 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.136 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.2 tt -146.22 163.83 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.796 . . . . 0.0 110.032 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.552 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -125.23 78.78 1.74 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.288 -0.883 . . . . 0.0 109.811 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.617 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 99.4 mttt -53.69 -16.54 1.69 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.448 -0.782 . . . . 0.0 110.794 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -91.96 -29.8 16.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.284 -0.885 . . . . 0.0 109.755 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -111.18 -0.18 16.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.563 -0.711 . . . . 0.0 109.651 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.69 ' O ' HD12 ' A' ' 104' ' ' LEU . 87.9 m-85 63.26 50.05 3.1 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.377 0.608 . . . . 0.0 110.667 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.552 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -118.55 148.67 42.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.207 179.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.585 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 84.7 t80 -144.85 139.14 27.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.065 -1.022 . . . . 0.0 110.433 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 m -148.07 133.4 18.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 110.116 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.7 p90 -135.17 178.36 7.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 98' ' ' ILE . 62.6 m -125.07 125.23 43.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.746 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.732 HD21 HD11 ' A' ' 91' ' ' LEU . 2.8 tp -94.11 136.94 33.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.997 . . . . 0.0 110.085 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 pt -124.1 -4.54 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 0.0 110.539 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 6.6 tt0 -137.87 156.49 47.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.004 . . . . 0.0 110.28 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.721 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 150.89 122.66 1.07 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.36 -17.35 4.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -1.171 . . . . 0.0 110.324 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.765 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -76.98 -29.22 55.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.732 HD11 HD21 ' A' ' 85' ' ' LEU . 17.2 mt -69.1 -27.63 65.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.06 -169.22 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.25 2.99 29.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -1.182 . . . . 0.0 110.175 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.513 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 30.5 p -85.74 -26.4 25.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.04 HD21 ' CG1' ' A' ' 128' ' ' ILE . 39.7 mt -122.25 156.59 33.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.868 . . . . 0.0 110.071 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.508 ' HG3' ' HB3' ' A' ' 123' ' ' LYS . 65.5 mm-40 -132.71 -79.81 0.49 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.247 -0.908 . . . . 0.0 110.129 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 22.1 mttp -80.11 129.57 34.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.605 -0.685 . . . . 0.0 110.763 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.732 HG21 ' CE2' ' A' ' 100' ' ' TYR . 6.2 mm -118.62 141.68 37.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.815 -1.178 . . . . 0.0 109.543 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.2 m -120.45 126.08 49.53 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.381 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.732 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.9 m-85 -122.12 133.38 54.76 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.434 -0.791 . . . . 0.0 110.244 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -133.22 148.75 52.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.392 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 81' ' ' TYR . 38.9 m -148.21 140.8 24.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.396 -0.815 . . . . 0.0 110.01 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 7.8 tttt -132.87 148.97 52.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -0.953 . . . . 0.0 110.124 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 79' ' ' TYR . 6.4 mt -126.39 148.39 49.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.149 -0.969 . . . . 0.0 110.346 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -152.31 -169.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.329 -0.857 . . . . 0.0 109.968 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.695 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -125.06 156.72 37.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 110.11 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 21.3 p -114.57 164.78 15.48 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.32 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.1 Cg_endo -72.6 -1.77 10.81 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.057 1.557 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.5 p -101.36 0.25 36.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.282 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.56 -38.05 3.39 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.16 -172.79 2.05 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 59.2 p -129.67 139.9 51.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -1.185 . . . . 0.0 110.251 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.824 ' HA ' HG22 ' A' ' 10' ' ' THR . 20.9 mt -89.02 149.5 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 110.199 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.631 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 14.9 mt -133.28 110.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.259 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.421 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 74.9 tttt -102.56 126.0 49.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.004 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 5.0 t -119.56 162.18 19.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.49 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.462 HG22 ' NE2' ' A' ' 119' ' ' HIS . 92.9 m -159.82 144.07 14.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.154 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 92.2 p -143.7 160.8 40.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.787 ' CE1' HG23 ' A' ' 4' ' ' THR . 75.7 m-70 -143.41 166.88 23.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.214 -0.929 . . . . 0.0 110.37 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 10.1 m-85 -129.46 145.81 51.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 110.61 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.2 m-70 -124.44 87.21 2.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -0.953 . . . . 0.0 109.352 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.536 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 2.2 p -65.39 157.82 28.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.411 -0.806 . . . . 0.0 110.644 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.508 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 74.6 tttt -137.84 126.08 23.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.462 -0.774 . . . . 0.0 110.124 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 99.71 23.27 11.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 8.6 t30 66.32 63.13 0.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -1.134 . . . . 0.0 110.189 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 30.2 m -137.03 166.03 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.129 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.488 ' HA ' HG21 ' A' ' 122' ' ' THR . 92.2 mt-10 -135.79 166.8 22.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 110.303 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.04 ' CG1' HD21 ' A' ' 95' ' ' LEU . 4.8 mp -90.75 172.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.575 ' N ' HG22 ' A' ' 128' ' ' ILE . 54.1 mttt -112.22 131.22 55.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.386 -0.821 . . . . 0.0 109.829 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 99.5 mt-10 -43.27 -44.47 5.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 110.05 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -54.81 -26.33 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.765 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 9.6 t-160 -83.29 -60.57 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 110.102 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.981 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.5 p -63.41 -39.79 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.967 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.523 ' N ' HG13 ' A' ' 133' ' ' VAL . 81.8 tttt -60.99 -37.74 83.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.89 . . . . 0.0 109.907 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.9 78.92 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.927 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.91 -33.47 85.77 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.04 -41.06 97.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -1.125 . . . . 0.0 109.906 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -75.03 -33.95 61.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.83 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -72.78 -37.29 67.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.421 -0.799 . . . . 0.0 109.781 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.49 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -72.23 -33.32 67.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.827 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.9 m -69.07 -44.32 72.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 109.944 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -63.54 -38.56 91.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.878 . . . . 0.0 109.9 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 146' ' ' LEU . 61.2 mt -64.77 -35.94 82.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.857 . . . . 0.0 109.989 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.622 ' CD2' ' CZ ' ' A' ' 9' ' ' PHE . 7.9 m-85 -63.55 -38.82 92.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.926 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -77.03 -14.5 59.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.873 . . . . 0.0 109.993 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.768 ' HB3' HG21 ' A' ' 33' ' ' ILE . 15.4 mt -84.02 -34.81 24.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.228 -0.92 . . . . 0.0 108.973 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.764 HG23 HD11 ' A' ' 29' ' ' LEU . 17.2 mt -71.56 -44.81 69.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.566 -0.709 . . . . 0.0 109.109 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.716 ' HB3' HD13 ' A' ' 13' ' ' ILE . 10.9 mm-40 -66.73 -38.75 87.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.505 -0.747 . . . . 0.0 109.651 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.7 m -69.99 -37.47 75.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -0.984 . . . . 0.0 109.669 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.651 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 77.7 t80 -56.4 -57.23 13.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.424 -0.797 . . . . 0.0 110.015 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.183 HD21 ' CE2' ' A' ' 158' ' ' TYR . 55.5 mt -68.58 -29.07 67.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.28 -0.887 . . . . 0.0 110.16 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.738 ' HD2' HD11 ' A' ' 13' ' ' ILE . 80.4 tttt -68.42 -33.59 74.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.66 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.494 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -100.8 -27.38 7.51 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.526 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.0 m-70 -107.45 89.19 4.7 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.303 -1.116 . . . . 0.0 110.045 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.2 Cg_endo -73.36 2.94 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.003 1.528 . . . . 0.0 110.833 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -106.9 -11.63 15.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 0.0 109.712 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.651 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -69.78 100.57 1.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.472 -0.768 . . . . 0.0 110.001 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.183 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.7 OUTLIER 34.34 33.11 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.751 -0.593 . . . . 0.0 110.483 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.831 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.707 HG22 ' ND1' ' A' ' 121' ' ' HIS . 76.1 t -109.52 109.74 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -1.143 . . . . 0.0 110.243 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.55 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 54.7 m-85 -74.58 155.95 37.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.231 -0.918 . . . . 0.0 110.414 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.889 HG23 ' CE1' ' A' ' 119' ' ' HIS . 89.4 m -140.89 89.08 2.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.078 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CG ' ' CG2' ' A' ' 133' ' ' VAL . 80.1 m-85 -109.73 127.58 54.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.809 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.2 pt-20 -128.35 152.36 48.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.204 -0.935 . . . . 0.0 110.527 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 p -128.35 142.27 51.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -0.823 . . . . 0.0 109.794 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -121.39 138.51 54.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.979 . . . . 0.0 110.647 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.663 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 4.3 p90 -157.21 -173.03 4.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.586 -0.696 . . . . 0.0 109.753 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 113' ' ' ILE . 18.0 p -140.15 -177.1 4.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 110.647 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.512 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 2.9 t -159.59 160.0 33.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.436 -0.79 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -88.11 5.15 42.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 110.224 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.785 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.7 mm -108.46 149.65 39.62 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.006 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.785 ' HD2' HG23 ' A' ' 13' ' ' ILE . 38.9 Cg_endo -64.44 144.54 85.68 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.886 1.466 . . . . 0.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.655 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 Cg_endo -72.63 -31.24 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.015 1.534 . . . . 0.0 112.918 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.3 Cg_endo -69.39 -23.4 32.53 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 110.19 -0.735 . . . . 0.0 110.19 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.535 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 5.2 mmp_? -83.93 -44.15 14.53 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.92 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -69.78 -31.88 70.05 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 77.0 t80 -63.83 -56.91 11.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.496 -0.753 . . . . 0.0 109.426 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 51.4 mttt -52.63 -33.86 48.64 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.904 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.065 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -72.96 -60.91 2.01 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.637 0.732 . . . . 0.0 110.718 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.038 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -51.96 -51.67 55.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.723 -0.611 . . . . 0.0 111.799 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.089 HG11 ' CD1' ' A' ' 74' ' ' ILE . 12.0 t -96.85 -61.71 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.012 -1.055 . . . . 0.0 112.334 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.617 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.9 mp -67.97 -1.09 5.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.057 -1.027 . . . . 0.0 111.872 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.98 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -147.69 15.22 1.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.664 -1.273 . . . . 0.0 110.845 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.038 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -54.05 -48.69 70.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 109.956 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 41' ' ' SER . 49.2 t0 -53.67 -20.34 5.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.955 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 69.5 m-80 -124.45 11.83 8.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.98 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -97.4 -46.02 6.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.0 110.26 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.989 HG21 HD13 ' A' ' 38' ' ' ILE . 6.0 p -75.59 -27.67 0.7 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.902 . . . . 0.0 112.032 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.82 ' HD3' HG12 ' A' ' 30' ' ' VAL . 50.7 Cg_endo -79.84 6.88 4.92 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 122.696 0.84 . . . . 0.0 110.297 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -130.94 -30.27 1.81 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.209 -0.932 . . . . 0.0 110.244 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.619 HD11 ' CD1' ' A' ' 29' ' ' LEU . 16.1 mt -74.67 -39.86 46.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.38 -0.825 . . . . 0.0 109.849 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -173.11 102.65 0.32 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.387 -0.821 . . . . 0.0 110.362 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.42 2.49 6.24 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.968 1.509 . . . . 0.0 110.56 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -85.03 -19.74 31.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.11 -0.994 . . . . 0.0 109.769 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.87 -44.94 8.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.416 -0.802 . . . . 0.0 110.048 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.989 HD13 HG21 ' A' ' 30' ' ' VAL . 1.2 mp -125.66 143.63 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 0.0 109.977 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 33.3 ttmt -79.63 -39.18 32.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.274 -0.891 . . . . 0.0 110.383 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.568 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER 178.73 139.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.917 . . . . 0.0 110.527 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 29.5 m -97.81 135.27 39.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 0.0 109.893 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.568 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 50.1 tt0 -143.77 110.26 5.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 110.397 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.9 mt -61.43 132.8 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.066 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 44' ' ' LEU . 19.5 mt -92.88 -43.92 8.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.332 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.91 ' O ' HG23 ' A' ' 52' ' ' THR . 6.0 mm-40 -135.44 131.6 36.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 110.145 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.08 -172.0 37.85 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -116.83 -3.6 11.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -1.162 . . . . 0.0 110.23 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.471 ' N ' HG21 ' A' ' 52' ' ' THR . . . 134.82 -4.71 4.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.531 ' C ' HG21 ' A' ' 71' ' ' ILE . . . -79.73 -167.23 34.43 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.06 131.83 21.61 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.047 1.551 . . . . 0.0 110.603 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.46 -8.85 66.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.91 HG23 ' O ' ' A' ' 45' ' ' GLU . 21.9 m -79.94 145.04 32.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -1.13 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.625 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.6 mm -111.71 117.16 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.64 ' HE2' HD11 ' A' ' 71' ' ' ILE . 44.9 mtmt -101.3 144.99 29.45 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.318 -0.864 . . . . 0.0 110.397 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -117.39 101.56 8.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.177 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.54 ' CG2' HG12 ' A' ' 38' ' ' ILE . 80.6 mt -91.32 138.23 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.123 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 38' ' ' ILE . 1.3 p -112.09 151.64 29.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.468 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' GLY . 32.9 m-85 -111.04 136.23 50.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.873 . . . . 0.0 110.241 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.23 23.56 34.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -118.13 127.38 53.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -1.165 . . . . 0.0 110.15 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.25 143.17 9.63 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.3 t -65.71 -38.12 88.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -1.178 . . . . 0.0 110.252 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -82.09 163.01 22.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 110.206 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.523 ' OH ' HG21 ' A' ' 57' ' ' THR . 3.3 t80 -69.33 128.18 35.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.963 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -122.51 96.19 0.56 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.486 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 26.5 p90 -133.05 166.75 21.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -1.232 . . . . 0.0 110.103 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.841 HG12 ' HA2' ' A' ' 88' ' ' GLY . 9.7 m -141.06 170.79 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 0.0 110.675 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' NZ ' ' OE1' ' A' ' 87' ' ' GLU . 98.4 mttt -123.17 121.13 35.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.607 -0.683 . . . . 0.0 109.585 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.504 ' CD2' HD12 ' A' ' 85' ' ' LEU . 15.7 m170 -111.57 125.9 54.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 110.981 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.625 ' HA ' HD13 ' A' ' 53' ' ' ILE . 80.0 tttt -99.68 116.97 33.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 109.279 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.64 HD11 ' HE2' ' A' ' 54' ' ' LYS . 39.8 mm -51.96 137.62 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 110.391 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.537 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 30.5 t0 -109.06 -49.15 3.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 109.85 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 3.1 m -176.72 159.47 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.522 -0.736 . . . . 0.0 110.14 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.089 ' CD1' HG11 ' A' ' 23' ' ' VAL . 6.3 tt -151.16 168.37 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 110.154 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -138.03 84.48 2.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 110.232 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.607 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 94.3 mttt -58.04 -12.17 3.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.429 -0.794 . . . . 0.0 111.008 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -89.81 -31.39 17.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.112 -0.993 . . . . 0.0 109.571 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -114.21 -2.16 13.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 109.667 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.823 ' O ' HD12 ' A' ' 104' ' ' LEU . 6.6 m-85 67.97 47.59 1.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.754 -0.591 . . . . 0.0 110.573 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.544 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -111.18 158.1 19.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 108.805 178.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.528 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 83.4 t80 -159.78 150.86 19.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.956 -1.09 . . . . 0.0 110.669 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.425 ' HB2' ' HA ' ' A' ' 101' ' ' GLU . 12.3 t -159.65 152.43 21.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 7.4 p90 -150.14 176.83 10.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.476 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 98' ' ' ILE . 91.4 m -124.1 126.08 45.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.797 . . . . 0.0 109.683 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.639 HD23 HG13 ' A' ' 98' ' ' ILE . 2.9 tp -93.52 134.48 35.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.945 . . . . 0.0 110.029 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.08 -10.57 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.153 -0.967 . . . . 0.0 110.465 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.578 ' C ' HD12 ' A' ' 91' ' ' LEU . 23.2 tt0 -140.74 149.09 41.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.424 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.841 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 162.47 149.9 5.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -65.1 -35.07 79.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -1.157 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.408 ' HB1' ' HE2' ' A' ' 132' ' ' HIS . . . -67.61 -21.11 65.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.254 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.81 HD21 ' CG1' ' A' ' 98' ' ' ILE . 41.0 mt -71.3 -32.06 68.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.47 -171.2 0.02 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -84.11 5.1 27.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -1.15 . . . . 0.0 110.006 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.6 p -92.34 -43.24 9.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.097 HD21 HD11 ' A' ' 128' ' ' ILE . 78.1 mt -94.58 164.51 12.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 110.073 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 36.3 tp10 -144.84 -80.71 0.17 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.243 -0.911 . . . . 0.0 110.21 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 58.8 mttt -80.31 128.88 34.06 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.633 -0.667 . . . . 0.0 110.486 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.81 ' CG1' HD21 ' A' ' 91' ' ' LEU . 7.5 mm -122.51 143.55 34.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.944 -1.097 . . . . 0.0 110.072 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.91 131.26 53.93 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.453 -0.779 . . . . 0.0 109.044 178.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.724 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.9 m-85 -127.08 133.37 50.46 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 110.47 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.425 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 75.3 tt0 -131.59 154.26 49.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.885 . . . . 0.0 110.213 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 81' ' ' TYR . 81.6 m -155.0 123.56 6.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.988 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 12.4 tttt -119.38 150.33 40.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 110.311 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 79' ' ' TYR . 13.0 mt -124.82 150.35 46.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 110.651 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.37 -169.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.397 -0.815 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.64 167.85 12.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.868 . . . . 0.0 110.238 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 60.2 p -126.42 162.52 46.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.117 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.5 Cg_endo -71.98 -2.48 11.59 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.971 1.511 . . . . 0.0 110.486 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -101.6 -2.61 30.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.264 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.84 -35.95 4.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.12 -172.56 2.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 15.6 p -128.71 136.21 50.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -1.213 . . . . 0.0 110.435 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.59 ' HA ' HG22 ' A' ' 10' ' ' THR . 62.4 mt -84.93 149.32 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 110.009 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.663 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 9.8 mt -134.33 121.11 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.318 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -110.84 134.61 52.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.91 . . . . 0.0 110.093 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.5 t -125.26 158.4 34.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.89 . . . . 0.0 110.319 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 84.8 m -159.92 126.59 4.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.88 . . . . 0.0 110.322 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.457 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 18.8 t -126.5 155.84 41.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.288 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.889 ' CE1' HG23 ' A' ' 4' ' ' THR . 80.6 m-70 -130.73 164.5 24.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.306 -0.871 . . . . 0.0 109.965 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.612 ' HD1' HD12 ' A' ' 98' ' ' ILE . 18.6 m-85 -133.67 134.49 43.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 111.037 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.707 ' ND1' HG22 ' A' ' 2' ' ' VAL . 85.4 m-70 -121.07 90.2 3.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.945 . . . . 0.0 108.848 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.877 ' HB ' HD23 ' A' ' 95' ' ' LEU . 2.2 t -91.59 -179.46 5.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 111.748 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -133.97 171.89 13.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.902 -0.498 . . . . 0.0 109.703 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 125' ' ' ASN . . . 76.45 2.48 74.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 16.6 t30 68.68 60.41 0.37 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.268 -1.137 . . . . 0.0 110.728 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.532 HG22 ' OG1' ' A' ' 122' ' ' THR . 6.6 m -126.01 162.08 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.668 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -118.64 145.91 45.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.02 . . . . 0.0 110.725 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.097 HD11 HD21 ' A' ' 95' ' ' LEU . 24.1 mm -55.77 173.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.388 -0.82 . . . . 0.0 110.083 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 128' ' ' ILE . 29.5 mtpt -110.15 131.69 54.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.042 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.53 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 60.6 mt-10 -43.26 -42.37 4.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 110.103 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 48.8 tt0 -60.83 -26.33 67.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 109.923 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.0 t-160 -85.97 -53.05 5.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 110.081 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.606 ' CG2' ' CG ' ' A' ' 5' ' ' TYR . 3.9 p -69.07 -30.78 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 110.126 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 64.6 tttp -79.3 -53.94 6.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 109.801 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -61.52 -25.74 67.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.95 -36.52 81.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.477 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 96.5 mttt -65.57 -33.96 77.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -1.119 . . . . 0.0 109.866 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.415 ' HG2' ' ND2' ' A' ' 142' ' ' ASN . 79.8 tt0 -81.53 -32.1 32.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.0 109.88 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -67.77 -44.67 76.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.374 -0.829 . . . . 0.0 109.873 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -71.2 -38.4 72.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 110.004 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.1 m -62.81 -49.35 75.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.395 -0.816 . . . . 0.0 109.993 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.415 ' ND2' ' HG2' ' A' ' 138' ' ' GLU . 80.3 m-20 -56.29 -43.13 78.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.982 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.47 ' O ' HG13 ' A' ' 147' ' ' ILE . 23.4 mt -60.74 -40.69 93.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.91 . . . . 0.0 109.944 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 19.1 m-85 -60.61 -39.88 89.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.439 -0.788 . . . . 0.0 109.86 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -67.91 -17.94 64.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 110.037 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 146' ' ' LEU . 16.0 mt -84.14 -34.9 23.96 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.19 -0.944 . . . . 0.0 108.965 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.714 HG22 HD23 ' A' ' 18' ' ' LEU . 55.2 mt -71.75 -41.64 70.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.548 -0.72 . . . . 0.0 109.06 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.663 ' OE2' HD11 ' A' ' 114' ' ' ILE . 14.9 mm-40 -59.97 -39.68 86.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.289 -0.882 . . . . 0.0 109.205 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 97.7 m -67.09 -35.99 81.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 109.185 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.648 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 72.3 t80 -53.15 -53.46 50.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.48 -0.763 . . . . 0.0 109.625 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.188 HD21 ' CE2' ' A' ' 158' ' ' TYR . 98.3 mt -76.08 -27.03 57.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.296 -0.877 . . . . 0.0 109.984 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.525 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 29.8 ttpt -75.88 -19.67 58.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -113.45 -30.73 2.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.475 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 15.3 m-70 -106.89 93.28 8.67 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.199 -1.177 . . . . 0.0 110.224 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.5 Cg_endo -74.22 4.77 4.05 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.086 1.572 . . . . 0.0 110.876 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -108.15 3.68 24.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 109.827 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.648 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -86.87 103.34 15.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.381 -0.824 . . . . 0.0 110.196 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.188 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.65 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.686 -0.634 . . . . 0.0 110.511 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.714 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.534 HG22 ' ND1' ' A' ' 121' ' ' HIS . 54.8 t -106.59 128.63 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -1.14 . . . . 0.0 110.306 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.717 ' CG ' HD13 ' A' ' 128' ' ' ILE . 9.0 m-85 -90.86 143.5 26.66 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.267 -0.896 . . . . 0.0 109.654 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.711 HG23 ' CE1' ' A' ' 119' ' ' HIS . 4.8 m -126.23 116.82 21.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.984 -1.073 . . . . 0.0 110.403 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 57.5 m-85 -131.76 137.25 48.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 109.915 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -136.08 149.75 48.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 110.565 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.4 p -139.69 149.98 44.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.78 . . . . 0.0 109.451 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.45 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 2.8 tt0 -133.79 138.33 45.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.968 -1.083 . . . . 0.0 110.854 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.608 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 3.6 p90 -154.34 -174.7 5.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.429 -0.794 . . . . 0.0 109.597 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 113' ' ' ILE . 14.0 p -136.88 178.35 7.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 110.687 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.412 ' OG ' HD11 ' A' ' 114' ' ' ILE . 83.0 p -157.36 153.1 26.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 110.24 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -79.34 -15.45 57.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.912 . . . . 0.0 110.267 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.843 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.9 mp -87.57 151.25 50.23 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 109.937 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.843 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.8 143.47 73.82 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.057 1.556 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.642 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.88 -31.14 10.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 124.065 1.561 . . . . 0.0 112.972 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.6 Cg_endo -70.52 -21.79 29.48 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 N-CA-C 110.103 -0.768 . . . . 0.0 110.103 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.495 ' NE ' ' HA ' ' A' ' 159' ' ' ASN . 9.1 mmp_? -83.44 -47.12 11.72 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -66.51 -27.87 68.11 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 81.6 t80 -65.65 -60.36 2.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.715 -0.616 . . . . 0.0 109.604 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 52.3 mttt -52.03 -32.97 36.56 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.4 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.023 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.13 -56.02 5.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.399 -0.813 . . . . 0.0 110.661 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.048 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -58.62 -49.15 78.55 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.542 -0.724 . . . . 0.0 111.384 -178.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.13 HG11 ' CD1' ' A' ' 74' ' ' ILE . 16.8 t -93.49 -65.25 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.973 -1.079 . . . . 0.0 111.717 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.9 mp -67.55 -1.07 4.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.287 -0.883 . . . . 0.0 111.819 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.792 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -149.04 25.24 0.92 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.795 -1.19 . . . . 0.0 110.729 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.048 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -63.79 -38.12 89.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.119 -0.988 . . . . 0.0 109.989 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.498 ' OD2' HD11 ' A' ' 43' ' ' ILE . 54.7 m-20 -65.02 -14.92 61.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 110.253 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.457 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 72.8 m-80 -125.15 7.72 7.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 110.058 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.829 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -95.43 -57.03 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 110.103 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.975 HG11 HD13 ' A' ' 38' ' ' ILE . 96.1 t -62.69 -40.51 64.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.765 . . . . 0.0 111.153 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -77.4 7.09 3.94 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.371 1.195 . . . . 0.0 110.85 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -127.48 -29.8 2.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.902 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.692 HD11 ' CD1' ' A' ' 29' ' ' LEU . 32.3 mt -80.07 -44.37 22.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.51 -0.744 . . . . 0.0 110.044 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.02 102.14 2.11 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 110.348 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.21 3.63 5.55 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.049 1.552 . . . . 0.0 110.717 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -90.74 -13.84 33.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.141 -0.975 . . . . 0.0 110.208 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.83 -29.05 12.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.198 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.975 HD13 HG11 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -142.07 150.26 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -88.69 -44.79 10.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.326 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.59 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -172.93 156.76 3.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.377 -0.827 . . . . 0.0 110.173 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -119.81 121.99 40.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 109.95 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.59 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 84.6 tt0 -124.31 114.49 19.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.498 HD11 ' OD2' ' A' ' 27' ' ' ASP . 23.4 mt -61.55 132.21 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.944 . . . . 0.0 110.088 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 55' ' ' LYS . 53.4 mt -92.89 -25.54 18.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 1.073 ' O ' HG23 ' A' ' 52' ' ' THR . 41.8 tt0 -156.46 171.31 20.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 58.07 -165.92 6.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -131.55 29.42 4.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -1.112 . . . . 0.0 110.291 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.51 ' H ' HG21 ' A' ' 52' ' ' THR . . . 103.36 2.25 47.57 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.485 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -92.53 -167.33 39.42 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.4 132.86 23.15 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.058 1.557 . . . . 0.0 110.522 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.17 -6.62 68.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 1.073 HG23 ' O ' ' A' ' 45' ' ' GLU . 19.4 m -80.06 147.91 31.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -1.174 . . . . 0.0 110.129 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.606 HD13 ' HA ' ' A' ' 70' ' ' LYS . 21.6 mm -116.53 114.96 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.071 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 35.7 mtmt -99.76 147.47 25.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HB2' HD11 ' A' ' 44' ' ' LEU . 83.6 tttt -116.78 98.62 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.898 . . . . 0.0 110.09 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.531 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.7 mt -88.22 146.42 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.5 p -120.16 155.62 32.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.38 -0.825 . . . . 0.0 110.574 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.692 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.1 m-85 -116.58 145.36 43.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.449 -0.782 . . . . 0.0 110.145 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.99 -8.59 57.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -118.03 148.66 42.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -1.138 . . . . 0.0 110.146 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.57 -157.69 14.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.0 p -57.52 -173.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -1.136 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -51.74 -66.48 0.38 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.205 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.401 ' CD1' ' HD2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -108.37 112.67 25.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.186 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -118.86 94.98 0.6 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 20.8 p90 -134.8 167.97 19.9 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.049 -1.265 . . . . 0.0 110.478 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.821 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.8 m -139.69 172.89 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 110.447 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.512 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 30.3 mtpt -123.9 129.37 50.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.528 -0.732 . . . . 0.0 109.518 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.605 ' CD2' HD12 ' A' ' 85' ' ' LEU . 8.3 m170 -117.19 125.94 51.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.99 -1.069 . . . . 0.0 110.931 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.606 ' HA ' HD13 ' A' ' 53' ' ' ILE . 64.6 tttp -104.94 110.49 22.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 109.3 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 29.2 mm -48.19 140.65 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.187 -0.945 . . . . 0.0 110.406 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 16.0 t0 -112.25 -40.32 4.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.393 -0.817 . . . . 0.0 109.629 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 0.6 OUTLIER 172.19 161.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.0 110.391 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.13 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.6 tt -152.03 165.33 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -131.34 80.73 1.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.601 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.6 mttt -55.78 -14.14 2.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.87 . . . . 0.0 110.827 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -90.18 -29.75 18.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.227 -0.92 . . . . 0.0 109.645 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -114.45 -1.68 13.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.486 -0.758 . . . . 0.0 109.965 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.766 ' O ' HD12 ' A' ' 104' ' ' LEU . 8.3 m-85 67.48 48.04 1.17 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.639 -0.663 . . . . 0.0 110.646 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -115.06 154.2 29.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.208 -0.932 . . . . 0.0 109.095 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.528 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 84.7 t80 -154.98 148.32 25.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.9 -1.125 . . . . 0.0 110.523 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.5 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 17.9 m -156.22 147.16 22.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.366 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 4.9 p90 -144.21 178.3 7.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.409 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 98' ' ' ILE . 71.0 m -124.83 125.19 43.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.535 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.68 HD21 HD11 ' A' ' 91' ' ' LEU . 5.3 tp -90.86 136.11 33.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.178 -0.951 . . . . 0.0 110.401 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.2 pt -123.58 -6.14 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.551 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.512 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 11.2 tt0 -141.37 160.44 40.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 110.429 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.821 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 145.77 123.69 1.58 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.34 -15.41 6.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -1.16 . . . . 0.0 110.402 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -77.1 -29.37 54.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.68 HD11 HD21 ' A' ' 85' ' ' LEU . 28.6 mt -67.46 -39.33 85.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.366 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 178.05 44.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -74.46 -0.01 16.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -1.148 . . . . 0.0 110.162 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.583 ' HB ' HG11 ' A' ' 126' ' ' VAL . 15.4 p -95.2 -40.41 9.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.165 -0.959 . . . . 0.0 110.305 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.891 HD11 HG13 ' A' ' 128' ' ' ILE . 1.8 mm? -79.84 136.98 36.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.165 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 5.7 tp10 -124.98 -83.44 0.64 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.318 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 26.7 mttt -80.16 126.87 31.65 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 110.695 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.69 HG21 ' HE2' ' A' ' 100' ' ' TYR . 5.3 mm -121.14 141.04 43.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 120.614 -1.304 . . . . 0.0 109.235 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.72 134.23 55.05 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.879 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.69 ' HE2' HG21 ' A' ' 98' ' ' ILE . 8.2 m-85 -130.3 132.7 46.0 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.422 -0.799 . . . . 0.0 110.169 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.5 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 5.9 mt-10 -129.71 167.01 18.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.223 -0.923 . . . . 0.0 110.619 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 81' ' ' TYR . 45.6 m -162.9 137.69 6.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.381 -0.824 . . . . 0.0 109.909 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.4 mttt -135.58 137.88 42.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.391 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.768 HD23 HG12 ' A' ' 114' ' ' ILE . 9.8 mt -117.12 149.92 39.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.319 -0.863 . . . . 0.0 110.127 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.79 -169.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -0.936 . . . . 0.0 110.153 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.64 166.85 13.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.268 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 24.8 p -125.02 165.69 24.42 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -73.17 -0.65 9.42 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.995 1.524 . . . . 0.0 110.488 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.6 p -110.42 7.66 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.263 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.38 -38.66 3.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.03 -172.72 0.14 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 16.8 p -133.63 135.26 44.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.171 -1.194 . . . . 0.0 110.385 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.623 ' HA ' HG22 ' A' ' 10' ' ' THR . 41.8 mt -86.44 152.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.056 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.768 HG12 HD23 ' A' ' 104' ' ' LEU . 5.3 mt -136.42 115.17 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.933 . . . . 0.0 110.614 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 44.4 tttp -101.06 127.28 47.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -0.842 . . . . 0.0 109.745 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.05 157.91 25.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.748 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.444 HG22 ' NE2' ' A' ' 119' ' ' HIS . 98.7 m -160.08 144.33 14.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.394 -0.816 . . . . 0.0 110.067 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.493 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -146.65 168.64 20.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.161 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.711 ' CE1' HG23 ' A' ' 4' ' ' THR . 48.4 m-70 -148.87 174.56 12.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.166 -0.959 . . . . 0.0 110.552 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.583 ' CD2' HG12 ' A' ' 128' ' ' ILE . 87.9 m-85 -138.09 156.91 47.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.217 -0.927 . . . . 0.0 110.958 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.534 ' ND1' HG22 ' A' ' 2' ' ' VAL . 76.4 m-70 -140.84 81.49 1.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.406 -0.809 . . . . 0.0 109.251 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.458 ' HB ' ' HB ' ' A' ' 126' ' ' VAL . 0.1 OUTLIER -63.08 142.36 58.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.334 -0.854 . . . . 0.0 110.648 -179.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -69.19 110.4 4.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.896 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.63 -116.36 5.45 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.516 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 2.6 p-10 -137.13 49.3 2.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -1.172 . . . . 0.0 110.244 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 127' ' ' GLU . 66.7 t -96.42 174.96 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.416 -0.803 . . . . 0.0 109.952 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.597 ' N ' HG12 ' A' ' 126' ' ' VAL . 96.0 mt-10 -126.22 161.2 28.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.891 HG13 HD11 ' A' ' 95' ' ' LEU . 4.5 mp -88.38 172.94 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.867 . . . . 0.0 110.095 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.615 ' N ' HG22 ' A' ' 128' ' ' ILE . 67.0 mmtt -90.83 151.96 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.332 -0.855 . . . . 0.0 109.958 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 61.7 mm-40 -58.16 -22.0 49.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.136 -0.978 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.836 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 98.2 mt-10 -68.03 -39.57 83.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.91 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 5.3 m170 -66.04 -47.55 74.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.162 -0.961 . . . . 0.0 110.02 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.589 HG23 ' CD1' ' A' ' 5' ' ' TYR . 2.5 p -76.47 -25.87 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.449 -0.782 . . . . 0.0 110.093 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 73.6 tttt -104.31 -65.37 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.958 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.836 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.68 -24.21 47.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.868 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.51 -28.58 67.33 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.11 -33.1 56.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -1.127 . . . . 0.0 110.017 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -81.39 -31.26 33.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.85 . . . . 0.0 109.813 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.617 ' HE3' ' HB1' ' A' ' 135' ' ' ALA . 85.8 mttt -73.42 -36.72 66.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 109.828 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.23 -35.94 61.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.852 . . . . 0.0 109.89 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.1 m -64.04 -45.46 88.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.386 -0.821 . . . . 0.0 109.973 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -56.41 -50.67 70.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 109.993 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.403 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.9 mm? -60.51 -33.98 73.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.949 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -65.16 -37.49 87.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.414 -0.803 . . . . 0.0 109.833 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 29.3 ttmt -79.63 -15.45 57.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.441 -0.787 . . . . 0.0 110.042 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.512 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 13.8 mt -83.23 -37.02 24.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.081 -1.012 . . . . 0.0 108.933 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.708 HD13 ' CD1' ' A' ' 22' ' ' PHE . 86.6 mt -70.72 -44.36 76.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.726 ' HB3' HD13 ' A' ' 13' ' ' ILE . 62.6 mt-10 -55.88 -40.01 72.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.327 -0.858 . . . . 0.0 109.202 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.436 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 18.6 m -71.25 -31.63 67.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.556 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.607 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 79.0 t80 -56.08 -49.94 72.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.474 -0.766 . . . . 0.0 109.775 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.171 HD21 ' CE2' ' A' ' 158' ' ' TYR . 59.3 mt -77.72 -29.02 51.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.997 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.679 ' HB2' HD11 ' A' ' 13' ' ' ILE . 52.4 tptt -66.98 -26.78 66.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.464 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -107.28 -28.41 4.92 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.556 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.7 m-70 -106.9 91.18 6.0 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.219 -1.165 . . . . 0.0 110.05 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.7 Cg_endo -73.29 4.58 3.74 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.062 1.559 . . . . 0.0 111.104 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -111.14 -7.72 14.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.019 -1.051 . . . . 0.0 109.97 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.646 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -70.49 101.33 1.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 110.109 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.171 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.8 OUTLIER 34.79 31.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.712 -0.618 . . . . 0.0 110.635 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.715 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 93.9 t -136.07 134.11 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -1.166 . . . . 0.0 110.363 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 128' ' ' ILE . 11.2 m-85 -101.18 131.9 46.94 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.66 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.78 126.41 47.34 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.858 -1.151 . . . . 0.0 110.687 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.824 ' CE1' HG11 ' A' ' 133' ' ' VAL . 50.4 m-85 -133.58 125.59 29.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -0.806 . . . . 0.0 109.907 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.791 ' CG ' HG23 ' A' ' 117' ' ' THR . 3.8 mt-10 -136.49 145.61 45.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.398 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 m -132.03 158.82 40.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.805 . . . . 0.0 110.015 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.456 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 98.9 mt-10 -143.72 123.67 13.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 110.443 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 p90 -147.47 -173.64 4.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.616 HG22 HG12 ' A' ' 113' ' ' ILE . 12.5 p -138.34 -179.4 5.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.578 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.3 p -157.1 164.15 38.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.41 -0.806 . . . . 0.0 110.206 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -86.1 -21.74 27.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.2 mm -84.91 150.26 55.27 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.146 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 42.2 Cg_endo -66.1 150.4 85.21 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.158 1.61 . . . . 0.0 110.14 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.674 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.5 Cg_endo -70.15 -32.93 16.05 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.912 1.48 . . . . 0.0 113.304 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.5 Cg_endo -66.92 -23.23 47.49 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 122.381 0.674 . . . . 0.0 110.408 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.528 ' HG3' ' HG2' ' A' ' 14' ' ' PRO . 10.7 mmp_? -84.5 -45.66 12.41 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.765 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -72.28 -25.4 61.58 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.564 -0.71 . . . . 0.0 109.241 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.619 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 85.2 t80 -70.74 -57.98 4.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.402 -0.811 . . . . 0.0 109.059 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 67.5 mttt -51.23 -35.99 39.62 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.33 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.045 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.48 -53.81 8.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 111.021 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.738 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -59.54 -46.23 89.47 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 111.706 -178.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.771 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -98.18 -61.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.947 -1.096 . . . . 0.0 111.57 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.5 mp -70.18 0.31 6.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.149 -0.969 . . . . 0.0 111.55 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.683 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -154.55 46.92 0.57 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.79 -1.194 . . . . 0.0 110.856 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -84.64 -25.22 28.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -0.999 . . . . 0.0 110.062 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 60.6 t0 -73.76 -11.66 60.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 109.907 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 71.6 m-20 -128.6 10.46 6.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.37 -0.831 . . . . 0.0 109.652 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.794 HD11 ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -97.9 -57.75 2.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.445 -0.784 . . . . 0.0 110.45 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.876 HG22 ' HD3' ' A' ' 31' ' ' PRO . 1.9 m -74.86 -29.1 0.87 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 112.101 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.876 ' HD3' HG22 ' A' ' 30' ' ' VAL . 51.0 Cg_endo -80.5 -1.51 11.35 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 O-C-N 122.878 0.936 . . . . 0.0 110.374 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -126.43 -32.09 2.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 109.756 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.634 ' CD1' HD13 ' A' ' 29' ' ' LEU . 11.9 mt -80.06 -34.17 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.489 -0.757 . . . . 0.0 109.393 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -160.38 99.06 1.4 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.586 -0.696 . . . . 0.0 109.896 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 43.2 Cg_endo -69.33 -4.33 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.984 1.518 . . . . 0.0 110.427 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -87.17 1.88 51.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.865 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.997 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -107.04 -47.6 3.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 109.997 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.997 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.9 mp -133.88 142.06 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 0.0 110.071 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -82.94 -36.57 25.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.576 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -175.42 132.69 0.29 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.375 -0.828 . . . . 0.0 109.946 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.491 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 2.3 m -100.26 131.24 46.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 77.5 tt0 -138.69 110.83 7.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 110.293 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 14.7 mt -64.11 134.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 110.203 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 55' ' ' LYS . 9.7 mp -97.89 -44.46 6.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.944 ' O ' HG23 ' A' ' 52' ' ' THR . 3.5 mt-10 -128.77 145.37 51.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.237 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.24 -162.46 53.57 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -139.52 23.02 2.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -1.123 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.541 ' H ' HG21 ' A' ' 52' ' ' THR . . . 119.15 -11.67 11.55 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -80.83 -168.0 38.48 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.9 Cg_endo -70.89 139.68 36.85 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.09 1.574 . . . . 0.0 110.377 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.05 -3.34 85.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.944 HG23 ' O ' ' A' ' 45' ' ' GLU . 31.9 m -80.09 139.0 37.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -1.198 . . . . 0.0 110.05 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.622 HD13 ' HA ' ' A' ' 70' ' ' LYS . 25.7 mm -109.87 109.59 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 110.295 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 88.1 mttt -99.04 138.4 36.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.323 -0.861 . . . . 0.0 110.217 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.496 ' HB2' HD13 ' A' ' 44' ' ' LEU . 83.2 tttt -109.41 97.28 6.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.202 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.44 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 91.1 mt -84.15 141.88 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 0.0 110.177 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.3 p -116.08 155.22 28.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.147 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 23.5 m-85 -111.8 166.63 11.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.863 . . . . 0.0 110.358 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.08 155.6 0.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -78.39 175.94 9.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -1.16 . . . . 0.0 110.215 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.42 -159.26 32.37 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.445 ' C ' ' HG3' ' A' ' 63' ' ' GLN . 97.3 p -49.47 -35.74 20.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -1.168 . . . . 0.0 110.099 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.445 ' HG3' ' C ' ' A' ' 62' ' ' SER . 62.7 mt-30 -141.15 149.22 41.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.848 . . . . 0.0 110.116 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.4 ' HE1' HG22 ' A' ' 57' ' ' THR . 1.8 t80 -60.17 148.23 36.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.23 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.14 88.29 0.28 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.5 p90 -126.84 164.36 21.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -1.168 . . . . 0.0 110.147 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.852 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.6 m -139.31 173.82 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 110.575 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.504 ' HE3' HG21 ' A' ' 53' ' ' ILE . 48.9 tttt -123.0 128.24 49.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.589 -0.694 . . . . 0.0 109.591 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.47 ' NE2' HD13 ' A' ' 85' ' ' LEU . 9.2 m170 -119.7 119.31 33.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 0.0 110.851 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.622 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.4 tttt -100.64 110.87 23.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.577 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.53 HG23 HD11 ' A' ' 74' ' ' ILE . 33.2 mm -46.33 142.79 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.475 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 12.9 t0 -114.64 -41.29 3.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.471 -0.768 . . . . 0.0 109.552 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.578 ' C ' HD12 ' A' ' 74' ' ' ILE . 67.5 p -174.48 157.91 2.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.82 . . . . 0.0 109.457 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.578 HD12 ' C ' ' A' ' 73' ' ' SER . 1.0 OUTLIER -138.99 151.02 23.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.084 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 6.5 m-20 -127.75 75.99 1.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.388 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 99.5 mttt -62.55 -12.85 25.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.101 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -97.98 -30.37 12.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 109.205 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -105.29 -3.08 23.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.653 -0.654 . . . . 0.0 109.715 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.619 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 83.1 m-85 61.26 53.35 3.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.49 -0.756 . . . . 0.0 110.083 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.541 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -125.82 152.67 45.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.568 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.771 ' CE1' HG13 ' A' ' 23' ' ' VAL . 25.8 t80 -138.78 134.5 33.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 110.391 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.457 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -141.54 123.13 15.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 110.555 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 8.8 p90 -135.0 175.89 9.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 110.134 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.6 m -124.41 127.82 48.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.779 HD23 HG13 ' A' ' 98' ' ' ILE . 3.3 tp -97.49 135.81 38.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 0.0 109.906 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.499 HG12 ' HB3' ' A' ' 68' ' ' LYS . 6.7 pt -128.53 -5.42 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 110.409 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' O ' HD11 ' A' ' 85' ' ' LEU . 23.0 tt0 -137.05 139.04 41.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.393 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.852 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 166.49 122.47 0.61 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -51.06 -21.31 1.78 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -1.105 . . . . 0.0 110.23 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -72.79 -27.09 61.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.169 -0.957 . . . . 0.0 110.069 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.667 HD21 HG13 ' A' ' 98' ' ' ILE . 64.7 mt -66.28 -27.84 68.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.177 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.03 -169.67 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -84.62 4.6 31.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -1.147 . . . . 0.0 110.11 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.516 ' O ' HG21 ' A' ' 126' ' ' VAL . 46.8 p -90.41 -30.06 17.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.063 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.052 HD21 ' CG1' ' A' ' 128' ' ' ILE . 44.8 mt -116.99 166.27 12.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.392 -0.818 . . . . 0.0 110.008 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 49.0 tt0 -143.23 -79.57 0.21 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.306 -0.871 . . . . 0.0 110.018 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 51.9 mttt -80.16 139.74 36.67 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.57 -0.706 . . . . 0.0 110.531 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.779 HG13 HD23 ' A' ' 85' ' ' LEU . 7.3 mm -128.24 140.91 47.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 120.861 -1.149 . . . . 0.0 109.722 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.6 m -118.35 125.88 50.94 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.462 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.754 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.3 m-85 -122.77 135.89 54.7 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 37.2 tt0 -141.86 138.45 32.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.844 . . . . 0.0 110.149 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 81' ' ' TYR . 88.8 m -135.76 157.65 46.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 110.059 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 0.3 OUTLIER -149.31 144.16 26.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.266 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.665 HD23 HG12 ' A' ' 114' ' ' ILE . 5.7 mt -121.33 149.19 43.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 110.776 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.82 -169.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 109.711 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -118.68 165.43 13.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.309 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 96.3 p -123.95 162.51 40.79 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.248 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.8 Cg_endo -72.03 -2.93 12.31 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.019 1.536 . . . . 0.0 110.422 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.7 p -102.12 -0.36 33.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.3 -35.42 5.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.59 -173.04 3.23 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 73.3 p -128.35 133.71 48.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -1.161 . . . . 0.0 110.337 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 10' ' ' THR . 71.9 mt -81.66 149.64 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 110.183 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.665 HG12 HD23 ' A' ' 104' ' ' LEU . 8.7 mt -132.98 107.56 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.268 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.2 tttt -95.32 132.63 40.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.882 . . . . 0.0 110.069 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.3 OUTLIER -126.2 151.62 47.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 110.259 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.791 HG23 ' CG ' ' A' ' 6' ' ' GLU . 99.2 m -150.06 137.2 19.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -0.892 . . . . 0.0 110.367 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.486 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 5.4 p -142.8 146.08 33.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 109.938 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.558 ' CE1' HG22 ' A' ' 117' ' ' THR . 41.6 m-70 -131.33 163.44 27.83 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 110.62 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 9.3 m-85 -122.91 150.29 43.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.579 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 93.8 m-70 -128.98 93.72 3.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 109.472 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.538 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.7 p -71.3 157.63 37.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 110.693 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.485 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 47.6 tptt -140.45 106.1 5.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.311 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 118.81 29.27 1.88 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.83 65.76 0.99 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -1.145 . . . . 0.0 110.214 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 94' ' ' THR . 26.9 m -141.67 162.15 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.176 -0.953 . . . . 0.0 110.099 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -130.6 168.51 16.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.27 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.052 ' CG1' HD21 ' A' ' 95' ' ' LEU . 4.7 mp -94.92 173.07 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.25 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.615 ' N ' HG22 ' A' ' 128' ' ' ILE . 34.5 mttt -110.38 129.92 55.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.387 -0.821 . . . . 0.0 109.658 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 130' ' ' GLU . 57.3 mm-40 -42.51 -39.32 2.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 110.267 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -60.95 -28.08 68.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.948 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.7 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 15.8 t-160 -78.01 -54.83 5.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 110.057 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.824 HG11 ' CE1' ' A' ' 5' ' ' TYR . 99.4 t -61.13 -38.32 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.847 . . . . 0.0 110.015 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.44 -39.46 88.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.062 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.35 83.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.991 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.79 -30.47 68.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.494 ' HE3' HG12 ' A' ' 133' ' ' VAL . 97.2 mttt -69.88 -31.41 69.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -1.123 . . . . 0.0 110.112 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.509 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 97.8 mt-10 -75.75 -39.33 57.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 110.05 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -62.45 -43.31 99.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -73.24 -34.52 65.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.018 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.0 m -71.51 -54.32 10.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.402 -0.811 . . . . 0.0 109.913 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 73.1 m-20 -51.53 -46.23 63.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.903 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 21.8 tp -57.74 -46.05 85.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 0.0 109.815 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 6.9 m-85 -53.89 -36.88 63.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.729 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 76.7 tttt -79.98 -13.14 59.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.47 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 20.9 mt -87.47 -36.57 17.6 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.211 -0.931 . . . . 0.0 108.927 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.704 HD13 ' CD1' ' A' ' 22' ' ' PHE . 45.3 mt -73.2 -41.67 58.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.518 ' O ' HG13 ' A' ' 13' ' ' ILE . 19.9 pt-20 -58.55 -31.98 68.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.344 -0.847 . . . . 0.0 109.243 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.463 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 31.8 m -80.0 -34.59 38.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.36 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.674 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 87.1 t80 -58.51 -53.88 53.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.501 -0.75 . . . . 0.0 109.883 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.167 HD21 ' CE2' ' A' ' 158' ' ' TYR . 76.5 mt -70.58 -31.35 68.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.268 -0.895 . . . . 0.0 110.047 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.4 tptt -70.08 -18.92 63.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.492 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.417 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.79 -31.65 2.88 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.592 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.0 m-70 -108.16 93.89 12.04 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.345 -1.091 . . . . 0.0 109.904 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.478 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.6 Cg_endo -74.01 5.81 3.3 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.077 1.567 . . . . 0.0 111.06 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -111.58 -9.07 14.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.056 -1.028 . . . . 0.0 109.683 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.69 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -64.81 102.33 0.58 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 110.03 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.167 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.8 OUTLIER 34.68 33.55 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.716 -0.615 . . . . 0.0 110.351 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.85 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 120' ' ' TYR . 74.4 t -122.53 142.37 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -1.159 . . . . 0.0 110.29 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.768 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.7 m-85 -91.72 152.36 20.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.891 . . . . 0.0 110.124 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.81 HG23 ' CE1' ' A' ' 119' ' ' HIS . 17.6 m -132.48 106.87 8.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 0.0 110.364 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.971 ' CE2' HG21 ' A' ' 133' ' ' VAL . 71.3 m-85 -121.54 143.04 49.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.312 -0.867 . . . . 0.0 109.98 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.65 152.17 42.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.099 -1.001 . . . . 0.0 110.381 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.8 t -132.38 162.54 30.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 110.048 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -145.31 117.32 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.41 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.4 p90 -144.78 -171.48 3.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.879 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.666 HG22 HG12 ' A' ' 113' ' ' ILE . 19.2 p -138.6 -179.61 5.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 0.0 110.621 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB2' ' CD1' ' A' ' 114' ' ' ILE . 3.0 t -154.19 168.99 24.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.805 . . . . 0.0 110.22 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -92.58 -28.06 16.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.765 HG23 ' HD2' ' A' ' 14' ' ' PRO . 12.3 mm -82.96 148.02 55.88 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.057 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.765 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.4 Cg_endo -64.71 152.47 81.84 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.016 1.535 . . . . 0.0 110.821 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.674 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.4 Cg_endo -63.18 -36.25 58.91 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.917 1.483 . . . . 0.0 112.928 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -63.81 -20.29 68.29 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 N-CA-C 109.862 -0.861 . . . . 0.0 109.862 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.925 ' HB3' HD13 ' A' ' 151' ' ' LEU . 9.8 mmp_? -81.1 -46.03 15.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.763 ' CD1' HG22 ' A' ' 147' ' ' ILE . 4.1 mm? -74.03 -37.08 64.45 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.545 -0.862 . . . . 0.0 108.751 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 37.8 t80 -57.87 -56.69 18.65 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.158 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 89.0 mttt -58.2 -36.45 73.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.708 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.08 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.09 -63.64 1.37 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.435 -0.791 . . . . 0.0 110.738 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.923 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -51.95 -34.36 41.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.516 -0.74 . . . . 0.0 111.622 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.777 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.5 t -108.68 -65.03 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.974 -1.079 . . . . 0.0 111.637 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.1 mp -69.68 -1.6 9.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.22 -0.925 . . . . 0.0 111.303 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.752 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -148.47 23.09 1.03 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.879 -1.138 . . . . 0.0 110.476 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.923 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -62.49 -44.92 95.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.887 . . . . 0.0 110.201 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.503 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 63.8 m-20 -58.22 -15.39 9.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 110.207 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 74.0 m-20 -124.91 4.86 8.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.017 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.83 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -93.2 -49.09 6.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.425 -0.797 . . . . 0.0 109.946 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.035 HG11 HD12 ' A' ' 38' ' ' ILE . 3.5 t -71.17 -42.0 11.33 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.83 . . . . 0.0 110.895 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.7 Cg_endo -77.2 6.61 4.2 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.422 1.222 . . . . 0.0 110.722 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 63.3 mttt -124.63 -33.97 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.264 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.598 HD11 ' CD1' ' A' ' 29' ' ' LEU . 35.3 mt -80.1 -34.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.597 -0.69 . . . . 0.0 109.606 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.46 98.52 1.4 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.512 -0.742 . . . . 0.0 110.109 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.28 2.15 6.53 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.027 1.54 . . . . 0.0 110.726 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -90.54 -3.64 57.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.141 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.5 -33.48 6.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 110.165 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.035 HD12 HG11 ' A' ' 30' ' ' VAL . 6.7 mt -135.97 134.44 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.892 . . . . 0.0 110.284 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.55 ' CG ' ' CA ' ' A' ' 59' ' ' GLY . 9.1 mtmt -73.34 -39.14 65.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.373 -0.829 . . . . 0.0 110.302 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.568 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 177.01 164.16 0.49 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 110.211 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 69.5 m -124.73 120.07 30.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.921 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.529 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 51.0 tp10 -122.7 102.44 8.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.302 -0.874 . . . . 0.0 110.183 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 28.2 mt -50.32 130.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 110.164 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 55' ' ' LYS . 46.6 mt -88.61 -26.45 21.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 110.091 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 1.062 ' O ' HG23 ' A' ' 52' ' ' THR . 50.0 tt0 -157.08 173.88 16.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 110.23 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 58.98 -159.98 16.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -143.87 31.2 1.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -1.153 . . . . 0.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.783 ' H ' HG21 ' A' ' 52' ' ' THR . . . 105.42 3.0 41.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -97.49 -167.18 32.45 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.5 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 44.2 Cg_endo -70.32 137.09 33.07 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.065 1.56 . . . . 0.0 110.506 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.17 -6.72 83.31 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 1.062 HG23 ' O ' ' A' ' 45' ' ' GLU . 46.4 m -80.05 138.17 36.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -1.14 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' A' ' 70' ' ' LYS . 36.7 mm -105.61 121.27 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 110.037 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 52.3 mtmt -106.29 120.11 41.0 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 110.293 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HB2' HD11 ' A' ' 44' ' ' LEU . 80.1 tttt -91.94 101.11 13.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 0.0 110.2 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.555 ' CG2' HD13 ' A' ' 38' ' ' ILE . 90.6 mt -91.51 147.13 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 110.111 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.49 HG22 ' HB3' ' A' ' 66' ' ' TYR . 3.3 p -119.84 153.09 36.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.952 . . . . 0.0 110.652 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 12.9 m-85 -116.22 125.49 52.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 110.152 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.55 ' CA ' ' CG ' ' A' ' 39' ' ' LYS . . . -92.28 10.85 73.48 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -119.0 128.66 54.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -1.137 . . . . 0.0 110.127 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.55 -140.67 16.51 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 98.1 p -62.08 -165.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -1.165 . . . . 0.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -83.35 -35.54 25.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.88 . . . . 0.0 110.268 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.27 103.79 10.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.33 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -136.19 80.62 0.3 Allowed Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 19.7 p90 -125.81 179.31 5.24 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.319 -1.106 . . . . 0.0 110.23 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 66' ' ' TYR . 4.1 m -152.39 177.7 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.398 -0.813 . . . . 0.0 110.694 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 1.077 ' CE ' HD11 ' A' ' 86' ' ' ILE . 28.0 ttpt -134.93 107.64 7.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.49 -0.756 . . . . 0.0 109.689 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.902 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.5 m170 -96.66 130.67 43.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 111.247 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.709 ' HA ' HD13 ' A' ' 53' ' ' ILE . 56.8 tttt -102.75 109.04 20.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.366 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.1 mm -43.62 138.76 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 110.267 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.546 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 15.0 t0 -108.95 -40.47 5.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.654 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.475 ' C ' HD12 ' A' ' 74' ' ' ILE . 11.0 p 178.39 158.57 0.5 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.427 -0.796 . . . . 0.0 109.782 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.475 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -140.24 156.54 24.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.104 -0.998 . . . . 0.0 110.909 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -139.4 80.96 1.81 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.689 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.57 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 35.1 ttpt -64.11 -12.33 38.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 110.093 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -87.36 -29.6 21.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 108.987 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -111.46 -3.23 15.27 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.409 0.623 . . . . 0.0 109.385 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.848 ' O ' HD12 ' A' ' 104' ' ' LEU . 67.5 m-85 62.5 53.12 2.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.599 -0.688 . . . . 0.0 110.108 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.88 155.72 39.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.539 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.777 ' CE1' HG13 ' A' ' 23' ' ' VAL . 73.5 t80 -143.26 147.47 34.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 110.108 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.4 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 68.8 m -153.6 135.01 14.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 110.97 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.682 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.4 p90 -144.8 173.08 12.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.37 -0.831 . . . . 0.0 110.118 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 98' ' ' ILE . 87.4 m -126.67 124.8 40.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.818 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.902 HD13 ' CD2' ' A' ' 69' ' ' HIS . 9.2 tp -92.6 133.0 36.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.0 110.205 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 1.077 HD11 ' CE ' ' A' ' 68' ' ' LYS . 13.3 pt -123.64 -25.64 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 110.59 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HB3' ' CB ' ' A' ' 68' ' ' LYS . 42.6 tt0 -112.05 133.21 54.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.183 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.44 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . 168.23 140.74 3.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -69.87 -19.09 63.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -1.155 . . . . 0.0 110.279 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.719 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -71.95 -25.04 61.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 92' ' ' GLY . 38.7 mt -62.37 -33.09 74.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 110.114 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.25 -179.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -76.79 1.27 17.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -1.156 . . . . 0.0 109.923 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.679 ' O ' HG21 ' A' ' 126' ' ' VAL . 70.0 p -92.39 -33.57 14.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.823 HD21 HG13 ' A' ' 128' ' ' ILE . 34.8 mt -114.71 163.76 15.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 110.081 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.445 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 39.6 mt-10 -143.56 -79.78 0.2 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.249 -0.907 . . . . 0.0 110.006 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 53.8 mttt -80.12 141.6 35.61 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 110.668 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 84' ' ' THR . 5.2 mm -129.36 143.24 41.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.366 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.1 m -123.27 126.8 47.59 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.731 ' HE2' HG21 ' A' ' 98' ' ' ILE . 13.0 m-85 -121.63 135.27 54.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 110.221 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 74.6 tt0 -136.24 140.12 43.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.242 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 92.5 m -137.95 146.76 43.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 110.228 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 115' ' ' LYS . 19.3 mttt -138.09 145.72 42.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -0.861 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.866 HD23 HG12 ' A' ' 114' ' ' ILE . 2.8 mt -123.21 152.96 40.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 110.461 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.36 -169.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -127.35 125.55 40.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.26 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.447 ' HB3' HG13 ' A' ' 113' ' ' ILE . 95.4 p -82.21 160.57 62.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 110.187 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.36 -1.31 10.0 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.031 1.543 . . . . 0.0 110.553 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.1 t -98.73 -4.03 34.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.47 -41.61 2.19 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.92 -179.17 5.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 4.6 m -121.15 135.66 55.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -1.181 . . . . 0.0 110.399 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.666 HG12 HG22 ' A' ' 10' ' ' THR . 74.9 mt -84.85 149.96 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.361 -0.837 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.866 HG12 HD23 ' A' ' 104' ' ' LEU . 4.7 mt -134.98 113.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 110.398 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 103' ' ' LYS . 22.4 ttmt -100.45 122.34 43.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.91 . . . . 0.0 109.831 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.0 t -114.7 158.12 22.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 0.0 110.619 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.616 HG22 ' NE2' ' A' ' 119' ' ' HIS . 93.4 m -156.32 133.64 10.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.38 -0.825 . . . . 0.0 110.043 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.6 p -133.02 157.78 44.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.153 -0.967 . . . . 0.0 110.334 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.81 ' CE1' HG23 ' A' ' 4' ' ' THR . 74.7 m-70 -141.25 167.06 23.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.131 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.803 ' O ' HG13 ' A' ' 2' ' ' VAL . 9.2 m-85 -131.33 150.03 52.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.43 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 92.9 m-70 -126.3 90.09 3.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -0.961 . . . . 0.0 109.561 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.619 ' HB ' HG23 ' A' ' 126' ' ' VAL . 3.0 p -71.27 166.45 21.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.395 -0.815 . . . . 0.0 110.67 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 21.4 tttp -119.75 121.1 38.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -0.834 . . . . 0.0 110.153 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.46 -108.24 3.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.615 ' O ' HG13 ' A' ' 126' ' ' VAL . 51.5 t30 -139.63 94.35 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -1.166 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.679 HG21 ' O ' ' A' ' 94' ' ' THR . 16.7 m -157.65 159.68 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 0.0 110.098 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -133.84 154.26 51.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 110.282 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.823 HG13 HD21 ' A' ' 95' ' ' LEU . 3.3 mp -76.97 173.07 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.383 -0.823 . . . . 0.0 110.257 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.599 ' N ' HG22 ' A' ' 128' ' ' ILE . 60.5 mttt -101.85 128.88 48.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 110.106 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.47 ' HA ' HG12 ' A' ' 133' ' ' VAL . 53.4 mm-40 -44.53 -48.56 10.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 110.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 35.3 tt0 -54.67 -31.22 57.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 109.861 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.719 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 17.4 t-160 -75.58 -55.67 5.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.971 HG21 ' CE2' ' A' ' 5' ' ' TYR . 11.6 p -67.0 -40.96 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.553 ' N ' HG13 ' A' ' 133' ' ' VAL . 93.7 mttt -66.59 -46.25 76.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.07 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -60.39 -33.29 72.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 110.045 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.07 -26.06 71.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -75.09 -35.13 61.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 110.172 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.34 -35.84 61.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 109.976 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.422 ' O ' HD23 ' A' ' 143' ' ' LEU . 48.2 mtmt -68.65 -37.69 79.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 109.845 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.55 78.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.863 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.7 t -65.88 -48.45 71.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.379 -0.825 . . . . 0.0 109.953 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -53.82 -42.28 68.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.928 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 147' ' ' ILE . 2.6 mm? -58.7 -47.8 83.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 109.951 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.458 ' CE1' HG21 ' A' ' 114' ' ' ILE . 9.8 m-85 -56.31 -38.42 71.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 110.162 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 78.3 mttt -74.03 -21.98 59.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.107 -0.995 . . . . 0.0 109.93 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 15.0 mt -87.4 -35.29 18.4 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 108.701 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.763 HG22 ' CD1' ' A' ' 18' ' ' LEU . 67.9 mt -75.44 -37.36 37.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.575 -0.703 . . . . 0.0 109.129 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 19.8 pt-20 -62.83 -32.82 74.1 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.144 -0.972 . . . . 0.0 109.006 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.482 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 16.8 m -79.93 -26.76 39.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.19 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.688 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.9 t80 -60.94 -52.22 65.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.596 -0.69 . . . . 0.0 109.845 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.18 HD21 ' CE1' ' A' ' 158' ' ' TYR . 80.5 mt -76.41 -36.65 57.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.266 -0.896 . . . . 0.0 109.972 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.745 ' HB2' HD11 ' A' ' 13' ' ' ILE . 45.0 tptt -64.36 -21.69 66.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.57 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -109.31 -32.14 3.07 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.573 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.9 m-70 -108.37 93.49 11.62 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -1.096 . . . . 0.0 110.025 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.9 Cg_endo -74.14 5.05 3.79 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.0 1.526 . . . . 0.0 110.954 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -108.74 -6.33 15.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 109.886 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.688 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -75.35 101.33 4.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.865 . . . . 0.0 110.005 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.18 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.5 p90 34.03 36.8 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.817 -0.552 . . . . 0.0 110.82 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.526 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.728 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 120' ' ' TYR . 45.8 t -120.2 117.55 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.169 . . . . 0.0 110.224 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.595 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 76.7 m-85 -88.15 125.4 34.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.818 HG23 ' CE1' ' A' ' 119' ' ' HIS . 25.1 m -105.48 113.73 27.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 110.388 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.694 ' CE1' HG13 ' A' ' 133' ' ' VAL . 60.3 m-85 -117.26 125.76 51.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.079 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 116' ' ' SER . 20.9 pt-20 -133.74 154.89 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 110.302 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t -127.47 164.68 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.119 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -142.6 116.48 9.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.9 p90 -148.29 -170.12 3.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.308 -0.87 . . . . 0.0 110.204 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 113' ' ' ILE . 10.4 p -141.15 174.84 10.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.393 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.418 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 1.4 t -154.65 157.31 37.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -87.8 -14.48 39.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 110.118 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.812 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.3 mp -81.42 149.95 66.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.812 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.9 Cg_endo -66.36 145.75 78.45 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.003 1.528 . . . . 0.0 110.438 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.671 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 Cg_endo -72.23 -31.68 11.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.91 1.479 . . . . 0.0 113.054 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.9 Cg_endo -69.74 -21.14 33.99 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 110.108 -0.766 . . . . 0.0 110.108 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.63 ' HB3' HD13 ' A' ' 151' ' ' LEU . 7.1 mmp_? -85.68 -43.35 13.49 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.791 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.3 tt -72.2 -29.92 64.43 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 73.8 t80 -67.21 -56.98 7.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.565 -0.709 . . . . 0.0 109.58 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 66.0 mttt -54.84 -34.12 62.49 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.293 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.069 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.42 -55.8 5.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.519 -0.738 . . . . 0.0 110.918 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.929 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -58.61 -46.14 87.65 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.559 -0.713 . . . . 0.0 111.494 -178.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.129 HG11 ' CD1' ' A' ' 74' ' ' ILE . 18.2 t -98.17 -65.39 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.075 -1.015 . . . . 0.0 111.897 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.628 HD22 ' N ' ' A' ' 24' ' ' LEU . 4.1 mm? -65.41 -4.64 5.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 111.548 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.655 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -148.19 36.64 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.942 -1.099 . . . . 0.0 110.427 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.929 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -73.97 -36.51 64.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.419 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 68.5 m-20 -62.86 -13.58 35.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.128 -0.982 . . . . 0.0 110.355 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 78.2 m-20 -127.53 7.19 6.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.928 . . . . 0.0 110.2 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.684 HD13 HD11 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -95.38 -52.18 4.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.903 179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.927 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.5 t -71.35 -41.47 10.29 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.574 -0.704 . . . . 0.0 110.871 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.4 Cg_endo -77.88 9.69 2.9 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.484 1.255 . . . . 0.0 110.964 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 29.3 mttm -129.83 -33.39 1.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.056 -1.027 . . . . 0.0 109.753 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.684 HD11 HD13 ' A' ' 29' ' ' LEU . 50.1 mt -80.18 -41.46 20.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.495 -0.753 . . . . 0.0 109.464 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -147.28 99.42 3.91 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.515 -0.741 . . . . 0.0 110.034 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 45.7 Cg_endo -71.35 -1.31 9.48 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.089 1.573 . . . . 0.0 110.659 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -84.82 -11.45 55.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.113 -0.992 . . . . 0.0 109.669 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.861 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -102.41 -57.64 2.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.396 -0.815 . . . . 0.0 110.177 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.927 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.1 mp -121.74 107.36 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.402 -0.811 . . . . 0.0 110.176 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 16.8 tppt? -59.82 -25.28 64.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 110.191 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.601 ' CG ' ' N ' ' A' ' 41' ' ' SER . 0.2 OUTLIER -173.44 176.77 2.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.601 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 70.5 m -150.86 151.16 31.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 109.905 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 82.3 tt0 -157.52 105.81 2.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.256 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 34.5 mt -51.71 132.97 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.461 ' HB3' ' O ' ' A' ' 53' ' ' ILE . 33.5 tp -93.85 -47.36 6.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.9 . . . . 0.0 110.326 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.873 ' O ' HG23 ' A' ' 52' ' ' THR . 5.1 mm-40 -132.09 134.59 45.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.206 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.62 -164.46 37.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -129.68 11.17 5.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.104 . . . . 0.0 110.162 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.455 ' N ' HG21 ' A' ' 52' ' ' THR . . . 125.04 -9.18 7.97 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -75.91 -168.76 26.27 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.413 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.6 Cg_endo -70.58 133.41 24.02 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.169 1.615 . . . . 0.0 110.526 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.38 -4.53 73.64 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.873 HG23 ' O ' ' A' ' 45' ' ' GLU . 16.9 m -80.14 147.63 31.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -1.149 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 70' ' ' LYS . 25.8 mm -116.33 108.42 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.092 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.645 ' HE3' HD11 ' A' ' 71' ' ' ILE . 90.1 mttt -91.83 134.97 34.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 0.0 110.319 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -106.24 94.05 4.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 110.052 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.662 HD12 ' CE1' ' A' ' 69' ' ' HIS . 86.8 mt -80.53 144.07 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.191 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.575 HG22 ' OH ' ' A' ' 64' ' ' TYR . 1.1 p -112.33 156.74 21.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 110.246 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.775 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.1 m-85 -114.04 162.99 15.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.871 . . . . 0.0 110.326 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.402 ' HA3' ' HE2' ' A' ' 39' ' ' LYS . . . -97.47 89.43 1.01 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' CD ' ' O ' ' A' ' 63' ' ' GLN . 46.9 tt0 -131.47 137.83 48.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 110.153 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 62' ' ' SER . . . -92.58 -48.29 3.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 61' ' ' GLY . 70.7 m -43.89 -52.75 6.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -1.149 . . . . 0.0 110.292 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' O ' ' CD ' ' A' ' 60' ' ' GLU . 50.1 tt0 -153.29 157.33 39.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.167 -0.958 . . . . 0.0 110.236 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.638 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 7.8 t80 -55.25 142.36 31.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.336 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -134.93 134.48 7.36 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.638 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 15.1 p90 -177.71 168.63 2.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -1.203 . . . . 0.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.2 m -142.19 173.5 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.35 -0.844 . . . . 0.0 110.422 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.518 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . 91.7 mttt -119.75 131.38 55.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.481 -0.762 . . . . 0.0 109.709 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.662 ' CE1' HD12 ' A' ' 56' ' ' ILE . 14.2 m170 -113.51 132.37 55.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.93 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.64 ' HA ' HD13 ' A' ' 53' ' ' ILE . 76.2 tttt -111.33 107.53 16.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.837 . . . . 0.0 109.253 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.645 HD11 ' HE3' ' A' ' 54' ' ' LYS . 27.8 mm -48.57 135.47 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.983 . . . . 0.0 110.412 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.466 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 15.8 m-20 -105.26 -45.36 4.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 109.398 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 29.0 p 177.4 156.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.641 -0.662 . . . . 0.0 110.13 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.129 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.8 tt -147.55 165.31 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.035 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-20 -134.84 80.1 1.83 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.328 -0.857 . . . . 0.0 110.041 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.566 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 24.0 mttt -56.13 -15.11 3.23 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.179 -0.95 . . . . 0.0 110.607 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -93.37 -30.81 14.91 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.294 -0.879 . . . . 0.0 109.557 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.4 m-80 -106.87 -1.34 22.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.552 -0.718 . . . . 0.0 109.424 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.639 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 68.7 m-85 63.66 52.85 2.14 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.369 0.604 . . . . 0.0 110.82 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.54 ' HB3' ' CG ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -126.88 151.11 48.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.634 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.596 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 77.3 t80 -145.57 163.64 34.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.189 -0.944 . . . . 0.0 110.14 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.496 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 84.8 p -168.51 146.21 4.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.015 -1.053 . . . . 0.0 110.799 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.622 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 2.6 p90 -148.23 -179.12 6.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.328 -0.857 . . . . 0.0 110.401 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 98' ' ' ILE . 24.7 m -136.41 128.19 29.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.438 -0.789 . . . . 0.0 109.992 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.65 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 7.0 tp -80.39 121.97 26.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.275 -0.89 . . . . 0.0 110.073 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.518 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 27.5 pt -101.77 -11.56 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.89 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 66.7 tt0 -154.17 151.85 29.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.178 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.848 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 168.36 157.18 10.97 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' ALA . 65.8 t0 -72.2 -54.14 10.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -1.141 . . . . 0.0 110.366 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' ASP . . . -42.4 -31.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.543 HD23 ' CD2' ' A' ' 95' ' ' LEU . 21.2 mt -52.42 -53.17 48.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 110.128 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.76 -171.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -72.49 -2.08 18.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.126 . . . . 0.0 110.189 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.713 ' O ' HG21 ' A' ' 126' ' ' VAL . 34.9 p -89.64 -60.46 1.93 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 110.37 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.956 HD11 HD11 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -105.06 163.07 12.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.317 -0.865 . . . . 0.0 109.258 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.77 ' H ' HD12 ' A' ' 95' ' ' LEU . 76.4 mm-40 -142.64 -81.12 0.21 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 110.324 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.489 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 71.2 mttt -80.25 153.64 28.39 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.545 -0.722 . . . . 0.0 110.621 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.956 HD11 HD11 ' A' ' 95' ' ' LEU . 35.1 mm -140.66 159.95 24.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.727 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -135.35 126.41 27.88 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.366 -0.834 . . . . 0.0 108.903 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.809 ' CE2' HG21 ' A' ' 98' ' ' ILE . 22.4 m-85 -123.77 135.68 53.96 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.189 -0.944 . . . . 0.0 110.497 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 71.7 tt0 -139.18 124.95 19.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 0.0 110.238 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 89.0 m -118.63 145.42 45.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.088 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.54 ' CG ' ' HB3' ' A' ' 80' ' ' SER . 7.5 mttt -136.72 132.89 35.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.317 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.871 HD23 HG12 ' A' ' 114' ' ' ILE . 4.4 mt -106.74 153.51 22.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.086 -1.009 . . . . 0.0 110.07 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.96 -168.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.173 -0.954 . . . . 0.0 109.964 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.692 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -119.46 158.61 25.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.225 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 25.8 p -119.67 165.35 17.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 110.216 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.6 Cg_endo -72.5 -1.48 10.33 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.089 1.573 . . . . 0.0 110.506 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.4 m -104.94 -5.9 20.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.149 -0.97 . . . . 0.0 110.227 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.33 -32.52 6.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.83 -171.76 2.88 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 5.9 m -129.85 132.72 46.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -1.14 . . . . 0.0 110.257 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.563 ' HA ' HG22 ' A' ' 10' ' ' THR . 11.4 mt -82.84 152.58 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 110.224 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.871 HG12 HD23 ' A' ' 104' ' ' LEU . 5.9 mt -133.55 114.31 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 110.184 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 103' ' ' LYS . 69.5 tttt -103.31 108.81 20.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.2 m -99.42 157.33 16.5 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.266 -0.896 . . . . 0.0 110.29 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 71.6 m -156.5 131.46 9.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.344 -0.848 . . . . 0.0 109.916 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 99' ' ' SER . 89.3 p -134.31 148.9 50.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.029 . . . . 0.0 110.696 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.818 ' CE1' HG23 ' A' ' 4' ' ' THR . 39.7 m-70 -131.56 138.92 49.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.461 -0.775 . . . . 0.0 110.015 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.631 ' HA ' HD13 ' A' ' 98' ' ' ILE . 12.1 m-30 -100.13 150.98 21.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 110.691 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.489 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 98.5 m-70 -128.08 90.7 3.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 0.0 109.488 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 95' ' ' LEU . 2.8 p -79.52 161.3 26.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.345 -0.847 . . . . 0.0 110.539 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -120.34 115.53 23.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 110.061 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.16 -141.54 15.37 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.468 ' C ' HG13 ' A' ' 126' ' ' VAL . 53.1 t30 -113.23 96.22 5.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -1.132 . . . . 0.0 110.223 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 94' ' ' THR . 21.8 m -151.45 168.62 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.297 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -138.9 160.19 40.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.591 HG12 ' CE1' ' A' ' 3' ' ' PHE . 35.5 mm -74.9 173.36 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.589 ' N ' HG22 ' A' ' 128' ' ' ILE . 40.6 mttt -110.9 133.75 53.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 0.0 110.228 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 129' ' ' LYS . 1.1 mt-10 -43.5 -49.21 7.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.148 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -58.53 -36.06 73.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 110.108 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -68.88 -44.2 73.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.195 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.694 HG13 ' CE1' ' A' ' 5' ' ' TYR . 60.6 t -61.64 -38.05 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.983 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -77.82 -42.49 33.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.57 -37.61 87.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.098 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.27 -29.97 74.93 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 84.9 mttt -79.26 -31.26 43.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -1.114 . . . . 0.0 110.111 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -78.03 -32.93 51.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.852 . . . . 0.0 110.092 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -73.81 -28.18 61.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.412 -0.805 . . . . 0.0 110.015 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -80.05 -36.72 35.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.925 . . . . 0.0 110.051 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.0 p -71.29 -46.76 60.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.409 -0.807 . . . . 0.0 110.025 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.429 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 98.4 m-20 -55.47 -49.3 72.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 110.01 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 147' ' ' ILE . 69.8 mt -57.48 -41.98 81.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.915 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 6.3 m-85 -59.74 -40.92 89.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.485 -0.76 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.43 ' HB3' ' HE3' ' A' ' 145' ' ' LYS . 18.3 mtpp -80.0 -16.79 54.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.115 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 142' ' ' ASN . 27.9 mt -84.26 -36.37 22.72 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.151 -0.968 . . . . 0.0 108.833 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.74 HD13 ' CD1' ' A' ' 22' ' ' PHE . 97.3 mt -72.58 -45.16 59.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.799 ' HB3' HD13 ' A' ' 13' ' ' ILE . 69.1 mt-10 -57.09 -40.58 77.23 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.3 m -68.53 -35.61 77.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.94 . . . . 0.0 109.459 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.653 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.5 t80 -54.27 -46.46 72.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.518 -0.739 . . . . 0.0 109.908 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.181 HD21 ' CE2' ' A' ' 158' ' ' TYR . 94.7 mt -79.87 -31.07 40.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.716 ' HB2' HD11 ' A' ' 13' ' ' ILE . 73.3 tttt -71.11 -25.51 62.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.573 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.33 -34.21 3.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.538 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.9 m-70 -106.91 92.67 7.84 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.259 -1.142 . . . . 0.0 110.179 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.514 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.5 Cg_endo -74.26 6.44 3.06 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.097 1.578 . . . . 0.0 111.072 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -107.43 -2.6 20.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.916 -1.115 . . . . 0.0 109.775 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.653 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -78.67 104.35 9.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.501 -0.749 . . . . 0.0 110.123 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.181 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.66 33.19 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.348 0.594 . . . . 0.0 110.357 -179.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.54 ' HA ' ' NH1' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.862 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 68.5 t -132.1 118.28 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 110.207 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.589 ' CE1' HG12 ' A' ' 128' ' ' ILE . 64.8 m-85 -93.47 125.92 38.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.34 -0.85 . . . . 0.0 110.06 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.854 HG23 ' CE1' ' A' ' 119' ' ' HIS . 28.9 m -107.88 111.04 22.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.853 . . . . 0.0 110.304 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.646 ' CE1' HG13 ' A' ' 133' ' ' VAL . 60.0 m-85 -116.65 138.17 51.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.836 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.576 ' HB3' HG23 ' A' ' 117' ' ' THR . 18.8 pt-20 -141.21 167.37 22.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.149 -0.97 . . . . 0.0 110.654 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.404 ' C ' ' HG3' ' A' ' 8' ' ' GLU . 32.1 t -143.63 157.75 44.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.43 -0.794 . . . . 0.0 109.806 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 7' ' ' SER . 97.1 mt-10 -141.93 117.51 10.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.008 . . . . 0.0 110.628 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 p90 -138.5 -175.09 4.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.84 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.563 HG22 HG12 ' A' ' 113' ' ' ILE . 23.2 p -136.57 178.92 6.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.524 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.516 ' CB ' ' OE2' ' A' ' 148' ' ' GLU . 59.1 p -160.04 163.73 33.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.464 -0.773 . . . . 0.0 110.458 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -89.21 -10.2 47.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.906 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.78 HG23 ' HD2' ' A' ' 14' ' ' PRO . 3.4 mp -92.32 149.87 39.17 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.828 . . . . 0.0 110.058 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.78 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.6 Cg_endo -66.02 145.31 79.09 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.997 1.525 . . . . 0.0 110.367 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.67 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.7 Cg_endo -71.11 -32.25 13.47 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.888 1.468 . . . . 0.0 112.796 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -68.38 -20.91 41.65 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.545 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 53.4 mmm-85 -84.29 -46.3 11.95 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.766 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -71.99 -24.95 61.66 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.609 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 89.1 t80 -68.61 -59.82 2.86 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.519 0.676 . . . . 0.0 109.346 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 77.5 mttt -52.04 -38.15 55.99 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.237 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.018 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -70.06 -55.44 9.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 110.711 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.044 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -57.12 -49.7 75.09 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 111.235 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.979 HG11 ' CD1' ' A' ' 74' ' ' ILE . 10.3 t -95.28 -65.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.971 -1.08 . . . . 0.0 111.722 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.598 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.3 mp -64.83 -4.37 4.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.177 -0.952 . . . . 0.0 111.805 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.634 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -148.28 33.19 0.81 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.715 -1.24 . . . . 0.0 110.548 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.044 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -71.99 -34.03 68.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 0.0 110.241 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 41' ' ' SER . 12.8 t70 -64.97 -13.85 58.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.91 . . . . 0.0 110.287 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 80.9 m-20 -126.78 3.34 6.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.112 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.702 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -90.15 -54.78 3.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 110.234 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.049 HG11 HD13 ' A' ' 38' ' ' ILE . 92.6 t -65.81 -41.26 45.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 111.109 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 48.4 Cg_endo -76.73 4.98 5.16 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.369 1.194 . . . . 0.0 110.608 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 47.1 mttm -125.87 -31.69 2.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.58 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.702 HD11 ' CD1' ' A' ' 29' ' ' LEU . 23.5 mt -80.06 -39.22 19.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.523 -0.735 . . . . 0.0 109.859 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -163.17 97.74 1.05 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 110.19 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.83 5.23 4.53 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.009 1.531 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -87.1 -15.75 37.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 110.025 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.44 -35.38 10.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.207 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.049 HD13 HG11 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -129.98 145.56 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 109.906 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -83.86 -35.18 24.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 110.48 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.564 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 178.8 157.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 110.249 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 58.5 m -118.19 126.95 53.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.066 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 58.2 tt0 -134.66 105.95 6.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 19.0 mt -59.63 134.0 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.5 tp -95.03 -44.31 7.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.334 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 1.02 ' O ' HG23 ' A' ' 52' ' ' THR . 11.5 mt-10 -127.18 159.32 34.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 61.8 -161.16 28.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -134.43 10.67 3.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -1.152 . . . . 0.0 110.181 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.526 ' N ' HG21 ' A' ' 52' ' ' THR . . . 128.08 -6.69 6.82 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.555 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -86.68 -163.19 38.25 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.72 131.83 20.64 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.013 1.533 . . . . 0.0 110.601 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.01 -6.54 69.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 1.02 HG23 ' O ' ' A' ' 45' ' ' GLU . 20.4 m -79.98 135.68 36.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -1.164 . . . . 0.0 110.144 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.55 HD13 ' HA ' ' A' ' 70' ' ' LYS . 25.9 mm -105.22 113.79 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.208 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.616 ' HE3' HD11 ' A' ' 71' ' ' ILE . 95.1 mttt -99.15 138.78 35.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.376 -0.828 . . . . 0.0 110.298 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -110.97 92.76 4.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.164 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.534 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.8 mt -79.99 143.83 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 109.881 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.489 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 6.8 p -116.87 160.16 21.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.688 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.768 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.4 m-85 -120.08 163.14 18.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.534 -0.729 . . . . 0.0 110.059 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.69 144.35 1.73 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 63' ' ' GLN . 22.8 pt-20 -57.26 -39.19 75.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -1.194 . . . . 0.0 110.213 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 60' ' ' GLU . . . 43.52 -150.84 0.52 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.2 p -68.23 -34.43 76.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -1.162 . . . . 0.0 110.119 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 60' ' ' GLU . 72.2 mt-30 -136.58 161.03 37.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 110.117 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.648 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 t80 -60.71 136.63 58.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.264 -0.897 . . . . 0.0 110.159 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -129.18 137.21 9.44 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.648 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 13.4 p90 -178.26 169.43 1.85 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -1.135 . . . . 0.0 110.081 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.992 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.5 m -142.42 172.21 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.895 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.442 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 43.7 mtpt -122.95 121.2 35.55 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.59 ' CD2' ' HG ' ' A' ' 85' ' ' LEU . 21.7 m170 -116.39 135.28 54.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.023 . . . . 0.0 111.31 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HA ' HD13 ' A' ' 53' ' ' ILE . 82.9 tttt -111.15 121.74 46.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.415 -0.803 . . . . 0.0 109.12 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.616 HD11 ' HE3' ' A' ' 54' ' ' LYS . 30.1 mm -60.58 134.89 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 110.436 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 19.2 t0 -105.73 -47.92 3.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.482 -0.761 . . . . 0.0 109.864 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -179.99 159.97 0.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.543 -0.723 . . . . 0.0 110.205 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.979 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.4 tt -149.13 164.55 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.992 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -127.13 78.9 1.85 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.877 . . . . 0.0 110.042 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.609 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 63.4 mttp -54.34 -15.81 1.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.42 -0.8 . . . . 0.0 110.819 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -92.07 -30.47 16.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.93 . . . . 0.0 109.861 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -110.59 -1.37 16.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.537 -0.727 . . . . 0.0 109.691 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.742 ' O ' HD12 ' A' ' 104' ' ' LEU . 9.1 m-85 66.01 48.48 1.76 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.688 -0.632 . . . . 0.0 110.518 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -118.56 151.77 37.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.345 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.654 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 84.4 t80 -148.11 143.79 27.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.047 -1.033 . . . . 0.0 110.285 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.487 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 66.5 m -149.61 134.0 17.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.393 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.654 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 4.0 p90 -137.54 179.29 6.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 110.048 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.86 HG23 ' O ' ' A' ' 98' ' ' ILE . 90.2 m -125.08 128.97 49.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.913 . . . . 0.0 110.17 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.762 HD22 HD11 ' A' ' 91' ' ' LEU . 1.5 tt -91.75 140.99 29.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.137 -0.977 . . . . 0.0 110.121 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.672 ' N ' HD23 ' A' ' 85' ' ' LEU . 21.1 pt -127.64 -24.62 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.033 -1.042 . . . . 0.0 110.487 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.442 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 72.6 tt0 -138.12 115.69 11.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.102 -0.999 . . . . 0.0 110.613 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.992 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -165.03 132.79 2.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 88' ' ' GLY . 60.2 t0 -42.85 -36.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -1.194 . . . . 0.0 110.402 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.855 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -62.76 -25.3 68.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.146 -0.971 . . . . 0.0 110.354 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.907 HD21 HG13 ' A' ' 98' ' ' ILE . 96.8 mt -68.04 -28.18 67.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.288 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.34 -168.54 0.31 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -90.04 12.72 16.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -1.158 . . . . 0.0 110.183 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 122' ' ' THR . 25.2 p -105.54 -52.11 2.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.145 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.919 HD21 ' CD1' ' A' ' 128' ' ' ILE . 48.7 mt -79.95 151.01 30.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.069 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.45 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 68.3 mt-10 -127.4 -80.91 0.6 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.34 -0.85 . . . . 0.0 110.269 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 85.5 mttt -80.26 147.15 31.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.593 -0.692 . . . . 0.0 110.292 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.907 HG13 HD21 ' A' ' 91' ' ' LEU . 10.5 mm -135.46 145.91 30.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.94 -1.1 . . . . 0.0 110.043 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -122.66 124.79 44.24 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.465 -0.772 . . . . 0.0 108.92 178.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.853 ' CE2' HG21 ' A' ' 98' ' ' ILE . 14.7 m-85 -121.62 132.64 54.78 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.384 -0.823 . . . . 0.0 110.359 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.487 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 26.6 tt0 -132.8 146.91 52.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -0.859 . . . . 0.0 110.205 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 81' ' ' TYR . 57.2 m -145.68 135.99 23.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 110.066 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 115' ' ' LYS . 4.1 tttt -129.07 148.63 51.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.185 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 79' ' ' TYR . 10.5 mt -122.64 148.06 45.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 110.458 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.712 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.09 -168.34 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.355 -0.84 . . . . 0.0 109.616 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.712 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -130.69 137.64 49.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.505 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.649 ' CB ' ' CD ' ' A' ' 108' ' ' PRO . 5.4 p -80.04 -161.09 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.367 -0.833 . . . . 0.0 109.211 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.649 ' CD ' ' CB ' ' A' ' 107' ' ' SER . 43.9 Cg_endo -83.46 70.72 6.32 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.348 1.183 . . . . 0.0 109.499 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 2.3 m 58.23 30.16 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.528 -0.733 . . . . 0.0 109.594 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.42 34.21 3.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . 107.75 -147.84 16.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 57.5 p -138.05 139.34 39.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.129 -1.218 . . . . 0.0 110.079 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.563 HG12 HG22 ' A' ' 10' ' ' THR . 33.3 mt -88.79 147.49 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.364 -0.835 . . . . 0.0 110.243 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.731 HD11 ' OE2' ' A' ' 148' ' ' GLU . 6.0 mt -127.63 108.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 110.069 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 103' ' ' LYS . 34.8 mtpt -90.22 145.95 24.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 110.291 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.2 t -140.95 155.7 46.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.12 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.576 HG23 ' HB3' ' A' ' 6' ' ' GLU . 24.2 m -159.99 153.31 22.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.342 -0.849 . . . . 0.0 110.137 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 99' ' ' SER . 94.4 p -153.26 154.7 35.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.173 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.854 ' CE1' HG23 ' A' ' 4' ' ' THR . 51.9 m-70 -136.92 136.56 38.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.233 -0.917 . . . . 0.0 110.072 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 7.1 m-30 -99.01 151.06 21.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.245 -0.909 . . . . 0.0 110.719 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 96.9 m-70 -130.14 78.13 1.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.729 HG23 HD23 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -73.5 157.44 36.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.359 -0.838 . . . . 0.0 110.686 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 86.2 tttt -105.43 120.41 41.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.741 . . . . 0.0 110.237 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.28 -161.77 21.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.558 ' C ' HG13 ' A' ' 126' ' ' VAL . 58.0 t30 -102.31 111.13 23.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -1.167 . . . . 0.0 110.245 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.558 HG13 ' C ' ' A' ' 125' ' ' ASN . 24.5 m -156.47 170.86 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.254 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -128.66 136.17 50.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.919 ' CD1' HD21 ' A' ' 95' ' ' LEU . 48.6 mm -57.91 173.4 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 0.0 110.035 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.587 ' N ' HG22 ' A' ' 128' ' ' ILE . 39.9 mtpt -102.82 130.4 49.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.938 . . . . 0.0 110.255 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -45.72 -51.06 13.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 110.157 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 35.9 tt0 -58.77 -34.86 71.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.32 -0.863 . . . . 0.0 110.074 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.855 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 18.3 t-160 -67.52 -41.48 84.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 0.0 110.074 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.646 HG13 ' CE1' ' A' ' 5' ' ' TYR . 85.7 t -65.94 -45.83 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.434 -0.791 . . . . 0.0 110.059 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -74.87 -39.28 61.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.289 -0.882 . . . . 0.0 110.049 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -62.67 -39.63 94.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 110.015 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.58 -29.67 75.7 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -76.5 -31.38 57.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -1.127 . . . . 0.0 110.075 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -78.8 -32.41 46.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.63 -41.12 69.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.0 109.938 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.574 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.27 -33.46 63.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.8 m -68.4 -48.47 64.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.389 -0.82 . . . . 0.0 109.936 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -55.91 -44.25 78.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.853 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 143' ' ' LEU . 24.9 mt -62.29 -35.7 79.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.89 . . . . 0.0 109.945 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 8.3 m-85 -64.12 -36.1 82.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.085 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -78.87 -13.95 59.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 0.0 110.169 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.515 ' HB3' HG21 ' A' ' 33' ' ' ILE . 17.3 mt -85.19 -36.82 20.76 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 108.969 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.675 HD11 ' CE1' ' A' ' 22' ' ' PHE . 11.6 mt -69.74 -44.31 79.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.731 ' OE2' HD11 ' A' ' 114' ' ' ILE . 12.3 mm-40 -59.31 -44.95 92.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 66.0 m -60.78 -35.98 77.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.977 . . . . 0.0 109.392 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.595 ' CD1' HG12 ' A' ' 33' ' ' ILE . 71.8 t80 -54.24 -55.63 26.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.525 -0.734 . . . . 0.0 109.693 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.968 HD21 ' CE1' ' A' ' 158' ' ' TYR . 26.7 mt -71.69 -29.46 64.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.403 -0.811 . . . . 0.0 110.25 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.758 ' HB2' HD11 ' A' ' 13' ' ' ILE . 74.5 tttt -61.15 -18.35 57.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.108 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.495 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -122.53 -16.26 3.84 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 14.5 m-70 -107.01 90.1 5.07 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.191 -1.182 . . . . 0.0 110.219 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.9 Cg_endo -73.15 2.21 5.8 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.072 1.564 . . . . 0.0 110.859 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -122.6 -2.03 8.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.109 -0.994 . . . . 0.0 109.933 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.675 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -49.45 110.02 0.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.421 -0.799 . . . . 0.0 110.398 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.018 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.46 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.584 -0.698 . . . . 0.0 110.618 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.536 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.744 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.453 ' O ' ' OG1' ' A' ' 122' ' ' THR . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 120' ' ' TYR . 26.4 t -129.09 134.94 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -1.15 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.638 ' CG ' ' CD1' ' A' ' 128' ' ' ILE . 25.4 m-85 -100.6 158.09 16.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.317 -0.865 . . . . 0.0 109.809 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.708 HG23 ' ND1' ' A' ' 119' ' ' HIS . 96.0 m -131.72 113.56 13.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -0.996 . . . . 0.0 110.504 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.814 ' CE1' HG22 ' A' ' 133' ' ' VAL . 85.7 m-85 -118.12 125.41 50.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 110.02 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.003 ' CG ' HG23 ' A' ' 117' ' ' THR . 7.3 mt-10 -137.12 151.59 49.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 110.128 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -133.97 153.76 51.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.283 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 94.6 mt-10 -133.88 116.68 15.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 110.142 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -146.57 -176.17 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 110.055 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -136.15 176.89 8.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 110.481 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 112' ' ' SER . 90.9 p -154.13 150.0 27.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.796 . . . . 0.0 110.186 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -73.45 -6.16 44.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.18 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.895 HD13 ' HB3' ' A' ' 148' ' ' GLU . 3.2 mp -94.06 149.59 37.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.034 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.812 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.4 Cg_endo -66.92 147.08 79.83 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.095 1.576 . . . . 0.0 110.246 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 Cg_endo -72.01 -32.09 11.5 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.836 1.44 . . . . 0.0 112.957 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.4 Cg_endo -71.31 -21.12 27.03 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 N-CA-C 110.058 -0.786 . . . . 0.0 110.058 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.95 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -83.28 -46.29 12.81 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.927 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -70.8 -30.57 67.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 53.6 t80 -64.99 -56.72 11.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.355 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 55.0 mttt -50.92 -40.33 56.8 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.027 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.016 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -68.71 -60.47 2.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.551 -0.718 . . . . 0.0 110.813 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.024 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -50.16 -57.02 8.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.653 -0.654 . . . . 0.0 112.046 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.039 HG11 ' CD1' ' A' ' 74' ' ' ILE . 6.6 t -94.7 -59.5 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.951 -1.093 . . . . 0.0 112.287 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.2 mp -68.92 -0.74 5.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.055 -1.028 . . . . 0.0 111.712 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.732 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -152.64 30.03 0.53 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.84 -1.162 . . . . 0.0 110.635 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.024 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.03 -41.79 86.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 110.093 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 16.4 m-20 -58.14 -15.54 10.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.159 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.532 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 67.2 m-80 -127.16 10.13 6.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.255 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.732 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -96.85 -50.57 4.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.308 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.004 HG21 HD13 ' A' ' 38' ' ' ILE . 6.9 p -73.83 -27.22 0.78 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 112.128 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.804 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -82.71 11.13 3.33 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.636 0.808 . . . . 0.0 110.588 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 28' ' ' ASN . 52.6 mtpt -136.83 -28.11 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.13 -0.981 . . . . 0.0 110.793 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.63 HD11 ' CD1' ' A' ' 29' ' ' LEU . 29.4 mt -76.27 -42.01 36.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.167 -0.958 . . . . 0.0 109.857 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.84 101.38 1.3 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.37 -0.831 . . . . 0.0 110.406 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.3 -0.45 9.21 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.086 1.571 . . . . 0.0 110.44 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -89.1 -17.9 28.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 110.015 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.21 -39.64 9.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 110.083 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.004 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -133.69 142.28 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 109.911 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 57' ' ' THR . 35.3 ttmt -76.66 -42.52 41.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.306 -0.871 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.538 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.44 158.68 0.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.9 . . . . 0.0 110.176 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 24.4 m -115.27 126.39 54.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.224 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.41 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 66.1 tt0 -133.8 103.45 5.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.911 . . . . 0.0 110.239 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 23.8 mt -52.58 130.45 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.239 -0.913 . . . . 0.0 110.209 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.541 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 44.8 mt -89.7 -46.85 8.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.931 ' O ' HG23 ' A' ' 52' ' ' THR . 9.4 mm-40 -132.52 151.83 51.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.411 -0.806 . . . . 0.0 110.192 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.54 -158.29 48.7 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -143.53 14.21 1.78 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -1.172 . . . . 0.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.588 ' H ' HG21 ' A' ' 52' ' ' THR . . . 121.27 -2.03 11.47 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.61 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -90.94 -168.07 41.77 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.82 130.95 20.15 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.146 1.603 . . . . 0.0 110.549 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.71 -2.76 70.35 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.931 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.5 m -79.96 145.43 32.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -1.182 . . . . 0.0 109.966 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.506 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 33.6 mm -111.14 114.88 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 110.44 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.717 ' CE ' HD11 ' A' ' 71' ' ' ILE . 99.5 mttt -100.74 139.79 35.93 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.415 -0.803 . . . . 0.0 110.033 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 85.6 tttt -116.09 95.47 5.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.096 -1.002 . . . . 0.0 110.438 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.535 ' CG2' HG12 ' A' ' 38' ' ' ILE . 78.3 mt -85.71 144.71 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 38' ' ' ILE . 5.5 p -114.57 158.16 22.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 110.842 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.808 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.3 m-85 -116.03 140.59 49.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.51 -0.744 . . . . 0.0 110.244 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.14 29.41 10.7 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -117.83 128.66 55.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -1.104 . . . . 0.0 110.271 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.6 142.21 12.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.6 t -60.41 -48.64 80.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.19 . . . . 0.0 110.229 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -57.97 156.9 8.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.877 . . . . 0.0 110.116 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.594 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 10.3 t80 -68.81 135.37 51.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -123.81 137.27 10.75 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.594 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 13.5 p90 -178.74 166.04 1.67 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.253 -1.145 . . . . 0.0 110.03 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.922 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.1 m -141.57 172.68 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 110.779 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.614 ' O ' HD22 ' A' ' 85' ' ' LEU . 93.1 mttt -125.95 125.19 42.33 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.971 ' CD2' HD23 ' A' ' 85' ' ' LEU . 11.3 m170 -115.67 118.81 34.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.964 -1.085 . . . . 0.0 111.429 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 1.085 ' HE3' HD13 ' A' ' 86' ' ' ILE . 35.5 mttt -92.59 104.32 16.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.193 -0.942 . . . . 0.0 108.878 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.717 HD11 ' CE ' ' A' ' 54' ' ' LYS . 44.2 mm -47.43 135.62 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 110.407 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.518 ' CB ' ' HA ' ' A' ' 83' ' ' TYR . 14.9 m-20 -109.22 -44.18 3.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.457 -0.777 . . . . 0.0 109.697 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER 175.5 160.2 0.25 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.45 -0.781 . . . . 0.0 110.509 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.039 ' CD1' HG11 ' A' ' 23' ' ' VAL . 4.4 tt -147.4 168.17 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.647 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.5 m-20 -134.97 82.22 1.95 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.106 -0.996 . . . . 0.0 110.263 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.583 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 95.4 mttt -58.43 -14.29 7.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.214 -0.929 . . . . 0.0 110.607 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -95.34 -30.54 13.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.217 -0.927 . . . . 0.0 109.591 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.4 m-80 -106.07 -2.84 22.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.712 -0.618 . . . . 0.0 109.428 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.514 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 96.3 m-85 62.56 54.19 2.48 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.463 0.649 . . . . 0.0 110.651 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -132.2 150.4 52.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.544 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 72.0 t80 -143.42 152.46 41.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 109.991 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.473 ' HB3' ' CG ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -158.7 149.95 20.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.022 -1.049 . . . . 0.0 110.697 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 38.1 p90 -158.6 173.3 16.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.411 -0.805 . . . . 0.0 110.367 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.496 ' HB ' ' HB2' ' A' ' 70' ' ' LYS . 88.5 m -113.29 123.66 50.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.376 -0.828 . . . . 0.0 109.871 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.971 HD23 ' CD2' ' A' ' 69' ' ' HIS . 2.5 tm? -95.73 136.49 36.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 1.085 HD13 ' HE3' ' A' ' 70' ' ' LYS . 13.3 pt -122.0 -28.33 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 110.548 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.585 ' O ' HD21 ' A' ' 85' ' ' LEU . 2.2 tt0 -116.07 141.08 48.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.934 . . . . 0.0 110.226 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.922 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 167.08 123.81 0.68 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 67.7 t0 -45.01 -25.08 0.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.418 -1.048 . . . . 0.0 110.139 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.403 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -70.02 -25.86 63.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.913 . . . . 0.0 110.343 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.538 HD21 ' CG1' ' A' ' 98' ' ' ILE . 89.6 mt -61.44 -33.02 73.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.3 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.71 -167.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -90.54 11.5 21.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -1.16 . . . . 0.0 110.227 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 122' ' ' THR . 36.9 p -102.93 -37.43 7.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.19 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.917 HD23 HG23 ' A' ' 122' ' ' THR . 15.7 mt -110.26 157.17 19.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.042 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -131.33 -78.79 0.52 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.294 -0.879 . . . . 0.0 110.345 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 37.8 mttp -80.18 148.11 31.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 0.0 110.384 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.909 HG21 ' CE2' ' A' ' 100' ' ' TYR . 6.7 mm -132.44 142.66 42.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.936 -1.103 . . . . 0.0 110.055 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.9 m -116.3 120.44 38.91 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.909 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.7 m-85 -115.41 137.66 51.81 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 110.882 -178.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.473 ' CG ' ' HB3' ' A' ' 82' ' ' SER . 4.7 mt-10 -141.21 137.11 32.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.453 -0.779 . . . . 0.0 109.803 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.9 m -131.98 148.01 52.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -136.99 133.83 35.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.077 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.69 HD22 HD12 ' A' ' 18' ' ' LEU . 8.0 mt -119.35 145.97 45.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 110.504 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.0 -169.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.375 -0.828 . . . . 0.0 109.86 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.7 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.53 139.94 52.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.257 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.425 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 84.7 p -95.3 162.87 23.22 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 110.219 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.8 Cg_endo -73.43 -1.09 10.16 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.02 1.537 . . . . 0.0 110.549 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.7 p -98.67 -11.04 22.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.58 -29.22 7.36 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.73 -162.55 7.99 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.504 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 11.8 p -132.33 134.57 45.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -1.087 . . . . 0.0 110.285 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' HG22 ' A' ' 10' ' ' THR . 15.7 mt -83.69 142.55 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.887 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.659 HG12 HD23 ' A' ' 104' ' ' LEU . 9.0 mt -129.62 113.0 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.972 . . . . 0.0 110.501 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 87.1 tttt -102.06 111.54 23.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.895 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 9' ' ' PHE . 1.5 m -93.47 160.08 14.96 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.197 -0.939 . . . . 0.0 110.475 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.003 HG23 ' CG ' ' A' ' 6' ' ' GLU . 40.5 m -154.7 142.47 19.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.391 -0.818 . . . . 0.0 110.29 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 99' ' ' SER . 4.4 p -155.53 139.21 16.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.708 ' ND1' HG23 ' A' ' 4' ' ' THR . 29.2 m-70 -130.5 130.62 44.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.215 -0.928 . . . . 0.0 109.802 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.721 ' HB3' HD22 ' A' ' 95' ' ' LEU . 6.1 m-30 -91.54 154.57 19.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.972 . . . . 0.0 110.795 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.5 m-70 -128.08 85.37 2.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.842 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.917 HG23 HD23 ' A' ' 95' ' ' LEU . 1.2 p -63.18 152.45 37.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 110.295 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 123' ' ' LYS . 50.5 tttt -117.96 97.65 5.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.49 -148.27 17.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.568 ' C ' HG13 ' A' ' 126' ' ' VAL . 46.6 t30 -97.93 91.75 5.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -1.088 . . . . 0.0 110.287 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.568 HG13 ' C ' ' A' ' 125' ' ' ASN . 30.4 m -156.82 159.7 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HG3' ' C ' ' A' ' 126' ' ' VAL . 91.4 mt-10 -145.04 146.06 31.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.181 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.774 ' CG1' HD21 ' A' ' 95' ' ' LEU . 2.7 mp -69.75 173.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 110.106 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.596 ' N ' HG22 ' A' ' 128' ' ' ILE . 46.1 mttt -105.91 160.77 15.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.186 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -66.71 -30.4 70.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 110.033 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.48 ' HG2' ' HB3' ' A' ' 129' ' ' LYS . 17.8 pt-20 -70.11 -36.66 75.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.939 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.493 ' HD1' HG23 ' A' ' 128' ' ' ILE . 20.2 t-160 -70.09 -40.87 74.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.998 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.814 HG22 ' CE1' ' A' ' 5' ' ' TYR . 42.9 t -62.77 -40.2 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 0.0 109.986 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -78.07 -41.86 34.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 110.001 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.98 98.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.942 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.88 -31.9 81.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -75.9 -33.24 59.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -1.095 . . . . 0.0 110.048 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -77.91 -33.05 52.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.907 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -72.49 -36.39 68.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 109.943 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.488 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -73.72 -34.77 64.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 109.937 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.0 m -66.4 -51.5 56.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 109.982 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -50.51 -46.59 57.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 0.0 109.957 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.72 -50.0 75.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 19.0 m-85 -54.94 -35.46 64.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.454 -0.779 . . . . 0.0 109.61 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -79.88 -16.81 54.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -0.831 . . . . 0.0 109.909 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 25.9 mt -84.05 -35.59 23.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.216 -0.928 . . . . 0.0 108.931 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.803 ' CG2' HD23 ' A' ' 18' ' ' LEU . 70.0 mt -70.61 -42.53 77.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.895 ' HB3' HD13 ' A' ' 13' ' ' ILE . 55.8 mt-10 -57.06 -42.04 79.83 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.328 -0.857 . . . . 0.0 109.32 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.445 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 86.5 m -66.29 -34.35 77.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.572 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.638 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 76.4 t80 -54.97 -51.9 64.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.881 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.111 HD21 ' CE1' ' A' ' 158' ' ' TYR . 76.8 mt -77.37 -33.77 55.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.32 -0.863 . . . . 0.0 110.183 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.785 ' HB2' HD11 ' A' ' 13' ' ' ILE . 52.3 tptt -64.6 -22.41 66.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.36 -30.56 3.31 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.547 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 8.6 m-70 -106.68 92.31 7.13 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.287 -1.125 . . . . 0.0 110.148 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.1 Cg_endo -73.89 4.12 4.43 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.052 1.553 . . . . 0.0 110.831 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -110.58 -9.07 14.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.073 -1.017 . . . . 0.0 109.961 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.649 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -63.83 104.63 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.854 . . . . 0.0 109.976 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.111 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.0 OUTLIER 34.52 33.41 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.724 -0.61 . . . . 0.0 110.373 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.547 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.793 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.582 HG22 ' ND1' ' A' ' 121' ' ' HIS . 85.0 t -97.44 134.07 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -1.16 . . . . 0.0 110.418 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.595 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 10.7 m-85 -93.91 149.55 21.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 110.024 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.746 HG23 ' CE1' ' A' ' 119' ' ' HIS . 6.5 m -127.25 112.01 14.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 110.293 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.087 ' CE2' HG21 ' A' ' 133' ' ' VAL . 65.0 m-85 -126.31 136.98 53.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.069 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 4.6 pm0 -139.91 162.03 36.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.893 . . . . 0.0 110.298 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -147.74 154.81 41.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.427 -0.795 . . . . 0.0 109.963 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -134.01 118.85 18.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.975 . . . . 0.0 110.473 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.65 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 3.8 p90 -142.4 -172.66 3.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 109.86 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.7 HG22 ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -143.03 178.72 7.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 110.603 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.406 ' OG ' ' OG ' ' A' ' 112' ' ' SER . 23.4 p -151.48 176.54 11.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.786 . . . . 0.0 109.966 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -92.72 -27.11 17.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.918 . . . . 0.0 110.076 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.78 HG23 ' HD2' ' A' ' 14' ' ' PRO . 24.7 mm -84.23 148.03 51.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.932 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.78 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.32 155.66 67.42 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.98 1.516 . . . . 0.0 111.007 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.655 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.3 Cg_endo -63.73 -37.21 47.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.87 1.458 . . . . 0.0 113.112 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -64.01 -19.68 66.75 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 N-CA-C 109.667 -0.936 . . . . 0.0 109.667 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.75 ' HG2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.91 -43.45 19.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 6.8 mp -75.7 -39.03 58.1 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.588 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.0 t80 -59.32 -54.71 43.67 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.455 0.645 . . . . 0.0 109.982 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.8 mttt -60.44 -34.06 73.44 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 109.839 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.047 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.0 -59.36 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 0.0 110.923 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.065 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -54.66 -39.53 68.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.626 -0.671 . . . . 0.0 111.856 -178.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.101 HG11 ' CD1' ' A' ' 74' ' ' ILE . 21.6 t -106.86 -65.3 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.817 -1.177 . . . . 0.0 112.084 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.0 mp -63.62 -4.72 3.17 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.183 -0.948 . . . . 0.0 112.164 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.95 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.1 m-20 -144.82 8.19 1.27 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.638 -1.289 . . . . 0.0 110.939 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.065 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -52.05 -26.8 11.74 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 110.961 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -68.41 -26.38 65.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.937 -1.102 . . . . 0.0 109.592 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 8.9 p30 -125.7 17.22 8.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.604 -0.685 . . . . 0.0 109.473 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.002 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -94.5 -45.56 7.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.465 -0.772 . . . . 0.0 110.083 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.035 HG21 HD13 ' A' ' 38' ' ' ILE . 4.6 p -79.18 -28.18 0.54 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 112.267 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.867 ' HD3' HG12 ' A' ' 30' ' ' VAL . 51.4 Cg_endo -78.29 4.42 6.27 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 122.69 0.837 . . . . 0.0 110.277 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 28' ' ' ASN . 94.2 mttt -123.41 -28.38 3.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.659 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.616 HG12 ' CD1' ' A' ' 150' ' ' TYR . 25.0 mt -78.48 -31.22 15.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 109.676 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.59 98.24 0.44 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.514 -0.741 . . . . 0.0 110.194 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.58 0.2 8.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.062 1.559 . . . . 0.0 110.543 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -89.96 -18.7 25.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 0.0 110.1 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.54 -49.07 6.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.195 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.035 HD13 HG21 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -120.15 137.2 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 109.973 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 9.4 mmtt -75.43 -42.71 52.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 110.017 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.534 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.02 156.54 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.448 -0.783 . . . . 0.0 110.128 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.1 m -114.88 125.97 54.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.181 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.41 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 55.1 tt0 -128.02 110.69 12.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.316 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 17.2 mt -60.85 131.08 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 110.125 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.508 HD11 ' HD2' ' A' ' 55' ' ' LYS . 47.7 mt -93.3 -44.7 8.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 52' ' ' THR . 1.7 tt0 -130.61 139.47 50.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.42 -0.8 . . . . 0.0 110.142 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.43 -163.92 46.97 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -130.82 2.7 4.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -1.123 . . . . 0.0 110.266 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.561 ' N ' HG21 ' A' ' 52' ' ' THR . . . 133.69 -4.61 4.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.527 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -85.04 -166.77 42.28 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.09 131.17 20.23 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.067 1.562 . . . . 0.0 110.475 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.58 -5.6 67.29 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 45' ' ' GLU . 39.7 m -80.04 140.46 36.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -1.096 . . . . 0.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.694 HD13 ' HA ' ' A' ' 70' ' ' LYS . 26.4 mm -110.18 114.6 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 110.276 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.55 ' HE3' HD11 ' A' ' 71' ' ' ILE . 92.4 mttt -98.0 159.45 14.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.826 . . . . 0.0 110.343 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HD2' HD11 ' A' ' 44' ' ' LEU . 88.3 tttt -133.06 100.55 4.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 110.108 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.557 ' CG2' HG12 ' A' ' 38' ' ' ILE . 88.8 mt -89.11 140.09 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.305 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.2 p -111.06 154.25 24.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 110.849 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.6 m-85 -124.4 122.6 38.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.445 -0.784 . . . . 0.0 110.279 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . 40.6 -162.61 0.01 OUTLIER Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -166.32 139.69 4.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -1.125 . . . . 0.0 110.207 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 62' ' ' SER . . . 174.15 -154.26 18.85 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 61' ' ' GLY . 52.3 m -43.88 -52.16 7.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -1.138 . . . . 0.0 110.157 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -109.45 125.81 52.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.154 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -83.85 134.62 34.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.258 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -113.1 96.84 0.83 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 9.7 p90 -133.41 153.21 51.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -1.173 . . . . 0.0 109.992 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.858 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.6 m -125.28 172.5 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.186 -0.946 . . . . 0.0 110.774 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HD2' ' OE1' ' A' ' 87' ' ' GLU . 69.6 mttt -124.92 129.19 49.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.708 -0.62 . . . . 0.0 109.371 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.582 ' CD2' HD12 ' A' ' 85' ' ' LEU . 10.1 m170 -117.59 120.31 37.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.161 -0.962 . . . . 0.0 110.993 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.694 ' HA ' HD13 ' A' ' 53' ' ' ILE . 55.3 tttm -96.67 109.85 22.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.821 . . . . 0.0 109.407 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.55 HD11 ' HE3' ' A' ' 54' ' ' LYS . 26.1 mm -48.55 139.46 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -0.982 . . . . 0.0 110.175 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.541 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 17.9 t0 -111.65 -40.55 4.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.477 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 0.7 OUTLIER 172.78 160.84 0.12 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.581 -0.7 . . . . 0.0 110.339 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.101 ' CD1' HG11 ' A' ' 23' ' ' VAL . 12.5 tt -149.27 172.24 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.536 -0.728 . . . . 0.0 109.505 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.7 m-20 -139.71 83.56 1.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.104 -0.998 . . . . 0.0 110.412 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.588 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 35.7 mtmm -59.27 -14.05 9.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.897 . . . . 0.0 110.44 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -96.02 -30.12 13.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 109.562 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.3 m-80 -107.68 -0.75 21.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.601 -0.687 . . . . 0.0 109.357 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.552 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 74.3 m-85 60.4 53.72 4.15 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.356 0.598 . . . . 0.0 110.598 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -127.74 156.0 43.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 109.617 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 86.5 t80 -152.99 146.89 25.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.079 -1.013 . . . . 0.0 110.434 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.435 ' CB ' ' HA ' ' A' ' 101' ' ' GLU . 1.8 m -156.34 145.64 20.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.385 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.6 p90 -143.86 177.78 8.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.518 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 98' ' ' ILE . 80.4 m -124.02 124.69 43.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.429 -0.794 . . . . 0.0 109.626 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.631 HD21 HD11 ' A' ' 91' ' ' LEU . 1.7 tp -93.59 137.32 32.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.32 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.3 pt -124.24 -12.2 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 110.257 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.465 ' O ' HD11 ' A' ' 85' ' ' LEU . 4.6 tt0 -129.21 160.45 32.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 110.236 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.858 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 146.55 132.0 2.29 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -64.81 -12.01 43.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -1.097 . . . . 0.0 110.033 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.585 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -81.38 -29.18 34.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.347 -0.846 . . . . 0.0 110.064 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.745 HD21 HG13 ' A' ' 98' ' ' ILE . 24.1 mt -66.11 -27.55 68.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 110.122 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.62 -172.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -82.49 6.38 17.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -1.163 . . . . 0.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 122' ' ' THR . 14.0 p -93.24 -30.8 15.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.064 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.022 HD21 ' CG1' ' A' ' 128' ' ' ILE . 34.0 mt -113.35 153.02 29.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.344 -0.848 . . . . 0.0 109.947 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 41.1 tt0 -131.45 -79.78 0.52 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.229 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.5 mttt -80.16 133.61 36.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.58 -0.7 . . . . 0.0 110.541 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.745 HG13 HD21 ' A' ' 91' ' ' LEU . 7.1 mm -123.9 143.36 37.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.863 -1.148 . . . . 0.0 109.683 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.76 127.43 50.63 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.203 179.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.693 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.2 m-85 -123.51 133.04 54.06 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.4 -0.812 . . . . 0.0 110.425 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.435 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 73.7 tt0 -130.3 158.17 40.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 110.118 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' TYR . 66.7 m -155.8 138.77 15.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.954 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 115' ' ' LYS . 3.4 mttt -132.28 136.05 46.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.818 HD23 HG12 ' A' ' 114' ' ' ILE . 2.9 mt -119.06 149.66 41.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 110.467 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.54 -169.23 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.409 -0.807 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.698 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.56 134.11 53.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 52.4 p -89.03 164.39 31.14 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.9 Cg_endo -73.22 -0.27 8.92 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.045 1.55 . . . . 0.0 110.598 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.1 p -104.38 5.19 34.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 110.247 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.04 -41.28 2.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.66 -172.11 0.55 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 82.4 p -130.13 138.24 50.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -1.135 . . . . 0.0 110.29 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.7 ' HA ' HG22 ' A' ' 10' ' ' THR . 14.0 mt -88.05 151.6 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.889 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.818 HG12 HD23 ' A' ' 104' ' ' LEU . 5.5 mt -136.41 110.08 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.339 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 103' ' ' LYS . 78.0 tttt -98.25 119.49 37.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.936 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -112.94 155.34 24.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 110.395 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.458 HG22 ' NE2' ' A' ' 119' ' ' HIS . 98.9 m -158.09 126.04 5.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.87 . . . . 0.0 109.999 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 p -127.87 165.3 20.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 110.366 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.746 ' CE1' HG23 ' A' ' 4' ' ' THR . 56.9 m-70 -142.46 168.45 19.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.325 -0.86 . . . . 0.0 110.055 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.542 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 9.1 m-85 -130.74 148.72 52.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.377 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.582 ' ND1' HG22 ' A' ' 2' ' ' VAL . 95.0 m-70 -131.67 86.46 2.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.182 -0.949 . . . . 0.0 109.701 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.527 HG21 ' O ' ' A' ' 126' ' ' VAL . 1.1 p -56.54 160.7 3.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.157 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 66.0 tttt -119.13 107.61 13.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.238 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.8 -111.6 4.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.611 ' O ' HG13 ' A' ' 126' ' ' VAL . 35.2 t30 -134.21 85.85 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -1.129 . . . . 0.0 110.402 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 125' ' ' ASN . 16.6 m -157.93 173.09 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 110.1 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HA ' HG21 ' A' ' 122' ' ' THR . 84.1 mt-10 -144.84 171.43 14.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.248 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.022 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.9 mp -91.42 172.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 110.02 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.607 ' N ' HG22 ' A' ' 128' ' ' ILE . 19.7 mttt -114.39 131.26 56.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.89 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.543 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 83.9 mt-10 -43.39 -47.59 6.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 110.107 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -58.3 -27.28 63.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.63 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.585 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 12.3 t-160 -83.42 -55.6 4.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.956 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.087 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.3 p -65.13 -42.15 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 109.961 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.56 ' N ' HG13 ' A' ' 133' ' ' VAL . 35.7 ttmt -63.31 -42.94 99.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.814 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.65 73.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.84 . . . . 0.0 109.87 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.5 -35.61 92.0 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 5' ' ' TYR . 69.5 mmtt -64.35 -32.44 74.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -1.114 . . . . 0.0 109.908 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -72.27 -38.55 68.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.442 -0.786 . . . . 0.0 109.937 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -62.81 -46.51 87.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.806 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.47 -40.2 95.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.8 t -72.46 -52.0 17.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.403 -0.81 . . . . 0.0 109.799 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -50.47 -48.76 56.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.593 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.1 mp -54.62 -49.76 69.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.481 ' HA ' HD12 ' A' ' 147' ' ' ILE . 4.1 m-85 -54.18 -41.88 69.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.725 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -66.46 -28.29 68.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 109.872 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 146' ' ' LEU . 14.5 mt -80.59 -35.37 34.3 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.542 ' HA ' HD13 ' A' ' 33' ' ' ILE . 96.8 mt -66.79 -41.25 87.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 49.5 mt-10 -54.84 -47.16 74.49 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.403 -0.811 . . . . 0.0 109.18 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.3 m -61.15 -31.53 71.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.445 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.616 ' CD1' HG12 ' A' ' 33' ' ' ILE . 59.7 t80 -64.01 -52.89 57.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.789 . . . . 0.0 109.655 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.061 HD21 ' CE1' ' A' ' 158' ' ' TYR . 56.8 mt -80.07 -33.68 38.74 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 110.408 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.568 ' CG ' HG12 ' A' ' 13' ' ' ILE . 49.5 mtpt -65.71 -14.04 60.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.119 -0.988 . . . . 0.0 109.426 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.481 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.77 -30.27 1.4 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.508 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.1 m-70 -106.43 93.49 8.39 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.189 -1.183 . . . . 0.0 110.253 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.512 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.3 Cg_endo -74.26 3.82 4.89 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.101 1.58 . . . . 0.0 110.644 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -106.99 -11.25 15.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -67.83 100.62 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.757 . . . . 0.0 109.919 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.061 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.1 p90 34.59 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.25 0.548 . . . . 0.0 110.604 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.771 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 78.5 t -110.1 132.86 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -1.191 . . . . 0.0 110.236 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.681 ' CE1' HD12 ' A' ' 128' ' ' ILE . 12.3 m-85 -94.3 149.08 21.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.253 -0.904 . . . . 0.0 109.983 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.627 HG23 ' CE1' ' A' ' 119' ' ' HIS . 8.6 m -127.56 114.19 17.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 110.443 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.155 ' CE2' HG21 ' A' ' 133' ' ' VAL . 64.8 m-85 -128.45 139.52 52.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.822 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 13.6 pt-20 -140.17 152.7 46.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 110.735 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.529 ' C ' ' HG ' ' A' ' 116' ' ' SER . 0.2 OUTLIER -147.22 166.04 28.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.499 -0.75 . . . . 0.0 109.45 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -144.23 145.78 32.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.058 -1.026 . . . . 0.0 110.553 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.642 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 6.3 p90 -159.01 -172.45 3.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.715 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.4 p -137.33 172.57 12.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.101 -1.0 . . . . 0.0 110.708 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 112' ' ' SER . 92.9 p -151.01 149.1 29.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 0.0 110.503 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -67.29 -25.97 66.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 0.0 110.184 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.721 HD13 ' CB ' ' A' ' 148' ' ' GLU . 4.7 mp -84.46 146.05 46.44 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 110.116 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.679 ' HD2' HG23 ' A' ' 13' ' ' ILE . 43.2 Cg_endo -67.96 154.65 72.25 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.136 1.598 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.667 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.0 Cg_endo -62.73 -37.13 58.53 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.748 1.394 . . . . 0.0 113.106 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 37.9 Cg_endo -63.58 -20.2 68.96 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 N-CA-C 109.823 -0.876 . . . . 0.0 109.823 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.855 ' HB3' HD13 ' A' ' 151' ' ' LEU . 5.7 mmp_? -80.64 -45.47 17.19 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.714 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.0 mp -75.51 -36.04 60.63 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.802 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 55.3 t80 -58.29 -58.01 10.38 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.107 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 87.4 mttt -59.86 -35.92 75.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.392 -0.818 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.083 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -79.33 -61.55 1.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.357 -0.84 . . . . 0.0 111.019 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.958 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -53.84 -38.28 64.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.448 -0.783 . . . . 0.0 111.653 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.827 HG13 ' CE1' ' A' ' 81' ' ' TYR . 8.0 t -105.22 -66.29 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.892 -1.13 . . . . 0.0 111.661 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.0 mp -66.74 -4.24 8.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.174 -0.954 . . . . 0.0 111.445 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.685 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -147.96 31.26 0.86 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.807 -1.183 . . . . 0.0 110.544 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.958 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -70.57 -32.67 70.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.98 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.57 ' OD2' HD11 ' A' ' 43' ' ' ILE . 94.7 m-20 -65.49 -15.89 63.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.869 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 74.0 m-80 -126.59 10.5 7.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 110.057 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.736 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -96.68 -54.2 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.926 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.0 t -67.38 -42.02 35.85 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 0.0 110.79 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -78.52 8.64 3.54 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.513 1.27 . . . . 0.0 110.693 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 35.1 mttt -126.77 -32.23 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.093 -1.005 . . . . 0.0 109.661 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.741 HD13 ' HA ' ' A' ' 147' ' ' ILE . 45.8 mt -80.0 -34.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.475 -0.766 . . . . 0.0 109.455 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.78 99.35 1.5 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.485 -0.759 . . . . 0.0 110.026 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.02 -0.75 8.98 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.092 1.575 . . . . 0.0 110.561 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -86.74 -9.69 55.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.878 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.714 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -101.18 -47.05 4.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.392 -0.817 . . . . 0.0 110.099 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.926 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.8 mp -124.98 143.02 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.459 -0.776 . . . . 0.0 109.874 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' THR . 36.5 ttmt -80.39 -37.92 31.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 110.262 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.549 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 178.8 139.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.248 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 3.2 m -102.17 128.11 48.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 110.314 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.549 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 27.0 tp10 -132.81 115.17 14.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.834 . . . . 0.0 110.14 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.57 HD11 ' OD2' ' A' ' 27' ' ' ASP . 10.7 mt -64.97 133.05 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 110.363 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 44' ' ' LEU . 24.3 mt -94.36 -45.74 7.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 110.204 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.894 ' O ' HG23 ' A' ' 52' ' ' THR . 6.9 mt-10 -130.51 141.3 50.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 110.116 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.86 -169.87 54.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -130.79 16.35 5.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -1.141 . . . . 0.0 110.304 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.495 ' N ' HG21 ' A' ' 52' ' ' THR . . . 124.39 -8.41 8.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -82.02 -168.92 42.31 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.2 Cg_endo -69.82 134.26 27.43 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.166 1.614 . . . . 0.0 110.468 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.21 76.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.894 HG23 ' O ' ' A' ' 45' ' ' GLU . 37.2 m -79.97 138.75 37.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -1.145 . . . . 0.0 110.069 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.635 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.9 mm -109.35 111.66 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 110.288 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 81.6 mttt -97.14 154.72 17.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 110.204 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -127.52 104.55 7.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.455 HD12 ' CE1' ' A' ' 69' ' ' HIS . 85.4 mt -90.82 140.84 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.3 p -113.28 150.97 31.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 110.333 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.7 m-85 -116.25 137.35 52.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 110.335 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -104.59 61.09 0.41 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -84.33 -23.7 30.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -1.117 . . . . 0.0 110.32 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.33 -160.7 27.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 t -61.32 -54.99 36.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.205 -1.174 . . . . 0.0 110.242 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -42.97 143.08 0.79 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.193 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.691 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 3.9 t80 -84.32 114.39 21.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.969 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -115.74 97.4 0.79 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.691 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 25.3 p90 -134.6 168.27 19.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.167 -1.196 . . . . 0.0 110.171 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.887 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.2 m -137.45 171.84 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 110.486 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' O ' HD12 ' A' ' 85' ' ' LEU . 87.3 mttt -123.03 124.05 42.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.617 -0.677 . . . . 0.0 109.577 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.599 ' CD2' HD13 ' A' ' 85' ' ' LEU . 22.5 m170 -111.62 136.27 51.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -0.988 . . . . 0.0 110.906 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.635 ' HA ' HD13 ' A' ' 53' ' ' ILE . 79.1 tttt -114.83 108.87 17.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.462 -0.774 . . . . 0.0 109.507 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 37.0 mm -44.99 137.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 110.047 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.522 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 25.8 t0 -107.47 -47.63 3.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.869 . . . . 0.0 109.51 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 9.4 m -171.94 156.88 4.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.578 -0.702 . . . . 0.0 109.688 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.7 mt -136.86 157.31 35.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 110.119 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 4.7 m-20 -135.28 79.26 1.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.344 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.582 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 81.3 mttt -63.77 -11.43 26.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.248 -0.908 . . . . 0.0 109.967 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -98.14 -30.14 12.83 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.739 0.78 . . . . 0.0 109.177 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -105.12 -2.69 23.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.67 -0.644 . . . . 0.0 109.432 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.545 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 76.6 m-85 59.75 55.18 4.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.677 -0.639 . . . . 0.0 110.408 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -130.64 162.17 29.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.8 . . . . 0.0 109.782 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.827 ' CE1' HG13 ' A' ' 23' ' ' VAL . 37.5 t80 -144.56 137.32 26.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 110.096 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 35.3 m -139.79 126.9 21.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.98 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 9.2 p90 -141.83 179.4 6.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.751 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 98' ' ' ILE . 91.5 m -135.88 152.17 50.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.494 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.599 HD13 ' CD2' ' A' ' 69' ' ' HIS . 52.3 tp -106.68 125.45 51.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.414 -0.804 . . . . 0.0 109.941 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.7 pt -109.28 -8.81 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.428 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.427 ' OE1' ' HD2' ' A' ' 68' ' ' LYS . 30.1 tt0 -150.48 159.25 44.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.326 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.887 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 160.43 139.95 2.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -71.26 -24.93 62.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -1.115 . . . . 0.0 110.075 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.26 -22.95 61.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 110.146 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.658 HD22 HD12 ' A' ' 98' ' ' ILE . 74.7 mt -60.81 -22.48 64.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.002 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.31 -179.39 0.01 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -80.14 6.01 12.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -1.139 . . . . 0.0 110.014 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.472 ' HA ' HG21 ' A' ' 126' ' ' VAL . 30.8 p -98.33 -23.29 15.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.038 HD21 ' CG1' ' A' ' 128' ' ' ILE . 42.1 mt -123.68 162.54 22.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 110.271 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -140.94 -81.69 0.24 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.3 -0.875 . . . . 0.0 109.861 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.556 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 34.8 mttt -80.41 161.04 25.14 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.709 -0.619 . . . . 0.0 110.103 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.658 HD12 HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -156.17 140.13 8.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 178.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 3.7 m -116.63 121.69 42.42 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 11.5 m-85 -112.82 139.78 48.16 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.413 -0.805 . . . . 0.0 110.3 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 80.8 tt0 -135.22 144.24 46.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 109.894 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.0 m -146.77 125.92 12.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.184 -0.948 . . . . 0.0 110.352 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 1.1 ttmt -116.22 146.94 41.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 109.813 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.787 HD23 HG12 ' A' ' 114' ' ' ILE . 6.3 mt -120.58 147.7 44.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.998 . . . . 0.0 110.78 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.89 -168.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.0 109.567 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.713 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -129.9 157.29 42.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 110.52 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -110.44 179.68 0.78 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.795 . . . . 0.0 109.618 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 107' ' ' SER . 40.6 Cg_endo -66.64 73.93 0.41 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.817 1.43 . . . . 0.0 109.577 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 4.0 m 57.35 37.29 27.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.497 -0.752 . . . . 0.0 109.742 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.53 42.72 1.47 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.34 -127.61 8.87 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 92.2 p -151.62 143.28 23.63 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.341 -1.093 . . . . 0.0 109.616 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.579 ' HA ' HG22 ' A' ' 10' ' ' THR . 34.4 mt -90.46 150.32 3.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.196 -0.94 . . . . 0.0 110.571 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.787 HG12 HD23 ' A' ' 104' ' ' LEU . 5.8 mt -138.16 108.92 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.198 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -81.67 143.8 31.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 109.931 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.529 ' HG ' ' C ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -128.01 140.64 51.85 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 110.5 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 53.4 m -152.3 131.86 13.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.346 -0.846 . . . . 0.0 109.847 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.441 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 52.6 p -137.97 165.09 27.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 110.578 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.627 ' CE1' HG23 ' A' ' 4' ' ' THR . 48.1 m-70 -145.48 161.28 40.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.33 -0.856 . . . . 0.0 110.041 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 10.3 m-85 -121.97 147.54 45.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 110.359 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.556 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 99.6 m-70 -130.94 85.6 2.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.272 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.535 ' OG1' HG23 ' A' ' 126' ' ' VAL . 1.4 t -72.89 176.58 5.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.313 -0.867 . . . . 0.0 110.948 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -132.9 131.28 40.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.622 -0.673 . . . . 0.0 110.186 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.06 -111.13 4.18 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.533 ' C ' HG13 ' A' ' 126' ' ' VAL . 36.0 t30 -151.41 81.34 1.3 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -1.143 . . . . 0.0 110.136 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.535 HG23 ' OG1' ' A' ' 122' ' ' THR . 30.8 m -154.1 160.82 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -126.94 161.26 28.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.152 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.038 ' CG1' HD21 ' A' ' 95' ' ' LEU . 4.7 mp -79.91 172.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.954 . . . . 0.0 110.351 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.587 ' N ' HG22 ' A' ' 128' ' ' ILE . 47.4 mttt -106.83 128.29 54.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.324 -0.86 . . . . 0.0 109.86 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.459 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 92.7 mt-10 -43.62 -46.99 7.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.46 -24.59 63.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 109.88 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 129' ' ' LYS . 12.5 t-160 -84.92 -54.16 4.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -0.805 . . . . 0.0 110.14 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.155 HG21 ' CE2' ' A' ' 5' ' ' TYR . 9.3 p -66.84 -41.41 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.065 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.551 ' N ' HG13 ' A' ' 133' ' ' VAL . 81.5 tttt -64.95 -43.56 92.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.907 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -29.27 69.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.926 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.76 -32.19 73.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -70.1 -36.69 75.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.986 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -68.73 -33.79 74.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 109.778 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -66.99 -37.37 84.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.823 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.16 90.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.296 -0.877 . . . . 0.0 109.791 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.7 m -61.32 -48.46 81.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.371 -0.831 . . . . 0.0 109.742 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 145' ' ' LYS . 98.4 m-20 -51.25 -42.69 61.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 146' ' ' LEU . 25.8 tp -56.32 -54.58 43.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.737 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.585 ' CE1' HG21 ' A' ' 114' ' ' ILE . 17.3 m-85 -48.03 -37.66 15.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.551 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 142' ' ' ASN . 98.9 mttt -68.75 -24.27 64.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.626 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.493 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 30.1 mt -84.51 -34.86 23.24 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.225 -0.922 . . . . 0.0 108.92 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.741 ' HA ' HD13 ' A' ' 33' ' ' ILE . 52.5 mt -71.88 -33.99 49.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.578 -0.702 . . . . 0.0 109.336 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.721 ' CB ' HD13 ' A' ' 13' ' ' ILE . 78.4 mt-10 -64.37 -38.49 91.23 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.502 -0.749 . . . . 0.0 109.55 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 90.0 m -70.06 -38.02 75.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 109.478 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.612 ' CD1' HG12 ' A' ' 33' ' ' ILE . 68.1 t80 -55.73 -51.52 67.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.416 -0.803 . . . . 0.0 109.774 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.09 HD21 ' CE1' ' A' ' 158' ' ' TYR . 77.8 mt -80.03 -41.48 25.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 110.1 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.635 ' HB2' HD11 ' A' ' 13' ' ' ILE . 49.2 tttp -64.06 -19.92 65.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.361 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.71 -34.78 2.75 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 3.8 m-70 -110.6 94.88 20.69 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.324 -1.104 . . . . 0.0 110.101 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -74.14 5.48 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.093 1.575 . . . . 0.0 110.985 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -105.55 -7.92 18.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.994 -1.066 . . . . 0.0 109.865 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -71.57 102.08 2.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.427 -0.795 . . . . 0.0 110.121 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.09 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.1 p90 34.24 32.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.797 -0.564 . . . . 0.0 110.71 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.763 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 86.0 t -122.35 118.53 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.133 -1.216 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.572 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 58.5 m-85 -86.31 163.29 17.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 110.307 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.867 HG23 ' CE1' ' A' ' 119' ' ' HIS . 75.7 m -141.35 92.87 2.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.686 ' CE1' HG11 ' A' ' 133' ' ' VAL . 83.5 m-85 -109.01 126.03 52.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.977 . . . . 0.0 109.815 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 116' ' ' SER . 16.1 pt-20 -128.79 153.03 47.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 110.445 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.8 m -123.88 141.06 52.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.917 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.443 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 83.0 mt-10 -121.62 124.02 43.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 110.447 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.2 p90 -151.13 -172.86 4.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.938 . . . . 0.0 109.947 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.568 HG22 HG12 ' A' ' 113' ' ' ILE . 17.3 p -138.84 -178.21 5.22 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 110.547 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 112' ' ' SER . 98.9 p -157.27 150.05 23.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.432 -0.792 . . . . 0.0 110.349 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -75.51 -8.39 56.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.124 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.0 mm -96.79 149.78 36.16 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.414 -0.804 . . . . 0.0 110.084 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -64.96 148.01 89.47 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.975 1.513 . . . . 0.0 110.376 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.668 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -71.14 -32.21 13.45 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.877 1.462 . . . . 0.0 112.899 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.12 -20.62 37.61 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 N-CA-C 109.871 -0.857 . . . . 0.0 109.871 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.866 ' HG2' HD13 ' A' ' 151' ' ' LEU . 4.5 ttm180 -83.36 -46.72 12.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.756 HD23 ' C ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -72.95 -28.87 62.68 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.086 178.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 87.0 t80 -65.86 -56.52 11.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.436 -0.79 . . . . 0.0 109.544 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.779 ' HA ' HD12 ' A' ' 24' ' ' LEU . 90.8 mttt -54.36 -39.25 66.98 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.279 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.061 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -68.82 -53.28 22.45 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.501 0.667 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.806 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -63.86 -45.47 89.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 111.511 -178.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.657 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.1 t -99.05 -57.23 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.99 -1.069 . . . . 0.0 111.725 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 20' ' ' LYS . 27.5 mt -76.42 1.72 15.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.136 -0.977 . . . . 0.0 111.678 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.707 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -154.68 38.8 0.43 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.733 -1.229 . . . . 0.0 110.898 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -76.3 -31.29 58.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.082 -1.011 . . . . 0.0 110.228 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 79.8 m-20 -65.41 -13.6 59.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.093 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.547 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 66.9 m-20 -128.81 8.23 5.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 110.073 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.9 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -94.93 -51.17 4.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.431 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.095 HG21 HD13 ' A' ' 38' ' ' ILE . 8.2 p -75.37 -27.14 0.67 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.925 . . . . 0.0 112.267 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.814 ' HD3' HG12 ' A' ' 30' ' ' VAL . 53.0 Cg_endo -81.37 8.61 4.29 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 122.743 0.865 . . . . 0.0 110.625 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -137.39 -30.29 0.85 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.056 -1.028 . . . . 0.0 110.609 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.9 HD11 ' CD1' ' A' ' 29' ' ' LEU . 67.2 mt -75.24 -41.29 43.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.274 -0.891 . . . . 0.0 109.692 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.57 90.76 2.84 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.422 -0.798 . . . . 0.0 110.374 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.78 1.68 7.34 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.112 1.585 . . . . 0.0 110.321 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -87.2 -23.2 24.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.161 -0.962 . . . . 0.0 109.892 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.48 -42.59 8.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.095 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -121.94 146.97 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.788 . . . . 0.0 109.827 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 17.1 tppt? -86.87 -42.22 13.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.371 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.55 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER 179.08 139.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 110.403 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 27' ' ' ASP . 4.2 m -94.25 137.32 33.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.55 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 20.7 tt0 -142.03 110.08 5.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 45.5 mt -60.46 132.16 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 110.143 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.9 tp -95.71 -39.04 10.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.38 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 52' ' ' THR . 2.5 mt-10 -136.43 137.63 40.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 110.133 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.412 ' O ' ' OD1' ' A' ' 47' ' ' ASP . . . 81.08 -162.41 44.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 89.0 m-20 -137.65 20.99 2.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -1.167 . . . . 0.0 110.213 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.537 ' H ' HG21 ' A' ' 52' ' ' THR . . . 118.88 -12.14 11.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.536 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -75.01 -169.93 25.52 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.65 132.46 20.38 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.123 1.591 . . . . 0.0 110.382 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.78 67.26 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 45' ' ' GLU . 32.1 m -79.84 143.19 34.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.186 . . . . 0.0 110.042 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.4 mm -111.49 104.27 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.953 . . . . 0.0 110.328 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 51.9 mtpt -89.5 137.22 32.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.383 -0.823 . . . . 0.0 110.245 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -113.79 103.08 10.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.842 . . . . 0.0 110.356 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.541 ' CG2' HG12 ' A' ' 38' ' ' ILE . 87.3 mt -89.15 140.65 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.177 -0.952 . . . . 0.0 109.976 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 40' ' ' HIS . 1.3 p -112.49 152.94 28.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.52 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.711 ' HE2' HG13 ' A' ' 67' ' ' VAL . 30.9 m-85 -113.26 160.25 18.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.883 . . . . 0.0 110.145 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.41 170.07 22.45 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 53.71 66.26 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -1.106 . . . . 0.0 110.193 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.24 -135.23 2.0 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.7 p -61.67 178.21 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -1.158 . . . . 0.0 110.087 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -54.2 -48.89 70.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.169 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.679 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 8.3 t80 -135.85 117.0 14.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -113.36 135.03 12.27 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.679 ' CD2' ' CE2' ' A' ' 64' ' ' TYR . 11.4 p90 -178.52 160.26 1.23 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 110.112 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.833 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.8 m -141.36 171.65 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.39 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.802 ' CD ' HD11 ' A' ' 86' ' ' ILE . 23.8 ttmt -123.09 124.11 42.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.598 -0.689 . . . . 0.0 109.881 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.468 ' NE2' HD13 ' A' ' 85' ' ' LEU . 10.6 m170 -113.56 123.52 50.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 110.751 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.562 ' HA ' HD13 ' A' ' 53' ' ' ILE . 84.4 tttt -100.09 110.79 23.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 109.612 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 49' ' ' GLY . 33.4 mm -50.97 133.85 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 110.439 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 83.2 m-20 -106.25 -37.15 6.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.316 -0.865 . . . . 0.0 109.87 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 11.8 p 178.16 157.72 0.44 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.747 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.466 HG13 ' HD1' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -138.66 153.62 25.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.051 -179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 79' ' ' TYR . 6.3 m-20 -131.02 77.49 1.79 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.529 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 85.1 mttt -63.04 -11.85 22.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.232 -0.918 . . . . 0.0 110.005 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -98.12 -31.82 11.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.746 . . . . 0.0 109.235 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -102.45 -3.26 27.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.634 -0.666 . . . . 0.0 109.342 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.552 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 74.8 m-85 60.87 54.76 3.39 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.524 0.678 . . . . 0.0 110.6 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -130.97 156.53 44.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.679 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.703 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 61.2 t80 -143.67 141.61 30.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.931 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.47 ' OG ' ' HG2' ' A' ' 101' ' ' GLU . 53.6 m -148.7 136.97 21.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.14 -0.975 . . . . 0.0 110.755 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.703 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.0 p90 -147.82 175.61 10.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.399 -0.813 . . . . 0.0 110.29 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 98' ' ' ILE . 44.9 m -124.47 128.84 49.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.858 . . . . 0.0 109.851 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.552 HD11 ' O ' ' A' ' 87' ' ' GLU . 4.5 tp -95.47 124.88 39.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -0.978 . . . . 0.0 110.167 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.802 HD11 ' CD ' ' A' ' 68' ' ' LYS . 16.9 pt -109.23 -5.83 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 110.229 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.552 ' O ' HD11 ' A' ' 85' ' ' LEU . 9.1 tt0 -136.56 162.35 33.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 110.327 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.833 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 149.14 125.08 1.38 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -57.89 -31.39 66.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -1.11 . . . . 0.0 110.187 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.18 -18.58 65.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.079 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.599 HD21 HG13 ' A' ' 98' ' ' ILE . 86.9 mt -70.72 -30.45 66.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.62 -174.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -80.89 4.51 19.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -1.146 . . . . 0.0 110.26 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.634 ' O ' HG22 ' A' ' 122' ' ' THR . 78.1 p -89.47 -41.47 12.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.92 . . . . 0.0 110.108 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.011 HD23 HG23 ' A' ' 122' ' ' THR . 62.9 mt -102.47 152.33 21.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.854 . . . . 0.0 109.987 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.51 ' CG ' ' HD3' ' A' ' 123' ' ' LYS . 5.6 tp10 -131.54 -80.56 0.52 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.304 -0.873 . . . . 0.0 110.087 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 59.3 mttt -80.21 127.78 32.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.581 -0.7 . . . . 0.0 110.522 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.746 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -116.77 139.05 45.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 120.702 -1.249 . . . . 0.0 109.856 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.49 127.68 54.24 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.405 -0.81 . . . . 0.0 108.974 178.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.746 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.6 m-85 -122.56 133.98 54.55 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.331 -0.856 . . . . 0.0 110.509 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.47 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 3.2 mt-10 -132.56 141.18 48.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.1 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 81' ' ' TYR . 63.6 m -137.04 143.13 42.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.792 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -137.19 135.76 37.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 110.169 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.752 HD23 HG12 ' A' ' 114' ' ' ILE . 4.9 mt -120.07 148.21 43.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.362 -0.836 . . . . 0.0 110.533 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.7 -169.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 0.0 109.799 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.698 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -115.35 167.16 11.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 110.214 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.532 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 57.6 p -126.42 175.42 3.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 109.948 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.8 Cg_endo -87.29 22.8 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.87 1.458 . . . . 0.0 110.498 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 t -126.67 -10.99 6.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.913 . . . . 0.0 110.409 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.96 -26.68 10.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.9 -149.59 1.56 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 8.4 p -149.12 137.79 21.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -1.17 . . . . 0.0 110.152 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.568 HG12 HG22 ' A' ' 10' ' ' THR . 68.5 mt -86.86 148.91 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 110.122 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.752 HG12 HD23 ' A' ' 104' ' ' LEU . 9.7 mt -132.79 125.26 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.391 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 75.1 tttt -115.86 108.43 16.28 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.2 m -98.84 158.85 15.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 110.538 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 101' ' ' GLU . 53.4 m -159.35 126.01 4.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.398 -0.814 . . . . 0.0 110.278 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.4 m -128.97 160.01 34.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 0.0 110.183 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.867 ' CE1' HG23 ' A' ' 4' ' ' THR . 62.3 m-70 -136.73 162.11 34.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.246 -0.909 . . . . 0.0 110.15 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.8 m-85 -126.58 136.24 52.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.912 . . . . 0.0 110.99 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 93.3 m-70 -119.0 81.49 1.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.915 . . . . 0.0 109.34 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 1.011 HG23 HD23 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -66.69 154.52 40.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 111.102 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HD3' ' CG ' ' A' ' 96' ' ' GLU . 37.8 mtmt -103.8 116.86 33.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.521 -0.737 . . . . 0.0 109.829 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 106.74 9.72 30.05 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 5.8 t30 69.4 51.4 0.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -1.134 . . . . 0.0 110.451 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 127' ' ' GLU . 85.4 t -92.63 175.15 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.331 -0.855 . . . . 0.0 109.549 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.601 ' N ' HG12 ' A' ' 126' ' ' VAL . 90.8 mt-10 -124.3 149.34 46.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.969 -1.082 . . . . 0.0 110.563 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.881 ' CD1' HD21 ' A' ' 95' ' ' LEU . 15.8 mm -75.42 172.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 110.202 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.594 ' N ' HG22 ' A' ' 128' ' ' ILE . 70.3 mmtt -111.29 129.88 55.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.288 -0.882 . . . . 0.0 109.842 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' LYS . 54.1 mt-10 -43.09 -43.5 4.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.147 -0.971 . . . . 0.0 110.184 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -62.45 -25.36 67.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 110.025 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.8 t-160 -78.11 -50.54 11.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.836 . . . . 0.0 110.147 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.686 HG11 ' CE1' ' A' ' 5' ' ' TYR . 72.7 t -57.24 -32.85 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.0 109.746 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -80.17 -40.77 26.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.831 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.92 -36.82 84.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.335 -0.853 . . . . 0.0 109.906 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.56 -30.04 69.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.461 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 91.7 mttt -77.49 -32.1 54.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 0.0 109.985 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -76.13 -33.24 59.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.387 -0.821 . . . . 0.0 109.973 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.21 -33.46 65.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.919 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -79.07 -36.11 41.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.0 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.0 m -62.11 -47.36 84.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.958 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -53.93 -50.03 67.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.816 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.48 ' HA ' HD12 ' A' ' 143' ' ' LEU . 15.9 tp -57.18 -45.32 83.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.789 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 21.6 m-85 -56.83 -41.34 77.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.406 -0.809 . . . . 0.0 109.643 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.417 ' HB2' ' HE3' ' A' ' 145' ' ' LYS . 45.9 mtmt -78.84 -14.92 58.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 109.828 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.498 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 19.7 mt -83.22 -36.69 24.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.258 -0.901 . . . . 0.0 108.818 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.747 HD11 ' CE1' ' A' ' 22' ' ' PHE . 16.1 mt -69.42 -46.22 76.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.495 ' O ' HG13 ' A' ' 13' ' ' ILE . 64.1 mt-10 -56.78 -36.65 70.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.402 -0.811 . . . . 0.0 109.551 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.4 m -72.23 -39.43 68.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.778 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.651 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 77.0 t80 -53.59 -52.13 60.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -0.843 . . . . 0.0 110.089 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.194 HD21 ' CE2' ' A' ' 158' ' ' TYR . 74.6 mt -75.25 -33.98 61.36 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.213 -0.93 . . . . 0.0 110.27 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 37.6 ttpt -69.98 -20.62 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -109.06 -31.13 3.42 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.53 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 9.9 m-70 -109.53 93.3 13.61 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.308 -1.113 . . . . 0.0 109.942 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.16 5.27 3.68 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.07 1.563 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -109.83 2.24 19.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.003 -1.06 . . . . 0.0 109.856 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.651 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -83.59 103.22 12.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 109.995 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.194 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.99 31.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.722 -0.611 . . . . 0.0 110.472 -179.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.721 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.876 HG13 ' O ' ' A' ' 120' ' ' TYR . 70.6 t -120.89 118.67 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.214 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.603 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 90.8 m-85 -75.91 149.88 37.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 110.162 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.725 HG23 ' CE1' ' A' ' 119' ' ' HIS . 39.9 m -133.1 119.94 20.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 110.228 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.015 ' CE2' HG21 ' A' ' 133' ' ' VAL . 69.9 m-85 -131.07 152.41 50.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 110.247 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -144.81 149.77 36.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.131 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.8 t -142.86 156.52 44.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.833 . . . . 0.0 109.816 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -141.23 145.89 36.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.005 . . . . 0.0 110.756 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.689 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 5.7 p90 -159.45 -172.89 3.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.608 -0.683 . . . . 0.0 109.704 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 113' ' ' ILE . 20.8 p -136.39 177.99 7.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.065 -1.022 . . . . 0.0 110.717 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 3.2 t -157.83 159.89 37.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.432 -0.793 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -87.45 -2.72 58.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 110.248 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.752 HG23 ' HD2' ' A' ' 14' ' ' PRO . 12.0 mm -98.06 148.3 34.29 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 110.215 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.752 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.59 144.84 80.22 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.099 1.579 . . . . 0.0 110.494 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.67 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.52 -31.12 11.45 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 124.018 1.536 . . . . 0.0 112.988 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.9 Cg_endo -69.04 -23.66 33.85 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 N-CA-C 110.121 -0.761 . . . . 0.0 110.121 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.541 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 3.7 mmp_? -84.44 -42.7 15.37 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.778 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -69.91 -31.31 69.03 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.565 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 48.8 t80 -66.27 -53.35 37.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.487 -0.758 . . . . 0.0 109.588 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 80.8 mttt -53.43 -37.48 62.61 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.212 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.06 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -72.3 -53.45 12.38 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.582 0.706 . . . . 0.0 110.769 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.055 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -61.37 -40.89 95.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.511 -0.743 . . . . 0.0 111.556 -178.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.532 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.6 t -104.68 -65.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.925 -1.109 . . . . 0.0 111.798 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.63 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.6 mp -65.95 -9.49 30.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.232 -0.917 . . . . 0.0 111.516 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 1.4 m-20 -145.68 33.39 1.04 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.823 -1.173 . . . . 0.0 110.71 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.055 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -73.46 -20.4 60.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.391 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 41' ' ' SER . 36.9 t0 -73.6 -20.56 60.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 109.73 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.522 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 6.9 p30 -123.88 15.34 9.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.429 -0.794 . . . . 0.0 109.684 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.866 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER -97.41 -57.75 2.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.837 . . . . 0.0 109.754 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.018 ' CG1' HD13 ' A' ' 38' ' ' ILE . 11.7 t -62.12 -41.46 75.67 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.48 -0.763 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.2 Cg_endo -78.27 7.75 3.92 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.348 1.183 . . . . 0.0 110.831 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 72.1 mmtt -126.43 -27.74 3.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.052 -1.03 . . . . 0.0 109.907 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 146' ' ' LEU . 20.9 mt -77.34 -42.77 30.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.387 -0.82 . . . . 0.0 109.58 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.03 101.99 1.58 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.498 -0.751 . . . . 0.0 110.073 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.97 1.18 6.8 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.077 1.567 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -84.42 -19.99 32.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.065 -1.022 . . . . 0.0 109.572 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.8 -53.31 4.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.321 -0.862 . . . . 0.0 109.913 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.018 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.2 mp -121.84 148.71 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.44 -0.788 . . . . 0.0 109.791 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -84.0 -41.14 17.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.931 . . . . 0.0 110.549 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.555 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -172.59 170.64 4.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -0.897 . . . . 0.0 110.204 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.428 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 68.3 m -126.93 136.5 52.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.14 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.555 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 76.2 tt0 -140.56 107.99 5.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 43.3 mt -58.7 133.27 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 110.206 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.556 HD12 HG22 ' A' ' 53' ' ' ILE . 52.8 mt -87.69 -27.64 22.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.3 -0.875 . . . . 0.0 110.044 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.985 ' O ' HG23 ' A' ' 52' ' ' THR . 29.4 tp10 -160.47 165.95 30.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 110.218 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.8 -168.99 27.02 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -127.69 24.6 6.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -1.182 . . . . 0.0 110.334 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.637 ' H ' HG21 ' A' ' 52' ' ' THR . . . 105.3 8.59 35.45 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.587 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -93.73 -164.09 36.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.79 130.8 18.64 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.047 1.551 . . . . 0.0 110.621 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.89 -3.69 77.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.985 HG23 ' O ' ' A' ' 45' ' ' GLU . 23.6 m -79.98 142.47 35.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -1.161 . . . . 0.0 109.982 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.556 HG22 HD12 ' A' ' 44' ' ' LEU . 32.5 mm -112.12 111.67 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.098 -1.001 . . . . 0.0 110.233 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.2 mttt -94.67 139.53 31.1 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.342 -0.849 . . . . 0.0 110.148 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HB2' ' HG ' ' A' ' 44' ' ' LEU . 80.3 tttt -111.34 96.21 5.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.961 . . . . 0.0 110.327 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.519 ' CG2' HG12 ' A' ' 38' ' ' ILE . 63.6 mt -84.94 147.29 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.819 ' O ' HG23 ' A' ' 38' ' ' ILE . 7.8 p -116.68 163.07 16.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 0.0 110.638 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.655 ' HE2' HG13 ' A' ' 67' ' ' VAL . 24.6 m-85 -117.2 158.95 23.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.522 -0.736 . . . . 0.0 110.142 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -42.04 144.95 0.83 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -68.0 172.24 5.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -1.171 . . . . 0.0 110.243 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.02 -164.26 37.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.0 t -48.61 -45.43 38.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 110.092 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 64' ' ' TYR . 95.5 mt-30 -125.53 123.77 39.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.119 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' GLN . 5.0 t80 -44.62 150.5 0.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.977 . . . . 0.0 110.124 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -132.93 135.23 7.98 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 10.7 p90 -177.95 163.1 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -1.18 . . . . 0.0 110.145 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.772 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.8 m -143.22 172.24 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.614 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.6 ' O ' HD12 ' A' ' 85' ' ' LEU . 98.4 mttt -122.17 133.37 54.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.591 -0.693 . . . . 0.0 109.767 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.656 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 14.8 m170 -112.31 137.28 50.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.118 -0.989 . . . . 0.0 110.706 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.8 tttt -111.45 109.84 19.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.892 . . . . 0.0 109.211 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.668 HG23 HD11 ' A' ' 74' ' ' ILE . 36.1 mm -52.77 127.52 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.171 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.45 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 95.1 m-20 -99.03 -38.71 8.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.489 -0.757 . . . . 0.0 109.878 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.633 ' C ' HD12 ' A' ' 74' ' ' ILE . 2.2 m -178.81 161.28 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.668 HD11 HG23 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -144.74 152.8 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.986 -1.071 . . . . 0.0 111.261 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -140.54 80.89 1.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.682 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.565 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 84.2 tttt -65.61 -11.72 46.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.13 -0.981 . . . . 0.0 109.968 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -85.7 -30.73 22.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 108.68 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -110.5 -2.92 16.27 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.612 ' O ' HD12 ' A' ' 104' ' ' LEU . 72.8 m-85 62.65 52.11 2.94 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.543 0.687 . . . . 0.0 110.444 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -123.31 153.02 40.82 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 109.352 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.684 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 59.0 t80 -142.38 148.98 38.77 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.14 -0.975 . . . . 0.0 110.255 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.436 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 60.3 m -152.13 137.04 17.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 110.791 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.684 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 4.1 p90 -149.32 179.31 8.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 110.009 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' ILE . 65.2 m -137.46 134.54 35.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.895 . . . . 0.0 110.372 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.656 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 9.2 tp -80.34 121.01 25.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.223 -0.923 . . . . 0.0 109.94 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.532 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 27.4 pt -100.16 -11.18 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.654 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -154.82 147.98 24.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.0 110.238 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.772 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 172.61 152.46 8.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -78.91 -35.38 43.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -1.122 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.869 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -58.78 -21.25 55.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.158 -0.964 . . . . 0.0 110.265 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.825 HD22 ' O ' ' A' ' 96' ' ' GLU . 19.8 mt -65.2 -42.86 93.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.309 -0.869 . . . . 0.0 109.694 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.67 -172.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -73.01 -3.73 27.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -1.106 . . . . 0.0 110.008 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.682 ' HA ' HG11 ' A' ' 126' ' ' VAL . 41.6 p -88.58 -45.49 9.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.12 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.801 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -118.89 159.46 23.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.383 -0.823 . . . . 0.0 109.067 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.825 ' O ' HD22 ' A' ' 91' ' ' LEU . 35.3 tt0 -140.31 -80.84 0.27 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 110.39 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 43.0 mtmt -80.26 148.42 30.78 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.619 -0.676 . . . . 0.0 110.681 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.858 HG21 ' CE2' ' A' ' 100' ' ' TYR . 17.8 mm -136.51 148.48 27.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.018 -1.051 . . . . 0.0 109.694 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -121.58 124.45 44.39 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.858 ' CE2' HG21 ' A' ' 98' ' ' ILE . 16.0 m-85 -117.31 135.67 53.67 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.306 -0.871 . . . . 0.0 110.741 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -135.88 134.73 39.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 109.923 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 89.3 m -134.1 147.8 50.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -0.988 . . . . 0.0 110.259 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 9.8 tttt -139.49 148.67 43.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.83 HD23 HG12 ' A' ' 114' ' ' ILE . 5.5 mt -125.06 152.36 44.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.257 -0.902 . . . . 0.0 110.447 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.77 -169.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.28 -0.888 . . . . 0.0 109.787 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.702 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.42 160.99 24.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.943 . . . . 0.0 110.311 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.441 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 35.3 p -120.59 164.12 24.95 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 110.13 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.5 -1.94 11.02 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.059 1.557 . . . . 0.0 110.363 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.6 m -102.72 0.45 32.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 110.326 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.46 -39.76 2.66 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.87 -171.67 0.36 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 54.8 p -131.93 134.62 45.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -1.166 . . . . 0.0 110.37 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.519 ' HA ' HG22 ' A' ' 10' ' ' THR . 31.9 mt -81.71 150.11 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.889 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.83 HG12 HD23 ' A' ' 104' ' ' LEU . 14.4 mt -135.45 112.98 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.593 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -103.54 136.37 43.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 109.759 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.6 t -131.91 158.67 40.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.976 . . . . 0.0 110.575 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 88.5 m -155.98 142.26 18.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 110.097 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.1 t -140.12 155.26 47.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.364 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.725 ' CE1' HG23 ' A' ' 4' ' ' THR . 64.4 m-70 -133.36 168.12 19.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.177 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.876 ' O ' HG13 ' A' ' 2' ' ' VAL . 32.0 m-85 -127.06 146.06 50.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.326 -0.859 . . . . 0.0 110.639 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 97.4 m-70 -127.18 92.07 3.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.702 HG21 ' O ' ' A' ' 126' ' ' VAL . 1.8 p -63.01 161.15 13.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.36 -0.837 . . . . 0.0 110.612 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 34.8 tttm -126.27 124.65 40.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.417 -0.802 . . . . 0.0 110.044 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 125' ' ' ASN . . . 93.48 22.61 26.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 11.9 t30 64.61 50.48 2.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -1.083 . . . . 0.0 110.304 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.702 ' O ' HG21 ' A' ' 122' ' ' THR . 72.3 t -119.51 174.64 4.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.414 -0.804 . . . . 0.0 109.818 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.668 ' HA ' HG21 ' A' ' 122' ' ' THR . 81.3 mt-10 -127.26 153.16 46.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.174 -0.954 . . . . 0.0 110.094 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.599 HG22 ' N ' ' A' ' 129' ' ' LYS . 3.4 mp -82.05 173.35 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.837 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.599 ' N ' HG22 ' A' ' 128' ' ' ILE . 88.4 mttt -96.42 133.86 40.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 110.189 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.558 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 93.1 mt-10 -51.7 -49.35 62.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.139 -0.976 . . . . 0.0 110.051 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.49 -34.09 64.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.896 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.869 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 12.6 t-160 -71.81 -53.04 14.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.355 -0.84 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.015 HG21 ' CE2' ' A' ' 5' ' ' TYR . 6.0 p -60.89 -35.32 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 110.023 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 81.4 tttt -70.99 -43.9 67.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.847 . . . . 0.0 109.884 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.92 91.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.936 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.81 -31.63 78.91 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.499 ' HE3' HG22 ' A' ' 133' ' ' VAL . 95.2 mttt -63.06 -32.76 74.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.341 -1.094 . . . . 0.0 109.945 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.471 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 79.8 mt-10 -70.78 -35.12 72.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.349 -0.845 . . . . 0.0 109.84 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.37 -42.83 87.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.388 -0.82 . . . . 0.0 109.875 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -70.73 -41.23 72.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.926 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.5 m -67.86 -53.71 24.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.781 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.2 m-20 -54.2 -40.07 67.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -0.905 . . . . 0.0 109.742 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.468 ' HG ' HD11 ' A' ' 147' ' ' ILE . 16.1 tp -60.98 -47.26 87.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.778 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 18.0 m-85 -53.6 -38.16 63.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.393 -0.817 . . . . 0.0 109.555 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -79.59 -17.11 54.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.225 -0.922 . . . . 0.0 109.671 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.67 ' HB3' HG21 ' A' ' 33' ' ' ILE . 26.8 mt -83.38 -35.52 25.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.291 -0.881 . . . . 0.0 108.625 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.574 HD11 ' CE1' ' A' ' 22' ' ' PHE . 27.3 mt -70.88 -46.65 67.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 13' ' ' ILE . 57.9 mt-10 -58.23 -38.77 77.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.664 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.404 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 99.8 m -70.32 -38.33 74.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.781 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.634 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.3 t80 -54.36 -48.21 71.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 110.014 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.176 HD21 ' CE2' ' A' ' 158' ' ' TYR . 92.0 mt -79.55 -30.15 41.63 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.545 ' CD ' HD11 ' A' ' 13' ' ' ILE . 47.4 tptt -73.9 -21.31 60.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.91 . . . . 0.0 109.463 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.47 -31.88 3.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.548 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.0 m-70 -110.73 93.45 16.9 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.355 -1.085 . . . . 0.0 110.059 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.415 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.4 Cg_endo -74.35 6.72 2.95 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.997 1.525 . . . . 0.0 111.035 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -108.72 1.42 21.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.053 -1.029 . . . . 0.0 109.764 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.634 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -81.87 104.5 12.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.365 -0.834 . . . . 0.0 110.196 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.176 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 34.9 32.17 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.691 -0.63 . . . . 0.0 110.528 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.735 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 120' ' ' TYR . 77.7 t -122.26 120.15 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -1.171 . . . . 0.0 110.265 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.6 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 94.2 m-85 -77.41 144.85 37.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.137 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.607 HG23 ' CE1' ' A' ' 119' ' ' HIS . 41.3 m -127.82 125.1 39.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 110.155 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.122 ' CE2' HG21 ' A' ' 133' ' ' VAL . 68.5 m-85 -134.47 159.13 42.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.237 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.7 pt-20 -151.28 152.48 33.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.886 . . . . 0.0 110.19 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 116' ' ' SER . 55.4 p -134.99 145.99 48.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.031 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 86.6 mt-10 -130.32 119.46 22.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.34 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.5 p90 -145.42 -175.98 4.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.834 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.678 HG22 HG12 ' A' ' 113' ' ' ILE . 18.4 p -136.56 -179.56 5.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.134 -0.979 . . . . 0.0 110.57 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.515 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 14.8 t -156.79 168.27 27.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 110.358 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.52 -16.24 24.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.972 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.837 HG23 ' HD2' ' A' ' 14' ' ' PRO . 6.8 mm -89.67 151.36 45.65 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.98 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.837 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.2 Cg_endo -64.74 145.28 86.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.053 1.554 . . . . 0.0 110.453 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -72.29 -31.63 11.41 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.028 1.541 . . . . 0.0 112.954 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.5 Cg_endo -69.33 -19.83 37.64 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 N-CA-C 110.148 -0.751 . . . . 0.0 110.148 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 4.2 mmp_? -85.65 -47.77 9.5 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.773 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.4 tt -67.3 -25.61 66.12 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 74' ' ' ILE . 82.6 t80 -68.57 -58.68 3.92 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.505 0.669 . . . . 0.0 109.463 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 47.9 mttt -52.18 -30.47 27.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 122.159 0.98 . . . . 0.0 108.399 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.974 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.8 -63.53 1.24 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.677 0.751 . . . . 0.0 110.96 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.026 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -57.83 -35.64 71.15 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 111.459 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.125 HG11 ' CD1' ' A' ' 74' ' ' ILE . 20.1 t -104.62 -67.85 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.118 . . . . 0.0 111.493 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.626 HD22 ' N ' ' A' ' 24' ' ' LEU . 4.0 mm? -65.29 -6.13 9.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 111.19 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -144.15 19.85 1.76 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.901 -1.124 . . . . 0.0 110.585 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.026 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -54.97 -34.44 63.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 0.0 110.164 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.54 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 89.6 m-20 -69.47 -12.0 61.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 110.279 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.507 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.7 m-20 -126.72 -4.98 6.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 110.3 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -85.86 -46.78 10.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.124 -0.985 . . . . 0.0 110.294 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.813 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.3 t -75.92 -42.01 3.51 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.885 . . . . 0.0 111.13 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.5 Cg_endo -77.86 9.71 2.89 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.402 1.212 . . . . 0.0 110.855 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HG2' ' OH ' ' A' ' 150' ' ' TYR . 37.3 tptt -123.16 -28.69 3.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.614 HG12 ' CD1' ' A' ' 150' ' ' TYR . 9.6 mt -80.08 -47.21 21.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.447 -0.783 . . . . 0.0 109.499 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.0 101.96 4.17 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.486 -0.759 . . . . 0.0 109.981 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.34 0.05 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.023 1.538 . . . . 0.0 110.715 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -83.53 -13.04 55.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 109.419 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.456 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -101.96 -62.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.994 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.813 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.8 mp -108.98 132.11 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.451 -0.781 . . . . 0.0 110.001 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HE2' ' HB ' ' A' ' 57' ' ' THR . 31.7 ttpt -83.33 -38.07 22.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.0 110.416 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -174.55 141.42 0.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.165 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.54 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 7.3 m -107.03 135.92 47.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.041 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.479 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 55.2 tt0 -136.31 109.15 7.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.3 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 9.1 mt -62.43 130.55 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.462 ' CD1' ' O ' ' A' ' 42' ' ' GLU . 10.6 mp -94.59 -41.99 9.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.38 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.898 ' O ' HG23 ' A' ' 52' ' ' THR . 5.3 mt-10 -132.91 142.79 49.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.134 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.4 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 77.99 -170.2 54.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -124.82 6.58 8.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -1.156 . . . . 0.0 110.215 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.556 ' N ' HG21 ' A' ' 52' ' ' THR . . . 130.32 -4.82 5.95 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.528 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -85.39 -164.68 39.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.38 132.03 21.53 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.153 1.607 . . . . 0.0 110.418 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.69 69.99 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.898 HG23 ' O ' ' A' ' 45' ' ' GLU . 29.6 m -80.06 136.47 36.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -1.155 . . . . 0.0 109.857 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.708 HG21 ' HE3' ' A' ' 68' ' ' LYS . 20.5 mm -107.15 117.97 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 0.0 110.17 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 87.2 mttt -105.2 145.9 29.99 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.3 -0.875 . . . . 0.0 110.496 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -118.88 101.43 8.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 110.058 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.74 141.99 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.883 . . . . 0.0 110.444 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.8 p -110.27 153.19 25.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 109.965 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.769 ' HE2' HG13 ' A' ' 67' ' ' VAL . 24.5 m-85 -111.75 123.95 51.32 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.0 111.001 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 58' ' ' PHE . . . 39.84 -162.78 0.01 OUTLIER Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.464 ' HB2' ' HD3' ' A' ' 39' ' ' LYS . 76.1 tt0 -146.92 131.12 17.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.459 -1.024 . . . . 0.0 110.011 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -176.21 -176.58 44.53 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.0 m -55.26 -33.94 63.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.355 -1.085 . . . . 0.0 110.334 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.14 112.86 24.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.345 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 2.6 t80 -72.34 126.53 30.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.253 -0.904 . . . . 0.0 110.033 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -126.32 99.05 0.54 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.508 ' CD2' ' CD2' ' A' ' 64' ' ' TYR . 33.2 p90 -138.83 169.98 16.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.134 -1.216 . . . . 0.0 110.369 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.921 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.9 m -137.49 173.44 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 110.563 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.708 ' HE3' HG21 ' A' ' 53' ' ' ILE . 37.8 tttt -122.81 127.96 49.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.596 -0.69 . . . . 0.0 109.43 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.64 ' CD2' HD13 ' A' ' 85' ' ' LEU . 10.5 m170 -117.32 126.37 52.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.965 . . . . 0.0 111.035 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HA ' HD13 ' A' ' 53' ' ' ILE . 84.1 tttt -106.01 118.04 35.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.287 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.536 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.0 mm -57.34 135.03 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.93 . . . . 0.0 110.454 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.51 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 9.5 t0 -107.05 -39.47 5.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.794 . . . . 0.0 109.795 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 0.7 OUTLIER 171.95 161.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.537 -0.727 . . . . 0.0 109.957 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.125 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.1 tt -154.64 163.51 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.224 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.7 OUTLIER -125.84 78.01 1.71 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.259 -0.9 . . . . 0.0 109.671 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.592 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 86.3 mttt -53.94 -15.26 1.29 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.331 -0.855 . . . . 0.0 110.863 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -91.76 -32.39 15.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 109.788 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.3 m-80 -107.83 -4.51 17.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.639 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.636 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 6.5 m-85 69.22 49.07 0.63 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.322 0.582 . . . . 0.0 110.543 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.547 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -118.43 147.18 43.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.159 -0.963 . . . . 0.0 109.107 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.681 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 79.7 t80 -141.49 142.89 33.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.02 . . . . 0.0 110.617 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.447 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 61.1 m -147.14 128.21 14.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 110.007 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.681 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 3.9 p90 -137.07 -176.71 4.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.062 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.4 m -135.41 140.07 44.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.296 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.667 HD12 ' O ' ' A' ' 68' ' ' LYS . 49.0 tp -100.47 128.67 46.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.964 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.537 HD11 ' HE2' ' A' ' 68' ' ' LYS . 16.5 pt -118.73 -7.7 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.366 -0.834 . . . . 0.0 110.246 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 79.7 tt0 -146.05 135.27 22.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.921 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 174.35 159.9 21.54 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 46.1 p-10 -71.29 -7.73 48.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -1.159 . . . . 0.0 110.285 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.455 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -79.07 -46.14 18.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.154 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.612 HD22 ' O ' ' A' ' 96' ' ' GLU . 19.6 mt -40.96 -46.42 2.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.595 -0.691 . . . . 0.0 110.224 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 41.31 -132.73 3.41 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.746 ' OD1' HG23 ' A' ' 94' ' ' THR . 57.5 p-10 -115.89 21.72 13.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -1.104 . . . . 0.0 110.062 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.746 HG23 ' OD1' ' A' ' 93' ' ' ASP . 72.5 p -122.4 -41.58 2.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -0.866 . . . . 0.0 110.214 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.056 HD21 HD11 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -114.41 163.35 15.44 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.341 -0.85 . . . . 0.0 109.141 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.805 ' H ' HD12 ' A' ' 95' ' ' LEU . 28.1 tp10 -142.03 -79.54 0.24 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.135 -0.978 . . . . 0.0 110.282 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.559 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 21.2 mtpt -80.18 151.66 29.59 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.616 -0.677 . . . . 0.0 109.845 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.056 HD11 HD21 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -146.62 135.37 16.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.063 -1.023 . . . . 0.0 109.819 179.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 5.1 m -114.99 118.41 33.34 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.43 -0.794 . . . . 0.0 109.597 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.621 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.7 m-85 -110.39 137.74 47.7 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.469 -0.769 . . . . 0.0 110.173 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 76.9 tt0 -132.85 143.18 49.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.203 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 90.6 m -139.39 135.67 33.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -128.31 138.89 52.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.823 HD23 HG12 ' A' ' 114' ' ' ILE . 6.5 mt -118.56 149.76 40.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.197 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.03 -169.68 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 109.961 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.2 125.7 45.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.972 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.47 ' HB3' ' CG1' ' A' ' 113' ' ' ILE . 3.2 p -80.15 170.36 16.12 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 110.219 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 50.7 Cg_endo -83.52 22.47 0.92 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.056 1.556 . . . . 0.0 110.966 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.5 p -127.89 4.03 5.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.938 -1.101 . . . . 0.0 110.412 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.16 -25.74 25.21 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.46 -174.33 43.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.52 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 19.9 p -124.35 131.32 53.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -1.201 . . . . 0.0 110.37 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.678 HG12 HG22 ' A' ' 10' ' ' THR . 84.8 mt -82.82 149.68 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 110.195 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.823 HG12 HD23 ' A' ' 104' ' ' LEU . 7.6 mt -133.68 128.82 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 110.359 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 85.9 tttt -118.66 111.11 18.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.315 -0.865 . . . . 0.0 109.781 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.44 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 1.4 m -101.58 162.31 13.0 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.158 -0.964 . . . . 0.0 110.834 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 53.7 m -160.05 132.65 6.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.44 -0.787 . . . . 0.0 109.773 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.1 p -132.58 159.11 40.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.107 -0.995 . . . . 0.0 110.745 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.607 ' CE1' HG23 ' A' ' 4' ' ' THR . 60.7 m-70 -141.37 155.37 45.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.419 -0.8 . . . . 0.0 110.038 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.653 ' O ' HG13 ' A' ' 2' ' ' VAL . 28.2 m-85 -119.03 138.07 53.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.39 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.559 ' HB2' ' CB ' ' A' ' 97' ' ' LYS . 95.4 m-70 -119.32 93.13 3.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 109.675 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.864 HG21 ' HA ' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -62.86 159.22 17.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.156 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 43.7 tttm -142.7 128.34 19.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 110.19 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 93.31 26.38 16.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 8.2 t30 64.91 65.96 0.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -1.189 . . . . 0.0 110.173 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.615 ' O ' HG21 ' A' ' 122' ' ' THR . 7.0 m -144.37 171.21 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.864 ' HA ' HG21 ' A' ' 122' ' ' THR . 86.5 mt-10 -140.25 152.37 45.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.215 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 129' ' ' LYS . 4.9 mp -81.89 173.53 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 109.964 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.591 ' N ' HG22 ' A' ' 128' ' ' ILE . 57.0 mttt -104.85 132.15 51.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.229 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.449 ' HA ' HG12 ' A' ' 133' ' ' VAL . 52.1 mt-10 -48.48 -39.79 24.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 110.101 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.01 -30.39 70.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.948 . . . . 0.0 109.882 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -75.34 -50.97 14.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 110.18 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.122 HG21 ' CE2' ' A' ' 5' ' ' TYR . 10.3 p -65.47 -41.81 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 110.038 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.551 ' N ' HG13 ' A' ' 133' ' ' VAL . 72.5 mmtt -63.04 -40.02 96.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.979 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.54 -34.69 72.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.831 . . . . 0.0 110.0 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 139' ' ' LYS . . . -73.08 -29.76 64.17 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -73.71 -32.95 64.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -1.08 . . . . 0.0 110.076 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -70.28 -54.73 11.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 109.948 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 136' ' ' GLY . 20.7 ptmt -56.54 -28.49 60.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.795 . . . . 0.0 109.866 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.81 -45.88 70.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 110.051 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -61.96 -40.88 97.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.978 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -62.07 -41.42 98.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 147' ' ' ILE . 30.1 mt -61.1 -41.22 96.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.934 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -61.54 -33.21 73.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.416 -0.802 . . . . 0.0 109.951 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 47.4 tptt -80.02 -19.05 48.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 110.26 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 146' ' ' LEU . 13.4 mt -79.95 -35.16 38.08 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.104 -0.997 . . . . 0.0 108.515 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.652 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 67.4 mt -70.67 -51.73 34.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 13' ' ' ILE . 78.0 mt-10 -49.41 -34.67 16.98 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.288 -0.883 . . . . 0.0 109.016 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.4 m -79.99 -28.33 39.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -0.916 . . . . 0.0 109.296 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.634 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.7 t80 -61.36 -54.07 48.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.561 -0.712 . . . . 0.0 109.977 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.192 HD21 ' CE2' ' A' ' 158' ' ' TYR . 59.0 mt -69.56 -27.96 65.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 110.077 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.454 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 57.3 tptt -74.04 -29.39 61.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 109.727 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -101.33 -29.15 6.45 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.521 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.5 m-70 -107.15 90.98 6.05 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.447 -1.031 . . . . 0.0 109.7 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.5 Cg_endo -73.54 5.22 3.4 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.009 1.531 . . . . 0.0 111.025 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 44.3 p30 -109.82 -9.37 14.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.013 -1.054 . . . . 0.0 109.685 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.634 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -69.36 99.62 1.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.477 -0.764 . . . . 0.0 110.091 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.192 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.9 31.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.727 -0.608 . . . . 0.0 110.554 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.799 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.039 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.5 p -79.86 145.64 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -1.206 . . . . 0.0 110.563 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 77.5 m-85 -93.18 167.7 11.59 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.332 -0.855 . . . . 0.0 110.242 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.769 HG23 ' CE1' ' A' ' 119' ' ' HIS . 91.9 m -131.39 110.84 11.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.944 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.648 ' CZ ' HG22 ' A' ' 133' ' ' VAL . 24.3 m-85 -113.18 125.34 54.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 110.085 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.5 pt-20 -133.13 152.94 51.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 110.085 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.2 t -128.52 155.81 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.359 -0.838 . . . . 0.0 110.172 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 76.0 mt-10 -136.0 118.03 15.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.333 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.2 p90 -147.24 -170.98 3.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.939 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 113' ' ' ILE . 18.2 p -140.64 -179.44 6.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 110.561 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 3.2 t -156.74 160.12 38.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.759 . . . . 0.0 110.165 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -84.7 -16.12 42.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.853 . . . . 0.0 110.251 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.789 HG23 ' HD2' ' A' ' 14' ' ' PRO . 7.4 mm -87.61 149.96 47.47 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 110.135 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.789 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.13 149.02 89.49 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.098 1.578 . . . . 0.0 110.412 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.677 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 Cg_endo -70.14 -32.72 16.46 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.899 1.473 . . . . 0.0 113.0 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.0 Cg_endo -68.0 -21.75 42.82 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 122.504 0.739 . . . . 0.0 110.207 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.676 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -83.65 -46.78 11.95 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.132 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.757 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -69.07 -28.33 66.42 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.635 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 62.6 t80 -66.04 -59.34 3.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.468 -0.77 . . . . 0.0 109.514 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 51.2 mttp -51.6 -34.79 38.88 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.521 -0.737 . . . . 0.0 109.604 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.04 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -75.29 -55.5 5.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.391 -0.818 . . . . 0.0 111.152 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.039 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -59.77 -45.51 92.05 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.48 -0.762 . . . . 0.0 111.738 -178.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.713 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.7 t -97.37 -66.3 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.02 -1.05 . . . . 0.0 111.392 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.6 mm? -64.44 -5.97 6.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.262 -0.899 . . . . 0.0 111.444 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.687 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -143.79 25.88 1.6 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.862 -1.149 . . . . 0.0 110.849 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.039 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -66.37 -30.02 70.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 110.195 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -71.56 -12.77 61.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.501 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 72.5 m-20 -129.1 6.32 5.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 110.118 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -92.99 -53.35 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -0.832 . . . . 0.0 110.056 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.01 HG11 HD13 ' A' ' 38' ' ' ILE . 17.1 t -67.2 -41.42 33.97 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.5 -0.75 . . . . 0.0 111.176 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -76.91 6.03 4.5 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.334 1.176 . . . . 0.0 110.881 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 66.6 mttt -127.54 -31.84 2.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 109.787 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.621 HD11 ' CD1' ' A' ' 29' ' ' LEU . 16.0 mt -79.89 -43.17 22.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.462 -0.774 . . . . 0.0 109.775 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.7 91.8 3.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.0 110.188 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.26 3.51 5.69 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.114 1.586 . . . . 0.0 110.594 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -87.23 -19.9 27.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.134 -0.979 . . . . 0.0 110.061 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.38 -40.77 8.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 110.201 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.01 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mt -125.72 145.99 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.447 -0.783 . . . . 0.0 110.047 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.461 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 28.2 ttpt -80.93 -46.36 15.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 110.32 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.557 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -176.93 158.88 1.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.293 -0.88 . . . . 0.0 110.038 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -113.01 120.57 41.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.945 . . . . 0.0 110.162 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.557 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 32.0 tt0 -121.46 102.08 8.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.003 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 37.6 mt -50.7 129.32 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.307 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.662 HD23 HG21 ' A' ' 53' ' ' ILE . 19.9 tp -91.72 -40.07 11.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.468 -0.77 . . . . 0.0 110.354 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.879 ' O ' HG23 ' A' ' 52' ' ' THR . 2.9 mt-10 -138.32 138.02 37.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 110.172 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 47' ' ' ASP . . . 82.21 -159.53 39.32 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 87.1 m-20 -138.24 9.55 2.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -1.192 . . . . 0.0 110.348 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.621 ' N ' HG21 ' A' ' 52' ' ' THR . . . 130.29 -2.94 5.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -87.6 -168.49 44.62 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -69.82 137.74 35.98 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.091 1.574 . . . . 0.0 110.507 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.93 -5.47 85.04 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.879 HG23 ' O ' ' A' ' 45' ' ' GLU . 18.0 m -80.0 138.94 37.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -1.177 . . . . 0.0 109.998 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.662 HG21 HD23 ' A' ' 44' ' ' LEU . 32.2 mm -105.15 127.58 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.0 110.001 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 93.5 mttt -110.39 126.71 54.56 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 110.019 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.638 ' HD3' HD13 ' A' ' 44' ' ' LEU . 43.4 mtmt -99.15 98.12 9.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.139 -0.976 . . . . 0.0 110.589 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.535 ' CG2' HG12 ' A' ' 38' ' ' ILE . 96.4 mt -87.07 146.71 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.155 -0.966 . . . . 0.0 109.66 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 38' ' ' ILE . 5.4 p -118.76 153.16 34.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.124 -0.985 . . . . 0.0 111.116 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.626 ' HE2' HG13 ' A' ' 67' ' ' VAL . 25.5 m-85 -117.44 138.47 51.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.509 -0.745 . . . . 0.0 109.973 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.12 41.86 2.06 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -60.8 -39.99 90.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -1.083 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.69 -153.01 7.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 63' ' ' GLN . 33.7 m -66.62 -55.89 13.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -1.138 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 62' ' ' SER . 94.9 mt-30 -41.93 138.88 1.41 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.879 . . . . 0.0 110.216 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.34 115.02 17.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.247 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -115.2 93.28 0.62 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.4 p90 -128.96 164.91 22.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -1.228 . . . . 0.0 110.234 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.734 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.9 m -134.63 175.28 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 0.0 110.486 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.664 ' O ' HD12 ' A' ' 85' ' ' LEU . 59.5 mttt -133.15 106.46 7.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.46 -0.775 . . . . 0.0 109.701 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.989 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.0 m170 -98.16 128.44 44.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 111.023 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.625 ' HA ' HD13 ' A' ' 53' ' ' ILE . 54.6 tttm -101.88 109.56 21.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.329 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.507 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.0 mm -42.59 140.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.341 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.521 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 23.9 t0 -111.43 -48.87 3.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.527 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.485 ' N ' ' OG ' ' A' ' 82' ' ' SER . 8.7 m -165.88 156.16 12.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.527 -0.733 . . . . 0.0 109.746 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 mt -138.36 153.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.396 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.7 m-20 -141.7 80.74 1.74 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.517 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 34.4 tttt -65.65 -13.32 58.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.179 -0.951 . . . . 0.0 109.853 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -89.94 -30.87 17.54 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.803 0.811 . . . . 0.0 109.013 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m-80 -106.91 -2.98 20.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.757 ' O ' HD12 ' A' ' 104' ' ' LEU . 73.8 m-85 60.94 54.35 3.47 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.652 0.739 . . . . 0.0 110.167 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -127.26 156.53 41.75 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.637 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.713 ' CE1' HG13 ' A' ' 23' ' ' VAL . 27.6 t80 -142.83 137.38 29.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.947 . . . . 0.0 110.003 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.485 ' OG ' ' N ' ' A' ' 73' ' ' SER . 13.9 p -143.87 124.18 13.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.112 -0.993 . . . . 0.0 111.263 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 13.7 p90 -137.73 172.53 12.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 110.23 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 98' ' ' ILE . 97.1 m -129.39 134.52 47.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.332 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.989 HD13 ' CD2' ' A' ' 69' ' ' HIS . 11.7 tp -101.5 133.78 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.05 -1.031 . . . . 0.0 110.221 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 85' ' ' LEU . 13.8 pt -113.11 -30.88 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.458 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.644 ' O ' HD11 ' A' ' 85' ' ' LEU . 70.1 tt0 -119.41 157.35 28.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.258 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.734 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 159.05 140.69 2.96 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.415 ' OD2' ' HA2' ' A' ' 65' ' ' GLY . 98.3 m-20 -69.6 -25.58 64.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -1.148 . . . . 0.0 110.139 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.08 -26.61 61.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 110.146 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 88' ' ' GLY . 15.5 mt -63.22 -31.59 72.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 110.104 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.54 -174.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 52.8 t0 -77.1 -1.02 26.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.138 . . . . 0.0 110.057 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 122' ' ' THR . 43.2 p -87.82 -41.96 12.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 110.056 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.062 HD21 ' CG1' ' A' ' 128' ' ' ILE . 68.4 mt -98.25 153.55 18.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.815 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 35.4 tt0 -137.24 -83.33 0.34 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.301 -0.874 . . . . 0.0 109.629 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.485 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 96.0 mttt -80.35 125.02 29.38 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.75 -0.594 . . . . 0.0 110.447 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.843 ' O ' HG23 ' A' ' 84' ' ' THR . 3.3 mm -116.86 135.01 58.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.789 -1.195 . . . . 0.0 109.827 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -120.89 127.07 51.53 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.644 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.1 m-85 -119.61 134.43 55.23 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.326 -0.859 . . . . 0.0 110.573 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.491 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 26.5 tt0 -137.16 133.58 35.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.427 -0.796 . . . . 0.0 109.92 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 54.5 m -134.35 144.1 48.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 110.361 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -135.25 146.93 49.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 110.256 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.769 HD23 HG12 ' A' ' 114' ' ' ILE . 6.1 mt -119.22 153.73 34.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.339 -0.851 . . . . 0.0 110.433 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.717 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.94 -168.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.289 -0.882 . . . . 0.0 109.93 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.717 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.88 128.19 51.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 110.27 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.567 ' HA ' HD11 ' A' ' 113' ' ' ILE . 87.2 p -81.47 160.02 65.72 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.181 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.4 -2.26 11.45 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.082 1.569 . . . . 0.0 110.547 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.4 p -103.07 4.82 37.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.351 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.62 -34.38 5.82 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.09 -174.18 6.51 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 23.6 p -123.66 135.82 54.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 107' ' ' SER . 23.4 mt -87.04 150.41 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.769 HG12 HD23 ' A' ' 104' ' ' LEU . 7.0 mt -132.85 117.67 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.178 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.487 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 80.8 tttt -110.05 109.69 20.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 110.079 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 8.6 m -97.6 164.21 12.52 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.173 -0.954 . . . . 0.0 110.474 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 29.4 m -160.01 126.17 4.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.411 -0.805 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.0 m -128.37 156.95 42.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.163 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.769 ' CE1' HG23 ' A' ' 4' ' ' THR . 90.9 m-70 -129.24 136.31 49.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -0.93 . . . . 0.0 110.255 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 1.039 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.0 m-30 -109.59 111.69 23.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.962 . . . . 0.0 111.169 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.673 ' CE1' HG21 ' A' ' 2' ' ' VAL . 90.3 m-70 -99.09 117.38 33.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.196 -0.94 . . . . 0.0 109.514 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 94' ' ' THR . 0.7 OUTLIER -87.27 138.76 31.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 110.569 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 74.1 tttt -72.3 123.1 22.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 110.223 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.48 -128.86 8.71 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -121.09 51.72 1.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -1.188 . . . . 0.0 110.12 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 127' ' ' GLU . 85.9 t -94.61 174.6 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.416 -0.802 . . . . 0.0 110.02 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.605 ' N ' HG12 ' A' ' 126' ' ' VAL . 45.8 mt-10 -143.16 125.73 15.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 110.408 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.062 ' CG1' HD21 ' A' ' 95' ' ' LEU . 1.8 mp -60.45 174.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.855 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.608 ' N ' HG22 ' A' ' 128' ' ' ILE . 62.3 mttt -100.7 151.52 21.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.26 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -66.55 -34.29 77.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.199 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 132' ' ' HIS . 22.2 pt-20 -68.26 -36.96 80.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 110.198 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.445 ' N ' ' CG ' ' A' ' 131' ' ' GLU . 17.8 t-160 -67.79 -33.53 75.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.648 HG22 ' CZ ' ' A' ' 5' ' ' TYR . 89.3 t -67.85 -43.77 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.22 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -73.83 -43.0 60.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 0.0 110.003 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.72 91.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.861 . . . . 0.0 110.083 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.92 -26.3 73.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -75.99 -31.94 59.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -1.156 . . . . 0.0 110.144 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.456 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 78.3 tt0 -79.02 -28.55 43.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.125 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.99 -32.86 59.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.71 -33.29 46.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.5 t -64.58 -45.29 87.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.165 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 73.5 m-20 -52.81 -48.72 66.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.03 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 143' ' ' LEU . 19.3 tp -55.89 -48.59 75.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.941 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.427 ' O ' ' CD ' ' A' ' 148' ' ' GLU . 25.8 m-85 -54.4 -39.77 67.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.807 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.439 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 42.7 tttm -79.81 -14.03 58.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.473 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 17.8 mt -83.97 -37.69 21.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.1 -1.0 . . . . 0.0 108.954 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.765 HD13 ' CD1' ' A' ' 22' ' ' PHE . 75.6 mt -71.21 -44.1 74.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.822 -0.751 . . . . 0.0 108.983 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' HG13 ' A' ' 13' ' ' ILE . 65.0 mt-10 -56.62 -36.24 69.23 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.435 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.6 m -76.68 -30.57 56.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.926 . . . . 0.0 109.511 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.648 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 89.9 t80 -57.38 -48.19 79.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.54 -0.725 . . . . 0.0 110.045 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.128 HD21 ' CE1' ' A' ' 158' ' ' TYR . 72.1 mt -76.48 -38.53 55.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 110.065 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.42 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 83.8 tttt -61.23 -14.83 28.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.374 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -116.52 -28.13 2.63 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.574 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 8.5 m-70 -109.08 93.91 13.86 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.333 -1.098 . . . . 0.0 110.058 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.8 4.24 4.28 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.028 1.541 . . . . 0.0 110.961 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -113.77 -6.56 13.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.124 -0.985 . . . . 0.0 110.047 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.685 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -67.03 102.67 1.03 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.128 ' CE1' HD21 ' A' ' 151' ' ' LEU . 0.6 OUTLIER 34.65 32.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.741 -0.599 . . . . 0.0 110.604 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.511 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.756 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 77.1 t -114.13 109.33 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -1.122 . . . . 0.0 110.195 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.61 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 82.6 m-85 -77.48 144.86 37.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 110.298 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.76 HG23 ' CE1' ' A' ' 119' ' ' HIS . 95.4 m -122.71 115.77 22.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 110.396 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.778 ' CE2' HG21 ' A' ' 133' ' ' VAL . 67.2 m-85 -124.08 154.54 39.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.897 . . . . 0.0 109.951 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 13.6 pt-20 -147.3 151.4 36.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.997 . . . . 0.0 110.566 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 m -137.36 144.21 42.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.777 . . . . 0.0 109.456 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -132.82 143.46 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.114 -0.991 . . . . 0.0 110.928 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.605 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 4.3 p90 -158.79 -176.04 5.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.57 -0.706 . . . . 0.0 109.492 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.6 HG22 HG12 ' A' ' 113' ' ' ILE . 21.1 p -135.64 -179.46 5.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.041 -1.037 . . . . 0.0 110.764 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 10.0 t -159.96 167.16 28.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.529 -0.732 . . . . 0.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -98.38 9.81 42.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 109.972 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.816 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.7 mp -107.75 149.88 39.54 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.033 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.816 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.2 Cg_endo -65.81 143.19 72.71 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.081 1.569 . . . . 0.0 110.554 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.676 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.9 Cg_endo -71.82 -31.67 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 124.027 1.541 . . . . 0.0 112.804 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.9 Cg_endo -67.94 -21.93 42.92 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 O-C-N 122.468 0.72 . . . . 0.0 110.322 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.529 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 8.7 mmp_? -83.91 -46.99 11.51 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.845 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -68.25 -29.3 68.08 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.551 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.0 t80 -66.3 -56.16 12.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.863 . . . . 0.0 109.9 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.529 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 76.1 mttt -53.92 -32.1 52.37 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.947 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -73.18 -64.82 0.9 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.713 0.768 . . . . 0.0 111.11 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.072 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -56.97 -39.08 73.93 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.634 -0.666 . . . . 0.0 112.228 -178.128 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.542 ' HB ' HD12 ' A' ' 24' ' ' LEU . 5.5 t -101.77 -58.03 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.777 -1.202 . . . . 0.0 111.578 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.751 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.4 mp -78.14 0.1 26.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.079 -1.013 . . . . 0.0 111.331 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.596 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -147.3 15.17 1.14 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.944 -1.098 . . . . 0.0 110.556 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.072 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -53.85 -39.88 66.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.95 . . . . 0.0 109.916 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 65.2 t0 -64.42 -14.19 55.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 109.907 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.526 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.2 m-20 -127.3 0.19 6.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.369 -0.832 . . . . 0.0 110.185 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -88.09 -45.52 10.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.355 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.054 ' CG1' HD13 ' A' ' 38' ' ' ILE . 31.2 t -72.89 -40.36 6.1 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.263 -0.898 . . . . 0.0 111.482 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -77.44 10.11 2.61 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.329 1.173 . . . . 0.0 111.113 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 49.6 mttt -122.77 -25.77 4.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.054 -1.029 . . . . 0.0 109.628 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.605 HG12 ' CD1' ' A' ' 150' ' ' TYR . 28.7 mt -79.99 -49.86 18.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.475 -0.765 . . . . 0.0 109.926 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.37 104.02 2.21 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.383 -0.823 . . . . 0.0 110.128 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.17 1.01 6.46 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.02 1.537 . . . . 0.0 110.794 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -83.54 -14.41 52.28 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.36 -53.88 3.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 110.071 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.054 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.1 mp -117.65 149.02 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.453 -0.779 . . . . 0.0 110.017 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -85.35 -42.3 14.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.861 . . . . 0.0 110.41 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.536 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -178.77 141.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 110.369 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.477 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 38.6 m -97.84 134.3 41.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 110.093 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.536 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 30.8 tt0 -137.26 110.98 8.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.211 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 37.2 mt -60.71 131.7 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.277 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 81.2 mt -92.18 -26.45 18.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 110.148 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 1.064 ' O ' HG23 ' A' ' 52' ' ' THR . 38.8 tt0 -151.41 173.53 14.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.895 . . . . 0.0 110.085 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.01 -155.23 2.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -147.97 34.17 0.83 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 110.22 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.709 ' H ' HG21 ' A' ' 52' ' ' THR . . . 108.5 -9.29 35.3 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.429 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -81.41 -172.84 47.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.9 Cg_endo -71.1 137.97 32.64 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 124.173 1.617 . . . . 0.0 110.464 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.84 -4.8 83.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 1.064 HG23 ' O ' ' A' ' 45' ' ' GLU . 27.3 m -79.98 146.38 32.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -1.193 . . . . 0.0 110.116 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 70' ' ' LYS . 32.3 mm -113.38 110.21 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 110.154 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.756 ' NZ ' ' HB3' ' A' ' 26' ' ' ALA . 46.2 mtpt -93.11 141.99 27.8 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 110.474 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 83.3 tttt -111.7 113.26 25.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.091 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.555 ' CG2' HG12 ' A' ' 38' ' ' ILE . 62.6 mt -102.97 138.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 110.118 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 38' ' ' ILE . 1.6 p -114.03 152.53 30.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 110.562 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 30.5 m-85 -112.88 137.6 50.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.333 -0.854 . . . . 0.0 110.079 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.91 -27.78 30.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -91.13 158.01 16.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.296 -1.12 . . . . 0.0 110.154 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.13 -156.16 20.81 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.6 m -62.18 179.31 0.31 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -1.11 . . . . 0.0 110.27 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -67.78 -27.38 66.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.351 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.24 95.85 4.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.189 -0.944 . . . . 0.0 110.35 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -131.92 90.8 0.28 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 17.5 p90 -138.73 168.15 20.42 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.201 -1.176 . . . . 0.0 110.402 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.903 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.4 m -137.49 172.72 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.449 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.56 ' CB ' ' CG1' ' A' ' 86' ' ' ILE . 91.7 mttt -123.95 131.44 53.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.593 -0.692 . . . . 0.0 109.719 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.648 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 13.6 m170 -111.43 138.42 47.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.132 -0.98 . . . . 0.0 110.532 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.546 ' HA ' HD13 ' A' ' 53' ' ' ILE . 82.0 tttt -114.93 107.82 15.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.436 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 50' ' ' PRO . 33.4 mm -53.2 122.43 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 110.489 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.8 m-20 -94.89 -40.71 9.57 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.534 -0.729 . . . . 0.0 109.543 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 m -176.63 158.76 1.77 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.514 -0.741 . . . . 0.0 109.558 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.402 HG12 ' HD1' ' A' ' 81' ' ' TYR . 2.4 mt -138.16 159.32 32.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.25 -0.907 . . . . 0.0 110.124 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -145.63 83.85 1.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.574 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.551 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 86.0 tttt -68.18 -13.42 62.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 0.0 110.168 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -85.47 -30.38 23.53 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -109.44 -3.68 16.86 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.201 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.541 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 48.4 m-85 63.36 52.02 2.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.666 -0.646 . . . . 0.0 110.359 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 13.5 t -121.59 174.34 6.85 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.152 -0.968 . . . . 0.0 110.208 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.528 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 21.0 t80 -157.77 146.55 19.39 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.149 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 50.6 m -149.98 125.24 10.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.042 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 6.7 p90 -142.49 176.45 9.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.404 -0.81 . . . . 0.0 109.862 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.93 HG23 ' O ' ' A' ' 98' ' ' ILE . 53.1 m -135.54 141.54 45.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.648 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 9.2 tp -87.66 120.27 28.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.233 -0.917 . . . . 0.0 110.247 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.56 ' CG1' ' CB ' ' A' ' 68' ' ' LYS . 24.3 pt -100.63 -12.04 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.425 -0.797 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 71.0 tt0 -153.46 145.54 23.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.479 -0.763 . . . . 0.0 110.203 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.903 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 174.77 165.93 31.89 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 29.7 p-10 -79.9 -44.79 19.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -1.173 . . . . 0.0 110.522 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.825 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -50.8 -40.69 56.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 110.155 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.564 HD22 ' O ' ' A' ' 96' ' ' GLU . 38.0 mt -40.42 -50.45 2.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.575 -0.703 . . . . 0.0 110.339 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.41 -166.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -81.5 5.21 18.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -1.132 . . . . 0.0 110.139 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 55.3 p -97.69 -45.85 6.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 110.393 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.784 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -118.4 163.06 17.29 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.112 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.784 ' H ' HD12 ' A' ' 95' ' ' LEU . 62.7 tt0 -140.79 -79.79 0.27 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.527 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 33.8 mttt -80.28 145.95 31.89 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.533 -0.729 . . . . 0.0 110.735 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.93 ' O ' HG23 ' A' ' 84' ' ' THR . 25.4 mm -134.49 150.98 31.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.123 -0.985 . . . . 0.0 109.57 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.7 OUTLIER -123.89 124.39 42.52 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.7 178.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.853 ' CE2' HG21 ' A' ' 98' ' ' ILE . 19.7 m-85 -117.86 134.64 54.73 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.32 -0.863 . . . . 0.0 110.625 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 117' ' ' THR . 6.0 mt-10 -134.36 126.43 29.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.821 . . . . 0.0 109.99 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 86.8 m -119.88 147.87 44.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.972 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LYS . 23.7 mttt -140.33 133.81 30.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 110.51 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.792 HD23 HG12 ' A' ' 114' ' ' ILE . 5.8 mt -112.71 151.81 29.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 110.185 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.36 -169.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.0 109.97 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.71 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -127.41 131.0 50.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.187 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.406 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 54.7 p -87.31 162.27 43.5 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.6 Cg_endo -72.51 -1.41 10.21 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.058 1.557 . . . . 0.0 110.594 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.9 p -101.05 -0.93 35.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.279 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.68 -39.72 2.79 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.78 -175.08 2.56 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 4.0 m -126.63 137.74 53.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -1.18 . . . . 0.0 110.468 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.6 HG12 HG22 ' A' ' 10' ' ' THR . 65.0 mt -87.89 151.5 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.394 -0.816 . . . . 0.0 110.105 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.792 HG12 HD23 ' A' ' 104' ' ' LEU . 9.8 mt -134.24 113.31 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.294 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 103' ' ' LYS . 79.4 tttt -102.11 131.34 48.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 109.974 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.74 154.74 33.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.488 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 101' ' ' GLU . 64.6 m -155.47 123.04 5.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.399 -0.813 . . . . 0.0 110.02 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 99' ' ' SER . 42.0 t -129.06 157.19 42.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.76 ' CE1' HG23 ' A' ' 4' ' ' THR . 44.6 m-70 -134.51 173.22 11.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.217 -0.927 . . . . 0.0 110.44 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.701 ' HA ' HD13 ' A' ' 98' ' ' ILE . 21.2 m-85 -129.91 144.44 51.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.271 -0.893 . . . . 0.0 110.575 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 96.8 m-70 -125.51 95.95 4.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 109.495 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.647 HG21 ' O ' ' A' ' 126' ' ' VAL . 3.1 p -56.87 164.93 1.36 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 0.0 110.572 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 78.9 tttt -115.52 119.2 35.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.45 -107.78 2.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.593 ' C ' HG13 ' A' ' 126' ' ' VAL . 43.4 t30 -130.51 86.8 2.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -1.145 . . . . 0.0 110.266 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.647 ' O ' HG21 ' A' ' 122' ' ' THR . 35.5 m -156.39 173.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 110.208 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.58 ' HA ' HG21 ' A' ' 122' ' ' THR . 96.9 mt-10 -148.27 147.7 29.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.216 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.686 HD12 ' H ' ' A' ' 128' ' ' ILE . 5.2 mp -78.68 173.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.064 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.601 ' N ' HG22 ' A' ' 128' ' ' ILE . 36.2 mtpt -103.94 136.04 44.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.284 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -49.45 -29.18 6.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 110.234 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.07 -35.51 78.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.064 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.825 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 17.6 t-160 -66.81 -42.64 85.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.097 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.778 HG21 ' CE2' ' A' ' 5' ' ' TYR . 68.9 t -62.57 -39.82 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.998 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -72.82 -39.16 66.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 110.179 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.15 93.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.133 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.24 -22.63 76.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.543 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 82.6 mttt -75.98 -32.67 59.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 110.094 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.56 -32.07 60.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.038 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -75.83 -27.59 57.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -84.76 -35.72 22.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 110.115 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 80.4 p -64.21 -46.0 85.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.876 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.19 -50.29 74.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.976 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 147' ' ' ILE . 3.6 mm? -58.49 -32.72 69.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.853 . . . . 0.0 109.993 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 4.9 m-85 -63.33 -38.43 91.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.051 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -78.54 -18.1 55.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.497 HD23 ' HA ' ' A' ' 146' ' ' LEU . 15.4 mt -81.09 -35.14 32.06 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.126 -0.984 . . . . 0.0 108.829 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.705 HG22 HD23 ' A' ' 18' ' ' LEU . 34.7 mt -69.62 -49.06 61.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.857 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.576 ' HB3' HD13 ' A' ' 13' ' ' ILE . 65.1 mm-40 -54.12 -41.7 68.65 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.394 -0.816 . . . . 0.0 109.362 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.436 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 45.1 m -71.38 -32.6 68.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.592 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.658 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 76.2 t80 -53.9 -58.75 6.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.934 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.162 HD21 ' CE2' ' A' ' 158' ' ' TYR . 62.8 mt -69.03 -29.73 67.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -0.962 . . . . 0.0 109.968 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.585 ' HB2' HD11 ' A' ' 13' ' ' ILE . 43.5 tptt -68.59 -35.64 77.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 109.775 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -98.44 -28.69 7.87 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.511 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 10.8 m-70 -107.2 89.1 4.36 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.359 -1.083 . . . . 0.0 109.897 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.0 Cg_endo -72.76 4.46 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.095 1.576 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 24.2 p30 -107.74 -12.64 15.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.007 -1.058 . . . . 0.0 109.728 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.658 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -66.49 100.57 0.67 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.409 -0.807 . . . . 0.0 109.999 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.162 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.86 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.279 0.562 . . . . 0.0 110.584 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.378 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.783 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 73.8 t -135.65 125.33 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.162 . . . . 0.0 110.456 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.572 ' CE1' HG12 ' A' ' 128' ' ' ILE . 52.9 m-85 -96.91 173.51 7.25 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.254 -0.904 . . . . 0.0 110.094 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.748 HG23 ' CE1' ' A' ' 119' ' ' HIS . 54.4 m -148.11 98.38 2.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CE1' HG11 ' A' ' 133' ' ' VAL . 78.5 m-85 -114.89 132.03 56.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.023 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.503 ' HB3' HG23 ' A' ' 117' ' ' THR . 18.9 pt-20 -130.84 159.6 36.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.569 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 p -132.0 143.91 50.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.424 -0.798 . . . . 0.0 109.895 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -124.81 125.71 44.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 0.0 110.387 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.624 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 3.8 p90 -152.84 -172.86 4.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 110.005 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 113' ' ' ILE . 10.8 p -140.19 179.89 6.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.272 -0.893 . . . . 0.0 110.446 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 112' ' ' SER . 2.6 t -157.51 158.96 36.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.268 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.603 ' CG ' HD12 ' A' ' 13' ' ' ILE . 17.1 pt-20 -85.76 -10.89 54.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.915 . . . . 0.0 110.044 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.845 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.0 mp -90.5 151.37 44.12 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.711 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.845 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.3 Cg_endo -66.86 143.04 65.18 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.975 1.513 . . . . 0.0 110.723 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.666 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 Cg_endo -71.63 -31.73 12.96 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.952 1.501 . . . . 0.0 112.584 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.2 Cg_endo -69.53 -18.99 37.77 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.511 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -84.47 -48.57 9.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.776 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -68.62 -24.55 64.58 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.593 ' CZ ' HD11 ' A' ' 74' ' ' ILE . 82.8 t80 -69.83 -57.12 5.46 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.498 0.666 . . . . 0.0 109.789 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 81.6 mttt -54.88 -30.56 58.31 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.892 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -73.3 -64.62 0.94 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.771 0.796 . . . . 0.0 111.167 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.046 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -57.43 -40.37 78.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.66 -0.65 . . . . 0.0 111.955 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.118 HG11 ' CD1' ' A' ' 74' ' ' ILE . 11.5 t -99.6 -59.41 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.786 -1.196 . . . . 0.0 111.798 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.671 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.3 mp -77.1 -0.55 25.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.015 . . . . 0.0 111.71 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.567 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -145.35 7.01 1.13 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.756 -1.215 . . . . 0.0 111.193 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.046 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -46.02 -48.06 16.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.873 -1.142 . . . . 0.0 110.01 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 74.0 m-20 -58.91 -15.43 12.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.831 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.472 ' HA ' ' CG ' ' A' ' 31' ' ' PRO . 80.0 m-20 -129.54 10.93 5.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.796 HD12 ' C ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -95.25 -46.26 6.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.982 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.998 HG21 HD13 ' A' ' 38' ' ' ILE . 6.3 p -76.91 -27.63 0.62 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 112.419 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.821 ' HD3' HG12 ' A' ' 30' ' ' VAL . 47.7 Cg_endo -75.68 3.14 6.22 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 122.563 0.77 . . . . 0.0 110.611 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' CD ' ' OH ' ' A' ' 150' ' ' TYR . 95.0 mttt -119.15 -26.5 5.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -0.941 . . . . 0.0 109.127 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.612 HG12 ' CD1' ' A' ' 150' ' ' TYR . 49.4 mt -79.35 -41.02 22.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.553 -0.717 . . . . 0.0 109.533 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -169.75 103.79 0.46 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.49 -0.756 . . . . 0.0 109.829 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 43.3 Cg_endo -69.56 -3.01 11.02 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.979 1.515 . . . . 0.0 110.688 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.421 HE21 ' HB1' ' A' ' 34' ' ' ALA . 13.2 pt20 -83.16 -14.87 52.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.494 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -92.06 -71.97 0.61 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 110.201 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.998 HD13 HG21 ' A' ' 30' ' ' VAL . 1.7 mp -94.06 125.79 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.868 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 57' ' ' THR . 13.0 tppt? -74.19 -36.19 64.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 110.339 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.538 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -179.56 151.96 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.862 . . . . 0.0 109.974 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.443 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 39.3 p -112.01 133.59 54.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.07 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.481 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 71.9 tt0 -139.88 108.72 5.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.971 . . . . 0.0 110.29 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.8 mt -66.07 134.54 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 110.189 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.8 tp -90.31 -27.03 19.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 1.073 ' O ' HG23 ' A' ' 52' ' ' THR . 33.3 tp10 -158.84 169.32 24.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.228 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 64.75 -166.17 32.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 48.7 t0 -135.88 29.71 3.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -1.167 . . . . 0.0 110.287 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.516 ' H ' HG21 ' A' ' 52' ' ' THR . . . 104.36 4.85 43.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.513 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -96.45 -167.31 33.91 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.64 132.12 21.3 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.143 1.602 . . . . 0.0 110.514 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.25 -7.31 66.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 1.073 HG23 ' O ' ' A' ' 45' ' ' GLU . 26.7 m -80.02 139.0 37.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -1.106 . . . . 0.0 110.161 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 70' ' ' LYS . 18.7 mm -109.06 110.84 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 110.226 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.1 mttt -97.84 153.27 18.42 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.378 -0.827 . . . . 0.0 110.392 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 78.2 tttt -124.94 100.6 6.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 110.075 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.5 mt -88.27 138.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 110.35 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.9 p -111.58 157.59 20.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.184 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 28.6 m-85 -117.83 159.44 23.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.356 -0.84 . . . . 0.0 110.3 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -134.43 20.59 3.92 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -48.78 -24.99 1.61 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -1.158 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.18 -37.31 1.16 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.1 m -50.32 158.45 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -1.124 . . . . 0.0 110.158 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.56 -45.28 69.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.243 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.01 110.11 9.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.249 -0.907 . . . . 0.0 110.31 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -139.47 82.83 0.24 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 14.7 p90 -131.6 163.65 27.59 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.219 -1.165 . . . . 0.0 110.198 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.83 HG12 ' HA2' ' A' ' 88' ' ' GLY . 9.5 m -137.71 172.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 110.627 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . 70.7 mttt -123.78 130.65 52.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.667 -0.646 . . . . 0.0 109.503 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.646 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 9.6 m170 -118.44 130.7 56.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.094 -1.004 . . . . 0.0 111.0 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.59 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.0 tttt -104.05 120.04 40.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.416 -0.802 . . . . 0.0 109.174 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.536 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 21.0 mm -62.4 129.58 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 110.693 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 73' ' ' SER . 72.3 m-20 -101.37 -49.6 4.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.359 -0.838 . . . . 0.0 109.308 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 79.6 p -179.68 157.36 0.74 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.529 -0.732 . . . . 0.0 110.286 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.118 ' CD1' HG11 ' A' ' 23' ' ' VAL . 3.2 tt -145.97 164.32 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -134.31 81.5 1.92 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 0.0 110.123 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 41.6 ttmt -55.9 -14.38 2.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.278 -0.889 . . . . 0.0 110.824 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -84.1 -29.91 26.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 0.0 109.006 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -116.63 -1.1 12.22 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.357 0.599 . . . . 0.0 109.532 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.592 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 7.6 m-85 65.5 49.82 1.77 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.684 -0.635 . . . . 0.0 110.108 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.518 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -116.41 142.14 47.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 109.285 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.646 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 72.9 t80 -137.24 155.1 49.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.267 -0.895 . . . . 0.0 110.284 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.451 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 77.9 p -158.51 140.86 14.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 110.474 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.646 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 5.9 p90 -148.59 177.69 9.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 110.161 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 90.0 m -128.5 131.6 48.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 110.004 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.896 HD23 HG13 ' A' ' 98' ' ' ILE . 15.5 tp -83.62 123.7 30.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.201 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.55 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 33.7 pt -104.93 -8.99 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 110.228 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -163.57 166.26 22.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 0.0 110.239 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.83 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 155.04 153.23 6.43 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -79.96 -22.18 42.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -1.214 . . . . 0.0 110.268 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.99 -20.23 63.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.307 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.91 ' CD2' HD11 ' A' ' 98' ' ' ILE . 71.1 mt -67.79 -18.75 64.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.27 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 50.87 -167.19 0.51 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.41 9.53 25.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -1.151 . . . . 0.0 110.128 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 122' ' ' THR . 40.8 p -110.55 -32.11 7.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 110.079 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.9 HD23 HG23 ' A' ' 122' ' ' THR . 72.3 mt -109.42 154.74 22.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 110.169 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.529 ' O ' HD13 ' A' ' 91' ' ' LEU . 68.8 tt0 -137.37 -80.83 0.37 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.159 -0.963 . . . . 0.0 110.004 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.916 ' O ' HD13 ' A' ' 98' ' ' ILE . 32.1 mttm -80.22 156.15 27.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.495 -0.753 . . . . 0.0 110.513 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 97' ' ' LYS . 4.2 mm -145.49 126.28 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.092 -1.005 . . . . 0.0 109.82 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -93.23 126.51 38.38 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.45 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 15.0 m-85 -121.05 144.56 48.47 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.317 -0.864 . . . . 0.0 110.961 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -149.89 128.02 11.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.481 -0.762 . . . . 0.0 109.938 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 85.6 m -127.69 134.62 49.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.989 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 115' ' ' LYS . 15.5 mttt -124.44 136.81 54.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.287 -0.883 . . . . 0.0 110.362 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.787 HD23 HG12 ' A' ' 114' ' ' ILE . 8.5 mt -117.19 150.33 38.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.359 -0.838 . . . . 0.0 110.063 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.57 -169.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.257 -0.902 . . . . 0.0 110.107 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -117.81 140.42 49.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.411 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 92.1 p -96.74 162.5 22.94 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -72.6 -1.73 10.75 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.469 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p -99.9 -8.86 23.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.3 -21.81 21.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . -74.34 -146.05 1.08 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 27.3 p -149.36 131.67 15.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -1.158 . . . . 0.0 110.057 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.609 ' HA ' HG22 ' A' ' 10' ' ' THR . 37.0 mt -83.19 148.98 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 110.132 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.787 HG12 HD23 ' A' ' 104' ' ' LEU . 7.0 mt -133.41 115.55 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 110.463 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 103' ' ' LYS . 81.3 tttt -108.37 117.66 34.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.325 -0.859 . . . . 0.0 109.748 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 8.7 t -113.5 164.72 13.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.753 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.533 HG22 ' CE1' ' A' ' 119' ' ' HIS . 30.8 m -160.01 120.23 2.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.375 -0.828 . . . . 0.0 109.795 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.492 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 26.5 m -122.69 133.93 54.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.383 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.748 ' CE1' HG23 ' A' ' 4' ' ' THR . 35.8 m-70 -114.3 156.82 23.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 109.763 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.8 m-85 -114.37 149.28 36.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 110.595 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 90.1 m-70 -125.74 88.17 2.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.018 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.9 HG23 HD23 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -74.15 146.06 43.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.514 -0.741 . . . . 0.0 111.083 -178.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 63.7 pttt -105.41 130.89 53.41 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.543 -0.723 . . . . 0.0 110.137 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.24 -117.47 4.62 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.678 ' O ' HG13 ' A' ' 126' ' ' VAL . 46.2 t30 -138.27 103.28 4.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.275 -1.132 . . . . 0.0 110.418 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 125' ' ' ASN . 8.7 m -159.5 165.49 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.833 . . . . 0.0 109.896 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -134.7 158.46 44.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.142 -0.974 . . . . 0.0 110.32 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.862 ' CD1' HD21 ' A' ' 95' ' ' LEU . 22.7 mm -70.7 172.93 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 110.196 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.582 ' N ' HG22 ' A' ' 128' ' ' ILE . 13.9 mttm -116.61 131.45 56.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.972 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 69.5 mm-40 -43.66 -44.4 6.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.15 -0.969 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -63.29 -24.63 67.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.933 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 129' ' ' LYS . 15.1 t-160 -81.06 -49.25 11.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.118 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.591 HG11 ' CE1' ' A' ' 5' ' ' TYR . 59.5 t -58.79 -37.66 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.758 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.03 -44.81 37.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.902 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -64.27 -32.69 74.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.349 -0.844 . . . . 0.0 110.057 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.06 -32.17 66.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -75.83 -34.08 60.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -1.1 . . . . 0.0 109.997 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.99 -37.73 58.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.916 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 94.3 mttt -69.5 -37.53 77.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 109.861 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.477 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -69.79 -34.98 74.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.797 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 64.9 m -72.64 -44.19 62.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 109.805 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -57.61 -43.94 85.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.877 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.6 -43.75 98.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.913 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.511 ' HA ' HD12 ' A' ' 147' ' ' ILE . 8.6 m-85 -59.89 -32.87 71.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.443 -0.786 . . . . 0.0 109.84 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -78.27 -20.21 52.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.483 ' HB3' HG21 ' A' ' 33' ' ' ILE . 17.5 mt -83.25 -36.29 24.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.174 -0.954 . . . . 0.0 108.826 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.648 HG23 HD11 ' A' ' 29' ' ' LEU . 8.9 mt -72.51 -43.75 62.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.557 ' HB3' HD13 ' A' ' 13' ' ' ILE . 54.7 mt-10 -60.95 -41.11 95.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.435 -0.791 . . . . 0.0 109.372 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.8 m -72.9 -32.8 65.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.622 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.656 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.2 t80 -56.48 -54.68 42.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.495 -0.753 . . . . 0.0 109.886 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.197 HD21 ' CE2' ' A' ' 158' ' ' TYR . 69.4 mt -69.27 -31.22 69.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.307 -0.871 . . . . 0.0 110.288 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.554 ' HB2' HD11 ' A' ' 13' ' ' ILE . 43.1 tttt -68.55 -28.43 66.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.88 . . . . 0.0 109.782 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.81 -26.72 6.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.513 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 11.2 m-70 -107.27 90.41 5.67 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.951 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.8 Cg_endo -73.47 3.75 4.51 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.101 1.579 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -109.56 -9.69 14.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.76 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.656 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -68.48 100.28 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.468 -0.77 . . . . 0.0 110.136 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.197 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.7 OUTLIER 34.4 32.72 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.253 0.549 . . . . 0.0 110.542 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.846 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 50.0 t -125.43 114.31 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.187 -1.184 . . . . 0.0 110.406 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.594 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 93.1 m-85 -74.83 152.83 38.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.954 . . . . 0.0 110.184 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.657 HG23 ' CE1' ' A' ' 119' ' ' HIS . 7.9 m -130.38 113.76 14.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.756 ' CD2' HG13 ' A' ' 133' ' ' VAL . 39.1 m-85 -126.61 125.84 42.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.089 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.576 ' CG ' ' N ' ' A' ' 7' ' ' SER . 16.3 tt0 -114.82 176.15 5.18 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.277 -0.889 . . . . 0.0 109.61 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.576 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 19.1 m -153.0 147.4 25.87 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.646 -0.659 . . . . 0.0 109.852 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.429 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 47.6 mt-10 -140.26 116.33 10.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.054 -1.028 . . . . 0.0 110.566 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.715 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 3.9 p90 -145.17 -172.08 3.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 109.887 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.78 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.6 p -140.59 172.63 12.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.465 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 53.8 p -150.69 142.24 23.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.465 -0.772 . . . . 0.0 110.097 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.17 -25.93 68.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.278 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.744 HD11 ' HB2' ' A' ' 152' ' ' LYS . 5.1 mp -81.34 146.38 57.74 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.148 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.677 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.7 Cg_endo -66.76 152.94 79.58 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.116 1.587 . . . . 0.0 110.719 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.7 Cg_endo -64.5 -36.08 45.38 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.763 1.401 . . . . 0.0 113.204 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 39.5 Cg_endo -65.24 -20.17 62.43 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 N-CA-C 109.748 -0.905 . . . . 0.0 109.748 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.974 ' HG3' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -80.92 -43.4 19.85 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 18' ' ' LEU . 8.0 mp -72.68 -38.08 67.69 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 47.9 t80 -56.84 -57.56 11.93 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.24 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 92.5 mttt -57.58 -37.47 73.22 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.529 -0.732 . . . . 0.0 110.134 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.073 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.03 -58.74 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 111.1 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.007 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -53.73 -40.52 66.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 0.0 111.958 -178.606 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.119 HG11 ' CD1' ' A' ' 74' ' ' ILE . 21.1 t -106.27 -65.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.845 -1.159 . . . . 0.0 111.693 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 24' ' ' LEU . 4.2 mm? -62.77 -8.58 7.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 111.216 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.734 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -144.76 28.52 1.27 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.876 -1.14 . . . . 0.0 110.63 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.007 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.57 -35.51 79.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -0.907 . . . . 0.0 110.112 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.449 ' OD1' ' CB ' ' A' ' 41' ' ' SER . 19.8 t70 -63.25 -16.05 59.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.208 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 81.8 m-20 -126.94 8.1 6.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.029 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.752 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -92.94 -53.64 4.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.178 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.911 ' CG1' HD13 ' A' ' 38' ' ' ILE . 2.5 t -72.02 -42.47 9.78 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.415 -0.803 . . . . 0.0 110.905 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.3 Cg_endo -77.74 9.48 2.94 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.541 1.285 . . . . 0.0 111.005 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 28' ' ' ASN . 33.3 ttmt -127.21 -31.2 2.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.968 -1.083 . . . . 0.0 109.831 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.605 HG12 ' CD1' ' A' ' 150' ' ' TYR . 36.7 mt -80.01 -38.97 19.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.443 -0.785 . . . . 0.0 109.733 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -154.28 99.75 2.49 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.449 -0.782 . . . . 0.0 110.026 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 43.7 Cg_endo -71.27 -2.0 10.51 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.066 1.561 . . . . 0.0 110.481 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -86.36 -12.6 48.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.751 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.659 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -96.03 -56.34 2.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.081 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.911 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.0 mp -115.12 132.28 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 110.08 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.587 ' CG ' ' CA ' ' A' ' 59' ' ' GLY . 0.5 OUTLIER -68.62 -37.28 79.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.891 . . . . 0.0 110.193 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.574 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 177.61 153.82 0.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 110.018 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.449 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 62.7 m -115.04 125.7 53.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.979 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.574 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 84.5 tt0 -130.18 106.93 8.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.293 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 22.2 mt -61.08 131.68 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.176 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 44' ' ' LEU . 49.7 mt -88.93 -26.09 21.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 110.044 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 1.013 ' O ' HG23 ' A' ' 52' ' ' THR . 55.7 tt0 -152.31 171.14 18.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.97 -169.03 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -130.37 28.14 4.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -1.121 . . . . 0.0 110.232 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.604 ' H ' HG21 ' A' ' 52' ' ' THR . . . 113.36 -5.49 24.96 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.516 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -79.97 -170.99 41.86 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -70.44 133.55 24.56 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.195 1.629 . . . . 0.0 110.574 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.27 -1.42 76.77 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 1.013 HG23 ' O ' ' A' ' 45' ' ' GLU . 32.4 m -80.16 145.42 32.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -1.193 . . . . 0.0 110.158 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 70' ' ' LYS . 36.0 mm -111.92 112.02 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 110.184 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 46.5 mtmt -99.12 150.57 21.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 110.374 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -123.14 98.84 6.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.877 . . . . 0.0 110.053 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.498 ' HB ' HG23 ' A' ' 67' ' ' VAL . 96.6 mt -88.97 140.12 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 110.193 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.9 p -115.0 152.77 31.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.56 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 26.7 m-85 -117.62 129.2 55.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.499 -0.75 . . . . 0.0 109.993 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.587 ' CA ' ' CG ' ' A' ' 39' ' ' LYS . . . -93.38 36.22 3.81 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -129.05 131.24 47.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -1.126 . . . . 0.0 110.269 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.67 138.54 9.83 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 65.2 p -55.63 -49.16 73.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -1.111 . . . . 0.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -73.65 153.0 40.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 110.076 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -62.31 136.23 57.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.2 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -122.38 88.0 0.4 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.1 p90 -123.62 163.42 21.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -1.211 . . . . 0.0 110.124 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.787 HG12 ' HA2' ' A' ' 88' ' ' GLY . 8.6 m -141.32 172.03 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.938 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.433 ' HD2' ' OE1' ' A' ' 87' ' ' GLU . 86.4 mttt -127.4 125.85 41.4 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.524 ' CD2' HD12 ' A' ' 85' ' ' LEU . 10.1 m170 -116.92 121.02 40.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 111.161 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.616 ' HD3' HD13 ' A' ' 86' ' ' ILE . 23.5 mtmt -96.46 106.88 19.2 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.324 -0.86 . . . . 0.0 109.242 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.7 mm -48.34 136.68 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.872 . . . . 0.0 110.074 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 73' ' ' SER . 14.9 m-20 -107.34 -44.6 4.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.343 -0.848 . . . . 0.0 109.744 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 12.9 p 176.18 156.57 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.522 -0.736 . . . . 0.0 110.365 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.119 ' CD1' HG11 ' A' ' 23' ' ' VAL . 6.1 tt -144.96 169.86 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.504 -0.748 . . . . 0.0 109.597 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.4 m-20 -142.47 84.29 1.85 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.075 -1.016 . . . . 0.0 110.317 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.544 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 81.1 tttt -59.67 -13.9 11.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 110.221 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -92.79 -34.2 13.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.2 m-80 -102.21 -3.9 26.61 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.524 0.678 . . . . 0.0 109.229 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.571 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 90.5 m-85 62.58 55.78 2.14 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.253 0.549 . . . . 0.0 110.919 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 2.7 m -132.14 162.38 31.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 0.0 109.658 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.61 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 80.2 t80 -158.08 146.71 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -0.974 . . . . 0.0 110.198 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.425 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 3.8 t -153.56 147.63 25.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.692 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 9.2 p90 -149.76 175.58 11.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.429 -0.794 . . . . 0.0 110.015 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 98' ' ' ILE . 97.6 m -125.61 128.82 48.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 2.7 tp -96.39 122.97 39.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.573 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.616 HD13 ' HD3' ' A' ' 70' ' ' LYS . 20.8 pt -112.63 -5.39 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 110.894 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 22.9 tt0 -147.29 120.86 9.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 110.672 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.787 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -168.74 149.05 13.11 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.68 -8.04 24.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -1.123 . . . . 0.0 110.065 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.768 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -80.4 -53.54 6.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.471 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.721 HD21 ' N ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -63.94 -30.7 71.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.269 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 39.08 -124.42 1.75 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -106.04 -6.46 18.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -1.125 . . . . 0.0 110.494 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.771 ' O ' HG21 ' A' ' 126' ' ' VAL . 64.1 p -80.04 -50.63 10.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 109.703 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.779 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -109.43 163.66 13.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.779 ' H ' HD12 ' A' ' 95' ' ' LEU . 42.0 tt0 -133.18 -77.84 0.48 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 110.912 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.6 mtpt -80.08 128.96 34.11 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.615 -0.678 . . . . 0.0 111.125 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.763 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.2 mm -117.74 140.47 40.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 120.868 -1.145 . . . . 0.0 109.811 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -117.76 126.72 52.97 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.38 -0.825 . . . . 0.0 108.974 178.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.763 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.4 m-85 -121.8 136.07 54.93 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.915 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 48.3 tt0 -137.14 150.72 48.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.571 -0.706 . . . . 0.0 109.606 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' TYR . 36.7 m -149.21 150.4 32.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -0.997 . . . . 0.0 110.408 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 2.3 tttt -138.68 147.22 42.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.681 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.803 HD23 HG12 ' A' ' 114' ' ' ILE . 2.7 mt -128.45 147.3 50.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.001 . . . . 0.0 110.688 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.72 -168.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.475 -0.765 . . . . 0.0 109.806 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.86 172.7 7.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.131 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.459 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 32.8 p -130.48 164.96 37.71 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -73.16 -1.3 10.35 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.995 1.524 . . . . 0.0 110.599 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.0 p -103.93 3.68 33.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.374 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.04 -36.76 3.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.97 -173.85 3.09 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.5 p -130.33 140.24 50.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -1.189 . . . . 0.0 110.357 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.78 ' HA ' HG22 ' A' ' 10' ' ' THR . 27.5 mt -89.8 149.5 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.854 . . . . 0.0 110.077 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.803 HG12 HD23 ' A' ' 104' ' ' LEU . 10.5 mt -135.95 110.61 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.313 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 37.1 ttmt -99.73 129.85 45.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.941 . . . . 0.0 110.135 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.6 t -121.03 157.18 30.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.958 . . . . 0.0 110.282 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 85.7 m -154.3 138.02 16.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 110.15 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.477 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 34.7 p -141.61 154.46 45.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 110.184 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.657 ' CE1' HG23 ' A' ' 4' ' ' THR . 82.2 m-70 -133.41 164.63 26.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 0.0 110.387 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.587 ' CD2' HG13 ' A' ' 128' ' ' ILE . 8.2 m-85 -124.06 141.92 51.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 110.435 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.2 m-70 -122.52 89.43 3.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.924 -1.11 . . . . 0.0 109.793 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.624 ' HB ' HG23 ' A' ' 126' ' ' VAL . 2.7 p -60.25 163.44 5.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 110.301 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 85.0 tttt -126.0 114.9 19.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.275 -0.891 . . . . 0.0 110.242 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.36 -105.37 2.99 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.628 ' O ' HG13 ' A' ' 126' ' ' VAL . 24.7 t30 -135.6 93.43 2.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -1.169 . . . . 0.0 110.202 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.771 HG21 ' O ' ' A' ' 94' ' ' THR . 15.9 m -157.76 165.55 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.305 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -145.21 149.5 35.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 110.316 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.762 HD11 ' HB2' ' A' ' 95' ' ' LEU . 37.8 mm -75.97 173.41 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 110.203 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.61 ' N ' HG22 ' A' ' 128' ' ' ILE . 31.5 mtpt -116.54 136.21 53.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.4 -0.813 . . . . 0.0 110.078 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -45.43 -43.26 11.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 110.268 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.62 -31.28 71.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 110.142 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.768 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 16.0 t-160 -74.02 -47.69 35.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 110.081 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.756 HG13 ' CD2' ' A' ' 5' ' ' TYR . 73.0 t -62.21 -40.96 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.381 -0.824 . . . . 0.0 110.008 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -69.37 -42.73 74.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.997 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.502 ' HB1' ' NZ ' ' A' ' 139' ' ' LYS . . . -62.4 -38.66 90.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.026 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -30.23 68.16 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 52.7 mtpt -77.37 -31.85 54.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -1.147 . . . . 0.0 110.055 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -76.67 -30.49 56.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 109.927 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.502 ' NZ ' ' HB1' ' A' ' 135' ' ' ALA . 46.1 mttp -68.37 -37.5 80.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.864 . . . . 0.0 110.051 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.42 -43.08 64.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.902 . . . . 0.0 110.007 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.1 p -63.42 -43.46 97.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.943 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -57.73 -41.68 82.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.863 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 147' ' ' ILE . 66.4 mt -58.61 -46.32 87.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 0.0 109.966 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.441 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 20.9 m-85 -54.42 -39.53 67.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.383 -0.823 . . . . 0.0 109.913 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.88 -28.19 68.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.88 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.562 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.9 mt -82.93 -34.5 26.53 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.222 -0.924 . . . . 0.0 108.791 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.636 HD13 ' CD1' ' A' ' 22' ' ' PHE . 81.8 mt -72.01 -34.79 51.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.606 -0.684 . . . . 0.0 109.329 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.597 ' CB ' HD13 ' A' ' 13' ' ' ILE . 30.8 mt-10 -64.91 -39.43 93.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.403 -0.811 . . . . 0.0 109.428 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.7 m -69.6 -35.47 75.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.498 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.609 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 71.5 t80 -58.58 -51.84 68.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.819 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.069 HD21 ' CE1' ' A' ' 158' ' ' TYR . 78.0 mt -80.05 -39.15 30.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 110.27 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.744 ' HB2' HD11 ' A' ' 13' ' ' ILE . 82.6 tttt -64.2 -19.16 65.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.495 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -110.31 -34.72 2.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.613 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 3.6 m-70 -107.03 94.47 10.88 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.276 -1.132 . . . . 0.0 109.983 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.4 Cg_endo -74.04 5.38 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.089 1.573 . . . . 0.0 110.973 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -106.89 -9.66 16.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.046 -1.034 . . . . 0.0 109.856 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.633 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -69.68 100.82 1.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.348 -0.845 . . . . 0.0 110.083 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.073 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 1.0 OUTLIER 34.09 33.6 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.342 0.591 . . . . 0.0 110.642 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.508 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 118.009 -0.995 . . . . 0.0 109.852 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.031 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.9 p -80.12 150.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -1.131 . . . . 0.0 110.35 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.612 ' CD1' HD12 ' A' ' 128' ' ' ILE . 26.1 m-85 -89.07 176.38 7.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 110.368 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.84 HG23 ' CE1' ' A' ' 119' ' ' HIS . 97.4 m -145.45 103.66 3.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.396 -0.815 . . . . 0.0 110.083 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.687 ' CD1' HG13 ' A' ' 133' ' ' VAL . 51.5 m-85 -116.23 129.34 56.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 110.098 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 116' ' ' SER . 25.5 pt-20 -131.52 157.94 42.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 110.505 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.4 m -133.95 139.42 46.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.895 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.481 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 99.9 mt-10 -121.24 127.32 51.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.385 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 3.8 p90 -154.3 -171.76 3.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.0 110.038 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.568 HG22 HG12 ' A' ' 113' ' ' ILE . 18.0 p -141.35 -176.46 4.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.57 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.489 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 3.7 t -159.6 160.9 34.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.776 . . . . 0.0 110.152 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -85.16 -19.11 32.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.978 . . . . 0.0 110.153 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 10.0 mm -85.47 149.8 52.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 110.095 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.9 Cg_endo -65.82 148.5 86.5 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.06 1.558 . . . . 0.0 110.57 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.682 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.3 Cg_endo -70.05 -32.57 17.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.885 1.466 . . . . 0.0 112.893 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.682 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.2 Cg_endo -67.58 -20.62 47.0 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 N-CA-C 110.149 -0.75 . . . . 0.0 110.149 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.883 ' HG2' HD13 ' A' ' 151' ' ' LEU . 4.6 ttm180 -84.73 -49.16 8.72 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.752 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -69.06 -26.73 65.1 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.205 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.9 t80 -71.29 -55.03 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 109.236 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 63.3 mttt -51.72 -32.98 32.49 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.403 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.079 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -79.83 -55.09 5.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 111.188 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.056 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -57.29 -44.39 84.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.527 -0.733 . . . . 0.0 112.52 -177.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.554 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -106.8 -55.68 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.792 -1.192 . . . . 0.0 112.06 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.661 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.9 mm? -68.84 -10.64 58.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.01 -1.056 . . . . 0.0 111.174 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.584 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.2 m-20 -145.36 28.58 1.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.886 -1.134 . . . . 0.0 110.734 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.056 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.29 -20.04 65.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.152 -0.968 . . . . 0.0 110.436 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -72.61 -20.19 61.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.096 -1.003 . . . . 0.0 109.588 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 5.7 p30 -126.85 14.76 7.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 109.672 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.913 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -96.42 -50.16 4.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.224 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.079 HG21 HD13 ' A' ' 38' ' ' ILE . 9.7 p -73.26 -26.99 0.79 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.332 -0.855 . . . . 0.0 112.183 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.802 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -82.91 10.38 3.66 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 122.621 0.8 . . . . 0.0 110.51 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -134.37 -27.04 1.4 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.13 -0.982 . . . . 0.0 110.603 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.687 HD11 ' CD1' ' A' ' 29' ' ' LEU . 34.3 mt -77.87 -36.29 21.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.225 -0.922 . . . . 0.0 109.899 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.95 100.13 0.82 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.342 -0.849 . . . . 0.0 110.338 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.85 -0.1 9.0 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.109 1.584 . . . . 0.0 110.346 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -88.29 -13.09 41.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 110.007 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.13 -47.1 4.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 110.315 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.079 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -125.79 145.24 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -0.82 . . . . 0.0 110.103 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -83.18 -42.04 17.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.269 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.546 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -178.44 163.53 1.58 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.244 -0.91 . . . . 0.0 110.123 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.6 m -120.27 125.68 48.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.185 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.546 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 83.9 tt0 -130.04 107.57 9.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 110.151 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 23.4 mt -56.54 134.89 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 110.071 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.83 HD22 ' CE ' ' A' ' 55' ' ' LYS . 63.8 tp -88.76 -46.51 8.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -0.958 . . . . 0.0 109.911 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.83 ' O ' HG23 ' A' ' 52' ' ' THR . 16.8 mm-40 -131.97 -169.81 2.28 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.442 -0.786 . . . . 0.0 110.179 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.44 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.08 -150.05 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 23.4 t0 -160.03 41.48 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -1.133 . . . . 0.0 110.093 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.655 ' H ' HG21 ' A' ' 52' ' ' THR . . . 103.31 -11.71 54.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -82.13 -175.54 50.62 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.3 Cg_endo -72.23 132.82 20.06 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.144 1.602 . . . . 0.0 110.43 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.91 -3.78 62.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.4 m -80.02 150.04 30.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -1.175 . . . . 0.0 109.986 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.718 HD13 ' HA ' ' A' ' 70' ' ' LYS . 20.9 mm -116.76 107.62 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.948 . . . . 0.0 110.324 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 73.0 mttt -90.32 144.88 25.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.398 -0.814 . . . . 0.0 110.097 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.83 ' CE ' HD22 ' A' ' 44' ' ' LEU . 31.7 mttt -117.95 95.4 4.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.267 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CG2' HG12 ' A' ' 38' ' ' ILE . 86.9 mt -83.44 145.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.904 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 38' ' ' ILE . 6.2 p -116.48 158.35 23.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 110.74 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.812 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.9 m-85 -116.42 145.87 42.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.226 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.91 4.93 53.16 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.65 151.54 51.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.167 -1.196 . . . . 0.0 110.285 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.51 -143.6 16.97 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.8 p -61.49 173.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -1.16 . . . . 0.0 110.208 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.421 ' OE1' ' HA ' ' A' ' 63' ' ' GLN . 10.8 tp60 -47.03 -58.43 4.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.085 -1.009 . . . . 0.0 110.112 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.495 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 7.1 t80 -108.51 116.67 32.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.26 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -116.8 135.86 12.31 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.9 p90 -179.08 166.57 1.57 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -1.153 . . . . 0.0 110.271 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.96 HG12 ' HA2' ' A' ' 88' ' ' GLY . 3.6 m -142.09 174.7 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.428 -0.795 . . . . 0.0 110.362 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.65 ' O ' HD12 ' A' ' 85' ' ' LEU . 96.6 mttt -126.15 124.75 41.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.481 -0.762 . . . . 0.0 109.705 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.617 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 10.1 m170 -113.73 130.3 56.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.135 -0.978 . . . . 0.0 110.814 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.718 ' HA ' HD13 ' A' ' 53' ' ' ILE . 76.7 tttt -107.31 102.31 11.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.381 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.503 HG22 ' HA ' ' A' ' 50' ' ' PRO . 34.6 mm -45.25 135.35 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.466 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.485 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 12.2 t0 -108.66 -38.69 5.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.446 -0.784 . . . . 0.0 109.617 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.488 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 6.4 p 179.07 156.58 0.5 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.505 -0.747 . . . . 0.0 110.019 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.447 HG12 HG11 ' A' ' 23' ' ' VAL . 1.9 mt -136.97 159.17 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.07 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 1.1 m-20 -144.67 83.97 1.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.62 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.578 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 57.4 tttp -66.65 -15.82 63.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.276 -0.89 . . . . 0.0 110.17 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -86.29 -31.04 21.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 0.0 108.809 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m-80 -106.1 -3.9 20.98 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.559 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 98.9 m-85 61.11 53.73 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.36 0.6 . . . . 0.0 110.584 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 12.9 t -125.47 175.2 7.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.85 . . . . 0.0 110.103 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.687 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 39.1 t80 -159.59 134.23 7.84 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.713 -0.617 . . . . 0.0 109.8 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.488 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 20.2 m -140.77 123.34 16.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 111.037 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.687 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 16.8 p90 -139.16 171.86 13.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.812 . . . . 0.0 110.01 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 98' ' ' ILE . 58.0 m -124.33 137.1 54.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.978 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 68' ' ' LYS . 15.5 tp -99.74 124.85 45.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.391 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.3 pt -102.22 -10.67 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 110.292 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.4 ' OE1' ' HE3' ' A' ' 68' ' ' LYS . 81.7 tt0 -151.51 155.71 39.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 110.232 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.96 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 157.61 143.47 3.67 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -61.54 -25.9 67.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -1.107 . . . . 0.0 110.184 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.553 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -60.21 -25.87 65.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 110.253 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.459 HD21 ' CG1' ' A' ' 98' ' ' ILE . 89.6 mt -62.52 -11.76 18.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.199 -0.938 . . . . 0.0 110.137 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.923 ' O ' HG23 ' A' ' 94' ' ' THR . . . 42.57 28.95 0.67 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 66.9 m-20 56.29 16.1 2.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -1.185 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.923 HG23 ' O ' ' A' ' 92' ' ' GLY . 19.6 p -111.93 -34.27 6.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.736 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.818 HD23 HG23 ' A' ' 122' ' ' THR . 96.2 mt -94.76 163.85 13.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.826 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.482 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 68.1 tt0 -127.98 -81.61 0.59 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.783 0.802 . . . . 0.0 109.782 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 60.4 mttt -80.3 127.97 32.99 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.657 -0.652 . . . . 0.0 110.142 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.81 ' O ' HG23 ' A' ' 84' ' ' THR . 3.8 mm -117.05 139.91 41.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.628 -1.295 . . . . 0.0 109.721 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -120.59 125.18 47.11 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.772 ' CE2' HG21 ' A' ' 98' ' ' ILE . 12.4 m-85 -120.07 132.06 55.31 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.398 -0.814 . . . . 0.0 110.396 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 117' ' ' THR . 5.7 mt-10 -131.53 133.87 45.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.022 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 88.8 m -129.35 146.65 51.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.917 . . . . 0.0 110.1 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 115' ' ' LYS . 1.5 mttm -139.89 134.45 31.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 110.294 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.708 HD23 HG12 ' A' ' 114' ' ' ILE . 10.1 mt -113.93 148.24 37.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.145 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.89 -168.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 110.092 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.697 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.96 161.09 24.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 110.106 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 26.1 p -119.73 163.95 24.75 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.28 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.6 Cg_endo -72.27 -1.97 10.95 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.064 1.56 . . . . 0.0 110.477 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.2 p -103.78 -0.74 28.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.263 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.17 -35.72 4.85 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.25 -174.05 2.57 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 55.5 p -129.17 137.5 51.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -1.171 . . . . 0.0 110.327 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.568 HG12 HG22 ' A' ' 10' ' ' THR . 59.2 mt -88.71 150.79 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 110.326 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.708 HG12 HD23 ' A' ' 104' ' ' LEU . 8.5 mt -132.86 111.35 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.1 tttt -101.11 123.39 45.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.108 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 1.5 t -117.17 156.53 27.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.49 HG22 ' CE1' ' A' ' 119' ' ' HIS . 57.7 m -158.97 125.23 4.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 110.201 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.482 ' HB2' ' CD1' ' A' ' 100' ' ' TYR . 31.3 t -127.09 162.23 26.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 110.172 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.84 ' CE1' HG23 ' A' ' 4' ' ' THR . 44.0 m-70 -140.75 128.83 22.1 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 1.031 ' C ' HG23 ' A' ' 2' ' ' VAL . 9.7 m-30 -100.28 119.76 38.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.182 -0.949 . . . . 0.0 110.953 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.581 ' N ' HG23 ' A' ' 2' ' ' VAL . 84.5 m-70 -93.59 101.27 13.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.379 -0.826 . . . . 0.0 109.373 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.818 HG23 HD23 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -81.06 154.12 27.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.042 -1.036 . . . . 0.0 110.525 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.423 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 33.4 tttp -127.64 117.36 21.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.424 -0.797 . . . . 0.0 110.116 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 116.26 -135.31 12.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.526 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 3.2 p-10 -125.84 53.53 1.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -1.15 . . . . 0.0 110.235 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 122' ' ' THR . 28.3 m -135.27 155.54 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 110.134 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.02 157.13 47.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.958 . . . . 0.0 110.371 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 129' ' ' LYS . 2.2 mp -65.36 173.27 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.973 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.623 ' N ' HG22 ' A' ' 128' ' ' ILE . 34.0 mttt -118.31 148.13 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 109.915 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.525 ' HG2' ' N ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -51.71 -22.88 3.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 110.395 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' HG2' ' A' ' 130' ' ' GLU . 49.2 tt0 -77.8 -35.46 51.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.838 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 19.8 t-160 -73.58 -36.47 65.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.687 HG13 ' CD1' ' A' ' 5' ' ' TYR . 59.5 t -63.73 -43.62 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.864 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.48 -42.94 77.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.84 . . . . 0.0 109.955 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.93 89.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.523 ' HA2' ' CD ' ' A' ' 139' ' ' LYS . . . -65.61 -29.88 76.16 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 141' ' ' SER . 94.5 mttt -78.43 -30.73 47.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -1.128 . . . . 0.0 110.156 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.504 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 96.5 mt-10 -76.27 -39.77 53.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.086 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.523 ' CD ' ' HA2' ' A' ' 136' ' ' GLY . 18.8 ptpt -66.69 -33.18 75.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.837 . . . . 0.0 109.875 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.506 ' N ' ' HG3' ' A' ' 139' ' ' LYS . . . -88.82 -40.13 13.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.002 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 137' ' ' LYS . 61.6 m -65.27 -44.74 87.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.349 -0.845 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.3 m-20 -58.81 -41.33 86.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.367 -0.833 . . . . 0.0 110.035 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.0 mt -61.28 -40.6 94.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.889 . . . . 0.0 110.053 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -61.54 -34.75 76.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.019 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -76.9 -17.84 58.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.017 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.503 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 16.7 mt -83.45 -35.19 25.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.242 -0.912 . . . . 0.0 108.938 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.759 HD13 ' CD1' ' A' ' 22' ' ' PHE . 93.1 mt -71.22 -43.14 74.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.508 ' HG3' HD12 ' A' ' 18' ' ' LEU . 55.1 mt-10 -57.62 -37.72 73.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.362 -0.836 . . . . 0.0 109.283 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 65.7 m -73.65 -33.56 64.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.458 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.621 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.1 t80 -54.3 -48.51 71.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.458 -0.776 . . . . 0.0 109.898 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.178 HD21 ' CE2' ' A' ' 158' ' ' TYR . 72.4 mt -78.35 -30.55 48.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.178 -0.951 . . . . 0.0 110.164 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.454 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 30.5 ttpt -71.65 -22.11 61.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.307 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.14 -31.24 3.88 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.562 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.9 m-70 -109.78 92.88 13.23 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.452 -1.028 . . . . 0.0 109.968 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.17 5.82 3.37 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.034 1.544 . . . . 0.0 111.067 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -109.35 -1.03 18.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 109.991 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.621 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -81.54 102.89 10.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 110.073 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.178 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.85 32.79 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.366 0.603 . . . . 0.0 110.517 -179.484 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.535 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.818 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' ' 120' ' ' TYR . 85.2 t -120.15 123.61 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -1.158 . . . . 0.0 110.375 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.6 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 86.9 m-85 -75.03 148.01 40.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 110.087 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.835 HG23 ' CE1' ' A' ' 119' ' ' HIS . 52.0 m -131.74 121.64 24.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.189 ' CE2' HG21 ' A' ' 133' ' ' VAL . 74.7 m-85 -131.17 156.7 44.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.059 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -148.67 152.95 37.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 110.105 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 116' ' ' SER . 54.5 p -136.18 148.71 48.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.442 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 95.4 mt-10 -136.88 117.82 14.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 110.28 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 2.9 p90 -144.88 -175.71 4.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.899 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.8 p -138.39 179.58 6.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.565 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.542 ' OG ' HD11 ' A' ' 114' ' ' ILE . 8.8 p -157.02 163.78 38.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.229 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.84 -13.62 47.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.239 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.877 HD11 ' HB2' ' A' ' 152' ' ' LYS . 3.1 mp -90.78 149.68 40.84 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 0.0 110.139 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.807 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.8 Cg_endo -66.98 148.55 82.07 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.995 1.524 . . . . 0.0 110.553 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.671 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -69.96 -32.95 16.77 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 O-C-N 123.947 1.498 . . . . 0.0 113.096 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.4 Cg_endo -67.12 -22.09 47.85 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 N-CA-C 109.934 -0.833 . . . . 0.0 109.934 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.995 ' CG ' HD13 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -82.23 -49.36 10.18 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.777 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.3 tt -68.21 -29.72 68.62 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 76' ' ' LYS . 67.6 t80 -61.85 -57.28 12.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.127 178.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 92.2 mttt -50.09 -53.08 29.59 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.137 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.18 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -55.29 -68.15 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 110.554 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.055 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -43.21 -58.89 2.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.714 -0.616 . . . . 0.0 111.845 -178.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG11 HG12 ' A' ' 74' ' ' ILE . 3.7 t -91.2 -61.14 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.066 -1.021 . . . . 0.0 112.246 -178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.604 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.7 mm? -69.94 -2.07 11.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.037 -1.039 . . . . 0.0 112.168 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.878 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -151.11 25.97 0.71 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.586 -1.321 . . . . 0.0 111.281 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.055 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -63.37 -37.53 87.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.031 . . . . 0.0 109.761 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' OD2' HD11 ' A' ' 43' ' ' ILE . 55.1 m-20 -64.75 -12.03 42.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.765 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.528 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 64.1 m-80 -130.17 7.83 5.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.456 -0.778 . . . . 0.0 109.889 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.878 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -94.14 -49.57 5.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.323 -0.861 . . . . 0.0 110.263 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.041 HG21 HD13 ' A' ' 38' ' ' ILE . 7.1 p -77.67 -26.21 0.52 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.352 -0.843 . . . . 0.0 112.526 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.738 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -79.39 6.58 5.01 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 O-C-N 122.501 0.737 . . . . 0.0 110.585 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -131.42 -29.07 1.81 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.108 -0.995 . . . . 0.0 110.217 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.613 HD11 HD13 ' A' ' 29' ' ' LEU . 67.2 mt -79.29 -37.6 19.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.296 -0.878 . . . . 0.0 109.755 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.61 91.25 2.31 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.391 -0.818 . . . . 0.0 110.251 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.34 0.01 8.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.01 1.531 . . . . 0.0 110.563 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -90.85 -24.48 20.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.121 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.36 -37.88 13.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.098 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.041 HD13 HG21 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -125.3 133.22 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.389 -0.819 . . . . 0.0 109.893 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.54 ' HG3' ' CA ' ' A' ' 59' ' ' GLY . 11.5 mttt -72.89 -41.94 64.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.901 . . . . 0.0 110.075 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.548 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -179.89 161.22 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 110.19 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 m -125.02 118.34 26.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 110.021 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -124.5 111.21 15.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.234 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.533 HD11 ' OD2' ' A' ' 27' ' ' ASP . 21.6 mt -57.86 127.25 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.756 HD13 ' CE ' ' A' ' 55' ' ' LYS . 12.3 tp -90.93 -40.04 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 0.0 110.087 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 1.003 ' O ' HG23 ' A' ' 52' ' ' THR . 0.6 OUTLIER -132.08 156.08 46.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.35 -162.86 18.41 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -141.25 25.51 2.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.279 -1.13 . . . . 0.0 110.059 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.624 ' H ' HG21 ' A' ' 52' ' ' THR . . . 120.66 -10.32 10.49 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.535 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -80.76 -170.57 42.9 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.8 Cg_endo -71.21 132.86 21.78 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.022 1.538 . . . . 0.0 110.443 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.7 -1.55 71.82 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 1.003 HG23 ' O ' ' A' ' 45' ' ' GLU . 22.7 m -80.04 140.35 36.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.17 . . . . 0.0 109.976 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.877 HD13 ' HA ' ' A' ' 70' ' ' LYS . 28.8 mm -110.4 117.87 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 110.382 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 89.5 mttt -104.53 119.33 38.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 0.0 110.159 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.756 ' CE ' HD13 ' A' ' 44' ' ' LEU . 46.9 mttm -88.6 97.69 11.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.388 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' HB ' HG23 ' A' ' 67' ' ' VAL . 93.8 mt -89.58 139.68 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.895 . . . . 0.0 110.018 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 6.6 p -115.51 157.34 24.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.937 . . . . 0.0 110.736 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 26.4 m-85 -117.86 125.28 50.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.423 -0.798 . . . . 0.0 110.15 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.54 ' CA ' ' HG3' ' A' ' 39' ' ' LYS . . . -106.91 11.29 41.23 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.64 -21.41 17.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -1.143 . . . . 0.0 110.211 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.27 166.72 26.68 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.9 p -71.02 -27.1 63.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -1.145 . . . . 0.0 110.238 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -63.26 161.73 13.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 110.161 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.44 120.06 23.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.584 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -137.51 92.17 0.21 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.951 -1.659 . . . . 0.0 108.951 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 15.9 p90 -132.73 169.44 16.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -1.158 . . . . 0.0 110.131 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.7 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.0 m -142.29 174.94 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.663 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.657 ' O ' HD12 ' A' ' 85' ' ' LEU . 94.1 mttt -132.39 106.49 7.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.731 . . . . 0.0 109.522 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.876 ' CD2' HD13 ' A' ' 85' ' ' LEU . 12.8 m170 -96.28 124.78 40.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 111.419 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.877 ' HA ' HD13 ' A' ' 53' ' ' ILE . 67.6 tttt -98.96 101.65 13.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.448 -0.782 . . . . 0.0 109.02 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.535 HG21 ' O ' ' A' ' 49' ' ' GLY . 22.7 mm -41.69 140.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.264 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 17.9 t0 -112.42 -45.58 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.986 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 16.8 m -169.88 157.21 6.62 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.431 -0.793 . . . . 0.0 110.146 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.411 HG12 HG11 ' A' ' 23' ' ' VAL . 1.7 mt -141.48 157.2 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.397 -0.814 . . . . 0.0 109.877 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 2.0 m-20 -144.53 83.64 1.72 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.821 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 82.3 tttt -66.24 -13.22 60.02 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.363 -0.836 . . . . 0.0 109.888 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -90.79 -30.72 16.84 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.805 0.812 . . . . 0.0 109.157 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m-80 -105.52 -4.49 21.19 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.516 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 90.0 m-85 63.57 53.69 2.03 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.297 0.57 . . . . 0.0 110.74 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 13.1 t -127.58 175.34 8.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.961 -1.087 . . . . 0.0 110.455 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.651 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 34.4 t80 -160.02 137.59 9.73 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.612 -0.68 . . . . 0.0 109.744 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 28.7 m -148.0 123.84 10.6 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.129 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.651 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 29.5 p90 -139.41 168.14 20.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.887 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 98' ' ' ILE . 25.4 m -122.19 140.9 52.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 110.228 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.876 HD13 ' CD2' ' A' ' 69' ' ' HIS . 10.7 tp -107.38 132.21 53.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 110.099 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 85' ' ' LEU . 11.5 pt -112.87 -31.67 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 110.353 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.668 ' O ' HD11 ' A' ' 85' ' ' LEU . 7.2 tt0 -116.52 141.63 47.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.898 . . . . 0.0 110.276 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.7 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 167.88 168.08 29.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.71 -28.87 45.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.281 -1.129 . . . . 0.0 110.227 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.73 ' HB1' ' HE1' ' A' ' 132' ' ' HIS . . . -60.99 -32.53 72.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.337 -0.852 . . . . 0.0 110.174 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.965 HD23 ' HG ' ' A' ' 95' ' ' LEU . 6.8 mt -64.64 -44.2 91.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 110.393 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 44.18 -142.53 2.72 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -106.34 27.57 8.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -1.131 . . . . 0.0 110.237 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 122' ' ' THR . 80.8 p -124.74 -45.18 1.92 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 110.126 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.965 ' HG ' HD23 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -102.41 160.57 14.44 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.448 -0.783 . . . . 0.0 109.272 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.863 ' H ' HD12 ' A' ' 95' ' ' LEU . 85.1 mt-10 -135.37 -78.63 0.44 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 110.823 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 57.4 mttt -80.22 134.93 36.16 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.452 -0.78 . . . . 0.0 110.973 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.733 ' O ' HG23 ' A' ' 84' ' ' THR . 4.5 mm -121.36 139.49 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.975 -1.078 . . . . 0.0 109.633 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.3 m -118.45 126.53 52.25 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.187 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.679 ' HE2' HG21 ' A' ' 98' ' ' ILE . 7.3 m-85 -118.84 136.74 53.86 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.529 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -137.17 145.89 44.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.022 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 45.3 m -145.43 152.6 40.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 110.019 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -141.67 140.83 33.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 110.372 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.653 HD23 HG12 ' A' ' 114' ' ' ILE . 8.8 mt -124.24 145.24 49.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.358 -0.839 . . . . 0.0 110.271 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.703 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.22 -169.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.227 -0.921 . . . . 0.0 109.941 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.703 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -118.72 170.33 9.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 110.012 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.2 p -127.54 161.78 52.83 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 110.021 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.58 -8.71 23.76 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.954 1.502 . . . . 0.0 110.387 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.9 p -93.77 -9.5 37.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 110.215 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.02 -36.25 4.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.87 -176.22 6.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.504 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 60.5 p -123.67 136.85 54.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -1.146 . . . . 0.0 110.351 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.599 HD12 ' O ' ' A' ' 106' ' ' ALA . 18.8 mt -86.49 150.03 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.838 . . . . 0.0 110.109 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.653 HG12 HD23 ' A' ' 104' ' ' LEU . 6.3 mt -135.42 115.36 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 110.364 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 103' ' ' LYS . 84.8 tttt -106.42 123.13 47.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 109.873 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 3.5 t -118.45 159.68 23.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -0.979 . . . . 0.0 110.598 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 5' ' ' TYR . 42.5 m -159.56 144.38 15.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.426 -0.796 . . . . 0.0 110.17 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.9 t -141.04 163.46 32.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.15 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.835 ' CE1' HG23 ' A' ' 4' ' ' THR . 82.0 m-70 -143.89 160.98 39.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.915 . . . . 0.0 110.484 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.804 ' O ' HG13 ' A' ' 2' ' ' VAL . 9.6 m-85 -124.85 140.88 52.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.316 -0.865 . . . . 0.0 110.224 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.504 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.8 m-70 -120.92 90.54 3.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 109.762 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.676 HG23 HD11 ' A' ' 128' ' ' ILE . 1.1 p -82.59 150.18 27.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.871 . . . . 0.0 110.364 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.432 ' HB3' ' CD ' ' A' ' 96' ' ' GLU . 78.4 tttt -123.03 129.1 51.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 110.202 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 -162.87 25.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.49 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 0.9 OUTLIER -87.62 54.13 3.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -1.181 . . . . 0.0 110.109 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.48 ' O ' ' HB ' ' A' ' 122' ' ' THR . 17.6 m -135.99 133.39 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.222 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.524 ' HA ' HG21 ' A' ' 122' ' ' THR . 17.9 pt-20 -127.7 165.54 19.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 0.0 110.092 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.676 HD11 HG23 ' A' ' 122' ' ' THR . 3.8 mp -82.8 173.0 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.889 . . . . 0.0 110.042 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.598 ' N ' HG22 ' A' ' 128' ' ' ILE . 75.0 mmtt -106.28 122.83 47.03 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.348 -0.845 . . . . 0.0 110.149 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 131' ' ' GLU . 24.1 pt-20 -43.45 -42.65 4.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 110.145 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.482 ' N ' ' CG ' ' A' ' 130' ' ' GLU . 16.5 pt-20 -58.16 -29.33 65.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.206 -0.934 . . . . 0.0 109.896 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.73 ' HE1' ' HB1' ' A' ' 90' ' ' ALA . 11.7 t-80 -74.36 -55.5 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.189 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.6 p -61.62 -39.39 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.387 -0.821 . . . . 0.0 110.009 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.515 ' N ' HG13 ' A' ' 133' ' ' VAL . 84.0 tttt -65.52 -45.83 81.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.84 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.39 87.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.89 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.08 -30.82 74.14 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 137' ' ' LYS . 59.0 mmtt -65.91 -34.75 78.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -1.106 . . . . 0.0 109.872 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -69.91 -35.62 74.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.859 . . . . 0.0 109.839 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -71.68 -29.95 65.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.738 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.31 -40.87 42.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.99 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.2 p -59.44 -45.3 91.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.752 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -56.44 -43.85 79.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.841 . . . . 0.0 109.779 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 39.4 tp -57.68 -47.31 82.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.767 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.474 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 29.3 m-85 -53.68 -44.57 69.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.648 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -75.78 -14.58 60.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.32 -0.862 . . . . 0.0 109.925 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.446 ' HB3' HG21 ' A' ' 33' ' ' ILE . 20.1 mt -83.2 -36.67 24.47 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.209 -0.932 . . . . 0.0 108.692 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.62 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 96.0 mt -67.16 -47.4 81.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.789 ' HB3' HD13 ' A' ' 13' ' ' ILE . 5.9 mm-40 -51.49 -47.09 63.33 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.388 -0.82 . . . . 0.0 109.218 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.6 m -63.15 -40.52 97.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.593 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.728 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 79.6 t80 -47.12 -51.84 16.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.97 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.14 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 80.3 mt -76.27 -37.97 56.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.789 . . . . 0.0 110.366 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.877 ' HB2' HD11 ' A' ' 13' ' ' ILE . 19.4 tptt -59.31 -16.9 24.8 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.166 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.493 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -117.61 -27.02 2.69 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 10.7 m-70 -106.28 91.89 6.19 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.266 -1.137 . . . . 0.0 110.167 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.1 Cg_endo -73.13 3.3 4.69 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.986 1.519 . . . . 0.0 111.006 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -119.0 -2.26 10.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.022 -1.049 . . . . 0.0 110.299 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.728 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -67.22 99.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.23 -0.918 . . . . 0.0 110.397 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.18 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 11.5 p90 37.55 23.45 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.55 -0.719 . . . . 0.0 112.346 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.727 ' OD1' HD22 ' A' ' 151' ' ' LEU . 9.1 m-80 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 120.473 -1.392 . . . . 0.0 109.992 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 85.8 t -101.04 119.23 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -1.114 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.597 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 77.6 m-85 -83.68 161.57 21.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.23 -0.919 . . . . 0.0 110.139 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.823 HG23 ' CE1' ' A' ' 119' ' ' HIS . 55.4 m -143.61 99.92 3.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CE2' HG22 ' A' ' 133' ' ' VAL . 77.9 m-85 -116.37 126.5 53.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.179 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.596 ' CG ' ' N ' ' A' ' 7' ' ' SER . 3.6 tt0 -126.16 178.57 5.71 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.204 -0.935 . . . . 0.0 109.89 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.596 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -155.56 -179.08 7.76 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.76 -0.587 . . . . 0.0 109.751 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 7' ' ' SER . 73.1 mt-10 -156.09 117.02 3.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 110.378 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 2.5 p90 -137.58 -174.05 3.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.213 -0.93 . . . . 0.0 109.954 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.817 HG22 ' HA ' ' A' ' 113' ' ' ILE . 4.4 p -142.15 173.94 11.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 110.718 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.432 ' HB2' ' CD ' ' A' ' 148' ' ' GLU . 85.8 p -150.26 147.96 28.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.432 -0.793 . . . . 0.0 110.065 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -72.03 -24.81 61.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.917 . . . . 0.0 110.138 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.8 HG23 ' HD2' ' A' ' 14' ' ' PRO . 6.1 mm -79.18 151.17 75.32 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.376 -0.828 . . . . 0.0 109.979 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.8 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -65.03 147.46 88.94 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.102 1.58 . . . . 0.0 110.394 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.673 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.6 Cg_endo -69.86 -32.46 18.11 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.006 1.529 . . . . 0.0 113.043 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.4 Cg_endo -67.66 -23.29 42.71 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 122.472 0.722 . . . . 0.0 110.233 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.875 ' HB3' HD13 ' A' ' 151' ' ' LEU . 6.0 mmp_? -82.26 -47.25 12.64 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.98 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.54 -29.62 69.06 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.429 -0.908 . . . . 0.0 108.905 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.9 t80 -63.44 -55.45 24.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.1 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.0 mttt -49.13 -50.76 35.85 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.984 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.156 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -56.77 -70.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.623 0.725 . . . . 0.0 111.089 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.067 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -43.68 -57.45 3.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.633 -0.667 . . . . 0.0 112.138 -178.626 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.625 ' HB ' HD12 ' A' ' 24' ' ' LEU . 7.1 t -90.27 -60.42 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.057 . . . . 0.0 112.386 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.7 mp -73.35 0.59 11.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.054 -1.029 . . . . 0.0 112.114 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.892 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -153.52 27.77 0.5 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.59 -1.319 . . . . 0.0 111.233 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.067 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -64.24 -40.35 95.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.047 -1.033 . . . . 0.0 109.721 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.513 ' OD2' ' CG1' ' A' ' 43' ' ' ILE . 83.0 m-20 -64.91 -11.03 33.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.478 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.433 ' C ' ' HD2' ' A' ' 31' ' ' PRO . 2.3 m120 -125.13 3.17 7.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.537 -0.727 . . . . 0.0 109.662 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.909 ' CD1' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -94.9 -47.12 6.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 -179.572 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.954 ' CG2' HD13 ' A' ' 38' ' ' ILE . 9.4 p -75.38 -26.9 0.65 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.91 . . . . 0.0 112.373 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.779 ' HD3' HG12 ' A' ' 30' ' ' VAL . 50.5 Cg_endo -79.18 7.27 4.49 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 122.435 0.703 . . . . 0.0 110.593 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -135.77 -30.9 0.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.225 -0.922 . . . . 0.0 110.381 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.909 HD11 ' CD1' ' A' ' 29' ' ' LEU . 64.5 mt -75.07 -39.74 44.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.331 -0.856 . . . . 0.0 109.56 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.64 87.58 2.55 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.396 -0.815 . . . . 0.0 110.171 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.57 -1.32 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.115 1.587 . . . . 0.0 110.516 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -90.22 -19.46 24.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.944 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.35 -36.08 10.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.848 . . . . 0.0 110.317 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.954 HD13 ' CG2' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -125.38 139.68 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 110.021 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 27.1 ttmt -78.09 -41.45 35.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.558 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 178.71 164.77 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 110.131 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.411 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 1.7 m -121.53 122.27 39.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 110.028 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 86.1 tt0 -126.54 107.18 10.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.188 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.513 ' CG1' ' OD2' ' A' ' 27' ' ' ASP . 14.6 mt -56.11 131.58 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 55' ' ' LYS . 58.7 mt -89.1 -23.72 22.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.124 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 1.06 ' O ' HG23 ' A' ' 52' ' ' THR . 41.1 tt0 -157.64 175.05 14.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 110.303 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 53.44 -160.33 3.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -137.66 16.71 2.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -1.103 . . . . 0.0 110.264 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.464 ' H ' HG21 ' A' ' 52' ' ' THR . . . 118.72 7.57 10.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -98.89 -166.63 30.5 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.1 Cg_endo -70.78 132.08 21.01 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.081 1.569 . . . . 0.0 110.551 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.8 -7.48 70.53 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 1.06 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.1 m -80.01 143.41 34.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -1.133 . . . . 0.0 110.097 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.619 HD13 ' HA ' ' A' ' 70' ' ' LYS . 32.9 mm -112.4 124.27 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.216 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.448 ' NZ ' HD11 ' A' ' 71' ' ' ILE . 66.9 mttt -107.58 147.58 30.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.332 -0.855 . . . . 0.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB2' HD11 ' A' ' 44' ' ' LEU . 75.0 tttt -120.85 90.21 3.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.482 ' CG2' HG12 ' A' ' 38' ' ' ILE . 94.5 mt -80.57 143.01 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.6 p -113.51 160.42 18.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.669 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.831 ' HE2' HG13 ' A' ' 67' ' ' VAL . 27.9 m-85 -118.78 137.93 53.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.466 -0.771 . . . . 0.0 110.202 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.37 96.59 0.82 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -126.71 169.47 13.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -1.188 . . . . 0.0 110.225 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.56 -65.56 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.438 ' C ' ' HG3' ' A' ' 63' ' ' GLN . 77.5 p -48.92 -49.63 39.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -1.148 . . . . 0.0 110.31 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.438 ' HG3' ' C ' ' A' ' 62' ' ' SER . 44.4 mt-30 -136.85 139.33 41.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.295 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -55.78 153.44 8.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.856 . . . . 0.0 110.247 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -136.05 137.12 8.88 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.5 p90 -179.32 164.05 1.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -1.082 . . . . 0.0 110.068 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.066 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.7 m -142.39 171.99 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.92 . . . . 0.0 110.663 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -125.43 123.86 40.2 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.601 ' CD2' ' HG ' ' A' ' 85' ' ' LEU . 13.3 m170 -116.52 138.26 51.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.023 -1.048 . . . . 0.0 111.327 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HA ' HD13 ' A' ' 53' ' ' ILE . 78.1 tttt -115.9 112.28 21.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.481 -0.762 . . . . 0.0 109.105 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.53 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 32.7 mm -49.0 136.63 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.96 . . . . 0.0 110.459 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 4.4 t0 -107.61 -50.11 3.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.396 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.482 ' HB2' ' OG ' ' A' ' 82' ' ' SER . 17.6 m -168.79 157.07 8.04 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.483 -0.76 . . . . 0.0 109.423 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.3 mt -134.94 157.94 41.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.078 -1.014 . . . . 0.0 110.616 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.563 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.9 m-20 -130.9 76.85 1.75 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.597 -0.69 . . . . 0.0 110.24 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.566 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 66.9 mttt -61.78 -12.75 18.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 109.918 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -96.4 -30.53 13.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 109.516 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -107.97 -1.44 20.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.661 -0.649 . . . . 0.0 109.744 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.837 ' O ' HD12 ' A' ' 104' ' ' LEU . 87.2 m-85 61.11 52.36 4.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.729 . . . . 0.0 109.89 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.563 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -123.49 156.65 35.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 109.575 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.53 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 20.1 t80 -141.87 133.92 27.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.913 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 73' ' ' SER . 70.4 p -139.1 119.49 13.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.852 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 3.2 p90 -130.89 179.12 6.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.986 HG23 ' O ' ' A' ' 98' ' ' ILE . 21.9 m -130.85 136.94 49.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.967 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.657 HD23 ' H ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -95.41 134.72 37.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.551 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.0 pt -114.83 -6.11 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.895 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.657 ' H ' HD23 ' A' ' 85' ' ' LEU . 87.3 tt0 -168.24 113.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.361 -0.837 . . . . 0.0 110.556 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 1.066 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -153.22 130.34 2.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -48.48 -26.7 2.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -1.162 . . . . 0.0 110.432 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.577 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -68.65 -17.32 64.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 110.456 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.802 HD21 HG13 ' A' ' 98' ' ' ILE . 60.3 mt -63.96 -13.0 42.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 110.245 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 94' ' ' THR . . . 65.62 26.76 72.09 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 50.64 21.05 0.82 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.229 -1.159 . . . . 0.0 110.2 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 92' ' ' GLY . 18.5 p -122.56 -33.07 3.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.084 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.792 HD11 HD11 ' A' ' 128' ' ' ILE . 2.3 mm? -80.04 170.27 16.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 110.283 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HG3' ' HB3' ' A' ' 123' ' ' LYS . 60.9 mm-40 -137.0 -79.4 0.39 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.48 -0.763 . . . . 0.0 109.611 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 58.6 mttt -80.32 127.46 32.4 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.204 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.986 ' O ' HG23 ' A' ' 84' ' ' THR . 18.4 mm -118.52 147.68 21.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.658 -1.276 . . . . 0.0 110.237 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -126.13 128.37 47.22 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.441 -0.787 . . . . 0.0 109.278 178.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.741 ' CE2' HG21 ' A' ' 98' ' ' ILE . 13.8 m-85 -126.7 131.9 51.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 110.017 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -135.96 136.23 40.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.925 . . . . 0.0 110.575 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.5 m -132.5 143.95 50.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.414 -0.804 . . . . 0.0 109.724 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 115' ' ' LYS . 5.0 mttt -136.18 143.77 44.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.194 -0.941 . . . . 0.0 110.482 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 79' ' ' TYR . 5.5 mt -118.8 151.06 38.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.244 -0.91 . . . . 0.0 110.49 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.73 -168.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 109.814 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.716 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.51 157.96 28.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 110.189 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 33.2 p -118.22 165.44 16.35 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.897 . . . . 0.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -72.88 -1.35 10.31 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.02 1.537 . . . . 0.0 110.495 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.0 m -105.56 -0.65 25.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.902 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.21 -36.11 4.59 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.93 -171.46 0.75 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.504 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 6.1 p -131.3 134.38 46.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -1.096 . . . . 0.0 110.228 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.817 ' HA ' HG22 ' A' ' 10' ' ' THR . 12.2 mt -84.33 148.07 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.81 HG12 HD23 ' A' ' 104' ' ' LEU . 9.1 mt -130.71 113.71 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.295 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 7.0 ttmt -87.4 138.58 31.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.162 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 1.1 p -124.43 132.04 53.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 110.257 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.507 HG23 ' HB2' ' A' ' 6' ' ' GLU . 62.0 m -148.22 123.25 10.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 110.533 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.7 m -130.91 164.9 24.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 109.886 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.823 ' CE1' HG23 ' A' ' 4' ' ' THR . 30.8 m-70 -142.12 170.62 15.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.115 -0.991 . . . . 0.0 110.096 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.536 ' HB3' ' CD1' ' A' ' 95' ' ' LEU . 26.2 m-85 -136.24 147.32 47.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.496 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 83.6 m-70 -128.35 88.75 2.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.399 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.586 HG22 HD22 ' A' ' 95' ' ' LEU . 4.2 p -68.9 161.26 29.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.849 . . . . 0.0 110.711 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.475 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 33.0 ttmt -152.48 94.72 1.94 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 110.314 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 133.5 35.94 0.27 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 3.3 t30 63.61 56.59 1.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.171 -1.193 . . . . 0.0 110.252 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.541 HG23 ' CG2' ' A' ' 122' ' ' THR . 8.4 m -142.86 145.82 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 110.005 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.75 179.04 5.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 110.358 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.792 HD11 HD11 ' A' ' 95' ' ' LEU . 16.2 mm -84.67 173.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.21 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.593 ' N ' HG22 ' A' ' 128' ' ' ILE . 18.8 mtpt -117.63 136.82 53.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.009 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -43.61 -41.09 4.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.166 -0.958 . . . . 0.0 110.245 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 51.4 tt0 -64.38 -26.13 68.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.091 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 13.8 t-160 -77.91 -48.46 16.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.649 HG22 ' CE2' ' A' ' 5' ' ' TYR . 69.1 t -56.26 -32.08 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 109.867 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -90.8 -51.37 5.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -57.9 -32.76 68.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.84 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.08 -33.81 62.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 141' ' ' SER . 52.5 mmtt -78.55 -32.89 48.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -1.122 . . . . 0.0 109.982 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -73.43 -34.97 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.887 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -70.7 -43.45 68.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.798 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -72.49 -31.12 65.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 109.947 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 22.7 t -64.76 -54.0 38.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.395 -0.815 . . . . 0.0 109.928 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -51.78 -49.78 62.02 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.705 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 24.0 mt -52.91 -41.66 64.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 110.059 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 16.7 m-85 -59.87 -50.88 72.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.689 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 75.7 tttt -63.44 -13.67 42.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.915 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.541 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 13.1 mt -85.2 -37.77 19.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.213 -0.93 . . . . 0.0 108.813 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.749 ' CG2' HD23 ' A' ' 18' ' ' LEU . 33.8 mt -69.56 -45.3 78.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 13' ' ' ILE . 67.8 mm-40 -51.56 -38.15 52.97 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.286 -0.884 . . . . 0.0 108.785 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 88.3 m -72.36 -38.1 68.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.303 -0.873 . . . . 0.0 109.01 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.818 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 66.2 t80 -44.19 -54.84 5.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.465 -0.772 . . . . 0.0 109.604 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.121 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 78.5 mt -75.41 -29.07 59.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.467 -0.771 . . . . 0.0 110.267 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 149' ' ' THR . 39.3 tttp -69.48 -13.27 62.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.715 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -123.63 -26.46 1.59 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.561 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.2 m-70 -110.77 89.64 9.58 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 0.0 110.378 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.31 0.33 8.13 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.037 1.546 . . . . 0.0 110.559 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -111.92 12.72 20.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.882 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.818 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -86.57 101.25 13.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.416 -0.802 . . . . 0.0 110.282 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.156 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 8.9 p90 38.52 21.8 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.689 -0.632 . . . . 0.0 112.354 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.551 ' OD1' HD22 ' A' ' 151' ' ' LEU . 33.4 m-20 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 120.415 -1.428 . . . . 0.0 110.12 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.956 HG13 ' O ' ' A' ' 120' ' ' TYR . 86.3 t -108.77 139.82 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -1.172 . . . . 0.0 110.223 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.644 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 16.3 m-85 -103.01 129.8 49.89 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.238 -0.914 . . . . 0.0 109.826 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.823 HG23 ' CE1' ' A' ' 119' ' ' HIS . 19.3 m -104.68 107.83 18.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.859 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.57 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 33.9 m-85 -116.27 124.92 51.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.552 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 116' ' ' SER . 23.1 pt-20 -122.63 164.17 18.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.15 -0.969 . . . . 0.0 111.035 -179.083 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.512 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.2 p -125.32 167.63 14.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.568 -0.707 . . . . 0.0 110.272 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 7' ' ' SER . 18.2 mt-10 -160.19 120.15 2.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.924 ' HB2' HD13 ' A' ' 114' ' ' ILE . 76.5 m-85 -141.18 -166.01 2.08 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.789 -1.194 . . . . 0.0 111.552 -178.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 9' ' ' PHE . 25.5 p -158.32 155.29 28.52 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.758 0.789 . . . . 0.0 110.368 178.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.527 ' O ' ' CA ' ' A' ' 111' ' ' GLY . 83.6 p -159.29 146.23 16.93 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.791 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -70.55 -32.93 70.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 110.046 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.777 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.0 mm -58.99 149.96 63.55 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.863 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.777 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.8 Cg_endo -65.47 144.27 78.92 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.0 1.526 . . . . 0.0 110.585 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.661 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 Cg_endo -72.05 -31.61 12.05 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 124.023 1.538 . . . . 0.0 112.802 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -70.19 -21.51 31.37 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 N-CA-C 110.042 -0.791 . . . . 0.0 110.042 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.964 ' HG2' HD13 ' A' ' 151' ' ' LEU . 10.3 ttm180 -83.2 -47.16 11.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.759 HD23 ' C ' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -68.01 -27.62 66.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.933 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.51 ' N ' HD23 ' A' ' 18' ' ' LEU . 52.0 t80 -68.24 -55.75 11.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.474 -0.766 . . . . 0.0 109.378 179.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 89.6 mttt -50.27 -37.83 37.95 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.244 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.029 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -70.89 -57.82 4.22 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.687 0.756 . . . . 0.0 110.943 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.961 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -54.46 -54.33 42.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.556 -0.715 . . . . 0.0 111.843 -178.669 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.704 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.0 t -92.82 -62.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.078 -1.014 . . . . 0.0 111.964 -178.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.7 mp -69.09 0.23 4.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.197 -0.939 . . . . 0.0 111.974 -178.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.819 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -150.18 24.33 0.82 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.736 -1.228 . . . . 0.0 111.014 -179.99 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.961 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -63.24 -37.98 89.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.011 -1.056 . . . . 0.0 110.135 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 33.9 m-20 -63.49 -13.96 46.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.109 -0.994 . . . . 0.0 110.099 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.512 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 84.2 m-20 -128.3 10.46 6.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.826 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.819 HD23 ' HB3' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -96.41 -53.73 3.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 110.51 -179.871 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.86 HG22 ' HD3' ' A' ' 31' ' ' PRO . 1.9 m -74.69 -29.31 0.91 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 111.97 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.86 ' HD3' HG22 ' A' ' 30' ' ' VAL . 49.5 Cg_endo -79.18 4.58 6.44 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 122.851 0.921 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -125.17 -35.29 2.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 109.109 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.773 HG21 ' HB3' ' A' ' 146' ' ' LEU . 40.5 mt -79.96 -24.32 11.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.549 0.69 . . . . 0.0 109.235 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.92 95.43 0.4 Allowed Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.618 -0.676 . . . . 0.0 109.78 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.68 0.22 7.94 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.041 1.548 . . . . 0.0 110.655 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -89.52 5.95 43.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.238 -0.914 . . . . 0.0 109.872 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.667 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -113.89 -55.35 2.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 110.013 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.667 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.9 mp -115.11 132.14 65.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 110.029 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.448 ' HE2' ' HG3' ' A' ' 60' ' ' GLU . 35.8 ttmt -79.99 -35.07 37.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.286 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.525 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -177.26 151.98 0.83 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.0 109.96 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.8 m -115.53 130.83 57.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.24 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 85.6 tt0 -137.79 110.59 7.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 0.0 110.207 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.1 mt -62.25 135.51 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.302 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 tp -87.9 -25.61 23.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.988 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 1.029 ' O ' HG23 ' A' ' 52' ' ' THR . 28.8 tp10 -161.45 170.28 20.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 59.32 -169.69 6.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -127.7 23.39 6.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -1.155 . . . . 0.0 110.252 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.493 ' H ' HG21 ' A' ' 52' ' ' THR . . . 111.07 1.45 28.38 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.496 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -86.0 -169.46 45.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.3 Cg_endo -70.96 131.85 20.3 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.015 1.534 . . . . 0.0 110.468 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.21 -6.59 68.88 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 1.029 HG23 ' O ' ' A' ' 45' ' ' GLU . 14.8 m -80.04 142.3 35.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -1.104 . . . . 0.0 109.961 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.607 HD13 ' HA ' ' A' ' 70' ' ' LYS . 27.3 mm -110.68 122.11 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 110.155 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 84.7 mttt -105.88 144.63 32.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 110.23 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -117.86 87.61 2.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 110.218 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.409 ' HB ' HG23 ' A' ' 67' ' ' VAL . 90.6 mt -80.01 144.39 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 110.331 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.509 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.7 p -111.48 164.2 13.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.191 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.766 ' HE2' HG13 ' A' ' 67' ' ' VAL . 25.9 m-85 -115.32 155.36 27.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 110.434 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' PHE . . . -43.49 165.17 0.03 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' HG3' ' HE2' ' A' ' 39' ' ' LYS . 60.7 mt-10 -70.53 164.1 25.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -1.108 . . . . 0.0 110.195 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.2 -157.44 18.94 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.43 ' C ' ' HG3' ' A' ' 63' ' ' GLN . 89.5 p -57.41 -32.88 67.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -1.124 . . . . 0.0 110.29 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.43 ' HG3' ' C ' ' A' ' 62' ' ' SER . 44.2 mt-30 -145.58 147.65 32.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.923 . . . . 0.0 110.283 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.434 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 8.6 t80 -42.93 143.21 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.232 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -128.81 135.3 8.43 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.4 p90 -178.73 162.84 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -1.167 . . . . 0.0 110.211 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.937 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.5 m -141.9 172.79 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -0.819 . . . . 0.0 110.512 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 88.5 mttt -124.49 129.41 50.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.575 -0.703 . . . . 0.0 109.449 179.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.482 ' CD2' HD12 ' A' ' 85' ' ' LEU . 8.2 m170 -118.14 123.98 46.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.15 -0.969 . . . . 0.0 111.034 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.607 ' HA ' HD13 ' A' ' 53' ' ' ILE . 85.0 tttt -100.32 113.64 26.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 25.8 mm -54.52 135.36 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.901 . . . . 0.0 110.468 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 1.6 t70 -110.16 -42.99 4.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 109.601 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 82' ' ' SER . 25.5 m -169.75 157.49 6.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 109.896 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mt -141.59 156.15 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 110.456 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.0 m-20 -136.18 79.04 1.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.576 -0.702 . . . . 0.0 109.991 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 78.4 mttt -62.62 -16.89 58.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.385 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -93.05 -30.72 15.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.88 . . . . 0.0 109.529 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -103.87 -6.12 21.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.545 -0.722 . . . . 0.0 109.694 179.8 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.2 m-85 65.36 52.13 1.47 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 109.988 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.536 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -124.91 154.97 40.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.839 . . . . 0.0 109.782 179.706 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.704 ' CE1' HG13 ' A' ' 23' ' ' VAL . 22.3 t80 -142.5 128.81 19.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.352 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 37.6 m -131.89 121.24 23.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.471 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 21.9 p90 -138.64 170.97 15.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.359 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 98' ' ' ILE . 98.9 m -123.46 132.6 53.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 109.893 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.747 HD21 HD11 ' A' ' 91' ' ' LEU . 3.1 tp -98.87 136.45 38.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.081 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.0 pt -119.46 -16.99 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.532 ' O ' HD11 ' A' ' 85' ' ' LEU . 23.9 tt0 -133.09 150.08 52.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.143 -0.973 . . . . 0.0 110.488 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.937 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 165.46 142.31 3.38 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -65.73 -35.35 80.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -1.156 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.735 ' HB1' ' HE2' ' A' ' 132' ' ' HIS . . . -65.13 -26.17 68.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 110.13 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.786 HD12 ' N ' ' A' ' 88' ' ' GLY . 35.3 mt -65.48 -25.38 67.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.181 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.84 -167.63 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -87.28 8.04 25.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -1.184 . . . . 0.0 110.149 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.695 ' O ' HG21 ' A' ' 126' ' ' VAL . 60.6 p -93.88 -40.33 10.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.151 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.001 HD23 HG23 ' A' ' 122' ' ' THR . 22.5 mt -102.11 155.04 18.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.027 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -134.65 -78.84 0.45 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.219 -0.925 . . . . 0.0 110.284 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 50.8 mttt -80.13 132.93 36.02 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.407 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.765 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.5 mm -124.77 136.93 59.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.734 -1.228 . . . . 0.0 110.06 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -116.3 127.1 54.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.74 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.765 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.4 m-85 -122.65 135.59 54.64 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.28 -0.888 . . . . 0.0 111.148 -178.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 117' ' ' THR . 4.2 mt-10 -133.0 133.26 42.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.567 -0.708 . . . . 0.0 109.658 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 81' ' ' TYR . 36.1 m -132.07 134.09 45.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.0 -1.062 . . . . 0.0 110.124 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.5 tttt -133.93 147.68 51.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 110.252 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 79' ' ' TYR . 22.7 mt -117.89 142.22 47.57 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.399 -0.813 . . . . 0.0 110.148 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.6 t -131.42 -172.64 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 0.0 110.371 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.637 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -118.13 148.53 42.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 110.454 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.438 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 52.9 p -106.92 163.78 16.23 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 110.366 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 44.4 Cg_endo -72.26 -2.13 11.19 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.017 1.535 . . . . 0.0 110.403 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.1 m -103.59 -7.17 20.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.072 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 109.79 -16.03 31.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 11' ' ' SER . . . -79.08 -171.66 41.03 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' SER . 42.1 p -128.81 122.31 30.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 110.221 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 10' ' ' THR . 7.0 mt -79.98 139.64 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.464 -0.772 . . . . 0.0 110.79 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.924 HD13 ' HB2' ' A' ' 9' ' ' PHE . 3.7 mp -93.02 151.88 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.129 -0.982 . . . . 0.0 110.049 179.076 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 103' ' ' LYS . 16.9 tttt -149.87 99.71 2.87 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 109.365 178.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 20.9 t -116.13 174.8 5.85 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.357 -0.839 . . . . 0.0 111.257 -178.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.572 HG22 ' CE1' ' A' ' 119' ' ' HIS . 31.4 m -160.07 128.97 4.98 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 5' ' ' TYR . 38.9 t -122.9 156.68 34.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.042 -1.036 . . . . 0.0 110.421 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.823 ' CE1' HG23 ' A' ' 4' ' ' THR . 76.7 m-70 -140.48 123.65 16.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.35 -0.844 . . . . 0.0 110.371 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.956 ' O ' HG13 ' A' ' 2' ' ' VAL . 8.8 m-30 -93.87 149.79 20.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -0.871 . . . . 0.0 110.416 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.509 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 91.9 m-70 -127.65 84.82 2.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 109.743 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 1.001 HG23 HD23 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -67.39 152.64 45.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.406 -0.809 . . . . 0.0 110.618 -179.545 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -115.31 113.58 24.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 110.132 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.0 -145.74 16.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.509 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 2.1 p-10 -104.53 54.67 0.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.208 -1.172 . . . . 0.0 110.237 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.695 HG21 ' O ' ' A' ' 94' ' ' THR . 10.8 m -116.88 156.33 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.246 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 9.8 pm0 -143.7 157.1 44.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.051 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.688 ' CG1' HD21 ' A' ' 95' ' ' LEU . 2.9 mp -78.27 173.29 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.126 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.602 ' N ' HG22 ' A' ' 128' ' ' ILE . 23.0 mttt -110.88 151.34 27.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.951 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.44 -31.88 64.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -0.975 . . . . 0.0 110.205 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -65.33 -40.87 94.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 109.982 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.735 ' HE2' ' HB1' ' A' ' 90' ' ' ALA . 17.2 t-160 -66.81 -45.5 78.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.305 -0.872 . . . . 0.0 110.043 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.57 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 61.2 t -62.89 -41.11 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -76.42 -42.01 45.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.65 96.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.959 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.51 -30.1 76.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.433 ' HE3' HG12 ' A' ' 133' ' ' VAL . 88.5 mttt -75.31 -32.81 61.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -1.137 . . . . 0.0 110.042 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -76.3 -34.32 59.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -0.863 . . . . 0.0 109.903 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.97 -34.77 64.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 179.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.5 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.51 -30.55 61.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.928 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 83.4 p -68.72 -50.99 46.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.904 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.421 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 82.5 m-20 -51.36 -44.48 62.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 18.7 tp -57.15 -50.05 74.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.867 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 25.9 m-85 -53.84 -39.57 65.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.431 -0.793 . . . . 0.0 109.765 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.447 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 32.3 mttp -78.51 -13.61 59.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.933 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.773 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.2 mt -84.81 -36.66 21.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.23 -0.919 . . . . 0.0 108.889 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.648 HD11 ' CE1' ' A' ' 22' ' ' PHE . 36.7 mt -70.47 -43.93 77.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 13' ' ' ILE . 52.3 mt-10 -59.27 -37.68 78.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.426 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 98.7 m -77.2 -38.9 50.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 179.471 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.656 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.7 t80 -52.6 -49.15 65.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.903 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.181 HD21 ' CE2' ' A' ' 158' ' ' TYR . 82.3 mt -79.03 -33.45 44.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 109.99 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.538 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 38.9 tttt -70.61 -16.97 62.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.347 179.237 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.77 -32.59 2.23 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.544 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 8.2 m-70 -109.41 94.8 16.81 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.389 -1.066 . . . . 0.0 109.978 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.34 6.75 2.92 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.061 1.559 . . . . 0.0 111.048 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -110.48 2.78 19.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.062 -1.024 . . . . 0.0 109.86 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.656 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -83.23 103.61 12.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.181 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.5 OUTLIER 34.57 32.44 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.747 -0.596 . . . . 0.0 110.532 -179.667 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.709 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.903 HG13 ' O ' ' A' ' 120' ' ' TYR . 73.2 t -130.33 122.01 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -1.226 . . . . 0.0 110.212 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.609 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 89.5 m-85 -73.69 147.42 43.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 110.138 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.834 HG23 ' CE1' ' A' ' 119' ' ' HIS . 52.9 m -129.32 119.57 24.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.242 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.171 ' CE2' HG21 ' A' ' 133' ' ' VAL . 61.6 m-85 -130.97 151.76 51.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.121 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -145.18 150.45 36.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 110.282 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.48 ' OG ' ' HB3' ' A' ' 116' ' ' SER . 78.0 p -132.37 148.51 52.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.838 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -136.67 117.17 13.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.102 -0.999 . . . . 0.0 110.625 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 p90 -141.18 -177.17 4.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.39 -0.819 . . . . 0.0 109.733 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.5 HG22 HG12 ' A' ' 113' ' ' ILE . 27.2 p -136.75 -179.25 5.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 110.838 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 148' ' ' GLU . 11.8 t -159.92 170.38 21.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 110.17 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -93.82 -21.76 19.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.819 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.6 mp -80.98 150.4 68.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.819 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.1 Cg_endo -66.51 145.49 76.78 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.991 1.522 . . . . 0.0 110.783 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.66 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 Cg_endo -72.14 -31.5 11.96 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 124.126 1.593 . . . . 0.0 112.993 -179.184 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.7 Cg_endo -69.3 -20.65 36.74 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 N-CA-C 109.724 -0.914 . . . . 0.0 109.724 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 1.033 ' HB3' HD13 ' A' ' 151' ' ' LEU . 1.3 mmp_? -82.74 -47.81 11.55 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.766 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.2 tt -67.94 -25.32 65.4 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.63 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 70.9 t80 -66.84 -61.2 2.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.512 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.616 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 34.3 mttp -49.0 -37.9 21.74 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.129 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -62.4 -66.32 0.56 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.803 0.811 . . . . 0.0 110.897 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.041 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -54.59 -47.48 73.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.842 -0.537 . . . . 0.0 111.959 -178.199 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.102 HG11 ' CD1' ' A' ' 74' ' ' ILE . 3.0 t -96.14 -64.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.87 -1.144 . . . . 0.0 112.154 -178.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.9 mm? -68.69 -3.63 12.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.051 -1.031 . . . . 0.0 111.644 -178.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.598 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -139.62 4.0 2.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.772 -1.205 . . . . 0.0 111.019 -179.706 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.041 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -42.57 -26.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.138 -0.976 . . . . 0.0 110.183 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 56.4 m-20 -74.7 -40.78 61.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.931 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -106.48 24.24 12.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -0.799 . . . . 0.0 109.891 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.887 HD12 ' C ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -106.11 -62.16 1.42 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 -179.867 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.027 HG11 HD13 ' A' ' 38' ' ' ILE . 44.7 t -61.92 -40.88 72.94 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.493 -0.754 . . . . 0.0 111.203 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.6 Cg_endo -78.37 9.28 3.2 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.353 1.186 . . . . 0.0 110.827 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HD2' ' OH ' ' A' ' 150' ' ' TYR . 17.7 mttt -121.87 -28.31 4.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.997 -1.064 . . . . 0.0 109.457 179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.783 HG21 ' HB3' ' A' ' 146' ' ' LEU . 29.0 mt -79.99 -56.86 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.516 -0.74 . . . . 0.0 109.767 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.439 ' HB1' HE21 ' A' ' 36' ' ' GLN . . . -151.62 106.14 2.9 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.476 -0.765 . . . . 0.0 110.085 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.21 1.22 6.91 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.661 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.439 HE21 ' HB1' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -86.54 -9.47 56.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.952 179.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.09 -36.27 9.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 110.187 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.027 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mt -136.49 149.74 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.332 -0.855 . . . . 0.0 110.009 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.542 ' CG ' ' HA2' ' A' ' 59' ' ' GLY . 10.5 mttt -78.9 -50.26 11.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 110.003 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.539 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -173.01 160.11 4.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.452 -0.78 . . . . 0.0 109.977 179.711 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.7 m -119.02 126.63 52.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.143 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -135.64 103.09 5.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 110.379 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 18.9 mt -50.42 131.32 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.3 tp -91.31 -46.55 7.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.253 -0.904 . . . . 0.0 110.218 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.855 ' O ' HG23 ' A' ' 52' ' ' THR . 3.9 mm-40 -132.63 136.97 46.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.246 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.82 -168.41 34.33 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -131.29 12.58 5.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -1.16 . . . . 0.0 110.255 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.507 ' H ' HG21 ' A' ' 52' ' ' THR . . . 122.47 -6.22 9.92 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -84.15 -168.31 43.76 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HA ' ' CG2' ' A' ' 71' ' ' ILE . 43.2 Cg_endo -70.71 135.91 29.27 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.024 1.539 . . . . 0.0 110.501 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.75 -5.49 79.6 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 45' ' ' GLU . 42.8 m -80.1 143.18 34.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -1.115 . . . . 0.0 110.042 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.777 HG21 ' HE3' ' A' ' 68' ' ' LYS . 29.2 mm -110.08 125.46 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.278 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 40.2 mtmt -108.29 139.7 42.62 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.365 -0.835 . . . . 0.0 110.083 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -112.9 89.94 3.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 110.129 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.46 ' CG2' HG12 ' A' ' 38' ' ' ILE . 88.8 mt -83.18 139.04 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.215 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 38' ' ' ILE . 6.7 p -110.27 160.81 16.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.494 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.751 ' HE2' HG13 ' A' ' 67' ' ' VAL . 27.3 m-85 -120.64 124.37 45.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -0.812 . . . . 0.0 110.377 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' HA2' ' CG ' ' A' ' 39' ' ' LYS . . . -66.6 -24.91 72.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -120.85 146.06 46.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -1.154 . . . . 0.0 110.177 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.35 92.13 0.48 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.3 t 48.7 -162.4 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -1.095 . . . . 0.0 110.245 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -53.97 -52.36 60.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.857 . . . . 0.0 110.289 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.443 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 9.2 t80 -135.46 141.83 45.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 110.28 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -127.82 136.7 9.36 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.536 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.9 p90 -179.66 161.19 0.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -1.088 . . . . 0.0 109.989 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.768 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.6 m -143.27 172.38 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 0.0 110.633 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.777 ' HE3' HG21 ' A' ' 53' ' ' ILE . 75.4 tttt -123.65 118.23 26.8 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -110.54 133.58 53.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.989 -1.069 . . . . 0.0 111.379 -178.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.542 ' HA ' HD13 ' A' ' 53' ' ' ILE . 77.1 tttt -111.12 119.23 38.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.563 -0.711 . . . . 0.0 109.218 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.531 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 42.2 mm -53.15 143.83 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 0.0 110.51 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.3 m-20 -117.49 -31.83 5.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.375 -0.828 . . . . 0.0 109.703 179.52 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 72' ' ' ASP . 2.2 p 168.28 157.43 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 110.15 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.102 ' CD1' HG11 ' A' ' 23' ' ' VAL . 4.1 tt -153.59 165.62 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.3 -0.875 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -140.64 83.97 1.92 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.251 -0.906 . . . . 0.0 109.977 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.563 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 85.6 tttt -58.62 -12.53 4.21 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.29 -0.881 . . . . 0.0 110.776 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.42 ' OE1' ' HA ' ' A' ' 77' ' ' GLU . 17.5 mm-40 -85.46 -34.41 21.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.191 -0.943 . . . . 0.0 108.918 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m-80 -109.4 -1.97 18.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.63 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 9.7 m-85 65.95 49.81 1.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.343 0.592 . . . . 0.0 110.449 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.544 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -115.32 157.89 23.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.108 -0.995 . . . . 0.0 109.129 179.19 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.593 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 80.8 t80 -160.02 150.18 18.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.016 -1.052 . . . . 0.0 110.116 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.418 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 9.7 t -160.98 150.52 17.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.94 . . . . 0.0 110.585 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.9 p90 -151.69 -171.13 3.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.51 -0.744 . . . . 0.0 109.871 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.921 HG23 ' O ' ' A' ' 98' ' ' ILE . 54.0 m -132.64 135.91 46.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.364 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.697 HD12 ' HE2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -94.18 116.09 28.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.231 -0.918 . . . . 0.0 110.096 179.765 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.731 HD11 ' HD3' ' A' ' 68' ' ' LYS . 16.7 pt -107.82 -10.54 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.199 -0.938 . . . . 0.0 110.112 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -138.81 126.52 22.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.84 . . . . 0.0 110.044 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.768 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -179.86 145.36 6.44 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 89' ' ' ASP . 44.3 p-10 -65.16 -9.86 26.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -1.143 . . . . 0.0 110.243 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.869 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -78.09 -36.15 48.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 110.19 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.967 HD23 ' HG ' ' A' ' 95' ' ' LEU . 4.1 mt -58.18 -40.66 82.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.396 -0.815 . . . . 0.0 110.337 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 91' ' ' LEU . . . 43.44 -132.33 5.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.664 ' OD1' HG23 ' A' ' 94' ' ' THR . 59.1 p30 -114.12 12.6 17.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.181 -1.188 . . . . 0.0 110.235 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.664 HG23 ' OD1' ' A' ' 93' ' ' ASP . 40.1 p -109.82 -33.15 6.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.967 ' HG ' HD23 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -116.53 159.98 21.3 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.27 -0.894 . . . . 0.0 109.222 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.797 ' O ' HD22 ' A' ' 91' ' ' LEU . 42.0 tt0 -138.53 -78.2 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.979 . . . . 0.0 110.807 -179.307 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 10.8 mttm -80.13 132.76 35.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.476 -0.765 . . . . 0.0 110.7 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.921 ' O ' HG23 ' A' ' 84' ' ' THR . 15.8 mm -118.56 148.63 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.885 -1.134 . . . . 0.0 110.212 179.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.538 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -125.14 125.23 43.38 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.057 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.828 ' CE2' HG21 ' A' ' 98' ' ' ILE . 13.5 m-85 -121.45 134.91 55.09 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.348 -0.845 . . . . 0.0 110.476 -178.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 58.6 tt0 -133.3 160.66 36.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 81' ' ' TYR . 35.9 m -160.92 121.09 2.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 0.4 OUTLIER -120.01 146.98 45.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.333 -179.889 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.555 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 14.7 mt -125.31 151.23 46.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -0.848 . . . . 0.0 110.266 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.708 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.35 -169.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.203 -0.936 . . . . 0.0 110.005 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.708 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -127.02 135.48 50.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 110.16 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.431 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 49.5 p -90.72 163.22 31.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 110.301 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -73.06 -2.87 12.68 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.14 1.6 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.4 p -96.87 -5.02 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 110.3 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.42 -40.46 2.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.26 -172.48 2.02 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -127.99 138.8 52.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -1.174 . . . . 0.0 110.336 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.5 HG12 HG22 ' A' ' 10' ' ' THR . 26.6 mt -89.88 147.36 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.589 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 7.0 mt -130.95 112.96 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.378 -0.826 . . . . 0.0 110.318 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -104.1 122.34 45.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.961 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.48 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 7.4 t -116.49 163.5 15.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.536 HG22 ' NE2' ' A' ' 119' ' ' HIS . 59.6 m -160.01 138.2 10.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 110.228 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.4 m -135.18 148.97 49.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.957 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.834 ' CE1' HG23 ' A' ' 4' ' ' THR . 73.8 m-70 -132.59 168.57 18.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.177 -0.952 . . . . 0.0 110.751 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.903 ' O ' HG13 ' A' ' 2' ' ' VAL . 35.9 m-85 -131.69 145.6 51.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.508 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.496 ' HA ' HG22 ' A' ' 2' ' ' VAL . 92.4 m-70 -126.34 95.01 4.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.129 -0.982 . . . . 0.0 109.956 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.719 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -58.5 154.81 13.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 110.207 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.526 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 57.9 tttt -118.23 111.19 18.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.293 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.62 -115.64 5.0 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -129.84 71.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 110.145 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.573 ' O ' HG21 ' A' ' 122' ' ' THR . 16.9 m -142.72 -179.46 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.719 ' HA ' HG21 ' A' ' 122' ' ' THR . 92.8 mt-10 -154.54 149.33 26.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.194 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.633 HD12 ' H ' ' A' ' 128' ' ' ILE . 4.9 mp -77.91 173.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.943 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.595 ' N ' HG22 ' A' ' 128' ' ' ILE . 33.1 mttt -107.03 129.05 54.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.878 . . . . 0.0 110.251 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.473 ' HB3' ' HE2' ' A' ' 134' ' ' LYS . 97.9 mt-10 -45.69 -44.89 13.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -58.52 -30.98 67.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 109.842 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.869 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 13.4 t-160 -73.7 -53.17 11.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.926 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.171 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.6 p -64.52 -40.14 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.442 -0.787 . . . . 0.0 109.959 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.524 ' N ' HG13 ' A' ' 133' ' ' VAL . 42.7 mtmt -63.61 -43.94 95.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.849 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.02 74.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 109.876 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.43 -30.52 66.74 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.465 ' HD2' ' HB3' ' A' ' 5' ' ' TYR . 3.9 mtpt -74.06 -32.41 63.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -1.099 . . . . 0.0 109.893 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -72.24 -29.78 64.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.38 -0.825 . . . . 0.0 109.884 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.48 -35.86 73.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -0.834 . . . . 0.0 109.883 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.05 -41.18 71.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.968 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.9 t -59.43 -49.86 76.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.367 -0.833 . . . . 0.0 109.92 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -55.06 -42.94 73.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.954 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.472 ' O ' HG13 ' A' ' 147' ' ' ILE . 59.3 mt -60.04 -39.03 84.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 0.0 109.924 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -62.39 -36.11 81.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 110.165 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 89.1 mttt -79.15 -8.88 59.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 110.078 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.783 ' HB3' HG21 ' A' ' 33' ' ' ILE . 13.2 mt -89.49 -37.37 14.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.257 -0.902 . . . . 0.0 108.747 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.746 HD11 ' CE1' ' A' ' 22' ' ' PHE . 32.6 mt -70.68 -44.63 76.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.715 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.537 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 23.5 pt-20 -52.1 -39.73 60.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.214 -0.994 . . . . 0.0 108.809 178.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.535 ' N ' ' HG3' ' A' ' 148' ' ' GLU . 19.8 m -76.25 -33.69 59.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 109.065 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.85 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 73.8 t80 -47.72 -57.93 4.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.585 -0.697 . . . . 0.0 109.901 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.057 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 62.8 mt -67.56 -45.74 74.74 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.437 -0.79 . . . . 0.0 110.709 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.619 ' HB2' HD11 ' A' ' 13' ' ' ILE . 81.9 tttt -58.81 -16.1 15.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 109.602 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.403 ' C ' ' CD2' ' A' ' 154' ' ' HIS . . . -115.21 -24.28 4.23 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.593 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.7 m-70 -119.56 92.84 46.7 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.248 -1.148 . . . . 0.0 110.313 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.61 0.54 7.42 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.049 1.552 . . . . 0.0 110.764 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -115.19 15.25 17.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.147 -0.97 . . . . 0.0 110.045 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.85 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -88.38 103.51 15.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.408 -0.807 . . . . 0.0 110.4 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.129 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 6.4 p90 38.99 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.574 -0.704 . . . . 0.0 112.32 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 28.8 m-20 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 120.457 -1.402 . . . . 0.0 110.132 179.117 . . . . . . . . 1 1 . 1 stop_ save_